Variant and risk allele,P-value,P-value annotation,RAF,OR,Beta,CI,Mapped gene,Reported trait,Trait(s),Study accession,Location
rs7382539-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"VTA1P1, THBS2",Liver disease severity in Alagille syndrome,"Alagille syndrome, liver disease",GCST003616,6:169268903
rs944961-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,'-,Liver disease severity in Alagille syndrome,"Alagille syndrome, liver disease",GCST003616,9:119810618
rs2896019-<b>G</b>,2 x 10-8,,0.46,3.37,'-,[2.21-5.14],PNPLA3,Nonalcoholic steatohepatitis-derived hepatocellular carcinoma,"hepatocellular carcinoma, non-alcoholic steatohepatitis",GCST005309,22:43937814
rs17007417-<b>T</b>,5 x 10-7,,0.17,2.74,'-,[1.85-4.06],'-,Nonalcoholic steatohepatitis-derived hepatocellular carcinoma,"hepatocellular carcinoma, non-alcoholic steatohepatitis",GCST005309,2:71808541
rs2143571-<b>A</b>,9 x 10-7,,0.43,2.7,'-,[1.82-4.0],SAMM50,Nonalcoholic steatohepatitis-derived hepatocellular carcinoma,"hepatocellular carcinoma, non-alcoholic steatohepatitis",GCST005309,22:43995806
rs77236434-<b>T</b>,3 x 10-7,,0.0144,9.87,'-,[3.46-28.16],DLC1,Familial hepatitis B virus-related hepatocellular carcinoma,"hepatitis B virus infection, hepatocellular carcinoma",GCST004736,8:13261659
rs117413665-<b>C</b>,6 x 10-6,,0.8406,4.17,'-,[2.17-8.33],RNA5SP172,Familial hepatitis B virus-related hepatocellular carcinoma,"hepatitis B virus infection, hepatocellular carcinoma",GCST004736,4:177496993
rs35523062-<b>C</b>,7 x 10-6,,0.8297,3.85,'-,[2.08-7.14],LINC02360,Familial hepatitis B virus-related hepatocellular carcinoma,"hepatitis B virus infection, hepatocellular carcinoma",GCST004736,4:11854239
rs4932397-<b>C</b>,7 x 10-6,,0.4964,2.17,'-,[1.56-3.13],"MRPS11, DET1",Familial hepatitis B virus-related hepatocellular carcinoma,"hepatitis B virus infection, hepatocellular carcinoma",GCST004736,15:88493060
rs4437130-<b>?</b>,2 x 10-7,,NR,6.8,'-,[3.3-14.1],RN7SKP144,Thiopurine-induced pancreatitis in inflammatory bowel disease,"pancreatitis, response to thiopurine, inflammatory bowel disease",GCST006208,3:2035283
rs62561366-<b>?</b>,5 x 10-7,,NR,7,'-,[3.3-14.8],PTCH1,Thiopurine-induced pancreatitis in inflammatory bowel disease,"pancreatitis, response to thiopurine, inflammatory bowel disease",GCST006208,9:95555669
rs12465911-<b>A</b>,2 x 10-7,,0.26,2.03,'-,'-,'-,Esophageal adenocarcinoma x gastroesophageal reflux disease interaction,"esophageal adenocarcinoma, gastroesophageal reflux disease",GCST006531,2:150929228
rs2971030-<b>G</b>,6 x 10-7,,0.42,1.77,'-,[NR],'-,Esophageal adenocarcinoma x gastroesophageal reflux disease interaction,"esophageal adenocarcinoma, gastroesophageal reflux disease",GCST006531,7:9966714
rs7141987-<b>G</b>,7 x 10-7,,0.42,1.77,'-,[NR],MEG8,Esophageal adenocarcinoma x gastroesophageal reflux disease interaction,"esophageal adenocarcinoma, gastroesophageal reflux disease",GCST006531,14:101025887
rs4676893-<b>?</b>,8 x 10-12,,NR,'-,0.1139 unit increase,[0.081-0.147],"FOXP1, RNU6-281P",Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST008831,3:70868488
rs11901649-<b>?</b>,1 x 10-7,,NR,'-,0.084 unit increase,[0.053-0.115],APOB,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST008831,2:21027351
rs10940767-<b>?</b>,2 x 10-6,,NR,'-,0.0747 unit decrease,[0.044-0.105],LINC02109,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST008831,5:29001417
rs10392-<b>A</b>,8 x 10-7,,0.1801,1.252,'-,'-,PPP1R16B,Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis,"alcoholic liver cirrhosis, alcohol dependence, alcoholic pancreatitis",GCST004757,20:38922292
rs454510-<b>A</b>,3 x 10-6,,0.02702,1.206,'-,'-,PHGDH,Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis,"alcoholic liver cirrhosis, alcohol dependence, alcoholic pancreatitis",GCST004757,1:119652419
rs2028201-<b>T</b>,5 x 10-6,,0.3763,1.183,'-,'-,SPATS2L,Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis,"alcoholic liver cirrhosis, alcohol dependence, alcoholic pancreatitis",GCST004757,2:200438287
rs2856723-<b>?</b>,3 x 10-43,,'-,2.68,'-,[2.32-3.09],"MTCO3P1, HLA-DQB1",Hepatocellular carcinoma in hepatitis C infection,"hepatitis C virus infection, hepatocellular carcinoma",GCST006037,6:32699985
rs12035735-<b>?</b>,7 x 10-7,,NR,5,'-,[2.7-9.6],LRRC8D,Thiopurine-induced digestive symptoms in inflammatory bowel disease,"digestive system disease, response to thiopurine, inflammatory bowel disease",GCST006210,1:89839786
rs7255-<b>T</b>,9 x 10-11,,'-,1.14,'-,[1.09-1.18],GDF7,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,2:20679060
rs2464469-<b>G</b>,5 x 10-10,,'-,1.12,'-,[1.09-1.18],ALDH1A2,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,15:58069827
rs17451754-<b>G</b>,5 x 10-10,,'-,1.19,'-,[1.12-1.25],CFTR,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,7:117616658
rs17749155-<b>A</b>,5 x 10-10,,'-,1.18,'-,[1.12-1.24],MSRA,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,8:10210563
rs10108511-<b>T</b>,2 x 10-9,,'-,1.12,'-,[1.08-1.16],LINC00208,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,8:11578007
rs2687202-<b>T</b>,2 x 10-9,,'-,1.13,'-,[1.08-1.17],"RNU6-281P, FOXP1",Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,3:70880832
rs1247942-<b>G</b>,2 x 10-9,,'-,1.12,'-,[1.09-1.16],LINC02459,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,12:114235918
rs62423175-<b>A</b>,3 x 10-9,,'-,1.17,'-,[1.11-1.23],MTRNR2L9,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,6:61485463
rs9918259-<b>T</b>,3 x 10-9,,'-,1.2,'-,[1.13-1.27],"CEP72, TPPP",Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,5:662977
rs9257809-<b>A</b>,6 x 10-9,,'-,1.23,'-,[1.14-1.31],OR5V1,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,6:29388554
rs7852462-<b>C</b>,2 x 10-8,,'-,1.12,'-,[1.08-1.16],TMOD1,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,9:97548219
rs139606545-<b>G</b>,2 x 10-8,,'-,1.11,'-,[1.08-1.16],RNU7-147P,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,2:199180316
rs1979654-<b>G</b>,3 x 10-8,,'-,1.11,'-,[1.08-1.16],LINC00917,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,16:86363229
rs199620551-<b>TG</b>,5 x 10-8,,'-,1.11,'-,[1.08-1.15],CRTC1,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST003740,19:18693485
rs4957294-<b>?</b>,8 x 10-13,,NR,'-,0.043 unit increase,NR,TTC33,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),"ulcerative colitis, Crohn's disease",GCST90016611,5:40446447
rs77150043-<b>?</b>,5 x 10-6,,NR,'-,0.028 unit increase,NR,ADCY7,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),"ulcerative colitis, Crohn's disease",GCST90016611,16:50270338
rs2076756-<b>?</b>,5 x 10-29,,NR,'-,0.068 unit increase,NR,NOD2,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),"ulcerative colitis, Crohn's disease",GCST90016611,16:50722970
rs6426833-<b>?</b>,3 x 10-18,,NR,'-,0.053 unit decrease,NR,"OTUD3, RNF186",Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),"ulcerative colitis, Crohn's disease",GCST90016611,1:19845367
rs1977160-<b>?</b>,1 x 10-17,,NR,'-,0.052 unit decrease,NR,"C1orf141, IL23R",Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),"ulcerative colitis, Crohn's disease",GCST90016611,1:67202253
rs2476601-<b>?</b>,3 x 10-9,,NR,'-,0.036 unit increase,NR,PTPN22,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),"ulcerative colitis, Crohn's disease",GCST90016611,1:113834946
rs6704109-<b>?</b>,6 x 10-6,,NR,'-,0.027 unit increase,NR,AIMP1P2,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),"ulcerative colitis, Crohn's disease",GCST90016611,1:172887910
rs3792108-<b>?</b>,4 x 10-17,,NR,'-,0.051 unit increase,NR,ATG16L1,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),"ulcerative colitis, Crohn's disease",GCST90016611,2:233276306
rs2424955-<b>C</b>,1 x 10-7,,0.143,44.03,'-,[NR],BPIFB4,Non-steroidal anti-inflammatory drug-induced enteropathy,"response to non-steroidal anti-inflammatory, small intestine enteropathy",GCST007258,20:33105621
rs2920283-<b>T</b>,2 x 10-13,,0.388,'-,0.633 unit decrease,[0.33-0.93],"JRK, PSCA",Severe gastric atrophy,atrophic gastritis,GCST008713,8:142675619
rs2294008-<b>C</b>,4 x 10-11,,0.389,'-,0.426 unit decrease,[0.26-0.6],"JRK, PSCA",Gastric atrophy,atrophic gastritis,GCST008714,8:142680513
rs4822112-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,TCF20,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,22:42335534
chr11:124744005-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,Mapping not available
chr13:28365664-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,Mapping not available
chr13:82687564-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,Mapping not available
rs3181382-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,ADCY4,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,14:24320104
chr16:60394055-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,Mapping not available
rs9927732-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,BANP,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,16:88043118
rs2017027-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,KIAA1328,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,18:37225231
chr18:39130032-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,Mapping not available
chr2:4838394-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,Mapping not available
rs61329746-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,"RN7SKP112, RNF144A",Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,2:7089647
rs62176284-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,2:217064297
chr3:8801391-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,Mapping not available
rs9310398-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,SYN2,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,3:12015255
rs11719409-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,"RNU6-1270P, CCDC75P1",Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,3:73189542
rs62278738-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,3:161954571
rs186049-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,MCTP1,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,5:94937747
rs6939601-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,TIAM2,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,6:155222857
rs9648634-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,GAPDHP68,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,7:9545334
rs56402448-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,SLC37A3,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,7:140387149
chr8:15436629-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,Mapping not available
rs58578562-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,ADAM28,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,8:24323415
rs2955885-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,IDO2,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,8:40008298
rs10505232-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,CARS1P2,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,8:114878275
rs60140289-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,RPS20P25,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,9:81314691
rs17694839-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,MACROD2,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,20:15609842
rs35198725-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"SRSF6, Y_RNA",Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,20:43455408
chr10:15127366-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,Mapping not available
chr10:23702385-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,'-,Surgical necrotising enterocolitis in extremely premature birth,"necrotizing enterocolitis, premature birth",GCST005800,Mapping not available
rs6571631-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,NDRG2,Pediatric nonalcoholic steatohepatitis,non-alcoholic steatohepatitis,GCST004943,14:21063674
rs6660749-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,'-,Pediatric nonalcoholic steatohepatitis,non-alcoholic steatohepatitis,GCST004943,1:34349852
rs2327990-<b>T</b>,3 x 10-10,(Cox proportional hazards regression model),NR,21.97,'-,[8.42-57.33],PPIAP17,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,20:16208618
rs11918092-<b>C</b>,5 x 10-9,(Cox proportional hazards regression model),NR,216.98,'-,[35.64-1321.13],"RNA5SP141, EPHB1",Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,3:134794514
rs2366964-<b>C</b>,5 x 10-9,(Cox proportional hazards regression model),NR,41.19,'-,[11.81-143.66],FHIT,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,3:59944946
rs7582977-<b>C</b>,6 x 10-9,(Cox proportional hazards regression model),NR,134.32,'-,[25.76-700.33],"CIR1, SP9",Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,2:174340785
rs9534678-<b>A</b>,6 x 10-9,(Cox proportional hazards regression model),NR,133.6,'-,[25.62-696.59],RN7SL700P,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,13:47544647
rs13402783-<b>G</b>,7 x 10-9,(Cox proportional hazards regression model),NR,20.91,'-,[7.47-58.50],ATOH8,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,2:85787998
rs11692570-<b>T</b>,8 x 10-9,(Cox proportional hazards regression model),NR,34.43,'-,[10.35-114.58],MIR7515HG,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,2:6637860
rs9285673-<b>C</b>,2 x 10-8,(Cox proportional hazards regression model),NR,36.7,'-,[10.53-127.95],ADRB2,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,5:148793365
rs17201864-<b>T</b>,2 x 10-8,(Cox proportional hazards regression model),NR,19.06,'-,[6.86-52.98],HAPLN3,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,15:88877743
rs1372330-<b>A</b>,2 x 10-8,(Cox proportional hazards regression model),NR,36.51,'-,[10.47-127.34],ASTN2,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,9:116757309
rs1145724-<b>G</b>,2 x 10-8,(Cox proportional hazards regression model),NR,30.76,'-,[9.27-102.03],MAP3K7,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,6:90477791
rs17082301-<b>A</b>,3 x 10-8,(Cox proportional hazards regression model),NR,129.98,'-,[23.29-725.52],SCFD2,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,4:53026989
rs10920654-<b>T</b>,3 x 10-8,(Cox proportional hazards regression model),NR,76.85,'-,[16.51-357.84],BRINP3,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,1:190162620
rs1023741-<b>C</b>,4 x 10-8,(Cox proportional hazards regression model),NR,18.64,'-,[6.57-52.84],PIK3AP1,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,10:96663139
rs1426107-<b>A</b>,4 x 10-8,(Cox proportional hazards regression model),NR,28.08,'-,[8.53-92.45],'-,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,4:14294676
rs3861289-<b>A</b>,5 x 10-8,(Cox proportional hazards regression model),NR,19.16,'-,[6.62-55.40],RIT2,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,18:43111710
rs4239258-<b>T</b>,6 x 10-8,(Cox proportional hazards regression model),NR,98.28,'-,[18.72-515.88],POLR2A,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,17:7493724
rs5749032-<b>G</b>,8 x 10-9,"(Recessive, Mixture cure model)",NR,9.55,'-,[4.44-20.55],"CECR9, CECR3",Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,22:17313079
rs12949587-<b>?</b>,1 x 10-8,"(Co-Dominant, Mixture cure model)",NR,7.92,'-,[3.88-16.16],RBFOX3,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,17:79365094
rs6110524-<b>?</b>,2 x 10-8,"(Co-Dominant, Mixture cure model)",NR,7.56,'-,[3.75-15.27],MACROD2,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,20:15130492
rs3815652-<b>T</b>,2 x 10-8,"(Recessive, Mixture cure model)",NR,20.75,'-,[7.20-59.80],BBS9,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,7:33873792
rs756055-<b>C</b>,3 x 10-8,"(Recessive, Mixture cure model)",NR,13.39,'-,[5.37-33.43],"DEGS2, YY1",Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,14:100224841
rs7153665-<b>A</b>,3 x 10-8,"(Recessive, Mixture cure model)",NR,13.39,'-,[5.37-33.44],YY1,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,14:100264583
rs4754687-<b>A</b>,3 x 10-8,"(Recessive, Mixture cure model)",NR,13.33,'-,[5.34-33.28],RN7SL222P,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,11:100559322
rs2163746-<b>C</b>,5 x 10-8,"(Dominant, Mixture cure model)",NR,6.45,'-,[3.29-12.63],SGCD,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,5:155918211
rs17053011-<b>T</b>,5 x 10-8,"(Dominant, Mixture cure model)",NR,6.45,'-,[3.29-12.64],SGCD,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),"metastasis measurement, metastatic colorectal cancer, disease progression measurement",GCST007434,5:155934106
rs10786560-<b>G</b>,4 x 10-6,(conditioned on lead SNPs in LD),0.762,1.05,'-,[1.03-1.08],"NKX2-3, SLC25A28",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,10:99555409
rs10849433-<b>C</b>,1 x 10-8,,0.267,1.06,'-,[1.04-1.08],"ATP5MFP5, PLEKHG6",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:6297738
rs116353863-<b>C</b>,9 x 10-9,,0.0165,1.2,'-,[1.13-1.27],"MUC22, HCG22",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,6:31042408
rs116685461-<b>G</b>,3 x 10-6,,0.8755,1.06,'-,[1.04-1.09],"LINC02571, HLA-B",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,6:31347735
rs117079142-<b>A</b>,2 x 10-16,,0.0432,1.19,'-,[1.14-1.24],UTP23,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,8:116778675
rs11884596-<b>C</b>,1 x 10-9,,0.3823,1.06,'-,[1.04-1.08],'-,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,2:198747683
rs12217641-<b>C</b>,8 x 10-6,(conditioned on lead SNPs in LD),0.6981,1.05,'-,[1.03-1.07],"RNA5SP299, CHCHD3P1",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,10:8621912
rs12447408-<b>A</b>,7 x 10-7,,0.2535,1.05,'-,[1.03-1.07],"LINC01081, LINC01082",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,16:86218938
rs1250567-<b>C</b>,3 x 10-8,,0.4405,1.05,'-,[1.03-1.07],ZMIZ1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,10:79286508
rs12594720-<b>C</b>,5 x 10-7,,0.7218,1.05,'-,[1.03-1.07],SMAD6,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,15:66714680
rs12708491-<b>G</b>,4 x 10-15,,0.5872,1.07,'-,[1.05-1.09],"GREM1, SCG5",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,15:32700635
rs13086367-<b>A</b>,7 x 10-8,,0.5262,1.05,'-,[1.03-1.07],"LINC02044, BOC",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,3:113185041
rs13204733-<b>G</b>,2 x 10-7,(conditioned on lead SNPs in LD),0.141,1.07,'-,[1.04-1.10],BMP5,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,6:55701310
rs1427760-<b>C</b>,3 x 10-7,,0.5268,1.05,'-,[1.03-1.06],"Y_RNA, TBX3",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:114662909
rs17816465-<b>A</b>,7 x 10-9,,0.2055,1.07,'-,[1.04-1.09],FMN1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,15:32864185
rs1924816-<b>A</b>,6 x 10-7,,0.7737,1.05,'-,[1.03-1.08],LINC00393,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,13:73423824
rs2293581-<b>A</b>,9 x 10-40,,0.2116,1.15,'-,[1.13-1.17],GREM1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,15:32718535
rs2516420-<b>C</b>,1 x 10-7,,0.9263,1.1,'-,[1.06-1.13],MICB-DT,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,6:31481843
rs28488-<b>T</b>,3 x 10-11,,0.6388,1.06,'-,[1.04-1.08],BMP2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:6781574
rs3217874-<b>T</b>,1 x 10-17,,0.4282,1.08,'-,[1.06-1.10],CCND2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:4291642
rs373585858-<b>A</b>,7 x 10-6,,0.0016,2,'-,[1.48-2.70],HEXD,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,17:82436680
rs4313119-<b>G</b>,1 x 10-9,,0.7486,1.06,'-,[1.04-1.08],CASC8,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,8:127559610
rs45597035-<b>A</b>,3 x 10-9,,0.6506,1.06,'-,[1.04-1.08],KLF5,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,13:73075014
rs4901473-<b>G</b>,5 x 10-10,,0.378,1.06,'-,[1.04-1.08],"ATP5F1CP1, BMP4",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,14:53978439
rs556532366-<b>T</b>,9 x 10-6,(conditioned on lead SNPs in LD),0.0029,1.6,'-,[1.30-1.97],PLCB1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:8587424
rs55864876-<b>G</b>,3 x 10-6,,0.9184,1.08,'-,[1.05-1.12],ARHGAP42,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,11:100846405
rs6067417-<b>C</b>,4 x 10-11,,0.5635,1.06,'-,[1.04-1.08],"LINC01271, RN7SL636P",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:50367160
rs6091189-<b>T</b>,2 x 10-7,,0.1529,1.07,'-,[1.04-1.09],RIPOR3,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:50639748
rs61389091-<b>C</b>,1 x 10-18,,0.9606,1.23,'-,[1.18-1.29],CHRDL2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,11:74716876
rs6469654-<b>C</b>,4 x 10-8,(conditioned on lead SNPs in LD),0.7712,1.07,'-,[1.04-1.10],EIF3H,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,8:116620726
rs7013278-<b>T</b>,2 x 10-56,,0.3761,1.15,'-,[1.13-1.17],"PCAT1, CASC8, POU5F1B",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,8:127402647
rs73975586-<b>A</b>,2 x 10-11,,0.8732,1.09,'-,[1.07-1.12],NXN,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,17:911003
rs745213-<b>G</b>,3 x 10-6,,0.8102,1.05,'-,[1.03-1.08],MAP2K5,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,15:67768051
rs7708610-<b>A</b>,4 x 10-9,(conditioned on lead SNPs in LD),0.3564,1.06,'-,[1.04-1.08],KRT18P56,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,5:40102341
rs78368589-<b>T</b>,9 x 10-12,,0.0597,1.14,'-,[1.10-1.18],SLC6A18,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,5:1240089
rs7946853-<b>C</b>,3 x 10-6,(conditioned on lead SNPs in LD),0.8624,1.06,'-,[1.04-1.09],CHRDL2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,11:74698032
rs80077929-<b>T</b>,6 x 10-6,,0.1107,1.07,'-,[1.04-1.10],"ZNF619P1, TTC4P1",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,7:46054491
rs8020436-<b>A</b>,5 x 10-11,,0.4016,1.06,'-,[1.04-1.08],LINC01500,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,14:58741719
rs994308-<b>C</b>,5 x 10-18,,0.5939,1.08,'-,[1.06-1.10],CASC20,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:6622975
rs11087784-<b>G</b>,3 x 10-13,,0.1523,1.09,'-,[1.07-1.12],'-,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:7760329
rs11190164-<b>G</b>,7 x 10-15,,0.2626,1.08,'-,[1.06-1.10],"SLC25A28, NKX2-3",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,10:99591947
rs11196170-<b>A</b>,3 x 10-7,,0.2178,1.06,'-,[1.03-1.08],TCF7L2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,10:112962862
rs11255841-<b>T</b>,2 x 10-21,,0.703,1.09,'-,[1.07-1.12],RNA5SP299,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,10:8697617
rs12149163-<b>T</b>,5 x 10-9,,0.4976,1.05,'-,[1.03-1.07],"LINC00917, LINC01081",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,16:86305709
rs12246635-<b>C</b>,5 x 10-12,,0.0983,1.1,'-,[1.07-1.14],VTI1A,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,10:112528860
rs12514517-<b>A</b>,4 x 10-21,,0.288,1.1,'-,[1.08-1.12],RNU1-150P,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,5:40279974
rs16892766-<b>C</b>,4 x 10-32,,0.0829,1.2,'-,[1.17-1.24],EIF3H,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,8:116618444
rs189583-<b>G</b>,1 x 10-22,,0.3298,1.1,'-,[1.08-1.12],CASC20,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:6395810
rs2250430-<b>T</b>,3 x 10-10,,0.7095,1.07,'-,[1.04-1.09],PLEKHG6,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:6312008
rs2735940-<b>G</b>,5 x 10-25,,0.4952,1.09,'-,[1.08-1.11],"MIR4457, TERT",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,5:1296371
rs3217810-<b>T</b>,4 x 10-19,,0.1253,1.13,'-,[1.10-1.17],CCND2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:4279105
rs35107139-<b>C</b>,2 x 10-22,,0.4235,1.09,'-,[1.07-1.11],BMP4,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,14:53952388
rs35808169-<b>C</b>,2 x 10-11,,0.1721,1.08,'-,[1.06-1.11],CCND2-AS1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:4259441
rs4813802-<b>G</b>,7 x 10-14,,0.3561,1.07,'-,[1.05-1.09],LINC01713,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:6718948
rs4968127-<b>G</b>,1 x 10-12,,0.3684,1.07,'-,[1.05-1.09],NXN,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,17:906403
rs6063514-<b>C</b>,8 x 10-13,,0.6086,1.07,'-,[1.05-1.09],"COX6CP2, RN7SL636P",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:50438781
rs62042090-<b>T</b>,5 x 10-6,,0.2164,1.05,'-,[1.03-1.07],"LINC02188, FOXL1",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,16:86670343
rs62404966-<b>C</b>,3 x 10-9,,0.7623,1.06,'-,[1.04-1.09],BMP5,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,6:55847326
rs6983267-<b>G</b>,3 x 10-64,,0.5228,1.16,'-,[1.14-1.18],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,8:127401060
rs704017-<b>G</b>,5 x 10-18,,0.5846,1.08,'-,[1.06-1.10],ZMIZ1-AS1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,10:79059375
rs7121958-<b>G</b>,1 x 10-20,,0.5105,1.08,'-,[1.07-1.10],POLD3,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,11:74568967
rs7300312-<b>C</b>,8 x 10-14,,0.5719,1.07,'-,[1.05-1.09],'-,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:115453117
rs10821907-<b>C</b>,5 x 10-10,,0.8276,1.08,'-,[1.05-1.10],"MIX23P2, A1CF",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,10:50888694
rs11874392-<b>A</b>,4 x 10-74,,0.545,1.17,'-,[1.15-1.19],SMAD7,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,18:48926786
rs12372718-<b>G</b>,2 x 10-23,,0.3924,1.09,'-,[1.07-1.11],ATF1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:50777307
rs13149359-<b>A</b>,1 x 10-8,,0.3663,1.05,'-,[1.03-1.07],'-,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,4:94017467
rs16878812-<b>A</b>,4 x 10-8,,0.8861,1.08,'-,[1.05-1.11],FKBP5,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,6:35601785
rs16969681-<b>T</b>,1 x 10-13,,0.0937,1.11,'-,[1.08-1.14],"SCG5, GREM1",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,15:32700910
rs17011141-<b>G</b>,6 x 10-16,,0.2087,1.09,'-,[1.07-1.12],LINC02257,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,1:221939292
rs1741640-<b>C</b>,1 x 10-26,,0.7652,1.12,'-,[1.10-1.15],LAMA5,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:62357358
rs174533-<b>G</b>,1 x 10-11,,0.6739,1.07,'-,[1.05-1.09],"MYRF, TMEM258",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,11:61781553
rs1963413-<b>A</b>,1 x 10-6,,0.6119,1.05,'-,[1.03-1.06],TMEM91,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,19:41365668
rs28840750-<b>T</b>,4 x 10-23,,0.948,1.21,'-,[1.17-1.26],RHPN2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,19:33029021
rs3087967-<b>T</b>,2 x 10-31,,0.2911,1.12,'-,[1.10-1.14],C11orf53,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,11:111286111
rs3133285-<b>G</b>,6 x 10-10,,0.8209,1.07,'-,[1.05-1.10],EIF3H,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,8:116617172
rs10049390-<b>A</b>,4 x 10-9,,0.7228,1.06,'-,[1.04-1.08],SLCO2A1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,3:133982275
rs1078643-<b>A</b>,7 x 10-12,,0.7589,1.08,'-,[1.05-1.10],"TMEM220-AS1, TMEM238L",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,17:10803924
rs10980628-<b>C</b>,3 x 10-9,,0.2097,1.07,'-,[1.04-1.09],LPAR1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,9:110909123
rs11610543-<b>G</b>,1 x 10-9,,0.5139,1.05,'-,[1.04-1.07],LINC02450,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:42740389
rs11727676-<b>C</b>,3 x 10-8,,0.0946,1.09,'-,[1.06-1.12],HHIP,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,4:144737912
rs12144319-<b>C</b>,3 x 10-11,,0.2722,1.07,'-,[1.05-1.09],TTC22,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,1:54780362
rs1391441-<b>A</b>,2 x 10-8,,0.66,1.05,'-,[1.03-1.07],TET2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,4:105207603
rs145364999-<b>T</b>,6 x 10-9,,0.9971,1.74,'-,[1.45-2.10],CHD1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,5:98870378
rs1537372-<b>G</b>,1 x 10-8,,0.5612,1.05,'-,[1.03-1.07],CDKN2B-AS1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,9:22103184
rs2738783-<b>T</b>,5 x 10-8,,0.2109,1.06,'-,[1.04-1.08],"RTEL1-TNFRSF6B, RTEL1",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:63677259
rs34405347-<b>T</b>,3 x 10-8,,0.9002,1.09,'-,[1.05-1.12],"COL15A1, NME2P3",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,9:98917470
rs34797592-<b>T</b>,4 x 10-10,,0.1153,1.09,'-,[1.06-1.12],KLF2-DT,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,19:16306387
rs4360494-<b>G</b>,4 x 10-9,,0.4654,1.05,'-,[1.04-1.07],"RNU6-510P, SF3A3",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,1:37990219
rs448513-<b>C</b>,4 x 10-8,,0.3385,1.05,'-,[1.03-1.07],TANC1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,2:159108040
rs4759277-<b>A</b>,9 x 10-9,,0.3442,1.05,'-,[1.04-1.07],LRP1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:57139907
rs6031311-<b>T</b>,7 x 10-9,,0.7639,1.06,'-,[1.04-1.08],TOX2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:44037835
rs73068325-<b>T</b>,4 x 10-8,,0.1815,1.07,'-,[1.04-1.09],"MZF1, MZF1-AS1",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,19:58567729
rs7333607-<b>G</b>,6 x 10-13,,0.2285,1.08,'-,[1.06-1.10],'-,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,Mapping not available
rs8000189-<b>T</b>,2 x 10-9,,0.64,1.06,'-,[1.04-1.08],COL4A2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,13:110423534
rs983318-<b>A</b>,6 x 10-9,,0.2451,1.06,'-,[1.04-1.08],LINC00511,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,17:72417112
rs9930005-<b>C</b>,2 x 10-8,,0.4381,1.05,'-,[1.03-1.07],'-,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,16:80009361
rs35470271-<b>G</b>,1 x 10-16,,0.154,1.1,'-,[1.08-1.13],'-,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,3:40873748
rs3731861-<b>T</b>,2 x 10-11,,0.6295,1.06,'-,[1.04-1.08],PNKD,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,2:218326533
rs377429877-<b>C</b>,3 x 10-7,,0.6117,1.05,'-,[1.03-1.07],'-,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,13:33518028
rs4976270-<b>C</b>,5 x 10-15,,0.5501,1.07,'-,[1.05-1.09],C5orf66,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,5:135131530
rs55990915-<b>A</b>,2 x 10-6,,0.131,1.07,'-,[1.04-1.09],NOS1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:117325504
rs58658771-<b>A</b>,6 x 10-37,,0.1937,1.15,'-,[1.13-1.18],"GREM1, SCG5",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,15:32709533
rs597808-<b>G</b>,3 x 10-16,,0.5166,1.08,'-,[1.06-1.10],ATXN2,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,12:111535554
rs6058093-<b>C</b>,3 x 10-7,,0.4942,1.05,'-,[1.03-1.06],PIGU,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:34625392
rs6066825-<b>A</b>,6 x 10-15,,0.6448,1.07,'-,[1.06-1.09],PREX1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,20:48723580
rs6678517-<b>A</b>,2 x 10-16,,0.5898,1.08,'-,[1.06-1.09],LAMC1,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,1:183033504
rs6781752-<b>A</b>,7 x 10-8,,0.205,1.06,'-,[1.04-1.08],SLC25A26,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,3:66314739
rs7160450-<b>T</b>,4 x 10-10,,0.3778,1.06,'-,[1.04-1.08],"BMP4, ATP5F1CP1",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,14:53990513
rs755229494-<b>G</b>,2 x 10-12,,0.0011,1.87,'-,[1.57-2.23],APC,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,5:112761654
rs9470361-<b>A</b>,9 x 10-8,,0.2488,1.06,'-,[1.03-1.08],"Y_RNA, RNU1-88P",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,6:36655602
rs9876206-<b>C</b>,8 x 10-6,,0.7507,1.05,'-,[1.03-1.07],LRRC34,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,3:169799648
rs9924886-<b>A</b>,3 x 10-8,,0.7321,1.06,'-,[1.04-1.08],CDH3,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,16:68710036
rs12672022-<b>T</b>,3 x 10-8,,0.8387,1.07,'-,[1.04-1.09],"TBRG4, NACAD",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,7:45096824
rs17094983-<b>G</b>,5 x 10-11,,0.8809,1.09,'-,[1.06-1.12],LINC01500,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,14:58722643
rs2186607-<b>T</b>,1 x 10-9,,0.5071,1.05,'-,[1.04-1.07],TRPC6,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,11:101785666
rs56324967-<b>C</b>,1 x 10-13,,0.6602,1.07,'-,[1.05-1.09],SMAD3,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,15:67110486
rs72942485-<b>G</b>,2 x 10-8,,0.9781,1.19,'-,[1.12-1.26],BOC,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,3:113280713
rs75954926-<b>G</b>,3 x 10-18,,0.647,1.09,'-,[1.07-1.11],'-,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,Mapping not available
rs78341008-<b>C</b>,3 x 10-10,,0.0692,1.12,'-,[1.08-1.16],"RNU4-10P, RNY1P8",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,13:73217417
rs9271695-<b>G</b>,1 x 10-13,,0.8044,1.09,'-,[1.07-1.12],"HLA-DQA1, HLA-DRB1",Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,6:32625303
rs983402-<b>T</b>,8 x 10-12,,0.3151,1.07,'-,[1.05-1.09],PKP4,Colorectal cancer or advanced adenoma,"colorectal cancer, colorectal adenoma",GCST007856,2:198916862
rs17112758-<b>A</b>,2 x 10-6,,0.174,1.29,'-,[NR],'-,Irritable bowel syndrome,irritable bowel syndrome,GCST006535,1:55758307
rs72987295-<b>A</b>,3 x 10-6,,0.246,1.67,'-,[NR],S1PR1,Irritable bowel syndrome,irritable bowel syndrome,GCST006535,1:101158974
rs7427882-<b>?</b>,5 x 10-6,,0.752,1.2987013,'-,[NR],RBMS3,Irritable bowel syndrome,irritable bowel syndrome,GCST006535,3:30043731
rs2366846-<b>A</b>,5 x 10-6,,0.177,1.4,'-,[NR],FHIT,Irritable bowel syndrome,irritable bowel syndrome,GCST006535,3:59720168
rs7802995-<b>?</b>,4 x 10-6,,0.774,1.3888888,'-,[NR],STK17A,Irritable bowel syndrome,irritable bowel syndrome,GCST006535,7:43605834
rs6973126-<b>C</b>,3 x 10-6,,0.486,1.22,'-,[NR],ASB4,Irritable bowel syndrome,irritable bowel syndrome,GCST006535,7:95501905
rs10424110-<b>G</b>,5 x 10-6,,0.273,1.66,'-,[NR],FAM187B2P,Irritable bowel syndrome,irritable bowel syndrome,GCST006535,19:35232920
rs4970469-<b>G</b>,1 x 10-6,,0.9,1.52,'-,[1.29-1.81],OSTCP2,Aggressive periodontitis,aggressive periodontitis,GCST004303,1:26986325
rs1122900-<b>A</b>,8 x 10-7,,0.4,1.27,'-,[1.16-1.40],SLC1A3,Aggressive periodontitis,aggressive periodontitis,GCST004303,5:36689079
rs2070901-<b>T</b>,4 x 10-6,,0.24,1.29,'-,[1.16-1.44],FCER1G,Aggressive periodontitis,aggressive periodontitis,GCST004303,1:161215268
rs2978951-<b>A</b>,2 x 10-7,,0.41,1.29,'-,[1.17-1.42],"DEFA9P, DEFA10P",Aggressive periodontitis,aggressive periodontitis,GCST004303,8:6965773
rs4284742-<b>G</b>,1 x 10-6,,0.76,1.34,'-,[1.19-1.50],SIGLEC5,Aggressive periodontitis,aggressive periodontitis,GCST004303,19:51628480
rs11644916-<b>?</b>,4 x 10-6,,'-,1.4,'-,[1.20-1.59],AXIN1,Metastatic colorectal cancer survival in treatment with chemotherapy plus biologics,"metastatic colorectal cancer, survival time, response to antineoplastic agent",GCST011584,16:309567
rs11246159-<b>?</b>,6 x 10-6,,'-,1.47,'-,[1.24-1.75],ANO9,Metastatic colorectal cancer survival in treatment with chemotherapy plus biologics,"metastatic colorectal cancer, survival time, response to antineoplastic agent",GCST011584,11:436461
rs12882491-<b>C</b>,1 x 10-7,(Chilean Latinos),0.69,1.4,'-,[1.20-1.60],TRAF3,Gallstone disease,gallstones,GCST007050,14:102816936
rs11887534-<b>C</b>,3 x 10-8,(Chilean Latinos),0.14,1.74,'-,[1.45-2.02],ABCG8,Gallstone disease,gallstones,GCST007050,2:43839108
rs1800961-<b>?</b>,6 x 10-26,,'-,1.29,'-,[1.23-1.35],HNF4A,Gallstone disease,gallstones,GCST007209,20:44413724
rs28929474-<b>?</b>,2 x 10-17,,'-,1.33,'-,[1.25-1.42],'-,Gallstone disease,gallstones,GCST007209,Mapping not available
rs56398830-<b>?</b>,2 x 10-12,,'-,1.36,'-,[1.25-1.49],SLC10A2,Gallstone disease,gallstones,GCST007209,13:103049340
rs2291428-<b>?</b>,2 x 10-27,,'-,1.12,'-,[1.10-1.15],MARCHF8,Gallstone disease,gallstones,GCST007209,10:45463408
rs2290846-<b>?</b>,5 x 10-27,,'-,1.12,'-,[1.09-1.14],LRBA,Gallstone disease,gallstones,GCST007209,4:150277928
rs601338-<b>?</b>,9 x 10-22,,'-,1.098901,'-,[1.08-1.11],FUT2,Gallstone disease,gallstones,GCST007209,19:48703417
rs708686-<b>?</b>,7 x 10-20,,'-,1.26,'-,[1.20-1.32],"FUT3, FUT6",Gallstone disease,gallstones,GCST007209,19:5840608
rs34851490-<b>?</b>,4 x 10-15,,'-,1.12,'-,[1.09-1.16],"IRF2BP1, FOXA3",Gallstone disease,gallstones,GCST007209,19:45881296
rs1169288-<b>?</b>,2 x 10-14,,'-,1.0869565,'-,[1.06-1.1],"HNF1A-AS1, HNF1A",Gallstone disease,gallstones,GCST007209,12:120978847
rs13280055-<b>?</b>,7 x 10-14,,'-,1.11,'-,[1.08-1.14],"GATA4, LINC00208",Gallstone disease,gallstones,GCST007209,8:11664844
rs174567-<b>?</b>,2 x 10-12,,'-,1.07,'-,[1.05-1.09],"FADS1, FADS2",Gallstone disease,gallstones,GCST007209,11:61825533
rs11012737-<b>?</b>,4 x 10-12,,'-,1.07,'-,[1.05-1.10],MLLT10,Gallstone disease,gallstones,GCST007209,10:21560840
rs2469991-<b>?</b>,9 x 10-12,,'-,1.0752687,'-,[1.05-1.1],"CCN3, MIR548AZ",Gallstone disease,gallstones,GCST007209,8:119335236
rs1935-<b>?</b>,9 x 10-12,,'-,1.07,'-,[1.05-1.09],JMJD1C,Gallstone disease,gallstones,GCST007209,10:63168063
rs17240268-<b>?</b>,6 x 10-11,,'-,1.1111112,'-,[1.08-1.15],ANPEP,Gallstone disease,gallstones,GCST007209,15:89804583
rs12004-<b>?</b>,1 x 10-10,,'-,1.07,'-,[1.04-1.09],KDELR3,Gallstone disease,gallstones,GCST007209,22:38481456
rs11641445-<b>?</b>,4 x 10-10,,'-,1.06,'-,[1.04-1.09],LITAF,Gallstone disease,gallstones,GCST007209,16:11545628
rs17138478-<b>?</b>,5 x 10-10,,'-,1.09,'-,[1.06-1.12],HNF1B,Gallstone disease,gallstones,GCST007209,17:37713312
rs2292553-<b>?</b>,1 x 10-8,,'-,1.0526316,'-,[1.03-1.08],"PNKD, TMBIM1",Gallstone disease,gallstones,GCST007209,2:218282080
rs12968116-<b>?</b>,1 x 10-8,,'-,1.0869565,'-,[1.05-1.11],ATP8B1,Gallstone disease,gallstones,GCST007209,18:57655270
rs12633863-<b>?</b>,4 x 10-30,,'-,1.11,'-,[1.09-1.13],TM4SF4,Gallstone disease,gallstones,GCST007209,3:149493725
rs11887534-<b>?</b>,1 x 10-353,,'-,1.94,'-,[1.88-2.08],ABCG8,Gallstone disease,gallstones,GCST007209,2:43839108
rs212100-<b>?</b>,2 x 10-31,,'-,1.1627907,'-,[1.14-1.2],SULT2A1,Gallstone disease,gallstones,GCST007209,19:47873738
rs4148808-<b>?</b>,9 x 10-28,,'-,1.1627907,'-,[1.14-1.19],ABCB4,Gallstone disease,gallstones,GCST007209,7:87476479
rs6471717-<b>?</b>,1 x 10-25,,'-,1.11,'-,[1.09-1.13],"UBXN2B, CYP7A1",Gallstone disease,gallstones,GCST007209,8:58464798
rs686030-<b>?</b>,2 x 10-20,,'-,1.1363636,'-,[1.11-1.18],TTC39B,Gallstone disease,gallstones,GCST007209,9:15304784
rs1260326-<b>?</b>,2 x 10-16,,'-,1.0752687,'-,[1.06-1.1],'-,Gallstone disease,gallstones,GCST007209,Mapping not available
rs2070959-<b>?</b>,9 x 10-11,,'-,1.07,'-,[1.05-1.09],"UGT1A6, UGT1A9, UGT1A8, UGT1A7, UGT1A10",Gallstone disease,gallstones,GCST007209,2:233693545
rs4498834-<b>C</b>,2 x 10-16,,0.43,1.4,'-,[1.29-1.52],CACNA1S,Tooth agenesis,tooth agenesis,GCST005389,1:201111170
rs35822372-<b>T</b>,6 x 10-15,,0.21,1.44,'-,[1.31-1.57],"RPL38P6, FOXI3",Tooth agenesis,tooth agenesis,GCST005389,2:88438931
rs2034604-<b>T</b>,8 x 10-16,,0.527,1.36,'-,[1.26-1.47],ARHGAP15,Tooth agenesis,tooth agenesis,GCST005389,2:143201176
rs121908120-<b>A</b>,2 x 10-40,,0.026,3.25,'-,[2.74-3.85],WNT10A,Tooth agenesis,tooth agenesis,GCST005389,2:218890289
rs917412-<b>T</b>,6 x 10-10,,0.092,1.6,'-,[1.38-1.86],"RPSAP34, LEF1-AS1",Tooth agenesis (mandibular second premolars),tooth agenesis,GCST005390,4:108350621
rs35956082-<b>A</b>,1 x 10-11,,0.748,1.92,'-,[1.59-2.32],FOXP1,Tooth agenesis (maxillary lateral incisors),tooth agenesis,GCST005391,3:71414748
rs55846652-<b>T</b>,5 x 10-12,,0.672,1.83,'-,[1.54-2.17],"EDA, FAM155B",Tooth agenesis (maxillary lateral incisors),tooth agenesis,GCST005391,X:69564858
rs758468472-<b>G</b>,3 x 10-8,,0.0004,27.4,'-,[8.47-88.7],NOL11,Tooth agenesis (maxillary second premolars),tooth agenesis,GCST005392,17:67718094
rs3761980-<b>C</b>,9 x 10-8,(Type 2 diabetes),NR,'-,'-,'-,"SLC26A8, MAPK14",Foot ulcer in diabetes and neuropathy,"type I diabetes mellitus, diabetic foot, type II diabetes mellitus, neuropathy",GCST004724,6:36026129
rs80028505-<b>T</b>,3 x 10-8,,0.09,1.71,'-,[1.41-2.06],MAPK14,Foot ulcer in diabetes and neuropathy,"type I diabetes mellitus, diabetic foot, type II diabetes mellitus, neuropathy",GCST004724,6:36030611
rs71597855-<b>?</b>,1 x 10-7,,NR,2.678,'-,[1.856-3.863],LNX1,Foot ulcer and neuropathy in diabetes,"type I diabetes mellitus, diabetic foot, type II diabetes mellitus, neuropathy",GCST004725,4:53790270
rs11154178-<b>?</b>,2 x 10-7,,NR,1.37,'-,[1.22-1.55],TRDN,Foot ulcer and neuropathy in diabetes,"type I diabetes mellitus, diabetic foot, type II diabetes mellitus, neuropathy",GCST004725,6:123540174
rs28485846-<b>?</b>,4 x 10-7,,NR,2.116,'-,[1.583-2.829],UNC5D,Foot ulcer and neuropathy in diabetes,"type I diabetes mellitus, diabetic foot, type II diabetes mellitus, neuropathy",GCST004725,8:35265058
rs1482588-<b>A</b>,2 x 10-6,,NR,'-,0.5164 unit decrease,[0.3-0.73],"LINC02040, ADAMTS9-AS2",Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,3:65151654
rs10433937-<b>T</b>,3 x 10-10,,NR,'-,0.2556 unit increase,[0.18-0.34],HSD17B13,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,4:87308948
rs11134977-<b>T</b>,1 x 10-7,,NR,'-,0.2241 unit increase,[0.14-0.31],FAF2,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,5:176477140
rs9494417-<b>A</b>,1 x 10-6,,NR,'-,0.3374 unit increase,[0.2-0.47],PDE7B,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,6:135923525
rs4749900-<b>T</b>,4 x 10-6,,NR,'-,0.4309 unit decrease,[0.25-0.61],LINC02663,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,10:9886549
rs115335372-<b>T</b>,3 x 10-6,,NR,'-,0.8334 unit decrease,[0.49-1.18],LINC02290,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,14:66124912
rs28929474-<b>T</b>,1 x 10-8,,NR,'-,0.7193 unit increase,[0.47-0.97],'-,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,Mapping not available
rs1676988-<b>A</b>,2 x 10-6,,NR,'-,0.3091 unit decrease,[0.18-0.44],TAF4B,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,18:26338981
rs10401969-<b>T</b>,5 x 10-11,,NR,'-,0.4728 unit decrease,[0.33-0.61],SUGP1,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,19:19296909
rs10424702-<b>A</b>,1 x 10-6,,NR,'-,0.2439 unit decrease,[0.15-0.34],GATAD2A,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,19:19397204
rs3794991-<b>T</b>,3 x 10-9,,NR,'-,0.42 unit increase,[0.28-0.56],GATAD2A,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,19:19499787
rs73004967-<b>A</b>,1 x 10-8,,NR,'-,0.5455 unit decrease,[0.36-0.73],PBX4,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,19:19606247
rs2576452-<b>T</b>,7 x 10-7,,NR,'-,0.2321 unit increase,[0.14-0.32],TMC4,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,19:54172738
rs2294915-<b>T</b>,1 x 10-58,,NR,'-,0.7387 unit increase,[0.65-0.83],PNPLA3,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST011639,22:43945024
rs2642438-<b>A</b>,1 x 10-43,,0.29,'-,'-,'-,MTARC1,Cirrhosis (multi-trait analysis),cirrhosis of liver,GCST011586,1:220796686
rs6834314-<b>G</b>,3 x 10-54,,0.26,'-,'-,'-,"KLHL8, MIR5705",Cirrhosis (multi-trait analysis),cirrhosis of liver,GCST011586,4:87292656
rs28929474-<b>T</b>,8 x 10-56,,0.02,'-,'-,'-,'-,Cirrhosis (multi-trait analysis),cirrhosis of liver,GCST011586,Mapping not available
rs58542926-<b>T</b>,3 x 10-83,,0.07,'-,'-,'-,TM6SF2,Cirrhosis (multi-trait analysis),cirrhosis of liver,GCST011586,19:19268740
rs738409-<b>G</b>,2 x 10-290,,0.23,'-,'-,'-,PNPLA3,Cirrhosis (multi-trait analysis),cirrhosis of liver,GCST011586,22:43928847
rs74652506-<b>T</b>,3 x 10-8,,NR,1.046551,'-,[1.03-1.06],"ANO10, SNRK",Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,3:43402386
rs4721096-<b>C</b>,3 x 10-9,,NR,1.043416,'-,[1.03-1.06],MAD1L1,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,7:1837675
rs9266237-<b>C</b>,2 x 10-11,,NR,1.0409149,'-,[1.03-1.05],"HLA-B, DHFRP2",Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,6:31357744
rs34796998-<b>G</b>,1 x 10-11,,NR,1.0394586,'-,[1.03-1.05],CA10,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,17:52230513
rs12792379-<b>A</b>,2 x 10-8,,NR,1.0383158,'-,[1.02-1.05],"CCKBR, CNGA4",Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,11:6247316
rs7763910-<b>G</b>,1 x 10-10,,NR,1.0371743,'-,[1.03-1.05],BTN2A1,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,6:26472427
rs10940767-<b>A</b>,1 x 10-10,,NR,1.0365522,'-,[1.02-1.05],LINC02109,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,5:29001417
rs12706746-<b>A</b>,8 x 10-9,,NR,1.0349984,'-,[1.02-1.05],GRM8,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,7:126802805
rs7282609-<b>G</b>,3 x 10-8,,NR,1.0341709,'-,[1.02-1.05],C21orf62-AS1,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,21:32906849
rs1937450-<b>G</b>,1 x 10-8,,NR,1.0328273,'-,[1.02-1.04],PDE4B,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,1:66013157
rs11171710-<b>A</b>,1 x 10-8,,NR,1.032724,'-,[1.02-1.04],RAB5B,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,12:55974294
rs10228350-<b>T</b>,2 x 10-8,,NR,1.0325176,'-,[1.02-1.04],FOXP2,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,7:114420608
rs7613875-<b>A</b>,3 x 10-8,,NR,1.0316918,'-,[1.02-1.04],"MON1A, RBM6",Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,3:49934081
rs1297211-<b>C</b>,2 x 10-8,,NR,1.0320014,'-,[1.0207-1.0432],"NRIP1, LINC02246",Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,21:14956635
rs597808-<b>A</b>,6 x 10-9,,NR,1.0330338,'-,[1.0218-1.0442],ATXN2,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,12:111535554
rs11901649-<b>G</b>,1 x 10-8,,NR,1.0331372,'-,[1.0217-1.0445],APOB,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,2:21027351
rs10242223-<b>A</b>,5 x 10-9,,NR,1.0353091,'-,[1.0234-1.0471],SDK1,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,7:3481941
rs7609078-<b>G</b>,9 x 10-10,,NR,1.0359304,'-,[1.0243-1.0475],AFF3,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,2:99873901
rs1363119-<b>A</b>,2 x 10-10,,NR,1.0363449,'-,[1.0251-1.0475],"PGPEP1, RN7SL513P",Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,19:18333999
rs12974777-<b>C</b>,2 x 10-9,,NR,1.0370706,'-,[1.0248-1.0492],KLHL26,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,19:18654853
rs809955-<b>G</b>,2 x 10-10,,NR,1.0375893,'-,[1.0259-1.0491],MAML3,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,4:139953606
rs4676893-<b>A</b>,2 x 10-10,,NR,1.0394586,'-,[1.0272-1.0516],"FOXP1, RNU6-281P",Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,3:70868488
rs72771256-<b>G</b>,2 x 10-8,,NR,1.0427902,'-,[1.0279-1.0576],"VCAN, HAPLN1",Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,5:83588743
rs7552188-<b>T</b>,2 x 10-10,,NR,1.0444599,'-,[1.0308-1.058],DPYD,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,1:97838601
rs4362541-<b>A</b>,2 x 10-10,,NR,1.0459232,'-,[1.0319-1.0599],LINC02831,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST008832,2:67615734
rs2505998-<b>A</b>,1 x 10-28,(European),0.22,4.17,'-,[3.23–5.26],"MIR5100, RET",Hirschsprung disease,Hirschsprung disease,GCST003764,10:43075477
rs80227144-<b>A</b>,5 x 10-10,(European),0.03,5.2,'-,[3.09–8.73],'-,Hirschsprung disease,Hirschsprung disease,GCST003764,7:84720526
rs2505998-<b>A</b>,4 x 10-43,(East Asian),0.48,3.57,'-,[2.94–4.35],"MIR5100, RET",Hirschsprung disease,Hirschsprung disease,GCST003764,10:43075477
rs7005606-<b>G</b>,1 x 10-11,(East Asian),0.21,2.12,'-,[1.70–2.63],NRG1,Hirschsprung disease,Hirschsprung disease,GCST003764,8:32543983
rs6826373-<b>C</b>,6 x 10-6,(East Asian),NR,1.7503225,'-,[0.448054680198781-0.728505575484536],PHOX2B,Hirschsprung disease,Hirschsprung disease,GCST003764,4:41744443
rs4672229-<b>A</b>,3 x 10-8,"(East Asian, recessive)",NR,2.48,'-,[1.80–3.41],VRK2,Hirschsprung disease,Hirschsprung disease,GCST003764,2:58049145
rs9282834-<b>A</b>,4 x 10-14,"(conditioned on rs2435357, East Asian)",0.03,20.3,'-,9.31-44.4,RET,Hirschsprung disease,Hirschsprung disease,GCST003764,10:43111408
rs6078460-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,'-,Postoperative survival time in hepatocellular carcinoma,"overall survival, hepatocellular carcinoma",GCST007731,20:12116249
rs913493-<b>?</b>,5 x 10-20,,NR,'-,'-,'-,PCDH9,Postoperative survival time in hepatocellular carcinoma,"overall survival, hepatocellular carcinoma",GCST007731,13:67148073
rs584368-<b>?</b>,2 x 10-14,,NR,'-,'-,'-,"MIR3166, CTSC",Postoperative survival time in hepatocellular carcinoma,"overall survival, hepatocellular carcinoma",GCST007731,11:88232053
rs3096380-<b>?</b>,1 x 10-17,,NR,'-,'-,'-,CMTR2,Postoperative survival time in hepatocellular carcinoma,"overall survival, hepatocellular carcinoma",GCST007731,16:71285743
rs34675408-<b>?</b>,1 x 10-32,,NR,'-,'-,'-,OSMR,Postoperative survival time in hepatocellular carcinoma,"overall survival, hepatocellular carcinoma",GCST007731,5:38883969
rs34675408-<b>?</b>,1 x 10-32,,NR,'-,'-,'-,OSMR,Postoperative survival time in hepatocellular carcinoma,"overall survival, hepatocellular carcinoma",GCST007650,5:38883969
rs913493-<b>?</b>,5 x 10-20,,NR,'-,'-,'-,PCDH9,Postoperative survival time in hepatocellular carcinoma,"overall survival, hepatocellular carcinoma",GCST007650,13:67148073
rs3096380-<b>?</b>,1 x 10-17,,NR,'-,'-,'-,CMTR2,Postoperative survival time in hepatocellular carcinoma,"overall survival, hepatocellular carcinoma",GCST007650,16:71285743
rs584368-<b>?</b>,2 x 10-14,,NR,'-,'-,'-,"MIR3166, CTSC",Postoperative survival time in hepatocellular carcinoma,"overall survival, hepatocellular carcinoma",GCST007650,11:88232053
rs6078460-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,'-,Postoperative survival time in hepatocellular carcinoma,"overall survival, hepatocellular carcinoma",GCST007650,20:12116249
rs140532807-<b>A</b>,3 x 10-6,,0.011,'-,0.289 unit increase,[0.17-0.41],PIK3CD,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,1:9716861
rs10923043-<b>T</b>,4 x 10-6,,0.548,'-,0.069 unit increase,[0.04-0.098],PKN2-AS1,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,1:88207913
rs116449111-<b>C</b>,2 x 10-6,,0.979,'-,0.218 unit decrease,[0.13-0.31],HNRNPA1P61,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,2:33636757
rs116781238-<b>A</b>,6 x 10-7,,0.048,'-,0.161 unit increase,[0.098-0.224],"RNU6-612P, ATP1B3P1",Irritable bowel syndrome,irritable bowel syndrome,GCST006304,2:60720593
rs1105615-<b>T</b>,3 x 10-6,,0.16,'-,0.091 unit increase,[0.052-0.13],ABLIM2,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,4:8108771
rs13212302-<b>T</b>,2 x 10-6,,0.59,'-,0.071 unit decrease,[0.042-0.1],R3HDM2P2,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,6:103945045
rs117107090-<b>A</b>,3 x 10-6,,0.98,'-,0.225 unit decrease,[0.13-0.32],LINC02153,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,8:21054610
rs4871509-<b>A</b>,2 x 10-6,,0.446,'-,0.071 unit increase,[0.042-0.1],MTSS1,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,8:124593700
rs10512344-<b>C</b>,4 x 10-8,,0.04,'-,0.19 unit increase,[0.12-0.26],LINC01505,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,9:106247214
rs925870-<b>T</b>,2 x 10-6,,0.848,'-,0.1 unit increase,[0.059-0.141],LINC02742,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,11:28828648
rs61939612-<b>T</b>,3 x 10-6,,0.373,'-,0.072 unit increase,[0.043-0.101],CPNE8-AS1,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,12:38970735
rs1540951-<b>A</b>,3 x 10-6,,0.334,'-,0.075 unit decrease,[0.044-0.106],EPSTI1,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,13:42957452
rs147085754-<b>A</b>,5 x 10-6,,0.025,'-,0.198 unit increase,[0.11-0.28],LIG4,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,13:108122441
rs146313367-<b>A</b>,3 x 10-6,,0.075,'-,0.125 unit increase,[0.072-0.178],'-,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,17:5841252
rs10512344-<b>C</b>,4 x 10-10,(women),0.0404,'-,0.245 unit increase,[0.17-0.32],LINC01505,Irritable bowel syndrome,irritable bowel syndrome,GCST006304,9:106247214
rs2976394-<b>C</b>,2 x 10-13,,0.52,0.7,'-,[0.64-0.77],PSCA,Gastric cancer,gastric carcinoma,GCST010956,8:142682204
rs300890-<b>A</b>,9 x 10-6,,NR,1.127,'-,1.069-1.187,"GAB1, Y_RNA",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST003578,4:143328617
rs2860580-<b>?</b>,3 x 10-31,,0.62,1.89,'-,[1.69-2.13],"HLA-A, HLA-U",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST003578,6:29938914
rs2894207-<b>?</b>,2 x 10-19,,0.84,1.96,'-,[1.69-2.27],LINC02571,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST003578,6:31295974
rs28421666-<b>?</b>,1 x 10-10,,0.87,1.64,'-,[1.43-1.92],"HLA-DRB1, HLA-DQA1",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST003578,6:32624960
rs401681-<b>?</b>,3 x 10-14,,0.67,1.22,'-,[1.15-1.28],CLPTM1L,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST003578,5:1321972
rs6498114-<b>?</b>,4 x 10-9,,0.54,1.15,'-,[1.10-1.20],CIITA,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST003578,16:10870261
rs7300446-<b>?</b>,1 x 10-6,,'-,1.56,'-,[1.30-1.87],MGST1,Metastatic colorectal cancer survival in treatment with chemotherapy plus biologics,"metastatic colorectal cancer, survival time, response to antineoplastic agent",GCST011584,12:16521286
rs2461035-<b>?</b>,5 x 10-6,,'-,0.72,'-,[0.62-0.83],"STMN2, HEY1",Metastatic colorectal cancer survival in treatment with chemotherapy plus biologics,"metastatic colorectal cancer, survival time, response to antineoplastic agent",GCST011584,8:79677902
rs16985284-<b>?</b>,5 x 10-6,,'-,1.56,'-,[1.29-1.89],RDH14,Metastatic colorectal cancer survival in treatment with chemotherapy plus biologics,"metastatic colorectal cancer, survival time, response to antineoplastic agent",GCST011584,2:18553898
rs898838-<b>?</b>,8 x 10-6,,'-,0.74,'-,[0.65-0.85],"MSGN1, KCNS3",Metastatic colorectal cancer survival in treatment with chemotherapy plus biologics,"metastatic colorectal cancer, survival time, response to antineoplastic agent",GCST011584,2:17858241
rs738409-<b>G</b>,2 x 10-15,,0.398,1.537,'-,[1.383-1.709],PNPLA3,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST005190,22:43928847
rs2143571-<b>A</b>,2 x 10-11,,0.395,1.437,'-,[1.292-1.597],SAMM50,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST005190,22:43995806
rs2395029-<b>?</b>,6 x 10-97,,0.4,35.48,'-,[25.38-49.58],HCP5,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,6:31464003
HLA-B*07:02-<b>?</b>,6 x 10-7,,0.15,3.125,'-,[2-5],'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,Mapping not available
HLA-C*07:02-<b>?</b>,4 x 10-7,,0.16,3.030303,'-,[1.96-4.55],'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,Mapping not available
HLA-DQA1*03:01-<b>?</b>,3 x 10-7,,0.21,2.3809524,'-,[1.72-3.33],'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,Mapping not available
HLA-A*01:01-<b>?</b>,2 x 10-8,,0.18,1.86,'-,[1.5-2.31],'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,Mapping not available
HLA-DRB1*07:01-<b>?</b>,4 x 10-35,,0.13,4.02,'-,[3.23-5.02],'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,Mapping not available
HLA-DQA1*02:01-<b>?</b>,5 x 10-35,,0.13,4.02,'-,[3.22-5.01],'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,Mapping not available
HLA-C*06:02-<b>?</b>,4 x 10-74,,0.09,10.11,'-,[7.88-12.97],'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,Mapping not available
HLA-DQB1*03:03-<b>?</b>,1 x 10-63,,0.05,10.18,'-,[7.77-13.34],'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,Mapping not available
HLA-B*57:01-<b>?</b>,3 x 10-97,,0.04,36.62,'-,[26.14-51.29],'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,Mapping not available
HLA-B*57:03-<b>?</b>,1 x 10-6,(conditional on rs2395029 and HLA-B*57:01),0.0003,79.21,'-,NR,'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST007606,Mapping not available
rs117491755-<b>?</b>,2 x 10-9,,0.037,4.37,'-,2.702-7.06,ASTN2,Drug-induced liver injury (isoniazid-containing anti-tuberculosis drugs),"response to anti-tuberculosis drug, drug-induced liver injury",GCST011752,9:116881377
rs7601541-<b>?</b>,2 x 10-8,,NR,6.78,'-,[3.49-13.15],"STEAP3, RN7SL468P",Severe skin toxicity response to cetuximab in stage 3 colon cancer,"skin disease, colon carcinoma, response to cetuximab",GCST011795,2:119184520
rs78201730-<b>?</b>,6 x 10-9,,NR,3.98,'-,[2.50-6.33],WIPF2,Severe skin toxicity response to cetuximab in stage 3 colon cancer,"skin disease, colon carcinoma, response to cetuximab",GCST011795,17:40276973
rs738409-<b>G</b>,2 x 10-48,,0.27,2.19,'-,[1.97–2.43],PNPLA3,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST003153,22:43928847
rs10401969-<b>C</b>,8 x 10-10,,0.08,1.72,'-,[1.44–2.04],SUGP1,Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST003153,19:19296909
rs626283-<b>C</b>,1 x 10-9,,0.44,1.35,'-,[1.23–1.49],"TMC4, MBOAT7",Cirrhosis (alcohol related),alcoholic liver cirrhosis,GCST003153,19:54173307
rs73112661-<b>G</b>,2 x 10-7,,0.17,1.22,'-,'-,ELMO1,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,7:37333575
rs694739-<b>A</b>,2 x 10-7,,0.61,1.18,'-,'-,"CCDC88B, PRDX5",Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,11:64329761
rs72678531-<b>G</b>,2 x 10-38,,0.17,1.61,'-,[1.49-1.73],IL12RB2,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,1:67332762
rs2488393-<b>A</b>,4 x 10-12,,0.21,1.28,'-,[1.19-1.37],DENND1B,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,1:197753110
rs3024921-<b>A</b>,3 x 10-18,,0.06,1.62,'-,[1.45-1.80],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
rs7574865-<b>A</b>,1 x 10-13,(conditioned on rs3024921),0.22,1.31,'-,[1.22-1.40],STAT4,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,2:191099907
rs2293370-<b>G</b>,7 x 10-16,,0.8,1.39,'-,[1.29-1.52],TIMMDC1,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,3:119501087
rs2366643-<b>A</b>,4 x 10-22,,0.57,1.35,'-,[1.27-1.44],"IL12A-AS1, LINC01100",Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,3:160018698
rs62270414-<b>G</b>,6 x 10-17,(conditioned on rs2366643),0.15,1.41,'-,[1.30-1.53],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
rs668998-<b>G</b>,5 x 10-9,(conditioned on rs62270414 & rs2366643),0.43,1.26,'-,[1.17-1.36],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
rs80014155-<b>A</b>,3 x 10-11,"(conditioned on rs668998, rs6227041 & rs2366643)",0.004,3.44,'-,[2.39-4.94],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
rs7665090-<b>G</b>,8 x 10-14,,0.52,1.26,'-,[1.19-1.34],"NFKB1, MANBA",Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,4:102630446
rs6871748-<b>A</b>,2 x 10-13,,0.72,1.3,'-,[1.21-1.4],"IL7R, CAPSL",Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,5:35885880
rs35188261-<b>A</b>,7 x 10-22,,0.17,1.52,'-,[1.39-1.63],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
rs3807307-<b>G</b>,4 x 10-9,(conditioned on rs35188261),0.47,1.22,'-,[1.14-1.30],IRF5,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,7:128939148
rs80065107-<b>A</b>,7 x 10-16,,0.79,1.39,'-,[1.28-1.5],"DDX6, SETP16",Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,11:118812058
rs1800693-<b>G</b>,1 x 10-14,,0.4,1.27,'-,[1.19-1.34],TNFRSF1A,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,12:6330843
rs11064157-<b>A</b>,2 x 10-9,(conditioned on rs1800693),0.25,1.23,'-,[1.15-1.32],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
rs11065979-<b>A</b>,3 x 10-9,,0.44,1.2,'-,[1.13-1.27],"BRAP, ATXN2-AS",Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,12:111621753
rs911263-<b>A</b>,1 x 10-10,,0.71,1.26,'-,[1.17-1.35],RAD51B,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,14:68286876
rs1646019-<b>G</b>,7 x 10-15,,0.71,1.31,'-,[1.23-141],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
rs12708715-<b>C</b>,2 x 10-13,(conditioned on rs1646019),0.68,1.29,'-,[1.21-1.38],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
rs80073729-<b>A</b>,3 x 10-8,(conditioned on rs12708715 & rs1646019),0.004,2.96,'-,[2.02-4.33],RMI2,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,16:11279940
rs11117433-<b>G</b>,1 x 10-9,,0.77,1.26,'-,[1.17-1.36],"LINC02132, LINC01081",Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,16:85985910
rs8067378-<b>G</b>,6 x 10-14,,0.52,1.26,'-,[1.19-1.34],"ZPBP2, GSDMB",Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,17:39895095
rs17564829-<b>G</b>,2 x 10-9,,0.24,1.25,'-,[1.16-1.35],MAPT,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,17:45929235
rs34536443-<b>G</b>,1 x 10-12,,0.95,1.91,'-,[1.59-2.28],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
rs2267407-<b>A</b>,1 x 10-13,,0.23,1.29,'-,[1.21-1.38],SYNGR1,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,22:39351045
HLA*DQA1:0401-<b>?</b>,6 x 10-45,,0.22,3.07,'-,'-,'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
HLA*DQB1:0602-<b>?</b>,2 x 10-15,,0.132,1.56,'-,'-,'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
HLA*DQB1:0301-<b>?</b>,6 x 10-14,,0.179,1.43,'-,'-,'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
HLA*DRB1:0404-<b>?</b>,1 x 10-9,,0.052,1.57,'-,'-,'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,Mapping not available
rs760077-<b>T</b>,2 x 10-12,,0.85,1.38,'-,[1.26-1.51],'-,Gastric cancer,gastric carcinoma,GCST008646,Mapping not available
rs6897169-<b>C</b>,5 x 10-12,,0.51,1.25,'-,[1.17-1.33],TTC33,Gastric cancer,gastric carcinoma,GCST008646,5:40726036
rs10509671-<b>C</b>,3 x 10-12,,0.15,1.34,'-,[1.23-1.45],PLCE1,Gastric cancer,gastric carcinoma,GCST008646,10:94309297
rs7624041-<b>G</b>,5 x 10-9,,0.08,1.21,'-,[1.13-1.28],'-,Gastric cancer,gastric carcinoma,GCST008646,3:94389819
rs10029005-<b>A</b>,3 x 10-11,,0.33,1.14,'-,[1.10-1.19],LINC02516,Gastric cancer,gastric carcinoma,GCST008646,4:124530209
rs9841504-<b>C</b>,4 x 10-6,,0.84,1.2345679,'-,[1.12-1.35],ZBTB20,Gastric cancer,gastric carcinoma,GCST008646,3:114643917
rs35226739-<b>?</b>,9 x 10-7,,'-,2.647,'-,[NR],GRM7,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,3:7428456
rs13129679-<b>?</b>,2 x 10-6,,'-,2.721,'-,[NR],"RNF4, FAM193A",Colorectal adenoma (advanced),colorectal adenoma,GCST005151,4:2574375
rs34548439-<b>?</b>,9 x 10-7,,'-,1.411,'-,[NR],OSMR-AS1,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,5:38831029
rs2110007-<b>?</b>,3 x 10-6,,'-,1.9704434,'-,[NR],RN7SL542P,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,7:21153722
rs11766140-<b>?</b>,1 x 10-6,,'-,1.366,'-,[NR],RNU6-1103P,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,7:24480037
rs6068583-<b>?</b>,3 x 10-7,,'-,1.554,'-,[NR],"Y_RNA, ZNF217",Colorectal adenoma (advanced),colorectal adenoma,GCST005151,20:53559566
rs2837983-<b>?</b>,8 x 10-6,,'-,1.4484357,'-,[NR],BACE2,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,21:41244830
rs12482500-<b>?</b>,6 x 10-6,,'-,1.365,'-,[NR],C2CD2,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,21:41933501
rs1131510-<b>?</b>,9 x 10-6,,'-,1.748,'-,[NR],CUL2,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,10:35010157
rs2125062-<b>?</b>,6 x 10-6,,'-,1.335,'-,[NR],BLNK,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,10:96220965
rs1018697-<b>?</b>,9 x 10-6,,'-,1.352997,'-,[NR],WBP1L,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,10:102789467
rs7944251-<b>?</b>,2 x 10-6,,'-,1.5547264,'-,[NR],FAT3,Colorectal adenoma (advanced),colorectal adenoma,GCST005153,11:92263265
rs13055076-<b>?</b>,2 x 10-6,,'-,1.455,'-,[NR],NF2,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,22:29673218
rs10898160-<b>?</b>,6 x 10-6,,'-,1.351,'-,[NR],DLG2,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,11:83847331
rs7944251-<b>?</b>,4 x 10-7,,'-,1.525553,'-,[NR],FAT3,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,11:92263265
rs829883-<b>?</b>,4 x 10-6,,'-,1.3734376,'-,[NR],LINC02453,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,12:98485828
rs3743102-<b>?</b>,5 x 10-6,,'-,1.452,'-,[NR],FSD2,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,15:82758642
rs17679617-<b>?</b>,7 x 10-6,,'-,1.443,'-,[NR],CDH13,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,16:83274396
rs338241-<b>?</b>,6 x 10-6,,'-,1.813,'-,[NR],"OMA1, DAB1",Colorectal adenoma (advanced),colorectal adenoma,GCST005151,1:58468483
rs17190422-<b>?</b>,9 x 10-6,,'-,2.073,'-,[NR],'-,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,2:56629125
rs10208443-<b>?</b>,7 x 10-6,,'-,1.348,'-,[NR],CYP26B1,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,2:72102473
rs7425956-<b>?</b>,7 x 10-6,,'-,1.3475273,'-,[NR],INPP5D,Colorectal adenoma (advanced),colorectal adenoma,GCST005151,2:233080855
rs17679617-<b>?</b>,3 x 10-6,,'-,1.609,'-,[NR],CDH13,Colorectal adenoma (advanced),colorectal adenoma,GCST005153,16:83274396
chr12:71074730-<b>?</b>,4 x 10-6,,'-,1.667,'-,[NR],'-,Colorectal adenoma (advanced),colorectal adenoma,GCST005153,Mapping not available
rs17342699-<b>?</b>,6 x 10-6,,'-,3.145,'-,[NR],"CSMD2-AS1, CSMD2",Colorectal adenoma (advanced),colorectal adenoma,GCST005153,1:33874352
rs2066844-<b>?</b>,8 x 10-6,,'-,2.345,'-,[NR],NOD2,Colorectal adenoma (advanced),colorectal adenoma,GCST005153,16:50712015
rs2110007-<b>?</b>,9 x 10-6,,'-,2.037905,'-,[NR],RN7SL542P,Colorectal adenoma (advanced),colorectal adenoma,GCST005153,7:21153722
rs7781557-<b>?</b>,9 x 10-6,,'-,1.5073862,'-,[NR],FBXL13,Colorectal adenoma (advanced),colorectal adenoma,GCST005153,7:102841444
rs7425956-<b>?</b>,9 x 10-6,,'-,1.4108351,'-,[NR],INPP5D,Colorectal adenoma (advanced),colorectal adenoma,GCST005153,2:233080855
rs4964759-<b>?</b>,9 x 10-6,,'-,1.398797,'-,[NR],SSH1,Colorectal adenoma (advanced),colorectal adenoma,GCST005153,12:108810035
rs181436801-<b>G</b>,6 x 10-6,,0.01063,4.334,'-,[2.295-8.185],ZNHIT6,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,1:85673646
rs9426948-<b>T</b>,2 x 10-6,,0.2029,1.852,'-,[1.434-2.391],"POU2F1, LINC02772",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,1:157326238
rs148981288-<b>A</b>,3 x 10-6,,0.0326,2.851,'-,[1.841-4.416],"RNA5SP107, GALNT13",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,2:154553335
rs140225704-<b>G</b>,4 x 10-6,,0.0104,4.606,'-,[2.404-8.826],EIF4A2,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,3:186789340
rs73250983-<b>A</b>,7 x 10-7,,0.0303,3.012,'-,[1.948-4.657],LNX1,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,4:53713292
rs77888609-<b>A</b>,1 x 10-6,,0.01251,4.313,'-,[2.388-7.79],LINC02267,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,4:96748175
rs117264960-<b>T</b>,1 x 10-6,,0.01797,3.475,'-,[2.092-5.771],'-,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,4:97022687
rs13103455-<b>C</b>,8 x 10-6,,0.02127,3.159,'-,[1.908-5.23],MARCHF1,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,4:163823743
rs149608518-<b>T</b>,1 x 10-8,,0.01035,5.587,'-,[3.086-10.12],RNU6-284P,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,4:164551523
rs555875634-<b>T</b>,9 x 10-6,,0.0105,4.209,'-,[2.235-7.92399999999999],"SDHAP3, MIR4277",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,5:1664084
rs11743474-<b>C</b>,4 x 10-6,,0.09698,2.083,'-,[1.528-2.841],'-,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,5:67803479
rs2431080-<b>C</b>,4 x 10-6,,0.0101,4.484,'-,[2.374-8.472],SLC36A2,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,5:151339313
rs112165107-<b>A</b>,6 x 10-6,,0.01113,4.22,'-,[2.258-7.886],FOXP4,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,6:41601665
rs12666678-<b>C</b>,6 x 10-7,,0.1485,2.013,'-,[1.528-2.65],ZFAND2A,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,7:1157039
rs2893552-<b>G</b>,5 x 10-6,,0.289,1.726,'-,[1.3659999999999899-2.18],"STARD3NL, SFRP4",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,7:38115961
rs6460547-<b>C</b>,7 x 10-6,,0.1372,1.87,'-,[1.424-2.455],AUTS2,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,7:70448404
rs184072253-<b>A</b>,4 x 10-6,,0.01352,3.87,'-,[2.174-6.88899999999999],"TMEM243, TP53TG1",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,7:87297887
rs184020833-<b>G</b>,8 x 10-6,,0.02613,3.062,'-,[1.876-4.999],VIPR2,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,7:159096037
rs631290-<b>G</b>,9 x 10-7,,0.2762,1.822,'-,[1.434-2.315],RN7SL474P,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,8:16786314
rs149551507-<b>C</b>,5 x 10-6,,0.01445,4.043,'-,[2.225-7.347],"SDR16C5, SDR16C6P",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,8:56372396
rs11781353-<b>G</b>,5 x 10-6,,0.3673,0.539,'-,[0.413-0.7036],XKR9,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,8:70736608
rs3098897-<b>C</b>,1 x 10-5,,0.3795,0.5569,'-,[0.4298-0.7217],'-,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,8:70904020
rs1018015-<b>T</b>,7 x 10-6,,0.3776,0.551,'-,[0.4247-0.7149],'-,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,8:71007335
rs79679798-<b>G</b>,8 x 10-7,,0.02579,3.246,'-,[2.032-5.187],TMEM74,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,8:108758274
rs148382232-<b>A</b>,5 x 10-6,,0.0484,2.432,'-,[1.658-3.568],'-,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,9:29190180
rs17494333-<b>G</b>,2 x 10-6,,0.1512,1.937,'-,[1.474-2.546],GDA,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,9:72214057
rs189233549-<b>G</b>,8 x 10-6,,0.01224,3.907,'-,[2.148-7.107],ASTN2,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,9:117365402
rs145992761-<b>G</b>,3 x 10-6,,0.01414,4.327,'-,[2.348-7.976],GDI2,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,10:5773631
rs4747862-<b>C</b>,9 x 10-6,,0.06349,2.243,'-,[1.57-3.203],"CELF2-DT, INPP5F",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,10:10500888
rs16934486-<b>T</b>,5 x 10-6,,0.03777,2.671,'-,[1.75199999999999-4.072],KCNMA1,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,10:77298188
rs117920745-<b>A</b>,8 x 10-7,,0.01363,4.377,'-,[2.435-7.867],CRTAC1,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,10:97963866
rs58973706-<b>G</b>,8 x 10-8,,0.01479,4.565,'-,[2.622-7.949],"CRTAC1, R3HCC1L",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,10:98108273
rs35016586-<b>T</b>,9 x 10-6,,0.04604,2.481,'-,[1.66-3.708],"PIK3C2G, RERGL",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,12:18285957
rs1314503368-<b>C</b>,2 x 10-6,,0.0119,2.032,'-,[1.514-2.726],HELLPAR,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,12:23156445
rs77422815-<b>C</b>,6 x 10-6,,0.02386,3.03,'-,[1.874-4.899],E2F7,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,12:23349880
rs17401474-<b>C</b>,3 x 10-6,,0.03976,2.722,'-,[1.793-4.13399999999999],SOX5,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,12:23985456
rs77290633-<b>C</b>,4 x 10-6,,0.01102,4.247,'-,[2.301-7.84],LINC02426,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,12:81977680
rs147623050-<b>T</b>,5 x 10-6,,0.01148,4.149,'-,[2.252-7.643],'-,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,12:82105545
rs12852885-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"SOWAHD, SEPTIN6",Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,X:119752407
rs1346763-<b>T</b>,9 x 10-7,(male),0.32,1.4,'-,[NR],DPP10,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,2:114515136
rs2858317-<b>A</b>,1 x 10-11,(male),0.63,1.73,'-,[NR],"HLA-DQB1, MTCO3P1",Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,6:32694503
rs76398191-<b>C</b>,2 x 10-7,(male),0.31,0.69,'-,[NR],AIFM1P1,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,10:18819130
rs1760726-<b>G</b>,2 x 10-6,(male),0.75,1.44,'-,[NR],GPR158,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,10:25389364
rs74597329-<b>T</b>,4 x 10-25,(male),0.52,2.19,'-,[NR],IFNL4,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,19:39248515
rs6087561-<b>C</b>,6 x 10-7,(male),0.12,1.6,'-,[NR],ASIP,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,20:34196021
rs10456404-<b>C</b>,2 x 10-7,(female),0.13,1.89,'-,[NR],"NOTCH4, TSBP1-AS1",Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,6:32245080
rs28368843-<b>T</b>,5 x 10-7,(female),0.07,2.38,'-,[NR],"HLA-DRB5, HLA-DRB9",Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,6:32484810
rs2858320-<b>G</b>,2 x 10-12,(female),0.58,1.96,'-,[NR],"MTCO3P1, HLA-DQB1",Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,6:32693516
rs1649709-<b>G</b>,9 x 10-7,(female),0.59,1.62,'-,[NR],'-,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,7:52712519
rs1838126-<b>T</b>,3 x 10-6,(female),0.24,1.8,'-,[NR],ANKRD20A9P,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,13:18870688
rs12161828-<b>T</b>,1 x 10-5,(female),0.08,2.01,'-,[NR],"LINC01058, LINC00426",Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,13:30383161
rs778086851-<b>CT</b>,5 x 10-21,(female),0.51,2.5,'-,[NR],IFNL4,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST011999,19:39248513
rs11335470-<b>?</b>,3 x 10-7,(Heterozygous),NR,2.4813895,'-,[NR],LINC00944,Severe malaria,malaria,GCST005356,12:126753075
rs113449872-<b>?</b>,2 x 10-7,(Heterozygous),NR,2.8248587,'-,[NR],'-,Severe malaria,malaria,GCST005356,5:43909241
rs144312179-<b>?</b>,6 x 10-7,(Additive),NR,4.830918,'-,[NR],FAM155A,Severe malaria,malaria,GCST005356,13:107575665
rs149085856-<b>?</b>,2 x 10-7,(Additive),NR,3.867,'-,[NR],LINC00670,Severe malaria,malaria,GCST005356,17:12496210
rs17624383-<b>?</b>,6 x 10-7,(Additive),NR,0.4,'-,[NR],LINC01446,Severe malaria,malaria,GCST005356,7:53609144
rs1878468-<b>?</b>,9 x 10-7,(Heterozygous),NR,2.6109662,'-,[NR],TENM3-AS1,Severe malaria,malaria,GCST005356,4:181901179
rs2967790-<b>?</b>,6 x 10-7,(Additive),NR,1.6949153,'-,[NR],KLHL3,Severe malaria,malaria,GCST005356,5:137676072
rs3133394-<b>?</b>,9 x 10-7,(Additive),NR,1.814882,'-,[NR],BAK1P2,Severe malaria,malaria,GCST005356,11:130547627
rs334-<b>?</b>,9 x 10-13,(Heterozygous),NR,7.633588,'-,[NR],HBB,Severe malaria,malaria,GCST005356,11:5227002
rs6682413-<b>?</b>,8 x 10-7,(Recessive),NR,2.0876827,'-,[NR],"IL23R, RNU4ATAC4P",Severe malaria,malaria,GCST005356,1:67265931
rs73505850-<b>?</b>,8 x 10-7,(Additive),NR,4.795,'-,[NR],CSMD1,Severe malaria,malaria,GCST005356,8:4897316
rs73832816-<b>?</b>,4 x 10-7,(Recessive),NR,3.4602075,'-,[NR],"C4orf17, ADH7",Severe malaria,malaria,GCST005356,4:99508600
rs8109875-<b>?</b>,9 x 10-7,(Recessive),NR,1.9723865,'-,[NR],ZNF536,Severe malaria,malaria,GCST005356,19:30578732
rs9296359-<b>?</b>,1 x 10-7,(Heterozygous),NR,4.087,'-,[NR],TREML4,Severe malaria,malaria,GCST005356,6:41237952
rs13429103-<b>A</b>,2 x 10-7,,0.15,2.04,'-,'-,"SLC4A1AP, LINC01875",Esophageal adenocarcinoma x smoking interaction,"esophageal adenocarcinoma, smoking status measurement",GCST006530,2:7377100
rs2434584-<b>C</b>,7 x 10-7,,0.08,2.52,'-,[NR],'-,Esophageal adenocarcinoma x smoking interaction,"esophageal adenocarcinoma, smoking status measurement",GCST006530,5:58270246
rs17002540-<b>C</b>,6 x 10-7,,0.81,1.01,'-,[NR],"MIR320D2, LINC00632",Esophageal adenocarcinoma x pack-years of smoking exposure interaction,"esophageal adenocarcinoma, pack-years measurement",GCST006532,X:140863896
rs6128907-<b>C</b>,1 x 10-6,(additive model),0.2067,'-,'-,'-,ACTR5,Liver fibrosis in pediatric non-alcoholic fatty acid liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST004938,20:38759219
rs3935794-<b>G</b>,4 x 10-6,(additive model),0.0625,'-,'-,'-,ETS1,Liver fibrosis in pediatric non-alcoholic fatty acid liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST004938,11:128520782
rs688020-<b>C</b>,6 x 10-6,(additive model),0.2428,'-,'-,'-,SDK1,Liver fibrosis in pediatric non-alcoholic fatty acid liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST004938,7:4188921
rs11465670-<b>C</b>,8 x 10-6,(additive model),0.04327,'-,'-,'-,"IL18RAP, SDR42E1P5",Liver fibrosis in pediatric non-alcoholic fatty acid liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST004938,2:102417980
rs12942311-<b>C</b>,9 x 10-6,(additive model),0.2212,'-,'-,'-,RAB37,Liver fibrosis in pediatric non-alcoholic fatty acid liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST004938,17:74714657
rs780094-<b>T</b>,2 x 10-8,,0.57,1.35,'-,[1.21-1.49],'-,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST005308,Mapping not available
rs1881396-<b>T</b>,1 x 10-6,,0.71,1.34,'-,[1.19-1.50],ZNF512,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST005308,2:27621734
rs2668423-<b>T</b>,1 x 10-6,,0.33,1.3,'-,[1.16-1.43],PWWP3A,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST005308,19:1370527
rs738491-<b>T</b>,1 x 10-18,,0.52,1.6,'-,[1.44-1.77],"SAMM50, PNPLA3",Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST005308,22:43958231
rs2896019-<b>G</b>,2 x 10-31,,0.46,1.85,'-,[1.67-2.05],PNPLA3,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST005308,22:43937814
rs1260326-<b>T</b>,1 x 10-9,,0.57,1.38,'-,[1.25-1.53],'-,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST005308,Mapping not available
rs4808199-<b>A</b>,2 x 10-8,,0.27,1.37,'-,[1.23-1.53],GATAD2A,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST005308,19:19434290
rs31489-<b>?</b>,6 x 10-13,,NR,1.2345679,'-,'-,CLPTM1L,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST005113,5:1342599
rs6774494-<b>?</b>,2 x 10-12,,NR,1.1904762,'-,'-,MECOM,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST005113,3:169364845
rs9510787-<b>?</b>,5 x 10-10,,NR,1.16,'-,'-,TNFRSF19,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST005113,13:23631056
rs1412829-<b>?</b>,3 x 10-8,,NR,1.25,'-,'-,CDKN2B-AS1,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST005113,9:22043927
rs3731239-<b>?</b>,1 x 10-6,,NR,1.1904762,'-,'-,CDKN2A,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST005113,9:21974219
rs4977756-<b>?</b>,7 x 10-7,,NR,1.1494253,'-,'-,CDKN2B-AS1,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST005113,9:22068653
rs1063192-<b>?</b>,8 x 10-7,,NR,1.1627907,'-,'-,"CDKN2B, CDKN2B-AS1",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST005113,9:22003368
rs2853668-<b>?</b>,4 x 10-6,,NR,1.12,'-,'-,"TERT, MIR4457",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST005113,5:1299910
rs491603-<b>A</b>,4 x 10-7,,0.16,1.08,'-,'-,AGO3,Barrett's esophagus x BMI interaction,"Barrett's esophagus, body mass index",GCST006529,1:36066715
rs11631094-<b>C</b>,3 x 10-7,,0.71,1.01,'-,'-,SLC12A6,Barrett's esophagus x pack-years of smoking exposure interaction,"pack-years measurement, Barrett's esophagus",GCST006528,15:34332237
rs9668109-<b>G</b>,6 x 10-7,,0.91,1.0204082,'-,[NR],IKBIP,Barrett's esophagus x pack-years of smoking exposure interaction,"pack-years measurement, Barrett's esophagus",GCST006528,12:98617494
rs1548445-<b>G</b>,8 x 10-7,,0.06,1.02,'-,[NR],VPS35L,Barrett's esophagus x pack-years of smoking exposure interaction,"pack-years measurement, Barrett's esophagus",GCST006528,16:19680261
rs2671828-<b>G</b>,1 x 10-6,,0.57,1.010101,'-,[NR],"SLFN12, UFM1P2",Barrett's esophagus x pack-years of smoking exposure interaction,"pack-years measurement, Barrett's esophagus",GCST006528,17:35404745
rs113988120-<b>A</b>,3 x 10-6,,0.015,1.79,'-,[1.40-2.29],PAIP2B,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,2:71220545
rs4568126-<b>C</b>,6 x 10-6,,0.38,1.18,'-,[1.10-1.27],"B4GALT4, B4GALT4-AS1",Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,3:119229409
rs4780973-<b>C</b>,4 x 10-6,,0.69,1.22,'-,[1.12-1.32],LINC02177,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,16:9301482
rs1000589-<b>T</b>,8 x 10-6,,NR,1.31,'-,[1.17-1.48],LINC00395,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,13:63567780
rs10734079-<b>T</b>,4 x 10-6,,NR,2.63,'-,[1.74-3.98],LINC02667,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128890376
rs10736390-<b>?</b>,2 x 10-6,,NR,1.3333333,'-,[1.19-1.52],ACOT11,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,1:54638272
rs10741177-<b>C</b>,4 x 10-6,,NR,2.17,'-,[1.56-3.03],"LINC02667, KCNMA1",Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128884838
rs10764826-<b>A</b>,3 x 10-6,,NR,2.19,'-,[1.58-3.04],LINC02667,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128888212
rs10767646-<b>?</b>,3 x 10-6,,NR,1.4084507,'-,[1.22-1.61],BDNF-AS,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,11:27538197
rs10817611-<b>C</b>,7 x 10-6,,NR,1.44,'-,[1.23-1.68],WHRN,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,9:114439119
rs10829514-<b>T</b>,3 x 10-6,,NR,2.18,'-,[1.57-3.03],LINC02667,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128887811
rs10829515-<b>C</b>,5 x 10-6,,NR,2.21,'-,[1.57-3.09],LINC02667,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128888461
rs10835188-<b>?</b>,1 x 10-6,,NR,1.4084507,'-,[1.22-1.61],LIN7C,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,11:27501639
rs10983614-<b>?</b>,9 x 10-7,,NR,1.369863,'-,[1.22-1.56],ASTN2,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,9:117306874
rs11016537-<b>A</b>,4 x 10-6,,NR,2.18,'-,[1.57-3.03],LINC02667,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128887353
rs11062040-<b>A</b>,8 x 10-6,,NR,1.4,'-,[1.2-1.7],"CACNA1C, DCP1B",Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,12:1982091
rs11639759-<b>T</b>,7 x 10-6,,NR,1.56,'-,[1.28-1.89],RBFOX1,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,16:5629160
rs1165805-<b>A</b>,8 x 10-6,,NR,1.43,'-,[1.22-1.67],'-,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,9:101906017
rs12101726-<b>C</b>,5 x 10-6,,NR,1.83,'-,[1.41-2.36],"LINC01581, LINC01579",Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,15:94038713
rs12209785-<b>G</b>,4 x 10-6,,NR,1.37,'-,[1.20-1.56],RUNX2,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,6:45538385
rs12362504-<b>C</b>,2 x 10-7,,NR,1.4,'-,[1.23-1.58],SBF2,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,11:9907995
rs12620038-<b>?</b>,1 x 10-6,,NR,1.3888888,'-,[1.22-1.59],EPCAM-DT,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,2:47248996
rs12786130-<b>?</b>,3 x 10-6,,NR,1.3888888,'-,[1.20-1.59],"LIN7C, LGR4-AS1",Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,11:27484407
rs1352757-<b>G</b>,4 x 10-6,,NR,1.35,'-,[1.19-1.53],KCTD12,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,13:63542441
rs1391315-<b>G</b>,4 x 10-6,,NR,1.82,'-,[1.41-2.35],SMAP2,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,1:40386710
rs1408536-<b>A</b>,6 x 10-6,,NR,2.16,'-,[1.55-3.01],LINC02667,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128879482
rs1408537-<b>C</b>,5 x 10-6,,NR,2.17,'-,[1.55-3.02],LINC02667,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128882085
rs1414153-<b>C</b>,2 x 10-6,,NR,1.41,'-,[1.23-1.62],DELEC1,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,9:115280074
rs1567532-<b>T</b>,4 x 10-6,,NR,1.38,'-,[1.20-1.58],CTNNA2,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,2:79729424
rs1630858-<b>C</b>,5 x 10-6,,NR,1.49,'-,[1.26-1.77],'-,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,9:101910258
rs16861827-<b>T</b>,4 x 10-7,,NR,1.7,'-,[1.39-2.09],IGSF21,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,1:18351676
rs17077369-<b>G</b>,3 x 10-6,,NR,1.63,'-,[1.33-2.00],SLITRK1,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,13:83861212
rs17124276-<b>T</b>,9 x 10-6,,NR,1.36,'-,[1.19-1.56],KCNK10,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,14:88218732
rs17275283-<b>C</b>,6 x 10-7,,NR,1.37,'-,[1.21-1.55],MED28P5,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,11:96970814
rs1924687-<b>A</b>,4 x 10-6,,NR,2.18,'-,[1.57-3.04],LINC02667,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128886429
rs1944782-<b>G</b>,2 x 10-6,,NR,1.36,'-,[1.20-1.54],MED28P5,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,11:96938030
rs1944788-<b>C</b>,9 x 10-7,,NR,1.37,'-,[1.21-1.55],MED28P5,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,11:96947703
rs2152155-<b>C</b>,4 x 10-6,,NR,2.18,'-,[1.57-3.04],LINC02667,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128886296
rs2218400-<b>A</b>,1 x 10-6,,NR,1.38,'-,[1.21-1.57],'-,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,13:63564941
rs2900174-<b>G</b>,1 x 10-6,,NR,3.3,'-,[2.0-5.5],"PRB1, PRB2",Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,12:11394598
rs2989505-<b>T</b>,3 x 10-6,,NR,1.43,'-,[1.23-1.66],DELEC1,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,9:115233945
rs361052-<b>A</b>,8 x 10-7,,NR,1.44,'-,[1.25-1.67],IQSEC1,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,3:13029299
rs3795244-<b>T</b>,3 x 10-6,,NR,2.46,'-,[1.69–3.58],ZNF207,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,17:32365377
rs4150579-<b>A</b>,9 x 10-6,,NR,1.34,'-,[1.18-1.53],GTF2H1,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,11:18335633
rs4285214-<b>G</b>,8 x 10-7,,NR,1.65,'-,[1.35–2.02],ZNF608,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,5:124688588
rs4382459-<b>T</b>,5 x 10-6,,NR,1.56,'-,[1.29-1.89],PREX2,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,8:68087703
rs4757645-<b>C</b>,5 x 10-6,,NR,1.42,'-,[1.22-1.65],"MIR3159, GTF2H1",Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,11:18372298
rs6662005-<b>A</b>,5 x 10-7,,NR,1.71,'-,[1.39-2.12],ERO1B,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,1:236276616
rs7076689-<b>A</b>,4 x 10-6,,NR,2.54,'-,[1.71-3.77],LINC02667,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,10:128889433
rs7202041-<b>A</b>,3 x 10-6,,NR,1.57,'-,[1.30-1.89],RBFOX1,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,16:5621791
rs7330800-<b>C</b>,1 x 10-6,,NR,1.38,'-,[1.21-1.58],LINC00395,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,13:63573938
rs763780-<b>G</b>,3 x 10-8,,NR,3.3,'-,[2.1-5.1],IL17F,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,6:52236941
rs770996-<b>T</b>,3 x 10-6,,NR,1.31,'-,[1.17-1.47],'-,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,3:3313860
rs7853844-<b>A</b>,2 x 10-6,,NR,1.44,'-,[1.24-1.67],DELEC1,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,9:115288135
rs823918-<b>G</b>,3 x 10-6,,NR,1.44,'-,[1.23-1.68],'-,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,9:101901014
rs823920-<b>G</b>,7 x 10-6,,NR,1.43,'-,[1.22-1.67],'-,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,9:101900303
rs9517906-<b>?</b>,8 x 10-6,,NR,1.3333333,'-,[1.18-1.52],CLYBL,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,13:99890797
rs9539806-<b>G</b>,6 x 10-6,,NR,1.32,'-,[1.17-1.50],'-,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,13:63548486
rs9593831-<b>T</b>,7 x 10-6,,NR,1.55,'-,[1.28-1.87],SLITRK1,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,13:83804984
rs981621-<b>G</b>,2 x 10-7,,NR,1.39,'-,[1.23-1.57],LDLRAD4,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,18:13357201
rs9874556-<b>A</b>,4 x 10-6,,NR,1.31,'-,[1.17-1.47],'-,Survival in pancreatic cancer,"overall survival, pancreatic carcinoma",GCST004485,3:3314490
rs8940-<b>G</b>,3 x 10-6,(dominant),'-,2.72,'-,[1.79-4.13],CAV2,Pancreatic ductal adenocarcinoma,pancreatic carcinoma,GCST011817,7:116506020
rs1495741-<b>A</b>,7 x 10-11,(recessive),0.59,6.01,'-,[3.42-10.57],NAT2,Liver injury in anti-tuberculosis drug treatment,"Tuberculosis, response to anti-tuberculosis drug, drug-induced liver injury",GCST007897,8:18415371
rs2756263-<b>G</b>,7 x 10-6,(dominant),0.4,4.47,'-,[2.19-9.11],PRND,Liver injury in anti-tuberculosis drug treatment,"Tuberculosis, response to anti-tuberculosis drug, drug-induced liver injury",GCST007897,20:4725110
rs3135394-<b>G</b>,5 x 10-113,,0.11,3.52,'-,[3.02–4.10],HLA-DRA,Sjögren's syndrome,Sjogren syndrome,GCST004878,6:32440720
rs115575857-<b>G</b>,8 x 10-114,,0.12,3.53,'-,[3.03–4.11],"HLA-DQB1, MTCO3P1",Sjögren's syndrome,Sjogren syndrome,GCST004878,6:32691868
rs116232857-<b>G</b>,1 x 10-96,,0.42,2.53,'-,[2.24–2.86],HLA-DQA1,Sjögren's syndrome,Sjogren syndrome,GCST004878,6:32629287
rs3757387-<b>C</b>,3 x 10-19,,0.45,1.44,'-,[1.29–1.62],"IRF5, KCP",Sjögren's syndrome,Sjogren syndrome,GCST004878,7:128936032
rs17339836-<b>T</b>,2 x 10-16,,0.12,1.58,'-,[1.36–1.84],TNPO3,Sjögren's syndrome,Sjogren syndrome,GCST004878,7:129041008
rs10954213-<b>A</b>,3 x 10-6,,0.62,1.2195122,'-,[1.09-1.37],IRF5,Sjögren's syndrome,Sjogren syndrome,GCST004878,7:128949373
rs10553577-<b>T</b>,7 x 10-15,,0.23,1.43,'-,[1.26–1.62],STAT4,Sjögren's syndrome,Sjogren syndrome,GCST004878,2:191090464
rs485497-<b>A</b>,1 x 10-10,,0.48,1.3,'-,[1.16–1.46],IL12A-AS1,Sjögren's syndrome,Sjogren syndrome,GCST004878,3:160001345
rs2736345-<b>G</b>,5 x 10-10,,0.29,1.3,'-,[1.16–1.47],BLK,Sjögren's syndrome,Sjogren syndrome,GCST004878,8:11494976
rs7119038-<b>A</b>,1 x 10-8,,0.77,1.3513513,'-,[1.16-1.56],"CXCR5, Y_RNA",Sjögren's syndrome,Sjogren syndrome,GCST004878,11:118867572
rs6579837-<b>T</b>,3 x 10-8,,0.09,1.43,'-,[1.20–1.71],TNIP1,Sjögren's syndrome,Sjogren syndrome,GCST004878,5:151055333
rs6933404-<b>C</b>,7 x 10-8,,0.21,1.29,'-,[1.13–1.47],"LINC02539, BTF3L4P3",Sjögren's syndrome,Sjogren syndrome,GCST004878,6:137638098
rs2431098-<b>G</b>,2 x 10-7,,0.49,1.2345679,'-,[1.10-1.37],MIR3142HG,Sjögren's syndrome,Sjogren syndrome,GCST004878,5:160460329
rs526531-<b>A</b>,3 x 10-6,,0.31,1.22,'-,[1.09–1.38],ATG5,Sjögren's syndrome,Sjogren syndrome,GCST004878,6:106122181
rs3733346-<b>C</b>,8 x 10-6,,0.49,1.2,'-,[1.22–1.18],DGKQ,Sjögren's syndrome,Sjogren syndrome,GCST004878,4:960487
rs1507153-<b>A</b>,7 x 10-7,,0.36,1.26,'-,[1.11–1.43],IRAK1BP1,Sjögren's syndrome,Sjogren syndrome,GCST004879,6:78774669
rs1545257-<b>C</b>,2 x 10-6,,0.52,1.2345679,'-,[1.10-1.41],"ITSN2, NCOA1",Sjögren's syndrome,Sjogren syndrome,GCST004879,2:24435925
rs10943608-<b>C</b>,6 x 10-6,,0.37,1.23,'-,[1.08–1.40],PHIP,Sjögren's syndrome,Sjogren syndrome,GCST004879,6:78965212
rs359457-<b>T</b>,9 x 10-7,,0.55,1.2658228,'-,[1.25-1.39],"CPEB4, LINC01485",Sjögren's syndrome,Sjogren syndrome,GCST005532,5:173852839
rs13425999-<b>C</b>,3 x 10-6,,0.92,1.5625,'-,[1.3-1.89],RASGRP3,Sjögren's syndrome,Sjogren syndrome,GCST005532,2:33477136
chr1:100993403-<b>G</b>,4 x 10-6,,0.04,1.68,'-,[1.35-2.09],'-,Sjögren's syndrome,Sjogren syndrome,GCST005532,Mapping not available
rs11915281-<b>T</b>,5 x 10-6,,0.02,2.09,'-,[1.52-2.87],SATB1-AS1,Sjögren's syndrome,Sjogren syndrome,GCST005532,3:18621496
rs4766578-<b>T</b>,8 x 10-6,,0.48,1.23,'-,[1.12-1.35],ATXN2,Sjögren's syndrome,Sjogren syndrome,GCST005532,12:111466567
rs1554770-<b>A</b>,8 x 10-6,,0.55,1.2345679,'-,[1.12-1.35],"LINC01117, RNU6-187P",Sjögren's syndrome,Sjogren syndrome,GCST005532,2:176906489
rs190283338-<b>A</b>,3 x 10-7,,0.01081,3.946,'-,[2.33-6.682],KCNS3,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,2:18200073
rs62125344-<b>C</b>,1 x 10-6,,0.01755,2.937,'-,[1.906-4.524],'-,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,2:18783757
rs148894474-<b>C</b>,3 x 10-6,,0.0324,2.171,'-,[1.567-3.00699999999999],GLS,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,2:190815604
rs146397235-<b>T</b>,5 x 10-7,,0.01178,3.412,'-,[2.117-5.497],ADAMTS3,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,4:72492529
rs6552940-<b>G</b>,7 x 10-6,,0.3552,1.431,'-,[1.224-1.674],SORBS2,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,4:185947813
rs13195460-<b>G</b>,8 x 10-7,,0.1268,1.676,'-,[1.3659999999999899-2.056],HECA,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,6:139175645
rs375800732-<b>C</b>,6 x 10-6,,0.1258,1.602,'-,[1.306-1.964],PTGES3P5,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,10:108313138
rs55724440-<b>C</b>,7 x 10-6,,0.06457,1.792,'-,[1.39-2.31],PTPRJ,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,11:47977268
rs150007474-<b>A</b>,6 x 10-6,,0.0173,2.807,'-,[1.799-4.382],SRRM4,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,12:119123145
rs148131145-<b>C</b>,2 x 10-6,,0.01916,2.713,'-,[1.797-4.096],TRPM7,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,15:50670386
rs145791702-<b>T</b>,1 x 10-6,,0.02445,2.493,'-,[1.723-3.608],RPL32P30,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,15:50801703
rs985183711-<b>G</b>,7 x 10-7,,0.01304,3.246,'-,[2.04-5.165],MAPK8IP3,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,16:1719705
rs139293840-<b>A</b>,1 x 10-6,,0.01013,3.359,'-,[2.058-5.484],RPTOR,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,17:80556559
rs142206837-<b>G</b>,9 x 10-6,,0.01071,2.986,'-,[1.84-4.845],RPTOR,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,17:80675272
rs79284447-<b>C</b>,6 x 10-6,,0.01656,2.679,'-,[1.746-4.111],SLC14A2,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,18:45339723
rs148241618-<b>A</b>,9 x 10-6,,0.02252,2.447,'-,[1.648-3.634],EPG5,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,18:45880124
rs2683043-<b>G</b>,7 x 10-6,,0.1169,1.622,'-,[1.314-2.003],CYP4F3,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,19:15653261
rs1882758-<b>C</b>,5 x 10-7,,0.3975,0.6509,'-,[0.5507-0.7694],DSCAM,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,21:40238869
rs193244257-<b>G</b>,1 x 10-6,,0.01903,2.678,'-,[1.793-3.998],RSPH14,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,22:23068108
rs75970667-<b>C</b>,5 x 10-6,,0.05579,2.361,'-,[1.635-3.409],"DEFA3, DEFA11P",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,8:7023694
"rs7574865-<b>C</b>, rs3024921-<b>A</b>",5 x 10-18,,0.06,1.61,'-,'-,STAT4; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,2:191099907
"rs7574865-<b>A</b>, rs3024921-<b>T</b>",3 x 10-9,,0.22,1.23,'-,'-,STAT4; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,2:191099907
"rs7574865-<b>C</b>, rs3024921-<b>T</b>",9 x 10-25,,0.72,0.72,'-,'-,STAT4; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,2:191099907
"rs2366643-<b>G</b>, rs80014155-<b>G</b>, rs668998-<b>A</b>, rs62270414-<b>A</b>",3 x 10-35,,0.3,0.62,'-,'-,LINC01100; IL12A-AS1; No mapped genes; No mapped genes; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,3:160018698
"rs2366643-<b>A</b>, rs80014155-<b>G</b>, rs668998-<b>G</b>, rs62270414-<b>G</b>",5 x 10-6,,0.01,2.53,'-,'-,LINC01100; IL12A-AS1; No mapped genes; No mapped genes; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,3:160018698
"rs2366643-<b>A</b>, rs80014155-<b>G</b>, rs668998-<b>A</b>, rs62270414-<b>G</b>",5 x 10-10,,0.05,1.52,'-,'-,LINC01100; IL12A-AS1; No mapped genes; No mapped genes; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,3:160018698
"rs2366643-<b>A</b>, rs80014155-<b>A</b>, rs668998-<b>A</b>, rs62270414-<b>A</b>",2 x 10-9,,0,3.22,'-,'-,LINC01100; IL12A-AS1; No mapped genes; No mapped genes; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,3:160018698
"rs2366643-<b>A</b>, rs80014155-<b>G</b>, rs668998-<b>G</b>, rs62270414-<b>A</b>",2 x 10-14,,0.38,1.28,'-,'-,LINC01100; IL12A-AS1; No mapped genes; No mapped genes; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,3:160018698
"rs3807307-<b>G</b>, rs35188261-<b>A</b>",7 x 10-22,,0.11,1.52,'-,'-,IRF5; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,7:128939148
"rs3807307-<b>A</b>, rs35188261-<b>G</b>",3 x 10-19,,0.53,0.76,'-,'-,IRF5; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,7:128939148
"rs1800693-<b>G</b>, rs11064157-<b>A</b>",2 x 10-16,,0.09,1.58,'-,'-,TNFRSF1A; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,12:6330843
"rs1800693-<b>A</b>, rs11064157-<b>C</b>",7 x 10-19,,0.45,0.74,'-,'-,TNFRSF1A; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,12:6330843
"rs80073729-<b>G</b>, rs12708715-<b>A</b>, rs1646019-<b>A</b>",6 x 10-20,,0.1,0.51,'-,'-,RMI2; No mapped genes; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,16:11279940
"rs80073729-<b>G</b>, rs12708715-<b>G</b>, rs1646019-<b>G</b>",2 x 10-23,,0.48,1.38,'-,'-,RMI2; No mapped genes; No mapped genes,Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,16:11279940
rs7774434-<b>C</b>,1 x 10-48,,0.38,1.57,'-,'-,"MTCO3P1, HLA-DQB1",Primary biliary cirrhosis,primary biliary cirrhosis,GCST005581,6:32689801
rs17047200-<b>T</b>,3 x 10-8,,'-,2.37,'-,[1.74-3.23],TLL1,Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy,"response to interferon, hepatocellular carcinoma, virologic response measurement",GCST004160,4:166008836
rs11335470-<b>?</b>,2 x 10-6,(Heterozygous),NR,'-,'-,[NR],LINC00944,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,12:126753075
rs113449872-<b>?</b>,3 x 10-7,(Heterozygous),NR,'-,'-,[NR],'-,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,5:43909241
rs114169033-<b>?</b>,1 x 10-6,(Additive),NR,'-,'-,[NR],FRG1-DT,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,4:189796550
rs144312179-<b>?</b>,3 x 10-6,(Additive),NR,'-,'-,[NR],FAM155A,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,13:107575665
rs149085856-<b>?</b>,1 x 10-6,(Additive),NR,'-,'-,[NR],LINC00670,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,17:12496210
rs17624383-<b>?</b>,3 x 10-6,(Additive),NR,'-,'-,[NR],LINC01446,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,7:53609144
rs1878468-<b>?</b>,1 x 10-6,(Heterozygous),NR,'-,'-,[NR],TENM3-AS1,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,4:181901179
rs2967790-<b>?</b>,2 x 10-6,(Additive),NR,'-,'-,[NR],KLHL3,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,5:137676072
rs3133394-<b>?</b>,1 x 10-6,(Additive),NR,'-,'-,[NR],BAK1P2,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,11:130547627
rs6588252-<b>?</b>,9 x 10-7,(Recessive),NR,'-,'-,[NR],"DNAJB6P4, RNU4ATAC4P",Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,1:67273345
rs73505850-<b>?</b>,1 x 10-6,(Additive),NR,'-,'-,[NR],CSMD1,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,8:4897316
rs73832816-<b>?</b>,9 x 10-7,(Recessive),NR,'-,'-,[NR],"C4orf17, ADH7",Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,4:99508600
rs8109875-<b>?</b>,4 x 10-6,(Recessive),NR,'-,'-,[NR],ZNF536,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,19:30578732
rs9296359-<b>?</b>,4 x 10-7,(Heterozygous),NR,'-,'-,[NR],TREML4,Severe malaria (adjusted for sickle cell variant rs334),malaria,GCST005357,6:41237952
rs114169033-<b>?</b>,7 x 10-7,(Additive),NR,3.326,'-,[NR],FRG1-DT,Severe malaria,malaria,GCST005356,4:189796550
rs2188554-<b>A</b>,6 x 10-9,,'-,1.2322,'-,[1.16-1.3],"CFTR, ASZ1",Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST003739,7:117400063
rs76014404-<b>T</b>,2 x 10-8,,'-,1.2102,'-,[1.14-1.28],KHDRBS2,Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST003739,6:61681634
rs9823696-<b>A</b>,2 x 10-8,,'-,1.1715,'-,[1.12-1.23],"HTR3C2P, HTR3C",Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST003739,3:184065565
rs75783973-<b>A</b>,2 x 10-8,,'-,1.3303,'-,[1.23-1.43],TPPP,Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST003739,5:668194
rs7255-<b>T</b>,4 x 10-8,,'-,1.1654,'-,[1.11-1.22],GDF7,Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST003739,2:20679060
rs13069567-<b>T</b>,6 x 10-7,,NR,'-,0.49 unit increase,[NR],"MECOM, LINC01997",Bone mineral density (lumbar spine) in inflammatory bowel disease,"inflammatory bowel disease, spine bone mineral density",GCST005783,3:169042362
rs2839073-<b>C</b>,8 x 10-7,,NR,'-,0.53 unit decrease,[NR],"PCBP3, COL6A1",Bone mineral density (lumbar spine) in inflammatory bowel disease,"inflammatory bowel disease, spine bone mineral density",GCST005783,21:45953845
rs8009169-<b>C</b>,1 x 10-6,,NR,'-,0.5 unit decrease,[NR],YWHAQP1,Bone mineral density (lumbar spine) in inflammatory bowel disease,"inflammatory bowel disease, spine bone mineral density",GCST005783,14:42813211
rs7968307-<b>C</b>,1 x 10-6,,NR,'-,0.52 unit increase,[NR],"OSTF1P1, Y_RNA",Bone mineral density (lumbar spine) in inflammatory bowel disease,"inflammatory bowel disease, spine bone mineral density",GCST005783,12:114620647
rs66725070-<b>GACAT</b>,3 x 10-10,,'-,1.15,'-,[1.11-1.19],ALDH1A2,Barrett's esophagus,Barrett's esophagus,GCST003738,15:57975219
rs17749155-<b>A</b>,2 x 10-9,,'-,1.2039,'-,[1.14-1.26],MSRA,Barrett's esophagus,Barrett's esophagus,GCST003738,8:10210563
rs2409797-<b>T</b>,3 x 10-9,,'-,1.1394,'-,[1.1-1.18],LINC00208,Barrett's esophagus,Barrett's esophagus,GCST003738,8:11576271
rs7852462-<b>C</b>,4 x 10-9,,'-,1.1466575,'-,[1.10-1.19],TMOD1,Barrett's esophagus,Barrett's esophagus,GCST003738,9:97548219
rs9257809-<b>A</b>,6 x 10-9,,'-,1.2634,'-,[1.18-1.34],OR5V1,Barrett's esophagus,Barrett's esophagus,GCST003738,6:29388554
rs1594318-<b>G</b>,4 x 10-8,(EA),0.4,1.1792454,'-,[NR],ALLC,Childhood dental caries in primary teeth,dental caries,GCST006312,2:3686354
rs1594318-<b>G</b>,4 x 10-7,,0.4,1.1520737,'-,[NR],ALLC,Childhood dental caries in primary teeth,dental caries,GCST006312,2:3686354
rs7738851-<b>A</b>,2 x 10-8,,0.85,1.28,'-,[NR],NEDD9,Childhood dental caries in permanent teeth,dental caries,GCST006311,6:11241555
rs2799083-<b>?</b>,2 x 10-6,,NR,2.27,'-,[1.61-3.19],TGFB2,Gemcitabine-induced early high-grade neutropenia in pancreatic cancer,"neutropenia, response to gemcitabine, pancreatic carcinoma",GCST007643,1:218408275
rs9835060-<b>?</b>,5 x 10-6,,NR,2.59,'-,[1.7-3.94],UPK1B,Gemcitabine-induced early high-grade neutropenia in pancreatic cancer,"neutropenia, response to gemcitabine, pancreatic carcinoma",GCST007643,3:119189379
rs12526817-<b>?</b>,3 x 10-6,,NR,2.22,'-,[1.57-3.14],NT5DC1,Gemcitabine-induced early high-grade neutropenia in pancreatic cancer,"neutropenia, response to gemcitabine, pancreatic carcinoma",GCST007643,6:116188473
rs17117434-<b>?</b>,5 x 10-6,,NR,2.86,'-,[1.78-4.6],'-,Gemcitabine-induced early high-grade neutropenia in pancreatic cancer,"neutropenia, response to gemcitabine, pancreatic carcinoma",GCST007643,8:13768307
rs7915425-<b>?</b>,4 x 10-6,,NR,2.34,'-,[1.62-3.39],"RPS26P39, LINC02641",Gemcitabine-induced early high-grade neutropenia in pancreatic cancer,"neutropenia, response to gemcitabine, pancreatic carcinoma",GCST007643,10:123256985
rs1941238-<b>?</b>,7 x 10-6,,NR,2.34,'-,[1.6-3.43],RN7SL97P,Gemcitabine-induced early high-grade neutropenia in pancreatic cancer,"neutropenia, response to gemcitabine, pancreatic carcinoma",GCST007643,18:25864505
rs34309238-<b>A</b>,5 x 10-10,,0.018,1.77,'-,[1.48–2.12],PKN1,Pancreatic cancer,pancreatic carcinoma,GCST009895,19:14464085
rs2242241-<b>G</b>,4 x 10-9,,0.014,1.85,'-,[1.50–2.27],DOK2,Pancreatic cancer,pancreatic carcinoma,GCST009895,8:21909370
rs183117027-<b>A</b>,4 x 10-8,,0.006,2.34,'-,[1.72–3.16],APOB,Pancreatic cancer,pancreatic carcinoma,GCST009895,2:21004340
rs6139258-<b>C</b>,6 x 10-7,,0.02,13.62,'-,[4.90-37.84],RNF24,Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury),"response to reverse transcriptase inhibitor, HIV infection, drug-induced liver injury",GCST004114,20:3977969
rs61907765-<b>T</b>,2 x 10-13,,'-,1.1712317,'-,'-,ETS1,Celiac disease,celiac disease,GCST009874,11:128522042
rs60600003-<b>G</b>,4 x 10-13,,'-,1.2354879,'-,'-,ELMO1,Celiac disease,celiac disease,GCST009874,7:37342861
rs2542148-<b>C</b>,8 x 10-12,,'-,1.1785113,'-,'-,"PTPN2, LINC01882",Celiac disease,celiac disease,GCST009874,18:12777574
rs212407-<b>G</b>,1 x 10-11,,'-,1.1342878,'-,'-,TAGAP-AS1,Celiac disease,celiac disease,GCST009874,6:159049385
rs10912267-<b>?</b>,1 x 10-11,,'-,1.1871982,'-,'-,"SLC25A38P1, FASLG",Celiac disease,celiac disease,GCST009874,1:172705636
rs7426056-<b>A</b>,2 x 10-11,,'-,1.1509169,'-,'-,"CD28, KRT18P39",Celiac disease,celiac disease,GCST009874,2:203747335
rs10892299-<b>?</b>,2 x 10-11,,'-,1.1708161,'-,'-,"Y_RNA, CXCR5",Celiac disease,celiac disease,GCST009874,11:118856134
rs74643882-<b>T</b>,4 x 10-11,,'-,1.6147691,'-,'-,KIAA1109,Celiac disease,celiac disease,GCST009874,4:122345366
rs1893592-<b>?</b>,9 x 10-11,,'-,1.1420285,'-,'-,UBASH3A,Celiac disease,celiac disease,GCST009874,21:42434957
rs11712165-<b>G</b>,4 x 10-10,,'-,1.1212375,'-,'-,ARHGAP31,Celiac disease,celiac disease,GCST009874,3:119399949
rs3087243-<b>?</b>,5 x 10-10,,'-,1.1201224,'-,'-,"CTLA4, ICOS",Celiac disease,celiac disease,GCST009874,2:203874196
rs7104791-<b>T</b>,8 x 10-10,,'-,1.1429985,'-,'-,"COLCA2, MIR4491",Celiac disease,celiac disease,GCST009874,11:111326133
rs6691768-<b>?</b>,1 x 10-9,,'-,1.1220081,'-,'-,NFIA,Celiac disease,celiac disease,GCST009874,1:61326191
rs66534072-<b>G</b>,1 x 10-9,,'-,1.155583,'-,'-,UBE2L3,Celiac disease,celiac disease,GCST009874,22:21581863
rs6749371-<b>?</b>,7 x 10-9,,'-,1.2320741,'-,'-,STAT4,Celiac disease,celiac disease,GCST009874,2:191037458
rs12132349-<b>?</b>,8 x 10-9,,'-,1.1243252,'-,'-,INAVA,Celiac disease,celiac disease,GCST009874,1:200906114
rs6664969-<b>?</b>,1 x 10-8,,'-,1.1169313,'-,'-,MMEL1,Celiac disease,celiac disease,GCST009874,1:2603539
rs13415465-<b>?</b>,1 x 10-7,,'-,1.1053423,'-,'-,AFF3,Celiac disease,celiac disease,GCST009874,2:100147542
rs947474-<b>?</b>,2 x 10-7,,'-,1.1307374,'-,'-,LINC02649,Celiac disease,celiac disease,GCST009874,10:6348488
rs11757201-<b>C</b>,4 x 10-7,,'-,1.223361,'-,'-,LINC02539,Celiac disease,celiac disease,GCST009874,6:137682685
rs72928038-<b>A</b>,4 x 10-7,,'-,1.1287999,'-,'-,BACH2,Celiac disease,celiac disease,GCST009874,6:90267049
rs34593439-<b>A</b>,2 x 10-6,,'-,1.1450393,'-,'-,CTSH,Celiac disease,celiac disease,GCST009874,15:78942615
rs2812378-<b>G</b>,5 x 10-6,,'-,1.091308,'-,'-,"FAM205A, CCL21",Celiac disease,celiac disease,GCST009874,9:34710263
rs2030519-<b>?</b>,5 x 10-52,,'-,1.3221326,'-,'-,LPP,Celiac disease,celiac disease,GCST009874,3:188402113
rs13132308-<b>?</b>,3 x 10-36,,'-,1.4120632,'-,'-,IL21-AS1,Celiac disease,celiac disease,GCST009874,4:122629959
rs1359062-<b>?</b>,4 x 10-30,,'-,1.3264511,'-,'-,RGS1,Celiac disease,celiac disease,GCST009874,1:192572342
rs17753641-<b>G</b>,7 x 10-29,,'-,1.3797095,'-,'-,IL12A-AS1,Celiac disease,celiac disease,GCST009874,3:159929885
rs3190930-<b>T</b>,2 x 10-20,,'-,1.2111726,'-,'-,PTPRK,Celiac disease,celiac disease,GCST009874,6:127970054
rs41432345-<b>C</b>,2 x 10-19,,'-,1.3497887,'-,'-,CCR3,Celiac disease,celiac disease,GCST009874,3:46208883
rs12619531-<b>G</b>,4 x 10-19,,'-,1.175986,'-,'-,LINC01934,Celiac disease,celiac disease,GCST009874,2:181192913
rs3184504-<b>?</b>,1 x 10-17,,'-,1.1699768,'-,'-,"SH2B3, ATXN2",Celiac disease,celiac disease,GCST009874,12:111446804
rs10469840-<b>T</b>,2 x 10-16,,'-,1.1902305,'-,'-,SLC9A4,Celiac disease,celiac disease,GCST009874,2:102476784
rs1353248-<b>?</b>,5 x 10-16,,'-,1.1798072,'-,'-,IL12A-AS1,Celiac disease,celiac disease,GCST009874,3:159905770
rs1250568-<b>?</b>,1 x 10-14,,'-,1.1538163,'-,'-,ZMIZ1,Celiac disease,celiac disease,GCST009874,10:79285523
rs4560096-<b>G</b>,2 x 10-13,,'-,1.1451596,'-,'-,PUS10,Celiac disease,celiac disease,GCST009874,2:60977782
rs200950799-<b>T</b>,2 x 10-9,,0.011,'-,28.361 unit decrease,[19.13-37.59],"RNU6-837P, EEF1A1P16",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,12:17004185
rs8026743-<b>A</b>,1 x 10-11,,0.338,'-,0.645 unit increase,[0.46-0.83],LINC02694,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,15:38937539
rs6145546-<b>G</b>,2 x 10-17,,0.45,'-,0.777 unit decrease,[0.6-0.96],GATM,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,15:45376406
rs1906436-<b>T</b>,2 x 10-9,,0.633,'-,0.559 unit increase,[0.37-0.74],WDR72,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,15:53590245
rs2047866-<b>T</b>,6 x 10-10,,0.459,'-,0.575 unit decrease,[0.39-0.76],UBE2Q2,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,15:75843853
rs12922822-<b>T</b>,2 x 10-82,,0.168,'-,2.287 unit increase,[2.05-2.52],"UMOD, PDILT",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,16:20356323
rs2079742-<b>T</b>,6 x 10-8,,0.824,'-,0.681 unit increase,[0.43-0.93],BCAS3,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,17:61388336
rs8096658-<b>C</b>,1 x 10-8,,0.558,'-,0.523 unit increase,[0.34-0.7],NFATC1,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,18:79396537
rs3765209-<b>T</b>,6 x 10-9,,0.322,'-,0.55 unit decrease,[0.36-0.74],CYCSP42,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,21:15417030
rs10084572-<b>T</b>,1 x 10-12,,0.014,'-,28.026 unit decrease,[20.31-35.74],"RNU6-1150P, AGPAT3",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,21:43992991
rs2023463-<b>T</b>,1 x 10-11,,0.092,'-,1.01 unit decrease,[0.72-1.3],OR11A1,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:29445226
rs2517601-<b>C</b>,4 x 10-12,,0.115,'-,0.956 unit decrease,[0.69-1.23],"TRIM31-AS1, TRIM31",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:30106295
rs1264347-<b>T</b>,1 x 10-12,,0.109,'-,1.01 unit decrease,[0.73-1.29],"LINC00243, LINC02570",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:30830920
rs2923008-<b>T</b>,2 x 10-12,,0.106,'-,1.017 unit decrease,[0.73-1.3],"LINC02571, HLA-B",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:31349134
rs497309-<b>A</b>,5 x 10-12,,0.902,'-,1.009 unit increase,[0.72-1.3],C2,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:31924707
rs2105903-<b>A</b>,4 x 10-12,,0.838,'-,0.821 unit increase,[0.59-1.05],"TSBP1-AS1, HLA-DRA",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:32427879
rs56013828-<b>A</b>,3 x 10-8,,0.211,'-,0.642 unit increase,[0.41-0.87],ARG1,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:131511584
rs145590578-<b>A</b>,5 x 10-12,,0.115,'-,0.944 unit decrease,[0.68-1.21],SLC22A2,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:160236104
rs62435145-<b>T</b>,2 x 10-11,,0.597,'-,0.643 unit decrease,[0.45-0.83],UNCX,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,7:1246931
rs10224210-<b>T</b>,5 x 10-23,,0.738,'-,0.998 unit increase,[0.8-1.2],PRKAG2,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,7:151716108
rs1556751-<b>A</b>,6 x 10-9,,0.618,'-,0.516 unit increase,[0.34-0.69],PIP5K1B,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,9:68818296
rs334-<b>A</b>,7 x 10-13,,0.059,'-,3.793 unit decrease,[2.76-4.83],HBB,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,11:5227002
rs963837-<b>T</b>,1 x 10-21,,0.584,'-,0.907 unit decrease,[0.72-1.09],MPPED2-AS1,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,11:30727543
rs60307791-<b>G</b>,2 x 10-8,,0.331,'-,0.545 unit decrease,[0.35-0.74],"AP5B1, KRT8P26",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,11:65767714
rs2421556-<b>T</b>,4 x 10-8,,0.65,'-,0.531 unit decrease,[0.34-0.72],TPRKB,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,2:73733254
rs1047891-<b>A</b>,3 x 10-12,,0.33,'-,0.64 unit decrease,[0.46-0.82],CPS1,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,2:210675783
rs13146355-<b>A</b>,2 x 10-13,,0.406,'-,0.666 unit decrease,[0.49-0.84],SHROOM3,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,4:76490987
rs413988-<b>T</b>,3 x 10-11,,0.694,'-,0.943 unit increase,[0.66-1.22],"TPPP, ZDHHC11B",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,5:698535
rs10941191-<b>A</b>,9 x 10-9,,0.541,'-,0.547 unit decrease,[0.36-0.73],'-,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,5:34504693
rs2542713-<b>A</b>,6 x 10-8,,0.451,'-,0.484 unit decrease,[0.31-0.66],"DAB2, C9",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,5:39385539
rs3812035-<b>T</b>,1 x 10-10,,0.303,'-,0.606 unit decrease,[0.42-0.79],SLC34A1,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,5:177390142
rs35789010-<b>A</b>,4 x 10-8,,0.061,'-,1.019 unit decrease,[0.65-1.38],CARMIL1,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:25513951
rs13191445-<b>A</b>,3 x 10-8,,0.07,'-,0.933 unit decrease,[0.6-1.26],"H3P26, TRIM38",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:26015261
rs61742093-<b>A</b>,1 x 10-8,,0.92,'-,0.926 unit increase,[0.61-1.24],OR2B2,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:27912204
rs3132374-<b>C</b>,3 x 10-9,,0.916,'-,0.959 unit increase,[0.64-1.27],"HCG14, TRIM27",Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:28900717
rs139706471-<b>C</b>,4 x 10-6,,0.03207,2.055,'-,[1.515-2.788],DEPDC1-AS1,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,1:68602584
rs144648928-<b>A</b>,2 x 10-6,,0.02297,2.343,'-,[1.644-3.339],"FGGY, LINC02884",Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,1:112174380
rs190283338-<b>A</b>,6 x 10-7,,0.01081,3.504,'-,[2.14-5.736],KCNS3,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,2:18200073
rs188585450-<b>A</b>,6 x 10-6,,0.01465,2.642,'-,[1.733-4.026],'-,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,2:18755763
rs11685304-<b>T</b>,5 x 10-6,,0.2525,1.404,'-,[1.214-1.623],"RNU6-440P, FZD7",Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,2:201991683
rs543659530-<b>A</b>,2 x 10-6,,0.01287,2.948,'-,[1.895-4.586],PCDH7,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,4:30844804
rs146397235-<b>T</b>,3 x 10-6,,0.01178,2.892,'-,[1.847-4.527],ADAMTS3,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,4:72492529
rs144192875-<b>T</b>,3 x 10-6,,0.02281,2.339,'-,[1.636-3.345],LINC02511,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,4:136733494
rs17691129-<b>G</b>,4 x 10-6,,0.08619,1.639,'-,[1.33-2.02],'-,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,7:91538287
rs62473335-<b>C</b>,9 x 10-6,,0.01981,2.373,'-,[1.62-3.476],PTPRN2,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,7:109630114
rs535035513-<b>T</b>,1 x 10-5,,0.01407,2.929,'-,[1.82-4.71399999999999],"TRMT112P7, RP1",Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,8:54500661
rs116946228-<b>G</b>,5 x 10-6,,0.01331,2.638,'-,[1.74-4.001],'-,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,9:80940338
rs776972026-<b>A</b>,3 x 10-6,,0.01058,2.953,'-,[1.876-4.648],CHORDC1,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,11:90205438
rs534128177-<b>T</b>,7 x 10-6,,0.0168,2.446,'-,[1.65699999999999-3.612],DISC1FP1,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,11:90455679
rs180986320-<b>G</b>,6 x 10-6,,0.01586,2.563,'-,[1.705-3.85399999999999],FGD6,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,12:95196849
rs150007474-<b>A</b>,9 x 10-6,,0.0173,2.525,'-,[1.676-3.805],SRRM4,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,12:119123145
rs8061878-<b>G</b>,8 x 10-6,,0.03292,1.975,'-,[1.466-2.661],"RNA5SP430, TERF2IP",Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,16:75842468
rs564085990-<b>A</b>,4 x 10-6,,0.01004,3.013,'-,[1.884-4.817],CRLF3,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,17:30815147
rs139970884-<b>G</b>,3 x 10-6,,0.01149,2.911,'-,[1.865-4.545],NSF,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,17:46752887
rs1057040-<b>A</b>,5 x 10-6,,0.3951,0.7166,'-,[0.6211-0.8268],USP36,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,17:78803713
rs954846345-<b>G</b>,2 x 10-6,,0.01019,2.959,'-,[1.891-4.629],RNF213,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,17:80294030
rs139293840-<b>A</b>,2 x 10-8,,0.01013,3.511,'-,[2.265-5.444],RPTOR,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,17:80556559
rs142206837-<b>G</b>,3 x 10-7,,0.01071,3.084,'-,[2.004-4.747],RPTOR,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,17:80675272
rs729743-<b>A</b>,8 x 10-6,,0.01073,2.78,'-,[1.774-4.357],RPTOR,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,17:80796014
rs79284447-<b>C</b>,2 x 10-6,,0.01656,2.563,'-,[1.738-3.778],SLC14A2,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,18:45339723
rs148241618-<b>A</b>,1 x 10-6,,0.02252,2.402,'-,[1.681-3.431],EPG5,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,18:45880124
rs2848859-<b>C</b>,9 x 10-6,,0.4049,1.354,'-,[1.184-1.548],'-,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,18:71010248
rs145889349-<b>G</b>,2 x 10-6,,0.01324,2.823,'-,[1.835-4.342],NCAM2,Cardio-cerebrovascular disease in diabetes mellitus,"Ischemic stroke, diabetes mellitus, coronary artery disease",GCST90014127,21:21106262
rs4646851-<b>A</b>,5 x 10-6,,0.01117,2.978,'-,[1.861-4.765],"ALDH5A1, KIAA0319",Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,6:24537413
rs6922162-<b>A</b>,8 x 10-6,,0.1772,1.515,'-,[1.262-1.817],"FAM83B, RNU6-1023P",Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,6:54823333
rs9389642-<b>T</b>,3 x 10-6,,0.2645,0.6342,'-,[0.5237-0.768],"ABRACL, REPS1",Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,6:138990228
rs146779282-<b>C</b>,9 x 10-6,,0.01299,2.983,'-,[1.844-4.826],DPP6,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,7:154584593
rs73155085-<b>A</b>,4 x 10-6,,0.1649,1.542,'-,[1.283-1.85199999999999],"LINC02557, PCAT14",Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST90014128,22:23535870
rs2293370-<b>A</b>,1 x 10-6,,0.288577154,1.3385916,'-,[1.189-1.507],TIMMDC1,Primary biliary cholangitis,primary biliary cirrhosis,GCST004145,3:119501087
rs644587-<b>T</b>,1 x 10-6,,0.115768463,1.5461389,'-,[1.293-1.848],IL12A-AS1,Primary biliary cholangitis,primary biliary cirrhosis,GCST004145,3:159945506
rs230534-<b>T</b>,1 x 10-7,,0.325249169,1.3360554,'-,[1.199-1.489],NFKB1,Primary biliary cholangitis,primary biliary cirrhosis,GCST004145,4:102527884
rs6897932-<b>T</b>,6 x 10-9,,0.195130087,1.5187576,'-,[1.319-1.749],IL7R,Primary biliary cholangitis,primary biliary cirrhosis,GCST004145,5:35874473
rs4979462-<b>C</b>,8 x 10-19,,0.463,1.6006049,'-,[1.442-1.777],TNFSF15,Primary biliary cholangitis,primary biliary cirrhosis,GCST004145,9:114804733
rs4938534-<b>A</b>,1 x 10-8,,0.447631755,1.3504277,'-,[1.217-1.498],POU2AF1,Primary biliary cholangitis,primary biliary cirrhosis,GCST004145,11:111404408
rs9303277-<b>T</b>,8 x 10-11,,0.308489305,1.4342519,'-,[1.286-1.599],IKZF3,Primary biliary cholangitis,primary biliary cirrhosis,GCST004145,17:39820216
rs7404928-<b>T</b>,4 x 10-9,,0.632,1.26,'-,[1.16-1.35],PRKCB,Primary biliary cholangitis,primary biliary cirrhosis,GCST004145,16:23877519
rs148933117-<b>?</b>,7 x 10-7,,'-,1.584535,'-,[1.33-1.90],"FBLIM1, RPL12P14",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15791573
rs149055315-<b>?</b>,2 x 10-9,,'-,2.5756361,'-,[1.92-3.40],RNF128,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106730962
rs149506335-<b>?</b>,2 x 10-18,,'-,1.7766,'-,[1.57-2.01],"WBP1LP1, PRSS2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142776454
rs150350251-<b>?</b>,6 x 10-6,,'-,2.516356,'-,[1.72-3.70],"MTPN, FAM180A",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:135830074
rs17211-<b>?</b>,7 x 10-7,,'-,1.4794,'-,[1.28-1.71],TRBV20-1,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142627230
rs17251-<b>?</b>,5 x 10-11,,'-,1.3213531,'-,[1.22-1.40],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs17777717-<b>?</b>,1 x 10-7,,'-,1.3678019,'-,[1.22-1.50],"WBP1LP1, TRBD1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142783765
rs1799886-<b>?</b>,5 x 10-7,,'-,1.2639029,'-,[1.16-1.40],"TRBC2, TRBJ2-7",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142800839
rs1800907-<b>?</b>,8 x 10-14,,'-,1.4134276,'-,[1.30-1.50],"TRBJ2-7, TRBC2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142800425
rs180741377-<b>?</b>,3 x 10-6,,'-,2.0588841,'-,[1.54-2.70],"KEL, OR9A2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142965992
rs186808650-<b>?</b>,6 x 10-6,,'-,1.2647022,'-,[1.15-1.40],NANOS1,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,10:119029751
rs192514996-<b>?</b>,5 x 10-18,,'-,2.1017,'-,[1.79-2.46],"PRSS2, WBP1LP1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142778229
rs1927309-<b>?</b>,5 x 10-6,,'-,1.6174753,'-,[1.33-1.96],"MORC4, EEF1A1P40",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107011960
rs2138717-<b>?</b>,3 x 10-6,,'-,1.613316,'-,[1.33-2.00],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:87315170
rs2179628-<b>?</b>,1 x 10-7,,'-,2.4949129,'-,[1.82-3.40],"KRT18P49, FRMPD3",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107434651
rs2226970-<b>?</b>,6 x 10-10,,'-,1.320132,'-,[1.22-1.40],"TRBV23-1, TRBV24-1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142648438
rs2420495-<b>?</b>,6 x 10-6,,'-,1.2197,'-,[1.12-1.32],DENND10,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,10:119134504
rs2473355-<b>?</b>,1 x 10-7,,'-,1.2678,'-,[1.17-1.38],EFHD2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15423721
rs2591158-<b>?</b>,4 x 10-6,,'-,1.24239,'-,[1.14-1.40],KCNJ3,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,2:154791154
rs2734221-<b>?</b>,1 x 10-22,,'-,1.5288182,'-,[1.41-1.70],WBP1LP1,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142779536
rs2855983-<b>?</b>,5 x 10-40,,'-,1.840265,'-,[1.69-2.00],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142770582
rs2886944-<b>?</b>,8 x 10-8,,'-,1.7788,'-,[1.46-2.17],"TRBVB, TRBV26",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142696365
rs3114479-<b>?</b>,4 x 10-7,,'-,1.2419275,'-,[1.15-1.40],"TRBV30, TRBC2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142804603
rs34689332-<b>?</b>,4 x 10-13,,'-,2.313175,'-,[1.85-2.90],"TBC1D8B, MORC4",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106834287
rs34810059-<b>?</b>,4 x 10-6,,'-,1.614726,'-,[1.33-2.00],LINC02101,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,5:58082045
rs11950121-<b>?</b>,3 x 10-6,,'-,1.2182,'-,[1.13-1.32],"ASS1P9, ARL15",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,5:53883127
rs12008279-<b>?</b>,6 x 10-15,,'-,1.7078514,'-,[1.52-1.90],"MORC4, CLDN2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106917472
rs12014762-<b>?</b>,2 x 10-19,,'-,2.2197094,'-,[1.89-2.60],MORC4,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106940440
rs12539868-<b>?</b>,2 x 10-16,,'-,1.8063,'-,[1.58-2.06],"PRSS2, WBP1LP1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142775169
rs12540839-<b>?</b>,3 x 10-6,,'-,1.7565432,'-,[1.41-2.20],TRBV30,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142813350
rs12562037-<b>?</b>,1 x 10-16,,'-,1.6326531,'-,[1.47-1.80],"CTRC, CELA2A",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15456025
rs12688091-<b>?</b>,1 x 10-32,,'-,2.570683,'-,[2.22-2.90],NUP62CL,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107131628
rs12847061-<b>?</b>,4 x 10-14,,'-,2.7257426,'-,[2.13-3.40],DNAAF6,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107230661
rs1285582-<b>?</b>,2 x 10-17,,'-,1.918779,'-,[1.66-2.21],NUP62CL,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107123872
rs1285594-<b>?</b>,1 x 10-8,,'-,1.8754969,'-,[1.54-2.30],NUP62CL,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107158099
rs12857658-<b>?</b>,6 x 10-10,,'-,2.5855854,'-,[1.96-3.40],"DNAJA1P3, MYCLP1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107281285
rs1298993-<b>?</b>,3 x 10-7,,'-,1.595169,'-,[1.35-1.89],"EEF1A1P40, RBM41",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107043226
rs13239736-<b>?</b>,8 x 10-10,,'-,1.3315579,'-,[1.22-1.40],"TRBV19, TRBV20-1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142620329
rs138520829-<b>?</b>,2 x 10-7,,'-,2.1889462,'-,[1.67-2.90],"SERPINA7P1, NAP1L4P2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106504267
rs138700403-<b>?</b>,2 x 10-21,,'-,1.7968,'-,[1.60-2.01],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142768604
rs141052845-<b>?</b>,2 x 10-12,,'-,2.9180622,'-,[2.22-3.80],MORC4,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106964394
rs141398135-<b>?</b>,3 x 10-6,,'-,1.5089784,'-,[1.28-1.80],"DNAJC16, AGMAT",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15572985
rs144184641-<b>?</b>,7 x 10-19,,'-,1.8983,'-,[1.66-2.17],"WBP1LP1, PRSS2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142775173
rs144878061-<b>?</b>,1 x 10-11,,'-,1.8480872,'-,[1.56-2.20],CELA2A,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15456801
rs146437551-<b>?</b>,3 x 10-15,,'-,3.816794,'-,[2.78-5.30],"SPINK1, JAKMIP2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,5:147808460
rs147767607-<b>?</b>,1 x 10-17,,'-,1.7258,'-,[1.53-1.94],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142769934
rs148655558-<b>?</b>,1 x 10-24,,'-,2.219048,'-,[1.92-2.60],RNF128,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106768355
rs148672699-<b>?</b>,1 x 10-6,,'-,2.758621,'-,[1.89-4.00],C1orf87,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:60008735
rs148771016-<b>?</b>,4 x 10-11,,'-,2.8437448,'-,[2.13-3.80],"DNAJA1P3, MYCLP1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107318205
rs148916504-<b>?</b>,5 x 10-15,,'-,1.6412,'-,[1.46-1.84],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142770747
rs35031873-<b>?</b>,6 x 10-22,,'-,1.6666666,'-,[1.52-1.90],"PRSS2, PRSS1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142758607
rs35585298-<b>?</b>,4 x 10-6,,'-,1.2726,'-,[1.16-1.40],LINC01478,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,18:75990278
rs35627987-<b>?</b>,1 x 10-6,,'-,1.5802782,'-,[1.33-1.90],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142765664
rs3857776-<b>?</b>,2 x 10-22,,'-,1.6931933,'-,[1.54-1.90],PRSS1,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142751439
rs4145394-<b>?</b>,9 x 10-21,,'-,1.8066847,'-,[1.61-2.00],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142770138
rs4355941-<b>?</b>,5 x 10-6,,'-,1.4151481,'-,[1.23-1.63],RADX,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106631560
rs4456003-<b>?</b>,8 x 10-6,,'-,2.1720865,'-,[1.57-3.00],"RADX, SERPINA7P1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106585073
rs4457242-<b>?</b>,8 x 10-18,,'-,1.6281341,'-,[1.47-1.80],"PRSS2, WBP1LP1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142777285
rs4601821-<b>?</b>,6 x 10-6,,'-,1.223,'-,[1.13-1.33],TTC12,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,11:113379624
rs4645995-<b>?</b>,6 x 10-9,,'-,1.5800284,'-,[1.37-1.80],CASP9,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15522508
rs4722748-<b>?</b>,9 x 10-6,,'-,1.218324,'-,[1.12-1.30],JAZF1,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:27963897
rs4725602-<b>?</b>,3 x 10-16,,'-,1.59821,'-,[1.43-1.80],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs4726575-<b>?</b>,9 x 10-32,,'-,1.7692852,'-,[1.61-1.90],"PRSS1, TRBV29-1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142747017
rs4726580-<b>?</b>,1 x 10-22,,'-,1.671123,'-,[1.52-1.90],"PRSS2, PRSS3P1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142762217
rs4826965-<b>?</b>,2 x 10-7,,'-,1.6855829,'-,[1.40-2.03],"DNAJA1P3, KRT18P49",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107370118
rs494526-<b>?</b>,7 x 10-6,,'-,1.2159534,'-,[1.12-1.30],"NANOS1, LDHAP5",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,10:119025482
rs4987704-<b>?</b>,2 x 10-6,,'-,1.404692,'-,[1.23-1.60],TRPV6,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142874551
rs545634-<b>?</b>,3 x 10-22,,'-,1.834526,'-,[1.64-2.00],CTRC,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15443607
rs55833042-<b>?</b>,3 x 10-29,,'-,1.7630465,'-,[1.61-1.90],"PRSS1, PRSS2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142758924
rs55916943-<b>?</b>,2 x 10-10,,'-,2.0607867,'-,[1.67-2.60],CSGALNACT2P2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106313139
rs55971108-<b>?</b>,7 x 10-6,,'-,1.3292569,'-,[1.18-1.50],"LINC02717, LINC02684",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,11:135046122
rs565421-<b>?</b>,3 x 10-6,,'-,1.2537,'-,[1.15-1.37],"CELA2A, CTRC",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15455633
rs57586289-<b>?</b>,5 x 10-13,,'-,1.3611,'-,[1.27-1.50],"TRBC2, TRBJ2-7",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142798480
rs58649169-<b>?</b>,3 x 10-15,,'-,1.6204829,'-,[1.45-1.80],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142772080
rs58854468-<b>?</b>,4 x 10-23,,'-,1.9076688,'-,[1.69-2.20],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142773734
chr1:15758679-<b>?</b>,2 x 10-10,,'-,1.4472,'-,[1.30-1.61],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
chr1:15759699-<b>?</b>,8 x 10-9,,'-,1.3435,'-,[1.22-1.48],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
chr1:16032902-<b>?</b>,1 x 10-6,,'-,1.4705882,'-,[1.27-1.70],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
chr10:120837903-<b>?</b>,5 x 10-6,,'-,1.2342632,'-,[1.14-1.40],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
chr16:75232655-<b>?</b>,2 x 10-6,,'-,1.3008976,'-,[1.18-1.40],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
chr16:75268060-<b>?</b>,7 x 10-6,,'-,1.3010669,'-,[1.16-1.40],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs762688-<b>?</b>,4 x 10-6,,'-,1.285017,'-,[1.16-1.40],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs762691-<b>?</b>,2 x 10-7,,'-,1.2461059,'-,[1.15-1.40],"TRBC2, TRBV30",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142809001
rs76288851-<b>?</b>,4 x 10-6,,'-,1.385,'-,[1.22-1.58],PLXNA1,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,3:127016172
chr7:142478368-<b>?</b>,4 x 10-16,,'-,1.7427,'-,[1.54-1.98],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs77808099-<b>?</b>,3 x 10-8,,'-,1.631055,'-,[1.39-1.90],DDI2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15618437
rs7795886-<b>?</b>,2 x 10-12,,'-,1.4852,'-,[1.34-1.65],"PRSS2, WBP1LP1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142776202
rs78907924-<b>?</b>,2 x 10-23,,'-,2.0391517,'-,[1.79-2.30],"PRSS2, WBP1LP1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142777210
chr7:142481922-<b>?</b>,3 x 10-12,,'-,1.5941,'-,[1.41-1.80],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs80076962-<b>?</b>,8 x 10-6,,'-,1.815871,'-,[1.41-2.30],LINC02794,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:48082176
chr9:15057589-<b>?</b>,4 x 10-6,,'-,2.451581,'-,[1.72-3.60],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs960438-<b>?</b>,9 x 10-6,,'-,1.25329,'-,[1.14-1.40],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,16:16805638
rs9928842-<b>?</b>,8 x 10-7,,'-,1.3368984,'-,[1.20-1.50],"CTRB1, CTRB2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,16:75208969
rs10808021-<b>?</b>,5 x 10-10,,'-,1.4427933,'-,[1.30-1.60],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142772288
chrX:106507551-<b>?</b>,6 x 10-6,,'-,1.8181826,'-,[1.43-2.32],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs112460630-<b>?</b>,7 x 10-6,,'-,1.9435148,'-,[1.48-2.56],NUP62CL,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107174072
chrX:106527804-<b>?</b>,1 x 10-7,,'-,2.0724483,'-,[1.61-2.68],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs11649684-<b>?</b>,8 x 10-7,,'-,1.3197836,'-,[1.19-1.50],"RNU6-758P, BCAR1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,16:75269081
rs117619580-<b>?</b>,7 x 10-6,,'-,1.7531557,'-,[1.39-2.20],EIF3A,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,10:119075359
rs10148610-<b>?</b>,9 x 10-6,,'-,1.2167,'-,[1.12-1.32],NPAS3,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,14:33257920
rs10243591-<b>?</b>,1 x 10-16,,'-,1.4662757,'-,[1.35-1.60],"PGBD4P1, TRBV29-1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142725721
rs1035539-<b>?</b>,1 x 10-7,,'-,1.2825446,'-,[1.18-1.40],BCAR1,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,16:75242877
rs10465287-<b>?</b>,4 x 10-11,,'-,1.901365,'-,[1.59-2.28],"SERPINA7P1, NAP1L4P2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106545130
rs10787903-<b>?</b>,2 x 10-7,,'-,1.2575,'-,[1.16-1.36],EIF3A,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,10:119064457
rs10803398-<b>?</b>,2 x 10-6,,'-,1.2933,'-,[1.17-1.43],FBLIM1,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15770742
rs7383917-<b>?</b>,2 x 10-7,,'-,1.3506213,'-,[1.22-1.50],"TRBV19, TRBV20-1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142619745
rs74054849-<b>?</b>,6 x 10-6,,'-,1.3950893,'-,[1.22-1.60],"TMEM82, SLC25A34-AS1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15743433
rs74376508-<b>?</b>,5 x 10-6,,'-,1.417635,'-,[1.23-1.60],"LINC02026, LINC02038",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,3:193943286
rs75475662-<b>?</b>,9 x 10-6,,'-,2.5665662,'-,[1.72-3.80],DNAAF6,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107210017
rs76047242-<b>?</b>,1 x 10-6,,'-,2.172843,'-,[1.61-2.90],"TBC1D8B, MORC4",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106816683
chr3:126728393-<b>?</b>,2 x 10-6,,'-,1.3563,'-,[1.20-1.53],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
chr7:142460744-<b>?</b>,3 x 10-14,,'-,1.5358624,'-,[1.39-1.70],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs7777677-<b>?</b>,6 x 10-6,,'-,1.2297097,'-,[1.14-1.30],"MTRNR2L6, TRBV24-1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142663616
chr7:142478687-<b>?</b>,2 x 10-14,,'-,1.6517,'-,[1.46-1.86],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
chr7:142481656-<b>?</b>,1 x 10-8,,'-,1.4151,'-,[1.26-1.58],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs79280654-<b>?</b>,6 x 10-6,,'-,1.5673981,'-,[1.30-1.90],EFHD2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15410646
chr9:14197788-<b>?</b>,2 x 10-6,,'-,1.3389,'-,[1.20-1.50],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs8055167-<b>?</b>,4 x 10-9,,'-,1.352448,'-,[1.23-1.50],CTRB1,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,16:75220991
chrX:106171175-<b>?</b>,2 x 10-6,,'-,1.6496834,'-,[1.36-2.00],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
chrX:106392776-<b>?</b>,1 x 10-7,,'-,1.918779,'-,[1.53-2.41],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs11092578-<b>?</b>,1 x 10-6,,'-,1.512408,'-,[1.29-1.77],MORC4,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106983213
chrX:106517502-<b>?</b>,5 x 10-8,,'-,1.8807379,'-,[1.52-2.33],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,Mapping not available
rs113340515-<b>?</b>,3 x 10-6,,'-,2.121975,'-,[1.57-2.86],"DNAJA1P3, MYCLP1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107296299
rs10074415-<b>?</b>,8 x 10-6,,'-,1.2292,'-,[1.13-1.34],LINC01331,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,5:74252539
rs11762011-<b>?</b>,2 x 10-18,,'-,1.7448962,'-,[1.56-2.00],"WBP1LP1, PRSS2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142775653
rs5916988-<b>?</b>,2 x 10-6,,'-,1.5010903,'-,[1.28-1.80],"Y_RNA, CSGALNACT2P2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106375530
rs5917046-<b>?</b>,3 x 10-6,,'-,2.0217996,'-,[1.53-2.67],"DNAJA1P3, MYCLP1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107296378
rs59320698-<b>?</b>,2 x 10-6,,'-,1.3095862,'-,[1.18-1.40],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142774010
rs5962770-<b>?</b>,2 x 10-7,,'-,1.5148686,'-,[1.31-1.76],MORC4,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106893680
rs60095957-<b>?</b>,8 x 10-20,,'-,1.5377518,'-,[1.41-1.70],"PRSS1, TRBV29-1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142742709
rs60096066-<b>?</b>,7 x 10-7,,'-,1.2640626,'-,[1.16-1.40],"TRBV29-1, PGBD4P1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142734441
rs6112176-<b>?</b>,2 x 10-6,,'-,1.2961,'-,[1.17-1.43],'-,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,20:18964936
rs62470035-<b>?</b>,6 x 10-7,,'-,1.5474,'-,[1.32-1.82],"TRBV23-1, TRBV24-1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142652944
rs62470644-<b>?</b>,2 x 10-7,,'-,1.330141,'-,[1.20-1.50],"TRBV29-1, PRSS1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142745362
rs62605968-<b>?</b>,1 x 10-12,,'-,1.7051136,'-,[1.48-1.96],"TBC1D8B, MORC4",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106829297
rs6464530-<b>?</b>,6 x 10-21,,'-,1.8773,'-,[1.66-2.13],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142769995
rs6564219-<b>?</b>,5 x 10-6,,'-,1.3058239,'-,[1.18-1.40],"CTRB2, ZFP1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,16:75188108
rs6622111-<b>?</b>,3 x 10-6,,'-,1.706681,'-,[1.38-2.11],RNF128,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106772108
rs6622126-<b>?</b>,8 x 10-16,,'-,1.7390733,'-,[1.54-2.00],MORC4,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106956972
rs6622208-<b>?</b>,2 x 10-8,,'-,1.8020377,'-,[1.49-2.18],"MYCLP1, DNAJA1P3",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107289163
rs66491909-<b>?</b>,6 x 10-20,,'-,2.1411645,'-,[1.85-2.50],RNF128,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106732269
rs6693417-<b>?</b>,8 x 10-10,,'-,1.3197,'-,[1.21-1.43],"CTRC, EFHD2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15436844
rs6695499-<b>?</b>,2 x 10-7,,'-,1.3255,'-,[1.20-1.47],EFHD2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15429180
rs6702946-<b>?</b>,6 x 10-7,,'-,1.3387,'-,[1.20-1.49],"CTRC, CELA2A",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,1:15455849
rs6735118-<b>?</b>,7 x 10-6,,'-,1.616554,'-,[1.33-2.00],"KIDINS220, MBOAT2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,2:8852250
rs6953502-<b>?</b>,2 x 10-25,,'-,1.5984654,'-,[1.47-1.70],"TRBV29-1, PGBD4P1",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142723525
rs6954663-<b>?</b>,1 x 10-9,,'-,1.3058239,'-,[1.20-1.40],"TRBVA, TRBV26",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142683246
rs7057398-<b>?</b>,2 x 10-29,,'-,2.281145,'-,[2.00-2.60],"RIPPLY1, CLDN2, MORC4",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106901299
rs71525726-<b>?</b>,3 x 10-6,,'-,1.299207,'-,[1.18-1.40],MCPH1,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,8:6332838
rs73247912-<b>?</b>,2 x 10-6,,'-,1.853097,'-,[1.45-2.40],"SERPINA7, CTDSPL2P2",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:106050079
rs73249839-<b>?</b>,6 x 10-6,,'-,2.4513547,'-,[1.69-3.60],"MYCLP1, DNAJA1P3",Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,X:107294522
rs73439730-<b>?</b>,8 x 10-6,,'-,1.568135,'-,[1.30-1.90],DRAIC,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,15:69857219
rs73740310-<b>?</b>,3 x 10-10,,'-,1.4649868,'-,[1.32-1.60],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142773515
rs73742434-<b>?</b>,8 x 10-18,,'-,1.6747613,'-,[1.49-1.90],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142769972
rs73742436-<b>?</b>,3 x 10-14,,'-,1.5681355,'-,[1.41-1.80],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142770727
rs73742446-<b>?</b>,4 x 10-19,,'-,2.0149102,'-,[1.75-2.30],PRSS2,Alcoholic chronic pancreatitis,alcoholic pancreatitis,GCST004860,7:142771453
rs4317455-<b>C</b>,1 x 10-7,,NR,'-,0.4538 unit decrease,[NR],PSMG4,Bone mineral density (femoral neck) in inflammatory bowel disease,"inflammatory bowel disease, femoral neck bone mineral density",GCST005784,6:3263257
rs17000400-<b>C</b>,2 x 10-7,,NR,'-,0.4654 unit increase,[NR],'-,Bone mineral density (femoral neck) in inflammatory bowel disease,"inflammatory bowel disease, femoral neck bone mineral density",GCST005784,4:75251521
rs2341557-<b>T</b>,1 x 10-6,,NR,'-,0.5282 unit decrease,[NR],PLXNA4,Bone mineral density (femoral neck) in inflammatory bowel disease,"inflammatory bowel disease, femoral neck bone mineral density",GCST005784,7:132134524
rs34461570-<b>A</b>,3 x 10-6,,NR,'-,0.9636 unit increase,[NR],LINC02791,Bone mineral density (femoral neck) in inflammatory bowel disease,"inflammatory bowel disease, femoral neck bone mineral density",GCST005784,1:69319822
rs6589564-<b>C</b>,3 x 10-6,,NR,'-,0.4551 unit decrease,[NR],BUD13,Bone mineral density (femoral neck) in inflammatory bowel disease,"inflammatory bowel disease, femoral neck bone mineral density",GCST005784,11:116753437
rs6596684-<b>G</b>,3 x 10-6,,NR,'-,0.3999 unit increase,[NR],'-,Bone mineral density (femoral neck) in inflammatory bowel disease,"inflammatory bowel disease, femoral neck bone mineral density",GCST005784,5:106609232
rs10815621-<b>T</b>,5 x 10-6,,NR,'-,0.402 unit increase,[NR],"DMRT1, KANK1",Bone mineral density (femoral neck) in inflammatory bowel disease,"inflammatory bowel disease, femoral neck bone mineral density",GCST005784,9:761623
rs2060886-<b>C</b>,6 x 10-6,,0.37,2.02,'-,[1.49-2.74],TCF4,Surgical recurrence in Crohn's disease,"response to surgery, Crohn's disease",GCST011589,18:55500289
rs10737481-<b>?</b>,3 x 10-19,,NR,'-,0.077 unit increase,NR,"RNF186, OTUD3",Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,1:19845021
rs11209026-<b>?</b>,3 x 10-13,,NR,'-,0.062 unit decrease,NR,IL23R,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,1:67240275
rs6679677-<b>?</b>,5 x 10-34,,NR,'-,0.1 unit decrease,NR,"RSBN1, PHTF1",Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,1:113761186
rs55838263-<b>?</b>,4 x 10-15,,NR,'-,0.067 unit decrease,NR,INAVA,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,1:200905600
rs3024493-<b>?</b>,1 x 10-10,,NR,'-,0.055 unit increase,NR,IL10,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,1:206770623
rs11889341-<b>?</b>,2 x 10-7,,NR,'-,0.045 unit decrease,NR,STAT4,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,2:191079016
rs113341849-<b>?</b>,6 x 10-8,,NR,'-,0.046 unit increase,NR,"UQCRC2P1, CCR2",Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,3:46342713
rs11130213-<b>?</b>,5 x 10-7,,NR,'-,0.043 unit increase,NR,APEH,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,3:49674864
rs10758669-<b>?</b>,6 x 10-8,,NR,'-,0.046 unit decrease,NR,"JAK2, HNRNPA1P41",Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,9:4981602
rs3812565-<b>?</b>,2 x 10-9,,NR,'-,0.052 unit increase,NR,SNAPC4,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,9:136378050
rs6584283-<b>?</b>,3 x 10-10,,NR,'-,0.054 unit decrease,NR,LINC01475,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,10:99530544
rs2212434-<b>?</b>,2 x 10-6,,NR,'-,0.041 unit increase,NR,"EMSY, LINC02757",Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,11:76570549
rs12817473-<b>?</b>,7 x 10-8,,NR,'-,0.046 unit increase,NR,IFNG-AS1,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,12:68103628
rs12720356-<b>?</b>,4 x 10-9,,NR,'-,0.05 unit increase,NR,TYK2,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,19:10359299
rs13048533-<b>?</b>,1 x 10-10,,NR,'-,0.055 unit decrease,NR,RPL23AP12,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, ulcerative colitis",GCST90016625,21:39087168
rs3749171-<b>T</b>,9 x 10-7,,0.826119,1.42,'-,'-,GPR35,Childhood onset ulcerative colitis,ulcerative colitis,GCST005815,2:240630275
rs17188113-<b>?</b>,9 x 10-7,,'-,1.8086454,'-,[1.57-2.05],TRIM15,Childhood onset ulcerative colitis,ulcerative colitis,GCST005815,6:30163346
HLA-DRB1*0103-<b>?</b>,2 x 10-13,,'-,6.9418,'-,[6.43-7.46],'-,Childhood onset ulcerative colitis,ulcerative colitis,GCST005815,Mapping not available
HLA-DRB1*1301-<b>?</b>,7 x 10-8,,'-,2.1073,'-,[1.84-2.38],'-,Childhood onset ulcerative colitis,ulcerative colitis,GCST005815,Mapping not available
rs1078186-<b>C</b>,2 x 10-6,(Female),0.574,0.615,'-,[0.51-0.72],SNX31,Colorectal cancer,colorectal cancer,GCST011973,8:100613251
rs118174020-<b>C</b>,1 x 10-6,(Female),0.949,0.357,'-,[0.24-0.48],LINC02055,Colorectal cancer,colorectal cancer,GCST011973,8:135843271
rs307385-<b>T</b>,2 x 10-6,(Female),0.23,1.684,'-,[1.36-2.01],LINC02646,Colorectal cancer,colorectal cancer,GCST011973,10:130452402
rs57751578-<b>T</b>,2 x 10-6,(Male),0.911,0.483,'-,[0.36-0.61],THRB,Colorectal cancer,colorectal cancer,GCST011973,3:24486090
rs4631227-<b>A</b>,3 x 10-6,(Male),0.293,1.663,'-,[1.34-1.98],"FSTL4, HSPA4",Colorectal cancer,colorectal cancer,GCST011973,5:133152748
rs72907251-<b>C</b>,1 x 10-6,(Male),0.937,0.446,'-,[0.32-0.57],RN7SL643P,Colorectal cancer,colorectal cancer,GCST011973,6:86515650
rs9579517-<b>C</b>,9 x 10-6,(Male),0.9,0.519,'-,[0.39-0.65],"MPHOSPH8, LINC00350",Colorectal cancer,colorectal cancer,GCST011973,13:19603453
rs689-<b>T</b>,1 x 10-160,,0.71,2.21,'-,[2.08-2.34],"INS, INS-IGF2",Type 1 diabetes,type I diabetes mellitus,GCST010681,11:2160994
rs2128344-<b>A</b>,8 x 10-12,,0.0055,2.12,'-,[1.71-2.63],LINC00320,Type 1 diabetes,type I diabetes mellitus,GCST010681,21:20724226
rs60587303-<b>C</b>,3 x 10-9,,0.0051,1.97,'-,[1.58-2.47],STK39,Type 1 diabetes,type I diabetes mellitus,GCST010681,2:168190122
rs192324744-<b>G</b>,2 x 10-11,,0.0131,1.63,'-,[1.41-1.88],LRP1B,Type 1 diabetes,type I diabetes mellitus,GCST010681,2:141543366
rs34536443-<b>G</b>,2 x 10-11,,0.0515,1.45,'-,[1.31-1.62],'-,Type 1 diabetes,type I diabetes mellitus,GCST010681,Mapping not available
rs2269247-<b>T</b>,1 x 10-10,,0.18,1.17,'-,[1.12-1.23],PGM1,Type 1 diabetes,type I diabetes mellitus,GCST010681,1:63641613
rs10751776-<b>C</b>,3 x 10-8,,0.509915,'-,0.07814535 unit increase,[0.051-0.106],"MIR4425, RUNX3",Type 1 diabetes,type I diabetes mellitus,GCST90014023,1:24970252
rs574384-<b>A</b>,2 x 10-8,,0.894668,'-,0.13360222 unit decrease,[0.087-0.18],PSMB2,Type 1 diabetes,type I diabetes mellitus,GCST90014023,1:35622060
rs12742756-<b>G</b>,4 x 10-8,,0.428204,'-,0.08310696 unit decrease,[0.054-0.113],INPP5B,Type 1 diabetes,type I diabetes mellitus,GCST90014023,1:37881745
rs855330-<b>C</b>,5 x 10-11,,0.259422,'-,0.111207716 unit increase,[0.078-0.144],PGM1,Type 1 diabetes,type I diabetes mellitus,GCST90014023,1:63648218
rs1493696-<b>A</b>,8 x 10-9,,0.13231,'-,0.12832591 unit increase,[0.085-0.172],NOTCH2,Type 1 diabetes,type I diabetes mellitus,GCST90014023,1:119962909
rs570794153-<b>GA</b>,4 x 10-11,,0.139675,'-,0.14543974 unit decrease,[0.1-0.19],"ATP6V1G3, PTPRC",Type 1 diabetes,type I diabetes mellitus,GCST90014023,1:198629260
rs12128789-<b>C</b>,4 x 10-9,,0.131779,'-,0.12696852 unit increase,[0.085-0.169],"LINC02773, BATF3",Type 1 diabetes,type I diabetes mellitus,GCST90014023,1:212679490
rs1881146-<b>T</b>,5 x 10-8,,0.310529,'-,0.09517027 unit decrease,[0.061-0.129],MIR3681HG,Type 1 diabetes,type I diabetes mellitus,GCST90014023,2:12494668
rs12464462-<b>G</b>,9 x 10-10,,0.410445,'-,0.0879553 unit decrease,[0.06-0.116],MIR4432HG,Type 1 diabetes,type I diabetes mellitus,GCST90014023,2:60409281
rs13018977-<b>A</b>,2 x 10-8,,0.224602,'-,0.100334994 unit increase,[0.065-0.135],SEPTIN2,Type 1 diabetes,type I diabetes mellitus,GCST90014023,2:241338592
rs12644686-<b>G</b>,2 x 10-8,,0.193778,'-,0.10774961 unit decrease,[0.07-0.146],LINC02362,Type 1 diabetes,type I diabetes mellitus,GCST90014023,4:184381748
rs114378220-<b>T</b>,5 x 10-9,,0.070292,'-,0.17790234 unit increase,[0.12-0.24],CAMK4,Type 1 diabetes,type I diabetes mellitus,GCST90014023,5:111230662
rs766751473-<b>T</b>,1 x 10-8,,0.40393,'-,0.080249354 unit increase,[0.053-0.108],IRF1-AS1,Type 1 diabetes,type I diabetes mellitus,GCST90014023,5:132431072
rs1050979-<b>G</b>,6 x 10-14,,0.515138,'-,0.106195554 unit increase,[0.079-0.134],IRF4,Type 1 diabetes,type I diabetes mellitus,GCST90014023,6:410417
rs7805218-<b>A</b>,9 x 10-9,,0.30774,'-,0.09541352 unit increase,[0.063-0.128],ITGB8,Type 1 diabetes,type I diabetes mellitus,GCST90014023,7:20339178
rs7795896-<b>T</b>,2 x 10-16,,0.691577,'-,0.13543522 unit decrease,[0.1-0.17],CFTR,Type 1 diabetes,type I diabetes mellitus,GCST90014023,7:117446559
rs1947178-<b>G</b>,2 x 10-9,,0.791944,'-,0.10326733 unit decrease,[0.07-0.137],TOX,Type 1 diabetes,type I diabetes mellitus,GCST90014023,8:58959618
rs13259300-<b>C</b>,3 x 10-10,,0.598278,'-,0.0921915 unit decrease,[0.063-0.121],COLEC10,Type 1 diabetes,type I diabetes mellitus,GCST90014023,8:119070702
rs3802214-<b>C</b>,3 x 10-8,,0.798827,'-,0.10660862 unit decrease,[0.069-0.144],AGO2,Type 1 diabetes,type I diabetes mellitus,GCST90014023,8:140606084
rs541856133-<b>T</b>,4 x 10-17,,0.001509,'-,1.1022301 unit increase,[0.85-1.36],"CEL, GTF3C5",Type 1 diabetes,type I diabetes mellitus,GCST90014023,9:133060938
rs537544-<b>T</b>,9 x 10-9,,0.615565,'-,0.08641077 unit decrease,[0.057-0.116],GATA3,Type 1 diabetes,type I diabetes mellitus,GCST90014023,10:8066419
rs78325861-<b>G</b>,2 x 10-11,,0.039037,'-,0.2820823 unit decrease,[0.2-0.36],"PRF1, ADAMTS14",Type 1 diabetes,type I diabetes mellitus,GCST90014023,10:70618733
rs140215710-<b>A</b>,4 x 10-8,,0.010339,'-,0.412643 unit increase,[0.27-0.56],"CDKN1C, KCNQ1DN",Type 1 diabetes,type I diabetes mellitus,GCST90014023,11:2881830
rs7936434-<b>C</b>,4 x 10-8,,0.464277,'-,0.07692268 unit increase,[0.05-0.104],"EMSY, LINC02757",Type 1 diabetes,type I diabetes mellitus,GCST90014023,11:76582761
rs607703-<b>T</b>,1 x 10-10,,0.484409,'-,0.09201457 unit increase,[0.064-0.12],FLI1,Type 1 diabetes,type I diabetes mellitus,GCST90014023,11:128734279
rs7301381-<b>C</b>,5 x 10-11,,0.463691,'-,0.09358772 unit decrease,[0.066-0.122],KLRG1,Type 1 diabetes,type I diabetes mellitus,GCST90014023,12:8971336
rs238265-<b>G</b>,2 x 10-9,,0.695162,'-,0.09082453 unit decrease,[0.061-0.121],LINC02341,Type 1 diabetes,type I diabetes mellitus,GCST90014023,13:42356523
rs4238595-<b>C</b>,2 x 10-11,,0.680478,'-,0.11213453 unit decrease,[0.079-0.145],"GP2, UMOD",Type 1 diabetes,type I diabetes mellitus,GCST90014023,16:20331769
rs8046043-<b>C</b>,2 x 10-8,,0.391629,'-,0.08458667 unit decrease,[0.055-0.114],'-,Type 1 diabetes,type I diabetes mellitus,GCST90014023,16:80250127
rs61759532-<b>T</b>,2 x 10-10,,0.234556,'-,0.11837882 unit increase,[0.082-0.155],ACAP1,Type 1 diabetes,type I diabetes mellitus,GCST90014023,17:7337072
rs11651753-<b>T</b>,1 x 10-9,,0.41983,'-,0.08688845 unit decrease,[0.059-0.115],"PNPO, PRR15L",Type 1 diabetes,type I diabetes mellitus,GCST90014023,17:47951723
rs57209021-<b>T</b>,4 x 10-8,,0.225582,'-,0.1006932 unit increase,[0.065-0.137],"ARHGAP27P2, RDM1P3",Type 1 diabetes,type I diabetes mellitus,GCST90014023,17:68168777
rs74203920-<b>T</b>,2 x 10-8,,0.019793,'-,0.3138792 unit increase,[0.2-0.42],AIRE,Type 1 diabetes,type I diabetes mellitus,GCST90014023,21:44294411
rs4263714-<b>A</b>,4 x 10-6,,'-,'-,0.20912386 unit increase,[0.12-0.3],COBL,Type 1 diabetes,type I diabetes mellitus,GCST90000529,7:50955790
rs4929965-<b>G</b>,2 x 10-31,,'-,'-,0.36365113 unit increase,[0.3-0.42],"MIR4686, ASCL2",Type 1 diabetes,type I diabetes mellitus,GCST90000529,11:2176056
rs72802342-<b>A</b>,6 x 10-10,,'-,'-,0.2877386 unit increase,[0.2-0.38],"ZFP1, CTRB2",Type 1 diabetes,type I diabetes mellitus,GCST90000529,16:75200974
rs4366464-<b>C</b>,1 x 10-9,,'-,'-,0.403326 unit increase,[0.27-0.53],"INS-IGF2, IGF2-AS",Type 1 diabetes,type I diabetes mellitus,GCST90000529,11:2143569
rs78896587-<b>T</b>,1 x 10-9,,'-,'-,0.20937194 unit decrease,[0.14-0.28],"IGF2, H19",Type 1 diabetes,type I diabetes mellitus,GCST90000529,11:2055620
rs10974438-<b>C</b>,1 x 10-6,,'-,'-,0.12805976 unit increase,[0.076-0.18],GLIS3,Type 1 diabetes,type I diabetes mellitus,GCST90000529,9:4291928
rs2269247-<b>T</b>,2 x 10-6,,'-,'-,0.13817546 unit increase,[0.081-0.195],PGM1,Type 1 diabetes,type I diabetes mellitus,GCST90000529,1:63641613
rs56337234-<b>T</b>,4 x 10-6,,'-,'-,0.1142075 unit increase,[0.066-0.163],"FGFR3, TACC3",Type 1 diabetes,type I diabetes mellitus,GCST90000529,4:1782676
rs116020851-<b>C</b>,3 x 10-7,,0.971,'-,0.182 unit increase,[0.11-0.25],"SFTA2, HCG21",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:30954755
rs9501130-<b>G</b>,2 x 10-11,,0.822,'-,0.099 unit increase,[0.07-0.128],"LINC01149, HCP5",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:31449679
rs17407280-<b>C</b>,7 x 10-6,,0.777,'-,0.058 unit increase,[0.033-0.083],KIF17,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,1:20693912
rs10919543-<b>G</b>,6 x 10-6,,0.346,'-,0.055 unit decrease,[0.031-0.079],"RPS23P10, FCGR3A",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,1:161538827
rs7524087-<b>G</b>,8 x 10-6,,0.019,'-,0.285 unit increase,[0.16-0.41],LINC02771,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,1:212470318
rs77155259-<b>G</b>,2 x 10-6,,0.944,'-,0.142 unit increase,[0.083-0.201],SLC4A10,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,2:161647730
rs111821448-<b>C</b>,5 x 10-6,,0.972,'-,0.164 unit increase,[0.093-0.235],PHLDB2,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,3:111874722
rs139881548-<b>C</b>,7 x 10-6,,0.984,'-,0.222 unit increase,[0.13-0.32],GABRA2,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,4:46372280
rs34740712-<b>C</b>,5 x 10-6,,0.104,'-,0.088 unit decrease,[0.051-0.125],TLL1,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,4:165916328
rs4513644-<b>T</b>,8 x 10-7,,0.794,'-,0.067 unit increase,[0.04-0.094],LINC02225,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,5:57837318
rs78824139-<b>C</b>,9 x 10-6,,0.986,'-,0.294 unit increase,[0.16-0.42],EYS,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:64748694
rs6461299-<b>C</b>,2 x 10-6,,0.422,'-,0.078 unit decrease,[0.047-0.109],AHR,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,7:17147155
rs10255565-<b>C</b>,1 x 10-6,,0.154,'-,0.086 unit decrease,[0.051-0.121],HECW1,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,7:43408191
rs35766765-<b>G</b>,3 x 10-6,,0.092,'-,0.091 unit decrease,[0.054-0.128],PHF20L1,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,8:132775726
rs74629033-<b>G</b>,5 x 10-6,,0.95,'-,0.116 unit increase,[0.067-0.165],PLGRKT,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,9:5421234
rs10961433-<b>G</b>,2 x 10-6,,0.867,'-,0.079 unit increase,[0.046-0.112],NFIB,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,9:14228472
rs4837404-<b>G</b>,5 x 10-6,,0.368,'-,0.064 unit increase,[0.037-0.091],PTGES,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,9:129743380
rs1110458-<b>C</b>,8 x 10-6,,0.239,'-,0.055 unit decrease,[0.031-0.079],"USP31, HS3ST2",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,16:22969144
rs2941522-<b>C</b>,7 x 10-9,,0.575,'-,0.069 unit decrease,[0.045-0.093],"GRB7, IKZF3",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,17:39754115
rs10258381-<b>G</b>,5 x 10-6,,0.049,'-,0.119 unit decrease,[0.068-0.17],'-,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,7:10057028
rs2158962-<b>A</b>,1 x 10-7,,0.54,4.94,'-,[2.65-9.24],TRAP1,Infliximab-induced mucosal healing in Crohn's disease,"response to TNF antagonist, Crohn's disease",GCST008397,16:3688026
rs5929166-<b>A</b>,5 x 10-9,,0.03,3.03,'-,[2.08-4.35],XACT,Poor prognosis in Crohn's disease,"Crohn's disease, disease prognosis measurement",GCST004053,X:113634280
rs147856773-<b>?</b>,1 x 10-8,,NR,1.75,'-,[1.43-2.13],FOXO3,Poor prognosis in Crohn's disease,"Crohn's disease, disease prognosis measurement",GCST004053,6:108666025
rs9279411-<b>?</b>,5 x 10-9,,NR,1.67,'-,[1.41-2.00],VWA7,Poor prognosis in Crohn's disease,"Crohn's disease, disease prognosis measurement",GCST004053,6:31766174
rs75764599-<b>A</b>,4 x 10-8,,0.01,3.02,'-,[2.04-4.49],"CCDC201, RNU6-326P",Poor prognosis in Crohn's disease,"Crohn's disease, disease prognosis measurement",GCST004053,7:45859651
rs2476601-<b>?</b>,8 x 10-67,,NR,'-,0.14 unit increase,NR,PTPN22,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,1:113834946
rs10912488-<b>?</b>,2 x 10-8,,NR,'-,0.047 unit increase,NR,AIMP1P2,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,1:172877652
rs7517847-<b>?</b>,5 x 10-43,,NR,'-,0.11 unit decrease,NR,"IL23R, C1orf141",Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,1:67215986
rs113973829-<b>?</b>,3 x 10-9,,NR,'-,0.05 unit decrease,NR,MAGI3,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,1:113318157
rs1432296-<b>?</b>,8 x 10-10,,NR,'-,0.051 unit decrease,NR,LINC01185,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,2:60841032
rs12612769-<b>?</b>,2 x 10-7,,NR,'-,0.044 unit increase,NR,STAT4,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,2:191089272
rs3792109-<b>?</b>,2 x 10-16,,NR,'-,0.068 unit increase,NR,"SCARNA5, ATG16L1",Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,2:233275771
rs9836291-<b>?</b>,6 x 10-6,,NR,'-,0.038 unit increase,NR,BSN,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,3:49660026
rs10073277-<b>?</b>,4 x 10-15,,NR,'-,0.065 unit increase,NR,TTC33,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,5:40488584
rs6894249-<b>?</b>,1 x 10-14,,NR,'-,0.064 unit increase,NR,"IRF1-AS1, IRF1",Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,5:132461855
rs147018773-<b>?</b>,2 x 10-9,,NR,'-,0.05 unit increase,NR,IRGM,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,5:150858959
rs10045431-<b>?</b>,1 x 10-8,,NR,'-,0.048 unit increase,NR,"LINC01845, IL12B",Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,5:159387525
rs212389-<b>?</b>,6 x 10-11,,NR,'-,0.054 unit decrease,NR,TAGAP-AS1,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,6:159068759
rs4266763-<b>?</b>,1 x 10-13,,NR,'-,0.062 unit increase,NR,SNAPC4,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,9:136395373
rs10761659-<b>?</b>,2 x 10-20,,NR,'-,0.077 unit increase,NR,ALDH7A1P4,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,10:62685804
rs1250573-<b>?</b>,1 x 10-6,,NR,'-,0.04 unit decrease,NR,ZMIZ1,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,10:79282718
rs7100689-<b>?</b>,7 x 10-8,,NR,'-,0.045 unit increase,NR,TSPAN14,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,10:80462422
rs1332099-<b>?</b>,5 x 10-10,,NR,'-,0.052 unit decrease,NR,"NKX2-3, SLC25A28",Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,10:99538694
rs28456-<b>?</b>,4 x 10-6,,NR,'-,0.038 unit increase,NR,"FADS2, FADS1",Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,11:61822009
rs7110818-<b>?</b>,2 x 10-14,,NR,'-,0.064 unit increase,NR,"LINC02757, EMSY",Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,11:76581531
rs2076756-<b>?</b>,5 x 10-13,,NR,'-,0.06 unit decrease,NR,NOD2,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,16:50722970
rs1883832-<b>?</b>,9 x 10-15,,NR,'-,0.064 unit decrease,NR,CD40,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,20:46118343
rs1003342-<b>?</b>,6 x 10-10,,NR,'-,0.052 unit decrease,NR,HORMAD2,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,22:30174033
rs151314883-<b>?</b>,4 x 10-11,,NR,'-,0.055 unit decrease,NR,"SYNGR1, RPL3",Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),"rheumatoid arthritis, Crohn's disease",GCST90016610,22:39339082
rs9268877-<b>A</b>,1 x 10-8,,0.35,1.72,'-,[1.43-2.07],HLA-DRB9,Poor prognosis in Crohn's disease,"Crohn's disease, disease prognosis measurement",GCST009878,6:32463370
rs117829974-<b>?</b>,2 x 10-7,,NR,2.1,'-,[1.6-2.7],"CADPS, LINC00698",Thiopurine-induced leukopenia in inflammatory bowel disease,"leukopenia, response to thiopurine, inflammatory bowel disease",GCST006201,3:62886233
rs116855232-<b>?</b>,1 x 10-33,,NR,5.8,'-,[4.4-7.7],NUDT15,Thiopurine-induced leukopenia in inflammatory bowel disease,"leukopenia, response to thiopurine, inflammatory bowel disease",GCST006201,13:48045719
rs2501846-<b>?</b>,1 x 10-6,,NR,1.94,'-,[1.49-2.52],"BATF3, LINC02773",Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232),"leukopenia, response to thiopurine, inflammatory bowel disease",GCST006202,1:212668592
rs116855232-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,NUDT15,Thiopurine-induced severe leukopenia in inflammatory bowel disease,"leukopenia, response to thiopurine, inflammatory bowel disease",GCST006204,13:48045719
rs116855232-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,NUDT15,Thiopurine-induced acute severe leukopenia in inflammatory bowel disease,"leukopenia, response to thiopurine, inflammatory bowel disease",GCST006205,13:48045719
rs75466870-<b>?</b>,5 x 10-7,,NR,4.5,'-,[2.5-8.0],"GRAMD2B, SV2C",Thiopurine-induced alopecia in inflammatory bowel disease,"Alopecia, response to thiopurine, inflammatory bowel disease",GCST006206,5:126346163
rs117927258-<b>?</b>,2 x 10-7,,NR,6.5,'-,[3.2-13.2],ADGRF1,Thiopurine-induced alopecia in inflammatory bowel disease,"Alopecia, response to thiopurine, inflammatory bowel disease",GCST006206,6:47108781
rs145080284-<b>?</b>,1 x 10-6,,NR,3.8,'-,[2.2-6.5],"CYP2C18, CTBP2P2",Thiopurine-induced alopecia in inflammatory bowel disease,"Alopecia, response to thiopurine, inflammatory bowel disease",GCST006206,10:94662973
rs78844412-<b>?</b>,6 x 10-7,,NR,6.9,'-,[3.2-14.8],LINC02745,Thiopurine-induced alopecia in inflammatory bowel disease,"Alopecia, response to thiopurine, inflammatory bowel disease",GCST006206,11:42131190
rs116855232-<b>?</b>,4 x 10-29,,NR,10.4,'-,[6.9-15.6],NUDT15,Thiopurine-induced alopecia in inflammatory bowel disease,"Alopecia, response to thiopurine, inflammatory bowel disease",GCST006206,13:48045719
rs116855232-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,NUDT15,Thiopurine-induced severe alopecia in inflammatory bowel disease,"Alopecia, response to thiopurine, inflammatory bowel disease",GCST006207,13:48045719
rs117506642-<b>?</b>,5 x 10-7,,NR,13.3,'-,[4.9-36.3],'-,Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232),"leukopenia, response to thiopurine, inflammatory bowel disease",GCST006215,2:195143585
rs9268644-<b>?</b>,8 x 10-31,,0.823,1.9607843,'-,[1.75-2.22],HLA-DRA,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,6:32440267
rs9501251-<b>G</b>,2 x 10-22,,0.044,2.01,'-,[1.76-2.32],HLA-DPB1,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,6:33081886
rs4979467-<b>A</b>,1 x 10-29,,0.322,1.53,'-,[1.42-1.64],DELEC1,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,9:114867763
rs9635726-<b>G</b>,2 x 10-16,,0.309,1.37,'-,[1.27-1.48],IKZF3,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,17:39863888
rs77871618-<b>A</b>,3 x 10-13,,0.158,1.4,'-,[1.28-1.53],"Y_RNA, CXCR5",Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,11:118862915
rs3732421-<b>?</b>,3 x 10-13,,0.66,1.3513513,'-,[1.25-1.47],TMEM39A,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,3:119431242
rs10168266-<b>A</b>,4 x 10-13,,0.366,1.31,'-,[1.22-1.41],STAT4,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,2:191071078
rs582537-<b>?</b>,2 x 10-11,,0.7,1.3333333,'-,[1.22-1.45],"IL12A-AS1, IL12A",Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,3:159992311
rs1598856-<b>G</b>,2 x 10-10,,0.474,1.26,'-,[1.17-1.35],NFKB1,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,4:102524958
rs4149576-<b>A</b>,4 x 10-9,,0.113,1.37,'-,[1.23-1.52],TNFRSF1A,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,12:6339949
rs137603-<b>?</b>,3 x 10-8,,0.85,1.37,'-,[1.23-1.54],"RPL3, PDGFB",Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,22:39298220
rs4305775-<b>?</b>,2 x 10-7,,0.714,1.25,'-,[1.14-1.35],"PSMG4, SLC22A23",Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,6:3296763
rs6456156-<b>?</b>,6 x 10-7,,0.51,1.2048193,'-,[1.11-1.28],"CCR6, CEP43",Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,6:167108812
rs6856421-<b>A</b>,2 x 10-6,,0.257,1.22,'-,[1.11-1.30],GLRA3,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,4:174635665
rs2189521-<b>?</b>,4 x 10-16,,0.7,1.4084507,'-,'-,IL21R,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,16:27402245
rs4675369-<b>G</b>,1 x 10-13,,0.448,1.31,'-,[1.22–1.41],"RNU6-474P, NPM1P33",Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,2:203778471
rs925550-<b>A</b>,4 x 10-13,,0.37,1.31,'-,[1.21–1.40],IL21-AS1,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,4:122667371
rs17005934-<b>G</b>,1 x 10-11,,0.352,1.29,'-,[1.21–1.39],IL21-AS1,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,4:122628544
rs2300747-<b>A</b>,2 x 10-12,,0.416,1.29,'-,[1.20–1.39],CD58,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,1:116561593
rs10415976-<b>?</b>,4 x 10-12,,0.51,1.2987013,'-,'-,ARID3A,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,19:941603
rs11556218-<b>C</b>,9 x 10-9,,0.189,1.29,'-,[1.18–1.41],IL16,Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,15:81305928
rs2550374-<b>?</b>,2 x 10-8,,0.51,1.2345679,'-,'-,"CCDC113, RN7SL645P",Primary biliary cholangitis,primary biliary cirrhosis,GCST004302,16:58220544
rs3129887-<b>?</b>,2 x 10-29,,NR,3.13,'-,[2.54-3.85],HLA-DRA,Primary biliary cholangitis,primary biliary cirrhosis,GCST004145,6:32442914
rs2293370-<b>A</b>,6 x 10-9,,NR,1.3736264,'-,'-,TIMMDC1,Primary biliary cholangitis,primary biliary cirrhosis,GCST007036,3:119501087
rs17033015-<b>?</b>,9 x 10-10,,NR,1.35,'-,'-,"MANBA, NFKB1",Primary biliary cholangitis,primary biliary cirrhosis,GCST007036,4:102625147
rs12697352-<b>?</b>,2 x 10-9,,NR,1.4705882,'-,'-,"SPEF2, IL7R",Primary biliary cholangitis,primary biliary cirrhosis,GCST007036,5:35837132
rs4979462-<b>?</b>,2 x 10-26,,NR,1.6666665,'-,'-,TNFSF15,Primary biliary cholangitis,primary biliary cirrhosis,GCST007036,9:114804733
rs4795395-<b>?</b>,4 x 10-12,,NR,1.42,'-,'-,IKZF3,Primary biliary cholangitis,primary biliary cirrhosis,GCST007036,17:39806734
rs7942260-<b>?</b>,7 x 10-6,,'-,1.4398848,'-,[NR],PIWIL4,Colorectal cancer,colorectal cancer,GCST005150,11:94612336
rs11224824-<b>?</b>,3 x 10-6,,'-,1.367,'-,[NR],TRPC6,Colorectal cancer,colorectal cancer,GCST005150,11:101538407
rs7927484-<b>?</b>,9 x 10-6,,'-,1.287,'-,[NR],"CLMP, U8",Colorectal cancer,colorectal cancer,GCST005150,11:123268252
rs323473-<b>?</b>,3 x 10-6,,'-,1.498,'-,[NR],'-,Colorectal cancer,colorectal cancer,GCST005150,13:104707293
rs12913832-<b>?</b>,7 x 10-6,,'-,1.252,'-,[NR],HERC2,Colorectal cancer,colorectal cancer,GCST005150,15:28120472
rs16944613-<b>?</b>,1 x 10-7,,'-,1.319,'-,[NR],CRTC3,Colorectal cancer,colorectal cancer,GCST005150,15:90595866
rs476605-<b>?</b>,4 x 10-6,,'-,1.24471,'-,[NR],RBFOX1,Colorectal cancer,colorectal cancer,GCST005150,16:5379576
rs917543-<b>?</b>,8 x 10-6,,'-,1.2420816,'-,[NR],RBFOX1,Colorectal cancer,colorectal cancer,GCST005150,16:7693745
rs9929215-<b>?</b>,3 x 10-6,,'-,1.767,'-,[NR],FENDRR,Colorectal cancer,colorectal cancer,GCST005150,16:86487884
rs12604637-<b>?</b>,8 x 10-6,,'-,1.346,'-,[NR],"RAB12, AKR1B1P6",Colorectal cancer,colorectal cancer,GCST005150,18:8556718
rs674617-<b>?</b>,9 x 10-6,,'-,1.408,'-,[NR],"RAB31, KRT18P8",Colorectal cancer,colorectal cancer,GCST005150,18:9701785
rs12953717-<b>?</b>,3 x 10-7,,'-,1.261,'-,[NR],SMAD7,Colorectal cancer,colorectal cancer,GCST005150,18:48927559
rs694339-<b>?</b>,4 x 10-7,,'-,1.792,'-,[NR],CBLN2,Colorectal cancer,colorectal cancer,GCST005150,18:72554745
rs4949330-<b>?</b>,4 x 10-6,,'-,1.802,'-,[NR],PUM1,Colorectal cancer,colorectal cancer,GCST005150,1:30976919
rs3753366-<b>?</b>,1 x 10-6,,'-,1.326,'-,[NR],GNG12,Colorectal cancer,colorectal cancer,GCST005150,1:67729450
rs2184857-<b>?</b>,7 x 10-7,,'-,1.2674271,'-,[NR],"CHRM3, RPS7P5",Colorectal cancer,colorectal cancer,GCST005150,1:239918447
rs4954585-<b>?</b>,1 x 10-6,,'-,1.258,'-,[NR],"HNRNPKP2, UBBP1",Colorectal cancer,colorectal cancer,GCST005150,2:136240824
rs17659990-<b>?</b>,5 x 10-9,,'-,1.875,'-,[NR],DOCK3,Colorectal cancer,colorectal cancer,GCST005150,3:50713718
rs1920324-<b>?</b>,9 x 10-6,,'-,1.3700507,'-,[NR],RAP1BP2,Colorectal cancer,colorectal cancer,GCST005150,3:104161190
rs13129679-<b>?</b>,2 x 10-7,,'-,2.3,'-,[NR],"RNF4, FAM193A",Colorectal cancer,colorectal cancer,GCST005150,4:2574375
rs13170463-<b>?</b>,6 x 10-7,,'-,1.62,'-,[NR],"SPEF2, RNU1-76P",Colorectal cancer,colorectal cancer,GCST005150,5:7983139
rs13355819-<b>?</b>,5 x 10-6,,'-,1.2425448,'-,[NR],LUCAT1,Colorectal cancer,colorectal cancer,GCST005150,5:91280462
rs742223-<b>?</b>,5 x 10-7,,'-,1.6647245,'-,[NR],"ADTRP, Metazoa_SRP",Colorectal cancer,colorectal cancer,GCST005150,6:11705467
rs811100-<b>?</b>,9 x 10-6,,'-,1.553,'-,[NR],KIAA0319,Colorectal cancer,colorectal cancer,GCST005150,6:24546799
rs1362126-<b>?</b>,1 x 10-7,,'-,1.3338668,'-,[NR],HLA-F,Colorectal cancer,colorectal cancer,GCST005150,6:29723242
rs16944613-<b>?</b>,2 x 10-6,,'-,1.343,'-,[NR],CRTC3,Colorectal cancer,colorectal cancer,GCST005149,15:90595866
rs17177725-<b>?</b>,8 x 10-6,,'-,1.6447369,'-,[NR],SLC25A21,Colorectal cancer,colorectal cancer,GCST005149,14:36888207
rs17416314-<b>?</b>,2 x 10-6,,'-,1.6490766,'-,[NR],PDZD2,Colorectal cancer,colorectal cancer,GCST005149,5:31804244
rs17659990-<b>?</b>,1 x 10-7,,'-,1.925,'-,[NR],DOCK3,Colorectal cancer,colorectal cancer,GCST005149,3:50713718
rs2184857-<b>?</b>,6 x 10-6,,'-,1.2934936,'-,[NR],"CHRM3, RPS7P5",Colorectal cancer,colorectal cancer,GCST005149,1:239918447
rs28541881-<b>?</b>,1 x 10-6,,'-,1.604,'-,[NR],GARRE1,Colorectal cancer,colorectal cancer,GCST005149,19:34277685
rs2965280-<b>?</b>,2 x 10-6,,'-,1.606,'-,[NR],"UBA2, PDCD2L",Colorectal cancer,colorectal cancer,GCST005149,19:34426795
rs302359-<b>?</b>,3 x 10-6,,'-,2.471,'-,[NR],TMTC1,Colorectal cancer,colorectal cancer,GCST005149,12:29797945
rs323473-<b>?</b>,4 x 10-6,,'-,1.578,'-,[NR],'-,Colorectal cancer,colorectal cancer,GCST005149,13:104707293
rs35874699-<b>?</b>,5 x 10-6,,'-,1.2886598,'-,[NR],LINC02195,Colorectal cancer,colorectal cancer,GCST005149,16:26527941
rs3914272-<b>?</b>,5 x 10-6,,'-,1.38,'-,[NR],TMEM212-AS1,Colorectal cancer,colorectal cancer,GCST005149,3:171840746
rs4086865-<b>?</b>,7 x 10-6,,'-,1.665,'-,[NR],'-,Colorectal cancer,colorectal cancer,GCST005149,11:25990646
rs4397989-<b>?</b>,3 x 10-6,,'-,1.3208295,'-,[NR],"PCDH17, MTND4P1",Colorectal cancer,colorectal cancer,GCST005149,13:84504393
rs4836891-<b>?</b>,9 x 10-7,,'-,1.582,'-,[NR],OR1J2,Colorectal cancer,colorectal cancer,GCST005149,9:122511295
rs4979489-<b>?</b>,9 x 10-6,,'-,1.3310263,'-,[NR],DELEC1,Colorectal cancer,colorectal cancer,GCST005149,9:115006400
rs511674-<b>?</b>,6 x 10-6,,'-,2.155,'-,[NR],SMAD9,Colorectal cancer,colorectal cancer,GCST005149,13:36848378
rs5753618-<b>?</b>,6 x 10-7,,'-,1.366,'-,[NR],"EIF4ENIF1, DRG1",Colorectal cancer,colorectal cancer,GCST005149,22:31442532
rs674617-<b>?</b>,9 x 10-6,,'-,1.486,'-,[NR],"RAB31, KRT18P8",Colorectal cancer,colorectal cancer,GCST005149,18:9701785
rs6853410-<b>?</b>,7 x 10-6,,'-,1.315,'-,[NR],RASGEF1B,Colorectal cancer,colorectal cancer,GCST005149,4:81772382
rs694339-<b>?</b>,1 x 10-7,,'-,1.973,'-,[NR],CBLN2,Colorectal cancer,colorectal cancer,GCST005149,18:72554745
rs7606512-<b>?</b>,9 x 10-7,,'-,1.837,'-,[NR],LINC01173,Colorectal cancer,colorectal cancer,GCST005149,2:234701030
rs926340-<b>?</b>,8 x 10-6,,'-,1.274,'-,[NR],OSBP2,Colorectal cancer,colorectal cancer,GCST005149,22:30743331
rs9676308-<b>?</b>,9 x 10-6,,'-,1.643,'-,[NR],"RPL7AP69, USP29",Colorectal cancer,colorectal cancer,GCST005149,19:57067709
rs926340-<b>?</b>,4 x 10-6,,'-,1.235,'-,[NR],OSBP2,Colorectal cancer,colorectal cancer,GCST005150,22:30743331
rs5753618-<b>?</b>,8 x 10-6,,'-,1.274,'-,[NR],"EIF4ENIF1, DRG1",Colorectal cancer,colorectal cancer,GCST005150,22:31442532
rs10495672-<b>?</b>,3 x 10-6,,'-,1.433,'-,[NR],KCNS3,Colorectal cancer,colorectal cancer,GCST005152,2:18313189
rs10878977-<b>?</b>,8 x 10-6,,'-,1.407,'-,[NR],"RPS26P45, RN7SL804P",Colorectal cancer,colorectal cancer,GCST005152,12:69405910
rs11123333-<b>?</b>,4 x 10-6,,'-,1.3757051,'-,[NR],'-,Colorectal cancer,colorectal cancer,GCST005152,2:116151675
rs1505758-<b>?</b>,3 x 10-6,,'-,1.3825521,'-,[NR],'-,Colorectal cancer,colorectal cancer,GCST005152,2:116321325
rs1654668-<b>?</b>,6 x 10-6,,'-,1.3610997,'-,[NR],LILRB4,Colorectal cancer,colorectal cancer,GCST005152,19:54662761
rs16869961-<b>?</b>,1 x 10-6,,'-,1.4186409,'-,[NR],KCNIP4,Colorectal cancer,colorectal cancer,GCST005152,4:20778692
rs17626293-<b>?</b>,7 x 10-6,,'-,2.1159544,'-,[NR],'-,Colorectal cancer,colorectal cancer,GCST005152,1:195682389
rs1912804-<b>?</b>,3 x 10-7,,'-,1.693,'-,[NR],WWOX,Colorectal cancer,colorectal cancer,GCST005152,16:78592686
rs7134911-<b>?</b>,9 x 10-6,,'-,1.3542795,'-,[NR],"PPIAP44, LINC00941",Colorectal cancer,colorectal cancer,GCST005152,12:30822535
rs7831492-<b>?</b>,6 x 10-6,,'-,1.369863,'-,[NR],ANK1,Colorectal cancer,colorectal cancer,GCST005152,8:41756985
rs845868-<b>?</b>,2 x 10-6,,'-,1.4667058,'-,[NR],LINC01622,Colorectal cancer,colorectal cancer,GCST005152,6:998578
rs954980-<b>?</b>,5 x 10-6,,'-,1.3933399,'-,[NR],"RFX3-AS1, GLIS3",Colorectal cancer,colorectal cancer,GCST005152,9:3761909
rs9583269-<b>?</b>,6 x 10-7,,'-,1.4427933,'-,[NR],MYO16,Colorectal cancer,colorectal cancer,GCST005152,13:108630682
rs7742915-<b>?</b>,9 x 10-8,,'-,1.308,'-,[NR],BTBD9,Colorectal cancer,colorectal cancer,GCST005150,6:38179969
rs582962-<b>?</b>,8 x 10-6,,'-,1.236,'-,[NR],ADGRB3,Colorectal cancer,colorectal cancer,GCST005150,6:68812086
rs9458376-<b>?</b>,8 x 10-6,,'-,2.005,'-,[NR],PRKN,Colorectal cancer,colorectal cancer,GCST005150,6:161798822
rs34541550-<b>?</b>,5 x 10-6,,'-,1.302,'-,[NR],CPVL,Colorectal cancer,colorectal cancer,GCST005150,7:29068376
rs6948772-<b>?</b>,4 x 10-6,,'-,1.2532898,'-,[NR],"CNPY1, RBM33",Colorectal cancer,colorectal cancer,GCST005150,7:155608201
rs2272613-<b>?</b>,2 x 10-6,,'-,1.504,'-,[NR],"KBTBD11-OT1, ARHGEF10",Colorectal cancer,colorectal cancer,GCST005150,8:1925374
rs16887197-<b>?</b>,2 x 10-6,,'-,1.5629884,'-,[NR],'-,Colorectal cancer,colorectal cancer,GCST005150,8:115234438
rs12378118-<b>?</b>,8 x 10-6,,'-,1.3142331,'-,[NR],RANBP6,Colorectal cancer,colorectal cancer,GCST005150,9:6033278
rs7873807-<b>?</b>,3 x 10-6,,'-,1.246,'-,[NR],PPIAP33,Colorectal cancer,colorectal cancer,GCST005150,9:7582632
rs12378124-<b>?</b>,2 x 10-6,,'-,1.41,'-,[NR],PTPRD,Colorectal cancer,colorectal cancer,GCST005150,9:9668869
rs11144217-<b>?</b>,5 x 10-6,,'-,1.276,'-,[NR],NMRK1,Colorectal cancer,colorectal cancer,GCST005150,9:75081761
rs10989517-<b>?</b>,8 x 10-6,,'-,1.494,'-,[NR],"TMEM246-AS1, ALDOB",Colorectal cancer,colorectal cancer,GCST005150,9:101460426
rs1056107-<b>?</b>,6 x 10-6,,'-,1.2291052,'-,[NR],PTBP3,Colorectal cancer,colorectal cancer,GCST005150,9:112324847
rs12627687-<b>?</b>,8 x 10-6,,'-,1.3,'-,[NR],"LINC00310, MRPS6",Colorectal cancer,colorectal cancer,GCST005150,21:34145184
rs11812485-<b>?</b>,8 x 10-6,,'-,1.6273394,'-,[NR],'-,Colorectal cancer,colorectal cancer,GCST005150,10:81288281
rs1912804-<b>?</b>,1 x 10-6,,'-,1.586,'-,[NR],WWOX,Colorectal cancer,colorectal cancer,GCST005148,16:78592686
rs6668441-<b>?</b>,5 x 10-6,,'-,1.9264112,'-,[NR],LINC01709,Colorectal cancer,colorectal cancer,GCST005148,1:101777361
rs35505947-<b>?</b>,6 x 10-6,,'-,1.460707,'-,[NR],MC2R,Colorectal cancer,colorectal cancer,GCST005148,18:13954110
rs17179503-<b>?</b>,6 x 10-6,,'-,1.8409425,'-,[NR],CACNA2D1,Colorectal cancer,colorectal cancer,GCST005148,7:82357973
rs17382698-<b>?</b>,9 x 10-6,,'-,1.522,'-,[NR],PVT1,Colorectal cancer,colorectal cancer,GCST005148,8:128126960
rs1155750-<b>?</b>,9 x 10-6,,'-,1.4334862,'-,[NR],FAM83B,Colorectal cancer,colorectal cancer,GCST005148,6:54865546
rs10790917-<b>?</b>,2 x 10-6,,'-,1.2884938,'-,[NR],SLC25A47P1,Colorectal cancer,colorectal cancer,GCST005149,11:127775792
rs11224824-<b>?</b>,3 x 10-6,,'-,1.436,'-,[NR],TRPC6,Colorectal cancer,colorectal cancer,GCST005149,11:101538407
rs11539086-<b>?</b>,9 x 10-6,,'-,1.522,'-,[NR],FAM107A,Colorectal cancer,colorectal cancer,GCST005149,3:58566602
rs11803759-<b>?</b>,6 x 10-6,,'-,1.851,'-,[NR],KAZN,Colorectal cancer,colorectal cancer,GCST005149,1:14338636
rs11853542-<b>?</b>,7 x 10-6,,'-,1.36,'-,[NR],"LINC00052, RNU6-185P",Colorectal cancer,colorectal cancer,GCST005149,15:87509536
rs11927424-<b>?</b>,1 x 10-6,,'-,1.307,'-,[NR],'-,Colorectal cancer,colorectal cancer,GCST005149,3:88708681
rs1202519-<b>?</b>,6 x 10-6,,'-,1.2845215,'-,[NR],"RNA5SP79, CAPN9",Colorectal cancer,colorectal cancer,GCST005149,1:230811394
rs12500234-<b>?</b>,4 x 10-6,,'-,1.2956724,'-,[NR],SMIM14,Colorectal cancer,colorectal cancer,GCST005149,4:39618250
rs1262463-<b>?</b>,5 x 10-6,,'-,1.595,'-,[NR],TCF4,Colorectal cancer,colorectal cancer,GCST005149,18:55287190
rs12667108-<b>?</b>,6 x 10-6,,'-,1.459641,'-,[NR],"RBAKDN, OR10AH1P",Colorectal cancer,colorectal cancer,GCST005149,7:5094305
rs1270639-<b>?</b>,3 x 10-6,,'-,1.437,'-,[NR],PTPRN2,Colorectal cancer,colorectal cancer,GCST005149,7:157662767
rs12916300-<b>?</b>,4 x 10-7,,'-,1.35,'-,[NR],HERC2,Colorectal cancer,colorectal cancer,GCST005149,15:28165345
rs12953717-<b>?</b>,9 x 10-7,,'-,1.302,'-,[NR],SMAD7,Colorectal cancer,colorectal cancer,GCST005149,18:48927559
rs12999616-<b>?</b>,7 x 10-6,,'-,1.338,'-,[NR],"C2orf92, ZAP70",Colorectal cancer,colorectal cancer,GCST005149,2:97707918
rs13170463-<b>?</b>,5 x 10-6,,'-,1.667,'-,[NR],"SPEF2, RNU1-76P",Colorectal cancer,colorectal cancer,GCST005149,5:7983139
rs1362126-<b>?</b>,3 x 10-7,,'-,1.3908206,'-,[NR],HLA-F,Colorectal cancer,colorectal cancer,GCST005149,6:29723242
rs1557614-<b>?</b>,9 x 10-6,,'-,1.292992,'-,[NR],LINC02641,Colorectal cancer,colorectal cancer,GCST005149,10:123487946
rs16845107-<b>?</b>,6 x 10-7,,'-,1.9069412,'-,[NR],"CFAP44, CFAP44-AS1",Colorectal cancer,colorectal cancer,GCST005149,3:113409144
rs16869961-<b>?</b>,2 x 10-6,,'-,1.3287271,'-,[NR],KCNIP4,Colorectal cancer,colorectal cancer,GCST005149,4:20778692
rs9828223-<b>A</b>,2 x 10-9,,0.1,15.87,'-,[4.38-57.49],CD96,Anti-adalimumab antibody production in response to treatment in Crohn's disease,"response to TNF antagonist, Crohn's disease",GCST008271,3:111506078
rs2476601-<b>A</b>,1 x 10-100,,0.09,1.89,'-,'-,PTPN22,Type 1 diabetes,type I diabetes mellitus,GCST005536,1:113834946
rs6691977-<b>C</b>,4 x 10-8,,0.19,1.13,'-,'-,CAMSAP2,Type 1 diabetes,type I diabetes mellitus,GCST005536,1:200845831
rs3024505-<b>G</b>,6 x 10-8,,0.84,1.1627907,'-,'-,"IL10, Y_RNA",Type 1 diabetes,type I diabetes mellitus,GCST005536,1:206766559
rs13415583-<b>T</b>,1 x 10-7,,0.65,1.1111112,'-,'-,AFF3,Type 1 diabetes,type I diabetes mellitus,GCST005536,2:100147625
rs4849135-<b>G</b>,4 x 10-8,,0.71,1.1235955,'-,'-,ACOXL,Type 1 diabetes,type I diabetes mellitus,GCST005536,2:110857502
rs2111485-<b>G</b>,4 x 10-18,,0.61,1.1764705,'-,'-,'-,Type 1 diabetes,type I diabetes mellitus,GCST005536,Mapping not available
rs35667974-<b>T</b>,9 x 10-9,(conditioned on rs2111485),0.98,1.6949153,'-,'-,IFIH1,Type 1 diabetes,type I diabetes mellitus,GCST005536,2:162268127
rs72871627-<b>A</b>,2 x 10-6,"(conditioned rs2111485, rs35667974)",0.99,1.6393442,'-,'-,IFIH1,Type 1 diabetes,type I diabetes mellitus,GCST005536,2:162280432
rs3087243-<b>G</b>,7 x 10-21,,0.55,1.1904762,'-,'-,"CTLA4, ICOS",Type 1 diabetes,type I diabetes mellitus,GCST005536,2:203874196
rs113010081-<b>T</b>,5 x 10-8,,0.89,1.1764705,'-,'-,"LINC02009, CCRL2",Type 1 diabetes,type I diabetes mellitus,GCST005536,3:46415921
rs75793288-<b>G</b>,6 x 10-13,,0.36,1.15,'-,'-,KIAA1109,Type 1 diabetes,type I diabetes mellitus,GCST005536,4:122322441
rs2611215-<b>A</b>,2 x 10-11,,0.15,1.18,'-,'-,LINC01179,Type 1 diabetes,type I diabetes mellitus,GCST005536,4:165653115
rs11954020-<b>G</b>,4 x 10-8,,0.39,1.11,'-,'-,"IL7R, CAPSL",Type 1 diabetes,type I diabetes mellitus,GCST005536,5:35883149
rs72928038-<b>A</b>,6 x 10-14,,0.17,1.2,'-,'-,BACH2,Type 1 diabetes,type I diabetes mellitus,GCST005536,6:90267049
rs1538171-<b>G</b>,7 x 10-10,,0.45,1.12,'-,'-,"MIR588, CENPW",Type 1 diabetes,type I diabetes mellitus,GCST005536,6:126431738
rs62447205-<b>A</b>,3 x 10-8,,0.72,1.1235955,'-,'-,IKZF1,Type 1 diabetes,type I diabetes mellitus,GCST005536,7:50398132
rs10277986-<b>A</b>,1 x 10-7,,0.96,1.3157895,'-,'-,COBL,Type 1 diabetes,type I diabetes mellitus,GCST005536,7:50961290
rs6476839-<b>T</b>,1 x 10-9,,0.4,1.12,'-,'-,GLIS3,Type 1 diabetes,type I diabetes mellitus,GCST005536,9:4290823
rs61839660-<b>C</b>,3 x 10-39,,0.9,1.6129031,'-,'-,IL2RA,Type 1 diabetes,type I diabetes mellitus,GCST005536,10:6052734
rs10795791-<b>G</b>,6 x 10-11,(conditioned rs61839660),0.41,1.16,'-,'-,"RPL32P23, IL2RA",Type 1 diabetes,type I diabetes mellitus,GCST005536,10:6066377
rs41295121-<b>C</b>,5 x 10-8,"(conditioned rs61839660, rs10795791)",0.99,2.0408163,'-,'-,"RPL32P23, RBM17",Type 1 diabetes,type I diabetes mellitus,GCST005536,10:6087680
rs12416116-<b>C</b>,4 x 10-15,,0.72,1.1764705,'-,'-,RNLS,Type 1 diabetes,type I diabetes mellitus,GCST005536,10:88275897
rs689-<b>T</b>,1 x 10-100,,0.7,2.3809524,'-,'-,"INS, INS-IGF2",Type 1 diabetes,type I diabetes mellitus,GCST005536,11:2160994
rs72853903-<b>C</b>,6 x 10-10,(conditioned on rs689),0.62,1.1764705,'-,'-,"MIR4686, ASCL2",Type 1 diabetes,type I diabetes mellitus,GCST005536,11:2177435
rs917911-<b>C</b>,2 x 10-7,,0.36,1.1,'-,'-,CD69,Type 1 diabetes,type I diabetes mellitus,GCST005536,12:9753255
rs705705-<b>C</b>,4 x 10-32,,0.34,1.25,'-,'-,RPS26,Type 1 diabetes,type I diabetes mellitus,GCST005536,12:56041720
rs653178-<b>C</b>,2 x 10-44,,0.48,1.3,'-,'-,'-,Type 1 diabetes,type I diabetes mellitus,GCST005536,Mapping not available
rs9585056-<b>C</b>,3 x 10-8,,0.24,1.12,'-,'-,"TM9SF2, CCR12P",Type 1 diabetes,type I diabetes mellitus,GCST005536,13:99429512
rs1456988-<b>G</b>,3 x 10-8,,0.27,1.12,'-,'-,LINC01550,Type 1 diabetes,type I diabetes mellitus,GCST005536,14:98021670
rs56994090-<b>T</b>,1 x 10-11,,0.59,1.1363636,'-,'-,MEG3,Type 1 diabetes,type I diabetes mellitus,GCST005536,14:100840110
rs72727394-<b>T</b>,4 x 10-10,,0.19,1.15,'-,'-,RASGRP1,Type 1 diabetes,type I diabetes mellitus,GCST005536,15:38554821
rs34593439-<b>G</b>,9 x 10-14,,0.9,1.2820514,'-,'-,CTSH,Type 1 diabetes,type I diabetes mellitus,GCST005536,15:78942615
rs151234-<b>C</b>,5 x 10-11,,0.12,1.19,'-,'-,CLN3,Type 1 diabetes,type I diabetes mellitus,GCST005536,16:28494339
rs12927355-<b>C</b>,3 x 10-22,,0.68,1.2195122,'-,'-,CLEC16A,Type 1 diabetes,type I diabetes mellitus,GCST005536,16:11100914
rs193778-<b>G</b>,4 x 10-10,,0.25,1.14,'-,'-,RMI2,Type 1 diabetes,type I diabetes mellitus,GCST005536,16:11257354
rs8056814-<b>A</b>,3 x 10-19,,0.07,1.32,'-,'-,"CTRB2, CTRB1",Type 1 diabetes,type I diabetes mellitus,GCST005536,16:75218429
rs12453507-<b>G</b>,1 x 10-8,,0.51,1.1111112,'-,'-,"GSDMB, ZPBP2",Type 1 diabetes,type I diabetes mellitus,GCST005536,17:39896954
rs757411-<b>T</b>,1 x 10-7,,0.64,1.1111112,'-,'-,"CCR7, SMARCE1",Type 1 diabetes,type I diabetes mellitus,GCST005536,17:40618898
rs1052553-<b>A</b>,8 x 10-8,,0.76,1.1235955,'-,'-,MAPT,Type 1 diabetes,type I diabetes mellitus,GCST005536,17:45996523
rs1893217-<b>G</b>,1 x 10-15,,0.16,1.21,'-,'-,PTPN2,Type 1 diabetes,type I diabetes mellitus,GCST005536,18:12809341
rs12971201-<b>G</b>,2 x 10-6,(conditioned on rs1893217),0.61,1.1235955,'-,'-,PTPN2,Type 1 diabetes,type I diabetes mellitus,GCST005536,18:12830539
rs1615504-<b>T</b>,2 x 10-11,,0.47,1.13,'-,'-,CD226,Type 1 diabetes,type I diabetes mellitus,GCST005536,18:69859408
rs34536443-<b>G</b>,4 x 10-15,,0.96,1.4925373,'-,'-,'-,Type 1 diabetes,type I diabetes mellitus,GCST005536,Mapping not available
rs12720356-<b>A</b>,4 x 10-7,(conditioned on rs34536443),0.91,1.2195122,'-,'-,TYK2,Type 1 diabetes,type I diabetes mellitus,GCST005536,19:10359299
rs402072-<b>T</b>,5 x 10-8,,0.84,1.1494253,'-,'-,PRKD2,Type 1 diabetes,type I diabetes mellitus,GCST005536,19:46715865
rs516246-<b>T</b>,5 x 10-14,,0.51,1.1494253,'-,'-,FUT2,Type 1 diabetes,type I diabetes mellitus,GCST005536,19:48702915
rs6043409-<b>G</b>,3 x 10-10,,0.65,1.1363636,'-,'-,"SIRPG, SIRPG-AS1",Type 1 diabetes,type I diabetes mellitus,GCST005536,20:1635560
rs11203202-<b>G</b>,1 x 10-15,,0.33,1.16,'-,'-,UBASH3A,Type 1 diabetes,type I diabetes mellitus,GCST005536,21:42405248
rs6518350-<b>A</b>,1 x 10-7,,0.82,1.1363636,'-,'-,GATD3A,Type 1 diabetes,type I diabetes mellitus,GCST005536,21:44201934
rs4820830-<b>C</b>,1 x 10-12,,0.38,1.14,'-,'-,HORMAD2,Type 1 diabetes,type I diabetes mellitus,GCST005536,22:30135102
rs229533-<b>C</b>,2 x 10-8,,0.43,1.11,'-,'-,C1QTNF6,Type 1 diabetes,type I diabetes mellitus,GCST005536,22:37191071
rs926169-<b>T</b>,9 x 10-6,,0.36,1.28,'-,[1.15–1.42],"CTLA4, RNU6-474P",Type 1 diabetes,type I diabetes mellitus,GCST009916,2:203858029
rs9273363-<b>A</b>,5 x 10-138,,0.13,5.48,'-,[4.80–6.27],"HLA-DQB1, HLA-DQA1",Type 1 diabetes,type I diabetes mellitus,GCST009916,6:32658495
rs1578060-<b>C</b>,2 x 10-6,,0.13,1.42,'-,[1.23–1.64],"CENPW, MIR588",Type 1 diabetes,type I diabetes mellitus,GCST009916,6:126391101
rs10788599-<b>?</b>,1 x 10-6,,0.83,1.4492754,'-,'-,RNLS,Type 1 diabetes,type I diabetes mellitus,GCST009916,10:88428167
rs3842727-<b>T</b>,1 x 10-13,,0.26,1.53,'-,[1.37–1.72],"TH, INS",Type 1 diabetes,type I diabetes mellitus,GCST009916,11:2163618
rs56380902-<b>C</b>,1 x 10-8,,0.44,1.35,'-,[1.22–1.50],GSDMB,Type 1 diabetes,type I diabetes mellitus,GCST009916,17:39910119
rs17206992-<b>G</b>,6 x 10-6,(EA),0.057,2.32,'-,[NR],GALNT13,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,2:154368670
rs113517532-<b>AGAT</b>,2 x 10-6,(EA),0.106,1.75,'-,[NR],LINC01117,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,2:176780863
rs73018809-<b>T</b>,2 x 10-7,(EA),0.024,3.5,'-,[NR],NUP210,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,3:13329174
rs28641753-<b>T</b>,2 x 10-7,(EA),0.071,2.1,'-,[NR],'-,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,3:104256574
rs78031527-<b>T</b>,5 x 10-6,(EA),0.201,1.7,'-,[NR],"C4orf50, JAKMIP1",Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,4:6169503
rs143537377-<b>C</b>,8 x 10-6,(EA),0.096,1.88,'-,[NR],LINC02212,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,5:10500534
rs115829748-<b>T</b>,1 x 10-9,(EA),0.04,3.16,'-,[NR],MAP1B,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,5:72098560
rs9354144-<b>A</b>,6 x 10-6,(EA),0.105,1.71,'-,[NR],'-,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,6:94847753
rs571622299-<b>A</b>,6 x 10-6,(EA),0.015,4.12,'-,[NR],KCNB2,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,8:72930288
rs143723948-<b>T</b>,6 x 10-7,(EA),0.499,1.65,'-,[NR],PAX5,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,9:37034098
rs117826205-<b>C</b>,6 x 10-6,(EA),0.026,2.72,'-,[NR],MALRD1,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,10:19168458
rs61879614-<b>C</b>,3 x 10-6,(EA),0.048,2.94,'-,[NR],TUB,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,11:8058878
rs34319244-<b>C</b>,3 x 10-6,(EA),0.44,1.51,'-,[NR],"SPNS3, UBE2G1",Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,17:4424870
rs113114656-<b>T</b>,2 x 10-6,(EA),0.04,2.67,'-,[NR],SMAD2,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,18:47872985
rs67213764-<b>G</b>,9 x 10-6,(EA),0.261,1.48,'-,[NR],LINC01683,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,21:19974842
rs12482425-<b>G</b>,9 x 10-6,(EA),0.686,1.5151515,'-,[NR],'-,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,21:23556791
rs373009901-<b>C</b>,9 x 10-6,(EA),0.019,3.94,'-,[NR],GRK3,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,22:25592812
rs138760780-<b>T</b>,9 x 10-6,(EA),0.018,3.48,'-,[NR],CDK18,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,1:205515245
rs12344245-<b>G</b>,9 x 10-6,(EA),0.035,2.52,'-,[NR],FAM189A2,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,9:69340801
rs12344245-<b>G</b>,9 x 10-6,,0.035,1.85,'-,[1.41-2.43],FAM189A2,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,9:69340801
rs138760780-<b>T</b>,2 x 10-6,,0.018,2.6,'-,[1.75-3.85],CDK18,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST006281,1:205515245
rs114631266-<b>C</b>,2 x 10-6,,0.974,'-,0.284 unit increase,[0.17-0.4],"OR2W1, OR2P1P",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:29058810
rs2471863-<b>C</b>,8 x 10-7,,0.526,'-,0.057 unit increase,[0.033-0.081],"HLA-K, HLA-U",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:29931850
rs34941730-<b>G</b>,2 x 10-9,,0.119,'-,0.102 unit decrease,[0.069-0.135],"HLA-A, HLA-W",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:29946109
rs45626136-<b>C</b>,1 x 10-6,,0.939,'-,0.111 unit increase,[0.066-0.156],"TRIM39-RPP21, RPP21",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:30345252
rs1265057-<b>C</b>,2 x 10-6,,0.491,'-,0.053 unit decrease,[0.031-0.075],"C6orf15, RNU6-1133P",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:31110838
rs116763857-<b>G</b>,1 x 10-14,,0.027,'-,0.295 unit decrease,[0.22-0.37],POU5F1,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:31173705
rs9264758-<b>G</b>,3 x 10-7,,0.866,'-,0.082 unit increase,[0.051-0.113],RPL3P2,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:31280657
rs3093664-<b>G</b>,3 x 10-7,,0.048,'-,0.13 unit increase,[0.081-0.179],TNF,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:31576865
rs3134938-<b>C</b>,8 x 10-7,,0.832,'-,0.076 unit decrease,[0.047-0.105],"TSBP1-AS1, NOTCH4",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:32238711
rs926592-<b>C</b>,6 x 10-6,,0.658,'-,0.059 unit increase,[0.034-0.084],"TSBP1, TSBP1-AS1",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:32337881
rs3135365-<b>C</b>,9 x 10-6,,0.022,'-,0.202 unit increase,[0.11-0.29],"TSBP1-AS1, HLA-DRA",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:32421478
rs9268576-<b>C</b>,2 x 10-8,,0.359,'-,0.111 unit decrease,[0.072-0.15],"HLA-DRA, TSBP1-AS1",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:32427864
rs7760731-<b>C</b>,6 x 10-11,,0.642,'-,0.087 unit increase,[0.062-0.112],"HLA-DQA1, HLA-DRB1",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:32615624
rs9275358-<b>G</b>,3 x 10-7,,0.475,'-,0.083 unit decrease,[0.052-0.114],"HLA-DQB1, MTCO3P1",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:32700118
rs35122968-<b>C</b>,4 x 10-11,,0.043,'-,0.2 unit increase,[0.14-0.26],"MTCO3P1, HLA-DQB3",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:32714422
rs3997848-<b>G</b>,2 x 10-14,,0.117,'-,0.135 unit increase,[0.1-0.17],"MTCO3P1, HLA-DQB3",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:32714617
rs241427-<b>G</b>,4 x 10-6,,0.797,'-,0.062 unit decrease,[0.035-0.089],TAP2,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:32836637
rs4148870-<b>C</b>,2 x 10-6,,0.402,'-,0.053 unit increase,[0.031-0.075],TAP2,Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:32838614
rs3128930-<b>C</b>,7 x 10-6,,0.683,'-,0.053 unit increase,[0.029-0.077],"COL11A2P1, HLA-DPB2",Type 1 diabetes (age at diagnosis),"type I diabetes mellitus, age at diagnosis",GCST011773,6:33107889
rs79538630-<b>T</b>,1 x 10-9,,0.035,1.213,'-,'-,"SLC15A3, CD6",Type 1 diabetes,type I diabetes mellitus,GCST90013445,11:60961822
rs968567-<b>T</b>,8 x 10-9,,0.177,0.903,'-,'-,"FADS1, FADS2",Type 1 diabetes,type I diabetes mellitus,GCST90013445,11:61828092
rs645078-<b>C</b>,3 x 10-9,,0.385,0.925,'-,'-,RPS6KA4,Type 1 diabetes,type I diabetes mellitus,GCST90013445,11:64367826
rs605093-<b>T</b>,4 x 10-9,,0.47,1.077,'-,'-,FLI1,Type 1 diabetes,type I diabetes mellitus,GCST90013445,11:128734337
rs1805731-<b>C</b>,4 x 10-8,,0.389,1.073,'-,'-,M6PR,Type 1 diabetes,type I diabetes mellitus,GCST90013445,12:8942630
rs7313065-<b>A</b>,3 x 10-9,,0.162,1.101,'-,'-,SPRYD3,Type 1 diabetes,type I diabetes mellitus,GCST90013445,12:53077434
rs74537115-<b>T</b>,5 x 10-9,,0.141,1.109,'-,'-,LINC02341,Type 1 diabetes,type I diabetes mellitus,GCST90013445,13:42343795
rs911263-<b>T</b>,3 x 10-8,,0.71,1.083,'-,'-,RAD51B,Type 1 diabetes,type I diabetes mellitus,GCST90013445,14:68286876
rs4238595-<b>C</b>,2 x 10-11,,0.687,0.912,'-,'-,"GP2, UMOD",Type 1 diabetes,type I diabetes mellitus,GCST90013445,16:20331769
rs1052553-<b>G</b>,2 x 10-15,,0.232,0.879,'-,'-,MAPT,Type 1 diabetes,type I diabetes mellitus,GCST90013445,17:45996523
rs2597169-<b>G</b>,3 x 10-9,,0.348,1.081,'-,'-,PRR15L,Type 1 diabetes,type I diabetes mellitus,GCST90013445,17:47956725
rs56178904-<b>T</b>,7 x 10-11,,0.187,0.898,'-,'-,GATD3A,Type 1 diabetes,type I diabetes mellitus,GCST90013445,21:44204668
rs34090353-<b>C</b>,1 x 10-8,,0.361,1.078,'-,'-,RPAP2,Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:92358141
rs2641348-<b>G</b>,2 x 10-8,,0.107,1.113,'-,'-,ADAM30,Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:119895261
rs2229238-<b>C</b>,1 x 10-12,,0.813,0.896,'-,'-,IL6R,Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:154465420
rs78037977-<b>G</b>,2 x 10-9,,0.124,0.884,'-,'-,"SLC25A38P1, FASLG",Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:172746562
rs2816313-<b>A</b>,5 x 10-9,,0.719,1.09,'-,'-,RGS1,Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:192570207
rs11120029-<b>T</b>,2 x 10-8,,0.147,1.102,'-,'-,TATDN3,Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:212796238
rs10169963-<b>T</b>,3 x 10-8,,0.58,1.074,'-,'-,MIR3681HG,Type 1 diabetes,type I diabetes mellitus,GCST90013445,2:12512805
rs12712067-<b>T</b>,4 x 10-9,,0.358,0.925,'-,'-,AFF3,Type 1 diabetes,type I diabetes mellitus,GCST90013445,2:100147438
rs7582694-<b>G</b>,3 x 10-9,,0.773,0.916,'-,'-,STAT4,Type 1 diabetes,type I diabetes mellitus,GCST90013445,2:191105394
rs10933559-<b>G</b>,3 x 10-11,,0.208,1.109,'-,'-,FARP2,Type 1 diabetes,type I diabetes mellitus,GCST90013445,2:241468331
rs113881148-<b>A</b>,6 x 10-9,,0.626,1.082,'-,'-,DGKQ,Type 1 diabetes,type I diabetes mellitus,GCST90013445,4:973543
rs337637-<b>A</b>,3 x 10-10,,0.364,0.919,'-,'-,KLF3-AS1,Type 1 diabetes,type I diabetes mellitus,GCST90013445,4:38602849
rs1876142-<b>T</b>,2 x 10-14,,0.658,0.905,'-,'-,TTC33,Type 1 diabetes,type I diabetes mellitus,GCST90013445,5:40521603
rs2269242-<b>C</b>,5 x 10-12,,0.196,1.11,'-,'-,'-,Type 1 diabetes,type I diabetes mellitus,GCST90013445,Mapping not available
rs34090353-<b>C</b>,1 x 10-8,,0.361,1.078,'-,'-,RPAP2,Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:92358141
rs2641348-<b>G</b>,2 x 10-8,,0.107,1.113,'-,'-,ADAM30,Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:119895261
rs2229238-<b>C</b>,1 x 10-12,,0.813,0.896,'-,'-,IL6R,Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:154465420
rs78037977-<b>G</b>,2 x 10-9,,0.124,0.884,'-,'-,"SLC25A38P1, FASLG",Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:172746562
rs2816313-<b>A</b>,5 x 10-9,,0.719,1.09,'-,'-,RGS1,Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:192570207
rs11120029-<b>T</b>,2 x 10-8,,0.147,1.102,'-,'-,TATDN3,Type 1 diabetes,type I diabetes mellitus,GCST90013445,1:212796238
rs10169963-<b>T</b>,3 x 10-8,,0.58,1.074,'-,'-,MIR3681HG,Type 1 diabetes,type I diabetes mellitus,GCST90013445,2:12512805
rs12712067-<b>T</b>,4 x 10-9,,0.358,0.925,'-,'-,AFF3,Type 1 diabetes,type I diabetes mellitus,GCST90013445,2:100147438
rs7582694-<b>G</b>,3 x 10-9,,0.773,0.916,'-,'-,STAT4,Type 1 diabetes,type I diabetes mellitus,GCST90013445,2:191105394
rs10933559-<b>G</b>,3 x 10-11,,0.208,1.109,'-,'-,FARP2,Type 1 diabetes,type I diabetes mellitus,GCST90013445,2:241468331
rs113881148-<b>A</b>,6 x 10-9,,0.626,1.082,'-,'-,DGKQ,Type 1 diabetes,type I diabetes mellitus,GCST90013445,4:973543
rs337637-<b>A</b>,3 x 10-10,,0.364,0.919,'-,'-,KLF3-AS1,Type 1 diabetes,type I diabetes mellitus,GCST90013445,4:38602849
rs1876142-<b>T</b>,2 x 10-14,,0.658,0.905,'-,'-,TTC33,Type 1 diabetes,type I diabetes mellitus,GCST90013445,5:40521603
rs10213692-<b>C</b>,3 x 10-9,,0.241,0.912,'-,'-,ANKRD55,Type 1 diabetes,type I diabetes mellitus,GCST90013445,5:56146422
rs9405661-<b>A</b>,2 x 10-9,,0.514,1.08,'-,'-,"EXOC2, IRF4",Type 1 diabetes,type I diabetes mellitus,GCST90013445,6:424915
rs2269242-<b>C</b>,5 x 10-12,,0.196,1.11,'-,'-,'-,Type 1 diabetes,type I diabetes mellitus,GCST90013445,Mapping not available
rs12665429-<b>C</b>,1 x 10-13,,0.37,0.907,'-,'-,LINC02539,Type 1 diabetes,type I diabetes mellitus,GCST90013445,6:137682468
rs212408-<b>T</b>,1 x 10-15,,0.638,1.112,'-,'-,TAGAP-AS1,Type 1 diabetes,type I diabetes mellitus,GCST90013445,6:159049210
rs17143056-<b>G</b>,2 x 10-8,,0.183,0.909,'-,'-,EEF1A1P27,Type 1 diabetes,type I diabetes mellitus,GCST90013445,7:20557306
rs10245867-<b>T</b>,3 x 10-8,,0.331,0.928,'-,'-,JAZF1,Type 1 diabetes,type I diabetes mellitus,GCST90013445,7:28102567
rs2250903-<b>T</b>,1 x 10-10,,0.283,0.905,'-,'-,"OR7E158P, CTSB",Type 1 diabetes,type I diabetes mellitus,GCST90013445,8:11877675
rs1405209-<b>C</b>,3 x 10-8,,0.375,1.075,'-,'-,"STX17-AS1, NR4A3",Type 1 diabetes,type I diabetes mellitus,GCST90013445,9:99823263
rs722988-<b>C</b>,3 x 10-15,,0.367,1.108,'-,'-,"IATPR, NRP1",Type 1 diabetes,type I diabetes mellitus,GCST90013445,10:33137219
rs11033048-<b>T</b>,2 x 10-10,,0.366,1.091,'-,'-,SLC1A2,Type 1 diabetes,type I diabetes mellitus,GCST90013445,11:35267496
rs10213692-<b>C</b>,3 x 10-9,,0.241,0.912,'-,'-,ANKRD55,Type 1 diabetes,type I diabetes mellitus,GCST90013445,5:56146422
rs9405661-<b>A</b>,2 x 10-9,,0.514,1.08,'-,'-,"EXOC2, IRF4",Type 1 diabetes,type I diabetes mellitus,GCST90013445,6:424915
rs12665429-<b>C</b>,1 x 10-13,,0.37,0.907,'-,'-,LINC02539,Type 1 diabetes,type I diabetes mellitus,GCST90013445,6:137682468
rs212408-<b>T</b>,1 x 10-15,,0.638,1.112,'-,'-,TAGAP-AS1,Type 1 diabetes,type I diabetes mellitus,GCST90013445,6:159049210
rs17143056-<b>G</b>,2 x 10-8,,0.183,0.909,'-,'-,EEF1A1P27,Type 1 diabetes,type I diabetes mellitus,GCST90013445,7:20557306
rs10245867-<b>T</b>,3 x 10-8,,0.331,0.928,'-,'-,JAZF1,Type 1 diabetes,type I diabetes mellitus,GCST90013445,7:28102567
rs2250903-<b>T</b>,1 x 10-10,,0.283,0.905,'-,'-,"OR7E158P, CTSB",Type 1 diabetes,type I diabetes mellitus,GCST90013445,8:11877675
rs1405209-<b>C</b>,3 x 10-8,,0.375,1.075,'-,'-,"STX17-AS1, NR4A3",Type 1 diabetes,type I diabetes mellitus,GCST90013445,9:99823263
rs722988-<b>C</b>,3 x 10-15,,0.367,1.108,'-,'-,"IATPR, NRP1",Type 1 diabetes,type I diabetes mellitus,GCST90013445,10:33137219
rs11033048-<b>T</b>,2 x 10-10,,0.366,1.091,'-,'-,SLC1A2,Type 1 diabetes,type I diabetes mellitus,GCST90013445,11:35267496
rs79538630-<b>T</b>,1 x 10-9,,0.035,1.213,'-,'-,"SLC15A3, CD6",Type 1 diabetes,type I diabetes mellitus,GCST90013445,11:60961822
rs968567-<b>T</b>,8 x 10-9,,0.177,0.903,'-,'-,"FADS1, FADS2",Type 1 diabetes,type I diabetes mellitus,GCST90013445,11:61828092
rs645078-<b>C</b>,3 x 10-9,,0.385,0.925,'-,'-,RPS6KA4,Type 1 diabetes,type I diabetes mellitus,GCST90013445,11:64367826
rs605093-<b>T</b>,4 x 10-9,,0.47,1.077,'-,'-,FLI1,Type 1 diabetes,type I diabetes mellitus,GCST90013445,11:128734337
rs1805731-<b>C</b>,4 x 10-8,,0.389,1.073,'-,'-,M6PR,Type 1 diabetes,type I diabetes mellitus,GCST90013445,12:8942630
rs7313065-<b>A</b>,3 x 10-9,,0.162,1.101,'-,'-,SPRYD3,Type 1 diabetes,type I diabetes mellitus,GCST90013445,12:53077434
rs74537115-<b>T</b>,5 x 10-9,,0.141,1.109,'-,'-,LINC02341,Type 1 diabetes,type I diabetes mellitus,GCST90013445,13:42343795
rs911263-<b>T</b>,3 x 10-8,,0.71,1.083,'-,'-,RAD51B,Type 1 diabetes,type I diabetes mellitus,GCST90013445,14:68286876
rs4238595-<b>C</b>,2 x 10-11,,0.687,0.912,'-,'-,"GP2, UMOD",Type 1 diabetes,type I diabetes mellitus,GCST90013445,16:20331769
rs1052553-<b>G</b>,2 x 10-15,,0.232,0.879,'-,'-,MAPT,Type 1 diabetes,type I diabetes mellitus,GCST90013445,17:45996523
rs2597169-<b>G</b>,3 x 10-9,,0.348,1.081,'-,'-,PRR15L,Type 1 diabetes,type I diabetes mellitus,GCST90013445,17:47956725
rs56178904-<b>T</b>,7 x 10-11,,0.187,0.898,'-,'-,GATD3A,Type 1 diabetes,type I diabetes mellitus,GCST90013445,21:44204668
rs3864055-<b>T</b>,6 x 10-6,,NR,1.79,'-,[1.39-2.31],"ARL8B, Y_RNA",Fulminant type 1 diabetes,type I diabetes mellitus,GCST007433,3:5093886
rs12644905-<b>C</b>,4 x 10-6,,NR,1.91,'-,[1.45-2.52],"CENPU, ACSL1",Fulminant type 1 diabetes,type I diabetes mellitus,GCST007433,4:184755529
rs12203596-<b>C</b>,6 x 10-6,,NR,2.84,'-,[1.78-4.53],STMND1,Fulminant type 1 diabetes,type I diabetes mellitus,GCST007433,6:17120009
rs9356171-<b>A</b>,9 x 10-6,,NR,1.9,'-,[1.43-2.52],RN7SL366P,Fulminant type 1 diabetes,type I diabetes mellitus,GCST007433,6:163922743
rs7871386-<b>C</b>,5 x 10-6,,NR,2.54,'-,[1.69-3.83],'-,Fulminant type 1 diabetes,type I diabetes mellitus,GCST007433,9:23166744
rs5790666-<b>?</b>,8 x 10-9,,NR,2.32,'-,[1.65-3.26],"BDNF, CBX3P1",Fulminant type 1 diabetes,type I diabetes mellitus,GCST007433,11:27778324
rs11170445-<b>T</b>,8 x 10-9,,NR,1.96,'-,[1.56-2.46],"HIGD1AP1, EIF4A1P4",Fulminant type 1 diabetes,type I diabetes mellitus,GCST007433,12:53151908
rs178050-<b>A</b>,7 x 10-6,,NR,1.66,'-,[1.33-2.07],PI4KA,Fulminant type 1 diabetes,type I diabetes mellitus,GCST007433,22:20814301
rs9268853-<b>?</b>,2 x 10-23,,NR,3.18,'-,[2.53-4.01],HLA-DRB9,Fulminant type 1 diabetes,type I diabetes mellitus,GCST007433,6:32461866
rs4445406-<b>T</b>,5 x 10-12,,0.656,1.1494253,'-,'-,MMEL1,Celiac disease,celiac disease,GCST005523,1:2607961
rs72657048-<b>G</b>,4 x 10-6,,0.502,1.0869565,'-,'-,RUNX3,Celiac disease,celiac disease,GCST005523,1:24963243
rs12068671-<b>?</b>,1 x 10-10,,0.815,1.1627907,'-,'-,"FASLG, SLC25A38P1",Celiac disease,celiac disease,GCST005523,1:172711891
rs12142280-<b>?</b>,8 x 10-9,(conditioned on rs12068671),0.82,1.1494253,'-,'-,"AIMP1P2, NUCKS1",Celiac disease,celiac disease,GCST005523,1:172895512
rs1359062-<b>G</b>,3 x 10-25,,0.82,1.2987013,'-,'-,RGS1,Celiac disease,celiac disease,GCST005523,1:192572342
rs10800746-<b>C</b>,3 x 10-8,,0.695,1.12,'-,'-,INAVA,Celiac disease,celiac disease,GCST005523,1:200912264
rs13003464-<b>G</b>,4 x 10-16,,0.388,1.17,'-,'-,PUS10,Celiac disease,celiac disease,GCST005523,2:60959694
rs990171-<b>A</b>,1 x 10-16,,0.225,1.2,'-,'-,"SLC9A4, IL18RAP",Celiac disease,celiac disease,GCST005523,2:102470310
rs1018326-<b>C</b>,3 x 10-16,,0.418,1.16,'-,'-,LINC01934,Celiac disease,celiac disease,GCST005523,2:181143073
rs6715106-<b>?</b>,8 x 10-9,,0.942,1.2658228,'-,'-,STAT4,Celiac disease,celiac disease,GCST005523,2:191048308
rs6752770-<b>?</b>,1 x 10-6,(conditioned on rs6715106),0.296,1.1,'-,'-,STAT4,Celiac disease,celiac disease,GCST005523,2:191108837
rs1980422-<b>?</b>,1 x 10-15,,0.233,1.19,'-,'-,"CD28, KRT18P39",Celiac disease,celiac disease,GCST005523,2:203745673
rs4678523-<b>C</b>,2 x 10-7,,0.313,1.11,'-,'-,"CCR4, GLB1",Celiac disease,celiac disease,GCST005523,3:32996229
rs2097282-<b>?</b>,1 x 10-20,,0.314,1.2,'-,'-,"UQCRC2P1, CCR2",Celiac disease,celiac disease,GCST005523,3:46336534
rs7616215-<b>C</b>,9 x 10-9,(conditioned on rs2097282),0.361,1.12,'-,'-,CCR3,Celiac disease,celiac disease,GCST005523,3:46164194
rs61579022-<b>A</b>,1 x 10-8,,0.39,1.11,'-,'-,ARHGAP31,Celiac disease,celiac disease,GCST005523,3:119404431
rs1353248-<b>?</b>,1 x 10-8,(conditioned on imm_3_161120372),0.712,1.1363636,'-,'-,IL12A-AS1,Celiac disease,celiac disease,GCST005523,3:159905770
rs2561288-<b>?</b>,8 x 10-8,"(conditioned on rs1353248, imm_3_161120372)",0.455,1.12,'-,'-,IL12A-AS1,Celiac disease,celiac disease,GCST005523,3:159957140
rs2030519-<b>A</b>,3 x 10-49,,0.514,1.3157895,'-,'-,LPP,Celiac disease,celiac disease,GCST005523,3:188402113
rs13132308-<b>A</b>,2 x 10-38,,0.834,1.4084507,'-,'-,IL21-AS1,Celiac disease,celiac disease,GCST005523,4:122629959
rs1050976-<b>?</b>,2 x 10-9,,0.512,1.1235955,'-,'-,IRF4,Celiac disease,celiac disease,GCST005523,6:408079
rs7753008-<b>C</b>,3 x 10-7,,0.38,1.1,'-,'-,BACH2,Celiac disease,celiac disease,GCST005523,6:90099920
rs55743914-<b>T</b>,1 x 10-18,,0.239,1.21,'-,'-,PTPRK,Celiac disease,celiac disease,GCST005523,6:127972417
rs17264332-<b>G</b>,5 x 10-30,,0.211,1.29,'-,'-,"SLC17A1, LINC02539",Celiac disease,celiac disease,GCST005523,6:137684378
rs182429-<b>A</b>,9 x 10-16,,0.427,1.16,'-,'-,TAGAP-AS1,Celiac disease,celiac disease,GCST005523,6:159048542
rs1107943-<b>?</b>,3 x 10-6,(conditioned on rs182429),0.071,1.18,'-,'-,TAGAP-AS1,Celiac disease,celiac disease,GCST005523,6:159077235
rs2387397-<b>?</b>,2 x 10-8,,0.771,1.1363636,'-,'-,LINC02649,Celiac disease,celiac disease,GCST005523,10:6348230
rs1250552-<b>A</b>,8 x 10-17,,0.53,1.1627907,'-,'-,ZMIZ1,Celiac disease,celiac disease,GCST005523,10:79298270
rs7104791-<b>?</b>,2 x 10-11,,0.209,1.16,'-,'-,"COLCA2, MIR4491",Celiac disease,celiac disease,GCST005523,11:111326133
rs10892258-<b>?</b>,2 x 10-11,,0.763,1.1627907,'-,'-,"RNU6-376P, DDX6",Celiac disease,celiac disease,GCST005523,11:118709156
rs61907765-<b>T</b>,3 x 10-13,,0.213,1.18,'-,'-,ETS1,Celiac disease,celiac disease,GCST005523,11:128522042
rs3184504-<b>C</b>,5 x 10-21,,0.488,1.19,'-,'-,"SH2B3, ATXN2",Celiac disease,celiac disease,GCST005523,12:111446804
rs11851414-<b>?</b>,5 x 10-8,,0.221,1.13,'-,'-,ZFP36L1,Celiac disease,celiac disease,GCST005523,14:68792785
rs1378938-<b>?</b>,8 x 10-9,,0.278,1.13,'-,'-,"CSK, LMAN1L",Celiac disease,celiac disease,GCST005523,15:74804102
rs6498114-<b>?</b>,6 x 10-10,,0.246,1.14,'-,'-,CIITA,Celiac disease,celiac disease,GCST005523,16:10870261
rs11875687-<b>C</b>,2 x 10-10,,0.15,1.17,'-,'-,PTPN2,Celiac disease,celiac disease,GCST005523,18:12843138
rs1893592-<b>?</b>,3 x 10-9,,0.718,1.1363636,'-,'-,UBASH3A,Celiac disease,celiac disease,GCST005523,21:42434957
rs58911644-<b>A</b>,6 x 10-7,,0.807,1.1235955,'-,'-,GATD3A,Celiac disease,celiac disease,GCST005523,21:44209238
rs4821124-<b>?</b>,6 x 10-11,,0.186,1.16,'-,'-,"UBE2L3, YDJC",Celiac disease,celiac disease,GCST005523,22:21625000
rs13397-<b>?</b>,3 x 10-8,,0.133,1.18,'-,'-,TMEM187,Celiac disease,celiac disease,GCST005523,X:153982797
imm_3_161120372-<b>A</b>,3 x 10-27,,0.111,1.36,'-,'-,'-,Celiac disease,celiac disease,GCST005523,Mapping not available
imm_6_138043754-<b>?</b>,2 x 10-7,(conditioned on rs17264332),0.81,1.1363636,'-,'-,'-,Celiac disease,celiac disease,GCST005523,Mapping not available
1kg_7_37384979-<b>?</b>,2 x 10-8,,0.101,1.18,'-,'-,'-,Celiac disease,celiac disease,GCST005523,Mapping not available
rs1788097-<b>A</b>,3 x 10-8,,0.483,1.15,'-,[1.10-1.21],CD226,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,18:69876452
rs60652743-<b>A</b>,7 x 10-10,,0.836,1.25,'-,[1.16-1.34],PRKD2,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,19:46702450
rs2836883-<b>G</b>,3 x 10-17,,0.728,1.28,'-,[1.21-1.36],RPL23AP12,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,21:39094818
rs3748816-<b>A</b>,7 x 10-12,,0.656,1.21,'-,[1.14-1.27],MMEL1,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,1:2595307
rs7426056-<b>A</b>,2 x 10-20,,0.229,1.3,'-,[1.23-1.37],"CD28, KRT18P39",Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,2:203747335
rs3197999-<b>A</b>,2 x 10-26,,0.285,1.33,'-,[1.26-1.40],MST1,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,3:49684099
rs13140464-<b>C</b>,9 x 10-13,,0.836,1.3,'-,[1.21-1.40],IL21,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,4:122578590
rs56258221-<b>G</b>,8 x 10-12,,0.183,1.23,'-,[1.16-1.31],MIR4464,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,6:90320722
rs4147359-<b>A</b>,8 x 10-17,,0.349,1.24,'-,[1.18-1.30],"IL2RA, RPL32P23",Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,10:6066476
rs7937682-<b>G</b>,3 x 10-9,,0.265,1.17,'-,[1.11-1.24],SIK2,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,11:111709215
rs11168249-<b>G</b>,5 x 10-9,,0.466,1.15,'-,[1.10-1.21],HDAC7,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,12:47814585
rs3184504-<b>A</b>,6 x 10-11,,0.488,1.18,'-,[1.12-1.24],"SH2B3, ATXN2",Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,12:111446804
HLA-B*08:01-<b>?</b>,4 x 10-246,,0.123434538,2.822609,'-,[2.6563824526-2.99923733834],'-,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,Mapping not available
HLA-DQA1*05:01-<b>?</b>,6 x 10-175,,0.160196701,2.3942578,'-,[2.2532871949-2.54404766025],'-,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,Mapping not available
HLA-DQA1*01:03-<b>?</b>,1 x 10-100,,0.072506785,2.2305722,'-,[2.07182852179-2.40147899116],'-,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,Mapping not available
HLA-DRB1*15:01-<b>?</b>,5 x 10-9,(conditioned on HLA-B*08:01),0.137703626,1.21,'-,'-,'-,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,Mapping not available
HLA-DQA*01:01-<b>?</b>,1 x 10-6,,0.83,1.1977854,'-,[1.11-1.29],'-,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,Mapping not available
rs4143332-<b>?</b>,1 x 10-250,,NR,'-,'-,'-,ZDHHC20P2,Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,6:31380588
rs2856674-<b>?</b>,1 x 10-6,(conditioned on rs4143332 + HLA-DQA*01:03 + rs532098 +rs1794282 + rs9263964),NR,'-,'-,'-,"MTCO3P1, HLA-DQB1",Primary sclerosing cholangitis,sclerosing cholangitis,GCST006670,6:32691868
rs9409565-<b>C</b>,2 x 10-8,(Light-to-moderate drinkers),NR,1.35,'-,[1.21-1.49],"RNU6-669P, MFSD14B",Colorectal cancer (alcohol consumption interaction),"colorectal cancer, alcohol consumption measurement",GCST003873,9:94488752
rs9409565-<b>C</b>,1 x 10-7,(light/moderate and heavy drinkers),NR,1.23,'-,[1.04-1.45],"RNU6-669P, MFSD14B",Colorectal cancer (alcohol consumption interaction),"colorectal cancer, alcohol consumption measurement",GCST003873,9:94488752
rs112319963-<b>?</b>,2 x 10-6,,0.01,4,'-,[2.22-7.69],'-,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,6:66197278
rs71564305-<b>?</b>,3 x 10-6,,0.04,2.3255813,'-,[1.59-20],CD83,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,6:14107800
rs9834244-<b>?</b>,8 x 10-7,,0.09,1.6949153,'-,[1.37-2.7],"LINC02066, AADACL2",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,3:151704793
rs12548629-<b>?</b>,3 x 10-7,,0.27,1.4084507,'-,[1.23-1.72],"BAALC-AS1, BAALC",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,8:103189173
rs13293114-<b>?</b>,4 x 10-6,,0.36,1.3157895,'-,[1.18-1.56],"FRMD3, RN7SKP242",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,9:83217469
rs6071641-<b>?</b>,6 x 10-6,,0.42,1.3157895,'-,[1.18-1.59],DHX35,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,20:39049018
rs4075454-<b>?</b>,5 x 10-6,,0.49,1.2987013,'-,[1.16-1.52],"SFT2D1, PRR18",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,6:166308998
rs7975553-<b>?</b>,6 x 10-6,,0.43,1.2987013,'-,[1.16-1.47],RIMBP2,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,12:130560585
rs742276-<b>?</b>,9 x 10-6,,0.44,1.2987013,'-,[1.15-1.52],DHX35,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,20:39051206
rs1023996-<b>G</b>,2 x 10-6,,0.58,1.32,'-,[1.18-1.48],SYT9,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,11:7379559
rs11013837-<b>T</b>,6 x 10-6,,0.77,1.37,'-,[1.19-1.58],KIAA1217,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,10:23995722
rs1468348-<b>T</b>,5 x 10-6,,0.8,1.39,'-,[1.25-1.6],VPS41,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,7:38728314
rs162277-<b>C</b>,7 x 10-6,,0.79,1.41,'-,[1.26-1.63],"ZNF808, ZNF578",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,19:52526945
rs7794030-<b>A</b>,1 x 10-6,,0.81,1.43,'-,[1.29-1.65],"FAM183BP, VPS41",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,7:38712494
rs34775372-<b>C</b>,6 x 10-6,,0.92,1.69,'-,[1.33-2.13],"LINC01396, STX18-AS1",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,4:4794716
chr1:34655226-<b>?</b>,7 x 10-6,,0.95,2.05,'-,[1.48-2.84]],'-,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,Mapping not available
rs112822051-<b>C</b>,3 x 10-6,,0.97,2.56,'-,[1.67-3.93],"GP6-AS1, GP6",Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,19:55035675
rs113118767-<b>T</b>,9 x 10-6,,0.99,4.02,'-,[1.99-8.13],SLC24A3,Breast cancer and/or colorectal cancer,"colorectal cancer, breast carcinoma",GCST006035,20:19518790
rs6065668-<b>T</b>,4 x 10-7,,0.4,1.07,'-,[1.04-1.10],"TOX2, LINC01728",Colorectal cancer,colorectal cancer,GCST007552,20:43904181
rs4711689-<b>A</b>,6 x 10-6,,0.85,1.09,'-,[1.05-1.13],TFEB,Colorectal cancer,colorectal cancer,GCST007552,6:41725074
rs6983267-<b>G</b>,1 x 10-31,,0.39,1.17,'-,[1.14-1.20],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST007552,8:127401060
rs10795668-<b>G</b>,5 x 10-24,,0.61,1.14,'-,[1.11-1.17],RNA5SP299,Colorectal cancer,colorectal cancer,GCST007552,10:8659256
rs4939827-<b>T</b>,5 x 10-15,,0.24,1.13,'-,[1.09-1.16],SMAD7,Colorectal cancer,colorectal cancer,GCST007552,18:48927093
rs6066825-<b>A</b>,4 x 10-11,,0.71,1.1,'-,[1.07-1.13],PREX1,Colorectal cancer,colorectal cancer,GCST007552,20:48723580
rs16969681-<b>T</b>,1 x 10-8,,0.46,1.08,'-,[1.05-1.11],"SCG5, GREM1",Colorectal cancer,colorectal cancer,GCST007552,15:32700910
rs4813802-<b>G</b>,1 x 10-8,,0.21,1.1,'-,[1.06-1.13],LINC01713,Colorectal cancer,colorectal cancer,GCST007552,20:6718948
rs3802842-<b>C</b>,5 x 10-7,,0.39,1.07,'-,[1.04-1.10],"COLCA1, COLCA2",Colorectal cancer,colorectal cancer,GCST007552,11:111300984
rs10411210-<b>C</b>,1 x 10-7,,0.83,1.1,'-,[1.06-1.14],RHPN2,Colorectal cancer,colorectal cancer,GCST007552,19:33041394
rs10936599-<b>C</b>,2 x 10-6,,0.39,1.06,'-,[1.04-1.09],MYNN,Colorectal cancer,colorectal cancer,GCST007552,3:169774313
rs2735940-<b>G</b>,6 x 10-6,,0.61,1.07,'-,[1.04-1.10],"MIR4457, TERT",Colorectal cancer,colorectal cancer,GCST007552,5:1296371
rs1321311-<b>A</b>,1 x 10-6,,0.15,1.09,'-,[1.05-1.13],"Y_RNA, RNU1-88P",Colorectal cancer,colorectal cancer,GCST007552,6:36655123
rs3824999-<b>G</b>,3 x 10-6,,0.41,1.07,'-,[1.04-1.09],POLD3,Colorectal cancer,colorectal cancer,GCST007552,11:74634505
rs1810502-<b>C</b>,1 x 10-6,,0.45,1.07,'-,[1.04-1.10],"COX6CP2, RN7SL636P",Colorectal cancer,colorectal cancer,GCST007552,20:50440951
rs7542665-<b>C</b>,4 x 10-8,,0.273,1.08,'-,[1.05-1.11],L1TD1,Colorectal cancer,colorectal cancer,GCST007552,1:62207365
rs201395236-<b>T</b>,5 x 10-8,,0.987,1.75,'-,[1.43-2.13],EFCAB2,Colorectal cancer,colorectal cancer,GCST007552,1:245018119
rs7606562-<b>T</b>,1 x 10-8,,0.813,1.1,'-,[1.07-1.14],PPP1R21,Colorectal cancer,colorectal cancer,GCST007552,2:48459556
rs113569514-<b>T</b>,2 x 10-12,,0.62,1.1,'-,[1.07-1.13],SLCO2A1,Colorectal cancer,colorectal cancer,GCST007552,3:134029945
rs12659017-<b>G</b>,4 x 10-8,,0.232,1.09,'-,[1.06-1.12],"TEX43, BOLA3P3",Colorectal cancer,colorectal cancer,GCST007552,5:126652483
rs1476570-<b>A</b>,7 x 10-9,,0.376,1.12,'-,[1.08-1.16],"HLA-G, HCP5B",Colorectal cancer,colorectal cancer,GCST007552,6:29842083
rs3830041-<b>T</b>,2 x 10-8,,0.14,1.16,'-,[1.10-1.21],NOTCH4,Colorectal cancer,colorectal cancer,GCST007552,6:32223562
rs77969132-<b>T</b>,5 x 10-8,,0.015,1.44,'-,[1.27-1.65],DENND5B,Colorectal cancer,colorectal cancer,GCST007552,12:31441879
rs2730985-<b>G</b>,1 x 10-8,,0.629,1.08,'-,[1.05-1.11],LINC02450,Colorectal cancer,colorectal cancer,GCST007552,12:42736822
rs1886450-<b>G</b>,6 x 10-12,,0.593,1.09,'-,[1.07-1.12],"LINC00393, MARK2P12",Colorectal cancer,colorectal cancer,GCST007552,13:73412491
rs689-<b>?</b>,1 x 10-6,,NR,2.44,'-,[1.69-3.45],"INS, INS-IGF2",Type 1 diabetes,type I diabetes mellitus,GCST008377,11:2160994
rs4320356-<b>T</b>,3 x 10-8,,0.28,1.26,'-,[1.16-1.36],BTN2A3P,Type 1 diabetes,type I diabetes mellitus,GCST008377,6:26423332
rs3802604-<b>C</b>,2 x 10-8,,0.38,1.24,'-,[1.15-1.33],GATA3,Type 1 diabetes,type I diabetes mellitus,GCST008377,10:8060309
rs1770-<b>G</b>,2 x 10-232,,0.46,4.28,'-,[3.92-4.68],"HLA-DQB1, HLA-DQB1-AS1",Type 1 diabetes,type I diabetes mellitus,GCST008377,6:32660056
rs705699-<b>T</b>,7 x 10-20,,0.26,1.46,'-,[1.34-1.58],RAB5B,Type 1 diabetes,type I diabetes mellitus,GCST008377,12:55991020
rs11893063-<b>A</b>,9 x 10-9,,0.47,1.07,'-,[1.04-1.09],'-,Colorectal cancer,colorectal cancer,GCST007992,2:198737201
rs77776598-<b>C</b>,8 x 10-9,,0.06,1.14,'-,[1.09-1.20],SLC6A18,Colorectal cancer,colorectal cancer,GCST007992,5:1240883
rs10951878-<b>C</b>,1 x 10-8,,0.49,1.06,'-,[1.04-1.09],'-,Colorectal cancer,colorectal cancer,GCST007992,7:46887097
rs12255141-<b>G</b>,3 x 10-9,,0.1,1.11,'-,[1.07-1.15],VTI1A,Colorectal cancer,colorectal cancer,GCST007992,10:112535133
rs12979278-<b>T</b>,6 x 10-10,,0.53,1.07,'-,[1.05-1.09],MAMSTR,Colorectal cancer,colorectal cancer,GCST007992,19:48715345
rs285245-<b>T</b>,4 x 10-8,,0.11,1.11,'-,[1.07-1.15],KLF2-DT,Colorectal cancer,colorectal cancer,GCST007992,19:16310006
rs9831861-<b>G</b>,4 x 10-10,,0.59,1.07,'-,[1.05-1.09],"SERBP1P3, SFMBT1",Colorectal cancer,colorectal cancer,GCST007992,3:53054269
rs10849438-<b>G</b>,1 x 10-10,,0.12,1.12,'-,[1.08-1.16],"PLEKHG6, ATP5MFP5",Colorectal cancer,colorectal cancer,GCST007992,12:6302870
rs12635946-<b>C</b>,1 x 10-11,,0.62,1.08,'-,[1.06-1.10],"BOC, LINC02044",Colorectal cancer,colorectal cancer,GCST007992,3:113198071
rs6055286-<b>A</b>,1 x 10-10,,0.15,1.11,'-,[1.07-1.14],'-,Colorectal cancer,colorectal cancer,GCST007992,20:7737398
rs7993934-<b>T</b>,3 x 10-11,,0.65,1.08,'-,[1.05-1.10],COL4A2,Colorectal cancer,colorectal cancer,GCST007992,13:110422568
rs12818766-<b>A</b>,2 x 10-9,,0.18,1.1,'-,[1.07-1.13],CCND2-AS1,Colorectal cancer,colorectal cancer,GCST007992,12:4266925
rs4811050-<b>A</b>,2 x 10-11,,0.18,1.1,'-,[1.07-1.13],"LINC01271, RN7SL636P",Colorectal cancer,colorectal cancer,GCST007992,20:50364133
rs10152518-<b>G</b>,3 x 10-8,,0.19,1.08,'-,[1.05-1.11],RNU6-1,Colorectal cancer,colorectal cancer,GCST007992,15:67884824
rs17816465-<b>A</b>,1 x 10-14,,0.2,1.11,'-,[1.08-1.14],FMN1,Colorectal cancer,colorectal cancer,GCST007992,15:32864185
rs899244-<b>T</b>,1 x 10-10,,0.21,1.09,'-,[1.06-1.12],"LINC02188, FOXL1",Colorectal cancer,colorectal cancer,GCST007992,16:86666424
rs7398375-<b>C</b>,4 x 10-10,,0.72,1.09,'-,[1.06-1.13],"LRP1, LRP1-AS",Colorectal cancer,colorectal cancer,GCST007992,12:57147065
rs4776316-<b>A</b>,1 x 10-8,,0.73,1.08,'-,[1.05-1.10],SMAD6,Colorectal cancer,colorectal cancer,GCST007992,15:66715475
rs1078643-<b>A</b>,4 x 10-11,,0.77,1.09,'-,[1.06-1.12],"TMEM220-AS1, TMEM238L",Colorectal cancer,colorectal cancer,GCST007992,17:10803924
rs9271770-<b>A</b>,4 x 10-8,,0.81,1.08,'-,[1.05-1.11],"HLA-DQA1, HLA-DRB1",Colorectal cancer,colorectal cancer,GCST007992,6:32626471
rs17035289-<b>T</b>,3 x 10-10,,0.83,1.1,'-,[1.07-1.13],TET2,Colorectal cancer,colorectal cancer,GCST007992,4:105127134
rs6085661-<b>T</b>,2 x 10-14,,0.39,1.09,'-,[1.06-1.11],LINC01713,Colorectal cancer,colorectal cancer,GCST007992,20:6712481
rs73975588-<b>A</b>,9 x 10-9,,0.87,1.1,'-,[1.06-1.13],NXN,Colorectal cancer,colorectal cancer,GCST007992,17:913501
rs1330889-<b>C</b>,7 x 10-10,,0.87,1.11,'-,[1.07-1.14],"LINC00446, OBI1-AS1",Colorectal cancer,colorectal cancer,GCST007992,13:78035480
rs11692435-<b>G</b>,1 x 10-8,,0.9,1.12,'-,[1.07-1.16],ACTR1B,Colorectal cancer,colorectal cancer,GCST007992,2:97658891
rs6928864-<b>C</b>,1 x 10-8,,0.91,1.13,'-,[1.09-1.19],"PREP, LINC02836",Colorectal cancer,colorectal cancer,GCST007992,6:105519019
rs16959063-<b>A</b>,4 x 10-8,,0.01,1.3,'-,[1.18-1.42],FMN1,Colorectal cancer,colorectal cancer,GCST007992,15:32813529
rs2070699-<b>T</b>,4 x 10-9,,0.48,1.07,'-,[1.04-1.09],EDN1,Colorectal cancer,colorectal cancer,GCST007992,6:12292539
rs16969681-<b>T</b>,3 x 10-27,,0.09,1.22,'-,[1.18-1.27],"SCG5, GREM1",Colorectal cancer,colorectal cancer,GCST007992,15:32700910
rs1412834-<b>T</b>,4 x 10-14,,0.5,1.08,'-,[1.06-1.11],CDKN2B-AS1,Colorectal cancer,colorectal cancer,GCST007992,9:22110132
rs75686861-<b>A</b>,2 x 10-9,,0.1,1.12,'-,[1.08-1.16],HHIP,Colorectal cancer,colorectal cancer,GCST007992,4:144700176
rs7593422-<b>T</b>,4 x 10-11,,0.55,1.07,'-,[1.05-1.10],"SATB2, RNU7-147P",Colorectal cancer,colorectal cancer,GCST007992,2:199266972
rs7495132-<b>T</b>,8 x 10-10,,0.12,1.11,'-,[1.07-1.14],"CRTC3-AS1, CRTC3",Colorectal cancer,colorectal cancer,GCST007992,15:90629669
rs704017-<b>G</b>,3 x 10-16,,0.6,1.1,'-,[1.08-1.13],ZMIZ1-AS1,Colorectal cancer,colorectal cancer,GCST007992,10:79059375
rs12143541-<b>G</b>,9 x 10-10,,0.15,1.1,'-,[1.06-1.13],TTC22,Colorectal cancer,colorectal cancer,GCST007992,1:54782179
rs45597035-<b>A</b>,2 x 10-10,,0.64,1.08,'-,[1.05-1.10],KLF5,Colorectal cancer,colorectal cancer,GCST007992,13:73075014
rs4450168-<b>C</b>,1 x 10-8,,0.17,1.1,'-,[1.06-1.13],SBF2,Colorectal cancer,colorectal cancer,GCST007992,11:10265208
rs6066825-<b>A</b>,4 x 10-17,,0.65,1.1,'-,[1.08-1.13],PREX1,Colorectal cancer,colorectal cancer,GCST007992,20:48723580
rs3801081-<b>G</b>,2 x 10-11,,0.68,1.08,'-,[1.06-1.11],TNS3,Colorectal cancer,colorectal cancer,GCST007992,7:47471563
rs9797885-<b>G</b>,3 x 10-10,,0.71,1.08,'-,[1.05-1.10],TMEM91,Colorectal cancer,colorectal cancer,GCST007992,19:41367096
rs2179593-<b>A</b>,5 x 10-9,,0.72,1.07,'-,[1.05-1.10],TOX2,Colorectal cancer,colorectal cancer,GCST007992,20:44031646
rs12427600-<b>C</b>,5 x 10-11,,0.24,1.09,'-,[1.06-1.11],SMAD9,Colorectal cancer,colorectal cancer,GCST007992,13:36886511
rs6091213-<b>C</b>,4 x 10-10,,0.26,1.08,'-,[1.05-1.11],"PARD6B, BCAS4",Colorectal cancer,colorectal cancer,GCST007992,20:50768208
rs61336918-<b>A</b>,2 x 10-12,,0.29,1.09,'-,[1.06-1.12],'-,Colorectal cancer,colorectal cancer,GCST007992,16:79973369
rs1570405-<b>G</b>,1 x 10-6,,0.31,1.06,'-,[1.03-1.08],ATP5F1CP1,Colorectal cancer,colorectal cancer,GCST007992,14:54087516
rs3787089-<b>C</b>,6 x 10-9,,0.32,1.07,'-,[1.05-1.10],"RTEL1-TNFRSF6B, RTEL1",Colorectal cancer,colorectal cancer,GCST007992,20:63685277
rs639933-<b>C</b>,1 x 10-9,,0.38,1.07,'-,[1.05-1.10],C5orf66,Colorectal cancer,colorectal cancer,GCST007992,5:135132061
rs6933790-<b>T</b>,4 x 10-10,,0.83,1.1,'-,[1.07-1.14],TFEB,Colorectal cancer,colorectal cancer,GCST007992,6:41705031
rs3131043-<b>G</b>,3 x 10-8,,0.43,1.07,'-,[1.05-1.1],HCG20,Colorectal cancer,colorectal cancer,GCST007992,6:30790689
rs61776719-<b>C</b>,2 x 10-10,,0.45,1.07,'-,[1.05-1.10],"FHL3, RNU6-510P",Colorectal cancer,colorectal cancer,GCST007992,1:37995647
rs4944940-<b>G</b>,1 x 10-20,,0.96,1.31,'-,[1.24-1.39],CHRDL2,Colorectal cancer,colorectal cancer,GCST007992,11:74704207
rs16892766-<b>C</b>,1 x 10-35,,NR,1.26,'-,[1.22-1.31],EIF3H,Colorectal cancer,colorectal cancer,GCST007992,8:116618444
rs1810502-<b>C</b>,2 x 10-10,,NR,1.07,'-,[1.05-1.1],"COX6CP2, RN7SL636P",Colorectal cancer,colorectal cancer,GCST007992,20:50440951
rs2696839-<b>G</b>,1 x 10-6,,NR,1.05,'-,[1.03-1.08],"LINC00917, LINC01081",Colorectal cancer,colorectal cancer,GCST007992,16:86306842
rs2735940-<b>A</b>,1 x 10-11,,NR,1.08,'-,[1.06-1.10],"MIR4457, TERT",Colorectal cancer,colorectal cancer,GCST007992,5:1296371
rs3217810-<b>T</b>,1 x 10-6,,NR,1.11,'-,[1.06-1.15],CCND2,Colorectal cancer,colorectal cancer,GCST007992,12:4279105
rs6983267-<b>G</b>,2 x 10-57,,NR,1.19,'-,[1.16-1.21],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST007992,8:127401060
rs72647484-<b>T</b>,2 x 10-10,,NR,1.13,'-,[1.09-1.17],MIR4418,Colorectal cancer,colorectal cancer,GCST007992,1:22261235
rs961253-<b>A</b>,5 x 10-20,,NR,1.11,'-,[1.08-1.13],CASC20,Colorectal cancer,colorectal cancer,GCST007992,20:6423634
rs4546885-<b>G</b>,1 x 10-14,,NR,1.09,'-,[1.07-1.11],LAMC1,Colorectal cancer,colorectal cancer,GCST007992,1:183056420
rs6658977-<b>T</b>,1 x 10-12,,NR,1.08,'-,[1.06-1.11],"LINC01655, LINC02257",Colorectal cancer,colorectal cancer,GCST007992,1:221876478
rs13020391-<b>C</b>,2 x 10-13,,NR,1.09,'-,[1.06-1.11],PNKD,Colorectal cancer,colorectal cancer,GCST007992,2:218319713
rs35470271-<b>G</b>,2 x 10-9,,NR,1.09,'-,[1.06-1.13],'-,Colorectal cancer,colorectal cancer,GCST007992,3:40873748
rs35446936-<b>G</b>,6 x 10-8,,NR,1.07,'-,[1.05-1.10],ACTRT3,Colorectal cancer,colorectal cancer,GCST007992,3:169768720
rs1445011-<b>C</b>,1 x 10-17,,NR,1.11,'-,[1.08-1.13],RNU1-150P,Colorectal cancer,colorectal cancer,GCST007992,5:40280100
rs16878812-<b>A</b>,2 x 10-9,,NR,1.11,'-,[1.07-1.15],FKBP5,Colorectal cancer,colorectal cancer,GCST007992,6:35601785
rs1321310-<b>C</b>,6 x 10-11,,NR,1.09,'-,[1.06-1.11],"Y_RNA, RNU1-88P",Colorectal cancer,colorectal cancer,GCST007992,6:36655347
rs62404966-<b>C</b>,3 x 10-9,,NR,1.08,'-,[1.05-1.10],BMP5,Colorectal cancer,colorectal cancer,GCST007992,6:55847326
rs7894531-<b>G</b>,4 x 10-24,,NR,1.13,'-,[1.10-1.15],RNA5SP299,Colorectal cancer,colorectal cancer,GCST007992,10:8692798
rs2193352-<b>G</b>,2 x 10-15,,NR,1.11,'-,[1.08-1.14],"SLC25A28, NKX2-3",Colorectal cancer,colorectal cancer,GCST007992,10:99586852
rs57796856-<b>T</b>,4 x 10-16,,NR,1.09,'-,[1.07-1.12],POLD3,Colorectal cancer,colorectal cancer,GCST007992,11:74627310
rs3087967-<b>T</b>,6 x 10-33,,NR,1.15,'-,[1.12-1.18],C11orf53,Colorectal cancer,colorectal cancer,GCST007992,11:111286111
rs11169572-<b>C</b>,6 x 10-14,,NR,1.09,'-,[1.06-1.11],"RN7SL519P, ATF1",Colorectal cancer,colorectal cancer,GCST007992,12:50823107
rs597808-<b>G</b>,8 x 10-15,,NR,1.09,'-,[1.07-1.11],ATXN2,Colorectal cancer,colorectal cancer,GCST007992,12:111535554
rs7315438-<b>T</b>,1 x 10-11,,NR,1.08,'-,[1.05-1.10],'-,Colorectal cancer,colorectal cancer,GCST007992,12:115453598
rs9537521-<b>G</b>,7 x 10-9,,NR,1.08,'-,[1.05-1.11],'-,Colorectal cancer,colorectal cancer,GCST007992,13:33464043
rs35107139-<b>C</b>,1 x 10-13,,NR,1.09,'-,[1.07-1.12],BMP4,Colorectal cancer,colorectal cancer,GCST007992,14:53952388
rs73376930-<b>G</b>,7 x 10-35,,NR,1.18,'-,[1.15-1.21],GREM1,Colorectal cancer,colorectal cancer,GCST007992,15:32720301
rs9939049-<b>A</b>,2 x 10-7,,NR,1.06,'-,[1.04-1.09],CDH1,Colorectal cancer,colorectal cancer,GCST007992,16:68778398
rs7226855-<b>A</b>,6 x 10-71,,NR,1.21,'-,[1.19-1.24],SMAD7,Colorectal cancer,colorectal cancer,GCST007992,18:48927678
rs73039434-<b>T</b>,2 x 10-18,,NR,1.3,'-,[1.22-1.38],RHPN2,Colorectal cancer,colorectal cancer,GCST007992,19:33034013
rs1741640-<b>C</b>,2 x 10-28,,NR,1.16,'-,[1.13-1.20],LAMA5,Colorectal cancer,colorectal cancer,GCST007992,20:62357358
rs2732875-<b>C</b>,8 x 10-12,,NR,1.18,'-,[1.13-1.24],SHROOM2,Colorectal cancer,colorectal cancer,GCST007992,X:9795858
rs11196171-<b>G</b>,3 x 10-6,,NR,1.07,'-,[1.04-1.10],TCF7L2,Colorectal cancer,colorectal cancer,GCST007992,10:112964714
rs4246215-<b>G</b>,1 x 10-6,,NR,1.06,'-,[1.03-1.08],"FADS2, FEN1",Colorectal cancer,colorectal cancer,GCST007992,11:61796827
rs11884596-<b>?</b>,2 x 10-6,,NR,1.05,'-,[1.03-1.08],'-,Colorectal cancer,colorectal cancer,GCST007992,2:198747683
rs75954926-<b>?</b>,1 x 10-7,,NR,1.08,'-,[1.05-1.11],'-,Colorectal cancer,colorectal cancer,GCST007992,Mapping not available
rs9465871-<b>?</b>,6 x 10-8,,NR,1.32,'-,'-,CDKAL1,Prevalent type 2 diabetes,type II diabetes mellitus,GCST004304,6:20717024
rs10761745-<b>?</b>,5 x 10-6,,NR,1.2,'-,'-,JMJD1C,Type 2 diabetes,type II diabetes mellitus,GCST004305,10:63341311
rs163177-<b>C</b>,1 x 10-6,,0.43,1.21,'-,'-,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST004305,11:2817183
rs11131794-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,RN7SKP188,Type 2 diabetes,type II diabetes mellitus,GCST008827,4:167738950
rs7903146-<b>T</b>,3 x 10-11,,0.38,1.66,'-,[1.50-1.81],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST007221,10:112998590
rs6598475-<b>T</b>,2 x 10-8,,0.36,1.56,'-,[1.40-1.72],PCSK6,Type 2 diabetes,type II diabetes mellitus,GCST007221,15:101446425
rs75444904-<b>C</b>,1 x 10-60,,0.275,'-,0.777 unit increase,[0.68-0.87],TXNL4B,Urinary haptoglobin levels in type 2 diabetes,"haptoglobin measurement, type II diabetes mellitus",GCST005807,16:72061751
rs75444904-<b>C</b>,7 x 10-12,,0.307,'-,0.567 unit increase,[0.40-0.73],TXNL4B,Plasma haptoglobin levels in type 2 diabetes,"haptoglobin measurement, type II diabetes mellitus",GCST005808,16:72061751
rs7903146-<b>T</b>,7 x 10-45,(additive model),NR,1.4,'-,[1.35-1.45],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST006801,10:112998590
rs9936385-<b>C</b>,1 x 10-9,(additive model),NR,1.152,'-,[1.11-1.2],FTO,Type 2 diabetes,type II diabetes mellitus,GCST006801,16:53785257
rs10811661-<b>T</b>,1 x 10-9,(additive model),NR,1.214,'-,[1.15-1.28],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST006801,9:22134095
rs4402960-<b>T</b>,2 x 10-9,(additive model),NR,1.155,'-,[1.11-1.2],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST006801,3:185793899
rs7756992-<b>G</b>,1 x 10-8,(additive model),NR,1.153,'-,[1.1-1.21],'-,Type 2 diabetes,type II diabetes mellitus,GCST006801,Mapping not available
rs1111875-<b>C</b>,2 x 10-8,(additive model),NR,1.142,'-,[1.09-1.19],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST006801,10:92703125
rs2261181-<b>T</b>,5 x 10-7,(additive model),NR,1.203,'-,[1.13-1.28],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST006801,12:65818538
rs459193-<b>G</b>,1 x 10-6,(additive model),NR,1.141,'-,[1.09-1.19],"C5orf67, RPL26P19",Type 2 diabetes,type II diabetes mellitus,GCST006801,5:56510924
rs3802177-<b>G</b>,1 x 10-6,(additive model),NR,1.131,'-,[1.08-1.18],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST006801,8:117172786
rs163184-<b>G</b>,3 x 10-6,(additive model),NR,1.114,'-,[1.07-1.16],'-,Type 2 diabetes,type II diabetes mellitus,GCST006801,Mapping not available
rs849135-<b>G</b>,3 x 10-6,(additive model),NR,1.113,'-,[1.07-1.16],'-,Type 2 diabetes,type II diabetes mellitus,GCST006801,Mapping not available
rs1552224-<b>A</b>,5 x 10-6,(additive model),NR,1.163,'-,[1.1-1.23],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST006801,11:72722053
rs11257655-<b>T</b>,5 x 10-6,(dominant model),NR,1.162,'-,[1.1-1.23],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST006801,10:12265895
rs2233580-<b>A</b>,2 x 10-10,,0.07,1.48,'-,[1.31-1.67],PAX4,Type 2 diabetes,type II diabetes mellitus,GCST010436,7:127613496
rs2206734-<b>A</b>,2 x 10-10,,0.46,1.25,'-,[1.17-1.34],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST010436,6:20694653
rs2237895-<b>C</b>,4 x 10-9,,0.31,1.25,'-,[1.16=1.34],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010436,11:2835964
rs11960799-<b>?</b>,1 x 10-7,,0.65,1.2195122,'-,[1.14-1.32],MARCHF3,Type 2 diabetes,type II diabetes mellitus,GCST010436,5:127020350
rs75680863-<b>?</b>,2 x 10-7,,0.65,1.5873016,'-,[1.35-1.96],TCN2,Type 2 diabetes,type II diabetes mellitus,GCST010436,22:30611036
rs2237892-<b>?</b>,5 x 10-7,,0.62,1.2048193,'-,[1.12-1.3],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010436,11:2818521
rs10965250-<b>?</b>,7 x 10-7,,0.57,1.1904762,'-,[1.11-1.41],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010436,9:22133285
rs4472028-<b>T</b>,2 x 10-10,,0.444249851,'-,0.0453 unit increase,[0.031-0.059],MBNL1,Type 2 diabetes,type II diabetes mellitus,GCST006867,3:152335461
rs11925227-<b>A</b>,2 x 10-8,,0.183438659,'-,0.0534 unit decrease,[0.035-0.072],"TNIK, SLC2A2",Type 2 diabetes,type II diabetes mellitus,GCST006867,3:171048829
rs7651090-<b>G</b>,4 x 10-57,,0.313376825,'-,0.1204 unit increase,[0.11-0.14],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST006867,3:185795604
rs3887925-<b>C</b>,2 x 10-9,,0.44682844,'-,0.0474 unit decrease,[0.032-0.063],ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST006867,3:186947857
rs6808574-<b>T</b>,4 x 10-13,,0.390373751,'-,0.0552 unit decrease,[0.04-0.07],LINC01991,Type 2 diabetes,type II diabetes mellitus,GCST006867,3:188022735
rs1801214-<b>C</b>,6 x 10-34,,0.400415373,'-,0.0903 unit decrease,[0.076-0.105],WFS1,Type 2 diabetes,type II diabetes mellitus,GCST006867,4:6301295
rs17086692-<b>T</b>,2 x 10-8,,0.313425861,'-,0.0467 unit decrease,[0.03-0.063],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,4:52268127
rs993380-<b>A</b>,5 x 10-10,,0.334449877,'-,0.0507 unit increase,[0.035-0.067],SCD5,Type 2 diabetes,type II diabetes mellitus,GCST006867,4:82663343
rs7674212-<b>T</b>,6 x 10-10,,0.408864362,'-,0.0465 unit decrease,[0.032-0.061],SLC9B2,Type 2 diabetes,type II diabetes mellitus,GCST006867,4:103067742
rs11098676-<b>T</b>,2 x 10-8,,0.212360865,'-,0.054 unit decrease,[0.035-0.073],NUDT6,Type 2 diabetes,type II diabetes mellitus,GCST006867,4:122911999
rs7685296-<b>T</b>,2 x 10-10,,0.279364612,'-,0.0511 unit decrease,[0.035-0.067],FBXW7,Type 2 diabetes,type II diabetes mellitus,GCST006867,4:152332969
rs735949-<b>C</b>,2 x 10-11,,0.141149742,'-,0.0711 unit decrease,[0.05-0.092],ACSL1,Type 2 diabetes,type II diabetes mellitus,GCST006867,4:184795078
rs1061813-<b>G</b>,3 x 10-9,,0.462880802,'-,0.0429 unit increase,[0.029-0.057],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST006867,5:14847222
rs4865796-<b>G</b>,1 x 10-11,,0.306909896,'-,0.053 unit decrease,[0.038-0.068],ARL15,Type 2 diabetes,type II diabetes mellitus,GCST006867,5:53976834
rs459193-<b>A</b>,9 x 10-18,,0.254662377,'-,0.0711 unit decrease,[0.055-0.087],"C5orf67, RPL26P19",Type 2 diabetes,type II diabetes mellitus,GCST006867,5:56510924
rs3900856-<b>A</b>,7 x 10-10,,0.039235036,'-,0.1136 unit increase,[0.077-0.15],C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST006867,5:56538065
rs2307111-<b>C</b>,3 x 10-8,,0.39726977,'-,0.0407 unit decrease,[0.026-0.055],POC5,Type 2 diabetes,type II diabetes mellitus,GCST006867,5:75707853
rs6878122-<b>G</b>,1 x 10-12,,0.318208635,'-,0.0564 unit increase,[0.041-0.072],ZBED3-AS1,Type 2 diabetes,type II diabetes mellitus,GCST006867,5:77131486
rs7729395-<b>T</b>,1 x 10-17,,0.050940934,'-,0.1373 unit increase,[0.11-0.17],PAM,Type 2 diabetes,type II diabetes mellitus,GCST006867,5:102764872
rs10077431-<b>A</b>,5 x 10-8,,0.21466813,'-,0.0487 unit decrease,[0.031-0.066],YTHDC2,Type 2 diabetes,type II diabetes mellitus,GCST006867,5:113591989
rs1050226-<b>G</b>,3 x 10-11,,0.406792301,'-,0.0491 unit decrease,[0.035-0.064],SSR1,Type 2 diabetes,type II diabetes mellitus,GCST006867,6:7281421
rs7756992-<b>G</b>,6 x 10-62,,0.266895681,'-,0.1297 unit increase,[0.11-0.14],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,Mapping not available
rs2296173-<b>G</b>,8 x 10-14,,0.212010576,'-,0.065 unit increase,[0.048-0.082],MACF1,Type 2 diabetes,type II diabetes mellitus,GCST006867,1:39447679
rs12088739-<b>G</b>,1 x 10-11,,0.089848136,'-,0.0884 unit decrease,[0.063-0.114],"CDKN2C, MIR4421",Type 2 diabetes,type II diabetes mellitus,GCST006867,1:51041214
rs1127655-<b>C</b>,2 x 10-8,,0.470936254,'-,0.0438 unit increase,[0.028-0.059],PTGFRN,Type 2 diabetes,type II diabetes mellitus,GCST006867,1:116987885
rs2493394-<b>G</b>,1 x 10-10,,0.107337868,'-,0.073 unit increase,[0.051-0.095],NOTCH2,Type 2 diabetes,type II diabetes mellitus,GCST006867,1:119928601
rs340874-<b>T</b>,8 x 10-18,,0.436095755,'-,0.0626 unit decrease,[0.048-0.077],"PROX1-AS1, PROX1",Type 2 diabetes,type II diabetes mellitus,GCST006867,1:213985913
rs2820426-<b>A</b>,1 x 10-12,,0.389942484,'-,0.0521 unit decrease,[0.038-0.066],LYPLAL1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST006867,1:219487193
rs348330-<b>G</b>,2 x 10-9,,0.366548876,'-,0.0487 unit increase,[0.033-0.065],ABCB10,Type 2 diabetes,type II diabetes mellitus,GCST006867,1:229537208
rs2867125-<b>T</b>,4 x 10-10,,0.172175282,'-,0.0601 unit decrease,[0.041-0.079],"LINC01875, TMEM18",Type 2 diabetes,type II diabetes mellitus,GCST006867,2:622827
rs780094-<b>T</b>,5 x 10-21,,0.387154701,'-,0.0692 unit decrease,[0.055-0.084],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,Mapping not available
rs17334919-<b>T</b>,7 x 10-28,,0.100217909,'-,0.1398 unit decrease,[0.11-0.16],THADA,Type 2 diabetes,type II diabetes mellitus,GCST006867,2:43480246
rs243019-<b>C</b>,2 x 10-15,,0.455830717,'-,0.0566 unit increase,[0.043-0.071],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST006867,2:60358671
rs1009358-<b>C</b>,1 x 10-11,,0.377278112,'-,0.0545 unit decrease,[0.039-0.07],"LINC02245, LINC02576",Type 2 diabetes,type II diabetes mellitus,GCST006867,2:65049318
rs10169613-<b>T</b>,4 x 10-8,,0.472133959,'-,0.0429 unit decrease,[0.028-0.058],MIR4435-2HG,Type 2 diabetes,type II diabetes mellitus,GCST006867,2:111177400
rs12617659-<b>T</b>,3 x 10-11,,0.147238129,'-,0.0685 unit decrease,[0.048-0.089],"Y_RNA, LINC01101",Type 2 diabetes,type II diabetes mellitus,GCST006867,2:120552183
rs7572970-<b>A</b>,1 x 10-11,,0.277953372,'-,0.059 unit decrease,[0.042-0.076],RBMS1,Type 2 diabetes,type II diabetes mellitus,GCST006867,2:160280145
rs13389219-<b>T</b>,2 x 10-22,,0.394367938,'-,0.0722 unit decrease,[0.058-0.087],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,Mapping not available
rs2972144-<b>A</b>,3 x 10-34,,0.354633108,'-,0.0913 unit decrease,[0.077-0.106],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,2:226236695
rs7561798-<b>G</b>,3 x 10-8,,0.482171025,'-,0.04 unit increase,[0.026-0.054],SPHKAP,Type 2 diabetes,type II diabetes mellitus,GCST006867,2:228108944
rs1899951-<b>T</b>,2 x 10-24,,0.123288182,'-,0.1118 unit decrease,[0.09-0.133],PPARG,Type 2 diabetes,type II diabetes mellitus,GCST006867,3:12353341
rs1496653-<b>G</b>,3 x 10-18,,0.204781843,'-,0.0769 unit decrease,[0.06-0.094],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST006867,3:23413299
rs11926707-<b>T</b>,2 x 10-8,,0.374443928,'-,0.0463 unit decrease,[0.03-0.062],PTH1R,Type 2 diabetes,type II diabetes mellitus,GCST006867,3:46884049
rs2292662-<b>T</b>,1 x 10-8,,0.151271964,'-,0.0629 unit decrease,[0.041-0.085],"SCAANT1, ATXN7",Type 2 diabetes,type II diabetes mellitus,GCST006867,3:63911539
rs6795735-<b>T</b>,2 x 10-14,,0.410911493,'-,0.0558 unit decrease,[0.041-0.07],ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST006867,3:64719689
rs11708067-<b>G</b>,6 x 10-29,,0.238989658,'-,0.0965 unit decrease,[0.08-0.113],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST006867,3:123346931
rs9844972-<b>C</b>,1 x 10-10,,0.069722918,'-,0.0956 unit increase,[0.067-0.125],"TSC22D2, LINC01214",Type 2 diabetes,type II diabetes mellitus,GCST006867,3:150379848
rs10811661-<b>C</b>,4 x 10-58,,0.173605396,'-,0.1569 unit decrease,[0.14-0.18],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST006867,9:22134095
rs1758632-<b>C</b>,1 x 10-9,,0.376593207,'-,0.0491 unit decrease,[0.033-0.065],UBAP2,Type 2 diabetes,type II diabetes mellitus,GCST006867,9:34025642
rs17791483-<b>G</b>,3 x 10-12,,0.062588323,'-,0.102 unit decrease,[0.073-0.131],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,9:79284065
rs2796441-<b>A</b>,2 x 10-22,,0.41645805,'-,0.0715 unit decrease,[0.057-0.086],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST006867,9:81694033
rs10114341-<b>C</b>,1 x 10-8,,0.440754141,'-,0.0409 unit decrease,[0.027-0.055],"MIRLET7A1HG, PTPDC1",Type 2 diabetes,type II diabetes mellitus,GCST006867,9:94156900
rs687621-<b>G</b>,1 x 10-8,,0.324802052,'-,0.0433 unit increase,[0.028-0.058],ABO,Type 2 diabetes,type II diabetes mellitus,GCST006867,9:133261662
rs11257655-<b>T</b>,2 x 10-17,,0.206773281,'-,0.0737 unit increase,[0.057-0.091],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST006867,10:12265895
rs2616132-<b>A</b>,7 x 10-9,,0.474257343,'-,0.0455 unit increase,[0.03-0.061],"RPL5P26, LINC02651",Type 2 diabetes,type II diabetes mellitus,GCST006867,10:69709758
rs2633310-<b>T</b>,2 x 10-8,,0.435073424,'-,0.0443 unit decrease,[0.029-0.06],CAMK2G,Type 2 diabetes,type II diabetes mellitus,GCST006867,10:73834292
rs753270-<b>T</b>,3 x 10-11,,0.416465397,'-,0.0528 unit decrease,[0.037-0.068],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST006867,10:79205218
rs7923866-<b>T</b>,9 x 10-40,,0.378774901,'-,0.0972 unit decrease,[0.083-0.112],Y_RNA,Type 2 diabetes,type II diabetes mellitus,GCST006867,10:92722319
rs11591741-<b>C</b>,1 x 10-9,,0.440386559,'-,0.0475 unit decrease,[0.032-0.063],CHUK,Type 2 diabetes,type II diabetes mellitus,GCST006867,10:100216744
rs7903146-<b>T</b>,1 x 10-347,,0.291584512,'-,0.3059 unit increase,[0.29-0.32],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST006867,10:112998590
rs4918796-<b>C</b>,4 x 10-13,,0.222568958,'-,0.0623 unit increase,[0.045-0.079],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST006867,10:113120583
rs2421016-<b>T</b>,1 x 10-10,,0.473761473,'-,0.0458 unit decrease,[0.032-0.06],PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST006867,10:122407996
rs2237892-<b>T</b>,9 x 10-10,,0.062489595,'-,0.096 unit decrease,[0.065-0.127],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST006867,11:2818521
rs5215-<b>C</b>,2 x 10-20,,0.360058778,'-,0.0678 unit increase,[0.053-0.082],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,Mapping not available
rs7929543-<b>C</b>,2 x 10-9,,0.083159887,'-,0.0828 unit increase,[0.056-0.11],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,Mapping not available
rs1552224-<b>C</b>,9 x 10-25,,0.154210453,'-,0.1034 unit decrease,[0.084-0.123],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST006867,11:72722053
rs10830963-<b>G</b>,6 x 10-30,,0.275768064,'-,0.0909 unit increase,[0.075-0.107],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST006867,11:92975544
rs7931302-<b>C</b>,8 x 10-9,,0.276869909,'-,0.0461 unit increase,[0.03-0.062],ETS1,Type 2 diabetes,type II diabetes mellitus,GCST006867,11:128366163
rs67232546-<b>T</b>,5 x 10-10,,0.209221793,'-,0.0596 unit increase,[0.041-0.078],"ETS1-AS1, ETS1",Type 2 diabetes,type II diabetes mellitus,GCST006867,11:128529043
rs12299509-<b>G</b>,2 x 10-10,,0.478621745,'-,0.0467 unit increase,[0.032-0.061],CCND2,Type 2 diabetes,type II diabetes mellitus,GCST006867,12:4297115
rs11048456-<b>C</b>,3 x 10-9,,0.243820871,'-,0.0488 unit increase,[0.033-0.065],"ITPR2, SSPN",Type 2 diabetes,type II diabetes mellitus,GCST006867,12:26310149
rs10842994-<b>T</b>,1 x 10-16,,0.197025395,'-,0.0755 unit decrease,[0.058-0.093],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST006867,12:27812217
rs9369425-<b>G</b>,1 x 10-10,,0.291815284,'-,0.0546 unit increase,[0.038-0.071],"LINC02537, VEGFA",Type 2 diabetes,type II diabetes mellitus,GCST006867,6:43843237
rs72892910-<b>T</b>,6 x 10-11,,0.172394288,'-,0.0648 unit increase,[0.045-0.084],"RPS17P5, TFAP2B",Type 2 diabetes,type II diabetes mellitus,GCST006867,6:50849174
rs853974-<b>T</b>,8 x 10-12,,0.262413847,'-,0.0601 unit increase,[0.043-0.077],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,Mapping not available
rs2246012-<b>C</b>,2 x 10-8,,0.164823311,'-,0.0527 unit increase,[0.034-0.071],"ARG1, MED23",Type 2 diabetes,type II diabetes mellitus,GCST006867,6:131577068
rs622217-<b>C</b>,3 x 10-10,,0.483931554,'-,0.0485 unit decrease,[0.033-0.064],"SLC22A2, SLC22A3",Type 2 diabetes,type II diabetes mellitus,GCST006867,6:160345738
rs17168486-<b>T</b>,2 x 10-15,,0.173603116,'-,0.0742 unit increase,[0.056-0.093],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST006867,7:14858657
rs2191348-<b>G</b>,3 x 10-19,,0.453064599,'-,0.0652 unit decrease,[0.051-0.08],GTF3AP5,Type 2 diabetes,type II diabetes mellitus,GCST006867,7:15024630
rs849135-<b>G</b>,1 x 10-43,,0.50094782,'-,0.0999 unit increase,[0.086-0.114],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,Mapping not available
rs2908282-<b>A</b>,4 x 10-9,,0.177394803,'-,0.0552 unit increase,[0.037-0.074],YKT6,Type 2 diabetes,type II diabetes mellitus,GCST006867,7:44209229
rs2299383-<b>T</b>,1 x 10-8,,0.423455222,'-,0.0412 unit increase,[0.027-0.056],RELN,Type 2 diabetes,type II diabetes mellitus,GCST006867,7:103778399
rs13239186-<b>T</b>,3 x 10-10,,0.302028596,'-,0.0539 unit increase,[0.037-0.071],CTTNBP2,Type 2 diabetes,type II diabetes mellitus,GCST006867,7:117870567
rs13234269-<b>A</b>,7 x 10-14,,0.492515171,'-,0.0583 unit decrease,[0.043-0.074],"H4P1, KLF14",Type 2 diabetes,type II diabetes mellitus,GCST006867,7:130744427
rs7786095-<b>G</b>,1 x 10-8,,0.103859861,'-,0.0743 unit decrease,[0.049-0.1],UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST006867,7:157191153
rs7841082-<b>T</b>,5 x 10-8,,0.438275981,'-,0.042 unit decrease,[0.027-0.057],"FAM86B3P, PRAG1",Type 2 diabetes,type II diabetes mellitus,GCST006867,8:8311465
rs11774915-<b>T</b>,9 x 10-9,,0.337128969,'-,0.0495 unit increase,[0.033-0.066],"RNU6-526P, RNU6-1151P",Type 2 diabetes,type II diabetes mellitus,GCST006867,8:9331252
rs10100265-<b>A</b>,6 x 10-10,,0.389510132,'-,0.0491 unit increase,[0.034-0.065],PINX1,Type 2 diabetes,type II diabetes mellitus,GCST006867,8:10775649
rs17411031-<b>G</b>,3 x 10-8,,0.261729326,'-,0.045 unit decrease,[0.029-0.061],LPL,Type 2 diabetes,type II diabetes mellitus,GCST006867,8:19994799
rs10087241-<b>G</b>,3 x 10-9,,0.405106648,'-,0.0475 unit increase,[0.032-0.063],PURG,Type 2 diabetes,type II diabetes mellitus,GCST006867,8:31006206
rs12681990-<b>C</b>,4 x 10-11,,0.163729642,'-,0.0634 unit increase,[0.045-0.082],"SMARCE1P4, KCNU1",Type 2 diabetes,type II diabetes mellitus,GCST006867,8:37001668
rs516946-<b>T</b>,3 x 10-22,,0.239366701,'-,0.0824 unit decrease,[0.066-0.099],ANK1,Type 2 diabetes,type II diabetes mellitus,GCST006867,8:41661730
rs7845219-<b>C</b>,5 x 10-9,,0.492785851,'-,0.0422 unit decrease,[0.028-0.056],NDUFAF6,Type 2 diabetes,type II diabetes mellitus,GCST006867,8:94925274
rs3802177-<b>A</b>,2 x 10-52,,0.311281439,'-,0.1217 unit decrease,[0.11-0.14],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST006867,8:117172786
rs2294120-<b>G</b>,2 x 10-8,,0.4558793,'-,0.0443 unit decrease,[0.029-0.06],ZNF34,Type 2 diabetes,type II diabetes mellitus,GCST006867,8:144778182
rs10974438-<b>C</b>,3 x 10-15,,0.351215241,'-,0.0591 unit increase,[0.044-0.074],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST006867,9:4291928
rs1063192-<b>G</b>,3 x 10-18,,0.440315561,'-,0.0634 unit decrease,[0.049-0.078],"CDKN2B, CDKN2B-AS1",Type 2 diabetes,type II diabetes mellitus,GCST006867,9:22003368
rs7364276-<b>T</b>,9 x 10-6,,0.788,1.23,'-,[1.13-1.35],'-,Type 2 diabetes,type II diabetes mellitus,GCST008114,22:49086117
rs73741124-<b>C</b>,2 x 10-6,,0.984,2.11,'-,[1.55-2.87],'-,Type 2 diabetes,type II diabetes mellitus,GCST008114,6:22925808
rs73838836-<b>A</b>,5 x 10-6,,0.023,1.48,'-,[1.13-1.94],UNC5C,Type 2 diabetes,type II diabetes mellitus,GCST008114,4:95452459
rs74073568-<b>G</b>,5 x 10-6,,0.883,1.29,'-,[1.15-1.45],FYB2,Type 2 diabetes,type II diabetes mellitus,GCST008114,1:56794686
rs74927455-<b>G</b>,5 x 10-6,,0.905,1.35,'-,[1.19-1.54],ST18,Type 2 diabetes,type II diabetes mellitus,GCST008114,8:52120383
rs7534008-<b>T</b>,7 x 10-6,,0.44,1.18,'-,[1.10-1.28],DEPDC1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST008114,1:68582346
rs76859863-<b>G</b>,2 x 10-7,,0.832,1.29,'-,[1.17-1.42],"KATNAL1, LINC00385",Type 2 diabetes,type II diabetes mellitus,GCST008114,13:30182070
rs7747641-<b>C</b>,5 x 10-6,,0.954,1.56,'-,[1.29-1.89],RPL12P23,Type 2 diabetes,type II diabetes mellitus,GCST008114,6:170103681
rs77741372-<b>C</b>,8 x 10-6,,0.031,1.41,'-,[1.13-1.75],AP3B1,Type 2 diabetes,type II diabetes mellitus,GCST008114,5:78236244
rs7903146-<b>T</b>,5 x 10-13,,0.356,1.32,'-,[1.22-1.33],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST008114,10:112998590
rs80240198-<b>T</b>,4 x 10-6,,0.958,1.54,'-,[1.28-1.86],RPL32P14,Type 2 diabetes,type II diabetes mellitus,GCST008114,5:19054069
rs80268399-<b>T</b>,5 x 10-6,,0.967,1.71,'-,[1.34-2.16],DLG2,Type 2 diabetes,type II diabetes mellitus,GCST008114,11:84441091
rs887400-<b>A</b>,4 x 10-6,,0.962,1.65,'-,[1.33-2.06],"MIR633, PRELID3BP3",Type 2 diabetes,type II diabetes mellitus,GCST008114,17:62868479
rs9847133-<b>T</b>,1 x 10-6,,0.633,1.2,'-,[1.11-1.30],LMCD1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST008114,3:8208835
rs111558778-<b>G</b>,8 x 10-7,,0.986,2.7777777,'-,[1.85-4.17],ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST008114,3:64763995
chr15:90080605-<b>A</b>,4 x 10-6,,0.913,1.34,'-,[1.17-1.53],'-,Type 2 diabetes,type II diabetes mellitus,GCST008114,Mapping not available
rs112328442-<b>C</b>,9 x 10-6,,0.98,1.84,'-,[1.42-2.38],CSMD1,Type 2 diabetes,type II diabetes mellitus,GCST008114,8:3359886
rs113052081-<b>T</b>,2 x 10-6,,0.986,2.55,'-,[1.74-3.72],"TREML3P, TREML2",Type 2 diabetes,type II diabetes mellitus,GCST008114,6:41201241
rs11466334-<b>A</b>,1 x 10-6,,0.094,1.41,'-,[1.23-1.63],TGFB1,Type 2 diabetes,type II diabetes mellitus,GCST008114,19:41341832
rs115175234-<b>G</b>,9 x 10-6,,0.034,1.64,'-,[1.31-2.05],SH2B2,Type 2 diabetes,type II diabetes mellitus,GCST008114,7:102299678
rs115351876-<b>T</b>,3 x 10-6,,0.033,1.69,'-,[1.36-2.10],ELFN1,Type 2 diabetes,type II diabetes mellitus,GCST008114,7:1729716
rs115585699-<b>T</b>,3 x 10-6,,0.975,1.8,'-,[1.42-2.29],RNU4-41P,Type 2 diabetes,type II diabetes mellitus,GCST008114,12:98386008
rs12231031-<b>C</b>,8 x 10-6,,0.832,1.27,'-,[1.15-1.40],'-,Type 2 diabetes,type II diabetes mellitus,GCST008114,12:63394241
rs12277475-<b>T</b>,2 x 10-7,,0.219,1.28,'-,[1.17-1.40],"MIR4686, ASCL2",Type 2 diabetes,type II diabetes mellitus,GCST008114,11:2185703
rs12885036-<b>C</b>,7 x 10-6,,0.91,1.34,'-,[1.18-1.53],SPTB,Type 2 diabetes,type II diabetes mellitus,GCST008114,14:64761876
rs138768039-<b>T</b>,4 x 10-6,,0.986,2.22,'-,[1.59-3.10],NPM1P10,Type 2 diabetes,type II diabetes mellitus,GCST008114,6:104114435
rs139481214-<b>T</b>,8 x 10-6,,0.97,1.62,'-,[1.31-2.01],'-,Type 2 diabetes,type II diabetes mellitus,GCST008114,18:30035671
rs140120210-<b>C</b>,8 x 10-6,,0.986,2.13,'-,[1.50-3.01],"TCAF2, RNU6-267P",Type 2 diabetes,type II diabetes mellitus,GCST008114,7:143735931
rs141311255-<b>C</b>,8 x 10-7,,0.938,1.45,'-,[1.24-1.70],"HNRNPA1P20, LINC02032",Type 2 diabetes,type II diabetes mellitus,GCST008114,3:148156847
rs144050412-<b>A</b>,4 x 10-6,,0.016,1.88,'-,[1.33-2.66],TAF12,Type 2 diabetes,type II diabetes mellitus,GCST008114,1:28632950
rs1468308-<b>C</b>,5 x 10-6,,0.422,1.2,'-,[1.11-1.29],"OR7A11P, OR7A3P",Type 2 diabetes,type II diabetes mellitus,GCST008114,19:14915251
rs17746147-<b>C</b>,7 x 10-6,,0.961,1.59,'-,[1.30-1.93],VTI1A,Type 2 diabetes,type II diabetes mellitus,GCST008114,10:112839276
rs2147479-<b>T</b>,4 x 10-6,,0.66,1.19,'-,[1.10-1.29],DAOA-AS1,Type 2 diabetes,type II diabetes mellitus,GCST008114,13:105422547
rs3897727-<b>T</b>,8 x 10-6,,0.252,1.22,'-,[1.12-1.33],ANO4,Type 2 diabetes,type II diabetes mellitus,GCST008114,12:100824525
rs4253735-<b>G</b>,4 x 10-6,,0.023,1.65,'-,[1.28-2.12],PPARA,Type 2 diabetes,type II diabetes mellitus,GCST008114,22:46215129
rs56981400-<b>G</b>,5 x 10-6,,0.979,1.59,'-,[1.23-2.05],EIF4E3,Type 2 diabetes,type II diabetes mellitus,GCST008114,3:71694973
rs57261374-<b>G</b>,1 x 10-6,,0.848,1.3,'-,[1.17-1.45],'-,Type 2 diabetes,type II diabetes mellitus,GCST008114,18:30843940
rs60227687-<b>A</b>,3 x 10-6,,0.058,1.5,'-,[1.26-1.77],"LRRC32, GUCY2EP",Type 2 diabetes,type II diabetes mellitus,GCST008114,11:76674684
rs6026382-<b>T</b>,3 x 10-6,,0.964,1.7,'-,[1.36-2.14],APCDD1L-DT,Type 2 diabetes,type II diabetes mellitus,GCST008114,20:58591228
rs73284431-<b>G</b>,5 x 10-9,,0.905,1.48,'-,[1.30-1.69],AGMO,Type 2 diabetes,type II diabetes mellitus,GCST008114,7:15394605
rs6679717-<b>?</b>,3 x 10-13,,'-,'-,'-,'-,"RNA5SP74, LRRN2",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,1:204591549
rs73913932-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,GRHL1,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,2:9954397
rs2289081-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,"LDAH, GDF7",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,2:20682080
rs12464616-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,ZNF512,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,2:27604225
rs11904510-<b>?</b>,8 x 10-17,,'-,'-,'-,'-,THADA,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,2:43570571
rs1009358-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,"LINC02245, LINC02576",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,2:65049318
rs17041869-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,"MIR4435-2HG, BCL2L11",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,2:111138666
rs2673148-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,'-,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,2:226310267
rs11709119-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,"GSTM5P1, SYN2",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,3:12234993
rs114460169-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,UBE2E2,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,3:23242812
rs6808932-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,SIDT1,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,3:113590302
rs11708733-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,EEFSEC,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,3:128321052
rs6763927-<b>T</b>,3 x 10-9,,0.44,'-,'-,'-,ZBTB38,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,3:141421524
rs76360965-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,MBNL1,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,3:152292353
rs4530726-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,ITGA1,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,5:52762839
rs10900829-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,"LINC01843, RN7SL541P",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,5:134513226
rs9356756-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,CDKAL1,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,6:20843920
rs1741652-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,RFX6,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,6:116943827
rs4385321-<b>A</b>,1 x 10-15,,0.35,'-,'-,'-,RGS17,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,6:153073593
rs316025-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,SLC22A2,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,6:160262349
rs6944344-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,LINC01162,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,7:20972525
rs38514-<b>?</b>,8 x 10-10,,'-,'-,'-,'-,JAZF1,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,7:27988813
rs73404162-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,LMTK2,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,7:98124762
rs67763258-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,DPY19L4,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,8:94727414
rs62516032-<b>?</b>,7 x 10-11,,'-,'-,'-,'-,"POU5F1B, CASC8, PCAT1",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,8:127379167
rs13287517-<b>C</b>,1 x 10-14,,0.39,'-,'-,'-,HAUS6,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,9:19064131
rs3217992-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,"CDKN2B, CDKN2B-AS1",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,9:22003224
rs1758632-<b>C</b>,1 x 10-12,,0.38,'-,'-,'-,UBAP2,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,9:34025642
rs1053403-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,"SEC61A2, NUDT5",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,10:12166308
rs12413648-<b>?</b>,9 x 10-10,,'-,'-,'-,'-,LINC01153,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,10:121279383
rs7103835-<b>A</b>,3 x 10-10,,0.31,'-,'-,'-,RAPSN,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,11:47440142
rs12284087-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,TPCN2,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,11:69127285
rs3753051-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,EMSY,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,11:76546171
rs11214775-<b>?</b>,3 x 10-11,,'-,'-,'-,'-,HTR3B,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,11:113936459
rs17522122-<b>T</b>,4 x 10-9,,0.48,'-,'-,'-,AKAP6,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,14:32833676
rs10400825-<b>G</b>,3 x 10-9,,0.15,'-,'-,'-,"Metazoa_SRP, KNL1",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,15:40588918
rs12912009-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,"AP3S2, ARPIN-AP3S2",Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,15:89885916
rs11656665-<b>?</b>,8 x 10-10,,'-,'-,'-,'-,SREBF1,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,17:17821475
rs9911983-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,OSBPL7,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,17:47808390
rs11079847-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,GIP,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,17:48959662
rs7236466-<b>G</b>,2 x 10-8,,0.38,'-,'-,'-,ZNF236,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,18:76850295
rs6011040-<b>?</b>,2 x 10-13,,'-,'-,'-,'-,ARFRP1,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,20:63706054
rs9607685-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,TNRC6B,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,22:40083807
rs17513135-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,"PABPC4, PABPC4-AS1",Type 2 diabetes,type II diabetes mellitus,GCST007077,1:39570014
rs58432198-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,FAF1,Type 2 diabetes,type II diabetes mellitus,GCST007077,1:50790419
rs2793829-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,NOTCH2,Type 2 diabetes,type II diabetes mellitus,GCST007077,1:119918630
rs340874-<b>?</b>,3 x 10-12,,NR,'-,'-,'-,"PROX1-AS1, PROX1",Type 2 diabetes,type II diabetes mellitus,GCST007077,1:213985913
rs348330-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,ABCB10,Type 2 diabetes,type II diabetes mellitus,GCST007077,1:229537208
rs1260326-<b>?</b>,1 x 10-15,,NR,'-,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST007077,Mapping not available
rs13414381-<b>?</b>,9 x 10-17,,NR,'-,'-,'-,THADA,Type 2 diabetes,type II diabetes mellitus,GCST007077,2:43340079
rs243018-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST007077,2:60359572
rs11688682-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,Y_RNA,Type 2 diabetes,type II diabetes mellitus,GCST007077,2:120590036
rs13007524-<b>?</b>,9 x 10-8,,NR,'-,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST007077,2:147076352
rs10184004-<b>?</b>,3 x 10-15,,NR,'-,'-,'-,"GRB14, COBLL1",Type 2 diabetes,type II diabetes mellitus,GCST007077,2:164651879
rs2972143-<b>?</b>,2 x 10-16,,NR,'-,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST007077,2:226251649
rs17036160-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,PPARG,Type 2 diabetes,type II diabetes mellitus,GCST007077,3:12288284
rs1496653-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST007077,3:23413299
rs6446298-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"UBA7, TRAIP",Type 2 diabetes,type II diabetes mellitus,GCST007077,3:49823421
rs112674299-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,ATXN7,Type 2 diabetes,type II diabetes mellitus,GCST007077,3:63996994
rs11720108-<b>?</b>,2 x 10-15,,NR,'-,'-,'-,ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST007077,3:123350211
rs4678408-<b>?</b>,9 x 10-8,,NR,'-,'-,'-,"NME9, MRAS",Type 2 diabetes,type II diabetes mellitus,GCST007077,3:138334345
rs7633675-<b>?</b>,3 x 10-27,,NR,'-,'-,'-,IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST007077,3:185792825
rs3887925-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST007077,3:186947857
rs10811660-<b>?</b>,3 x 10-31,,NR,'-,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST007077,Mapping not available
rs2796441-<b>?</b>,8 x 10-16,,NR,'-,'-,'-,"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST007077,9:81694033
rs28641468-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST007077,9:136345132
rs11257655-<b>?</b>,4 x 10-14,,NR,'-,'-,'-,"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST007077,10:12265895
rs41277236-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,NEUROG3,Type 2 diabetes,type II diabetes mellitus,GCST007077,10:69572545
rs703972-<b>?</b>,6 x 10-15,,NR,'-,'-,'-,ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST007077,10:79193069
rs34744311-<b>?</b>,5 x 10-27,,NR,'-,'-,'-,"Y_RNA, HHEX",Type 2 diabetes,type II diabetes mellitus,GCST007077,10:92707530
rs117229942-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST007077,10:112978018
rs7903146-<b>?</b>,3 x 10-203,,NR,'-,'-,'-,TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST007077,10:112998590
rs4918796-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST007077,10:113120583
rs7482891-<b>?</b>,7 x 10-11,,NR,'-,'-,'-,"ASCL2, MIR4686",Type 2 diabetes,type II diabetes mellitus,GCST007077,11:2175882
rs231362-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"KCNQ1OT1, KCNQ1",Type 2 diabetes,type II diabetes mellitus,GCST007077,11:2670241
rs2237895-<b>?</b>,3 x 10-23,,NR,'-,'-,'-,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST007077,11:2835964
rs2074314-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,"ABCC8, KCNJ11",Type 2 diabetes,type II diabetes mellitus,GCST007077,11:17390274
rs2510078-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,"LTBP3, ZNRD2-AS1",Type 2 diabetes,type II diabetes mellitus,GCST007077,11:65564802
rs11602873-<b>?</b>,3 x 10-17,,NR,'-,'-,'-,ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST007077,11:72749717
rs10830963-<b>?</b>,2 x 10-16,,NR,'-,'-,'-,MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST007077,11:92975544
rs76895963-<b>?</b>,2 x 10-31,,NR,'-,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST007077,Mapping not available
rs2258238-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,HMGA2,Type 2 diabetes,type II diabetes mellitus,GCST007077,12:65827280
rs7968902-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"MIR6074, HMGA2",Type 2 diabetes,type II diabetes mellitus,GCST007077,12:65969290
rs1169299-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,HNF1A,Type 2 diabetes,type II diabetes mellitus,GCST007077,12:120991391
rs7988007-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST007077,13:58414137
rs1215468-<b>?</b>,2 x 10-19,,NR,'-,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST007077,13:80133294
rs4287436-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,LINC00370,Type 2 diabetes,type II diabetes mellitus,GCST007077,13:109288515
rs34715063-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,"LINC02694, RASGRP1",Type 2 diabetes,type II diabetes mellitus,GCST007077,15:38580914
rs4686471-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,LINC01991,Type 2 diabetes,type II diabetes mellitus,GCST007077,3:188023111
rs56337234-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,"FGFR3, TACC3",Type 2 diabetes,type II diabetes mellitus,GCST007077,4:1782676
rs1801212-<b>?</b>,3 x 10-18,,NR,'-,'-,'-,WFS1,Type 2 diabetes,type II diabetes mellitus,GCST007077,4:6300792
rs28690107-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,MTND3P22,Type 2 diabetes,type II diabetes mellitus,GCST007077,4:49309067
rs6885132-<b>?</b>,3 x 10-13,,NR,'-,'-,'-,ANKH,Type 2 diabetes,type II diabetes mellitus,GCST007077,5:14767983
rs9686661-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST007077,5:56565959
rs72783884-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,PAM,Type 2 diabetes,type II diabetes mellitus,GCST007077,5:102912212
rs115505614-<b>?</b>,4 x 10-16,,NR,'-,'-,'-,GIN1,Type 2 diabetes,type II diabetes mellitus,GCST007077,5:103087264
rs9379084-<b>?</b>,2 x 10-15,,NR,'-,'-,'-,RREB1,Type 2 diabetes,type II diabetes mellitus,GCST007077,6:7231610
rs7756992-<b>?</b>,5 x 10-31,,NR,'-,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST007077,Mapping not available
rs4715207-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,TFAP2B,Type 2 diabetes,type II diabetes mellitus,GCST007077,6:50841565
rs11759026-<b>?</b>,7 x 10-12,,NR,'-,'-,'-,MIR588,Type 2 diabetes,type II diabetes mellitus,GCST007077,6:126470949
rs3383-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,HIVEP2,Type 2 diabetes,type II diabetes mellitus,GCST007077,6:142751904
rs11763876-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,C1GALT1,Type 2 diabetes,type II diabetes mellitus,GCST007077,7:7210116
rs10228456-<b>?</b>,1 x 10-14,,NR,'-,'-,'-,GTF3AP5,Type 2 diabetes,type II diabetes mellitus,GCST007077,7:15024301
rs860262-<b>?</b>,2 x 10-18,,NR,'-,'-,'-,JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST007077,7:28154778
rs4729854-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,"RASA4DP, FAM185A",Type 2 diabetes,type II diabetes mellitus,GCST007077,7:102743216
rs6951280-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,DOCK4,Type 2 diabetes,type II diabetes mellitus,GCST007077,7:111746160
rs10260148-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,"H4P1, KLF14",Type 2 diabetes,type II diabetes mellitus,GCST007077,7:130746210
rs1182395-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST007077,7:157240230
rs508419-<b>?</b>,2 x 10-15,,NR,'-,'-,'-,ANK1,Type 2 diabetes,type II diabetes mellitus,GCST007077,8:41665473
rs1320164-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"TP53INP1, NDUFAF6",Type 2 diabetes,type II diabetes mellitus,GCST007077,8:94948539
rs3802177-<b>?</b>,2 x 10-24,,NR,'-,'-,'-,SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST007077,8:117172786
rs12719778-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,"Metazoa_SRP, ARHGAP39",Type 2 diabetes,type II diabetes mellitus,GCST007077,8:144654498
rs10974438-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST007077,9:4291928
rs7166281-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,"IMP3, SNUPN",Type 2 diabetes,type II diabetes mellitus,GCST007077,15:75635851
rs12910361-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST007077,15:77489993
rs8031576-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"ARPIN-AP3S2, AP3S2",Type 2 diabetes,type II diabetes mellitus,GCST007077,15:89836982
rs9931702-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,AKTIP,Type 2 diabetes,type II diabetes mellitus,GCST007077,16:53492639
rs1421085-<b>?</b>,4 x 10-29,,NR,'-,'-,'-,FTO,Type 2 diabetes,type II diabetes mellitus,GCST007077,16:53767042
rs244420-<b>?</b>,7 x 10-10,,NR,'-,'-,'-,NFAT5,Type 2 diabetes,type II diabetes mellitus,GCST007077,16:69624093
rs72802365-<b>?</b>,4 x 10-14,,NR,'-,'-,'-,"CTRB2, CTRB1",Type 2 diabetes,type II diabetes mellitus,GCST007077,16:75212137
rs2278524-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"ANKFY1, CYB5D2",Type 2 diabetes,type II diabetes mellitus,GCST007077,17:4178680
rs7501939-<b>?</b>,2 x 10-17,,NR,'-,'-,'-,HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST007077,17:37741165
rs35895680-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,"GIP, IGF2BP1",Type 2 diabetes,type II diabetes mellitus,GCST007077,17:48982960
rs12967878-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,"RPS3AP49, RNU4-17P",Type 2 diabetes,type II diabetes mellitus,GCST007077,18:60159337
rs2303700-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,MAP2K7,Type 2 diabetes,type II diabetes mellitus,GCST007077,19:7911644
rs10420309-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,"RN7SL836P, EML2",Type 2 diabetes,type II diabetes mellitus,GCST007077,19:45646924
rs7274168-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,CHMP4B,Type 2 diabetes,type II diabetes mellitus,GCST007077,20:33848172
rs1800961-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST007077,20:44413724
rs2735940-<b>G</b>,3 x 10-13,(EA),0.489,1.0869565,'-,[1.06-1.12],"MIR4457, TERT",Colorectal cancer,colorectal cancer,GCST006131,5:1296371
rs58791712-<b>GT</b>,7 x 10-14,(EA),0.255,1.098901,'-,[1.08-1.12],RNU1-150P,Colorectal cancer,colorectal cancer,GCST006131,5:40281696
rs10911251-<b>A</b>,5 x 10-8,(EA),0.547,1.07,'-,[1.04-1.10],LAMC1,Colorectal cancer,colorectal cancer,GCST006131,1:183112059
rs6687758-<b>G</b>,1 x 10-8,(EA),0.222,1.0869565,'-,[1.05-1.12],"LINC02474, LINC01705",Colorectal cancer,colorectal cancer,GCST006131,1:221991606
rs992157-<b>A</b>,1 x 10-7,(EA),0.583,1.07,'-,[1.04-1.09],"PNKD, TMBIM1",Colorectal cancer,colorectal cancer,GCST006131,2:218290058
rs35360328-<b>A</b>,6 x 10-13,(EA),0.156,1.13,'-,[1.09-1.17],'-,Colorectal cancer,colorectal cancer,GCST006131,3:40883471
rs812481-<b>G</b>,1 x 10-6,(EA),0.559,1.0638298,'-,[1.03-1.09],LRIG1,Colorectal cancer,colorectal cancer,GCST006131,3:66392011
rs16892766-<b>C</b>,4 x 10-24,(EA),0.09,1.2195122,'-,[1.18-1.28],EIF3H,Colorectal cancer,colorectal cancer,GCST006131,8:116618444
rs6983267-<b>G</b>,8 x 10-27,(EA),0.499,1.1363636,'-,[1.11-1.16],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST006131,8:127401060
rs11255841-<b>T</b>,3 x 10-12,(EA),0.691,1.098901,'-,[1.06-1.12],RNA5SP299,Colorectal cancer,colorectal cancer,GCST006131,10:8697617
rs704017-<b>G</b>,2 x 10-8,(EA),0.562,1.0752687,'-,[1.04-1.1],ZMIZ1-AS1,Colorectal cancer,colorectal cancer,GCST006131,10:79059375
rs1035209-<b>T</b>,1 x 10-8,(EA),0.195,1.09,'-,[1.06-1.12],"NKX2-3, SLC25A28",Colorectal cancer,colorectal cancer,GCST006131,10:99585609
rs1535-<b>A</b>,4 x 10-8,(EA),0.65,1.07,'-,[1.05-1.10],FADS2,Colorectal cancer,colorectal cancer,GCST006131,11:61830500
rs3824999-<b>G</b>,4 x 10-10,(EA),0.524,1.0752687,'-,[1.05-1.1],POLD3,Colorectal cancer,colorectal cancer,GCST006131,11:74634505
rs3802842-<b>C</b>,5 x 10-19,(EA),0.269,1.1235955,'-,[1.1-1.15],"COLCA1, COLCA2",Colorectal cancer,colorectal cancer,GCST006131,11:111300984
rs3217810-<b>T</b>,2 x 10-11,(EA),0.121,1.15,'-,[1.11-1.20],CCND2,Colorectal cancer,colorectal cancer,GCST006131,12:4279105
rs3184504-<b>C</b>,2 x 10-10,(EA),0.536,1.0752687,'-,[1.05-1.1],"SH2B3, ATXN2",Colorectal cancer,colorectal cancer,GCST006131,12:111446804
rs73208120-<b>G</b>,8 x 10-7,(EA),0.084,1.1111112,'-,[1.06-1.16],NOS1,Colorectal cancer,colorectal cancer,GCST006131,12:117309785
rs4444235-<b>C</b>,1 x 10-9,(EA),0.493,1.0752687,'-,[1.05-1.1],"LINC02331, MIR5580",Colorectal cancer,colorectal cancer,GCST006131,14:53944201
rs17094983-<b>G</b>,8 x 10-10,(EA),0.879,1.1111112,'-,[1.08-1.15],LINC01500,Colorectal cancer,colorectal cancer,GCST006131,14:58722643
rs73376930-<b>G</b>,4 x 10-18,(EA),0.207,1.1363636,'-,[1.1-1.18],GREM1,Colorectal cancer,colorectal cancer,GCST006131,15:32720301
rs9929218-<b>G</b>,7 x 10-6,(EA),0.706,1.0638298,'-,[1.03-1.09],CDH1,Colorectal cancer,colorectal cancer,GCST006131,16:68787043
rs4939827-<b>T</b>,3 x 10-30,(EA),0.532,1.14,'-,[1.12-1.17],SMAD7,Colorectal cancer,colorectal cancer,GCST006131,18:48927093
rs10411210-<b>C</b>,3 x 10-7,(EA),0.903,1.098901,'-,[1.06-1.15],RHPN2,Colorectal cancer,colorectal cancer,GCST006131,19:33041394
rs961253-<b>A</b>,6 x 10-11,(EA),0.361,1.08,'-,[1.06-1.11],CASC20,Colorectal cancer,colorectal cancer,GCST006131,20:6423634
rs4813802-<b>G</b>,1 x 10-9,(EA),0.318,1.0752687,'-,[1.05-1.11],LINC01713,Colorectal cancer,colorectal cancer,GCST006131,20:6718948
rs6066825-<b>A</b>,2 x 10-6,(EA),0.622,1.06,'-,[1.03-1.09],PREX1,Colorectal cancer,colorectal cancer,GCST006131,20:48723580
rs2427308-<b>C</b>,2 x 10-13,(EA),0.766,1.1235955,'-,[1.09-1.16],CABLES2,Colorectal cancer,colorectal cancer,GCST006131,20:62394395
rs3738441-<b>?</b>,9 x 10-7,(AA),NR,'-,0.039 unit increase,'-,TGFBR3,HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"HDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004763,1:91758510
rs2028196-<b>?</b>,9 x 10-7,,NR,'-,0.013 unit decrease,'-,"LINC01381, POMC",HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"HDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004763,2:25175973
rs1597595-<b>?</b>,7 x 10-7,(AA),NR,'-,0.025 unit increase,'-,'-,HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"HDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004763,2:147192553
rs7709909-<b>?</b>,1 x 10-8,(AA),NR,'-,0.045 unit decrease,'-,MSH3,HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"HDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004763,5:80705351
rs7214842-<b>?</b>,1 x 10-6,(AA),NR,'-,0.024 unit increase,'-,STX8,HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"HDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004763,17:9445693
rs71313049-<b>?</b>,7 x 10-7,(AA),NR,'-,0.043 unit decrease,'-,CELSR1,HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"HDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004763,22:46458337
rs9285630-<b>?</b>,8 x 10-7,(EA),NR,'-,0.022 unit decrease,'-,SNX7,LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"LDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004764,1:98677991
rs1653969-<b>?</b>,9 x 10-7,(AA),NR,'-,0.037 unit increase,'-,FOXP1,LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"LDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004764,3:71282213
rs112284299-<b>?</b>,7 x 10-7,(AA),NR,'-,0.107 unit increase,'-,PEX5L,LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"LDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004764,3:179850308
rs72804453-<b>?</b>,4 x 10-7,(AA),NR,'-,0.111 unit increase,'-,BICC1,LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"LDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004764,10:58827232
rs2607653-<b>?</b>,4 x 10-7,,NR,'-,0.038 unit increase,'-,FGF14,LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"LDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004764,13:102066314
rs73354145-<b>?</b>,2 x 10-7,,NR,'-,0.032 unit increase,'-,MRPL12,LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"LDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004764,17:81706393
rs150268548-<b>?</b>,9 x 10-8,(EA),NR,'-,0.028 unit decrease,'-,"GATAD2A, MAU2",LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"LDL cholesterol change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004764,19:19383674
rs2631781-<b>?</b>,1 x 10-6,(AA),NR,'-,0.051 unit increase,'-,ST6GALNAC3,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,1:76128101
rs181126208-<b>?</b>,7 x 10-8,(AA),NR,'-,0.066 unit increase,'-,EDARADD,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,1:236495210
rs75639901-<b>?</b>,5 x 10-7,(AA),NR,'-,0.039 unit increase,'-,SCGN,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,6:25667803
rs9472719-<b>?</b>,9 x 10-7,,NR,'-,0.008 unit increase,'-,"ENPP5, ACTG1P9",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,6:46183649
rs7810240-<b>?</b>,2 x 10-7,,NR,'-,0.015 unit decrease,'-,ZNF775,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,7:150387372
rs34030778-<b>?</b>,4 x 10-8,(AA),NR,'-,0.124 unit increase,'-,"CLN8, KBTBD11-OT1",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,8:1771328
rs114007472-<b>?</b>,8 x 10-7,(AA),NR,'-,0.071 unit increase,'-,RN7SKP135,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,8:63563681
rs4988198-<b>?</b>,9 x 10-7,(AA),NR,'-,0.058 unit increase,'-,MCM6,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,2:135861240
rs141864436-<b>?</b>,1 x 10-7,(AA),NR,'-,0.062 unit increase,'-,NRXN1,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,2:50971652
rs145010525-<b>?</b>,8 x 10-7,(AA),NR,'-,0.058 unit increase,'-,DARS1,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,2:135975206
rs115990514-<b>?</b>,5 x 10-7,(AA),NR,'-,0.065 unit increase,'-,KCNH8,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,3:19055898
rs115092681-<b>?</b>,1 x 10-6,(AA),NR,'-,0.061 unit increase,'-,NLGN1,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,3:174201323
rs112284299-<b>?</b>,1 x 10-7,(AA),NR,'-,0.065 unit increase,'-,PEX5L,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,3:179850308
rs10034465-<b>?</b>,1 x 10-7,(AA),NR,'-,0.053 unit increase,'-,LINC02484,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,4:34193882
rs6847878-<b>?</b>,1 x 10-6,(AA),NR,'-,0.062 unit increase,'-,"RASGEF1B, RNU5A-2P",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,4:81419698
rs80333777-<b>?</b>,5 x 10-7,,NR,'-,0.02 unit increase,'-,FBXL7,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,5:15524361
rs75298135-<b>?</b>,4 x 10-7,(AA),NR,'-,0.065 unit increase,'-,'-,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,5:28184372
rs113816795-<b>?</b>,2 x 10-7,(AA),NR,'-,0.072 unit increase,'-,HSPB3,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,5:99159794
rs146807753-<b>?</b>,7 x 10-7,(AA),NR,'-,0.06 unit increase,'-,"TDGF1P4, FAM50B",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,6:3904005
rs72804453-<b>?</b>,8 x 10-11,(AA),NR,'-,0.078 unit increase,'-,BICC1,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,10:58827232
rs116616455-<b>?</b>,7 x 10-7,(AA),NR,'-,0.047 unit increase,'-,"LINC02403, RN7SKP65",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,12:58041829
rs112209655-<b>?</b>,2 x 10-7,(AA),NR,'-,0.066 unit increase,'-,"TSPAN19, SLC6A15",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,12:84947358
rs143838781-<b>?</b>,4 x 10-7,(AA),NR,'-,0.061 unit increase,'-,RBM19,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,12:113940539
rs138270994-<b>?</b>,6 x 10-7,(AA),NR,'-,0.045 unit increase,'-,"DDX39AP1, SNORD36",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,13:22791997
rs2607653-<b>?</b>,1 x 10-7,,NR,'-,0.023 unit increase,'-,FGF14,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,13:102066314
rs76043556-<b>?</b>,7 x 10-7,(AA),NR,'-,0.058 unit increase,'-,"GOLGA8J, SYNGR2P1",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,15:30060226
rs117168171-<b>?</b>,2 x 10-7,(AA),NR,'-,0.066 unit increase,'-,"OR4F28P, OR4F13P",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,15:101854599
rs250567-<b>?</b>,1 x 10-7,(AA),NR,'-,0.072 unit increase,'-,"SCNN1B, COG7",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,16:23383078
rs80147136-<b>?</b>,2 x 10-8,(AA),NR,'-,0.071 unit increase,'-,"NETO2, DNAJA2-DT",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,16:47050042
rs73354145-<b>?</b>,3 x 10-7,,NR,'-,0.018 unit increase,'-,MRPL12,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,17:81706393
rs57504626-<b>?</b>,6 x 10-7,(EA),NR,'-,0.014 unit decrease,'-,PBX4,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,19:19609590
rs2823310-<b>?</b>,3 x 10-7,(AA),NR,'-,0.043 unit increase,'-,CYCSP42,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,21:15497529
rs62210650-<b>?</b>,7 x 10-7,(AA),NR,'-,0.064 unit increase,'-,"NIPA2P3, SREK1IP1P1",Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,21:19649854
rs58847779-<b>?</b>,7 x 10-7,(AA),NR,'-,0.039 unit increase,'-,TRIOBP,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,22:37736644
rs6693796-<b>?</b>,6 x 10-8,,NR,'-,0.019 unit increase,'-,PRRX1,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,"response to simvastatin, type II diabetes mellitus, total cholesterol change measurement, response to fenofibrate",GCST004765,1:170674137
rs79128089-<b>?</b>,3 x 10-8,(AA),NR,'-,0.108 unit increase,'-,BCL9,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,1:147605222
rs2185774-<b>?</b>,3 x 10-7,(AA),NR,'-,0.159 unit increase,'-,"PRSS38, WNT9A",Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,1:227908878
rs73934724-<b>?</b>,4 x 10-7,(AA),NR,'-,0.174 unit increase,'-,ASB3,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,2:53557787
rs200803778-<b>?</b>,7 x 10-7,(AA),NR,'-,0.152 unit increase,'-,LINC02010,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,3:146921799
rs138945390-<b>?</b>,2 x 10-7,(AA),NR,'-,0.167 unit increase,'-,ENPP7P10,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,4:9112775
rs137945355-<b>?</b>,3 x 10-7,(AA),NR,'-,0.127 unit increase,'-,CCDC149,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,4:24942593
rs7657890-<b>?</b>,5 x 10-7,,NR,'-,0.019 unit decrease,'-,'-,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,4:156252512
rs116116673-<b>?</b>,3 x 10-7,(AA),NR,'-,0.147 unit increase,'-,'-,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,5:143951835
rs148347825-<b>?</b>,2 x 10-8,(AA),NR,'-,0.166 unit increase,'-,LRFN2,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,6:40416077
rs114176593-<b>?</b>,5 x 10-8,(AA),NR,'-,0.153 unit increase,'-,LINC01010,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,6:134370090
rs1017568-<b>?</b>,3 x 10-7,(AA),NR,'-,0.265 unit increase,'-,GLIS3,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,9:3948365
rs7357773-<b>?</b>,4 x 10-7,(AA),NR,'-,0.114 unit increase,'-,LINGO2,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,9:28227169
rs77972797-<b>?</b>,8 x 10-7,(AA),NR,'-,0.111 unit increase,'-,RHOBTB1,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,10:60978985
rs75229567-<b>?</b>,9 x 10-7,,NR,'-,0.041 unit increase,'-,BEST3,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,12:69694564
rs201486960-<b>?</b>,2 x 10-7,(AA),NR,'-,0.124 unit increase,'-,'-,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,12:84532353
rs116517707-<b>?</b>,1 x 10-7,(AA),NR,'-,0.147 unit increase,'-,"MIR4472-2, LINC02457",Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,12:116481563
rs11619726-<b>?</b>,6 x 10-8,(AA),NR,'-,0.173 unit increase,'-,SERTM1,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,13:36601856
rs61960346-<b>?</b>,5 x 10-8,(AA),NR,'-,0.162 unit increase,'-,MTND4P1,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,13:84421272
rs11636249-<b>?</b>,5 x 10-7,(AA),NR,'-,0.153 unit increase,'-,LINC02694,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,15:38887084
rs73607972-<b>?</b>,2 x 10-7,(EA),NR,'-,0.026 unit decrease,'-,RPGRIP1L,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,16:53634741
rs76069656-<b>?</b>,5 x 10-7,(AA),NR,'-,0.103 unit increase,'-,"SLC7A5, KLHDC4",Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,16:87822832
rs41308713-<b>?</b>,2 x 10-7,(AA),NR,'-,0.114 unit increase,'-,SNHG17,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,20:38421365
rs2823310-<b>?</b>,7 x 10-8,(AA),NR,'-,0.109 unit increase,'-,CYCSP42,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,21:15497529
rs111886096-<b>?</b>,3 x 10-7,,NR,'-,0.022 unit decrease,'-,"RPGRIP1L, AKTIP",Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,16:53564398
rs62056376-<b>?</b>,5 x 10-7,(AA),NR,'-,0.244 unit increase,'-,"CCL8, CCL13",Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,17:34342002
rs115025532-<b>?</b>,8 x 10-7,(AA),NR,'-,0.103 unit increase,'-,TTLL8,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,"triglyceride change measurement, response to simvastatin, type II diabetes mellitus, response to fenofibrate",GCST004766,22:50032791
rs6134031-<b>T</b>,1 x 10-8,(Greater Middle Eastern),0.23,9.66,'-,[NR],LINC01752,Type 2 diabetes,type II diabetes mellitus,GCST004782,20:10771962
rs2943656-<b>G</b>,3 x 10-10,,NR,1.1089349,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST005413,2:226257202
12:71611896-<b>A</b>,2 x 10-6,,NR,1.1004289,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST005413,Mapping not available
10:94433455-<b>A</b>,3 x 10-9,,NR,1.1010894,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST005413,Mapping not available
rs76895963-<b>T</b>,2 x 10-10,,NR,1.72,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST005413,Mapping not available
rs7732041-<b>?</b>,4 x 10-6,,NR,'-,0.136 unit increase,[0.063-0.209],MIR4458HG,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,5:8512823
rs72891772-<b>?</b>,7 x 10-6,,NR,'-,0.124 unit decrease,[0.051-0.197],ERI3,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,1:44296039
rs149725802-<b>?</b>,7 x 10-6,,NR,'-,0.275 unit decrease,[0.14-0.41],"CLCA1, CLCA2",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,1:86459814
rs2294263-<b>?</b>,5 x 10-6,,NR,'-,0.111 unit increase,[0.046-0.176],"MDH1P2, MYLIP",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,6:16108703
rs7752317-<b>?</b>,4 x 10-6,,NR,'-,0.157 unit decrease,[0.086-0.228],'-,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,6:76721314
rs9384331-<b>?</b>,3 x 10-7,,NR,'-,0.283 unit decrease,[0.17-0.4],"RNU4-7P, PPP1R14C",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,6:150279905
rs147565452-<b>?</b>,7 x 10-6,,NR,'-,0.273 unit decrease,[0.095-0.451],"LINC02519, WDR27",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,6:169448871
rs113805659-<b>?</b>,3 x 10-7,,NR,'-,0.185 unit decrease,[0.1-0.27],MAGI2,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,7:78663475
rs61751050-<b>?</b>,4 x 10-6,,NR,'-,0.292 unit decrease,[0.12-0.46],"GIMAP1-GIMAP5, GIMAP5",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,7:150742952
rs4272321-<b>?</b>,8 x 10-7,,NR,'-,0.262 unit increase,[0.16-0.37],PTPRN2,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,7:158159143
rs112032253-<b>?</b>,8 x 10-6,,NR,'-,0.213 unit increase,[0.097-0.329],MSRA,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,8:10204842
rs2106045-<b>?</b>,4 x 10-6,,NR,'-,0.101 unit decrease,[0.05-0.152],"NAT1, ASAH1",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,8:18133187
rs7820474-<b>?</b>,7 x 10-6,,NR,'-,0.149 unit increase,[0.078-0.22],ASNSP1,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,8:46605288
rs3955298-<b>?</b>,5 x 10-6,,NR,'-,0.203 unit decrease,[0.099-0.307],RNU2-54P,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,8:76185280
rs73319666-<b>?</b>,5 x 10-6,,NR,'-,0.152 unit decrease,[0.066-0.238],"SAMD12-AS1, TNFRSF11B",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,8:118918785
rs59811240-<b>?</b>,2 x 10-6,,NR,'-,0.214 unit decrease,[0.067-0.361],MTSS1,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,8:124709787
rs142754775-<b>?</b>,4 x 10-6,,NR,'-,0.235 unit decrease,[0.13-0.34],"CDKN2A-DT, MTAP",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,9:21948944
rs7032482-<b>?</b>,4 x 10-6,,NR,'-,0.196 unit decrease,[0.12-0.27],RPS20P25,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,9:81419260
rs191660985-<b>?</b>,9 x 10-6,,NR,'-,0.267 unit increase,[0.13-0.4],PTPN3,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,9:109377459
rs2229973-<b>?</b>,5 x 10-6,,NR,'-,0.308 unit increase,[0.18-0.44],NOTCH1,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,9:136500807
rs10904785-<b>?</b>,8 x 10-6,,NR,'-,0.223 unit increase,[0.12-0.32],RSU1,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,10:16671774
rs10740039-<b>?</b>,3 x 10-6,,NR,'-,0.155 unit increase,[0.077-0.233],ANK3,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,10:60654924
rs7442201-<b>?</b>,3 x 10-7,,NR,'-,0.268 unit decrease,[0.16-0.38],NSG1,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,4:4360022
rs2900783-<b>?</b>,2 x 10-6,,NR,'-,0.186 unit increase,[0.11-0.26],LINC01435,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,10:107749780
rs6829172-<b>?</b>,8 x 10-6,,NR,'-,0.347 unit increase,[0.18-0.51],NAAA,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,4:75915281
rs76294234-<b>?</b>,1 x 10-6,,NR,'-,0.294 unit increase,[0.18-0.41],COQ2,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,4:83241025
rs116074745-<b>?</b>,5 x 10-6,,NR,'-,0.295 unit decrease,[0.13-0.46],ADAM29,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,4:175027928
rs183050992-<b>?</b>,2 x 10-6,,NR,'-,0.16 unit increase,[0.072-0.248],"OR5AP2, OR5AP1P",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,11:56640698
rs55637147-<b>?</b>,5 x 10-6,,NR,'-,0.12 unit increase,[0.046-0.194],P2RX3,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,11:57343922
rs595585-<b>?</b>,2 x 10-6,,NR,'-,0.271 unit decrease,[0.15-0.4],FLI1,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,11:128734115
rs10841529-<b>?</b>,2 x 10-6,,NR,'-,0.309 unit decrease,[0.17-0.45],PDE3A,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,12:20445632
rs370245-<b>?</b>,2 x 10-6,,NR,'-,0.136 unit increase,[0.058-0.214],NAV3,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,12:78160830
rs75418803-<b>?</b>,8 x 10-6,,NR,'-,0.197 unit decrease,[0.068-0.326],"LINC02391, Y_RNA",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,12:92180085
rs7301405-<b>?</b>,8 x 10-6,,NR,'-,0.132 unit increase,[0.061-0.203],"SOCS2, CRADD",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,12:93668412
rs111855470-<b>?</b>,3 x 10-6,,NR,'-,0.226 unit increase,[0.13-0.33],"LINC02463, MED13L",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,12:115929576
rs73169578-<b>?</b>,5 x 10-7,,NR,'-,0.224 unit decrease,[0.13-0.31],"SNORD27, IPPKP1",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,13:21120420
rs7339373-<b>?</b>,7 x 10-6,,NR,'-,0.106 unit increase,[0.055-0.157],LINC00378,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,13:60662221
rs913970-<b>?</b>,6 x 10-6,,NR,'-,0.221 unit increase,[0.13-0.32],UBBP5,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,13:87207797
rs56869057-<b>?</b>,9 x 10-6,,NR,'-,0.139 unit decrease,[0.072-0.206],"Y_RNA, SEC23A",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,14:39008792
rs4077265-<b>?</b>,9 x 10-6,,NR,'-,0.169 unit increase,[0.093-0.245],TRIM9,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,14:51064135
rs8006682-<b>?</b>,7 x 10-6,,NR,'-,0.138 unit increase,[0.087-0.189],RAD51B,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,14:68657043
rs73371357-<b>?</b>,3 x 10-6,,NR,'-,0.325 unit decrease,[0.17-0.48],LINC02325,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,14:97390041
rs6606859-<b>?</b>,2 x 10-7,,NR,'-,0.089 unit increase,[0.016-0.162],GABRG3,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,15:27032254
rs7495211-<b>?</b>,7 x 10-6,,NR,'-,0.268 unit decrease,[0.13-0.41],LINC02251,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,15:98016526
rs57545798-<b>?</b>,5 x 10-6,,NR,'-,0.139 unit decrease,[0.068-0.21],ADAMTS17,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,15:100110087
rs7501731-<b>?</b>,9 x 10-6,,NR,'-,0.38 unit increase,[0.21-0.55],"P2RX1, ATP2A3",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,17:3918004
rs77370764-<b>?</b>,7 x 10-6,,NR,'-,0.154 unit decrease,[0.078-0.23],"ANKFN1, RPL39P33",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,17:56557322
rs4459623-<b>?</b>,2 x 10-6,,NR,'-,0.261 unit decrease,[0.083-0.439],"DSG1, DSC1",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,18:31218470
rs76038129-<b>?</b>,9 x 10-6,,NR,'-,0.211 unit increase,[0.084-0.338],DTNA,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,18:34812280
rs28589923-<b>?</b>,2 x 10-6,,NR,'-,0.309 unit increase,[0.17-0.45],"DTNA, MAPRE2",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,18:34966632
rs9952051-<b>?</b>,5 x 10-6,,NR,'-,0.248 unit increase,[0.14-0.36],'-,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,18:65549989
rs62121679-<b>?</b>,4 x 10-6,,NR,'-,0.182 unit decrease,[0.11-0.26],GNG7,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,19:2529481
rs112073242-<b>?</b>,8 x 10-6,,NR,'-,0.227 unit decrease,[0.086-0.368],"ASPDH, LRRC4B",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,19:50515588
rs114927288-<b>?</b>,4 x 10-6,,NR,'-,0.213 unit increase,[0.12-0.31],"ZNF586, ZNF776",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,19:57764717
rs4640459-<b>?</b>,7 x 10-6,,NR,'-,0.113 unit decrease,[0.058-0.168],MIR8062,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,20:7467217
rs6033180-<b>?</b>,8 x 10-6,,NR,'-,0.224 unit increase,[0.13-0.32],PGAM3P,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,20:11563044
rs2427062-<b>?</b>,4 x 10-6,,NR,'-,0.116 unit decrease,[0.049-0.183],CDH4,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,20:61304093
rs115453770-<b>?</b>,5 x 10-6,,NR,'-,0.216 unit decrease,[0.098-0.334],RBBP8NL,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,20:62410436
rs8134546-<b>?</b>,4 x 10-7,,NR,'-,0.337 unit decrease,[0.18-0.49],LINC01426,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,21:34782568
rs139205844-<b>?</b>,3 x 10-6,,NR,'-,0.195 unit decrease,[0.075-0.315],MICAL3,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,22:17949180
rs139320-<b>?</b>,8 x 10-6,,NR,'-,0.174 unit increase,[0.1-0.248],"APOBEC3H, CBX7",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,22:39105191
rs58957777-<b>?</b>,7 x 10-6,,NR,'-,1.409 unit decrease,[0.58-2.24],POU2F1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,1:167398423
rs6688579-<b>?</b>,8 x 10-6,,NR,'-,1.13 unit increase,[0.47-1.79],ASTN1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,1:176922297
rs1532002-<b>?</b>,1 x 10-6,,NR,'-,1.066 unit increase,[0.53-1.61],LRP1B,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,2:140292500
rs75107833-<b>?</b>,8 x 10-6,,NR,'-,1.758 unit decrease,[0.83-2.69],OLA1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,2:174100883
rs6754498-<b>?</b>,6 x 10-7,,NR,'-,0.832 unit increase,[0.4-1.27],RPL21P32,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,2:185953121
rs138586319-<b>?</b>,4 x 10-6,,NR,'-,1.537 unit decrease,[0.74-2.33],"RBM44, RAMP1",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,2:237845060
rs6445525-<b>?</b>,9 x 10-6,,NR,'-,0.618 unit decrease,[0.23-1],MAGI1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,3:66007429
rs846178-<b>?</b>,2 x 10-6,,NR,'-,1.012 unit decrease,[0.45-1.57],RNF4,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,4:2483888
rs6446601-<b>?</b>,3 x 10-6,,NR,'-,0.428 unit increase,[0.16-0.7],ZBTB49,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,4:4298683
rs7689240-<b>?</b>,1 x 10-6,,NR,'-,0.607 unit decrease,[0.32-0.89],'-,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,4:35313869
rs5743605-<b>?</b>,4 x 10-6,,NR,'-,0.915 unit decrease,[0.41-1.42],TLR1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,4:38799424
rs111915800-<b>?</b>,7 x 10-6,,NR,'-,0.835 unit decrease,[0.37-1.3],ARL9,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,4:56521209
rs9715521-<b>?</b>,7 x 10-6,,NR,'-,0.668 unit increase,[0.25-1.09],LINC02619,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,4:58958769
rs116191236-<b>?</b>,9 x 10-6,,NR,'-,0.784 unit decrease,[0.32-1.25],RPS23P3,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,4:66384883
rs116376586-<b>?</b>,8 x 10-6,,NR,'-,0.928 unit decrease,[0.4-1.46],FSTL5,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,4:161712567
rs17295603-<b>?</b>,8 x 10-6,,NR,'-,1.185 unit decrease,[0.53-1.84],"HPGD, GLRA3",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,4:174540366
rs12040333-<b>?</b>,1 x 10-6,,NR,'-,0.179 unit decrease,[0.1-0.25],ST3GAL3,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,1:43848369
rs663970-<b>?</b>,9 x 10-6,,NR,'-,0.163 unit decrease,[0.09-0.236],"GUSBP1, CDH12",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,5:21665532
rs74910095-<b>?</b>,9 x 10-7,,NR,'-,0.302 unit decrease,[0.11-0.49],'-,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,5:63545132
rs73303785-<b>?</b>,3 x 10-6,,NR,'-,0.247 unit decrease,[0.13-0.36],LINC01847,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,5:159754803
rs61828378-<b>?</b>,7 x 10-6,,NR,'-,0.186 unit decrease,[0.1-0.27],CAPN9,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,1:230751478
rs6758955-<b>?</b>,8 x 10-6,,NR,'-,0.142 unit increase,[0.071-0.213],'-,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,Mapping not available
rs6730144-<b>?</b>,3 x 10-6,,NR,'-,0.156 unit increase,[0.076-0.236],"ZFYVE9P2, PSMC1P10",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,2:17307513
rs2680830-<b>?</b>,8 x 10-8,,NR,'-,0.176 unit decrease,[0.12-0.24],VSNL1,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,2:17596817
rs2862774-<b>?</b>,5 x 10-6,,NR,'-,0.16 unit increase,[0.086-0.234],IL36B,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,2:113040100
rs12623054-<b>?</b>,4 x 10-6,,NR,'-,0.127 unit increase,[0.056-0.198],"RN7SL283P, LINC01853",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,2:140015877
rs75107833-<b>?</b>,2 x 10-6,,NR,'-,0.336 unit decrease,[0.17-0.5],OLA1,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,2:174100883
rs7593919-<b>?</b>,5 x 10-6,,NR,'-,0.108 unit decrease,[0.039-0.177],IMPDH1P7,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,2:186954207
rs80176144-<b>?</b>,7 x 10-6,,NR,'-,0.399 unit decrease,[0.2-0.59],"DOCK10, CCDC195",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,2:224758388
rs10211205-<b>?</b>,2 x 10-6,,NR,'-,0.131 unit increase,[0.057-0.205],AGAP1,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,2:235708822
rs35061271-<b>?</b>,9 x 10-6,,NR,'-,0.181 unit decrease,[0.1-0.26],"LSM3, LINC01267",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,3:14283089
rs12715234-<b>?</b>,9 x 10-6,,NR,'-,0.211 unit decrease,[0.12-0.3],LINC01811,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,3:34017837
rs2046867-<b>?</b>,5 x 10-6,,NR,'-,0.328 unit increase,[0.19-0.47],"RNA5SP136, SHQ1",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,3:72731924
rs450495-<b>?</b>,3 x 10-6,,NR,'-,0.167 unit increase,[0.083-0.251],"CADM2, LINC02025",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,3:84956870
rs1404100-<b>?</b>,2 x 10-6,,NR,'-,0.158 unit decrease,[0.087-0.229],U7,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,3:99071923
rs6800780-<b>?</b>,9 x 10-6,,NR,'-,0.119 unit increase,[0.062-0.176],"NIT2, TBC1D23",Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,3:100327768
rs72928364-<b>?</b>,1 x 10-6,,NR,'-,0.18 unit decrease,[0.11-0.25],ABI3BP,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,3:100894935
rs74155456-<b>?</b>,2 x 10-6,,NR,'-,0.201 unit decrease,[0.095-0.307],LINC00845,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,10:61070020
rs3774830-<b>?</b>,3 x 10-6,,NR,'-,0.116 unit decrease,[0.061-0.171],STK32B,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,4:5438356
rs116731241-<b>?</b>,2 x 10-6,,NR,'-,1.427 unit increase,[0.7-2.16],RPL15P2,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,14:94850442
rs78450122-<b>?</b>,8 x 10-6,,NR,'-,0.961 unit increase,[0.29-1.63],RAB11FIP3,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,16:455954
rs288646-<b>?</b>,6 x 10-6,,NR,'-,1.35 unit decrease,[0.7-2],'-,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,16:62566885
rs115689251-<b>?</b>,1 x 10-6,,NR,'-,1.924 unit increase,[1-2.84],"CCL23, CCL18",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,17:36032377
rs60229149-<b>?</b>,4 x 10-6,,NR,'-,0.506 unit decrease,[0.23-0.78],ANKFN1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,17:56379283
rs9897733-<b>?</b>,9 x 10-6,,NR,'-,0.499 unit increase,[0.21-0.79],"RNA5SP447, PSMD12",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,17:67332883
rs6506900-<b>?</b>,7 x 10-7,,NR,'-,1.926 unit decrease,[0.89-2.96],"DSC1, DSG1",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,18:31226433
rs28589923-<b>?</b>,3 x 10-6,,NR,'-,1.479 unit increase,[0.71-2.25],"DTNA, MAPRE2",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,18:34966632
rs8103771-<b>?</b>,2 x 10-6,,NR,'-,0.741 unit increase,[0.35-1.13],MYADM-AS1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,19:53864343
rs149406809-<b>?</b>,8 x 10-6,,NR,'-,1.018 unit decrease,[0.45-1.58],CABLES2,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,20:62399351
rs139205844-<b>?</b>,7 x 10-6,,NR,'-,0.963 unit decrease,[0.33-1.6],MICAL3,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,22:17949180
rs188349311-<b>?</b>,4 x 10-6,,NR,'-,0.893 unit increase,[0.38-1.41],"FAM230I, LINC01659",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,22:23449031
rs2861451-<b>?</b>,3 x 10-6,,NR,'-,0.22 unit decrease,[0.1-0.34],POU2F1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,1:167343172
rs113533135-<b>?</b>,3 x 10-7,,NR,'-,0.189 unit increase,[0.091-0.287],LRP1B,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,2:140268867
rs16866369-<b>?</b>,7 x 10-6,,NR,'-,0.121 unit decrease,[0.056-0.186],TTN-AS1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,2:178524267
rs9973676-<b>?</b>,6 x 10-7,,NR,'-,0.202 unit decrease,[0.1-0.3],GPR55,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,2:230954091
rs162211-<b>?</b>,4 x 10-6,,NR,'-,0.147 unit increase,[0.067-0.227],GRM7,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,3:7781368
rs7632954-<b>?</b>,4 x 10-6,,NR,'-,0.089 unit increase,[0.04-0.138],LMCD1-AS1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,3:8486196
rs139034117-<b>?</b>,3 x 10-6,,NR,'-,0.178 unit decrease,[0.086-0.27],NFU1P1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,3:39656373
rs7620766-<b>?</b>,8 x 10-6,,NR,'-,0.128 unit increase,[0.057-0.199],ARHGEF3,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,3:56886346
rs77719492-<b>?</b>,4 x 10-6,,NR,'-,0.272 unit increase,[0.13-0.41],LINC01322,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,3:165346697
rs80183344-<b>?</b>,5 x 10-6,,NR,'-,0.153 unit decrease,[0.073-0.233],'-,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,4:32768534
rs74570061-<b>?</b>,1 x 10-6,,NR,'-,0.186 unit decrease,[0.096-0.276],ARL9,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,4:56517605
rs17865343-<b>?</b>,6 x 10-6,,NR,'-,0.198 unit decrease,[0.088-0.308],LINC02262,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,4:117351922
rs6451042-<b>?</b>,9 x 10-6,,NR,'-,0.154 unit decrease,[0.068-0.24],HSPD1P15,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,5:19210783
rs10079927-<b>?</b>,4 x 10-6,,NR,'-,0.204 unit increase,[0.086-0.322],GUSBP1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,5:21282998
rs7730262-<b>?</b>,4 x 10-6,,NR,'-,0.121 unit decrease,[0.041-0.201],"MEF2C-AS1, MEF2C",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,5:88892421
rs74409630-<b>?</b>,5 x 10-6,,NR,'-,0.278 unit decrease,[0.092-0.464],"CTBP2P4, MTCO1P24",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,5:98504497
rs6898559-<b>?</b>,5 x 10-7,,NR,'-,0.09 unit increase,[0.041-0.139],ALDH7A1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,5:126557237
rs2546338-<b>?</b>,7 x 10-6,,NR,'-,0.128 unit increase,[0.059-0.197],WSPAR,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,5:133866276
rs16879003-<b>?</b>,1 x 10-7,,NR,'-,0.194 unit decrease,[0.11-0.28],ATXN1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,6:16745008
rs12529540-<b>?</b>,7 x 10-6,,NR,'-,0.218 unit decrease,[0.11-0.33],STMND1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,6:17031825
rs115202710-<b>?</b>,7 x 10-6,,NR,'-,0.184 unit decrease,[0.066-0.302],ACOT13,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,6:24704340
rs190225848-<b>?</b>,5 x 10-6,,NR,'-,0.153 unit decrease,[0.053-0.253],"FAXC, BDH2P1",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,6:99252162
rs183838294-<b>?</b>,4 x 10-6,,NR,'-,0.189 unit increase,[0.093-0.285],'-,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,6:102343343
rs59490629-<b>?</b>,9 x 10-7,,NR,'-,0.16 unit increase,[0.076-0.244],PDSS2,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,6:107256268
rs114450476-<b>?</b>,6 x 10-6,,NR,'-,0.285 unit decrease,[0.077-0.493],VTA1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,6:142181498
rs91-<b>?</b>,7 x 10-7,,NR,'-,0.157 unit increase,[0.079-0.235],'-,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:24409992
rs73081523-<b>?</b>,6 x 10-6,,NR,'-,0.129 unit increase,[0.058-0.2],"ZNRF2, RPS27P16",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:30204283
rs7791980-<b>?</b>,8 x 10-6,,NR,'-,0.173 unit decrease,[0.083-0.263],"MINDY4, INMT-MINDY4",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:30846884
rs1583674-<b>?</b>,4 x 10-6,,NR,'-,0.146 unit decrease,[0.068-0.224],'-,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:47139764
rs113805659-<b>?</b>,1 x 10-7,,NR,'-,0.191 unit decrease,[0.11-0.27],MAGI2,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:78663475
rs113865535-<b>?</b>,6 x 10-6,,NR,'-,0.128 unit decrease,[0.057-0.199],CACNA2D1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:82295568
rs6944685-<b>?</b>,9 x 10-6,,NR,'-,0.161 unit increase,[0.055-0.267],'-,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:85727431
rs11509197-<b>?</b>,2 x 10-7,,NR,'-,0.133 unit decrease,[0.064-0.202],'-,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:118641356
rs7806345-<b>?</b>,4 x 10-6,,NR,'-,0.125 unit decrease,[0.054-0.196],"RPL7P59, EI24P4",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:145029551
rs7804216-<b>?</b>,1 x 10-6,,NR,'-,0.194 unit decrease,[0.1-0.29],ATP6V0E2,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:149941248
rs75785055-<b>?</b>,2 x 10-6,,NR,'-,0.211 unit increase,[0.11-0.32],MSRA,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,8:10174422
rs28448403-<b>?</b>,6 x 10-6,,NR,'-,0.131 unit increase,[0.057-0.205],FAM167A,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,8:11448055
rs141947670-<b>?</b>,5 x 10-6,,NR,'-,0.321 unit decrease,[0.15-0.5],PSD3,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,8:18584539
rs111594438-<b>?</b>,6 x 10-6,,NR,'-,0.748 unit increase,[0.32-1.18],EGFLAM,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,5:38444698
rs277939-<b>?</b>,3 x 10-6,,NR,'-,1.082 unit decrease,[0.49-1.67],BDP1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,5:71560551
rs74543823-<b>?</b>,2 x 10-6,,NR,'-,1.306 unit increase,[0.66-1.96],ELL2,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,5:95895062
rs73790215-<b>?</b>,6 x 10-6,,NR,'-,1.37 unit decrease,[0.56-2.18],"HSPA4, FSTL4",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,5:133121505
rs13175840-<b>?</b>,1 x 10-6,,NR,'-,0.809 unit increase,[0.35-1.27],WSPAR,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,5:133861647
rs73307775-<b>?</b>,4 x 10-6,,NR,'-,0.998 unit decrease,[0.46-1.54],"IL12B, UBLCP1",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,5:159299527
rs115395006-<b>?</b>,4 x 10-6,,NR,'-,1.264 unit decrease,[0.6-1.93],'-,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,6:86603212
rs17214144-<b>?</b>,1 x 10-6,,NR,'-,0.864 unit decrease,[0.45-1.28],OSBPL3,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,7:24846128
rs117854110-<b>?</b>,5 x 10-7,,NR,'-,2.739 unit decrease,[1.44-4.04],"EFCAB10, ATXN7L1",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,7:105603002
rs9641609-<b>?</b>,2 x 10-7,,NR,'-,0.936 unit decrease,[0.52-1.35],'-,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,7:118657790
rs6956570-<b>?</b>,9 x 10-6,,NR,'-,0.788 unit decrease,[0.36-1.22],KCND2,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,7:120181139
rs140365914-<b>?</b>,3 x 10-6,,NR,'-,0.502 unit decrease,[0.2-0.81],"INSIG1, BLACE",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,7:155314860
rs6993194-<b>?</b>,4 x 10-6,,NR,'-,1.93 unit decrease,[0.88-2.98],EYA1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,8:71117967
rs59811240-<b>?</b>,8 x 10-7,,NR,'-,1.356 unit decrease,[0.55-2.16],MTSS1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,8:124709787
rs6559463-<b>?</b>,9 x 10-6,,NR,'-,1.834 unit decrease,[0.76-2.91],'-,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,9:79179488
rs10123021-<b>?</b>,9 x 10-6,,NR,'-,0.721 unit increase,[0.33-1.11],ACTG1P19,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,9:100689786
rs10978777-<b>?</b>,1 x 10-7,,NR,'-,0.628 unit decrease,[0.31-0.95],RAD23B,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,9:107268309
rs10793968-<b>?</b>,5 x 10-6,,NR,'-,0.832 unit increase,[0.39-1.27],ABL1,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,9:130754074
rs74155456-<b>?</b>,1 x 10-6,,NR,'-,1.087 unit decrease,[0.54-1.63],LINC00845,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,10:61070020
rs73419826-<b>?</b>,4 x 10-6,,NR,'-,0.746 unit decrease,[0.34-1.15],"TEAD1, PARVA",Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,11:12624958
rs10896609-<b>?</b>,9 x 10-6,,NR,'-,0.646 unit increase,[0.28-1.01],P2RX3,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,11:57341899
rs597539-<b>?</b>,8 x 10-6,,NR,'-,1.948 unit decrease,[0.74-3.16],CPT1A,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,11:68834506
rs114223427-<b>?</b>,9 x 10-6,,NR,'-,0.619 unit decrease,[0.3-0.94],GRM5,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,11:88570609
rs189380010-<b>?</b>,8 x 10-6,,NR,'-,1.43 unit decrease,[0.6-2.26],LINC02405,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,12:126930445
rs543554-<b>?</b>,5 x 10-7,,NR,'-,0.993 unit increase,[0.42-1.56],FRY,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005174,13:32127501
rs629562-<b>?</b>,6 x 10-6,,NR,'-,0.116 unit decrease,[0.047-0.185],PTPRM,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,18:7751791
rs874536-<b>?</b>,8 x 10-6,,NR,'-,0.131 unit decrease,[0.06-0.202],PTPRM,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,18:8333854
rs6506897-<b>?</b>,5 x 10-7,,NR,'-,0.323 unit decrease,[0.14-0.5],DSC1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,18:31215320
rs408302-<b>?</b>,9 x 10-6,,NR,'-,0.109 unit increase,[0.04-0.178],GRIK1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,21:29828186
rs4819052-<b>?</b>,8 x 10-6,,NR,'-,0.132 unit increase,[0.059-0.205],POFUT2,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,21:45279862
rs1481805-<b>?</b>,1 x 10-6,,NR,'-,0.347 unit decrease,[0.16-0.53],EYA1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,8:71121190
rs73319666-<b>?</b>,3 x 10-6,,NR,'-,0.158 unit decrease,[0.074-0.242],"SAMD12-AS1, TNFRSF11B",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,8:118918785
rs75629841-<b>?</b>,1 x 10-6,,NR,'-,0.235 unit decrease,[0.096-0.374],MTSS1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,8:124714135
rs73414446-<b>?</b>,5 x 10-6,,NR,'-,0.39 unit decrease,[0.22-0.56],CNTLN,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,9:17456712
rs11794666-<b>?</b>,5 x 10-6,,NR,'-,0.123 unit increase,[0.052-0.194],HMGB3P23,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,9:31665127
rs191660985-<b>?</b>,7 x 10-6,,NR,'-,0.248 unit increase,[0.12-0.37],PTPN3,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,9:109377459
rs7901181-<b>?</b>,7 x 10-6,,NR,'-,0.138 unit decrease,[0.05-0.226],LINC02669,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,10:3600363
rs114408555-<b>?</b>,9 x 10-6,,NR,'-,0.219 unit decrease,[0.099-0.339],'-,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,10:8795875
rs73279468-<b>?</b>,7 x 10-6,,NR,'-,0.318 unit decrease,[0.13-0.5],"CUBNP2, RNU6-1207P",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,10:45227524
rs7088647-<b>?</b>,7 x 10-6,,NR,'-,0.174 unit decrease,[0.076-0.272],LINC01374,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,10:90012421
rs7906829-<b>?</b>,6 x 10-6,,NR,'-,0.139 unit decrease,[0.063-0.215],"PNLIPP1, PNLIPRP1",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,10:116588374
rs192211484-<b>?</b>,9 x 10-6,,NR,'-,0.343 unit decrease,[0.15-0.54],LINC00867,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,10:118452055
rs114031744-<b>?</b>,1 x 10-6,,NR,'-,0.229 unit decrease,[0.12-0.34],"GPR26, LINC02641",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,10:123610085
rs77934287-<b>?</b>,5 x 10-7,,NR,'-,0.376 unit decrease,[0.17-0.58],TBX5,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,12:23071319
rs80114852-<b>?</b>,9 x 10-6,,NR,'-,0.287 unit decrease,[0.13-0.44],RNU6-735P,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,12:95437900
rs448792-<b>?</b>,6 x 10-7,,NR,'-,0.211 unit increase,[0.11-0.31],FRY,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,13:32103287
rs9575182-<b>?</b>,6 x 10-6,,NR,'-,0.148 unit decrease,[0.066-0.23],GYG1P2,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,13:82832889
rs9555620-<b>?</b>,8 x 10-6,,NR,'-,0.31 unit decrease,[0.13-0.49],LINC00676,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,13:109653368
rs7158214-<b>?</b>,4 x 10-6,,NR,'-,0.133 unit increase,[0.06-0.206],"C14orf132, BDKRB2",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,14:96176310
rs34745104-<b>?</b>,9 x 10-6,,NR,'-,0.212 unit decrease,[0.087-0.337],LINC02691,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,14:104287049
rs7495517-<b>?</b>,8 x 10-6,,NR,'-,0.158 unit decrease,[0.042-0.274],GABRG3,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,15:27265527
rs77757620-<b>?</b>,4 x 10-7,,NR,'-,0.155 unit increase,[0.081-0.229],STARD9,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,15:42661399
rs16976116-<b>?</b>,8 x 10-6,,NR,'-,0.108 unit decrease,[0.035-0.181],RSL24D1,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,15:55188269
rs114625006-<b>?</b>,2 x 10-6,,NR,'-,0.197 unit increase,[0.085-0.309],MYO1E,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,15:59361839
rs115620807-<b>?</b>,7 x 10-6,,NR,'-,0.25 unit decrease,[0.11-0.39],"LINC00927, ARNT2",Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,15:80377010
rs7903146-<b>C</b>,1 x 10-9,,0.61,1.53,'-,[1.39-1.67],TCF7L2,Schizophrenia vs type 2 diabetes,"schizophrenia, type II diabetes mellitus",GCST007223,10:112998590
chr6:163319442-<b>G</b>,5 x 10-9,,0.91,3.81,'-,[3.32-4.29],'-,Schizophrenia and type 2 diabetes,"schizophrenia, type II diabetes mellitus",GCST007220,Mapping not available
rs1449245-<b>A</b>,3 x 10-8,,0.79,1.96,'-,[1.71-2.20],'-,Schizophrenia and type 2 diabetes,"schizophrenia, type II diabetes mellitus",GCST007220,8:92576112
rs6662618-<b>?</b>,3 x 10-10,,NR,'-,'-,[1.0965-1.1754],"RN7SL824P, GFI1",Multiple sclerosis and type 2 diabetes (pleiotropy),"multiple sclerosis, type II diabetes mellitus",GCST007120,1:92469854
rs11864333-<b>?</b>,8 x 10-6,,NR,'-,'-,[1.0444-1.1097],RMI2,Multiple sclerosis and type 2 diabetes (pleiotropy),"multiple sclerosis, type II diabetes mellitus",GCST007120,16:11381719
rs2857605-<b>C</b>,6 x 10-14,,0.210611041,'-,0.0672 unit decrease,[0.05-0.085],NFKBIL1,Type 2 diabetes,type II diabetes mellitus,GCST006867,6:31557074
rs1063355-<b>T</b>,4 x 10-19,,0.397563658,'-,0.0709 unit decrease,[0.055-0.086],"HLA-DQB1-AS1, HLA-DQB1",Type 2 diabetes,type II diabetes mellitus,GCST006867,6:32659937
rs2071479-<b>T</b>,7 x 10-11,,0.027361741,'-,0.1473 unit increase,[0.1-0.19],HLA-DOB,Type 2 diabetes,type II diabetes mellitus,GCST006867,6:32813335
rs174584-<b>?</b>,2 x 10-20,,NR,'-,'-,'-,FADS2,Adult onset asthma or type 2 diabetes,"adult onset asthma, type II diabetes mellitus",GCST009859,11:61843278
rs2185756-<b>?</b>,3 x 10-29,,NR,'-,'-,'-,"EIF2S2P3, HHEX",Adult onset asthma or type 2 diabetes,"adult onset asthma, type II diabetes mellitus",GCST009859,10:92670740
rs3104369-<b>?</b>,9 x 10-15,,NR,'-,'-,'-,HLA-DQA1,Adult onset asthma or type 2 diabetes,"adult onset asthma, type II diabetes mellitus",GCST009859,6:32634705
rs429358-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,'-,Adult onset asthma or type 2 diabetes,"adult onset asthma, type II diabetes mellitus",GCST009859,Mapping not available
rs4933236-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"EXOC6, Y_RNA",Adult onset asthma or type 2 diabetes,"adult onset asthma, type II diabetes mellitus",GCST009859,10:92738679
rs9275511-<b>?</b>,4 x 10-18,,NR,'-,'-,'-,MTCO3P1,Adult onset asthma or type 2 diabetes,"adult onset asthma, type II diabetes mellitus",GCST009859,6:32706552
rs11187027-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,IDE,Nonatopic asthma or type 2 diabetes,"type II diabetes mellitus, asthma",GCST009857,10:92499423
rs1512226-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,MIR4432HG,Nonatopic asthma or type 2 diabetes,"type II diabetes mellitus, asthma",GCST009857,2:60324666
rs174584-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,FADS2,Nonatopic asthma or type 2 diabetes,"type II diabetes mellitus, asthma",GCST009857,11:61843278
rs3768321-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"PABPC4, PABPC4-AS1",Nonatopic asthma or type 2 diabetes,"type II diabetes mellitus, asthma",GCST009857,1:39570256
rs849139-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,JAZF1,Nonatopic asthma or type 2 diabetes,"type II diabetes mellitus, asthma",GCST009857,7:28139777
rs2820446-<b>G</b>,3 x 10-12,,0.2863,'-,'-,'-,ZC3H11B,Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,1:219575476
rs1128249-<b>T</b>,3 x 10-11,,0.4344,'-,'-,'-,COBLL1,Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,2:164672114
rs2943652-<b>C</b>,4 x 10-20,,0.3748,'-,'-,'-,'-,Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,2:226243730
rs2881654-<b>A</b>,8 x 10-16,,0.1213,'-,'-,'-,PPARG,Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,3:12355456
rs11708067-<b>G</b>,2 x 10-14,,0.171,'-,'-,'-,ADCY5,Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,3:123346931
rs9686661-<b>C</b>,5 x 10-9,,0.8141,'-,'-,'-,C5orf67,Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,5:56565959
rs9385400-<b>T</b>,4 x 10-11,,0.5457,'-,'-,'-,"MIR588, CENPW",Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,6:126443044
rs4731702-<b>T</b>,5 x 10-9,,0.4493,'-,'-,'-,"H4P1, KLF14",Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,7:130748625
rs7896600-<b>G</b>,1 x 10-9,,0.7416,'-,'-,'-,CDC123,Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,10:12213176
rs7903146-<b>C</b>,7 x 10-77,,0.6829,'-,'-,'-,TCF7L2,Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,10:112998590
rs11603334-<b>A</b>,2 x 10-10,,0.1501,'-,'-,'-,ARAP1,Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,11:72721940
rs4672505-<b>A</b>,2 x 10-9,,'-,1.07,'-,'-,RN7SL51P,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,2:62333197
rs1990760-<b>T</b>,2 x 10-13,,'-,1.08,'-,'-,IFIH1,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,2:162267541
rs3906814-<b>C</b>,5 x 10-10,,'-,1.07,'-,'-,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,Mapping not available
rs771576-<b>C</b>,2 x 10-8,,'-,1.06,'-,'-,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,Mapping not available
rs1295685-<b>G</b>,2 x 10-14,,'-,1.1,'-,'-,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,Mapping not available
rs2233278-<b>C</b>,5 x 10-30,,'-,1.26,'-,'-,TNIP1,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,5:151087628
rs62377586-<b>G</b>,3 x 10-50,,'-,1.18,'-,'-,IL12B,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,5:159339014
rs6928012-<b>C</b>,2 x 10-13,,'-,1.08,'-,'-,CDKAL1,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,6:20728282
rs10484554-<b>T</b>,2 x 10-302,,'-,1.67,'-,'-,"HLA-B, LINC02571",Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,6:31306778
rs9481169-<b>T</b>,8 x 10-24,,'-,1.18,'-,'-,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,Mapping not available
rs610604-<b>G</b>,9 x 10-15,,'-,1.09,'-,'-,TNFAIP3,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,6:137878280
rs1838488-<b>C</b>,4 x 10-8,,'-,1.07,'-,'-,TMC1,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,9:72717879
rs1108617-<b>A</b>,3 x 10-11,,'-,1.07,'-,'-,ZMIZ1,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,10:79283816
rs10882102-<b>G</b>,2 x 10-20,,'-,1.1,'-,'-,"Y_RNA, HHEX",Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,10:92706738
rs35198068-<b>C</b>,5 x 10-65,,'-,1.21,'-,'-,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,Mapping not available
rs1648153-<b>G</b>,3 x 10-10,,'-,1.07,'-,'-,RDX,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,11:110088912
rs7108992-<b>A</b>,8 x 10-9,,'-,1.06,'-,'-,ETS1,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,11:128511972
rs111885088-<b>A</b>,4 x 10-13,,'-,1.17,'-,'-,"ANKRD52, COQ10A",Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,12:56263432
rs74899623-<b>G</b>,3 x 10-8,,'-,1.17,'-,'-,DLEU1,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,13:50220092
rs8016947-<b>G</b>,9 x 10-14,,'-,1.08,'-,'-,"NFKBIA, PSMA6",Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,14:35363460
rs413024-<b>A</b>,4 x 10-8,,'-,1.06,'-,'-,RMI2,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,16:11260234
rs4889526-<b>A</b>,6 x 10-11,,'-,1.07,'-,'-,"STX1B, STX4",Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,16:31019023
rs28998802-<b>A</b>,8 x 10-14,,'-,1.11,'-,'-,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,Mapping not available
rs34536443-<b>G</b>,2 x 10-25,,'-,1.38,'-,'-,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,Mapping not available
rs6063454-<b>G</b>,5 x 10-14,,'-,1.08,'-,'-,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,Mapping not available
rs10830963-<b>G</b> x rs116472028-<b>A</b>,2 x 10-7,,NR,'-,1.49 unit decrease,[0.92-2.06],MTNR1B x M1AP,"Type 2 diabetes (SNP x SNP interaction, 1df)",type II diabetes mellitus,GCST006494,11:92975544|2:74645439
rs10830963-<b>G</b> x rs16846841-<b>C</b>,7 x 10-7,,NR,'-,0.81 unit decrease,[0.5-1.12],MTNR1B x HECW2,"Type 2 diabetes (SNP x SNP interaction, 1df)",type II diabetes mellitus,GCST006494,11:92975544|2:196198526
rs10830963-<b>G</b> x rs17197883-<b>C</b>,1 x 10-8,,NR,'-,1.12 unit increase,[0.73-1.51],MTNR1B x CMIP,"Type 2 diabetes (SNP x SNP interaction, 1df)",type II diabetes mellitus,GCST006494,11:92975544|16:81489408
rs10830963-<b>G</b> x rs7228666-<b>G</b>,2 x 10-6,,NR,'-,0.68 unit increase,[0.41-0.95],MTNR1B x PRELID3A,"Type 2 diabetes (SNP x SNP interaction, 1df)",type II diabetes mellitus,GCST006494,11:92975544|18:12427119
rs10830963-<b>G</b> x rs1807685-<b>A</b>,3 x 10-6,,NR,'-,'-,'-,MTNR1B x CRYBB2 - IGLL3P,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|22:25243891
rs10830963-<b>G</b> x rs2291268-<b>A</b>,3 x 10-6,,NR,'-,'-,'-,MTNR1B x MMP19,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|12:55842259
rs10830963-<b>G</b> x rs1360814-<b>G</b>,3 x 10-6,,NR,'-,'-,'-,MTNR1B x LINC01038 - LINC00382,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|13:79829782
rs10830963-<b>G</b> x rs17197883-<b>C</b>,5 x 10-8,,NR,'-,'-,'-,MTNR1B x CMIP,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|16:81489408
rs10830963-<b>G</b> x rs7228666-<b>G</b>,4 x 10-6,,NR,'-,'-,'-,MTNR1B x PRELID3A,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|18:12427119
rs10830963-<b>G</b> x rs10412272-<b>T</b>,4 x 10-6,,NR,'-,'-,'-,MTNR1B x RPL7AP69 - USP29,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|19:57086516
rs10830963-<b>G</b> x rs58538128-<b>T</b>,4 x 10-6,,NR,'-,'-,'-,MTNR1B x FCGR3A - FCGR2C,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|1:161551068
rs10830963-<b>G</b> x rs6735529-<b>A</b>,5 x 10-6,,NR,'-,'-,'-,"MTNR1B x LINC01814, LINC00299","Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|2:8474254
rs10830963-<b>G</b> x rs79029870-<b>T</b>,1 x 10-6,,NR,'-,'-,'-,MTNR1B x MRPL50P1 - N/A,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|2:35773250
rs10830963-<b>G</b> x rs116472028-<b>A</b>,1 x 10-6,,NR,'-,'-,'-,MTNR1B x M1AP,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|2:74645439
rs10830963-<b>G</b> x rs16846841-<b>C</b>,4 x 10-6,,NR,'-,'-,'-,MTNR1B x HECW2,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|2:196198526
rs10830963-<b>G</b> x rs115597883-<b>T</b>,3 x 10-6,,NR,'-,'-,'-,MTNR1B x SLC19A3,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|2:227694473
rs10830963-<b>G</b> x rs9842579-<b>T</b>,2 x 10-6,,NR,'-,'-,'-,MTNR1B x NAALADL2,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|3:174982802
rs10830963-<b>G</b> x rs10866267-<b>T</b>,2 x 10-6,,NR,'-,'-,'-,MTNR1B x MYL12BP2 - LINC02363,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|4:184318008
rs10830963-<b>G</b> x rs73659516-<b>C</b>,1 x 10-6,,NR,'-,'-,'-,MTNR1B,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|8:2729847
rs10830963-<b>G</b> x rs2924879-<b>A</b>,2 x 10-6,,NR,'-,'-,'-,MTNR1B x N/A - CSMD1,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|8:2844694
rs10830963-<b>G</b> x rs1369455-<b>A</b>,2 x 10-6,,NR,'-,'-,'-,MTNR1B x YTHDF3,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|8:63170404
rs10830963-<b>G</b> x rs4739079-<b>T</b>,4 x 10-6,,NR,'-,'-,'-,MTNR1B x RN7SL135P - N/A,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|8:63288263
rs10830963-<b>G</b> x rs16870669-<b>G</b>,5 x 10-6,,NR,'-,'-,'-,MTNR1B x RIMS2,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|8:103761233
rs10830963-<b>G</b> x rs6043626-<b>C</b>,2 x 10-6,,NR,'-,'-,'-,MTNR1B x MACROD2,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|20:15935547
rs10830963-<b>G</b> x rs2836995-<b>G</b>,3 x 10-7,,NR,'-,'-,'-,MTNR1B x RNF6P1,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|21:39376875
rs10830963-<b>G</b> x rs7903146-<b>T</b>,5 x 10-11,,NR,'-,'-,'-,MTNR1B x TCF7L2,"Type 2 diabetes (SNP x SNP interaction, 2df)",type II diabetes mellitus,GCST006495,11:92975544|10:112998590
rs10830963-<b>G</b> x rs73659517-<b>G</b>,9 x 10-6,,NR,'-,0.88 unit decrease,[0.49-1.27],MTNR1B,"Type 2 diabetes (SNP x SNP interaction, 1df)",type II diabetes mellitus,GCST006494,11:92975544|8:2729924
rs10830963-<b>G</b> x rs2924879-<b>A</b>,7 x 10-7,,NR,'-,0.59 unit decrease,[0.35-0.83],MTNR1B x N/A - CSMD1,"Type 2 diabetes (SNP x SNP interaction, 1df)",type II diabetes mellitus,GCST006494,11:92975544|8:2844694
rs10830963-<b>G</b> x rs4818032-<b>C</b>,3 x 10-7,,NR,'-,0.61 unit decrease,[0.37-0.85],MTNR1B x RNF6P1,"Type 2 diabetes (SNP x SNP interaction, 1df)",type II diabetes mellitus,GCST006494,11:92975544|21:39375657
rs62069176-<b>T</b>,3 x 10-7,,0.7,1.5873016,'-,'-,RTN4RL1,Type 2 diabetes,type II diabetes mellitus,GCST005912,17:1962297
rs2581685-<b>A</b>,3 x 10-6,,0.78,1.46,'-,'-,"LINC01910, LARP7P3",Type 2 diabetes,type II diabetes mellitus,GCST005912,18:70391003
rs6557473-<b>A</b>,3 x 10-6,,0.3,1.36,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST005912,6:156146708
rs2459446-<b>C</b>,2 x 10-12,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs12265333-<b>A</b>,1 x 10-9,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs35198068-<b>C</b>,9 x 10-48,,NR,1.18,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs5215-<b>C</b>,1 x 10-11,,NR,1.07,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs685870-<b>T</b>,1 x 10-11,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs4561177-<b>A</b>,4 x 10-10,,NR,1.07,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs10893884-<b>T</b>,4 x 10-10,,NR,1.07,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs76895963-<b>T</b>,4 x 10-9,,NR,1.39,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs57137641-<b>G</b>,5 x 10-15,,NR,1.18,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs653178-<b>C</b>,5 x 10-8,,NR,1.06,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs9591325-<b>T</b>,2 x 10-10,,NR,1.14,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs12884468-<b>C</b>,2 x 10-12,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs2199036-<b>T</b>,5 x 10-10,,NR,1.07,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs17817712-<b>G</b>,2 x 10-9,,NR,1.06,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs28998802-<b>A</b>,1 x 10-14,,NR,1.12,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs2292749-<b>T</b>,2 x 10-9,,NR,1.07,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs34536443-<b>G</b>,8 x 10-29,,NR,1.41,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs6063454-<b>G</b>,1 x 10-14,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs4649201-<b>G</b>,3 x 10-11,,'-,1.11,'-,'-,IFNLR1,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,1:24182945
rs6672420-<b>T</b>,3 x 10-12,,'-,1.07,'-,'-,RUNX3,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,1:24964519
rs113935720-<b>T</b>,2 x 10-15,,'-,1.19,'-,'-,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,Mapping not available
rs11205044-<b>C</b>,2 x 10-14,,'-,1.09,'-,'-,"LCE3B, LCE3A",Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,1:152620961
rs340874-<b>C</b>,3 x 10-8,,'-,1.06,'-,'-,"PROX1-AS1, PROX1",Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,1:213985913
rs6544662-<b>C</b>,3 x 10-8,,'-,1.1,'-,'-,THADA,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,2:43484954
rs35741374-<b>T</b>,7 x 10-14,,'-,1.08,'-,'-,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),"psoriasis, type II diabetes mellitus",GCST011990,Mapping not available
rs438650-<b>C</b>,2 x 10-8,,NR,1.07,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs78312791-<b>C</b>,2 x 10-13,,NR,1.12,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs11249215-<b>A</b>,7 x 10-14,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs113935720-<b>T</b>,4 x 10-13,,NR,1.18,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs6677595-<b>T</b>,1 x 10-13,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs35741374-<b>T</b>,1 x 10-13,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs840967-<b>C</b>,1 x 10-8,,NR,1.06,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs2111485-<b>A</b>,3 x 10-13,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs7607980-<b>T</b>,2 x 10-8,,NR,1.11,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs3906814-<b>C</b>,3 x 10-8,,NR,1.06,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs771576-<b>C</b>,5 x 10-9,,NR,1.06,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs4686392-<b>G</b>,1 x 10-11,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs39841-<b>G</b>,2 x 10-11,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs1295685-<b>A</b>,5 x 10-13,,NR,1.1,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs75851973-<b>G</b>,3 x 10-35,,NR,1.28,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs12188300-<b>T</b>,2 x 10-56,,NR,1.31,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs7756992-<b>G</b>,2 x 10-20,,NR,1.11,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs13214872-<b>G</b>,2 x 10-302,,NR,1.67,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs9481169-<b>T</b>,1 x 10-22,,NR,1.18,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs582757-<b>C</b>,3 x 10-13,,NR,1.08,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs849135-<b>G</b>,5 x 10-10,,NR,1.06,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs9650069-<b>C</b>,1 x 10-8,,NR,1.07,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs10811660-<b>G</b>,1 x 10-11,,NR,1.11,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs11795343-<b>T</b>,1 x 10-10,,NR,1.07,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs10761661-<b>C</b>,3 x 10-8,,NR,1.06,'-,NR,'-,Psoriasis or type 2 diabetes (trans-disease meta-analysis),"psoriasis, type II diabetes mellitus",GCST011991,Mapping not available
rs3184504-<b>?</b>,1 x 10-31,,0.49,1.3109596,'-,'-,"SH2B3, ATXN2",Type 1 diabetes,type II diabetes mellitus,GCST009875,12:111446804
rs4244808-<b>G</b>,4 x 10-27,,0.46,1.28,'-,'-,"INS-IGF2, IGF2-AS",Type 1 diabetes,type II diabetes mellitus,GCST009875,11:2141880
rs7202844-<b>G</b>,2 x 10-20,,0.087,1.411,'-,'-,"CTRB1, CTRB2",Type 1 diabetes,type II diabetes mellitus,GCST009875,16:75213493
rs11171739-<b>C</b>,1 x 10-18,,0.43,1.225,'-,'-,ERBB3,Type 1 diabetes,type II diabetes mellitus,GCST009875,12:56076841
rs3087243-<b>?</b>,2 x 10-16,,0.55,1.2083132,'-,'-,"CTLA4, ICOS",Type 1 diabetes,type II diabetes mellitus,GCST009875,2:203874196
rs741172-<b>?</b>,2 x 10-16,,0.69,1.2268434,'-,'-,CLEC16A,Type 1 diabetes,type II diabetes mellitus,GCST009875,16:11106941
rs2542148-<b>C</b>,3 x 10-16,,0.166,1.27,'-,'-,"PTPN2, LINC01882",Type 1 diabetes,type II diabetes mellitus,GCST009875,18:12777574
rs984971-<b>?</b>,3 x 10-14,,0.64,1.201057,'-,'-,GCA,Type 1 diabetes,type II diabetes mellitus,GCST009875,2:162368011
rs9981624-<b>C</b>,2 x 10-12,,0.334,1.184,'-,'-,UBASH3A,Type 1 diabetes,type II diabetes mellitus,GCST009875,21:42405613
rs12416116-<b>?</b>,7 x 10-12,,0.3,1.1927481,'-,'-,RNLS,Type 1 diabetes,type II diabetes mellitus,GCST009875,10:88275897
rs34593439-<b>?</b>,1 x 10-11,,0.15,1.3066771,'-,'-,CTSH,Type 1 diabetes,type II diabetes mellitus,GCST009875,15:78942615
rs72928038-<b>A</b>,1 x 10-11,,0.177,1.217,'-,'-,BACH2,Type 1 diabetes,type II diabetes mellitus,GCST009875,6:90267049
rs35667974-<b>?</b>,1 x 10-11,,0.978,1.9022256,'-,'-,IFIH1,Type 1 diabetes,type II diabetes mellitus,GCST009875,2:162268127
rs4336042-<b>G</b>,2 x 10-11,,0.389,1.168,'-,'-,HORMAD2,Type 1 diabetes,type II diabetes mellitus,GCST009875,22:30156522
rs151234-<b>C</b>,1 x 10-10,,0.129,1.235,'-,'-,CLN3,Type 1 diabetes,type II diabetes mellitus,GCST009875,16:28494339
rs3118470-<b>C</b>,1 x 10-10,,0.32,1.175,'-,'-,IL2RA,Type 1 diabetes,type II diabetes mellitus,GCST009875,10:6059750
rs3024493-<b>?</b>,5 x 10-10,,0.84,1.2244399,'-,'-,IL10,Type 1 diabetes,type II diabetes mellitus,GCST009875,1:206770623
rs74956615-<b>?</b>,5 x 10-10,,0.943,1.3984058,'-,'-,RAVER1,Type 1 diabetes,type II diabetes mellitus,GCST009875,19:10317045
rs1893592-<b>?</b>,2 x 10-9,,0.7,1.1625204,'-,'-,UBASH3A,Type 1 diabetes,type II diabetes mellitus,GCST009875,21:42434957
rs2045258-<b>G</b>,2 x 10-9,,0.449,1.146,'-,'-,CENPW,Type 1 diabetes,type II diabetes mellitus,GCST009875,6:126353208
rs72776098-<b>?</b>,6 x 10-9,,0.975,1.6363933,'-,'-,"RBM17, RPL32P23",Type 1 diabetes,type II diabetes mellitus,GCST009875,10:6074291
rs7780389-<b>?</b>,6 x 10-9,,0.952,1.4112335,'-,'-,COBL,Type 1 diabetes,type II diabetes mellitus,GCST009875,7:50947496
rs229533-<b>C</b>,7 x 10-9,,0.433,1.142,'-,'-,C1QTNF6,Type 1 diabetes,type II diabetes mellitus,GCST009875,22:37191071
rs1217403-<b>?</b>,4 x 10-8,,0.75,1.1566043,'-,'-,PTPN22,Type 1 diabetes,type II diabetes mellitus,GCST009875,1:113846182
rs2476601-<b>A</b>,1 x 10-91,,0.096,2.004,'-,'-,PTPN22,Type 1 diabetes,type II diabetes mellitus,GCST009875,1:113834946
rs7937915-<b>?</b>,4 x 10-79,,0.75,1.6963528,'-,'-,"ASCL2, MIR4686",Type 1 diabetes,type II diabetes mellitus,GCST009875,11:2193158
rs34766496-<b>A</b>,4 x 10-6,,NR,2.3,'-,[1.61-3.29],ARAP2,Diabetic retinopathy in type 2 diabetes,"diabetic retinopathy, type II diabetes mellitus",GCST009840,4:35995088
rs62328468-<b>T</b>,4 x 10-6,,NR,2.21,'-,[1.58-3.09],"GUCY1B1, ASIC5",Diabetic retinopathy in type 2 diabetes,"diabetic retinopathy, type II diabetes mellitus",GCST009840,4:155813921
rs1894151-<b>G</b>,3 x 10-6,,NR,3.96,'-,[2.23-7.03],"LINC01539, LINC01905",Diabetic retinopathy in type 2 diabetes,"diabetic retinopathy, type II diabetes mellitus",GCST009840,18:56096220
rs4616635-<b>G</b>,2 x 10-12,,0.2664,'-,'-,'-,ADAMTS9-AS2,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,3:64716599
rs11708067-<b>G</b>,5 x 10-12,,0.171,'-,'-,'-,ADCY5,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,3:123346931
rs4481184-<b>C</b>,5 x 10-22,,0.6958,'-,'-,'-,IGF2BP2,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,3:185787999
rs3776717-<b>G</b>,2 x 10-8,,0.7197,'-,'-,'-,ARL15,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,5:54002932
rs864745-<b>T</b>,9 x 10-12,,0.4801,'-,'-,'-,JAZF1,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,7:28140937
rs7903146-<b>C</b>,2 x 10-77,,0.6829,'-,'-,'-,TCF7L2,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,10:112998590
rs7928810-<b>A</b>,2 x 10-12,,0.6392,'-,'-,'-,"NCR3LG1, NUCB2",Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,11:17350896
rs11603334-<b>A</b>,2 x 10-11,,0.1501,'-,'-,'-,ARAP1,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,11:72721940
rs12454712-<b>C</b>,3 x 10-8,,0.3857,'-,'-,'-,BCL2,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,18:63178651
rs1010447-<b>T</b>,2 x 10-8,,0.2763,'-,'-,'-,MTOR,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,1:11209739
rs3789588-<b>A</b>,3 x 10-9,,0.0964,'-,'-,'-,FAF1,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,1:50800851
rs1128249-<b>T</b>,4 x 10-10,,0.4344,'-,'-,'-,COBLL1,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,2:164672114
rs2943652-<b>C</b>,1 x 10-12,,0.3748,'-,'-,'-,'-,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,2:226243730
rs2881654-<b>A</b>,9 x 10-14,,0.1213,'-,'-,'-,PPARG,Body mass index and type 2 diabetes (pairwise),"type II diabetes mellitus, body mass index",GCST011329,3:12355456
rs2881654-<b>A</b>,9 x 10-12,,0.1213,'-,'-,'-,PPARG,Waist-hip ratio and type 2 diabetes (pairwise),"waist-hip ratio, type II diabetes mellitus",GCST011321,3:12355456
rs459193-<b>A</b>,1 x 10-15,,0.2913,'-,'-,'-,"C5orf67, RPL26P19",Waist-hip ratio and type 2 diabetes (pairwise),"waist-hip ratio, type II diabetes mellitus",GCST011321,5:56510924
rs13417783-<b>?</b>,8 x 10-12,(EA),NR,1.5873016,'-,[1.39-1.82],'-,Diabetic peripheral neuropathy in type 2 diabetes,"peripheral neuropathy, type II diabetes mellitus",GCST008223,2:166773339
rs1202660-<b>?</b>,3 x 10-6,(EA),NR,1.3333333,'-,[1.18-1.49],GALNT17,Diabetic peripheral neuropathy in type 2 diabetes,"peripheral neuropathy, type II diabetes mellitus",GCST008223,7:71193191
rs11073752-<b>?</b>,7 x 10-7,(EA),NR,1.3157895,'-,[1.18-1.47],NTRK3,Diabetic peripheral neuropathy in type 2 diabetes,"peripheral neuropathy, type II diabetes mellitus",GCST008223,15:87879820
rs9948095-<b>?</b>,5 x 10-6,(EA),NR,1.369863,'-,[1.19-1.56],IMPA2,Diabetic peripheral neuropathy in type 2 diabetes,"peripheral neuropathy, type II diabetes mellitus",GCST008223,18:12018666
rs10555080-<b>A</b>,3 x 10-7,(EA),0.3,1.34,'-,[1.20-1.50],LINC02841,Diabetic peripheral neuropathy in type 2 diabetes,"peripheral neuropathy, type II diabetes mellitus",GCST008223,19:31552265
rs66502159-<b>C</b>,1 x 10-7,,NR,1.1488943,'-,'-,"CTRB1, CTRB2",Type 2 diabetes,type II diabetes mellitus,GCST005414,16:75212039
chr11:72470915-<b>GGTTT</b>,2 x 10-6,,NR,1.1167247,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST005414,Mapping not available
rs11616380-<b>G</b>,1 x 10-7,,NR,1.0974618,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST005414,13:80131180
chr5:53307054-<b>GAATTC</b>,2 x 10-7,,NR,1.0900244,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST005414,Mapping not available
chr7:130446737-<b>AAG</b>,8 x 10-6,,NR,1.0879552,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST005414,Mapping not available
rs340874-<b>C</b>,1 x 10-7,,NR,1.0869565,'-,'-,"PROX1-AS1, PROX1",Type 2 diabetes,type II diabetes mellitus,GCST005414,1:213985913
rs2396083-<b>G</b>,1 x 10-6,,NR,1.0869565,'-,'-,"LINC02537, VEGFA",Type 2 diabetes,type II diabetes mellitus,GCST005414,6:43837071
rs12912009-<b>G</b>,4 x 10-6,,NR,1.0840456,'-,'-,"AP3S2, ARPIN-AP3S2",Type 2 diabetes,type II diabetes mellitus,GCST005414,15:89885916
rs2358954-<b>G</b>,3 x 10-6,,NR,1.0825291,'-,'-,"MIR6074, HMGA2",Type 2 diabetes,type II diabetes mellitus,GCST005414,12:65985724
rs10011174-<b>G</b>,8 x 10-6,,NR,1.0790704,'-,'-,"RPS3AP18, TMEM154",Type 2 diabetes,type II diabetes mellitus,GCST005414,4:152574363
rs7589501-<b>A</b>,5 x 10-6,,NR,1.0747628,'-,'-,MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST005414,2:60330570
rs10771367-<b>T</b>,3 x 10-6,,NR,1.077992,'-,'-,"KLHL42, RN7SKP15",Type 2 diabetes,type II diabetes mellitus,GCST005414,12:27805180
rs1002061-<b>A</b>,2 x 10-6,,NR,1.0789626,'-,'-,GTF3AP5,Type 2 diabetes,type II diabetes mellitus,GCST005414,7:14999874
rs11708067-<b>A</b>,3 x 10-6,,NR,1.09,'-,'-,ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST005414,3:123346931
rs4234733-<b>A</b>,7 x 10-8,,NR,1.0902424,'-,'-,"WFS1, PPP2R2C",Type 2 diabetes,type II diabetes mellitus,GCST005414,4:6314654
rs7113297-<b>T</b>,4 x 10-7,,NR,1.1118219,'-,'-,"SNRPGP16, MTNR1B",Type 2 diabetes,type II diabetes mellitus,GCST005414,11:92938578
rs703983-<b>A</b>,5 x 10-6,,NR,1.1341687,'-,'-,ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST005414,10:79182128
rs10404333-<b>A</b>,1 x 10-6,,NR,1.1468282,'-,'-,"RN7SL836P, GIPR",Type 2 diabetes,type II diabetes mellitus,GCST005414,19:45657402
rs2820443-<b>T</b>,3 x 10-8,,NR,1.07,'-,[1.04-1.09],ZC3H11B,Type 2 diabetes,type II diabetes mellitus,GCST005414,1:219580167
rs505922-<b>C</b>,5 x 10-8,,NR,1.06,'-,[1.04-1.09],ABO,Type 2 diabetes,type II diabetes mellitus,GCST005414,9:133273813
rs3794205-<b>G</b>,4 x 10-8,,NR,1.07,'-,[1.04-1.10],CAMKK2,Type 2 diabetes,type II diabetes mellitus,GCST005414,12:121249126
rs12453394-<b>A</b>,3 x 10-8,,NR,1.07,'-,[1.05-1.10],UBE2Z,Type 2 diabetes,type II diabetes mellitus,GCST005414,17:48917608
rs757110-<b>C</b>,7 x 10-8,,NR,1.09,'-,'-,ABCC8,Type 2 diabetes,type II diabetes mellitus,GCST005414,11:17396930
rs6986080-<b>G</b>,2 x 10-6,,NR,1.09,'-,'-,"GPAT4, NKX6-3",Type 2 diabetes,type II diabetes mellitus,GCST005414,8:41630519
rs2642587-<b>G</b>,8 x 10-9,,NR,1.12,'-,[1.08-1.16],"LINC02651, RPL5P26",Type 2 diabetes,type II diabetes mellitus,GCST005413,10:69706172
rs34872471-<b>C</b>,1 x 10-94,,NR,1.4231888,'-,'-,TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST005413,10:112994312
rs71304101-<b>G</b>,4 x 10-16,,NR,1.2229916,'-,'-,PPARG,Type 2 diabetes,type II diabetes mellitus,GCST005413,3:12355414
rs10811662-<b>G</b>,1 x 10-13,,NR,1.1729243,'-,'-,CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST005413,9:22134254
rs1708302-<b>C</b>,3 x 10-19,,NR,1.1503888,'-,'-,JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST005413,7:28159058
rs13266634-<b>C</b>,3 x 10-15,,NR,1.1476312,'-,'-,SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST005413,8:117172544
rs4607103-<b>C</b>,1 x 10-7,,NR,1.1014197,'-,'-,ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST005413,3:64726228
rs1563575-<b>A</b>,6 x 10-8,,NR,1.100759,'-,'-,RBMS1,Type 2 diabetes,type II diabetes mellitus,GCST005413,2:160275183
rs3768321-<b>T</b>,9 x 10-9,,NR,1.118625,'-,'-,"PABPC4, PABPC4-AS1",Type 2 diabetes,type II diabetes mellitus,GCST005413,1:39570256
rs11257655-<b>T</b>,4 x 10-10,,NR,1.1279479,'-,'-,"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST005413,10:12265895
rs3843467-<b>T</b>,2 x 10-10,,NR,1.1300931,'-,'-,C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST005413,5:56560548
rs71320321-<b>A</b>,5 x 10-16,,NR,1.1456819,'-,'-,IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST005413,3:185801319
rs115918645-<b>A</b>,1 x 10-11,,NR,1.14,'-,'-,HLA-DRB9,Type 2 diabetes,type II diabetes mellitus,GCST005413,6:32460338
rs35261542-<b>A</b>,2 x 10-14,,NR,1.1423643,'-,'-,CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST005413,6:20675561
rs6743071-<b>T</b>,6 x 10-10,,NR,1.1863722,'-,'-,THADA,Type 2 diabetes,type II diabetes mellitus,GCST005413,2:43359148
rs75432112-<b>A</b>,4 x 10-7,,NR,1.1985351,'-,'-,"PPIP5K2, MACIR",Type 2 diabetes,type II diabetes mellitus,GCST005413,5:103250706
rs115884658-<b>A</b>,3 x 10-10,,NR,1.21,'-,[1.14-1.29],EHMT2,Type 2 diabetes,type II diabetes mellitus,GCST005899,6:31896761
rs146662075-<b>T</b>,8 x 10-9,,NR,1.95,'-,[1.56-2.45],'-,Type 2 diabetes,type II diabetes mellitus,GCST005898,X:116277556
rs8192675-<b>C</b>,7 x 10-14,(EA),'-,'-,0.17 unit increase,[0.13-0.21],SLC2A2,Response to metformin in type 2 diabetes (HbA1c reduction),"HbA1c measurement, type II diabetes mellitus, response to metformin",GCST004522,3:171007094
rs6813195-<b>T</b>,7 x 10-9,(EA),0.2913,'-,0.0639 unit decrease,[0.042-0.085],"TMEM154, RPS3AP18",Type 2 diabetes,type II diabetes mellitus,GCST004894,4:152599323
rs231362-<b>G</b>,4 x 10-9,(EA),0.498,'-,0.0679 unit increase,[0.045-0.09],"KCNQ1OT1, KCNQ1",Type 2 diabetes,type II diabetes mellitus,GCST004894,11:2670241
rs2237892-<b>T</b>,1 x 10-9,(EA),0.0626,'-,0.1389 unit decrease,[0.094-0.183],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST004894,11:2818521
rs163184-<b>G</b>,5 x 10-14,(EA),0.493,'-,0.079 unit increase,[0.058-0.1],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,Mapping not available
rs5215-<b>T</b>,8 x 10-14,(EA),0.6471,'-,0.0754 unit decrease,[0.056-0.095],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,Mapping not available
rs329122-<b>A</b>,6 x 10-6,(EA),0.4274,'-,0.0454 unit increase,[0.026-0.065],JADE2,Type 2 diabetes,type II diabetes mellitus,GCST004894,5:134528909
rs10830963-<b>G</b>,3 x 10-16,(EA),0.2883,'-,0.094 unit increase,[0.071-0.117],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST004894,11:92975544
rs11063069-<b>G</b>,2 x 10-8,(EA),0.2018,'-,0.0736 unit increase,[0.048-0.099],CCND2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:4265207
rs3130501-<b>G</b>,6 x 10-9,(EA),0.7833,'-,0.0693 unit increase,[0.046-0.093],POU5F1,Type 2 diabetes,type II diabetes mellitus,GCST004894,6:31168676
rs2050188-<b>T</b>,9 x 10-6,(EA),0.673,'-,0.0509 unit increase,[0.028-0.073],TSBP1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004894,6:32372120
rs4897182-<b>G</b>,2 x 10-7,(EA),0.4553,'-,0.0513 unit increase,[0.032-0.071],"MIR588, CENPW",Type 2 diabetes,type II diabetes mellitus,GCST004894,6:126434496
rs17168486-<b>T</b>,2 x 10-12,(EA),0.166,'-,0.0928 unit increase,[0.067-0.119],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST004894,7:14858657
rs2191349-<b>T</b>,1 x 10-6,(EA),0.505,'-,0.0497 unit increase,[0.03-0.07],GTF3AP5,Type 2 diabetes,type II diabetes mellitus,GCST004894,7:15024684
rs864745-<b>C</b>,8 x 10-18,(EA),0.5199,'-,0.0851 unit decrease,[0.066-0.105],JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST004894,7:28140937
rs4607517-<b>A</b>,6 x 10-6,(EA),0.1759,'-,0.0648 unit increase,[0.037-0.093],GCK,Type 2 diabetes,type II diabetes mellitus,GCST004894,7:44196069
rs9648716-<b>T</b>,4 x 10-7,(EA),0.1531,'-,0.0759 unit increase,[0.047-0.105],BRAF,Type 2 diabetes,type II diabetes mellitus,GCST004894,7:140912363
rs516946-<b>C</b>,5 x 10-11,(EA),0.7694,'-,0.0778 unit increase,[0.054-0.101],ANK1,Type 2 diabetes,type II diabetes mellitus,GCST004894,8:41661730
rs2925979-<b>C</b>,8 x 10-7,(EA),0.7117,'-,0.0554 unit decrease,[0.033-0.077],CMIP,Type 2 diabetes,type II diabetes mellitus,GCST004894,16:81501185
rs12970134-<b>A</b>,5 x 10-10,(EA),0.2674,'-,0.0714 unit increase,[0.049-0.094],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST004894,18:60217517
rs11873305-<b>C</b>,5 x 10-7,(EA),0.0308,'-,0.1442 unit decrease,[0.088-0.2],MC4R,Type 2 diabetes,type II diabetes mellitus,GCST004894,18:60381959
rs10811661-<b>C</b>,1 x 10-30,(EA),0.168,'-,0.1563 unit decrease,[0.13-0.18],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004894,9:22134095
rs13292136-<b>T</b>,4 x 10-6,(EA),0.0646,'-,0.1294 unit decrease,[0.074-0.184],CHCHD2P9,Type 2 diabetes,type II diabetes mellitus,GCST004894,9:79337213
rs2796441-<b>A</b>,8 x 10-10,(EA),0.4155,'-,0.064 unit decrease,[0.044-0.084],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST004894,9:81694033
rs11257655-<b>T</b>,3 x 10-10,(EA),0.2266,'-,0.0773 unit increase,[0.053-0.101],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST004894,10:12265895
rs12571751-<b>G</b>,3 x 10-11,(EA),0.4503,'-,0.0664 unit decrease,[0.047-0.086],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST004894,10:79182874
rs1111875-<b>T</b>,3 x 10-26,(EA),0.4245,'-,0.1066 unit decrease,[0.087-0.126],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST004894,10:92703125
rs7903146-<b>T</b>,2 x 10-184,(EA),0.3171,'-,0.3286 unit increase,[0.31-0.35],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST004894,10:112998590
rs188247550-<b>T</b>,5 x 10-6,,0.0195,1.15,'-,[1.08-1.22],SUGP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:19285807
rs10406327-<b>C</b>,4 x 10-8,,0.5226,1.04,'-,[1.02-1.05],PEPD,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:33399932
rs745903616-<b>A</b>,8 x 10-6,,0.0013,1.61,'-,[1.30-1.98],ZNF229,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:44434695
rs429358-<b>T</b>,3 x 10-18,,0.8458,1.08,'-,[1.06-1.10],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,Mapping not available
rs10406431-<b>A</b>,1 x 10-13,,0.5625,1.05,'-,[1.04-1.06],"RN7SL836P, GIPR",Type 2 diabetes,type II diabetes mellitus,GCST009379,19:45653761
rs2238689-<b>C</b>,5 x 10-9,,0.4177,1.04,'-,[1.03-1.05],GIPR,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:45675403
rs533172266-<b>T</b>,4 x 10-6,,6.00E-04,2.33,'-,[1.63-3.33],SYMPK,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:45848579
rs3810291-<b>A</b>,9 x 10-12,,0.673,1.05,'-,[1.03-1.06],ZC3H4,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:47065746
rs13041756-<b>C</b>,1 x 10-8,,0.1072,1.06,'-,[1.04-1.08],"GSTM3P1, RN7SKP140",Type 2 diabetes,type II diabetes mellitus,GCST009379,20:21486157
rs2268078-<b>A</b>,2 x 10-10,,0.6572,1.04,'-,[1.03-1.06],RALY,Type 2 diabetes,type II diabetes mellitus,GCST009379,20:34008898
rs76811102-<b>T</b>,1 x 10-7,,0.0424,1.09,'-,[1.06-1.13],GDAP1L1,Type 2 diabetes,type II diabetes mellitus,GCST009379,20:44276775
rs4810426-<b>T</b>,3 x 10-17,,0.1064,1.09,'-,[1.07-1.12],"HNF4A-AS1, HNF4A",Type 2 diabetes,type II diabetes mellitus,GCST009379,20:44373081
rs191830490-<b>G</b>,2 x 10-6,,0.9941,1.24,'-,[1.13-1.36],"HNF4A, HNF4A-AS1",Type 2 diabetes,type II diabetes mellitus,GCST009379,20:44394715
rs1800961-<b>T</b>,2 x 10-22,,0.0353,1.18,'-,[1.15-1.23],HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST009379,20:44413724
rs6063048-<b>G</b>,2 x 10-11,,0.7246,1.05,'-,[1.03-1.06],EYA2,Type 2 diabetes,type II diabetes mellitus,GCST009379,20:46969925
rs11699802-<b>C</b>,2 x 10-11,,0.5359,1.04,'-,[1.03-1.06],"CEBPB, PELATON",Type 2 diabetes,type II diabetes mellitus,GCST009379,20:50215598
rs34454109-<b>A</b>,7 x 10-9,,0.7709,1.04,'-,[1.03-1.06],LINC01524,Type 2 diabetes,type II diabetes mellitus,GCST009379,20:52607055
rs6070625-<b>G</b>,5 x 10-14,,0.5174,1.05,'-,[1.04-1.06],GNAS-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,20:58819573
rs862016-<b>G</b>,1 x 10-7,,0.0783,1.07,'-,[1.04-1.09],"NELFCD, GNAS",Type 2 diabetes,type II diabetes mellitus,GCST009379,20:58976044
rs6518681-<b>G</b>,1 x 10-12,,0.9136,1.09,'-,[1.06-1.11],"HORMAD2, LIF-AS1",Type 2 diabetes,type II diabetes mellitus,GCST009379,22:30213565
rs117001013-<b>C</b>,2 x 10-8,,0.9117,1.07,'-,[1.04-1.09],YWHAH,Type 2 diabetes,type II diabetes mellitus,GCST009379,22:31952854
rs5758223-<b>A</b>,4 x 10-8,,0.7167,1.04,'-,[1.03-1.05],EP300,Type 2 diabetes,type II diabetes mellitus,GCST009379,22:41093916
rs738408-<b>T</b>,1 x 10-10,,0.2261,1.05,'-,[1.03-1.07],PNPLA3,Type 2 diabetes,type II diabetes mellitus,GCST009379,22:43928850
rs1801645-<b>C</b>,2 x 10-8,,0.275,1.04,'-,[1.02-1.05],PIM3,Type 2 diabetes,type II diabetes mellitus,GCST009379,22:49963202
rs112915006-<b>G</b>,1 x 10-6,,0.0512,1.08,'-,[1.05-1.11],"MOV10L1, PANX2",Type 2 diabetes,type II diabetes mellitus,GCST009379,22:50166267
rs2102278-<b>G</b>,4 x 10-8,,0.3186,1.04,'-,[1.02-1.05],"LRRC66, DCUN1D4",Type 2 diabetes,type II diabetes mellitus,GCST009379,4:51952498
rs114447556-<b>T</b>,8 x 10-6,,0.0839,1.06,'-,[1.03-1.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:52340927
rs12642790-<b>A</b>,4 x 10-10,,0.3378,1.04,'-,[1.03-1.06],SCD5,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:82657118
rs1903002-<b>G</b>,3 x 10-8,,0.5005,1.04,'-,[1.02-1.05],FAM13A,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:88819743
rs576406049-<b>T</b>,2 x 10-6,,0.0013,1.65,'-,[1.35-2.03],FAM13A,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:88936140
rs6821438-<b>A</b>,4 x 10-11,,0.5342,1.04,'-,[1.03-1.06],HMGB3P15,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:94170760
rs1580278-<b>C</b>,2 x 10-10,,0.4728,1.04,'-,[1.03-1.05],"CENPE, LINC02428",Type 2 diabetes,type II diabetes mellitus,GCST009379,4:103219691
rs1296328-<b>A</b>,4 x 10-8,,0.4457,1.04,'-,[1.02-1.05],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:136162038
rs7669833-<b>T</b>,1 x 10-14,,0.7045,1.06,'-,[1.04-1.07],"TMEM154, RPS3AP18",Type 2 diabetes,type II diabetes mellitus,GCST009379,4:152592217
rs28819812-<b>C</b>,2 x 10-8,,0.6767,1.04,'-,[1.03-1.06],"PDGFC, LINC02272",Type 2 diabetes,type II diabetes mellitus,GCST009379,4:156731601
rs58730668-<b>T</b>,1 x 10-13,,0.858,1.07,'-,[1.05-1.09],ACSL1,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:184796605
rs3845281-<b>G</b>,2 x 10-11,,0.9039,1.08,'-,[1.06-1.10],OTULINL,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:14610025
rs146886108-<b>C</b>,8 x 10-13,,0.9938,1.41,'-,[1.28-1.55],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:14751196
rs17250977-<b>G</b>,2 x 10-11,,0.0376,1.12,'-,[1.09-1.16],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:14753636
rs6885132-<b>C</b>,2 x 10-8,,0.904,1.07,'-,[1.04-1.09],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:14767983
rs76549217-<b>T</b>,3 x 10-10,,0.0295,1.14,'-,[1.10-1.19],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:14768657
rs62368490-<b>T</b>,3 x 10-6,,0.0313,1.1,'-,[1.06-1.14],LINC02224,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:44534262
rs6884702-<b>G</b>,2 x 10-10,,0.3932,1.04,'-,[1.03-1.06],"LINC02224, RN7SL383P",Type 2 diabetes,type II diabetes mellitus,GCST009379,5:44682487
rs17261179-<b>T</b>,1 x 10-8,,0.5172,1.04,'-,[1.02-1.05],MFSD4BP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:52495391
rs3811978-<b>G</b>,8 x 10-11,,0.1668,1.06,'-,[1.04-1.07],ITGA1,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:52804655
rs62357230-<b>A</b>,6 x 10-6,,0.0339,1.09,'-,[1.05-1.13],ITGA2,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:53019852
rs62370480-<b>A</b>,2 x 10-6,,0.2195,1.04,'-,[1.02-1.05],FST,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:53478680
rs702634-<b>A</b>,8 x 10-14,,0.69,1.05,'-,[1.04-1.07],ARL15,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:53975590
rs279744-<b>C</b>,3 x 10-8,,0.6909,1.04,'-,[1.03-1.05],ARL15,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:54116790
rs465002-<b>T</b>,6 x 10-38,,0.7421,1.11,'-,[1.09-1.12],C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:56512648
rs9927842-<b>C</b>,7 x 10-10,,0.7886,'-,0.0307 unit decrease,[0.021-0.04],PDXDC1,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:15059860
rs7134150-<b>G</b>,3 x 10-10,,0.9011,'-,0.0443 unit decrease,[0.031-0.058],PDE3A,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:20438398
rs62262091-<b>C</b>,2 x 10-10,,0.9134,'-,0.0538 unit decrease,[0.037-0.07],SMARCC1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:47652174
rs524903-<b>G</b>,2 x 10-10,,0.8164,'-,0.0428 unit increase,[0.03-0.056],HPSE2,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:98662084
rs12041243-<b>G</b>,3 x 10-10,,0.2426,'-,0.0293 unit decrease,[0.02-0.039],MDM4,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:204521342
rs12056338-<b>G</b>,2 x 10-10,,0.6086,'-,0.0251 unit decrease,[0.017-0.033],"LINC00681, LONRF1",Type 2 diabetes,type II diabetes mellitus,GCST010557,8:12785546
rs3753693-<b>C</b>,1 x 10-10,,0.549,'-,0.0255 unit increase,[0.018-0.033],"GMEB1, YTHDF2",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:28734386
rs506597-<b>G</b>,2 x 10-10,,0.8812,'-,0.041 unit increase,[0.028-0.054],"POP7, EPO",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:100715797
rs35901985-<b>G</b>,3 x 10-10,,0.1853,'-,0.0332 unit decrease,[0.023-0.044],SORBS2,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:185658908
rs1194592-<b>G</b>,5 x 10-10,,0.4687,'-,0.0242 unit decrease,[0.017-0.032],"ATP8B2, RPSAP17",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:154351908
rs11108094-<b>C</b>,1 x 10-10,,0.9339,'-,0.0571 unit decrease,[0.04-0.074],USP44,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:95534337
rs72692804-<b>G</b>,3 x 10-10,,0.9274,'-,0.0532 unit increase,[0.037-0.07],"SV2A, SF3B4",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:149919476
rs62271373-<b>T</b>,1 x 10-10,,0.946,'-,0.0645 unit decrease,[0.045-0.084],"TSC22D2, LINC01214",Type 2 diabetes,type II diabetes mellitus,GCST010557,3:150348753
rs200995462-<b>T</b>,2 x 10-10,,0.4886,'-,0.0299 unit decrease,[0.021-0.039],HHIP,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:144691401
rs71495046-<b>C</b>,2 x 10-10,,0.121,'-,0.0399 unit increase,[0.028-0.052],LINC00838,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:33708299
rs11998023-<b>G</b>,9 x 10-10,,0.1765,'-,0.0324 unit increase,[0.022-0.043],EBF2,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:26014205
rs9370243-<b>G</b>,1 x 10-10,,0.8339,'-,0.0394 unit decrease,[0.027-0.051],"LRRC1, MLIP",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:53925032
rs149447188-<b>C</b>,2 x 10-10,,0.9911,'-,0.1702 unit decrease,[0.12-0.22],ACVR1C,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:157592569
rs2066827-<b>G</b>,2 x 10-10,,0.289,'-,0.0321 unit increase,[0.022-0.042],CDKN1B,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:12718165
rs6972291-<b>C</b>,2 x 10-9,,0.3457,'-,0.0283 unit increase,[0.019-0.038],"SUMO2P3, CICP11",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:55734370
rs11114650-<b>G</b>,3 x 10-9,,0.7758,'-,0.0447 unit decrease,[0.03-0.059],LIN7A,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:80915483
rs2408252-<b>C</b>,1 x 10-9,,0.5375,'-,0.0264 unit decrease,[0.018-0.035],ANO6,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:45474840
rs10766076-<b>T</b>,1 x 10-9,,0.7137,'-,0.026 unit increase,[0.018-0.034],ARNTL,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:13319163
rs5010712-<b>G</b>,3 x 10-9,,0.8124,'-,0.03 unit increase,[0.02-0.04],EML6,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:54930777
rs11159347-<b>C</b>,1 x 10-9,,0.3435,'-,0.0248 unit decrease,[0.017-0.033],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:25478230
rs247975-<b>C</b>,2 x 10-11,,0.5623,'-,0.0254 unit increase,[0.018-0.033],NLGN1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:173389653
rs11201992-<b>C</b>,6 x 10-11,,0.4767,'-,0.0251 unit increase,[0.018-0.033],GRID1,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:86357561
rs7483027-<b>C</b>,6 x 10-11,,0.3277,'-,0.0267 unit decrease,[0.019-0.035],"OR5B1P, OR5B17",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:58360542
rs2872246-<b>C</b>,3 x 10-11,,0.5962,'-,0.0266 unit decrease,[0.019-0.034],"ABCC5, EEF1A1P8",Type 2 diabetes,type II diabetes mellitus,GCST010557,3:184020672
rs13415288-<b>C</b>,9 x 10-11,,0.3654,'-,0.0262 unit increase,[0.018-0.034],SPHKAP,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:228107168
rs242105-<b>C</b>,4 x 10-11,,0.4085,'-,0.039 unit increase,[0.027-0.051],"ACTN1-AS1, RPS29P1",Type 2 diabetes,type II diabetes mellitus,GCST010557,14:68992512
rs2867570-<b>G</b>,2 x 10-11,,0.5716,'-,0.026 unit increase,[0.018-0.034],TSHZ3-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,19:31375040
rs4906272-<b>C</b>,5 x 10-11,,0.7332,'-,0.0299 unit decrease,[0.021-0.039],TRAF3,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:102909694
rs6835992-<b>G</b>,6 x 10-11,,0.7049,'-,0.0287 unit increase,[0.02-0.037],"CDKL2, ODAPH",Type 2 diabetes,type II diabetes mellitus,GCST010557,4:75571607
rs12932337-<b>C</b>,8 x 10-11,,0.8301,'-,0.034 unit decrease,[0.024-0.044],RPL13,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:89564222
rs1408579-<b>C</b>,6 x 10-11,,0.5591,'-,0.0275 unit increase,[0.019-0.036],ERLIN1,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:100152437
rs9568868-<b>G</b>,6 x 10-11,,0.8396,'-,0.035 unit decrease,[0.025-0.045],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,13:53533448
rs4777857-<b>G</b>,5 x 10-11,,0.4391,'-,0.0255 unit increase,[0.018-0.033],SEPHS1P2,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:93382098
rs12539264-<b>G</b>,9 x 10-11,,0.2656,'-,0.029 unit increase,[0.02-0.038],LINC02838,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:48799407
rs9913225-<b>G</b>,5 x 10-11,,0.3742,'-,0.0262 unit increase,[0.018-0.034],"TWF1P1, CRYBA1",Type 2 diabetes,type II diabetes mellitus,GCST010557,17:29243604
rs3744347-<b>G</b>,5 x 10-11,,0.253,'-,0.0301 unit decrease,[0.021-0.039],CBX1,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:48101312
rs12185519-<b>C</b>,3 x 10-11,,0.8081,'-,0.036 unit decrease,[0.025-0.047],"KDM4B, UHRF1",Type 2 diabetes,type II diabetes mellitus,GCST010557,19:4967728
rs4479849-<b>G</b>,3 x 10-11,,0.5861,'-,0.0258 unit decrease,[0.018-0.033],LINC02224,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:44643904
rs924753-<b>G</b>,1 x 10-11,,0.4649,'-,0.0263 unit increase,[0.019-0.034],BTD,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:15664617
rs379417-<b>G</b>,5 x 10-11,,0.6491,'-,0.0278 unit decrease,[0.02-0.036],BRD3OS,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:134025582
rs76789970-<b>C</b>,9 x 10-11,,0.8868,'-,0.0387 unit decrease,[0.027-0.05],SBF2,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:9834468
rs7240767-<b>C</b>,2 x 10-11,,0.4776,'-,0.034 unit increase,[0.024-0.044],LAMA1,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:7070643
rs727734-<b>T</b>,7 x 10-11,,0.2363,'-,0.0292 unit decrease,[0.02-0.038],JARID2,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:15474820
rs6712905-<b>C</b>,2 x 10-11,,0.3181,'-,0.0279 unit increase,[0.02-0.036],"DNAH7, STK17B",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:196087286
rs174541-<b>C</b>,2 x 10-11,,0.3493,'-,0.0277 unit decrease,[0.02-0.036],FADS2,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:61798436
rs9564268-<b>C</b>,8 x 10-10,,0.544,'-,0.0243 unit decrease,[0.016-0.032],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,13:65630748
rs2956092-<b>C</b>,2 x 10-10,,0.6526,'-,0.0254 unit decrease,[0.018-0.033],APIP,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:34887233
rs12151653-<b>C</b>,6 x 10-10,,0.7352,'-,0.0267 unit decrease,[0.018-0.035],TEX41,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:144969089
rs10096633-<b>C</b>,8 x 10-10,,0.8211,'-,0.033 unit increase,[0.022-0.044],LPL,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:19973410
rs73121277-<b>C</b>,7 x 10-10,,0.2966,'-,0.026 unit increase,[0.018-0.034],"DDC, FIGNL1",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:50510270
rs1431819-<b>G</b>,2 x 10-10,,0.7075,'-,0.0294 unit increase,[0.02-0.038],COL27A1,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:114181077
rs4976033-<b>G</b>,1 x 10-10,,0.4337,'-,0.0251 unit increase,[0.017-0.033],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:68418419
rs1570247-<b>G</b>,3 x 10-10,,0.5982,'-,0.0244 unit increase,[0.017-0.032],GBA2,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:35749017
rs1885234-<b>G</b>,3 x 10-10,,0.3946,'-,0.0244 unit increase,[0.017-0.032],ASTN2,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:116489998
rs1327123-<b>G</b>,7 x 10-10,,0.6447,'-,0.0242 unit decrease,[0.017-0.032],"TSEN15, COLGALT2",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:184045459
rs9937296-<b>C</b>,2 x 10-10,,0.7708,'-,0.0445 unit increase,[0.031-0.058],ZFPM1,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:88488072
rs34298980-<b>C</b>,1 x 10-10,,0.4713,'-,0.0354 unit decrease,[0.025-0.046],LRFN2,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:40441504
rs11046164-<b>C</b>,4 x 10-10,,0.7576,'-,0.0289 unit increase,[0.02-0.038],LDHB,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:21690642
rs7546252-<b>G</b>,2 x 10-10,,0.5727,'-,0.0262 unit decrease,[0.018-0.034],"DNM3, PIGC",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:172399170
rs4384608-<b>C</b>,4 x 10-10,,0.4076,'-,0.0266 unit increase,[0.018-0.035],"KLHDC4, SLC7A5",Type 2 diabetes,type II diabetes mellitus,GCST010557,16:87822818
rs10750840-<b>T</b>,5 x 10-10,,0.5524,'-,0.0239 unit decrease,[0.016-0.032],TPCN2,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:69067714
rs261967-<b>C</b>,8 x 10-10,,0.414,'-,0.0235 unit increase,[0.016-0.031],"PCSK1, CAST",Type 2 diabetes,type II diabetes mellitus,GCST010557,5:96514546
rs34329895-<b>G</b>,1 x 10-10,,0.5376,'-,0.0255 unit decrease,[0.018-0.033],PLEKHM3,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:208005293
rs2150999-<b>C</b>,6 x 10-10,,0.5367,'-,0.0243 unit increase,[0.017-0.032],FOCAD,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:20790623
rs13099581-<b>C</b>,1 x 10-10,,0.8192,'-,0.0371 unit increase,[0.026-0.048],EGFEM1P,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:168508264
rs4655617-<b>C</b>,2 x 10-10,,0.4786,'-,0.0256 unit increase,[0.018-0.033],SGIP1,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:66544971
rs10767659-<b>G</b>,5 x 10-10,,0.3538,'-,0.026 unit increase,[0.018-0.034],"BDNF-AS, BDNF",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:27664649
rs9319943-<b>C</b>,2 x 10-10,,0.2071,'-,0.0308 unit decrease,[0.021-0.04],"GRP, SEC11C",Type 2 diabetes,type II diabetes mellitus,GCST010557,18:59212595
rs11240351-<b>G</b>,1 x 10-10,,0.4696,'-,0.0256 unit increase,[0.018-0.033],CNTN2,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:205075211
chr16:20334808-<b>C</b>,1 x 10-10,,0.9103,'-,0.1004 unit decrease,[0.07-0.131],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,Mapping not available
rs529623-<b>C</b>,4 x 10-9,,0.4961,'-,0.0224 unit decrease,[0.015-0.03],"FXYD6-FXYD2, FXYD2",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:117822540
rs6561273-<b>G</b>,8 x 10-9,,0.3995,'-,0.0303 unit decrease,[0.02-0.04],"ZC3H13, SIAH3",Type 2 diabetes,type II diabetes mellitus,GCST010557,13:45940357
rs4942883-<b>C</b>,9 x 10-9,,0.6053,'-,0.0306 unit increase,[0.02-0.041],"KPNA3, RNY4P30",Type 2 diabetes,type II diabetes mellitus,GCST010557,13:49857851
rs11929640-<b>G</b>,9 x 10-9,,0.6454,'-,0.0245 unit decrease,[0.016-0.033],SIDT1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:113569583
rs62452060-<b>G</b>,2 x 10-9,,0.8638,'-,0.0354 unit decrease,[0.024-0.047],FOXK1,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:4643941
rs6870983-<b>C</b>,6 x 10-9,,0.7415,'-,0.0287 unit increase,[0.019-0.038],TMEM161B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:88401716
rs9869477-<b>G</b>,4 x 10-9,,0.562,'-,0.0226 unit increase,[0.015-0.03],RBMS3,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:28690319
rs884847-<b>G</b>,4 x 10-9,,0.8026,'-,0.0293 unit decrease,[0.02-0.039],NOS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:117285808
rs3828242-<b>G</b>,6 x 10-9,,0.2696,'-,0.0252 unit decrease,[0.017-0.034],ERBB4,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:211410212
rs138771-<b>G</b>,4 x 10-9,,0.6895,'-,0.0259 unit decrease,[0.017-0.035],TOM1,Type 2 diabetes,type II diabetes mellitus,GCST010557,22:35309366
rs12586772-<b>T</b>,6 x 10-9,,0.3963,'-,0.0228 unit decrease,[0.015-0.03],"SYNDIG1L, NPC2",Type 2 diabetes,type II diabetes mellitus,GCST010557,14:74465938
rs73146095-<b>C</b>,8 x 10-9,,0.9016,'-,0.0406 unit increase,[0.027-0.054],"CGGBP1, ZNF654",Type 2 diabetes,type II diabetes mellitus,GCST010557,3:88080986
rs978444-<b>G</b>,4 x 10-9,,0.4136,'-,0.0229 unit increase,[0.015-0.031],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:94262216
rs723355-<b>G</b>,2 x 10-9,,0.5624,'-,0.0237 unit increase,[0.016-0.031],MDGA2,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:46834888
rs7316626-<b>G</b>,3 x 10-9,,0.7968,'-,0.0322 unit decrease,[0.022-0.043],CHD4,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:6582286
rs1812707-<b>C</b>,6 x 10-9,,0.4367,'-,0.0227 unit decrease,[0.015-0.03],ADAMTSL3,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:83878470
rs17810376-<b>G</b>,3 x 10-9,,0.2974,'-,0.0279 unit increase,[0.019-0.037],GLP2R,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:9884528
rs76263492-<b>G</b>,3 x 10-9,,0.9579,'-,0.0675 unit decrease,[0.045-0.09],CACNA2D3,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:54794800
rs7758115-<b>G</b>,4 x 10-9,,0.4997,'-,0.0232 unit decrease,[0.016-0.031],"LINC02523, HEY2",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:125740356
rs12128213-<b>G</b>,2 x 10-9,,0.4713,'-,0.0256 unit decrease,[0.017-0.034],"LINC00862, CCNQP1",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:200228410
rs2252115-<b>G</b>,1 x 10-9,,0.4284,'-,0.0237 unit decrease,[0.016-0.031],TSHZ2,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:53004318
rs12856169-<b>G</b>,3 x 10-9,,0.7716,'-,0.0364 unit increase,[0.024-0.048],"HMGB1, UBE2L5",Type 2 diabetes,type II diabetes mellitus,GCST010557,13:30443131
rs7274134-<b>C</b>,2 x 10-9,,0.6695,'-,0.0247 unit increase,[0.017-0.033],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:22447646
rs2125799-<b>C</b>,4 x 10-9,,0.3305,'-,0.0244 unit increase,[0.016-0.032],GUCY1B1,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:155776632
rs1470560-<b>G</b>,1 x 10-9,,0.6433,'-,0.0245 unit decrease,[0.017-0.032],ARPP21,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:35628658
rs72803684-<b>C</b>,6 x 10-9,,0.9555,'-,0.0666 unit decrease,[0.044-0.089],KIF3C,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:25969933
rs73642097-<b>G</b>,2 x 10-9,,0.2052,'-,0.0291 unit increase,[0.019-0.039],NFIB,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:14141704
rs59646751-<b>G</b>,3 x 10-9,,0.6929,'-,0.0241 unit decrease,[0.016-0.032],IGF1R,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:98733292
rs11870735-<b>C</b>,8 x 10-9,,0.824,'-,0.0314 unit decrease,[0.021-0.042],VPS53,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:578364
rs4673712-<b>C</b>,2 x 10-9,,0.2897,'-,0.0269 unit decrease,[0.018-0.036],"IKZF2, MIR4776-1",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:212964997
rs2780215-<b>G</b>,6 x 10-9,,0.1001,'-,0.0531 unit decrease,[0.035-0.071],"NUDT3, RPL35P2",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:34269196
rs12669521-<b>G</b>,3 x 10-9,,0.2961,'-,0.0263 unit decrease,[0.018-0.035],"GSAP, GCNT1P5",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:77417785
rs17439448-<b>C</b>,4 x 10-9,,0.8842,'-,0.0393 unit decrease,[0.026-0.052],SUGCT,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:40777054
rs10119430-<b>G</b>,2 x 10-9,,0.2209,'-,0.0279 unit increase,[0.019-0.037],EPB41L4B,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:109175988
rs11096542-<b>G</b>,3 x 10-9,,0.3756,'-,0.0254 unit decrease,[0.017-0.034],RDH14,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:18526607
rs10404726-<b>C</b>,1 x 10-9,,0.4829,'-,0.0255 unit increase,[0.017-0.034],CRTC1,Type 2 diabetes,type II diabetes mellitus,GCST010557,19:18723704
rs28408270-<b>G</b>,1 x 10-9,,0.4896,'-,0.0239 unit increase,[0.016-0.032],HMGB3P15,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:94193421
rs1075855-<b>G</b>,4 x 10-9,,0.2791,'-,0.0263 unit increase,[0.017-0.035],ZFHX3,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:73064192
rs13059382-<b>G</b>,1 x 10-9,,0.7216,'-,0.0356 unit increase,[0.024-0.047],CASR,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:122242614
rs77424687-<b>C</b>,3 x 10-9,,0.6959,'-,0.0274 unit increase,[0.018-0.036],HEATR5B,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:36977025
rs11258422-<b>C</b>,3 x 10-9,,0.4091,'-,0.0241 unit increase,[0.016-0.032],BEND7,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:13498869
rs410150-<b>C</b>,1 x 10-9,,0.2139,'-,0.0289 unit increase,[0.019-0.038],LINC00907,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:42486041
rs10758950-<b>T</b>,7 x 10-9,,0.7077,'-,0.026 unit decrease,[0.017-0.035],PTPRD,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:8290816
rs4902002-<b>G</b>,1 x 10-9,,0.3474,'-,0.0246 unit increase,[0.017-0.033],MNAT1,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:60762693
rs2816177-<b>G</b>,7 x 10-9,,0.3994,'-,0.0224 unit increase,[0.015-0.03],"COX5BP8, SOAT1",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:179279817
rs38221-<b>C</b>,2 x 10-9,,0.764,'-,0.0286 unit decrease,[0.019-0.038],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:15886603
rs10889560-<b>C</b>,2 x 10-9,,0.8891,'-,0.0376 unit decrease,[0.025-0.05],LEPR,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:65524195
rs55812705-<b>C</b>,1 x 10-9,,0.2379,'-,0.0301 unit decrease,[0.02-0.04],"MFSD4B, REV3L",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:111417590
rs74677818-<b>C</b>,3 x 10-9,,0.8646,'-,0.0357 unit decrease,[0.024-0.047],TMEM87B,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:112065537
rs17265513-<b>C</b>,3 x 10-9,,0.189,'-,0.0327 unit increase,[0.022-0.043],ZHX3,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:41203988
rs116861182-<b>C</b>,5 x 10-9,,0.0534,'-,0.0615 unit increase,[0.041-0.082],"OR5L2, OR5D18",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:55820740
rs197374-<b>C</b>,8 x 10-9,,0.5929,'-,0.0224 unit decrease,[0.015-0.03],"INKA2, INKA2-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:111747361
rs10787518-<b>T</b>,9 x 10-9,,0.4495,'-,0.0292 unit increase,[0.019-0.039],"ADRB1, RNU6-709P",Type 2 diabetes,type II diabetes mellitus,GCST010557,10:114062119
rs1109442-<b>C</b>,6 x 10-9,,0.4629,'-,0.0218 unit increase,[0.015-0.029],MYO19,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:36506381
rs4834232-<b>C</b>,9 x 10-9,,0.787,'-,0.0272 unit decrease,[0.018-0.036],LARP1B,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:128103118
rs12422600-<b>G</b>,3 x 10-9,,0.6382,'-,0.024 unit increase,[0.016-0.032],HOXC4,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:54035601
rs33959228-<b>C</b>,3 x 10-9,,0.9785,'-,0.0915 unit increase,[0.061-0.122],ZNF76,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:35291620
rs4788815-<b>T</b>,7 x 10-9,,0.6518,'-,0.0231 unit increase,[0.015-0.031],"MARVELD3, TAT-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010557,16:71600908
rs11150745-<b>G</b>,5 x 10-9,,0.3173,'-,0.0312 unit decrease,[0.021-0.042],RPTOR,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:80783826
rs73184014-<b>G</b>,1 x 10-8,,0.2094,'-,0.0298 unit decrease,[0.02-0.04],LHFPL3,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:104875827
rs4294149-<b>C</b>,2 x 10-8,,0.6027,'-,0.0217 unit decrease,[0.014-0.029],"MIR30B, ZFAT",Type 2 diabetes,type II diabetes mellitus,GCST010557,8:134763303
rs10101067-<b>G</b>,1 x 10-8,,0.9141,'-,0.0391 unit decrease,[0.026-0.053],EYA1,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:71495139
rs17772814-<b>G</b>,3 x 10-8,,0.917,'-,0.0685 unit increase,[0.044-0.093],CASC11,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:127699497
chr22:40541838-<b>C</b>,2 x 10-8,,0.4673,'-,0.0225 unit decrease,[0.015-0.03],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,Mapping not available
rs11236524-<b>C</b>,1 x 10-8,,0.2408,'-,0.0363 unit increase,[0.024-0.049],"RN7SL786P, DGAT2",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:75753299
rs2216063-<b>G</b>,3 x 10-8,,0.1982,'-,0.0296 unit decrease,[0.019-0.04],"IRX3, LINC02140",Type 2 diabetes,type II diabetes mellitus,GCST010557,16:54353172
rs28792187-<b>G</b>,4 x 10-8,,0.0729,'-,0.0414 unit increase,[0.027-0.056],STAU2,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:73655864
rs9449295-<b>C</b>,4 x 10-8,,0.5169,'-,0.0216 unit increase,[0.014-0.029],EEF1B2P5,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:63453902
rs7169799-<b>C</b>,3 x 10-8,,0.4477,'-,0.0213 unit increase,[0.014-0.029],FAM227B,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:49501823
rs4482463-<b>C</b>,2 x 10-8,,0.2443,'-,0.0316 unit increase,[0.021-0.043],"KCNS3, PARD3B",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:204511186
rs4820323-<b>G</b>,4 x 10-8,,0.5841,'-,0.0214 unit increase,[0.014-0.029],"PLA2G6, MAFF",Type 2 diabetes,type II diabetes mellitus,GCST010557,22:38203760
rs62490267-<b>C</b>,5 x 10-8,,0.2791,'-,0.031 unit increase,[0.02-0.042],"ZNF746, ZNF767P",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:149541732
rs59489841-<b>C</b>,3 x 10-8,,0.7015,'-,0.0235 unit increase,[0.015-0.032],NLGN1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:173992905
rs243513-<b>G</b>,5 x 10-8,,0.71,'-,0.0232 unit increase,[0.015-0.032],CUL1,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:148732714
rs11858759-<b>G</b>,4 x 10-8,,0.7302,'-,0.0236 unit increase,[0.015-0.032],ALDH1A2,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:58384622
rs9560114-<b>T</b>,3 x 10-8,,0.2435,'-,0.0259 unit decrease,[0.017-0.035],LINC02337,Type 2 diabetes,type II diabetes mellitus,GCST010557,13:111535535
rs11848361-<b>G</b>,2 x 10-8,,0.9213,'-,0.0478 unit increase,[0.031-0.064],UNC79,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:93573499
rs7991679-<b>T</b>,1 x 10-8,,0.7562,'-,0.0274 unit increase,[0.018-0.037],LINC02338,Type 2 diabetes,type II diabetes mellitus,GCST010557,13:58116973
rs12825669-<b>G</b>,4 x 10-8,,0.6672,'-,0.0226 unit increase,[0.015-0.031],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:105894667
rs7664347-<b>C</b>,1 x 10-8,,0.6601,'-,0.0234 unit decrease,[0.015-0.031],SLIT2,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:20263912
rs75307421-<b>G</b>,3 x 10-8,,0.9687,'-,0.0737 unit decrease,[0.048-0.1],DEPDC5,Type 2 diabetes,type II diabetes mellitus,GCST010557,22:31807348
rs4463416-<b>C</b>,1 x 10-8,,0.3518,'-,0.0237 unit decrease,[0.016-0.032],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:34645053
rs4440243-<b>C</b>,1 x 10-8,,0.4217,'-,0.0246 unit decrease,[0.016-0.033],ART3,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:76096527
rs56281442-<b>G</b>,1 x 10-8,,0.3558,'-,0.025 unit decrease,[0.016-0.034],SHROOM3,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:76612786
rs217256-<b>C</b>,1 x 10-8,,0.4926,'-,0.021 unit increase,[0.014-0.028],"NME5, WNT8A",Type 2 diabetes,type II diabetes mellitus,GCST010557,5:138095812
rs712315-<b>T</b>,4 x 10-8,,0.783,'-,0.0282 unit increase,[0.018-0.038],SRP54-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:34940495
rs56365443-<b>G</b>,2 x 10-8,,0.3202,'-,0.0238 unit decrease,[0.016-0.032],MARK3,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:103493689
rs366577-<b>C</b>,4 x 10-8,,0.4942,'-,0.0222 unit increase,[0.014-0.03],ENO3,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:4951185
rs7127212-<b>C</b>,2 x 10-8,,0.6067,'-,0.0227 unit decrease,[0.015-0.031],"HMBS, VPS11",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:119082492
rs2913873-<b>G</b>,2 x 10-8,,0.1435,'-,0.0316 unit decrease,[0.021-0.043],RANBP17,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:171256130
rs2031847-<b>G</b>,1 x 10-8,,0.9668,'-,0.0752 unit decrease,[0.049-0.101],"MED20, USP49",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:41896703
rs305686-<b>C</b>,2 x 10-8,,0.6267,'-,0.0294 unit increase,[0.019-0.04],KCNH7,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:162767422
rs6137042-<b>G</b>,2 x 10-8,,0.697,'-,0.0263 unit increase,[0.017-0.036],STK35,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:2119449
chr2:149428856-<b>T</b>,3 x 10-8,,0.4255,'-,0.0501 unit decrease,[0.032-0.068],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,Mapping not available
rs6897117-<b>C</b>,2 x 10-8,,0.7055,'-,0.0234 unit decrease,[0.015-0.032],SLC38A9,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:55690947
rs4807125-<b>C</b>,3 x 10-8,,0.8476,'-,0.0326 unit decrease,[0.021-0.044],TCF3,Type 2 diabetes,type II diabetes mellitus,GCST010557,19:1646713
rs111283203-<b>G</b>,3 x 10-8,,0.7612,'-,0.0257 unit decrease,[0.016-0.035],"AMFR, NUDT21",Type 2 diabetes,type II diabetes mellitus,GCST010557,16:56425677
rs10806906-<b>C</b>,1 x 10-8,,0.4479,'-,0.0223 unit increase,[0.015-0.03],LNC-LBCS,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:19751285
rs302395-<b>G</b>,1 x 10-8,,0.3221,'-,0.0232 unit increase,[0.015-0.031],"LINC01933, GLRA1",Type 2 diabetes,type II diabetes mellitus,GCST010557,5:151945039
rs13330163-<b>G</b>,4 x 10-8,,0.4576,'-,0.021 unit decrease,[0.014-0.028],IL34,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:70626340
rs12735779-<b>C</b>,8 x 10-6,,NR,3.72,'-,[2.09-6.63],PRDM16,Cardiovascular disease in type 2 diabetes,"cardiovascular disease, type II diabetes mellitus",GCST011371,1:3435664
rs140767541-<b>A</b>,7 x 10-6,,NR,3.5,'-,[2.02-6.04],'-,Cardiovascular disease in type 2 diabetes,"cardiovascular disease, type II diabetes mellitus",GCST011371,2:142707683
rs191571564-<b>T</b>,2 x 10-6,,NR,4.72,'-,[2.49-8.94],"RDH8, C3P1",Cardiovascular disease in type 2 diabetes,"cardiovascular disease, type II diabetes mellitus",GCST011371,19:10029981
rs6960043-<b>C</b>,3 x 10-7,,0.470992007,1.06,'-,[1.04-1.09],GTF3AP5,Type 2 diabetes,type II diabetes mellitus,GCST005047,7:15013235
rs849135-<b>G</b>,3 x 10-17,,0.51679314,1.11,'-,[1.08-1.13],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs10278336-<b>A</b>,6 x 10-6,,0.497434855,1.07,'-,[1.04-1.10],YKT6,Type 2 diabetes,type II diabetes mellitus,GCST005047,7:44205764
rs516946-<b>C</b>,2 x 10-10,,0.764476253,1.09,'-,[1.06-1.12],ANK1,Type 2 diabetes,type II diabetes mellitus,GCST005047,8:41661730
rs7845219-<b>T</b>,5 x 10-6,,0.522527585,1.06,'-,[1.03-1.08],NDUFAF6,Type 2 diabetes,type II diabetes mellitus,GCST005047,8:94925274
rs3802177-<b>G</b>,1 x 10-21,,0.662967097,1.14,'-,[1.11-1.17],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST005047,8:117172786
rs10758593-<b>A</b>,3 x 10-7,,0.424978206,1.06,'-,[1.04-1.09],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST005047,9:4292083
rs10811661-<b>T</b>,4 x 10-27,,0.824988873,1.18,'-,[1.15-1.22],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,9:22134095
rs17791513-<b>A</b>,3 x 10-7,,0.910610003,1.12,'-,[1.07-1.17],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,9:79290675
rs2796441-<b>G</b>,5 x 10-9,,0.57466868,1.07,'-,[1.05-1.10],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST005047,9:81694033
rs11257655-<b>T</b>,2 x 10-6,,0.231035683,1.07,'-,[1.04-1.10],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST005047,10:12265895
rs12571751-<b>A</b>,1 x 10-10,,0.51705701,1.08,'-,[1.05-1.10],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST005047,10:79182874
rs1111875-<b>C</b>,2 x 10-19,,0.581455301,1.11,'-,[1.09-1.14],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST005047,10:92703125
rs7903146-<b>T</b>,1 x 10-139,,0.268379563,1.39,'-,[1.35-1.42],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST005047,10:112998590
rs163184-<b>G</b>,1 x 10-11,,0.498159619,1.09,'-,[1.06-1.11],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs231361-<b>A</b>,1 x 10-9,,0.285885252,1.09,'-,[1.06-1.12],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST005047,11:2670270
rs5215-<b>C</b>,9 x 10-10,,0.407702923,1.07,'-,[1.05-1.10],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs1552224-<b>A</b>,2 x 10-10,,0.813602029,1.11,'-,[1.07-1.14],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST005047,11:72722053
rs10830963-<b>G</b>,5 x 10-13,,0.306095573,1.1,'-,[1.07-1.13],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST005047,11:92975544
rs11063069-<b>G</b>,3 x 10-7,,0.214449806,1.08,'-,[1.05-1.11],CCND2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,12:4265207
rs10842994-<b>C</b>,6 x 10-10,,0.801137991,1.1,'-,[1.06-1.13],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST005047,12:27812217
rs2261181-<b>T</b>,1 x 10-9,,0.100953558,1.13,'-,[1.08-1.17],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST005047,12:65818538
rs7955901-<b>C</b>,7 x 10-9,,0.446519036,1.07,'-,[1.05-1.10],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST005047,12:71039513
rs12427353-<b>G</b>,7 x 10-8,,0.794085917,1.08,'-,[1.05-1.12],HNF1A,Type 2 diabetes,type II diabetes mellitus,GCST005047,12:120989098
rs1359790-<b>G</b>,1 x 10-8,,0.718542081,1.08,'-,[1.05-1.10],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,13:80143021
rs11651052-<b>A</b>,3 x 10-9,(female),NR,1.13,'-,[1.09-1.18],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST005047,17:37742390
rs11709077-<b>G</b>,1 x 10-8,(female),NR,1.14,'-,[1.09-1.20],PPARG,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:12295008
rs849135-<b>G</b>,2 x 10-8,(female),NR,1.1,'-,[1.06-1.13],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs8108269-<b>G</b>,2 x 10-7,(female),NR,1.1,'-,[1.06-1.14],"RN7SL836P, GIPR",Type 2 diabetes,type II diabetes mellitus,GCST005047,19:45655255
rs4611812-<b>C</b>,3 x 10-7,(female),NR,1.09,'-,[1.05-1.13],ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:64713769
rs1801214-<b>T</b>,5 x 10-7,(female),NR,1.09,'-,[1.05-1.13],WFS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,4:6301295
rs12571751-<b>A</b>,1 x 10-6,(female),NR,1.08,'-,[1.05-1.12],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST005047,10:79182874
rs6467314-<b>G</b>,2 x 10-6,(female),NR,1.09,'-,[1.05-1.13],"KLF14, H4P1",Type 2 diabetes,type II diabetes mellitus,GCST005047,7:130757382
rs2075423-<b>G</b>,8 x 10-9,,0.622753027,1.07,'-,[1.05-1.10],PROX1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,1:213981376
rs780094-<b>C</b>,5 x 10-7,,0.613751766,1.06,'-,[1.04-1.09],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs10203174-<b>C</b>,1 x 10-11,,0.893890367,1.14,'-,[1.10-1.19],THADA,Type 2 diabetes,type II diabetes mellitus,GCST005047,2:43462891
rs243088-<b>T</b>,2 x 10-8,,0.446763001,1.07,'-,[1.04-1.09],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST005047,2:60341610
rs7593730-<b>C</b>,2 x 10-6,,NR,1.11,'-,[1.06-1.15],RBMS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,2:160314943
rs13389219-<b>C</b>,1 x 10-8,,0.600895198,1.07,'-,[1.05-1.10],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs2943640-<b>C</b>,3 x 10-14,,0.634514929,1.1,'-,[1.07-1.12],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,2:226228869
rs1801282-<b>C</b>,1 x 10-12,,0.855203373,1.13,'-,[1.09-1.17],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs1496653-<b>A</b>,4 x 10-9,,0.750927056,1.09,'-,[1.06-1.12],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:23413299
rs6795735-<b>C</b>,7 x 10-11,,0.589987599,1.08,'-,[1.06-1.11],ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:64719689
rs11717195-<b>T</b>,6 x 10-14,,0.771509899,1.11,'-,[1.08-1.14],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:123363551
rs4402960-<b>T</b>,2 x 10-23,,0.325385419,1.13,'-,[1.10-1.16],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:185793899
rs4458523-<b>G</b>,2 x 10-15,,0.573657632,1.1,'-,[1.07-1.12],WFS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,4:6288259
rs459193-<b>G</b>,6 x 10-9,,0.702406933,1.08,'-,[1.05-1.11],"C5orf67, RPL26P19",Type 2 diabetes,type II diabetes mellitus,GCST005047,5:56510924
rs6878122-<b>G</b>,5 x 10-11,,0.279958209,1.1,'-,[1.07-1.13],ZBED3-AS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,5:77131486
rs7756992-<b>G</b>,7 x 10-35,,0.292255246,1.17,'-,[1.14-1.20],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs17168486-<b>T</b>,6 x 10-11,,0.192640555,1.11,'-,[1.07-1.14],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST005047,7:14858657
rs4502156-<b>T</b>,2 x 10-6,,0.51835942,1.06,'-,[1.03-1.08],"C2CD4B, NPM1P47",Type 2 diabetes,type II diabetes mellitus,GCST005047,15:62090956
rs7177055-<b>A</b>,5 x 10-9,,0.678861782,1.08,'-,[1.05-1.10],"LINGO1, HMG20A",Type 2 diabetes,type II diabetes mellitus,GCST005047,15:77540420
rs12899811-<b>G</b>,6 x 10-9,,0.30968868,1.08,'-,[1.05-1.10],VPS33B,Type 2 diabetes,type II diabetes mellitus,GCST005047,15:91000846
rs9936385-<b>C</b>,3 x 10-23,,0.408448081,1.13,'-,[1.10-1.16],FTO,Type 2 diabetes,type II diabetes mellitus,GCST005047,16:53785257
rs7202877-<b>T</b>,4 x 10-8,,0.890915967,1.12,'-,[1.07-1.16],"CTRB2, CTRB1",Type 2 diabetes,type II diabetes mellitus,GCST005047,16:75213347
rs11651052-<b>A</b>,2 x 10-11,,0.444815276,1.1,'-,[1.07-1.14],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST005047,17:37742390
rs11873305-<b>A</b>,4 x 10-7,,0.959771168,1.18,'-,[1.11-1.26],MC4R,Type 2 diabetes,type II diabetes mellitus,GCST005047,18:60381959
rs8108269-<b>G</b>,4 x 10-7,,0.310741117,1.07,'-,[1.04-1.10],"RN7SL836P, GIPR",Type 2 diabetes,type II diabetes mellitus,GCST005047,19:45655255
rs10401969-<b>C</b>,7 x 10-9,,0.080536978,1.13,'-,[1.09-1.18],SUGP1,Type 2 diabetes,type II diabetes mellitus,GCST005047,19:19296909
rs12970134-<b>A</b>,1 x 10-8,,0.270057407,1.08,'-,[1.05-1.11],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST005047,18:60217517
rs10401969-<b>C</b>,3 x 10-7,(men),NR,1.15,'-,[1.09-1.21],SUGP1,Type 2 diabetes,type II diabetes mellitus,GCST005047,19:19296909
rs9936385-<b>C</b>,3 x 10-18,(men),NR,1.14,'-,[1.11-1.17],FTO,Type 2 diabetes,type II diabetes mellitus,GCST005047,16:53785257
rs7640539-<b>A</b>,2 x 10-17,(men),NR,1.14,'-,[1.11-1.18],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:185795508
rs3802177-<b>G</b>,1 x 10-16,(men),NR,1.15,'-,[1.11-1.18],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST005047,8:117172786
rs10965250-<b>G</b>,9 x 10-15,(men),NR,1.17,'-,[1.13-1.22],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,9:22133285
rs163184-<b>G</b>,9 x 10-15,(men),NR,1.12,'-,[1.09-1.16],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs849135-<b>G</b>,3 x 10-13,(men),NR,1.11,'-,[1.08-1.15],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs17168486-<b>T</b>,7 x 10-13,(men),NR,1.15,'-,[1.11-1.19],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST005047,7:14858657
rs1801214-<b>T</b>,3 x 10-12,(men),NR,1.11,'-,[1.08-1.15],WFS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,4:6301295
rs1111875-<b>C</b>,5 x 10-12,(men),NR,1.11,'-,[1.07-1.14],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST005047,10:92703125
rs516946-<b>C</b>,8 x 10-11,(men),NR,1.12,'-,[1.08-1.16],ANK1,Type 2 diabetes,type II diabetes mellitus,GCST005047,8:41661730
rs6878122-<b>G</b>,3 x 10-10,(men),NR,1.12,'-,[1.08-1.15],ZBED3-AS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,5:77131486
rs10830963-<b>G</b>,3 x 10-10,(men),NR,1.11,'-,[1.07-1.14],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST005047,11:92975544
rs13405158-<b>T</b>,5 x 10-10,(men),NR,1.16,'-,[1.11-1.22],THADA,Type 2 diabetes,type II diabetes mellitus,GCST005047,2:43478147
rs243088-<b>T</b>,7 x 10-10,(men),NR,1.1,'-,[1.06-1.13],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST005047,2:60341610
rs11063069-<b>G</b>,1 x 10-9,(men),NR,1.12,'-,[1.08-1.16],CCND2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,12:4265207
rs7756992-<b>G</b>,2 x 10-22,(men),NR,1.17,'-,[1.35-1.44],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs7903146-<b>T</b>,4 x 10-73,(female),NR,1.39,'-,[1.34-1.44],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST005047,10:112998590
rs7756992-<b>G</b>,2 x 10-20,(female),NR,1.17,'-,[1.14-1.22],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,Mapping not available
rs10965250-<b>G</b>,6 x 10-16,(female),NR,1.2,'-,[1.15-1.26],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,9:22133285
rs1111875-<b>C</b>,7 x 10-13,(female),NR,1.12,'-,[1.09-1.16],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST005047,10:92703125
rs9936385-<b>C</b>,6 x 10-11,(female),NR,1.12,'-,[1.08-1.15],FTO,Type 2 diabetes,type II diabetes mellitus,GCST005047,16:53785257
rs3802177-<b>G</b>,7 x 10-11,(female),NR,1.13,'-,[1.09-1.17],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST005047,8:117172786
rs11708067-<b>A</b>,2 x 10-10,(female),NR,1.13,'-,[1.09-1.18],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:123346931
rs2943640-<b>C</b>,1 x 10-9,(female),NR,1.11,'-,[1.07-1.14],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,2:226228869
rs7640539-<b>A</b>,2 x 10-9,(female),NR,1.11,'-,[1.07-1.15],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:185795508
rs3923113-<b>A</b>,2 x 10-9,(female),NR,1.11,'-,[1.08-1.15],"COBLL1, GRB14",Type 2 diabetes,type II diabetes mellitus,GCST005047,2:164645339
rs7903146-<b>T</b>,6 x 10-92,(men),NR,1.39,'-,[1.35-1.44],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST005047,10:112998590
rs11708067-<b>A</b>,4 x 10-7,(men),NR,1.09,'-,[1.06-1.13],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:123346931
rs1496653-<b>A</b>,4 x 10-7,(men),NR,1.09,'-,[1.05-1.13],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:23413299
rs10758593-<b>A</b>,6 x 10-7,(men),NR,1.08,'-,[1.05-1.11],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST005047,9:4292083
rs12571751-<b>A</b>,6 x 10-7,(men),NR,1.07,'-,[1.04-1.11],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST005047,10:79182874
rs4611812-<b>C</b>,1 x 10-6,(men),NR,1.08,'-,[1.05-1.11],ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:64713769
rs7138300-<b>C</b>,2 x 10-6,(men),NR,1.07,'-,[1.04-1.10],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST005047,12:71045809
rs7177055-<b>A</b>,2 x 10-6,(men),NR,1.08,'-,[1.05-1.11],"LINGO1, HMG20A",Type 2 diabetes,type II diabetes mellitus,GCST005047,15:77540420
rs757110-<b>C</b>,3 x 10-6,(men),NR,1.07,'-,[1.04-1.11],ABCC8,Type 2 diabetes,type II diabetes mellitus,GCST005047,11:17396930
rs17791513-<b>A</b>,3 x 10-6,(men),NR,1.14,'-,[1.08-1.20],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,9:79290675
rs459193-<b>G</b>,3 x 10-6,(men),NR,1.08,'-,[1.05-1.12],"C5orf67, RPL26P19",Type 2 diabetes,type II diabetes mellitus,GCST005047,5:56510924
rs11651052-<b>A</b>,7 x 10-6,(men),NR,1.09,'-,[1.05-1.12],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST005047,17:37742390
rs7845219-<b>T</b>,7 x 10-6,(men),NR,1.07,'-,[1.04-1.10],NDUFAF6,Type 2 diabetes,type II diabetes mellitus,GCST005047,8:94925274
rs2075423-<b>G</b>,9 x 10-6,(men),NR,1.07,'-,[1.04-1.10],PROX1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST005047,1:213981376
rs2796441-<b>G</b>,5 x 10-9,(men),NR,1.09,'-,[1.06-1.13],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST005047,9:81694033
rs1552224-<b>A</b>,9 x 10-9,(men),NR,1.12,'-,[1.08-1.16],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST005047,11:72722053
rs2943640-<b>C</b>,3 x 10-8,(men),NR,1.09,'-,[1.06-1.12],'-,Type 2 diabetes,type II diabetes mellitus,GCST005047,2:226228869
rs10842994-<b>C</b>,3 x 10-8,(men),NR,1.11,'-,[1.07-1.15],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST005047,12:27812217
rs8089364-<b>C</b>,6 x 10-8,(men),NR,1.09,'-,[1.06-1.13],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST005047,18:60191596
rs7202877-<b>T</b>,7 x 10-8,(men),NR,1.15,'-,[1.09-1.20],"CTRB2, CTRB1",Type 2 diabetes,type II diabetes mellitus,GCST005047,16:75213347
rs12899811-<b>G</b>,8 x 10-8,(men),NR,1.09,'-,[1.05-1.12],VPS33B,Type 2 diabetes,type II diabetes mellitus,GCST005047,15:91000846
rs2261181-<b>T</b>,1 x 10-7,(men),NR,1.14,'-,[1.09-1.19],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST005047,12:65818538
rs11709077-<b>G</b>,2 x 10-7,(men),NR,1.12,'-,[1.07-1.17],PPARG,Type 2 diabetes,type II diabetes mellitus,GCST005047,3:12295008
rs60780116-<b>T</b>,2 x 10-10,,0.84,1.09,'-,[1.06-1.12],ACSL1,Type 2 diabetes,type II diabetes mellitus,GCST004773,4:184787653
rs9271774-<b>C</b>,1 x 10-9,,0.74,1.09,'-,[1.06-1.12],"HLA-DRB1, HLA-DQA1",Type 2 diabetes,type II diabetes mellitus,GCST004773,6:32626532
rs6918311-<b>A</b>,7 x 10-9,,0.53,1.06,'-,[1.04-1.08],"Y_RNA, RPL35AP3",Type 2 diabetes,type II diabetes mellitus,GCST004773,6:136966564
rs1182436-<b>C</b>,2 x 10-8,,0.8,1.08,'-,[1.05-1.10],UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST004773,7:157235059
rs635634-<b>T</b>,2 x 10-8,,0.18,1.08,'-,[1.05-1.10],"ABO, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST004773,9:133279427
rs2292626-<b>C</b>,2 x 10-13,,0.5,1.07,'-,[1.05-1.09],PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST004773,10:122427198
rs1061810-<b>A</b>,4 x 10-10,,0.28,1.07,'-,[1.05-1.09],HSD17B12,Type 2 diabetes,type II diabetes mellitus,GCST004773,11:43856384
rs111669836-<b>A</b>,4 x 10-8,,0.25,1.06,'-,[1.04-1.09],"KCNK7, MAP3K11",Type 2 diabetes,type II diabetes mellitus,GCST004773,11:65596914
rs10146997-<b>G</b>,2 x 10-9,,0.21,1.07,'-,[1.05-1.09],NRXN3,Type 2 diabetes,type II diabetes mellitus,GCST004773,14:79478819
rs2925979-<b>T</b>,2 x 10-9,,0.3,1.07,'-,[1.04-1.09],CMIP,Type 2 diabetes,type II diabetes mellitus,GCST004773,16:81501185
rs7224685-<b>T</b>,3 x 10-10,,0.3,1.07,'-,[1.05-1.09],ZZEF1,Type 2 diabetes,type II diabetes mellitus,GCST004773,17:4111090
rs78761021-<b>G</b>,3 x 10-8,,0.34,1.06,'-,[1.04-1.08],GLP2R,Type 2 diabetes,type II diabetes mellitus,GCST004773,17:9877070
rs79349575-<b>A</b>,4 x 10-8,,0.51,1.06,'-,[1.03-1.08],SUMO2P17,Type 2 diabetes,type II diabetes mellitus,GCST004773,17:48889676
rs10498828-<b>C</b>,9 x 10-6,,0.82,1.0526316,'-,[1.03-1.08],EYS,Type 2 diabetes,type II diabetes mellitus,GCST004773,6:64823173
rs989128-<b>G</b>,4 x 10-6,,0.726,1.0526316,'-,[1.03-1.08],CACNA1G-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004773,17:50559173
rs8192675-<b>T</b>,1 x 10-7,,0.7233,1.0526316,'-,[1.03-1.08],SLC2A2,Type 2 diabetes,type II diabetes mellitus,GCST004773,3:171007094
rs797973-<b>G</b>,2 x 10-6,,0.2882,1.05,'-,[1.03-1.07],"RPL35AP35, NUFIP2",Type 2 diabetes,type II diabetes mellitus,GCST004773,17:29320612
rs4846569-<b>C</b>,1 x 10-7,,0.7057,1.0638298,'-,[1.04-1.09],ZC3H11B,Type 2 diabetes,type II diabetes mellitus,GCST004773,1:219598379
rs11656775-<b>A</b>,7 x 10-7,,0.3223,1.05,'-,[1.03-1.08],RAI1,Type 2 diabetes,type II diabetes mellitus,GCST004773,17:17751005
rs1904096-<b>A</b>,2 x 10-6,,0.484,1.0526316,'-,[1.03-1.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST004773,4:94091533
rs137848-<b>C</b>,6 x 10-8,,0.5163,1.0526316,'-,[1.03-1.08],IL17REL,Type 2 diabetes,type II diabetes mellitus,GCST004773,22:50001867
rs1019029-<b>G</b>,6 x 10-6,,0.479,1.05,'-,[1.03-1.07],ETV1,Type 2 diabetes,type II diabetes mellitus,GCST004773,7:13854651
rs367943-<b>C</b>,6 x 10-7,,0.66,1.05,'-,[1.03-1.07],MCC,Type 2 diabetes,type II diabetes mellitus,GCST004773,5:113474031
rs6438234-<b>G</b>,3 x 10-6,,0.237,1.0526316,'-,[1.03-1.08],"EIF4E2P2, ZBTB20",Type 2 diabetes,type II diabetes mellitus,GCST004773,3:115194661
rs4975241-<b>C</b>,5 x 10-7,,0.0607,1.14,'-,[1.08-1.19],LINC02615,Type 2 diabetes,type II diabetes mellitus,GCST004774,4:128605841
rs917195-<b>C</b>,7 x 10-6,,0.7651,1.0752687,'-,[1.04-1.11],CRHR2,Type 2 diabetes,type II diabetes mellitus,GCST004774,7:30688836
rs10841855-<b>G</b>,2 x 10-6,,0.7504,1.0752687,'-,[1.04-1.11],GYS2,Type 2 diabetes,type II diabetes mellitus,GCST004774,12:21599174
rs2548724-<b>T</b>,6 x 10-7,,0.2554,1.07,'-,[1.04-1.10],SLCO4C1,Type 2 diabetes,type II diabetes mellitus,GCST004774,5:102284470
rs62530366-<b>G</b>,9 x 10-6,,0.38,1.05,'-,[1.03-1.07],HSF1,Type 2 diabetes,type II diabetes mellitus,GCST004774,8:144312370
rs816750-<b>C</b>,3 x 10-7,,0.5046,1.06,'-,[1.04-1.08],"RIT2, SYT4",Type 2 diabetes,type II diabetes mellitus,GCST004774,18:43192321
rs4809627-<b>T</b>,5 x 10-6,,0.5223,1.05,'-,[1.03-1.08],EYA2,Type 2 diabetes,type II diabetes mellitus,GCST004774,20:47129016
rs1625526-<b>A</b>,5 x 10-6,,0.7496,1.06,'-,[1.04-1.09],MIR466,Type 2 diabetes,type II diabetes mellitus,GCST004774,3:31135383
rs17815608-<b>A</b>,3 x 10-6,,0.8276,1.08,'-,[1.04-1.11],E2F7,Type 2 diabetes,type II diabetes mellitus,GCST004774,12:77004941
rs182719694-<b>A</b>,6 x 10-6,,0.8546,1.08,'-,[1.05-1.12],PMP2,Type 2 diabetes,type II diabetes mellitus,GCST004774,8:81431203
rs6691335-<b>C</b>,5 x 10-7,,0.0984,1.098901,'-,[1.06-1.14],PKN2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004774,1:87950907
rs13268287-<b>A</b>,1 x 10-6,,0.929,1.13,'-,[1.08-1.19],LRP12,Type 2 diabetes,type II diabetes mellitus,GCST004774,8:104548593
rs35264875-<b>A</b>,2 x 10-6,,0.827,1.06,'-,[1.04-1.09],TPCN2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,11:69078931
rs56200889-<b>G</b>,2 x 10-9,,0.721,1.05,'-,[1.04-1.07],ARAP1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,11:72697010
rs1127787-<b>G</b>,3 x 10-8,,0.84,1.05,'-,[1.03-1.07],MRPS35,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,12:27714794
rs3764002-<b>C</b>,6 x 10-8,,0.726,1.04,'-,[1.02-1.05],WSCD2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,12:108224853
rs1169288-<b>C</b>,1 x 10-7,,0.337,1.04,'-,[1.02-1.05],"HNF1A-AS1, HNF1A",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,12:120978847
rs1060105-<b>C</b>,4 x 10-6,,0.796,1.04,'-,[1.02-1.06],SBNO1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,12:123321672
rs781852-<b>G</b>,8 x 10-9,,0.387,1.04,'-,[1.03-1.06],ZZEF1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,17:4049808
rs10278-<b>C</b>,3 x 10-6,,0.706,1.04,'-,[1.02-1.05],CALCOCO2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,17:48862296
rs58542926-<b>T</b>,1 x 10-12,,0.079,1.09,'-,[1.06-1.12],TM6SF2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,19:19268740
rs1800437-<b>C</b>,3 x 10-12,,0.218,1.06,'-,[1.04-1.08],GIPR,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,19:45678134
rs17265513-<b>C</b>,3 x 10-6,,0.211,1.04,'-,[1.02-1.05],ZHX3,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,20:41203988
rs1800961-<b>T</b>,7 x 10-7,,0.035,1.09,'-,[1.05-1.13],HNF4A,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,20:44413724
rs28265-<b>C</b>,1 x 10-12,,0.916,1.09,'-,[1.06-1.12],ASCC2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,22:29804772
rs738409-<b>G</b>,3 x 10-8,,0.227,1.04,'-,[1.03-1.06],PNPLA3,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,22:43928847
rs7572857-<b>G</b>,7 x 10-7,,0.846,1.05,'-,[1.03-1.07],CEP68,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,2:65069664
rs7607980-<b>T</b>,5 x 10-23,,0.879,1.09,'-,[1.07-1.12],'-,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,Mapping not available
rs1801282-<b>C</b>,3 x 10-19,,0.887,1.1,'-,[1.07-1.12],'-,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,Mapping not available
rs2276853-<b>A</b>,5 x 10-8,,0.588,1.03,'-,[1.02-1.05],"KIF9-AS1, KIF9",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,3:47240813
rs6762208-<b>A</b>,3 x 10-8,,0.367,1.03,'-,[1.02-1.05],SENP2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,3:185613377
rs1801212-<b>A</b>,7 x 10-21,,0.748,1.07,'-,[1.05-1.08],WFS1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,4:6300792
rs146886108-<b>C</b>,4 x 10-7,,0.996,1.27,'-,[1.13-1.41],ANKH,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,5:14751196
rs35658696-<b>G</b>,7 x 10-15,,0.045,1.13,'-,[1.09-1.17],PAM,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,5:103003107
rs9379084-<b>G</b>,2 x 10-17,,0.884,1.1,'-,[1.07-1.13],RREB1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,6:7231610
rs2073721-<b>G</b>,2 x 10-9,,0.749,1.04,'-,[1.02-1.05],TCF19,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,6:31161839
rs2233580-<b>T</b>,4 x 10-13,,0.0294,1.38,'-,[1.26-1.51],PAX4,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,7:127613496
rs328-<b>C</b>,2 x 10-7,,0.903,1.05,'-,[1.03-1.07],LPL,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,8:19962213
rs13266634-<b>C</b>,1 x 10-47,,0.691,1.09,'-,[1.08-1.11],SLC30A8,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,8:117172544
rs60980157-<b>C</b>,7 x 10-16,,0.771,1.06,'-,[1.05-1.08],GPSM1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,9:136340958
rs5219-<b>T</b>,2 x 10-22,,0.364,1.07,'-,[1.05-1.08],KCNJ11,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,11:17388025
rs35169799-<b>T</b>,2 x 10-6,,0.0585,1.05,'-,[1.03-1.08],PLCB3,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,11:64263769
rs72928978-<b>G</b>,2 x 10-8,,0.89,1.05,'-,[1.03-1.07],TPCN2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,11:69063896
rs56200889-<b>G</b>,5 x 10-10,,0.733,1.05,'-,[1.03-1.06],ARAP1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,11:72697010
rs1127787-<b>G</b>,2 x 10-8,,0.85,1.05,'-,[1.03-1.07],MRPS35,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,12:27714794
rs3764002-<b>C</b>,1 x 10-7,,0.719,1.03,'-,[1.02-1.05],WSCD2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,12:108224853
rs1169288-<b>C</b>,2 x 10-10,,0.323,1.04,'-,[1.02-1.06],"HNF1A-AS1, HNF1A",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,12:120978847
rs1060105-<b>C</b>,1 x 10-7,,0.815,1.04,'-,[1.02-1.06],SBNO1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,12:123321672
rs781831-<b>C</b>,2 x 10-7,,0.422,1.03,'-,[1.02-1.05],ZZEF1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,17:4044350
rs58542926-<b>T</b>,3 x 10-15,,0.0755,1.09,'-,[1.06-1.11],TM6SF2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,19:19268740
rs1800437-<b>C</b>,7 x 10-12,,0.2,1.06,'-,[1.04-1.07],GIPR,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,19:45678134
rs1800574-<b>T</b>,6 x 10-8,,0.029,1.11,'-,[1.06-1.15],"HNF1A-AS1, HNF1A",Type 2 diabetes,type II diabetes mellitus,GCST007515,12:120979061
rs35742417-<b>C</b>,6 x 10-8,,0.836,1.04,'-,[1.03-1.06],RREB1,Type 2 diabetes,type II diabetes mellitus,GCST007515,6:7247111
rs2296172-<b>G</b>,7 x 10-16,,0.193,1.06,'-,[1.05-1.08],MACF1,Type 2 diabetes,type II diabetes mellitus,GCST007515,1:39370145
rs140386498-<b>A</b>,8 x 10-8,,0.988,1.21,'-,[1.14-1.28],MINDY1,Type 2 diabetes,type II diabetes mellitus,GCST007515,1:151000483
rs1260326-<b>C</b>,5 x 10-25,,0.63,1.06,'-,[1.05-1.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST007515,Mapping not available
rs35720761-<b>C</b>,5 x 10-15,,0.895,1.08,'-,[1.05-1.10],THADA,Type 2 diabetes,type II diabetes mellitus,GCST007515,2:43292838
rs7572857-<b>G</b>,8 x 10-9,,0.846,1.05,'-,[1.04-1.07],CEP68,Type 2 diabetes,type II diabetes mellitus,GCST007515,2:65069664
rs7607980-<b>T</b>,9 x 10-20,,0.879,1.08,'-,[1.06-1.11],'-,Type 2 diabetes,type II diabetes mellitus,GCST007515,Mapping not available
rs1801282-<b>C</b>,1 x 10-17,,0.887,1.09,'-,[1.07-1.11],'-,Type 2 diabetes,type II diabetes mellitus,GCST007515,Mapping not available
rs6762208-<b>A</b>,2 x 10-6,,0.367,1.03,'-,[1.01-1.04],SENP2,Type 2 diabetes,type II diabetes mellitus,GCST007515,3:185613377
rs1801212-<b>A</b>,1 x 10-24,,0.748,1.07,'-,[1.06-1.09],WFS1,Type 2 diabetes,type II diabetes mellitus,GCST007515,4:6300792
rs146886108-<b>C</b>,1 x 10-7,,0.996,1.29,'-,[1.16-1.45],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST007515,5:14751196
rs2307111-<b>T</b>,2 x 10-15,,0.562,1.05,'-,[1.04-1.07],POC5,Type 2 diabetes,type II diabetes mellitus,GCST007515,5:75707853
rs35658696-<b>G</b>,1 x 10-16,,0.045,1.13,'-,[1.10-1.17],PAM,Type 2 diabetes,type II diabetes mellitus,GCST007515,5:103003107
rs9379084-<b>G</b>,1 x 10-13,,0.884,1.08,'-,[1.06-1.11],RREB1,Type 2 diabetes,type II diabetes mellitus,GCST007515,6:7231610
rs2073721-<b>G</b>,2 x 10-10,,0.749,1.04,'-,[1.02-1.05],TCF19,Type 2 diabetes,type II diabetes mellitus,GCST007515,6:31161839
rs2233580-<b>T</b>,2 x 10-12,,0.0294,1.36,'-,[1.25-1.48],PAX4,Type 2 diabetes,type II diabetes mellitus,GCST007515,7:127613496
rs328-<b>C</b>,7 x 10-9,,0.903,1.05,'-,[1.03-1.08],LPL,Type 2 diabetes,type II diabetes mellitus,GCST007515,8:19962213
rs13266634-<b>C</b>,2 x 10-47,,0.691,1.09,'-,[1.08-1.11],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST007515,8:117172544
rs60980157-<b>C</b>,3 x 10-16,,0.771,1.06,'-,[1.05-1.08],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST007515,9:136340958
rs5219-<b>T</b>,6 x 10-22,,0.364,1.06,'-,[1.05-1.07],KCNJ11,Type 2 diabetes,type II diabetes mellitus,GCST007515,11:17388025
rs72928978-<b>G</b>,5 x 10-7,,0.89,1.05,'-,[1.02-1.07],TPCN2,Type 2 diabetes,type II diabetes mellitus,GCST007515,11:69063896
rs56200889-<b>G</b>,5 x 10-8,,0.733,1.04,'-,[1.02-1.05],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST007515,11:72697010
rs1127787-<b>G</b>,1 x 10-11,,0.85,1.06,'-,[1.04-1.08],MRPS35,Type 2 diabetes,type II diabetes mellitus,GCST007515,12:27714794
rs3764002-<b>C</b>,3 x 10-8,,0.719,1.03,'-,[1.02-1.05],WSCD2,Type 2 diabetes,type II diabetes mellitus,GCST007515,12:108224853
rs11887534-<b>C</b>,9 x 10-6,,0.07,2.01,'-,[1.94-2.08],ABCG8,Gallstone disease,"cholelithiasis, gallstones",GCST007364,2:43839108
rs2687201-<b>T</b>,5 x 10-9,,0.303,1.18,'-,[1.12-1.25],"FOXP1, RNU6-281P",Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),"esophageal adenocarcinoma, digestive system disease, Barrett's esophagus",GCST002231,3:70879779
rs7632500-<b>C</b>,1 x 10-6,,0.038,1.37,'-,[1.21-1.55],"GOLIM4, HMGN2P26",Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),"esophageal adenocarcinoma, digestive system disease, Barrett's esophagus",GCST002231,3:168007561
rs2342002-<b>T</b>,7 x 10-6,,0.214,1.15,'-,[1.08-1.23],'-,Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),"esophageal adenocarcinoma, digestive system disease, Barrett's esophagus",GCST002231,6:61285855
rs11771429-<b>G</b>,8 x 10-6,,0.816,1.1905,'-,[1.1-1.28],'-,Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),"esophageal adenocarcinoma, digestive system disease, Barrett's esophagus",GCST002231,7:153574792
rs11789015-<b>A</b>,1 x 10-9,,0.717,1.2048,'-,[1.14-1.27],BARX1,Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),"esophageal adenocarcinoma, digestive system disease, Barrett's esophagus",GCST002231,9:93953746
rs3784262-<b>A</b>,7 x 10-7,,0.54,1.1364,'-,[1.09-1.2],ALDH1A2,Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),"esophageal adenocarcinoma, digestive system disease, Barrett's esophagus",GCST002231,15:57960908
rs2178146-<b>A</b>,1 x 10-6,,0.587,1.1364,'-,[1.09-1.2],"LINC00917, FENDRR",Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),"esophageal adenocarcinoma, digestive system disease, Barrett's esophagus",GCST002231,16:86430089
rs10419226-<b>A</b>,4 x 10-10,,0.456,1.18,'-,[1.12-1.24],CRTC1,Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),"esophageal adenocarcinoma, digestive system disease, Barrett's esophagus",GCST002231,19:18692362
rs2927438-<b>C</b>,2 x 10-6,,0.778,1.1628,'-,[1.1-1.25],"BCL3, CEACAM16-AS1",Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),"esophageal adenocarcinoma, digestive system disease, Barrett's esophagus",GCST002231,19:44738850
rs4800353-<b>T</b>,3 x 10-7,,0.864,1.22,'-,[1.14-1.32],"RNU6ATAC20P, LINC01900",Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),"esophageal adenocarcinoma, digestive system disease, Barrett's esophagus",GCST002231,18:22074176
rs3129859-<b>C</b>,7 x 10-19,,0.15,1.83,'-,[1.60-2.09],"TSBP1-AS1, HLA-DRA",Acute-on-chronic liver failure in hepatitis B,"acute-on-chronic liver failure, hepatitis B virus infection",GCST004165,6:32433162
rs12532051-<b>C</b>,1 x 10-9,,0.96,1.08,'-,'-,CNTNAP2,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,7:148109889
rs9800013-<b>A</b>,3 x 10-9,,0.77,0.96,'-,'-,"MIR4456, CEP72","Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,5:541908
rs149140438-<b>A</b>,1 x 10-8,,0.98,0.9,'-,'-,DEPDC5,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,22:31881896
rs72915655-<b>T</b>,1 x 10-8,,0.83,1.04,'-,'-,'-,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,2:193136387
rs3863241-<b>C</b>,2 x 10-8,,0.47,0.97,'-,'-,"KCNB2, TERF1","Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,8:72978100
undefined,4 x 10-8,,0.76,0.97,'-,'-,'-,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,Mapping not available
rs200964-<b>G</b>,3 x 10-13,,0.81,1.05,'-,'-,"OR2B2, RNU7-26P","Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,6:27899165
rs967823-<b>A</b>,2 x 10-12,,0.61,0.96,'-,'-,CA10,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,17:52239916
rs10500661-<b>T</b>,1 x 10-11,,0.8,0.96,'-,'-,"CNGA4, CCKBR","Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,11:6252514
chr19:18793695-<b>AAAAG</b>,3 x 10-11,,0.67,1.04,'-,'-,'-,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,Mapping not available
rs2861694-<b>A</b>,1 x 10-10,,0.31,1.04,'-,'-,LINC02831,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,2:67618607
rs12631337-<b>A</b>,2 x 10-10,,0.45,1.03,'-,'-,SEMA3F,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,3:50161104
rs61787782-<b>A</b>,8 x 10-10,,0.78,0.96,'-,'-,DPYD,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,1:97844683
chr2:100485494-<b>CCCTCTG</b>,2 x 10-9,,0.64,1.03,'-,'-,'-,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,Mapping not available
rs10641969-<b>T</b>,3 x 10-9,,0.62,1.03,'-,'-,MAML3,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,4:140018944
rs62435650-<b>A</b>,4 x 10-9,,0.8,1.04,'-,'-,"MAD1L1, ELFN1","Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,7:1783629
rs12064884-<b>A</b>,5 x 10-9,,0.5,1.03,'-,'-,PDE4B,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,1:65898968
rs13097265-<b>G</b>,8 x 10-9,,0.71,0.97,'-,'-,"FOXP1, RNU6-281P","Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,3:70893992
rs1873914-<b>G</b>,5 x 10-8,,0.58,1.03,'-,'-,RAB5B,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment","peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease",GCST011500,12:55985643
rs72743477-<b>G</b>,8 x 10-11,,0.21,'-,'-,'-,SMAD3,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,15:67171953
rs12598357-<b>G</b>,4 x 10-9,,0.39,'-,'-,'-,"NPIPB6, SBK1",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,16:28329624
rs12928404-<b>C</b>,6 x 10-7,,0.38,'-,'-,'-,ATXN2L,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,16:28835925
rs117372389-<b>T</b>,8 x 10-11,,0.02,'-,'-,'-,NKD1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,16:50634166
rs12232497-<b>C</b>,3 x 10-7,,0.45,'-,'-,'-,"ZPBP2, GSDMB",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,17:39883866
rs62131887-<b>T</b>,4 x 10-7,,0.28,'-,'-,'-,"KEAP1, PDE4A",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,19:10476920
rs602662-<b>G</b>,5 x 10-8,,0.49,'-,'-,'-,FUT2,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,19:48703728
rs2738774-<b>A</b>,9 x 10-7,,0.32,'-,'-,'-,"STMN3, MHENCR",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,20:63637985
rs2836882-<b>A</b>,5 x 10-8,,0.27,'-,'-,'-,RPL23AP12,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,21:39094644
rs2066363-<b>C</b>,8 x 10-11,,0.34,'-,'-,'-,ADGRL2,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:81771892
rs114846446-<b>A</b>,2 x 10-7,,0.01,'-,'-,'-,LINC01250,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, psoriasis, ankylosing spondylitis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,2:2944140
rs7672495-<b>C</b>,1 x 10-7,,0.18,'-,'-,'-,"RN7SKP113, CYTL1",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,4:4990640
rs7660520-<b>A</b>,8 x 10-11,,0.26,'-,'-,'-,"TENM3, DCTD",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,4:182824168
rs7831697-<b>G</b>,5 x 10-7,,0.25,'-,'-,'-,RNU6-144P,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,8:137124061
rs7042370-<b>T</b>,1 x 10-7,,0.43,'-,'-,'-,"LURAP1L-AS1, LURAP1L",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,9:12785074
rs10988542-<b>C</b>,7 x 10-7,,0.08,'-,'-,'-,FNBP1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,9:129894985
rs7100025-<b>G</b>,8 x 10-11,,0.34,'-,'-,'-,LINC00993,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,10:37303610
rs11839053-<b>C</b>,1 x 10-6,,0.02,'-,'-,'-,"LINC00460, RPL35P9",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,13:106410694
rs77150043-<b>T</b>,6 x 10-9,,0.23,'-,'-,'-,ADCY7,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,16:50270338
rs2807264-<b>C</b>,1 x 10-8,,0.21,'-,'-,'-,"RNU6-320P, LINC00892",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,X:136583619
rs12863738-<b>T</b>,6 x 10-8,,0.17,'-,'-,'-,"RPL22P23, SRRM1P3",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,X:136949968
rs11580078-<b>G</b>,8 x 10-11,,0.43,'-,'-,'-,"IL23R, C1orf141",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:67203951
rs6679677-<b>A</b>,8 x 10-11,,0.09,'-,'-,'-,"RSBN1, PHTF1",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:113761186
rs34884278-<b>C</b>,4 x 10-7,,0.3,'-,'-,'-,AIMP1P2,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:172869708
rs6689858-<b>C</b>,2 x 10-7,,0.29,'-,'-,'-,CRB1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:197406337
rs55705316-<b>G</b>,1 x 10-6,,0.14,'-,'-,'-,"Y_RNA, IL10",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,1:206760172
rs2075184-<b>T</b>,9 x 10-8,,0.23,'-,'-,'-,"IL18RAP, SLC9A4",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,2:102464132
rs36001488-<b>C</b>,8 x 10-11,,0.48,'-,'-,'-,ATG16L1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,2:233276621
rs4676410-<b>A</b>,2 x 10-7,,0.19,'-,'-,'-,GPR35,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,2:240624322
rs4625-<b>G</b>,8 x 10-11,,0.31,'-,'-,'-,DAG1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,3:49534707
rs62324212-<b>A</b>,3 x 10-8,,0.42,'-,'-,'-,IL21-AS1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,4:122639784
rs7725052-<b>C</b>,8 x 10-11,,0.43,'-,'-,'-,TTC33,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,5:40487168
rs7731626-<b>A</b>,1 x 10-10,,0.39,'-,'-,'-,ANKRD55,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,5:56148856
rs4869313-<b>T</b>,9 x 10-8,,0.42,'-,'-,'-,ERAP2,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,5:96888176
rs11741255-<b>A</b>,2 x 10-9,,0.42,'-,'-,'-,"IRF1-AS1, IRF1",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,5:132475490
rs755374-<b>T</b>,2 x 10-10,,0.32,'-,'-,'-,"LINC01845, IL12B",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,5:159402286
rs36051895-<b>T</b>,9 x 10-8,,0.29,'-,'-,'-,"JAK2, HNRNPA1P41",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,9:4981866
rs4246905-<b>T</b>,1 x 10-8,,0.28,'-,'-,'-,TNFSF15,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,9:114790969
rs11145763-<b>C</b>,3 x 10-8,,0.4,'-,'-,'-,CARD9,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,9:136369144
rs706778-<b>T</b>,6 x 10-9,,0.41,'-,'-,'-,IL2RA,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,10:6056986
rs10822050-<b>C</b>,8 x 10-11,,0.39,'-,'-,'-,ALDH7A1P4,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,10:62679011
rs1250563-<b>C</b>,1 x 10-8,,0.29,'-,'-,'-,ZMIZ1,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,10:79287626
rs1332099-<b>T</b>,9 x 10-11,,0.46,'-,'-,'-,"NKX2-3, SLC25A28",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,10:99538694
rs17885785-<b>T</b>,8 x 10-11,,0.2,'-,'-,'-,"IGF2-AS, INS-IGF2",Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,11:2146620
rs17466626-<b>G</b>,3 x 10-10,,0.02,'-,'-,'-,LRRK2,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,12:40366829
rs1689510-<b>C</b>,4 x 10-9,,0.31,'-,'-,'-,SUOX,Pediatric autoimmune diseases,"autoimmune thyroid disease, type I diabetes mellitus, Common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus",GCST003097,12:56002984
rs2249296-<b>C</b>,1 x 10-6,(Ileal involvement),0.78,1.69,'-,[1.35-2.13],CLCA2,Crohn's disease-related phenotypes,"ileocolitis, Crohn's disease",GCST002729,1:86444581
rs1529093-<b>A</b>,2 x 10-6,(BallonTT),0.41,'-,4.13 unit increase,[NR],RNA5SP112,Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,2:177044867
rs2645424-<b>A</b>,7 x 10-7,(NAS),0.4,'-,0.77 unit decrease,[NR],FDFT1,Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,8:11826954
rs343064-<b>A</b>,3 x 10-8,(Fibrosis),0.4,'-,1.31 unit increase,[NR],'-,Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,7:35515178
rs6487679-<b>G</b>,1 x 10-6,,0.16,'-,0.4 unit increase,[NR],"PZP, A2MP1",Non-alcoholic fatty liver disease histology (AST),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000767,12:9218736
rs2710833-<b>A</b>,6 x 10-7,,0.17,'-,0.41 unit increase,[NR],DDX60L,Non-alcoholic fatty liver disease histology (AST),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000767,4:168488807
rs1414896-<b>G</b>,2 x 10-6,,0.4,'-,0.26 unit increase,[NR],TLCD4-RWDD3,Non-alcoholic fatty liver disease histology (AST),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000767,1:95226754
rs2499604-<b>A</b>,2 x 10-6,,0.44,'-,0.39 unit decrease,[NR],"MTCO1P38, ZP4",Non-alcoholic fatty liver disease histology (AST),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000767,1:237940201
rs2049953-<b>C</b>,4 x 10-6,,0.3,'-,0.26 unit increase,[NR],MEMO1P2,Non-alcoholic fatty liver disease histology (AST),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000767,6:134817852
rs12344488-<b>A</b>,5 x 10-6,,0.07,'-,0.51 unit decrease,[NR],"OTX2P1, PCSK5",Non-alcoholic fatty liver disease histology (AST),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000767,9:75811009
rs2216228-<b>G</b>,4 x 10-6,,0.18,'-,0.45 unit increase,[NR],ST8SIA1,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,12:22212901
rs1227756-<b>G</b>,2 x 10-7,,0.46,'-,0.57 unit increase,[NR],COL13A1,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,10:69828748
rs2645424-<b>A</b>,3 x 10-6,,0.4,'-,0.3 unit decrease,[NR],FDFT1,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,8:11826954
rs7632299-<b>A</b>,4 x 10-6,,0.17,'-,0.45 unit increase,[NR],SLC9A9,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,3:143337625
rs10954668-<b>A</b>,7 x 10-6,,0.33,'-,0.32 unit decrease,[NR],CACNA2D1,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,7:82218335
rs4237591-<b>G</b>,2 x 10-6,,0.35,'-,0.33 unit decrease,[NR],'-,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,11:98595538
rs6591182-<b>A</b>,9 x 10-7,,0.47,'-,0.54 unit increase,[NR],EHBP1L1,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,11:65582285
rs9584805-<b>G</b>,2 x 10-6,,0.35,'-,0.44 unit decrease,[NR],FARP1,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,13:98341776
rs887304-<b>A</b>,8 x 10-7,,0.31,'-,0.36 unit increase,[NR],CRACR2A,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,12:3648382
rs11083271-<b>A</b>,8 x 10-6,,0.34,'-,0.61 unit increase,[NR],TCF4,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,18:28346095
rs2986971-<b>G</b>,3 x 10-6,,0.48,'-,0.49 unit increase,[NR],SVIL,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,10:29807699
rs10067427-<b>G</b>,5 x 10-6,,0.3,'-,0.75 unit increase,[NR],"EEF1A1P20, Y_RNA",Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,5:100006343
rs7077164-<b>A</b>,7 x 10-6,,0.3,'-,0.67 unit increase,[NR],COL13A1,Non-alcoholic fatty liver disease histology (lobular),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000766,10:69823442
rs11669592-<b>A</b>,4 x 10-6,(NAS),0.45,'-,1.31 unit decrease,[NR],NFIC,Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,19:3318512
rs6027755-<b>A</b>,6 x 10-6,(Fibrosis),0.39,'-,1.09 unit increase,[NR],MIR646HG,Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,20:60693652
rs959903-<b>A</b>,7 x 10-6,(Ballon TT),0.29,'-,3.81 unit increase,[NR],SEL1L3,Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,4:25808474
rs1836127-<b>A</b>,3 x 10-6,(NAS),0.42,'-,0.76 unit increase,[NR],"NACAP8, LINC02412",Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,12:93156525
rs2358462-<b>G</b>,4 x 10-6,(Steatosis),0.44,'-,0.6 unit increase,[NR],"ATP5MGP4, RNA5SP166",Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,4:148649528
rs9977253-<b>G</b>,5 x 10-6,(Steatosis),0.33,'-,0.76 unit increase,[NR],"RPL13AP7, RNA5SP489",Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,21:25272769
rs10510146-<b>A</b>,7 x 10-6,(Ballon TT),0.13,'-,0.23 unit increase,[NR],TEX36,Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,10:125607576
rs643608-<b>G</b>,1 x 10-6,(Steatosis),0.38,'-,0.74 unit increase,[NR],"LINC00322, LINC01679",Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,21:43348682
rs4243849-<b>G</b>,2 x 10-6,(Steatosis),0.52,'-,0.14 unit increase,[NR],"RNU1-35P, KHDRBS3",Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,8:135700894
rs6079395-<b>A</b>,7 x 10-6,(Fibrosis),0.49,'-,0.92 unit increase,[NR],MACROD2,Non-alcoholic fatty liver disease histology (other),"non-alcoholic fatty liver disease, cirrhosis of liver",GCST000765,20:14347253
rs9481067-<b>G</b>,1 x 10-6,"(univariable, recessive)",'-,4.17,'-,[2.33-7.43],SLC22A16,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,6:110429349
rs10511330-<b>C</b>,1 x 10-6,"(multivariable, dominant)",'-,4.85,'-,[2.54-9.23],ZBTB20,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,3:114402172
rs16822593-<b>A</b>,2 x 10-6,"(multivariable, dominant)",'-,4.83,'-,[2.53-9.20],ZBTB20,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,3:114398480
rs13019215-<b>C</b>,8 x 10-6,"(multivariable, dominant)",'-,4.347826,'-,[2.33-8.33],CCDC141,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,2:178995835
rs12471607-<b>C</b>,8 x 10-6,"(multivariable, dominant)",'-,4.347826,'-,[2.33-8.33],CCDC141,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,2:179003258
rs716897-<b>T</b>,5 x 10-6,"(univariable, dominant)",'-,3.7037036,'-,[2.13-6.67],RASGRF2,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,5:81187755
rs4837345-<b>T</b>,4 x 10-6,"(univariable, recessive)",'-,4.72,'-,[2.40-9.05],"PTPA, IER5L",Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,9:129161670
rs10819474-<b>C</b>,4 x 10-6,"(univariable, recessive)",'-,4.72,'-,[2.40-9.05],"PTPA, IER5L",Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,9:129168215
rs11159673-<b>A</b>,7 x 10-6,"(univariable, additive)",NR,3.096,'-,[1.879-5.073],RNU6-976P,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,14:84647825
kgp4136779-<b>T</b>,4 x 10-6,"(univariable, recessive)",NR,4.721,'-,[2.403-9.052],'-,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,Mapping not available
rs1075650-<b>G</b>,4 x 10-6,"(univariable, recessive)",NR,4.721,'-,[2.403-9.052],IER5L,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,9:129176634
rs6596805-<b>G</b>,6 x 10-6,"(univariable, recessive)",NR,3.862,'-,[2.139-6.908],FOXQ1,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,6:1294916
rs11047047-<b>G</b>,6 x 10-6,"(univariable, recessive)",NR,3.734,'-,[2.104-6.613],SOX5,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,12:23683278
rs1661281-<b>T</b>,6 x 10-6,"(univariable, recessive)",NR,5.284,'-,[2.518-10.764],ANKRD22,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,10:88820573
rs919001-<b>A</b>,7 x 10-6,"(univariable, recessive)",NR,3.913,'-,[2.134-7.077],TRPM1,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,15:31064935
rs7314811-<b>C</b>,3 x 10-6,"(univariable, co-dominant)",NR,5.974,'-,[2.803-12.805],ETV6,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,12:11809639
rs16907305-<b>A</b>,8 x 10-6,"(univariable, co-dominant)",NR,5.55,'-,[2.611-11.857],ETV6,Mucinous adenocarcinoma in colorectal cancer,"colorectal cancer, colorectal mucinous adenocarcinoma",GCST006411,12:11812006
rs2120243-<b>?</b>,2 x 10-6,,NR,1.76,'-,1.39-2.22,VEPH1,Hepatocellular carcinoma in hepatitis B infection,"hepatitis B virus infection, hepatocellular carcinoma",GCST003189,3:157429779
rs1350171-<b>?</b>,6 x 10-6,,NR,1.66,'-,[1.33-2.07],PRSS23,Hepatocellular carcinoma in hepatitis B infection,"hepatitis B virus infection, hepatocellular carcinoma",GCST003189,11:86933347
rs11877682-<b>T</b>,5 x 10-8,,NR,5.032713,'-,NR,SIGLEC15,Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,18:45831894
rs149015592-<b>C</b>,7 x 10-7,,NR,4.6061726,'-,NR,MAST2,Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,1:45986078
rs7512851-<b>A</b>,5 x 10-7,,NR,4.3840423,'-,NR,"U6, FAM183A",Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,1:43102462
rs138233937-<b>T</b>,4 x 10-7,,NR,4.291846,'-,NR,ACYP2,Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,2:54227422
rs117977426-<b>T</b>,4 x 10-7,,0.011123,2.37023,'-,NR,'-,Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,11:87944873
rs189358636-<b>A</b>,5 x 10-7,,0.013195,2.2256844,'-,NR,"BDKRB1, ATG2B",Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,14:96275234
rs75460256-<b>G</b>,1 x 10-8,,0.023935,1.8737118,'-,NR,ECRG4,Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,2:106071382
rs141107350-<b>A</b>,6 x 10-7,,0.030463,1.6458197,'-,NR,TRPM1,Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,15:31004873
rs62134018-<b>A</b>,3 x 10-7,,0.058934,1.4858841,'-,NR,RMDN2,Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,2:37945021
rs13324393-<b>A</b>,6 x 10-7,,0.121031,1.3460763,'-,NR,NPM1P28,Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,3:147677285
rs618688-<b>A</b>,6 x 10-7,,0.413291,1.241465,'-,NR,'-,Esophageal or stomach cancer,"esophageal carcinoma, gastric carcinoma",GCST90011807,6:147908493
rs6935723-<b>C</b>,1 x 10-21,,0.27,2.46,'-,[2.04-2.98],"MTCO3P1, HLA-DQB3",Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine),"response to thiopurine, thiopurine immunosuppressant-induced pancreatitis, inflammatory bowel disease",GCST002607,6:32713892
rs1229984-<b>G</b>,2 x 10-15,,0.94,1.7898692,'-,'-,ADH1B,Oral cavity and pharyngeal cancer,"pharynx cancer, oral cavity cancer",GCST003857,4:99318162
rs79767424-<b>C</b>,4 x 10-10,,0.97,1.812908,'-,'-,RPL32P14,Oral cavity and pharyngeal cancer,"pharynx cancer, oral cavity cancer",GCST003857,5:19108581
rs1453414-<b>C</b>,5 x 10-8,,0.2,1.1945,'-,'-,TRIM5,Oral cavity and pharyngeal cancer,"pharynx cancer, oral cavity cancer",GCST003857,11:5807854
rs3828805-<b>C</b>,3 x 10-13,,0.72,1.2759,'-,'-,HLA-DQB1,Oral cavity and pharyngeal cancer,"pharynx cancer, oral cavity cancer",GCST003857,6:32668343
rs77452476-<b>C</b>,3 x 10-7,,0.16,1.24,'-,'-,LAMC3,Oral cavity and pharyngeal cancer,"pharynx cancer, oral cavity cancer",GCST003857,9:131087186
rs7552722-<b>A</b>,7 x 10-6,,0.32,1.27,'-,[1.00-1.61],NGF-AS1,Pediatric non-alcoholic fatty liver disease activity score,"non-alcoholic fatty liver disease, cirrhosis of liver",GCST001928,1:115378734
rs6691847-<b>C</b>,7 x 10-6,,0.77,1.32,'-,[0.98-1.77],'-,Pediatric non-alcoholic fatty liver disease activity score,"non-alcoholic fatty liver disease, cirrhosis of liver",GCST001928,1:29792805
rs2051090-<b>G</b>,7 x 10-6,,0.81,1.19,'-,[0.88-1.62],DCLK1,Pediatric non-alcoholic fatty liver disease activity score,"non-alcoholic fatty liver disease, cirrhosis of liver",GCST001928,13:35880056
rs2896019-<b>G</b>,2 x 10-20,,0.45,2.02,'-,[1.60-2.56],PNPLA3,Pediatric non-alcoholic fatty liver disease activity score,"non-alcoholic fatty liver disease, cirrhosis of liver",GCST001928,22:43937814
rs16841904-<b>?</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,DENND1B,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:197732862
rs7552167-<b>?</b>,1 x 10-8,(subset analysis),NR,'-,'-,'-,"IFNLR1, LINC02800","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:24192153
rs12131796-<b>?</b>,5 x 10-41,(subset analysis),NR,'-,'-,'-,INAVA,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:200909599
rs3024493-<b>?</b>,1 x 10-38,(subset analysis),NR,'-,'-,'-,IL10,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:206770623
rs12075255-<b>?</b>,3 x 10-11,(subset analysis),NR,'-,'-,'-,IL19,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:206788283
rs2666218-<b>?</b>,9 x 10-10,(subset analysis),NR,'-,'-,'-,ASAP2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:9262859
rs13407913-<b>?</b>,3 x 10-18,(subset analysis),NR,'-,'-,'-,ADCY3,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:24874775
rs201014116-<b>?</b>,2 x 10-7,(subset analysis),NR,'-,'-,'-,DNMT3A,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:25278036
rs1260326-<b>?</b>,2 x 10-23,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,Mapping not available
rs6600247-<b>?</b>,9 x 10-29,(subset analysis),NR,'-,'-,'-,"RUNX3, MIR4425","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:24978623
rs77981966-<b>?</b>,2 x 10-16,(subset analysis),NR,'-,'-,'-,THADA,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:43550825
rs7608910-<b>?</b>,2 x 10-32,(subset analysis),NR,'-,'-,'-,PUS10,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:60977721
rs702872-<b>?</b>,4 x 10-11,(subset analysis),NR,'-,'-,'-,LINC01185,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:60854175
rs4672505-<b>?</b>,2 x 10-52,(subset analysis),NR,'-,'-,'-,RN7SL51P,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:62333197
rs11675538-<b>?</b>,3 x 10-8,(subset analysis),NR,'-,'-,'-,"DNAJB12P1, SPRED2","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:65459327
rs4851529-<b>?</b>,1 x 10-14,(subset analysis),NR,'-,'-,'-,"IL1R1, IL1R2","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:102030838
rs12987977-<b>?</b>,3 x 10-17,(subset analysis),NR,'-,'-,'-,IL18R1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:102358876
rs871656-<b>?</b>,1 x 10-9,(subset analysis),NR,'-,'-,'-,IL1R1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:102154822
rs11691685-<b>?</b>,5 x 10-8,(subset analysis),NR,'-,'-,'-,TEX41,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:144724260
rs2111485-<b>?</b>,3 x 10-13,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,Mapping not available
rs35667974-<b>?</b>,5 x 10-10,(subset analysis),NR,'-,'-,'-,IFIH1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:162268127
rs3747517-<b>?</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,IFIH1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:162272314
rs72871627-<b>?</b>,1 x 10-8,(subset analysis),NR,'-,'-,'-,IFIH1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:162280432
rs17229679-<b>?</b>,3 x 10-17,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:198696033
rs6434978-<b>?</b>,1 x 10-10,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:198702963
rs34920465-<b>?</b>,3 x 10-13,(subset analysis),NR,'-,'-,'-,"ZBTB40, PPIAP34","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:22373858
rs2816958-<b>?</b>,4 x 10-15,(subset analysis),NR,'-,'-,'-,NR5A2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:200132792
rs6697886-<b>?</b>,2 x 10-10,(subset analysis),NR,'-,'-,'-,"C1QTNF12, B3GALT6","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:1238231
rs2234161-<b>?</b>,2 x 10-11,(subset analysis),NR,'-,'-,'-,TNFRSF14,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:2559766
rs3766606-<b>?</b>,9 x 10-14,(subset analysis),NR,'-,'-,'-,PARK7,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:7962137
rs6426833-<b>?</b>,7 x 10-62,(subset analysis),NR,'-,'-,'-,"OTUD3, RNF186","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:19845367
rs3806308-<b>?</b>,1 x 10-24,(subset analysis),NR,'-,'-,'-,"RNF186, OTUD3","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:19816373
rs4655215-<b>?</b>,8 x 10-20,(subset analysis),NR,'-,'-,'-,"RNF186, TMCO4","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:19811221
rs925255-<b>?</b>,8 x 10-18,(subset analysis),NR,'-,'-,'-,FLJ31356,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:28391927
rs80174646-<b>?</b>,1 x 10-143,(subset analysis),NR,'-,'-,'-,IL23R,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:67242472
rs7517847-<b>?</b>,1 x 10-98,(subset analysis),NR,'-,'-,'-,"IL23R, C1orf141","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:67215986
rs10889676-<b>?</b>,2 x 10-24,(subset analysis),NR,'-,'-,'-,IL23R,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:67256884
rs183686347-<b>?</b>,6 x 10-14,(subset analysis),NR,'-,'-,'-,IL23R,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:67237759
rs2476601-<b>?</b>,3 x 10-12,(subset analysis),NR,'-,'-,'-,PTPN22,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:113834946
rs114202211-<b>?</b>,5 x 10-8,(subset analysis),NR,'-,'-,'-,HIPK1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:113943285
rs4845604-<b>?</b>,2 x 10-16,(subset analysis),NR,'-,'-,'-,RORC,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:151829204
rs6693105-<b>?</b>,4 x 10-24,(subset analysis),NR,'-,'-,'-,"LCE3B, LCE3A","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:152618187
rs4129267-<b>?</b>,9 x 10-18,(subset analysis),NR,'-,'-,'-,IL6R,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:154453788
rs4971079-<b>?</b>,3 x 10-10,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,Mapping not available
rs78973538-<b>?</b>,3 x 10-8,(subset analysis),NR,'-,'-,'-,GBAP1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:155224224
rs1333062-<b>?</b>,2 x 10-11,(subset analysis),NR,'-,'-,'-,"ITLN1, CD244","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:160876494
rs10800314-<b>?</b>,1 x 10-32,(subset analysis),NR,'-,'-,'-,FCGR2A,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:161502999
rs61802846-<b>?</b>,1 x 10-9,(subset analysis),NR,'-,'-,'-,FCGR2A,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:161504083
rs79568124-<b>?</b>,8 x 10-7,(subset analysis),NR,'-,'-,'-,"HSPA6, RPS23P10","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:161533059
rs6425143-<b>?</b>,1 x 10-17,(subset analysis),NR,'-,'-,'-,AIMP1P2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,1:172875212
rs1847472-<b>?</b>,5 x 10-10,(subset analysis),NR,'-,'-,'-,BACH2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:90263440
rs4946717-<b>?</b>,1 x 10-21,(subset analysis),NR,'-,'-,'-,PRDM1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:106026874
rs28701841-<b>?</b>,6 x 10-10,(subset analysis),NR,'-,'-,'-,"PRDM1, ATG5","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:106082455
rs9491891-<b>?</b>,5 x 10-15,(subset analysis),NR,'-,'-,'-,"PTPRK, THEMIS","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:127956006
rs582757-<b>?</b>,1 x 10-16,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,Mapping not available
rs928722-<b>?</b>,4 x 10-14,(subset analysis),NR,'-,'-,'-,LINC02539,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:137652695
rs9494840-<b>?</b>,3 x 10-9,(subset analysis),NR,'-,'-,'-,"LINC02539, BTF3L4P3","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:137641937
rs2451258-<b>?</b>,5 x 10-17,(subset analysis),NR,'-,'-,'-,TAGAP-AS1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:159085568
rs67025039-<b>?</b>,9 x 10-25,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,Mapping not available
rs111305875-<b>?</b>,3 x 10-7,(subset analysis),NR,'-,'-,'-,"CEP43, CCR6","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:167098098
rs2301436-<b>?</b>,8 x 10-7,(subset analysis),NR,'-,'-,'-,CEP43,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:167024500
rs1182188-<b>?</b>,4 x 10-11,(subset analysis),NR,'-,'-,'-,GNA12,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:2830351
rs1525735-<b>?</b>,9 x 10-9,(subset analysis),NR,'-,'-,'-,AHR,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:17157947
rs28550029-<b>?</b>,3 x 10-18,(subset analysis),NR,'-,'-,'-,SKAP2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:26832962
rs860262-<b>?</b>,7 x 10-9,(subset analysis),NR,'-,'-,'-,JAZF1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:28154778
rs4917129-<b>?</b>,4 x 10-12,(subset analysis),NR,'-,'-,'-,IKZF1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:50283578
rs12718244-<b>?</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,SPATA48,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:50136058
rs9297145-<b>?</b>,1 x 10-8,(subset analysis),NR,'-,'-,'-,"SMURF1, KPNA7","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:99161494
rs6466198-<b>?</b>,1 x 10-21,(subset analysis),NR,'-,'-,'-,"DLD, PIGCP2","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:107839681
rs7805114-<b>?</b>,5 x 10-11,(subset analysis),NR,'-,'-,'-,"DLD, PIGCP2","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:107809588
rs4728142-<b>?</b>,2 x 10-11,(subset analysis),NR,'-,'-,'-,"IRF5, KCP","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:128933913
rs2538470-<b>?</b>,2 x 10-10,(subset analysis),NR,'-,'-,'-,"RPL32P17, RN7SL72P","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,7:148523356
rs10094579-<b>?</b>,2 x 10-10,(subset analysis),NR,'-,'-,'-,"RNU6-925P, COX6B1P6","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,8:89837077
rs1551399-<b>?</b>,4 x 10-19,(subset analysis),NR,'-,'-,'-,TRIB1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,8:125527723
rs2042011-<b>?</b>,4 x 10-8,(subset analysis),NR,'-,'-,'-,"PVT1, RN7SKP226","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,8:128215706
rs6651252-<b>?</b>,2 x 10-17,(subset analysis),NR,'-,'-,'-,LINC00824,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,8:128554935
rs10758669-<b>?</b>,5 x 10-43,(subset analysis),NR,'-,'-,'-,"JAK2, HNRNPA1P41","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,9:4981602
rs2812378-<b>?</b>,6 x 10-9,(subset analysis),NR,'-,'-,'-,"FAM205A, CCL21","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,9:34710263
rs7848647-<b>?</b>,1 x 10-25,(subset analysis),NR,'-,'-,'-,"TNFSF15, DELEC1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,9:114806766
rs726657-<b>?</b>,1 x 10-14,(subset analysis),NR,'-,'-,'-,DELEC1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,9:114934056
rs7468800-<b>?</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,"TNFSF15, DELEC1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,9:114829725
rs4986790-<b>?</b>,1 x 10-8,(subset analysis),NR,'-,'-,'-,TLR4,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,9:117713024
rs10870077-<b>?</b>,6 x 10-45,(subset analysis),NR,'-,'-,'-,CARD9,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,9:136369439
rs141992399-<b>?</b>,1 x 10-31,(subset analysis),NR,'-,'-,'-,CARD9,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,9:136365140
rs3124998-<b>?</b>,9 x 10-9,(subset analysis),NR,'-,'-,'-,NOTCH1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,9:136494980
rs61839660-<b>?</b>,1 x 10-15,(subset analysis),NR,'-,'-,'-,IL2RA,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:6052734
rs3118471-<b>?</b>,4 x 10-13,(subset analysis),NR,'-,'-,'-,IL2RA,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:6060794
rs76913543-<b>?</b>,4 x 10-12,(subset analysis),NR,'-,'-,'-,"IL2RA, IL15RA","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:6000052
rs2104286-<b>?</b>,4 x 10-8,(subset analysis),NR,'-,'-,'-,IL2RA,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:6057082
rs2236379-<b>?</b>,9 x 10-9,(subset analysis),NR,'-,'-,'-,PRKCQ,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:6485181
rs2050392-<b>?</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,"CCND3P1, NIFKP1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:30402574
rs34779708-<b>?</b>,5 x 10-29,(subset analysis),NR,'-,'-,'-,CREM,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:35177257
rs10995271-<b>?</b>,3 x 10-48,(subset analysis),NR,'-,'-,'-,ALDH7A1P4,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:62678726
rs7915475-<b>?</b>,3 x 10-10,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:62621908
rs2227551-<b>?</b>,3 x 10-8,(subset analysis),NR,'-,'-,'-,PLAU,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:73909432
rs1250573-<b>?</b>,2 x 10-22,(subset analysis),NR,'-,'-,'-,ZMIZ1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:79282718
rs7097656-<b>?</b>,1 x 10-13,(subset analysis),NR,'-,'-,'-,TSPAN14,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:80491075
rs1800682-<b>?</b>,4 x 10-9,(subset analysis),NR,'-,'-,'-,ACTA2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:88990206
rs2497318-<b>?</b>,3 x 10-11,(subset analysis),NR,'-,'-,'-,"EIF2S2P3, HHEX","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:92672243
rs10748781-<b>?</b>,6 x 10-51,(subset analysis),NR,'-,'-,'-,"GOT1, LINC01475","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:99523573
rs11190133-<b>?</b>,6 x 10-9,(subset analysis),NR,'-,'-,'-,"GOT1, LINC01475","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:99518968
rs10743181-<b>?</b>,2 x 10-8,(subset analysis),NR,'-,'-,'-,"MIR4686, ASCL2","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:2208529
rs11229555-<b>?</b>,4 x 10-8,(subset analysis),NR,'-,'-,'-,GLYAT,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:58641214
rs10750899-<b>?</b>,2 x 10-7,(subset analysis),NR,'-,'-,'-,"LPXN, OR5B21","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:58517478
rs11230563-<b>?</b>,5 x 10-15,(subset analysis),NR,'-,'-,'-,CD6,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:61008737
rs174535-<b>?</b>,2 x 10-11,(subset analysis),NR,'-,'-,'-,"TMEM258, MYRF","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:61783884
rs559928-<b>?</b>,8 x 10-14,(subset analysis),NR,'-,'-,'-,"RPS6KA4, LINC02723","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:64382898
rs568617-<b>?</b>,4 x 10-8,(subset analysis),NR,'-,'-,'-,FIBP,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:65885771
rs11236797-<b>?</b>,3 x 10-43,(subset analysis),NR,'-,'-,'-,"EMSY, LINC02757","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:76588605
rs7115956-<b>?</b>,8 x 10-12,(subset analysis),NR,'-,'-,'-,RDX,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:110085620
rs4561177-<b>?</b>,1 x 10-9,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,Mapping not available
rs661054-<b>?</b>,2 x 10-14,(subset analysis),NR,'-,'-,'-,NXPE1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:114559688
rs7933433-<b>?</b>,1 x 10-10,(subset analysis),NR,'-,'-,'-,LINC02098,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:128324555
rs11221332-<b>?</b>,2 x 10-10,(subset analysis),NR,'-,'-,'-,ETS1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:128511079
rs11221322-<b>?</b>,1 x 10-6,(subset analysis),NR,'-,'-,'-,ETS1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,11:128476898
rs1860545-<b>?</b>,3 x 10-17,(subset analysis),NR,'-,'-,'-,TNFRSF1A,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,12:6337611
rs11616188-<b>?</b>,3 x 10-14,(subset analysis),NR,'-,'-,'-,"LTBR, SRP14P1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,12:6393576
rs7313895-<b>?</b>,4 x 10-17,(subset analysis),NR,'-,'-,'-,LRRK2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,12:40350592
rs11168249-<b>?</b>,6 x 10-9,(subset analysis),NR,'-,'-,'-,HDAC7,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,12:47814585
rs11614178-<b>?</b>,2 x 10-34,(subset analysis),NR,'-,'-,'-,IFNG-AS1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,12:68114342
rs12369214-<b>?</b>,2 x 10-8,(subset analysis),NR,'-,'-,'-,RIC8B,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,12:106804833
rs3184504-<b>?</b>,4 x 10-10,(subset analysis),NR,'-,'-,'-,"SH2B3, ATXN2","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,12:111446804
rs17085007-<b>?</b>,2 x 10-13,(subset analysis),NR,'-,'-,'-,"FGFR1OP2P1, RPS21P8","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,13:26957130
rs941823-<b>?</b>,7 x 10-11,(subset analysis),NR,'-,'-,'-,LINC00598,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,13:40439840
rs6561151-<b>?</b>,1 x 10-22,(subset analysis),NR,'-,'-,'-,NRAD1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,13:43910570
rs2026029-<b>?</b>,1 x 10-7,(subset analysis),NR,'-,'-,'-,FNDC3A,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,13:49021195
rs9554587-<b>?</b>,9 x 10-10,(subset analysis),NR,'-,'-,'-,"CCR12P, UBAC2","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,13:99388400
rs2145623-<b>?</b>,3 x 10-10,(subset analysis),NR,'-,'-,'-,"NFKBIA, PSMA6","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,14:35370030
rs8006884-<b>?</b>,7 x 10-10,(subset analysis),NR,'-,'-,'-,"FAM177A1, PPP2R3C","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,14:35094005
rs12879003-<b>?</b>,3 x 10-7,(subset analysis),NR,'-,'-,'-,"NFKBIA, PSMA6","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,14:35359535
rs1569328-<b>?</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,"FOS, U2","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,14:75275048
rs11624293-<b>?</b>,2 x 10-17,(subset analysis),NR,'-,'-,'-,LINC01147,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,14:88022477
rs16967103-<b>?</b>,5 x 10-9,(subset analysis),NR,'-,'-,'-,"RASGRP1, LINC02694","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,15:38606989
rs17293632-<b>?</b>,1 x 10-16,(subset analysis),NR,'-,'-,'-,SMAD3,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,15:67150258
rs35874463-<b>?</b>,1 x 10-11,(subset analysis),NR,'-,'-,'-,SMAD3,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,15:67165360
rs367569-<b>?</b>,5 x 10-14,(subset analysis),NR,'-,'-,'-,RMI2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:11271643
rs11649613-<b>?</b>,3 x 10-10,(subset analysis),NR,'-,'-,'-,"CLEC16A, HNRNPCP4","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:11225500
rs8061882-<b>?</b>,3 x 10-7,(subset analysis),NR,'-,'-,'-,CLEC16A,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:11067551
rs7195296-<b>?</b>,3 x 10-13,(subset analysis),NR,'-,'-,'-,"LITAF, SNN","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:11655918
rs7404095-<b>?</b>,3 x 10-9,(subset analysis),NR,'-,'-,'-,PRKCB,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:23853269
rs26528-<b>?</b>,3 x 10-29,(subset analysis),NR,'-,'-,'-,IL27,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:28506388
rs34670647-<b>?</b>,4 x 10-30,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,Mapping not available
rs11574938-<b>?</b>,5 x 10-14,(subset analysis),NR,'-,'-,'-,ITGAL,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:30474072
rs1870293-<b>?</b>,1 x 10-10,(subset analysis),NR,'-,'-,'-,SETD1A,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:30959620
rs2066845-<b>?</b>,6 x 10-94,(subset analysis),NR,'-,'-,'-,NOD2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:50722629
rs2357623-<b>?</b>,4 x 10-48,(subset analysis),NR,'-,'-,'-,"SNX20, NKD1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:50660100
rs72796367-<b>?</b>,1 x 10-16,(subset analysis),NR,'-,'-,'-,"NOD2, CYLD-AS1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:50728860
rs5743293-<b>?</b>,1 x 10-320,(subset analysis),NR,'-,'-,'-,"NOD2, CYLD-AS1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:50729868
rs11117431-<b>?</b>,5 x 10-16,(subset analysis),NR,'-,'-,'-,LINC02132,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:85981710
rs12932970-<b>?</b>,1 x 10-8,(subset analysis),NR,'-,'-,'-,LINC02132,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,16:85970504
rs11749040-<b>?</b>,7 x 10-28,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:40396323
rs9687958-<b>?</b>,3 x 10-16,(subset analysis),NR,'-,'-,'-,TTC33,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:40496321
rs353339-<b>?</b>,5 x 10-13,(subset analysis),NR,'-,'-,'-,LINC00604,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:40201698
rs71624119-<b>?</b>,2 x 10-8,(subset analysis),NR,'-,'-,'-,ANKRD55,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:56144903
rs4703855-<b>?</b>,3 x 10-8,(subset analysis),NR,'-,'-,'-,"PTCD2, YBX1P5","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:72398072
rs34804116-<b>?</b>,3 x 10-10,(subset analysis),NR,'-,'-,'-,"TMEM174, LINC02230","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:73244023
rs469758-<b>?</b>,6 x 10-54,(subset analysis),NR,'-,'-,'-,ERAP1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:96786011
rs2910686-<b>?</b>,2 x 10-21,(subset analysis),NR,'-,'-,'-,ERAP2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:96916885
rs2549803-<b>?</b>,4 x 10-12,(subset analysis),NR,'-,'-,'-,"ERAP2, ERAP1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:96839226
rs17622378-<b>?</b>,2 x 10-55,(subset analysis),NR,'-,'-,'-,"IRF1, IRF1-AS1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:132442760
rs17622517-<b>?</b>,1 x 10-7,(subset analysis),NR,'-,'-,'-,"IRF1, IRF1-AS1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:132467845
rs1004234-<b>?</b>,4 x 10-7,(subset analysis),NR,'-,'-,'-,"LINC02863, IRF1-AS1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:132421409
rs6863411-<b>?</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,NDFIP1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:142133639
rs11749391-<b>?</b>,2 x 10-42,(subset analysis),NR,'-,'-,'-,IRGM,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:150849504
rs74817271-<b>?</b>,2 x 10-26,(subset analysis),NR,'-,'-,'-,TNIP1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:151090412
rs56167332-<b>?</b>,3 x 10-43,(subset analysis),NR,'-,'-,'-,"LINC01845, IL12B","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:159400761
rs12188300-<b>?</b>,3 x 10-34,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,Mapping not available
rs4921482-<b>?</b>,9 x 10-25,(subset analysis),NR,'-,'-,'-,IL12B,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:159337470
rs6556411-<b>?</b>,3 x 10-11,(subset analysis),NR,'-,'-,'-,"LINC01845, IL12B","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:159356215
rs72812861-<b>?</b>,1 x 10-8,(subset analysis),NR,'-,'-,'-,CPEB4,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:173960506
rs1267499-<b>?</b>,1 x 10-11,(subset analysis),NR,'-,'-,'-,RNU6-793P,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:14715651
rs2328530-<b>?</b>,1 x 10-17,(subset analysis),NR,'-,'-,'-,CDKAL1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:20643496
rs714830-<b>?</b>,5 x 10-9,(subset analysis),NR,'-,'-,'-,CDKAL1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:20624151
rs71559680-<b>?</b>,6 x 10-12,(subset analysis),NR,'-,'-,'-,LINC00581,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:21430497
rs72928038-<b>?</b>,2 x 10-10,(subset analysis),NR,'-,'-,'-,BACH2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,6:90267049
rs1405108-<b>?</b>,8 x 10-8,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:198880294
rs7426056-<b>?</b>,1 x 10-20,(subset analysis),NR,'-,'-,'-,"CD28, KRT18P39","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:203747335
rs11306716-<b>?</b>,3 x 10-12,(subset analysis),NR,'-,'-,'-,"CTLA4, RNU6-474P","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:203843041
rs11676348-<b>?</b>,2 x 10-11,(subset analysis),NR,'-,'-,'-,"CXCR1, CXCR2","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:218145423
rs7556897-<b>?</b>,8 x 10-12,(subset analysis),NR,'-,'-,'-,"CCL20, SNRPGP8","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:227795396
rs12694846-<b>?</b>,5 x 10-15,(subset analysis),NR,'-,'-,'-,SP140,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:230283413
rs35300242-<b>?</b>,5 x 10-67,(subset analysis),NR,'-,'-,'-,ATG16L1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:233260144
rs3749171-<b>?</b>,2 x 10-25,(subset analysis),NR,'-,'-,'-,GPR35,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:240630275
rs4676406-<b>?</b>,6 x 10-10,(subset analysis),NR,'-,'-,'-,"AQP12B, GPR35","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:240639691
rs35320439-<b>?</b>,7 x 10-10,(subset analysis),NR,'-,'-,'-,GAL3ST2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,2:241797926
rs73178598-<b>?</b>,3 x 10-13,(subset analysis),NR,'-,'-,'-,SATB1-AS1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,3:18763719
rs10510607-<b>?</b>,4 x 10-7,(subset analysis),NR,'-,'-,'-,CMC1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,3:28244770
rs1001007-<b>?</b>,2 x 10-8,(subset analysis),NR,'-,'-,'-,CCR5AS,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,3:46387167
rs3197999-<b>?</b>,7 x 10-55,(subset analysis),NR,'-,'-,'-,MST1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,3:49684099
rs116046827-<b>?</b>,8 x 10-11,(subset analysis),NR,'-,'-,'-,BSN,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,3:49618715
rs6781808-<b>?</b>,8 x 10-9,(subset analysis),NR,'-,'-,'-,NPM1P17,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,3:137722530
rs11098964-<b>?</b>,2 x 10-8,(subset analysis),NR,'-,'-,'-,ANTXR2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,4:79966815
rs13107612-<b>?</b>,3 x 10-10,(subset analysis),NR,'-,'-,'-,BANK1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,4:101818823
rs3774937-<b>?</b>,2 x 10-18,(subset analysis),NR,'-,'-,'-,NFKB1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,4:102513096
rs59867199-<b>?</b>,7 x 10-20,(subset analysis),NR,'-,'-,'-,"IL2, IL21","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,4:122531076
rs13132308-<b>?</b>,5 x 10-8,(subset analysis),NR,'-,'-,'-,IL21-AS1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,4:122629959
rs11750385-<b>?</b>,4 x 10-8,(subset analysis),NR,'-,'-,'-,LINC02213,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:10521556
rs3776414-<b>?</b>,6 x 10-9,(subset analysis),NR,'-,'-,'-,DAP,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:10689450
rs395157-<b>?</b>,8 x 10-15,(subset analysis),NR,'-,'-,'-,OSMR,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:38867630
rs1992661-<b>?</b>,1 x 10-74,(subset analysis),NR,'-,'-,'-,TTC33,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,5:40414887
rs10775412-<b>?</b>,3 x 10-19,(subset analysis),NR,'-,'-,'-,KSR1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:27542007
rs28998802-<b>?</b>,7 x 10-12,(subset analysis),NR,'-,'-,'-,'-,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,Mapping not available
rs9797244-<b>?</b>,1 x 10-10,(subset analysis),NR,'-,'-,'-,NOS2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:27770105
rs2779255-<b>?</b>,1 x 10-7,(subset analysis),NR,'-,'-,'-,"NOS2, LYRM9","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:27810514
rs9889296-<b>?</b>,5 x 10-21,(subset analysis),NR,'-,'-,'-,"CCL2, LINC01989","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:34243528
rs35736272-<b>?</b>,6 x 10-30,(subset analysis),NR,'-,'-,'-,ZPBP2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:39876427
rs12942547-<b>?</b>,2 x 10-15,(subset analysis),NR,'-,'-,'-,STAT3,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:42375526
rs12943464-<b>?</b>,2 x 10-14,(subset analysis),NR,'-,'-,'-,"NPEPPS, KPNB1-DT","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:47612985
rs3853824-<b>?</b>,2 x 10-8,(subset analysis),NR,'-,'-,'-,C17orf67,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:56803632
rs1292035-<b>?</b>,3 x 10-11,(subset analysis),NR,'-,'-,'-,RPS6KB1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:59912196
rs196941-<b>?</b>,8 x 10-10,(subset analysis),NR,'-,'-,'-,ERN1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:64069832
rs17780256-<b>?</b>,6 x 10-11,(subset analysis),NR,'-,'-,'-,SLC39A11,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,17:72646784
rs7236492-<b>?</b>,1 x 10-7,(subset analysis),NR,'-,'-,'-,NFATC1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,18:79460616
rs12968719-<b>?</b>,2 x 10-26,(subset analysis),NR,'-,'-,'-,PTPN2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,18:12879467
rs62097857-<b>?</b>,1 x 10-11,(subset analysis),NR,'-,'-,'-,PTPN2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,18:12857759
rs66504140-<b>?</b>,2 x 10-8,(subset analysis),NR,'-,'-,'-,CD226,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,18:69894282
rs587259-<b>?</b>,4 x 10-7,(subset analysis),NR,'-,'-,'-,"LSM14A, CHCHD2P3","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,19:34165501
rs2024092-<b>?</b>,2 x 10-18,(subset analysis),NR,'-,'-,'-,SBNO2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,19:1124032
rs72977586-<b>?</b>,4 x 10-9,(subset analysis),NR,'-,'-,'-,STK11,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,19:1186317
rs74956615-<b>?</b>,2 x 10-22,(subset analysis),NR,'-,'-,'-,RAVER1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,19:10317045
rs35018800-<b>?</b>,5 x 10-12,(subset analysis),NR,'-,'-,'-,TYK2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,19:10354167
rs12720356-<b>?</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,TYK2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,19:10359299
rs35074907-<b>?</b>,6 x 10-9,(subset analysis),NR,'-,'-,'-,KEAP1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,19:10489742
rs4802307-<b>?</b>,2 x 10-11,(subset analysis),NR,'-,'-,'-,"PPP5C, HIF3A","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,19:46346549
rs679574-<b>?</b>,1 x 10-17,(subset analysis),NR,'-,'-,'-,FUT2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,19:48702851
rs4243971-<b>?</b>,5 x 10-9,(subset analysis),NR,'-,'-,'-,"KIF3B, POFUT1","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,20:32261714
rs6058869-<b>?</b>,4 x 10-9,(subset analysis),NR,'-,'-,'-,"COMMD7, DNMT3B","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,20:32760944
rs4812833-<b>?</b>,7 x 10-16,(subset analysis),NR,'-,'-,'-,LINC01620,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,20:44440356
rs79493594-<b>?</b>,4 x 10-7,(subset analysis),NR,'-,'-,'-,PKIG,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,20:44561731
rs1883832-<b>?</b>,4 x 10-12,(subset analysis),NR,'-,'-,'-,CD40,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,20:46118343
rs1328454-<b>?</b>,4 x 10-9,(subset analysis),NR,'-,'-,'-,SLC9A8,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,20:49823486
rs259964-<b>?</b>,4 x 10-12,(subset analysis),NR,'-,'-,'-,ZNF831,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,20:59249254
rs6062496-<b>?</b>,2 x 10-30,(subset analysis),NR,'-,'-,'-,"RTEL1-TNFRSF6B, TNFRSF6B","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,20:63697746
rs2823288-<b>?</b>,4 x 10-28,(subset analysis),NR,'-,'-,'-,CYCSP42,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,21:15448569
rs2284553-<b>?</b>,4 x 10-16,(subset analysis),NR,'-,'-,'-,IFNGR2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,21:33404389
rs9977672-<b>?</b>,5 x 10-54,(subset analysis),NR,'-,'-,'-,RPL23AP12,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,21:39091357
rs1893592-<b>?</b>,6 x 10-9,(subset analysis),NR,'-,'-,'-,UBASH3A,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,21:42434957
rs4456788-<b>?</b>,6 x 10-25,(subset analysis),NR,'-,'-,'-,GATD3A,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,21:44196441
rs2266961-<b>?</b>,4 x 10-15,(subset analysis),NR,'-,'-,'-,UBE2L3,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,22:21574308
rs140135-<b>?</b>,6 x 10-9,(subset analysis),NR,'-,'-,'-,UQCR10,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,22:29767846
rs2143178-<b>?</b>,2 x 10-33,(subset analysis),NR,'-,'-,'-,"PDGFB, RPL3","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,22:39264824
rs5757584-<b>?</b>,4 x 10-9,(subset analysis),NR,'-,'-,'-,"RPL3, PDGFB","Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,22:39266545
rs1569414-<b>?</b>,6 x 10-10,(subset analysis),NR,'-,'-,'-,FAM118A,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,22:45331684
rs10761648-<b>?</b>,6 x 10-16,(subset analysis),NR,'-,'-,'-,ZEB1-AS1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)","ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis",GCST005537,10:62594503
rs3891175-<b>?</b>,5 x 10-11,,NR,2.41,'-,'-,HLA-DQB1,Autoimmune hepatitis in primary sclerosing cholangitis,"Autoimmune Hepatitis, sclerosing cholangitis",GCST005853,6:32666690
DQA1*05:01-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,'-,Autoimmune hepatitis in primary sclerosing cholangitis,"Autoimmune Hepatitis, sclerosing cholangitis",GCST005853,Mapping not available
DQB1*02:01-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,'-,Autoimmune hepatitis in primary sclerosing cholangitis,"Autoimmune Hepatitis, sclerosing cholangitis",GCST005853,Mapping not available
rs10272859-<b>G</b>,9 x 10-10,,0.313,1.28,'-,[1.18-1.38],CDK14,Hepatitis B virus-related hepatocellular carcinoma,"hepatitis B virus infection, hepatocellular carcinoma",GCST005570,7:90689160
rs17401966-<b>G</b>,6 x 10-6,,0.269,1.89,'-,[1.43-2.44],KIF1B,Hepatitis B virus-related hepatocellular carcinoma,"hepatitis B virus infection, hepatocellular carcinoma",GCST005570,1:10325413
rs1110446-<b>?</b>,3 x 10-10,(Japanese),NR,1.93,'-,[1.57–2.37],TRIM31,Hepatocellular carcinoma in hepatitis B infection,"hepatitis B virus infection, hepatocellular carcinoma",GCST005746,6:30103160
rs2523961-<b>?</b>,6 x 10-11,,NR,1.91,'-,[1.56–2.37],MICD,Hepatocellular carcinoma in hepatitis B infection,"hepatitis B virus infection, hepatocellular carcinoma",GCST005746,6:29971803
rs1110446-<b>?</b>,9 x 10-13,,NR,1.93,'-,[1.57–2.37],TRIM31,Hepatocellular carcinoma in hepatitis B infection,"hepatitis B virus infection, hepatocellular carcinoma",GCST005746,6:30103160
rs2523961-<b>?</b>,6 x 10-10,(Japanese),NR,1.91,'-,[1.56-2.37],MICD,Hepatocellular carcinoma in hepatitis B infection,"hepatitis B virus infection, hepatocellular carcinoma",GCST005746,6:29971803
rs16851720-<b>C</b>,9 x 10-9,(QTF),0.19,'-,'-,'-,RNF7,Hepatitis C induced liver fibrosis,"hepatitis C virus infection, cirrhosis of liver",GCST001623,3:141744456
rs4374383-<b>A</b>,1 x 10-9,"(Duration F0-1/F3-4, transfused)",0.42,'-,'-,'-,'-,Hepatitis C induced liver fibrosis,"hepatitis C virus infection, cirrhosis of liver",GCST001623,Mapping not available
rs9380516-<b>T</b>,5 x 10-7,"(Duration F0-1/F3-4, male)",0.17,'-,'-,'-,"TULP1, FKBP5",Hepatitis C induced liver fibrosis,"hepatitis C virus infection, cirrhosis of liver",GCST001623,6:35534425
rs2629751-<b>G</b>,1 x 10-7,(Binary F0/F4),0.31,'-,'-,'-,GLT8D2,Hepatitis C induced liver fibrosis,"hepatitis C virus infection, cirrhosis of liver",GCST001623,12:104028030
rs883924-<b>A</b>,2 x 10-6,"(Duration F0-1/F3-4,>20yo)",0.26,'-,'-,'-,LINC01508,Hepatitis C induced liver fibrosis,"hepatitis C virus infection, cirrhosis of liver",GCST001623,9:90419249
rs7800244-<b>T</b>,3 x 10-6,(Binary F0-1/F3-4),0.18,'-,'-,'-,PKD1L1,Hepatitis C induced liver fibrosis,"hepatitis C virus infection, cirrhosis of liver",GCST001623,7:47740371
rs17321041-<b>T</b>,5 x 10-6,,NR,1.52,'-,[1.27-1.82],DPYSL2,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (1df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011463,8:26587678
rs112894788-<b>T</b>,7 x 10-9,,NR,'-,'-,'-,'-,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011462,6:61470581
rs35827298-<b>A</b>,4 x 10-8,,NR,'-,'-,'-,MGST1,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011462,12:16414631
rs2003476-<b>T</b>,6 x 10-8,,NR,'-,'-,'-,CRTC1,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011462,19:18695858
rs13259457-<b>C</b>,2 x 10-8,,NR,'-,'-,'-,"PRSS55, RP1L1",Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011462,8:10577843
rs17321041-<b>T</b>,3 x 10-7,,NR,'-,'-,'-,DPYSL2,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011462,8:26587678
rs149938398-<b>CCCCCTACACACT</b>,4 x 10-9,,NR,'-,'-,'-,"MIR4456, CEP72",Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011462,5:611271
rs4957081-<b>C</b>,4 x 10-9,,NR,'-,'-,'-,CEP72,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011462,5:646303
rs2880866-<b>T</b>,2 x 10-8,,NR,'-,'-,'-,MTRNR2L9,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011462,6:61490740
rs11955068-<b>T</b>,2 x 10-8,,NR,'-,'-,'-,"MIR4456, CEP72",Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011462,5:582209
rs10225824-<b>A</b>,4 x 10-8,,NR,'-,'-,'-,"CFTR, ASZ1",Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),"esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement",GCST011462,7:117371969
rs112894788-<b>T</b>,4 x 10-9,(male),NR,0.84,'-,[0.79-0.89],'-,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,6:61470581
rs35827298-<b>A</b>,1 x 10-8,(male),NR,0.87,'-,[0.82-0.91],MGST1,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,12:16414631
rs2003476-<b>T</b>,2 x 10-8,(male),NR,1.16,'-,[1.10-1.22],CRTC1,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,19:18695858
rs13259457-<b>C</b>,7 x 10-9,(female),NR,0.62,'-,[0.53-0.73],"PRSS55, RP1L1",Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,8:10577843
rs17321041-<b>T</b>,5 x 10-8,(female),NR,1.56,'-,[1.33-1.84],DPYSL2,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,8:26587678
rs112894788-<b>T</b>,3 x 10-9,,NR,0.84,'-,[0.79-0.89],'-,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,6:61470581
rs35827298-<b>A</b>,5 x 10-9,,NR,0.87,'-,[0.83-0.91],MGST1,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,12:16414631
rs2003476-<b>T</b>,1 x 10-8,,NR,0.87,'-,[0.82-0.91],CRTC1,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,19:18695858
rs149938398-<b>CCCCCTACACACT</b>,1 x 10-7,,NR,0.85,'-,[0.80-0.90],"MIR4456, CEP72",Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,5:611271
rs4957081-<b>C</b>,7 x 10-8,,NR,1.18,'-,[1.11-1.25],CEP72,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,5:646303
rs2880866-<b>T</b>,1 x 10-8,,NR,1.19,'-,[1.12-1.26],MTRNR2L9,Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,6:61490740
rs11955068-<b>T</b>,1 x 10-6,,NR,1.15,'-,[1.09-1.22],"MIR4456, CEP72",Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,5:582209
rs10225824-<b>A</b>,6 x 10-8,,NR,0.84,'-,[0.79-0.90],"CFTR, ASZ1",Barrett's esophagus  or Esophageal adenocarcinoma,"esophageal adenocarcinoma, Barrett's esophagus",GCST011461,7:117371969
rs7731017-<b>G</b>,1 x 10-6,,0.011,4.81,'-,[2.57-9.02],DCTN4,Cholangiocarcinoma in primary sclerosing cholangitis,"cholangiocarcinoma, sclerosing cholangitis",GCST005855,5:150732056
rs2675647-<b>C</b>,3 x 10-6,,NR,'-,'-,'-,CABCOCO1,Cholangiocarcinoma in primary sclerosing cholangitis (time to event),"cholangiocarcinoma, sclerosing cholangitis",GCST005860,10:61758862
rs34985176-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,"DOCK3, LINC02019",Cholangiocarcinoma in primary sclerosing cholangitis (time to event),"cholangiocarcinoma, sclerosing cholangitis",GCST005860,3:50673570
rs3769839-<b>G</b>,1 x 10-6,,NR,'-,'-,'-,"SP110, SP140",Cholangiocarcinoma in primary sclerosing cholangitis (time to event),"cholangiocarcinoma, sclerosing cholangitis",GCST005860,2:230211910
rs2295119-<b>?</b>,6 x 10-7,(Japanese),NR,1.59,'-,[1.32-1.89],HLA-DPA2,Hepatocellular carcinoma in hepatitis B infection,"hepatitis B virus infection, hepatocellular carcinoma",GCST005746,6:33093093
rs3094137-<b>?</b>,4 x 10-7,(Japanese),NR,1.76,'-,[1.41–2.19],"HCG17, TRIM26",Hepatocellular carcinoma in hepatitis B infection,"hepatitis B virus infection, hepatocellular carcinoma",GCST005746,6:30233096
rs2295119-<b>?</b>,5 x 10-7,,NR,1.5873016,'-,[1.32-1.89],HLA-DPA2,Hepatocellular carcinoma in hepatitis B infection,"hepatitis B virus infection, hepatocellular carcinoma",GCST005746,6:33093093
rs7586405-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,"RNA5SP89, PLB1",Fecal incontinence,fecal incontinence,GCST009925,2:28683778
rs2715291-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,PRPF19P1,Fecal incontinence,fecal incontinence,GCST009925,18:66064503
rs9273368-<b>G</b>,8 x 10-40,,0.35,2.99,'-,[2.60-3.91],"HLA-DQA1, HLA-DQB1",Latent autoimmune diabetes vs. type 1 diabetes,"type I diabetes mellitus, latent autoimmune diabetes in adults",GCST007247,6:32658698
rs2006996-<b>T</b>,4 x 10-13,(UC vs. CD),0.47,1.67,'-,[1.47-1.92],"DELEC1, TNFSF15",Ulcerative colitis or Crohn's disease,"ulcerative colitis, Crohn's disease",GCST001118,9:114830358
rs9273368-<b>?</b>,3 x 10-78,,0.301,2.439,'-,[2.222-2.676],"HLA-DQA1, HLA-DQB1",Latent autoimmune diabetes vs. type 2 diabetes,"latent autoimmune diabetes in adults, type II diabetes mellitus",GCST007246,6:32658698
rs689-<b>?</b>,1 x 10-18,,0.715,1.473,'-,[1.352-1.605],"INS, INS-IGF2",Latent autoimmune diabetes vs. type 2 diabetes,"latent autoimmune diabetes in adults, type II diabetes mellitus",GCST007246,11:2160994
rs2476601-<b>?</b>,5 x 10-16,,0.14,1.529,'-,[1.38-1.693],PTPN22,Latent autoimmune diabetes vs. type 2 diabetes,"latent autoimmune diabetes in adults, type II diabetes mellitus",GCST007246,1:113834946
rs3184504-<b>?</b>,2 x 10-8,,0.52,1.24,'-,[1.151-1.336],"SH2B3, ATXN2",Latent autoimmune diabetes vs. type 2 diabetes,"latent autoimmune diabetes in adults, type II diabetes mellitus",GCST007246,12:111446804
rs146562173-<b>?</b>,3 x 10-8,,'-,1.0453,'-,[NR],RPS23P5,Acute cholecystitis,"Cholecystitis, Acute",GCST010176,5:13263262
rs9271366-<b>C</b>,2 x 10-70,(UC vs. CD),0.21,4.44,'-,[3.74-5.27],"HLA-DRB1, HLA-DQA1",Ulcerative colitis or Crohn's disease,"ulcerative colitis, Crohn's disease",GCST001118,6:32619077
rs505922-<b>T</b>,1 x 10-10,(Recessive),0.54,1.32,'-,[NR],ABO,Duodenal ulcer,duodenal ulcer,GCST001433,9:133273813
rs2294008-<b>C</b>,2 x 10-33,(Additive),0.37,1.41,'-,[NR],"JRK, PSCA",Duodenal ulcer,duodenal ulcer,GCST001433,8:142680513
rs58296998-<b>T</b>,4 x 10-8,,NR,2.4,'-,[NR],PRKCA,Cryptosporidiosis,cryptosporidiosis,GCST009861,17:66473763
rs4758351-<b>A</b>,4 x 10-7,,NR,2.39,'-,[NR],"OR56A4, KRT18P58",Cryptosporidiosis,cryptosporidiosis,GCST009861,11:5997956
rs9937140-<b>G</b>,8 x 10-7,,NR,1.99,'-,[NR],"APOOP5, LINC02141",Cryptosporidiosis,cryptosporidiosis,GCST009861,16:59784010
rs10188217-<b>C</b>,1 x 10-11,(combined),NR,'-,'-,'-,PUS10,Crohn's disease and celiac disease,"celiac disease, Crohn's disease",GCST000955,2:60990407
rs212388-<b>C</b>,2 x 10-10,(combined),NR,'-,'-,'-,TAGAP-AS1,Crohn's disease and celiac disease,"celiac disease, Crohn's disease",GCST000955,6:159069404
rs17650401-<b>T</b>,2 x 10-6,,0.077,6.9,'-,[3.10-15.37],'-,Molar-incisor hypomineralization,molar-incisor hypomineralization,GCST002114,4:24374210
rs13288553-<b>T</b>,2 x 10-6,,0.148,4.25,'-,[2.33-7.75],'-,Molar-incisor hypomineralization,molar-incisor hypomineralization,GCST002114,9:84126546
rs1126179-<b>G</b>,3 x 10-6,,0.595,2.13,'-,[1.55-2.92],'-,Molar-incisor hypomineralization,molar-incisor hypomineralization,GCST002114,16:65861461
rs4811117-<b>T</b>,5 x 10-6,,0.124,3.13,'-,[1.92-5.13],"KCNG1, RPSAP1",Molar-incisor hypomineralization,molar-incisor hypomineralization,GCST002114,20:51054898
rs13058467-<b>C</b>,4 x 10-7,,0.104,4.4,'-,[2.5-7.8],TTLL12,Molar-incisor hypomineralization,molar-incisor hypomineralization,GCST002114,22:43183043
rs2129979-<b>G</b>,2 x 10-23,,0.31,1.12,'-,1.09-1.14,"MIR297, LINC01438",Appendicitis,appendicitis,GCST007595,4:110799841
rs2540513-<b>?</b>,3 x 10-9,,NR,1.87,'-,[NR],"RN7SL88P, YPEL5P3",Small intestine neuroendocrine tumor,small intestine neuroendocrine tumor,GCST003786,12:96098670
rs2187668-<b>?</b>,2 x 10-11,,0.126,2.06,'-,[1.67-2.55],HLA-DQA1,Collagenous colitis,collagenous colitis,GCST005879,6:32638107
kgp12506180-<b>C</b>,7 x 10-6,,0.2217,3.9077766,'-,[NR],'-,Diabetes (gestational),gestational diabetes,GCST008448,Mapping not available
rs10220124-<b>A</b>,3 x 10-6,,0.008696,14.65,'-,[NR],SLITRK6,Diabetes (gestational),gestational diabetes,GCST008448,13:85834386
rs7254268-<b>A</b>,7 x 10-6,,0.213,2.595,'-,[NR],"NUMBL, LTBP4",Diabetes (gestational),gestational diabetes,GCST008448,19:40635529
rs6445797-<b>C</b>,2 x 10-6,(Females),NR,1.402,'-,[NR],"ERC2, CCDC66",Gastritis,gastritis,GCST002638,3:56529312
rs1503059-<b>?</b>,2 x 10-6,(Females),NR,1.2764871,'-,[NR],CA10,Gastritis,gastritis,GCST002638,17:52127096
rs10955971-<b>T</b>,2 x 10-6,(Females),NR,1.319,'-,[NR],COL14A1,Gastritis,gastritis,GCST002638,8:120364107
rs7826906-<b>G</b>,3 x 10-6,(Females),NR,1.316,'-,[NR],MTBP,Gastritis,gastritis,GCST002638,8:120489483
rs945144-<b>?</b>,9 x 10-6,(Females),NR,1.2627857,'-,[NR],LY86-AS1,Gastritis,gastritis,GCST002638,6:6476045
rs8112449-<b>T</b>,2 x 10-6,(Males),NR,1.304,'-,[NR],CDC37,Gastritis,gastritis,GCST002638,19:10409388
rs11088226-<b>G</b>,4 x 10-6,(Males),NR,1.3,'-,[NR],"TCP10L, CFAP298-TCP10L",Gastritis,gastritis,GCST002638,21:32553221
rs1470579-<b>C</b>,2 x 10-7,,0.293,1.332,'-,[1.197-1.484],IGF2BP2,Diabetes (gestational),gestational diabetes,GCST001375,3:185811292
rs7754840-<b>C</b>,7 x 10-16,,0.445,1.518,'-,[1.372-1.680],CDKAL1,Diabetes (gestational),gestational diabetes,GCST001375,6:20661019
rs2041570-<b>A</b>,2 x 10-8,,0.41,2.36,'-,[1.73-3.21],ADCYAP1R1,Refractory celiac disease type II,refractory celiac disease,GCST005928,7:31159653
HLA-DQ2-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,'-,Refractory celiac disease type II,refractory celiac disease,GCST005928,Mapping not available
rs2284932-<b>C</b>,3 x 10-6,,NR,4.35,'-,[2.32-8.16],KLF7,Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis,"salivary gland lesion, autoimmune pancreatitis type 1, lachrymal gland lesion",GCST002913,2:207147785
rs9371942-<b>A</b>,4 x 10-7,,NR,5,'-,[2.38-10],MIR1202,Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis,"salivary gland lesion, autoimmune pancreatitis type 1, lachrymal gland lesion",GCST002913,6:155913388
rs9868898-<b>G</b>,2 x 10-6,(Perianal disease),0.16,1.49,'-,[1.26-1.76],"PHLDB2, PLCXD2",Crohn's disease-related phenotypes,perianal Crohn's disease,GCST002729,3:111762099
rs3811647-<b>?</b>,2 x 10-20,(Trasferrin),NR,'-,0.4 unit decrease,[0.32-0.48],TF,Hereditary hemochromatosis-related traits (HFE mutation homozygotes),"hereditary hemochromatosis type 1, transferrin measurement",GCST002660,3:133765185
rs3811647-<b>?</b>,9 x 10-11,(Serum Iron levels),NR,'-,0.28 unit decrease,[0.20-0.36],TF,Hereditary hemochromatosis-related traits (HFE mutation homozygotes),"hereditary hemochromatosis type 1, serum iron measurement",GCST002660,3:133765185
rs7504990-<b>A</b>,7 x 10-8,,0.21,6.95,'-,[3.43-14.08],DCC,Gallbladder cancer,gallbladder neoplasm,GCST001404,18:52991406
rs975334-<b>C</b>,9 x 10-7,,0.16,8.3,'-,[3.57-19.26],CNTN4,Gallbladder cancer,gallbladder neoplasm,GCST001404,3:2804632
rs13294589-<b>G</b>,2 x 10-6,,0.11,12.78,'-,[4.43-36.83],'-,Gallbladder cancer,gallbladder neoplasm,GCST001404,9:26694890
rs6869388-<b>C</b>,7 x 10-6,,0.04,72.7,'-,[11.19-472.10],KIAA0825,Gallbladder cancer,gallbladder neoplasm,GCST001404,5:94474503
rs10953615-<b>C</b>,9 x 10-6,,0.11,7.51,'-,[3.08-18.30],'-,Gallbladder cancer,gallbladder neoplasm,GCST001404,7:109512654
rs910049-<b>A</b>,9 x 10-11,,0.142,1.46,'-,[1.28-1.62],"TSBP1, TSBP1-AS1",Hepatitis C induced liver cirrhosis,hepatitis C induced liver cirrhosis,GCST001815,6:32347950
rs3817963-<b>A</b>,1 x 10-8,,0.315,1.3,'-,[1.18-1.42],"TSBP1-AS1, BTNL2",Hepatitis C induced liver cirrhosis,hepatitis C induced liver cirrhosis,GCST001815,6:32400310
rs9405098-<b>A</b>,1 x 10-10,,0.253,1.37,'-,[1.24-1.51],"TSBP1-AS1, HLA-DRA",Hepatitis C induced liver cirrhosis,hepatitis C induced liver cirrhosis,GCST001815,6:32411959
rs3135363-<b>C</b>,1 x 10-10,,0.702,1.37,'-,[1.24-1.51],'-,Hepatitis C induced liver cirrhosis,hepatitis C induced liver cirrhosis,GCST001815,Mapping not available
rs3129860-<b>A</b>,1 x 10-9,,0.231,1.36,'-,[1.22-1.49],"TSBP1-AS1, HLA-DRA",Hepatitis C induced liver cirrhosis,hepatitis C induced liver cirrhosis,GCST001815,6:32433302
rs4812219-<b>?</b>,7 x 10-7,(overall survival),'-,3.27,'-,[2.05-5.23],'-,Survival in colon cancer,"colonic neoplasm, overall survival",GCST002822,20:60847915
rs6105057-<b>?</b>,2 x 10-6,(overall survival),'-,2.2,'-,[1.59-3.04],ISM1,Survival in colon cancer,"colonic neoplasm, overall survival",GCST002822,20:13248679
rs13180087-<b>?</b>,3 x 10-6,(overall survival),'-,2.4,'-,[1.66-3.46],HCN1,Survival in colon cancer,"colonic neoplasm, overall survival",GCST002822,5:45265666
rs17325431-<b>?</b>,3 x 10-6,(overall survival),'-,2.47,'-,[1.69-3.61],IDS,Survival in colon cancer,"colonic neoplasm, overall survival",GCST002822,X:149380542
rs3794924-<b>?</b>,4 x 10-6,(overall survival),'-,2.37,'-,[1.65-3.43],DSG3,Survival in colon cancer,"colonic neoplasm, overall survival",GCST002822,18:31461771
rs10921219-<b>?</b>,4 x 10-6,(overall survival),'-,1.9,'-,[1.44-2.49],"RGS13, RGS1",Survival in colon cancer,"colonic neoplasm, overall survival",GCST002822,1:192618733
rs17280262-<b>?</b>,4 x 10-6,(overall survival),'-,2.66,'-,[1.75-4.04],"PAPOLA, RN7SKP108",Survival in colon cancer,"colonic neoplasm, overall survival",GCST002822,14:96587587
rs17048372-<b>?</b>,6 x 10-6,(overall survival),'-,2.17,'-,[1.55-3.03],DPP10,Survival in colon cancer,"colonic neoplasm, overall survival",GCST002822,2:114456179
rs139156-<b>?</b>,7 x 10-6,(overall survival),'-,2.76,'-,[1.77-4.29],PARVG,Survival in colon cancer,"colonic neoplasm, overall survival",GCST002822,22:44200205
rs17280262-<b>?</b>,1 x 10-7,(disease-free survival),'-,3.02,'-,[2.00-4.55],"PAPOLA, RN7SKP108",Survival in colon cancer,"disease free survival, colonic neoplasm",GCST002822,14:96587587
rs8035094-<b>?</b>,5 x 10-6,(disease-free survival),'-,2.68,'-,[1.75-4.09],"TMCO5B, RYR3-DT",Survival in colon cancer,"disease free survival, colonic neoplasm",GCST002822,15:33272281
rs658495-<b>?</b>,7 x 10-6,(disease-free survival),'-,2.53,'-,[1.69-3.78],C20orf27,Survival in colon cancer,"disease free survival, colonic neoplasm",GCST002822,20:3756848
rs140081212-<b>G</b>,2 x 10-8,,0.646,1.2658228,'-,[1.16-1.37],GBAP1,Gastric adenocarcinoma (histologically verified),gastric adenocarcinoma,GCST002990,1:155215184
chr11:102118158-<b>A</b>,4 x 10-7,,0.0096,4.88,'-,[2.65-8.98],'-,Gastric adenocarcinoma (histologically verified),gastric adenocarcinoma,GCST002990,Mapping not available
chr2:85874332-<b>T</b>,8 x 10-8,,4.00E-04,12.7,'-,[5.03-32.08],'-,Gastric adenocarcinoma (histologically verified),gastric adenocarcinoma,GCST002990,Mapping not available
chr11:107643195-<b>T</b>,2 x 10-7,,0.0016,4.84,'-,[2.67-8.77],'-,Gastric adenocarcinoma (histologically verified),gastric adenocarcinoma,GCST002990,Mapping not available
chr11:107629783-<b>A</b>,1 x 10-6,,7.00E-04,7.78,'-,[3.38-17.91],'-,Gastric adenocarcinoma (histologically verified),gastric adenocarcinoma,GCST002990,Mapping not available
rs55864139-<b>A</b>,7 x 10-6,,0.0029,3.12,'-,[1.9-5.11],CHD6,Gastric adenocarcinoma (histologically verified),gastric adenocarcinoma,GCST002990,20:41420939
rs2294008-<b>T</b>,1 x 10-6,,0.471,1.21,'-,[NR],"JRK, PSCA",Gastric adenocarcinoma (histologically verified),gastric adenocarcinoma,GCST002990,8:142680513
rs10830962-<b>G</b>,2 x 10-13,,0.43,1.454,'-,[1.315-1.608],"MTNR1B, SNRPGP16",Diabetes (gestational),gestational diabetes,GCST001375,11:92965261
rs6761893-<b>T</b>,3 x 10-8,,0.34,1.54,'-,[1.30-1.81],EFEMP1,Biliary atresia,Biliary atresia,GCST006390,2:55891970
rs356287-<b>G</b>,4 x 10-6,,0.36,1.48,'-,[1.25-1.74],"HNRNPA1P64, LINC01781",Biliary atresia,Biliary atresia,GCST006390,1:80512278
rs12023563-<b>G</b>,4 x 10-6,,0.68,1.5873016,'-,[1.3-1.92],"ST13P19, SERTAD4",Biliary atresia,Biliary atresia,GCST006390,1:210262765
rs7183231-<b>C</b>,7 x 10-6,,NR,1.0897,'-,[1.05-1.13],TYRO3,Gastrointestinal infection,digestive system infectious disease,GCST010008,15:41583162
rs35439759-<b>CTT</b>,5 x 10-6,,NR,1.0886,'-,[1.05-1.13],LUC7L3,Gastrointestinal infection,digestive system infectious disease,GCST010008,17:50726160
rs635634-<b>T</b>,3 x 10-8,,NR,1.1336,'-,[1.09-1.18],"ABO, Y_RNA",Gastrointestinal infection,digestive system infectious disease,GCST010008,9:133279427
rs12517727-<b>A</b>,4 x 10-6,,NR,1.1574,'-,[1.1-1.22],LINC02242,Gastrointestinal infection,digestive system infectious disease,GCST010008,5:67720940
rs41302673-<b>G</b>,5 x 10-7,,NR,1.169,'-,[1.11-1.23],STKLD1,Gastrointestinal infection,digestive system infectious disease,GCST010008,9:133405414
rs117347473-<b>A</b>,2 x 10-6,,NR,1.2641,'-,[1.17-1.36],LINC02402,Gastrointestinal infection,digestive system infectious disease,GCST010008,12:42624720
chr2:207883727-<b>G</b>,9 x 10-6,,NR,1.325,'-,[1.2-1.45],'-,Gastrointestinal infection,digestive system infectious disease,GCST010008,Mapping not available
rs1866164-<b>T</b>,2 x 10-6,,NR,1.3466,'-,[1.22-1.47],"PPIAP16, FLNB",Gastrointestinal infection,digestive system infectious disease,GCST010008,3:57985796
rs11995244-<b>T</b>,7 x 10-6,,NR,1.3719,'-,[1.23-1.51],MFHAS1,Gastrointestinal infection,digestive system infectious disease,GCST010008,8:8832883
chr3:188240857-<b>G</b>,8 x 10-6,,NR,1.441,'-,[1.28-1.6],'-,Gastrointestinal infection,digestive system infectious disease,GCST010008,Mapping not available
rs376479926-<b>C</b>,7 x 10-6,,NR,1.4867,'-,[1.31-1.66],LINC02758,Gastrointestinal infection,digestive system infectious disease,GCST010008,11:91380674
rs115249766-<b>C</b>,1 x 10-6,,NR,1.4912,'-,[1.33-1.65],RBMS3,Gastrointestinal infection,digestive system infectious disease,GCST010008,3:28650645
rs143538360-<b>C</b>,4 x 10-6,,NR,1.5529,'-,[1.37-1.74],'-,Gastrointestinal infection,digestive system infectious disease,GCST010008,2:147162376
rs369614251-<b>C</b>,2 x 10-6,,NR,1.1487651,'-,[1.09-1.21],CD96,Gastrointestinal infection,digestive system infectious disease,GCST010008,3:111561865
rs3010256-<b>T</b>,2 x 10-6,,NR,1.3351135,'-,[1.22-1.45],"LINC02056, RPL7P22",Gastrointestinal infection,digestive system infectious disease,GCST010008,5:72682599
rs3793102-<b>A</b>,6 x 10-6,,NR,1.0899183,'-,[1.05-1.13],ATXN1,Gastrointestinal infection,digestive system infectious disease,GCST010008,6:16680847
rs75887387-<b>G</b>,5 x 10-6,,NR,1.1214534,'-,[1.07-1.17],"BUD13P1, SESN3",Gastrointestinal infection,digestive system infectious disease,GCST010008,11:95146961
rs7112253-<b>A</b>,4 x 10-6,,NR,1.1215792,'-,[1.07-1.17],CNTN5,Gastrointestinal infection,digestive system infectious disease,GCST010008,11:100065492
rs3825165-<b>T</b>,8 x 10-6,,NR,1.1641443,'-,[1.1-1.23],ITPR2,Gastrointestinal infection,digestive system infectious disease,GCST010008,12:26402797
rs1652362-<b>T</b>,9 x 10-6,,NR,1.1914691,'-,[1.11-1.27],"NPC1, ANKRD29",Gastrointestinal infection,digestive system infectious disease,GCST010008,18:23596806
rs10074991-<b>G</b>,7 x 10-12,,0.483,1.2048193,'-,[1.14-1.27],PRKAA1,Cardia gastric cancer,gastric cardia carcinoma,GCST003009,5:40790449
rs139816984-<b>AAAAAAAAT</b>,3 x 10-7,,NR,1.35,'-,NR,"TOMM40P3, TARS1",Meconium ileus in cystic fibrosis,cystic fibrosis associated meconium ileus,GCST007367,5:33470898
rs1799886-<b>T</b>,2 x 10-7,,0.55,1.33,'-,NR,"TRBC2, TRBJ2-7",Meconium ileus in cystic fibrosis,cystic fibrosis associated meconium ileus,GCST007367,7:142800839
rs2094716-<b>A</b>,5 x 10-7,,NR,1.3,'-,NR,"PELATON, CEBPB",Meconium ileus in cystic fibrosis,cystic fibrosis associated meconium ileus,GCST007367,20:50218794
rs3757377-<b>T</b>,3 x 10-7,,0.39,1.29,'-,NR,"TRBV29-1, PRSS1",Meconium ileus in cystic fibrosis,cystic fibrosis associated meconium ileus,GCST007367,7:142747687
rs3788766-<b>T</b>,2 x 10-16,,0.61,1.44,'-,NR,"SLC6A14, RNU6-154P",Meconium ileus in cystic fibrosis,cystic fibrosis associated meconium ileus,GCST007367,X:116435671
rs61948108-<b>T</b>,4 x 10-10,,0.11,1.55,'-,NR,ATP12A,Meconium ileus in cystic fibrosis,cystic fibrosis associated meconium ileus,GCST007367,13:24708681
rs7549173-<b>C</b>,3 x 10-11,,0.39,1.37,'-,NR,SLC26A9,Meconium ileus in cystic fibrosis,cystic fibrosis associated meconium ileus,GCST007367,1:205937769
rs17102823-<b>C</b>,7 x 10-7,,0.139,2.29,'-,[1.65-3.17],"SRP54-AS1, BAZ1A",Colorectal carcinoma in primary sclerosing cholangitis,"colorectal cancer, sclerosing cholangitis",GCST005856,14:34894698
rs938036-<b>T</b>,8 x 10-6,,'-,2.88,'-,[1.81-4.59],RPL7AP50,Tooth agenesis (mandibular third molar),tooth agenesis,GCST002258,10:63898984
rs906628-<b>G</b>,8 x 10-6,,'-,4.35,'-,[2.28-8.30],LINC02697,Tooth agenesis (mandibular third molar),tooth agenesis,GCST002258,11:134868376
rs1469622-<b>T</b>,8 x 10-6,,NR,1.88,'-,[1.43-2.47],THSD7B,Tooth agenesis (third molar),tooth agenesis,GCST002256,2:137118305
rs9504361-<b>G</b>,6 x 10-6,,0.4504,'-,1.156 unit increase,[NR],EXOC2,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST001897,6:577820
rs2022068-<b>A</b>,7 x 10-6,,0.3926,'-,1.1831 unit increase,[NR],PVALB,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST001897,22:36803762
rs17145638-<b>C</b>,2 x 10-7,,0.1169,'-,2.329 unit decrease,[NR],BCOR,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST001897,X:40026377
rs10486722-<b>C</b>,7 x 10-6,,0.3349,'-,1.215 unit increase,[NR],INHBA-AS1,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST001897,7:41772310
rs9311745-<b>C</b>,5 x 10-6,,0.0466,'-,2.9914 unit increase,[NR],FHIT,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST001897,3:60016099
rs6560397-<b>T</b>,2 x 10-7,,0.4671,'-,1.289 unit decrease,[NR],PIP5K1B,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST001897,9:68856996
rs2046315-<b>T</b>,7 x 10-7,,0.1322,'-,1.871 unit increase,[NR],RPSAP74,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST001897,8:89198871
rs6806253-<b>A</b>,6 x 10-6,,0.8295,'-,1.5595 unit decrease,[NR],"TMED10P2, LINC01565",Pit-and-Fissure caries,pit and fissure surface dental caries,GCST001897,3:128563854
rs5967638-<b>A</b>,1 x 10-6,,0.0665,'-,2.019 unit increase,[NR],"MIR1321, SFR1P2",Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,X:85840734
rs12542759-<b>T</b>,4 x 10-6,,0.2881,'-,0.8026 unit increase,[NR],"OC90, EFR3A",Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,8:132022590
rs13273891-<b>A</b>,2 x 10-6,,0.1933,'-,0.953 unit increase,[NR],FAM110B,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,8:58073900
rs197480-<b>T</b>,4 x 10-6,,0.0394,'-,1.428 unit increase,[NR],HIVEP2,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,6:142749368
rs9788927-<b>A</b>,2 x 10-6,,0.1481,'-,1.019 unit decrease,[NR],'-,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,16:7879826
rs11082098-<b>A</b>,3 x 10-7,,0.0558,'-,1.032 unit increase,[NR],'-,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,18:38618768
rs12850804-<b>T</b>,2 x 10-6,,0.1345,'-,0.7501 unit increase,[NR],"LARP1BP3, CCDC160",Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,X:134211258
rs11822667-<b>A</b>,4 x 10-6,,0.0546,'-,1.6601 unit increase,[NR],SIK3,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,11:127590676
rs17736906-<b>A</b>,2 x 10-6,,0.1558,'-,0.7446 unit decrease,[NR],"LINC02854, HAUS6P3",Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,7:53914933
rs10958998-<b>A</b>,4 x 10-6,,0.0289,'-,1.194 unit decrease,[NR],PTPRD,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,9:10275798
rs758569-<b>A</b>,4 x 10-6,,0.3616,'-,0.8017 unit increase,[NR],"EMX2OS, PDZD8",Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,10:117433642
rs17013524-<b>T</b>,9 x 10-6,,0.0578,'-,1.833 unit decrease,[NR],CNTN4,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,3:2381443
rs17236529-<b>T</b>,2 x 10-9,,0.0344,'-,1.7754 unit increase,[NR],KPNA4,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,3:160508519
rs7121800-<b>T</b>,7 x 10-6,,0.3458,'-,0.7138 unit increase,[NR],MPPED2,Pit-and-Fissure caries,pit and fissure surface dental caries,GCST002358,11:30543030
rs11712066-<b>A</b>,2 x 10-17,,0.75,1.61,'-,[1.44-1.79],'-,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST001399,3:152112520
rs573872-<b>G</b>,4 x 10-12,,0.23,1.41,'-,[1.28-1.56],LINC02006,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST001399,3:153754374
rs29784-<b>A</b>,1 x 10-15,,0.45,1.42,'-,[1.30-1.55],"RPL7AP33, BNIP1",Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST001399,5:173168305
rs1208285-<b>C</b>,6 x 10-7,,0.39,1.25,'-,[1.14-1.36],"LINC01312, TARID",Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST001399,6:133837662
rs11216185-<b>G</b>,1 x 10-7,,0.05,1.57,'-,[1.33-1.86],SIK3,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST001399,11:116912258
rs1558375-<b>A</b>,2 x 10-10,,0.74,1.47,'-,[1.30-1.66],ABCB4,Gallbladder cancer,gallbladder neoplasm,GCST004201,7:87449753
rs17209837-<b>A</b>,2 x 10-9,,0.85,1.61,'-,[1.38-1.89],"ABCB4, ABCB1",Gallbladder cancer,gallbladder neoplasm,GCST004201,7:87495506
rs1945615-<b>A</b>,4 x 10-7,,0.302,1.18,'-,[1.11-1.26],CALCB,Diverticulitis,diverticulitis,GCST008256,11:15081931
rs17636410-<b>A</b>,7 x 10-7,,0.251,1.19,'-,[1.11-1.28],"ZFAND5, RNU6-1013P",Diverticulitis,diverticulitis,GCST008256,9:72401105
rs4662344-<b>T</b>,5 x 10-9,,0.177,1.26,'-,[1.16-1.36],ARHGAP15,Diverticulitis,diverticulitis,GCST008256,2:143591289
rs761545809-<b>A</b>,1 x 10-6,,0.0022,3.06,'-,[1.94-4.81],PDE7B,Diverticulitis,diverticulitis,GCST008256,6:136194523
rs760491413-<b>A</b>,3 x 10-6,,5.00E-04,6.99,'-,[3.11-15.7],NID1,Diverticulitis,diverticulitis,GCST008256,1:235999377
rs11263878-<b>C</b>,2 x 10-6,,0.821,1.2195122,'-,[1.12-1.33],LSM10,Diverticulitis,diverticulitis,GCST008256,1:36392266
rs9514637-<b>G</b>,5 x 10-8,,0.724,1.2195122,'-,[1.14-1.32],FAM155A,Diverticulitis,diverticulitis,GCST008256,13:107249894
rs67153654-<b>T</b>,2 x 10-7,,0.814,1.25,'-,[1.15-1.35],FAM155A,Diverticulitis,diverticulitis,GCST008256,13:107572636
rs7609897-<b>G</b>,2 x 10-9,,0.753,1.25,'-,[1.16-1.35],COLQ,Diverticulitis,diverticulitis,GCST008256,3:15461174
rs2272901-<b>G</b>,6 x 10-7,,0.721,1.1904762,'-,[1.11-1.28],TAB2,Diverticulitis,diverticulitis,GCST008256,6:149218637
rs12122337-<b>G</b>,1 x 10-6,(CDC Perianal),0.06,2.2,'-,[1.56-3.07],"TAGLN2, CFAP45",Crohn's disease-related phenotypes,"perianal Crohn's disease, complicated disease course",GCST002729,1:159916632
chr20:2374455-<b>?</b>,3 x 10-6,,NR,'-,0.00046 unit decrease,[0.00027-0.00065],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr1:102300829-<b>?</b>,1 x 10-6,,NR,'-,0.00039 unit decrease,[0.00023-0.00055],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr1:211852006-<b>?</b>,7 x 10-6,,NR,'-,0.000483 unit increase,[0.00027-0.00069],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr2:29002900-<b>?</b>,5 x 10-6,,NR,'-,0.00088 unit decrease,[0.0005-0.00126],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr2:44211546-<b>?</b>,4 x 10-6,,NR,'-,0.00031 unit decrease,[0.00018-0.00044],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr3:21580556-<b>?</b>,8 x 10-6,,NR,'-,0.0009 unit decrease,[0.00051-0.00129],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr4:24338324-<b>?</b>,1 x 10-6,,NR,'-,0.00038 unit decrease,[0.00023-0.00053],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr4:108478191-<b>?</b>,3 x 10-7,,NR,'-,0.000448 unit increase,[0.00028-0.00062],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr5:6222490-<b>?</b>,5 x 10-6,,NR,'-,0.00093 unit decrease,[0.00053-0.00133],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr5:24256226-<b>?</b>,4 x 10-6,,NR,'-,0.00066 unit decrease,[0.00038-0.00094],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr6:31355318-<b>?</b>,3 x 10-8,,NR,'-,0.00042 unit decrease,[0.00027-0.00057],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr6:65350792-<b>?</b>,3 x 10-6,,NR,'-,0.000415 unit increase,[0.00024-0.00059],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr6:104003704-<b>?</b>,8 x 10-6,,NR,'-,0.00057 unit decrease,[0.00032-0.00082],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr6:106000790-<b>?</b>,9 x 10-8,,NR,'-,0.00082 unit decrease,[0.00052-0.00112],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr7:25573204-<b>?</b>,1 x 10-6,,NR,'-,0.00039 unit decrease,[0.00023-0.00055],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr7:47391321-<b>?</b>,2 x 10-6,,NR,'-,0.00092 unit decrease,[0.00055-0.00129],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr8:12517525-<b>?</b>,5 x 10-7,,NR,'-,0.00097 unit decrease,[0.00059-0.00135],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr11:11931183-<b>?</b>,3 x 10-6,,NR,'-,0.00071 unit decrease,[0.00041-0.00101],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr11:105858586-<b>?</b>,2 x 10-6,,NR,'-,0.00055 unit decrease,[0.00032-0.00078],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr13:54703907-<b>?</b>,3 x 10-7,,NR,'-,0.00107 unit decrease,[0.00066-0.00148],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr14:41804188-<b>?</b>,6 x 10-6,,NR,'-,0.0003 unit decrease,[0.00017-0.00043],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr15:64768700-<b>?</b>,3 x 10-7,,NR,'-,0.00102 unit decrease,[0.00063-0.00141],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr16:26117039-<b>?</b>,1 x 10-6,,NR,'-,0.00048 unit decrease,[0.00029-0.00067],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
chr17:6571439-<b>?</b>,6 x 10-7,,NR,'-,0.00088 unit decrease,[0.00054-0.00122],'-,Microscopic colitis,microscopic colitis,GCST009081,Mapping not available
rs4751240-<b>?</b>,2 x 10-8,,'-,'-,0.1 kg/m2 increase,[0.067-0.133],DOCK1,Body mass index (change over time) in gastrointestinal cancer,"longitudinal BMI measurement, Digestive System Carcinoma",GCST004101,10:127338145
rs3758141-<b>?</b>,7 x 10-6,,'-,'-,0.087 unit increase,[0.050-0.124],PSD3,Body mass index (change over time) in gastrointestinal cancer,"longitudinal BMI measurement, Digestive System Carcinoma",GCST004101,8:18870439
rs927251-<b>?</b>,9 x 10-6,,'-,'-,0.083 unit increase,[0.048-0.118],SLC35F4,Body mass index (change over time) in gastrointestinal cancer,"longitudinal BMI measurement, Digestive System Carcinoma",GCST004101,14:57844417
rs681343-<b>C</b>,2 x 10-15,,0.49,0.92,'-,NR,FUT2,Peptic ulcer disease,peptic ulcer disease,GCST011504,19:48703205
rs2976388-<b>G</b>,2 x 10-14,,0.58,1.09,'-,NR,"JRK, PSCA",Peptic ulcer disease,peptic ulcer disease,GCST011504,8:142678838
rs10500661-<b>T</b>,4 x 10-14,,0.8,0.9,'-,NR,"CNGA4, CCKBR",Peptic ulcer disease,peptic ulcer disease,GCST011504,11:6252514
rs147048677-<b>C</b>,9 x 10-12,,0.94,0.86,'-,NR,MUC1,Peptic ulcer disease,peptic ulcer disease,GCST011504,1:155192003
rs78459074-<b>A</b>,3 x 10-10,,0.89,1.12,'-,NR,MUC6,Peptic ulcer disease,peptic ulcer disease,GCST011504,11:1029905
rs34074411-<b>C</b>,3 x 10-10,,0.56,0.93,'-,NR,"GAST, EIF1",Peptic ulcer disease,peptic ulcer disease,GCST011504,17:41710996
rs687621-<b>A</b>,1 x 10-9,,0.68,1.08,'-,NR,ABO,Peptic ulcer disease,peptic ulcer disease,GCST011504,9:133261662
rs9581957-<b>C</b>,4 x 10-9,,0.68,0.93,'-,NR,URAD,Peptic ulcer disease,peptic ulcer disease,GCST011504,13:27983752
rs75508464-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,"CELA3B, HSPG2",NASH resolution in nonalcoholic steatohepatitis,"remission, non-alcoholic steatohepatitis",GCST009548,1:21962163
rs118086828-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,FYN,NASH resolution in nonalcoholic steatohepatitis,"remission, non-alcoholic steatohepatitis",GCST009548,6:111720429
rs4969304-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,RPTOR,NASH resolution in nonalcoholic steatohepatitis,"remission, non-alcoholic steatohepatitis",GCST009548,17:80918247
rs2959341-<b>?</b>,6 x 10-6,"(adjusted for age, gender and PCs)",NR,'-,'-,'-,TMCO5A,NASH resolution in nonalcoholic steatohepatitis,"remission, non-alcoholic steatohepatitis",GCST009548,15:37948114
rs6718351-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,'-,Fibrosis improvement in nonalcoholic steatohepatitis,"non-alcoholic steatohepatitis, liver fibrosis measurement",GCST009547,2:35112204
rs73138351-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,CIP2A,Fibrosis improvement in nonalcoholic steatohepatitis,"non-alcoholic steatohepatitis, liver fibrosis measurement",GCST009547,3:99440397
rs56217753-<b>T</b>,6 x 10-7,,'-,'-,'-,'-,CRYBB2P1,Early onset periodontitis x smoking status interaction,"smoking status measurement, aggressive periodontitis",GCST009253,22:25517801
rs10029338-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,ABLIM2,Early onset periodontitis x smoking status interaction,"smoking status measurement, aggressive periodontitis",GCST009253,4:8048616
rs11198898-<b>A</b>,6 x 10-7,,'-,'-,'-,'-,GRK5,Early onset periodontitis x smoking status interaction,"smoking status measurement, aggressive periodontitis",GCST009253,10:119358980
rs198712-<b>?</b>,4 x 10-6,,0.37,2.36,'-,[1.63-3.42],RNA5SP228,Aggressive periodontitis (sex interaction),"sex interaction measurement, aggressive periodontitis",GCST002635,7:24141436
rs2435357-<b>?</b>,3 x 10-21,,NR,23.12,'-,'-,RET,Hirschsprung disease,Hirschsprung disease,GCST006271,10:43086608
rs78871841-<b>A</b>,4 x 10-6,,0.0507,'-,'-,'-,DDX51,Hirschsprung disease,Hirschsprung disease,GCST008016,12:132143736
rs11652075-<b>C</b>,8 x 10-6,,0.353,'-,'-,'-,CARD14,Hirschsprung disease,Hirschsprung disease,GCST008016,17:80205094
rs11725593-<b>?</b>,2 x 10-6,"(Conditioned on rs2435357, rs1800860, rs7078220 and rs16879552)",NR,'-,'-,'-,STIM2,Hirschsprung disease,Hirschsprung disease,GCST002658,4:27064416
rs4299518-<b>?</b>,3 x 10-6,"(Conditioned on rs2435357, rs1800860, rs7078220 and rs16879552)",NR,20,'-,[2.78-100.00],SLC6A20,Hirschsprung disease,Hirschsprung disease,GCST002658,3:45767781
rs6074578-<b>?</b>,4 x 10-6,"(Conditioned on rs2435357, rs1800860, rs7078220 and rs16879552)",NR,'-,'-,'-,"DEFB128, DEFB129",Hirschsprung disease,Hirschsprung disease,GCST002658,20:211156
rs12639288-<b>?</b>,5 x 10-6,"(Conditioned on rs2435357, rs1800860, rs7078220 and rs16879552)",NR,'-,'-,'-,"HMGN2P26, LRRC77P",Hirschsprung disease,Hirschsprung disease,GCST002658,3:167943348
rs1864400-<b>?</b>,6 x 10-19,,NR,'-,'-,'-,RET,Hirschsprung disease,Hirschsprung disease,GCST002658,10:43114918
rs7005606-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,NRG1,Hirschsprung disease,Hirschsprung disease,GCST002658,8:32543983
rs7947502-<b>C</b>,3 x 10-8,,0.41,1.05,'-,'-,NCAM1,Irritable bowel syndrome,irritable bowel syndrome,GCST011502,11:113038674
rs2523599-<b>C</b>,4 x 10-8,,0.39,0.95,'-,'-,"HLA-C, USP8P1",Irritable bowel syndrome,irritable bowel syndrome,GCST011502,6:31273315
rs1555895-<b>?</b>,3 x 10-6,(overall survival),'-,2.94,'-,[1.85-4.55],LARP4B,Survival in rectal cancer,"rectum cancer, overall survival",GCST002821,10:791467
rs16867335-<b>?</b>,4 x 10-6,(overall survival),'-,3.27,'-,[1.98-5.42],SCHLAP1,Survival in rectal cancer,"rectum cancer, overall survival",GCST002821,2:180594207
rs17026425-<b>?</b>,7 x 10-7,(overall survival),'-,5.06,'-,[2.67-9.60],IQCM,Survival in rectal cancer,"rectum cancer, overall survival",GCST002821,4:149751362
rs6854845-<b>?</b>,9 x 10-7,(overall survival),'-,4.12,'-,[2.34-7.26],"BTC, HSPE1P23",Survival in rectal cancer,"rectum cancer, overall survival",GCST002821,4:74821455
rs157411-<b>?</b>,2 x 10-6,(overall survival),'-,2.89,'-,[1.86-4.47],'-,Survival in rectal cancer,"rectum cancer, overall survival",GCST002821,5:67999079
rs7004484-<b>?</b>,2 x 10-6,(overall survival),'-,2.79,'-,[1.83-4.25],EFR3A,Survival in rectal cancer,"rectum cancer, overall survival",GCST002821,8:131922291
rs338389-<b>?</b>,3 x 10-6,(overall survival),'-,3.4,'-,[2.04-5.67],PIAS1,Survival in rectal cancer,"rectum cancer, overall survival",GCST002821,15:67967670
rs1573948-<b>?</b>,4 x 10-6,(overall survival),'-,2.71,'-,[1.77-4.15],BTF3P7,Survival in rectal cancer,"rectum cancer, overall survival",GCST002821,6:6786192
rs10152207-<b>?</b>,5 x 10-6,(overall survival),'-,3.06,'-,[1.90-4.93],TMCO5A,Survival in rectal cancer,"rectum cancer, overall survival",GCST002821,15:37837578
rs56848936-<b>A</b>,2 x 10-8,,0.94,1.64,'-,[1.37-1.92],SYMPK,Colon cancer,colonic neoplasm,GCST004167,19:45818249
rs56848936-<b>A</b>,5 x 10-7,(right-sided colon tumor),0.94,1.79,'-,[1.43-2.22],SYMPK,Colon cancer,colonic neoplasm,GCST004167,19:45818249
rs10462706-<b>C</b>,8 x 10-11,,0.84,1.369863,'-,[1.25-1.52],CLPTM1L,Oral cavity cancer,oral cavity cancer,GCST010287,5:1343679
rs1049055-<b>T</b>,3 x 10-9,,0.78,1.2820514,'-,[1.18-1.39],HLA-DQB1,Oral cavity cancer,oral cavity cancer,GCST010287,6:32666610
rs62103056-<b>A</b>,4 x 10-8,,0.25,2.98,'-,[1.99-4.46],'-,Tafenoquine efficacy in P. vivax malaria (recurrence by 6 months),"Plasmodium vivax malaria, disease recurrence, response to tafenoquine",GCST010503,18:43844132
rs11104986-<b>G</b>,4 x 10-9,,'-,42.3,'-,[7.95–225.10],RNU1-117P,Tafenoquine efficacy in P. vivax malaria (recurrence by 4 months),"Plasmodium vivax malaria, disease recurrence, response to tafenoquine",GCST010502,12:88657857
rs2677780-<b>A</b>,2 x 10-6,,0.9356,'-,6.3471 unit decrease,[NR],PROM1,Smooth-surface caries,smooth surface dental caries,GCST001896,4:16020917
rs2010809-<b>C</b>,2 x 10-6,,0.9883,'-,14.0668 unit decrease,[NR],RNU6-743P,Smooth-surface caries,smooth surface dental caries,GCST001896,20:43362961
rs2032381-<b>G</b>,4 x 10-6,,0.9212,'-,5.6947 unit decrease,[NR],MTND4LP18,Smooth-surface caries,smooth surface dental caries,GCST001896,11:81524108
rs2046315-<b>T</b>,8 x 10-8,,0.1322,'-,5.187 unit increase,[NR],RPSAP74,Smooth-surface caries,smooth surface dental caries,GCST001896,8:89198871
rs649057-<b>T</b>,8 x 10-6,,0.05057,'-,6.806 unit increase,[NR],STX17-AS1,Smooth-surface caries,smooth surface dental caries,GCST001896,9:99472041
rs2078454-<b>A</b>,6 x 10-6,,0.2094,'-,3.603 unit decrease,[NR],OPCML,Smooth-surface caries,smooth surface dental caries,GCST001896,11:133251042
rs723794-<b>G</b>,6 x 10-7,,0.2686,'-,3.645 unit increase,[NR],"Y_RNA, ZNF827",Smooth-surface caries,smooth surface dental caries,GCST001896,4:145954399
rs11134654-<b>A</b>,2 x 10-7,,0.1735,'-,4.6139 unit increase,[NR],GABRP,Smooth-surface caries,smooth surface dental caries,GCST001896,5:170813419
rs1079204-<b>A</b>,2 x 10-6,,0.0378,'-,8.4526 unit increase,[NR],AAMP,Smooth-surface caries,smooth surface dental caries,GCST001896,2:218265791
rs10429371-<b>C</b>,3 x 10-6,,0.2142,'-,3.8 unit increase,[NR],'-,Smooth-surface caries,smooth surface dental caries,GCST001896,8:88981259
rs1934620-<b>A</b>,8 x 10-6,,0.8656,'-,4.2462 unit decrease,[NR],KCNH1,Smooth-surface caries,smooth surface dental caries,GCST001896,1:210724921
rs17236529-<b>T</b>,3 x 10-6,,0.0346,'-,1.5126 unit increase,[NR],KPNA4,Smooth-surface caries,smooth surface dental caries,GCST002361,3:160508519
rs6818964-<b>T</b>,7 x 10-7,,0.022,'-,5.63 unit increase,[NR],ANKRD17,Smooth-surface caries,smooth surface dental caries,GCST002361,4:73104747
rs3798305-<b>T</b>,7 x 10-6,,0.0103,'-,4.8339 unit increase,[NR],RNASET2,Smooth-surface caries,smooth surface dental caries,GCST002361,6:166949985
rs6953213-<b>A</b>,6 x 10-6,,0.0429,'-,2.4305 unit increase,[NR],"C1GALT1, COL28A1",Smooth-surface caries,smooth surface dental caries,GCST002361,7:7273854
rs215738-<b>A</b>,8 x 10-6,,0.0321,'-,3.778 unit decrease,[NR],PDE1C,Smooth-surface caries,smooth surface dental caries,GCST002361,7:32404823
rs17169807-<b>T</b>,4 x 10-6,,0.0787,'-,2.5493 unit decrease,[NR],BBS9,Smooth-surface caries,smooth surface dental caries,GCST002361,7:33141626
rs16867579-<b>A</b>,1 x 10-6,,0.0155,'-,8.4163 unit decrease,[NR],NACA4P,Smooth-surface caries,smooth surface dental caries,GCST002361,8:101363039
rs7138744-<b>A</b>,3 x 10-6,,0.3386,'-,1.4071 unit decrease,[NR],"ITPR2, INTS13",Smooth-surface caries,smooth surface dental caries,GCST002361,12:26853027
rs17826057-<b>A</b>,3 x 10-7,,0.0503,'-,2.65 unit increase,[NR],IRAK3,Smooth-surface caries,smooth surface dental caries,GCST002361,12:66239384
rs10143866-<b>T</b>,2 x 10-6,,0.117,'-,1.472 unit decrease,[NR],"TXNDC16, PTGER2",Smooth-surface caries,smooth surface dental caries,GCST002361,14:52417637
rs1064524-<b>T</b>,2 x 10-7,,0.0485,'-,0.5404 unit increase,[NR],ITGAL,Smooth-surface caries,smooth surface dental caries,GCST002361,16:30481502
rs10486187-<b>T</b>,5 x 10-6,,0.0897,'-,1.886 unit decrease,[NR],UMAD1,Smooth-surface caries,smooth surface dental caries,GCST002361,7:7739693
rs16882396-<b>C</b>,2 x 10-6,,0.015,'-,1.1568 unit decrease,[NR],TMEM178B,Smooth-surface caries,smooth surface dental caries,GCST002361,7:141188521
rs1488864-<b>A</b>,1 x 10-6,,0.0932,'-,1.295 unit increase,[NR],"CAVIN3, SMPD1",Smooth-surface caries,smooth surface dental caries,GCST002361,11:6321099
rs16954776-<b>A</b>,9 x 10-7,,0.0156,'-,5.1206 unit decrease,[NR],"FARP1, IPO5",Smooth-surface caries,smooth surface dental caries,GCST002361,13:98048363
rs17124372-<b>T</b>,2 x 10-6,,0.0241,'-,5.1975 unit decrease,[NR],"BPIFA4P, BPIFA3",Smooth-surface caries,smooth surface dental caries,GCST002361,20:33210631
rs5967638-<b>A</b>,8 x 10-7,,0.0658,'-,3.485 unit increase,[NR],"MIR1321, SFR1P2",Smooth-surface caries,smooth surface dental caries,GCST002361,X:85840734
rs12037343-<b>T</b>,3 x 10-6,,0.0609,'-,2.2172 unit increase,[NR],'-,Smooth-surface caries,smooth surface dental caries,GCST002361,1:218758563
rs10495332-<b>T</b>,8 x 10-6,,0.0227,'-,4.119 unit decrease,[NR],SIPA1L2,Smooth-surface caries,smooth surface dental caries,GCST002361,1:232620280
rs10176394-<b>T</b>,2 x 10-6,,0.1431,'-,1.7701 unit decrease,[NR],ARHGAP15,Smooth-surface caries,smooth surface dental caries,GCST002361,2:143338805
rs4016429-<b>C</b>,2 x 10-6,,0.0157,'-,4.564 unit decrease,[NR],RBMS3,Smooth-surface caries,smooth surface dental caries,GCST002361,3:28923310
rs3732783-<b>T</b>,9 x 10-6,,0.0582,'-,1.8772 unit decrease,[NR],DRD3,Smooth-surface caries,smooth surface dental caries,GCST002361,3:114171942
rs9471075-<b>A</b>,1 x 10-6,,0.0247,'-,5.25 unit decrease,[NR],KIF6,Smooth-surface caries,smooth surface dental caries,GCST002361,6:39339256
rs17128007-<b>T</b>,7 x 10-6,,0.021,'-,4.7991 unit increase,[NR],SH2D4A,Smooth-surface caries,smooth surface dental caries,GCST002361,8:19225642
rs2877649-<b>T</b>,2 x 10-6,,0.0339,'-,0.1877 unit increase,[NR],"SDR39U1, CMA1",Smooth-surface caries,smooth surface dental caries,GCST002361,14:24484796
rs17111530-<b>T</b>,1 x 10-6,,0.0667,'-,2.529 unit decrease,[NR],TSHR,Smooth-surface caries,smooth surface dental caries,GCST002361,14:81132568
rs11082098-<b>A</b>,2 x 10-6,,0.0558,'-,1.138 unit increase,[NR],'-,Smooth-surface caries,smooth surface dental caries,GCST002361,18:38618768
rs17088439-<b>T</b>,3 x 10-6,,0.0434,'-,2.2772 unit decrease,[NR],'-,Smooth-surface caries,smooth surface dental caries,GCST002361,18:73854856
rs6076960-<b>A</b>,6 x 10-6,,0.475,'-,1.2722 unit increase,[NR],TARDBPP1,Smooth-surface caries,smooth surface dental caries,GCST002361,20:6205510
rs6120141-<b>T</b>,3 x 10-6,,0.0252,'-,5.0772 unit decrease,[NR],BPIFA2,Smooth-surface caries,smooth surface dental caries,GCST002361,20:33180849
rs4654438-<b>T</b>,2 x 10-6,,0.4593,'-,1.6269 unit decrease,[NR],"LINC01646, LINC01777",Smooth-surface caries,smooth surface dental caries,GCST002361,1:4499841
rs4240384-<b>?</b>,2 x 10-7,,0.818,1.4326648,'-,'-,LINC02240,Eosinophilic esophagitis,eosinophilic esophagitis,GCST009070,5:124955709
rs11495981-<b>?</b>,9 x 10-7,,0.206,1.308,'-,'-,JAZF1,Eosinophilic esophagitis,eosinophilic esophagitis,GCST009070,7:28137682
rs12924112-<b>?</b>,1 x 10-7,,0.64,1.310616,'-,'-,CLEC16A,Eosinophilic esophagitis,eosinophilic esophagitis,GCST009070,16:11125863
rs149864795-<b>A</b>,5 x 10-10,,0.052,2.216,'-,[1.97-2.47],CAPN14,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002697,2:31179541
rs252716-<b>C</b>,4 x 10-14,,0.447,1.516,'-,[1.41-1.62],"TSLP, WDR36",Eosinophilic esophagitis,eosinophilic esophagitis,GCST002697,5:111089365
rs61894547-<b>T</b>,4 x 10-11,,0.043,2.439,'-,[2.17-2.7],EMSY,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002697,11:76537586
rs167769-<b>T</b>,2 x 10-7,,0.377,1.351,'-,[1.24-1.46],STAT6,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002697,12:57109992
rs3815700-<b>C</b>,2 x 10-9,,0.14,1.618,'-,[1.46-1.78],ANKRD27,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002697,19:32602346
rs8008716-<b>G</b>,7 x 10-8,,0.087,1.712,'-,[1.52-1.91],LINC02588,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002697,14:26656559
rs17095355-<b>T</b>,7 x 10-9,,0.409,1.77,'-,[1.38-2.26],ADD3-AS1,Biliary atresia,Biliary atresia,GCST000681,10:109975992
rs2120991-<b>A</b>,9 x 10-6,,0.134,2.14,'-,[1.58-2.89],"RN7SKP289, HOXC13-AS",Biliary atresia,Biliary atresia,GCST000681,12:53876444
rs9314986-<b>G</b>,2 x 10-6,,0.044,2.95,'-,[1.89-4.60],LINC00297,Biliary atresia,Biliary atresia,GCST000681,13:29884600
rs76766811-<b>T</b>,2 x 10-8,,1.6,2.63,'-,[1.88-3.67],"LINC02860, KIAA0087",Survival in colon cancer,"colon carcinoma, overall survival",GCST010716,7:26620935
rs146225887-<b>A</b>,8 x 10-7,,0.011024,1.676446,'-,NR,'-,Colon cancer,colon carcinoma,GCST90011811,10:57845564
rs71518872-<b>G</b>,1 x 10-8,,0.015359,1.5725743,'-,NR,"RNU6-1224P, ODF1",Colon cancer,colon carcinoma,GCST90011811,8:102549750
rs139372065-<b>G</b>,8 x 10-7,,0.012974,1.5422578,'-,NR,ZCWPW2,Colon cancer,colon carcinoma,GCST90011811,3:28471912
rs112408346-<b>T</b>,3 x 10-7,,0.020995,1.4218683,'-,NR,CRISPLD1,Colon cancer,colon carcinoma,GCST90011811,8:74969644
rs117079142-<b>A</b>,8 x 10-7,,NR,1.283697,'-,NR,UTP23,Colon cancer,colon carcinoma,GCST90011811,8:116778675
rs8114643-<b>G</b>,2 x 10-9,,0.135812,1.2072921,'-,NR,HAO1,Colon cancer,colon carcinoma,GCST90011811,20:7852399
rs12140498-<b>T</b>,9 x 10-9,,NR,1.1737089,'-,NR,LINC02257,Colon cancer,colon carcinoma,GCST90011811,1:221925348
rs4381148-<b>C</b>,3 x 10-7,,0.444434,1.1261,'-,NR,RGL1,Colon cancer,colon carcinoma,GCST90011811,1:183834292
rs10951878-<b>C</b>,2 x 10-7,,0.491105,1.1292,'-,NR,'-,Colon cancer,colon carcinoma,GCST90011811,7:46887097
rs6066825-<b>A</b>,1 x 10-7,,0.634792,1.1387,'-,NR,PREX1,Colon cancer,colon carcinoma,GCST90011811,20:48723580
rs6507874-<b>T</b>,3 x 10-8,,NR,1.1402,'-,NR,SMAD7,Colon cancer,colon carcinoma,GCST90011811,18:48922435
rs7014346-<b>A</b>,4 x 10-17,,NR,1.2191,'-,NR,"PCAT1, POU5F1B, CASC8",Colon cancer,colon carcinoma,GCST90011811,8:127412547
rs17841839-<b>C</b>,9 x 10-7,,NR,1.3663,'-,NR,RHPN2,Colon cancer,colon carcinoma,GCST90011811,19:33026295
rs12721025-<b>A</b>,2 x 10-10,,0.0569,1.59,'-,[1.38-1.83],"APOC3, APOA1",Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST002145,11:116835331
rs11712066-<b>A</b>,3 x 10-21,,0.7484,1.55,'-,[1.42-1.70],'-,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST002145,3:152112520
rs573872-<b>G</b>,5 x 10-14,,0.2282,1.37,'-,[1.26-1.48],LINC02006,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST002145,3:153754374
rs29784-<b>T</b>,8 x 10-18,,0.4504,1.36,'-,[1.27-1.46],"RPL7AP33, BNIP1",Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST002145,5:173168305
rs11712066-<b>A</b>,3 x 10-27,,0.760041453,1.5625,'-,[1.39-1.82],'-,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,3:152112520
rs6736913-<b>A</b>,3 x 10-15,(EA),0.016985168,2.32,'-,[2.11-2.53],EML4,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,2:42282878
rs7644486-<b>C</b>,2 x 10-7,(EA),0.268075729,1.2,'-,[1.13-1.27],SLMAP,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,3:57884236
rs7644486-<b>C</b>,5 x 10-8,,0.2766,1.19,'-,[1.13-1.26],SLMAP,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,3:57884236
rs11712066-<b>A</b>,3 x 10-27,(EA),0.760041453,1.5625,'-,[1.39-1.82],'-,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,3:152112520
rs573872-<b>G</b>,5 x 10-13,(EA),0.219046149,1.31,'-,[1.24-1.38],LINC02006,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,3:153754374
rs573872-<b>G</b>,2 x 10-15,,0.2175,1.32,'-,[1.25-1.38],LINC02006,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,3:153754374
rs6556059-<b>T</b>,1 x 10-31,(EA),0.35116369,1.48,'-,[1.41-1.54],"BNIP1, RPL7AP33",Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,5:173218763
rs6556059-<b>T</b>,2 x 10-10,,0.3402,1.43,'-,[1.18-1.67],"BNIP1, RPL7AP33",Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,5:173218763
rs1933683-<b>G</b>,3 x 10-9,(EA),0.102306986,1.34,'-,[1.24-1.43],BARX1,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,9:93950489
rs1933683-<b>G</b>,9 x 10-11,,0.1044,1.34,'-,[1.25-1.43],BARX1,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,9:93950489
rs12721025-<b>A</b>,1 x 10-9,(EA),0.060630698,1.45,'-,[1.33-1.57],"APOC3, APOA1",Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,11:116835331
rs12870105-<b>G</b>,2 x 10-7,(EA),0.124637839,1.37,'-,[1.25-1.49],'-,Infantile hypertrophic pyloric stenosis,infantile hypertrophic pyloric stenosis,GCST006705,13:64542179
rs6000782-<b>?</b>,3 x 10-6,,0.04,1.7,'-,[1.40-2.10],"CARD10, CDC42EP1",Autoimmune hepatitis type-1,Autoimmune Hepatitis,GCST002423,22:37532179
rs2187668-<b>?</b>,2 x 10-78,,0.15,2.9,'-,[2.60-3.40],HLA-DQA1,Autoimmune hepatitis type-1,Autoimmune Hepatitis,GCST002423,6:32638107
rs3184504-<b>?</b>,8 x 10-8,,0.43,1.4,'-,[1.20-1.60],"SH2B3, ATXN2",Autoimmune hepatitis type-1,Autoimmune Hepatitis,GCST002423,12:111446804
rs671-<b>A</b>,3 x 10-24,,NR,1.67,'-,[1.58-1.76],ALDH2,Esophageal cancer,esophageal carcinoma,GCST000466,12:111803962
rs1229984-<b>G</b>,8 x 10-24,,NR,1.79,'-,[1.69-1.88],ADH1B,Esophageal cancer,esophageal carcinoma,GCST000466,4:99318162
rs12293535-<b>A</b>,6 x 10-10,,0.275110056,'-,0.0037064 unit increase,[NR],CALCB,Diverticular disease,diverticular disease,GCST006479,11:14993308
rs875107-<b>A</b>,2 x 10-9,,0.517213131,'-,0.0032043 unit decrease,[NR],ANO1,Diverticular disease,diverticular disease,GCST006479,11:70159268
rs72945112-<b>T</b>,6 x 10-6,,0.147931327,'-,0.0034137 unit decrease,[NR],"FADD, PPFIA1",Diverticular disease,diverticular disease,GCST006479,11:70247466
rs3823878-<b>A</b>,3 x 10-9,,0.061691713,'-,0.0066196 unit increase,[NR],ELN,Diverticular disease,diverticular disease,GCST006479,7:74028915
rs10471645-<b>C</b>,3 x 10-9,,0.835307642,'-,0.0042784 unit decrease,[NR],CWC27,Diverticular disease,diverticular disease,GCST006479,5:64999536
rs1888693-<b>A</b>,4 x 10-9,,0.343452699,'-,0.0033327 unit decrease,[NR],CACNB2,Diverticular disease,diverticular disease,GCST006479,10:18151515
rs4871180-<b>T</b>,4 x 10-9,,0.244148467,'-,0.003674 unit increase,[NR],'-,Diverticular disease,diverticular disease,GCST006479,8:121246834
rs2049865-<b>A</b>,6 x 10-9,,0.578298576,'-,0.0031835 unit increase,[NR],TRPS1,Diverticular disease,diverticular disease,GCST006479,8:115576319
rs1544387-<b>T</b>,6 x 10-9,,0.576508859,'-,0.0031715 unit increase,[NR],BMPR1B,Diverticular disease,diverticular disease,GCST006479,4:94852434
rs11934833-<b>G</b>,6 x 10-9,,0.304434815,'-,0.0034045 unit decrease,[NR],LINC02272,Diverticular disease,diverticular disease,GCST006479,4:156636431
rs2784255-<b>C</b>,1 x 10-8,,0.485307354,'-,0.0030642 unit decrease,[NR],HLX,Diverticular disease,diverticular disease,GCST006479,1:220893031
rs10120333-<b>G</b>,2 x 10-8,,0.530818715,'-,0.003041 unit increase,[NR],PCSK5,Diverticular disease,diverticular disease,GCST006479,9:76125437
rs12942267-<b>T</b>,3 x 10-8,,0.638953586,'-,0.0031127 unit increase,[NR],ZBTB4,Diverticular disease,diverticular disease,GCST006479,17:7469318
rs62126581-<b>A</b>,4 x 10-8,,0.170302907,'-,0.003927 unit decrease,[NR],'-,Diverticular disease,diverticular disease,GCST006479,2:18806974
rs115490395-<b>A</b>,4 x 10-8,,0.008365602,'-,0.01638 unit increase,[NR],"SLC6A17, UBL4B",Diverticular disease,diverticular disease,GCST006479,1:110120397
rs2470653-<b>A</b>,5 x 10-8,,0.228251899,'-,0.0035186 unit decrease,[NR],'-,Diverticular disease,diverticular disease,GCST006479,3:5804815
rs10173528-<b>T</b>,5 x 10-8,,0.60676146,'-,0.0030036 unit decrease,[NR],BABAM2,Diverticular disease,diverticular disease,GCST006479,2:28065525
rs34126945-<b>G</b>,6 x 10-8,,0.334946301,'-,0.0030812 unit decrease,[NR],SNX24,Diverticular disease,diverticular disease,GCST006479,5:122994034
rs200217504-<b>?</b>,6 x 10-8,,NR,'-,'-,[NR],MTHFD2P4,Diverticular disease,diverticular disease,GCST006479,4:162280955
rs13247106-<b>G</b>,6 x 10-8,,0.309812032,'-,0.0031645 unit decrease,[NR],CALD1,Diverticular disease,diverticular disease,GCST006479,7:134874629
rs9960286-<b>G</b>,7 x 10-8,,0.242931258,'-,0.0033679 unit increase,[NR],ATP7BP1,Diverticular disease,diverticular disease,GCST006479,18:22448774
rs4461115-<b>C</b>,7 x 10-8,,0.275192956,'-,0.0032336 unit increase,[NR],"TBX21, TBKBP1",Diverticular disease,diverticular disease,GCST006479,17:47722212
rs6011570-<b>G</b>,9 x 10-8,,0.999991883,'-,0.54382 unit decrease,[NR],LINC01749,Diverticular disease,diverticular disease,GCST006479,20:63059658
rs2056544-<b>A</b>,1 x 10-7,,0.576838224,'-,0.0029364 unit increase,[NR],SCAPER,Diverticular disease,diverticular disease,GCST006479,15:76533662
rs10519134-<b>A</b>,7 x 10-6,,0.111406492,'-,0.0038848 unit increase,[NR],ETFA,Diverticular disease,diverticular disease,GCST006479,15:76286749
rs1973232-<b>A</b>,1 x 10-7,,0.81533624,'-,0.0036585 unit decrease,[NR],TIMP2,Diverticular disease,diverticular disease,GCST006479,17:78860884
rs759555-<b>C</b>,1 x 10-7,,0.755706188,'-,0.0032893 unit decrease,[NR],"LINC02565, RNU6-737P",Diverticular disease,diverticular disease,GCST006479,18:57223332
rs12041565-<b>T</b>,1 x 10-7,,0.18134713,'-,0.0036567 unit increase,[NR],KIF26B,Diverticular disease,diverticular disease,GCST006479,1:245609739
rs57114474-<b>A</b>,2 x 10-7,,0.08341364,'-,0.0051055 unit decrease,[NR],BTD,Diverticular disease,diverticular disease,GCST006479,3:15646391
rs74159124-<b>C</b>,2 x 10-7,,0.059699741,'-,0.0059034 unit decrease,[NR],"PLEKHA1, RNU6-728P",Diverticular disease,diverticular disease,GCST006479,10:122365153
rs4515160-<b>G</b>,2 x 10-7,,0.260417456,'-,0.0031546 unit increase,[NR],"C1QTNF7, C1QTNF7-AS1",Diverticular disease,diverticular disease,GCST006479,4:15382920
rs428022-<b>G</b>,3 x 10-7,,0.6557503,'-,0.0029139 unit decrease,[NR],PIAS1,Diverticular disease,diverticular disease,GCST006479,15:67956797
rs6800707-<b>G</b>,3 x 10-7,,0.809876809,'-,0.0035131 unit increase,[NR],NISCH,Diverticular disease,diverticular disease,GCST006479,3:52482277
rs34119918-<b>C</b>,3 x 10-7,,0.54654981,'-,0.0028375 unit decrease,[NR],ING5,Diverticular disease,diverticular disease,GCST006479,2:241726187
rs2119790-<b>G</b>,3 x 10-7,,0.544545824,'-,0.0027521 unit increase,[NR],"RNU6-1096P, HAND2",Diverticular disease,diverticular disease,GCST006479,4:173462088
rs3762086-<b>A</b>,4 x 10-7,,0.160610332,'-,0.0037144 unit increase,[NR],KIAA1217,Diverticular disease,diverticular disease,GCST006479,10:24431559
rs1427669-<b>G</b>,4 x 10-7,,0.226277454,'-,0.0032665 unit decrease,[NR],TNS1,Diverticular disease,diverticular disease,GCST006479,2:217930633
rs73230688-<b>T</b>,5 x 10-7,,0.379292528,'-,0.0027841 unit decrease,[NR],"RN7SL252P, MARK2P10",Diverticular disease,diverticular disease,GCST006479,7:96880690
rs79586998-<b>T</b>,5 x 10-7,,0.019543142,'-,0.0097507 unit decrease,[NR],GTSCR1,Diverticular disease,diverticular disease,GCST006479,18:70617285
rs7608769-<b>C</b>,6 x 10-7,,0.657299234,'-,0.0028349 unit increase,[NR],"PKP4-AS1, DAPL1",Diverticular disease,diverticular disease,GCST006479,2:158740458
rs2028386-<b>G</b>,7 x 10-7,,0.494876665,'-,0.0026624 unit increase,[NR],LOXL1,Diverticular disease,diverticular disease,GCST006479,15:73934367
rs585458-<b>T</b>,7 x 10-7,,0.494809788,'-,0.0026616 unit decrease,[NR],STARD13,Diverticular disease,diverticular disease,GCST006479,13:33144128
rs55983503-<b>G</b>,7 x 10-7,,0.154425624,'-,0.0037265 unit decrease,[NR],OPCML,Diverticular disease,diverticular disease,GCST006479,11:133187586
rs3104841-<b>G</b>,7 x 10-7,,0.452048882,'-,0.002673 unit increase,[NR],TMEM26-AS1,Diverticular disease,diverticular disease,GCST006479,10:61485227
rs139711468-<b>A</b>,8 x 10-7,,0.031334513,'-,0.0078033 unit decrease,[NR],TCP1P3,Diverticular disease,diverticular disease,GCST006479,12:19939051
rs138699-<b>A</b>,8 x 10-7,,0.246221748,'-,0.00307 unit increase,[NR],GTPBP1,Diverticular disease,diverticular disease,GCST006479,22:38733703
rs742184-<b>T</b>,8 x 10-7,,0.282356176,'-,0.0029374 unit decrease,[NR],MAPK12,Diverticular disease,diverticular disease,GCST006479,22:50258690
rs74887298-<b>A</b>,8 x 10-7,,0.039771711,'-,0.0067409 unit increase,[NR],KCNK3,Diverticular disease,diverticular disease,GCST006479,2:26706228
rs11920441-<b>C</b>,8 x 10-7,,0.343474198,'-,0.0027808 unit increase,[NR],DOCK3,Diverticular disease,diverticular disease,GCST006479,3:51062589
rs189921337-<b>T</b>,9 x 10-7,,1.39E-05,'-,0.28936 unit increase,[NR],MTCO3P41,Diverticular disease,diverticular disease,GCST006479,7:67679580
rs2874890-<b>G</b>,9 x 10-7,,0.259341157,'-,0.0030048 unit increase,[NR],KCNIP4,Diverticular disease,diverticular disease,GCST006479,4:21126053
rs11727676-<b>C</b>,1 x 10-6,,0.096320613,'-,0.0044496 unit decrease,[NR],HHIP,Diverticular disease,diverticular disease,GCST006479,4:144737912
rs208814-<b>G</b>,1 x 10-6,,0.644506404,'-,0.0027462 unit decrease,[NR],PPP1R16B,Diverticular disease,diverticular disease,GCST006479,20:38864933
rs9364190-<b>C</b>,1 x 10-6,,0.205148311,'-,0.0032499 unit decrease,[NR],'-,Diverticular disease,diverticular disease,GCST006479,6:168930406
rs61916264-<b>G</b>,1 x 10-6,,0.165210841,'-,0.0035423 unit decrease,[NR],TSPAN9,Diverticular disease,diverticular disease,GCST006479,12:3109418
rs62369011-<b>T</b>,1 x 10-6,,0.338739291,'-,0.0027432 unit increase,[NR],CENPK,Diverticular disease,diverticular disease,GCST006479,5:65549600
rs78628486-<b>A</b>,1 x 10-6,,0.012360121,'-,0.012186 unit increase,[NR],LINC01508,Diverticular disease,diverticular disease,GCST006479,9:90303436
rs150700179-<b>G</b>,3 x 10-6,,8.01E-06,'-,0.374 unit increase,[NR],"OMG, NF1",Diverticular disease,diverticular disease,GCST006479,17:31282303
rs1545550-<b>G</b>,2 x 10-6,,0.122106872,'-,0.0039389 unit decrease,[NR],LTBP1,Diverticular disease,diverticular disease,GCST006479,2:33135059
rs6001872-<b>G</b>,1 x 10-6,,0.351096023,'-,0.002715 unit increase,[NR],TNRC6B,Diverticular disease,diverticular disease,GCST006479,22:40307241
rs182799903-<b>T</b>,1 x 10-6,,2.67E-05,'-,0.28936 unit increase,[NR],FIBCD1,Diverticular disease,diverticular disease,GCST006479,9:130922006
rs12531839-<b>C</b>,1 x 10-6,,0.236835348,'-,0.0030449 unit increase,[NR],ELFN1,Diverticular disease,diverticular disease,GCST006479,7:1714917
rs11736215-<b>C</b>,2 x 10-6,,0.453261605,'-,0.002595 unit decrease,[NR],"AFAP1, AFAP1-AS1",Diverticular disease,diverticular disease,GCST006479,4:7760775
rs2205558-<b>A</b>,2 x 10-6,,0.394577754,'-,0.0026438 unit decrease,[NR],LINC01697,Diverticular disease,diverticular disease,GCST006479,21:28112392
rs6733972-<b>C</b>,2 x 10-6,,0.479799247,'-,0.0025801 unit increase,[NR],ICA1L,Diverticular disease,diverticular disease,GCST006479,2:202788115
rs35926103-<b>G</b>,2 x 10-6,,0.260733842,'-,0.0029097 unit increase,[NR],BTC,Diverticular disease,diverticular disease,GCST006479,4:74750496
rs4762743-<b>T</b>,2 x 10-6,,0.526095532,'-,0.0025784 unit decrease,[NR],RNU1-146P,Diverticular disease,diverticular disease,GCST006479,12:19768141
rs190502327-<b>T</b>,2 x 10-6,,1.54E-06,'-,2.7788 unit increase,[NR],METAP2P1,Diverticular disease,diverticular disease,GCST006479,2:145881279
rs7569198-<b>T</b>,2 x 10-6,,0.143357815,'-,0.0036619 unit increase,[NR],RN7SKP93,Diverticular disease,diverticular disease,GCST006479,2:133599273
rs899245-<b>A</b>,2 x 10-6,,0.217065075,'-,0.0030797 unit increase,[NR],"LINC02188, FOXL1",Diverticular disease,diverticular disease,GCST006479,16:86666161
rs6980251-<b>C</b>,2 x 10-6,,0.083021164,'-,0.0046345 unit increase,[NR],LHFPL3,Diverticular disease,diverticular disease,GCST006479,7:104420903
rs10405423-<b>A</b>,2 x 10-6,,0.657829922,'-,0.0027017 unit increase,[NR],INSR,Diverticular disease,diverticular disease,GCST006479,19:7211300
rs17133574-<b>C</b>,2 x 10-6,,0.169870344,'-,0.0033899 unit decrease,[NR],"STARD4-AS1, NREP",Diverticular disease,diverticular disease,GCST006479,5:111669061
rs7218632-<b>G</b>,2 x 10-6,,0.35027422,'-,0.0026574 unit decrease,[NR],ITGB3,Diverticular disease,diverticular disease,GCST006479,17:47287787
rs41313101-<b>A</b>,2 x 10-6,,0.025661331,'-,0.0082643 unit decrease,[NR],KCNH2,Diverticular disease,diverticular disease,GCST006479,7:150972232
rs113477191-<b>T</b>,5 x 10-6,,0.023017103,'-,0.0083106 unit increase,[NR],FAM180A,Diverticular disease,diverticular disease,GCST006479,7:135734133
rs138262539-<b>G</b>,5 x 10-6,,0.010292872,'-,0.012394 unit increase,[NR],"IFNAR1, IFNGR2",Diverticular disease,diverticular disease,GCST006479,21:33393039
rs1868382-<b>C</b>,6 x 10-6,,0.823578097,'-,0.0032094 unit decrease,[NR],"B3GALT1-AS1, CTAGE14P",Diverticular disease,diverticular disease,GCST006479,2:167720960
rs78114187-<b>T</b>,6 x 10-6,,0.008568043,'-,0.013998 unit decrease,[NR],"DHTKD1, UPF2",Diverticular disease,diverticular disease,GCST006479,10:12062989
rs35580034-<b>A</b>,6 x 10-6,,0.521848421,'-,0.002428 unit increase,[NR],"LACTB2, LACTB2-AS1",Diverticular disease,diverticular disease,GCST006479,8:70659838
rs1841041-<b>G</b>,6 x 10-6,,0.117586584,'-,0.0037622 unit increase,[NR],"UGT2B7, UGT2B11",Diverticular disease,diverticular disease,GCST006479,4:69142682
rs2236617-<b>G</b>,6 x 10-6,,0.659640201,'-,0.0025658 unit decrease,[NR],PRMT2,Diverticular disease,diverticular disease,GCST006479,21:46651618
rs10853101-<b>A</b>,7 x 10-6,,0.722751802,'-,0.0026982 unit decrease,[NR],"HOXB3, HOXB-AS3, HOXB6",Diverticular disease,diverticular disease,GCST006479,17:48599098
rs36023555-<b>G</b>,7 x 10-6,,0.589923587,'-,0.0024746 unit decrease,[NR],NOTUM,Diverticular disease,diverticular disease,GCST006479,17:81957753
rs143076357-<b>A</b>,7 x 10-6,,0.115195977,'-,0.0037959 unit decrease,[NR],KRTAP5-AS1,Diverticular disease,diverticular disease,GCST006479,11:1581842
rs12122642-<b>G</b>,7 x 10-6,,0.322753825,'-,0.0025826 unit decrease,[NR],GPR37L1,Diverticular disease,diverticular disease,GCST006479,1:202124558
rs7100912-<b>G</b>,7 x 10-6,,0.656026751,'-,0.0025422 unit decrease,[NR],"RNU6-523P, RPL12P8",Diverticular disease,diverticular disease,GCST006479,10:67871149
rs9569447-<b>T</b>,8 x 10-6,,0.646489808,'-,0.0025101 unit decrease,[NR],SPATA2P1,Diverticular disease,diverticular disease,GCST006479,13:56236446
rs111703420-<b>G</b>,8 x 10-6,,0.028974179,'-,0.0074621 unit decrease,[NR],"KLF16, ABHD17A",Diverticular disease,diverticular disease,GCST006479,19:1868788
rs4782347-<b>G</b>,8 x 10-6,,0.469551548,'-,0.0024242 unit increase,[NR],PIEZO1,Diverticular disease,diverticular disease,GCST006479,16:88755300
rs6062497-<b>T</b>,8 x 10-6,,0.665712483,'-,0.0025325 unit decrease,[NR],ARFRP1,Diverticular disease,diverticular disease,GCST006479,20:63704906
rs9308434-<b>T</b>,8 x 10-6,,0.452241057,'-,0.0024096 unit increase,[NR],SMYD2,Diverticular disease,diverticular disease,GCST006479,1:214283831
rs80261783-<b>T</b>,8 x 10-6,,0.019308661,'-,0.0086976 unit increase,[NR],VAPA,Diverticular disease,diverticular disease,GCST006479,18:9922405
rs577026-<b>G</b>,8 x 10-6,,0.559060613,'-,0.0024063 unit increase,[NR],MAPKAP1,Diverticular disease,diverticular disease,GCST006479,9:125578744
rs5997449-<b>C</b>,8 x 10-6,,0.08280724,'-,0.004369 unit increase,[NR],KREMEN1,Diverticular disease,diverticular disease,GCST006479,22:29163399
rs140094156-<b>T</b>,8 x 10-6,,0.033863369,'-,0.0068326 unit increase,[NR],ZNF28,Diverticular disease,diverticular disease,GCST006479,19:52809791
rs141727959-<b>A</b>,9 x 10-6,,0.023158187,'-,0.0086002 unit increase,[NR],EPB41L3,Diverticular disease,diverticular disease,GCST006479,18:5597208
rs12219062-<b>T</b>,9 x 10-6,,0.032392249,'-,0.0070008 unit increase,[NR],"U3, ZNF101P1",Diverticular disease,diverticular disease,GCST006479,10:28392609
rs7913576-<b>T</b>,9 x 10-6,,0.563513385,'-,0.0024063 unit increase,[NR],"ENTPD1-AS1, CC2D2B",Diverticular disease,diverticular disease,GCST006479,10:95930862
rs139044580-<b>T</b>,9 x 10-6,,0.00687437,'-,0.014924 unit decrease,[NR],"LINC00856, GNAI2P2",Diverticular disease,diverticular disease,GCST006479,10:78086376
rs73486316-<b>A</b>,2 x 10-6,,0.010404551,'-,0.012784 unit increase,[NR],"LINC02361, GALNT9",Diverticular disease,diverticular disease,GCST006479,12:132191245
rs10748858-<b>G</b>,3 x 10-6,,0.409929348,'-,0.0025712 unit increase,[NR],STN1,Diverticular disease,diverticular disease,GCST006479,10:103879756
rs72818515-<b>A</b>,3 x 10-6,,0.731090874,'-,0.0028272 unit decrease,[NR],ADK,Diverticular disease,diverticular disease,GCST006479,10:74300960
rs116439690-<b>A</b>,3 x 10-6,,0.028970851,'-,0.0075124 unit decrease,[NR],'-,Diverticular disease,diverticular disease,GCST006479,4:18617544
rs183318239-<b>T</b>,9 x 10-6,,0.016891544,'-,0.0098232 unit increase,[NR],ROBO1,Diverticular disease,diverticular disease,GCST006479,3:79667241
rs62406524-<b>C</b>,3 x 10-6,,0.098204374,'-,0.0043753 unit decrease,[NR],PI16,Diverticular disease,diverticular disease,GCST006479,6:36958200
rs721920-<b>G</b>,3 x 10-6,,0.166889902,'-,0.0033501 unit decrease,[NR],"CPA3, UBQLN4P1",Diverticular disease,diverticular disease,GCST006479,3:148960893
rs11855441-<b>T</b>,3 x 10-6,,0.175588251,'-,0.0032688 unit decrease,[NR],GPR176,Diverticular disease,diverticular disease,GCST006479,15:39844727
rs7130416-<b>C</b>,3 x 10-6,,0.438536639,'-,0.0025266 unit decrease,[NR],"LINC02708, KRTAP5-6",Diverticular disease,diverticular disease,GCST006479,11:1694102
rs191699548-<b>A</b>,3 x 10-6,,1.95E-07,'-,26.83 unit increase,[NR],"PKP2, YARS2",Diverticular disease,diverticular disease,GCST006479,12:32782333
rs2551395-<b>T</b>,4 x 10-6,,0.991917484,'-,0.014189 unit increase,[NR],TBX5,Diverticular disease,diverticular disease,GCST006479,12:114380933
rs138074947-<b>C</b>,4 x 10-6,,7.73E-04,'-,0.04781 unit increase,[NR],"RN7SKP280, INSIG1-DT",Diverticular disease,diverticular disease,GCST006479,7:155227723
rs12814314-<b>G</b>,4 x 10-6,,0.066485195,'-,0.0049595 unit increase,[NR],'-,Diverticular disease,diverticular disease,GCST006479,12:83263146
rs2815376-<b>A</b>,4 x 10-6,,0.59797335,'-,0.002543 unit increase,[NR],SLC35D1,Diverticular disease,diverticular disease,GCST006479,1:67042848
rs34275187-<b>G</b>,4 x 10-6,,0.125388817,'-,0.0037769 unit increase,[NR],POU2AF1,Diverticular disease,diverticular disease,GCST006479,11:111449369
rs3790087-<b>G</b>,4 x 10-6,,0.124339757,'-,0.0037534 unit decrease,[NR],WWP2,Diverticular disease,diverticular disease,GCST006479,16:69853611
rs7255-<b>C</b>,4 x 10-6,,0.557415868,'-,0.002492 unit decrease,[NR],GDF7,Diverticular disease,diverticular disease,GCST006479,2:20679060
rs3938-<b>G</b>,4 x 10-6,,0.60394823,'-,0.0025268 unit increase,[NR],KIAA0408,Diverticular disease,diverticular disease,GCST006479,6:127439350
rs340286-<b>G</b>,4 x 10-6,,0.048745854,'-,0.005748 unit decrease,[NR],"GPR79, IQCJ-SCHIP1",Diverticular disease,diverticular disease,GCST006479,3:158865215
rs118088914-<b>T</b>,4 x 10-6,,0.026146362,'-,0.0079442 unit decrease,[NR],"TMPRSS3, UBASH3A",Diverticular disease,diverticular disease,GCST006479,21:42399525
rs34837306-<b>T</b>,4 x 10-6,,0.129227495,'-,0.0037411 unit increase,[NR],"MIR8059, WFIKKN2",Diverticular disease,diverticular disease,GCST006479,17:50812872
rs78838948-<b>C</b>,4 x 10-6,,0.078796104,'-,0.0045781 unit decrease,[NR],"LINC02104, DAB2",Diverticular disease,diverticular disease,GCST006479,5:39504098
rs117969400-<b>A</b>,5 x 10-6,,0.024114491,'-,0.0083368 unit increase,[NR],"SLCO5A1, Metazoa_SRP",Diverticular disease,diverticular disease,GCST006479,8:69837910
rs71371957-<b>T</b>,5 x 10-6,,0.037519167,'-,0.0065814 unit increase,[NR],PYY,Diverticular disease,diverticular disease,GCST006479,17:43994169
rs11634793-<b>T</b>,5 x 10-6,,0.516079634,'-,0.0024416 unit decrease,[NR],SMAD3,Diverticular disease,diverticular disease,GCST006479,15:67155114
rs6734367-<b>G</b>,4 x 10-44,,0.821932561,'-,0.0097186 unit decrease,[NR],ARHGAP15,Diverticular disease,diverticular disease,GCST006479,2:143556678
rs4333882-<b>G</b>,4 x 10-22,,0.191980857,'-,0.0066512 unit increase,[NR],SLC35F3,Diverticular disease,diverticular disease,GCST006479,1:234217153
rs7609897-<b>T</b>,3 x 10-18,,0.214190296,'-,0.0059783 unit decrease,[NR],COLQ,Diverticular disease,diverticular disease,GCST006479,3:15461174
rs7086249-<b>C</b>,5 x 10-16,,0.464687746,'-,0.0043427 unit decrease,[NR],GPR158,Diverticular disease,diverticular disease,GCST006479,10:25522506
rs1802575-<b>C</b>,8 x 10-16,,0.132914713,'-,0.0063514 unit increase,[NR],EFEMP1,Diverticular disease,diverticular disease,GCST006479,2:55866069
rs11667256-<b>T</b>,1 x 10-14,,0.51999474,'-,0.004131 unit decrease,[NR],SPINT2,Diverticular disease,diverticular disease,GCST006479,19:38245164
rs962369-<b>C</b>,2 x 10-14,,0.309319589,'-,0.0047332 unit decrease,[NR],BDNF,Diverticular disease,diverticular disease,GCST006479,11:27712873
rs6949391-<b>T</b>,4 x 10-14,,0.336454917,'-,0.0042875 unit increase,[NR],FAM185A,Diverticular disease,diverticular disease,GCST006479,7:102806416
rs61823192-<b>T</b>,1 x 10-13,,0.030150955,'-,0.012297 unit decrease,[NR],LYPLAL1-DT,Diverticular disease,diverticular disease,GCST006479,1:219121228
rs9520344-<b>A</b>,5 x 10-12,,0.241527556,'-,0.0043373 unit decrease,[NR],FAM155A,Diverticular disease,diverticular disease,GCST006479,13:107250422
rs11619840-<b>A</b>,2 x 10-9,,0.185341502,'-,0.0041742 unit decrease,[NR],FAM155A,Diverticular disease,diverticular disease,GCST006479,13:107566610
rs7098322-<b>T</b>,1 x 10-11,,0.875223596,'-,0.0055034 unit decrease,[NR],"ENTPD7, SLC25A28",Diverticular disease,diverticular disease,GCST006479,10:99631412
rs10472291-<b>A</b>,1 x 10-11,,0.331624285,'-,0.0038704 unit increase,[NR],"WDR70, GDNF-AS1",Diverticular disease,diverticular disease,GCST006479,5:37772678
rs582094-<b>T</b>,2 x 10-11,,0.31857582,'-,0.0038815 unit decrease,[NR],ABO,Diverticular disease,diverticular disease,GCST006479,9:133270074
rs75434097-<b>A</b>,5 x 10-11,,0.144581074,'-,0.0050236 unit increase,[NR],COL6A1,Diverticular disease,diverticular disease,GCST006479,21:45999606
rs2280028-<b>A</b>,7 x 10-11,,0.142187257,'-,0.0050202 unit decrease,[NR],"LINC01082, LINC01081",Diverticular disease,diverticular disease,GCST006479,16:86199807
rs9856118-<b>G</b>,9 x 10-11,,0.167201967,'-,0.0046717 unit decrease,[NR],"P2RY12, MED12L",Diverticular disease,diverticular disease,GCST006479,3:151360428
rs71472433-<b>C</b>,9 x 10-11,,0.165547583,'-,0.004677 unit increase,[NR],"DISP2, PHGR1",Diverticular disease,diverticular disease,GCST006479,15:40357408
rs2131755-<b>G</b>,2 x 10-10,,0.406873364,'-,0.0034941 unit increase,[NR],CRISPLD2,Diverticular disease,diverticular disease,GCST006479,16:84823772
rs4839715-<b>A</b>,2 x 10-10,,0.371411884,'-,0.0035474 unit decrease,[NR],'-,Diverticular disease,diverticular disease,GCST006479,6:97917413
rs148376933-<b>T</b>,2 x 10-10,,6.88E-06,'-,1.1564 unit increase,[NR],UNC50,Diverticular disease,diverticular disease,GCST006479,2:98612512
rs1381335-<b>T</b>,2 x 10-10,,0.242395397,'-,0.0039879 unit decrease,[NR],"CCN3, MIR548AZ",Diverticular disease,diverticular disease,GCST006479,8:119415408
rs61814883-<b>A</b>,2 x 10-10,,0.299364986,'-,0.0037215 unit decrease,[NR],"NBPF18P, S100A10",Diverticular disease,diverticular disease,GCST006479,1:151998153
rs8074740-<b>A</b>,2 x 10-10,,0.320481473,'-,0.0036384 unit increase,[NR],"SHC1P2, SLC4A1",Diverticular disease,diverticular disease,GCST006479,17:44235410
rs3113037-<b>T</b>,3 x 10-10,,0.23236475,'-,0.0040179 unit increase,[NR],"RNU7-188P, SEM1",Diverticular disease,diverticular disease,GCST006479,7:96449252
rs113101273-<b>A</b>,9 x 10-6,,0.011675583,'-,0.011108 unit decrease,[NR],"GPR32, ACP4",Diverticular disease,diverticular disease,GCST006479,19:50780680
rs153035-<b>A</b>,9 x 10-6,,0.296841187,'-,0.0025997 unit decrease,[NR],"ADCY9, SRL",Diverticular disease,diverticular disease,GCST006479,16:4163368
rs12455063-<b>C</b>,9 x 10-6,,0.362354725,'-,0.0024753 unit increase,[NR],LINC01539,Diverticular disease,diverticular disease,GCST006479,18:56158799
rs4939827-<b>?</b>,2 x 10-10,(women),'-,'-,'-,'-,SMAD7,Colorectal cancer x BMI interaction (2df),"colorectal adenocarcinoma, body mass index",GCST010992,18:48927093
rs1379650-<b>?</b>,2 x 10-6,,NR,6.94,'-,NR,ANO5,Pruritus in nonalcoholic steatohepatitis,"Pruritus, non-alcoholic steatohepatitis",GCST009549,11:22013323
rs13118664-<b>?</b>,2 x 10-7,,NR,1.3966479,'-,[1.23-1.58],HSD17B13,Nonalcoholic steatohepatitis,non-alcoholic steatohepatitis,GCST010861,4:87318457
rs9992651-<b>?</b>,3 x 10-7,,NR,1.3927578,'-,[1.23-1.58],HSD17B13,Nonalcoholic steatohepatitis,non-alcoholic steatohepatitis,GCST010861,4:87311358
rs1260326-<b>?</b>,4 x 10-7,,NR,1.302,'-,[1.176-1.442],'-,Nonalcoholic steatohepatitis,non-alcoholic steatohepatitis,GCST010861,Mapping not available
rs58542926-<b>?</b>,2 x 10-7,,NR,1.606,'-,[1.344-1.919],TM6SF2,Nonalcoholic steatohepatitis,non-alcoholic steatohepatitis,GCST010861,19:19268740
rs8107974-<b>?</b>,1 x 10-7,,NR,1.609,'-,[1.348-1.920],SUGP1,Nonalcoholic steatohepatitis,non-alcoholic steatohepatitis,GCST010861,19:19277691
rs12077210-<b>?</b>,4 x 10-9,,NR,1.671,'-,[1.390-2.008],"LEPROT, LEPR",Nonalcoholic steatohepatitis,non-alcoholic steatohepatitis,GCST010861,1:65428477
rs80084600-<b>?</b>,7 x 10-8,,NR,1.977,'-,[1.543-2.533],LINC01036,Nonalcoholic steatohepatitis,non-alcoholic steatohepatitis,GCST010861,1:187379678
rs738409-<b>?</b>,3 x 10-44,,NR,2.053,'-,[1.856-2.271],PNPLA3,Nonalcoholic steatohepatitis,non-alcoholic steatohepatitis,GCST010861,22:43928847
rs62472985-<b>G</b>,3 x 10-11,,0.16,1.74,'-,[NR],RPL7P30,Hirschsprung disease,Hirschsprung disease,GCST005289,7:84567995
rs117617821-<b>C</b>,7 x 10-16,,0.04,2.71,'-,[NR],'-,Hirschsprung disease,Hirschsprung disease,GCST005289,7:84692873
rs17653445-<b>G</b>,5 x 10-10,,0.16,1.67,'-,[NR],"MTND1P18, TACC1P1",Hirschsprung disease,Hirschsprung disease,GCST005289,10:37546726
rs2505994-<b>T</b>,2 x 10-101,,0.23,5.3,'-,[NR],"MIR5100, RET",Hirschsprung disease,Hirschsprung disease,GCST005289,10:43073439
rs4519046-<b>A</b>,3 x 10-15,,0.18,1.85,'-,[NR],"HNRNPF, FXYD4",Hirschsprung disease,Hirschsprung disease,GCST005289,10:43379369
rs12428625-<b>T</b>,4 x 10-11,,0.01,3.63,'-,[NR],'-,Hirschsprung disease,Hirschsprung disease,GCST005289,13:86134644
rs144432435-<b>T</b>,6 x 10-7,(conditioned on rs2505994),0.01,3.734,'-,[NR],"RET, MIR5100",Hirschsprung disease,Hirschsprung disease,GCST005289,10:43063942
rs16879552-<b>G</b>,2 x 10-8,,0.61,1.68,'-,[1.40-2.00],NRG1,Hirschsprung disease,Hirschsprung disease,GCST000334,8:32553698
rs2742234-<b>T</b>,4 x 10-18,,NR,'-,'-,'-,RET,Hirschsprung disease,Hirschsprung disease,GCST000334,10:43117161
rs10825269-<b>T</b>,5 x 10-6,,0.12,1.55,'-,[1.28-1.87],PCDH15,Irritable bowel syndrome,irritable bowel syndrome,GCST002436,10:54195850
rs9999118-<b>G</b>,8 x 10-8,(IBS-D ),0.025,7.3,'-,[3.53-15.03],SPATA5,Irritable bowel syndrome,irritable bowel syndrome,GCST002436,4:123130312
rs738408-<b>T</b>,7 x 10-18,,0.216,'-,0.472 unit increase,[0.36-0.58],PNPLA3,Cirrhosis,cirrhosis of liver,GCST009609,22:43928850
rs4318431-<b>T</b>,3 x 10-9,,0.08,1.39,'-,[1.25-1.55],"GALNT14, CAPN13",Oropharynx cancer,oropharynx cancer,GCST010286,2:30875199
rs146801533-<b>G</b>,4 x 10-7,,0.01007,1.8221574,'-,NR,SLC24A3,Rectal cancer,rectum cancer,GCST90011810,20:19186027
rs145503185-<b>C</b>,4 x 10-8,,0.01279,1.8050541,'-,NR,'-,Rectal cancer,rectum cancer,GCST90011810,9:23455766
rs72716373-<b>C</b>,1 x 10-6,,0.011799,1.7262213,'-,NR,SCOC,Rectal cancer,rectum cancer,GCST90011810,4:140385611
rs17604996-<b>G</b>,1 x 10-7,,0.03886,1.4509577,'-,NR,MEGF10,Rectal cancer,rectum cancer,GCST90011810,5:127427395
rs16892766-<b>C</b>,8 x 10-7,,NR,1.2921567,'-,NR,EIF3H,Rectal cancer,rectum cancer,GCST90011810,8:116618444
rs34829185-<b>A</b>,7 x 10-7,,0.093672,1.271941,'-,NR,'-,Rectal cancer,rectum cancer,GCST90011810,8:13706716
rs58658771-<b>A</b>,1 x 10-8,,NR,1.242236,'-,NR,"GREM1, SCG5",Rectal cancer,rectum cancer,GCST90011810,15:32709533
rs12612141-<b>G</b>,7 x 10-7,,0.327816,1.1741,'-,NR,'-,Rectal cancer,rectum cancer,GCST90011810,2:199006308
rs2027077-<b>G</b>,2 x 10-7,,NR,1.181,'-,NR,LAMC1,Rectal cancer,rectum cancer,GCST90011810,1:183104318
rs4939827-<b>T</b>,5 x 10-8,,NR,1.1864,'-,NR,SMAD7,Rectal cancer,rectum cancer,GCST90011810,18:48927093
rs3087967-<b>T</b>,3 x 10-8,,NR,1.1994,'-,NR,C11orf53,Rectal cancer,rectum cancer,GCST90011810,11:111286111
rs6983267-<b>G</b>,5 x 10-10,,NR,1.2151,'-,NR,"PCAT1, CCAT2, CASC8, POU5F1B",Rectal cancer,rectum cancer,GCST90011810,8:127401060
rs17057166-<b>?</b>,2 x 10-7,(disease-free survival),'-,5.56,'-,[2.91-10.64],LINC01847,Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,5:159821007
rs4868304-<b>?</b>,3 x 10-7,(disease-free survival),'-,2.91,'-,[1.94-4.37],LINC01942,Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,5:173704454
rs6854845-<b>?</b>,6 x 10-7,(disease-free survival),'-,3.31,'-,[2.07-5.30],"BTC, HSPE1P23",Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,4:74821455
rs1570271-<b>?</b>,1 x 10-7,(disease-free survival),'-,3.66,'-,[2.26-5.94],"PPIAP39, HABP2",Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,10:113528742
rs4959799-<b>?</b>,5 x 10-6,(disease-free survival),'-,3.5,'-,[2.05-5.99],"SLC22A23, PSMG4",Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,6:3294794
rs11138220-<b>?</b>,8 x 10-6,(disease-free survival),'-,2.76,'-,[1.77-4.31],"LNCARSR, CHCHD2P9",Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,9:79445613
rs10275272-<b>?</b>,8 x 10-6,(disease-free survival),'-,3.19,'-,[1.92-5.31],"TWIST1, FERD3L",Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,7:19121274
rs3781663-<b>?</b>,8 x 10-6,(disease-free survival),'-,2.24,'-,[1.57-3.19],ANO1,Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,11:70153146
rs9419702-<b>?</b>,9 x 10-6,(disease-free survival),'-,2.54,'-,[1.68-3.83],LINC01164,Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,10:131698817
rs142021700-<b>C</b>,3 x 10-9,,0.01,3.95,'-,[2.51-6.21],RTTN,Hypopharyngeal or laryngeal cancer,"laryngeal squamous cell carcinoma, hypopharynx cancer",GCST010285,18:70034347
rs77045180-<b>T</b>,1 x 10-7,,0.02,2.51,'-,[3.52-1.79],AKR1C1,Hypopharyngeal or laryngeal cancer,"laryngeal squamous cell carcinoma, hypopharynx cancer",GCST010285,10:4981859
rs77968610-<b>T</b>,3 x 10-8,,0.88,0.95,'-,[NR],NAV3,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST011503,12:78139079
rs32546-<b>C</b>,4 x 10-8,,0.6,1.04,'-,[NR],RPS23P5,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST011503,5:13204975
rs10891491-<b>C</b>,4 x 10-8,,0.89,0.95,'-,[NR],NCAM1,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST011503,11:113027494
rs2523589-<b>G</b>,5 x 10-13,,0.5,0.95,'-,[NR],"DHFRP2, HLA-B",Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST011503,6:31359557
rs967823-<b>A</b>,2 x 10-10,,0.61,0.96,'-,[NR],CA10,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST011503,17:52239916
rs1430788-<b>C</b>,8 x 10-9,,0.31,1.04,'-,[NR],LINC02831,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST011503,2:67641280
rs9366816-<b>C</b>,3 x 10-10,,0.414,1.43,'-,[1.28-1.60],'-,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002490,Mapping not available
rs2936519-<b>A</b>,2 x 10-7,,NR,1.8867927,'-,[1.49-2.33],"XKR5, AGPAT5",Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab),"progression free survival, metastatic colorectal cancer, response to cetuximab, response to CAPOX-B",GCST003058,8:6781719
rs2073016-<b>T</b>,4 x 10-6,,NR,1.62,'-,[1.31-2],OARD1,Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab),"progression free survival, metastatic colorectal cancer, response to cetuximab, response to CAPOX-B",GCST003058,6:41053183
rs4377367-<b>C</b>,6 x 10-6,,NR,1.5873016,'-,[1.32-1.92],ARHGEF4,Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab),"progression free survival, metastatic colorectal cancer, response to cetuximab, response to CAPOX-B",GCST003058,2:130967332
rs885036-<b>A</b>,2 x 10-8,,'-,2.13,'-,[1.64-2.78],MGAT4A,Progression free survival in metastatic colorectal cancer (chemotherapy interaction),"progression free survival, metastatic colorectal cancer, response to cetuximab, response to CAPOX-B",GCST003057,2:98688331
rs11887534-<b>C</b>,1 x 10-14,,0.1,2.2,'-,[1.80-2.60],ABCG8,Gallstone disease,gallstones,GCST000055,2:43839108
rs6441286-<b>G</b>,2 x 10-14,,0.39,1.54,'-,[1.38-1.72],IL12A-AS1,Primary biliary cholangitis,biliary liver cirrhosis,GCST000408,3:160011091
rs3790567-<b>A</b>,3 x 10-11,,0.24,1.51,'-,[1.33-1.70],IL12RB2,Primary biliary cholangitis,biliary liver cirrhosis,GCST000408,1:67356694
rs10488631-<b>G</b>,2 x 10-7,,NR,1.52,'-,[1.30-1.78],"IRF5, TNPO3",Primary biliary cholangitis,biliary liver cirrhosis,GCST000408,7:128954129
rs907092-<b>A</b>,8 x 10-6,,0.45,1.29,'-,[1.15-1.44],IKZF3,Primary biliary cholangitis,biliary liver cirrhosis,GCST000408,17:39766006
rs4679904-<b>G</b>,1 x 10-6,,0.72,1.38,'-,[1.21-1.57],"ARL14, RPL6P8",Primary biliary cholangitis,biliary liver cirrhosis,GCST000408,3:160623108
"rs2395148-<b>A</b>, rs2856683-<b>C</b>, rs3135363-<b>A</b>, rs9357152-<b>A</b>",1 x 10-10,,0.01,'-,'-,'-,TSBP1; TSBP1-AS1; No mapped genes; No mapped genes; No mapped genes,Primary biliary cholangitis,biliary liver cirrhosis,GCST000408,6:32353777
"rs2395148-<b>C</b>, rs2856683-<b>C</b>, rs3135363-<b>A</b>, rs9357152-<b>A</b>",7 x 10-10,,0.2,'-,'-,'-,TSBP1; TSBP1-AS1; No mapped genes; No mapped genes; No mapped genes,Primary biliary cholangitis,biliary liver cirrhosis,GCST000408,6:32353777
rs12134279-<b>T</b>,2 x 10-14,,0.2,1.34,'-,[1.25-1.45],"DENND1B, C1orf53",Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,1:197812068
rs860413-<b>A</b>,1 x 10-11,,0.72,1.3,'-,[1.21-1.40],"CAPSL, UGT3A1",Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,5:35942940
rs6974491-<b>A</b>,4 x 10-8,,0.17,1.25,'-,[1.16-1.36],ELMO1,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,7:37334906
rs12531711-<b>G</b>,9 x 10-17,,0.11,1.58,'-,[1.41-1.76],TNPO3,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,7:128977412
rs3745516-<b>A</b>,2 x 10-13,,0.23,1.38,'-,[1.32-1.44],SPIB,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,19:50423485
rs1800693-<b>C</b>,2 x 10-9,,0.4,1.22,'-,[1.14-1.30],TNFRSF1A,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,12:6330843
rs12924729-<b>G</b>,3 x 10-12,,0.68,1.29,'-,[1.20-1.38],CLEC16A,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,16:11093926
rs11117432-<b>G</b>,5 x 10-11,,0.76,1.31,'-,[1.21-1.43],LINC02132,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,16:85985665
rs485499-<b>T</b>,2 x 10-16,,0.57,1.38,'-,[1.28-1.50],"LINC01100, IL12A-AS1",Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,3:160028076
rs7774434-<b>C</b>,4 x 10-34,,0.38,1.6,'-,[1.48-1.73],"MTCO3P1, HLA-DQB1",Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,6:32689801
rs2293370-<b>G</b>,3 x 10-11,,0.8,1.35,'-,[1.23-1.47],TIMMDC1,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,3:119501087
rs10931468-<b>A</b>,2 x 10-19,,0.12,1.5,'-,[1.37-1.64],NAB1,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,2:190673836
rs7665090-<b>C</b>,4 x 10-12,,0.52,1.26,'-,[1.18-1.34],"NFKB1, MANBA",Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,4:102630446
rs6421571-<b>C</b>,3 x 10-12,,0.81,1.37,'-,[1.25-1.50],"Y_RNA, CXCR5",Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,11:118873063
rs911263-<b>T</b>,2 x 10-11,,0.71,1.29,'-,[1.20-1.39],RAD51B,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,14:68286876
rs968451-<b>T</b>,1 x 10-9,,0.19,1.27,'-,[1.18-1.38],"PDGFB, RPL3",Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,22:39274846
rs17129789-<b>C</b>,9 x 10-20,,0.18,1.52,'-,[1.39-1.67],IL12RB2,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,1:67324915
rs7208487-<b>T</b>,8 x 10-7,,0.84,1.32,'-,[1.18-1.48],FBXL20,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,17:39387196
rs1372072-<b>A</b>,2 x 10-8,,0.37,1.2,'-,[1.12-1.27],PLCL2,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,3:16913767
rs538147-<b>G</b>,2 x 10-10,,0.61,1.23,'-,[1.15-1.31],RPS6KA4,Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,11:64362250
rs8017161-<b>A</b>,3 x 10-13,,0.4,1.22,'-,[1.16-1.27],"LBHD2, EXOC3L4",Primary biliary cholangitis,biliary liver cirrhosis,GCST001010,14:103096858
rs599707-<b>?</b>,3 x 10-9,,0.886,1.6920472,'-,'-,"NEU1, SNHG32",Eosinophilic esophagitis,eosinophilic esophagitis,GCST009070,6:31840659
rs3806932-<b>?</b>,3 x 10-9,,0.54,1.85,'-,[NR],TSLP,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,5:111069977
rs6799767-<b>?</b>,4 x 10-7,,0.58,1.49,'-,[1.18-1.85],'-,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,3:176312308
rs1032757-<b>T</b>,2 x 10-6,,0.07,1.96,'-,[1.40-2.74],'-,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,5:82643499
rs6501384-<b>T</b>,6 x 10-6,,0.33,1.41,'-,[1.13-1.76],CALM2P1,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,17:70294992
rs1986734-<b>?</b>,1 x 10-6,,0.49,1.54,'-,[1.22-1.89],SHROOM3,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,4:76499631
rs167769-<b>T</b>,2 x 10-6,,0.37,1.36,'-,[1.10-1.69],STAT6,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,12:57109992
rs1939875-<b>T</b>,3 x 10-6,,0.26,1.54,'-,[1.22-1.93],FAM76B,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,11:95689703
rs13106227-<b>?</b>,4 x 10-6,,0.62,1.52,'-,[1.20-1.92],SHROOM3,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,4:76497528
rs13278732-<b>T</b>,6 x 10-6,,0.27,1.31,'-,[1.04-1.65],ERICH5,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,8:98076353
rs7236477-<b>G</b>,7 x 10-6,,0.03,2.22,'-,[1.39-3.55],DSG1,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,18:31322359
rs2224865-<b>G</b>,9 x 10-6,,0.31,1.44,'-,[1.15-1.79],LINC02650,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,10:83663098
rs371915-<b>?</b>,2 x 10-8,,0.87,1.9,'-,[1.44-2.50],MEAK7,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,16:84544635
rs9500256-<b>?</b>,5 x 10-6,,0.58,2.04,'-,[1.52-2.70],GAPDHP15,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,6:57982677
rs11989782-<b>A</b>,7 x 10-6,,0.23,1.53,'-,[1.21-1.93],SNTB1,Eosinophilic esophagitis (pediatric),eosinophilic esophagitis,GCST000620,8:120682410
rs11206830-<b>?</b>,8 x 10-8,,0.02,2.162,'-,[NR],"PLPP3, LINC01767",Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,1:56494451
rs9956738-<b>?</b>,4 x 10-7,,0.01,2.472,'-,[NR],DCC,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,18:52414603
rs2000260-<b>A</b>,7 x 10-7,,0.57,1.32,'-,[NR],"LINC02785, SLC25A24",Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,1:108130783
rs77569859-<b>G</b>,3 x 10-10,,0.05,1.98,'-,[NR],CAPN14,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,2:31188421
rs3806933-<b>G</b>,2 x 10-8,,0.56,1.37,'-,[NR],TSLP,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,5:111071044
rs2055376-<b>A</b>,7 x 10-8,,0.02,2.3,'-,[NR],LINC02214,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,5:116845732
rs2898261-<b>C</b>,5 x 10-8,,0.58,1.35,'-,[NR],XKR6,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,8:11101029
rs11819199-<b>G</b>,3 x 10-7,,0.06,1.62,'-,[NR],MIR4675,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,10:20576228
rs2155219-<b>A</b>,4 x 10-7,,0.51,1.37,'-,[NR],"EMSY, LINC02757",Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,11:76588150
rs118086209-<b>C</b>,2 x 10-7,,0.02,2.19,'-,[NR],CCDC81,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,11:86393453
rs8041227-<b>G</b>,6 x 10-10,,0.72,1.52,'-,[NR],"KLF13, LINC02352",Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,15:31246339
rs17004598-<b>C</b>,1 x 10-7,,0.01,2.57,'-,[NR],HSF2BP,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,21:43658675
rs28530674-<b>?</b>,3 x 10-7,,0.04,1.826,'-,[NR],IFFO2,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,1:18907640
rs2296225-<b>?</b>,1 x 10-7,,0.08,1.626,'-,[NR],KIF17,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,1:20704549
rs77301713-<b>?</b>,1 x 10-7,,0.02,2.22,'-,[NR],CAPN5,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,11:77121400
rs3744790-<b>?</b>,8 x 10-7,,0.8,1.54,'-,[NR],"CEP295NL, TIMP2",Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,17:78897053
rs2075277-<b>?</b>,9 x 10-7,,0.09,1.544,'-,[NR],P2RX6,Eosinophilic esophagitis,eosinophilic esophagitis,GCST002527,22:21028193
rs2237353-<b>C</b> x rs1607979-<b>G</b>,1 x 10-10,,NR,'-,'-,'-,No mapped genes x No mapped genes,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,17:53255898
rs6460664-<b>C</b> x rs2300932-<b>A</b>,9 x 10-10,,NR,'-,'-,'-,GALNT17 x C5,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,7:71535629|9:121008158
rs6821696-<b>A</b> x rs1380439-<b>A</b>,9 x 10-10,,NR,'-,'-,'-,No mapped genes x ADAM12,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,10:126079541
rs10933155-<b>A</b> x rs1888469-<b>A</b>,1 x 10-9,,NR,'-,'-,'-,No mapped genes x ERG,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,21:38527580
rs10487781-<b>G</b> x rs17154507-<b>A</b>,1 x 10-9,,NR,'-,'-,'-,No mapped genes x PIGCP2 - DLD,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,7:107836572
rs1332173-<b>G</b> x rs2127065-<b>A</b>,2 x 10-9,,NR,'-,'-,'-,No mapped genes x RBFOX1,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,16:7151421
rs6726261-<b>G</b> x rs11140659-<b>A</b>,2 x 10-9,,NR,'-,'-,'-,No mapped genes,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,9:84547446
rs7589636-<b>A</b> x rs730402-<b>A</b>,2 x 10-9,,NR,'-,'-,'-,No mapped genes x No mapped genes,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,2:59867571
rs6545648-<b>A</b> x rs730402-<b>A</b>,3 x 10-9,,NR,'-,'-,'-,No mapped genes x No mapped genes,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,2:59867571
rs4660176-<b>A</b> x rs740576-<b>A</b>,2 x 10-9,,NR,'-,'-,'-,No mapped genes x DPP6,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,7:153889746
rs4571472-<b>A</b> x rs7075349-<b>G</b>,3 x 10-9,,NR,'-,'-,'-,No mapped genes x N/A - ALDH7A1P4,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,10:62667889
rs1904382-<b>G</b> x rs9399364-<b>G</b>,5 x 10-9,,NR,'-,'-,'-,No mapped genes,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,6:141371689
rs6539598-<b>G</b> x rs7208838-<b>G</b>,5 x 10-9,,NR,'-,'-,'-,No mapped genes x WDR45BP1 - RHOT1,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,17:32141547
rs37181-<b>C</b> x rs512064-<b>A</b>,7 x 10-9,,NR,'-,'-,'-,No mapped genes x NRG3,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,10:82863970
rs6979066-<b>G</b> x rs1861315-<b>A</b>,1 x 10-8,,NR,'-,'-,'-,No mapped genes x CASC22,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,16:52267910
rs1413615-<b>G</b> x rs2018259-<b>A</b>,1 x 10-8,,NR,'-,'-,'-,No mapped genes x N/A - OLFM4,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,13:52949817
rs982790-<b>G</b> x rs816960-<b>A</b>,3 x 10-8,,NR,'-,'-,'-,No mapped genes x FAM155A - N/A,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,13:107870173
rs10974873-<b>G</b> x rs12932445-<b>G</b>,1 x 10-8,,NR,'-,'-,'-,No mapped genes x ZFHX3,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,16:73035989
rs12120788-<b>C</b> x rs489631-<b>G</b>,1 x 10-8,,NR,'-,'-,'-,No mapped genes x OSBPL1A - IMPACT,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,18:24409060
rs918402-<b>C</b> x rs9534199-<b>A</b>,2 x 10-8,,NR,'-,'-,'-,No mapped genes x CBY2 - Metazoa_SRP,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,13:45717391
rs4728351-<b>A</b> x rs10112728-<b>G</b>,2 x 10-8,,NR,'-,'-,'-,No mapped genes x CPA6,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,8:67662124
rs17442753-<b>A</b> x rs1683163-<b>A</b>,2 x 10-8,,NR,'-,'-,'-,No mapped genes x IRAG2,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,12:25080684
rs2997338-<b>C</b> x rs11960332-<b>G</b>,2 x 10-8,,NR,'-,'-,'-,No mapped genes x FLT4,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,5:180644276
rs2761367-<b>A</b> x rs8066210-<b>G</b>,2 x 10-8,,NR,'-,'-,'-,No mapped genes x GAS7,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,17:10119126
rs17258848-<b>G</b> x rs11637659-<b>A</b>,2 x 10-8,,NR,'-,'-,'-,No mapped genes x SMAD3,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,15:67150048
rs6934929-<b>G</b> x rs7276462-<b>A</b>,2 x 10-8,,NR,'-,'-,'-,No mapped genes x No mapped genes,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,21:30057318
rs6907357-<b>C</b> x rs9617490-<b>A</b>,1 x 10-8,,NR,'-,'-,'-,No mapped genes x TAFA5,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,22:48663744
rs6579767-<b>G</b> x rs2505366-<b>A</b>,3 x 10-8,,NR,'-,'-,'-,No mapped genes x EPC1,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,10:32370459
rs2776747-<b>G</b> x rs17006285-<b>G</b>,3 x 10-8,,NR,'-,'-,'-,No mapped genes x ADD2,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,2:70753754
rs10128762-<b>A</b> x rs2824444-<b>A</b>,3 x 10-8,,NR,'-,'-,'-,No mapped genes x BTG3-AS1 - C21orf91-OT1,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,21:17690876
rs10057387-<b>G</b> x rs2111505-<b>A</b>,4 x 10-8,,NR,'-,'-,'-,No mapped genes x RNA5SP472 - ZNF507,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,19:32288713
rs9867490-<b>C</b> x rs2894771-<b>G</b>,4 x 10-8,,NR,'-,'-,'-,No mapped genes x N/A - MIR3147,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,7:57349862
rs12477036-<b>G</b> x rs1352409-<b>G</b>,5 x 10-8,,NR,'-,'-,'-,No mapped genes x SUMF1,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,3:3769039
rs2235718-<b>A</b> x rs11102213-<b>G</b>,5 x 10-8,,NR,'-,'-,'-,No mapped genes x HENMT1 - PRPF38B,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,1:108678990
rs6973203-<b>A</b> x rs376620-<b>G</b>,8 x 10-8,,NR,'-,'-,'-,No mapped genes x ADGRE1 - ADGRE4P,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,19:6945850
rs1354156-<b>G</b> x rs11655550-<b>G</b>,9 x 10-8,,NR,'-,'-,'-,No mapped genes x MED1 - CDK12,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,17:39453870
rs1500453-<b>A</b> x rs10512514-<b>A</b>,2 x 10-7,,NR,'-,'-,'-,No mapped genes x HELZ,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,17:67215760
rs11201128-<b>G</b> x rs6114101-<b>A</b>,2 x 10-7,,NR,'-,'-,'-,No mapped genes x Y_RNA - CST12P,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,20:23465685
rs2523849-<b>G</b> x rs4947296-<b>G</b>,8 x 10-9,,NR,'-,'-,'-,No mapped genes x RNU6-1133P - C6orf15,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,6:31090401
rs7761965-<b>A</b> x rs2596501-<b>A</b>,2 x 10-8,,NR,'-,'-,'-,No mapped genes x LINC02571 - HLA-B,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,6:31353434
rs9277535-<b>?</b>,4 x 10-40,,NR,1.89,'-,[1.72-2.08],HLA-DPB1,Chronic hepatitis B infection,hepatitis B virus infection,GCST002068,6:33087084
rs652888-<b>?</b>,7 x 10-13,,NR,1.38,'-,[1.22-1.57],"EHMT2-AS1, EHMT2",Chronic hepatitis B infection,hepatitis B virus infection,GCST002068,6:31883457
rs1419881-<b>?</b>,1 x 10-18,,NR,1.37,'-,[1.23-1.52],TCF19,Chronic hepatitis B infection,hepatitis B virus infection,GCST002068,6:31162816
rs11866328-<b>G</b>,2 x 10-8,,NR,1.68,'-,[1.40-2.02],GRIN2A,Hepatitis B,hepatitis B virus infection,GCST001257,16:9768699
rs2856718-<b>A</b>,4 x 10-37,,0.48,1.56,'-,[1.45-1.67],"MTCO3P1, HLA-DQB1",Hepatitis B,hepatitis B virus infection,GCST001150,6:32702478
rs3077-<b>G</b>,2 x 10-61,,0.6,1.87,'-,[1.73-2.01],HLA-DPA1,Hepatitis B,hepatitis B virus infection,GCST001150,6:33065245
rs9277535-<b>G</b>,3 x 10-54,,0.57,1.77,'-,[1.65-1.91],HLA-DPB1,Hepatitis B,hepatitis B virus infection,GCST001150,6:33087084
rs7453920-<b>G</b>,6 x 10-28,,0.83,1.81,'-,[1.62-2.01],HLA-DQB2,Hepatitis B,hepatitis B virus infection,GCST001150,6:32762235
rs9277535-<b>G</b>,6 x 10-39,,'-,1.75,'-,[1.61-1.92],HLA-DPB1,Hepatitis B,hepatitis B virus infection,GCST000375,6:33087084
rs887829-<b>A</b>,5 x 10-25,,0.45,'-,0.19 unit increase,[NR],"UGT1A10, UGT1A3, UGT1A5, UGT1A6, UGT1A8, UGT1A7, UGT1A9, UGT1A4",Cholelithiasis-related traits in sickle cell anemia,"Sickle cell anemia, cholelithiasis, bilirubin measurement",GCST001497,2:233759924
rs76766811-<b>T</b>,4 x 10-7,,0.016,2.09,'-,[1.57-2.78],"LINC02860, KIAA0087",Disease free survival in colon cancer,"disease free survival, colon carcinoma",GCST010717,7:26620935
rs2074356-<b>T</b>,2 x 10-31,,0.13,1.56,'-,[1.45-1.68],HECTD4,Esophageal cancer,esophageal carcinoma,GCST001089,12:112207597
rs10058728-<b>T</b>,5 x 10-9,,0.98,2.04,'-,[1.61-2.56],CSNK1A1,Esophageal cancer,esophageal carcinoma,GCST001089,5:149524529
rs11066280-<b>A</b>,2 x 10-15,,0.21,1.3,'-,[1.22-1.38],HECTD4,Esophageal cancer,esophageal carcinoma,GCST001089,12:112379979
rs6772209-<b>G</b>,3 x 10-7,,0.97,1.49,'-,[1.28-1.75],ACTG1P23,Esophageal cancer,esophageal carcinoma,GCST001089,3:175929377
rs9868873-<b>G</b>,1 x 10-7,,0.82,1.19,'-,[1.11-1.27],SEMA5B,Esophageal cancer,esophageal carcinoma,GCST001089,3:123012063
rs8030672-<b>A</b>,1 x 10-11,,0.03,1.56,'-,[1.37-1.78],"ANP32A, CARS1P1",Esophageal cancer,esophageal carcinoma,GCST001089,15:68766745
rs2274223-<b>G</b>,4 x 10-20,,0.21,1.34,'-,[1.26-1.42],PLCE1,Esophageal cancer,esophageal carcinoma,GCST001089,10:94306584
rs10052657-<b>C</b>,2 x 10-19,,0.78,1.49,'-,[1.37-1.61],PDE4D,Esophageal cancer,esophageal carcinoma,GCST001089,5:59111944
rs11066015-<b>A</b>,7 x 10-21,,0.19,1.38,'-,[1.29-1.48],ACAD10,Esophageal cancer,esophageal carcinoma,GCST001089,12:111730205
rs2014300-<b>G</b>,8 x 10-22,,0.83,1.43,'-,[1.33-1.54],RUNX1,Esophageal cancer,esophageal carcinoma,GCST001089,21:34985564
rs10484761-<b>G</b>,7 x 10-12,,0.09,1.33,'-,[1.23-1.45],'-,Esophageal cancer,esophageal carcinoma,GCST001089,6:40834522
rs1012068-<b>G</b>,1 x 10-13,,0.12,1.75,'-,[1.51-2.03],DEPDC5,Chronic hepatitis C infection,chronic hepatitis C virus infection,GCST001139,22:31869917
rs7270101-<b>C</b>,9 x 10-76,,0.11,'-,'-,'-,ITPA,Chronic hepatitis C infection,chronic hepatitis C virus infection,GCST000604,20:3213247
rs1127354-<b>A</b>,2 x 10-58,,0.069,'-,'-,'-,ITPA,Chronic hepatitis C infection,chronic hepatitis C virus infection,GCST000604,20:3213196
rs17067123-<b>?</b>,8 x 10-6,(combined),NR,'-,'-,'-,'-,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST000465,4:179127208
rs9400317-<b>?</b>,7 x 10-6,(combined),NR,'-,'-,'-,AK9,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST000465,6:109686444
rs12979860-<b>C</b>,1 x 10-28,"(combined, EA)",0.72,2,'-,[1.8-2.3],IFNL4,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST000465,19:39248147
rs10776934-<b>T</b>,1 x 10-6,,NR,'-,0.281 ug/L decrease,[0.17-0.39],OLFM1,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,9:135137855
rs16864968-<b>G</b>,3 x 10-6,,NR,'-,0.826 ug/L decrease,[0.48-1.17],"CCDC141, SCG2",Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,2:223594965
rs11725957-<b>G</b>,8 x 10-6,,NR,'-,0.727 ug/L increase,[0.41-1.05],CWH43,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,4:49060875
rs2504916-<b>T</b>,2 x 10-6,,NR,'-,0.306 ug/L increase,[0.18-0.43],SLC22A3,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,6:160402996
rs11242704-<b>G</b>,5 x 10-6,,NR,'-,0.257 ug/L decrease,[0.15-0.37],"FOXCUT, RN7SL352P",Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,6:1535763
rs12527818-<b>T</b>,7 x 10-6,,NR,'-,0.274 ug/L increase,[0.15-0.39],EPHA7,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,6:93201401
rs10789491-<b>G</b>,1 x 10-6,,NR,'-,0.312 ug/L increase,[0.19-0.44],EFCAB14,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,1:46713638
rs2254135-<b>T</b>,3 x 10-6,,NR,'-,0.269 ug/L increase,[0.16-0.38],"ARHGEF10L, RCC2",Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,1:17508246
rs12144715-<b>T</b>,7 x 10-6,,NR,'-,0.636 ug/L decrease,[0.36-0.91],DNASE2B,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,1:84399547
rs11697186-<b>T</b>,5 x 10-17,(Decrease of PLT),0.15,4.5,'-,[3.10-6.50],DDRGK1,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001094,20:3204477
rs6139030-<b>C</b>,1 x 10-15,(Decrease of PLT),0.17,3.9,'-,[2.80-5.50],"DDRGK1, ITPA",Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001094,20:3207087
rs11697186-<b>A</b>,9 x 10-25,(Change in Hb),0.85,33.33,'-,[12.50-100],DDRGK1,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001094,20:3204477
rs6139030-<b>T</b>,2 x 10-25,(Change of Hb),0.83,25,'-,[11.11-50.0],"DDRGK1, ITPA",Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001094,20:3207087
rs8099917-<b>G</b>,1 x 10-20,,0.083,3,'-,[2.4-3.8],"IFNL4, MSRB1P1",Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST000944,19:39252525
rs117026326-<b>T</b>,1 x 10-15,,0.119,1.982,'-,[1.673–2.348],GTF2I,Sjögren's syndrome,Sjogren syndrome,GCST003604,7:74711703
rs9277554-<b>?</b>,3 x 10-7,,'-,1.65,'-,[1.37-2.00],HLA-DPB1,Sjögren's syndrome,Sjogren syndrome,GCST004062,6:33087761
rs11048434-<b>?</b>,6 x 10-7,,'-,1.5873016,'-,[1.33-1.89],KLRG1,Sjögren's syndrome,Sjogren syndrome,GCST004062,12:9001336
rs12546471-<b>C</b>,4 x 10-6,,0.61,'-,'-,'-,CSMD1,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST003631,8:4323543
rs2326825-<b>T</b>,4 x 10-6,,0.33,'-,'-,'-,BTF3P7,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST003631,6:6805938
rs10987145-<b>T</b>,7 x 10-6,,0.32,'-,'-,'-,'-,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST003631,9:126091364
rs10852151-<b>A</b>,2 x 10-7,,0.57,'-,'-,'-,CRAT37,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST003631,15:91540065
rs7175566-<b>T</b>,9 x 10-6,,0.65,'-,'-,'-,CTXND1,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST003631,15:93606556
rs4965272-<b>T</b>,6 x 10-6,,0.74,'-,'-,'-,ADAMTS17,Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST003631,15:100044534
rs2213770-<b>A</b>,7 x 10-6,,0.28,'-,'-,'-,"MIATNB, LINC01422",Gastroesophageal reflux disease,gastroesophageal reflux disease,GCST003631,22:26848722
rs10273639-<b>C</b>,2 x 10-14,,0.576,1.36,'-,[1.30-1.42],'-,Pancreatitis,pancreatitis,GCST001741,Mapping not available
rs12688220-<b>T</b>,2 x 10-22,,0.261,1.385,'-,[1.28-1.49],"EEF1A1P40, MORC4",Pancreatitis,pancreatitis,GCST001741,X:107001537
rs11988997-<b>T</b>,6 x 10-6,,0.071,1.359,'-,[1.21-1.50],SAMD12-AS1,Pancreatitis,pancreatitis,GCST001741,8:118753955
rs2995271-<b>T</b>,8 x 10-7,,0.762,1.27,'-,[1.20-1.34],RNU6-598P,Pancreatitis,pancreatitis,GCST001741,10:30230903
rs379742-<b>T</b>,6 x 10-7,,0.2,1.203,'-,[1.10-1.30],"PWWP3B, CSGALNACT2P2",Pancreatitis,pancreatitis,GCST001741,X:106250703
rs4663866-<b>C</b>,5 x 10-6,,0.1,1.45,'-,[1.18-1.89],"PER2, HES6",Irritable bowel syndrome,irritable bowel syndrome,GCST002629,2:238242174
rs12702514-<b>T</b>,5 x 10-6,,0.41,1.21,'-,[1.13-1.30],"DAGLB, KDELR2",Irritable bowel syndrome,irritable bowel syndrome,GCST002629,7:6476404
rs13211972-<b>A</b>,1 x 10-10,,0.05,1.55,'-,[1.36-1.77],"MUC21, MUC22",Oropharynx cancer,oropharynx cancer,GCST010286,6:30991224
rs34518860-<b>G</b>,3 x 10-17,,0.89,1.6393442,'-,[1.47-1.85],"HLA-DQA1, HLA-DRB1",Oropharynx cancer,oropharynx cancer,GCST010286,6:32626326
rs140471080-<b>C</b>,4 x 10-7,,NR,3.7778618,'-,NR,RERGL,Oral cavity and pharyngeal cancer,oropharynx cancer,GCST90011806,12:18182994
rs189602139-<b>A</b>,3 x 10-8,,NR,3.6062026,'-,NR,"RNU6-474P, CTLA4",Oral cavity and pharyngeal cancer,oropharynx cancer,GCST90011806,2:203794513
rs17696932-<b>C</b>,3 x 10-7,,NR,3.3288949,'-,NR,CCDC192,Oral cavity and pharyngeal cancer,oropharynx cancer,GCST90011806,5:127807962
rs74393397-<b>C</b>,6 x 10-7,,0.010202,2.1762786,'-,NR,STK31,Oral cavity and pharyngeal cancer,oropharynx cancer,GCST90011806,7:23842997
rs34017101-<b>T</b>,6 x 10-7,,0.013225,2.1101499,'-,NR,"IL1A, IL1B",Oral cavity and pharyngeal cancer,oropharynx cancer,GCST90011806,2:112804195
rs116168967-<b>A</b>,4 x 10-7,,0.017861,1.8291568,'-,NR,LINC00882,Oral cavity and pharyngeal cancer,oropharynx cancer,GCST90011806,3:106482561
rs73018258-<b>A</b>,5 x 10-7,,0.02693,1.7262213,'-,NR,MTDHP3,Oral cavity and pharyngeal cancer,oropharynx cancer,GCST90011806,19:21678153
rs7574514-<b>G</b>,7 x 10-7,,0.121944,1.3255566,'-,NR,"MCFD2, LINC01119",Oral cavity and pharyngeal cancer,oropharynx cancer,GCST90011806,2:46898775
rs2734963-<b>T</b>,6 x 10-7,,0.193283,1.2753475,'-,NR,"HCP5B, HLA-H",Oral cavity and pharyngeal cancer,oropharynx cancer,GCST90011806,6:29874768
rs61776819-<b>T</b>,3 x 10-7,,0.0133098,2.0453,'-,NR,"MACO1, LDLRAP1",Oral cavity and pharyngeal cancer,oropharynx cancer,GCST90011806,1:25540804
chr11:102118158-<b>A</b>,3 x 10-8,,0.0015,4.9,'-,[2.79-8.62],'-,Gastric cancer,gastric carcinoma,GCST002992,Mapping not available
chr2:85874332-<b>T</b>,1 x 10-7,,4.00E-04,11.1,'-,[4.53-27.19],'-,Gastric cancer,gastric carcinoma,GCST002992,Mapping not available
chr11:107643195-<b>T</b>,6 x 10-7,,0.0016,4.27,'-,[2.42-7.54],'-,Gastric cancer,gastric carcinoma,GCST002992,Mapping not available
chr11:107629783-<b>A</b>,3 x 10-6,,7.00E-04,6.87,'-,[3.07-15.37],'-,Gastric cancer,gastric carcinoma,GCST002992,Mapping not available
rs9841504-<b>?</b>,2 x 10-9,,NR,1.32,'-,[1.20-1.45],ZBTB20,Gastric cancer,gastric carcinoma,GCST001300,3:114643917
rs4751240-<b>?</b>,9 x 10-10,,'-,'-,0.1 unit increase,[0.071-0.129],DOCK1,Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease,"longitudinal BMI measurement, Digestive System Carcinoma, chronic obstructive pulmonary disease",GCST004100,10:127338145
rs9847124-<b>?</b>,6 x 10-7,,'-,'-,0.07 unit increase,[0.17-0.45],P2RY1,Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease,"longitudinal BMI measurement, Digestive System Carcinoma, chronic obstructive pulmonary disease",GCST004100,3:152872973
rs3774854-<b>?</b>,1 x 10-6,,'-,'-,0.05 unit increase,[0.028-0.072],"EVC, EVC2",Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease,"longitudinal BMI measurement, Digestive System Carcinoma, chronic obstructive pulmonary disease",GCST004100,4:5709641
rs10120246-<b>?</b>,4 x 10-6,,'-,'-,0.08 unit increase,[0.049-0.111],PTPRD,Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease,"longitudinal BMI measurement, Digestive System Carcinoma, chronic obstructive pulmonary disease",GCST004100,9:9799050
rs76755915-<b>?</b>,5 x 10-7,,NR,4.5454545,'-,NR,'-,Response to interferon treatment in hepatitis C virus genotype 3,"response to interferon, hepatitis C virus infection",GCST008517,4:97038456
rs2492965-<b>?</b>,1 x 10-6,,NR,2.857143,'-,NR,RIMS1,Response to interferon treatment in hepatitis C virus genotype 3,"response to interferon, hepatitis C virus infection",GCST008517,6:72445473
rs7332270-<b>?</b>,1 x 10-6,,NR,1.6393442,'-,NR,Metazoa_SRP,Response to interferon treatment in hepatitis C virus genotype 3,"response to interferon, hepatitis C virus infection",GCST008517,13:34857816
rs6445096-<b>?</b>,3 x 10-7,,NR,1.57,'-,NR,SPATA16,Response to interferon treatment in hepatitis C virus genotype 3,"response to interferon, hepatitis C virus infection",GCST008517,3:173063177
rs74597329-<b>?</b>,2 x 10-7,,NR,1.59,'-,NR,IFNL4,Response to interferon treatment in hepatitis C virus genotype 3,"response to interferon, hepatitis C virus infection",GCST008517,19:39248515
rs13401937-<b>?</b>,9 x 10-7,,NR,1.94,'-,NR,RTN4,Response to interferon treatment in hepatitis C virus genotype 3,"response to interferon, hepatitis C virus infection",GCST008517,2:55025078
rs75707332-<b>?</b>,1 x 10-6,,NR,2.56,'-,NR,"CMAS, ABCC9",Response to interferon treatment in hepatitis C virus genotype 3,"response to interferon, hepatitis C virus infection",GCST008517,12:22022003
rs72799981-<b>?</b>,1 x 10-6,,NR,6.64,'-,NR,ARHGAP26,Response to interferon treatment in hepatitis C virus genotype 3,"response to interferon, hepatitis C virus infection",GCST008517,5:143150821
rs56378326-<b>?</b>,7 x 10-7,,NR,Infinity,'-,NR,PKIB,Response to direct-acting antiviral treatment in hepatitis C virus genotype 3,"hepatitis C virus infection, response to antiviral drug",GCST008520,6:122670278
rs76810409-<b>?</b>,1 x 10-6,,NR,Infinity,'-,NR,'-,Response to direct-acting antiviral treatment in hepatitis C virus genotype 3,"hepatitis C virus infection, response to antiviral drug",GCST008520,7:109456395
rs59888390-<b>?</b>,5 x 10-7,,NR,3.846154,'-,NR,RPL23AP56,Response to direct-acting antiviral treatment in hepatitis C virus genotype 3,"hepatitis C virus infection, response to antiviral drug",GCST008520,8:134989069
rs35384524-<b>?</b>,5 x 10-7,,NR,3.5714285,'-,NR,NCAM2,Response to direct-acting antiviral treatment in hepatitis C virus genotype 3,"hepatitis C virus infection, response to antiviral drug",GCST008520,21:21017373
rs7670514-<b>?</b>,2 x 10-6,,NR,2.4,'-,NR,"HSBP1P2, ELOVL6",Response to direct-acting antiviral treatment in hepatitis C virus genotype 3,"hepatitis C virus infection, response to antiviral drug",GCST008520,4:110212212
rs10011468-<b>?</b>,2 x 10-6,,NR,2.43,'-,NR,"APELA, SMIM31",Response to direct-acting antiviral treatment in hepatitis C virus genotype 3,"hepatitis C virus infection, response to antiviral drug",GCST008520,4:164845587
rs62042908-<b>?</b>,1 x 10-6,,NR,2.56,'-,NR,'-,Response to direct-acting antiviral treatment in hepatitis C virus genotype 3,"hepatitis C virus infection, response to antiviral drug",GCST008520,15:93306014
rs12323963-<b>?</b>,2 x 10-6,,NR,2.75,'-,NR,SHC4,Response to direct-acting antiviral treatment in hepatitis C virus genotype 3,"hepatitis C virus infection, response to antiviral drug",GCST008520,15:48938914
rs57030374-<b>?</b>,2 x 10-6,,NR,3.72,'-,NR,'-,Response to direct-acting antiviral treatment in hepatitis C virus genotype 3,"hepatitis C virus infection, response to antiviral drug",GCST008520,6:91130685
rs116399066-<b>?</b>,1 x 10-6,,NR,6.39,'-,NR,"RNVU1-23, RNVU1-18",Response to direct-acting antiviral treatment in hepatitis C virus genotype 3,"hepatitis C virus infection, response to antiviral drug",GCST008520,1:143723149
rs4803221-<b>?</b>,2 x 10-11,,NR,'-,0.284517 unit decrease,[0.21-0.36],IFNL4,Pre-treatment viral load in hepatitis C virus genotype 3,"hepatitis C virus infection, viral load",GCST008515,19:39248489
rs7262634-<b>?</b>,1 x 10-6,,NR,25,'-,[NR],"ZMYND8, EYA2",Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity),"hepatitis C virus infection, response to protease inhibitor, bilirubin measurement",GCST002347,20:47205635
kgp6774393-<b>?</b>,6 x 10-6,,NR,4.35,'-,[NR],'-,Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity),"hepatitis C virus infection, response to protease inhibitor, bilirubin measurement",GCST002347,Mapping not available
kgp9755615-<b>?</b>,8 x 10-6,,NR,3.23,'-,[NR],'-,Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity),"hepatitis C virus infection, response to protease inhibitor, bilirubin measurement",GCST002347,Mapping not available
rs2978048-<b>?</b>,1 x 10-6,,NR,'-,0.25 unit increase,[NR],"ST3GAL1-DT, Metazoa_SRP",Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels),"hepatitis C virus infection, response to protease inhibitor, bilirubin measurement",GCST002349,8:133603893
kgp3085785-<b>?</b>,1 x 10-6,,NR,'-,0.36 unit increase,[NR],'-,Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels),"hepatitis C virus infection, response to protease inhibitor, bilirubin measurement",GCST002349,Mapping not available
kgp11613116-<b>?</b>,2 x 10-6,,NR,'-,0.37 unit increase,[NR],'-,Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels),"hepatitis C virus infection, response to protease inhibitor, bilirubin measurement",GCST002349,Mapping not available
rs7224000-<b>?</b>,3 x 10-6,,NR,'-,0.12 unit increase,[NR],PITPNC1,Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels),"hepatitis C virus infection, response to protease inhibitor, bilirubin measurement",GCST002349,17:67414818
rs7944135-<b>A</b>,4 x 10-6,,0.13,4.16,'-,[2.27-7.63],"WARS1P1, RN7SL42P",Hepatitis B surface antigen seroclearance in chronic hepatitis B infection,"Hepatitis B virus surface antigen seropositivity, chronic hepatitis B virus infection",GCST006364,11:59253514
rs171941-<b>A</b>,4 x 10-6,,0.19,3.69,'-,[2.13-6.42],"LINC01455, CMYA5",Hepatitis B surface antigen seroclearance in chronic hepatitis B infection,"Hepatitis B virus surface antigen seropositivity, chronic hepatitis B virus infection",GCST006364,5:79884303
rs6462008-<b>T</b>,3 x 10-6,,0.42,2.9411764,'-,[1.85-4.55],"HNRNPA1P73, RPL35P4",Hepatitis B surface antigen seroclearance in chronic hepatitis B infection,"Hepatitis B virus surface antigen seropositivity, chronic hepatitis B virus infection",GCST006364,7:27309860
rs199869387-<b>A</b>,8 x 10-6,,0.35,2.97,'-,[1.84-4.79],'-,Hepatitis B surface antigen seroclearance in chronic hepatitis B infection,"Hepatitis B virus surface antigen seropositivity, chronic hepatitis B virus infection",GCST006364,2:59481514
rs7549785-<b>?</b>,5 x 10-7,"(endpoint 6, East Asian)",'-,8.22,'-,[NR],FCER1A,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,1:159308078
rs9287655-<b>?</b>,1 x 10-6,"(endpoint 4, additive)",'-,1.5151515,'-,[NR],NBAS,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,2:15245360
rs9287655-<b>?</b>,1 x 10-6,"(endpoint 5, additive)",'-,1.5625,'-,[NR],NBAS,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,2:15245360
rs1550116-<b>?</b>,8 x 10-6,"(endpoint 5, East Asian, additive)",'-,1.7857143,'-,[NR],CENPO,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,2:24799729
rs2082881-<b>?</b>,7 x 10-6,"(endpoint 5, East Asian, additive)",'-,1.7857143,'-,[NR],CENPO,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,2:24815399
rs1550115-<b>?</b>,7 x 10-6,"(endpoint 5, East Asian, additive)",'-,1.7857143,'-,[NR],CENPO,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,2:24818751
rs1040084-<b>?</b>,4 x 10-6,"(endpoint 3, additive)",'-,2.37,'-,[NR],"LNX1-AS1, LNX1",Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,4:53544057
rs1913484-<b>?</b>,4 x 10-6,"(endpoint 3, dominant)",'-,2.36,'-,[NR],"LNX1, LNX1-AS1",Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,4:53544157
rs2803073-<b>?</b>,3 x 10-6,"(endpoint 4, additive)",'-,1.5,'-,[NR],PRKN,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,6:162541796
rs10236906-<b>?</b>,8 x 10-6,"(endpoint 4, dominant)",'-,1.754386,'-,[NR],HDAC9,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,7:18700047
rs9691873-<b>?</b>,9 x 10-6,"(endpoint 5, East Asian)",'-,'-,'-,[NR],CREB5,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,7:28690392
rs2370220-<b>?</b>,8 x 10-6,"(endpoint 5, dominant)",'-,1.75,'-,[NR],DMRT1,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,9:917667
rs10814834-<b>?</b>,7 x 10-6,"(endpoint 6, dominant)",'-,2.173913,'-,[NR],GLIS3,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,9:4086370
rs7042473-<b>?</b>,5 x 10-6,"(endpoint 4, dominant)",'-,1.71,'-,[NR],CDC14B,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,9:96584288
rs10491723-<b>?</b>,5 x 10-6,"(endpoint 6, additive)",'-,2.11,'-,[NR],CORO2A,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,9:98165350
rs1411283-<b>?</b>,9 x 10-6,"(endpoint 1, dominant)",'-,2.0408163,'-,[NR],ANKRD26,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,10:27013843
rs2279519-<b>?</b>,8 x 10-6,"(endpoint 5, dominant)",'-,1.75,'-,[NR],GRAMD1B,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,11:123606644
rs216312-<b>?</b>,5 x 10-6,"(endpoint 5, dominant)",'-,1.5151515,'-,[NR],VWF,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,12:6019818
rs7968170-<b>?</b>,5 x 10-6,"(endpoint 4, East Asian, dominant)",'-,2.0408163,'-,[NR],DERA,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,12:15996401
rs7968170-<b>?</b>,5 x 10-6,"(endpoint 5, East Asian, dominant)",'-,2.173913,'-,[NR],DERA,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,12:15996401
rs8012912-<b>?</b>,7 x 10-6,"(endpoint 5, East Asian, additive)",'-,1.62,'-,[NR],SMOC1,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,14:70007490
rs11158827-<b>?</b>,8 x 10-6,"(endpoint 5, East Asian, additive)",'-,1.62,'-,[NR],SMOC1,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,14:70012457
rs6576456-<b>?</b>,8 x 10-6,"(endpoint 3, dominant)",'-,2.4390244,'-,[NR],ATP10A,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,15:25764093
rs2899723-<b>?</b>,3 x 10-6,"(endpoint 3, additive)",'-,2.04,'-,[NR],"IQCH, IQCH-AS1",Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,15:67443685
rs646097-<b>?</b>,9 x 10-6,"(endpoint 2, dominant)",'-,2.173913,'-,[NR],LASP1,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,17:38920078
rs7770370-<b>G</b>,3 x 10-35,,0.5739,1.6393442,'-,[1.52-1.79],HLA-DPB1,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST010560,6:33081144
rs28747027-<b>G</b>,7 x 10-21,,0.4639,1.41,'-,[1.32-1.52],"MTCO3P1, HLA-DQB1",Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST010560,6:32687200
rs11868362-<b>?</b>,4 x 10-6,"(endpoint 2, East Asian)",'-,2.9411764,'-,[NR],MSI2,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,17:57420875
rs16943470-<b>?</b>,5 x 10-6,"(endpoint 6, dominant)",'-,2.97,'-,[NR],YPEL2,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,17:59369227
rs3077-<b>?</b>,5 x 10-39,,NR,1.89,'-,[1.69-2.08],HLA-DPA1,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002068,6:33065245
rs2856718-<b>?</b>,2 x 10-24,,NR,1.6,'-,[1.46-1.75],"MTCO3P1, HLA-DQB1",Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002068,6:32702478
rs7453920-<b>?</b>,7 x 10-26,,NR,2,'-,[1.72-2.27],HLA-DQB2,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002068,6:32762235
rs9276370-<b>T</b>,2 x 10-12,,0.076,1.95,'-,[1.62-2.34],"HLA-DQB3, HLA-DQA2",Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002490,6:32739518
rs7453920-<b>G</b>,7 x 10-15,,0.051,2.31,'-,[1.87-2.85],HLA-DQB2,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002490,6:32762235
rs9277535-<b>G</b>,5 x 10-14,,0.251,1.59,'-,[1.41-1.79],HLA-DPB1,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002490,6:33087084
"rs7453920-<b>G</b>, rs9277535-<b>G</b>, rs7756516-<b>T</b>, rs9276370-<b>T</b>, rs9366816-<b>T</b>",1 x 10-12,,0.4305,1.49,'-,[1.33-1.66],HLA-DQB2; HLA-DPB1; No mapped genes; HLA-DQB3 - HLA-DQA2; No mapped genes,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002490,6:32762235|6:33087084|6:32739518
rs1983890-<b>C</b>,3 x 10-8,,0.642,1.2302363,'-,[1.14396450049362-1.32301382549448],"PFKFB3, RBM17",Latent autoimmune diabetes,latent autoimmune diabetes in adults,GCST007245,10:6136651
rs11755527-<b>?</b>,1 x 10-7,,0.443857,1.203898,'-,[1.125016-1.288312],BACH2,Latent autoimmune diabetes,latent autoimmune diabetes in adults,GCST007245,6:90248512
rs11888640-<b>?</b>,2 x 10-6,,0.481522,1.1833298,'-,[1.1-1.27],THADA,Latent autoimmune diabetes,latent autoimmune diabetes in adults,GCST007245,2:43579243
rs9484606-<b>?</b>,3 x 10-6,,NR,1.7,'-,[1.36-2.13],"ADGRG6, VTA1",Response to radiotherapy in nasopharyngeal carcinoma (acute oral mucositis),"oral mucositis, response to radiation, nasopharyngeal neoplasm",GCST010511,6:142257955
rs16876733-<b>?</b>,3 x 10-6,,NR,1.95,'-,[1.47-2.59],"Y_RNA, NDUFA4",Response to radiotherapy in nasopharyngeal carcinoma (acute oral mucositis),"oral mucositis, response to radiation, nasopharyngeal neoplasm",GCST010511,7:10905566
rs117157809-<b>C</b>,6 x 10-6,,0.01,3.72,'-,[2.10-6.57],TNKS,Response to radiotherapy in nasopharyngeal carcinoma (acute oral mucositis),"oral mucositis, response to radiation, nasopharyngeal neoplasm",GCST010511,8:9709372
rs4433399-<b>?</b>,9 x 10-6,,NR,1.69,'-,[1.34-2.12],'-,Response to radiotherapy in nasopharyngeal carcinoma (acute oral mucositis),"oral mucositis, response to radiation, nasopharyngeal neoplasm",GCST010511,1:5751064
rs6918008-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,LINC02836,Response to radiotherapy in nasopharyngeal carcinoma (acute oral mucositis),"oral mucositis, response to radiation, nasopharyngeal neoplasm",GCST010511,6:105596474
A*11:01-<b>?</b>,2 x 10-19,(NPC vs. Control),NR,1.69,'-,[1.52-1.89],'-,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST001752,Mapping not available
*A11:01-<b>?</b>,2 x 10-16,(NPC vs. EP Controls),NR,1.75,'-,[1.54-2],'-,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST001752,Mapping not available
A*11:01-<b>?</b>,3 x 10-14,(NPC vs. EN Controls),NR,1.64,'-,[1.45-1.89],'-,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST001752,Mapping not available
B*38:02-<b>?</b>,7 x 10-11,(NPC vs. Control),NR,1.67,'-,[1.43-1.94],'-,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST001752,Mapping not available
B*38:02-<b>?</b>,2 x 10-10,(NPC vs. EP Controls),NR,1.88,'-,[1.55-2.28],'-,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST001752,Mapping not available
B*55:02-<b>?</b>,5 x 10-10,(NPC vs. EN Controls),NR,3.85,'-,[2.5-5.88],'-,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST001752,Mapping not available
rs879882-<b>G</b> x rs7770216-<b>A</b>,7 x 10-8,,NR,'-,'-,'-,POU5F1 x RNU6-283P - FGFR3P1,Nasopharyngeal carcinoma (SNP x SNP interaction),nasopharyngeal neoplasm,GCST006524,6:31171675|6:31372834
rs2517713-<b>A</b>,4 x 10-20,,0.62,1.88,'-,[1.65-2.15],"HLA-W, HLA-A",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000460,6:29950322
rs3129055-<b>G</b>,7 x 10-11,,0.31,1.51,'-,[1.34-1.71],"ZFP57, ZDHHC20P1",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000460,6:29702484
rs29232-<b>A</b>,9 x 10-17,,0.46,1.67,'-,[1.48-1.88],"SUMO2P1, MOG",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000460,6:29643654
rs189897-<b>A</b>,7 x 10-8,,0.09,3.18,'-,[1.94-5.21],ITGA9,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000413,3:37477054
rs2860580-<b>?</b>,5 x 10-67,,0.62,1.72,'-,[1.61-1.82],"HLA-A, HLA-U",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000687,6:29938914
rs9510787-<b>G</b>,2 x 10-9,,0.37,1.2,'-,[1.10-1.30],TNFRSF19,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000687,13:23631056
rs6774494-<b>?</b>,1 x 10-8,,0.35,1.19,'-,[1.12-1.27],MECOM,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000687,3:169364845
rs1412829-<b>?</b>,5 x 10-7,,0.89,1.28,'-,[1.18-1.41],CDKN2B-AS1,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000687,9:22043927
rs2894207-<b>?</b>,3 x 10-33,,0.82,1.64,'-,[1.52-1.75],LINC02571,Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000687,6:31295974
rs28421666-<b>?</b>,2 x 10-18,,0.88,1.49,'-,[1.37-1.64],"HLA-DRB1, HLA-DQA1",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000687,6:32624960
rs1572072-<b>?</b>,1 x 10-8,,0.74,1.19,'-,[1.11-1.27],"TNFRSF19, LINC00352",Nasopharyngeal carcinoma,nasopharyngeal neoplasm,GCST000687,13:23553071
rs162171-<b>A</b>,6 x 10-9,,0.182,1.46,'-,[1.29-1.66],CEP128,Radiation-induced brain injury in nasopharyngeal carcinoma,"response to radiation, nasopharyngeal neoplasm, radiation-induced brain injury",GCST007200,14:80794033
rs17111237-<b>G</b>,3 x 10-7,,0.137,1.45,'-,[1.26-1.66],CEP128,Radiation-induced brain injury in nasopharyngeal carcinoma,"response to radiation, nasopharyngeal neoplasm, radiation-induced brain injury",GCST007200,14:80939997
rs4245791-<b>T</b>,5 x 10-31,(EA),0.69,1.28,'-,[1.25-1.32],ABCG8,Gallstone disease,gallstones,GCST003725,2:43847292
rs1260326-<b>C</b>,8 x 10-8,(EA),0.59,1.12,'-,[1.09–1.15],'-,Gallstone disease,gallstones,GCST003725,Mapping not available
rs11887534-<b>C</b>,2 x 10-75,(EA),0.07,1.78,'-,[1.70–1.86],ABCG8,Gallstone disease,gallstones,GCST003725,2:43839108
rs9843304-<b>C</b>,3 x 10-6,(EA),0.45,1.11,'-,[1.08–1.14],TM4SF4,Gallstone disease,gallstones,GCST003725,3:149493600
rs6471717-<b>G</b>,3 x 10-6,(EA),0.35,1.11,'-,[1.08–1.14],"UBXN2B, CYP7A1",Gallstone disease,gallstones,GCST003725,8:58464798
rs2547231-<b>A</b>,1 x 10-7,(EA),0.84,1.17,'-,[1.13–1.22],SULT2A1,Gallstone disease,gallstones,GCST003725,19:47881800
rs242016-<b>A</b>,2 x 10-8,,0.21,3.7,'-,[2.32-6.29],CRACR2A,Chronic periodontitis (localised),periodontitis,GCST007197,12:3679094
rs11659841-<b>?</b>,9 x 10-6,(PD1),0.13,2.48,'-,[NR],CDH2,Periodontal disease-related phenotype (Socransky),periodontitis,GCST002312,18:28206916
rs8094794-<b>?</b>,6 x 10-6,(PD1),0.79,2.17,'-,[NR],FHOD3,Periodontal disease-related phenotype (Socransky),periodontitis,GCST002312,18:36672786
rs3870371-<b>?</b>,6 x 10-6,(PD1),0.32,2.15,'-,[NR],"HAS2-AS1, LINC02855",Periodontal disease-related phenotype (Socransky),periodontitis,GCST002312,8:121684892
rs733048-<b>?</b>,1 x 10-6,(PD1),0.22,2.4,'-,[NR],HSP90AB2P,Periodontal disease-related phenotype (Socransky),periodontitis,GCST002312,4:13241173
rs12799172-<b>?</b>,5 x 10-6,(PD1),0.64,2.12,'-,[NR],GVINP1,Periodontal disease-related phenotype (Socransky),periodontitis,GCST002312,11:6728826
rs7749983-<b>?</b>,2 x 10-6,(PD1),0.19,2.39,'-,[NR],"ARHGAP18, LAMA2",Periodontal disease-related phenotype (Socransky),periodontitis,GCST002312,6:129553210
rs733048-<b>?</b>,4 x 10-6,(PD2),0.22,1.95,'-,[NR],HSP90AB2P,Periodontal disease-related phenotype (Socransky),periodontitis,GCST002312,4:13241173
rs12630931-<b>?</b>,6 x 10-6,(PD2),0.3,1.89,'-,[NR],OSBPL10,Periodontal disease-related phenotype (Socransky),periodontitis,GCST002312,3:31940275
rs12589327-<b>?</b>,7 x 10-6,(PD2),0.39,2.13,'-,[NR],"EIF3LP1, RPL9P6",Periodontal disease-related phenotype (Socransky),periodontitis,GCST002312,14:81832829
rs3783412-<b>?</b>,8 x 10-6,(PD2),0.53,1.85,'-,[NR],CDKL1,Periodontal disease-related phenotype (Socransky),periodontitis,GCST002312,14:50389923
rs9446777-<b>G</b>,5 x 10-6,,0.86,1.22,'-,[1.14-1.35],KCNQ5,Periodontitis,periodontitis,GCST002781,6:72871328
rs2392510-<b>T</b>,4 x 10-6,,0.59,1.15,'-,[1.09-1.22],"GPR141, EPDR1",Periodontitis,periodontitis,GCST002781,7:37706967
rs1537415-<b>G</b>,6 x 10-9,,0.38,1.59,'-,[1.36-1.86],GLT6D1,Periodontitis,periodontitis,GCST000521,9:135637876
rs11800854-<b>G</b>,3 x 10-7,(Red),0.947,12.3,'-,[3.70-41.3],KCNK1,Periodontal microbiota,periodontitis,GCST001588,1:233584238
rs12032672-<b>C</b>,1 x 10-6,(Red),0.332,1.99,'-,[1.50-2.62],PKN2-AS1,Periodontal microbiota,periodontitis,GCST001588,1:88159953
rs1932040-<b>G</b>,1 x 10-6,(Orange),0.808,2.47,'-,[1.67-3.65],RUNX2,Periodontal microbiota,periodontitis,GCST001588,6:45729051
rs9942773-<b>A</b>,2 x 10-6,(Orange),0.703,2.07,'-,[1.51-2.82],MIR3622B,Periodontal microbiota,periodontitis,GCST001588,8:114108798
rs1616122-<b>T</b>,5 x 10-6,(Orange),0.506,1.85,'-,[1.41-2.42],CAMTA1,Periodontal microbiota,periodontitis,GCST001588,1:7461525
rs11621969-<b>T</b>,9 x 10-7,(A. actino),0.789,2.46,'-,[1.68-3.62],"JDP2, LINC01220",Periodontal microbiota,periodontitis,GCST001588,14:75347325
rs6885116-<b>G</b>,1 x 10-6,(A. actino),0.078,2.57,'-,[1.76-3.74],TENM2,Periodontal microbiota,periodontitis,GCST001588,5:168216540
rs1970525-<b>G</b>,4 x 10-6,(A. actino),0.054,2.89,'-,[1.85-4.52],GRID1,Periodontal microbiota,periodontitis,GCST001588,10:85875167
rs11800854-<b>G</b>,4 x 10-6,(A. actino),0.947,8.12,'-,[2.73-24.11],KCNK1,Periodontal microbiota,periodontitis,GCST001588,1:233584238
rs9287989-<b>C</b>,4 x 10-6,(A. actino),0.484,1.8,'-,[1.39-2.33],"EXTL2P1, LNPK",Periodontal microbiota,periodontitis,GCST001588,2:175853013
rs10760187-<b>C</b>,5 x 10-7,(P. gingi),0.498,2.07,'-,[1.55-2.76],"TTLL11, DAB2IP",Periodontal microbiota,periodontitis,GCST001588,9:121803541
rs1360573-<b>A</b>,2 x 10-6,(P. gingi),0.752,2.75,'-,[1.78-4.26],"NAMPTP1, Y_RNA",Periodontal microbiota,periodontitis,GCST001588,10:36596993
rs1011108-<b>T</b>,2 x 10-6,(P. gingi),0.341,1.79,'-,[1.40-2.27],"FAM166C, OTOF",Periodontal microbiota,periodontitis,GCST001588,2:26559753
rs10043775-<b>T</b>,2 x 10-6,(Red),0.703,2.06,'-,[1.51-2.83],FBXO38,Periodontal microbiota,periodontitis,GCST001588,5:148425557
rs16924631-<b>C</b>,3 x 10-6,(Red),0.122,2.29,'-,[1.61-3.24],UHRF2,Periodontal microbiota,periodontitis,GCST001588,9:6486308
rs10010758-<b>C</b>,4 x 10-6,(Red),0.291,1.91,'-,[1.45-2.51],TBC1D1,Periodontal microbiota,periodontitis,GCST001588,4:37936897
rs2521634-<b>?</b>,4 x 10-7,(Severe CPd),NR,1.49,'-,[1.28-1.73],NPY,Periodontitis,periodontitis,GCST001888,7:24338421
rs7762544-<b>?</b>,8 x 10-8,(Moderate CPd),NR,1.4,'-,[1.24-1.59],"FOXP4-AS1, NCR2",Periodontitis,periodontitis,GCST001888,6:41411577
rs3826782-<b>?</b>,8 x 10-7,(Moderate CPd),NR,2.01,'-,[1.52-2.65],ADGRE1,Periodontitis,periodontitis,GCST001888,19:6887725
rs17132883-<b>T</b>,2 x 10-6,(Age 20-60 years),0.04,2.19,'-,[1.59-3.01],"WDR36, RPS3AP21",Periodontitis (PAL4Q3),periodontitis,GCST002136,5:111166731
rs9806183-<b>C</b>,2 x 10-6,(Age 20-60 years),0.66,1.37,'-,[1.20-1.57],THSD4,Periodontitis (PAL4Q3),periodontitis,GCST002136,15:71282460
rs264537-<b>C</b>,3 x 10-6,(Age 20-60 years),0.43,1.35,'-,[1.19-1.54],ROBO2,Periodontitis (PAL4Q3),periodontitis,GCST002136,3:76673615
rs17120400-<b>?</b>,4 x 10-6,(Age 20-60 years),0.9,1.69,'-,[1.35-2.13],LINC02778,Periodontitis (PAL4Q3),periodontitis,GCST002136,1:60225916
rs2738058-<b>T</b>,7 x 10-6,(Age 20-60 years),0.43,1.33,'-,[1.18-1.51],"DEFA10P, DEFA9P",Periodontitis (PAL4Q3),periodontitis,GCST002136,8:6964095
rs2882926-<b>A</b>,7 x 10-6,(Age 20-60 years),0.11,1.56,'-,[1.28-1.90],NKAIN3,Periodontitis (PAL4Q3),periodontitis,GCST002136,8:62709010
rs7567687-<b>?</b>,8 x 10-6,(Age 20-60 years),0.47,1.32,'-,[1.18-1.49],LINC01854,Periodontitis (PAL4Q3),periodontitis,GCST002136,2:129276753
rs11089937-<b>A</b>,8 x 10-6,(Age 20-60 years),0.58,1.33,'-,[1.17-1.51],"IGLV4-60, ABHD17AP5",Periodontitis (PAL4Q3),periodontitis,GCST002136,22:22152176
rs57440971-<b>T</b>,4 x 10-6,(Age 20-60 years),0.06,'-,0.1413 unit decrease,[0.082-0.201],ROCK1P1,Periodontitis (Mean PAL),periodontitis,GCST002127,18:120296
rs2676071-<b>T</b>,7 x 10-6,(Age 20-81 years),0.58,'-,0.0443 unit decrease,[0.025-0.064],RYR3-DT,Periodontitis (Mean PAL),periodontitis,GCST002127,15:33304875
rs111854052-<b>A</b>,9 x 10-6,(Age 20-60 years),0.99,'-,0.3228 unit decrease,[0.18-0.47],SMURF2,Periodontitis (Mean PAL),periodontitis,GCST002127,17:64604817
rs9966832-<b>A</b>,5 x 10-6,(Age 20-81 years),0.98,'-,0.1502 unit increase,[0.086-0.215],RN7SL97P,Periodontitis (Mean PAL),periodontitis,GCST002127,18:25825224
rs36035742-<b>T</b>,4 x 10-6,(Age 20-60 years),0.05,'-,0.1239 unit increase,[0.072-0.176],"ST20, ST20-MTHFS",Periodontitis (Mean PAL),periodontitis,GCST002127,15:79900633
rs1442779-<b>A</b>,7 x 10-6,(Age 20-60 years),0.28,'-,0.0543 unit decrease,[0.031-0.078],THSD4,Periodontitis (Mean PAL),periodontitis,GCST002127,15:71284416
rs149546760-<b>C</b>,5 x 10-6,(Age 20-60 years),0.01,'-,0.339 unit decrease,[0.19-0.48],ZNF579,Periodontitis (Mean PAL),periodontitis,GCST002127,19:55579966
rs4149263-<b>A</b>,7 x 10-6,(Age 20-81 years),0.8,'-,0.056 unit decrease,[0.032-0.080],ABCA1,Periodontitis (Mean PAL),periodontitis,GCST002127,9:104915008
rs12792526-<b>A</b>,3 x 10-6,(Age 20-81 years),0.87,'-,0.2011 unit increase,[0.12-0.29],MIR8052,Periodontitis (Mean PAL),periodontitis,GCST002127,11:130659324
rs2361405-<b>A</b>,5 x 10-6,(Age 20-60 years),0.89,'-,0.0677 unit increase,[0.038-0.097],"UTP14A, BCORL1",Periodontitis (Mean PAL),periodontitis,GCST002127,X:129970758
rs17879146-<b>T</b>,1 x 10-6,(Age 20-60 years),0.99,'-,0.2549 unit decrease,[0.15-0.36],BIRC5,Periodontitis (Mean PAL),periodontitis,GCST002127,17:78223864
rs11829373-<b>C</b>,7 x 10-6,(Age 20-60 years),0.1,'-,0.08 unit increase,[0.045-0.115],'-,Periodontitis (Mean PAL),periodontitis,GCST002127,12:92593432
rs75598935-<b>A</b>,6 x 10-6,(Age 20-60 years),0.02,'-,0.1721 unit increase,[0.098-0.246],"ST20-AS1, BCL2A1",Periodontitis (Mean PAL),periodontitis,GCST002127,15:79927251
rs149740259-<b>A</b>,9 x 10-6,(Age 20-60 years),0.01,'-,0.2412 unit increase,[0.14-0.35],CDH13,Periodontitis (Mean PAL),periodontitis,GCST002127,16:83750223
rs1500251-<b>A</b>,9 x 10-6,(Age 20-81 years),0.2,'-,0.0545 unit decrease,[0.031-0.078],'-,Periodontitis (Mean PAL),periodontitis,GCST002127,5:99257749
rs12497795-<b>T</b>,2 x 10-6,(Age 20-81 years),0.1,'-,0.0778 unit decrease,[0.046-0.110],ICE2P2,Periodontitis (Mean PAL),periodontitis,GCST002127,3:88928747
rs9979250-<b>T</b>,4 x 10-7,(Age 20-60 years),0.04,'-,0.1497 unit increase,[0.092-0.208],"LINC01700, RPSAP64",Periodontitis (Mean PAL),periodontitis,GCST002127,21:38911809
rs12587630-<b>A</b>,7 x 10-6,(Age 20-60 years),0.98,2.69,'-,[1.75-4.15],TTC6,Periodontitis (CDC/AAP),periodontitis,GCST002126,14:37597370
rs111571364-<b>T</b>,8 x 10-6,(Age 20-60 years),0.02,3.46,'-,[2.01-5.97],GPN1,Periodontitis (CDC/AAP),periodontitis,GCST002126,2:27636450
rs3128935-<b>T</b>,9 x 10-6,(Age 20-60 years),0.97,2.28,'-,[1.59-3.28],HLA-DOA,Periodontitis (CDC/AAP),periodontitis,GCST002126,6:33004627
rs28643277-<b>A</b>,9 x 10-6,(Age 20-60 years),0.35,1.32,'-,[1.17-1.50],ITGA8,Periodontitis (CDC/AAP),periodontitis,GCST002126,10:15558672
rs6890783-<b>A</b>,5 x 10-6,(Age 20-60 years),0.01,6.45,'-,[2.89-14.38],ERGIC1,Periodontitis (CDC/AAP),periodontitis,GCST002126,5:172865303
rs72899866-<b>A</b>,5 x 10-6,(Age 20-60 years),0.22,1.39,'-,[1.21-1.60],LRP1B,Periodontitis (CDC/AAP),periodontitis,GCST002126,2:140468740
rs71455379-<b>?</b>,9 x 10-6,(Age 20-60 years),0.06,1.89,'-,[1.43-2.5],PRB2,Periodontitis (CDC/AAP),periodontitis,GCST002126,12:11405943
rs73389468-<b>?</b>,9 x 10-6,(Age 20-60 years),0.98,2.78,'-,[1.75-4.35],"LINC02870, LINC01165",Periodontitis (CDC/AAP),periodontitis,GCST002126,10:132482311
rs1953021-<b>T</b>,1 x 10-6,(Age 20-81 years),0.71,1.35,'-,[1.20-1.53],"Y_RNA, PRDX1P1",Periodontitis (CDC/AAP),periodontitis,GCST002126,9:12914397
rs2009196-<b>C</b>,2 x 10-6,(Age 20-81 years),0.23,1.41,'-,[1.22-1.62],"TIMP2, CEP295NL",Periodontitis (CDC/AAP),periodontitis,GCST002126,17:78874499
rs12048046-<b>T</b>,3 x 10-6,(Age 20-81 years),0.9,1.52,'-,[1.28-1.81],ACTN2,Periodontitis (CDC/AAP),periodontitis,GCST002126,1:236748757
rs263063-<b>T</b>,6 x 10-6,(Age 20-81 years),0.08,1.63,'-,[1.32-2.01],KDM4B,Periodontitis (CDC/AAP),periodontitis,GCST002126,19:5022593
rs1833219-<b>?</b>,8 x 10-6,(Age 20-81 years),0.72,1.32,'-,[1.16-1.49],"LINC01799, LINC01828",Periodontitis (CDC/AAP),periodontitis,GCST002126,2:67070277
rs2243407-<b>?</b>,9 x 10-6,(Age 20-81 years),0.65,1.3,'-,[1.16-1.47],"LINC00208, GATA4",Periodontitis (CDC/AAP),periodontitis,GCST002126,8:11622948
rs13237474-<b>T</b>,2 x 10-7,(Age 20-60 years),0.03,3.05,'-,[2.00-4.65],FAM180A,Periodontitis (CDC/AAP),periodontitis,GCST002126,7:135816721
rs6802315-<b>?</b>,3 x 10-7,(Age 20-60 years),0.45,1.37,'-,[1.2-1.54],MFSD1,Periodontitis (CDC/AAP),periodontitis,GCST002126,3:158796571
rs13145041-<b>A</b>,7 x 10-7,(Age 20-60 years),0.78,1.65,'-,[1.35-2.00],LINC01262,Periodontitis (CDC/AAP),periodontitis,GCST002126,4:189616909
rs78797168-<b>A</b>,2 x 10-6,(Age 20-60 years),0.93,1.75,'-,[1.39-2.22],IGF2R,Periodontitis (CDC/AAP),periodontitis,GCST002126,6:160038159
rs34069323-<b>?</b>,2 x 10-6,(Age 20-60 years),0.01,6.25,'-,[2.94-14.29],"WDR73, SCAND2P",Periodontitis (CDC/AAP),periodontitis,GCST002126,15:84644014
rs78411303-<b>?</b>,3 x 10-6,(Age 20-60 years),0.094,1.96,'-,[1.47-2.56],PARP15,Periodontitis (CDC/AAP),periodontitis,GCST002126,3:122637604
rs7819988-<b>T</b>,3 x 10-6,(Age 20-60 years),0.55,1.32,'-,[1.17-1.48],'-,Periodontitis (CDC/AAP),periodontitis,GCST002126,8:121198650
rs28455997-<b>T</b>,3 x 10-6,(Age 20-60 years),0.84,1.48,'-,[1.26-1.75],CSMD1,Periodontitis (CDC/AAP),periodontitis,GCST002126,8:3219437
rs2293335-<b>?</b>,5 x 10-6,(Age 20-60 years),0.3,1.35,'-,[1.19-1.54],ETNK2,Periodontitis (CDC/AAP),periodontitis,GCST002126,1:204134490
rs73082373-<b>T</b>,6 x 10-6,(Age 20-60 years),0.95,'-,0.126 unit decrease,[0.071-0.181],FAM126A,Periodontitis (Mean PAL),periodontitis,GCST002127,7:22954567
rs13204086-<b>T</b>,2 x 10-6,(Age 20-81 years),0.04,'-,0.1616 unit increase,[0.095-0.228],NKAIN2,Periodontitis (Mean PAL),periodontitis,GCST002127,6:124084010
rs11877878-<b>A</b>,5 x 10-6,(Age 20-81 years),0.93,'-,0.0906 unit increase,[0.052-0.129],PSMA8,Periodontitis (Mean PAL),periodontitis,GCST002127,18:26184271
rs1875110-<b>T</b>,4 x 10-6,(Age 20-60 years),0.95,'-,0.1283 unit decrease,[0.074-0.183],ERC2,Periodontitis (Mean PAL),periodontitis,GCST002127,3:55529316
rs12792526-<b>A</b>,4 x 10-6,(Age 20-60 years),0.87,'-,0.2189 unit increase,[0.13-0.31],MIR8052,Periodontitis (Mean PAL),periodontitis,GCST002127,11:130659324
rs12050161-<b>T</b>,4 x 10-6,(Age 20-60 years),0.84,'-,0.07 unit increase,[0.040-0.100],ACTN1,Periodontitis (Mean PAL),periodontitis,GCST002127,14:68893914
rs112125027-<b>A</b>,5 x 10-6,(Age 20-60 years),0.94,'-,0.1042 unit increase,[0.060-0.149],"DKK1, RPL31P44",Periodontitis (Mean PAL),periodontitis,GCST002127,10:52370993
rs113065570-<b>T</b>,8 x 10-6,(Age 20-60 years),0.32,'-,0.0469 unit decrease,[0.026-0.067],'-,Periodontitis (Mean PAL),periodontitis,GCST002127,X:33793724
rs140900046-<b>A</b>,4 x 10-6,(Age 20-60 years),0.01,'-,0.3405 unit decrease,[0.20-0.49],FIZ1,Periodontitis (Mean PAL),periodontitis,GCST002127,19:55599709
rs61862032-<b>T</b>,9 x 10-6,(Age 20-60 years),0.98,'-,0.1957 unit increase,[0.11-0.28],"HMX3, ACADSB",Periodontitis (Mean PAL),periodontitis,GCST002127,10:123127609
rs7892161-<b>T</b>,9 x 10-6,(Age 20-60 years),0.54,'-,0.0413 unit increase,[0.023-0.060],HS6ST2,Periodontitis (Mean PAL),periodontitis,GCST002127,X:132890476
rs10127000-<b>T</b>,6 x 10-6,(Age 20-60 years),0.06,'-,0.1006 unit decrease,[0.057-0.144],LINC01278,Periodontitis (Mean PAL),periodontitis,GCST002127,X:63405319
rs1995138-<b>A</b>,4 x 10-6,(Age 20-60 years),0.08,'-,0.0957 unit increase,[0.055-0.136],'-,Periodontitis (Mean PAL),periodontitis,GCST002127,18:54000198
rs77490164-<b>T</b>,8 x 10-7,(Age 20-60 years),0.05,'-,0.1282 unit increase,[0.077-0.179],NKAIN2,Periodontitis (Mean PAL),periodontitis,GCST002127,6:124238586
rs146696563-<b>T</b>,4 x 10-6,(Age 20-60 years),0.99,'-,0.2396 unit increase,[0.14-0.34],"HNRNPA1P58, NRSN1",Periodontitis (Mean PAL),periodontitis,GCST002127,6:24062560
rs145744974-<b>A</b>,4 x 10-6,(Age 20-60 years),0.99,'-,0.2942 unit increase,[0.17-0.42],LINC01811,Periodontitis (Mean PAL),periodontitis,GCST002127,3:34218600
rs78015699-<b>T</b>,7 x 10-6,(Age 20-60 years),0.02,'-,0.2155 unit increase,[0.12-0.31],GDF15,Periodontitis (Mean PAL),periodontitis,GCST002127,19:18376857
rs8097810-<b>A</b>,4 x 10-6,(Age 20-60 years),0.94,'-,0.105 unit increase,[0.060-0.150],NPM1P2,Periodontitis (Mean PAL),periodontitis,GCST002127,18:26205684
rs149784093-<b>T</b>,3 x 10-6,(Age 20-60 years),0.01,'-,0.2236 unit increase,[0.13-0.32],"PTEN, MED6P1",Periodontitis (Mean PAL),periodontitis,GCST002127,10:87992454
rs7345986-<b>A</b>,9 x 10-6,(Age 20-60 years),0.74,'-,0.0637 unit increase,[0.036-0.092],PTPRT,Periodontitis (Mean PAL),periodontitis,GCST002127,20:42212139
rs1540507-<b>?</b>,9 x 10-6,(Age 20-81 years),0.78,1.47,'-,[1.23-1.75],CSMD1,Periodontitis (CDC/AAP),periodontitis,GCST002126,8:3231241
rs6497031-<b>A</b>,5 x 10-6,(Age 20-60 years),0.17,1.84,'-,[1.41 - 2.39],RGMA,Periodontitis (CDC/AAP),periodontitis,GCST002126,15:93170437
rs2243407-<b>?</b>,6 x 10-6,(Age 20-60 years),0.65,1.33,'-,[1.18-1.52],"LINC00208, GATA4",Periodontitis (CDC/AAP),periodontitis,GCST002126,8:11622948
rs2243407-<b>?</b>,6 x 10-6,(Age 20-60 years),0.64,1.33,'-,[1.18-1.49],"LINC00208, GATA4",Periodontitis (CDC/AAP),periodontitis,GCST002126,8:11622948
rs11673509-<b>T</b>,6 x 10-6,(Age 20-60 years),0.08,1.66,'-,[1.34-2.07],KDM4B,Periodontitis (CDC/AAP),periodontitis,GCST002126,19:5080636
rs12153048-<b>G</b>,6 x 10-6,(Age 20-60 years),0.05,'-,0.3459 unit increase,[0.20-0.49],'-,Periodontitis (DPAL),periodontitis,GCST002129,5:117177909
rs17655948-<b>T</b>,7 x 10-6,(Age 20-60 years),0.64,'-,0.1638 unit increase,[0.093-0.234],DAOA-AS1,Periodontitis (DPAL),periodontitis,GCST002129,13:105415571
rs457352-<b>T</b>,7 x 10-6,(Age 20-60 years),0.13,'-,0.2401 unit increase,[0.14-0.34],GRIK1,Periodontitis (DPAL),periodontitis,GCST002129,21:29872161
rs12153048-<b>G</b>,2 x 10-6,(Age 20-81 years),0.06,'-,0.3396 unit increase,[0.20-0.48],'-,Periodontitis (DPAL),periodontitis,GCST002129,5:117177909
rs11709498-<b>C</b>,6 x 10-6,(Age 20-81 years),0.65,'-,0.1549 unit decrease,[0.089-0.221],NLGN1,Periodontitis (DPAL),periodontitis,GCST002129,3:173462843
rs339665-<b>T</b>,6 x 10-6,(Age 20-81 years),0.95,'-,0.4063 unit decrease,[0.23-0.58],CCDC13,Periodontitis (DPAL),periodontitis,GCST002129,3:42766579
rs8030136-<b>T</b>,6 x 10-6,(Age 20-81 years),0.17,'-,0.1934 unit decrease,[0.11-0.28],PWRN1,Periodontitis (DPAL),periodontitis,GCST002129,15:24777841
rs2587949-<b>G</b>,8 x 10-6,(Age 20-81 years),0.44,'-,0.1432 unit increase,[0.081-0.206],SUMF1,Periodontitis (DPAL),periodontitis,GCST002129,3:4181932
rs11536940-<b>A</b>,2 x 10-6,(Age 20-60 years),0.06,'-,0.384 unit increase,[0.23-0.54],LBP,Periodontitis (DPAL),periodontitis,GCST002129,20:38349233
rs2569991-<b>C</b>,1 x 10-6,(Age 20-81 years),0.22,'-,0.2 unit increase,[0.12-0.28],LINC02022,Periodontitis (DPAL),periodontitis,GCST002129,3:12881698
rs12936361-<b>T</b>,5 x 10-6,(Age 20-60 years),0.83,'-,0.2338 unit increase,[0.13-0.33],KCNJ16,Periodontitis (DPAL),periodontitis,GCST002129,17:70112276
rs16850317-<b>T</b>,5 x 10-6,(Age 20-60 years),0.94,'-,0.3519 unit decrease,[0.20-0.50],SCN2A,Periodontitis (DPAL),periodontitis,GCST002129,2:165287904
rs12457997-<b>T</b>,5 x 10-6,(Age 20-60 years),0.67,'-,0.1663 unit increase,[0.096-0.237],TGIF1,Periodontitis (DPAL),periodontitis,GCST002129,18:3415833
rs12902137-<b>T</b>,6 x 10-6,(Age 20-60 years),0.72,'-,0.1809 unit decrease,[0.10-0.26],"PWRN1, NPAP1",Periodontitis (DPAL),periodontitis,GCST002129,15:24679516
rs4734806-<b>G</b>,6 x 10-6,(Age 20-60 years),0.16,'-,0.2075 unit decrease,[0.12-0.30],ZFPM2,Periodontitis (DPAL),periodontitis,GCST002129,8:104688452
rs7567687-<b>?</b>,8 x 10-7,(Age 20-81 years),0.46,1.32,'-,[1.18-1.47],LINC01854,Periodontitis (PAL4Q3),periodontitis,GCST002136,2:129276753
rs346452-<b>?</b>,2 x 10-6,(Age 20-81 years),0.54,1.32,'-,[1.18-1.47],LINC00907,Periodontitis (PAL4Q3),periodontitis,GCST002136,18:42361001
rs11866781-<b>?</b>,5 x 10-6,(Age 20-81 years),0.58,1.3,'-,[1.16-1.45],RBFOX1,Periodontitis (PAL4Q3),periodontitis,GCST002136,16:7089172
rs294958-<b>A</b>,5 x 10-6,(Age 20-81 years),0.48,1.29,'-,[1.16-1.44],LINC01933,Periodontitis (PAL4Q3),periodontitis,GCST002136,5:152188538
rs17011371-<b>A</b>,6 x 10-6,(Age 20-81 years),0.95,2.09,'-,[1.52-2.88],HMGB1P5,Periodontitis (PAL4Q3),periodontitis,GCST002136,3:22432238
rs2738058-<b>T</b>,6 x 10-6,(Age 20-81 years),0.43,1.29,'-,[1.16-1.45],"DEFA10P, DEFA9P",Periodontitis (PAL4Q3),periodontitis,GCST002136,8:6964095
rs346221-<b>A</b>,4 x 10-6,(Age 20-81 years),0.64,1.31,'-,[1.17-1.47],LINC00907,Periodontitis (PAL4Q3),periodontitis,GCST002136,18:42443341
rs1442779-<b>?</b>,7 x 10-6,(Age 20-81 years),0.72,1.33,'-,[1.18-1.52],THSD4,Periodontitis (PAL4Q3),periodontitis,GCST002136,15:71284416
rs10875423-<b>?</b>,9 x 10-6,(Age 20-81 years),0.18,1.43,'-,[1.22-1.67],FAM135B,Periodontitis (PAL4Q3),periodontitis,GCST002136,8:138289135
rs1370967-<b>A</b>,8 x 10-7,(Age 20-60 years),0.04,2.21,'-,[1.61-3.02],"CAMK4, RPS3AP21",Periodontitis (PAL4Q3),periodontitis,GCST002136,5:111203694
rs738409-<b>?</b>,4 x 10-16,,NR,'-,'-,'-,PNPLA3,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010096,22:43928847
rs58542926-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,TM6SF2,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010096,19:19268740
rs2076529-<b>?</b>,2 x 10-7,,NR,1.66,'-,[1.37-2.00],"BTNL2, TSBP1-AS1",Lean nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010460,6:32396178
rs2189883-<b>?</b>,4 x 10-7,,NR,1.77,'-,[1.42-2.22],CNTNAP2,Lean nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010460,7:147991795
rs2301610-<b>?</b>,8 x 10-7,,NR,1.7,'-,[1.38-2.09],MYL2,Lean nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010460,12:110915752
rs66781047-<b>?</b>,1 x 10-6,,NR,1.74,'-,[1.39-2.17],GPC6,Lean nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010460,13:94367384
rs7324845-<b>A</b>,3 x 10-6,,0.096,3.29,'-,[0.76-5.82],"LCP1, CPB2-AS1",Non-alcoholic fatty liver disease histology (other),non-alcoholic fatty liver disease,GCST001766,13:46129007
rs11864146-<b>A</b>,2 x 10-6,,0.1,3.14,'-,[0.65-5.63],SLC38A8,Non-alcoholic fatty liver disease histology (other),non-alcoholic fatty liver disease,GCST001766,16:84013110
rs12743824-<b>C</b>,5 x 10-6,,0.441,2.3,'-,[-0.05200-4.65200],PLPPR4,Non-alcoholic fatty liver disease histology (other),non-alcoholic fatty liver disease,GCST001766,1:99317401
rs222054-<b>C</b>,1 x 10-6,,0.301,2.54,'-,[0.17-4.91],GC,Non-alcoholic fatty liver disease histology (other),non-alcoholic fatty liver disease,GCST001766,4:71738582
rs894177-<b>G</b>,3 x 10-6,(ALT),0.34,'-,0.28 unit decrease,[NR],"PBX2P1, CHST2",Non-alcoholic fatty liver disease histology (other),"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST000765,3:143175569
rs1305088-<b>A</b>,9 x 10-6,(ALT),0.06,'-,0.58 unit increase,[NR],SLC46A3,Non-alcoholic fatty liver disease histology (other),"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST000765,13:28704313
rs2800-<b>G</b>,3 x 10-6,(ALT),0.34,'-,0.61 unit increase,[NR],SLC9A9,Non-alcoholic fatty liver disease histology (other),"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST000765,3:143705980
rs7453920-<b>G</b>,5 x 10-37,,0.87,1.8868,'-,[1.69-2.08],HLA-DQB2,Hepatitis B,hepatitis B virus infection,GCST002246,6:32762235
rs3130542-<b>A</b>,9 x 10-14,,0.13,1.33,'-,[1.23-1.44],"HCG27, HLA-C",Hepatitis B,hepatitis B virus infection,GCST002246,6:31264334
rs4821116-<b>G</b>,2 x 10-12,,0.59,1.2195,'-,[1.15-1.3],UBE2L3,Hepatitis B,hepatitis B virus infection,GCST002246,22:21619030
rs6547741-<b>G</b>,4 x 10-8,,0.46,1.1983223,'-,NR,GPN1,Oral cavity cancer,oral cavity cancer,GCST003858,2:27633057
rs1229984-<b>G</b>,1 x 10-9,,0.94,1.7436792,'-,NR,ADH1B,Oral cavity cancer,oral cavity cancer,GCST003858,4:99318162
rs10462706-<b>C</b>,6 x 10-10,,0.85,1.3594345,'-,NR,CLPTM1L,Oral cavity cancer,oral cavity cancer,GCST003858,5:1343679
rs8181047-<b>A</b>,4 x 10-9,,0.24,1.24,'-,NR,CDKN2B-AS1,Oral cavity cancer,oral cavity cancer,GCST003858,9:22064466
rs928674-<b>G</b>,2 x 10-8,,0.12,1.3252,'-,NR,LAMC3,Oral cavity cancer,oral cavity cancer,GCST003858,9:131076637
rs10851478-<b>G</b>,4 x 10-7,,0.36,1.1865,'-,NR,FAM227B,Oral cavity cancer,oral cavity cancer,GCST003858,15:49536822
rs2398180-<b>T</b>,3 x 10-7,,0.53,1.201,'-,NR,NR2F2-AS1,Oral cavity cancer,oral cavity cancer,GCST003858,15:96319940
rs3129780-<b>A</b>,6 x 10-8,,0.64,1.2373,'-,NR,"HLA-DQB1, MTCO3P1",Oral cavity cancer,oral cavity cancer,GCST003858,6:32679924
rs1800628-<b>A</b>,7 x 10-8,,0.07,1.3962,'-,NR,"LTB, TNF",Oral cavity cancer,oral cavity cancer,GCST003858,6:31579073
rs3765524-<b>T</b>,2 x 10-9,(ESCC),0.207,1.35,'-,[1.22-1.49],PLCE1,Esophageal cancer and gastric cancer,esophageal carcinoma,GCST000777,10:94298541
rs738722-<b>T</b>,1 x 10-8,(ESCC),0.25,1.3,'-,[1.19-1.43],CHEK2,Esophageal cancer and gastric cancer,esophageal carcinoma,GCST000777,22:28734024
rs1042026-<b>?</b>,3 x 10-7,,0.22,1.27,'-,[1.16-1.38],ADH1B,Esophageal cancer  (alcohol interaction),esophageal carcinoma,GCST001672,4:99307309
rs3805322-<b>?</b>,6 x 10-7,,0.51,1.23,'-,[1.14-1.33],ADH4,Esophageal cancer  (alcohol interaction),esophageal carcinoma,GCST001672,4:99135847
rs9288520-<b>?</b>,4 x 10-11,,0.34,1.33,'-,[1.22-1.45],"IGFBP2, PSMB3P2",Esophageal cancer  (alcohol interaction),esophageal carcinoma,GCST001672,2:216616548
rs17450420-<b>?</b>,5 x 10-8,,0.04,1.7,'-,[1.41-2.06],'-,Esophageal cancer  (alcohol interaction),esophageal carcinoma,GCST001672,13:104386796
rs137931178-<b>?</b>,7 x 10-6,,NR,79,'-,[11.72-533.7],"TSBP1-AS1, TSBP1",Drug-induced liver injury,"response to flupirtine, drug-induced liver injury",GCST003426,6:32361373
rs7828135-<b>?</b>,5 x 10-8,"(Maximum ALT, Conditioned on HLA- DRB1*07:01)",NR,'-,'-,'-,TPD52,Lapatinib-induced hepatotoxicity,"response to lapatinib, drug-induced liver injury",GCST002918,8:80146584
HLA-<b>DRB1*07:01</b>,8 x 10-11,(case/control),NR,'-,'-,'-,'-,Lapatinib-induced hepatotoxicity,"response to lapatinib, drug-induced liver injury",GCST002918,Mapping not available
HLA-<b>DRB1*07:01</b>,2 x 10-18,(Maximum ALT),NR,'-,'-,'-,'-,Lapatinib-induced hepatotoxicity,"response to lapatinib, drug-induced liver injury",GCST002918,Mapping not available
rs10946737-<b>A</b>,4 x 10-6,,NR,3.4,'-,[2.2-5.3],RIPOR2,Liver injury in anti-tuberculosis drug treatment,"response to rifampicin, Tuberculosis, drug-induced liver injury",GCST003792,6:24967012
rs320035-<b>G</b>,5 x 10-6,,NR,2.3,'-,[1.6-3.3],AGBL4,Liver injury in anti-tuberculosis drug treatment,"response to rifampicin, Tuberculosis, drug-induced liver injury",GCST003792,1:48623525
rs17036170-<b>?</b>,2 x 10-8,(Diclofenac),NR,11.3,'-,[4.9-25.9],PPARG,Drug-induced liver injury,drug-induced liver injury,GCST001673,3:12288912
rs10937275-<b>?</b>,1 x 10-8,(B*5701 positive),0.09,4.1,'-,[NR],ST6GAL1,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST000415,3:186933001
rs10812428-<b>?</b>,1 x 10-6,,0.31,2.85,'-,[NR],'-,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST000415,9:26614849
rs1497546-<b>?</b>,2 x 10-7,,0.02,6.57,'-,[NR],"OR5K4, OR5H8",Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST000415,3:98315682
rs2395029-<b>?</b>,9 x 10-33,,0.05,45,'-,[19.4-105],HCP5,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST000415,6:31464003
rs6582630-<b>?</b>,1 x 10-6,,0.38,2.82,'-,[NR],ALG10B,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST000415,12:38349706
rs4984390-<b>?</b>,4 x 10-6,,0.41,3.27,'-,[NR],MCTP2,Drug-induced liver injury (flucloxacillin),drug-induced liver injury,GCST000415,15:94396279
rs3129900-<b>?</b>,7 x 10-25,,0.105,7.5,'-,[5.0-11.3],"TSBP1, TSBP1-AS1",Lumiracoxib-related liver injury,drug-induced liver injury,GCST000735,6:32338202
rs7562732-<b>?</b>,2 x 10-6,,NR,5,'-,NR,'-,Depression in response to interferon-based therapy in chronic hepatitis C,"chronic hepatitis C virus infection, response to interferon, depressive symptom measurement",GCST003824,2:118328332
rs1863918-<b>T</b>,8 x 10-8,,NR,2.55,'-,[1.8-3.61],ADAMTS2,Depression in response to interferon-based therapy in chronic hepatitis C,"chronic hepatitis C virus infection, response to interferon, depressive symptom measurement",GCST003824,5:179112381
rs9386749-<b>?</b>,9 x 10-6,,NR,2.173913,'-,NR,LINC00222,Depression in response to interferon-based therapy in chronic hepatitis C,"chronic hepatitis C virus infection, response to interferon, depressive symptom measurement",GCST003824,6:108752513
rs2779180-<b>?</b>,1 x 10-6,,NR,2.564103,'-,NR,PLIN3,Depression in response to interferon-based therapy in chronic hepatitis C,"chronic hepatitis C virus infection, response to interferon, depressive symptom measurement",GCST003824,19:4841139
rs2071286-<b>?</b>,2 x 10-8,,0.29,2.15,'-,[NR],NOTCH4,Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection,"chronic hepatitis C virus infection, cryoglobulinemia",GCST002534,6:32212119
rs9461776-<b>G</b>,7 x 10-9,,0.29,2.02,'-,[NR],"HLA-DQA1, HLA-DRB1",Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection,"chronic hepatitis C virus infection, cryoglobulinemia",GCST002534,6:32607958
rs965469-<b>?</b>,1 x 10-9,(IFN-related thrombocytopenia at wk 4),NR,'-,'-,'-,C20orf194,IFN-related cytopenia,chronic hepatitis C virus infection,GCST001076,20:3400902
rs9275572-<b>T</b>,4 x 10-16,,0.359,1.27,'-,[1.19-1.33],"HLA-DQB3, MTCO3P1",Chronic hepatitis C infection,chronic hepatitis C virus infection,GCST002316,6:32711222
rs8099917-<b>G</b>,6 x 10-9,,0.24,2.31,'-,[1.74-3.06],"IFNL4, MSRB1P1",Chronic hepatitis C infection,chronic hepatitis C virus infection,GCST000557,19:39252525
rs8099917-<b>G</b>,9 x 10-9,,NR,1.98,'-,[1.57-2.52],"IFNL4, MSRB1P1",Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST000485,19:39252525
rs8099917-<b>G</b>,3 x 10-32,,0.12,27.1,'-,[14.6-50.3],"IFNL4, MSRB1P1",Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST000486,19:39252525
rs12979860-<b>?</b>,2 x 10-30,,NR,2.2,'-,'-,IFNL4,Chronic hepatitis C infection,chronic hepatitis C virus infection,GCST001867,19:39248147
rs4273729-<b>?</b>,5 x 10-17,,NR,1.59,'-,'-,"HLA-DQB3, MTCO3P1",Chronic hepatitis C infection,chronic hepatitis C virus infection,GCST001867,6:32710820
rs12980275-<b>?</b>,5 x 10-17,,NR,'-,'-,'-,"IFNL3, IFNL3P1",Lipid levels in hepatitis C treatment,"chronic hepatitis C virus infection, low density lipoprotein cholesterol measurement",GCST001418,19:39241143
rs16837677-<b>?</b>,2 x 10-6,,'-,1.54,'-,[1.29-1.84],"PRCC, SH2D2A",Sjögren's syndrome,Sjogren syndrome,GCST004061,1:156804319
rs11889341-<b>?</b>,9 x 10-10,,'-,1.4,'-,[1.26-1.56],STAT4,Sjögren's syndrome,Sjogren syndrome,GCST004061,2:191079016
rs10474500-<b>?</b>,8 x 10-6,,'-,1.3333333,'-,[1.18-1.52],PDE8B,Sjögren's syndrome,Sjogren syndrome,GCST004061,5:77324177
rs9271573-<b>?</b>,3 x 10-42,,'-,2.02,'-,[1.82-2.23],"HLA-DQA1, HLA-DRB1",Sjögren's syndrome,Sjogren syndrome,GCST004061,6:32622724
rs3823536-<b>?</b>,3 x 10-14,,'-,1.49,'-,[1.34-1.65],IRF5,Sjögren's syndrome,Sjogren syndrome,GCST004061,7:128939612
rs7341475-<b>?</b>,3 x 10-7,,'-,1.39,'-,[1.23-1.57],RELN,Sjögren's syndrome,Sjogren syndrome,GCST004061,7:103764368
rs7999279-<b>?</b>,1 x 10-6,,'-,1.42,'-,[1.23-1.63],"RN7SL700P, GNG5P5",Sjögren's syndrome,Sjogren syndrome,GCST004061,13:47376590
rs17074492-<b>?</b>,2 x 10-6,,'-,1.37,'-,[1.20-1.56],'-,Sjögren's syndrome,Sjogren syndrome,GCST004061,13:81587764
rs1957173-<b>?</b>,7 x 10-7,,'-,1.6393442,'-,[1.35-2],LINC00871,Sjögren's syndrome,Sjogren syndrome,GCST004061,14:45937713
rs7192380-<b>?</b>,2 x 10-6,,'-,1.28,'-,[1.16-1.42],NFAT5,Sjögren's syndrome,Sjogren syndrome,GCST004061,16:69670439
rs7574865-<b>?</b>,2 x 10-8,(EA),'-,1.51,'-,[ 1.31-1.75],STAT4,Sjögren's syndrome,Sjogren syndrome,GCST004061,2:191099907
rs79407237-<b>?</b>,5 x 10-6,(EA),'-,1.6393442,'-,[1.33-2.04],"C3orf20, CCDC174",Sjögren's syndrome,Sjogren syndrome,GCST004061,3:14673131
rs181851-<b>?</b>,3 x 10-6,(EA),'-,1.4925373,'-,[1.27-1.79],PDE8B,Sjögren's syndrome,Sjogren syndrome,GCST004061,5:77295276
rs9271573-<b>?</b>,3 x 10-34,(EA),'-,2.29,'-,[2.01-2.62],"HLA-DQA1, HLA-DRB1",Sjögren's syndrome,Sjogren syndrome,GCST004061,6:32622724
rs3823536-<b>?</b>,7 x 10-11,(EA),'-,1.54,'-,[1.36-1.76],IRF5,Sjögren's syndrome,Sjogren syndrome,GCST004061,7:128939612
rs7341475-<b>?</b>,9 x 10-6,(EA),'-,1.43,'-,[1.22-1.68],RELN,Sjögren's syndrome,Sjogren syndrome,GCST004061,7:103764368
rs4842091-<b>?</b>,5 x 10-6,(EA),'-,1.39,'-,[1.21-1.61],NACC2,Sjögren's syndrome,Sjogren syndrome,GCST004061,9:136055321
rs7999279-<b>?</b>,3 x 10-6,(EA),'-,1.52,'-,[1.27-1.81],"RN7SL700P, GNG5P5",Sjögren's syndrome,Sjogren syndrome,GCST004061,13:47376590
rs9938751-<b>?</b>,1 x 10-6,(EA),'-,1.6949153,'-,[1.37-2.08],SHISA9,Sjögren's syndrome,Sjogren syndrome,GCST004061,16:12908502
rs17074492-<b>?</b>,6 x 10-8,(EA),'-,1.53,'-,[1.31-1.79],'-,Sjögren's syndrome,Sjogren syndrome,GCST004061,13:81587764
rs817156-<b>?</b>,4 x 10-6,,'-,'-,4.865 unit increase,[2.94-6.79],LINC00476,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,9:95707077
rs112246048-<b>?</b>,4 x 10-6,,'-,'-,4.998 unit increase,[3.14-6.86],"RNU6-535P, ITIH5","Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,10:7520083
rs7107282-<b>?</b>,3 x 10-6,,'-,'-,3.959 unit increase,[2.38-5.54],FIBIN,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,11:26944204
rs483743-<b>?</b>,1 x 10-6,,'-,'-,3.82 unit increase,[2.36-5.28],F10,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,13:113132633
rs4331298-<b>?</b>,3 x 10-6,,'-,'-,4.054 unit increase,[2.45-5.66],THSD4,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,15:71626012
rs72787939-<b>?</b>,6 x 10-7,,'-,'-,4.617 unit increase,[3.01-6.22],LINC02195,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,16:26545566
chr16:28719857-<b>?</b>,4 x 10-6,,'-,'-,5.25 unit increase,[3.36-7.14],'-,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,Mapping not available
rs2317828-<b>?</b>,2 x 10-6,,'-,'-,3.72 unit increase,[2.3-5.14],RN7SKP190,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,16:82232986
rs321946-<b>?</b>,3 x 10-6,,'-,'-,3.552 unit decrease,[2.15-4.96],ZNF610,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,19:52356575
rs62225548-<b>?</b>,6 x 10-7,,'-,'-,3.693 unit decrease,[2.32-5.07],DSCAM,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,21:40530804
rs2838538-<b>?</b>,4 x 10-6,,'-,'-,4.606 unit increase,[2.81-6.4],"DNMT3L, AIRE","Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,21:44267388
chr1:158438592-<b>?</b>,3 x 10-6,,'-,'-,2.263 unit increase,[1.42-3.1],'-,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,Mapping not available
rs11718323-<b>?</b>,2 x 10-6,,'-,'-,9.527 unit increase,[6.66-12.39],SGO1-AS1,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,3:20874022
rs78777602-<b>?</b>,1 x 10-6,,'-,'-,9.482 unit increase,[6.66-12.3],THRB-AS1,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,3:24779564
rs1568206-<b>?</b>,9 x 10-7,,'-,'-,3.087 unit increase,[2.1-4.08],LINC00882,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,3:106920872
rs1505809-<b>?</b>,5 x 10-6,,'-,'-,1.867 unit increase,[0.71-3.02],CPNE4,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,3:132182548
rs11932181-<b>?</b>,2 x 10-6,,'-,'-,2.104 unit decrease,[1.3-2.91],"SNORA75B, LINC02493",Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,4:17277894
rs1352733-<b>?</b>,3 x 10-6,,'-,'-,2.372 unit increase,[1.5-3.24],RNU6-289P,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,4:111359586
rs62316615-<b>?</b>,3 x 10-6,,'-,'-,8.023 unit increase,[5.55-10.5],ZGRF1,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,4:112605916
rs57805404-<b>?</b>,2 x 10-6,,'-,'-,3.667 unit increase,[2.48-4.86],HSP90AA4P,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,4:189482498
rs11741099-<b>?</b>,3 x 10-6,,'-,'-,1.96 unit increase,[1.18-2.74],ADAMTS2,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,5:179237462
rs61497549-<b>?</b>,3 x 10-6,,'-,'-,2.343 unit increase,[1.46-3.22],"ZNF815P, RNF216",Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,7:5803211
rs1235058-<b>?</b>,3 x 10-6,,'-,'-,2.256 unit increase,[1.42-3.09],VSTM2A,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,7:54546452
rs2515501-<b>?</b>,5 x 10-6,,'-,'-,6.477 unit increase,[5.06-7.89],"ANGPT2, MCPH1",Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,8:6555104
rs10504504-<b>?</b>,3 x 10-6,,'-,'-,4.624 unit increase,[3.11-6.14],EYA1,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,8:71273689
rs1122613-<b>?</b>,3 x 10-6,,'-,'-,12.54 unit decrease,[7.59-17.49],CEP104,"Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,1:3852001
rs1003652-<b>?</b>,5 x 10-6,,'-,'-,11.67 unit decrease,[6.83-16.51],HPCAL1,"Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,2:10328170
rs12488352-<b>?</b>,3 x 10-6,,'-,'-,12.68 unit increase,[7.63-17.73],C3orf20,"Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,3:14684161
chr3:194035416-<b>?</b>,2 x 10-6,,'-,'-,18.1 unit decrease,[11.55-24.65],'-,"Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,Mapping not available
rs28503910-<b>?</b>,2 x 10-6,,'-,'-,17.13 unit increase,[11.14-23.12],"TEMN3-AS1, AFAP1","Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,4:181759556
rs12171500-<b>?</b>,2 x 10-6,,'-,'-,57.37 unit increase,[41.72-73.02],ZBED3-AS1,"Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,5:77164309
rs6947348-<b>?</b>,1 x 10-6,,'-,'-,14.59 unit increase,[9.3-19.88],SNX10,"Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,7:26344128
rs66691214-<b>?</b>,7 x 10-7,,'-,'-,13.79 unit increase,[8.97-18.61],MTURN,"Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,7:30149188
rs7011390-<b>?</b>,3 x 10-6,,'-,'-,12.96 unit increase,[7.81-18.11],PPIAP86,"Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,8:65392094
rs72787939-<b>?</b>,2 x 10-7,,'-,'-,15.85 unit increase,[10.7-21],LINC02195,"Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,16:26545566
rs4801855-<b>?</b>,3 x 10-6,,'-,'-,17.33 unit decrease,[10.55-24.11],"KLK15, KLK3","Dental caries (decayed, missing and filled tooth surfaces)",dental caries,GCST009268,19:50845316
rs74086974-<b>?</b>,3 x 10-6,,'-,'-,4.522 unit increase,[2.75-6.29],PTGER3,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,1:70870070
rs1003652-<b>?</b>,4 x 10-6,,'-,'-,3.563 unit decrease,[2.12-5],HPCAL1,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,2:10328170
rs340349-<b>?</b>,2 x 10-7,,'-,'-,4.79 unit increase,[3.16-6.42],"SESTD1, CCDC141","Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,2:179068685
rs6434873-<b>?</b>,4 x 10-6,,'-,'-,3.955 unit increase,[2.35-5.56],CCDC150,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,2:196640102
rs12488352-<b>?</b>,3 x 10-6,,'-,'-,3.736 unit increase,[2.24-5.23],C3orf20,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,3:14684161
rs6441084-<b>?</b>,3 x 10-6,,'-,'-,4.57 unit increase,[2.8-6.34],"TIPARP-AS1, SSR3","Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,3:156592987
chr3:194035416-<b>?</b>,2 x 10-7,,'-,'-,5.782 unit decrease,[4.04-7.53],'-,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,Mapping not available
rs62295581-<b>?</b>,2 x 10-6,,'-,'-,6.403 unit increase,[4.1-8.7],"TTC29, LINC02360","Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,4:11843235
chr4:158617368-<b>?</b>,3 x 10-6,,'-,'-,7.46 unit increase,[4.77-10.16],'-,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,Mapping not available
rs28503910-<b>?</b>,5 x 10-6,,'-,'-,4.983 unit increase,[3.08-6.89],"TEMN3-AS1, AFAP1","Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,4:181759556
rs12171500-<b>?</b>,1 x 10-6,,'-,'-,15.92 unit increase,[11.01-20.83],ZBED3-AS1,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,5:77164309
rs12154393-<b>?</b>,3 x 10-6,,'-,'-,3.828 unit increase,[2.33-5.32],"PHF14, NPM1P11","Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,7:11171304
rs6947348-<b>?</b>,2 x 10-7,,'-,'-,4.615 unit increase,[3.05-6.18],SNX10,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,7:26344128
rs10224789-<b>?</b>,8 x 10-7,,'-,'-,5.797 unit increase,[3.76-7.84],ZNF277,"Dental caries (decayed, missing and filled teeth)",dental caries,GCST009267,7:112313387
rs74949229-<b>?</b>,4 x 10-6,,'-,'-,7.142 unit increase,[6.25-8.03],'-,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,10:9484983
rs6585998-<b>?</b>,3 x 10-6,,'-,'-,2.107 unit decrease,[1.27-2.95],GRID1,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,10:86183852
rs11020123-<b>?</b>,4 x 10-6,,'-,'-,2.269 unit decrease,[0.33-4.21],"SNRPGP16, MTNR1B",Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,11:92956112
rs79812076-<b>?</b>,2 x 10-6,,'-,'-,6.012 unit increase,[4.12-7.91],'-,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,12:102595378
rs9630337-<b>?</b>,4 x 10-6,,'-,'-,6.97 unit increase,[4.76-9.18],OR7E33P,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,13:68008838
chr13:96271864-<b>?</b>,4 x 10-6,,'-,'-,8.184 unit increase,[5.62-10.75],'-,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,Mapping not available
rs422342-<b>?</b>,2 x 10-6,,'-,'-,2.865 unit increase,[1.8-3.93],"HMGN2P47, SMAD3",Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,15:67055348
rs7174369-<b>?</b>,2 x 10-6,,'-,'-,2.586 unit increase,[1.64-3.53],LRRC28,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,15:99290117
rs9915753-<b>?</b>,5 x 10-6,,'-,'-,3.814 unit increase,[1.64-5.98],MRPL58,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,17:75015353
rs2012033-<b>?</b>,8 x 10-7,,'-,'-,2.248 unit increase,[1.42-3.08],CHST8,Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,19:33672392
rs55928325-<b>?</b>,5 x 10-6,,'-,'-,3.22 unit increase,[1.16-5.28],"NLRP5, NLRP8",Dental caries (decayed and filled deciduous teeth),dental caries,GCST009269,19:55996582
rs11240576-<b>?</b>,4 x 10-6,,'-,'-,6.548 unit increase,[3.93-9.17],PM20D1,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,1:205847795
rs74574927-<b>?</b>,2 x 10-6,,'-,'-,16.13 unit increase,[11.72-20.54],"LINC00877, THRB-AS1",Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,3:24727374
rs7630386-<b>?</b>,1 x 10-6,,'-,'-,22.38 unit increase,[16.88-27.88],RBMS3,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,3:28982746
rs552922-<b>?</b>,4 x 10-6,,'-,'-,6.1 unit increase,[3.99-8.21],"RNA5SP525, MIR4330",Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,X:151112589
rs11932181-<b>?</b>,5 x 10-6,,'-,'-,5.766 unit decrease,[2.51-9.02],"SNORA75B, LINC02493",Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,4:17277894
rs1602815-<b>?</b>,2 x 10-6,,'-,'-,7.756 unit increase,[5.11-10.4],'-,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,4:130183917
rs36162355-<b>?</b>,4 x 10-6,,'-,'-,11.62 unit increase,[7.85-15.39],Y_RNA,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,5:2246355
rs17606253-<b>?</b>,2 x 10-6,,'-,'-,12.19 unit increase,[8.41-15.97],SLC16A10,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,6:111205242
rs10815750-<b>?</b>,2 x 10-6,,'-,'-,5.522 unit increase,[3.46-7.58],'-,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,9:8087319
rs1434274-<b>?</b>,5 x 10-6,,'-,'-,6.899 unit increase,[4.34-9.46],PTPRD,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,9:8817244
rs11008779-<b>?</b>,3 x 10-6,,'-,'-,9.853 unit increase,[6.47-13.23],"RNU7-22P, RPS4XP11",Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,10:32125059
rs6585998-<b>?</b>,4 x 10-6,,'-,'-,5.642 unit decrease,[3.32-7.96],GRID1,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,10:86183852
rs6483205-<b>?</b>,1 x 10-6,,'-,'-,7.844 unit decrease,[5.11-10.58],"SNRPGP16, LINC02746",Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,11:92936742
rs61950818-<b>?</b>,3 x 10-6,,'-,'-,15.35 unit increase,[10.75-19.95],LINC00448,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,13:62642546
rs9915753-<b>?</b>,4 x 10-7,,'-,'-,12.24 unit increase,[8.51-15.97],MRPL58,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,17:75015353
rs2012033-<b>?</b>,1 x 10-6,,'-,'-,5.763 unit increase,[3.54-7.99],CHST8,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,19:33672392
rs1505809-<b>?</b>,5 x 10-6,,NR,'-,5.215 unit increase,[3.08-7.35],CPNE4,Dental caries (decayed and filled deciduous tooth surfaces),dental caries,GCST009266,3:132182548
rs10111661-<b>?</b>,2 x 10-6,"(DMFS5max,DMFS5)",NR,'-,'-,'-,'-,Dental caries,dental caries,GCST001713,8:20479062
rs399593-<b>?</b>,9 x 10-9,(DMFS2),NR,'-,'-,'-,LYZL2,Dental caries,dental caries,GCST001713,10:30623101
rs848452-<b>?</b>,2 x 10-6,(DMFS2),NR,'-,'-,'-,"DDX3ILA1, PHTF2",Dental caries,dental caries,GCST001713,7:77967495
rs10242311-<b>?</b>,6 x 10-7,(DMFS5mand),NR,'-,'-,'-,ATXN7L1,Dental caries,dental caries,GCST001713,7:105633273
rs1429138-<b>?</b>,2 x 10-7,"(DMFS2,DMFS5mand)",NR,'-,'-,'-,"PRMT5P1, MIR548G",Dental caries,dental caries,GCST001713,4:147361190
rs3896439-<b>?</b>,2 x 10-8,"(DMFS5max, DMFS5)",NR,'-,'-,'-,"AJAP1, LINC01646",Dental caries,dental caries,GCST001713,1:4608610
rs9308447-<b>?</b>,5 x 10-7,(DMFS5mand),NR,'-,'-,'-,"LINC02606, SPSB1",Dental caries,dental caries,GCST001713,1:9372331
rs10180496-<b>?</b>,1 x 10-7,"(DMFS5, DMFS5mand)",NR,'-,'-,'-,TRIB2,Dental caries,dental caries,GCST001713,2:12828774
rs1204798-<b>?</b>,2 x 10-6,(DMFS2),NR,'-,'-,'-,NT5DC1,Dental caries,dental caries,GCST001713,6:116222684
rs3788848-<b>?</b>,3 x 10-6,"(DMFS5,DMFS5max)",NR,'-,'-,'-,ELF4,Dental caries,dental caries,GCST001713,X:130065837
rs2531154-<b>?</b>,9 x 10-7,(DMFS5max),NR,'-,'-,'-,PROM1,Dental caries,dental caries,GCST001713,4:16016701
rs12602978-<b>?</b>,7 x 10-7,(DMFS5mand),NR,'-,'-,'-,RPL34P31,Dental caries,dental caries,GCST001713,17:27240054
rs2829459-<b>?</b>,3 x 10-6,(DMFS5mand),NR,'-,'-,'-,LINC01692,Dental caries,dental caries,GCST001713,21:24907037
rs357894-<b>?</b>,4 x 10-6,(DMFS5max),NR,'-,'-,'-,DYM,Dental caries,dental caries,GCST001713,18:49053600
rs2875517-<b>?</b>,3 x 10-6,(DMFS3),NR,'-,'-,'-,PCDH9,Dental caries,dental caries,GCST001713,13:67122013
rs3114018-<b>?</b>,7 x 10-8,"(DMFS5mand,DMFS5)",NR,'-,'-,'-,ABCG2,Dental caries,dental caries,GCST001713,4:88143429
rs7552806-<b>?</b>,3 x 10-6,"(DMFS5,DMFS5max)",NR,'-,'-,'-,NFASC,Dental caries,dental caries,GCST001713,1:204814890
rs735539-<b>?</b>,4 x 10-6,(DMFS2),NR,'-,'-,'-,IL17D,Dental caries,dental caries,GCST001713,13:20705895
rs931608-<b>?</b>,1 x 10-6,(DMFS5mand),NR,'-,'-,'-,ZNF98,Dental caries,dental caries,GCST001713,19:22431320
rs2441755-<b>?</b>,4 x 10-6,(DMFS5),NR,'-,'-,'-,CTNNA3,Dental caries,dental caries,GCST001713,10:66405509
rs13381277-<b>?</b>,4 x 10-6,(DMFS3),NR,'-,'-,'-,LINC00683,Dental caries,dental caries,GCST001713,18:76606653
rs1750491-<b>?</b>,2 x 10-6,(LPAR3),NR,'-,'-,'-,"SSX2IP, LPAR3",Dental caries,dental caries,GCST001713,1:84760616
rs11166135-<b>?</b>,1 x 10-6,(DMFS3),NR,'-,'-,'-,PLPPR5,Dental caries,dental caries,GCST001713,1:98883280
rs7078219-<b>?</b>,6 x 10-6,(DMFS5mand),NR,'-,'-,'-,"GOT1, LINC01475",Dental caries,dental caries,GCST001713,10:99514608
rs649057-<b>?</b>,5 x 10-6,(DMFS5),NR,'-,'-,'-,STX17-AS1,Dental caries,dental caries,GCST001713,9:99472041
rs17485138-<b>?</b>,7 x 10-6,(DMFS2),NR,'-,'-,'-,MYO16,Dental caries,dental caries,GCST001713,13:108850501
rs9810890-<b>?</b>,6 x 10-6,(DMFS2),NR,'-,'-,'-,CFAP92,Dental caries,dental caries,GCST001713,3:128933710
rs11100904-<b>?</b>,2 x 10-6,(DMFS3),NR,'-,'-,'-,"Y_RNA, LINC01095",Dental caries,dental caries,GCST001713,4:145983152
rs7552806-<b>?</b>,3 x 10-6,"(DMFS5, DMFS5max)",NR,'-,'-,'-,NFASC,Dental caries,dental caries,GCST001713,1:204814890
rs2476842-<b>?</b>,3 x 10-6,(DMFS3),NR,'-,'-,'-,EXOC2,Dental caries,dental caries,GCST001713,6:566741
rs11256676-<b>?</b>,5 x 10-6,(DMFS5mand),NR,'-,'-,'-,CELF2-DT,Dental caries,dental caries,GCST001713,10:10559897
rs2864527-<b>?</b>,4 x 10-6,(DMFS2),NR,'-,'-,'-,"TWSG1-DT, ANKRD12",Dental caries,dental caries,GCST001713,18:9288458
rs17401966-<b>A</b>,2 x 10-18,,0.72,1.64,'-,[1.49-1.82],KIF1B,Hepatocellular carcinoma,hepatocellular carcinoma,GCST000752,1:10325413
rs2596542-<b>A</b>,4 x 10-13,,0.33,1.39,'-,[1.27-1.52],"MICA, HLA-S",Hepatocellular carcinoma,hepatocellular carcinoma,GCST001041,6:31398818
rs9275572-<b>A</b>,6 x 10-9,,0.36,1.3,'-,[1.19-1.42],"HLA-DQB3, MTCO3P1",Hepatocellular carcinoma,hepatocellular carcinoma,GCST001041,6:32711222
rs12100561-<b>?</b>,4 x 10-6,,0.39,1.52,'-,[1.26-1.83],EFCAB11,Hepatocellular carcinoma,hepatocellular carcinoma,GCST000902,14:89834691
rs4678680-<b>?</b>,2 x 10-7,,0.07,2.27,'-,[1.68-3.08],'-,Hepatocellular carcinoma,hepatocellular carcinoma,GCST000902,Mapping not available
rs9267673-<b>?</b>,2 x 10-6,,0.08,1.97,'-,[1.47-2.64],C2,Hepatocellular carcinoma,hepatocellular carcinoma,GCST000902,6:31915902
"rs760077-<b>?</b>, rs4072037-<b>?</b>",2 x 10-9,,NR,1.27,'-,[NR],No mapped genes; MUC1,Gastric cancer,gastric carcinoma,GCST002992,1:155192276
rs140081212-<b>G</b>,8 x 10-10,,0.646,1.2658228,'-,[1.18-1.37],GBAP1,Gastric cancer,gastric carcinoma,GCST002992,1:155215184
rs2294008-<b>T</b>,2 x 10-7,,0.471,1.21,'-,[NR],"JRK, PSCA",Gastric cancer,gastric carcinoma,GCST002992,8:142680513
rs10036575-<b>T</b>,5 x 10-6,,0.784,1.2345679,'-,[NR],"PTGER4, TTC33",Gastric cancer,gastric carcinoma,GCST002992,5:40685693
rs4072037-<b>A</b>,7 x 10-8,,NR,1.32,'-,[1.19-1.45],MUC1,Gastric cancer,gastric carcinoma,GCST003010,1:155192276
rs4578395-<b>C</b>,2 x 10-6,,0.092,1.19,'-,[1.11-1.28],OPCML,Gastric cancer,gastric carcinoma,GCST003010,11:133242868
rs10074991-<b>G</b>,5 x 10-26,,0.483,1.25,'-,[1.2-1.3],PRKAA1,Gastric cancer,gastric carcinoma,GCST003010,5:40790449
rs2294693-<b>C</b>,7 x 10-8,,0.238,1.14,'-,[1.09-1.20],"OARD1, UNC5CL",Gastric cancer,gastric carcinoma,GCST003010,6:41037763
rs2294693-<b>C</b>,3 x 10-8,,0.238,1.18,'-,[1.12-1.26],"OARD1, UNC5CL",Non-cardia gastric cancer,gastric carcinoma,GCST003007,6:41037763
rs10074991-<b>G</b>,2 x 10-23,,0.483,1.3,'-,[1.23-1.37],PRKAA1,Non-cardia gastric cancer,gastric carcinoma,GCST003007,5:40790449
rs3850997-<b>?</b>,2 x 10-9,,0.302,1.15,'-,[1.10-1.20],NPIPB2,Gastric cancer,gastric carcinoma,GCST010462,16:11949655
rs3850997-<b>?</b>,2 x 10-8,(East Asian),NR,1.15,'-,[1.09-1.19],NPIPB2,Gastric cancer,gastric carcinoma,GCST010462,16:11949655
rs13361707-<b>?</b>,8 x 10-29,,NR,1.41,'-,[1.32-1.49],PRKAA1,Gastric cancer,gastric carcinoma,GCST001300,5:40791782
rs4072037-<b>A</b>,4 x 10-7,(Total gastric),0.84,1.33,'-,[1.19-1.49],MUC1,Esophageal cancer and gastric cancer,gastric carcinoma,GCST000777,1:155192276
rs3781264-<b>C</b>,4 x 10-9,(Total gastric),0.15,1.36,'-,[1.23-1.50],PLCE1,Esophageal cancer and gastric cancer,gastric carcinoma,GCST000777,10:94310618
rs1057941-<b>A</b>,2 x 10-33,,NR,1.3315579,'-,'-,GBAP1,Gastric cancer,gastric carcinoma,GCST006707,1:155216951
rs13361707-<b>C</b>,1 x 10-21,,NR,1.18,'-,'-,PRKAA1,Gastric cancer,gastric carcinoma,GCST006707,5:40791782
rs2294008-<b>T</b>,1 x 10-44,,NR,1.3140606,'-,'-,"JRK, PSCA",Gastric cancer,gastric carcinoma,GCST006707,8:142680513
rs7849280-<b>G</b>,3 x 10-13,,NR,1.148,'-,'-,ABO,Gastric cancer,gastric carcinoma,GCST006707,9:133251249
rs6490061-<b>C</b>,3 x 10-8,,NR,1.1049724,'-,'-,CUX2,Gastric cancer,gastric carcinoma,GCST006707,12:111335541
rs2376549-<b>C</b>,8 x 10-10,,NR,1.109,'-,'-,DEFB121,Gastric cancer,gastric carcinoma,GCST006707,20:31411284
rs7499584-<b>A</b>,2 x 10-6,,0.297,'-,0.15939355 unit increase,'-,"UNGP1, SALL1",Diabetes mellitus,diabetes mellitus,GCST005766,16:51205506
rs10497721-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,TMEFF2,Diabetes (incident),diabetes mellitus,GCST000108,2:192049636
rs10437851-<b>A</b>,3 x 10-6,,0.0597,2.356,'-,[1.641-3.381],"MIR4497, GLTP",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,12:109848624
rs141229873-<b>C</b>,5 x 10-6,,0.02766,2.841,'-,[1.811-4.457],'-,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,13:31457661
rs117760252-<b>G</b>,8 x 10-6,,0.04684,2.38,'-,[1.628-3.478],RPP40P2,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,13:59189406
rs75065922-<b>A</b>,4 x 10-7,,0.0101,4.89,'-,[2.646-9.037],'-,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,13:105158847
rs145964053-<b>A</b>,2 x 10-7,,0.02576,3.3,'-,[2.096-5.193],"PPP2R5E, GCATP1",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,14:63558017
rs563061914-<b>G</b>,7 x 10-6,,0.01014,4.456,'-,[2.322-8.551],DTWD1,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,15:49755304
rs78330668-<b>A</b>,6 x 10-6,,0.1661,1.823,'-,[1.406-2.364],"ARNT2, RNU6-380P",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,15:80603000
rs571674178-<b>A</b>,7 x 10-7,,0.01272,4.382,'-,[2.44599999999999-7.849],"EFCAB3, TBC1D3P2",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,17:62286593
rs140272419-<b>A</b>,4 x 10-6,,0.1009,2.069,'-,[1.519-2.82],"SIGLEC15, SLC14A1",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,18:45779354
rs76141775-<b>T</b>,8 x 10-6,,0.03838,2.536,'-,[1.68699999999999-3.813],MC4R,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,18:60380321
rs182325265-<b>A</b>,9 x 10-7,,0.01412,4.14,'-,[2.347-7.302],"ZNF516, LINC01893",Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,18:76260869
rs140013767-<b>G</b>,3 x 10-6,,0.02802,3.24,'-,[1.983-5.29299999999999],PTPRT,Ischemic stroke in diabetes mellitus,"Ischemic stroke, diabetes mellitus",GCST90014129,20:42663082
rs2647006-<b>C</b>,1 x 10-21,,0.62,1.79,'-,NR,"HLA-DQB1, MTCO3P1",Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST007631,6:32692805
rs74597329-<b>T</b>,6 x 10-50,,0.37,2.14,'-,NR,IFNL4,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST007631,19:39248515
rs1754257-<b>A</b>,2 x 10-7,,0.76,1.55,'-,NR,GPR158,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST007631,10:25385685
rs74597329-<b>T</b>,1 x 10-15,,0.37,2.14,'-,NR,IFNL4,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST007632,19:39248515
chr19:39739129-<b>C</b>,7 x 10-24,,0.8,2.78,'-,[2.57-2.99],'-,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST007633,Mapping not available
rs2647051-<b>C</b>,1 x 10-9,,0.64,1.79,'-,NR,"HLA-DQB1, MTCO3P1",Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST007633,6:32703120
rs74597329-<b>T</b>,3 x 10-12,,0.58,3.28,'-,NR,IFNL4,Hepatitis C (spontaneous viral clearance),"remission, hepatitis C virus infection",GCST007634,19:39248515
rs4662344-<b>T</b>,2 x 10-18,,0.177,1.23,'-,[1.17-1.29],ARHGAP15,Diverticular disease,diverticular disease,GCST008257,2:143591289
rs7609897-<b>G</b>,2 x 10-10,,0.753,1.1494253,'-,[1.1-1.2],COLQ,Diverticular disease,diverticular disease,GCST008257,3:15461174
rs67153654-<b>T</b>,1 x 10-8,,0.814,1.1494253,'-,[1.1-1.2],FAM155A,Diverticular disease,diverticular disease,GCST008257,13:107572636
rs61756577-<b>C</b>,1 x 10-6,,0.0064,1.74,'-,[1.40-2.18],HECW1,Diverticular disease,diverticular disease,GCST008257,7:43492135
rs12614-<b>T</b>,1 x 10-34,,0.92,1.89,'-,[1.69-2.08],CFB,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:31946402
rs422951-<b>G</b>,5 x 10-16,,0.81,1.27,'-,[1.20-1.35],NOTCH4,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:32220606
rs378352-<b>T</b>,1 x 10-23,,0.39,1.26,'-,[1.20-1.31],HLA-DOA,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:33007157
rs1883832-<b>T</b>,3 x 10-15,,0.37,1.19,'-,[1.14-1.25],CD40,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,20:46118343
rs3130542-<b>A</b>,9 x 10-7,,0.16,1.17,'-,[1.10-1.24],"HCG27, HLA-C",Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:31264334
rs652888-<b>G</b>,1 x 10-6,,0.24,1.14,'-,[1.08-1.19],"EHMT2-AS1, EHMT2",Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:31883457
rs2856718-<b>C</b>,7 x 10-28,,0.55,1.28,'-,[1.22-1.33],"MTCO3P1, HLA-DQB1",Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:32702478
rs7453920-<b>A</b>,1 x 10-60,,0.88,2,'-,[1.82-2.17],HLA-DQB2,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:32762235
rs3077-<b>A</b>,1 x 10-53,,0.66,1.45,'-,[1.39-1.52],HLA-DPA1,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:33065245
rs9277535-<b>A</b>,1 x 10-70,,0.58,1.52,'-,[1.45-1.59],HLA-DPB1,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:33087084
rs2853953-<b>A</b>,5 x 10-20,,0.9,1.47,'-,[1.35-1.59],"HCG27, HLA-C",Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:31267728
rs1419881-<b>G</b>,3 x 10-7,,0.55,1.12,'-,[1.08-1.18],TCF19,Chronic hepatitis B infection,chronic hepatitis B virus infection,GCST002879,6:31162816
rs113776891-<b>?</b>,1 x 10-6,,0.924,2.2222223,'-,[1.61-3.03],PTPRM,Recurrence of mild malaria attacks,"disease recurrence, malaria",GCST009514,18:7754656
rs186873296-<b>?</b>,4 x 10-11,(East African),NR,'-,'-,'-,"GYPE, FREM3",Severe malaria,malaria,GCST003145,4:143781321
rs77389579-<b>?</b>,6 x 10-6,(East African),NR,'-,'-,'-,INPP4B,Severe malaria,malaria,GCST003145,4:142617358
rs186873296-<b>?</b>,1 x 10-10,,NR,1.49,'-,[1.32-1.67],"GYPE, FREM3",Severe malaria,malaria,GCST003145,4:143781321
rs35189640-<b>T</b>,2 x 10-6,,0.017563824,1.7533,'-,'-,BTBD11,Oropharynx cancer,oropharynx cancer,GCST003859,12:107582831
rs1229984-<b>G</b>,9 x 10-9,,0.940145546,1.832173,'-,'-,ADH1B,Oropharynx cancer,oropharynx cancer,GCST003859,4:99318162
rs4284656-<b>T</b>,2 x 10-6,,0.044039014,1.7409471,'-,'-,"LINC01229, MAFTRR",Oropharynx cancer,oropharynx cancer,GCST003859,16:79768943
rs62178732-<b>G</b>,2 x 10-6,,0.916861023,1.3898541,'-,'-,"SATB2, RNU7-147P",Oropharynx cancer,oropharynx cancer,GCST003859,2:199223244
rs17358800-<b>A</b>,1 x 10-6,,0.76254589,1.2551776,'-,'-,KCNC4,Oropharynx cancer,oropharynx cancer,GCST003859,1:110235437
rs1021455-<b>C</b>,4 x 10-6,,0.811067492,1.2520347,'-,'-,BAK1P2,Oropharynx cancer,oropharynx cancer,GCST003859,11:130558363
rs111510828-<b>G</b>,2 x 10-6,,0.824176007,1.2493753,'-,'-,RNU6-1145P,Oropharynx cancer,oropharynx cancer,GCST003859,2:61645668
rs112500619-<b>C</b>,5 x 10-6,,0.797527099,1.2391574,'-,'-,TENM3,Oropharynx cancer,oropharynx cancer,GCST003859,4:182335224
rs76122614-<b>G</b>,4 x 10-6,,0.740588266,1.206127,'-,'-,ADCY2,Oropharynx cancer,oropharynx cancer,GCST003859,5:7439973
rs7870381-<b>A</b>,3 x 10-6,,0.57725999,1.1848341,'-,'-,"JAK2, HNRNPA1P41",Oropharynx cancer,oropharynx cancer,GCST003859,9:4970909
rs9644630-<b>C</b>,3 x 10-6,,0.403417289,1.1837121,'-,'-,CSGALNACT1,Oropharynx cancer,oropharynx cancer,GCST003859,8:19513087
rs6847067-<b>A</b>,1 x 10-6,,0.404213487,1.1861,'-,'-,WDFY3,Oropharynx cancer,oropharynx cancer,GCST003859,4:84811016
rs1837494-<b>G</b>,3 x 10-6,,0.631347604,1.1912,'-,'-,"ACSL3, KCNE4",Oropharynx cancer,oropharynx cancer,GCST003859,2:223036938
rs1961637-<b>T</b>,3 x 10-7,,0.601490383,1.2057,'-,'-,"ACSL3, KCNE4",Oropharynx cancer,oropharynx cancer,GCST003859,2:223040390
rs1453414-<b>C</b>,4 x 10-6,,0.200985866,1.2157,'-,'-,TRIM5,Oropharynx cancer,oropharynx cancer,GCST003859,11:5807854
rs2216824-<b>A</b>,3 x 10-6,,0.09072456,1.3186,'-,'-,"GALNT14, CAPN13",Oropharynx cancer,oropharynx cancer,GCST003859,2:30871379
rs3828805-<b>C</b>,2 x 10-12,,0.720208999,1.3699,'-,'-,HLA-DQB1,Oropharynx cancer,oropharynx cancer,GCST003859,6:32668343
rs7254232-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,C5AR1,Chronic periodontitis,periodontitis,GCST002524,19:47293543
rs10501568-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,DLG2,Chronic periodontitis,periodontitis,GCST002524,11:84536080
rs729876-<b>T</b>,1 x 10-8,,0.8,1.23,'-,[1.15-1.32],SHISA9,Periodontitis,periodontitis,GCST006486,16:13294921
rs11084095-<b>A</b>,5 x 10-8,,0.41,1.17,'-,[1.11-1.24],SIGLEC5,Periodontitis,periodontitis,GCST006486,19:51623777
rs9982623-<b>C</b>,9 x 10-7,,0.86,1.23,'-,[1.13-1.33],MCM3AP,Periodontitis,periodontitis,GCST006486,21:46271302
rs9984417-<b>T</b>,9 x 10-7,,0.61,1.16,'-,[1.09-1.23],MAPK6P2,Periodontitis,periodontitis,GCST006486,21:22474790
rs6725179-<b>A</b>,3 x 10-6,,'-,1.15,'-,[1.08-1.22],RNU6-675P,Periodontitis,periodontitis,GCST006486,2:126759652
rs9992954-<b>T</b>,9 x 10-6,,'-,1.18,'-,[1.10-1.27],"LYPLA1P2, MIR297",Periodontitis,periodontitis,GCST006486,4:110885393
rs1247559-<b>C</b>,4 x 10-6,,'-,1.19,'-,[1.10-1.28],PLG,Periodontitis,periodontitis,GCST006486,6:160782724
rs7031401-<b>G</b>,6 x 10-6,,'-,1.27,'-,[1.15-1.42],LINC01239,Periodontitis,periodontitis,GCST006486,9:22804479
rs7086701-<b>T</b>,1 x 10-6,,'-,1.15,'-,[1.09-1.21],"CELF2-DT, CUX2P1",Periodontitis,periodontitis,GCST006486,10:10298081
rs3780866-<b>G</b>,8 x 10-6,,'-,1.17,'-,[1.09-1.26],NUDT5,Periodontitis,periodontitis,GCST006486,10:12185581
rs886431-<b>G</b>,4 x 10-6,,'-,1.19,'-,[1.10-1.27],"RAPGEF3, ENDOU",Periodontitis,periodontitis,GCST006486,12:47733232
rs2833579-<b>G</b>,3 x 10-6,,'-,1.15,'-,[1.08-1.21],HUNK,Periodontitis,periodontitis,GCST006486,21:31956217
rs2687201-<b>T</b>,6 x 10-7,,0.303,1.2,'-,[1.12-1.29],"FOXP1, RNU6-281P",Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST002232,3:70879779
rs4610302-<b>G</b>,4 x 10-6,,0.59,1.1765,'-,[1.1-1.27],SPARCL1,Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST002232,4:87478958
rs2342002-<b>T</b>,9 x 10-7,,0.214,1.22,'-,[1.13-1.33],'-,Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST002232,6:61285855
rs17172185-<b>T</b>,5 x 10-6,,0.946,1.4706,'-,[1.25-1.75],HECW1,Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST002232,7:43247240
rs11789015-<b>A</b>,2 x 10-7,,0.717,1.2346,'-,[1.14-1.33],BARX1,Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST002232,9:93953746
rs6479527-<b>C</b>,2 x 10-6,,0.511,1.1765,'-,[1.1-1.27],PTPDC1,Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST002232,9:94096129
rs2178146-<b>A</b>,4 x 10-6,,0.587,1.1765,'-,[1.1-1.27],"LINC00917, FENDRR",Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST002232,16:86430089
rs10419226-<b>A</b>,8 x 10-7,,0.456,1.19,'-,[1.11-1.27],CRTC1,Esophageal adenocarcinoma,esophageal adenocarcinoma,GCST002232,19:18692362
rs2642438-<b>?</b>,6 x 10-6,,NR,1.2239902,'-,NR,MTARC1,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST90011885,1:220796686
rs738409-<b>G</b>,1 x 10-49,,NR,1.827,'-,[1.687-1.979],PNPLA3,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST90011885,22:43928847
rs10827317-<b>?</b>,5 x 10-7,,NR,1.9607843,'-,[1.52-2.56],LINC02629,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010597,10:33972178
rs58778359-<b>?</b>,6 x 10-7,,NR,1.9607843,'-,[1.49-2.5],LINC02629,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010597,10:33972351
rs386734729-<b>?</b>,3 x 10-7,,NR,1.8518518,'-,[1.47-2.38],PIP5K1B,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010597,9:68729886
rs6086536-<b>?</b>,8 x 10-7,,NR,1.5873016,'-,[1.32-1.92],PLCB1,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010597,20:8610549
rs10797551-<b>?</b>,9 x 10-7,,NR,1.5151515,'-,[1.28-1.79],"LINC01354, TARBP1",Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010597,1:234512408
chr5:130017402-<b>?</b>,8 x 10-7,,NR,2.43,'-,[1.71-3.46],'-,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010597,Mapping not available
rs78276535-<b>?</b>,9 x 10-7,,NR,3.89,'-,[2.26-6.68],LMBRD1,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010597,6:69829026
rs77249491-<b>?</b>,7 x 10-7,,NR,4,'-,[2.31-6.93],LMBRD1,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST010597,6:69829361
rs913295-<b>G</b>,3 x 10-6,,0.731735,1.368605,'-,[1.2-1.56],FAM107B,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,10:14664455
rs6936723-<b>C</b>,8 x 10-6,,0.572646,1.2917644,'-,[1.15-1.45],MIR1202,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,6:155990370
rs2980888-<b>T</b>,6 x 10-7,,0.311977,1.35507,'-,[1.20268-1.52677],TRIB1,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,8:125495066
rs72996252-<b>A</b>,9 x 10-6,,0.0973442,1.51091,'-,[1.25962-1.81233],"LINC01029, RNU6-655P",Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,18:78034265
rs56408111-<b>C</b>,5 x 10-6,,0.0839103,1.54577,'-,[1.28158-1.86442],ZNF101,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,19:19682736
rs28946269-<b>T</b>,9 x 10-6,,0.0612277,1.6264,'-,[1.31188-2.01632],"IL36B, IL36A",Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,2:113011237
rs738409-<b>G</b>,2 x 10-20,,0.23282,1.7882,'-,[1.58162-2.02176],PNPLA3,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,22:43928847
rs117542855-<b>T</b>,2 x 10-7,,0.0435052,1.9366,'-,[1.50758-2.48771],"KRTAP5-5, FAM99A",Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,11:1635713
rs113180498-<b>A</b>,4 x 10-6,,0.0308463,1.95477,'-,[1.4712-2.59728],COMMD1,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,2:62023103
rs4439433-<b>T</b>,8 x 10-6,,0.0292446,1.96192,'-,[1.4585-2.63909],MIR378C,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,10:130872184
rs45607632-<b>C</b>,5 x 10-6,,0.0275395,2.0079,'-,[1.48801-2.70945],FAM171A1,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,10:15371761
rs112845472-<b>A</b>,7 x 10-6,,0.0256278,2.01414,'-,[1.48369-2.73423],FAM171A1,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,10:15265098
rs71413689-<b>A</b>,1 x 10-6,,0.0248011,2.25717,'-,[1.62157-3.14189],"LINC01818, RND3",Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,2:150398953
rs61951392-<b>T</b>,8 x 10-6,,0.0123489,2.60856,'-,[1.71111-3.97672],'-,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,13:64417489
rs61950023-<b>G</b>,2 x 10-6,,0.0132789,2.74006,'-,[1.80165-4.16726],'-,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,13:64591706
rs61951503-<b>A</b>,5 x 10-6,,0.0122455,2.75224,'-,[1.78166-4.25155],'-,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST008468,13:64298255
rs2188761-<b>?</b> x rs738409-<b>?</b>,7 x 10-6,,NR,1.5,'-,NR,No mapped genes x PNPLA3,Nonalcoholic fatty liver disease (SNP x SNP interaction),non-alcoholic fatty liver disease,GCST008470,22:43928847
rs11206226-<b>A</b>,5 x 10-6,,0.848,1.72,'-,[1.35-2.22],YIPF1,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST001576,1:53854664
rs1390096-<b>A</b>,3 x 10-6,,0.372,1.44,'-,[1.24-1.68],"NAA15, HS3ST1",Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST001576,4:11501980
rs2143571-<b>A</b>,6 x 10-7,,0.458,1.47,'-,[1.27-1.72],SAMM50,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST001576,22:43995806
rs2073080-<b>T</b>,8 x 10-7,,0.458,1.47,'-,[1.26-1.71],SAMM50,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST001576,22:43998522
rs738409-<b>G</b>,1 x 10-10,,0.484,1.66,'-,[1.43-1.94],PNPLA3,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST001576,22:43928847
rs2687201-<b>T</b>,2 x 10-6,,0.303,1.18,'-,[1.10-1.26],"FOXP1, RNU6-281P",Barrett's esophagus,Barrett's esophagus,GCST002230,3:70879779
rs6449586-<b>A</b>,1 x 10-6,,0.553,1.1628,'-,[1.1-1.25],ISL1,Barrett's esophagus,Barrett's esophagus,GCST002230,5:51339044
rs11771429-<b>G</b>,7 x 10-6,,0.816,1.2195,'-,[1.12-1.33],'-,Barrett's esophagus,Barrett's esophagus,GCST002230,7:153574792
rs11789015-<b>A</b>,5 x 10-6,,0.717,1.1765,'-,[1.1-1.27],BARX1,Barrett's esophagus,Barrett's esophagus,GCST002230,9:93953746
rs7904985-<b>T</b>,6 x 10-6,,0.29,1.17,'-,[1.10-1.26],GRID1,Barrett's esophagus,Barrett's esophagus,GCST002230,10:86356722
rs3784262-<b>A</b>,4 x 10-7,,0.54,1.1765,'-,[1.11-1.25],ALDH1A2,Barrett's esophagus,Barrett's esophagus,GCST002230,15:57960908
rs10419226-<b>A</b>,6 x 10-8,,0.456,1.19,'-,[1.12-1.26],CRTC1,Barrett's esophagus,Barrett's esophagus,GCST002230,19:18692362
rs3745516-<b>A</b>,8 x 10-11,,0.23,1.46,'-,[NR],SPIB,Primary biliary cholangitis,biliary liver cirrhosis,GCST000733,19:50423485
rs9303277-<b>T</b>,2 x 10-9,,0.51,1.38,'-,[NR],IKZF3,Primary biliary cholangitis,biliary liver cirrhosis,GCST000733,17:39820216
rs10488631-<b>C</b>,3 x 10-10,,0.11,1.63,'-,[NR],"IRF5, TNPO3",Primary biliary cholangitis,biliary liver cirrhosis,GCST000733,7:128954129
rs3790567-<b>A</b>,8 x 10-12,,0.232,1.48,'-,[NR],IL12RB2,Primary biliary cholangitis,biliary liver cirrhosis,GCST000733,1:67356694
rs6441286-<b>G</b>,8 x 10-12,,0.394,1.44,'-,[NR],IL12A-AS1,Primary biliary cholangitis,biliary liver cirrhosis,GCST000733,3:160011091
rs7774434-<b>C</b>,3 x 10-26,,0.371,1.75,'-,[NR],"MTCO3P1, HLA-DQB1",Primary biliary cholangitis,biliary liver cirrhosis,GCST000733,6:32689801
rs6890853-<b>G</b>,4 x 10-8,,NR,1.47,'-,[1.28-1.69],"SPEF2, IL7R",Primary biliary cholangitis,biliary liver cirrhosis,GCST001685,5:35852209
rs9303277-<b>T</b>,4 x 10-9,,NR,1.44,'-,[1.28-1.63],IKZF3,Primary biliary cholangitis,biliary liver cirrhosis,GCST001685,17:39820216
rs7574865-<b>T</b>,1 x 10-6,,NR,1.35,'-,[1.19-1.52],STAT4,Primary biliary cholangitis,biliary liver cirrhosis,GCST001685,2:191099907
rs2293370-<b>C</b>,3 x 10-9,,NR,1.48,'-,[1.29-1.68],TIMMDC1,Primary biliary cholangitis,biliary liver cirrhosis,GCST001685,3:119501087
rs7665590-<b>G</b>,1 x 10-7,,NR,1.35,'-,[1.21-1.52],EIF4E,Primary biliary cholangitis,biliary liver cirrhosis,GCST001685,4:98875633
rs4979462-<b>T</b>,3 x 10-14,,0.46,1.56,'-,[1.39-1.76],TNFSF15,Primary biliary cholangitis,biliary liver cirrhosis,GCST001685,9:114804733
rs4938534-<b>A</b>,2 x 10-8,,0.44,1.39,'-,[1.24-1.56],POU2AF1,Primary biliary cholangitis,biliary liver cirrhosis,GCST001685,11:111404408
rs7243066-<b>?</b>,9 x 10-6,(Comparatively Younger),NR,'-,'-,'-,'-,Dental caries,dental caries,GCST001786,18:11282320
rs3204270-<b>?</b>,5 x 10-6,(Comparatively Older),NR,'-,'-,'-,'-,Dental caries,dental caries,GCST001786,Mapping not available
rs9793739-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,LINC02814,Dental caries,dental caries,GCST001786,1:229150111
rs4269515-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,'-,Dental caries,dental caries,GCST001786,8:106896781
rs4865673-<b>?</b>,9 x 10-6,(Comparatively Younger),NR,'-,'-,'-,'-,Dental caries,dental caries,GCST001786,5:51632976
rs4922199-<b>?</b>,8 x 10-6,(Comparatively Younger),NR,'-,'-,'-,'-,Dental caries,dental caries,GCST001786,8:20443926
rs4888966-<b>?</b>,5 x 10-6,(Comparatively Younger),NR,'-,'-,'-,'-,Dental caries,dental caries,GCST001786,16:79397956
rs7634533-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,U3,Dental caries,dental caries,GCST001786,3:30330561
rs1383934-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,ADAMTS3,Dental caries,dental caries,GCST001786,4:72551807
rs1953743-<b>?</b>,2 x 10-6,(Comparatively younger),NR,'-,'-,'-,'-,Dental caries,dental caries,GCST001786,14:54185761
rs7447927-<b>C</b>,8 x 10-20,,0.54,1.18,'-,[1.14-1.22],STING1,Esophageal squamous cell carcinoma,esophageal squamous cell carcinoma,GCST002568,5:139481561
rs1642764-<b>C</b>,3 x 10-13,,0.501,1.14,'-,[1.1-1.18],ATP1B2,Esophageal squamous cell carcinoma,esophageal squamous cell carcinoma,GCST002568,17:7654516
rs35597309-<b>A</b>,1 x 10-7,,0.072,1.19,'-,[1.12-1.27],"HLA-DQA1, HLA-DRB1",Esophageal squamous cell carcinoma,esophageal squamous cell carcinoma,GCST002568,6:32621489
rs61271866-<b>A</b>,7 x 10-7,,0.19,1.11,'-,[1.07-1.16],CDKN2B-AS1,Esophageal squamous cell carcinoma,esophageal squamous cell carcinoma,GCST002568,9:21997016
rs7822239-<b>A</b>,8 x 10-6,,0.73,1.1,'-,[1.05-1.14],HHLA1,Esophageal squamous cell carcinoma,esophageal squamous cell carcinoma,GCST002568,8:132107714
rs2274223-<b>G</b>,4 x 10-18,,0.209,1.35,'-,[1.26-1.45],PLCE1,Esophageal squamous cell carcinoma,esophageal squamous cell carcinoma,GCST002568,10:94306584
rs13016963-<b>A</b>,4 x 10-13,,0.283,1.27,'-,[1.19-1.33],FLACC1,Esophageal squamous cell carcinoma,esophageal squamous cell carcinoma,GCST002568,2:201298088
rs2014300-<b>G</b>,8 x 10-9,,0.843,1.28,'-,[1.18-1.39],RUNX1,Esophageal squamous cell carcinoma,esophageal squamous cell carcinoma,GCST002568,21:34985564
rs2239815-<b>T</b>,4 x 10-7,,0.387,1.16,'-,[1.1-1.23],XBP1,Esophageal squamous cell carcinoma,esophageal squamous cell carcinoma,GCST002568,22:28796682
rs10052657-<b>C</b>,1 x 10-6,,0.88,1.25,'-,[1.15-1.37],PDE4D,Esophageal squamous cell carcinoma,esophageal squamous cell carcinoma,GCST002568,5:59111944
rs66562280-<b>T</b>,3 x 10-8,,0.32,1.55,'-,[1.33-1.81],"MTDHP3, ZNF429",Pancreatic cancer,pancreatic carcinoma,GCST011117,19:21650212
rs2656937-<b>C</b>,1 x 10-7,,0.34,1.53,'-,[1.31-1.78],ARRDC5,Pancreatic cancer,pancreatic carcinoma,GCST011117,19:4892075
rs6736997-<b>A</b>,6 x 10-6,(recessive),0.33,1.57,'-,[1.29-1.91],LINC01173,Pancreatic cancer,pancreatic carcinoma,GCST000745,2:234706553
rs6464375-<b>A</b>,4 x 10-7,(recessive),0.1,3.73,'-,[2.24-6.21],DPP6,Pancreatic cancer,pancreatic carcinoma,GCST000745,7:153928758
rs9502893-<b>G</b>,3 x 10-7,(allelic),0.35,1.29,'-,[1.17-1.43],"FOXF2-DT, LINC01394",Pancreatic cancer,pancreatic carcinoma,GCST000745,6:1339954
rs10088262-<b>A</b>,4 x 10-6,(dominant),0.34,1.4,'-,[1.21-1.61],"ANXA13, FAM91A1",Pancreatic cancer,pancreatic carcinoma,GCST000745,8:123753462
rs12615966-<b>A</b>,7 x 10-6,(recessive),0.1,3.15,'-,[1.91-5.21],"LINC01114, HMGB3P11",Pancreatic cancer,pancreatic carcinoma,GCST000745,2:104762499
rs1886449-<b>A</b>,9 x 10-6,(recessive),0.38,1.51,'-,[1.26-1.80],MARK2P12,Pancreatic cancer,pancreatic carcinoma,GCST000745,13:73357977
rs2039553-<b>A</b>,7 x 10-6,(recessive),0.27,1.73,'-,[1.36-2.19],LINC01038,Pancreatic cancer,pancreatic carcinoma,GCST000745,13:79725587
rs4924935-<b>G</b>,8 x 10-6,(dominant),0.23,1.37,'-,[1.19-1.58],PRPSAP2,Pancreatic cancer,pancreatic carcinoma,GCST000745,17:18850557
rs7832232-<b>A</b>,5 x 10-6,(recessive),0.45,1.45,'-,[1.24-1.71],RNF5P1,Pancreatic cancer,pancreatic carcinoma,GCST000745,8:38611785
rs6879627-<b>G</b>,8 x 10-6,(allelic),0.52,1.25,'-,[1.14-1.39],Y_RNA,Pancreatic cancer,pancreatic carcinoma,GCST000745,5:2109787
rs708224-<b>A</b>,3 x 10-7,(allelic),0.66,1.32,'-,[1.19-1.47],BICD1,Pancreatic cancer,pancreatic carcinoma,GCST000745,12:32283475
rs225190-<b>G</b>,6 x 10-6,(allelic),0.36,1.26,'-,[1.14-1.39],MYO1D,Pancreatic cancer,pancreatic carcinoma,GCST000745,17:32550640
rs3016539-<b>A</b>,7 x 10-6,(dominant),0.87,1.5,'-,[1.26-1.79],PRKN,Pancreatic cancer,pancreatic carcinoma,GCST000745,6:161815043
rs6711606-<b>A</b>,4 x 10-6,(recessive),0.12,2.81,'-,[1.81-4.37],RNF149,Pancreatic cancer,pancreatic carcinoma,GCST000745,2:101305708
rs2257205-<b>A</b>,8 x 10-6,(dominant),0.33,1.38,'-,[1.20-1.59],"RNF43, TSPOAP1-AS1",Pancreatic cancer,pancreatic carcinoma,GCST000745,17:58370936
rs1427593-<b>A</b>,7 x 10-6,(dominant),0.08,1.49,'-,[1.25-1.77],THSD7B,Pancreatic cancer,pancreatic carcinoma,GCST000745,2:136797654
rs1585440-<b>C</b>,9 x 10-6,(allelic),0.71,1.3,'-,[1.16-1.45],LINC01052,Pancreatic cancer,pancreatic carcinoma,GCST000745,13:65907683
rs2205986-<b>?</b>,2 x 10-8,,'-,8.3,'-,[3.6-19.2],SYT14,Drug-induced liver injury in interferon-beta-treated multiple sclerosis,"multiple sclerosis, response to interferon beta, drug-induced liver injury",GCST006270,1:209942767
rs2523822-<b>?</b>,2 x 10-10,,NR,2.3,'-,[1.80-2.90],"HLA-G, HCP5B",Drug-induced liver injury (amoxicillin-clavulanate),drug-induced liver injury,GCST001036,6:29860883
rs9274407-<b>?</b>,5 x 10-14,,NR,3.1,'-,[2.30-4.20],HLA-DQB1,Drug-induced liver injury (amoxicillin-clavulanate),drug-induced liver injury,GCST001036,6:32665055
rs9849262-<b>T</b>,8 x 10-6,,0.01,1.4,'-,[0.81-1.99],FHIT,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,3:60951377
rs199695765-<b>T</b>,2 x 10-8,,0,6.6,'-,'-,CPA2,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,7:130269008
rs144556038-<b>T</b>,2 x 10-6,,3.00E-04,3.6,'-,'-,ZNF701,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,19:52582594
rs112141546-<b>T</b>,4 x 10-10,,3.00E-04,3.3,'-,'-,ADAMTS18,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,16:77367618
rs45461499-<b>A</b>,4 x 10-9,,0.002,4.6,'-,'-,CDC20,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,1:43363065
rs200495769-<b>T</b>,3 x 10-7,,2.00E-04,5.7,'-,'-,PDLIM5,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,4:94573377
rs141708090-<b>T</b>,6 x 10-7,,2.00E-04,3.6,'-,'-,C3orf20,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,3:14761602
19:49564629-<b>T</b>,7 x 10-7,,0,5.1,'-,'-,'-,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,Mapping not available
rs201734206-<b>T</b>,2 x 10-6,,0,4.9,'-,'-,SBSPON,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,8:73071865
rs202124287-<b>T</b>,4 x 10-6,,0,4.8,'-,'-,NEB,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,2:151677702
rs112141546-<b>T</b>,1 x 10-6,,3.00E-04,3.5,'-,'-,ADAMTS18,Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time),"asparaginase-induced acute pancreatitis, acute lymphoblastic leukemia",GCST003501,16:77367618
rs421446-<b>G</b>,3 x 10-6,,'-,1.47,'-,[1.25-1.72],"MIR219A1, HSD17B8",Susceptibility to persistent hepatitis B virus infection,"hepatitis B virus infection, Susceptibility to viral and mycobacterial infections",GCST003615,6:33207006
rs9277535-<b>A</b>,4 x 10-6,,'-,1.45,'-,[1.23-1.69],HLA-DPB1,Susceptibility to persistent hepatitis B virus infection,"hepatitis B virus infection, Susceptibility to viral and mycobacterial infections",GCST003615,6:33087084
rs7000921-<b>C</b>,3 x 10-12,,0.278,1.28,'-,[1.19-1.37],'-,Susceptibility to persistent hepatitis B virus infection,"hepatitis B virus infection, Susceptibility to viral and mycobacterial infections",GCST003615,8:20535695
rs7453920-<b>A</b>,6 x 10-6,,'-,2,'-,[1.47-2.78],HLA-DQB2,Susceptibility to persistent hepatitis B virus infection,"hepatitis B virus infection, Susceptibility to viral and mycobacterial infections",GCST003615,6:32762235
rs3077-<b>C</b>,1 x 10-9,(Clearance of HBV),0.6,1.67,'-,[1.43-2.0],HLA-DPA1,Hepatitis B (viral clearance),hepatitis B virus infection,GCST001582,6:33065245
rs9277535-<b>G</b>,2 x 10-17,(Clearance of HBV),0.57,1.52,'-,[1.37-1.67],HLA-DPB1,Hepatitis B (viral clearance),hepatitis B virus infection,GCST001582,6:33087084
rs3077-<b>C</b>,4 x 10-45,(Protective effects against CHB),0.6,1.82,'-,[1.67-1.96],HLA-DPA1,Hepatitis B (viral clearance),hepatitis B virus infection,GCST001582,6:33065245
rs9277535-<b>G</b>,2 x 10-21,(Protective effects against CHB),0.57,1.64,'-,[1.47-1.82],HLA-DPB1,Hepatitis B (viral clearance),hepatitis B virus infection,GCST001582,6:33087084
rs2834617-<b>C</b>,4 x 10-8,,0.01222155,3.7493832,'-,[2.338710768-6.010950142],"LINC00160, LINC01426",Esophageal cancer,esophageal carcinoma,GCST90013738,21:34743557
rs4646776-<b>C</b>,2 x 10-25,,0.239775697,1.6248133,'-,[1.483142071-1.780017247],ALDH2,Esophageal cancer,esophageal carcinoma,GCST90013699,12:111792215
rs1229984-<b>C</b>,3 x 10-44,,0.261191323,2.0655997,'-,[1.865488484-2.287176659],ADH1B,Esophageal cancer,esophageal carcinoma,GCST90013699,4:99318162
rs4785204-<b>T</b>,2 x 10-20,,0.26,1.24,'-,[1.18-1.29],HEATR3,Esophageal cancer (squamous cell),"squamous cell carcinoma, esophageal carcinoma",GCST001674,16:50069823
rs6503659-<b>A</b>,3 x 10-16,,0.13,1.27,'-,[1.20-1.34],"JUP, HAP1",Esophageal cancer (squamous cell),"squamous cell carcinoma, esophageal carcinoma",GCST001674,17:41741012
rs2239815-<b>T</b>,4 x 10-15,,0.37,1.18,'-,[1.13-1.23],XBP1,Esophageal cancer (squamous cell),"squamous cell carcinoma, esophageal carcinoma",GCST001674,22:28796682
rs2239612-<b>T</b>,6 x 10-14,,0.19,1.21,'-,[1.15-1.27],ST6GAL1,Esophageal cancer (squamous cell),"squamous cell carcinoma, esophageal carcinoma",GCST001674,3:187075454
rs17761864-<b>A</b>,2 x 10-11,,0.14,1.21,'-,[1.14-1.28],SMG6,Esophageal cancer (squamous cell),"squamous cell carcinoma, esophageal carcinoma",GCST001674,17:2268343
rs2847281-<b>C</b>,2 x 10-11,,0.16,1.2,'-,[1.14-1.26],PTPN2,Esophageal cancer (squamous cell),"squamous cell carcinoma, esophageal carcinoma",GCST001674,18:12821594
rs4822983-<b>T</b>,2 x 10-22,,0.2,1.27,'-,[1.21-1.34],CHEK2,Esophageal cancer (squamous cell),"squamous cell carcinoma, esophageal carcinoma",GCST001674,22:28719078
rs1050631-<b>T</b>,4 x 10-8,,0.18,1.3,'-,[1.19-1.43],SLC39A6,Esophageal squamous cell cancer (length of survival),"survival time, squamous cell carcinoma, esophageal carcinoma",GCST002010,18:36114157
rs117026326-<b>T</b>,1 x 10-53,,0.1501,2.2,'-,[1.99-2.42],GTF2I,Sjögren's syndrome,Sjogren syndrome,GCST002217,7:74711703
rs10168266-<b>T</b>,2 x 10-17,,0.3357,1.44,'-,[1.32-1.57],STAT4,Sjögren's syndrome,Sjogren syndrome,GCST002217,2:191071078
rs5029939-<b>G</b>,8 x 10-9,,0.0445,1.67,'-,[1.40-1.99],TNFAIP3,Sjögren's syndrome,Sjogren syndrome,GCST002217,6:137874586
rs9271588-<b>T</b>,9 x 10-37,,0.532,1.75,'-,[1.59-1.89],"HLA-DQA1, HLA-DRB1",Sjögren's syndrome,Sjogren syndrome,GCST002217,6:32623176
rs4282438-<b>G</b>,9 x 10-25,,0.3546,1.58,'-,[1.45-1.72],COL11A2P1,Sjögren's syndrome,Sjogren syndrome,GCST002217,6:33104395
rs2474619-<b>?</b>,2 x 10-8,,NR,1.28,'-,[1.18-1.41],BACH2,Celiac disease,celiac disease,GCST002520,6:90170316
rs2157453-<b>?</b>,8 x 10-7,,NR,1.29,'-,[1.17–1.42],AIMP1P2,Celiac disease,celiac disease,GCST002520,1:172894808
rs531930-<b>?</b>,5 x 10-7,,NR,1.3,'-,[1.17–1.44],NKAIN2,Celiac disease,celiac disease,GCST002520,6:124422361
rs4558075-<b>?</b>,2 x 10-7,,NR,1.37,'-,[1.22-1.54],"PRKCQ, LINC02649",Celiac disease,celiac disease,GCST002520,10:6359663
rs8081319-<b>?</b>,8 x 10-7,,NR,1.36,'-,[1.20–1.54],ACACA,Celiac disease,celiac disease,GCST002520,17:37374139
rs13096142-<b>?</b>,4 x 10-8,,'-,1.3,'-,[1.18-1.43],CCR3,Celiac disease,celiac disease,GCST002520,3:46240253
rs13151961-<b>?</b>,3 x 10-11,,'-,1.54,'-,[1.37-1.75],KIAA1109,Celiac disease,celiac disease,GCST002520,4:122194347
rs212402-<b>?</b>,8 x 10-9,,'-,1.31,'-,[1.20-1.44],TAGAP-AS1,Celiac disease,celiac disease,GCST002520,6:159051263
rs12734338-<b>C</b>,3 x 10-7,,'-,'-,'-,'-,PPP1R12B,Celiac disease,celiac disease,GCST002112,1:202500595
rs1032355-<b>C</b>,5 x 10-6,,'-,'-,'-,'-,MTTP,Celiac disease,celiac disease,GCST002112,4:99618739
rs2605393-<b>G</b>,6 x 10-6,,'-,'-,'-,'-,STAC,Celiac disease,celiac disease,GCST002112,3:36368109
rs13128441-<b>C</b>,8 x 10-6,,'-,'-,'-,'-,STK32B,Celiac disease,celiac disease,GCST002112,4:5160662
rs17760268-<b>C</b>,4 x 10-6,,'-,'-,'-,'-,"ANKFN1, RPL39P33",Celiac disease,celiac disease,GCST002112,17:56533930
rs10439884-<b>A</b>,2 x 10-6,,'-,'-,'-,'-,TPTE,Celiac disease,celiac disease,GCST002112,21:10540506
rs4911642-<b>C</b>,5 x 10-6,,'-,'-,'-,'-,YME1L1P1,Celiac disease,celiac disease,GCST002112,22:15473564
rs157640-<b>G</b>,5 x 10-6,,'-,'-,'-,'-,RNU4ATAC7P,Celiac disease,celiac disease,GCST002112,20:54798000
rs1958589-<b>C</b>,4 x 10-6,,'-,'-,'-,'-,EGLN3,Celiac disease,celiac disease,GCST002112,14:34375170
rs10886159-<b>C</b>,7 x 10-7,,'-,'-,'-,'-,'-,Celiac disease,celiac disease,GCST002112,10:117854099
rs195656-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,HYDIN,Celiac disease,celiac disease,GCST002112,16:71013581
rs2664156-<b>C</b>,6 x 10-6,,'-,'-,'-,'-,KLK2,Celiac disease,celiac disease,GCST002112,19:50873907
rs2068824-<b>C</b>,6 x 10-6,,'-,'-,'-,'-,NAV1,Celiac disease,celiac disease,GCST002112,1:201625537
rs74617384-<b>T</b>,3 x 10-12,,NR,1.38,'-,[1.26-1.51],LPA,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST006405,6:160576086
rs10811652-<b>C</b>,6 x 10-11,,NR,1.19,'-,[1.13-1.26],CDKN2B-AS1,Coronary artery disease in diabetes,"diabetes mellitus, coronary artery disease",GCST006405,9:22077086
rs6978712-<b>A</b>,5 x 10-7,,0.175,2.02,'-,[1.53-2.68],"GCC1, ZNF800",Medication adherence in chronic diseases,"diabetes mellitus, hypertension, medication adherence behavior",GCST002637,7:127507709
rs7690819-<b>G</b>,1 x 10-6,,0.521,1.63,'-,[1.34-2.00],'-,Medication adherence in chronic diseases,"diabetes mellitus, hypertension, medication adherence behavior",GCST002637,4:111199502
rs72678531-<b>C</b>,3 x 10-23,,'-,1.68,'-,[1.51-1.86],IL12RB2,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,1:67332762
rs1539414-<b>A</b>,4 x 10-6,,'-,1.26,'-,[1.14-1.39],DENND1B,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,1:197774376
rs3024921-<b>A</b>,5 x 10-11,,'-,1.75,'-,[1.48-2.07],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,Mapping not available
rs9877910-<b>T</b>,1 x 10-17,,'-,1.47,'-,[1.34-1.60],IL12A-AS1,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,3:160013032
rs1131265-<b>G</b>,5 x 10-9,,'-,1.42,'-,[1.26-1.60],TIMMDC1,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,3:119503609
rs700172-<b>A</b>,2 x 10-6,,'-,1.27,'-,[1.15-1.40],CAPSL,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,5:35934055
rs6920220-<b>A</b>,1 x 10-6,,'-,1.29,'-,[1.16-1.43],LINC02539,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,6:137685367
rs10488631-<b>C</b>,3 x 10-12,,'-,1.56,'-,[1.38-1.77],"IRF5, TNPO3",Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,7:128954129
rs2608029-<b>C</b>,3 x 10-6,,'-,1.23,'-,[1.13-1.34],PVT1,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,8:128157880
rs10898201-<b>A</b>,5 x 10-6,,'-,1.31,'-,[1.17-1.48],NADSYN1,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,11:71490481
rs7117261-<b>C</b>,3 x 10-10,,'-,1.46,'-,[1.30-1.64],"Y_RNA, CXCR5",Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,11:118870448
rs3862738-<b>G</b>,2 x 10-8,,'-,1.33,'-,[1.20-1.47],"LINC02341, TNFSF11",Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,13:42512771
rs911263-<b>A</b>,4 x 10-6,,'-,1.25,'-,[1.14-1.37],RAD51B,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,14:68286876
rs413024-<b>T</b>,2 x 10-8,,'-,1.31,'-,[1.19-1.44],RMI2,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,16:11260234
rs907091-<b>C</b>,4 x 10-9,,'-,1.29,'-,[1.19-1.41],IKZF3,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,17:39765489
rs715505-<b>C</b>,1 x 10-11,,'-,1.41,'-,[1.28-1.60],SYNGR1,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,22:39355246
DQB1*0402-<b>?</b>,8 x 10-36,,NR,3.93,'-,[3.17–4.87],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,Mapping not available
DRB1*0801-<b>?</b>,3 x 10-33,,NR,3.99,'-,[3.19–5.00],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,Mapping not available
DQB1*0301-<b>?</b>,2 x 10-20,,NR,1.8518518,'-,'-,'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,Mapping not available
DRB1*1101-<b>?</b>,4 x 10-14,,NR,2.0408163,'-,'-,'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,Mapping not available
DQA1*0501-<b>?</b>,7 x 10-11,,NR,1.5151515,'-,'-,'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,Mapping not available
DRB1*1501-<b>?</b>,8 x 10-9,,NR,1.6129031,'-,'-,'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,Mapping not available
DQB1*0302-<b>?</b>,3 x 10-8,,NR,1.51,'-,[1.31–1.75],'-,Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,Mapping not available
rs4973341-<b>T</b>,2 x 10-10,,'-,1.2195122,'-,[1.11-1.35],"SNRPGP8, CCL20",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,2:227795646
rs526231-<b>C</b>,1 x 10-8,,'-,1.1494253,'-,[1.08-1.23],"PDZPH1P, MACIR",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,5:103345680
rs2546890-<b>A</b>,1 x 10-10,,'-,1.1494253,'-,[1.08-1.22],IL12B,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,5:159332892
rs1859308-<b>C</b>,2 x 10-7,,'-,1.1764705,'-,[1.08-1.30],"IL21R, IL4R",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,16:27386677
rs9591325--<b>T</b>,1 x 10-10,,0.94,1.63,'-,NR,'-,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,Mapping not available
rs10488631-<b>C</b>,5 x 10-23,,0.09,1.5873016,'-,NR,"IRF5, TNPO3",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,7:128954129
rs3771317-<b>C</b>,2 x 10-14,,0.14,1.4084507,'-,NR,NAB1,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,2:190679236
rs485499-<b>T</b>,1 x 10-23,,0.6,1.4084507,'-,NR,"LINC01100, IL12A-AS1",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,3:160028076
rs2297067-<b>T</b>,6 x 10-19,,0.18,1.3888888,'-,NR,EXOC3L4,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,14:103100448
rs3745516-<b>A</b>,1 x 10-20,,0.24,1.3888888,'-,NR,SPIB,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,19:50423485
rs17641524-<b>T</b>,1 x 10-11,,0.17,1.2987013,'-,NR,DENND1B,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,1:197735587
rs2304256-<b>C</b>,1 x 10-10,,0.71,1.2658228,'-,NR,TYK2,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,19:10364976
rs2069235-<b>A</b>,2 x 10-11,,0.32,1.2658228,'-,NR,SYNGR1,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,22:39351775
rs510372-<b>C</b>,2 x 10-9,,0.57,1.2345679,'-,NR,CCDC88B,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,11:64347665
rs9303277-<b>T</b>,3 x 10-11,,0.5,1.2345679,'-,NR,IKZF3,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,17:39820216
rs1800693-<b>C</b>,2 x 10-9,,0.51,1.2195122,'-,NR,TNFRSF1A,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,12:6330843
rs11065987-<b>G</b>,3 x 10-8,,0.37,1.1904762,'-,NR,"BRAP, ATXN2-AS",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,12:111634620
rs1372072-<b>A</b>,4 x 10-8,,0.38,1.2,'-,NR,PLCL2,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,3:16913767
rs1054037-<b>T</b>,8 x 10-10,,0.52,1.22,'-,NR,MANBA,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,4:102631552
rs911263-<b>T</b>,2 x 10-9,,0.73,1.24,'-,NR,RAD51B,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,14:68286876
rs4952108-<b>C</b>,5 x 10-8,,0.81,1.28,'-,NR,"SNORA10B, H3P5",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,2:30206869
rs860413-<b>A</b>,5 x 10-11,,0.79,1.28,'-,NR,"CAPSL, UGT3A1",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,5:35942940
rs12924729-<b>G</b>,2 x 10-14,,0.67,1.31,'-,NR,CLEC16A,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,16:11093926
rs6421571-<b>C</b>,2 x 10-13,,0.8,1.39,'-,NR,"Y_RNA, CXCR5",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,11:118873063
rs2293370-<b>G</b>,4 x 10-15,,0.86,1.42,'-,NR,TIMMDC1,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,3:119501087
rs6679356-<b>C</b>,7 x 10-28,,0.21,1.52,'-,NR,IL12RB2,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,1:67354511
rs7774434-<b>C</b>,2 x 10-56,,0.47,1.68,'-,NR,"MTCO3P1, HLA-DQB1",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,6:32689801
rs6933404-<b>C</b>,1 x 10-10,,NR,1.18,'-,[1.09-1.27],"LINC02539, BTF3L4P3",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,6:137638098
rs12712133-<b>A</b>,5 x 10-9,,NR,1.14,'-,[1.07-1.21],"IL1RL2, FAM183DP",Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,2:102249813
rs11724804-<b>A</b>,9 x 10-12,,NR,1.22,'-,[1.12-1.33],DGKQ,Primary biliary cholangitis,primary biliary cirrhosis,GCST003129,4:971991
rs6734367-<b>T</b>,4 x 10-55,,0.178,1.17,'-,[1.15-1.19],ARHGAP15,Diverticular disease,diverticular disease,GCST008105,2:143556678
rs7077800-<b>C</b>,2 x 10-22,,0.524,1.0752687,'-,[1.06-1.1],GPR158,Diverticular disease,diverticular disease,GCST008105,10:25530299
rs9555371-<b>A</b>,1 x 10-13,,0.802,1.0752687,'-,[1.05-1.1],FAM155A,Diverticular disease,diverticular disease,GCST008105,13:107563056
rs9272105-<b>A</b>,5 x 10-22,,0.45,1.28,'-,[1.22-1.35],HLA-DQA1,Hepatocellular carcinoma,hepatocellular carcinoma,GCST001603,6:32632222
rs455804-<b>C</b>,5 x 10-10,,0.66,1.19,'-,[1.12-1.25],GRIK1,Hepatocellular carcinoma,hepatocellular carcinoma,GCST001603,21:29773850
"HLA_DRB1_0901-<b>?</b>, rs9272105-<b>A</b>, HLA_DRB1_0405-<b>?</b>",2 x 10-7,,NR,1.32,'-,[1.19-1.46],No mapped genes; HLA-DQA1; No mapped genes,Hepatocellular carcinoma,hepatocellular carcinoma,GCST001603,6:32632222
rs9275319-<b>A</b>,3 x 10-17,,0.88,1.49,'-,[1.36-1.63],"HLA-DQB1, MTCO3P1",Hepatocellular carcinoma in hepatitis B infection,hepatocellular carcinoma,GCST001775,6:32698518
rs7574865-<b>G</b>,2 x 10-10,,0.67,1.21,'-,[1.14-1.28],STAT4,Hepatocellular carcinoma in hepatitis B infection,hepatocellular carcinoma,GCST001775,2:191099907
rs9871671-<b>A</b>,8 x 10-6,,0.11,1.49,'-,[1.22-1.81],UROC1,Recurrence of malaria infection (mild or asymptomatic),"disease recurrence, malaria",GCST009515,3:126499368
rs6124419-<b>A</b>,4 x 10-7,,0.12,1.58,'-,[1.31-1.91],PTPRT,Recurrence of malaria infection (mild or asymptomatic),"disease recurrence, malaria",GCST009515,20:42134228
rs76088706-<b>T</b>,4 x 10-7,,0.025,2.22,'-,[1.59-3.11],"LINC02521, GMDS-DT",Recurrence of mild malaria attacks,"disease recurrence, malaria",GCST009514,6:2606805
rs142480106-<b>T</b>,5 x 10-8,,0.019,2.52,'-,[1.73-3.66],MYLK4,Recurrence of mild malaria attacks,"disease recurrence, malaria",GCST009514,6:2666821
rs182416945-<b>A</b>,8 x 10-7,,0.12,1.55,'-,[1.28-1.87],KNDC1,Recurrence of mild malaria attacks,"disease recurrence, malaria",GCST009514,10:133220763
rs62639692-<b>G</b>,6 x 10-6,,0.047,1.69,'-,[1.33-2.16],SYT16,Recurrence of mild malaria attacks,"disease recurrence, malaria",GCST009514,14:61996593
rs6124419-<b>A</b>,7 x 10-7,,0.12,1.53,'-,[1.28-1.83],PTPRT,Recurrence of mild malaria attacks,"disease recurrence, malaria",GCST009514,20:42134228
rs6755404-<b>A</b>,1 x 10-6,,NR,1.26,'-,[1.15-1.38],ZNF804A,Malaria,malaria,GCST002033,2:184932501
rs8176722-<b>A</b>,9 x 10-10,,NR,1.28,'-,[1.19-1.39],ABO,Malaria,malaria,GCST002033,9:133257367
rs12788102-<b>A</b>,2 x 10-16,,NR,2.15,'-,[1.79-2.59],"OR51F1, MMP26",Malaria,malaria,GCST002033,11:4769345
rs1469170-<b>A</b>,8 x 10-8,,NR,1.2,'-,[1.12-1.29],HNRNPA1P60,Malaria,malaria,GCST002033,11:110870290
rs12590640-<b>T</b>,4 x 10-6,,NR,1.15,'-,[1.09-1.23],"DPPA3P2, RNU7-93P",Malaria,malaria,GCST002033,14:36384931
rs9940464-<b>T</b>,5 x 10-7,,NR,1.17,'-,[1.10-1.25],CDH13,Malaria,malaria,GCST002033,16:83327170
rs372091-<b>C</b>,6 x 10-14,,0.972,2.17,'-,[NR],"HBE1, OR51B5, HBG2",Malaria,malaria,GCST001637,11:5496926
rs10900585-<b>T</b>,2 x 10-10,,0.62,1.64,'-,[NR],ATP2B4,Malaria,malaria,GCST001637,1:203684896
rs8176719-<b>G</b>,4 x 10-21,,0.37,1.48,'-,[NR],'-,Malaria,malaria,GCST001637,Mapping not available
rs2334880-<b>C</b>,2 x 10-6,,0.45,1.19,'-,[NR],"TAT-AS1, MARVELD3",Malaria,malaria,GCST001637,16:71619734
rs4072037-<b>T</b>,6 x 10-17,,0.84,1.3513513,'-,[1.27-1.45],MUC1,Non-cardia gastric cancer,gastric carcinoma,GCST003218,1:155192276
rs80142782-<b>T</b>,2 x 10-19,,0.93,1.6129031,'-,[1.45-1.79],ASH1L,Non-cardia gastric cancer,gastric carcinoma,GCST003218,1:155515236
rs7712641-<b>C</b>,1 x 10-11,,0.54,1.1904762,'-,[1.14-1.25],LINC02161,Non-cardia gastric cancer,gastric carcinoma,GCST003218,5:89607147
rs2294008-<b>T</b>,6 x 10-11,,0.26,1.2,'-,[1.15-1.28],"JRK, PSCA",Non-cardia gastric cancer,gastric carcinoma,GCST003218,8:142680513
rs1108143-<b>G</b>,3 x 10-7,,0.11,1.23,'-,[1.14-1.34],ARL4C,Non-cardia gastric cancer,gastric carcinoma,GCST003218,2:234557214
rs13361707-<b>C</b>,1 x 10-10,,0.503,1.32,'-,[0.88-1.43],PRKAA1,Non-cardia gastric cancer,gastric carcinoma,GCST003218,5:40791782
rs1364229-<b>A</b>,2 x 10-10,,NR,1.3459,'-,'-,'-,Marginal zone lymphoma or rheumatoid arthritis,"rheumatoid arthritis, marginal zone B-cell lymphoma",GCST008726,16:62594871
rs1439112-<b>?</b>,3 x 10-8,,NR,1.1698643,'-,'-,MGAT5,Marginal zone lymphoma or systemic lupus erythematosus,"marginal zone B-cell lymphoma, systemic lupus erythematosus",GCST008729,2:134305027
rs1444766-<b>G</b>,2 x 10-8,,NR,1.1692,'-,'-,KALRN,Marginal zone lymphoma or systemic lupus erythematosus,"marginal zone B-cell lymphoma, systemic lupus erythematosus",GCST008729,3:124206424
rs7382170-<b>?</b>,6 x 10-8,,NR,1.1456066,'-,'-,'-,Marginal zone lymphoma or systemic lupus erythematosus,"marginal zone B-cell lymphoma, systemic lupus erythematosus",GCST008729,6:16970739
rs2941509-<b>T</b>,2 x 10-8,,NR,1.4118,'-,'-,IKZF3,Marginal zone lymphoma or systemic lupus erythematosus,"marginal zone B-cell lymphoma, systemic lupus erythematosus",GCST008729,17:39764941
rs1323292-<b>?</b>,2 x 10-8,,NR,1.1227125,'-,'-,RGS1,Marginal zone lymphoma or multiple sclerosis,"multiple sclerosis, marginal zone B-cell lymphoma",GCST008723,1:192571891
rs1107345-<b>?</b>,3 x 10-8,,NR,1.105461,'-,'-,IL2RA,Marginal zone lymphoma or multiple sclerosis,"multiple sclerosis, marginal zone B-cell lymphoma",GCST008723,10:6045332
rs1250550-<b>?</b>,9 x 10-8,,NR,1.0931351,'-,'-,ZMIZ1,Marginal zone lymphoma or multiple sclerosis,"multiple sclerosis, marginal zone B-cell lymphoma",GCST008723,10:79300560
rs2777899-<b>?</b>,2 x 10-8,,NR,1.0932546,'-,'-,VMP1,Marginal zone lymphoma or multiple sclerosis,"multiple sclerosis, marginal zone B-cell lymphoma",GCST008723,17:59755030
rs8021741-<b>?</b>,2 x 10-8,,NR,1.0946907,'-,'-,"FLVCR2, BATF",Marginal zone lymphoma or multiple sclerosis,"multiple sclerosis, marginal zone B-cell lymphoma",GCST008723,14:75556057
rs2425752-<b>?</b>,1 x 10-7,,NR,1.0957704,'-,'-,NCOA5,Marginal zone lymphoma or multiple sclerosis,"multiple sclerosis, marginal zone B-cell lymphoma",GCST008723,20:46073481
rs6062314-<b>?</b>,2 x 10-8,,NR,1.1615751,'-,'-,ZBTB46,Marginal zone lymphoma or multiple sclerosis,"multiple sclerosis, marginal zone B-cell lymphoma",GCST008723,20:63778360
rs16947122-<b>C</b>,5 x 10-9,,NR,1.8634,'-,'-,FBXW8,Marginal zone lymphoma or rheumatoid arthritis,"rheumatoid arthritis, marginal zone B-cell lymphoma",GCST008726,12:116928726
rs9461741-<b>C</b>,4 x 10-15,,0.018,2.66,'-,[2.08-3.39],"TSBP1-AS1, BTNL2",Marginal zone lymphoma,marginal zone B-cell lymphoma,GCST002742,6:32402810
rs2922994-<b>G</b>,2 x 10-9,,0.113,1.64,'-,[1.39-1.92],"DHFRP2, RNU6-283P",Marginal zone lymphoma,marginal zone B-cell lymphoma,GCST002742,6:31368124
rs76788097-<b>G</b>,2 x 10-6,,0.062,1.53,'-,[1.28-1.82],PRKCH,Marginal zone lymphoma,marginal zone B-cell lymphoma,GCST002742,14:61262775
rs76588427-<b>A</b>,3 x 10-6,,0.017,2.05,'-,[1.52-2.76],"APOB, LINC02850",Marginal zone lymphoma,marginal zone B-cell lymphoma,GCST002742,2:20935927
rs859472-<b>G</b>,5 x 10-6,,0.417749,'-,0.455954 unit increase,[0.27-0.65],TNR,Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,1:175418543
rs12373751-<b>T</b>,1 x 10-6,,0.205628,'-,0.577478 unit increase,[0.35-0.8],ERBB4,Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,2:212072166
rs59531931-<b>G</b>,3 x 10-6,,0.116883,'-,0.740945 unit increase,[0.44-1.04],"LINC00888, KLHL6",Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,3:183482214
rs13132061-<b>C</b>,2 x 10-6,,0.212121,'-,0.548454 unit increase,[0.33-0.77],"AFAP1-AS1, SORCS2",Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,4:7742857
rs34057381-<b>T</b>,9 x 10-6,,0.329004,'-,0.458781 unit decrease,[0.26-0.66],'-,Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,5:166233635
rs497408-<b>T</b>,1 x 10-7,,0.11039,'-,0.826007 unit increase,[0.53-1.12],HNRNPA1P58,Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,6:23993395
rs6972194-<b>A</b>,9 x 10-6,,0.313853,'-,0.48495 unit increase,[0.28-0.69],'-,Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,7:125916439
rs72680117-<b>A</b>,8 x 10-6,,0.493506,'-,0.423056 unit decrease,[0.24-0.6],"RNU6-1172P, SDC2",Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,8:96432556
rs11794552-<b>T</b>,1 x 10-6,,0.192641,'-,0.617349 unit increase,[0.37-0.86],PLPP7,Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,9:131344938
rs34637163-<b>A</b>,8 x 10-6,,0.132035,'-,0.698704 unit increase,[0.4-1],ASCL1,Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,12:102997486
rs1953124-<b>C</b>,4 x 10-7,,0.255411,'-,0.557501 unit increase,[0.35-0.77],HNRNPA3P5,Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,13:65771915
rs4904585-<b>C</b>,9 x 10-6,,0.158009,'-,0.594838 unit decrease,[0.34-0.85],FOXN3,Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,14:89480165
rs2651424-<b>T</b>,8 x 10-6,,0.222944,'-,0.515867 unit increase,[0.3-0.74],"RNU6-18P, Y_RNA",Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,15:32224426
rs698718-<b>A</b>,3 x 10-11,,0.225108,'-,0.834304 unit increase,[0.6-1.07],"ZFP90, RPL35AP33",Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,16:68526282
rs6499186-<b>C</b>,7 x 10-10,,0.231602,'-,0.783774 unit increase,[0.55-1.02],"CDH3, ZFP90",Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,16:68626662
rs149074870-<b>C</b>,2 x 10-6,,0.047619,'-,1.1332 unit increase,[0.68-1.59],"CYP2A13, CYP2F1",Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,19:41100315
rs72943235-<b>A</b>,8 x 10-8,,0.012987,'-,2.37522 unit increase,[1.54-3.21],THNSL2,Liver fibrosis in non-alcoholic fatty liver disease,"non-alcoholic fatty liver disease, Hepatic fibrosis",GCST008469,2:88201127
rs569963-<b>A</b>,8 x 10-6,,0.104283,'-,0.295252 unit decrease,[0.17-0.42],"TPI1P1, RNU6-161P",Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,1:76717334
rs115634042-<b>A</b>,4 x 10-6,,0.0232126,'-,0.575996 unit decrease,[0.33-0.82],ARL2BPP6,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,5:175302814
rs149021062-<b>T</b>,3 x 10-6,,0.0143918,'-,0.736343 unit increase,[0.43-1.04],DDR1-DT,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,6:74969709
rs76468848-<b>C</b>,2 x 10-6,,0.100743,'-,0.303623 unit increase,[0.18-0.43],'-,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,6:115826807
rs11976006-<b>A</b>,1 x 10-6,,0.0176416,'-,0.688165 unit increase,[0.41-0.96],CREB5,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,7:28691895
rs2214354-<b>C</b>,9 x 10-6,,0.333333,'-,0.176894 unit decrease,[0.099-0.255],SEMA3E,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,7:83290053
rs12231559-<b>T</b>,6 x 10-6,,0.206128,'-,0.209341 unit increase,[0.12-0.3],RESF1,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,12:31964013
rs1310679-<b>G</b>,9 x 10-6,,0.503714,'-,0.172678 unit increase,[0.097-0.248],LINC02392,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,12:90375351
rs11117487-<b>A</b>,6 x 10-6,,0.157846,'-,0.234424 unit increase,[0.13-0.34],"FENDRR, LINC00917",Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,16:86387664
rs16997877-<b>C</b>,8 x 10-6,,0.247447,'-,0.188926 unit increase,[0.11-0.27],KIF16B,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,20:16552517
rs2294915-<b>T</b>,4 x 10-7,,0.341226,'-,0.196268 unit increase,[0.12-0.27],PNPLA3,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,22:43945024
rs112852859-<b>T</b>,7 x 10-6,,0.133613,'-,0.26713 unit decrease,[0.15-0.38],"BECN2, RPL23AP20",Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,1:241921127
rs62141163-<b>A</b>,2 x 10-7,,0.106145,'-,0.341415 unit increase,[0.21-0.47],"XDH, SRD5A2",Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,2:31440248
rs2138497-<b>G</b>,5 x 10-6,,0.414804,'-,0.18667 unit decrease,[0.11-0.27],AGAP1,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,2:235710411
rs78897411-<b>A</b>,7 x 10-6,,0.033054,'-,0.512307 unit increase,[0.29-0.74],SUMF1,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,3:4033670
rs4956410-<b>A</b>,8 x 10-6,,0.0744879,'-,0.34206 unit decrease,[0.19-0.49],IL15,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,4:141766642
rs75282487-<b>C</b>,2 x 10-6,,0.0470205,'-,0.458644 unit decrease,[0.27-0.65],"ST13P12, TMEM167A",Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,5:83003611
rs155960-<b>A</b>,4 x 10-6,,0.468343,'-,0.179932 unit decrease,[0.1-0.26],"PCSK1, CAST",Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,5:96463997
rs72791070-<b>T</b>,3 x 10-6,,0.08473,'-,0.347508 unit increase,[0.2-0.49],'-,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,5:133812603
rs744689-<b>T</b>,3 x 10-6,,0.235102,'-,0.215189 unit increase,[0.13-0.3],LINC01016,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,6:33884727
rs509342-<b>A</b>,9 x 10-6,,0.363128,'-,0.184519 unit increase,[0.1-0.27],PDE7B,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,6:136160253
rs10272006-<b>G</b>,6 x 10-9,,0.331937,'-,0.248191 unit increase,[0.17-0.33],SP4,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,7:21480514
rs55827704-<b>A</b>,9 x 10-6,,0.0549348,'-,0.387469 unit increase,[0.22-0.56],SLC23A4P,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,7:135291519
rs2195588-<b>G</b>,5 x 10-6,,0.113128,'-,0.293446 unit decrease,[0.17-0.42],ZMAT4,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,8:40499181
rs139271658-<b>G</b>,2 x 10-7,,0.0256052,'-,0.662866 unit decrease,[0.42-0.91],PTPRD,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,9:9797383
rs11820744-<b>T</b>,2 x 10-7,,0.227188,'-,0.254587 unit increase,[0.16-0.35],OSBPL5,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,11:3147308
rs1481412-<b>A</b>,3 x 10-6,,0.254655,'-,0.212287 unit increase,[0.12-0.3],RNU6-976P,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,14:84783214
rs525798-<b>T</b>,6 x 10-6,,0.248839,'-,0.198534 unit decrease,[0.11-0.28],"GRIK3, PADI2",Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,1:36775285
rs4657180-<b>T</b>,8 x 10-6,,0.111885,'-,0.26943 unit increase,[0.15-0.39],NOS1AP,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,1:162277948
rs17766890-<b>T</b>,5 x 10-6,,0.0594243,'-,0.358929 unit decrease,[0.21-0.51],"TSNAX-DISC1, DISC1",Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,1:231813586
rs6531223-<b>G</b>,5 x 10-6,,0.406685,'-,0.174855 unit increase,[0.1-0.25],"RNU6-961P, SDC1",Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,2:20188754
rs206833-<b>A</b>,3 x 10-7,,0.165738,'-,0.25726 unit increase,[0.16-0.36],"XDH, SRD5A2",Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,2:31485750
rs1522976-<b>A</b>,6 x 10-6,,0.0218199,'-,0.582261 unit increase,[0.33-0.83],FECHP1,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,3:34886781
rs187099436-<b>A</b>,2 x 10-6,,0.0194986,'-,0.649916 unit increase,[0.38-0.92],'-,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,3:34996590
rs4490355-<b>C</b>,9 x 10-6,,0.188487,'-,0.210668 unit decrease,[0.12-0.3],ADAMTS9-AS2,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,3:64713038
rs116262938-<b>T</b>,9 x 10-6,,0.0389972,'-,0.437098 unit decrease,[0.25-0.63],TRMT44,Alanine aminotransferase levels in non-alcoholic fatty liver disease,"serum alanine aminotransferase measurement, non-alcoholic fatty liver disease",GCST008466,4:8459094
rs738409-<b>G</b>,4 x 10-34,(GOLD),0.23,'-,0.26 unit increase,[0.22-0.30],PNPLA3,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,GCST001008,22:43928847
rs73132848-<b>?</b>,1 x 10-9,,'-,'-,1.13 unit increase,[0.78-1.48],"OXTR, CAV3",Liver fibrosis severity in HIV/hepatitis C co-infection,"HIV-1 infection, Hepatic fibrosis, hepatitis C virus infection",GCST003606,3:8764738
rs143633948-<b>?</b>,9 x 10-8,,'-,'-,1.07 unit increase,[0.68-1.46],ARG1,Liver fibrosis severity in HIV/hepatitis C co-infection,"HIV-1 infection, Hepatic fibrosis, hepatitis C virus infection",GCST003606,6:131504454
rs11790131-<b>?</b>,9 x 10-9,,'-,'-,0.6 unit increase,[0.4-0.8],"MAP1LC3BP1, SLC24A2",Liver fibrosis severity in HIV/hepatitis C co-infection,"HIV-1 infection, Hepatic fibrosis, hepatitis C virus infection",GCST003606,9:19469848
rs35897606-<b>?</b>,6 x 10-8,,'-,'-,0.8 unit increase,[0.51-1.09],KIAA1549L,Liver fibrosis severity in HIV/hepatitis C co-infection,"HIV-1 infection, Hepatic fibrosis, hepatitis C virus infection",GCST003606,11:33436311
rs79709413-<b>?</b>,8 x 10-7,,'-,'-,0.95 unit increase,[0.58-1.32],"IRX1P1, ATP12A",Liver fibrosis severity in HIV/hepatitis C co-infection,"HIV-1 infection, Hepatic fibrosis, hepatitis C virus infection",GCST003606,13:24740488
rs35467001-<b>?</b>,5 x 10-7,,'-,'-,0.87 unit increase,[0.54-1.2],SDK2,Liver fibrosis severity in HIV/hepatitis C co-infection,"HIV-1 infection, Hepatic fibrosis, hepatitis C virus infection",GCST003606,17:73383923
rs73084982-<b>?</b>,2 x 10-7,,'-,'-,0.92 unit increase,[0.57-1.27],"ATRN, C20orf194",Liver fibrosis severity in HIV/hepatitis C co-infection,"HIV-1 infection, Hepatic fibrosis, hepatitis C virus infection",GCST003606,20:3430406
rs3821977-<b>A</b>,2 x 10-6,,0.8304,'-,1.126 unit increase,[0.66-1.59],G3BP2,Response to (pegylated) interferon in HBeAg-negative hepatitis B,"response to interferon, chronic hepatitis B virus infection",GCST009172,4:75703167
rs6928374-<b>A</b>,3 x 10-6,,0.5523,'-,0.8138 unit decrease,[0.47-1.16],SLC16A10,Response to (pegylated) interferon in HBeAg-negative hepatitis B,"response to interferon, chronic hepatitis B virus infection",GCST009172,6:8204180
rs9419644-<b>G</b>,3 x 10-6,,0.08867,'-,1.302 unit increase,[0.76-1.85],LINC01164,Response to (pegylated) interferon in HBeAg-negative hepatitis B,"response to interferon, chronic hepatitis B virus infection",GCST009172,10:131720732
rs11043479-<b>G</b>,2 x 10-6,,0.3278,'-,0.8571 unit increase,[0.51-1.21],"TIMM17BP1, LINC02378",Response to (pegylated) interferon in HBeAg-negative hepatitis B,"response to interferon, chronic hepatitis B virus infection",GCST009172,12:17476022
rs371991-<b>G</b>,3 x 10-6,,0.5519,'-,0.7406 unit decrease,[0.43-1.05],PRELID2,Response to (pegylated) interferon in HBeAG-positive hepatitis B,"response to interferon, chronic hepatitis B virus infection",GCST009173,5:145833218
rs9399955-<b>T</b>,4 x 10-6,,0.08606,'-,1.422 unit increase,[0.82-2.03],RN7SKP211,Response to (pegylated) interferon in HBeAG-positive hepatitis B,"response to interferon, chronic hepatitis B virus infection",GCST009173,6:105877510
rs78900671-<b>C</b>,6 x 10-7,,0.03649,'-,1.434 unit increase,[0.87-2],COL22A1,Response to (pegylated) interferon in chronic hepatitis B,"response to interferon, chronic hepatitis B virus infection",GCST009174,8:138653967
rs61886277-<b>T</b>,1 x 10-6,,0.2252,'-,0.6342 unit increase,[0.38-0.89],PLCE1,Response to (pegylated) interferon in chronic hepatitis B,"response to interferon, chronic hepatitis B virus infection",GCST009174,10:94012060
rs2824122-<b>A</b>,3 x 10-6,,0.3259,'-,0.5717 unit decrease,[0.33-0.81],'-,Response to (pegylated) interferon in chronic hepatitis B,"response to interferon, chronic hepatitis B virus infection",GCST009174,21:16913154
rs6856616-<b>G</b>,5 x 10-10,,0.23,'-,'-,'-,LINC02513,Inflammatory bowel disease,inflammatory bowel disease,GCST003602,4:38323415
rs1819333-<b>C</b>,1 x 10-6,,0.39,'-,'-,'-,"MIR3939, RNASET2",Inflammatory bowel disease,inflammatory bowel disease,GCST003602,6:166960059
rs3766920-<b>A</b>,2 x 10-9,,0.08,1.35,'-,[1.22 -1.49],"PYGO2, SHC1",Inflammatory bowel disease,inflammatory bowel disease,GCST003602,1:154962487
rs16953946-<b>C</b>,2 x 10-8,,0.17,1.23,'-,[1.14-1.32],CDYL2,Inflammatory bowel disease,inflammatory bowel disease,GCST003602,16:80751551
rs4821558-<b>C</b>,8 x 10-7,,0.34,1.16,'-,[NR],"NCF4, CSF2RB",Inflammatory bowel disease,inflammatory bowel disease,GCST003602,22:36912743
rs11788518-<b>T</b>,7 x 10-6,,0.03,1.39,'-,[NR],PCSK5,Inflammatory bowel disease,inflammatory bowel disease,GCST003602,9:76302462
rs3731257-<b>G</b>,5 x 10-8,,0.46,1.17,'-,[NR],"MTAP, CDKN2A-DT",Inflammatory bowel disease,inflammatory bowel disease,GCST003602,9:21966222
rs1321366-<b>A</b>,5 x 10-6,,0.35,1.15,'-,[NR],RFX6,Inflammatory bowel disease,inflammatory bowel disease,GCST003602,6:116919430
rs1816854-<b>T</b>,6 x 10-6,,0.94,1.38,'-,[NR],"TWF1, TMEM117",Inflammatory bowel disease,inflammatory bowel disease,GCST003602,12:43811215
rs7973572-<b>C</b>,3 x 10-6,,0.07,1.29,'-,[NR],SOX5,Inflammatory bowel disease,inflammatory bowel disease,GCST003602,12:24136432
rs6740462-<b>C</b>,2 x 10-6,,0.15,'-,'-,'-,"DNAJB12P1, SPRED2",Inflammatory bowel disease,inflammatory bowel disease,GCST003602,2:65440138
rs13300483-<b>A</b>,2 x 10-27,,0.34,'-,'-,'-,DELEC1,Inflammatory bowel disease,inflammatory bowel disease,GCST003602,9:114881082
rs12942547-<b>G</b>,2 x 10-9,,0.33,'-,'-,'-,STAT3,Inflammatory bowel disease,inflammatory bowel disease,GCST003602,17:42375526
rs6677524-<b>T</b>,3 x 10-6,,0.88,1.25,'-,[NR],'-,Inflammatory bowel disease,inflammatory bowel disease,GCST003602,1:208362429
rs3798544-<b>A</b>,1 x 10-7,,0.2,1.2,'-,[NR],SPDEF,Inflammatory bowel disease,inflammatory bowel disease,GCST003602,6:34552490
rs10737482-<b>T</b>,3 x 10-16,,0.39,0.86,'-,[NR],"RNF186, OTUD3",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,1:19847365
rs12568930-<b>T</b>,3 x 10-8,,0.82,1.14,'-,[NR],"PPIAP34, ZBTB40",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,1:22375738
rs11581607-<b>G</b>,2 x 10-24,,0.93,1.51,'-,[NR],IL23R,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,1:67242007
rs1521186-<b>G</b>,8 x 10-9,,0.55,0.91,'-,[NR],RORC,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,1:151812071
rs6671847-<b>G</b>,2 x 10-12,,0.49,1.13,'-,[NR],FCGR2A,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,1:161509020
rs905634-<b>C</b>,8 x 10-13,,0.69,1.14,'-,[NR],"INAVA, MROH3P",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,1:200915857
rs3024505-<b>G</b>,9 x 10-15,,0.85,0.84,'-,[NR],"IL10, Y_RNA",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,1:206766559
rs10188217-<b>T</b>,4 x 10-8,,0.48,0.91,'-,[NR],PUS10,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,2:60990407
rs13384671-<b>A</b>,9 x 10-9,,0.69,0.9,'-,[NR],"ITGA4, LINC01934",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,2:181446867
chr5:17098189-<b>AT</b>,1 x 10-8,,0.78,1.13,'-,[NR],'-,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,Mapping not available
rs4551125-<b>G</b>,8 x 10-10,,0.39,0.9,'-,[NR],TTC33,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,5:40438582
rs55722650-<b>C</b>,5 x 10-9,,0.58,0.9,'-,[NR],"PDLIM4, P4HA2",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,5:132271607
rs148844907-<b>T</b>,1 x 10-40,,0.99,0.47,'-,[NR],"C6orf47-AS1, C6orf47",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,6:31660620
rs17264332-<b>A</b>,3 x 10-9,,0.78,0.89,'-,[NR],"SLC17A1, LINC02539",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,6:137684378
rs6961243-<b>G</b>,5 x 10-9,,0.59,1.11,'-,[NR],"DLD, PIGCP2",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,7:107880959
rs142738614-<b>C</b>,3 x 10-8,,0.55,0.91,'-,[NR],IRF5,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,7:128937861
chr9:5057580-<b>CTTT</b>,5 x 10-10,,0.56,0.9,'-,[NR],'-,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,Mapping not available
rs10761659-<b>A</b>,1 x 10-11,,0.46,0.89,'-,[NR],ALDH7A1P4,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,10:62685804
rs73370726-<b>C</b>,2 x 10-8,,0.9,1.19,'-,[NR],MIR4679-2,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,10:89093116
rs11403745-<b>C</b>,2 x 10-11,,0.48,1.12,'-,[NR],"GOT1, LINC01475",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,10:99522848
rs7936312-<b>G</b>,7 x 10-11,,0.52,0.9,'-,[NR],"LINC02757, EMSY",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,11:76582682
rs35788599-<b>G</b>,3 x 10-11,,0.62,0.89,'-,[NR],IFNG-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,12:68082969
rs2066847-<b>G</b>,2 x 10-9,,0.98,0.71,'-,[NR],"CYLD-AS1, NOD2",Inflammatory bowel disease,inflammatory bowel disease,GCST011501,16:50729868
rs12720356-<b>A</b>,2 x 10-8,,0.9,0.86,'-,[NR],TYK2,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,19:10359299
rs6017342-<b>A</b>,2 x 10-14,,0.48,0.88,'-,[NR],LINC01620,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,20:44436388
rs1297261-<b>T</b>,2 x 10-12,,0.57,1.13,'-,[NR],CYCSP42,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,21:15440304
rs2836878-<b>G</b>,2 x 10-21,,0.73,1.21,'-,[NR],RPL23AP12,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,21:39093608
rs59998884-<b>T</b>,1 x 10-9,,0.4,1.11,'-,[NR],GATD3A,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,21:44198231
rs1521186-<b>G</b>,8 x 10-9,,0.55,0.91,'-,NR,RORC,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,1:151812071
chr5:17098189-<b>AT</b>,1 x 10-8,,0.78,1.13,'-,NR,'-,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,Mapping not available
rs73370726-<b>C</b>,2 x 10-8,,0.9,1.19,'-,NR,MIR4679-2,Inflammatory bowel disease,inflammatory bowel disease,GCST011501,10:89093116
rs11031093-<b>?</b>,8 x 10-6,,NR,1.36,'-,[-0.73720-3.45720],MPPED2,Dental caries,dental caries,GCST001244,11:30445953
rs545610-<b>?</b>,9 x 10-6,,NR,1.34,'-,[-0.75720-3.43720],MPPED2,Dental caries,dental caries,GCST001244,11:30486561
rs2302189-<b>?</b>,8 x 10-6,,NR,1.33,'-,[-0.76720-3.42720],MTMR4,Dental caries,dental caries,GCST001244,17:58506844
rs1865075-<b>?</b>,6 x 10-6,(Comparatively Younger),NR,'-,'-,'-,"ZNF98, RPL34P34",Dental caries,dental caries,GCST001786,19:22372052
rs2832191-<b>?</b>,5 x 10-6,(Comparatively Younger),NR,'-,'-,'-,MAP3K7CL,Dental caries,dental caries,GCST001786,21:29116979
rs1383934-<b>?</b>,2 x 10-6,(Comparatively Older),NR,'-,'-,'-,ADAMTS3,Dental caries,dental caries,GCST001786,4:72551807
rs10905651-<b>?</b>,8 x 10-6,(Comparatively Older),NR,'-,'-,'-,LINC02670,Dental caries,dental caries,GCST001786,10:10031581
rs2888830-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,"FZD1, NIPA2P1",Dental caries,dental caries,GCST001786,7:91286039
rs1571500-<b>?</b>,2 x 10-6,(Comparatively Younger),NR,'-,'-,'-,PLPPR5,Dental caries,dental caries,GCST001786,1:98920737
rs4438497-<b>?</b>,7 x 10-6,(Comparatively Younger),NR,'-,'-,'-,"SCN9A, SCN1A-AS1",Dental caries,dental caries,GCST001786,2:166320849
rs775227-<b>?</b>,2 x 10-6,(Comparatively Younger),NR,'-,'-,'-,BOC,Dental caries,dental caries,GCST001786,3:113276227
rs13092825-<b>?</b>,2 x 10-6,(Comparatively Younger),NR,'-,'-,'-,SIDT1,Dental caries,dental caries,GCST001786,3:113571621
rs4466078-<b>?</b>,8 x 10-6,(Comparatively Younger),NR,'-,'-,'-,APBB2,Dental caries,dental caries,GCST001786,4:40971510
rs9402592-<b>?</b>,3 x 10-6,(Comparatively Younger),NR,'-,'-,'-,LINC01010,Dental caries,dental caries,GCST001786,6:134398929
rs635808-<b>?</b>,1 x 10-7,(Comparatively Younger),NR,'-,'-,'-,RPS6KA2,Dental caries,dental caries,GCST001786,6:166763934
rs6973392-<b>?</b>,7 x 10-6,(Comparatively Younger),NR,'-,'-,'-,ZNF804B,Dental caries,dental caries,GCST001786,7:89431419
rs17057381-<b>?</b>,4 x 10-7,(Comparatively Younger),NR,'-,'-,'-,"GULOP, EPHX2",Dental caries,dental caries,GCST001786,8:27559284
rs2046315-<b>?</b>,3 x 10-6,(Comparatively Younger),NR,'-,'-,'-,RPSAP74,Dental caries,dental caries,GCST001786,8:89198871
rs4251631-<b>?</b>,2 x 10-7,(Comparatively Younger),NR,'-,'-,'-,CDKN3,Dental caries,dental caries,GCST001786,14:54409466
rs9961915-<b>?</b>,5 x 10-6,(Comparatively Younger),NR,'-,'-,'-,"AQP4-AS1, CHST9",Dental caries,dental caries,GCST001786,18:27107360
rs10404998-<b>?</b>,3 x 10-6,(Comparatively Younger),NR,'-,'-,'-,ZNF98,Dental caries,dental caries,GCST001786,19:22425572
rs6011002-<b>?</b>,3 x 10-6,(Comparatively Younger),NR,'-,'-,'-,"RTEL1-TNFRSF6B, RTEL1",Dental caries,dental caries,GCST001786,20:63666449
rs9793739-<b>?</b>,5 x 10-7,(Comparatively Older),NR,'-,'-,'-,LINC02814,Dental caries,dental caries,GCST001786,1:229150111
rs2108258-<b>?</b>,2 x 10-6,(Comparatively Older),NR,'-,'-,'-,ABCB5,Dental caries,dental caries,GCST001786,7:20752375
rs2888830-<b>?</b>,7 x 10-6,(Comparatively Older),NR,'-,'-,'-,"FZD1, NIPA2P1",Dental caries,dental caries,GCST001786,7:91286039
rs1163656-<b>?</b>,9 x 10-6,(Comparatively Older),NR,'-,'-,'-,ACSS3,Dental caries,dental caries,GCST001786,12:80943679
rs4251631-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,CDKN3,Dental caries,dental caries,GCST001786,14:54409466
rs77962525-<b>T</b>,3 x 10-7,,NR,10.66098,'-,NR,ABLIM2,Pancreatic cancer,pancreatic carcinoma,GCST90011815,4:8106216
rs76974703-<b>A</b>,2 x 10-8,,NR,4.697041,'-,NR,"C20orf85, ANKRD60",Pancreatic cancer,pancreatic carcinoma,GCST90011815,20:58203411
rs192904742-<b>A</b>,9 x 10-7,,NR,4.1220117,'-,NR,"MIR7515HG, LINC01824",Pancreatic cancer,pancreatic carcinoma,GCST90011815,2:6581986
rs71411601-<b>C</b>,2 x 10-7,,0.011795,2.7862916,'-,NR,MIR4431,Pancreatic cancer,pancreatic carcinoma,GCST90011815,2:52785787
rs145695688-<b>T</b>,6 x 10-7,,0.011151,2.7107618,'-,NR,POLA2,Pancreatic cancer,pancreatic carcinoma,GCST90011815,11:65271879
rs148512905-<b>C</b>,1 x 10-7,,0.010386,2.6845636,'-,NR,"RNU6-138P, SATB1-AS1",Pancreatic cancer,pancreatic carcinoma,GCST90011815,3:18943255
rs144239147-<b>A</b>,5 x 10-7,,0.020768,2.293052,'-,NR,ITGA3,Pancreatic cancer,pancreatic carcinoma,GCST90011815,17:50077304
rs28884829-<b>A</b>,6 x 10-7,,0.018539,2.290426,'-,NR,"PPP1R10P1, LINC02873",Pancreatic cancer,pancreatic carcinoma,GCST90011815,11:130754476
rs138585571-<b>T</b>,3 x 10-7,,0.038192,1.8076645,'-,NR,OR5K1,Pancreatic cancer,pancreatic carcinoma,GCST90011815,3:98469736
chr13:73918729-<b>AG</b>,3 x 10-7,,NR,1.3299,'-,NR,'-,Pancreatic cancer,pancreatic carcinoma,GCST90011815,Mapping not available
rs2735948-<b>A</b>,2 x 10-8,,NR,1.4475,'-,NR,"MIR4457, TERT",Pancreatic cancer,pancreatic carcinoma,GCST90011815,5:1299098
chr14:104000802-<b>AG</b>,3 x 10-8,,NR,1.4989,'-,NR,'-,Pancreatic cancer,pancreatic carcinoma,GCST90011815,Mapping not available
rs763780-<b>G</b>,3 x 10-8,,NR,3.3,'-,[2.10-5.10],IL17F,Response to gemcitabine in pancreatic cancer,"response to gemcitabine, pancreatic carcinoma",GCST001346,6:52236941
rs2900174-<b>G</b>,1 x 10-6,,NR,3.3,'-,[2.00-5.50],"PRB1, PRB2",Response to gemcitabine in pancreatic cancer,"response to gemcitabine, pancreatic carcinoma",GCST001346,12:11394598
rs11062040-<b>A</b>,8 x 10-6,,NR,1.4,'-,[1.20-1.70],"CACNA1C, DCP1B",Response to gemcitabine in pancreatic cancer,"response to gemcitabine, pancreatic carcinoma",GCST001346,12:1982091
rs1901440-<b>C</b>,3 x 10-6,(Recessive),0.2,34,'-,[4.29-269.48],RN7SKP93,Response to gemcitabine in pancreatic cancer,"response to gemcitabine, pancreatic carcinoma",GCST001390,2:133680388
rs11141915-<b>T</b>,1 x 10-6,(Allelic),0.62,4.1,'-,[2.21-7.62],DAPK1,Response to gemcitabine in pancreatic cancer,"response to gemcitabine, pancreatic carcinoma",GCST001390,9:87620879
rs2359952-<b>A</b>,4 x 10-7,,0.6,1.31,'-,[1.13-1.51],PTPRC,Ulcerative colitis,ulcerative colitis,GCST002453,1:198687278
rs6811556-<b>A</b>,9 x 10-6,(Analysis II),NR,'-,'-,'-,'-,Ulcerative colitis,ulcerative colitis,GCST000853,Mapping not available
rs4571457-<b>G</b>,7 x 10-6,(Analysis II),NR,'-,'-,'-,'-,Ulcerative colitis,ulcerative colitis,GCST000853,5:108498546
rs11764116-<b>A</b>,2 x 10-6,(Analysis II),NR,'-,'-,'-,HDAC9,Ulcerative colitis,ulcerative colitis,GCST000853,7:18760790
rs929351-<b>C</b>,8 x 10-6,(Analysis II),NR,'-,'-,'-,CACNA2D1,Ulcerative colitis,ulcerative colitis,GCST000853,7:82228577
rs7319358-<b>A</b>,3 x 10-6,(Analysis II),NR,'-,'-,'-,CCT5P2,Ulcerative colitis,ulcerative colitis,GCST000853,13:78976799
rs6059101-<b>A</b>,4 x 10-6,(Analysis II),NR,'-,'-,'-,"BPIFB4, BPIFA2",Ulcerative colitis,ulcerative colitis,GCST000853,20:33130847
rs1956388-<b>A</b>,2 x 10-6,(Analysis II),NR,'-,'-,'-,"LINC02300, BTF3P2",Ulcerative colitis,ulcerative colitis,GCST000853,14:28663671
rs17207986-<b>G</b>,1 x 10-16,(Analysis III),NR,3.95,'-,[NR],TNXB,Ulcerative colitis,ulcerative colitis,GCST000853,6:32111790
rs11554257-<b>G</b>,1 x 10-6,(Analysis III),NR,1.82,'-,[NR],"TNFSF15, DELEC1",Ulcerative colitis,ulcerative colitis,GCST000853,9:114842790
rs199650082-<b>T</b>,2 x 10-6,,0.03,18.2,'-,[7.1-46.9],ERN1,Liver injury in anti-retroviral drug treated HIV,"response to efavirenz, HIV infection, drug-induced liver injury",GCST004261,17:64044166
rs4842407-<b>C</b>,3 x 10-7,,0.44,5.4,'-,[2.8-10.3],SYT1,Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis,"response to rifampicin, Tuberculosis, response to efavirenz, HIV infection, drug-induced liver injury",GCST004262,12:78807293
rs11012476-<b>A</b>,1 x 10-6,,0.03,14.3,'-,[5.3-39.9],NEBL,Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis,"response to rifampicin, Tuberculosis, response to efavirenz, HIV infection, drug-induced liver injury",GCST004262,10:21003994
rs251891-<b>A</b>,4 x 10-6,,0.11,5.2,'-,[2.9-9.5],"TMED7, H3P24",Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis,"response to rifampicin, Tuberculosis, response to efavirenz, HIV infection, drug-induced liver injury",GCST004262,5:115714665
A*33:01-B*14:02-C*08:02-<b>?</b>,1 x 10-10,,0.009,49.2,'-,'-,'-,Drug-induced liver injury (terbinafine),"drug-induced liver injury, response to terbinafine",GCST004078,Mapping not available
rs28521457-<b>?</b>,5 x 10-9,,0.04,2.1,'-,1.6-2.7,LRBA,Drug-induced hepatocellular liver injury,drug-induced liver injury,GCST004079,4:150759175
rs116561224-<b>?</b>,7 x 10-9,,0.09,5.4,'-,3.0-9.5,RNU6-1037P,Drug-induced liver injury (statins),"response to statin, drug-induced liver injury",GCST004080,18:66962261
rs72631567-<b>?</b>,1 x 10-6,,0.03,2.4,'-,1.7-3.4,'-,Drug-induced cholestatic/mixed liver injury,drug-induced liver injury,GCST004081,2:5092045
A*33:01-<b>?</b>,4 x 10-13,,0.01,5,'-,3.3-7.9,'-,Drug-induced cholestatic/mixed liver injury,drug-induced liver injury,GCST004081,Mapping not available
A*33:01-B*14:02-C*08:02-<b>?</b>,4 x 10-13,,0.009,5.7,'-,'-,'-,Drug-induced cholestatic/mixed liver injury,drug-induced liver injury,GCST004081,Mapping not available
rs72696020-<b>?</b>,6 x 10-8,,'-,7.8,'-,3.52-14.66,"KCNK10, LINC01146",Drug-induced liver injury (nitrofurantoin),"response to nitrofurantoin, drug-induced liver injury",GCST004082,14:88105563
rs6694270-<b>?</b>,2 x 10-7,,'-,2.59,'-,1.81-3.71,"TAS1R2, PAX7",Drug-induced liver injury (nitrofurantoin),"response to nitrofurantoin, drug-induced liver injury",GCST004082,1:18793883
rs10404821-<b>?</b>,2 x 10-7,,'-,2.56,'-,1.80-3.65,C19orf81,Drug-induced liver injury (nitrofurantoin),"response to nitrofurantoin, drug-induced liver injury",GCST004082,19:50657831
rs61858823-<b>?</b>,5 x 10-7,,'-,5.63,'-,2.88-11.02,"MYL6P3, NEK4P3",Drug-induced liver injury (nitrofurantoin),"response to nitrofurantoin, drug-induced liver injury",GCST004082,10:65095495
rs114811931-<b>?</b>,3 x 10-9,,NR,6.59,'-,3.54-12.28,GABRB2,Drug-induced liver injury (diclofenac),"response to diclofenac, drug-induced liver injury",GCST004083,5:161257724
rs113206698-<b>?</b>,6 x 10-7,,NR,3.79,'-,2.25-6.39,EXOC6,Drug-induced liver injury (diclofenac),"response to diclofenac, drug-induced liver injury",GCST004083,10:92818147
rs115266745-<b>?</b>,7 x 10-7,,'-,6.8,'-,3.19-14.48,LINC01266,Drug-induced liver injury (diclofenac),"response to diclofenac, drug-induced liver injury",GCST004083,3:779530
rs149014830-<b>?</b>,7 x 10-7,,NR,6.04,'-,2.96-12.3,RPL23AP44,Drug-induced liver injury (diclofenac),"response to diclofenac, drug-induced liver injury",GCST004083,5:121540642
rs117491755-<b>?</b>,1 x 10-7,,'-,3.92,'-,2.35-6.51,ASTN2,Drug-induced liver injury (anti-tuberculosis drugs),"response to anti-tuberculosis drug, drug-induced liver injury",GCST004084,9:116881377
rs143575776-<b>?</b>,2 x 10-7,,'-,4.96,'-,2.70-9.09,PTPRD,Drug-induced liver injury (anti-tuberculosis drugs),"response to anti-tuberculosis drug, drug-induced liver injury",GCST004084,9:9593742
rs73122578-<b>?</b>,5 x 10-7,,NR,2.42,'-,1.71-3.40,ROBO1,Drug-induced liver injury (anti-tuberculosis drugs),"response to anti-tuberculosis drug, drug-induced liver injury",GCST004084,3:79310483
rs186920977-<b>?</b>,1 x 10-7,,'-,7.22,'-,3.47-15.01,CCDC85A,Drug-induced liver injury (fluoroquinolones),"response to fluoroquinolones, drug-induced liver injury",GCST004085,2:56422795
rs191153876-<b>?</b>,2 x 10-7,,'-,7.33,'-,3.46-15.5,CCDC14,Drug-induced liver injury (fluoroquinolones),"response to fluoroquinolones, drug-induced liver injury",GCST004085,3:123918335
rs116606120-<b>?</b>,3 x 10-7,,'-,8.6,'-,3.79-19.5,RNU6-909P,Drug-induced liver injury (fluoroquinolones),"response to fluoroquinolones, drug-induced liver injury",GCST004085,5:28665845
rs112655218-<b>?</b>,3 x 10-7,,'-,4.54,'-,'-,RAB31,Drug-induced liver injury (fluoroquinolones),"response to fluoroquinolones, drug-induced liver injury",GCST004085,18:9841518
rs2240395-<b>?</b>,3 x 10-7,,'-,1.84,'-,1.45-2.31,TBXAS1,Drug-induced liver injury (nonsteroidal anti-inflammatory drugs),"response to non-steroidal anti-inflammatory, drug-induced liver injury",GCST004087,7:140018347
rs185305928-<b>?</b>,3 x 10-7,,'-,4.55,'-,2.55-8.11,CAMTA1,Drug-induced liver injury (nonsteroidal anti-inflammatory drugs),"response to non-steroidal anti-inflammatory, drug-induced liver injury",GCST004087,1:6845651
rs597480-<b>?</b>,4 x 10-7,,'-,1.84,'-,1.45-2.32,SYTL2,Drug-induced liver injury (nonsteroidal anti-inflammatory drugs),"response to non-steroidal anti-inflammatory, drug-induced liver injury",GCST004087,11:85725825
rs2025009-<b>?</b>,7 x 10-7,,'-,1.81,'-,1.43-2.29,RAD51B,Drug-induced liver injury (nonsteroidal anti-inflammatory drugs),"response to non-steroidal anti-inflammatory, drug-induced liver injury",GCST004087,14:68376888
rs72631567-<b>?</b>,1 x 10-8,,0.03,2,'-,1.6-2.5,'-,Drug-induced liver injury,drug-induced liver injury,GCST004086,2:5092045
rs114577328-<b>?</b>,2 x 10-8,,0.01,2.7,'-,1.9-3.8,"HLA-W, MICD",Drug-induced liver injury,drug-induced liver injury,GCST004086,6:29959505
A3*33:01-<b>?</b>,8 x 10-8,,0.01,2.6,'-,1.8-3.7,'-,Drug-induced liver injury,drug-induced liver injury,GCST004086,Mapping not available
A*33:01-B*14:02-C*08:02-<b>?</b>,2 x 10-7,,0.009,2.7,'-,'-,'-,Drug-induced liver injury,drug-induced liver injury,GCST004086,Mapping not available
rs77778931-<b>?</b>,2 x 10-8,,NR,'-,0.1616 unit increase,'-,ELMO1,Celiac disease,celiac disease,GCST008489,7:37365375
rs859715-<b>?</b>,3 x 10-8,,NR,'-,0.1073 unit decrease,'-,"AIMP1P2, SLC25A38P1",Celiac disease,celiac disease,GCST008489,1:172790982
rs59655222-<b>?</b>,3 x 10-8,,NR,'-,0.1137 unit increase,'-,INAVA,Celiac disease,celiac disease,GCST008489,1:200906769
rs1250557-<b>?</b>,1 x 10-8,,NR,'-,0.1073 unit decrease,'-,ZMIZ1,Celiac disease,celiac disease,GCST008489,10:79306017
rs45565037-<b>?</b>,2 x 10-8,,NR,'-,0.124 unit decrease,'-,PHLDB1,Celiac disease,celiac disease,GCST008489,11:118625403
rs4128561-<b>?</b>,1 x 10-8,,NR,'-,0.1053 unit increase,'-,ETS1,Celiac disease,celiac disease,GCST008489,11:128545234
rs971290-<b>?</b>,3 x 10-8,,NR,'-,0.1216 unit increase,'-,"MAGOH3P, ZFP36L1",Celiac disease,celiac disease,GCST008489,14:68805252
rs1468788-<b>?</b>,3 x 10-8,,NR,'-,0.101 unit decrease,'-,SLC9A4,Celiac disease,celiac disease,GCST008489,2:102476054
rs13401064-<b>?</b>,3 x 10-8,,NR,'-,0.1844 unit increase,'-,STAT4,Celiac disease,celiac disease,GCST008489,2:191105604
rs45620941-<b>?</b>,4 x 10-8,,NR,'-,0.1284 unit increase,'-,CD28,Celiac disease,celiac disease,GCST008489,2:203735734
rs62184863-<b>?</b>,2 x 10-8,,NR,'-,0.204 unit increase,'-,"CTLA4, RNU6-474P",Celiac disease,celiac disease,GCST008489,2:203819074
rs231804-<b>?</b>,2 x 10-8,,NR,'-,0.1035 unit increase,'-,"RNU6-474P, CTLA4",Celiac disease,celiac disease,GCST008489,2:203843923
rs6726160-<b>?</b>,2 x 10-8,,NR,'-,0.1045 unit decrease,'-,NONOP2,Celiac disease,celiac disease,GCST008489,2:60937594
rs6032606-<b>?</b>,5 x 10-8,,NR,'-,0.2274 unit decrease,'-,ZNF335,Celiac disease,celiac disease,GCST008489,20:45967568
rs9873580-<b>?</b>,3 x 10-8,,NR,'-,0.1631 unit decrease,'-,IL12A-AS1,Celiac disease,celiac disease,GCST008489,3:159911578
rs2187670-<b>?</b>,4 x 10-8,,NR,'-,0.116 unit increase,'-,"CCR2, UQCRC2P1",Celiac disease,celiac disease,GCST008489,3:46325463
rs62321692-<b>?</b>,1 x 10-8,,NR,'-,0.1924 unit decrease,'-,KIAA1109,Celiac disease,celiac disease,GCST008489,4:122340375
rs2069772-<b>?</b>,1 x 10-8,,NR,'-,0.1158 unit decrease,'-,IL2,Celiac disease,celiac disease,GCST008489,4:122451978
rs4897233-<b>?</b>,2 x 10-8,,NR,'-,0.1047 unit decrease,'-,THEMIS,Celiac disease,celiac disease,GCST008489,6:127835743
rs9457515-<b>?</b>,3 x 10-8,,NR,'-,0.1912 unit decrease,'-,C6orf99,Celiac disease,celiac disease,GCST008489,6:158913093
rs3120630-<b>?</b>,2 x 10-8,,NR,'-,0.1411 unit decrease,'-,"FNDC1, TAGAP-AS1",Celiac disease,celiac disease,GCST008489,6:159093828
rs6691768-<b>?</b>,2 x 10-8,,NR,'-,0.1065 unit increase,'-,NFIA,Celiac disease,celiac disease,GCST008489,1:61326191
rs936229-<b>?</b>,3 x 10-8,,NR,'-,0.1109 unit increase,'-,ULK3,Celiac disease,celiac disease,GCST008489,15:74839978
rs17849502-<b>T</b>,2 x 10-16,,0.06,1.43,'-,'-,"NCF2, SMG7",Celiac disease,celiac disease,GCST010064,1:183563445
rs6806528-<b>T</b>,9 x 10-9,,0.13,1.19,'-,'-,FRMD4B,Celiac disease,celiac disease,GCST010064,3:69203748
rs2364484-<b>C</b>,5 x 10-9,,0.28,1.13,'-,'-,"LTBR, SRP14P1",Celiac disease,celiac disease,GCST010064,12:6402830
rs9610686-<b>C</b>,3 x 10-8,,0.39,1.11,'-,'-,RAC2,Celiac disease,celiac disease,GCST010064,22:37237811
rs4930144-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,H19,Celiac disease,celiac disease,GCST002112,11:2027258
rs424232-<b>C</b>,5 x 10-21,,'-,'-,'-,'-,"TSBP1-AS1, NOTCH4",Celiac disease,celiac disease,GCST002112,6:32240547
rs11124945-<b>G</b>,5 x 10-8,,0.19,7.61,'-,[3.39-17.09],PLEKHH2,Diabetes in response to antihypertensive drug treatment (treatment strategy interaction),"response to antihypertensive drug, diabetes mellitus, hypertension, response to beta blocker, response to calcium channel blocker",GCST003797,2:43650017
rs113296370-<b>C</b>,2 x 10-7,(European),0.19,8.83,'-,[8.01-9.65],"Y_RNA, PLEKHH2",Diabetes in response to antihypertensive drug treatment (treatment strategy interaction),"response to antihypertensive drug, diabetes mellitus, hypertension, response to beta blocker, response to calcium channel blocker",GCST003797,2:43636315
rs4833103-<b>?</b>,1 x 10-7,(European),0.5,5.26,'-,[4.63-5.89],TLR1,Diabetes in response to antihypertensive drug treatment (treatment strategy interaction),"response to antihypertensive drug, diabetes mellitus, hypertension, response to beta blocker, response to calcium channel blocker",GCST003797,4:38813881
rs7775055-<b>C</b>,1 x 10-33,,'-,3.71,'-,[3.00-4.59],"MTCO3P1, HLA-DQB1",Primary biliary cirrhosis,primary biliary cirrhosis,GCST009956,6:32690139
rs1794280-<b>T</b>,6 x 10-28,,0.181,3.89,'-,[3.05-4.96],"MTCO3P1, HLA-DQB1",Anti-sp100 seropositivity in primary biliary cholangitis,"primary biliary cirrhosis, antinuclear antibody measurement",GCST007737,6:32699394
rs492899-<b>G</b>,3 x 10-22,,0.193,2.9,'-,[2.34-3.66],SKIV2L,Anti-sp100 seropositivity in primary biliary cholangitis,"primary biliary cirrhosis, antinuclear antibody measurement",GCST007737,6:31965741
rs1452787-<b>A</b>,3 x 10-8,(PSC),0.72,1.33,'-,[1.20-1.47],TCF4,Sclerosing cholangitis and ulcerative colitis (combined),sclerosing cholangitis,GCST001615,18:55539976
rs4676410-<b>A</b>,2 x 10-9,(PSC),0.2,1.38,'-,[1.24-1.53],GPR35,Sclerosing cholangitis and ulcerative colitis (combined),sclerosing cholangitis,GCST001615,2:240624322
rs8113007-<b>T</b>,7 x 10-28,,0.104228627,1.4280615,'-,[1.339831592-1.522101518],"MSRB1P1, IFNL4",Chronic hepatitis C infection,chronic hepatitis C virus infection,GCST90013691,19:39252463
rs79206939-<b>A</b>,1 x 10-8,,0.015,4.3,'-,[2.50-7.40],FTO,Thiopurine-induced leukopenia in inflammatory bowel disease,"leukopenia, response to thiopurine, inflammatory bowel disease",GCST003603,16:53826140
rs116855232-<b>C</b>,1 x 10-22,,0.05,3.9,'-,[2.90-5.30],NUDT15,Thiopurine-induced leukopenia in inflammatory bowel disease,"leukopenia, response to thiopurine, inflammatory bowel disease",GCST003603,13:48045719
rs10184704-<b>C</b>,6 x 10-6,,NR,2.3,'-,[1.60-3.30],GYPC,Pyoderma gangrenosum in inflammatory bowel disease,"pyoderma gangrenosum, inflammatory bowel disease",GCST002379,2:126695188
rs13392177-<b>C</b>,5 x 10-6,,NR,2.3,'-,[1.60-3.40],ARPC2,Pyoderma gangrenosum in inflammatory bowel disease,"pyoderma gangrenosum, inflammatory bowel disease",GCST002379,2:218248233
rs161857-<b>T</b>,7 x 10-6,,NR,3,'-,[1.90-4.90],HSD17B4,Pyoderma gangrenosum in inflammatory bowel disease,"pyoderma gangrenosum, inflammatory bowel disease",GCST002379,5:119520576
rs11174436-<b>A</b>,5 x 10-6,,NR,2.3,'-,[1.60-3.40],USP15,Pyoderma gangrenosum in inflammatory bowel disease,"pyoderma gangrenosum, inflammatory bowel disease",GCST002379,12:62349567
rs12607055-<b>C</b>,2 x 10-6,,NR,3.5,'-,[2.10-5.90],RIT2,Pyoderma gangrenosum in inflammatory bowel disease,"pyoderma gangrenosum, inflammatory bowel disease",GCST002379,18:43119237
rs17770334-<b>C</b>,2 x 10-6,,NR,3.1,'-,[1.90-4.80],"SERPINB12, SERPINB5",Pyoderma gangrenosum in inflammatory bowel disease,"pyoderma gangrenosum, inflammatory bowel disease",GCST002379,18:63535022
rs130555-<b>C</b>,6 x 10-7,,NR,2.5,'-,[1.70-3.50],SYN3,Pyoderma gangrenosum in inflammatory bowel disease,"pyoderma gangrenosum, inflammatory bowel disease",GCST002379,22:32787803
rs390966-<b>G</b>,3 x 10-6,,NR,2.17,'-,[1.60-3.00],OR7E91P,Erythema nodosum in inflammatory bowel disease,"Erythema nodosum, inflammatory bowel disease",GCST002380,2:71028561
rs6828740-<b>C</b>,5 x 10-8,,NR,4.14,'-,[2.50-6.90],"RPSAP35, LINC01378",Erythema nodosum in inflammatory bowel disease,"Erythema nodosum, inflammatory bowel disease",GCST002380,4:117413463
rs9405444-<b>A</b>,8 x 10-6,,NR,2.21,'-,[1.60-3.10],LINC01622,Erythema nodosum in inflammatory bowel disease,"Erythema nodosum, inflammatory bowel disease",GCST002380,6:1168812
rs10138297-<b>G</b>,7 x 10-6,,NR,2.63,'-,[1.70-4.00],LINC01588,Erythema nodosum in inflammatory bowel disease,"Erythema nodosum, inflammatory bowel disease",GCST002380,14:50018609
rs11079757-<b>A</b>,8 x 10-6,,NR,2.2,'-,[1.60-3.10],CDC27,Erythema nodosum in inflammatory bowel disease,"Erythema nodosum, inflammatory bowel disease",GCST002380,17:47118484
rs2836878-<b>?</b>,2 x 10-29,,'-,'-,'-,'-,RPL23AP12,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,21:39093608
rs2823286-<b>?</b>,4 x 10-29,,'-,'-,'-,'-,CYCSP42,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,21:15445619
rs75900472-<b>?</b>,1 x 10-28,,'-,'-,'-,'-,"JAK2, HNRNPA1P41",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,9:4981601
rs7608910-<b>?</b>,3 x 10-28,,'-,'-,'-,'-,PUS10,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:60977721
rs6752107-<b>?</b>,3 x 10-28,,'-,'-,'-,'-,ATG16L1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:233252802
rs12946510-<b>?</b>,2 x 10-26,,'-,'-,'-,'-,"IKZF3, GRB7",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,17:39756124
rs6062496-<b>?</b>,3 x 10-26,,'-,'-,'-,'-,"RTEL1-TNFRSF6B, TNFRSF6B",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,20:63697746
rs2413583-<b>?</b>,5 x 10-24,,'-,'-,'-,'-,"PDGFB, RPL3",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,22:39263768
rs7282490-<b>?</b>,2 x 10-23,,'-,'-,'-,'-,GATD3A,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,21:44195858
rs11614178-<b>?</b>,4 x 10-23,,'-,'-,'-,'-,IFNG-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,12:68114342
rs7554511-<b>?</b>,1 x 10-21,,'-,'-,'-,'-,INAVA,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:200908434
rs17293632-<b>?</b>,3 x 10-21,,'-,'-,'-,'-,SMAD3,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,15:67150258
rs6426833-<b>?</b>,1 x 10-19,,'-,'-,'-,'-,"OTUD3, RNF186",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:19845367
rs6017342-<b>?</b>,1 x 10-17,,'-,'-,'-,'-,LINC01620,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,20:44436388
rs12942547-<b>?</b>,2 x 10-17,,'-,'-,'-,'-,STAT3,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,17:42375526
rs2024092-<b>?</b>,5 x 10-17,,'-,'-,'-,'-,SBNO2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,19:1124032
rs80262450-<b>?</b>,1 x 10-16,,'-,'-,'-,'-,PTPN2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,18:12818923
rs4380874-<b>?</b>,8 x 10-16,,'-,'-,'-,'-,"PIGCP2, DLD",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,7:107839870
rs148319899-<b>?</b>,3 x 10-15,,'-,'-,'-,'-,LRRK2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,12:40346421
rs2266959-<b>?</b>,4 x 10-15,,'-,'-,'-,'-,UBE2L3,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,22:21568615
rs12568930-<b>?</b>,8 x 10-15,,'-,'-,'-,'-,"PPIAP34, ZBTB40",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:22375738
rs4676408-<b>?</b>,8 x 10-15,,'-,'-,'-,'-,"AQP12B, GPR35",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:240634984
rs1819333-<b>?</b>,9 x 10-15,,'-,'-,'-,'-,"MIR3939, RNASET2",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,6:166960059
rs56116661-<b>?</b>,9 x 10-10,,'-,'-,'-,'-,LPP,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,3:188683372
rs1847472-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,BACH2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,6:90263440
rs653178-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,'-,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,Mapping not available
rs11195128-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,DUSP5-DT,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,10:110426390
rs259964-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,ZNF831,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,20:59249254
rs4976646-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,RGS14,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:177361569
rs17656349-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,CAMK2A,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:150226431
rs10495903-<b>?</b>,6 x 10-9,,'-,'-,'-,'-,THADA,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:43579779
rs2284553-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,IFNGR2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,21:33404389
rs7517810-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,AIMP1P2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:172884320
rs9297145-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,"SMURF1, KPNA7",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,7:99161494
rs6920220-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,LINC02539,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,6:137685367
rs4656958-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,"ITLN1, ITLN2",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:160887174
rs11221332-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,ETS1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,11:128511079
rs3764147-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,LACC1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,13:43883789
rs5763767-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,HORMAD2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,22:30097893
rs7240004-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,"SMAD7, CTIF",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,18:48868651
rs6586030-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,TSPAN14,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,10:80494291
rs2816958-<b>?</b>,9 x 10-8,,'-,'-,'-,'-,NR5A2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:200132792
rs1260326-<b>?</b>,1 x 10-7,,'-,'-,'-,'-,'-,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,Mapping not available
rs1479918-<b>?</b>,1 x 10-7,,'-,'-,'-,'-,"ADAD1, IL2",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,4:122430276
rs798502-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,"AMZ1, GNA12",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,7:2750246
rs7404095-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,PRKCB,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,16:23853269
rs2382817-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,"TMBIM1, PNKD",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:218286495
rs1801274-<b>?</b>,9 x 10-14,,'-,'-,'-,'-,FCGR2A,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:161509955
rs7746082-<b>?</b>,9 x 10-13,,'-,'-,'-,'-,"RN7SKP211, PRDM1",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,6:105987394
rs3766606-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,PARK7,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:7962137
rs17694108-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,"CEBPA, SLC7A10",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,19:33240645
rs3091316-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,"CCL7, CCL2",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,17:34266955
rs78534766-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,ADCY7,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,16:50301163
rs921720-<b>?</b>,3 x 10-12,,'-,'-,'-,'-,TRIB1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,8:125522429
rs1042058-<b>?</b>,3 x 10-12,,'-,'-,'-,'-,MAP3K8,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,10:30439172
rs1250550-<b>?</b>,4 x 10-12,,'-,'-,'-,'-,ZMIZ1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,10:79300560
rs34779708-<b>?</b>,6 x 10-12,,'-,'-,'-,'-,CREM,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,10:35177257
rs11879191-<b>?</b>,2 x 10-11,,'-,'-,'-,'-,CDC37,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,19:10402235
rs16940202-<b>?</b>,3 x 10-11,,'-,'-,'-,'-,LINC02132,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,16:85980635
rs8005161-<b>?</b>,3 x 10-11,,'-,'-,'-,'-,GPR65,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,14:88006251
rs17780256-<b>?</b>,4 x 10-11,,'-,'-,'-,'-,SLC39A11,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,17:72646784
rs2488397-<b>?</b>,4 x 10-11,,'-,'-,'-,'-,DENND1B,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:197732149
rs13001325-<b>?</b>,5 x 10-11,,'-,'-,'-,'-,"IL18R1, IL1RL1",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:102322576
rs1456896-<b>?</b>,5 x 10-11,,'-,'-,'-,'-,IKZF1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,7:50264865
rs925255-<b>?</b>,6 x 10-11,,'-,'-,'-,'-,FLJ31356,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:28391927
rs17119-<b>?</b>,9 x 10-11,,'-,'-,'-,'-,"PPIAP9, RNU6-793P",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,6:14719265
rs1363907-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,ERAP2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:96917099
rs3851228-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,TRAF3IP2-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,6:111526988
rs395157-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,OSMR,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:38867630
rs6863411-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,NDFIP1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:142133639
rs17085007-<b>?</b>,7 x 10-10,,'-,'-,'-,'-,"FGFR1OP2P1, RPS21P8",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,13:26957130
rs59043219-<b>A</b>,1 x 10-8,,0.379,1.08,'-,1.05-1.10,IRF6,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:209797265
rs6740847-<b>A</b>,1 x 10-13,,0.508,1.1,'-,1.07-1.12,"LINC01934, ITGA4",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:181443625
rs144344067-<b>A</b>,1 x 10-8,,0.895,1.12,'-,1.08-1.16,FAM171B,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:186711652
rs76527535-<b>C</b>,3 x 10-8,,0.745,1.09,'-,1.06-1.12,BOK-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:241545286
rs2593855-<b>C</b>,3 x 10-9,,0.663,1.09,'-,1.06-1.11,FOXP1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,3:71126344
rs503734-<b>A</b>,3 x 10-8,,0.513,1.07,'-,1.05-1.10,IMPG2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,3:101304904
rs11734570-<b>A</b>,5 x 10-8,,0.368,1.07,'-,1.05-1.10,"KLF3-AS1, LINC02278",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,4:38586832
rs67289879-<b>T</b>,3 x 10-8,,0.179,1.09,'-,1.06-1.13,CCND3,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,6:42039665
rs11768365-<b>A</b>,4 x 10-8,,0.816,1.09,'-,1.06-1.12,GRID2IP,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,7:6505557
rs149169037-<b>G</b>,3 x 10-8,,0.895,1.14,'-,1.10-1.19,"EEF1A1P27, MAD1L1",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,7:20537675
rs243505-<b>A</b>,3 x 10-10,,0.624,1.08,'-,1.06-1.11,CUL1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,7:148738247
rs111456533-<b>G</b>,1 x 10-9,,0.829,1.11,'-,1.08-1.14,EEF1AKMT2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,10:124750812
rs11548656-<b>A</b>,5 x 10-11,,0.961,1.27,'-,1.20-1.34,PLCG2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,16:81883307
rs4256018-<b>G</b>,1 x 10-8,,0.25,1.08,'-,1.05-1.11,FERMT1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,20:6113242
rs4845604-<b>?</b>,7 x 10-14,,NR,'-,'-,'-,RORC,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:151829204
rs11581607-<b>?</b>,5 x 10-111,,'-,'-,'-,'-,IL23R,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:67242007
rs11742570-<b>?</b>,4 x 10-40,,'-,'-,'-,'-,'-,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:40410482
rs2066844-<b>?</b>,1 x 10-38,,'-,'-,'-,'-,NOD2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,16:50712015
rs56167332-<b>?</b>,3 x 10-38,,'-,'-,'-,'-,"LINC01845, IL12B",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:159400761
rs10761659-<b>?</b>,2 x 10-36,,'-,'-,'-,'-,ALDH7A1P4,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,10:62685804
rs10781499-<b>?</b>,5 x 10-36,,'-,'-,'-,'-,CARD9,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,9:136371953
rs4409764-<b>?</b>,2 x 10-34,,'-,'-,'-,'-,"LINC01475, GOT1",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,10:99524480
rs11236797-<b>?</b>,7 x 10-33,,'-,'-,'-,'-,"EMSY, LINC02757",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,11:76588605
rs3024505-<b>?</b>,6 x 10-31,,'-,'-,'-,'-,"IL10, Y_RNA",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:206766559
rs1811711-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,CCL20,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:227805760
rs12103-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,INTS11,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:1312114
rs9358372-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,CDKAL1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,6:20812357
rs7495132-<b>?</b>,3 x 10-7,,'-,'-,'-,'-,"CRTC3-AS1, CRTC3",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,15:90629669
rs11681525-<b>?</b>,3 x 10-7,,'-,'-,'-,'-,TEX41,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:144734815
rs13407913-<b>?</b>,3 x 10-7,,'-,'-,'-,'-,ADCY3,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:24874775
rs941823-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,LINC00598,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,13:40439840
rs913678-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,"LINC01271, RN7SL636P",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,20:50338887
rs71559680-<b>?</b>,5 x 10-7,,'-,'-,'-,'-,LINC00581,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,6:21430497
rs7911264-<b>?</b>,5 x 10-7,,'-,'-,'-,'-,"HHEX, EIF2S2P3",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,10:92677094
rs6651252-<b>?</b>,6 x 10-7,,'-,'-,'-,'-,LINC00824,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,8:128554935
rs10797432-<b>?</b>,8 x 10-7,,'-,'-,'-,'-,"TNFRSF14, PRXL2B",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:2569899
rs907611-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,LSP1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,11:1852842
rs529866-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,RMI2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,16:11279463
rs1991866-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,CCDC26,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,8:129611859
rs9557195-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,"GPR183, UBAC2",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,13:99304368
rs1819658-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,IPMK,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,10:58153390
rs200349593-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,NXPE1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,11:114526441
rs254560-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,C5orf66,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:135107916
rs11230563-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,CD6,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,11:61008737
rs1569723-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,"CD40, RPL13P2",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,20:46113425
rs564349-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,ERGIC1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:172897975
rs7954567-<b>?</b>,3 x 10-6,,'-,'-,'-,'-,LTBR,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,12:6381959
rs4743820-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,LINC00484,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,9:91166134
rs13126505-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,BANK1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,4:101944147
rs38904-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,"ST7, MTND4P6",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,7:117252792
rs516246-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,FUT2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,19:48702915
rs2930047-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,DAP,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:10695414
rs6716753-<b>?</b>,6 x 10-6,,'-,'-,'-,'-,SP140,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,2:230232414
rs7011507-<b>?</b>,6 x 10-6,,'-,'-,'-,'-,IDI1P2,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,8:48216682
rs6142618-<b>?</b>,6 x 10-6,,'-,'-,'-,'-,TM9SF4,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,20:32137845
rs80244186-<b>?</b>,6 x 10-6,,'-,'-,'-,'-,LINC02341,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,13:42343725
rs11168249-<b>?</b>,7 x 10-6,,'-,'-,'-,'-,HDAC7,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,12:47814585
rs138788-<b>?</b>,8 x 10-6,,'-,'-,'-,'-,TOM1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,22:35333728
rs2315008-<b>G</b>,9 x 10-15,,0.69,1.36,'-,[1.05-1.76],ZGPAT,Inflammatory bowel disease,inflammatory bowel disease,GCST000225,20:63712604
rs5743289-<b>T</b>,4 x 10-10,,0.17,1.46,'-,[1.29-1.64],NOD2,Inflammatory bowel disease,inflammatory bowel disease,GCST000225,16:50722863
rs477515-<b>?</b>,1 x 10-8,,0.69,1.38,'-,[1.23-1.54],"HLA-DRB1, HLA-DQA1",Inflammatory bowel disease,inflammatory bowel disease,GCST000225,6:32601914
rs6478109-<b>?</b>,3 x 10-8,,0.69,1.36,'-,[1.22-1.52],"DELEC1, TNFSF15",Inflammatory bowel disease,inflammatory bowel disease,GCST000225,9:114806486
rs2836878-<b>?</b>,4 x 10-12,,0.72,1.41,'-,[1.08-1.84],RPL23AP12,Inflammatory bowel disease,inflammatory bowel disease,GCST000225,21:39093608
rs11209026-<b>?</b>,7 x 10-11,,0.94,2.56,'-,[1.92-3.45],IL23R,Inflammatory bowel disease,inflammatory bowel disease,GCST000225,1:67240275
rs2076756-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,NOD2,Inflammatory bowel disease,inflammatory bowel disease,GCST000008,16:50722970
chr2:151914525-<b>T</b>,9 x 10-6,,0.0589587,'-,'-,'-,'-,Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,Mapping not available
rs10144920-<b>A</b>,7 x 10-6,,0.0245171,'-,'-,'-,SYNDIG1L,Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,14:74415130
rs11950172-<b>C</b>,3 x 10-6,,0.396837,'-,'-,'-,'-,Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,5:101171505
rs12442493-<b>C</b>,5 x 10-6,,0.304455,'-,'-,'-,RN7SKP181,Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,15:96933041
rs2965118-<b>G</b>,9 x 10-6,,0.109351,'-,'-,'-,CBLC,Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,19:44789032
rs4700080-<b>G</b>,9 x 10-6,,0.0340237,'-,'-,'-,ADAMTS6,Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,5:65343061
rs940145-<b>C</b>,4 x 10-6,,0.237037,'-,'-,'-,CSMD1,Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,8:3951280
rs9921472-<b>A</b>,6 x 10-6,,0.103316,'-,'-,'-,RPL7P47,Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,16:18006634
rs11209026-<b>?</b>,4 x 10-21,,NR,3.18,'-,[2.91-3.44],IL23R,Crohn's disease,Crohn's disease,GCST001396,1:67240275
rs78069066-<b>A</b>,1 x 10-12,,0.23114833,0.7572751,'-,[0.701480784-0.817507204],"ADAM1A, MAPKAPK5",Cirrhosis,cirrhosis of liver,GCST90013710,12:111900120
rs12484700-<b>G</b>,1 x 10-12,,0.453955229,1.2448415,'-,[1.172047324-1.322156697],PNPLA3,Cirrhosis,cirrhosis of liver,GCST90013710,22:43931393
rs8107030-<b>G</b>,8 x 10-10,,0.100665624,1.4438809,'-,[1.284266499-1.623333001],"IFNL4, IFNL3",Hepatocellular carcinoma,hepatocellular carcinoma,GCST90013702,19:39246079
rs760077-<b>T</b>,2 x 10-36,,0.847348519,1.3920238,'-,[1.322222625-1.465509734],'-,Gastric cancer,gastric carcinoma,GCST90013700,Mapping not available
rs3805495-<b>T</b>,9 x 10-20,,0.580090633,0.8475453,'-,[0.817886381-0.878279842],TTC33,Gastric cancer,gastric carcinoma,GCST90013700,5:40755466
rs2978977-<b>A</b>,3 x 10-43,,0.491371594,1.2872158,'-,[1.241855113-1.334233523],"JRK, PSCA",Gastric cancer,gastric carcinoma,GCST90013700,8:142674302
rs1205528-<b>C</b>,3 x 10-10,,NR,0.91564685,'-,[0.890920765149198-0.94105922271986],GAPDHP77,Gastric cancer,gastric carcinoma,GCST90013700,X:109298785
rs4971092-<b>T</b>,1 x 10-8,,NR,0.6760802,'-,[0.590822946283968-0.773640360594401],KRTCAP2,Gastric cancer,gastric carcinoma,GCST90013700,1:155171470
rs2494938-<b>A</b>,1 x 10-12,(All Cancers),0.23,1.15,'-,[1.10-1.19],LRFN2,"Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)","lung carcinoma, squamous cell carcinoma, gastric carcinoma",GCST001718,6:40568389
rs2285947-<b>A</b>,1 x 10-16,(All Cancers),0.27,1.17,'-,[1.12-1.21],DNAH11,"Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)","lung carcinoma, squamous cell carcinoma, gastric carcinoma",GCST001718,7:21544470
rs1555791-<b>C</b>,2 x 10-6,,0.48,1.22,'-,'-,"PRXL2B, TNFRSF14",Ulcerative colitis,ulcerative colitis,GCST008483,1:2567423
rs76418789-<b>G</b>,1 x 10-8,,0.93,1.75,'-,'-,"C1orf141, IL23R",Ulcerative colitis,ulcerative colitis,GCST008483,1:67182913
rs880790-<b>T</b>,4 x 10-6,,0.69,1.24,'-,'-,IL19,Ulcerative colitis,ulcerative colitis,GCST008483,1:206786871
rs4728142-<b>A</b>,3 x 10-8,,0.11,1.4,'-,'-,"IRF5, KCP",Ulcerative colitis,ulcerative colitis,GCST008483,7:128933913
rs1830610-<b>T</b>,2 x 10-9,,0.19,1.35,'-,'-,"INSL4, RLN2",Ulcerative colitis,ulcerative colitis,GCST008483,9:5260079
rs117506082-<b>G</b>,4 x 10-88,,NR,3.39,'-,[2.99-3.83],"HLA-C, HCG27",Ulcerative colitis,ulcerative colitis,GCST010001,6:31245448
rs76418789-<b>?</b>,9 x 10-11,,NR,1.9607843,'-,[1.59-2.38],"C1orf141, IL23R",Ulcerative colitis,ulcerative colitis,GCST010001,1:67182913
rs16940202-<b>?</b>,7 x 10-6,,NR,1.28,'-,[1.15-1.42],LINC02132,Ulcerative colitis,ulcerative colitis,GCST010001,16:85980635
rs549182-<b>A</b>,8 x 10-10,,0.11,1.59,'-,[1.37-1.85],"NOTCH4, TSBP1-AS1",Ulcerative colitis,ulcerative colitis,GCST002453,6:32237268
rs4151657-<b>G</b>,5 x 10-14,,0.29,1.54,'-,[1.38-1.73],CFB,Ulcerative colitis,ulcerative colitis,GCST002453,6:31949763
rs3749946-<b>A</b>,2 x 10-15,,0.07,1.97,'-,[1.66-2.33],MICB-DT,Ulcerative colitis,ulcerative colitis,GCST002453,6:31481085
rs1063355-<b>A</b>,2 x 10-6,,NR,1.43,'-,[1.23-1.66],"HLA-DQB1-AS1, HLA-DQB1",Ulcerative colitis,ulcerative colitis,GCST002453,6:32659937
rs1801274-<b>?</b>,2 x 10-12,,0.78,1.59,'-,[1.39-1.82],FCGR2A,Ulcerative colitis,ulcerative colitis,GCST000529,1:161509955
rs9263739-<b>T</b>,4 x 10-67,,0.15,2.73,'-,[2.43-3.07],CCHCR1,Ulcerative colitis,ulcerative colitis,GCST000529,6:31143579
rs17085007-<b>C</b>,7 x 10-8,,0.23,1.35,'-,[1.21-1.51],"FGFR1OP2P1, RPS21P8",Ulcerative colitis,ulcerative colitis,GCST000529,13:26957130
rs10975003-<b>C</b>,1 x 10-6,,0.19,1.34,'-,[1.18-1.51],"INSL6, INSL4",Ulcerative colitis,ulcerative colitis,GCST000529,9:5213687
rs2395185-<b>G</b>,5 x 10-22,,0.61,1.92,'-,[1.68-2.19],HLA-DRB9,Ulcerative colitis,ulcerative colitis,GCST000529,6:32465390
rs2108225-<b>A</b>,1 x 10-7,,0.65,1.32,'-,[1.19-1.47],"DLD, PIGCP2",Ulcerative colitis,ulcerative colitis,GCST000529,7:107812658
rs9268480-<b>G</b>,3 x 10-6,,0.91,1.82,'-,[1.43-2.33],"TSBP1-AS1, BTNL2",Ulcerative colitis,ulcerative colitis,GCST000529,6:32396067
rs9501030-<b>A</b>,4 x 10-6,(Analysis II),NR,'-,'-,'-,"LINC02570, LINC00243",Ulcerative colitis,ulcerative colitis,GCST000853,6:30831622
rs17085007-<b>C</b>,3 x 10-7,,0.17,1.37,'-,[1.22-1.55],"FGFR1OP2P1, RPS21P8",Ulcerative colitis,ulcerative colitis,GCST001934,13:26957130
rs6935053-<b>?</b>,2 x 10-6,(Conditioned on rs9271366),NR,'-,'-,'-,"HLA-W, MICD",Ulcerative colitis,ulcerative colitis,GCST001938,6:29966386
rs9271366-<b>G</b>,1 x 10-18,,0.11,2.1,'-,[1.78-2.48],"HLA-DRB1, HLA-DQA1",Ulcerative colitis,ulcerative colitis,GCST001938,6:32619077
rs16940186-<b>G</b>,4 x 10-10,,0.21,1.56,'-,[1.36-1.80],LINC02132,Ulcerative colitis,ulcerative colitis,GCST001938,16:85976134
rs4654903-<b>?</b>,7 x 10-9,,0.75,1.56,'-,[1.35-1.82],"RNF186, OTUD3",Ulcerative colitis,ulcerative colitis,GCST001938,1:19874497
rs16940202-<b>C</b>,3 x 10-9,,0.22,1.52,'-,[1.32-1.74],LINC02132,Ulcerative colitis,ulcerative colitis,GCST001938,16:85980635
rs9268853-<b>T</b>,3 x 10-6,,0.64,1.37,'-,[1.20-1.56],HLA-DRB9,Ulcerative colitis,ulcerative colitis,GCST001938,6:32461866
rs17085007-<b>C</b>,8 x 10-6,,0.18,1.4,'-,[1.21-1.63],"FGFR1OP2P1, RPS21P8",Ulcerative colitis,ulcerative colitis,GCST001938,13:26957130
rs55769264-<b>A</b>,3 x 10-8,,0.45,'-,0.015 unit increase,[0.0097-0.0203],CDH9,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,5:26927939
rs10772314-<b>A</b>,3 x 10-8,,0.4,'-,0.015 unit decrease,[0.0097-0.0203],"LINC02446, SLC25A39P2","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,12:10551751
rs7918807-<b>T</b>,4 x 10-8,,0.52,'-,0.015 unit increase,[0.0097-0.0203],LINC02670,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,10:9978231
rs2652452-<b>A</b>,3 x 10-9,,0.45,'-,0.016 unit decrease,[0.011-0.021],KCNJ3,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,2:154813691
rs7429279-<b>A</b>,1 x 10-9,,0.41,'-,0.016 unit increase,[0.011-0.021],"RNA5SP125, RARB","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,3:25077146
rs61790808-<b>A</b>,9 x 10-9,,0.64,'-,0.016 unit decrease,[0.011-0.021],STAG1,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,3:136724166
rs34559440-<b>T</b>,1 x 10-8,,0.68,'-,0.016 unit decrease,[0.011-0.021],TBX4,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,17:70402971
rs5922945-<b>T</b>,2 x 10-8,,0.34,'-,0.016 unit decrease,[0.011-0.021],"MIR548I4, HDX","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,X:84268007
rs6495046-<b>C</b>,3 x 10-10,,0.36,'-,0.017 unit decrease,[0.012-0.022],NEO1,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,15:73060834
rs4816017-<b>A</b>,7 x 10-9,,0.29,'-,0.017 unit decrease,[0.011-0.023],RN7SL547P,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,20:7673726
chr3:50135699-<b>?</b>,5 x 10-12,,0.48,'-,0.018 unit decrease,[0.013-0.023],'-,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,Mapping not available
rs1352724-<b>A</b>,4 x 10-8,,0.22,'-,0.018 unit decrease,[0.012-0.024],"RN7SL782P, RN7SKP122","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,5:107747786
rs10811723-<b>A</b>,3 x 10-11,,0.3,'-,0.019 unit decrease,[0.013-0.025],DMRTA1,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,9:22542286
rs2046850-<b>T</b>,2 x 10-8,,0.19,'-,0.019 unit decrease,[0.013-0.025],SYT14,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,1:210130974
rs3820640-<b>T</b>,3 x 10-8,,0.84,'-,0.02 unit increase,[0.013-0.027],ITPKB,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,1:226681217
rs1569414-<b>T</b>,1 x 10-11,,0.73,'-,0.02 unit decrease,[0.014-0.026],FAM118A,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,22:45331684
rs28822480-<b>A</b>,7 x 10-13,,0.29,'-,0.021 unit increase,[0.015-0.027],RNU4-17P,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,18:60257590
rs7852129-<b>A</b>,8 x 10-11,,0.89,'-,0.025 unit decrease,[0.018-0.032],"PRUNE2, PCA3","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,9:76731288
rs140357883-<b>?</b>,2 x 10-9,,0.84,'-,0.022 unit increase,[0.015-0.029],MTMR3,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,22:29896823
rs80270335-<b>T</b>,2 x 10-9,,0.09,'-,0.027 unit increase,[0.018-0.036],ALK,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,2:29393789
rs9905793-<b>A</b>,7 x 10-9,,0.091,'-,0.027 unit increase,[0.018-0.036],"HOXB-AS2, HOXB-AS3, HOXB3","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,17:48558287
rs62106258-<b>T</b>,9 x 10-12,,0.95,'-,0.042 unit increase,[0.03-0.054],"LINC01874, LINC01865","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,2:417167
rs1122171-<b>T</b>,3 x 10-62,,0.59,'-,0.044 unit increase,[0.039-0.049],C5orf66,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,5:135174297
rs185566659-<b>A</b>,2 x 10-9,,0.032,'-,0.045 unit increase,[0.03-0.06],OPA1,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,3:193676936
rs3865314-<b>A</b>,1 x 10-8,,0.51,'-,0.015 unit increase,[0.0099-0.0201],NPEPPS,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,17:47592158
rs11676272-<b>A</b>,1 x 10-8,,0.52,'-,0.015 unit decrease,[0.0099-0.0201],ADCY3,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,2:24918669
rs898797-<b>T</b>,2 x 10-8,,0.59,'-,0.015 unit increase,[0.0097-0.0203],RNU6-526P,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,8:9372179
rs9831002-<b>T</b>,9 x 10-10,,0.49,'-,0.016 unit decrease,[0.011-0.021],SATB1-AS1,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,3:18811205
rs57067187-<b>T</b>,7 x 10-9,,0.63,'-,0.015 unit increase,[0.0097-0.0203],"BAHCC1, RENO1","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,17:81387532
rs5831974-<b>?</b>,7 x 10-10,,0.45,'-,0.016 unit decrease,[0.011-0.021],AAK1,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,2:69477205
rs10851907-<b>A</b>,1 x 10-9,,0.41,'-,0.016 unit increase,[0.011-0.021],"CHRNA3, CHRNB4","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,15:78623522
rs8054556-<b>A</b>,2 x 10-9,,0.46,'-,0.016 unit increase,[0.011-0.021],TMEM219,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,16:29946895
rs7217268-<b>A</b>,1 x 10-9,,0.38,'-,0.016 unit increase,[0.011-0.021],LINC00511,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,17:72341986
rs1108343-<b>T</b>,1 x 10-8,,0.36,'-,0.016 unit increase,[0.011-0.021],SALL1,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,16:51177684
rs2238651-<b>T</b>,4 x 10-8,,0.24,'-,0.017 unit increase,[0.011-0.023],TMEM59L,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,19:18608036
rs263771-<b>A</b>,7 x 10-9,,0.23,'-,0.018 unit increase,[0.012-0.024],SCN1A-AS1,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,2:185056965
rs1482698-<b>C</b>,1 x 10-13,,0.38,'-,0.02 unit increase,[0.015-0.025],LINC02224,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,5:44539351
rs11672900-<b>A</b>,5 x 10-14,,0.47,'-,0.02 unit decrease,[0.015-0.025],MAMSTR,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,19:48717066
rs10987008-<b>A</b>,7 x 10-14,,0.64,'-,0.021 unit increase,[0.016-0.026],PBX3,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,9:125899321
rs4971099-<b>A</b>,7 x 10-15,,0.55,'-,0.021 unit decrease,[0.016-0.026],TRIM46,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,1:155183132
rs72694438-<b>A</b>,2 x 10-10,,0.21,'-,0.021 unit increase,[0.015-0.027],AMY1C,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,1:103822256
rs10048146-<b>A</b>,5 x 10-14,,0.81,'-,0.026 unit decrease,[0.019-0.033],"FOXL1, LINC02188","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,16:86677054
rs72748935-<b>T</b>,1 x 10-26,,0.46,'-,0.028 unit decrease,[0.023-0.033],CA12,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,15:63347217
rs9366651-<b>T</b>,3 x 10-28,,0.51,'-,0.029 unit decrease,[0.024-0.034],"BTN3A2, H3C9P","Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,6:26336468
rs149467613-<b>A</b>,3 x 10-8,,0.05,'-,0.034 unit decrease,[0.022-0.046],P2RY2,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,11:73232438
rs121908120-<b>A</b>,2 x 10-22,,0.03,'-,0.081 unit decrease,[0.065-0.097],WNT10A,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,2:218890289
rs2072693-<b>T</b>,5 x 10-8,,0.48,'-,0.014 unit increase,[0.0089-0.0191],RHCG,"Number of decayed, missing and filled tooth surfaces or use of dentures","dental caries, dentures",GCST008295,15:89471714
rs1122171-<b>T</b>,2 x 10-13,,0.59,'-,0.064 unit increase,[0.047-0.081],C5orf66,"Number of decayed, missing and filled tooth surfaces",dental caries,GCST008302,5:135174297
rs72748935-<b>T</b>,2 x 10-8,,0.46,'-,0.052 unit decrease,[0.034-0.07],CA12,"Number of decayed, missing and filled tooth surfaces",dental caries,GCST008302,15:63347217
rs962856-<b>C</b>,2 x 10-8,,0.379,1.12,'-,[1.08-1.17],LINC01829,Pancreatic cancer,pancreatic carcinoma,GCST002991,2:67366671
rs1517037-<b>C</b>,3 x 10-7,,0.818,1.1494253,'-,[1.09-1.2],"SEC11C, GRP",Pancreatic cancer,pancreatic carcinoma,GCST002991,18:59211042
rs7310409-<b>A</b>,6 x 10-7,,0.386,1.11,'-,[1.06-1.15],HNF1A,Pancreatic cancer,pancreatic carcinoma,GCST002991,12:120987058
rs351365-<b>C</b>,7 x 10-7,,0.743,1.1235955,'-,[1.08-1.18],WNT2B,Pancreatic cancer,pancreatic carcinoma,GCST002991,1:112503773
rs6073450-<b>A</b>,9 x 10-7,,0.381,1.11,'-,[1.06-1.15],LINC01620,Pancreatic cancer,pancreatic carcinoma,GCST002991,20:44458008
rs1747924-<b>A</b>,7 x 10-6,,0.767,1.1111112,'-,[1.06-1.16],ROR1,Pancreatic cancer,pancreatic carcinoma,GCST002991,1:64073289
rs505922-<b>?</b>,2 x 10-13,,NR,1.27,'-,[1.19-1.35],ABO,Pancreatic cancer,pancreatic carcinoma,GCST002991,9:133273813
rs9543325-<b>?</b>,2 x 10-10,,NR,1.24,'-,[1.16-1.32],MARK2P12,Pancreatic cancer,pancreatic carcinoma,GCST002991,13:73342491
rs3790844-<b>?</b>,3 x 10-6,,NR,1.2048193,'-,[1.11-1.3],NR5A2,Pancreatic cancer,pancreatic carcinoma,GCST002991,1:200038304
rs401681-<b>?</b>,3 x 10-8,,NR,1.2,'-,[1.13-1.28],CLPTM1L,Pancreatic cancer,pancreatic carcinoma,GCST002991,5:1321972
rs6971499-<b>?</b>,7 x 10-6,,NR,1.2345679,'-,[1.14-1.35],LINC-PINT,Pancreatic cancer,pancreatic carcinoma,GCST002991,7:130995762
rs9581943-<b>?</b>,2 x 10-7,,NR,1.17,'-,[1.10-1.24],"PLUT, PDX1",Pancreatic cancer,pancreatic carcinoma,GCST002991,13:27919860
rs11655237-<b>T</b>,1 x 10-14,,0.11,1.26,'-,[1.19-1.34],LINC00511,Pancreatic cancer,pancreatic carcinoma,GCST002991,17:72404025
rs1486134-<b>G</b>,3 x 10-9,,0.275,1.14,'-,[1.09-1.19],ETAA1,Pancreatic cancer,pancreatic carcinoma,GCST002991,2:67412637
rs17688601-<b>C</b>,1 x 10-8,,0.737,1.1363636,'-,[1.09-1.19],SUGCT,Pancreatic cancer,pancreatic carcinoma,GCST002991,7:40827064
rs9854771-<b>G</b>,2 x 10-8,,0.638,1.1235955,'-,[1.08-1.18],TP63,Pancreatic cancer,pancreatic carcinoma,GCST002991,3:189790682
rs9554197-<b>T</b>,9 x 10-11,,0.399,1.14,'-,[1.1-1.19],PLUT,Pancreatic cancer,pancreatic carcinoma,GCST002991,13:27902841
rs12456874-<b>G</b>,6 x 10-7,,0.25,1.38,'-,[1.22-1.57],LDLRAD4,Pancreatic cancer,pancreatic carcinoma,GCST001749,18:13366863
rs9874556-<b>A</b>,4 x 10-6,,0.46,1.31,'-,[1.17-1.46],'-,Pancreatic cancer,pancreatic carcinoma,GCST001749,3:3314490
rs7853844-<b>A</b>,2 x 10-6,,0.17,1.43,'-,[1.23-1.65],DELEC1,Pancreatic cancer,pancreatic carcinoma,GCST001749,9:115288135
rs10788473-<b>T</b>,3 x 10-6,,0.38,1.27,'-,[1.15-1.41],GRID1,Pancreatic cancer,pancreatic carcinoma,GCST001749,10:85980996
rs9783347-<b>A</b>,9 x 10-6,,0.3,1.36,'-,[1.19-1.56],GTF2H1,Pancreatic cancer,pancreatic carcinoma,GCST001749,11:18363391
rs1000589-<b>T</b>,3 x 10-6,,0.53,1.27,'-,[1.15-1.39],LINC00395,Pancreatic cancer,pancreatic carcinoma,GCST001749,13:63567780
rs10500715-<b>T</b>,2 x 10-7,,0.63,1.32,'-,[1.19-1.47],SBF2,Pancreatic cancer,pancreatic carcinoma,GCST001749,11:9951515
rs4269383-<b>C</b>,7 x 10-7,,NR,1.2,'-,[1.12-1.30],MIR1202,Pancreatic cancer,pancreatic carcinoma,GCST001350,6:155876368
rs4927850-<b>A</b>,2 x 10-7,,NR,1.24,'-,[1.14-1.35],"TFRC, SDHAP1",Pancreatic cancer,pancreatic carcinoma,GCST001350,3:196024759
rs372883-<b>T</b>,2 x 10-13,,NR,1.27,'-,[1.19-1.33],BACH1,Pancreatic cancer,pancreatic carcinoma,GCST001350,21:29345416
rs2255280-<b>T</b>,4 x 10-10,,NR,1.23,'-,[1.15-1.32],"DAB2, C9",Pancreatic cancer,pancreatic carcinoma,GCST001350,5:39394887
rs12413624-<b>T</b>,5 x 10-11,,0.37,1.23,'-,[1.16-1.31],SLC25A18P1,Pancreatic cancer,pancreatic carcinoma,GCST001350,10:118519432
rs9363918-<b>A</b>,1 x 10-6,,NR,1.27,'-,[1.15-1.39],'-,Pancreatic cancer,pancreatic carcinoma,GCST001350,6:68432116
rs10974531-<b>A</b>,5 x 10-6,,NR,1.24,'-,[1.13-1.35],"RNU6-694P, SLC1A1",Pancreatic cancer,pancreatic carcinoma,GCST001350,9:4426631
rs1547374-<b>A</b>,4 x 10-13,,NR,1.27,'-,[1.19-1.35],"TFF1, TFF2",Pancreatic cancer,pancreatic carcinoma,GCST001350,21:42358786
rs9573163-<b>G</b>,5 x 10-13,,0.43,1.26,'-,[1.18-1.34],MARK2P12,Pancreatic cancer,pancreatic carcinoma,GCST001350,13:73334709
rs5768709-<b>G</b>,1 x 10-10,,0.23,1.25,'-,[1.17-1.34],TAFA5,Pancreatic cancer,pancreatic carcinoma,GCST001350,22:48533757
rs2689154-<b>G</b>,6 x 10-6,,0.17,1.2,'-,[1.11-1.29],MIPEPP2,Pancreatic cancer,pancreatic carcinoma,GCST001350,1:238745053
rs17087282-<b>?</b>,2 x 10-6,(overall survival),'-,2.47,'-,[1.71-3.56],'-,Survival in microsatellite instability low/stable colorectal cancer,"colorectal cancer, microsatellite instability measurement, overall survival",GCST002820,6:156266886
rs17048372-<b>?</b>,2 x 10-6,(overall survival),'-,1.91,'-,[1.46-2.48],DPP10,Survival in microsatellite instability low/stable colorectal cancer,"colorectal cancer, microsatellite instability measurement, overall survival",GCST002820,2:114456179
rs1998584-<b>?</b>,2 x 10-6,(overall survival),'-,1.76,'-,[1.39-2.22],'-,Survival in microsatellite instability low/stable colorectal cancer,"colorectal cancer, microsatellite instability measurement, overall survival",GCST002820,9:13704540
rs12187751-<b>?</b>,3 x 10-6,(overall survival),'-,2.48,'-,[1.70-3.64],'-,Survival in microsatellite instability low/stable colorectal cancer,"colorectal cancer, microsatellite instability measurement, overall survival",GCST002820,5:163158639
rs1573948-<b>?</b>,5 x 10-6,(overall survival),'-,1.93,'-,[1.46-2.57],BTF3P7,Survival in microsatellite instability low/stable colorectal cancer,"colorectal cancer, microsatellite instability measurement, overall survival",GCST002820,6:6786192
rs13180087-<b>?</b>,9 x 10-6,(overall survival),'-,2.06,'-,[1.50-2.83],HCN1,Survival in microsatellite instability low/stable colorectal cancer,"colorectal cancer, microsatellite instability measurement",GCST002820,5:45265666
rs6720296-<b>?</b>,5 x 10-7,(disease-free survival),'-,1.74,'-,[1.40-2.16],LINC01121,Survival in microsatellite instability low/stable colorectal cancer,"disease free survival, colorectal cancer, microsatellite instability measurement",GCST002820,2:45181130
rs1407508-<b>?</b>,9 x 10-7,(disease-free survival),'-,2.53,'-,[1.75-3.66],"NME2P3, GALNT12",Survival in microsatellite instability low/stable colorectal cancer,"disease free survival, colorectal cancer, microsatellite instability measurement",GCST002820,9:98882256
rs912294-<b>?</b>,5 x 10-6,(disease-free survival),'-,1.67,'-,[1.34-2.08],"WDR95P, HSPH1",Survival in microsatellite instability low/stable colorectal cancer,"disease free survival, colorectal cancer, microsatellite instability measurement",GCST002820,13:31124157
rs6720296-<b>?</b>,3 x 10-6,(overall survival),'-,1.74,'-,[1.38-2.19],LINC01121,Survival in microsatellite instability low/stable colorectal cancer,"colorectal cancer, microsatellite instability measurement, overall survival",GCST002820,2:45181130
rs10040610-<b>?</b>,8 x 10-6,(overall survival),'-,1.96,'-,[1.46-2.63],"LINC02145, MED10",Survival in microsatellite instability low/stable colorectal cancer,"colorectal cancer, microsatellite instability measurement, overall survival",GCST002820,5:6353702
rs1493383-<b>?</b>,8 x 10-6,(overall survival),'-,1.81,'-,[1.39-2.35],GRIA1,Survival in microsatellite instability low/stable colorectal cancer,"colorectal cancer, microsatellite instability measurement, overall survival",GCST002820,5:153611838
rs9979383-<b>?</b>,1 x 10-8,,NR,0.92,'-,'-,RUNX1,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,21:35343463
rs212400-<b>?</b>,6 x 10-11,,NR,1.1,'-,'-,TAGAP-AS1,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,6:159052542
rs11217040-<b>?</b>,2 x 10-11,,NR,0.89,'-,'-,"SETP16, DDX6",Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,11:118809939
rs62323881-<b>?</b>,6 x 10-9,,NR,1.16,'-,'-,"RN7SL335P, KIAA1109",Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,4:122117140
rs4073285-<b>?</b>,2 x 10-13,,NR,0.9,'-,'-,MMEL1,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,1:2608357
rs6696533-<b>?</b>,3 x 10-8,,NR,1.08,'-,'-,"PTPRC, MIR181A1HG",Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,1:198764438
rs10203477-<b>?</b>,4 x 10-8,,NR,0.93,'-,'-,LINC01185,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,2:60877850
rs11123810-<b>?</b>,7 x 10-12,,NR,0.91,'-,'-,AFF3,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,2:100142823
rs6749371-<b>?</b>,7 x 10-11,,NR,0.84,'-,'-,STAT4,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,2:191037458
rs1980422-<b>?</b>,2 x 10-17,,NR,1.14,'-,'-,"CD28, KRT18P39",Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,2:203745673
rs72928038-<b>?</b>,4 x 10-11,,NR,1.13,'-,'-,BACH2,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,6:90267049
rs17264332-<b>?</b>,3 x 10-27,,NR,1.19,'-,'-,"SLC17A1, LINC02539",Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,6:137684378
rs74830391-<b>?</b>,3 x 10-9,,NR,1.14,'-,'-,ELMO1,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,7:37387686
rs6651252-<b>?</b>,8 x 10-9,,NR,0.89,'-,'-,LINC00824,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,8:128554935
rs947474-<b>?</b>,8 x 10-11,,NR,0.89,'-,'-,LINC02649,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,10:6348488
rs11066188-<b>?</b>,9 x 10-10,,NR,1.09,'-,'-,HECTD4,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,12:112172910
rs80209296-<b>?</b>,1 x 10-12,,NR,1.14,'-,'-,PTPN2,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,18:12860802
rs1893592-<b>?</b>,8 x 10-11,,NR,0.91,'-,'-,UBASH3A,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,21:42434957
rs4821124-<b>?</b>,2 x 10-11,,NR,1.12,'-,'-,"UBE2L3, YDJC",Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,22:21625000
rs7579944-<b>?</b>,2 x 10-8,,NR,1.08,'-,'-,"H3P5, LBH",Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,2:30222160
rs6679677-<b>?</b>,1 x 10-53,,NR,1.41,'-,'-,"RSBN1, PHTF1",Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,1:113761186
rs17849502-<b>?</b>,1 x 10-14,,NR,1.26,'-,'-,"NCF2, SMG7",Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,1:183563445
rs16867384-<b>?</b>,6 x 10-9,,NR,1.1,'-,'-,LINC01934,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,2:181246479
rs67676925-<b>?</b>,2 x 10-11,,NR,1.18,'-,'-,CCR3,Celiac disease and Rheumatoid arthritis,"rheumatoid arthritis, celiac disease",GCST008644,3:46232768
rs2187668-<b>A</b>,1 x 10-19,,0.14,7.04,'-,[6.08-8.15],HLA-DQA1,Celiac disease,celiac disease,GCST000048,6:32638107
rs6822844-<b>G</b>,1 x 10-14,,0.82,1.59,'-,[1.41-1.75],IL21,Celiac disease,celiac disease,GCST000048,4:122588266
rs2816316-<b>C</b>,3 x 10-11,,NR,1.39,'-,[1.26-1.53],RGS1,Celiac disease,celiac disease,GCST000157,1:192567683
rs17810546-<b>G</b>,1 x 10-9,,NR,1.35,'-,[1.23-1.49],IL12A-AS1,Celiac disease,celiac disease,GCST000157,3:159947262
rs1738074-<b>A</b>,7 x 10-8,,NR,1.21,'-,[1.13-1.30],"TAGAP, TAGAP-AS1",Celiac disease,celiac disease,GCST000157,6:159044945
rs1464510-<b>A</b>,5 x 10-9,,NR,1.23,'-,[1.15-1.32],LPP,Celiac disease,celiac disease,GCST000157,3:188394766
rs6441961-<b>A</b>,3 x 10-7,,0.3,1.21,'-,[1.13-1.30],UQCRC2P1,Celiac disease,celiac disease,GCST000157,3:46310893
rs13015714-<b>C</b>,4 x 10-9,,NR,1.28,'-,[1.18-1.39],IL18R1,Celiac disease,celiac disease,GCST000157,2:102355405
rs653178-<b>G</b>,8 x 10-8,,0.48,1.21,'-,[1.13-1.30],'-,Celiac disease,celiac disease,GCST000157,Mapping not available
rs6822844-<b>C</b>,3 x 10-13,,0.81,1.44,'-,[1.30-1.58],IL21,Celiac disease,celiac disease,GCST000157,4:122588266
rs2304256-<b>C</b>,4 x 10-9,,0.71,1.16,'-,[1.11-1.22],TYK2,Type 1 diabetes,type I diabetes mellitus,GCST000539,19:10364976
rs941576-<b>A</b>,1 x 10-10,,0.57,1.11,'-,[1.06-1.16],MEG3,Type 1 diabetes,type I diabetes mellitus,GCST000539,14:100839708
rs61839660-<b>?</b>,5 x 10-9,,NR,1.6,'-,[1.44-1.76],IL2RA,Type 1 diabetes,type I diabetes mellitus,GCST001394,10:6052734
rs1265564-<b>?</b>,1 x 10-16,,NR,1.45,'-,[1.28-1.67],CUX2,Type 1 diabetes,type I diabetes mellitus,GCST001394,12:111270654
rs3749172-<b>A</b>,6 x 10-11,,0.28,1.45,'-,[1.29–1.61],GPR35,Crohn's disease,Crohn's disease,GCST008485,2:240630832
rs224143-<b>G</b>,2 x 10-9,,0.59,1.38,'-,[1.24–1.53],ALDH7A1P4,Crohn's disease,Crohn's disease,GCST008485,10:62718076
rs1250569-<b>T</b>,3 x 10-7,,0.48,1.3,'-,[1.18–1.44],ZMIZ1,Crohn's disease,Crohn's disease,GCST008485,10:79285450
rs4409764-<b>T</b>,8 x 10-8,,0.46,1.32,'-,[1.19–1.46],"LINC01475, GOT1",Crohn's disease,Crohn's disease,GCST008485,10:99524480
rs514000-<b>C</b>,9 x 10-8,,0.33,1.33,'-,[1.20–1.48],PTPN2,Crohn's disease,Crohn's disease,GCST008485,18:12854073
rs2823256-<b>G</b>,2 x 10-7,,0.7,1.35,'-,[1.20–1.51],CYCSP42,Crohn's disease,Crohn's disease,GCST008485,21:15414477
rs10977466-<b>G</b>,9 x 10-6,,0.224215,'-,'-,'-,PTPRD,Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,9:9065941
rs62167560-<b>C</b>,6 x 10-6,,0.0207101,'-,'-,'-,"RBM43, FABP5P10",Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,2:151206431
rs7614127-<b>A</b>,7 x 10-6,,0.501515,'-,'-,'-,"CD200R1L-AS1, LINC02042",Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,3:112789332
rs78885963-<b>T</b>,6 x 10-6,,0.0540958,'-,'-,'-,DPH6-DT,Crohn's disease (time to progression),"disease progression measurement, Crohn's disease",GCST007497,15:35639966
rs10763930-<b>A</b>,2 x 10-6,,0.0188679,'-,'-,'-,NRP1,Crohn's disease (time to first abdominal surgery),"disease progression measurement, Crohn's disease",GCST007498,10:33378350
rs116417499-<b>A</b>,4 x 10-7,,0.0154867,'-,'-,'-,ALDH5A1,Crohn's disease (time to first abdominal surgery),"disease progression measurement, Crohn's disease",GCST007498,6:24523528
rs3936663-<b>T</b>,4 x 10-6,,0.300895,'-,'-,'-,"SORCS2, RN7SKP36",Crohn's disease (time to first abdominal surgery),"disease progression measurement, Crohn's disease",GCST007498,4:7183972
rs62072729-<b>T</b>,4 x 10-6,,0.11853,'-,'-,'-,NLRP1,Crohn's disease (time to first abdominal surgery),"disease progression measurement, Crohn's disease",GCST007498,17:5522104
rs6778300-<b>C</b>,5 x 10-6,,0.0119647,'-,'-,'-,RARB,Crohn's disease (time to first abdominal surgery),"disease progression measurement, Crohn's disease",GCST007498,3:25251475
rs76804613-<b>T</b>,4 x 10-6,,0.173569,'-,'-,'-,LINC02814,Crohn's disease (time to first abdominal surgery),"disease progression measurement, Crohn's disease",GCST007498,1:229142587
rs9521997-<b>G</b>,2 x 10-6,,0.145542,'-,'-,'-,"ANKRD10, PARP1P1",Crohn's disease (time to first abdominal surgery),"disease progression measurement, Crohn's disease",GCST007498,13:110931075
chr2:26187269-<b>C</b>,7 x 10-6,,0.0876106,'-,'-,'-,'-,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,Mapping not available
chr20:41202388-<b>TC</b>,3 x 10-6,,0.488444,'-,'-,'-,'-,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,Mapping not available
rs11223177-<b>T</b>,7 x 10-6,,0.2,'-,'-,'-,OPCML,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,11:132706651
rs1499555-<b>A</b>,1 x 10-6,,0.436396,'-,'-,'-,LINC01239,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,9:22589172
rs1544254-<b>G</b>,5 x 10-6,,0.425242,'-,'-,'-,LINC01898,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,18:75743798
rs1603949-<b>T</b>,2 x 10-6,,0.115551,'-,'-,'-,LINC00448,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,13:62645344
rs16845844-<b>G</b>,7 x 10-6,,0.0876652,'-,'-,'-,PSMD14,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,2:161408759
rs1873103-<b>G</b>,5 x 10-6,,0.54458,'-,'-,'-,"TRMT112P1, MTRNR2L13",Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,4:116341004
rs1972081-<b>C</b>,8 x 10-6,,0.34669,'-,'-,'-,LUZP2,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,11:24637287
rs4723416-<b>G</b>,4 x 10-6,,0.419929,'-,'-,'-,SDK1,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,7:4134757
rs56259952-<b>C</b>,9 x 10-6,,0.115247,'-,'-,'-,'-,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,11:98730321
rs5742831-<b>A</b>,5 x 10-6,,0.411713,'-,'-,'-,DAD1,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,14:22570239
rs7566270-<b>T</b>,7 x 10-6,,0.0846491,'-,'-,'-,"PSMD14, LINC01806",Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,2:161291619
rs75986423-<b>C</b>,6 x 10-6,,0.108761,'-,'-,'-,LINC02360,Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,4:11728827
rs7780850-<b>C</b>,7 x 10-6,,0.279322,'-,'-,'-,"SYPL1, CDHR3",Crohn's disease (indolent vs progressive),"disease progression measurement, Crohn's disease",GCST007499,7:106059997
rs114985235-<b>C</b>,9 x 10-23,,0.12,2.25,'-,[1.91-2.66],"LINC02571, HLA-B",Crohn's disease,Crohn's disease,GCST003360,6:31301916
rs9271060-<b>G</b>,1 x 10-22,,0.77,2.857143,'-,[2.33-3.57],"HLA-DQA1, HLA-DRB1",Crohn's disease,Crohn's disease,GCST003360,6:32607736
rs293526-<b>T</b>,2 x 10-11,,0.82,2.1276596,'-,[1.69-2.63],UBE3D,Crohn's disease,Crohn's disease,GCST003360,6:82938337
rs6478109-<b>G</b>,5 x 10-25,,0.51,2.0833335,'-,[1.82-2.38],"DELEC1, TNFSF15",Crohn's disease,Crohn's disease,GCST003360,9:114806486
rs140068907-<b>C</b>,1 x 10-11,,0.08,1.98,'-,[1.62-2.41],"HLA-DQB1, MTCO3P1",Crohn's disease,Crohn's disease,GCST003360,6:32691666
rs12481514-<b>A</b>,3 x 10-7,,NR,'-,4.469 unit increase,'-,ADRA1D,Paneth cell defects in Crohn's disease,"abnormal paneth cell measurement, Crohn's disease",GCST004251,20:4245273
rs723080-<b>C</b>,5 x 10-7,,NR,'-,4.754 unit decrease,'-,MAFB,Paneth cell defects in Crohn's disease,"abnormal paneth cell measurement, Crohn's disease",GCST004251,20:40728825
rs147629807-<b>?</b>,7 x 10-7,,NR,'-,8.139 unit decrease,'-,'-,Paneth cell defects in Crohn's disease,"abnormal paneth cell measurement, Crohn's disease",GCST004251,5:108553338
rs17318450-<b>A</b>,2 x 10-6,,NR,'-,5.826 unit decrease,'-,U3,Paneth cell defects in Crohn's disease,"abnormal paneth cell measurement, Crohn's disease",GCST004251,5:35482212
rs12494894-<b>A</b>,2 x 10-6,,NR,'-,6.381 unit decrease,'-,"GPR79, IQCJ-SCHIP1",Paneth cell defects in Crohn's disease,"abnormal paneth cell measurement, Crohn's disease",GCST004251,3:158878626
rs629922-<b>C</b>,3 x 10-6,,NR,'-,4.142 unit increase,'-,ZBTB16,Paneth cell defects in Crohn's disease,"abnormal paneth cell measurement, Crohn's disease",GCST004251,11:114194103
rs72622838-<b>A</b>,3 x 10-6,,NR,'-,4.181 unit decrease,'-,EYA1,Paneth cell defects in Crohn's disease,"abnormal paneth cell measurement, Crohn's disease",GCST004251,8:71188090
rs11978753-<b>G</b>,4 x 10-6,,NR,'-,5.941 unit decrease,'-,'-,Paneth cell defects in Crohn's disease,"abnormal paneth cell measurement, Crohn's disease",GCST004251,7:153020025
rs2238823-<b>A</b>,4 x 10-6,,NR,'-,5.626 unit decrease,'-,FBLN1,Paneth cell defects in Crohn's disease,"abnormal paneth cell measurement, Crohn's disease",GCST004251,22:45540440
rs76418789-<b>?</b>,4 x 10-7,,NR,1.1363636,'-,[1.08-1.19],"C1orf141, IL23R",Crohn's disease,Crohn's disease,GCST010577,1:67182913
rs117742432-<b>?</b>,7 x 10-6,,NR,1.1627907,'-,[1.09-1.23],SULF1,Crohn's disease,Crohn's disease,GCST010577,8:69560258
rs55951892-<b>?</b>,2 x 10-23,,NR,1.1235955,'-,[1.1-1.16],"TNFSF15, DELEC1",Crohn's disease,Crohn's disease,GCST010577,9:114813633
rs117223925-<b>?</b>,6 x 10-6,,NR,1.1111112,'-,[1.06-1.16],VSTM2B,Crohn's disease,Crohn's disease,GCST010577,19:29530539
rs12647478-<b>?</b>,8 x 10-6,,NR,1.0869565,'-,[1.05-1.14],'-,Crohn's disease,Crohn's disease,GCST010577,4:188972159
rs224136-<b>?</b>,1 x 10-7,,NR,1.0752687,'-,[1.05-1.11],ALDH7A1P4,Crohn's disease,Crohn's disease,GCST010577,10:62710915
rs151258497-<b>?</b>,5 x 10-6,,NR,1.0638298,'-,[1.03-1.09],TRPM3,Crohn's disease,Crohn's disease,GCST010577,9:71266959
rs6126698-<b>?</b>,8 x 10-6,,NR,1.0638298,'-,[1.03-1.1],"RPL36P1, TSHZ2",Crohn's disease,Crohn's disease,GCST010577,20:52931763
rs534888-<b>?</b>,7 x 10-6,,NR,1.0526316,'-,[1.03-1.09],RAP1A,Crohn's disease,Crohn's disease,GCST010577,1:111680080
rs12678162-<b>?</b>,3 x 10-6,,NR,1.06,'-,[1.03-1.08],"PVT1, RN7SKP226",Crohn's disease,Crohn's disease,GCST010577,8:128212448
rs56167332-<b>?</b>,3 x 10-7,,NR,1.07,'-,[1.04-1.09],"LINC01845, IL12B",Crohn's disease,Crohn's disease,GCST010577,5:159400761
rs2833577-<b>?</b>,1 x 10-6,,NR,1.07,'-,[1.04-1.11],HUNK,Crohn's disease,Crohn's disease,GCST010577,21:31954469
rs55843528-<b>?</b>,2 x 10-7,,NR,1.08,'-,[1.05-1.11],LINC02513,Crohn's disease,Crohn's disease,GCST010577,4:38359795
rs56354901-<b>?</b>,2 x 10-6,,NR,1.09,'-,[1.05-1.13],IL27,Crohn's disease,Crohn's disease,GCST010577,16:28511823
rs7515774-<b>?</b>,1 x 10-6,,NR,1.1,'-,[1.06-1.15],"PLA2G5, PLA2G2D",Crohn's disease,Crohn's disease,GCST010577,1:20111141
rs781387485-<b>?</b>,3 x 10-6,,NR,1.11,'-,[1.06-1.16],"GABRB3, GABRA5",Crohn's disease,Crohn's disease,GCST010577,15:26911391
rs11227126-<b>?</b>,2 x 10-6,,NR,1.12,'-,[1.07-1.18],"SYVN1, HIGD1AP10",Crohn's disease,Crohn's disease,GCST010577,11:65140591
rs4727354-<b>?</b>,3 x 10-6,,NR,1.14,'-,[1.08-1.20],"CCDC146, GSAP",Crohn's disease,Crohn's disease,GCST010577,7:77319034
rs9623882-<b>?</b>,2 x 10-6,,NR,1.14,'-,[1.08-1.20],IGLV3-21,Crohn's disease,Crohn's disease,GCST010577,22:22712129
rs184950714-<b>?</b>,1 x 10-17,,NR,1.16,'-,[1.12-1.19],"MTCO3P1, HLA-DQB1",Crohn's disease,Crohn's disease,GCST010577,6:32668951
rs10068082-<b>?</b>,2 x 10-6,,NR,1.17,'-,[1.10-1.26],PIK3R1,Crohn's disease,Crohn's disease,GCST010577,5:68395641
rs200319458-<b>?</b>,8 x 10-6,,NR,1.19,'-,[1.10-1.29],TMEM106B,Crohn's disease,Crohn's disease,GCST010577,7:12182175
chr20:47804952-<b>?</b>,3 x 10-6,,NR,1.21,'-,[1.12-1.32],'-,Crohn's disease,Crohn's disease,GCST010577,Mapping not available
rs79536569-<b>?</b>,4 x 10-6,,NR,1.23,'-,[1.13-1.35],SERPINB6,Crohn's disease,Crohn's disease,GCST010577,6:2957593
rs116855232-<b>T</b>,5 x 10-94,,0.04,35.63,'-,[22.47-56.51],NUDT15,Thiopurine-induced early leukopenia in Crohn's disease,"leukopenia, response to thiopurine, Crohn's disease",GCST007229,13:48045719
rs5743289-<b>?</b>,6 x 10-17,,NR,'-,'-,'-,NOD2,Crohn's disease,Crohn's disease,GCST000071,16:50722863
rs2076756-<b>?</b>,7 x 10-14,,0.24,'-,'-,'-,NOD2,Crohn's disease,Crohn's disease,GCST000023,16:50722970
rs224136-<b>?</b>,1 x 10-10,,0.81,1.67,'-,[NR],ALDH7A1P4,Crohn's disease,Crohn's disease,GCST000023,10:62710915
rs7517847-<b>?</b>,3 x 10-12,,0.4,'-,'-,'-,"IL23R, C1orf141",Crohn's disease,Crohn's disease,GCST000023,1:67215986
rs2241880-<b>G</b>,1 x 10-13,,0.55,1.45,'-,[1.27-1.64],ATG16L1,Crohn's disease,Crohn's disease,GCST000023,2:233274722
rs7551188-<b>T</b>,9 x 10-6,,NR,1.18,'-,[1.10-1.28],RUNX3,Crohn's disease,Crohn's disease,GCST001785,1:24946709
rs1487630-<b>T</b>,1 x 10-11,,NR,1.33,'-,[1.22-1.44],LINC02513,Crohn's disease,Crohn's disease,GCST001785,4:38334202
rs7329174-<b>G</b>,8 x 10-9,,NR,1.27,'-,[1.17-1.38],ELF1,Crohn's disease,Crohn's disease,GCST001785,13:40983974
rs9891119-<b>A</b>,2 x 10-15,,NR,1.37,'-,[1.27-1.48],STAT3,Crohn's disease,Crohn's disease,GCST001785,17:42355962
rs11894081-<b>T</b>,4 x 10-9,,0.55,1.22,'-,[1.2-1.22],LINC01248,Crohn's disease,Crohn's disease,GCST001785,2:5523876
rs72981516-<b>T</b>,4 x 10-7,,0.12,1.28,'-,[1.27-1.29],FCHSD2,Crohn's disease,Crohn's disease,GCST001785,11:72959855
rs3094188-<b>C</b>,7 x 10-7,,0.28,1.61,'-,[1.33-1.94],"PSORS1C3, POU5F1",Crohn's disease,Crohn's disease,GCST001785,6:31174468
rs9267911-<b>T</b>,3 x 10-7,,0.479,1.5,'-,[1.29-1.76],"TSBP1-AS1, NOTCH4",Crohn's disease,Crohn's disease,GCST001785,6:32237333
rs7765379-<b>G</b>,9 x 10-59,,NR,1.93,'-,[1.78-2.09],"HLA-DQB3, MTCO3P1",Crohn's disease,Crohn's disease,GCST001785,6:32713151
rs2274471-<b>A</b>,5 x 10-6,,NR,1.27,'-,[1.15-1.41],JAK2,Crohn's disease,Crohn's disease,GCST001785,9:4985879
rs6478106-<b>T</b>,5 x 10-46,,NR,1.73,'-,[1.60-1.86],TNFSF15,Crohn's disease,Crohn's disease,GCST001785,9:114783386
rs2241880-<b>?</b>,3 x 10-6,,NR,1.32,'-,[1.18-1.47],ATG16L1,Crohn's disease,Crohn's disease,GCST000705,2:233274722
rs2066847-<b>?</b>,2 x 10-15,,NR,1.62,'-,[1.42-1.86],"CYLD-AS1, NOD2",Crohn's disease,Crohn's disease,GCST000705,16:50729868
rs504963-<b>A</b>,2 x 10-8,,0.431,'-,'-,'-,FUT2,Crohn's disease,Crohn's disease,GCST000705,19:48705608
rs11465804-<b>?</b>,1 x 10-6,,NR,1.89,'-,[1.47-2.44],IL23R,Crohn's disease,Crohn's disease,GCST000705,1:67236843
rs2188962-<b>?</b>,1 x 10-7,,NR,1.36,'-,[1.21-1.52],IRF1-AS1,Crohn's disease,Crohn's disease,GCST000705,5:132435113
rs10045431-<b>?</b>,7 x 10-8,,NR,1.45,'-,[1.27-1.64],"LINC01845, IL12B",Crohn's disease,Crohn's disease,GCST000705,5:159387525
rs2301436-<b>?</b>,6 x 10-8,,NR,1.37,'-,[1.22-1.53],CEP43,Crohn's disease,Crohn's disease,GCST000705,6:167024500
rs7195303-<b>G</b>,9 x 10-6,,NR,2.1,'-,[1.5-2.8],"ZFP1, LDHD",Crohn's disease (time to surgery),Crohn's disease,GCST002018,16:75133681
rs11103429-<b>G</b>,6 x 10-6,,0.05,3.6,'-,[2.10-6.30],COL5A1,Crohn's disease (need for surgery),Crohn's disease,GCST002017,9:134614732
rs11978472-<b>?</b>,6 x 10-6,,0.7,2,'-,[1.43-2.50],CACNA2D1,Crohn's disease (need for surgery),Crohn's disease,GCST002017,7:82210237
rs11209026-<b>?</b>,2 x 10-18,,0.92,2.92,'-,[NR],IL23R,Crohn's disease,Crohn's disease,GCST000014,1:67240275
rs1373692-<b>?</b>,2 x 10-12,,0.59,1.46,'-,[NR],TTC33,Crohn's disease,Crohn's disease,GCST000014,5:40431081
rs5743289-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,NOD2,Crohn's disease,Crohn's disease,GCST000014,16:50722863
rs35990859-<b>G</b>,7 x 10-6,,NR,2.5445292,'-,[1.69-3.83],"IL12B, LINC01845",Inflammatory bowel disease,inflammatory bowel disease,GCST008731,5:159372740
rs730086-<b>A</b>,2 x 10-6,,NR,1.373,'-,[1.204-1.567],KAT2A,Inflammatory bowel disease,inflammatory bowel disease,GCST008731,17:42119739
rs7224339-<b>A</b>,9 x 10-6,,NR,1.8115942,'-,[1.39-2.35],STAT3,Inflammatory bowel disease,inflammatory bowel disease,GCST008731,17:42333197
rs11969064-<b>?</b>,5 x 10-9,,NR,2.3,'-,[1.7-3.1],NHLRC1,Thiopurine-induced myelosuppression in inflammatory bowel disease,"myelosuppression, response to thiopurine, inflammatory bowel disease",GCST008801,6:18104864
rs7547569-<b>?</b>,2 x 10-170,(EA),NR,'-,'-,'-,"RNU4ATAC4P, IL23R",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:67265685
rs13300218-<b>G</b>,7 x 10-20,(EA),0.9,1.1674234,'-,'-,NOTCH1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,9:136505189
rs72634258-<b>?</b>,1 x 10-19,(EA),NR,'-,'-,'-,ERRFI1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:8090578
rs2024092-<b>A</b>,1 x 10-18,(EA),0.2162,1.1127257,'-,[1.09-1.14],SBNO2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,19:1124032
rs116392568-<b>G</b>,2 x 10-18,(EA),0.3529,1.0993203,'-,[1.08-1.12],"LINC02571, HLA-B",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:31306603
rs12627970-<b>G</b>,2 x 10-18,(EA),0.2081,1.1155151,'-,[1.09-1.14],"SYNGR1, RPL3",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,22:39325740
rs4676410-<b>?</b>,4 x 10-18,(EA),NR,'-,'-,'-,GPR35,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:240624322
rs9868809-<b>A</b>,8 x 10-18,(EA),0.1036,1.14707,'-,[1.12-1.18],CELSR3,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,3:48643620
rs2179070-<b>?</b>,9 x 10-18,(EA),NR,'-,'-,'-,"TRAF3IP2, TRAF3IP2-AS1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:111564549
rs4845604-<b>G</b>,1 x 10-17,(EA),0.85,1.1315535,'-,'-,RORC,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:151829204
rs444210-<b>?</b>,2 x 10-17,(EA),NR,'-,'-,'-,"MIR3939, RNASET2",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:166976754
rs55808324-<b>?</b>,5 x 10-17,(EA),NR,'-,'-,'-,GALC,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,14:87978408
rs11641016-<b>?</b>,1 x 10-16,(EA),NR,'-,'-,'-,LINC02132,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,16:85981275
rs10956252-<b>?</b>,2 x 10-16,(EA),NR,'-,'-,'-,TRIB1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,8:125523895
rs12720356-<b>C</b>,4 x 10-16,(EA),0.08572,1.1598983,'-,[1.12-1.2],TYK2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,19:10359299
rs2488397-<b>?</b>,5 x 10-16,(EA),NR,'-,'-,'-,DENND1B,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:197732149
rs13300483-<b>A</b>,6 x 10-16,(EA),0.2394,1.0976037,'-,[1.08-1.12],DELEC1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,9:114881082
rs78487399-<b>?</b>,8 x 10-16,(EA),NR,'-,'-,'-,THADA,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:43582208
rs3764147-<b>G</b>,9 x 10-16,(EA),0.2297,1.099218,'-,[1.08-1.12],LACC1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,13:43883789
rs7097656-<b>G</b>,1 x 10-15,(EA),0.8,1.1044418,'-,'-,TSPAN14,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:80491075
rs4380874-<b>A</b>,2 x 10-15,(EA),0.4093,1.0839795,'-,[1.06-1.1],"PIGCP2, DLD",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,7:107839870
rs4768236-<b>C</b>,2 x 10-15,(EA),0.3295,1.0849894,'-,[1.06-1.11],LRRK2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,12:40362670
rs11677953-<b>?</b>,3 x 10-15,(EA),NR,'-,'-,'-,"ARPC2, GPBAR1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:218256940
rs2279990-<b>?</b>,3 x 10-15,(EA),NR,'-,'-,'-,FOSL2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:28413873
rs1003342-<b>?</b>,3 x 10-15,(EA),NR,'-,'-,'-,HORMAD2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,22:30174033
rs1842076-<b>A</b>,4 x 10-15,(EA),0.72,1.090434,'-,'-,LINC00604,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:40236916
rs1363907-<b>A</b>,5 x 10-15,(EA),0.4212,1.084916,'-,[1.06-1.11],ERAP2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:96917099
rs6933404-<b>?</b>,6 x 10-15,(EA),NR,'-,'-,'-,"LINC02539, BTF3L4P3",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:137638098
rs2395022-<b>?</b>,9 x 10-15,(EA),NR,'-,'-,'-,"KPNA7, SMURF1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,7:99152756
rs1260326-<b>A</b>,1 x 10-14,(EA),0.4059,1.080162,'-,[1.06-1.1],'-,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,Mapping not available
rs11641184-<b>A</b>,1 x 10-14,(EA),0.4762,1.0803548,'-,[1.06-1.1],LITAF,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,16:11610795
rs17694108-<b>A</b>,1 x 10-14,(EA),0.2797,1.089548,'-,[1.07-1.11],"CEBPA, SLC7A10",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,19:33240645
rs6920220-<b>A</b>,1 x 10-14,(EA),0.2086,1.0993968,'-,[1.08-1.12],LINC02539,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:137685367
rs11230563-<b>G</b>,2 x 10-14,(EA),0.65,1.0845813,'-,'-,CD6,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,11:61008737
rs449454-<b>?</b>,2 x 10-14,(EA),NR,'-,'-,'-,NDFIP1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:142153497
rs3776414-<b>?</b>,3 x 10-14,(EA),NR,'-,'-,'-,DAP,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:10689450
rs12718244-<b>A</b>,3 x 10-14,(EA),0.4081,1.079147,'-,[1.06-1.1],SPATA48,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,7:50136058
rs1517352-<b>C</b>,4 x 10-14,(EA),0.6,1.0809946,'-,'-,STAT4,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:191066738
rs6708413-<b>G</b>,9 x 10-14,(EA),0.2376,1.0917488,'-,[1.07-1.11],IL18RAP,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:102446909
rs516246-<b>A</b>,1 x 10-13,(EA),0.4652,1.0784879,'-,[1.06-1.1],FUT2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,19:48702915
rs2328546-<b>?</b>,1 x 10-13,(EA),NR,'-,'-,'-,CDKAL1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:20657114
rs7657746-<b>A</b>,2 x 10-13,(EA),0.76,1.0907376,'-,'-,KIAA1109,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,4:122240464
rs2266961-<b>?</b>,3 x 10-13,(EA),NR,'-,'-,'-,UBE2L3,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,22:21574308
rs559928-<b>G</b>,3 x 10-13,(EA),0.81,1.098986,'-,'-,"RPS6KA4, LINC02723",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,11:64382898
rs1456896-<b>A</b>,3 x 10-13,(EA),0.69,1.0815443,'-,'-,IKZF1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,7:50264865
rs9557207-<b>?</b>,4 x 10-13,(EA),NR,'-,'-,'-,UBAC2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,13:99384164
rs941823-<b>G</b>,6 x 10-13,(EA),0.75,1.0865605,'-,'-,LINC00598,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,13:40439840
rs3742130-<b>G</b>,9 x 10-13,(EA),0.78,1.0902634,'-,'-,"UBAC2, GPR18",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,13:99255087
rs1292053-<b>G</b>,1 x 10-12,(EA),0.442,1.0726192,'-,[1.05-1.09],TUBD1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,17:59886176
rs4976646-<b>G</b>,3 x 10-12,(EA),0.3415,1.0757427,'-,[1.06-1.1],RGS14,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:177361569
rs12722515-<b>C</b>,5 x 10-12,(EA),0.84,1.1039582,'-,'-,IL2RA,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:6039267
rs1505992-<b>A</b>,7 x 10-32,(EA),0.68,1.1339794,'-,'-,TTC33,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:40498475
rs17800987-<b>?</b>,2 x 10-31,(EA),NR,'-,'-,'-,ZNF300P1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:150943866
rs1297258-<b>?</b>,5 x 10-30,(EA),NR,'-,'-,'-,CYCSP42,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,21:15434390
rs8127691-<b>?</b>,9 x 10-30,(EA),NR,'-,'-,'-,GATD3A,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,21:44194977
rs2847278-<b>?</b>,8 x 10-28,(EA),NR,'-,'-,'-,"PTPN2, LINC01882",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,18:12778716
rs1893217-<b>G</b>,1 x 10-27,(EA),0.1602,1.1539862,'-,[1.13-1.18],PTPN2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,18:12809341
rs12318183-<b>?</b>,2 x 10-27,(EA),NR,'-,'-,'-,IFNG-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,12:68110056
rs9313808-<b>G</b>,1 x 10-25,(EA),0.83,1.1528302,'-,'-,"LINC01845, IL12B",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:159393836
rs34779708-<b>?</b>,2 x 10-25,(EA),NR,'-,'-,'-,CREM,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:35177257
rs11010067-<b>G</b>,6 x 10-25,(EA),0.3513,1.1115612,'-,[1.09-1.13],"LINC02635, CUL2",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:35006503
rs11743851-<b>G</b>,2 x 10-23,(EA),0.3698,1.1078569,'-,[1.09-1.13],CDC42SE2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:131277907
rs744166-<b>?</b>,1 x 10-22,(EA),NR,'-,'-,'-,STAT3,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,17:42362183
rs4946717-<b>?</b>,4 x 10-22,(EA),NR,'-,'-,'-,PRDM1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:106026874
rs62037363-<b>?</b>,6 x 10-22,(EA),NR,'-,'-,'-,SH2B1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,16:28853721
rs1388585-<b>?</b>,7 x 10-22,(EA),NR,'-,'-,'-,"LINC02555, SLC2A13",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,12:40137889
rs26528-<b>G</b>,1 x 10-21,(EA),0.4576,1.1017768,'-,[1.08-1.12],IL27,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,16:28506388
rs11554257-<b>G</b>,4 x 10-21,(EA),0.1294,1.1484206,'-,[1.12-1.18],"TNFSF15, DELEC1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,9:114842790
rs9889296-<b>?</b>,1 x 10-20,(EA),NR,'-,'-,'-,"CCL2, LINC01989",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,17:34243528
rs13407913-<b>G</b>,2 x 10-20,(EA),0.4306,1.0960438,'-,[1.08-1.12],ADCY3,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:24874775
rs1420098-<b>?</b>,2 x 10-20,(EA),NR,'-,'-,'-,IL18R1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:102367819
rs395157-<b>A</b>,2 x 10-20,(EA),0.4842,1.0956664,'-,[1.08-1.12],OSMR,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:38867630
rs35164067-<b>?</b>,3 x 10-20,(EA),NR,'-,'-,'-,CDC37,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,19:10414505
rs17293632-<b>A</b>,3 x 10-20,(EA),0.2364,1.1131175,'-,[1.09-1.14],SMAD3,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,15:67150258
rs3091315-<b>A</b>,4 x 10-20,(EA),0.73,1.1091312,'-,'-,"CCL7, CCL2",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,17:34266646
rs1250566-<b>?</b>,5 x 10-20,(EA),NR,'-,'-,'-,ZMIZ1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:79286696
rs10798069-<b>C</b>,2 x 10-7,(EA),0.51,1.0524286,'-,'-,PLA2G4A,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:186906327
rs2189234-<b>A</b>,4 x 10-7,(EA),0.3692,1.0531957,'-,[1.03-1.07],TET2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,4:105154341
rs12199775-<b>A</b>,4 x 10-7,(EA),0.93,1.1094881,'-,'-,PHACTR2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:143577757
rs7165170-<b>A</b>,4 x 10-7,(EA),0.82,1.0670352,'-,'-,"CRTC3-AS1, CRTC3",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,15:90638257
rs16967103-<b>G</b>,4 x 10-7,(EA),0.1937,1.0664214,'-,[1.04-1.09],"RASGRP1, LINC02694",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,15:38606989
rs3116494-<b>G</b>,5 x 10-7,(EA),0.2539,1.0607666,'-,[1.04-1.08],CD28,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:203727298
rs4728142-<b>A</b>,6 x 10-7,(EA),0.439,1.0520436,'-,[1.03-1.07],"IRF5, KCP",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,7:128933913
rs1077773-<b>A</b>,6 x 10-7,(EA),0.52,1.0502108,'-,'-,LINC02888,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,7:17403055
rs17229285-<b>G</b>,8 x 10-7,(EA),0.4966,1.0505787,'-,[1.03-1.07],PLCL1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:198658398
rs11150589-<b>A</b>,9 x 10-7,(EA),0.4732,1.0513153,'-,[1.03-1.07],Y_RNA,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,16:30471173
rs4243971-<b>C</b>,9 x 10-7,(EA),0.56,1.0498904,'-,'-,"KIF3B, POFUT1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,20:32261714
rs7438704-<b>G</b>,9 x 10-7,(EA),0.64,1.0524054,'-,'-,SLAIN2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,4:48361228
rs490608-<b>?</b>,1 x 10-6,(EA),NR,'-,'-,'-,DAP3,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:155713079
rs6856616-<b>G</b>,1 x 10-6,(EA),0.06662,1.0979221,'-,[1.06-1.14],LINC02513,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,4:38323415
rs13204048-<b>A</b>,1 x 10-6,(EA),0.61,1.0509611,'-,'-,SLC22A23,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:3420172
rs6667605-<b>G</b>,1 x 10-6,(EA),0.51,1.0500121,'-,'-,"TNFRSF14, PRXL2B",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:2571341
rs10061469-<b>A</b>,1 x 10-6,(EA),0.67,1.0531912,'-,'-,TMEM174,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:73222321
rs11583043-<b>A</b>,2 x 10-6,(EA),0.2658,1.0553302,'-,[1.03-1.08],DPH5,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:101000498
rs11083840-<b>C</b>,2 x 10-6,(EA),0.4025,1.0484828,'-,[1.03-1.07],"CALM3, PTGIR",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,19:46616653
rs727563-<b>G</b>,3 x 10-6,(EA),0.2027,1.0581502,'-,[1.03-1.08],ACO2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,22:41471373
rs732072-<b>?</b>,4 x 10-6,(EA),NR,'-,'-,'-,RELA,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,11:65660097
rs2641348-<b>A</b>,4 x 10-6,(EA),0.89,1.0770205,'-,'-,ADAM30,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:119895261
rs11054935-<b>G</b>,5 x 10-6,(EA),0.2756,1.0518209,'-,[1.03-1.07],DUSP16,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,12:12495909
rs9525625-<b>A</b>,7 x 10-6,(EA),0.4706,1.0460321,'-,[1.03-1.07],LINC02341,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,13:42443894
rs653178-<b>G</b>,1 x 10-8,(EA),0.4942,1.0580138,'-,[1.04-1.08],'-,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,Mapping not available
rs4692386-<b>G</b>,1 x 10-8,(EA),0.59,1.0596887,'-,'-,"RBPJ, LINC02357",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,4:26130739
rs7236492-<b>G</b>,1 x 10-8,(EA),0.85,1.0835682,'-,'-,NFATC1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,18:79460616
rs72810983-<b>A</b>,2 x 10-8,(EA),0.69,1.0646069,'-,'-,CPEB4,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:173891251
rs907611-<b>A</b>,2 x 10-8,(EA),0.3211,1.0621415,'-,[1.04-1.08],LSP1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,11:1852842
rs4802307-<b>C</b>,2 x 10-8,(EA),0.7,1.0630091,'-,'-,"PPP5C, HIF3A",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,19:46346549
rs7011507-<b>G</b>,2 x 10-8,(EA),0.88,1.0882828,'-,'-,IDI1P2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,8:48216682
rs6025-<b>G</b>,3 x 10-8,(EA),0.97,1.1942284,'-,'-,F5,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:169549811
rs4664304-<b>A</b>,3 x 10-8,(EA),0.4379,1.0576227,'-,[1.04-1.08],PLA2R1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:159937497
rs6058869-<b>?</b>,3 x 10-8,(EA),NR,'-,'-,'-,"COMMD7, DNMT3B",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,20:32760944
rs2945412-<b>A</b>,3 x 10-8,(EA),0.59,1.0579644,'-,'-,KSR1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,17:27516617
rs7015630-<b>A</b>,3 x 10-8,(EA),0.73,1.0647925,'-,'-,"RNU6-925P, COX6B1P6",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,8:89863690
rs7404095-<b>G</b>,3 x 10-8,(EA),0.58,1.0573224,'-,'-,PRKCB,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,16:23853269
rs113010081-<b>G</b>,4 x 10-8,(EA),0.1073,1.0966138,'-,[1.06-1.13],"LINC02009, CCRL2",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,3:46415921
rs17057051-<b>A</b>,6 x 10-8,(EA),0.69,1.060473,'-,'-,PTK2B,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,8:27370037
rs11064881-<b>A</b>,6 x 10-8,(EA),0.07342,1.1044849,'-,[1.07-1.14],CIT,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,12:119709120
rs483905-<b>A</b>,7 x 10-8,(EA),0.289,1.0595956,'-,[1.04-1.08],MAML2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,11:96290263
rs10065637-<b>G</b>,1 x 10-7,(EA),0.79,1.0710944,'-,'-,ANKRD55,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:56143024
rs7517810-<b>A</b>,1 x 10-7,(EA),0.2361,1.0629416,'-,[1.04-1.09],AIMP1P2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:172884320
rs7758080-<b>G</b>,1 x 10-7,(EA),0.2694,1.0597305,'-,[1.04-1.08],"TAB2, TAB2-AS1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:149255943
rs13277237-<b>G</b>,1 x 10-7,(EA),0.435,1.0555866,'-,[1.04-1.08],CCDC26,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,8:129592317
rs2073505-<b>A</b>,1 x 10-7,(EA),0.07545,1.0996872,'-,[1.06-1.14],HGFAC,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,4:3442776
rs564349-<b>G</b>,2 x 10-7,(EA),0.3183,1.056796,'-,[1.04-1.08],ERGIC1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:172897975
rs212388-<b>G</b>,2 x 10-7,(EA),0.3957,1.0551589,'-,[1.03-1.08],TAGAP-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:159069404
rs10486483-<b>A</b>,2 x 10-7,(EA),0.2371,1.0620762,'-,[1.04-1.08],SKAP2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,7:26852821
rs4812833-<b>A</b>,9 x 10-6,(EA),0.52,1.0450912,'-,'-,LINC01620,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,20:44440356
rs6880778-<b>?</b>,5 x 10-65,(EA),NR,'-,'-,'-,'-,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:40398994
rs10748781-<b>?</b>,2 x 10-63,(EA),NR,'-,'-,'-,"GOT1, LINC01475",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:99523573
rs113653754-<b>C</b>,3 x 10-58,(EA),0.73,1.213039,'-,'-,"HLA-DQA1, HLA-DQB1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:32658495
rs4077515-<b>?</b>,1 x 10-53,(EA),NR,'-,'-,'-,CARD9,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,9:136372044
rs10761659-<b>G</b>,5 x 10-53,(EA),0.54,1.1662705,'-,'-,ALDH7A1P4,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:62685804
rs9836291-<b>?</b>,1 x 10-52,(EA),NR,'-,'-,'-,BSN,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,3:49660026
rs11236797-<b>?</b>,9 x 10-52,(EA),NR,'-,'-,'-,"EMSY, LINC02757",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,11:76588605
rs3024493-<b>?</b>,2 x 10-50,(EA),NR,'-,'-,'-,IL10,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:206770623
rs56167332-<b>A</b>,7 x 10-50,(EA),0.3375,1.1686567,'-,[1.15-1.19],"LINC01845, IL12B",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:159400761
rs2836883-<b>?</b>,3 x 10-48,(EA),NR,'-,'-,'-,RPL23AP12,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,21:39094818
rs75900472-<b>C</b>,5 x 10-48,(EA),0.3496,1.160397,'-,[1.14-1.18],"JAK2, HNRNPA1P41",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,9:4981601
rs35730213-<b>?</b>,8 x 10-45,(EA),NR,'-,'-,'-,INAVA,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:200905101
rs4795397-<b>?</b>,8 x 10-44,(EA),NR,'-,'-,'-,"ZPBP2, IKZF3",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,17:39867492
rs56399423-<b>?</b>,4 x 10-43,(EA),NR,'-,'-,'-,"SLC22A4, MIR3936HG",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:132336964
rs17622378-<b>G</b>,1 x 10-42,(EA),0.4186,1.1465615,'-,[1.13-1.17],"IRF1, IRF1-AS1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:132442760
rs12994997-<b>A</b>,3 x 10-41,(EA),0.53,1.1429542,'-,'-,ATG16L1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:233264857
rs12946510-<b>A</b>,2 x 10-39,(EA),0.4675,1.1405234,'-,[1.12-1.16],"IKZF3, GRB7",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,17:39756124
rs2143178-<b>?</b>,5 x 10-38,(EA),NR,'-,'-,'-,"PDGFB, RPL3",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,22:39264824
rs10800309-<b>?</b>,6 x 10-37,(EA),NR,'-,'-,'-,FCGR2A,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:161502368
rs7608910-<b>G</b>,3 x 10-36,(EA),0.3909,1.1347865,'-,[1.12-1.15],PUS10,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:60977721
rs6426833-<b>A</b>,3 x 10-36,(EA),0.54,1.1322339,'-,'-,"OTUD3, RNF186",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:19845367
rs1801274-<b>A</b>,9 x 10-36,(EA),0.5,1.1334659,'-,'-,FCGR2A,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:161509955
rs7848647-<b>?</b>,3 x 10-35,(EA),NR,'-,'-,'-,"TNFSF15, DELEC1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,9:114806766
rs6062496-<b>?</b>,2 x 10-33,(EA),NR,'-,'-,'-,"RTEL1-TNFRSF6B, TNFRSF6B",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,20:63697746
rs6556412-<b>A</b>,1 x 10-32,(EA),0.326,1.1336317,'-,[1.11-1.15],"LINC01845, IL12B",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:159360377
rs11229555-<b>C</b>,5 x 10-12,(EA),0.75,1.0819354,'-,'-,GLYAT,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,11:58641214
rs6740462-<b>A</b>,6 x 10-12,(EA),0.74,1.0832434,'-,'-,"DNAJB12P1, SPRED2",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:65440138
rs259964-<b>A</b>,7 x 10-12,(EA),0.4586,1.0697858,'-,[1.05-1.09],ZNF831,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,20:59249254
rs2153283-<b>?</b>,2 x 10-11,(EA),NR,'-,'-,'-,IPMK,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:58212538
rs2050392-<b>?</b>,2 x 10-11,(EA),NR,'-,'-,'-,"CCND3P1, NIFKP1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:30402574
rs2297559-<b>?</b>,2 x 10-11,(EA),NR,'-,'-,'-,ITLN1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:160884736
rs17119-<b>A</b>,2 x 10-11,(EA),0.81,1.0868671,'-,'-,"PPIAP9, RNU6-793P",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:14719265
rs2538470-<b>A</b>,3 x 10-11,(EA),0.3622,1.0698943,'-,[1.05-1.09],"RPL32P17, RN7SL72P",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,7:148523356
rs17780256-<b>A</b>,3 x 10-11,(EA),0.81,1.0870057,'-,'-,SLC39A11,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,17:72646784
rs12103-<b>A</b>,3 x 10-11,(EA),0.1834,1.0906081,'-,[1.06-1.12],INTS11,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:1312114
rs12585310-<b>?</b>,5 x 10-11,(EA),NR,'-,'-,'-,"RPS21P8, FGFR1OP2P1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,13:26954210
rs913678-<b>A</b>,5 x 10-11,(EA),0.67,1.0716122,'-,'-,"LINC01271, RN7SL636P",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,20:50338887
rs4703855-<b>G</b>,7 x 10-11,(EA),0.7,1.0736468,'-,'-,"PTCD2, YBX1P5",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:72398072
rs11708026-<b>?</b>,8 x 10-11,(EA),NR,'-,'-,'-,SATB1-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,3:18700310
rs6074022-<b>G</b>,8 x 10-11,(EA),0.2503,1.0770855,'-,[1.05-1.1],"RPL13P2, CD40",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,20:46111557
rs13126505-<b>A</b>,1 x 10-10,(EA),0.06306,1.1371485,'-,[1.1-1.18],BANK1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,4:101944147
rs7240004-<b>A</b>,1 x 10-10,(EA),0.62,1.068784,'-,'-,"SMAD7, CTIF",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,18:48868651
rs6716753-<b>G</b>,1 x 10-10,(EA),0.1896,1.0847341,'-,[1.06-1.11],SP140,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:230232414
rs34920465-<b>?</b>,1 x 10-10,(EA),NR,'-,'-,'-,"ZBTB40, PPIAP34",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:22373858
rs423674-<b>C</b>,2 x 10-10,(EA),0.8,1.0876718,'-,'-,RMI2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,16:11279548
rs11187157-<b>?</b>,2 x 10-10,(EA),NR,'-,'-,'-,"EXOC6, Y_RNA",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:92742487
rs7556897-<b>A</b>,2 x 10-10,(EA),0.66,1.0683979,'-,'-,"CCL20, SNRPGP8",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:227795396
rs71559680-<b>G</b>,2 x 10-10,(EA),0.53,1.0647465,'-,'-,LINC00581,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:21430497
rs2688608-<b>?</b>,3 x 10-10,(EA),NR,'-,'-,'-,"CAMK2G, PLAU",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:73898591
rs1990760-<b>?</b>,4 x 10-10,(EA),NR,'-,'-,'-,IFIH1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:162267541
rs2816958-<b>G</b>,4 x 10-10,(EA),0.89,1.1040689,'-,'-,NR5A2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:200132792
rs314313-<b>G</b>,4 x 10-10,(EA),0.3043,1.0688285,'-,[1.05-1.09],EPHB4,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,7:100825743
rs13204742-<b>A</b>,5 x 10-10,(EA),0.1267,1.0959492,'-,[1.07-1.12],"THEMIS, PTPRK",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:127924620
rs1847472-<b>C</b>,7 x 10-10,(EA),0.66,1.0695955,'-,'-,BACH2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:90263440
rs3853824-<b>G</b>,8 x 10-10,(EA),0.64,1.0661255,'-,'-,C17orf67,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,17:56803632
rs254560-<b>A</b>,9 x 10-10,(EA),0.4024,1.0634166,'-,[1.04-1.08],C5orf66,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:135107916
rs6651252-<b>A</b>,9 x 10-10,(EA),0.87,1.095103,'-,'-,LINC00824,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,8:128554935
rs1182188-<b>A</b>,1 x 10-9,(EA),0.7,1.068123,'-,'-,GNA12,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,7:2830351
rs3184504-<b>?</b>,1 x 10-9,(EA),NR,'-,'-,'-,"SH2B3, ATXN2",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,12:111446804
rs561722-<b>G</b>,2 x 10-9,(EA),0.66,1.0666672,'-,'-,"NXPE1, NXPE2P1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,11:114516108
rs17207042-<b>?</b>,2 x 10-9,(EA),NR,'-,'-,'-,CD226,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,18:69870115
rs11681525-<b>G</b>,2 x 10-9,(EA),0.91,1.1134332,'-,'-,TEX41,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,2:144734815
rs7555082-<b>A</b>,3 x 10-9,(EA),0.1069,1.1006883,'-,[1.07-1.13],"PTPRC, ATP6V1G3",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:198629533
rs1535-<b>?</b>,3 x 10-9,(EA),NR,'-,'-,'-,FADS2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,11:61830500
rs915286-<b>A</b>,3 x 10-9,(EA),0.55,1.0604076,'-,'-,LINC00598,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,13:40121855
rs1569328-<b>G</b>,3 x 10-9,(EA),0.83,1.0843407,'-,'-,"FOS, U2",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,14:75275048
rs4743820-<b>A</b>,4 x 10-9,(EA),0.7,1.0660416,'-,'-,LINC00484,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,9:91166134
rs17061048-<b>A</b>,5 x 10-9,(EA),0.95,1.1451334,'-,'-,LINC00598,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,13:40258875
rs2284553-<b>G</b>,5 x 10-9,(EA),0.59,1.061271,'-,'-,IFNGR2,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,21:33404389
rs7773324-<b>A</b>,6 x 10-9,(EA),0.6,1.0637687,'-,'-,"IRF4, DUSP22",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:382559
rs9358372-<b>G</b>,6 x 10-9,(EA),0.3668,1.0623451,'-,[1.04-1.08],CDKAL1,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,6:20812357
rs2274351-<b>?</b>,7 x 10-9,(EA),NR,'-,'-,'-,SUFU,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,10:102504350
rs10051722-<b>A</b>,9 x 10-9,(EA),0.7,1.0635655,'-,'-,'-,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,5:130768383
rs34856868-<b>G</b>,1 x 10-8,(EA),0.97,1.2156452,'-,'-,BTBD8,Inflammatory bowel disease,inflammatory bowel disease,GCST003043,1:92088726
rs10142466-<b>?</b>,1 x 10-8,(EA),NR,'-,'-,'-,"MAGOH3P, ZFP36L1",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,14:68805067
rs4903214-<b>?</b>,8 x 10-6,,NR,1.5393178,'-,[1.27-1.87],VSX2,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,14:74252096
rs6596-<b>?</b>,4 x 10-22,(Children),NR,2.2327087,'-,[1.89-2.63],SNX20,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,16:50675812
rs13333062-<b>?</b>,6 x 10-9,(Children),NR,1.6329753,'-,[1.38-1.93],LINC02128,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,16:50888875
rs1049526-<b>?</b>,2 x 10-8,(Children),NR,2.3504539,'-,[1.73-3.19],BRD2,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,6:32981027
rs501916-<b>?</b>,1 x 10-8,(Children),NR,1.5665871,'-,[1.34-1.83],SEMA6D,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,15:47761032
rs6596-<b>?</b>,5 x 10-13,(Adult),NR,1.9665943,'-,[1.64-2.36],SNX20,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,16:50675812
rs13333062-<b>?</b>,3 x 10-6,(Adult),NR,1.5508206,'-,[1.29-1.86],LINC02128,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,16:50888875
rs1049526-<b>?</b>,9 x 10-10,(Adult),NR,2.659634,'-,[1.93-3.66],BRD2,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,6:32981027
rs2395128-<b>?</b>,1 x 10-8,(Adult),NR,1.6475215,'-,[1.39-1.96],DUSP29,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,10:75052692
rs2187668-<b>?</b>,2 x 10-7,(Adult),NR,1.9647566,'-,[1.52-2.56],HLA-DQA1,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,6:32638107
rs11209026-<b>?</b>,2 x 10-6,(Adult),NR,3.0934768,'-,[1.89-5],IL23R,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,1:67240275
rs6596-<b>?</b>,3 x 10-24,,NR,2.1309102,'-,[1.83-2.48],SNX20,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,16:50675812
rs13333062-<b>?</b>,4 x 10-10,,NR,1.5971283,'-,[1.38-1.85],LINC02128,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,16:50888875
rs1049526-<b>?</b>,5 x 10-11,,NR,2.434453,'-,[1.83-3.24],BRD2,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,6:32981027
rs501916-<b>?</b>,4 x 10-6,,NR,1.3860564,'-,[1.20-1.59],SEMA6D,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,15:47761032
rs2395128-<b>?</b>,9 x 10-9,,NR,1.5015358,'-,[1.31-1.73],DUSP29,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,10:75052692
rs11209026-<b>?</b>,2 x 10-6,,NR,2.169659,'-,[1.56-3.03],IL23R,Inflammatory bowel disease,inflammatory bowel disease,GCST003958,1:67240275
rs3024505-<b>?</b>,6 x 10-6,,NR,1.4241549,'-,[1.22-1.66],"IL10, Y_RNA",Inflammatory bowel disease,inflammatory bowel disease,GCST003958,1:206766559
rs2188962-<b>?</b>,4 x 10-27,,'-,'-,'-,'-,IRF1-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:132435113
rs11741861-<b>?</b>,3 x 10-15,,'-,'-,'-,'-,"IRGM, ZNF300",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,5:150898347
rs3180018-<b>?</b>,6 x 10-8,,'-,'-,'-,'-,SCAMP3,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,1:155260340
rs28449958-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,"NUPR1, IL27",Inflammatory bowel disease,inflammatory bowel disease,GCST004131,16:28517460
rs3197999-<b>?</b>,1 x 10-33,,'-,'-,'-,'-,MST1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,3:49684099
rs6927022-<b>?</b>,2 x 10-31,,'-,'-,'-,'-,HLA-DQA1,Inflammatory bowel disease,inflammatory bowel disease,GCST004131,6:32644620
rs853974-<b>A</b>,6 x 10-9,,NR,'-,'-,'-,'-,Liver transplant-free survival in primary sclerosing cholangitis (time to event),sclerosing cholangitis,GCST005859,Mapping not available
rs1532244-<b>G</b>,9 x 10-7,,NR,'-,'-,'-,LINC01967,Liver transplant-free survival in primary sclerosing cholangitis (time to event),sclerosing cholangitis,GCST005859,3:28016414
rs17649817-<b>A</b>,7 x 10-8,,NR,'-,'-,'-,KCNIP1,Liver transplant-free survival in primary sclerosing cholangitis (time to event),sclerosing cholangitis,GCST005859,5:170529575
rs72980770-<b>C</b>,2 x 10-6,,0.85,1.19,'-,[1.11-1.28],"TNFAIP3, LINC02528",Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,6:137913152
rs74407346-<b>T</b>,2 x 10-6,,0.01,1.97,'-,[1.49-2.61],CRAT37,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,15:91517544
rs681343-<b>T</b>,3 x 10-6,,0.46,1.11,'-,[1.06-1.17],FUT2,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,19:48703205
rs61954180-<b>C</b>,2 x 10-6,,0.08,1.21,'-,[1.12-1.31],LINC00598,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,13:40220445
rs61762349-<b>A</b>,3 x 10-6,,0.02,1.47,'-,[1.25-1.72],MME,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,3:155089424
rs3748816-<b>A</b>,5 x 10-13,,0.66,1.2,'-,[1.14-1.26],MMEL1,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,1:2595307
rs7426056-<b>A</b>,2 x 10-16,,0.25,1.25,'-,[1.19-1.32],"CD28, KRT18P39",Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,2:203747335
rs3197999-<b>A</b>,5 x 10-26,,0.3,1.33,'-,[1.26-1.40],MST1,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,3:49684099
rs13140464-<b>G</b>,1 x 10-13,,0.84,1.28,'-,[1.20-1.36],IL21,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,4:122578590
rs56258221-<b>C</b>,1 x 10-9,,0.18,1.21,'-,[1.14-1.29],MIR4464,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,6:90320722
rs4147359-<b>A</b>,8 x 10-17,,0.36,1.22,'-,[1.16-1.28],"IL2RA, RPL32P23",Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,10:6066476
rs7937682-<b>C</b>,5 x 10-7,,0.28,1.14,'-,[1.08-1.20],SIK2,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,11:111709215
rs3184504-<b>T</b>,4 x 10-13,,0.5,1.18,'-,[1.13-1.24],"SH2B3, ATXN2",Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,12:111446804
rs1788097-<b>T</b>,7 x 10-12,,0.49,1.19,'-,[1.13-1.25],CD226,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,18:69876452
rs60652743-<b>A</b>,2 x 10-12,,0.84,1.28,'-,[1.20-1.37],PRKD2,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,19:46702450
rs2836883-<b>G</b>,4 x 10-13,,0.74,1.23,'-,[1.17-1.31],RPL23AP12,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,21:39094818
rs72837826-<b>T</b>,2 x 10-11,,0.12,1.29,'-,[1.19-1.39],MIR4435-2HG,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,2:111175424
rs80060485-<b>C</b>,3 x 10-15,,0.07,1.44,'-,[1.32-1.58],FOXP1,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,3:71104739
rs663743-<b>G</b>,2 x 10-13,,0.66,1.2,'-,[1.14-1.26],CCDC88B,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,11:64340263
rs725613-<b>T</b>,4 x 10-13,,0.65,1.2,'-,[1.14-1.26],CLEC16A,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,16:11075826
rs1893592-<b>A</b>,2 x 10-12,,0.73,1.22,'-,[1.15-1.29],UBASH3A,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,21:42434957
rs61861422-<b>T</b>,1 x 10-8,,0.13,1.23,'-,[1.15-1.32],INPP5A,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,10:132544853
rs36023390-<b>C</b>,2 x 10-8,,0.63,1.16,'-,[1.10-1.22],FOXP1,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,3:71473942
rs145832854-<b>G</b>,3 x 10-8,,0.98,1.87,'-,[1.50-2.33],SGSM1,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,22:24914162
rs228614-<b>G</b>,1 x 10-7,,0.52,1.13,'-,[1.08-1.18],MANBA,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,4:102657480
rs4293777-<b>C</b>,3 x 10-7,,0.48,1.12,'-,[1.07-1.17],"CLNK, LINC02498",Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,4:10715315
rs74856421-<b>T</b>,4 x 10-7,,0.07,1.26,'-,[1.15-1.38],"CREBBP, TRAP1",Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,16:3723109
rs79390277-<b>C</b>,7 x 10-7,,0.05,1.28,'-,[1.16-1.42],TANGO6,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,16:68908687
rs850526-<b>C</b>,1 x 10-6,,0.29,1.2,'-,[1.11-1.29],GNGT2,Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,17:49208404
rs11632488-<b>G</b>,1 x 10-6,,0.24,1.18,'-,[1.10-1.26],"Metazoa_SRP, BCL2A1",Primary sclerosing cholangitis,sclerosing cholangitis,GCST004030,15:79975159
rs3197999-<b>?</b>,1 x 10-16,,0.28,1.39,'-,[1.24-1.56],MST1,Primary sclerosing cholangitis,sclerosing cholangitis,GCST000915,3:49684099
rs6720394-<b>?</b>,4 x 10-8,,0.11,1.29,'-,[1.10-1.51],MIR4435-2HG,Primary sclerosing cholangitis,sclerosing cholangitis,GCST000915,2:111231795
rs2655211-<b>G</b>,7 x 10-6,,NR,1.6155089,'-,[1.31-1.99],"NUP210, HDAC11-AS1",Ulcerative colitis,ulcerative colitis,GCST008732,3:13451731
rs1049526-<b>?</b>,2 x 10-8,,'-,2.3810558,'-,[1.74-3.26],BRD2,Ulcerative colitis,ulcerative colitis,GCST003960,6:32981027
rs501916-<b>?</b>,5 x 10-7,,'-,1.512222,'-,[1.29-1.78],SEMA6D,Ulcerative colitis,ulcerative colitis,GCST003960,15:47761032
rs2395128-<b>?</b>,2 x 10-7,,'-,1.5446734,'-,[1.31-1.82],DUSP29,Ulcerative colitis,ulcerative colitis,GCST003960,10:75052692
rs56404409-<b>?</b>,6 x 10-6,,'-,1.5007368,'-,[1.26-1.79],GRAMD1B,Ulcerative colitis,ulcerative colitis,GCST003960,11:123459759
rs501916-<b>?</b>,4 x 10-10,(Children),'-,1.8129687,'-,[1.51-2.18],SEMA6D,Ulcerative colitis,ulcerative colitis,GCST003960,15:47761032
rs1049526-<b>?</b>,3 x 10-7,(Adults),'-,2.697503,'-,[1.87-3.90],BRD2,Ulcerative colitis,ulcerative colitis,GCST003960,6:32981027
rs2239802-<b>?</b>,2 x 10-7,(Adults),'-,1.7715251,'-,[1.43-2.19],HLA-DRA,Ulcerative colitis,ulcerative colitis,GCST003960,6:32444069
rs2187668-<b>?</b>,4 x 10-6,(Adults),'-,2.21266,'-,[1.54-3.12],HLA-DQA1,Ulcerative colitis,ulcerative colitis,GCST003960,6:32638107
rs979961-<b>?</b>,8 x 10-7,(Adults),'-,1.8414419,'-,[1.45-2.34],RNU6-119P,Ulcerative colitis,ulcerative colitis,GCST003960,4:116929300
rs1811711-<b>C</b>,6 x 10-9,,0.826,1.14,'-,[1.10–1.18],CCL20,Ulcerative colitis,ulcerative colitis,GCST004133,2:227805760
rs17656349-<b>T</b>,2 x 10-8,,0.466,1.09,'-,[1.06–1.13],CAMK2A,Ulcerative colitis,ulcerative colitis,GCST004133,5:150226431
rs113986290-<b>C</b>,8 x 10-9,,0.989,1.36,'-,[1.25–1.46],LNC-LBCS,Ulcerative colitis,ulcerative colitis,GCST004133,6:19780778
rs7911117-<b>T</b>,2 x 10-8,,0.871,1.14,'-,[1.10–1.19],"FAM238C, ABI1",Ulcerative colitis,ulcerative colitis,GCST004133,10:26890667
rs138788-<b>A</b>,3 x 10-8,,0.418,1.09,'-,[1.06–1.13],TOM1,Ulcerative colitis,ulcerative colitis,GCST004133,22:35333728
rs78534766-<b>?</b>,3 x 10-13,,'-,'-,'-,'-,ADCY7,Ulcerative colitis,ulcerative colitis,GCST004133,16:50301163
rs7282490-<b>?</b>,5 x 10-13,,'-,'-,'-,'-,GATD3A,Ulcerative colitis,ulcerative colitis,GCST004133,21:44195858
rs4845604-<b>?</b>,2 x 10-11,,'-,'-,'-,'-,RORC,Ulcerative colitis,ulcerative colitis,GCST004133,1:151829204
rs798502-<b>?</b>,4 x 10-11,,'-,'-,'-,'-,"AMZ1, GNA12",Ulcerative colitis,ulcerative colitis,GCST004133,7:2750246
rs12942547-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,STAT3,Ulcerative colitis,ulcerative colitis,GCST004133,17:42375526
rs10797432-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,"TNFRSF14, PRXL2B",Ulcerative colitis,ulcerative colitis,GCST004133,1:2569899
rs5771069-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,IL17REL,Ulcerative colitis,ulcerative colitis,GCST004133,22:49997051
rs16940202-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,LINC02132,Ulcerative colitis,ulcerative colitis,GCST004133,16:85980635
rs2413583-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,"PDGFB, RPL3",Ulcerative colitis,ulcerative colitis,GCST004133,22:39263768
rs4728142-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,"IRF5, KCP",Ulcerative colitis,ulcerative colitis,GCST004133,7:128933913
rs17780256-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,SLC39A11,Ulcerative colitis,ulcerative colitis,GCST004133,17:72646784
rs3851228-<b>?</b>,6 x 10-10,,'-,'-,'-,'-,TRAF3IP2-AS1,Ulcerative colitis,ulcerative colitis,GCST004133,6:111526988
rs200349593-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,NXPE1,Ulcerative colitis,ulcerative colitis,GCST004133,11:114526441
rs3766606-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,PARK7,Ulcerative colitis,ulcerative colitis,GCST004133,1:7962137
rs17694108-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,"CEBPA, SLC7A10",Ulcerative colitis,ulcerative colitis,GCST004133,19:33240645
rs17293632-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,SMAD3,Ulcerative colitis,ulcerative colitis,GCST004133,15:67150258
rs254560-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,C5orf66,Ulcerative colitis,ulcerative colitis,GCST004133,5:135107916
rs1728785-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,ZFP90,Ulcerative colitis,ulcerative colitis,GCST004133,16:68557327
rs4976646-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,RGS14,Ulcerative colitis,ulcerative colitis,GCST004133,5:177361569
rs11548656-<b>?</b>,8 x 10-8,,'-,'-,'-,'-,PLCG2,Ulcerative colitis,ulcerative colitis,GCST004133,16:81883307
rs11672983-<b>?</b>,1 x 10-7,,'-,'-,'-,'-,"RNU6-222P, FCAR",Ulcerative colitis,ulcerative colitis,GCST004133,19:54871595
rs907611-<b>?</b>,1 x 10-7,,'-,'-,'-,'-,LSP1,Ulcerative colitis,ulcerative colitis,GCST004133,11:1852842
rs4957048-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,"MIR4456, CEP72",Ulcerative colitis,ulcerative colitis,GCST004133,5:583327
rs7404095-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,PRKCB,Ulcerative colitis,ulcerative colitis,GCST004133,16:23853269
rs11742570-<b>?</b>,3 x 10-7,,'-,'-,'-,'-,'-,Ulcerative colitis,ulcerative colitis,GCST004133,5:40410482
rs6426833-<b>?</b>,3 x 10-42,,'-,'-,'-,'-,"OTUD3, RNF186",Ulcerative colitis,ulcerative colitis,GCST004133,1:19845367
rs11581607-<b>?</b>,4 x 10-41,,'-,'-,'-,'-,IL23R,Ulcerative colitis,ulcerative colitis,GCST004133,1:67242007
rs2836878-<b>?</b>,2 x 10-32,,'-,'-,'-,'-,RPL23AP12,Ulcerative colitis,ulcerative colitis,GCST004133,21:39093608
rs6017342-<b>?</b>,4 x 10-30,,'-,'-,'-,'-,LINC01620,Ulcerative colitis,ulcerative colitis,GCST004133,20:44436388
rs11614178-<b>?</b>,1 x 10-29,,'-,'-,'-,'-,IFNG-AS1,Ulcerative colitis,ulcerative colitis,GCST004133,12:68114342
rs56167332-<b>?</b>,1 x 10-23,,'-,'-,'-,'-,"LINC01845, IL12B",Ulcerative colitis,ulcerative colitis,GCST004133,5:159400761
rs3024505-<b>?</b>,2 x 10-23,,'-,'-,'-,'-,"IL10, Y_RNA",Ulcerative colitis,ulcerative colitis,GCST004133,1:206766559
rs7608910-<b>?</b>,4 x 10-23,,'-,'-,'-,'-,PUS10,Ulcerative colitis,ulcerative colitis,GCST004133,2:60977721
rs4409764-<b>?</b>,2 x 10-21,,'-,'-,'-,'-,"LINC01475, GOT1",Ulcerative colitis,ulcerative colitis,GCST004133,10:99524480
rs4380874-<b>?</b>,9 x 10-21,,'-,'-,'-,'-,"PIGCP2, DLD",Ulcerative colitis,ulcerative colitis,GCST004133,7:107839870
rs3197999-<b>?</b>,8 x 10-20,,'-,'-,'-,'-,MST1,Ulcerative colitis,ulcerative colitis,GCST004133,3:49684099
rs75900472-<b>?</b>,1 x 10-19,,'-,'-,'-,'-,"JAK2, HNRNPA1P41",Ulcerative colitis,ulcerative colitis,GCST004133,9:4981601
rs1801274-<b>?</b>,2 x 10-18,,'-,'-,'-,'-,FCGR2A,Ulcerative colitis,ulcerative colitis,GCST004133,1:161509955
rs4676408-<b>?</b>,1 x 10-17,,'-,'-,'-,'-,"AQP12B, GPR35",Ulcerative colitis,ulcerative colitis,GCST004133,2:240634984
rs6062496-<b>?</b>,9 x 10-17,,'-,'-,'-,'-,"RTEL1-TNFRSF6B, TNFRSF6B",Ulcerative colitis,ulcerative colitis,GCST004133,20:63697746
rs12946510-<b>?</b>,2 x 10-16,,'-,'-,'-,'-,"IKZF3, GRB7",Ulcerative colitis,ulcerative colitis,GCST004133,17:39756124
rs10781499-<b>?</b>,2 x 10-16,,'-,'-,'-,'-,CARD9,Ulcerative colitis,ulcerative colitis,GCST004133,9:136371953
rs7554511-<b>?</b>,4 x 10-16,,'-,'-,'-,'-,INAVA,Ulcerative colitis,ulcerative colitis,GCST004133,1:200908434
rs10761659-<b>?</b>,1 x 10-15,,'-,'-,'-,'-,ALDH7A1P4,Ulcerative colitis,ulcerative colitis,GCST004133,10:62685804
rs12568930-<b>?</b>,2 x 10-15,,'-,'-,'-,'-,"PPIAP34, ZBTB40",Ulcerative colitis,ulcerative colitis,GCST004133,1:22375738
rs6920220-<b>?</b>,3 x 10-15,,'-,'-,'-,'-,LINC02539,Ulcerative colitis,ulcerative colitis,GCST004133,6:137685367
rs11236797-<b>?</b>,5 x 10-15,,'-,'-,'-,'-,"EMSY, LINC02757",Ulcerative colitis,ulcerative colitis,GCST004133,11:76588605
rs17085007-<b>?</b>,1 x 10-14,,'-,'-,'-,'-,"FGFR1OP2P1, RPS21P8",Ulcerative colitis,ulcerative colitis,GCST004133,13:26957130
rs2823286-<b>?</b>,2 x 10-13,,'-,'-,'-,'-,CYCSP42,Ulcerative colitis,ulcerative colitis,GCST004133,21:15445619
rs2816958-<b>?</b>,2 x 10-13,,'-,'-,'-,'-,NR5A2,Ulcerative colitis,ulcerative colitis,GCST004133,1:200132792
rs11168249-<b>?</b>,3 x 10-7,,'-,'-,'-,'-,HDAC7,Ulcerative colitis,ulcerative colitis,GCST004133,12:47814585
rs28374715-<b>?</b>,3 x 10-7,,'-,'-,'-,'-,CHP1,Ulcerative colitis,ulcerative colitis,GCST004133,15:41271752
rs941823-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,LINC00598,Ulcerative colitis,ulcerative colitis,GCST004133,13:40439840
rs17119-<b>?</b>,7 x 10-7,,'-,'-,'-,'-,"PPIAP9, RNU6-793P",Ulcerative colitis,ulcerative colitis,GCST004133,6:14719265
rs9297145-<b>?</b>,7 x 10-7,,'-,'-,'-,'-,"SMURF1, KPNA7",Ulcerative colitis,ulcerative colitis,GCST004133,7:99161494
rs483905-<b>?</b>,7 x 10-7,,'-,'-,'-,'-,MAML2,Ulcerative colitis,ulcerative colitis,GCST004133,11:96290263
rs2651244-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,"CHORDC1P5, CTH",Ulcerative colitis,ulcerative colitis,GCST004133,1:70529879
rs11150589-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,Y_RNA,Ulcerative colitis,ulcerative colitis,GCST004133,16:30471173
rs111456533-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,EEF1AKMT2,Ulcerative colitis,ulcerative colitis,GCST004133,10:124750812
rs6740847-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,"LINC01934, ITGA4",Ulcerative colitis,ulcerative colitis,GCST004133,2:181443625
rs113010081-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,"LINC02009, CCRL2",Ulcerative colitis,ulcerative colitis,GCST004133,3:46415921
rs2188962-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,IRF1-AS1,Ulcerative colitis,ulcerative colitis,GCST004133,5:132435113
rs11768365-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,GRID2IP,Ulcerative colitis,ulcerative colitis,GCST004133,7:6505557
rs1991866-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,CCDC26,Ulcerative colitis,ulcerative colitis,GCST004133,8:129611859
rs7495132-<b>?</b>,3 x 10-6,,'-,'-,'-,'-,"CRTC3-AS1, CRTC3",Ulcerative colitis,ulcerative colitis,GCST004133,15:90629669
rs12103-<b>?</b>,3 x 10-6,,'-,'-,'-,'-,INTS11,Ulcerative colitis,ulcerative colitis,GCST004133,1:1312114
rs395157-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,OSMR,Ulcerative colitis,ulcerative colitis,GCST004133,5:38867630
rs1042058-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,MAP3K8,Ulcerative colitis,ulcerative colitis,GCST004133,10:30439172
rs11221332-<b>?</b>,6 x 10-6,,'-,'-,'-,'-,ETS1,Ulcerative colitis,ulcerative colitis,GCST004133,11:128511079
rs1077773-<b>?</b>,6 x 10-6,,'-,'-,'-,'-,LINC02888,Ulcerative colitis,ulcerative colitis,GCST004133,7:17403055
rs38904-<b>?</b>,6 x 10-6,,'-,'-,'-,'-,"ST7, MTND4P6",Ulcerative colitis,ulcerative colitis,GCST004133,7:117252792
rs2858829-<b>?</b>,9 x 10-6,,'-,'-,'-,'-,"CBX3P9, DSE",Ulcerative colitis,ulcerative colitis,GCST004133,6:116447754
rs11229555-<b>?</b>,9 x 10-6,,'-,'-,'-,'-,GLYAT,Ulcerative colitis,ulcerative colitis,GCST004133,11:58641214
rs2266959-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,UBE2L3,Ulcerative colitis,ulcerative colitis,GCST004133,22:21568615
rs78534766-<b>?</b>,1 x 10-14,,NR,2.16,'-,[1.77-2.62],ADCY7,Ulcerative colitis,ulcerative colitis,GCST008658,16:50301163
rs2395185-<b>?</b>,1 x 10-16,,0.67,1.52,'-,'-,HLA-DRB9,Ulcerative colitis,ulcerative colitis,GCST000311,6:32465390
rs1558744-<b>A</b>,3 x 10-12,,0.38,1.35,'-,'-,IFNG-AS1,Ulcerative colitis,ulcerative colitis,GCST000311,12:68110812
rs11209026-<b>?</b>,1 x 10-8,,0.93,1.79,'-,'-,IL23R,Ulcerative colitis,ulcerative colitis,GCST000311,1:67240275
rs6426833-<b>G</b>,5 x 10-13,,0.54,1.37,'-,'-,"OTUD3, RNF186",Ulcerative colitis,ulcerative colitis,GCST000311,1:19845367
rs4598195-<b>?</b>,1 x 10-6,,0.54,1.23,'-,'-,"PIGCP2, DLD",Ulcerative colitis,ulcerative colitis,GCST000311,7:107862996
rs4730276-<b>?</b>,9 x 10-6,,0.39,1.22,'-,'-,"DLD, PIGCP2",Ulcerative colitis,ulcerative colitis,GCST000311,7:107843992
rs3806308-<b>?</b>,7 x 10-9,,0.63,1.28,'-,'-,"RNF186, OTUD3",Ulcerative colitis,ulcerative colitis,GCST000311,1:19816373
rs10889677-<b>A</b>,1 x 10-8,,0.3,1.29,'-,'-,'-,Ulcerative colitis,ulcerative colitis,GCST000311,Mapping not available
rs4730273-<b>?</b>,5 x 10-6,,0.7,1.22,'-,'-,"PIGCP2, DLD",Ulcerative colitis,ulcerative colitis,GCST000311,7:107839074
rs2158836-<b>A</b>,7 x 10-6,,0.35,1.21,'-,'-,LAMB1,Ulcerative colitis,ulcerative colitis,GCST000311,7:107940394
rs2870946-<b>G</b>,5 x 10-7,,0.055,1.54,'-,'-,"IFNG-AS1, IL26",Ulcerative colitis,ulcerative colitis,GCST000311,12:68202881
rs668853-<b>G</b>,2 x 10-6,,0.39,1.2,'-,'-,RPS6P12,Ulcerative colitis,ulcerative colitis,GCST000311,9:82696232
rs2858829-<b>?</b>,8 x 10-10,,NR,1.12,'-,[1.08-1.16],"CBX3P9, DSE",Ulcerative colitis,ulcerative colitis,GCST002548,6:116447754
rs2642575-<b>?</b>,5 x 10-6,(Southern European),NR,1.11,'-,[NR],"COL13A1, RPL5P26",Ulcerative colitis,ulcerative colitis,GCST002548,10:69783412
rs8179646-<b>T</b>,6 x 10-6,(Southern European),0.38,1.17,'-,[1.03-1.34],"RPLP0P7, LINC01958",Ulcerative colitis,ulcerative colitis,GCST002548,2:156742166
rs11133504-<b>?</b>,1 x 10-7,(Southern European),0.86,1.33,'-,[1.14-1.59],LINC02380,Ulcerative colitis,ulcerative colitis,GCST002548,4:57514156
rs4725479-<b>?</b>,5 x 10-7,(Southern European),0.66,1.19,'-,[1.04-1.35],'-,Ulcerative colitis,ulcerative colitis,GCST002548,7:153048725
rs4246949-<b>?</b>,7 x 10-6,(Southern European),0.77,1.22,'-,[1.05-1.41],CPXM2,Ulcerative colitis,ulcerative colitis,GCST002548,10:123757564
rs11679592-<b>C</b>,9 x 10-6,(Southern European),0.48,1.16,'-,[1.03-1.31],MYT1L,Ulcerative colitis,ulcerative colitis,GCST002548,2:2402716
rs7554511-<b>?</b>,5 x 10-6,(Southern European),NR,1.41,'-,[1.22-1.64],INAVA,Ulcerative colitis,ulcerative colitis,GCST002548,1:200908434
rs3197999-<b>?</b>,8 x 10-7,(Southern European),NR,1.38,'-,[1.21-1.56],MST1,Ulcerative colitis,ulcerative colitis,GCST002548,3:49684099
rs4654925-<b>G</b>,9 x 10-22,,0.52,1.41,'-,[1.30-1.54],OTUD3,Ulcerative colitis,ulcerative colitis,GCST000623,1:19901230
rs7809799-<b>G</b>,9 x 10-11,,0.04,1.56,'-,[1.36-1.78],"KPNA7, SMURF1",Ulcerative colitis,ulcerative colitis,GCST000623,7:99162881
rs5771069-<b>G</b>,4 x 10-8,,0.49,1.17,'-,[1.11-1.25],IL17REL,Ulcerative colitis,ulcerative colitis,GCST000623,22:49997051
rs9268923-<b>C</b>,4 x 10-15,,0.67,1.45,'-,[1.33-1.59],HLA-DRB9,Ulcerative colitis,ulcerative colitis,GCST000623,6:32465058
rs6584283-<b>T</b>,2 x 10-6,,0.46,1.22,'-,[1.12-1.32],LINC01475,Ulcerative colitis,ulcerative colitis,GCST000623,10:99530544
rs3024493-<b>T</b>,1 x 10-12,,0.16,1.35,'-,[1.22-1.50],IL10,Ulcerative colitis,ulcerative colitis,GCST000623,1:206770623
rs9268877-<b>T</b>,6 x 10-18,,0.45,1.45,'-,[1.33-1.58],HLA-DRB9,Ulcerative colitis,ulcerative colitis,GCST000243,6:32463370
rs3024505-<b>T</b>,1 x 10-12,,0.15,1.46,'-,[1.31-1.62],"IL10, Y_RNA",Ulcerative colitis,ulcerative colitis,GCST000243,1:206766559
rs1451375-<b>?</b>,6 x 10-6,,0.78,1.33,'-,[1.18-1.52],DDC,Malaria,malaria,GCST000410,7:50555014
rs6503319-<b>T</b>,7 x 10-7,,0.45,1.21,'-,[1.12-1.31],"MYH3, SCO1",Malaria,malaria,GCST000410,17:10670842
rs11036238-<b>?</b>,4 x 10-11,,0.14,1.59,'-,[1.39-1.82],"OR51V1, HBB",Malaria,malaria,GCST000410,11:5204405
rs116423146-<b>?</b>,3 x 10-9,(heterogeneous),'-,'-,0.278 unit increase,[0.19-0.37],"SNORA72, ARL14",Malaria,malaria,GCST010725,3:160679075
rs116126306-<b>?</b>,8 x 10-6,(heterogeneous),'-,'-,0.403 unit increase,[0.23-0.58],PIGZ,Malaria,malaria,GCST010725,3:196954604
rs58491357-<b>?</b>,3 x 10-6,(heterogeneous),'-,'-,0.257 unit increase,[0.15-0.36],MAML3,Malaria,malaria,GCST010725,4:139952603
rs567544458-<b>?</b>,4 x 10-10,(heterogeneous),'-,'-,0.596 unit decrease,[0.41-0.78],FREM3,Malaria,malaria,GCST010725,4:143592208
rs2914266-<b>?</b>,9 x 10-6,(heterogeneous),'-,'-,0.284 unit decrease,[0.16-0.41],PRDM9,Malaria,malaria,GCST010725,5:23566881
rs115594123-<b>?</b>,9 x 10-7,(heterogeneous),'-,'-,0.365 unit increase,[0.22-0.51],SLC1A3,Malaria,malaria,GCST010725,5:36723279
rs7701116-<b>?</b>,2 x 10-6,(heterogeneous),'-,'-,0.156 unit increase,[0.091-0.221],SIL1,Malaria,malaria,GCST010725,5:139070389
rs183954794-<b>?</b>,2 x 10-6,(heterogeneous),'-,'-,0.481 unit increase,[0.28-0.68],LINC00581,Malaria,malaria,GCST010725,6:21390601
rs73727186-<b>?</b>,6 x 10-6,(heterogeneous),'-,'-,0.235 unit increase,[0.13-0.34],"MUC22, HCG22",Malaria,malaria,GCST010725,6:31048409
rs5784724-<b>?</b>,3 x 10-7,(heterogeneous),'-,'-,0.208 unit increase,[0.13-0.29],SMPDL3A,Malaria,malaria,GCST010725,6:122807710
rs572459786-<b>?</b>,4 x 10-6,(heterogeneous),'-,'-,0.441 unit increase,[0.25-0.63],"LINC02528, TNFAIP3",Malaria,malaria,GCST010725,6:137904008
rs144224092-<b>?</b>,3 x 10-6,(heterogeneous),'-,'-,0.44 unit increase,[0.26-0.62],PLEKHG1,Malaria,malaria,GCST010725,6:150652487
rs549107698-<b>?</b>,8 x 10-6,(heterogeneous),'-,'-,0.464 unit decrease,[0.26-0.67],STX1A,Malaria,malaria,GCST010725,7:73716908
rs75060108-<b>?</b>,9 x 10-7,(heterogeneous),'-,'-,0.263 unit decrease,[0.16-0.37],NRG1,Malaria,malaria,GCST010725,8:31834243
rs199722126-<b>?</b>,2 x 10-7,(heterogeneous),'-,'-,0.215 unit increase,[0.13-0.3],STAU2,Malaria,malaria,GCST010725,8:73585144
rs186421274-<b>?</b>,9 x 10-6,(heterogeneous),'-,'-,0.603 unit increase,[0.34-0.87],IARS1,Malaria,malaria,GCST010725,9:92225835
rs7045306-<b>?</b>,5 x 10-6,(heterogeneous),'-,'-,0.259 unit decrease,[0.15-0.37],NDUFA8,Malaria,malaria,GCST010725,9:122159474
rs57032711-<b>?</b>,2 x 10-7,(heterogeneous),'-,'-,0.219 unit decrease,[0.14-0.3],MVB12B,Malaria,malaria,GCST010725,9:126487840
rs8176719-<b>?</b>,9 x 10-11,(heterogeneous),'-,'-,0.211 unit increase,[0.15-0.27],'-,Malaria,malaria,GCST010725,Mapping not available
rs334-<b>?</b>,4 x 10-69,(heterogeneous),'-,'-,1.572 unit decrease,[1.4-1.75],HBB,Malaria,malaria,GCST010725,11:5227002
rs78308377-<b>?</b>,8 x 10-6,(heterogeneous),'-,'-,0.447 unit increase,[0.25-0.64],"LINC02408, DYRK2",Malaria,malaria,GCST010725,12:67624766
rs116830894-<b>?</b>,3 x 10-6,(heterogeneous),'-,'-,0.274 unit decrease,[0.16-0.39],AVEN,Malaria,malaria,GCST010725,15:33951328
chr15:41093534-<b>?</b>,2 x 10-6,(heterogeneous),'-,'-,0.244 unit increase,[0.14-0.34],'-,Malaria,malaria,GCST010725,Mapping not available
rs16974953-<b>?</b>,6 x 10-6,(heterogeneous),'-,'-,0.257 unit decrease,[0.15-0.37],KC6,Malaria,malaria,GCST010725,18:41548233
rs59309986-<b>?</b>,7 x 10-6,(heterogeneous),'-,'-,0.39 unit increase,[0.22-0.56],"PDK3, RPS26P58",Malaria,malaria,GCST010725,X:24432031
rs4951377-<b>?</b>,9 x 10-8,(additive),'-,'-,0.14 unit increase,[0.089-0.191],ATP2B4,Malaria,malaria,GCST010725,1:203689343
rs113065354-<b>?</b>,2 x 10-6,(additive),'-,'-,0.234 unit decrease,[0.14-0.33],RNU4-67P,Malaria,malaria,GCST010725,12:25364251
rs116782507-<b>?</b>,2 x 10-7,(additive),'-,'-,0.375 unit decrease,[0.24-0.51],'-,Malaria,malaria,GCST010725,2:5295571
rs116830894-<b>?</b>,5 x 10-6,(additive),'-,'-,0.256 unit decrease,[0.15-0.37],AVEN,Malaria,malaria,GCST010725,15:33951328
rs2874666-<b>?</b>,9 x 10-7,(additive),'-,'-,0.114 unit increase,[0.069-0.159],CRBN,Malaria,malaria,GCST010725,3:3218754
rs16974953-<b>?</b>,3 x 10-6,(additive),'-,'-,0.248 unit decrease,[0.14-0.35],KC6,Malaria,malaria,GCST010725,18:41548233
rs59309986-<b>?</b>,8 x 10-7,(additive),'-,'-,0.595 unit increase,[0.36-0.83],"PDK3, RPS26P58",Malaria,malaria,GCST010725,X:24432031
rs4951377-<b>?</b>,1 x 10-11,(dominant),'-,'-,0.401 unit increase,[0.33-0.47],ATP2B4,Malaria,malaria,GCST010725,1:203689343
rs567544458-<b>?</b>,7 x 10-11,(additive),'-,'-,0.588 unit decrease,[0.41-0.76],FREM3,Malaria,malaria,GCST010725,4:143592208
rs115594123-<b>?</b>,5 x 10-6,(additive),'-,'-,0.321 unit increase,[0.18-0.46],SLC1A3,Malaria,malaria,GCST010725,5:36723279
rs62380051-<b>?</b>,2 x 10-6,(additive),'-,'-,0.134 unit increase,[0.079-0.189],TRIM36,Malaria,malaria,GCST010725,5:115077821
rs58491357-<b>?</b>,1 x 10-6,(dominant),'-,'-,0.264 unit increase,[NR],MAML3,Malaria,malaria,GCST010725,4:139952603
rs567544458-<b>?</b>,7 x 10-11,(dominant),'-,'-,0.612 unit decrease,[NR],FREM3,Malaria,malaria,GCST010725,4:143592208
rs2914266-<b>?</b>,9 x 10-6,(dominant),'-,'-,0.279 unit decrease,[NR],PRDM9,Malaria,malaria,GCST010725,5:23566881
rs115594123-<b>?</b>,1 x 10-6,(dominant),'-,'-,0.351 unit increase,[NR],SLC1A3,Malaria,malaria,GCST010725,5:36723279
rs572459786-<b>?</b>,2 x 10-6,(additive),'-,'-,0.451 unit increase,[0.27-0.64],"LINC02528, TNFAIP3",Malaria,malaria,GCST010725,6:137904008
rs7701116-<b>?</b>,4 x 10-7,(dominant),'-,'-,0.165 unit increase,[0.043-0.287],SIL1,Malaria,malaria,GCST010725,5:139070389
rs183954794-<b>?</b>,6 x 10-6,(dominant),'-,'-,0.451 unit increase,[NR],LINC00581,Malaria,malaria,GCST010725,6:21390601
rs73727186-<b>?</b>,5 x 10-6,(dominant),'-,'-,0.233 unit increase,[-0.43732-0.90332],"MUC22, HCG22",Malaria,malaria,GCST010725,6:31048409
rs76995465-<b>?</b>,2 x 10-6,(dominant),'-,'-,0.275 unit decrease,[NR],NKAIN2,Malaria,malaria,GCST010725,6:124585841
rs572459786-<b>?</b>,2 x 10-6,(dominant),'-,'-,0.451 unit increase,[NR],"LINC02528, TNFAIP3",Malaria,malaria,GCST010725,6:137904008
rs199722126-<b>?</b>,6 x 10-6,(additive),'-,'-,0.163 unit increase,[0.092-0.234],STAU2,Malaria,malaria,GCST010725,8:73585144
rs549107698-<b>?</b>,6 x 10-6,(dominant),'-,'-,0.465 unit decrease,[NR],STX1A,Malaria,malaria,GCST010725,7:73716908
rs7045306-<b>?</b>,9 x 10-7,(additive),'-,'-,0.266 unit decrease,[0.16-0.37],NDUFA8,Malaria,malaria,GCST010725,9:122159474
rs57032711-<b>?</b>,1 x 10-8,(additive),'-,'-,0.209 unit decrease,[0.14-0.28],MVB12B,Malaria,malaria,GCST010725,9:126487840
rs8176719-<b>?</b>,1 x 10-19,(additive),'-,'-,0.223 unit increase,[0.17-0.27],'-,Malaria,malaria,GCST010725,Mapping not available
rs74806154-<b>?</b>,8 x 10-8,(additive),'-,'-,0.138 unit increase,[0.087-0.189],DIP2C,Malaria,malaria,GCST010725,10:574544
rs7079449-<b>?</b>,3 x 10-6,(additive),'-,'-,0.368 unit decrease,[0.21-0.52],GFRA1,Malaria,malaria,GCST010725,10:116260869
rs75060108-<b>?</b>,1 x 10-6,(dominant),'-,'-,0.253 unit decrease,[-0.47612-0.98212],NRG1,Malaria,malaria,GCST010725,8:31834243
rs199722126-<b>?</b>,4 x 10-7,(dominant),'-,'-,0.205 unit increase,[-0.089-0.499],STAU2,Malaria,malaria,GCST010725,8:73585144
rs186421274-<b>?</b>,6 x 10-6,(dominant),'-,'-,0.613 unit increase,[NR],IARS1,Malaria,malaria,GCST010725,9:92225835
rs7045306-<b>?</b>,1 x 10-6,(dominant),'-,'-,0.271 unit decrease,[NR],NDUFA8,Malaria,malaria,GCST010725,9:122159474
rs57032711-<b>?</b>,1 x 10-8,(dominant),'-,'-,0.234 unit decrease,[-0.05412-0.52212],MVB12B,Malaria,malaria,GCST010725,9:126487840
rs8176719-<b>?</b>,9 x 10-21,(dominant),'-,'-,0.305 unit increase,[0.2-0.41],'-,Malaria,malaria,GCST010725,Mapping not available
rs74806154-<b>?</b>,2 x 10-7,(dominant),'-,'-,0.172 unit increase,[0.056-0.288],DIP2C,Malaria,malaria,GCST010725,10:574544
rs334-<b>?</b>,2 x 10-67,(dominant),'-,'-,1.385 unit decrease,[0.84-1.93],HBB,Malaria,malaria,GCST010725,11:5227002
rs113065354-<b>?</b>,6 x 10-6,(dominant),'-,'-,0.237 unit decrease,[-0.53916-1.01316],RNU4-67P,Malaria,malaria,GCST010725,12:25364251
rs78308377-<b>?</b>,9 x 10-6,(dominant),'-,'-,0.442 unit increase,[NR],"LINC02408, DYRK2",Malaria,malaria,GCST010725,12:67624766
rs9598973-<b>?</b>,5 x 10-7,(dominant),'-,'-,0.226 unit increase,[0.16-0.29],'-,Malaria,malaria,GCST010725,13:65417774
rs116830894-<b>?</b>,3 x 10-6,(dominant),'-,'-,0.272 unit decrease,[NR],AVEN,Malaria,malaria,GCST010725,15:33951328
chr15:41093534-<b>?</b>,3 x 10-6,(dominant),'-,'-,0.238 unit increase,[-0.4872-0.9632],'-,Malaria,malaria,GCST010725,Mapping not available
rs16974953-<b>?</b>,3 x 10-6,(dominant),'-,'-,0.263 unit decrease,[NR],KC6,Malaria,malaria,GCST010725,18:41548233
chr20:43956636-<b>?</b>,1 x 10-6,(dominant),'-,'-,0.17 unit decrease,[0.092-0.248],'-,Malaria,malaria,GCST010725,Mapping not available
rs59309986-<b>?</b>,8 x 10-6,(dominant),'-,'-,0.384 unit increase,[0.08-0.688],"PDK3, RPS26P58",Malaria,malaria,GCST010725,X:24432031
rs2874666-<b>?</b>,5 x 10-7,(recessive),'-,'-,0.171 unit increase,[0.1-0.24],CRBN,Malaria,malaria,GCST010725,3:3218754
rs2523650-<b>?</b>,5 x 10-7,(recessive),'-,'-,0.167 unit decrease,[0.1-0.23],MICB-DT,Malaria,malaria,GCST010725,6:31481245
rs7821609-<b>?</b>,5 x 10-6,(recessive),'-,'-,0.191 unit increase,[0.11-0.27],CSMD1,Malaria,malaria,GCST010725,8:4157057
rs7079449-<b>?</b>,5 x 10-6,(recessive),'-,'-,0.368 unit decrease,[0.21-0.52],GFRA1,Malaria,malaria,GCST010725,10:116260869
chr12:10062759-<b>?</b>,1 x 10-6,(recessive),'-,'-,0.435 unit increase,[0.26-0.61],'-,Malaria,malaria,GCST010725,Mapping not available
rs8044133-<b>?</b>,6 x 10-7,(recessive),'-,'-,0.19 unit decrease,[0.12-0.26],VAC14,Malaria,malaria,GCST010725,16:70794366
rs6117276-<b>?</b>,4 x 10-7,(recessive),'-,'-,0.461 unit increase,[0.28-0.64],CASC20,Malaria,malaria,GCST010725,20:6467874
rs116782507-<b>?</b>,9 x 10-7,(heterogeneous),'-,'-,0.356 unit decrease,[0.21-0.5],'-,Malaria,malaria,GCST010725,2:5295571
rs56291704-<b>?</b>,3 x 10-7,(heterogeneous),'-,'-,0.165 unit decrease,[0.1-0.23],LINC01320,Malaria,malaria,GCST010725,2:33976154
rs334-<b>?</b>,1 x 10-55,(additive),'-,'-,1.106 unit decrease,[0.97-1.24],HBB,Malaria,malaria,GCST010725,11:5227002
rs12083051-<b>?</b>,4 x 10-7,(additive),'-,'-,0.14 unit increase,[0.085-0.195],SMYD3,Malaria,malaria,GCST010725,1:245838142
rs9598973-<b>?</b>,4 x 10-6,(additive),'-,'-,0.11 unit increase,[0.063-0.157],'-,Malaria,malaria,GCST010725,13:65417774
rs115075175-<b>?</b>,5 x 10-6,(additive),'-,'-,0.716 unit decrease,[0.41-1.02],EXOC6B,Malaria,malaria,GCST010725,2:72374866
chr15:41093534-<b>?</b>,7 x 10-6,(additive),'-,'-,0.215 unit increase,[0.12-0.31],'-,Malaria,malaria,GCST010725,Mapping not available
rs5853768-<b>?</b>,6 x 10-6,(additive),'-,'-,0.145 unit decrease,[0.082-0.208],'-,Malaria,malaria,GCST010725,Mapping not available
rs116423146-<b>?</b>,2 x 10-8,(additive),'-,'-,0.244 unit increase,[0.16-0.33],"SNORA72, ARL14",Malaria,malaria,GCST010725,3:160679075
rs58491357-<b>?</b>,9 x 10-7,(additive),'-,'-,0.252 unit increase,[0.15-0.35],MAML3,Malaria,malaria,GCST010725,4:139952603
rs116782507-<b>?</b>,3 x 10-7,(dominant),'-,'-,0.369 unit decrease,[NR],'-,Malaria,malaria,GCST010725,2:5295571
rs115075175-<b>?</b>,7 x 10-6,(dominant),'-,'-,0.717 unit decrease,[NR],EXOC6B,Malaria,malaria,GCST010725,2:72374866
rs5853768-<b>?</b>,1 x 10-6,(dominant),'-,'-,0.185 unit decrease,[0.026-0.344],'-,Malaria,malaria,GCST010725,Mapping not available
rs116423146-<b>?</b>,3 x 10-9,(dominant),'-,'-,0.273 unit increase,[-0.47376-1.01976],"SNORA72, ARL14",Malaria,malaria,GCST010725,3:160679075
rs2523650-<b>?</b>,3 x 10-6,(additive),'-,'-,0.121 unit decrease,[0.07-0.172],MICB-DT,Malaria,malaria,GCST010725,6:31481245
rs76995465-<b>?</b>,5 x 10-7,(additive),'-,'-,0.281 unit decrease,[0.17-0.39],NKAIN2,Malaria,malaria,GCST010725,6:124585841
rs62380051-<b>?</b>,7 x 10-6,(dominant),'-,'-,0.151 unit increase,[0.004-0.298],TRIM36,Malaria,malaria,GCST010725,5:115077821
rs144224092-<b>?</b>,3 x 10-6,(additive),'-,'-,0.427 unit increase,[0.25-0.61],PLEKHG1,Malaria,malaria,GCST010725,6:150652487
rs549107698-<b>?</b>,7 x 10-6,(additive),'-,'-,0.45 unit decrease,[0.25-0.65],STX1A,Malaria,malaria,GCST010725,7:73716908
rs12335348-<b>?</b>,1 x 10-6,(additive),'-,'-,0.13 unit decrease,[0.077-0.183],NUGGC,Malaria,malaria,GCST010725,8:28073360
rs75060108-<b>?</b>,6 x 10-6,(additive),'-,'-,0.223 unit decrease,[0.13-0.32],NRG1,Malaria,malaria,GCST010725,8:31834243
rs144224092-<b>?</b>,2 x 10-6,(dominant),'-,'-,0.44 unit increase,[NR],PLEKHG1,Malaria,malaria,GCST010725,6:150652487
rs186421274-<b>?</b>,6 x 10-6,(additive),'-,'-,0.604 unit increase,[0.34-0.86],IARS1,Malaria,malaria,GCST010725,9:92225835
rs146842860-<b>?</b>,9 x 10-6,(dominant),'-,'-,0.331 unit increase,[NR],'-,Malaria,malaria,GCST010725,7:109736674
rs1912785-<b>?</b>,8 x 10-6,(Circumference),NR,'-,0.15 unit decrease,[0.091-0.209],PLSCR5,Barrett's esophagus,Barrett's esophagus,GCST001675,3:146684384
rs1531228-<b>?</b>,9 x 10-6,(Circumference),NR,'-,0.2 unit increase,[0.10-0.30],GRIN2B,Barrett's esophagus,Barrett's esophagus,GCST001675,12:13476447
rs12901001-<b>?</b>,6 x 10-6,(Circumference),NR,'-,0.15 unit increase,[0.091-0.209],"AGBL1-AS1, AGBL1",Barrett's esophagus,Barrett's esophagus,GCST001675,15:86316245
rs9257809-<b>A</b>,4 x 10-9,,0.87,1.21,'-,[1.13-1.28],OR5V1,Barrett's esophagus,Barrett's esophagus,GCST001675,6:29388554
rs9936833-<b>C</b>,3 x 10-10,,0.37,1.14,'-,[1.10-1.19],LINC00917,Barrett's esophagus,Barrett's esophagus,GCST001675,16:86369512
rs7912831-<b>?</b>,9 x 10-8,,'-,1.27,'-,[1.16-1.39],RNA5SP299,Colorectal cancer,colorectal cancer,GCST004839,10:8689292
rs12603526-<b>C</b>,3 x 10-6,Han Chinese,0.184,1.44,'-,[1.24-1.68],NXN,Colorectal cancer,colorectal cancer,GCST003494,17:897353
rs1800469-<b>A</b>,4 x 10-7,Han Chinese,0.456,1.36,'-,[1.21-1.53],TMEM91,Colorectal cancer,colorectal cancer,GCST003494,19:41354391
rs2238126-<b>G</b>,3 x 10-11,,'-,1.17,'-,[1.12-1.23],ETV6,Colorectal cancer,colorectal cancer,GCST003494,12:11856807
rs2238126-<b>G</b>,3 x 10-10,Han Chinese,0.477,1.17,'-,1.11-1.23,ETV6,Colorectal cancer,colorectal cancer,GCST003494,12:11856807
rs72647484-<b>?</b>,1 x 10-8,,0.91,1.24,'-,[1.15-1.33],MIR4418,Colorectal cancer,colorectal cancer,GCST002919,1:22261235
rs202110856-<b>?</b>,7 x 10-8,,0.99,1.51,'-,[1.23-1.86],ERAP1,Colorectal cancer,colorectal cancer,GCST002919,5:96794170
rs10904849-<b>?</b>,7 x 10-8,,0.68,1.13,'-,[1.08-1.19],CUBN,Colorectal cancer,colorectal cancer,GCST002919,10:16955267
rs79900961-<b>?</b>,5 x 10-8,,0.98,1.49,'-,[1.26-1.76],RPL21P119,Colorectal cancer,colorectal cancer,GCST002919,16:9203955
rs16941835-<b>?</b>,5 x 10-8,,0.21,1.16,'-,[1.09-1.22],"FOXL1, LINC02188",Colorectal cancer,colorectal cancer,GCST002919,16:86662114
rs11118883-<b>A</b>,5 x 10-6,,0.35,1.12,'-,[NR],LINC02257,Colorectal cancer,colorectal cancer,GCST002919,1:221887680
rs76316943-<b>A</b>,2 x 10-11,,0.01,1.58,'-,[NR],UTP23,Colorectal cancer,colorectal cancer,GCST002919,8:116836068
rs7014346-<b>A</b>,6 x 10-15,,0.34,1.19,'-,[NR],"PCAT1, POU5F1B, CASC8",Colorectal cancer,colorectal cancer,GCST002919,8:127412547
rs11255841-<b>T</b>,4 x 10-13,,0.68,1.18,'-,[NR],RNA5SP299,Colorectal cancer,colorectal cancer,GCST002919,10:8697617
rs11190164-<b>G</b>,8 x 10-7,,0.29,1.13,'-,[NR],"SLC25A28, NKX2-3",Colorectal cancer,colorectal cancer,GCST002919,10:99591947
rs3824999-<b>C</b>,8 x 10-11,,0.47,1.15,'-,[NR],POLD3,Colorectal cancer,colorectal cancer,GCST002919,11:74634505
rs3802842-<b>C</b>,2 x 10-6,,0.27,1.13,'-,[NR],"COLCA1, COLCA2",Colorectal cancer,colorectal cancer,GCST002919,11:111300984
rs4768903-<b>A</b>,4 x 10-8,,0.61,1.1,'-,[NR],DIP2B,Colorectal cancer,colorectal cancer,GCST002919,12:50651666
rs35107139-<b>C</b>,2 x 10-6,,0.4,1.1,'-,[NR],BMP4,Colorectal cancer,colorectal cancer,GCST002919,14:53952388
rs2293582-<b>A</b>,3 x 10-11,,0.21,1.21,'-,[NR],GREM1,Colorectal cancer,colorectal cancer,GCST002919,15:32718211
rs7226855-<b>A</b>,4 x 10-23,,0.55,1.25,'-,[NR],SMAD7,Colorectal cancer,colorectal cancer,GCST002919,18:48927678
rs57046232-<b>T</b>,5 x 10-7,,0.37,1.11,'-,[NR],CASC20,Colorectal cancer,colorectal cancer,GCST002919,20:6399697
rs1015563-<b>T</b>,2 x 10-6,,0.35,1.12,'-,[NR],LINC01713,Colorectal cancer,colorectal cancer,GCST002919,20:6709454
rs2427308-<b>C</b>,3 x 10-11,,0.78,1.19,'-,[NR],CABLES2,Colorectal cancer,colorectal cancer,GCST002919,20:62394395
rs7252505-<b>G</b>,4 x 10-8,,0.38,1.19,'-,[1.12-1.27],GPATCH1,Colorectal cancer,colorectal cancer,GCST004168,19:33084158
rs56848936-<b>A</b>,9 x 10-7,(AA),0.94,1.45,'-,[1.25-1.69],SYMPK,Colorectal cancer,colorectal cancer,GCST004168,19:45818249
rs7528276-<b>T</b>,3 x 10-7,,0.03,1.86,'-,[1.47-2.36],MACF1,Colorectal cancer,colorectal cancer,GCST003420,1:39344315
rs1367374-<b>C</b>,4 x 10-7,,0.13,1.37,'-,[1.21-1.55],"ATP5PBP4, PAIP2B",Colorectal cancer,colorectal cancer,GCST003420,2:153074663
rs143046984-<b>TA</b>,4 x 10-7,,0.04,1.65,'-,[1.36-2.01],PCNX1,Colorectal cancer,colorectal cancer,GCST003420,14:70937530
rs142319636-<b>G</b>,8 x 10-7,,0.04,1.69,'-,[1.37-2.08],MMP2,Colorectal cancer,colorectal cancer,GCST003420,16:55504828
rs658191-<b>G</b>,4 x 10-7,,0.03,1.86,'-,[1.46-2.36],MACF1,Colorectal cancer,colorectal cancer,GCST003420,1:39458103
rs2286313-<b>G</b>,4 x 10-7,,0.04,1.66,'-,[1.36-2.02],PCNX1,Colorectal cancer,colorectal cancer,GCST003420,14:71047446
rs11874392-<b>A</b>,7 x 10-8,,0.49,1.27,'-,[1.17-1.39],SMAD7,Colorectal cancer,colorectal cancer,GCST003420,18:48926786
rs847208-<b>A</b>,3 x 10-9,,NR,1.107,'-,[1.071-1.145],"LINC01081, LINC01082",Colorectal cancer,colorectal cancer,GCST005591,16:86220445
rs4924045-<b>C</b>,3 x 10-6,,NR,1.113,'-,[1.064-1.164],GOLGA8B,Colorectal cancer,colorectal cancer,GCST005591,15:34585308
rs11196172-<b>A</b>,1 x 10-9,,NR,1.114,'-,[1.076-1.154],TCF7L2,Colorectal cancer,colorectal cancer,GCST005591,10:112967084
rs174594-<b>A</b>,2 x 10-13,,NR,1.134,'-,[1.097-1.172],FADS2,Colorectal cancer,colorectal cancer,GCST005591,11:61852357
rs9733843-<b>A</b>,1 x 10-14,,NR,1.142,'-,[1.104-1.181],RNA5SP299,Colorectal cancer,colorectal cancer,GCST005591,10:8676041
rs4813802-<b>?</b>,6 x 10-6,,0.206,1.1135857,'-,[1.06-1.17],LINC01713,Colorectal cancer,colorectal cancer,GCST005591,20:6718948
rs174537-<b>G</b>,2 x 10-7,,0.601,1.111,'-,[1.068-1.155],"MYRF, TMEM258",Colorectal cancer,colorectal cancer,GCST005591,11:61785208
rs2427308-<b>C</b>,2 x 10-6,,0.912,1.189,'-,[1.106-1.278],CABLES2,Colorectal cancer,colorectal cancer,GCST005591,20:62394395
rs6687758-<b>?</b>,2 x 10-8,,0.279,1.1273957,'-,[1.08-1.18],"LINC02474, LINC01705",Colorectal cancer,colorectal cancer,GCST005591,1:221991606
rs2450115-<b>T</b>,5 x 10-7,,0.522,1.105,'-,[1.063-1.149],EIF3H,Colorectal cancer,colorectal cancer,GCST005591,8:116611854
rs704017-<b>?</b>,7 x 10-6,,0.349,1.0952903,'-,[1.05-1.14],ZMIZ1-AS1,Colorectal cancer,colorectal cancer,GCST005591,10:79059375
rs11255841-<b>T</b>,2 x 10-14,,0.614,1.17,'-,[1.123-1.219],RNA5SP299,Colorectal cancer,colorectal cancer,GCST005591,10:8697617
rs6983267-<b>?</b>,1 x 10-19,,0.332,1.2033695,'-,[1.16-1.25],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST005591,8:127401060
rs7229639-<b>?</b>,3 x 10-12,,0.145,1.2004802,'-,[1.14-1.26],SMAD7,Colorectal cancer,colorectal cancer,GCST005591,18:48924606
rs11196172-<b>A</b>,4 x 10-10,,0.662,1.146,'-,[1.098-1.196],TCF7L2,Colorectal cancer,colorectal cancer,GCST005591,10:112967084
rs114436839-<b>A</b>,1 x 10-6,,NR,1.4265335,'-,[1.24-1.64],PLCH1,Colorectal cancer,colorectal cancer,GCST005591,3:155691561
rs75853696-<b>G</b>,3 x 10-6,,NR,1.3020833,'-,[1.16-1.45],MBNL1,Colorectal cancer,colorectal cancer,GCST005591,3:152228136
rs1453514-<b>G</b>,1 x 10-6,,NR,1.242236,'-,[1.14-1.36],'-,Colorectal cancer,colorectal cancer,GCST005591,16:16899146
rs12682374-<b>C</b>,7 x 10-29,,NR,1.2033695,'-,[1.16-1.24],"PCAT1, POU5F1B, CASC8",Colorectal cancer,colorectal cancer,GCST005591,8:127398703
rs4939567-<b>G</b>,1 x 10-22,,NR,1.1820331,'-,[1.14-1.22],SMAD7,Colorectal cancer,colorectal cancer,GCST005591,18:48925503
rs12241008-<b>C</b>,3 x 10-12,,NR,1.1350738,'-,[1.1-1.18],VTI1A,Colorectal cancer,colorectal cancer,GCST005591,10:112520943
rs4572213-<b>T</b>,2 x 10-9,,NR,1.1248593,'-,[1.08-1.17],CCND2-AS1,Colorectal cancer,colorectal cancer,GCST005591,12:4256383
rs6691195-<b>A</b>,3 x 10-10,,NR,1.1160713,'-,[1.08-1.15],"LINC01705, LINC02474",Colorectal cancer,colorectal cancer,GCST005591,1:221989031
rs254563-<b>A</b>,1 x 10-9,,NR,1.1160713,'-,[1.08-1.16],C5orf66,Colorectal cancer,colorectal cancer,GCST005591,5:135104736
rs6065668-<b>T</b>,4 x 10-11,,NR,1.1148272,'-,[1.08-1.15],"TOX2, LINC01728",Colorectal cancer,colorectal cancer,GCST005591,20:43904181
rs4407073-<b>T</b>,7 x 10-8,,NR,1.0976949,'-,[1.06-1.14],'-,Colorectal cancer,colorectal cancer,GCST005591,16:80022910
rs2723362-<b>C</b>,7 x 10-6,,NR,1.081081,'-,[1.04-1.12],AADACL2-AS1,Colorectal cancer,colorectal cancer,GCST005591,3:151958534
rs2450115-<b>T</b>,9 x 10-7,,NR,1.084,'-,[1.049-1.119],EIF3H,Colorectal cancer,colorectal cancer,GCST005591,8:116611854
rs61510274-<b>G</b>,1 x 10-6,,NR,1.087,'-,[1.051-1.124],SLCO2A1,Colorectal cancer,colorectal cancer,GCST005591,3:134030671
rs2189261-<b>G</b>,1 x 10-6,,NR,1.101,'-,[1.059-1.145],"CALB1, LINC00534",Colorectal cancer,colorectal cancer,GCST005591,8:90159507
rs4971775-<b>G</b>,4 x 10-9,,0.062,1.21,'-,[1.14-1.29],CCDC12P1,Colorectal cancer x fine particulate matter exposure levels interaction,"colorectal cancer, particulate matter air pollution measurement",GCST011108,2:51959960
rs9313579-<b>T</b>,2 x 10-9,,0.059,0.8,'-,[0.74-0.86],STK10,Colorectal cancer x fine particulate matter exposure levels interaction,"colorectal cancer, particulate matter air pollution measurement",GCST011108,5:172151880
rs6950598-<b>C</b>,2 x 10-9,,0.196,0.88,'-,[0.84-0.92],HDAC9,Colorectal cancer x fine particulate matter exposure levels interaction,"colorectal cancer, particulate matter air pollution measurement",GCST011108,7:18931900
rs11761214-<b>C</b>,3 x 10-9,,0.299,0.89,'-,[0.86-0.93],CICP17,Colorectal cancer x fine particulate matter exposure levels interaction,"colorectal cancer, particulate matter air pollution measurement",GCST011108,7:51473441
rs10902298-<b>T</b>,1 x 10-10,,0.054,1.23,'-,[1.16-1.31],'-,Colorectal cancer x fine particulate matter exposure levels interaction,"colorectal cancer, particulate matter air pollution measurement",GCST011108,11:54880568
rs12646351-<b>?</b>,2 x 10-7,,NR,25,'-,[3.03-100],ZNF827,Severe skin toxicity response to cetuximab in colorectal cancer,"colorectal cancer, skin disease, response to cetuximab",GCST007259,4:145819473
rs17806780-<b>?</b>,3 x 10-7,,NR,25,'-,[2.86-100],ZNF827,Severe skin toxicity response to cetuximab in colorectal cancer,"colorectal cancer, skin disease, response to cetuximab",GCST007259,4:145811502
rs7692430-<b>?</b>,4 x 10-7,,NR,4.57,'-,[2.46-8.49],EPHA5,Severe skin toxicity response to cetuximab in colorectal cancer,"colorectal cancer, skin disease, response to cetuximab",GCST007259,4:65354979
chr2:3625175-<b>?</b>,1 x 10-6,,NR,7.142857,'-,[2.56-20],'-,Severe skin toxicity response to cetuximab in colorectal cancer,"colorectal cancer, skin disease, response to cetuximab",GCST007259,Mapping not available
rs11183750-<b>?</b>,2 x 10-6,,NR,7.142857,'-,[2.5-20],PCED1B,Severe skin toxicity response to cetuximab in colorectal cancer,"colorectal cancer, skin disease, response to cetuximab",GCST007259,12:47123912
rs7012009-<b>?</b>,2 x 10-6,,NR,25,'-,[2.7-100],"SLCO5A1, Metazoa_SRP",Severe skin toxicity response to cetuximab in colorectal cancer,"colorectal cancer, skin disease, response to cetuximab",GCST007259,8:69841638
rs2422088-<b>?</b>,2 x 10-6,,NR,5.882353,'-,[0.075-0.41],"POLE4, TACR1",Severe skin toxicity response to cetuximab in colorectal cancer,"colorectal cancer, skin disease, response to cetuximab",GCST007259,2:75024234
rs13155752-<b>?</b>,2 x 10-6,,NR,3.82,'-,[2.11-6.92],"RN7SL383P, LINC02224",Severe skin toxicity response to cetuximab in colorectal cancer,"colorectal cancer, skin disease, response to cetuximab",GCST007259,5:44680585
rs7229639-<b>A</b>,3 x 10-11,,0.145,1.22,'-,[1.15-1.29],SMAD7,Colorectal cancer,colorectal cancer,GCST002340,18:48924606
rs35509282-<b>A</b>,8 x 10-9,,NR,1.53,'-,[1.39-1.67],MTHFD2P4,Colorectal cancer,colorectal cancer,GCST002528,4:162412253
rs7758229-<b>T</b>,8 x 10-9,(distal colon cancer),NR,1.28,'-,[1.18-1.39],SLC22A3,Colorectal cancer,colorectal cancer,GCST000948,6:160419220
rs6983267-<b>G</b>,2 x 10-8,(colorectal cancer),0.34,1.18,'-,[1.11-1.25],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST000948,8:127401060
rs4939827-<b>T</b>,1 x 10-12,,0.52,1.16,'-,[1.09-1.27],SMAD7,Colorectal cancer,colorectal cancer,GCST000113,18:48927093
rs8180040-<b>?</b>,2 x 10-6,,NR,1.28,'-,[1.15-1.41],"KLHL18, PTPN23",Colorectal cancer,colorectal cancer,GCST001832,3:47347457
rs12548021-<b>?</b>,3 x 10-6,,NR,1.28,'-,[1.155-1.418],RNU6-1213P,Colorectal cancer,colorectal cancer,GCST001832,8:29486945
rs3104964-<b>?</b>,4 x 10-6,,NR,1.265,'-,[1.144-1.398],C8orf37-AS1,Colorectal cancer,colorectal cancer,GCST001832,8:95583508
rs6983267-<b>G</b>,1 x 10-14,,0.49,1.27,'-,[1.16-1.39],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST000053,8:127401060
rs6983267-<b>T</b>,7 x 10-12,,0.481,'-,'-,'-,"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST008372,8:127401060
rs58658771-<b>A</b>,1 x 10-10,,0.179,'-,'-,'-,"GREM1, SCG5",Colorectal cancer,colorectal cancer,GCST008372,15:32709533
rs6507874-<b>C</b>,2 x 10-14,,0.473,'-,'-,'-,SMAD7,Colorectal cancer,colorectal cancer,GCST008372,18:48922435
rs78898421-<b>?</b>,3 x 10-26,,0.47,2.1,'-,NR,"TNFSF15, DELEC1",Crohn's disease,Crohn's disease,GCST007216,9:114831987
rs224136-<b>?</b>,9 x 10-9,,0.703,1.5873016,'-,NR,ALDH7A1P4,Crohn's disease,Crohn's disease,GCST007216,10:62710915
rs73243351-<b>?</b>,4 x 10-8,,0.203,1.53,'-,NR,LINC02513,Crohn's disease,Crohn's disease,GCST007216,4:38333446
rs56167332-<b>?</b>,9 x 10-8,,0.381,1.43,'-,NR,"LINC01845, IL12B",Crohn's disease,Crohn's disease,GCST007216,5:159400761
rs56354901-<b>?</b>,6 x 10-7,,0.122,1.59,'-,NR,IL27,Crohn's disease,Crohn's disease,GCST007216,16:28511823
rs76418789-<b>?</b>,7 x 10-7,,0.923,2.3255813,'-,NR,"C1orf141, IL23R",Crohn's disease,Crohn's disease,GCST007216,1:67182913
rs184950714-<b>?</b>,4 x 10-19,,0.156,2.05,'-,NR,"MTCO3P1, HLA-DQB1",Crohn's disease,Crohn's disease,GCST007216,6:32668951
rs488200-<b>T</b>,4 x 10-8,,0.451,1.31,'-,'-,INKA2,Crohn's disease,Crohn's disease,GCST007216,1:111720204
rs4727354-<b>T</b>,7 x 10-6,,0.043,1.59,'-,NR,"CCDC146, GSAP",Crohn's disease,Crohn's disease,GCST007216,7:77319034
rs6596-<b>?</b>,2 x 10-54,,NR,3.5578997,'-,[3.02-4.20],SNX20,Crohn's disease,Crohn's disease,GCST003959,16:50675812
rs13333062-<b>?</b>,4 x 10-22,,NR,2.2456965,'-,[1.90-2.65],LINC02128,Crohn's disease,Crohn's disease,GCST003959,16:50888875
rs1049526-<b>?</b>,5 x 10-9,,NR,2.4428785,'-,[1.79-3.33],BRD2,Crohn's disease,Crohn's disease,GCST003959,6:32981027
rs6596-<b>?</b>,6 x 10-26,(Adults),NR,3.2372465,'-,[2.61-4.01],SNX20,Crohn's disease,Crohn's disease,GCST003959,16:50675812
rs13333062-<b>?</b>,6 x 10-14,(Adults),NR,2.3493187,'-,[1.89-2.92],LINC02128,Crohn's disease,Crohn's disease,GCST003959,16:50888875
rs1049526-<b>?</b>,3 x 10-6,(Adults),NR,2.530363,'-,[1.73-3.70],BRD2,Crohn's disease,Crohn's disease,GCST003959,6:32981027
rs6596-<b>?</b>,8 x 10-45,(Children),NR,3.735511,'-,[3.10-4.49],SNX20,Crohn's disease,Crohn's disease,GCST003959,16:50675812
rs13333062-<b>?</b>,1 x 10-15,(Children),NR,2.1826217,'-,[1.81-2.64],LINC02128,Crohn's disease,Crohn's disease,GCST003959,16:50888875
rs1049526-<b>?</b>,3 x 10-7,(Children),NR,2.4273632,'-,[1.72-3.42],BRD2,Crohn's disease,Crohn's disease,GCST003959,6:32981027
rs34804116-<b>?</b>,6 x 10-6,,'-,'-,'-,'-,"TMEM174, LINC02230",Crohn's disease,Crohn's disease,GCST004132,5:73244023
rs2593855-<b>?</b>,7 x 10-6,,'-,'-,'-,'-,FOXP1,Crohn's disease,Crohn's disease,GCST004132,3:71126344
rs630923-<b>?</b>,7 x 10-6,,'-,'-,'-,'-,"CXCR5, Y_RNA",Crohn's disease,Crohn's disease,GCST004132,11:118883644
rs9491891-<b>?</b>,7 x 10-6,,'-,'-,'-,'-,"PTPRK, THEMIS",Crohn's disease,Crohn's disease,GCST004132,6:127956006
rs7555082-<b>?</b>,9 x 10-6,,'-,'-,'-,'-,"PTPRC, ATP6V1G3",Crohn's disease,Crohn's disease,GCST004132,1:198629533
rs2066844-<b>?</b>,6 x 10-99,,'-,'-,'-,'-,NOD2,Crohn's disease,Crohn's disease,GCST004132,16:50712015
rs11581607-<b>?</b>,6 x 10-93,,'-,'-,'-,'-,IL23R,Crohn's disease,Crohn's disease,GCST004132,1:67242007
rs6752107-<b>?</b>,2 x 10-61,,'-,'-,'-,'-,ATG16L1,Crohn's disease,Crohn's disease,GCST004132,2:233252802
rs11742570-<b>?</b>,1 x 10-55,,'-,'-,'-,'-,'-,Crohn's disease,Crohn's disease,GCST004132,5:40410482
rs2188962-<b>?</b>,6 x 10-36,,'-,'-,'-,'-,IRF1-AS1,Crohn's disease,Crohn's disease,GCST004132,5:132435113
rs10781499-<b>?</b>,6 x 10-30,,'-,'-,'-,'-,CARD9,Crohn's disease,Crohn's disease,GCST004132,9:136371953
rs10761659-<b>?</b>,8 x 10-29,,'-,'-,'-,'-,ALDH7A1P4,Crohn's disease,Crohn's disease,GCST004132,10:62685804
rs11236797-<b>?</b>,9 x 10-28,,'-,'-,'-,'-,"EMSY, LINC02757",Crohn's disease,Crohn's disease,GCST004132,11:76588605
rs56167332-<b>?</b>,1 x 10-27,,'-,'-,'-,'-,"LINC01845, IL12B",Crohn's disease,Crohn's disease,GCST004132,5:159400761
rs2823286-<b>?</b>,6 x 10-26,,'-,'-,'-,'-,CYCSP42,Crohn's disease,Crohn's disease,GCST004132,21:15445619
rs4409764-<b>?</b>,2 x 10-24,,'-,'-,'-,'-,"LINC01475, GOT1",Crohn's disease,Crohn's disease,GCST004132,10:99524480
rs3197999-<b>?</b>,3 x 10-23,,'-,'-,'-,'-,MST1,Crohn's disease,Crohn's disease,GCST004132,3:49684099
rs7517810-<b>?</b>,2 x 10-21,,'-,'-,'-,'-,AIMP1P2,Crohn's disease,Crohn's disease,GCST004132,1:172884320
rs2413583-<b>?</b>,8 x 10-21,,'-,'-,'-,'-,"PDGFB, RPL3",Crohn's disease,Crohn's disease,GCST004132,22:39263768
rs2024092-<b>?</b>,1 x 10-20,,'-,'-,'-,'-,SBNO2,Crohn's disease,Crohn's disease,GCST004132,19:1124032
rs80262450-<b>?</b>,1 x 10-20,,'-,'-,'-,'-,PTPN2,Crohn's disease,Crohn's disease,GCST004132,18:12818923
rs1819333-<b>?</b>,2 x 10-20,,'-,'-,'-,'-,"MIR3939, RNASET2",Crohn's disease,Crohn's disease,GCST004132,6:166960059
rs148319899-<b>?</b>,6 x 10-20,,'-,'-,'-,'-,LRRK2,Crohn's disease,Crohn's disease,GCST004132,12:40346421
rs11741861-<b>?</b>,2 x 10-19,,'-,'-,'-,'-,"IRGM, ZNF300",Crohn's disease,Crohn's disease,GCST004132,5:150898347
rs17293632-<b>?</b>,2 x 10-19,,'-,'-,'-,'-,SMAD3,Crohn's disease,Crohn's disease,GCST004132,15:67150258
rs259964-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,ZNF831,Crohn's disease,Crohn's disease,GCST004132,20:59249254
rs2930047-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,DAP,Crohn's disease,Crohn's disease,GCST004132,5:10695414
rs503734-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,IMPG2,Crohn's disease,Crohn's disease,GCST004132,3:101304904
rs11681525-<b>?</b>,5 x 10-7,,'-,'-,'-,'-,TEX41,Crohn's disease,Crohn's disease,GCST004132,2:144734815
rs243505-<b>?</b>,6 x 10-7,,'-,'-,'-,'-,CUL1,Crohn's disease,Crohn's disease,GCST004132,7:148738247
rs1819658-<b>?</b>,6 x 10-7,,'-,'-,'-,'-,IPMK,Crohn's disease,Crohn's disease,GCST004132,10:58153390
rs4845604-<b>?</b>,6 x 10-7,,'-,'-,'-,'-,RORC,Crohn's disease,Crohn's disease,GCST004132,1:151829204
rs4656958-<b>?</b>,6 x 10-7,,'-,'-,'-,'-,"ITLN1, ITLN2",Crohn's disease,Crohn's disease,GCST004132,1:160887174
rs653178-<b>?</b>,7 x 10-7,,'-,'-,'-,'-,'-,Crohn's disease,Crohn's disease,GCST004132,Mapping not available
rs59043219-<b>?</b>,7 x 10-7,,'-,'-,'-,'-,IRF6,Crohn's disease,Crohn's disease,GCST004132,1:209797265
rs5763767-<b>?</b>,8 x 10-7,,'-,'-,'-,'-,HORMAD2,Crohn's disease,Crohn's disease,GCST004132,22:30097893
rs144344067-<b>?</b>,8 x 10-7,,'-,'-,'-,'-,FAM171B,Crohn's disease,Crohn's disease,GCST004132,2:186711652
rs4246215-<b>?</b>,9 x 10-7,,'-,'-,'-,'-,"FADS2, FEN1",Crohn's disease,Crohn's disease,GCST004132,11:61796827
rs1479918-<b>?</b>,9 x 10-7,,'-,'-,'-,'-,"ADAD1, IL2",Crohn's disease,Crohn's disease,GCST004132,4:122430276
rs1292053-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,TUBD1,Crohn's disease,Crohn's disease,GCST004132,17:59886176
rs16967103-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,"RASGRP1, LINC02694",Crohn's disease,Crohn's disease,GCST004132,15:38606989
rs3766606-<b>?</b>,3 x 10-6,,'-,'-,'-,'-,PARK7,Crohn's disease,Crohn's disease,GCST004132,1:7962137
rs7240004-<b>?</b>,3 x 10-6,,'-,'-,'-,'-,"SMAD7, CTIF",Crohn's disease,Crohn's disease,GCST004132,18:48868651
rs111456533-<b>?</b>,3 x 10-6,,'-,'-,'-,'-,EEF1AKMT2,Crohn's disease,Crohn's disease,GCST004132,10:124750812
rs1748195-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,DOCK7,Crohn's disease,Crohn's disease,GCST004132,1:62583922
rs3853824-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,C17orf67,Crohn's disease,Crohn's disease,GCST004132,17:56803632
rs2636006-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,MAGI3,Crohn's disease,Crohn's disease,GCST004132,1:113623135
rs559928-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,"RPS6KA4, LINC02723",Crohn's disease,Crohn's disease,GCST004132,11:64382898
rs10065637-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,ANKRD55,Crohn's disease,Crohn's disease,GCST004132,5:56143024
rs76527535-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,BOK-AS1,Crohn's disease,Crohn's disease,GCST004132,2:241545286
rs7954567-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,LTBR,Crohn's disease,Crohn's disease,GCST004132,12:6381959
rs2581828-<b>C</b>,6 x 10-9,,0.597,1.1,'-,[1.07–1.13],RFT1,Crohn's disease,Crohn's disease,GCST004132,3:53099133
rs2581828-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,RFT1,Crohn's disease,Crohn's disease,GCST004132,3:53099133
rs80244186-<b>C</b>,4 x 10-8,,0.111,1.13,'-,[1.09–1.18],LINC02341,Crohn's disease,Crohn's disease,GCST004132,13:42343725
rs9358372-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,CDKAL1,Crohn's disease,Crohn's disease,GCST004132,6:20812357
rs10492862-<b>A</b>,1 x 10-9,,0.308,1.11,'-,[1.08–1.15],CDH13,Crohn's disease,Crohn's disease,GCST004132,16:82833851
rs71559680-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,LINC00581,Crohn's disease,Crohn's disease,GCST004132,6:21430497
rs12942547-<b>?</b>,2 x 10-11,,'-,'-,'-,'-,STAT3,Crohn's disease,Crohn's disease,GCST004132,17:42375526
rs13126505-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,BANK1,Crohn's disease,Crohn's disease,GCST004132,4:101944147
rs10495903-<b>?</b>,4 x 10-11,,'-,'-,'-,'-,THADA,Crohn's disease,Crohn's disease,GCST004132,2:43579779
rs2488397-<b>?</b>,5 x 10-11,,'-,'-,'-,'-,DENND1B,Crohn's disease,Crohn's disease,GCST004132,1:197732149
rs11195128-<b>?</b>,5 x 10-11,,'-,'-,'-,'-,DUSP5-DT,Crohn's disease,Crohn's disease,GCST004132,10:110426390
rs13001325-<b>?</b>,6 x 10-11,,'-,'-,'-,'-,"IL18R1, IL1RL1",Crohn's disease,Crohn's disease,GCST004132,2:102322576
rs1260326-<b>?</b>,6 x 10-11,,'-,'-,'-,'-,'-,Crohn's disease,Crohn's disease,GCST004132,Mapping not available
rs6651252-<b>?</b>,9 x 10-11,,'-,'-,'-,'-,LINC00824,Crohn's disease,Crohn's disease,GCST004132,8:128554935
rs212388-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,TAGAP-AS1,Crohn's disease,Crohn's disease,GCST004132,6:159069404
rs6740847-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,"LINC01934, ITGA4",Crohn's disease,Crohn's disease,GCST004132,2:181443625
rs7554511-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,INAVA,Crohn's disease,Crohn's disease,GCST004132,1:200908434
rs28449958-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,"NUPR1, IL27",Crohn's disease,Crohn's disease,GCST004132,16:28517460
rs1042058-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,MAP3K8,Crohn's disease,Crohn's disease,GCST004132,10:30439172
rs56116661-<b>?</b>,6 x 10-10,,'-,'-,'-,'-,LPP,Crohn's disease,Crohn's disease,GCST004132,3:188683372
rs11734570-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,"KLF3-AS1, LINC02278",Crohn's disease,Crohn's disease,GCST004132,4:38586832
rs17694108-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,"CEBPA, SLC7A10",Crohn's disease,Crohn's disease,GCST004132,19:33240645
rs2062305-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,LINC02341,Crohn's disease,Crohn's disease,GCST004132,13:42478744
rs9491697-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,RSPO3,Crohn's disease,Crohn's disease,GCST004132,6:127134977
rs34687326-<b>G</b>,1 x 10-6,,0.9,1.18,'-,[1.12–1.24],SLAMF8,Crohn's disease,Crohn's disease,GCST004132,1:159830120
rs1847472-<b>?</b>,6 x 10-9,,'-,'-,'-,'-,BACH2,Crohn's disease,Crohn's disease,GCST004132,6:90263440
rs56116661-<b>C</b>,6 x 10-10,,0.795,1.14,'-,[1.10–1.18],LPP,Crohn's disease,Crohn's disease,GCST004132,3:188683372
rs34687326-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,SLAMF8,Crohn's disease,Crohn's disease,GCST004132,1:159830120
rs4821544-<b>C</b>,2 x 10-8,,0.321,1.1,'-,[1.07–1.13],"NCF4, NCF4-AS1",Crohn's disease,Crohn's disease,GCST004132,22:36862461
rs61839660-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,IL2RA,Crohn's disease,Crohn's disease,GCST004132,10:6052734
rs1456896-<b>?</b>,9 x 10-12,,'-,'-,'-,'-,IKZF1,Crohn's disease,Crohn's disease,GCST004132,7:50264865
rs10775412-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,KSR1,Crohn's disease,Crohn's disease,GCST004132,17:27542007
rs516246-<b>?</b>,4 x 10-11,,'-,'-,'-,'-,FUT2,Crohn's disease,Crohn's disease,GCST004132,19:48702915
rs6738825-<b>?</b>,7 x 10-8,,'-,'-,'-,'-,PLCL1,Crohn's disease,Crohn's disease,GCST004132,2:198032171
rs6586030-<b>?</b>,7 x 10-8,,'-,'-,'-,'-,TSPAN14,Crohn's disease,Crohn's disease,GCST004132,10:80494291
rs724016-<b>?</b>,8 x 10-8,,'-,'-,'-,'-,ZBTB38,Crohn's disease,Crohn's disease,GCST004132,3:141386728
rs13407913-<b>?</b>,9 x 10-8,,'-,'-,'-,'-,ADCY3,Crohn's disease,Crohn's disease,GCST004132,2:24874775
rs529866-<b>?</b>,1 x 10-7,,'-,'-,'-,'-,RMI2,Crohn's disease,Crohn's disease,GCST004132,16:11279463
rs1569328-<b>?</b>,1 x 10-7,,'-,'-,'-,'-,"FOS, U2",Crohn's disease,Crohn's disease,GCST004132,14:75275048
rs17119-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,"PPIAP9, RNU6-793P",Crohn's disease,Crohn's disease,GCST004132,6:14719265
rs395157-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,OSMR,Crohn's disease,Crohn's disease,GCST004132,5:38867630
rs1569723-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,"CD40, RPL13P2",Crohn's disease,Crohn's disease,GCST004132,20:46113425
rs3180018-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,SCAMP3,Crohn's disease,Crohn's disease,GCST004132,1:155260340
rs67289879-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,CCND3,Crohn's disease,Crohn's disease,GCST004132,6:42039665
rs4256018-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,FERMT1,Crohn's disease,Crohn's disease,GCST004132,20:6113242
rs925255-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,FLJ31356,Crohn's disease,Crohn's disease,GCST004132,2:28391927
rs4802307-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,"PPP5C, HIF3A",Crohn's disease,Crohn's disease,GCST004132,19:46346549
rs2227564-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,"PLAU, C10orf55",Crohn's disease,Crohn's disease,GCST004132,10:73913343
rs2836878-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,RPL23AP12,Crohn's disease,Crohn's disease,GCST004132,21:39093608
rs7282490-<b>?</b>,2 x 10-18,,'-,'-,'-,'-,GATD3A,Crohn's disease,Crohn's disease,GCST004132,21:44195858
rs3091316-<b>?</b>,2 x 10-17,,'-,'-,'-,'-,"CCL7, CCL2",Crohn's disease,Crohn's disease,GCST004132,17:34266955
rs12946510-<b>?</b>,1 x 10-16,,'-,'-,'-,'-,"IKZF3, GRB7",Crohn's disease,Crohn's disease,GCST004132,17:39756124
rs75900472-<b>?</b>,3 x 10-16,,'-,'-,'-,'-,"JAK2, HNRNPA1P41",Crohn's disease,Crohn's disease,GCST004132,9:4981601
rs2266959-<b>?</b>,1 x 10-15,,'-,'-,'-,'-,UBE2L3,Crohn's disease,Crohn's disease,GCST004132,22:21568615
rs921720-<b>?</b>,3 x 10-15,,'-,'-,'-,'-,TRIB1,Crohn's disease,Crohn's disease,GCST004132,8:125522429
rs1250550-<b>?</b>,9 x 10-15,,'-,'-,'-,'-,ZMIZ1,Crohn's disease,Crohn's disease,GCST004132,10:79300560
rs2284553-<b>?</b>,1 x 10-14,,'-,'-,'-,'-,IFNGR2,Crohn's disease,Crohn's disease,GCST004132,21:33404389
rs1363907-<b>?</b>,1 x 10-14,,'-,'-,'-,'-,ERAP2,Crohn's disease,Crohn's disease,GCST004132,5:96917099
rs3024505-<b>?</b>,3 x 10-14,,'-,'-,'-,'-,"IL10, Y_RNA",Crohn's disease,Crohn's disease,GCST004132,1:206766559
rs34779708-<b>?</b>,4 x 10-14,,'-,'-,'-,'-,CREM,Crohn's disease,Crohn's disease,GCST004132,10:35177257
rs7608910-<b>?</b>,6 x 10-14,,'-,'-,'-,'-,PUS10,Crohn's disease,Crohn's disease,GCST004132,2:60977721
rs3764147-<b>?</b>,1 x 10-13,,'-,'-,'-,'-,LACC1,Crohn's disease,Crohn's disease,GCST004132,13:43883789
rs6716753-<b>?</b>,1 x 10-13,,'-,'-,'-,'-,SP140,Crohn's disease,Crohn's disease,GCST004132,2:230232414
rs6062496-<b>?</b>,3 x 10-13,,'-,'-,'-,'-,"RTEL1-TNFRSF6B, TNFRSF6B",Crohn's disease,Crohn's disease,GCST004132,20:63697746
rs11879191-<b>?</b>,3 x 10-13,,'-,'-,'-,'-,CDC37,Crohn's disease,Crohn's disease,GCST004132,19:10402235
rs7746082-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,"RN7SKP211, PRDM1",Crohn's disease,Crohn's disease,GCST004132,6:105987394
rs8005161-<b>?</b>,5 x 10-12,,'-,'-,'-,'-,GPR65,Crohn's disease,Crohn's disease,GCST004132,14:88006251
rs6863411-<b>?</b>,7 x 10-12,,'-,'-,'-,'-,NDFIP1,Crohn's disease,Crohn's disease,GCST004132,5:142133639
rs11209026-<b>G</b>,1 x 10-18,,0.921,2.2,'-,[2.10-2.35],IL23R,Crohn's disease,Crohn's disease,GCST001438,1:67240275
rs2241880-<b>G</b>,1 x 10-12,,0.601,1.32,'-,[1.24-1.41],ATG16L1,Crohn's disease,Crohn's disease,GCST001438,2:233274722
rs6545946-<b>C</b>,7 x 10-9,,0.77,1.16,'-,[1.06-1.27],RN7SL18P,Crohn's disease,Crohn's disease,GCST001438,2:62486398
rs9292777-<b>T</b>,2 x 10-11,,0.597,1.37,'-,[1.28-1.48],TTC33,Crohn's disease,Crohn's disease,GCST001438,5:40437846
rs7705924-<b>G</b>,2 x 10-8,,0.066,1.48,'-,[1.17-1.87],"LINC00492, LINC00491",Crohn's disease,Crohn's disease,GCST001438,5:102611094
rs9258260-<b>T</b>,2 x 10-10,,0.104,1.45,'-,[1.21-1.68],"HLA-V, IFITM4P",Crohn's disease,Crohn's disease,GCST001438,6:29755384
rs12677663-<b>T</b>,2 x 10-8,,0.659,1.15,'-,[1.04-1.28],SBSPON,Crohn's disease,Crohn's disease,GCST001438,8:73095112
rs10734105-<b>G</b>,3 x 10-8,,0.375,1.27,'-,[1.10-1.43],TCERG1L,Crohn's disease,Crohn's disease,GCST001438,10:131373856
rs7076156-<b>G</b>,7 x 10-9,,0.751,1.19,'-,[1.10-1.30],ALDH7A1P4,Crohn's disease,Crohn's disease,GCST001438,10:62655424
rs11190141-<b>C</b>,5 x 10-7,,0.739,1.34,'-,[1.25-1.43],"LINC01475, NKX2-3",Crohn's disease,Crohn's disease,GCST001438,10:99532633
rs11229030-<b>C</b>,8 x 10-9,,0.305,1.15,'-,[1.10-1.39],"RNA5SP341, SLC43A3",Crohn's disease,Crohn's disease,GCST001438,11:57435536
rs2076756-<b>G</b>,1 x 10-37,,0.246,1.66,'-,[1.48-1.88],NOD2,Crohn's disease,Crohn's disease,GCST001438,16:50722970
rs11574514-<b>A</b>,2 x 10-7,,0.045,1.44,'-,[1.35-1.52],"PSMB10, LCAT",Crohn's disease,Crohn's disease,GCST001438,16:67937477
rs3091316-<b>G</b>,4 x 10-8,,0.732,1.14,'-,[1.03-1.27],"CCL7, CCL2",Crohn's disease,Crohn's disease,GCST001438,17:34266955
rs13003464-<b>G</b>,5 x 10-9,,0.487,1.05,'-,[1.00-1.40],PUS10,Crohn's disease,Crohn's disease,GCST001438,2:60959694
rs3091338-<b>T</b>,4 x 10-8,,0.328,1.23,'-,[1.08-1.42],"CSF2, IL3",Crohn's disease,Crohn's disease,GCST001438,5:132067045
rs1906493-<b>A</b>,3 x 10-6,,0.432,1.19,'-,[1.09-1.28],LINC00861,Crohn's disease,Crohn's disease,GCST001438,8:126080638
rs11924265-<b>C</b>,2 x 10-8,(CDC stricturing),0.06,2.27,'-,[1.68-3.09],MAGI1,Crohn's disease-related phenotypes,"stricture, Crohn's disease, complicated disease course",GCST002729,3:65774667
rs10929956-<b>C</b>,2 x 10-6,(EIM Erythema nodosum),0.54,1.85,'-,[1.43-2.44],"LY75-CD302, LY75",Crohn's disease-related phenotypes,"Erythema nodosum, Crohn's disease",GCST002729,2:159858104
rs1520339-<b>C</b>,6 x 10-7,(MDC),0.69,1.724138,'-,[1.39-2.13],'-,Crohn's disease-related phenotypes,"Crohn's disease, mild disease course",GCST002729,2:155895409
rs11924265-<b>C</b>,5 x 10-7,(B2),0.06,2.03,'-,[1.52-2.73],MAGI1,Crohn's disease-related phenotypes,"stricture, Crohn's disease",GCST002729,3:65774667
rs1869839-<b>?</b>,7 x 10-6,,0.64,1.2,'-,[1.11-1.3],FOXP2,Crohn's disease,Crohn's disease,GCST001652,7:114717488
rs2834215-<b>?</b>,3 x 10-7,,0.58,1.22,'-,[1.12-1.32],IFNGR2,Crohn's disease,Crohn's disease,GCST001652,21:33424579
rs4820425-<b>A</b>,3 x 10-8,,0.24,1.27,'-,[1.17-1.38],"RBX1, Y_RNA",Crohn's disease,Crohn's disease,GCST001652,22:41035338
rs2076756-<b>G</b>,3 x 10-10,,NR,1.46,'-,[NR],NOD2,Crohn's disease,Crohn's disease,GCST001652,16:50722970
rs11209026-<b>G</b>,4 x 10-14,,NR,2.84,'-,[NR],IL23R,Crohn's disease,Crohn's disease,GCST001652,1:67240275
rs3792109-<b>A</b>,5 x 10-9,,NR,1.38,'-,[NR],"SCARNA5, ATG16L1",Crohn's disease,Crohn's disease,GCST001652,2:233275771
rs11742570-<b>C</b>,1 x 10-6,,NR,1.32,'-,[NR],'-,Crohn's disease,Crohn's disease,GCST001652,5:40410482
rs10761659-<b>G</b>,5 x 10-6,,NR,1.28,'-,[NR],ALDH7A1P4,Crohn's disease,Crohn's disease,GCST001652,10:62685804
rs9348876-<b>T</b>,3 x 10-6,,0.06,1.41,'-,[1.22-1.63],"NCR3, UQCRHP1",Crohn's disease,Crohn's disease,GCST001652,6:31607499
rs4077515-<b>T</b>,4 x 10-6,,NR,1.29,'-,[NR],CARD9,Crohn's disease,Crohn's disease,GCST001652,9:136372044
rs9271366-<b>A</b>,5 x 10-12,,0.888,1.66,'-,[1.44-1.92],"HLA-DRB1, HLA-DQA1",Crohn's disease,Crohn's disease,GCST002094,6:32619077
rs76418789-<b>G</b>,2 x 10-10,,0.931,2.06,'-,[1.64-2.58],"C1orf141, IL23R",Crohn's disease,Crohn's disease,GCST002094,1:67182913
rs6856616-<b>C</b>,4 x 10-14,,0.23,1.43,'-,[1.31-1.57],LINC02513,Crohn's disease,Crohn's disease,GCST002094,4:38323415
rs10947261-<b>T</b>,3 x 10-12,,0.294,1.36,'-,[1.25-1.49],"TSBP1-AS1, BTNL2",Crohn's disease,Crohn's disease,GCST002094,6:32405455
rs751728-<b>T</b>,1 x 10-8,,0.733,1.32,'-,[1.20-1.45],MLN,Crohn's disease,Crohn's disease,GCST002094,6:33796256
rs2149085-<b>T</b>,8 x 10-12,,0.379,1.34,'-,[1.23-1.45],"MIR3939, RNASET2",Crohn's disease,Crohn's disease,GCST002094,6:166957622
rs11195128-<b>T</b>,2 x 10-10,,0.152,1.42,'-,[1.28-1.58],DUSP5-DT,Crohn's disease,Crohn's disease,GCST002094,10:110426390
rs11235667-<b>G</b>,7 x 10-9,,0.096,1.46,'-,[1.28-1.65],"FCHSD2, P2RY2",Crohn's disease,Crohn's disease,GCST002094,11:73152652
rs1992660-<b>?</b>,4 x 10-7,,0.39,1.42,'-,[1.24-1.67],TTC33,Crohn's disease,Crohn's disease,GCST000066,5:40414965
rs1793004-<b>?</b>,3 x 10-6,,0.27,1.3,'-,[1.12-1.52],NELL1,Crohn's disease,Crohn's disease,GCST000066,11:20677383
rs2076756-<b>?</b>,1 x 10-21,,0.27,1.71,'-,[1.42-2.05],NOD2,Crohn's disease,Crohn's disease,GCST000066,16:50722970
"rs10789230-<b>?</b>, rs11209026-<b>?</b>, rs1343151-<b>?</b>, rs6669582-<b>?</b>, rs10889676-<b>?</b>, rs11209003-<b>?</b>, rs12567232-<b>?</b>, rs11209002-<b>?</b>, rs11465804-<b>?</b>, rs10889677-<b>?</b>, rs2201841-<b>?</b>, rs1004819-<b>?</b>, rs9988642-<b>?</b>, rs2902440-<b>?</b>, rs2064689-<b>?</b>, rs11465802-<b>?</b>",1 x 10-8,,0.23,1.38,'-,[1.23-1.53],IL23R - RNU4ATAC4P; IL23R; No mapped genes; No mapped genes; IL23R; No mapped genes; No mapped genes; No mapped genes; IL23R; No mapped genes; C1orf141; IL23R; No mapped genes; IL23R - RNU4ATAC4P; No mapped genes; No mapped genes; No mapped genes,Crohn's disease,Crohn's disease,GCST000071,1:67264945|1:67240275|1:67256884|1:67236843|1:67228519|1:67260421
"rs10789230-<b>?</b>, rs11209026-<b>?</b>, rs1343151-<b>?</b>, rs6669582-<b>?</b>, rs10889676-<b>?</b>, rs11209003-<b>?</b>, rs12567232-<b>?</b>, rs11209002-<b>?</b>, rs11465804-<b>?</b>, rs10889677-<b>?</b>, rs2201841-<b>?</b>, rs1004819-<b>?</b>, rs9988642-<b>?</b>, rs2902440-<b>?</b>, rs2064689-<b>?</b>, rs11465802-<b>?</b>",2 x 10-7,,0.97,2.56,'-,[1.75-3.70],IL23R - RNU4ATAC4P; IL23R; No mapped genes; No mapped genes; IL23R; No mapped genes; No mapped genes; No mapped genes; IL23R; No mapped genes; C1orf141; IL23R; No mapped genes; IL23R - RNU4ATAC4P; No mapped genes; No mapped genes; No mapped genes,Crohn's disease,Crohn's disease,GCST000071,1:67264945|1:67240275|1:67256884|1:67236843|1:67228519|1:67260421
rs10883365-<b>?</b>,4 x 10-10,,0.48,1.18,'-,[1.05-1.32],LINC01475,Crohn's disease,Crohn's disease,GCST000039,10:99528007
rs2542151-<b>?</b>,3 x 10-8,,0.18,1.15,'-,[1.00-1.32],"PTPN2, LINC01882",Crohn's disease,Crohn's disease,GCST000039,18:12779948
rs9292777-<b>?</b>,3 x 10-18,,0.4,1.34,'-,[1.20-1.50],TTC33,Crohn's disease,Crohn's disease,GCST000039,5:40437846
rs6887695-<b>?</b>,9 x 10-6,,0.32,1.26,'-,[1.12-1.41],"IL12B, LINC01845",Crohn's disease,Crohn's disease,GCST000039,5:159395637
rs13361189-<b>?</b>,2 x 10-10,,0.08,1.38,'-,[1.15-1.66],"SMIM3, IRGM",Crohn's disease,Crohn's disease,GCST000039,5:150843825
rs12035082-<b>?</b>,2 x 10-7,,0.4,1.14,'-,[1.02-1.27],AIMP1P2,Crohn's disease,Crohn's disease,GCST000039,1:172929237
rs2836754-<b>?</b>,5 x 10-7,,0.35,1.15,'-,[1.03-1.28],"LINC01700, RPSAP64",Crohn's disease,Crohn's disease,GCST000039,21:38919816
rs10801047-<b>?</b>,3 x 10-8,,0.08,1.47,'-,[1.22-1.76],'-,Crohn's disease,Crohn's disease,GCST000039,1:191590226
rs9858542-<b>?</b>,5 x 10-8,,0.29,1.17,'-,[1.14-1.31],BSN,Crohn's disease,Crohn's disease,GCST000039,3:49664550
rs1398024-<b>A</b>,4 x 10-6,,0.25,1.23,'-,[1.04-1.45],"OTUD1, C10orf67",Crohn's disease and sarcoidosis (combined),"Sarcoidosis, Crohn's disease",GCST000212,10:23376509
rs2816938-<b>A</b>,5 x 10-15,,0.216,1.2,'-,[1.15-1.25],"RNU6-609P, NR5A2",Pancreatic cancer,pancreatic carcinoma,GCST003758,1:200016240
rs10094872-<b>T</b>,3 x 10-9,,0.35,1.15,'-,[1.10-1.20],CASC11,Pancreatic cancer,pancreatic carcinoma,GCST003758,8:127707639
rs35226131-<b>C</b>,2 x 10-8,,0.959,1.4084507,'-,[1.25-1.59],"TERT, MIR4457",Pancreatic cancer,pancreatic carcinoma,GCST003758,5:1295258
rs351365-<b>C</b>,6 x 10-6,,0.74,1.1111112,'-,[1.05-1.16],WNT2B,Pancreatic cancer,pancreatic carcinoma,GCST005434,1:112503773
rs7200646-<b>C</b>,4 x 10-6,,0.34,1.09,'-,[1.05 – 1.13],"LINC00917, LINC01081",Pancreatic cancer,pancreatic carcinoma,GCST005434,16:86301745
rs2417487-<b>A</b>,6 x 10-7,,0.44,1.09,'-,[1.05-1.12],SMC2,Pancreatic cancer,pancreatic carcinoma,GCST005434,9:104125300
rs450960-<b>T</b>,8 x 10-7,(EA),0.3,1.11,'-,[1.07 -1.15],MICAL3,Pancreatic cancer,pancreatic carcinoma,GCST005434,22:17833538
rs12478462-<b>G</b>,3 x 10-7,(EA),0.22,1.14,'-,[1.08-1.19],"UBQLN4P2, ARL6IP6",Pancreatic cancer,pancreatic carcinoma,GCST005434,2:152798206
rs77038344-<b>T</b>,1 x 10-6,(EA),0.08,1.17,'-,[1.11 -1.24],TNS4,Pancreatic cancer,pancreatic carcinoma,GCST005434,17:40487962
rs6537481-<b>A</b>,4 x 10-6,,0.75,1.1111112,'-,[1.06-1.15],"EDNRA, PRMT5P1",Pancreatic cancer,pancreatic carcinoma,GCST005434,4:147474942
rs13303010-<b>G</b>,8 x 10-14,,0.11,1.26,'-,[1.19–1.35],NOC2L,Pancreatic cancer,pancreatic carcinoma,GCST005434,1:959193
rs73328514-<b>A</b>,1 x 10-7,,0.88,1.1764705,'-,[1.11-1.25],TNS3,Pancreatic cancer,pancreatic carcinoma,GCST005434,7:47448971
rs1517037-<b>C</b>,3 x 10-8,,0.82,1.16,'-,[1.10-1.25],"SEC11C, GRP",Pancreatic cancer,pancreatic carcinoma,GCST005434,18:59211042
rs4795218-<b>G</b>,1 x 10-8,,0.77,1.1363636,'-,[1.09-1.19],HNF1B,Pancreatic cancer,pancreatic carcinoma,GCST005434,17:37718512
rs2941471-<b>A</b>,7 x 10-10,,0.57,1.1235955,'-,[1.08-1.18],HNF4G,Pancreatic cancer,pancreatic carcinoma,GCST005434,8:75558169
rs1486134-<b>G</b>,5 x 10-9,,0.28,1.13,'-,[1.09-1.17],ETAA1,Pancreatic cancer,pancreatic carcinoma,GCST005434,2:67412637
rs16986825-<b>T</b>,1 x 10-8,,0.15,1.15,'-,[1.10 -1.20],ZNRF3,Pancreatic cancer,pancreatic carcinoma,GCST005434,22:28904318
rs10094872-<b>T</b>,1 x 10-9,(EA),0.36,1.14,'-,[1.10-1.19],CASC11,Pancreatic cancer,pancreatic carcinoma,GCST005434,8:127707639
rs9581943-<b>A</b>,5 x 10-14,,0.39,1.15,'-,[1.12-1.19],"PLUT, PDX1",Pancreatic cancer,pancreatic carcinoma,GCST005434,13:27919860
rs401681-<b>T</b>,9 x 10-17,(EA),0.44,1.19,'-,[1.15-1.23],CLPTM1L,Pancreatic cancer,pancreatic carcinoma,GCST005434,5:1321972
rs2816938-<b>A</b>,3 x 10-15,(EA),0.23,1.21,'-,[1.17-1.26],"RNU6-609P, NR5A2",Pancreatic cancer,pancreatic carcinoma,GCST005434,1:200016240
rs9543325-<b>C</b>,1 x 10-22,(EA),0.37,1.24,'-,[1.19-1.28],MARK2P12,Pancreatic cancer,pancreatic carcinoma,GCST005434,13:73342491
rs7214041-<b>T</b>,9 x 10-15,,0.11,1.25,'-,[1.19-1.30],LINC00511,Pancreatic cancer,pancreatic carcinoma,GCST005434,17:72405335
rs505922-<b>C</b>,7 x 10-27,(EA),0.35,1.27,'-,[1.22-1.31],ABO,Pancreatic cancer,pancreatic carcinoma,GCST005434,9:133273813
rs7190458-<b>A</b>,1 x 10-11,,0.04,1.36,'-,[1.27-1.44],BCAR1,Pancreatic cancer,pancreatic carcinoma,GCST005434,16:75229763
rs35226131-<b>C</b>,2 x 10-8,(EA),0.97,1.4925373,'-,[1.23-1.89],"TERT, MIR4457",Pancreatic cancer,pancreatic carcinoma,GCST005434,5:1295258
rs3790844-<b>A</b>,8 x 10-16,(EA),0.77,1.2345679,'-,[1.16-1.32],NR5A2,Pancreatic cancer,pancreatic carcinoma,GCST005434,1:200038304
rs6971499-<b>T</b>,7 x 10-14,,0.84,1.2345679,'-,[1.15-1.32],LINC-PINT,Pancreatic cancer,pancreatic carcinoma,GCST005434,7:130995762
rs2736098-<b>C</b>,7 x 10-15,,0.73,1.1904762,'-,[1.14-1.27],TERT,Pancreatic cancer,pancreatic carcinoma,GCST005434,5:1293971
rs17688601-<b>C</b>,1 x 10-8,,0.73,1.1363636,'-,[1.08-1.19],SUGCT,Pancreatic cancer,pancreatic carcinoma,GCST005434,7:40827064
rs1561927-<b>T</b>,7 x 10-8,,0.74,1.1235955,'-,[1.08-1.18],LINC00824,Pancreatic cancer,pancreatic carcinoma,GCST005434,8:128555832
rs9854771-<b>G</b>,5 x 10-8,,0.64,1.1111112,'-,[1.06-1.16],TP63,Pancreatic cancer,pancreatic carcinoma,GCST005434,3:189790682
rs10991043-<b>C</b>,7 x 10-6,,0.36,1.09,'-,[1.05 - 1.13],SMC2-DT,Pancreatic cancer,pancreatic carcinoma,GCST005434,9:104035107
rs6073450-<b>A</b>,5 x 10-6,,0.37,1.09,'-,[1.05 - 1.13],LINC01620,Pancreatic cancer,pancreatic carcinoma,GCST005434,20:44458008
rs1182933-<b>T</b>,3 x 10-7,,0.3,1.11,'-,[1.07 - 1.15],"OASL, C12orf43",Pancreatic cancer,pancreatic carcinoma,GCST005434,12:121016819
rs1326889-<b>C</b>,4 x 10-7,,NR,1.1111112,'-,[1.06-1.16],AGT,Pancreatic ductal adenocarcinoma,pancreatic carcinoma,GCST007235,1:230727252
rs6537481-<b>A</b>,1 x 10-7,,NR,1.1363636,'-,[1.09-1.2],"EDNRA, PRMT5P1",Pancreatic ductal adenocarcinoma,pancreatic carcinoma,GCST007235,4:147474942
rs876493-<b>G</b>,1 x 10-6,,NR,1.1111112,'-,[1.06-1.16],PNMT,Pancreatic ductal adenocarcinoma,pancreatic carcinoma,GCST007235,17:39668292
rs57791062-<b>C</b>,2 x 10-6,,NR,1.1363636,'-,[1.08-1.2],"SEC11C, GRP",Pancreatic ductal adenocarcinoma,pancreatic carcinoma,GCST007235,18:59212979
rs1169296-<b>G</b>,3 x 10-7,,NR,1.12,'-,[1.07-1.17],HNF1A,Pancreatic ductal adenocarcinoma,pancreatic carcinoma,GCST007235,12:120990604
rs12951345-<b>A</b>,1 x 10-6,,NR,1.1363636,'-,[1.08-1.19],HNF1B,Pancreatic ductal adenocarcinoma,pancreatic carcinoma,GCST007235,17:37717865
rs7225411-<b>C</b>,7 x 10-6,,NR,1.16,'-,[1.09-1.23],"IGFBP4, TNS4",Pancreatic ductal adenocarcinoma,pancreatic carcinoma,GCST007235,17:40463878
rs7859034-<b>G</b>,3 x 10-7,,NR,1.1111112,'-,[1.08-1.16],SMC2,Pancreatic ductal adenocarcinoma,pancreatic carcinoma,GCST007235,9:104103411
rs8078692-<b>A</b>,7 x 10-6,,NR,1.098901,'-,[1.05-1.15],"THRA, MED24",Pancreatic ductal adenocarcinoma,pancreatic carcinoma,GCST007235,17:40058864
rs60579835-<b>T</b>,1 x 10-8,,0.468237803,1.4807987,'-,[1.294742339-1.69359157],ST7L,Pancreatic cancer,pancreatic carcinoma,GCST90013705,1:112570572
rs9581943-<b>A</b>,2 x 10-9,,0.406,1.15,'-,[1.10–1.20],"PLUT, PDX1",Pancreatic cancer,pancreatic carcinoma,GCST002553,13:27919860
rs16986825-<b>T</b>,1 x 10-8,,0.149,1.18,'-,[1.12–1.25],ZNRF3,Pancreatic cancer,pancreatic carcinoma,GCST002553,22:28904318
rs1561927-<b>T</b>,1 x 10-7,,0.721,1.15,'-,[1.09-1.2],LINC00824,Pancreatic cancer,pancreatic carcinoma,GCST002553,8:128555832
rs687289-<b>?</b>,2 x 10-16,,NR,1.27,'-,[1.20–1.35],ABO,Pancreatic cancer,pancreatic carcinoma,GCST002553,9:133261703
rs9543325-<b>?</b>,4 x 10-14,,NR,1.23,'-,[1.18-1.30],MARK2P12,Pancreatic cancer,pancreatic carcinoma,GCST002553,13:73342491
rs10919791-<b>?</b>,1 x 10-11,,NR,1.27,'-,[1.18-1.33],"PEX14, RNU6-716P",Pancreatic cancer,pancreatic carcinoma,GCST002553,1:199996040
rs31490-<b>?</b>,2 x 10-11,,NR,1.2,'-,[1.14-1.27],CLPTM1L,Pancreatic cancer,pancreatic carcinoma,GCST002553,5:1344343
rs2736098-<b>C</b>,1 x 10-13,,0.716,1.25,'-,[1.18-1.32],TERT,Pancreatic cancer,pancreatic carcinoma,GCST002553,5:1293971
rs6971499-<b>T</b>,3 x 10-12,,0.853,1.27,'-,[1.19-1.35],LINC-PINT,Pancreatic cancer,pancreatic carcinoma,GCST002553,7:130995762
rs7190458-<b>A</b>,1 x 10-10,,0.039,1.46,'-,[1.30–1.65],BCAR1,Pancreatic cancer,pancreatic carcinoma,GCST002553,16:75229763
rs505922-<b>C</b>,5 x 10-8,,0.35,1.2,'-,[1.12-1.28],ABO,Pancreatic cancer,pancreatic carcinoma,GCST000456,9:133273813
rs9543325-<b>C</b>,3 x 10-11,,0.37,1.26,'-,[1.18-1.35],MARK2P12,Pancreatic cancer,pancreatic carcinoma,GCST000574,13:73342491
rs3790844-<b>T</b>,2 x 10-10,,0.76,1.3,'-,[1.19-1.41],NR5A2,Pancreatic cancer,pancreatic carcinoma,GCST000574,1:200038304
rs401681-<b>T</b>,7 x 10-7,,0.45,1.19,'-,[1.11-1.27],CLPTM1L,Pancreatic cancer,pancreatic carcinoma,GCST000574,5:1321972
rs559047-<b>A</b>,4 x 10-6,,0.24,'-,0.28 unit decrease,[0.16-0.40],KRT18P32,Stimulated C-peptide levels in type I diabetes,"C-peptide measurement, type I diabetes mellitus",GCST005435,1:238590616
rs61211515-<b>?</b>,1 x 10-7,,0.16,'-,0.39 unit decrease,[0.25-0.53],"TRIM40, TRIM31-AS1",Stimulated C-peptide levels in type I diabetes,"C-peptide measurement, type I diabetes mellitus",GCST005435,6:30133199
rs3135002-<b>A</b>,3 x 10-8,,0.03,'-,'-,'-,"MTCO3P1, HLA-DQB1",Random C-peptide levels in type I diabetes,"C-peptide measurement, type I diabetes mellitus",GCST005437,6:32700662
rs559047-<b>A</b>,4 x 10-8,,0.23,'-,'-,'-,KRT18P32,C-peptide levels in type I diabetes,"C-peptide measurement, type I diabetes mellitus",GCST005436,1:238590616
rs9260151-<b>T</b>,8 x 10-8,,0.09,'-,'-,'-,HLA-A,C-peptide levels in type I diabetes,"C-peptide measurement, type I diabetes mellitus",GCST005436,6:29943253
rs61211515-<b>?</b>,2 x 10-6,,0.16,'-,'-,'-,"TRIM40, TRIM31-AS1",C-peptide levels in type I diabetes,"C-peptide measurement, type I diabetes mellitus",GCST005436,6:30133199
rs3135002-<b>A</b>,7 x 10-8,,0.03,'-,'-,'-,"MTCO3P1, HLA-DQB1",C-peptide levels in type I diabetes,"C-peptide measurement, type I diabetes mellitus",GCST005436,6:32700662
rs3842727-<b>A</b>,3 x 10-7,,0.716,1.9841269,'-,'-,"TH, INS",Type 1 diabetes in high risk HLA genotype individuals (time to event),"disease free survival, type I diabetes mellitus, carrier status",GCST006196,11:2163618
rs73043122-<b>C</b>,4 x 10-6,,0.013,3.351,'-,'-,"MIR3939, RNASET2",Type 1 diabetes in high risk HLA genotype individuals (time to event),"disease free survival, type I diabetes mellitus, carrier status",GCST006196,6:166969779
rs113306148-<b>A</b>,3 x 10-6,,0.013,3.067,'-,'-,PLEKHA1,Type 1 diabetes in high risk HLA genotype individuals (time to event),"disease free survival, type I diabetes mellitus, carrier status",GCST006196,10:122400322
rs10831551-<b>C</b>,5 x 10-6,,0.048,2.219,'-,'-,"MIR4686, ASCL2",Type 1 diabetes in high risk HLA genotype individuals (time to event),"disease free survival, type I diabetes mellitus, carrier status",GCST006196,11:2217058
rs428595-<b>A</b>,2 x 10-6,,0.011,3.424,'-,'-,"MIR130B, PPIL2",Type 1 diabetes in high risk HLA genotype individuals (time to event),"disease free survival, type I diabetes mellitus, carrier status",GCST006196,22:21662102
rs6679677-<b>A</b>,2 x 10-6,(any IA),0.114,1.46,'-,'-,"RSBN1, PHTF1",Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event),"event free survival time, type I diabetes mellitus, carrier status, autoantibody measurement",GCST006197,1:113761186
rs3184504-<b>A</b>,4 x 10-7,(any IA),0.462,1.35,'-,'-,"SH2B3, ATXN2",Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event),"event free survival time, type I diabetes mellitus, carrier status, autoantibody measurement",GCST006197,12:111446804
rs428595-<b>A</b>,1 x 10-6,(any IA),0.011,2.47,'-,'-,"MIR130B, PPIL2",Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event),"event free survival time, type I diabetes mellitus, carrier status, autoantibody measurement",GCST006197,22:21662102
rs6679677-<b>A</b>,2 x 10-6,(multiple-IA),0.114,1.592,'-,'-,"RSBN1, PHTF1",Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event),"event free survival time, type I diabetes mellitus, carrier status, autoantibody measurement",GCST006197,1:113761186
rs3842727-<b>A</b>,1 x 10-7,(multiple-IA),0.716,1.6638935,'-,'-,"TH, INS",Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event),"event free survival time, type I diabetes mellitus, carrier status, autoantibody measurement",GCST006197,11:2163618
rs11705721-<b>G</b>,9 x 10-6,(multiple-IA),0.321,1.41,'-,'-,PXK,Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event),"event free survival time, type I diabetes mellitus, carrier status, autoantibody measurement",GCST006197,3:58414687
rs28600853-<b>G</b>,6 x 10-6,(IAA-first),0.011,3.233,'-,'-,TTC34,Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event),"event free survival time, type I diabetes mellitus, carrier status, autoantibody measurement",GCST006197,1:2863195
rs3842727-<b>A</b>,6 x 10-6,(IAA-first),0.716,1.7513134,'-,'-,"TH, INS",Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event),"event free survival time, type I diabetes mellitus, carrier status, autoantibody measurement",GCST006197,11:2163618
rs9934817-<b>G</b>,8 x 10-6,(GADA-first),0.019,2.663,'-,'-,RBFOX1,Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event),"event free survival time, type I diabetes mellitus, carrier status, autoantibody measurement",GCST006197,16:6086218
rs7533564-<b>C</b>,2 x 10-9,,'-,'-,0.138 unit increase,[0.093-0.183],"PTGFR, MGC27382",Skin fluorescence in type 1 diabetes,"skin fluorescence measurement, type I diabetes mellitus",GCST003418,1:78360228
rs2085277-<b>T</b>,4 x 10-8,,0.039,'-,0.046 unit increase,[0.030-0.062],'-,Glycated hemoglobin levels in type 1 diabetes,"type I diabetes mellitus, HbA1c measurement",GCST007605,13:31593580
rs11725853-<b>A</b>,8 x 10-7,,0.15,'-,0.11 unit increase,[0.07-0.16],GLRA3,Urinary albumin excretion rate in type 1 diabetes,"type I diabetes mellitus, urinary albumin excretion rate",GCST002382,4:174721548
rs2410601-<b>G</b>,4 x 10-6,,0.47,'-,0.08 unit increase,[0.04-0.11],PSD3,Urinary albumin excretion rate in type 1 diabetes,"type I diabetes mellitus, urinary albumin excretion rate",GCST002382,8:19065067
rs478222-<b>?</b>,4 x 10-9,,0.59,1.22,'-,[NR],EFR3B,Type 1 diabetes,type I diabetes mellitus,GCST001255,2:25078886
rs539514-<b>?</b>,6 x 10-11,,0.5,1.43,'-,[NR],LMO7,Type 1 diabetes,type I diabetes mellitus,GCST001255,13:75752146
rs924043-<b>?</b>,8 x 10-9,,0.85,1.35,'-,[NR],'-,Type 1 diabetes,type I diabetes mellitus,GCST001255,6:170063801
rs550448-<b>?</b>,5 x 10-7,,0.86,1.32,'-,[NR],JAZF1-AS1,Type 1 diabetes,type I diabetes mellitus,GCST001255,7:28189423
rs12679857-<b>?</b>,4 x 10-7,,0.69,1.2,'-,[NR],"RNU6-12P, TNFRSF11B",Type 1 diabetes,type I diabetes mellitus,GCST001255,8:118965098
rs6547853-<b>?</b>,8 x 10-7,,0.6,1.19,'-,[NR],"FOSL2, PLB1",Type 1 diabetes,type I diabetes mellitus,GCST001255,2:28423934
rs4084127-<b>?</b>,3 x 10-6,,NR,1.11,'-,[NR],"FGF4, FGF3",Type 1 diabetes,type I diabetes mellitus,GCST001255,11:69781755
rs10786436-<b>T</b>,8 x 10-7,,NR,1.1,'-,[NR],HPSE2,Type 1 diabetes,type I diabetes mellitus,GCST001255,10:98540425
rs10137082-<b>?</b>,6 x 10-6,,NR,1.1,'-,[NR],"EFS, IL25",Type 1 diabetes,type I diabetes mellitus,GCST001255,14:23370824
rs9810233-<b>G</b>,7 x 10-7,,0.27,'-,'-,'-,ALCAM,Erectile dysfunction in type 1 diabetes,"type I diabetes mellitus, erectile dysfunction",GCST001572,3:105292046
rs836589-<b>A</b>,2 x 10-6,,0.186,'-,'-,'-,"PDK1, RAPGEF4-AS1",Erectile dysfunction in type 1 diabetes,"type I diabetes mellitus, erectile dysfunction",GCST001572,2:172628350
rs6931865-<b>A</b>,4 x 10-6,,0.336,'-,'-,'-,PHACTR2,Erectile dysfunction in type 1 diabetes,"type I diabetes mellitus, erectile dysfunction",GCST001572,6:143758717
rs950146-<b>C</b>,4 x 10-6,,0.491,'-,'-,'-,"NBPF21P, RN7SKP227",Erectile dysfunction in type 1 diabetes,"type I diabetes mellitus, erectile dysfunction",GCST001572,3:36638607
rs2990510-<b>G</b>,6 x 10-6,,0.305,'-,'-,'-,F13B,Erectile dysfunction in type 1 diabetes,"type I diabetes mellitus, erectile dysfunction",GCST001572,1:197051528
rs9850224-<b>A</b>,5 x 10-6,,0.01,'-,'-,'-,LINC02050,Erectile dysfunction in type 1 diabetes,"type I diabetes mellitus, erectile dysfunction",GCST001572,3:80816613
rs2523989-<b>A</b>,2 x 10-8,,NR,1.7499,'-,'-,"TRIM31-AS1, TRIM31",Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,6:30110498
rs886424-<b>A</b>,3 x 10-14,,NR,2.2107,'-,'-,LINC00243,Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,6:30814225
rs2251396-<b>T</b>,1 x 10-22,,NR,2.2132,'-,'-,"HLA-S, MICA",Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,6:31396930
rs2857595-<b>T</b>,2 x 10-23,,NR,2.3765,'-,'-,"NCR3, UQCRHP1",Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,6:31600692
rs1270942-<b>C</b>,5 x 10-25,,NR,3.0494,'-,'-,CFB,Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,6:31951083
rs1980493-<b>G</b>,2 x 10-20,,NR,2.5034,'-,'-,"BTNL2, TSBP1-AS1",Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,6:32395438
rs1015166-<b>T</b>,4 x 10-22,,NR,2.1428,'-,'-,TAP2,Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,6:32830954
rs2153977-<b>T</b>,4 x 10-7,,NR,1.491,'-,'-,MAGI3,Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,1:113537449
rs2476601-<b>A</b>,7 x 10-20,,NR,2.7073,'-,'-,PTPN22,Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,1:113834946
rs2358994-<b>A</b>,2 x 10-11,,NR,1.8688,'-,'-,"BCL2L15, AP4B1-AS1",Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,1:113886839
rs7679475-<b>A</b>,4 x 10-10,,NR,1.6198,'-,'-,"QRFPR, TUBB4BP5",Type 1 diabetes and autoimmune thyroid diseases,"autoimmune thyroid disease, type I diabetes mellitus",GCST002876,4:121392885
rs3757247-<b>A</b>,1 x 10-6,,NR,1.13,'-,[1.08-1.19],BACH2,Type 1 diabetes,type I diabetes mellitus,GCST000244,6:90247744
rs8035957-<b>C</b>,4 x 10-6,,NR,1.14,'-,[1.08-1.21],RASGRP1,Type 1 diabetes,type I diabetes mellitus,GCST000244,15:38546063
rs9976767-<b>C</b>,2 x 10-8,,NR,1.16,'-,[1.10-1.22],UBASH3A,Type 1 diabetes,type I diabetes mellitus,GCST000244,21:42416281
rs1983853-<b>?</b>,2 x 10-6,,NR,1.2,'-,[1.11-1.29],LPAR3,Type 1 diabetes,type I diabetes mellitus,GCST000244,1:84845509
rs10758593-<b>A</b>,3 x 10-6,,NR,1.13,'-,[1.07-1.19],GLIS3,Type 1 diabetes,type I diabetes mellitus,GCST000244,9:4292083
rs17696736-<b>G</b>,2 x 10-16,,0.42,1.22,'-,[1.15-1.28],NAA25,Type 1 diabetes,type I diabetes mellitus,GCST000038,12:112049014
rs763361-<b>A</b>,1 x 10-8,,0.47,1.16,'-,[1.10-1.22],CD226,Type 1 diabetes,type I diabetes mellitus,GCST000038,18:69864406
rs1445898-<b>G</b>,8 x 10-6,,0.55,1.12,'-,[1.06-1.19],CAPSL,Type 1 diabetes,type I diabetes mellitus,GCST000038,5:35910427
rs2292239-<b>A</b>,2 x 10-20,,0.34,1.28,'-,[1.21-1.35],ERBB3,Type 1 diabetes,type I diabetes mellitus,GCST000038,12:56088396
rs12708716-<b>A</b>,3 x 10-18,,0.68,1.23,'-,[1.16-1.30],CLEC16A,Type 1 diabetes,type I diabetes mellitus,GCST000038,16:11086016
rs2542151-<b>C</b>,1 x 10-14,,0.16,1.3,'-,[1.22-1.40],"PTPN2, LINC01882",Type 1 diabetes,type I diabetes mellitus,GCST000038,18:12779948
rs2476601-<b>T</b>,2 x 10-80,,0.09,1.98,'-,[1.82-2.15],PTPN22,Type 1 diabetes,type I diabetes mellitus,GCST000038,1:113834946
rs6897932-<b>G</b>,8 x 10-6,,0.71,1.12,'-,[1.06-1.19],IL7R,Type 1 diabetes,type I diabetes mellitus,GCST000038,5:35874473
rs9653442-<b>G</b>,5 x 10-6,,0.46,1.11,'-,[1.05-1.17],LINC01104,Type 1 diabetes,type I diabetes mellitus,GCST000038,2:100208905
rs6679677-<b>A</b>,8 x 10-24,,0.1,1.89,'-,[1.67-2.13],"RSBN1, PHTF1",Type 1 diabetes,type I diabetes mellitus,GCST000038,1:113761186
rs3741208-<b>T</b>,2 x 10-7,,0.38,1.25,'-,[1.15-1.35],"IGF2-AS, INS-IGF2",Type 1 diabetes,type I diabetes mellitus,GCST000038,11:2148544
rs1990760-<b>A</b>,2 x 10-11,,0.6,1.18,'-,[1.11-1.23],IFIH1,Type 1 diabetes,type I diabetes mellitus,GCST000038,2:162267541
rs1004446-<b>C</b>,4 x 10-9,,0.65,1.61,'-,[1.37-1.89],INS-IGF2,Type 1 diabetes,type I diabetes mellitus,GCST000054,11:2148913
rs2903692-<b>G</b>,7 x 10-11,,0.62,1.54,'-,[1.32-1.79],CLEC16A,Type 1 diabetes,type I diabetes mellitus,GCST000054,16:11144926
rs2476601-<b>A</b>,1 x 10-7,,0.09,1.8,'-,[1.44-2.24],PTPN22,Type 1 diabetes,type I diabetes mellitus,GCST000054,1:113834946
rs2647044-<b>A</b>,1 x 10-16,,0.13,8.3,'-,[6.97-9.89],"MTCO3P1, HLA-DQB1",Type 1 diabetes,type I diabetes mellitus,GCST000054,6:32700133
rs11258747-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,PRKCQ,Type 1 diabetes,type I diabetes mellitus,GCST000392,10:6430929
rs2292239-<b>?</b>,2 x 10-25,,NR,'-,'-,'-,ERBB3,Type 1 diabetes,type I diabetes mellitus,GCST000392,12:56088396
rs3184504-<b>?</b>,3 x 10-27,,NR,'-,'-,'-,"SH2B3, ATXN2",Type 1 diabetes,type I diabetes mellitus,GCST000392,12:111446804
rs3825932-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,CTSH,Type 1 diabetes,type I diabetes mellitus,GCST000392,15:78943104
rs1893217-<b>?</b>,4 x 10-15,,NR,'-,'-,'-,PTPN2,Type 1 diabetes,type I diabetes mellitus,GCST000392,18:12809341
rs11203203-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,UBASH3A,Type 1 diabetes,type I diabetes mellitus,GCST000392,21:42416077
rs3024505-<b>?</b>,2 x 10-9,,0.83,1.19,'-,[1.10-1.30],"IL10, Y_RNA",Type 1 diabetes,type I diabetes mellitus,GCST000392,1:206766559
rs9388489-<b>G</b>,4 x 10-13,,0.45,1.17,'-,[1.10-1.24],CENPW,Type 1 diabetes,type I diabetes mellitus,GCST000392,6:126377573
rs4948088-<b>?</b>,4 x 10-8,,0.95,1.3,'-,[1.11-1.49],COBL,Type 1 diabetes,type I diabetes mellitus,GCST000392,7:50959497
rs10509540-<b>?</b>,1 x 10-28,,0.71,1.33,'-,[1.25-1.43],RNLS,Type 1 diabetes,type I diabetes mellitus,GCST000392,10:88263276
rs4763879-<b>A</b>,2 x 10-11,,0.37,1.09,'-,[1.02-1.16],CD69,Type 1 diabetes,type I diabetes mellitus,GCST000392,12:9757568
rs4900384-<b>G</b>,4 x 10-9,,0.29,1.09,'-,[1.02-1.16],LINC01550,Type 1 diabetes,type I diabetes mellitus,GCST000392,14:98032614
rs7202877-<b>G</b>,3 x 10-15,,0.1,1.28,'-,[1.17-1.41],"CTRB2, CTRB1",Type 1 diabetes,type I diabetes mellitus,GCST000392,16:75213347
rs2281808-<b>?</b>,1 x 10-11,,0.64,1.11,'-,[1.05-1.19],SIRPG,Type 1 diabetes,type I diabetes mellitus,GCST000392,20:1629905
rs5753037-<b>T</b>,3 x 10-16,,0.39,1.1,'-,[1.04-1.17],"HORMAD2, LIF-AS1",Type 1 diabetes,type I diabetes mellitus,GCST000392,22:30185733
rs2269241-<b>G</b>,4 x 10-7,,0.19,1.1,'-,[1.02-1.18],PGM1,Type 1 diabetes,type I diabetes mellitus,GCST000392,1:63643100
rs1534422-<b>G</b>,2 x 10-6,,0.46,1.08,'-,[1.02-1.15],MIR3681HG,Type 1 diabetes,type I diabetes mellitus,GCST000392,2:12500615
rs9268645-<b>?</b>,1 x 10-100,,NR,'-,'-,'-,HLA-DRA,Type 1 diabetes,type I diabetes mellitus,GCST000392,6:32440750
rs2476601-<b>?</b>,9 x 10-85,,NR,'-,'-,'-,PTPN22,Type 1 diabetes,type I diabetes mellitus,GCST000392,1:113834946
rs1990760-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,IFIH1,Type 1 diabetes,type I diabetes mellitus,GCST000392,2:162267541
rs4505848-<b>?</b>,5 x 10-13,,NR,'-,'-,'-,KIAA1109,Type 1 diabetes,type I diabetes mellitus,GCST000392,4:122211337
rs2290400-<b>?</b>,6 x 10-13,,0.5,1.15,'-,[1.08-1.22],GSDMB,Type 1 diabetes,type I diabetes mellitus,GCST000392,17:39909987
rs3087243-<b>?</b>,1 x 10-15,,NR,'-,'-,'-,"CTLA4, ICOS",Type 1 diabetes,type I diabetes mellitus,GCST000392,2:203874196
rs7804356-<b>?</b>,5 x 10-9,,0.76,1.14,'-,[1.06-1.22],SKAP2,Type 1 diabetes,type I diabetes mellitus,GCST000392,7:26852046
rs16956936-<b>?</b>,5 x 10-7,,0.86,1.09,'-,[1.00-1.19],DNAH2,Type 1 diabetes,type I diabetes mellitus,GCST000392,17:7730374
rs425105-<b>?</b>,3 x 10-11,,0.84,1.16,'-,[1.08-1.27],PRKD2,Type 1 diabetes,type I diabetes mellitus,GCST000392,19:46705224
rs7221109-<b>?</b>,1 x 10-9,,0.65,1.05,'-,[0.99-1.12],"CCR7, SMARCE1",Type 1 diabetes,type I diabetes mellitus,GCST000392,17:40614034
rs2664170-<b>G</b>,8 x 10-9,,0.32,1.16,'-,[1.07-1.24],GAB3,Type 1 diabetes,type I diabetes mellitus,GCST000392,X:154717327
rs12444268-<b>A</b>,2 x 10-7,,0.3,1.1,'-,[1.03-1.17],"GP2, UMOD",Type 1 diabetes,type I diabetes mellitus,GCST000392,16:20331250
rs11755527-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BACH2,Type 1 diabetes,type I diabetes mellitus,GCST000392,6:90248512
rs12251307-<b>?</b>,1 x 10-13,,NR,'-,'-,'-,"RBM17, RPL32P23",Type 1 diabetes,type I diabetes mellitus,GCST000392,10:6081532
rs7111341-<b>?</b>,4 x 10-48,,NR,'-,'-,'-,"MIR4686, ASCL2",Type 1 diabetes,type I diabetes mellitus,GCST000392,11:2191936
rs12708716-<b>?</b>,2 x 10-16,,NR,'-,'-,'-,CLEC16A,Type 1 diabetes,type I diabetes mellitus,GCST000392,16:11086016
rs229541-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,C1QTNF6,Type 1 diabetes,type I diabetes mellitus,GCST000392,22:37195278
rs10517086-<b>A</b>,5 x 10-10,,0.3,1.09,'-,[1.02-1.17],LINC02357,Type 1 diabetes,type I diabetes mellitus,GCST000392,4:26083889
rs7020673-<b>?</b>,5 x 10-12,,0.5,1.14,'-,[1.08-1.20],GLIS3,Type 1 diabetes,type I diabetes mellitus,GCST000392,9:4291747
rs1465788-<b>?</b>,2 x 10-12,,0.71,1.16,'-,[1.10-1.25],"ZFP36L1, MAGOH3P",Type 1 diabetes,type I diabetes mellitus,GCST000392,14:68796882
rs4788084-<b>G</b>,3 x 10-13,,0.42,1.09,'-,[1.02-1.16],"IL27, NUPR1",Type 1 diabetes,type I diabetes mellitus,GCST000392,16:28528527
rs1701704-<b>C</b>,9 x 10-10,,0.35,1.25,'-,[1.12-1.40],IKZF4,Type 1 diabetes,type I diabetes mellitus,GCST000141,12:56018703
rs11755527-<b>G</b>,5 x 10-12,,0.47,1.13,'-,[1.08-1.19],BACH2,Type 1 diabetes,type I diabetes mellitus,GCST000258,6:90248512
rs947474-<b>G</b>,4 x 10-9,,0.19,1.1,'-,[1.03-1.18],LINC02649,Type 1 diabetes,type I diabetes mellitus,GCST000258,10:6348488
rs3825932-<b>T</b>,3 x 10-15,,0.68,1.16,'-,[1.10-1.22],CTSH,Type 1 diabetes,type I diabetes mellitus,GCST000258,15:78943104
rs229541-<b>T</b>,2 x 10-8,,0.43,1.11,'-,[1.05-1.16],C1QTNF6,Type 1 diabetes,type I diabetes mellitus,GCST000258,22:37195278
rs416603-<b>T</b>,3 x 10-6,,0.44,1.06,'-,[1.01-1.12],RMI2,Type 1 diabetes,type I diabetes mellitus,GCST000258,16:11270222
rs6679677-<b>A</b>,1 x 10-40,,NR,'-,'-,'-,"RSBN1, PHTF1",Type 1 diabetes,type I diabetes mellitus,GCST000258,1:113761186
rs3087243-<b>A</b>,8 x 10-11,,NR,'-,'-,'-,"CTLA4, ICOS",Type 1 diabetes,type I diabetes mellitus,GCST000258,2:203874196
rs17696736-<b>G</b>,6 x 10-18,,NR,'-,'-,'-,NAA25,Type 1 diabetes,type I diabetes mellitus,GCST000258,12:112049014
rs2292239-<b>A</b>,3 x 10-16,,NR,'-,'-,'-,ERBB3,Type 1 diabetes,type I diabetes mellitus,GCST000258,12:56088396
rs2542151-<b>C</b>,9 x 10-8,,NR,'-,'-,'-,"PTPN2, LINC01882",Type 1 diabetes,type I diabetes mellitus,GCST000258,18:12779948
rs9272346-<b>G</b>,6 x 10-129,,NR,'-,'-,'-,HLA-DQA1,Type 1 diabetes,type I diabetes mellitus,GCST000258,6:32636595
rs2165738-<b>C</b>,4 x 10-6,,0.27,1.07,'-,[1.01-1.13],"NCOA1, PUM2",Type 1 diabetes,type I diabetes mellitus,GCST000258,2:24469940
rs12251307-<b>T</b>,2 x 10-6,,NR,'-,'-,'-,"RBM17, RPL32P23",Type 1 diabetes,type I diabetes mellitus,GCST000258,10:6081532
rs12708716-<b>G</b>,7 x 10-13,,NR,'-,'-,'-,CLEC16A,Type 1 diabetes,type I diabetes mellitus,GCST000258,16:11086016
rs3024505-<b>G</b>,5 x 10-10,,NR,1.2,'-,[NR],"IL10, Y_RNA",Type 1 diabetes,type I diabetes mellitus,GCST001191,1:206766559
rs1990760-<b>C</b>,2 x 10-14,,NR,1.2,'-,[NR],IFIH1,Type 1 diabetes,type I diabetes mellitus,GCST001191,2:162267541
rs17388568-<b>A</b>,6 x 10-6,,NR,1.1,'-,[NR],ADAD1,Type 1 diabetes,type I diabetes mellitus,GCST001191,4:122408207
rs12722495-<b>A</b>,1 x 10-38,,NR,1.61,'-,[NR],IL2RA,Type 1 diabetes,type I diabetes mellitus,GCST001191,10:6055320
rs1004446-<b>G</b>,3 x 10-23,,NR,1.4,'-,[NR],INS-IGF2,Type 1 diabetes,type I diabetes mellitus,GCST001191,11:2148913
rs2292239-<b>T</b>,3 x 10-27,,NR,1.3,'-,[NR],ERBB3,Type 1 diabetes,type I diabetes mellitus,GCST001191,12:56088396
rs12708716-<b>G</b>,5 x 10-14,,NR,1.2,'-,[NR],CLEC16A,Type 1 diabetes,type I diabetes mellitus,GCST001191,16:11086016
rs3788013-<b>A</b>,1 x 10-7,,NR,1.1,'-,[NR],UBASH3A,Type 1 diabetes,type I diabetes mellitus,GCST001191,21:42421219
rs743777-<b>G</b>,2 x 10-6,,NR,1.1,'-,[NR],IL2RB,Type 1 diabetes,type I diabetes mellitus,GCST001191,22:37155567
rs3087243-<b>A</b>,2 x 10-17,,NR,1.2,'-,[NR],"CTLA4, ICOS",Type 1 diabetes,type I diabetes mellitus,GCST001191,2:203874196
rs2069762-<b>A</b>,5 x 10-7,,NR,1.12,'-,[NR],IL2,Type 1 diabetes,type I diabetes mellitus,GCST001191,4:122456825
rs4788084-<b>C</b>,1 x 10-8,,NR,1.15,'-,[NR],"IL27, NUPR1",Type 1 diabetes,type I diabetes mellitus,GCST001191,16:28528527
rs763361-<b>C</b>,1 x 10-9,,NR,1.12,'-,[NR],CD226,Type 1 diabetes,type I diabetes mellitus,GCST001191,18:69864406
rs2304256-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,TYK2,Type 1 diabetes,type I diabetes mellitus,GCST001191,19:10364976
rs2476601-<b>A</b>,2 x 10-111,,NR,2,'-,[NR],PTPN22,Type 1 diabetes,type I diabetes mellitus,GCST001191,1:113834946
rs3184504-<b>T</b>,2 x 10-38,,NR,1.3,'-,[NR],"SH2B3, ATXN2",Type 1 diabetes,type I diabetes mellitus,GCST001191,12:111446804
rs7171171-<b>G</b>,2 x 10-7,,NR,'-,'-,'-,"RASGRP1, LINC02694",Type 1 diabetes,type I diabetes mellitus,GCST001191,15:38614840
rs11755527-<b>G</b>,3 x 10-8,,NR,1.1,'-,[NR],BACH2,Type 1 diabetes,type I diabetes mellitus,GCST001191,6:90248512
rs1701704-<b>T</b>,5 x 10-18,,NR,1.25,'-,[NR],IKZF4,Type 1 diabetes,type I diabetes mellitus,GCST001191,12:56018703
rs2872507-<b>A</b>,2 x 10-6,,NR,1.1,'-,[NR],"GSDMB, ZPBP2",Type 1 diabetes,type I diabetes mellitus,GCST001191,17:39884510
rs689-<b>A</b>,5 x 10-196,,NR,'-,'-,'-,"INS, INS-IGF2",Type 1 diabetes,type I diabetes mellitus,GCST001191,11:2160994
rs2542151-<b>G</b>,4 x 10-13,,NR,1.3,'-,[NR],"PTPN2, LINC01882",Type 1 diabetes,type I diabetes mellitus,GCST001191,18:12779948
rs7528684-<b>T</b>,8 x 10-9,,NR,1.45,'-,'-,"FCRL3, VDAC1P9",Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes,"type I diabetes mellitus, autoantibody measurement",GCST004381,1:157701026
rs657152-<b>G</b>,1 x 10-13,,'-,2.94,'-,[2.13-4.00],ABO,Gastric parietal cell autoantibody levels in type 1 diabetes,"type I diabetes mellitus, autoantibody measurement",GCST004382,9:133263862
rs11755527-<b>G</b>,1 x 10-6,,'-,1.2,'-,'-,BACH2,Thyroid peroxidase autoantibody levels in type 1 diabetes,"type I diabetes mellitus, thyroid peroxidase antibody measurement",GCST004383,6:90248512
rs1970112-<b>C</b>,1 x 10-8,,0.41,1.27,'-,[1.17-1.38],CDKN2B-AS1,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST011116,9:22085599
rs181176493-<b>A</b>,2 x 10-7,,0.01,3.88,'-,[2.33-6.47],RN7SL807P,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST011116,2:223293148
rs70962766-<b>C</b>,5 x 10-7,,0.99,0.2,'-,[0.11-0.37],"COMMD1, B3GNT2",Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST011116,2:62179865
rs138181578-<b>AT</b>,7 x 10-7,,0.99,0.18,'-,[0.09-0.35],RUNX2,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST011116,6:45758094
rs10625784-<b>TAAA</b>,8 x 10-7,,0.99,0.23,'-,[0.13-0.42],'-,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST011116,11:106323171
rs79237700-<b>C</b>,2 x 10-6,,0.04,1.82,'-,[1.42-2.33],WDR72,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST011116,15:53449415
rs574480779-<b>T</b>,9 x 10-7,,0.03,2.27,'-,[1.64-3.15],"KIF4B, MRPL22",Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST011116,5:155011321
rs1344228-<b>T</b>,8 x 10-6,,0.11,1.33,'-,[1.17-1.51],'-,Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST011116,2:123529348
rs6055069-<b>C</b>,1 x 10-6,,0.98,0.38,'-,[0.25-0.56],"DEFB127, DEFB126",Coronary artery disease in type 1 diabetes,"type I diabetes mellitus, coronary artery disease",GCST011116,20:153643
rs17771967-<b>G</b>,6 x 10-6,(EA),0.424,1.0475605,'-,[1.03-1.07],"RNU6-222P, KIR3DL2",Inflammatory bowel disease,inflammatory bowel disease,GCST003043,19:54868759
rs5979785-<b>?</b>,6 x 10-8,,0.74,1.14,'-,[1.09-1.19],"TLR8, TMSB4X",Celiac disease,celiac disease,GCST000612,X:12953405
rs13010713-<b>G</b>,5 x 10-11,,0.45,1.13,'-,[1.09-1.18],LINC01934,Celiac disease,celiac disease,GCST000612,2:181131318
rs1464510-<b>A</b>,3 x 10-40,,0.49,1.29,'-,[1.25-1.34],LPP,Celiac disease,celiac disease,GCST000612,3:188394766
rs1738074-<b>A</b>,3 x 10-15,,0.43,1.16,'-,[1.12-1.21],"TAGAP, TAGAP-AS1",Celiac disease,celiac disease,GCST000612,6:159044945
rs6974491-<b>A</b>,2 x 10-7,,0.17,1.14,'-,[1.09-1.20],ELMO1,Celiac disease,celiac disease,GCST000612,7:37334906
rs10936599-<b>A</b>,5 x 10-7,,0.25,1.12,'-,[1.07-1.16],MYNN,Celiac disease,celiac disease,GCST000612,3:169774313
rs2762051-<b>A</b>,7 x 10-7,,0.18,1.13,'-,[1.08-1.18],DLEU1,Celiac disease,celiac disease,GCST000612,13:50261579
rs1893217-<b>G</b>,3 x 10-10,,0.17,1.17,'-,[1.12-1.23],PTPN2,Celiac disease,celiac disease,GCST000612,18:12809341
rs9792269-<b>?</b>,3 x 10-9,,0.76,1.14,'-,[1.10-1.19],RN7SKP226,Celiac disease,celiac disease,GCST000612,8:128252343
rs12928822-<b>?</b>,3 x 10-8,,0.84,1.16,'-,[1.10-1.22],RMI2,Celiac disease,celiac disease,GCST000612,16:11310036
rs2816316-<b>?</b>,2 x 10-17,,0.84,1.25,'-,[1.19-1.32],RGS1,Celiac disease,celiac disease,GCST000612,1:192567683
rs3748816-<b>?</b>,3 x 10-9,,0.66,1.12,'-,[1.09-1.18],MMEL1,Celiac disease,celiac disease,GCST000612,1:2595307
rs10903122-<b>?</b>,2 x 10-10,,0.52,1.12,'-,[1.09-1.18],"MIR4425, RUNX3",Celiac disease,celiac disease,GCST000612,1:24977085
rs4899260-<b>A</b>,4 x 10-7,,0.26,1.12,'-,[1.07-1.16],"MAGOH3P, ZFP36L1",Celiac disease,celiac disease,GCST000612,14:68811487
rs2074404-<b>?</b>,1 x 10-6,,0.75,1.11,'-,[1.06-1.16],WNT3,Celiac disease,celiac disease,GCST000612,17:46788073
rs864537-<b>?</b>,4 x 10-7,,0.61,1.1,'-,[1.06-1.15],CD247,Celiac disease,celiac disease,GCST000612,1:167442147
rs296547-<b>?</b>,4 x 10-9,,0.64,1.12,'-,[1.09-1.16],MROH3P,Celiac disease,celiac disease,GCST000612,1:200923009
rs13003464-<b>G</b>,4 x 10-13,,0.4,1.15,'-,[1.11-1.20],PUS10,Celiac disease,celiac disease,GCST000612,2:60959694
rs2327832-<b>G</b>,4 x 10-19,,0.22,1.23,'-,[1.17-1.28],LINC02539,Celiac disease,celiac disease,GCST000612,6:137651931
rs17035378-<b>?</b>,8 x 10-9,,0.72,1.14,'-,[1.09-1.19],PLEK,Celiac disease,celiac disease,GCST000612,2:68371823
rs13314993-<b>C</b>,3 x 10-9,,0.46,1.13,'-,[1.08-1.17],"CCR4, GLB1",Celiac disease,celiac disease,GCST000612,3:32973977
rs11712165-<b>C</b>,8 x 10-9,,0.39,1.13,'-,[1.08-1.17],ARHGAP31,Celiac disease,celiac disease,GCST000612,3:119399949
rs10806425-<b>A</b>,4 x 10-10,,0.4,1.13,'-,[1.09-1.17],BACH2,Celiac disease,celiac disease,GCST000612,6:90216893
rs802734-<b>G</b>,3 x 10-14,,0.31,1.17,'-,[1.12-1.22],"PTPRK, THEMIS",Celiac disease,celiac disease,GCST000612,6:127957653
rs1250552-<b>?</b>,9 x 10-10,,0.53,1.12,'-,[1.09-1.16],ZMIZ1,Celiac disease,celiac disease,GCST000612,10:79298270
rs11221332-<b>A</b>,5 x 10-16,,0.24,1.21,'-,[1.16-1.27],ETS1,Celiac disease,celiac disease,GCST000612,11:128511079
rs4819388-<b>?</b>,2 x 10-9,,0.72,1.14,'-,[1.09-1.19],ICOSLG,Celiac disease,celiac disease,GCST000612,21:44227538
rs1033180-<b>A</b>,6 x 10-8,,0.08,1.21,'-,[1.13-1.29],"IRF4, DUSP22",Celiac disease,celiac disease,GCST000612,6:383546
rs2298428-<b>A</b>,2 x 10-7,,0.2,1.13,'-,[1.08-1.19],YDJC,Celiac disease,celiac disease,GCST000612,22:21628603
rs917997-<b>A</b>,1 x 10-15,,0.24,1.19,'-,[1.14-1.25],"IL18RAP, SLC9A4",Celiac disease,celiac disease,GCST000612,2:102454108
rs4675374-<b>A</b>,6 x 10-9,,0.22,1.14,'-,[1.09-1.19],ICOS,Celiac disease,celiac disease,GCST000612,2:203937855
rs13098911-<b>A</b>,3 x 10-17,,0.1,1.3,'-,[1.23-1.39],CCR3,Celiac disease,celiac disease,GCST000612,3:46193709
rs17810546-<b>G</b>,4 x 10-28,,0.13,1.36,'-,[1.29-1.44],IL12A-AS1,Celiac disease,celiac disease,GCST000612,3:159947262
rs13151961-<b>?</b>,2 x 10-27,,0.86,1.35,'-,[1.28-1.43],KIAA1109,Celiac disease,celiac disease,GCST000612,4:122194347
rs2187668-<b>A</b>,1 x 10-50,,0.26,6.23,'-,[5.95-6.52],HLA-DQA1,Celiac disease,celiac disease,GCST000612,6:32638107
rs653178-<b>G</b>,7 x 10-21,,0.5,1.2,'-,[1.15-1.24],'-,Celiac disease,celiac disease,GCST000612,Mapping not available
rs6691768-<b>?</b>,1 x 10-7,,0.62,1.11,'-,[1.06-1.15],NFIA,Celiac disease,celiac disease,GCST000612,1:61326191
rs859637-<b>A</b>,2 x 10-6,,0.49,1.1,'-,[1.06-1.14],"SLC25A38P1, FASLG",Celiac disease,celiac disease,GCST000612,1:172741860
rs12727642-<b>A</b>,9 x 10-8,,0.19,1.14,'-,[1.09-1.20],"PARK7, ERRFI1",Celiac disease,celiac disease,GCST000612,1:7986612
rs6806528-<b>A</b>,2 x 10-7,,0.1,1.19,'-,[1.12-1.27],FRMD4B,Celiac disease,celiac disease,GCST000612,3:69203748
rs13427836-<b>T</b>,6 x 10-7,,0.15,'-,0.19 unit increase,[0.11-0.27],HS6ST1,Urinary albumin-to-creatinine ratio in diabetes,"diabetes mellitus, urinary albumin to creatinine ratio",GCST003250,2:128270387
rs649529-<b>T</b>,6 x 10-7,,0.43,'-,0.14 unit decrease,[0.081-0.199],CTSC,Urinary albumin-to-creatinine ratio in diabetes,"diabetes mellitus, urinary albumin to creatinine ratio",GCST003250,11:88275083
rs765547-<b>?</b>,2 x 10-44,,NR,'-,'-,'-,'-,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,Mapping not available
rs2980853-<b>?</b>,3 x 10-18,,NR,'-,'-,'-,TRIB1,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,8:125466108
rs1333049-<b>?</b>,9 x 10-8,,NR,'-,'-,'-,CDKN2B-AS1,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,9:22125504
rs760762-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,PLCG1,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,20:41147406
rs2866611-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,"ADI1P1, ZHX3","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,20:41322165
rs460976-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,MX1,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,21:41463567
rs7081476-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,"FAM238C, ANKRD26","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,10:26969741
rs4506565-<b>?</b>,8 x 10-17,,NR,'-,'-,'-,TCF7L2,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,10:112996282
rs7190256-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,ZFHX3,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,16:72963084
rs8082812-<b>?</b>,5 x 10-67,,NR,'-,'-,'-,"AKR1B1P6, THEMIS3P","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,18:8522684
rs10401969-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,SUGP1,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,19:19296909
rs4420638-<b>?</b>,1 x 10-22,,NR,'-,'-,'-,"APOC1, APOC1P1","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,19:44919689
rs4803750-<b>?</b>,1 x 10-13,,NR,'-,'-,'-,"BCL3, CEACAM16-AS1","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,19:44744370
rs629301-<b>?</b>,1 x 10-49,,NR,'-,'-,'-,'-,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,Mapping not available
rs16867253-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,GRHL1,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,2:9956965
rs562338-<b>?</b>,5 x 10-21,,NR,'-,'-,'-,"APOB, TDRD15","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,2:21065449
rs478442-<b>?</b>,4 x 10-16,,NR,'-,'-,'-,TDRD15,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,2:21176344
rs6759518-<b>?</b>,8 x 10-10,,NR,'-,'-,'-,SLC30A3,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,2:27263727
rs1728918-<b>?</b>,1 x 10-31,,NR,'-,'-,'-,"PPM1G, NRBP1","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,2:27412596
rs780094-<b>?</b>,4 x 10-91,,NR,'-,'-,'-,'-,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,Mapping not available
rs222826-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,RNU7-2P,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,2:146120964
rs940274-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,ABCA12,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,2:215086907
rs7632505-<b>?</b>,7 x 10-19,,NR,'-,'-,'-,SEMA5B,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,3:123019460
rs13114738-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,SLC39A8,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,4:102363708
rs6533530-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,"MIR297, LINC01438","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,4:110810780
rs1869717-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,MAML3,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,4:139829967
rs7703051-<b>?</b>,9 x 10-12,,NR,'-,'-,'-,"ANKRD31, HMGCR","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,5:75329662
rs4704221-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CERT1,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,5:75463358
rs5744680-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,POLK,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,5:75584065
rs10057967-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,POC5,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,5:75701931
rs17140821-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,FERD3L,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,7:19177581
rs2074755-<b>?</b>,1 x 10-17,,NR,'-,'-,'-,BAZ1B,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,7:73462836
rs799165-<b>?</b>,9 x 10-15,,NR,'-,'-,'-,"VPS37D, MLXIPL","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,7:73637727
rs12420422-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,"BSX, RPL34P23",Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,11:123009573
rs12310617-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"TSPAN9, TEAD4",Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,12:3060327
rs16867253-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,GRHL1,Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,2:9956965
rs222826-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,RNU7-2P,Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,2:146120964
rs4905014-<b>?</b>,5 x 10-16,,NR,'-,'-,'-,ITPK1,Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,14:92945686
rs7632505-<b>?</b>,8 x 10-22,,NR,'-,'-,'-,SEMA5B,Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,3:123019460
rs7190256-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,ZFHX3,Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,16:72963084
rs3803802-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,DNAH2,Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,17:7718146
rs17140821-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,FERD3L,Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,7:19177581
rs8082812-<b>?</b>,6 x 10-64,,NR,'-,'-,'-,"AKR1B1P6, THEMIS3P",Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,18:8522684
rs1333048-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,CDKN2B-AS1,Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,9:22125348
rs460976-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,MX1,Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,21:41463567
rs7081476-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"FAM238C, ANKRD26",Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,10:26969741
rs4506565-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,TCF7L2,Age-related diseases and mortality,"cancer, heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease",GCST004044,10:112996282
rs174547-<b>?</b>,7 x 10-25,,NR,'-,'-,'-,"FADS1, FADS2","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,11:61803311
rs964184-<b>?</b>,2 x 10-108,,NR,'-,'-,'-,ZPR1,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,11:116778201
rs7115242-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,SIK3,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,11:117037567
rs12420422-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,"BSX, RPL34P23","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,11:123009573
rs12310617-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,"TSPAN9, TEAD4","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,12:3060327
rs12579302-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,ATP2B1,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,12:89656726
rs12369179-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,ZCCHC8,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,12:122479003
rs4905014-<b>?</b>,9 x 10-15,,NR,'-,'-,'-,ITPK1,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,14:92945686
rs261332-<b>?</b>,2 x 10-35,,NR,'-,'-,'-,"LIPC-AS1, LIPC, ALDH1A2","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,15:58435126
rs9939609-<b>?</b>,1 x 10-14,,NR,'-,'-,'-,FTO,"Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,16:53786615
rs247617-<b>?</b>,1 x 10-149,,NR,'-,'-,'-,"CETP, HERPUD1","Age-related diseases, mortality and associated endophenotypes","total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, cancer, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality",GCST004045,16:56956804
rs10224002-<b>A</b>,3 x 10-7,(EA),0.74,1.89,'-,[1.17-2.62],PRKAG2,Glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST005891,7:151717955
rs13333226-<b>?</b>,3 x 10-10,(EA),'-,2.41,'-,[1.66-3.15],UMOD,Glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST005891,16:20354332
rs77559408-<b>?</b>,4 x 10-7,,'-,4.92,'-,[3.01-6.82],THSD7B,Glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST005891,2:137542339
rs1974990-<b>G</b>,1 x 10-6,,0.08,3.17,'-,[1.88-4.45],CYB5AP2,Glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST005891,2:169790406
rs10224002-<b>A</b>,3 x 10-8,,0.74,2.01,'-,[1.30-2.72],PRKAG2,Glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST005891,7:151717955
rs865162-<b>?</b>,2 x 10-6,,'-,2.07,'-,[1.22-2.93],ATRNL1,Glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST005891,10:115429864
rs11864909-<b>T</b>,2 x 10-12,,0.28,2.11,'-,[1.52-2.70],PDILT,Glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST005891,16:20389517
rs117989384-<b>?</b>,6 x 10-6,(EA),'-,2.26,'-,[1.15-4.42],"BCAS1, CYP24A1",Diabetic kidney disease in diabetes (ESRD vs. no ESRD),"diabetes mellitus, diabetic nephropathy",GCST005894,20:54129184
rs11622435-<b>?</b>,2 x 10-7,(EA),'-,1.48,'-,[1.20-1.81],"TSHR, GTF2A1",Chronic kidney disease in diabetes,"chronic kidney disease, diabetes mellitus",GCST005880,14:81151652
chr6:32525987:I-<b>?</b>,5 x 10-6,,'-,1.17,'-,[1.08-1.26],'-,Chronic kidney disease and diabetic kidney disease in diabetes,"chronic kidney disease, diabetes mellitus, diabetic nephropathy",GCST005884,Mapping not available
rs768920-<b>?</b>,2 x 10-6,(EA),'-,1.39,'-,[1.14-1.69],"RPL26P31, MTNR1B",Early diabetic kidney disease in diabetes,"diabetes mellitus, diabetic nephropathy",GCST005890,11:93008790
rs1143914-<b>?</b>,3 x 10-6,(EA),'-,1.15,'-,[1.09-1.22],COL4A1,Early diabetic kidney disease in diabetes,"diabetes mellitus, diabetic nephropathy",GCST005890,13:110214888
rs7222331-<b>?</b>,1 x 10-7,(EA),'-,1.37,'-,[1.18-1.59],"KRTAP3-2, KRTAP3-3",Early diabetic kidney disease in diabetes,"diabetes mellitus, diabetic nephropathy",GCST005890,17:40995605
rs768920-<b>?</b>,4 x 10-6,,'-,1.39,'-,[1.14-1.69],"RPL26P31, MTNR1B",Early diabetic kidney disease in diabetes,"diabetes mellitus, diabetic nephropathy",GCST005890,11:93008790
rs7222331-<b>?</b>,1 x 10-6,,'-,1.37,'-,[1.18-1.59],"KRTAP3-2, KRTAP3-3",Early diabetic kidney disease in diabetes,"diabetes mellitus, diabetic nephropathy",GCST005890,17:40995605
rs9271366-<b>A</b>,7 x 10-6,,NR,1.627,'-,[1.315-2.013],"HLA-DRB1, HLA-DQA1",Ulcerative colitis,ulcerative colitis,GCST008732,6:32619077
rs11230563-<b>G</b>,2 x 10-8,(EA),0.65,1.077956,'-,'-,CD6,Ulcerative colitis,ulcerative colitis,GCST003045,11:61008737
rs11010067-<b>G</b>,2 x 10-8,(EA),0.3513,1.075212,'-,[1.05-1.1],"LINC02635, CUL2",Ulcerative colitis,ulcerative colitis,GCST003045,10:35006503
rs7556897-<b>A</b>,3 x 10-8,(EA),0.66,1.0756639,'-,'-,"CCL20, SNRPGP8",Ulcerative colitis,ulcerative colitis,GCST003045,2:227795396
rs11083840-<b>C</b>,3 x 10-8,(EA),0.4025,1.0715772,'-,[1.05-1.1],"CALM3, PTGIR",Ulcerative colitis,ulcerative colitis,GCST003045,19:46616653
rs17736589-<b>G</b>,4 x 10-8,(EA),0.2075,1.0858142,'-,[1.06-1.12],CYTH1,Ulcerative colitis,ulcerative colitis,GCST003045,17:78741036
rs17771967-<b>G</b>,5 x 10-8,(EA),0.424,1.073007,'-,[1.05-1.1],"RNU6-222P, KIR3DL2",Ulcerative colitis,ulcerative colitis,GCST003045,19:54868759
rs11054935-<b>G</b>,6 x 10-8,(EA),0.2756,1.0779562,'-,[1.05-1.11],DUSP16,Ulcerative colitis,ulcerative colitis,GCST003045,12:12495909
rs11583043-<b>A</b>,6 x 10-8,(EA),0.2658,1.0797532,'-,[1.05-1.11],DPH5,Ulcerative colitis,ulcerative colitis,GCST003045,1:101000498
rs559928-<b>G</b>,6 x 10-8,(EA),0.81,1.0923722,'-,'-,"RPS6KA4, LINC02723",Ulcerative colitis,ulcerative colitis,GCST003045,11:64382898
rs7011507-<b>G</b>,6 x 10-8,(EA),0.88,1.1094613,'-,'-,IDI1P2,Ulcerative colitis,ulcerative colitis,GCST003045,8:48216682
rs11741861-<b>G</b>,7 x 10-8,(EA),0.07656,1.128044,'-,[1.08-1.17],"IRGM, ZNF300",Ulcerative colitis,ulcerative colitis,GCST003045,5:150898347
rs2777491-<b>?</b>,8 x 10-8,(EA),NR,'-,'-,'-,RTF1,Ulcerative colitis,ulcerative colitis,GCST003045,15:41443512
rs13407913-<b>G</b>,9 x 10-8,(EA),0.4306,1.0690905,'-,[1.04-1.09],ADCY3,Ulcerative colitis,ulcerative colitis,GCST003045,2:24874775
rs28374715-<b>A</b>,9 x 10-8,(EA),0.74,1.0816516,'-,'-,CHP1,Ulcerative colitis,ulcerative colitis,GCST003045,15:41271752
rs2488389-<b>A</b>,9 x 10-8,(EA),0.2092,1.0841732,'-,[1.05-1.11],DENND1B,Ulcerative colitis,ulcerative colitis,GCST003045,1:197662011
rs2930047-<b>G</b>,1 x 10-7,(EA),0.372,1.0703659,'-,[1.05-1.1],DAP,Ulcerative colitis,ulcerative colitis,GCST003045,5:10695414
rs17293632-<b>A</b>,1 x 10-7,(EA),0.2364,1.0799718,'-,[1.05-1.11],SMAD3,Ulcerative colitis,ulcerative colitis,GCST003045,15:67150258
rs3116494-<b>G</b>,1 x 10-7,(EA),0.2539,1.080307,'-,[1.05-1.11],CD28,Ulcerative colitis,ulcerative colitis,GCST003045,2:203727298
rs11064881-<b>A</b>,2 x 10-7,(EA),0.07342,1.1273501,'-,[1.08-1.17],CIT,Ulcerative colitis,ulcerative colitis,GCST003045,12:119709120
rs7746082-<b>C</b>,2 x 10-7,(EA),0.2869,1.0753639,'-,[1.05-1.1],"RN7SKP211, PRDM1",Ulcerative colitis,ulcerative colitis,GCST003045,6:105987394
rs80174646-<b>C</b>,4 x 10-62,(EA),0.93,1.614317,'-,'-,IL23R,Ulcerative colitis,ulcerative colitis,GCST003045,1:67242472
rs76901167-<b>?</b>,2 x 10-94,(EA),NR,'-,'-,'-,"HLA-DRB1, HLA-DQA1",Ulcerative colitis,ulcerative colitis,GCST003045,6:32608701
rs113653754-<b>C</b>,1 x 10-86,(EA),0.73,1.3593605,'-,'-,"HLA-DQA1, HLA-DQB1",Ulcerative colitis,ulcerative colitis,GCST003045,6:32658495
rs9271209-<b>?</b>,2 x 10-85,(EA),NR,'-,'-,'-,"HLA-DQA1, HLA-DRB1",Ulcerative colitis,ulcerative colitis,GCST003045,6:32611258
rs6426833-<b>A</b>,3 x 10-76,(EA),0.54,1.2616084,'-,'-,"OTUD3, RNF186",Ulcerative colitis,ulcerative colitis,GCST003045,1:19845367
rs6426833-<b>?</b>,1 x 10-55,(EA),NR,'-,'-,'-,"OTUD3, RNF186",Ulcerative colitis,ulcerative colitis,GCST003045,1:19845367
rs2836878-<b>G</b>,7 x 10-53,(EA),0.73,1.25304,'-,'-,RPL23AP12,Ulcerative colitis,ulcerative colitis,GCST003045,21:39093608
rs3024505-<b>A</b>,5 x 10-43,(EA),0.1573,1.2520686,'-,[1.22-1.28],"IL10, Y_RNA",Ulcerative colitis,ulcerative colitis,GCST003045,1:206766559
rs1801274-<b>A</b>,1 x 10-41,(EA),0.5,1.1863672,'-,'-,FCGR2A,Ulcerative colitis,ulcerative colitis,GCST003045,1:161509955
rs3806308-<b>G</b>,6 x 10-39,(EA),0.62,1.1850245,'-,'-,"RNF186, OTUD3",Ulcerative colitis,ulcerative colitis,GCST003045,1:19816373
rs3197999-<b>A</b>,2 x 10-37,(EA),0.2812,1.1865767,'-,[1.16-1.21],MST1,Ulcerative colitis,ulcerative colitis,GCST003045,3:49684099
rs7134472-<b>A</b>,6 x 10-37,(EA),0.3855,1.1745031,'-,[1.15-1.2],IFNG-AS1,Ulcerative colitis,ulcerative colitis,GCST003045,12:68106206
rs4409764-<b>A</b>,2 x 10-36,(EA),0.4821,1.1710649,'-,[1.15-1.2],"LINC01475, GOT1",Ulcerative colitis,ulcerative colitis,GCST003045,10:99524480
rs7554511-<b>C</b>,7 x 10-31,(EA),0.72,1.1808171,'-,'-,INAVA,Ulcerative colitis,ulcerative colitis,GCST003045,1:200908434
rs75900472-<b>C</b>,1 x 10-28,(EA),0.3496,1.1539809,'-,[1.13-1.18],"JAK2, HNRNPA1P41",Ulcerative colitis,ulcerative colitis,GCST003045,9:4981601
rs56167332-<b>A</b>,7 x 10-27,(EA),0.3375,1.1518488,'-,[1.13-1.18],"LINC01845, IL12B",Ulcerative colitis,ulcerative colitis,GCST003045,5:159400761
rs10781499-<b>A</b>,4 x 10-26,(EA),0.4263,1.142511,'-,[1.12-1.17],CARD9,Ulcerative colitis,ulcerative colitis,GCST003045,9:136371953
rs12946510-<b>A</b>,1 x 10-25,(EA),0.4675,1.141072,'-,[1.12-1.17],"IKZF3, GRB7",Ulcerative colitis,ulcerative colitis,GCST003045,17:39756124
rs6466198-<b>?</b>,2 x 10-25,(EA),NR,'-,'-,'-,"DLD, PIGCP2",Ulcerative colitis,ulcerative colitis,GCST003045,7:107839681
rs10800309-<b>?</b>,4 x 10-25,(EA),NR,'-,'-,'-,FCGR2A,Ulcerative colitis,ulcerative colitis,GCST003045,1:161502368
rs4380874-<b>A</b>,6 x 10-25,(EA),0.4093,1.1398237,'-,[1.11-1.16],"PIGCP2, DLD",Ulcerative colitis,ulcerative colitis,GCST003045,7:107839870
rs7608910-<b>G</b>,1 x 10-23,(EA),0.3909,1.1355296,'-,[1.11-1.16],PUS10,Ulcerative colitis,ulcerative colitis,GCST003045,2:60977721
rs6920220-<b>A</b>,5 x 10-22,(EA),0.2086,1.1582799,'-,[1.13-1.19],LINC02539,Ulcerative colitis,ulcerative colitis,GCST003045,6:137685367
rs2155219-<b>A</b>,8 x 10-21,(EA),0.4994,1.1254078,'-,[1.1-1.15],"EMSY, LINC02757",Ulcerative colitis,ulcerative colitis,GCST003045,11:76588150
rs10761659-<b>G</b>,2 x 10-20,(EA),0.54,1.1244732,'-,'-,ALDH7A1P4,Ulcerative colitis,ulcerative colitis,GCST003045,10:62685804
rs661054-<b>?</b>,3 x 10-20,(EA),NR,'-,'-,'-,NXPE1,Ulcerative colitis,ulcerative colitis,GCST003045,11:114559688
rs561722-<b>G</b>,4 x 10-20,(EA),0.66,1.1328671,'-,'-,"NXPE1, NXPE2P1",Ulcerative colitis,ulcerative colitis,GCST003045,11:114516108
rs6466198-<b>?</b>,1 x 10-18,(EA),NR,'-,'-,'-,"DLD, PIGCP2",Ulcerative colitis,ulcerative colitis,GCST003045,7:107839681
rs2816958-<b>G</b>,1 x 10-18,(EA),0.89,1.1982042,'-,'-,NR5A2,Ulcerative colitis,ulcerative colitis,GCST003045,1:200132792
rs4845604-<b>G</b>,1 x 10-18,(EA),0.85,1.1778549,'-,'-,RORC,Ulcerative colitis,ulcerative colitis,GCST003045,1:151829204
rs4722672-<b>G</b>,5 x 10-6,(EA),0.1881,1.0755208,'-,[1.04-1.11],"HOXA11-AS, HOXA13",Ulcerative colitis,ulcerative colitis,GCST003045,7:27192143
rs2538470-<b>A</b>,3 x 10-7,(EA),0.3622,1.0682071,'-,[1.04-1.09],"RPL32P17, RN7SL72P",Ulcerative colitis,ulcerative colitis,GCST003045,7:148523356
rs3740415-<b>A</b>,3 x 10-7,(EA),0.53,1.0690618,'-,'-,"ACTR1A, MFSD13A",Ulcerative colitis,ulcerative colitis,GCST003045,10:102472959
rs9297145-<b>C</b>,4 x 10-7,(EA),0.2581,1.073924,'-,[1.05-1.1],"SMURF1, KPNA7",Ulcerative colitis,ulcerative colitis,GCST003045,7:99161494
rs2457996-<b>A</b>,4 x 10-7,(EA),0.89,1.1094414,'-,'-,"CXCL5, PPBP",Ulcerative colitis,ulcerative colitis,GCST003045,4:73990818
rs1595825-<b>?</b>,4 x 10-7,(EA),NR,'-,'-,'-,PLCL1,Ulcerative colitis,ulcerative colitis,GCST003045,2:198010740
rs11641184-<b>A</b>,4 x 10-10,(EA),0.4762,1.0811478,'-,[1.06-1.11],LITAF,Ulcerative colitis,ulcerative colitis,GCST003045,16:11610795
rs6863411-<b>T</b>,6 x 10-7,(EA),0.63,1.0674366,'-,'-,NDFIP1,Ulcerative colitis,ulcerative colitis,GCST003045,5:142133639
rs1405108-<b>C</b>,6 x 10-10,(EA),0.3358,1.0854406,'-,[1.06-1.11],'-,Ulcerative colitis,ulcerative colitis,GCST003045,2:198880294
rs11168249-<b>G</b>,7 x 10-7,(EA),0.4676,1.0644168,'-,[1.04-1.09],HDAC7,Ulcerative colitis,ulcerative colitis,GCST003045,12:47814585
rs12103-<b>A</b>,1 x 10-9,(EA),0.1834,1.1046834,'-,[1.07-1.14],INTS11,Ulcerative colitis,ulcerative colitis,GCST003045,1:1312114
rs727088-<b>G</b>,1 x 10-6,(EA),0.4822,1.0637558,'-,[1.04-1.09],CD226,Ulcerative colitis,ulcerative colitis,GCST003045,18:69863203
rs4976646-<b>G</b>,3 x 10-9,(EA),0.3415,1.0819606,'-,[1.06-1.11],RGS14,Ulcerative colitis,ulcerative colitis,GCST003045,5:177361569
rs26528-<b>G</b>,1 x 10-6,(EA),0.4576,1.06364,'-,[1.04-1.09],IL27,Ulcerative colitis,ulcerative colitis,GCST003045,16:28506388
rs4656958-<b>G</b>,3 x 10-9,(EA),0.68,1.0859073,'-,'-,"ITLN1, ITLN2",Ulcerative colitis,ulcerative colitis,GCST003045,1:160887174
rs11739663-<b>A</b>,2 x 10-6,(EA),0.77,1.0785052,'-,'-,"CEP72, MIR4456",Ulcerative colitis,ulcerative colitis,GCST003045,5:593968
rs1077773-<b>A</b>,6 x 10-9,(EA),0.52,1.0747931,'-,'-,LINC02888,Ulcerative colitis,ulcerative colitis,GCST003045,7:17403055
rs4703855-<b>G</b>,2 x 10-6,(EA),0.7,1.0675422,'-,'-,"PTCD2, YBX1P5",Ulcerative colitis,ulcerative colitis,GCST003045,5:72398072
rs6062504-<b>G</b>,1 x 10-8,(EA),0.69,1.0814869,'-,'-,ZGPAT,Ulcerative colitis,ulcerative colitis,GCST003045,20:63717555
rs12422544-<b>G</b>,3 x 10-6,(EA),0.01915,1.2153448,'-,[1.13-1.3],"LINC02555, SLC2A13",Ulcerative colitis,ulcerative colitis,GCST003045,12:40134630
rs314313-<b>G</b>,4 x 10-6,(EA),0.3043,1.0641211,'-,[1.04-1.09],EPHB4,Ulcerative colitis,ulcerative colitis,GCST003045,7:100825743
rs1363907-<b>A</b>,4 x 10-6,(EA),0.4212,1.0618593,'-,[1.04-1.09],ERAP2,Ulcerative colitis,ulcerative colitis,GCST003045,5:96917099
rs259964-<b>A</b>,4 x 10-6,(EA),0.4586,1.0585915,'-,[1.03-1.08],ZNF831,Ulcerative colitis,ulcerative colitis,GCST003045,20:59249254
rs7404095-<b>G</b>,2 x 10-8,(EA),0.58,1.0744067,'-,'-,PRKCB,Ulcerative colitis,ulcerative colitis,GCST003045,16:23853269
rs9847710-<b>G</b>,3 x 10-7,(EA),0.4118,1.067568,'-,[1.04-1.09],SFMBT1,Ulcerative colitis,ulcerative colitis,GCST003045,3:53028645
rs6087990-<b>G</b>,6 x 10-6,(EA),0.4056,1.0586283,'-,[1.03-1.08],"COMMD7, DNMT3B",Ulcerative colitis,ulcerative colitis,GCST003045,20:32762102
rs38911-<b>G</b>,6 x 10-6,(EA),0.54,1.0574577,'-,'-,"MTND4P6, ST7",Ulcerative colitis,ulcerative colitis,GCST003045,7:117255109
rs616597-<b>C</b>,9 x 10-6,(EA),0.77,1.0701488,'-,'-,NFKBIZ,Ulcerative colitis,ulcerative colitis,GCST003045,3:101850882
rs11150589-<b>A</b>,3 x 10-10,(EA),0.4732,1.0831269,'-,[1.06-1.11],Y_RNA,Ulcerative colitis,ulcerative colitis,GCST003045,16:30471173
rs254560-<b>A</b>,4 x 10-10,(EA),0.4024,1.0823938,'-,[1.06-1.11],C5orf66,Ulcerative colitis,ulcerative colitis,GCST003045,5:135107916
rs1440088-<b>A</b>,6 x 10-7,(EA),0.81,1.0840102,'-,'-,PLCL1,Ulcerative colitis,ulcerative colitis,GCST003045,2:198006693
rs7657746-<b>A</b>,5 x 10-10,(EA),0.76,1.0973365,'-,'-,KIAA1109,Ulcerative colitis,ulcerative colitis,GCST003045,4:122240464
rs3742130-<b>G</b>,6 x 10-7,(EA),0.78,1.0792593,'-,'-,"UBAC2, GPR18",Ulcerative colitis,ulcerative colitis,GCST003045,13:99255087
rs113010081-<b>G</b>,9 x 10-10,(EA),0.1073,1.1354866,'-,[1.09-1.18],"LINC02009, CCRL2",Ulcerative colitis,ulcerative colitis,GCST003045,3:46415921
rs6088765-<b>C</b>,1 x 10-6,(EA),0.4467,1.0630414,'-,[1.04-1.09],"MMP24OS, PROCR",Ulcerative colitis,ulcerative colitis,GCST003045,20:35211477
rs1517352-<b>C</b>,2 x 10-9,(EA),0.6,1.0808891,'-,'-,STAT4,Ulcerative colitis,ulcerative colitis,GCST003045,2:191066738
rs5763767-<b>A</b>,1 x 10-6,(EA),0.4538,1.0639322,'-,[1.04-1.09],HORMAD2,Ulcerative colitis,ulcerative colitis,GCST003045,22:30097893
rs8005161-<b>A</b>,3 x 10-9,(EA),0.08653,1.1371082,'-,[1.09-1.18],GPR65,Ulcerative colitis,ulcerative colitis,GCST003045,14:88006251
rs2651244-<b>G</b>,2 x 10-6,(EA),0.61,1.063159,'-,'-,"CHORDC1P5, CTH",Ulcerative colitis,ulcerative colitis,GCST003045,1:70529879
rs4743820-<b>A</b>,4 x 10-9,(EA),0.7,1.0842872,'-,'-,LINC00484,Ulcerative colitis,ulcerative colitis,GCST003045,9:91166134
rs12778642-<b>A</b>,2 x 10-6,(EA),0.4347,1.0610541,'-,[1.04-1.09],"HHEX, Y_RNA",Ulcerative colitis,ulcerative colitis,GCST003045,10:92704550
rs907611-<b>A</b>,1 x 10-8,(EA),0.3211,1.0787733,'-,[1.05-1.1],LSP1,Ulcerative colitis,ulcerative colitis,GCST003045,11:1852842
rs564349-<b>G</b>,2 x 10-6,(EA),0.3183,1.0646768,'-,[1.04-1.09],ERGIC1,Ulcerative colitis,ulcerative colitis,GCST003045,5:172897975
rs11229555-<b>C</b>,1 x 10-8,(EA),0.75,1.0858196,'-,'-,GLYAT,Ulcerative colitis,ulcerative colitis,GCST003045,11:58641214
rs913678-<b>A</b>,1 x 10-8,(EA),0.67,1.0787014,'-,'-,"LINC01271, RN7SL636P",Ulcerative colitis,ulcerative colitis,GCST003045,20:50338887
rs12718244-<b>A</b>,1 x 10-8,(EA),0.4081,1.0744148,'-,[1.05-1.1],SPATA48,Ulcerative colitis,ulcerative colitis,GCST003045,7:50136058
rs12149608-<b>?</b>,2 x 10-8,(EA),NR,'-,'-,'-,ZFP90,Ulcerative colitis,ulcerative colitis,GCST003045,16:68552601
rs6908425-<b>G</b>,4 x 10-6,(EA),0.78,1.0734457,'-,'-,CDKAL1,Ulcerative colitis,ulcerative colitis,GCST003045,6:20728500
rs1728785-<b>C</b>,5 x 10-6,(EA),0.78,1.0728852,'-,'-,ZFP90,Ulcerative colitis,ulcerative colitis,GCST003045,16:68557327
rs2382817-<b>A</b>,2 x 10-8,(EA),0.3988,1.0740336,'-,[1.05-1.1],"TMBIM1, PNKD",Ulcerative colitis,ulcerative colitis,GCST003045,2:218286495
rs3749171-<b>A</b>,4 x 10-18,(EA),0.1806,1.1533448,'-,[1.12-1.19],GPR35,Ulcerative colitis,ulcerative colitis,GCST003045,2:240630275
rs17085007-<b>G</b>,1 x 10-16,(EA),0.1799,1.1413064,'-,[1.11-1.17],"FGFR1OP2P1, RPS21P8",Ulcerative colitis,ulcerative colitis,GCST003045,13:26957130
rs4812833-<b>A</b>,2 x 10-16,(EA),0.52,1.1088746,'-,'-,LINC01620,Ulcerative colitis,ulcerative colitis,GCST003045,20:44440356
rs7282490-<b>G</b>,2 x 10-15,(EA),0.3934,1.1100584,'-,[1.09-1.13],GATD3A,Ulcerative colitis,ulcerative colitis,GCST003045,21:44195858
rs4246905-<b>G</b>,1 x 10-15,(EA),0.72,1.1206568,'-,'-,TNFSF15,Ulcerative colitis,ulcerative colitis,GCST003045,9:114790969
rs1182188-<b>A</b>,5 x 10-15,(EA),0.7,1.1136187,'-,'-,GNA12,Ulcerative colitis,ulcerative colitis,GCST003045,7:2830351
rs2413583-<b>G</b>,7 x 10-15,(EA),0.83,1.1438878,'-,'-,"PDGFB, RPL3",Ulcerative colitis,ulcerative colitis,GCST003045,22:39263768
rs3851228-<b>A</b>,1 x 10-14,(EA),0.06375,1.2023339,'-,[1.16-1.25],TRAF3IP2-AS1,Ulcerative colitis,ulcerative colitis,GCST003045,6:111526988
rs10185424-<b>A</b>,1 x 10-14,(EA),0.4604,1.1014192,'-,[1.08-1.13],"IL1R2, IL1R1",Ulcerative colitis,ulcerative colitis,GCST003045,2:102046427
rs4728142-<b>A</b>,2 x 10-14,(EA),0.439,1.1018242,'-,[1.08-1.13],"IRF5, KCP",Ulcerative colitis,ulcerative colitis,GCST003045,7:128933913
rs17229285-<b>G</b>,3 x 10-14,(EA),0.4966,1.1000017,'-,[1.08-1.12],PLCL1,Ulcerative colitis,ulcerative colitis,GCST003045,2:198658398
rs3774937-<b>G</b>,5 x 10-14,(EA),0.3257,1.1043711,'-,[1.08-1.13],NFKB1,Ulcerative colitis,ulcerative colitis,GCST003045,4:102513096
rs3766606-<b>C</b>,6 x 10-14,(EA),0.83,1.143554,'-,'-,PARK7,Ulcerative colitis,ulcerative colitis,GCST003045,1:7962137
rs941823-<b>G</b>,1 x 10-13,(EA),0.75,1.1147928,'-,'-,LINC00598,Ulcerative colitis,ulcerative colitis,GCST003045,13:40439840
rs1893217-<b>G</b>,3 x 10-13,(EA),0.1602,1.1283141,'-,[1.1-1.16],PTPN2,Ulcerative colitis,ulcerative colitis,GCST003045,18:12809341
rs9868809-<b>A</b>,3 x 10-13,(EA),0.1036,1.1570203,'-,[1.12-1.2],CELSR3,Ulcerative colitis,ulcerative colitis,GCST003045,3:48643620
rs12568930-<b>A</b>,4 x 10-13,(EA),0.84,1.1360025,'-,'-,"PPIAP34, ZBTB40",Ulcerative colitis,ulcerative colitis,GCST003045,1:22375738
rs17780256-<b>A</b>,6 x 10-13,(EA),0.81,1.1223103,'-,'-,SLC39A11,Ulcerative colitis,ulcerative colitis,GCST003045,17:72646784
rs2823286-<b>G</b>,2 x 10-12,(EA),0.71,1.1033705,'-,'-,CYCSP42,Ulcerative colitis,ulcerative colitis,GCST003045,21:15445619
rs17694108-<b>A</b>,6 x 10-12,(EA),0.2797,1.1005878,'-,[1.07-1.13],"CEBPA, SLC7A10",Ulcerative colitis,ulcerative colitis,GCST003045,19:33240645
rs395157-<b>A</b>,9 x 10-12,(EA),0.4842,1.0890996,'-,[1.06-1.11],OSMR,Ulcerative colitis,ulcerative colitis,GCST003045,5:38867630
rs10910092-<b>?</b>,1 x 10-11,(EA),NR,'-,'-,'-,"TNFRSF14, PRXL2B",Ulcerative colitis,ulcerative colitis,GCST003045,1:2570077
rs12720356-<b>C</b>,2 x 10-11,(EA),0.08572,1.1656502,'-,[1.12-1.21],TYK2,Ulcerative colitis,ulcerative colitis,GCST003045,19:10359299
rs10010325-<b>?</b>,2 x 10-11,(EA),NR,'-,'-,'-,TET2,Ulcerative colitis,ulcerative colitis,GCST003045,4:105185196
rs17622378-<b>G</b>,4 x 10-11,(EA),0.4186,1.0865855,'-,[1.06-1.11],"IRF1, IRF1-AS1",Ulcerative colitis,ulcerative colitis,GCST003045,5:132442760
rs11742570-<b>G</b>,6 x 10-11,(EA),0.61,1.0874969,'-,'-,'-,Ulcerative colitis,ulcerative colitis,GCST003045,5:40410482
rs12942547-<b>A</b>,7 x 10-11,(EA),0.58,1.0883672,'-,'-,STAT3,Ulcerative colitis,ulcerative colitis,GCST003045,17:42375526
rs2189234-<b>A</b>,2 x 10-10,(EA),0.3692,1.0847058,'-,[1.06-1.11],TET2,Ulcerative colitis,ulcerative colitis,GCST003045,4:105154341
rs2111485-<b>A</b>,2 x 10-10,(EA),0.3915,1.0891383,'-,[1.06-1.12],'-,Ulcerative colitis,ulcerative colitis,GCST003045,Mapping not available
rs13300218-<b>G</b>,2 x 10-10,(EA),0.9,1.1441684,'-,'-,NOTCH1,Ulcerative colitis,ulcerative colitis,GCST003045,9:136505189
rs7240004-<b>A</b>,3 x 10-10,(EA),0.62,1.0858526,'-,'-,"SMAD7, CTIF",Ulcerative colitis,ulcerative colitis,GCST003045,18:48868651
rs254562-<b>?</b>,3 x 10-10,(EA),NR,'-,'-,'-,C5orf66,Ulcerative colitis,ulcerative colitis,GCST003045,5:135105767
rs6667605-<b>G</b>,3 x 10-10,(EA),0.51,1.0831845,'-,'-,"TNFRSF14, PRXL2B",Ulcerative colitis,ulcerative colitis,GCST003045,1:2571341
rs483905-<b>A</b>,3 x 10-10,(EA),0.289,1.0887091,'-,[1.06-1.12],MAML2,Ulcerative colitis,ulcerative colitis,GCST003045,11:96290263
rs6927022-<b>?</b>,5 x 10-65,,'-,'-,'-,'-,HLA-DQA1,Ulcerative colitis,ulcerative colitis,GCST004133,6:32644620
rs3806308-<b>G</b>,3 x 10-8,,NR,1.15,'-,'-,"RNF186, OTUD3",Ulcerative colitis,ulcerative colitis,GCST000624,1:19816373
rs1992950-<b>A</b>,5 x 10-6,,NR,1.25,'-,'-,SATB2,Ulcerative colitis,ulcerative colitis,GCST000624,2:199425636
rs2395185-<b>G</b>,9 x 10-23,,NR,1.49,'-,[NR],HLA-DRB9,Ulcerative colitis,ulcerative colitis,GCST000624,6:32465390
rs2836878-<b>G</b>,1 x 10-8,,NR,1.27,'-,[NR],RPL23AP12,Ulcerative colitis,ulcerative colitis,GCST000624,21:39093608
rs4781011-<b>T</b>,3 x 10-6,,NR,1.15,'-,[NR],CIITA,Ulcerative colitis,ulcerative colitis,GCST000624,16:10881454
rs10758669-<b>C</b>,1 x 10-6,,NR,1.16,'-,[NR],"JAK2, HNRNPA1P41",Ulcerative colitis,ulcerative colitis,GCST000624,9:4981602
rs10800309-<b>A</b>,3 x 10-9,,NR,1.23,'-,[NR],FCGR2A,Ulcerative colitis,ulcerative colitis,GCST000624,1:161502368
rs11190140-<b>T</b>,1 x 10-8,,NR,1.23,'-,[NR],"LINC01475, NKX2-3",Ulcerative colitis,ulcerative colitis,GCST000624,10:99531836
rs11584383-<b>C</b>,2 x 10-7,,NR,1.11,'-,[NR],"MROH3P, KIF21B",Ulcerative colitis,ulcerative colitis,GCST000624,1:200966738
rs13003464-<b>G</b>,7 x 10-9,,NR,1.18,'-,[NR],PUS10,Ulcerative colitis,ulcerative colitis,GCST000624,2:60959694
rs1317209-<b>T</b>,2 x 10-10,,NR,1.34,'-,[NR],"RNF186, TMCO4",Ulcerative colitis,ulcerative colitis,GCST000624,1:19813543
rs1558744-<b>A</b>,4 x 10-12,,NR,1.2,'-,[NR],IFNG-AS1,Ulcerative colitis,ulcerative colitis,GCST000624,12:68110812
rs1736135-<b>T</b>,2 x 10-7,,NR,1.06,'-,[NR],CYCSP42,Ulcerative colitis,ulcerative colitis,GCST000624,21:15432901
rs2201841-<b>C</b>,1 x 10-13,,NR,1.16,'-,[NR],"C1orf141, IL23R",Ulcerative colitis,ulcerative colitis,GCST000624,1:67228519
rs2305480-<b>T</b>,3 x 10-8,,NR,1.25,'-,[NR],GSDMB,Ulcerative colitis,ulcerative colitis,GCST000624,17:39905943
rs3024505-<b>T</b>,1 x 10-8,,NR,1.28,'-,[NR],"IL10, Y_RNA",Ulcerative colitis,ulcerative colitis,GCST000624,1:206766559
rs3197999-<b>T</b>,4 x 10-9,,NR,1.21,'-,[NR],MST1,Ulcerative colitis,ulcerative colitis,GCST000624,3:49684099
rs4077515-<b>A</b>,5 x 10-8,,NR,1.22,'-,[NR],CARD9,Ulcerative colitis,ulcerative colitis,GCST000624,9:136372044
rs4598195-<b>A</b>,8 x 10-8,,NR,1.11,'-,[NR],"PIGCP2, DLD",Ulcerative colitis,ulcerative colitis,GCST000624,7:107862996
rs4957048-<b>C</b>,1 x 10-9,,NR,1.11,'-,[NR],"MIR4456, CEP72",Ulcerative colitis,ulcerative colitis,GCST000624,5:583327
rs6426833-<b>A</b>,2 x 10-21,,NR,1.3,'-,[NR],"OTUD3, RNF186",Ulcerative colitis,ulcerative colitis,GCST000624,1:19845367
rs10505477-<b>A</b>,3 x 10-22,,NR,1.19,'-,[1.15-1.23],"CASC8, POU5F1B, PCAT1",Colorectal cancer,colorectal cancer,GCST004895,8:127395198
rs992157-<b>A</b>,2 x 10-9,,NR,1.12,'-,[1.08-1.16],"PNKD, TMBIM1",Colorectal cancer,colorectal cancer,GCST004895,2:218290058
rs6589219-<b>G</b>,2 x 10-9,,NR,1.12,'-,[1.08-1.17],"COLCA2, COLCA1",Colorectal cancer,colorectal cancer,GCST004895,11:111302186
rs961253-<b>A</b>,7 x 10-6,,0.303,'-,0.0168 unit increase,[0.00947-0.0242],CASC20,Colorectal cancer,colorectal cancer,GCST004895,20:6423634
rs6983267-<b>G</b>,2 x 10-21,,NR,1.18,'-,[1.18-1.18],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST004895,8:127401060
rs35917784-<b>A</b>,4 x 10-6,"(East Asian, joint analysis)",0.1,1.12,'-,[1.07-1.17],C5orf66,Colorectal cancer,colorectal cancer,GCST009869,5:135161909
rs78894077-<b>?</b>,6 x 10-6,"(East Asian, joint analysis)",0.94,1.1764705,'-,[1.1-1.27],SH2B3,Colorectal cancer,colorectal cancer,GCST009869,12:111418869
rs140851213-<b>T</b>,8 x 10-6,"(East Asian, joint analysis)",0.72,1.098901,'-,[1.05-1.14],"LINC01229, MAFTRR",Colorectal cancer,colorectal cancer,GCST009869,16:79720537
rs10936599-<b>C</b>,9 x 10-6,(East Asian),NR,1.06,'-,[1.03-1.09],MYNN,Colorectal cancer,colorectal cancer,GCST009869,3:169774313
rs2735940-<b>G</b>,2 x 10-6,(East Asian),NR,1.07,'-,[1.04-1.10],"MIR4457, TERT",Colorectal cancer,colorectal cancer,GCST009869,5:1296371
rs1321311-<b>A</b>,2 x 10-6,(East Asian),NR,1.09,'-,[1.05-1.13],"Y_RNA, RNU1-88P",Colorectal cancer,colorectal cancer,GCST009869,6:36655123
rs6983267-<b>G</b>,3 x 10-33,(East Asian),NR,1.17,'-,[1.14-1.19],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST009869,8:127401060
rs10795668-<b>G</b>,1 x 10-23,(East Asian),NR,1.14,'-,[1.11-1.17],RNA5SP299,Colorectal cancer,colorectal cancer,GCST009869,10:8659256
rs3824999-<b>G</b>,1 x 10-6,(East Asian),NR,1.07,'-,[1.04-1.09],POLD3,Colorectal cancer,colorectal cancer,GCST009869,11:74634505
rs3802842-<b>C</b>,3 x 10-7,(East Asian),NR,1.07,'-,[1.04-1.10],"COLCA1, COLCA2",Colorectal cancer,colorectal cancer,GCST009869,11:111300984
rs12818766-<b>A</b>,2 x 10-19,(East Asian),NR,1.16,'-,[1.12-1.19],CCND2-AS1,Colorectal cancer,colorectal cancer,GCST009869,12:4266925
rs3217874-<b>T</b>,3 x 10-6,(East Asian),NR,1.06,'-,[1.04-1.09],CCND2,Colorectal cancer,colorectal cancer,GCST009869,12:4291642
rs11610543-<b>G</b>,2 x 10-9,(East Asian),NR,1.08,'-,[1.06-1.11],LINC02450,Colorectal cancer,colorectal cancer,GCST009869,12:42740389
rs16969681-<b>T</b>,7 x 10-8,(East Asian),NR,1.07,'-,[1.05-1.10],"SCG5, GREM1",Colorectal cancer,colorectal cancer,GCST009869,15:32700910
rs9930005-<b>C</b>,2 x 10-10,(East Asian),NR,1.09,'-,[1.06-1.12],'-,Colorectal cancer,colorectal cancer,GCST009869,16:80009361
rs4939827-<b>T</b>,1 x 10-15,(East Asian),NR,1.13,'-,[1.09-1.16],SMAD7,Colorectal cancer,colorectal cancer,GCST009869,18:48927093
rs10411210-<b>C</b>,9 x 10-9,(East Asian),NR,1.1,'-,[1.07-1.14],RHPN2,Colorectal cancer,colorectal cancer,GCST009869,19:33041394
rs4813802-<b>G</b>,3 x 10-9,(East Asian),NR,1.1,'-,[1.06-1.13],LINC01713,Colorectal cancer,colorectal cancer,GCST009869,20:6718948
rs6066825-<b>A</b>,8 x 10-12,(East Asian),NR,1.1,'-,[1.07-1.14],PREX1,Colorectal cancer,colorectal cancer,GCST009869,20:48723580
rs1810502-<b>C</b>,2 x 10-6,(East Asian),NR,1.06,'-,[1.04-1.09],"COX6CP2, RN7SL636P",Colorectal cancer,colorectal cancer,GCST009869,20:50440951
rs2242936-<b>C</b>,9 x 10-6,(East Asian),0.1413,1.09,'-,[1.05-1.14],"LINC01700, RPL23AP12",Colorectal cancer,colorectal cancer,GCST009869,21:39051545
rs2226738-<b>C</b>,2 x 10-6,(East Asian),0.1688,1.1,'-,[1.06-1.14],ELOCP20,Colorectal cancer,colorectal cancer,GCST009869,1:115543035
rs60911071-<b>G</b>,6 x 10-8,,NR,1.07,'-,[1.04-1.09],STC1,Colorectal cancer,colorectal cancer,GCST009869,8:23807119
rs13419069-<b>G</b>,7 x 10-6,(East Asian),0.3134,1.07,'-,[1.04-1.10],"MIR4431, FTH1P6",Colorectal cancer,colorectal cancer,GCST009869,2:52658893
rs35413825-<b>A</b>,8 x 10-7,(East Asian),0.3036,1.08,'-,[1.05-1.12],CCDC195,Colorectal cancer,colorectal cancer,GCST009869,2:224713074
rs2163735-<b>G</b>,2 x 10-6,(East Asian),0.7472,1.08,'-,[1.05-1.12],GRM7,Colorectal cancer,colorectal cancer,GCST009869,3:6953739
rs116265807-<b>G</b>,7 x 10-6,(East Asian),0.9226,1.14,'-,[1.08-1.21],NFKBIZ,Colorectal cancer,colorectal cancer,GCST009869,3:101845752
rs67999259-<b>C</b>,2 x 10-6,(East Asian),0.5369,1.07,'-,[1.04-1.10],"HIP1, CCL26",Colorectal cancer,colorectal cancer,GCST009869,7:75741828
rs60911071-<b>G</b>,1 x 10-6,(East Asian),0.6371,1.07,'-,[1.04-1.10],STC1,Colorectal cancer,colorectal cancer,GCST009869,8:23807119
rs193044-<b>A</b>,3 x 10-6,,NR,1.04,'-,[1.02-1.05],BMP7,Colorectal cancer,colorectal cancer,GCST009869,20:57229060
rs62558833-<b>T</b>,4 x 10-7,(East Asian),0.5472,1.08,'-,[1.05-1.11],UBAP2,Colorectal cancer,colorectal cancer,GCST009869,9:34039004
rs7722513-<b>C</b>,9 x 10-20,(East Asian),0.25,1.15,'-,[1.11-1.18],C5orf66,Colorectal cancer,colorectal cancer,GCST009869,5:135128376
rs74995296-<b>C</b>,8 x 10-6,(East Asian),0.6759,1.08,'-,[1.04-1.12],"CAMSAP1, KCNT1",Colorectal cancer,colorectal cancer,GCST009869,9:135798543
rs11196172-<b>A</b>,2 x 10-15,(East Asian),0.69,1.12,'-,[1.09-1.15],TCF7L2,Colorectal cancer,colorectal cancer,GCST009869,10:112967084
rs1245518-<b>C</b>,9 x 10-6,(East Asian),0.5577,1.06,'-,[1.04-1.09],"CHST3, SPOCK2",Colorectal cancer,colorectal cancer,GCST009869,10:72024267
rs4554811-<b>?</b>,8 x 10-14,(East Asian),0.27,1.1111112,'-,[1.09-1.15],VTI1A,Colorectal cancer,colorectal cancer,GCST009869,10:112518975
rs11114149-<b>A</b>,2 x 10-6,(East Asian),0.6278,1.07,'-,[1.04-1.10],"NOP56P3, SYT1",Colorectal cancer,colorectal cancer,GCST009869,12:79514963
rs4341754-<b>?</b>,5 x 10-12,(East Asian),0.57,1.098901,'-,[1.06-1.12],'-,Colorectal cancer,colorectal cancer,GCST009869,16:80005724
rs17550549-<b>C</b>,7 x 10-6,(East Asian),0.7913,1.09,'-,[1.05-1.13],MYL2,Colorectal cancer,colorectal cancer,GCST009869,12:110919667
rs9915645-<b>?</b>,5 x 10-10,(East Asian),0.52,1.0869565,'-,[1.05-1.11],NXN,Colorectal cancer,colorectal cancer,GCST009869,17:909294
rs12855244-<b>A</b>,9 x 10-6,(East Asian),0.2004,1.08,'-,[1.04-1.12],ABCC4,Colorectal cancer,colorectal cancer,GCST009869,13:95248822
rs6085662-<b>C</b>,2 x 10-9,(East Asian),0.21,1.12,'-,[1.07-1.14],LINC01713,Colorectal cancer,colorectal cancer,GCST009869,20:6717725
rs3830041-<b>T</b>,4 x 10-9,(East Asian),0.14,1.15,'-,[1.10-1.21],NOTCH4,Colorectal cancer,colorectal cancer,GCST009869,6:32223562
rs7398375-<b>C</b>,1 x 10-7,(East Asian),0.43,1.08,'-,[1.05-1.12],"LRP1, LRP1-AS",Colorectal cancer,colorectal cancer,GCST009869,12:57147065
rs17550549-<b>?</b>,2 x 10-7,(East Asian),0.8,1.098901,'-,[1.05-1.14],MYL2,Colorectal cancer,colorectal cancer,GCST009869,12:110919667
rs11203467-<b>G</b>,7 x 10-7,(East Asian),0.8844,1.13,'-,[1.07-1.18],ACTL8,Colorectal cancer,colorectal cancer,GCST009869,1:17804474
rs4308634-<b>G</b>,6 x 10-9,,NR,1.04,'-,[1.03-1.06],EPS15P1,Colorectal cancer,colorectal cancer,GCST009869,7:46847615
rs13426988-<b>G</b>,2 x 10-6,(East Asian),0.8523,1.1,'-,[1.06-1.14],COX7A2L,Colorectal cancer,colorectal cancer,GCST009869,2:42376941
rs826732-<b>C</b>,2 x 10-6,,NR,1.04,'-,[1.02-1.05],TOX,Colorectal cancer,colorectal cancer,GCST009869,8:58830080
rs62558833-<b>T</b>,8 x 10-8,,NR,1.05,'-,[1.03-1.06],UBAP2,Colorectal cancer,colorectal cancer,GCST009869,9:34039004
rs11108175-<b>A</b>,3 x 10-11,,NR,1.05,'-,[1.04-1.07],PGAM1P5,Colorectal cancer,colorectal cancer,GCST009869,12:95657111
rs67052019-<b>?</b>,4 x 10-8,(East Asian),0.18,1.13,'-,[1.08-1.18],"NDUFA5P10, LINC01768",Colorectal cancer,colorectal cancer,GCST009869,1:109822839
rs9634162-<b>A</b>,2 x 10-10,,NR,1.05,'-,[1.03-1.07],"Y_RNA, TBX3",Colorectal cancer,colorectal cancer,GCST009869,12:114660289
rs2279237-<b>A</b>,4 x 10-6,,NR,1.05,'-,[1.03-1.07],FBN1,Colorectal cancer,colorectal cancer,GCST009869,15:48528851
rs826732-<b>C</b>,4 x 10-6,(East Asian),0.583,1.07,'-,[1.04-1.10],TOX,Colorectal cancer,colorectal cancer,GCST009869,8:58830080
rs7894531-<b>?</b>,3 x 10-28,(East Asian),0.64,1.1627907,'-,[1.12-1.19],RNA5SP299,Colorectal cancer,colorectal cancer,GCST009869,10:8692798
rs12235741-<b>G</b>,1 x 10-6,(East Asian),0.5135,1.08,'-,[1.04-1.11],UBQLN1,Colorectal cancer,colorectal cancer,GCST009869,9:83695388
rs6469654-<b>C</b>,2 x 10-17,(East Asian),0.5,1.12,'-,[1.09-1.15],EIF3H,Colorectal cancer,colorectal cancer,GCST009869,8:116620726
rs2750055-<b>T</b>,7 x 10-6,(East Asian),0.3487,1.07,'-,[1.04-1.09],IATPR,Colorectal cancer,colorectal cancer,GCST009869,10:33116647
rs61510274-<b>?</b>,3 x 10-14,(East Asian),0.59,1.1111112,'-,[1.08-1.14],SLCO2A1,Colorectal cancer,colorectal cancer,GCST009869,3:134030671
rs11217091-<b>C</b>,7 x 10-7,(East Asian),0.1118,1.11,'-,[1.07-1.16],BCL9L,Colorectal cancer,colorectal cancer,GCST009869,11:118922904
rs1078643-<b>A</b>,2 x 10-13,(East Asian),0.77,1.13,'-,[1.09-1.17],"TMEM220-AS1, TMEM238L",Colorectal cancer,colorectal cancer,GCST009869,17:10803924
rs11108175-<b>A</b>,6 x 10-6,(East Asian),0.8,1.08,'-,[1.05-1.12],PGAM1P5,Colorectal cancer,colorectal cancer,GCST009869,12:95657111
rs6584283-<b>?</b>,6 x 10-11,(East Asian),0.56,1.0869565,'-,[1.06-1.11],LINC01475,Colorectal cancer,colorectal cancer,GCST009869,10:99530544
rs1012053-<b>C</b>,7 x 10-7,(East Asian),0.5059,1.07,'-,[1.04-1.10],DGKH,Colorectal cancer,colorectal cancer,GCST009869,13:42079301
rs2730985-<b>?</b>,1 x 10-9,(East Asian),0.63,1.0869565,'-,[1.05-1.11],LINC02450,Colorectal cancer,colorectal cancer,GCST009869,12:42736822
rs7171219-<b>C</b>,8 x 10-6,(East Asian),0.1476,1.09,'-,[1.05-1.13],SKOR1,Colorectal cancer,colorectal cancer,GCST009869,15:67821433
rs4777372-<b>C</b>,2 x 10-6,(East Asian),0.2302,1.08,'-,[1.05-1.12],THSD4,Colorectal cancer,colorectal cancer,GCST009869,15:71351448
rs8083786-<b>A</b>,2 x 10-6,(East Asian),0.6737,1.08,'-,[1.04-1.11],PTPN2,Colorectal cancer,colorectal cancer,GCST009869,18:12881362
rs8117408-<b>C</b>,3 x 10-6,(East Asian),0.1336,1.1,'-,[1.06-1.15],PLCB1,Colorectal cancer,colorectal cancer,GCST009869,20:8468727
rs964293-<b>?</b>,5 x 10-9,(Empirical Bayes),NR,1.6393442,'-,[1.39-1.92],"PFDN4, CYP24A1",Colorectal cancer (oestrogen-progestogen hormone therapy interaction),"colorectal cancer, hormone replacement therapy",GCST003386,20:54200178
rs651907-<b>C</b>,9 x 10-6,,0.54,1.0752687,'-,[1.04-1.1],"LINC02085, NFKBIZ",Colorectal cancer,colorectal cancer,GCST003799,3:101881880
rs4711689-<b>A</b>,4 x 10-8,,0.85,1.11,'-,[1.07-1.15],TFEB,Colorectal cancer,colorectal cancer,GCST003799,6:41725074
rs2450115-<b>T</b>,1 x 10-12,,0.58,1.12,'-,[1.08-1.15],EIF3H,Colorectal cancer,colorectal cancer,GCST003799,8:116611854
rs6469656-<b>A</b>,2 x 10-12,,0.67,1.11,'-,[1.08-1.14],EIF3H,Colorectal cancer,colorectal cancer,GCST003799,8:116635549
rs4948317-<b>C</b>,2 x 10-7,,0.27,1.0869565,'-,[1.05-1.12],BICC1,Colorectal cancer,colorectal cancer,GCST003799,10:58811675
rs12412391-<b>G</b>,4 x 10-7,,0.4,1.0752687,'-,[1.04-1.1],LINC01475,Colorectal cancer,colorectal cancer,GCST003799,10:99529178
rs4919687-<b>G</b>,8 x 10-12,,0.8,1.14,'-,[1.10-1.19],CYP17A1,Colorectal cancer,colorectal cancer,GCST003799,10:102835491
rs10506868-<b>T</b>,4 x 10-9,,0.28,1.1,'-,[1.06-1.13],VTI1A,Colorectal cancer,colorectal cancer,GCST003799,10:112559621
rs11064437-<b>C</b>,4 x 10-11,,0.75,1.12,'-,[1.08-1.16],SPSB2,Colorectal cancer,colorectal cancer,GCST003799,12:6872998
rs17817050-<b>A</b>,3 x 10-6,,0.9,1.12,'-,[1.07-1.18],TMEM220-AS1,Colorectal cancer,colorectal cancer,GCST003799,17:10806436
rs6061231-<b>C</b>,8 x 10-11,,0.91,1.18,'-,[1.13-1.25],"LAMA5, RPS21",Colorectal cancer,colorectal cancer,GCST003799,20:62381861
rs647161-<b>A</b>,2 x 10-14,,0.31,1.15,'-,[1.11-1.19],C5orf66,Colorectal cancer,colorectal cancer,GCST003799,5:135163402
rs704017-<b>G</b>,2 x 10-8,,0.32,1.1,'-,[1.06-1.13],ZMIZ1-AS1,Colorectal cancer,colorectal cancer,GCST003799,10:79059375
rs11196172-<b>A</b>,1 x 10-12,,0.68,1.14,'-,[1.10-1.18],TCF7L2,Colorectal cancer,colorectal cancer,GCST003799,10:112967084
rs174537-<b>G</b>,9 x 10-21,,0.59,1.16,'-,[1.12-1.19],"MYRF, TMEM258",Colorectal cancer,colorectal cancer,GCST003799,11:61785208
rs10849432-<b>T</b>,4 x 10-10,,0.82,1.14,'-,[1.09-1.18],"PLEKHG6, ATP5MFP5",Colorectal cancer,colorectal cancer,GCST003799,12:6276561
rs10774214-<b>T</b>,1 x 10-10,,0.37,1.14,'-,[1.09-1.18],CCND2-AS1,Colorectal cancer,colorectal cancer,GCST003799,12:4259186
rs12603526-<b>C</b>,3 x 10-8,,0.3,1.1,'-,[1.06-1.14],NXN,Colorectal cancer,colorectal cancer,GCST003799,17:897353
rs7229639-<b>A</b>,3 x 10-15,,0.16,1.2,'-,[1.16-1.25],SMAD7,Colorectal cancer,colorectal cancer,GCST003799,18:48924606
rs1800469-<b>G</b>,1 x 10-8,,0.48,1.09,'-,[1.06-1.12],TMEM91,Colorectal cancer,colorectal cancer,GCST003799,19:41354391
rs2423279-<b>C</b>,3 x 10-12,,0.31,1.13,'-,[1.09-1.17],HAO1,Colorectal cancer,colorectal cancer,GCST003799,20:7831703
rs6687758-<b>G</b>,9 x 10-9,,0.24,1.12,'-,[1.08-1.17],"LINC02474, LINC01705",Colorectal cancer,colorectal cancer,GCST003799,1:221991606
rs10505477-<b>A</b>,3 x 10-13,,0.38,1.15,'-,[1.11-1.20],"CASC8, POU5F1B, PCAT1",Colorectal cancer,colorectal cancer,GCST003799,8:127395198
rs6983267-<b>G</b>,5 x 10-14,,0.38,1.14,'-,[1.10-1.18],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST003799,8:127401060
rs7014346-<b>A</b>,2 x 10-8,,0.27,1.13,'-,[1.08-1.17],"PCAT1, POU5F1B, CASC8",Colorectal cancer,colorectal cancer,GCST003799,8:127412547
rs10795668-<b>G</b>,5 x 10-15,,0.6,1.15,'-,[1.11-1.19],RNA5SP299,Colorectal cancer,colorectal cancer,GCST003799,10:8659256
rs3802842-<b>C</b>,3 x 10-7,,0.38,1.09,'-,[1.05-1.12],"COLCA1, COLCA2",Colorectal cancer,colorectal cancer,GCST003799,11:111300984
rs4939827-<b>T</b>,2 x 10-8,,0.24,1.12,'-,[1.08-1.16],SMAD7,Colorectal cancer,colorectal cancer,GCST003799,18:48927093
rs10411210-<b>C</b>,3 x 10-6,,0.82,1.12,'-,[1.07-1.17],RHPN2,Colorectal cancer,colorectal cancer,GCST003799,19:33041394
"rs6469656-<b>A</b>, rs2450115-<b>T</b>",1 x 10-15,,NR,1.2,'-,NR,N/A - EIF3H; N/A - EIF3H,Colorectal cancer,colorectal cancer,GCST003799,8:116635549|8:116611854
rs12224794-<b>?</b>,3 x 10-6,(Overall Survival),0.55,1.1494253,'-,[1.09-1.22],LRRC4C,Survival in colorectal cancer,"colorectal cancer, survival time",GCST003229,11:41047350
rs1075232-<b>A</b>,3 x 10-6,(Overall Survival),0.05,1.49,'-,[1.26-1.76],"KLF13, OTUD7A",Survival in colorectal cancer (non-distant metastatic),"metastasis measurement, colorectal cancer, survival time",GCST003231,15:31449013
rs209489-<b>C</b>,4 x 10-9,(Overall Survival),0.08,1.77,'-,[1.46-2.14],ELOVL5,Survival in colorectal cancer (distant metastatic),"metastasis measurement, colorectal cancer, survival time",GCST003230,6:53312880
rs1372474-<b>G</b>,2 x 10-6,(Overall Survival),0.1,1.53,'-,[1.28-1.83],LINC01919,Survival in colorectal cancer (distant metastatic),"metastasis measurement, colorectal cancer, survival time",GCST003230,18:53590462
rs209489-<b>C</b>,8 x 10-10,(Disease-Specific Survival),0.08,1.83,'-,[1.51-2.22],ELOVL5,Survival in colorectal cancer (distant metastatic),"metastasis measurement, colorectal cancer, survival time",GCST003230,6:53312880
rs1442089-<b>C</b>,2 x 10-6,(Disease-Specific Survival),0.09,1.56,'-,[1.3-1.87],"LINC01917, LINC01919",Survival in colorectal cancer (distant metastatic),"metastasis measurement, colorectal cancer, survival time",GCST003230,18:53580709
rs10879357-<b>?</b> x rs1571218-<b>?</b>,3 x 10-6,,0.62,1.25,'-,[1.14-1.39],No mapped genes x N/A - CASC20,Colorectal cancer (SNP x SNP interaction),colorectal cancer,GCST001794,20:6389406
rs367615-<b>?</b> x rs10795668-<b>?</b>,4 x 10-8,,0.73,1.35,'-,[1.20-1.49],No mapped genes x RNA5SP299 - N/A,Colorectal cancer (SNP x SNP interaction),colorectal cancer,GCST001794,10:8659256
rs10114408-<b>?</b> x rs4779584-<b>?</b>,3 x 10-6,,0.76,1.37,'-,[1.20-1.56],No mapped genes x SCG5 - GREM1,Colorectal cancer (SNP x SNP interaction),colorectal cancer,GCST001794,15:32702555
rs9365723-<b>?</b> x rs6687758-<b>?</b>,4 x 10-6,,0.57,1.27,'-,[1.15-1.41],No mapped genes x LINC02474 - LINC01705,Colorectal cancer (SNP x SNP interaction),colorectal cancer,GCST001794,1:221991606
rs39453-<b>?</b> x rs6687758-<b>?</b>,2 x 10-6,,0.63,1.28,'-,[1.16-1.43],No mapped genes x LINC02474 - LINC01705,Colorectal cancer (SNP x SNP interaction),colorectal cancer,GCST001794,1:221991606
rs17730929-<b>?</b> x rs7136702-<b>?</b>,3 x 10-6,,0.9,1.47,'-,[1.25-1.72],No mapped genes x LARP4 - DIP2B,Colorectal cancer (SNP x SNP interaction),colorectal cancer,GCST001794,12:50486433
rs4591517-<b>?</b> x rs4925386-<b>?</b>,3 x 10-6,,0.28,1.06,'-,[0.88-1.29],No mapped genes x LAMA5,Colorectal cancer (SNP x SNP interaction),colorectal cancer,GCST001794,20:62345988
rs7014346-<b>A</b>,9 x 10-26,,0.18,1.19,'-,[1.15-1.23],"PCAT1, POU5F1B, CASC8",Colorectal cancer,colorectal cancer,GCST000168,8:127412547
rs3802842-<b>C</b>,6 x 10-10,,0.43,1.11,'-,[1.08-1.15],"COLCA1, COLCA2",Colorectal cancer,colorectal cancer,GCST000168,11:111300984
rs4939827-<b>T</b>,8 x 10-28,,0.52,1.2,'-,[1.16-1.24],SMAD7,Colorectal cancer,colorectal cancer,GCST000168,18:48927093
rs6687758-<b>G</b>,9 x 10-9,(East Asian),0.24,1.12,'-,[1.08-1.17],"LINC02474, LINC01705",Colorectal cancer,colorectal cancer,GCST002454,1:221991606
rs10795668-<b>G</b>,5 x 10-15,(East Asian),0.6,1.15,'-,[1.11-1.19],RNA5SP299,Colorectal cancer,colorectal cancer,GCST002454,10:8659256
rs10411210-<b>C</b>,3 x 10-6,(East Asian),0.82,1.12,'-,[1.07-1.17],RHPN2,Colorectal cancer,colorectal cancer,GCST002454,19:33041394
rs4948317-<b>C</b>,7 x 10-8,(East Asian),0.27,1.1,'-,[1.06-1.13],BICC1,Colorectal cancer,colorectal cancer,GCST002454,10:58811675
rs704017-<b>G</b>,2 x 10-8,(East Asian),0.32,1.1,'-,[1.06-1.13],ZMIZ1-AS1,Colorectal cancer,colorectal cancer,GCST002454,10:79059375
rs12412391-<b>G</b>,7 x 10-7,(East Asian),0.42,1.08,'-,[1.05-1.11],LINC01475,Colorectal cancer,colorectal cancer,GCST002454,10:99529178
rs11196172-<b>A</b>,1 x 10-12,(East Asian),0.68,1.14,'-,[1.10-1.18],TCF7L2,Colorectal cancer,colorectal cancer,GCST002454,10:112967084
rs174537-<b>G</b>,9 x 10-21,(East Asian),0.59,1.16,'-,[1.12-1.19],"MYRF, TMEM258",Colorectal cancer,colorectal cancer,GCST002454,11:61785208
rs12309274-<b>T</b>,3 x 10-6,(East Asian),0.85,1.11,'-,[1.06-1.16],WNK1,Colorectal cancer,colorectal cancer,GCST002454,12:866782
rs10849432-<b>T</b>,6 x 10-10,(East Asian),0.82,1.14,'-,[1.09-1.18],"PLEKHG6, ATP5MFP5",Colorectal cancer,colorectal cancer,GCST002454,12:6276561
rs12603526-<b>C</b>,3 x 10-8,(East Asian),0.3,1.1,'-,[1.06-1.14],NXN,Colorectal cancer,colorectal cancer,GCST002454,17:897353
rs1800469-<b>G</b>,1 x 10-8,(East Asian),0.48,1.09,'-,[1.06-1.12],TMEM91,Colorectal cancer,colorectal cancer,GCST002454,19:41354391
rs647161-<b>A</b>,2 x 10-14,(East Asian),0.31,1.15,'-,[1.11-1.19],C5orf66,Colorectal cancer,colorectal cancer,GCST002454,5:135163402
rs10752881-<b>A</b>,5 x 10-6,(East Asian),0.39,1.07,'-,[1.04-1.10],"LAMC1, RNU6-41P",Colorectal cancer,colorectal cancer,GCST002454,1:183004356
rs6469656-<b>A</b>,5 x 10-8,(East Asian),0.65,1.09,'-,[1.06-1.13],EIF3H,Colorectal cancer,colorectal cancer,GCST002454,8:116635549
rs6983267-<b>G</b>,5 x 10-14,(East Asian),0.38,1.14,'-,[1.10-1.18],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST002454,8:127401060
rs3802842-<b>C</b>,3 x 10-7,(East Asian),0.38,1.09,'-,[1.05-1.12],"COLCA1, COLCA2",Colorectal cancer,colorectal cancer,GCST002454,11:111300984
rs10774214-<b>T</b>,1 x 10-10,(East Asian),0.37,1.14,'-,[1.09-1.18],CCND2-AS1,Colorectal cancer,colorectal cancer,GCST002454,12:4259186
rs7229639-<b>A</b>,2 x 10-8,(East Asian),0.16,1.2,'-,[1.16-1.25],SMAD7,Colorectal cancer,colorectal cancer,GCST002454,18:48924606
rs2423279-<b>C</b>,3 x 10-12,(East Asian),0.31,1.13,'-,[1.09-1.17],HAO1,Colorectal cancer,colorectal cancer,GCST002454,20:7831703
rs1933755-<b>T</b>,2 x 10-6,(Total calcium intake),0.9,1.19,'-,[1.11-1.28],Y_RNA,Colorectal cancer (calcium intake interaction),"calcium intake measurement, colorectal cancer",GCST002596,6:130604622
rs6855885-<b>A</b>,2 x 10-6,(Dietary calcium intake),0.5,1.11,'-,[1.06-1.16],CCSER1,Colorectal cancer (calcium intake interaction),"calcium intake measurement, colorectal cancer",GCST002596,4:91117856
rs1028166-<b>G</b>,7 x 10-7,(Supplemental calcium intake),0.31,1.49,'-,[1.27-1.74],TENM3-AS1,Colorectal cancer (calcium intake interaction),"calcium intake measurement, colorectal cancer",GCST002596,4:181892145
rs10505477-<b>A</b>,3 x 10-11,,0.5,1.17,'-,[1.12-1.23],"CASC8, POU5F1B, PCAT1",Colorectal cancer,colorectal cancer,GCST000052,8:127395198
rs11255841-<b>T</b>,7 x 10-11,,0.68,1.19,'-,[NR],RNA5SP299,Colorectal cancer,colorectal cancer,GCST002411,10:8697617
rs34245511-<b>C</b>,3 x 10-8,,0.346,1.144,'-,[NR],LIMA1,Colorectal cancer,colorectal cancer,GCST002411,12:50179650
rs73376930-<b>G</b>,1 x 10-11,,0.207,1.246,'-,[NR],GREM1,Colorectal cancer,colorectal cancer,GCST002411,15:32720301
rs13343954-<b>T</b>,7 x 10-8,,0.857,1.183,'-,[NR],RHPN2,Colorectal cancer,colorectal cancer,GCST002411,19:33036982
rs57046232-<b>T</b>,3 x 10-6,,0.369,1.107,'-,[NR],CASC20,Colorectal cancer,colorectal cancer,GCST002411,20:6399697
rs2427308-<b>C</b>,3 x 10-11,,0.78,1.235,'-,[NR],CABLES2,Colorectal cancer,colorectal cancer,GCST002411,20:62394395
rs1035209-<b>T</b>,5 x 10-11,,0.195,1.12,'-,[1.08-1.16],"NKX2-3, SLC25A28",Colorectal cancer,colorectal cancer,GCST002411,10:99585609
rs140355816-<b>G</b>,2 x 10-8,,0.017,1.591,'-,[NR],EIF3H,Colorectal cancer,colorectal cancer,GCST002411,8:116562277
rs10505477-<b>T</b>,8 x 10-13,,0.54,1.198,'-,[NR],"CASC8, POU5F1B, PCAT1",Colorectal cancer,colorectal cancer,GCST002411,8:127395198
rs12241008-<b>C</b>,1 x 10-9,,0.09,1.13,'-,[1.09–1.18],VTI1A,Colorectal cancer,colorectal cancer,GCST002561,10:112520943
rs10774214-<b>T</b>,3 x 10-8,,0.379,1.09,'-,[1.06-1.13],CCND2-AS1,Colorectal cancer,colorectal cancer,GCST001792,12:4259186
rs10774214-<b>T</b>,5 x 10-10,(East Asian),0.352,1.17,'-,[1.11-1.23],CCND2-AS1,Colorectal cancer,colorectal cancer,GCST001792,12:4259186
rs1665650-<b>T</b>,9 x 10-7,(East Asian),0.315,1.13,'-,[1.08-1.19],HSPA12A,Colorectal cancer,colorectal cancer,GCST001792,10:116727589
rs2423279-<b>C</b>,7 x 10-9,,0.252,1.1,'-,[1.06-1.14],HAO1,Colorectal cancer,colorectal cancer,GCST001792,20:7831703
rs647161-<b>A</b>,4 x 10-10,(East Asian),0.313,1.17,'-,[1.11-1.22],C5orf66,Colorectal cancer,colorectal cancer,GCST001792,5:135163402
rs2423279-<b>C</b>,2 x 10-7,(East Asian),0.302,1.14,'-,[1.08-1.19],HAO1,Colorectal cancer,colorectal cancer,GCST001792,20:7831703
rs647161-<b>A</b>,1 x 10-10,,0.667,1.11,'-,[1.08-1.15],C5orf66,Colorectal cancer,colorectal cancer,GCST001792,5:135163402
rs2965667-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,PSMC1P8,Colorectal cancer (aspirin and/or NSAID use interaction),"drug use measurement, aspirin use measurement, NSAID use measurement, colorectal cancer",GCST002816,12:17291799
rs16973225-<b>?</b>,8 x 10-9,(Case only),NR,'-,'-,'-,'-,Colorectal cancer (aspirin and/or NSAID use interaction),"drug use measurement, aspirin use measurement, NSAID use measurement, colorectal cancer",GCST002816,15:81937658
rs7315438-<b>?</b>,6 x 10-6,,0.58,1.11,'-,[1.06-1.15],'-,Colorectal cancer,colorectal cancer,GCST001161,12:115453598
rs4939827-<b>?</b>,1 x 10-7,,0.51,1.14,'-,[1.08-1.18],SMAD7,Colorectal cancer,colorectal cancer,GCST001161,18:48927093
rs4779584-<b>?</b>,2 x 10-8,,0.19,1.18,'-,[1.11-1.24],"SCG5, GREM1",Colorectal cancer,colorectal cancer,GCST001161,15:32702555
rs16892766-<b>?</b>,4 x 10-7,,0.08,1.24,'-,[1.14-1.34],EIF3H,Colorectal cancer,colorectal cancer,GCST001161,8:116618444
rs3802842-<b>?</b>,4 x 10-7,,0.28,1.14,'-,[1.08-1.20],"COLCA1, COLCA2",Colorectal cancer,colorectal cancer,GCST001161,11:111300984
rs6989010-<b>?</b>,2 x 10-6,(Vegetable),0.98-0.99,1.64,'-,[1.33-2],"TRMT9B, LINC00681",Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,8:12915246
rs7999699-<b>?</b>,3 x 10-6,(Fruit),0.38-0.47,1.32,'-,[1.18-1.47],SUCLA2,Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,13:47795595
rs11671104-<b>?</b>,4 x 10-6,(Fruit),0.89-0.94,1.25,'-,[1.13-1.37],"RAD54L2P1, LINC01785",Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,19:22611884
rs7248888-<b>?</b>,5 x 10-6,(Fruit),0.93-0.97,1.37,'-,[1.19-1.56],PNMA8A,Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,19:46470746
rs2593957-<b>?</b>,2 x 10-6,(Fiber),0.40-0.46,1.15,'-,[1.09-1.2],MORC1,Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,3:108984178
rs12534701-<b>?</b>,2 x 10-6,(Fiber),0.54-0.62,1.17,'-,[1.09-1.24],DPP6,Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,7:154889200
rs4855695-<b>?</b>,2 x 10-6,(Fiber),0.51-0.58,1.14,'-,[1.08-1.20],C3orf85,Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,3:109132637
rs4143094-<b>T</b>,9 x 10-9,(Processed meat),0.21-0.27,1.17,'-,[1.11-1.23],GATA3,Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,10:8047173
rs2901879-<b>?</b>,7 x 10-7,(Red meat),0.41-0.49,1.11,'-,[1.06-1.16],"DNMT3AP1, LINC01798",Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,2:66738934
rs1871438-<b>?</b>,8 x 10-7,(Red meat),0.51-0.56,1.11,'-,[1.07-1.16],"ST8SIA2, NPM1P5",Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,15:92316651
rs1370916-<b>?</b>,2 x 10-6,(Red meat),0.46-0.52,1.11,'-,[1.06-1.15],TNS3,Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,7:47199109
rs4849303-<b>?</b>,1 x 10-6,(Vegetable),0.47-0.54,1.12,'-,[1.08-1.18],ACOXL,Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,2:110970905
rs4147045-<b>?</b>,1 x 10-6,(Vegetable),0.08-0.12,1.2,'-,[1.11-1.3],'-,Colorectal cancer (diet interaction),"colorectal cancer, diet measurement",GCST002415,4:18793707
rs6687758-<b>G</b>,2 x 10-9,,NR,1.09,'-,[1.06-1.12],"LINC02474, LINC01705",Colorectal cancer,colorectal cancer,GCST000843,1:221991606
rs4925386-<b>C</b>,2 x 10-10,,NR,1.08,'-,[1.05-1.10],LAMA5,Colorectal cancer,colorectal cancer,GCST000843,20:62345988
rs10936599-<b>C</b>,3 x 10-8,,NR,1.04,'-,[1.04-1.10],MYNN,Colorectal cancer,colorectal cancer,GCST000843,3:169774313
rs11169552-<b>C</b>,2 x 10-10,,NR,1.09,'-,[1.05-1.11],"ATF1, DIP2B",Colorectal cancer,colorectal cancer,GCST000843,12:50761880
rs6691170-<b>T</b>,1 x 10-9,,NR,1.06,'-,[1.03-1.09],"LINC02257, LINC01655",Colorectal cancer,colorectal cancer,GCST000843,1:221872104
rs4444235-<b>C</b>,8 x 10-10,,0.46,1.11,'-,[1.08-1.15],"LINC02331, MIR5580",Colorectal cancer,colorectal cancer,GCST000270,14:53944201
rs10411210-<b>C</b>,5 x 10-9,,0.9,1.15,'-,[1.10-1.20],RHPN2,Colorectal cancer,colorectal cancer,GCST000270,19:33041394
rs9929218-<b>G</b>,1 x 10-8,,0.29,1.1,'-,[1.06-1.12],CDH1,Colorectal cancer,colorectal cancer,GCST000270,16:68787043
rs961253-<b>A</b>,2 x 10-10,,0.36,1.12,'-,[1.08-1.16],CASC20,Colorectal cancer,colorectal cancer,GCST000270,20:6423634
rs4341754-<b>G</b>,2 x 10-9,,0.57,1.09,'-,[1.06-1.12],'-,Colorectal cancer,colorectal cancer,GCST007552,16:80005724
rs1078643-<b>A</b>,8 x 10-13,,0.771,1.13,'-,[1.09-1.17],"TMEM220-AS1, TMEM238L",Colorectal cancer,colorectal cancer,GCST007552,17:10803924
rs13831-<b>G</b>,2 x 10-8,,0.684,1.08,'-,[1.05-1.11],GNAS,Colorectal cancer,colorectal cancer,GCST007552,20:58900136
rs6584283-<b>C</b>,1 x 10-10,,0.564,1.09,'-,[1.06-1.12],LINC01475,Colorectal cancer,colorectal cancer,GCST007552,10:99530544
rs7229639-<b>A</b>,2 x 10-27,,0.17,1.21,'-,[1.17-1.25],SMAD7,Colorectal cancer,colorectal cancer,GCST007552,18:48924606
rs647161-<b>A</b>,3 x 10-15,,0.33,1.12,'-,[1.09-1.15],C5orf66,Colorectal cancer,colorectal cancer,GCST007552,5:135163402
rs11196172-<b>A</b>,3 x 10-15,,0.69,1.12,'-,[1.09-1.16],TCF7L2,Colorectal cancer,colorectal cancer,GCST007552,10:112967084
rs2450115-<b>T</b>,2 x 10-14,,0.56,1.11,'-,[1.08-1.14],EIF3H,Colorectal cancer,colorectal cancer,GCST007552,8:116611854
rs174537-<b>G</b>,8 x 10-12,,0.62,1.1,'-,[1.07-1.13],"MYRF, TMEM258",Colorectal cancer,colorectal cancer,GCST007552,11:61785208
rs12241008-<b>C</b>,2 x 10-11,,0.27,1.11,'-,[1.07-1.14],VTI1A,Colorectal cancer,colorectal cancer,GCST007552,10:112520943
rs6469656-<b>A</b>,2 x 10-10,,0.65,1.09,'-,[1.06-1.12],EIF3H,Colorectal cancer,colorectal cancer,GCST007552,8:116635549
rs2423279-<b>C</b>,3 x 10-10,,0.31,1.1,'-,[1.06-1.13],HAO1,Colorectal cancer,colorectal cancer,GCST007552,20:7831703
rs704017-<b>G</b>,1 x 10-9,,0.33,1.09,'-,[1.06-1.12],ZMIZ1-AS1,Colorectal cancer,colorectal cancer,GCST007552,10:79059375
rs10774214-<b>T</b>,3 x 10-9,,0.4,1.09,'-,[1.06-1.13],CCND2-AS1,Colorectal cancer,colorectal cancer,GCST007552,12:4259186
rs847208-<b>A</b>,3 x 10-7,,0.67,1.08,'-,[1.05-1.11],"LINC01081, LINC01082",Colorectal cancer,colorectal cancer,GCST007552,16:86220445
rs4286721-<b>G</b>,3 x 10-6,,NR,1.3368983,'-,[1.18-1.51],TTC33,Crohn's disease,Crohn's disease,GCST008730,5:40497502
rs6659932-<b>A</b>,1 x 10-11,,'-,'-,'-,[NR],IL12RB2,Crohn's disease or systemic sclerosis,"systemic scleroderma, Crohn's disease",GCST010124,1:67336688
rs2548998-<b>G</b>,2 x 10-11,,'-,'-,'-,[NR],IRF1,Crohn's disease or systemic sclerosis,"systemic scleroderma, Crohn's disease",GCST010124,5:132496822
rs68191-<b>C</b>,1 x 10-10,,'-,'-,'-,[NR],"GGNBP1, ZBTB9",Crohn's disease or systemic sclerosis,"systemic scleroderma, Crohn's disease",GCST010124,6:33512961
rs4796791-<b>T</b>,3 x 10-8,,'-,'-,'-,[NR],STAT3,Crohn's disease or systemic sclerosis,"systemic scleroderma, Crohn's disease",GCST010124,17:42378745
rs7517847-<b>A</b>,1 x 10-159,(EA),0.56,1.3990791,'-,[1.37-1.42],"IL23R, C1orf141",Crohn's disease,Crohn's disease,GCST003044,1:67215986
rs11742570-<b>G</b>,4 x 10-87,(EA),0.61,1.2804482,'-,[1.26-1.3],'-,Crohn's disease,Crohn's disease,GCST003044,5:40410482
rs2413583-<b>G</b>,8 x 10-34,(EA),0.83,1.2341797,'-,[1.2-1.27],"PDGFB, RPL3",Crohn's disease,Crohn's disease,GCST003044,22:39263768
rs34856868-<b>G</b>,2 x 10-6,(EA),0.97,1.2122864,'-,[1.13-1.29],BTBD8,Crohn's disease,Crohn's disease,GCST003044,1:92088726
rs10761659-<b>G</b>,1 x 10-49,(EA),0.54,1.1978161,'-,[1.17-1.22],ALDH7A1P4,Crohn's disease,Crohn's disease,GCST003044,10:62685804
rs2361755-<b>G</b>,6 x 10-14,(EA),0.92,1.1951665,'-,[1.15-1.24],LINC02132,Crohn's disease,Crohn's disease,GCST003044,16:85976080
rs13300218-<b>G</b>,7 x 10-16,(EA),0.9,1.1831077,'-,[1.14-1.22],NOTCH1,Crohn's disease,Crohn's disease,GCST003044,9:136505189
rs17061048-<b>A</b>,1 x 10-7,(EA),0.95,1.1618136,'-,[1.11-1.22],LINC00598,Crohn's disease,Crohn's disease,GCST003044,13:40258875
rs7554511-<b>C</b>,2 x 10-27,(EA),0.72,1.1616178,'-,[1.13-1.19],INAVA,Crohn's disease,Crohn's disease,GCST003044,1:200908434
rs6651252-<b>A</b>,4 x 10-16,(EA),0.87,1.1607062,'-,[1.12-1.2],LINC00824,Crohn's disease,Crohn's disease,GCST003044,8:128554935
rs11681525-<b>G</b>,4 x 10-11,(EA),0.91,1.1577194,'-,[1.11-1.2],TEX41,Crohn's disease,Crohn's disease,GCST003044,2:144734815
rs9525625-<b>A</b>,1 x 10-9,(EA),0.4706,1.0763987,'-,[1.05-1.1],LINC02341,Crohn's disease,Crohn's disease,GCST003044,13:42443894
rs259964-<b>A</b>,2 x 10-9,(EA),0.4586,1.07394,'-,[1.05-1.1],ZNF831,Crohn's disease,Crohn's disease,GCST003044,20:59249254
rs10185424-<b>A</b>,3 x 10-9,(EA),0.4604,1.0748146,'-,[1.05-1.1],"IL1R2, IL1R1",Crohn's disease,Crohn's disease,GCST003044,2:102046427
rs17694108-<b>A</b>,3 x 10-9,(EA),0.2797,1.0828425,'-,[1.06-1.11],"CEBPA, SLC7A10",Crohn's disease,Crohn's disease,GCST003044,19:33240645
rs2382817-<b>A</b>,4 x 10-9,(EA),0.3988,1.0738211,'-,[1.05-1.1],"TMBIM1, PNKD",Crohn's disease,Crohn's disease,GCST003044,2:218286495
rs670523-<b>A</b>,6 x 10-9,(EA),0.329,1.0770509,'-,[1.05-1.1],RIT1,Crohn's disease,Crohn's disease,GCST003044,1:155908941
rs7758080-<b>G</b>,7 x 10-9,(EA),0.2694,1.0790637,'-,[1.05-1.1],"TAB2, TAB2-AS1",Crohn's disease,Crohn's disease,GCST003044,6:149255943
rs568617-<b>A</b>,2 x 10-8,(EA),0.1883,1.0888312,'-,[1.06-1.12],FIBP,Crohn's disease,Crohn's disease,GCST003044,11:65885771
rs3851228-<b>A</b>,3 x 10-8,(EA),0.06375,1.1365786,'-,[1.09-1.18],TRAF3IP2-AS1,Crohn's disease,Crohn's disease,GCST003044,6:111526988
rs314313-<b>G</b>,3 x 10-8,(EA),0.3043,1.0734991,'-,[1.05-1.1],EPHB4,Crohn's disease,Crohn's disease,GCST003044,7:100825743
rs4976646-<b>G</b>,3 x 10-8,(EA),0.3415,1.0721266,'-,[1.05-1.1],RGS14,Crohn's disease,Crohn's disease,GCST003044,5:177361569
rs9297145-<b>C</b>,4 x 10-8,(EA),0.2581,1.0761806,'-,[1.05-1.1],"SMURF1, KPNA7",Crohn's disease,Crohn's disease,GCST003044,7:99161494
rs1748195-<b>G</b>,7 x 10-8,(EA),0.3299,1.0702562,'-,[1.05-1.09],DOCK7,Crohn's disease,Crohn's disease,GCST003044,1:62583922
rs653178-<b>G</b>,7 x 10-8,(EA),0.4942,1.0667465,'-,[1.04-1.09],'-,Crohn's disease,Crohn's disease,GCST003044,Mapping not available
rs194749-<b>G</b>,1 x 10-7,(EA),0.2289,1.0796018,'-,[1.05-1.11],"MAGOH3P, ZFP36L1",Crohn's disease,Crohn's disease,GCST003044,14:68807188
rs17622378-<b>G</b>,7 x 10-56,(EA),0.4186,1.2094882,'-,[1.19-1.23],"IRF1, IRF1-AS1",Crohn's disease,Crohn's disease,GCST003044,5:132442760
rs4409764-<b>A</b>,6 x 10-47,(EA),0.4821,1.1889576,'-,[1.17-1.21],"LINC01475, GOT1",Crohn's disease,Crohn's disease,GCST003044,10:99524480
rs2155219-<b>A</b>,6 x 10-46,(EA),0.4994,1.188493,'-,[1.16-1.21],"EMSY, LINC02757",Crohn's disease,Crohn's disease,GCST003044,11:76588150
rs11741861-<b>G</b>,6 x 10-44,(EA),0.07656,1.3292114,'-,[1.29-1.37],"IRGM, ZNF300",Crohn's disease,Crohn's disease,GCST003044,5:150898347
rs10781499-<b>A</b>,8 x 10-43,(EA),0.4263,1.181867,'-,[1.16-1.21],CARD9,Crohn's disease,Crohn's disease,GCST003044,9:136371953
rs75900472-<b>C</b>,4 x 10-34,(EA),0.3496,1.1615441,'-,[1.14-1.19],"JAK2, HNRNPA1P41",Crohn's disease,Crohn's disease,GCST003044,9:4981601
rs3197999-<b>A</b>,2 x 10-33,(EA),0.2812,1.1677914,'-,[1.14-1.19],MST1,Crohn's disease,Crohn's disease,GCST003044,3:49684099
rs116392568-<b>G</b>,7 x 10-32,(EA),0.3529,1.1627572,'-,[1.14-1.19],"LINC02571, HLA-B",Crohn's disease,Crohn's disease,GCST003044,6:31306603
rs11743851-<b>G</b>,1 x 10-31,(EA),0.3698,1.1548939,'-,[1.13-1.18],CDC42SE2,Crohn's disease,Crohn's disease,GCST003044,5:131277907
rs224090-<b>A</b>,4 x 10-26,(EA),0.4075,1.1376477,'-,[1.11-1.16],"ALDH7A1P4, ADO",Crohn's disease,Crohn's disease,GCST003044,10:62781559
rs12722515-<b>C</b>,8 x 10-13,(EA),0.84,1.1332967,'-,[1.1-1.17],IL2RA,Crohn's disease,Crohn's disease,GCST003044,10:6039267
rs423674-<b>C</b>,2 x 10-14,(EA),0.8,1.1317871,'-,[1.1-1.16],RMI2,Crohn's disease,Crohn's disease,GCST003044,16:11279548
rs2641348-<b>A</b>,1 x 10-9,(EA),0.89,1.1290045,'-,[1.09-1.17],ADAM30,Crohn's disease,Crohn's disease,GCST003044,1:119895261
rs17391694-<b>G</b>,3 x 10-9,(EA),0.88,1.1264268,'-,[1.09-1.17],"GIPC2, RNFT1P2",Crohn's disease,Crohn's disease,GCST003044,1:78157942
rs921720-<b>G</b>,1 x 10-21,(EA),0.62,1.1255294,'-,[1.1-1.15],TRIB1,Crohn's disease,Crohn's disease,GCST003044,8:125522429
rs12199775-<b>A</b>,5 x 10-6,(EA),0.93,1.1207099,'-,[1.07-1.17],PHACTR2,Crohn's disease,Crohn's disease,GCST003044,6:143577757
rs2945412-<b>A</b>,5 x 10-20,(EA),0.59,1.1196703,'-,[1.1-1.14],KSR1,Crohn's disease,Crohn's disease,GCST003044,17:27516617
rs1819333-<b>A</b>,2 x 10-19,(EA),0.54,1.1177828,'-,[1.09-1.14],"MIR3939, RNASET2",Crohn's disease,Crohn's disease,GCST003044,6:166960059
rs1250546-<b>A</b>,3 x 10-19,(EA),0.58,1.1170506,'-,[1.09-1.14],ZMIZ1,Crohn's disease,Crohn's disease,GCST003044,10:79272775
rs6062504-<b>G</b>,8 x 10-17,(EA),0.69,1.1168494,'-,[1.09-1.14],ZGPAT,Crohn's disease,Crohn's disease,GCST003044,20:63717555
rs1842076-<b>A</b>,2 x 10-16,(EA),0.72,1.1168399,'-,[1.09-1.14],LINC00604,Crohn's disease,Crohn's disease,GCST003044,5:40236916
rs1569328-<b>G</b>,6 x 10-11,(EA),0.83,1.1154022,'-,[1.08-1.15],"FOS, U2",Crohn's disease,Crohn's disease,GCST003044,14:75275048
rs2836878-<b>G</b>,5 x 10-15,(EA),0.73,1.114705,'-,[1.09-1.14],RPL23AP12,Crohn's disease,Crohn's disease,GCST003044,21:39093608
rs113653754-<b>C</b>,2 x 10-13,(EA),0.73,1.1104809,'-,[1.08-1.14],"HLA-DQA1, HLA-DQB1",Crohn's disease,Crohn's disease,GCST003044,6:32658495
rs6908425-<b>G</b>,5 x 10-12,(EA),0.78,1.1095867,'-,[1.08-1.14],CDKAL1,Crohn's disease,Crohn's disease,GCST003044,6:20728500
rs12942547-<b>A</b>,1 x 10-16,(EA),0.58,1.1087568,'-,[1.08-1.13],STAT3,Crohn's disease,Crohn's disease,GCST003044,17:42375526
rs2284553-<b>G</b>,6 x 10-17,(EA),0.59,1.1087041,'-,[1.08-1.13],IFNGR2,Crohn's disease,Crohn's disease,GCST003044,21:33404389
rs1199103-<b>A</b>,5 x 10-11,(EA),0.78,1.1072454,'-,[1.08-1.14],IPMK,Crohn's disease,Crohn's disease,GCST003044,10:58187470
rs3766606-<b>C</b>,5 x 10-9,(EA),0.83,1.1060587,'-,[1.07-1.14],PARK7,Crohn's disease,Crohn's disease,GCST003044,1:7962137
rs925255-<b>G</b>,1 x 10-16,(EA),0.55,1.1052196,'-,[1.08-1.13],FLJ31356,Crohn's disease,Crohn's disease,GCST003044,2:28391927
rs6740462-<b>A</b>,2 x 10-12,(EA),0.74,1.1048803,'-,[1.08-1.13],"DNAJB12P1, SPRED2",Crohn's disease,Crohn's disease,GCST003044,2:65440138
rs7236492-<b>G</b>,9 x 10-9,(EA),0.85,1.1047964,'-,[1.07-1.14],NFATC1,Crohn's disease,Crohn's disease,GCST003044,18:79460616
rs2227551-<b>A</b>,5 x 10-13,(EA),0.73,1.1045585,'-,[1.08-1.13],PLAU,Crohn's disease,Crohn's disease,GCST003044,10:73909432
rs559928-<b>G</b>,4 x 10-10,(EA),0.81,1.1042032,'-,[1.07-1.14],"RPS6KA4, LINC02723",Crohn's disease,Crohn's disease,GCST003044,11:64382898
rs1456896-<b>A</b>,1 x 10-13,(EA),0.69,1.1026409,'-,[1.08-1.13],IKZF1,Crohn's disease,Crohn's disease,GCST003044,7:50264865
rs1517037-<b>?</b>,8 x 10-7,(EA),NR,'-,'-,'-,"SEC11C, GRP",Crohn's disease,Crohn's disease,GCST003044,18:59211042
rs6738490-<b>?</b>,4 x 10-78,(EA),NR,'-,'-,'-,ATG16L1,Crohn's disease,Crohn's disease,GCST003044,2:233252937
rs11679753-<b>?</b>,5 x 10-11,(EA),NR,'-,'-,'-,RN7SL51P,Crohn's disease,Crohn's disease,GCST003044,2:62325186
rs76181804-<b>?</b>,1 x 10-10,(EA),NR,'-,'-,'-,"PTPRC, ATP6V1G3",Crohn's disease,Crohn's disease,GCST003044,1:198632575
rs61959448-<b>?</b>,2 x 10-10,(EA),NR,'-,'-,'-,"AKAP11, LINC02341",Crohn's disease,Crohn's disease,GCST003044,13:42336183
rs71624119-<b>?</b>,7 x 10-10,(EA),NR,'-,'-,'-,ANKRD55,Crohn's disease,Crohn's disease,GCST003044,5:56144903
rs10276381-<b>?</b>,7 x 10-10,(EA),NR,'-,'-,'-,JAZF1,Crohn's disease,Crohn's disease,GCST003044,7:28150502
rs631106-<b>?</b>,6 x 10-8,(EA),NR,'-,'-,'-,USP1,Crohn's disease,Crohn's disease,GCST003044,1:62436136
rs7556897-<b>A</b>,6 x 10-6,(EA),0.66,1.0588406,'-,[1.03-1.08],"CCL20, SNRPGP8",Crohn's disease,Crohn's disease,GCST003044,2:227795396
rs71485777-<b>?</b>,1 x 10-36,(EA),NR,'-,'-,'-,"GOT1, LINC01475",Crohn's disease,Crohn's disease,GCST003044,10:99523571
rs6561151-<b>?</b>,5 x 10-25,(EA),NR,'-,'-,'-,NRAD1,Crohn's disease,Crohn's disease,GCST003044,13:43910570
rs9264942-<b>?</b>,5 x 10-25,(EA),NR,'-,'-,'-,"LINC02571, HLA-B",Crohn's disease,Crohn's disease,GCST003044,6:31306603
rs6425143-<b>?</b>,3 x 10-22,(EA),NR,'-,'-,'-,AIMP1P2,Crohn's disease,Crohn's disease,GCST003044,1:172875212
rs780094-<b>?</b>,4 x 10-22,(EA),NR,'-,'-,'-,'-,Crohn's disease,Crohn's disease,GCST003044,Mapping not available
rs7869487-<b>?</b>,7 x 10-19,(EA),NR,'-,'-,'-,"TNFSF15, DELEC1",Crohn's disease,Crohn's disease,GCST003044,9:114818634
rs9989735-<b>?</b>,2 x 10-18,(EA),NR,'-,'-,'-,SP140,Crohn's disease,Crohn's disease,GCST003044,2:230250739
rs9457247-<b>?</b>,2 x 10-18,(EA),NR,'-,'-,'-,"MIR3939, RNASET2",Crohn's disease,Crohn's disease,GCST003044,6:166978686
rs2476601-<b>?</b>,4 x 10-17,(EA),NR,'-,'-,'-,PTPN22,Crohn's disease,Crohn's disease,GCST003044,1:113834946
rs9491891-<b>?</b>,3 x 10-16,(EA),NR,'-,'-,'-,"PTPRK, THEMIS",Crohn's disease,Crohn's disease,GCST003044,6:127956006
rs34592089-<b>?</b>,1 x 10-15,(EA),NR,'-,'-,'-,BANK1,Crohn's disease,Crohn's disease,GCST003044,4:102005766
rs6503695-<b>?</b>,1 x 10-14,(EA),NR,'-,'-,'-,STAT3,Crohn's disease,Crohn's disease,GCST003044,17:42347515
rs34804116-<b>?</b>,1 x 10-13,(EA),NR,'-,'-,'-,"TMEM174, LINC02230",Crohn's disease,Crohn's disease,GCST003044,5:73244023
rs72727394-<b>?</b>,5 x 10-12,(EA),NR,'-,'-,'-,RASGRP1,Crohn's disease,Crohn's disease,GCST003044,15:38554821
rs56163845-<b>?</b>,9 x 10-12,(EA),NR,'-,'-,'-,CPEB4,Crohn's disease,Crohn's disease,GCST003044,5:173946945
rs4692386-<b>G</b>,3 x 10-7,(EA),0.59,1.0656859,'-,[1.04-1.09],"RBPJ, LINC02357",Crohn's disease,Crohn's disease,GCST003044,4:26130739
rs17057051-<b>A</b>,2 x 10-6,(EA),0.69,1.0649383,'-,[1.04-1.09],PTK2B,Crohn's disease,Crohn's disease,GCST003044,8:27370037
rs4243971-<b>C</b>,3 x 10-6,(EA),0.56,1.0574708,'-,[1.03-1.08],"KIF3B, POFUT1",Crohn's disease,Crohn's disease,GCST003044,20:32261714
rs12103-<b>A</b>,6 x 10-7,(EA),0.1834,1.082054,'-,[1.05-1.11],INTS11,Crohn's disease,Crohn's disease,GCST003044,1:1312114
rs2073505-<b>A</b>,9 x 10-7,(EA),0.07545,1.1113101,'-,[1.07-1.15],HGFAC,Crohn's disease,Crohn's disease,GCST003044,4:3442776
rs4664304-<b>A</b>,1 x 10-6,(EA),0.4379,1.0610188,'-,[1.04-1.08],PLA2R1,Crohn's disease,Crohn's disease,GCST003044,2:159937497
rs7134472-<b>A</b>,2 x 10-6,(EA),0.3855,1.0596101,'-,[1.04-1.08],IFNG-AS1,Crohn's disease,Crohn's disease,GCST003044,12:68106206
rs724016-<b>G</b>,3 x 10-6,(EA),0.4413,1.0572861,'-,[1.03-1.08],ZBTB38,Crohn's disease,Crohn's disease,GCST003044,3:141386728
rs3749171-<b>A</b>,6 x 10-6,(EA),0.1806,1.075187,'-,[1.04-1.11],GPR35,Crohn's disease,Crohn's disease,GCST003044,2:240630275
rs4541435-<b>A</b>,9 x 10-6,(EA),0.01341,1.2494621,'-,[1.15-1.35],C3orf84,Crohn's disease,Crohn's disease,GCST003044,3:49191068
rs26528-<b>G</b>,1 x 10-22,(EA),0.4576,1.1273222,'-,[1.1-1.15],IL27,Crohn's disease,Crohn's disease,GCST003044,16:28506388
rs1893217-<b>G</b>,6 x 10-25,(EA),0.1602,1.1773959,'-,[1.15-1.21],PTPN2,Crohn's disease,Crohn's disease,GCST003044,18:12809341
rs11010067-<b>G</b>,1 x 10-26,(EA),0.3513,1.1415846,'-,[1.12-1.17],"LINC02635, CUL2",Crohn's disease,Crohn's disease,GCST003044,10:35006503
rs56167332-<b>A</b>,2 x 10-41,(EA),0.3375,1.1859788,'-,[1.16-1.21],"LINC01845, IL12B",Crohn's disease,Crohn's disease,GCST003044,5:159400761
rs10486483-<b>A</b>,2 x 10-11,(EA),0.2371,1.0987586,'-,[1.07-1.13],SKAP2,Crohn's disease,Crohn's disease,GCST003044,7:26852821
rs12720356-<b>C</b>,3 x 10-11,(EA),0.08572,1.154103,'-,[1.11-1.2],TYK2,Crohn's disease,Crohn's disease,GCST003044,19:10359299
rs12718244-<b>A</b>,5 x 10-11,(EA),0.4081,1.0833611,'-,[1.06-1.11],SPATA48,Crohn's disease,Crohn's disease,GCST003044,7:50136058
rs7555082-<b>A</b>,1 x 10-10,(EA),0.1069,1.1317531,'-,[1.09-1.17],"PTPRC, ATP6V1G3",Crohn's disease,Crohn's disease,GCST003044,1:198629533
rs727563-<b>G</b>,2 x 10-10,(EA),0.2027,1.0965022,'-,[1.07-1.12],ACO2,Crohn's disease,Crohn's disease,GCST003044,22:41471373
rs11641184-<b>A</b>,3 x 10-10,(EA),0.4762,1.0798526,'-,[1.06-1.1],LITAF,Crohn's disease,Crohn's disease,GCST003044,16:11610795
rs10865331-<b>A</b>,4 x 10-10,(EA),0.377,1.0816035,'-,[1.06-1.11],RN7SL51P,Crohn's disease,Crohn's disease,GCST003044,2:62324337
rs35320439-<b>G</b>,1 x 10-9,(EA),0.3104,1.0876893,'-,[1.06-1.11],GAL3ST2,Crohn's disease,Crohn's disease,GCST003044,2:241797926
rs9868809-<b>A</b>,1 x 10-9,(EA),0.1036,1.1240871,'-,[1.09-1.16],CELSR3,Crohn's disease,Crohn's disease,GCST003044,3:48643620
rs2538470-<b>A</b>,1 x 10-9,(EA),0.3622,1.0778457,'-,[1.05-1.1],"RPL32P17, RN7SL72P",Crohn's disease,Crohn's disease,GCST003044,7:148523356
rs7954567-<b>A</b>,1 x 10-9,(EA),0.3338,1.0857501,'-,[1.06-1.11],LTBR,Crohn's disease,Crohn's disease,GCST003044,12:6381959
rs11879191-<b>G</b>,5 x 10-20,(EA),0.8,1.1537393,'-,[1.12-1.18],CDC37,Crohn's disease,Crohn's disease,GCST003044,19:10402235
rs3091315-<b>A</b>,8 x 10-25,(EA),0.73,1.1525311,'-,[1.13-1.18],"CCL7, CCL2",Crohn's disease,Crohn's disease,GCST003044,17:34266646
rs2823286-<b>G</b>,1 x 10-24,(EA),0.71,1.1480856,'-,[1.12-1.17],CYCSP42,Crohn's disease,Crohn's disease,GCST003044,21:15445619
rs4246905-<b>G</b>,7 x 10-23,(EA),0.72,1.1446497,'-,[1.12-1.17],TNFSF15,Crohn's disease,Crohn's disease,GCST003044,9:114790969
rs7097656-<b>G</b>,4 x 10-18,(EA),0.8,1.1411755,'-,[1.11-1.17],TSPAN14,Crohn's disease,Crohn's disease,GCST003044,10:80491075
rs12422544-<b>G</b>,4 x 10-25,(EA),0.01915,1.4551913,'-,[1.38-1.53],"LINC02555, SLC2A13",Crohn's disease,Crohn's disease,GCST003044,12:40134630
rs3024505-<b>A</b>,4 x 10-25,(EA),0.1573,1.1797599,'-,[1.15-1.21],"IL10, Y_RNA",Crohn's disease,Crohn's disease,GCST003044,1:206766559
rs2024092-<b>A</b>,7 x 10-25,(EA),0.2162,1.159123,'-,[1.13-1.19],SBNO2,Crohn's disease,Crohn's disease,GCST003044,19:1124032
rs12946510-<b>A</b>,2 x 10-24,(EA),0.4675,1.1311512,'-,[1.11-1.15],"IKZF3, GRB7",Crohn's disease,Crohn's disease,GCST003044,17:39756124
rs7608910-<b>G</b>,3 x 10-23,(EA),0.3909,1.1281834,'-,[1.1-1.15],PUS10,Crohn's disease,Crohn's disease,GCST003044,2:60977721
rs7746082-<b>C</b>,3 x 10-23,(EA),0.2869,1.1415608,'-,[1.12-1.17],"RN7SKP211, PRDM1",Crohn's disease,Crohn's disease,GCST003044,6:105987394
rs7282490-<b>G</b>,6 x 10-23,(EA),0.3934,1.1274672,'-,[1.1-1.15],GATD3A,Crohn's disease,Crohn's disease,GCST003044,21:44195858
rs13407913-<b>G</b>,1 x 10-21,(EA),0.4306,1.1213214,'-,[1.1-1.14],ADCY3,Crohn's disease,Crohn's disease,GCST003044,2:24874775
rs4768236-<b>C</b>,4 x 10-21,(EA),0.3295,1.1238824,'-,[1.1-1.15],LRRK2,Crohn's disease,Crohn's disease,GCST003044,12:40362670
rs516246-<b>A</b>,1 x 10-20,(EA),0.4652,1.1213977,'-,[1.1-1.15],FUT2,Crohn's disease,Crohn's disease,GCST003044,19:48702915
rs17293632-<b>A</b>,4 x 10-20,(EA),0.2364,1.1369898,'-,[1.11-1.16],SMAD3,Crohn's disease,Crohn's disease,GCST003044,15:67150258
rs212388-<b>G</b>,2 x 10-16,(EA),0.3957,1.1078008,'-,[1.08-1.13],TAGAP-AS1,Crohn's disease,Crohn's disease,GCST003044,6:159069404
rs395157-<b>A</b>,2 x 10-16,(EA),0.4842,1.1031193,'-,[1.08-1.13],OSMR,Crohn's disease,Crohn's disease,GCST003044,5:38867630
rs6708413-<b>G</b>,3 x 10-16,(EA),0.2376,1.1225724,'-,[1.09-1.15],IL18RAP,Crohn's disease,Crohn's disease,GCST003044,2:102446909
rs1363907-<b>A</b>,4 x 10-16,(EA),0.4212,1.10802,'-,[1.08-1.13],ERAP2,Crohn's disease,Crohn's disease,GCST003044,5:96917099
rs2488389-<b>A</b>,9 x 10-15,(EA),0.2092,1.1191661,'-,[1.09-1.15],DENND1B,Crohn's disease,Crohn's disease,GCST003044,1:197662011
rs1292053-<b>G</b>,2 x 10-14,(EA),0.442,1.0954721,'-,[1.07-1.12],TUBD1,Crohn's disease,Crohn's disease,GCST003044,17:59886176
rs4256159-<b>A</b>,7 x 10-14,(EA),0.1459,1.1343944,'-,[1.1-1.17],SATB1-AS1,Crohn's disease,Crohn's disease,GCST003044,3:18725912
rs8005161-<b>A</b>,9 x 10-14,(EA),0.08653,1.1677363,'-,[1.13-1.21],GPR65,Crohn's disease,Crohn's disease,GCST003044,14:88006251
rs10495903-<b>A</b>,3 x 10-13,(EA),0.1316,1.1337671,'-,[1.1-1.17],THADA,Crohn's disease,Crohn's disease,GCST003044,2:43579779
rs2930047-<b>G</b>,1 x 10-12,(EA),0.372,1.0912733,'-,[1.07-1.12],DAP,Crohn's disease,Crohn's disease,GCST003044,5:10695414
rs174537-<b>A</b>,2 x 10-12,(EA),0.3313,1.0922968,'-,[1.07-1.12],"MYRF, TMEM258",Crohn's disease,Crohn's disease,GCST003044,11:61785208
rs2256609-<b>G</b>,6 x 10-12,(EA),0.1971,1.1082332,'-,[1.08-1.14],UBE2L3,Crohn's disease,Crohn's disease,GCST003044,22:21570728
rs5763767-<b>A</b>,6 x 10-13,(EA),0.4538,1.0924478,'-,[1.07-1.12],HORMAD2,Crohn's disease,Crohn's disease,GCST003044,22:30097893
rs6074022-<b>G</b>,3 x 10-12,(EA),0.2503,1.1011126,'-,[1.07-1.13],"RPL13P2, CD40",Crohn's disease,Crohn's disease,GCST003044,20:46111557
rs6863411-<b>T</b>,2 x 10-14,(EA),0.63,1.1018033,'-,[1.08-1.13],NDFIP1,Crohn's disease,Crohn's disease,GCST003044,5:142133639
rs71559680-<b>G</b>,2 x 10-15,(EA),0.53,1.1003201,'-,[1.08-1.12],LINC00581,Crohn's disease,Crohn's disease,GCST003044,6:21430497
rs3742130-<b>G</b>,1 x 10-10,(EA),0.78,1.0992312,'-,[1.07-1.13],"UBAC2, GPR18",Crohn's disease,Crohn's disease,GCST003044,13:99255087
rs4845604-<b>G</b>,1 x 10-7,(EA),0.85,1.0955864,'-,[1.06-1.13],RORC,Crohn's disease,Crohn's disease,GCST003044,1:151829204
rs10051722-<b>A</b>,4 x 10-12,(EA),0.7,1.0947279,'-,[1.07-1.12],'-,Crohn's disease,Crohn's disease,GCST003044,5:130768383
rs4802307-<b>C</b>,9 x 10-12,(EA),0.7,1.0939962,'-,[1.07-1.12],"PPP5C, HIF3A",Crohn's disease,Crohn's disease,GCST003044,19:46346549
rs1847472-<b>C</b>,1 x 10-10,(EA),0.66,1.0891367,'-,[1.06-1.12],BACH2,Crohn's disease,Crohn's disease,GCST003044,6:90263440
rs7657746-<b>A</b>,2 x 10-9,(EA),0.76,1.0890222,'-,[1.06-1.12],KIAA1109,Crohn's disease,Crohn's disease,GCST003044,4:122240464
rs17119-<b>A</b>,2 x 10-8,(EA),0.81,1.0885191,'-,[1.06-1.12],"PPIAP9, RNU6-793P",Crohn's disease,Crohn's disease,GCST003044,6:14719265
rs11230563-<b>G</b>,4 x 10-11,(EA),0.65,1.0883777,'-,[1.06-1.11],CD6,Crohn's disease,Crohn's disease,GCST003044,11:61008737
rs7015630-<b>A</b>,9 x 10-10,(EA),0.73,1.0879005,'-,[1.06-1.11],"RNU6-925P, COX6B1P6",Crohn's disease,Crohn's disease,GCST003044,8:89863690
rs7438704-<b>G</b>,3 x 10-11,(EA),0.64,1.0875221,'-,[1.06-1.11],SLAIN2,Crohn's disease,Crohn's disease,GCST003044,4:48361228
rs3853824-<b>G</b>,1 x 10-10,(EA),0.64,1.0847627,'-,[1.06-1.11],C17orf67,Crohn's disease,Crohn's disease,GCST003044,17:56803632
rs1517352-<b>C</b>,1 x 10-10,(EA),0.6,1.0832976,'-,[1.06-1.11],STAT4,Crohn's disease,Crohn's disease,GCST003044,2:191066738
rs7773324-<b>A</b>,1 x 10-9,(EA),0.6,1.0819273,'-,[1.06-1.11],"IRF4, DUSP22",Crohn's disease,Crohn's disease,GCST003044,6:382559
rs1801274-<b>A</b>,9 x 10-11,(EA),0.5,1.0816648,'-,[1.06-1.11],FCGR2A,Crohn's disease,Crohn's disease,GCST003044,1:161509955
rs7165170-<b>A</b>,7 x 10-7,(EA),0.82,1.0798767,'-,[1.05-1.11],"CRTC3-AS1, CRTC3",Crohn's disease,Crohn's disease,GCST003044,15:90638257
rs1042058-<b>G</b>,2 x 10-9,(EA),0.6,1.0776412,'-,[1.05-1.1],MAP3K8,Crohn's disease,Crohn's disease,GCST003044,10:30439172
rs4703855-<b>G</b>,3 x 10-8,(EA),0.7,1.0760114,'-,[1.05-1.1],"PTCD2, YBX1P5",Crohn's disease,Crohn's disease,GCST003044,5:72398072
rs10798069-<b>C</b>,4 x 10-9,(EA),0.51,1.0729233,'-,[1.05-1.1],PLA2G4A,Crohn's disease,Crohn's disease,GCST003044,1:186906327
rs13204048-<b>A</b>,3 x 10-8,(EA),0.61,1.0708697,'-,[1.05-1.1],SLC22A23,Crohn's disease,Crohn's disease,GCST003044,6:3420172
rs11229555-<b>C</b>,1 x 10-6,(EA),0.75,1.0702233,'-,[1.04-1.1],GLYAT,Crohn's disease,Crohn's disease,GCST003044,11:58641214
rs4656958-<b>G</b>,5 x 10-7,(EA),0.68,1.0694069,'-,[1.04-1.1],"ITLN1, ITLN2",Crohn's disease,Crohn's disease,GCST003044,1:160887174
rs915286-<b>A</b>,3 x 10-8,(EA),0.55,1.068916,'-,[1.05-1.09],LINC00598,Crohn's disease,Crohn's disease,GCST003044,13:40121855
rs2503322-<b>G</b>,6 x 10-8,(EA),0.54,1.0676966,'-,[1.04-1.09],RSPO3,Crohn's disease,Crohn's disease,GCST003044,6:127136115
rs1250544-<b>G</b>,7 x 10-14,(same-effect analysis),NR,1.16,'-,[NR],ZMIZ1,Crohn's disease and psoriasis,"psoriasis, Crohn's disease",GCST001473,10:79273128
rs4780355-<b>T</b>,1 x 10-13,(same-effect analysis),NR,1.16,'-,[NR],RMI2,Crohn's disease and psoriasis,"psoriasis, Crohn's disease",GCST001473,16:11254001
rs7667-<b>?</b>,8 x 10-6,(opposite-effect analysis),NR,1.11,'-,[NR],CAPZB,Crohn's disease and psoriasis,"psoriasis, Crohn's disease",GCST001473,1:19392330
rs1386478-<b>A</b>,7 x 10-6,(opposite-effect analysis),NR,1.12,'-,[NR],ZDHHC23,Crohn's disease and psoriasis,"psoriasis, Crohn's disease",GCST001473,3:113962104
rs3764147-<b>G</b>,2 x 10-13,,0.22,1.25,'-,[NR],LACC1,Crohn's disease,Crohn's disease,GCST000207,13:43883789
rs7746082-<b>C</b>,2 x 10-10,,0.29,1.17,'-,[NR],"RN7SKP211, PRDM1",Crohn's disease,Crohn's disease,GCST000207,6:105987394
rs2274910-<b>C</b>,1 x 10-9,,0.68,1.14,'-,[NR],ITLN1,Crohn's disease,Crohn's disease,GCST000207,1:160882256
rs2188962-<b>T</b>,2 x 10-18,,0.43,1.25,'-,[NR],IRF1-AS1,Crohn's disease,Crohn's disease,GCST000207,5:132435113
rs4263839-<b>G</b>,3 x 10-10,,0.68,1.22,'-,[NR],TNFSF15,Crohn's disease,Crohn's disease,GCST000207,9:114804160
rs11190140-<b>T</b>,3 x 10-16,,0.48,1.2,'-,[NR],"LINC01475, NKX2-3",Crohn's disease,Crohn's disease,GCST000207,10:99531836
rs2542151-<b>G</b>,5 x 10-17,,0.15,1.35,'-,[NR],"PTPN2, LINC01882",Crohn's disease,Crohn's disease,GCST000207,18:12779948
rs10045431-<b>C</b>,4 x 10-13,,0.71,1.11,'-,[NR],"LINC01845, IL12B",Crohn's disease,Crohn's disease,GCST000207,5:159387525
rs2301436-<b>T</b>,1 x 10-12,,0.46,1.21,'-,[NR],CEP43,Crohn's disease,Crohn's disease,GCST000207,6:167024500
rs744166-<b>A</b>,7 x 10-12,,0.57,1.18,'-,[NR],STAT3,Crohn's disease,Crohn's disease,GCST000207,17:42362183
rs11175593-<b>T</b>,3 x 10-10,,0.02,1.54,'-,[NR],"LRRK2-DT, LINC02471, LRRK2",Crohn's disease,Crohn's disease,GCST000207,12:40208138
rs10758669-<b>C</b>,3 x 10-9,,0.35,1.12,'-,[NR],"JAK2, HNRNPA1P41",Crohn's disease,Crohn's disease,GCST000207,9:4981602
rs3197999-<b>A</b>,1 x 10-12,,0.27,1.2,'-,[NR],MST1,Crohn's disease,Crohn's disease,GCST000207,3:49684099
rs11747270-<b>G</b>,3 x 10-16,,0.09,1.33,'-,[NR],IRGM,Crohn's disease,Crohn's disease,GCST000207,5:150879305
rs2066847-<b>C</b>,3 x 10-24,,0.02,3.99,'-,[NR],"CYLD-AS1, NOD2",Crohn's disease,Crohn's disease,GCST000207,16:50729868
rs10995271-<b>C</b>,4 x 10-20,,0.39,1.25,'-,[NR],ALDH7A1P4,Crohn's disease,Crohn's disease,GCST000207,10:62678726
rs6908425-<b>C</b>,9 x 10-10,,0.78,1.21,'-,[NR],CDKAL1,Crohn's disease,Crohn's disease,GCST000207,6:20728500
rs1551398-<b>A</b>,5 x 10-9,,0.62,1.08,'-,[NR],TRIB1,Crohn's disease,Crohn's disease,GCST000207,8:125527809
rs2476601-<b>G</b>,1 x 10-8,,0.9,1.31,'-,[NR],PTPN22,Crohn's disease,Crohn's disease,GCST000207,1:113834946
rs9286879-<b>G</b>,2 x 10-9,,0.24,1.19,'-,[NR],AIMP1P2,Crohn's disease,Crohn's disease,GCST000207,1:172893094
rs11584383-<b>T</b>,1 x 10-11,,0.7,1.18,'-,[NR],"MROH3P, KIF21B",Crohn's disease,Crohn's disease,GCST000207,1:200966738
rs1456893-<b>A</b>,5 x 10-9,,0.68,1.2,'-,[NR],"IKZF1, SPATA48",Crohn's disease,Crohn's disease,GCST000207,7:50230076
rs17582416-<b>G</b>,2 x 10-9,,0.35,1.16,'-,[NR],"CUL2, LINC02635",Crohn's disease,Crohn's disease,GCST000207,10:34998722
rs7927894-<b>T</b>,1 x 10-9,,0.39,1.16,'-,[NR],"EMSY, LINC02757",Crohn's disease,Crohn's disease,GCST000207,11:76590272
rs2872507-<b>A</b>,5 x 10-9,,0.47,1.12,'-,[NR],"GSDMB, ZPBP2",Crohn's disease,Crohn's disease,GCST000207,17:39884510
rs762421-<b>G</b>,1 x 10-9,,0.39,1.13,'-,[NR],GATD3A,Crohn's disease,Crohn's disease,GCST000207,21:44195678
rs11465804-<b>T</b>,7 x 10-63,,0.93,2.5,'-,[NR],IL23R,Crohn's disease,Crohn's disease,GCST000207,1:67236843
rs3828309-<b>G</b>,2 x 10-32,,0.53,1.25,'-,[NR],ATG16L1,Crohn's disease,Crohn's disease,GCST000207,2:233271764
rs4613763-<b>C</b>,7 x 10-27,,0.13,1.32,'-,[NR],'-,Crohn's disease,Crohn's disease,GCST000207,5:40392626
rs1736135-<b>T</b>,7 x 10-9,,0.57,1.18,'-,[NR],CYCSP42,Crohn's disease,Crohn's disease,GCST000207,21:15432901
rs55703767-<b>G</b>,5 x 10-12,,0.794,1.2658228,'-,[NR],"COL4A3, MFF-DT",Diabetic nephropathy in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009278,2:227256385
rs191449639-<b>A</b>,1 x 10-8,,0.005,32.42,'-,[NR],"MUC7, AMTN",Diabetic nephropathy in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009278,4:70493059
rs55703767-<b>G</b>,9 x 10-9,,0.794,1.2820514,'-,[NR],"COL4A3, MFF-DT",Macroalbuminuria in type 1 diabetes,"albuminuria, type I diabetes mellitus",GCST009284,2:227256385
rs113554206-<b>A</b>,5 x 10-7,,0.012,4.6,'-,[NR],PAPLN,Macroalbuminuria in type 1 diabetes,"albuminuria, type I diabetes mellitus",GCST009284,14:73273542
rs115061173-<b>A</b>,4 x 10-8,,0.014,9.4,'-,[NR],LINC01266,End-stage renal disease in Type 1 diabetics,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009279,3:884662
rs551191707-<b>CA</b>,4 x 10-8,,0.122,1.7,'-,[NR],"CASC19, PRNCR1, PCAT1",Kidney disease (end stage renal disease vs macroalbuminuria) in type 1 diabetes,"albuminuria, type I diabetes mellitus, type 1 diabetes nephropathy",GCST009285,8:127087785
rs142823282-<b>G</b>,8 x 10-10,,0.011,6.73,'-,[NR],FANCD2P2,Microalbuminuria in type 1 diabetes,"type I diabetes mellitus, Moderate albuminuria",GCST009281,3:11869161
rs145681168-<b>G</b>,2 x 10-7,,0.014,5.53,'-,[NR],HAND2-AS1,Microalbuminuria in type 1 diabetes,"type I diabetes mellitus, Moderate albuminuria",GCST009281,4:173579655
rs118124843-<b>T</b>,4 x 10-8,,0.011,3.79,'-,[NR],VARS2,Microalbuminuria in type 1 diabetes,"type I diabetes mellitus, Moderate albuminuria",GCST009281,6:30919688
rs61983410-<b>C</b>,1 x 10-7,,0.787,1.2658228,'-,[NR],'-,Microalbuminuria in type 1 diabetes,"type I diabetes mellitus, Moderate albuminuria",GCST009281,14:25535506
rs144434404-<b>T</b>,3 x 10-9,,0.011,6.78,'-,[NR],BMP7,Microalbuminuria in type 1 diabetes,"type I diabetes mellitus, Moderate albuminuria",GCST009281,20:57262207
rs77273076-<b>T</b>,1 x 10-8,,0.008,9.16,'-,[NR],"RPL7P60, MBLAC1",Microalbuminuria in type 1 diabetes,"type I diabetes mellitus, Moderate albuminuria",GCST009281,7:100130923
rs183937294-<b>G</b>,2 x 10-8,,0.007,17.22,'-,[NR],PLEKHA7,Microalbuminuria in type 1 diabetes,"type I diabetes mellitus, Moderate albuminuria",GCST009281,11:16916299
rs12615970-<b>A</b>,9 x 10-9,,0.867,1.3157895,'-,[NR],ALLC,Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009286,2:3697625
rs185299109-<b>T</b>,1 x 10-8,,0.007,20.75,'-,[NR],'-,Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009286,18:1811107
rs149641852-<b>T</b>,1 x 10-8,,0.012,9.01,'-,[NR],"MGC32805, SNCAIP",Chronic kidney disease (end stage renal disease vs. normal eGFR) in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009287,5:122438887
rs55703767-<b>G</b>,5 x 10-9,,0.794,1.2987013,'-,[NR],"COL4A3, MFF-DT",Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in type 1 diabetes,"type I diabetes mellitus, type 1 diabetes nephropathy",GCST009289,2:227256385
rs55703767-<b>G</b>,4 x 10-10,,0.794,1.2048193,'-,[NR],"COL4A3, MFF-DT",Kidney disease (end stage renal disease or albuminuria) in type 1 diabetes,"albuminuria, type I diabetes mellitus, type 1 diabetes nephropathy",GCST009292,2:227256385
rs4972593-<b>A</b>,4 x 10-8,(Women),0.14,1.81,'-,[1.47-2.24],'-,End-stage renal disease in Type 1 diabetics,"type I diabetes mellitus, chronic kidney disease",GCST002182,2:173598126
rs1326934-<b>T</b>,6 x 10-7,,0.57,1.19,'-,[1.11-1.27],SORBS1,Diabetic nephropathy in type 1 diabetes,"type I diabetes mellitus, diabetic nephropathy",GCST002716,10:95524324
rs8005161-<b>T</b>,2 x 10-14,,0.089,1.153,'-,[1.097-1.211],GPR65,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,14:88006251
rs17293632-<b>T</b>,6 x 10-16,,0.235,1.067,'-,[1.032-1.102],SMAD3,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,15:67150258
rs7495132-<b>C</b>,9 x 10-11,,0.891,1.134,'-,[1.082-1.189],"CRTC3-AS1, CRTC3",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,15:90629669
rs7404095-<b>C</b>,1 x 10-9,,0.572,1.06,'-,[1.03-1.091],PRKCB,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,16:23853269
rs26528-<b>C</b>,1 x 10-21,,0.451,1.099,'-,[1.067-1.13],IL27,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,16:28506388
rs10521318-<b>C</b>,1 x 10-9,,0.915,1.155,'-,[1.094-1.219],LINC02132,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,16:85977731
rs12946510-<b>T</b>,4 x 10-38,,0.465,1.157,'-,[1.124-1.19],"IKZF3, GRB7",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,17:39756124
rs12942547-<b>A</b>,6 x 10-22,,0.58,1.103,'-,[1.072-1.136],STAT3,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,17:42375526
rs1292053-<b>G</b>,9 x 10-13,,0.446,1.076,'-,[1.045-1.106],TUBD1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,17:59886176
rs1893217-<b>G</b>,3 x 10-26,,0.157,1.171,'-,[1.127-1.216],PTPN2,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,18:12809341
rs7240004-<b>A</b>,1 x 10-9,,0.616,1.057,'-,[1.026-1.088],"SMAD7, CTIF",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,18:48868651
rs727088-<b>G</b>,5 x 10-9,,0.484,1.077,'-,[1.046-1.108],CD226,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,18:69863203
rs11879191-<b>G</b>,2 x 10-18,,0.797,1.136,'-,[1.096-1.177],CDC37,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,19:10402235
rs17694108-<b>A</b>,6 x 10-15,,0.282,1.1,'-,[1.065-1.135],"CEBPA, SLC7A10",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,19:33240645
rs11672983-<b>A</b>,7 x 10-11,,0.392,1.087,'-,[1.055-1.119],"RNU6-222P, FCAR",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,19:54871595
rs6142618-<b>G</b>,6 x 10-10,,0.564,1.072,'-,[1.041-1.103],TM9SF4,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,20:32137845
rs4911259-<b>G</b>,1 x 10-9,,0.383,1.075,'-,[1.044-1.106],DNMT3B,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,20:32788476
rs1569723-<b>C</b>,1 x 10-13,,0.259,1.091,'-,[1.056-1.126],"CD40, RPL13P2",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,20:46113425
rs913678-<b>T</b>,5 x 10-8,,0.662,1.056,'-,[1.024-1.088],"LINC01271, RN7SL636P",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,20:50338887
rs259964-<b>A</b>,1 x 10-12,,0.464,1.085,'-,[1.054-1.116],ZNF831,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,20:59249254
rs6062504-<b>G</b>,1 x 10-23,,0.684,1.104,'-,[1.071-1.139],ZGPAT,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,20:63717555
rs2823286-<b>G</b>,9 x 10-30,,0.708,1.157,'-,[1.121-1.194],CYCSP42,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,21:15445619
rs1363907-<b>A</b>,6 x 10-13,,0.411,1.068,'-,[1.037-1.099],ERAP2,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,5:96917099
rs11741861-<b>G</b>,3 x 10-37,,0.093,1.249,'-,[1.186-1.314],"IRGM, ZNF300",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,5:150898347
rs9358372-<b>G</b>,9 x 10-14,,0.379,1.089,'-,[1.057-1.121],CDKAL1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,6:20812357
rs2790216-<b>G</b>,8 x 10-9,,0.778,1.066,'-,[1.029-1.104],IPMK,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,10:58238165
rs10761659-<b>G</b>,6 x 10-46,,0.543,1.166,'-,[1.134-1.20],ALDH7A1P4,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,10:62685804
rs2227564-<b>C</b>,7 x 10-10,,0.77,1.082,'-,[1.048-1.118],"PLAU, C10orf55",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,10:73913343
rs1250546-<b>A</b>,3 x 10-18,,0.604,1.096,'-,[1.065-1.128],ZMIZ1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,10:79272775
rs6586030-<b>G</b>,9 x 10-16,,0.847,1.115,'-,[1.076-1.156],TSPAN14,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,10:80494291
rs7911264-<b>C</b>,3 x 10-8,,0.519,1.066,'-,[1.035-1.097],"HHEX, EIF2S2P3",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,10:92677094
rs4409764-<b>T</b>,1 x 10-54,,0.491,1.182,'-,[1.149-1.217],"LINC01475, GOT1",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,10:99524480
rs907611-<b>A</b>,3 x 10-10,,0.315,1.068,'-,[1.035-1.101],LSP1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,11:1852842
rs10896794-<b>T</b>,7 x 10-10,,0.762,1.08,'-,[1.045-1.116],LPXN,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,11:58571651
rs11230563-<b>C</b>,9 x 10-13,,0.654,1.085,'-,[1.053-1.118],CD6,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,11:61008737
rs4246215-<b>T</b>,2 x 10-15,,0.338,1.079,'-,[1.046-1.112],"FADS2, FEN1",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,11:61796827
rs559928-<b>C</b>,4 x 10-11,,0.821,1.101,'-,[1.061-1.142],"RPS6KA4, LINC02723",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,11:64382898
rs2231884-<b>T</b>,3 x 10-10,,0.157,1.083,'-,[1.044-1.122],"FIBP, CCDC85B",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,11:65889093
rs2155219-<b>T</b>,4 x 10-36,,0.509,1.151,'-,[1.119-1.185],"EMSY, LINC02757",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,11:76588150
rs6592362-<b>A</b>,2 x 10-8,,0.248,1.083,'-,[1.049-1.117],PSMA2P1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,11:87414396
rs630923-<b>C</b>,7 x 10-9,,0.846,1.074,'-,[1.039-1.11],"CXCR5, Y_RNA",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,11:118883644
rs11612508-<b>G</b>,1 x 10-8,,0.267,1.058,'-,[1.025-1.091],DUSP16,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,12:12504579
rs11168249-<b>C</b>,8 x 10-9,,0.467,1.054,'-,[1.024-1.084],HDAC7,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,12:47814585
rs7134599-<b>A</b>,9 x 10-32,,0.378,1.096,'-,[1.064-1.128],IFNG-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,12:68106295
rs941823-<b>C</b>,2 x 10-14,,0.758,1.071,'-,[1.036-1.107],LINC00598,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,13:40439840
rs9557195-<b>T</b>,2 x 10-14,,0.772,1.112,'-,[1.075-1.151],"GPR183, UBAC2",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,13:99304368
rs194749-<b>C</b>,3 x 10-10,,0.226,1.075,'-,[1.039-1.111],"MAGOH3P, ZFP36L1",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,14:68807188
rs3851228-<b>T</b>,1 x 10-13,,0.073,1.153,'-,[1.089-1.219],TRAF3IP2-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,6:111526988
rs11564258-<b>A</b>,6 x 10-29,,0.025,1.334,'-,[1.217-1.461],MUC19,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,12:40398498
rs17085007-<b>C</b>,3 x 10-19,,0.183,1.106,'-,[1.065-1.147],"FGFR1OP2P1, RPS21P8",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,13:26957130
rs4899554-<b>C</b>,3 x 10-8,,0.819,1.083,'-,[1.042-1.125],"U2, RNU4ATAC14P",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,14:75234518
rs529866-<b>C</b>,2 x 10-16,,0.803,1.124,'-,[1.085-1.166],RMI2,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,16:11279463
rs3091316-<b>G</b>,1 x 10-26,,0.722,1.122,'-,[1.087-1.158],"CCL7, CCL2",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,17:34266955
rs11209026-<b>G</b>,8 x 10-161,,0.933,2.013,'-,[1.885-2.15],IL23R,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:67240275
rs12103-<b>A</b>,8 x 10-13,,0.182,1.099,'-,[1.059-1.139],INTS11,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:1312114
rs35675666-<b>G</b>,1 x 10-15,,0.838,1.112,'-,[1.07-1.156],PARK7,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:7961913
rs12568930-<b>T</b>,1 x 10-17,,0.821,1.095,'-,[1.054-1.138],"PPIAP34, ZBTB40",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:22375738
rs2651244-<b>G</b>,2 x 10-8,,0.599,1.015,'-,[0.986-1.044],"CHORDC1P5, CTH",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:70529879
rs4845604-<b>G</b>,4 x 10-16,,0.857,1.144,'-,[1.098-1.192],RORC,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:151829204
rs670523-<b>A</b>,6 x 10-11,,0.324,1.06,'-,[1.028-1.092],RIT1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:155908941
rs4656958-<b>G</b>,7 x 10-9,,0.686,1.061,'-,[1.029-1.094],"ITLN1, ITLN2",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:160887174
rs1801274-<b>A</b>,2 x 10-38,,0.509,1.124,'-,[1.092-1.157],FCGR2A,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:161509955
rs2488389-<b>A</b>,8 x 10-13,,0.22,1.115,'-,[1.077-1.153],DENND1B,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:197662011
rs7554511-<b>C</b>,1 x 10-32,,0.725,1.164,'-,[1.128-1.202],INAVA,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:200908434
rs3024505-<b>A</b>,7 x 10-42,,0.16,1.208,'-,[1.163-1.254],"IL10, Y_RNA",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,1:206766559
rs6545800-<b>T</b>,6 x 10-16,,0.445,1.109,'-,[1.077-1.141],ADCY3,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,2:24896016
rs925255-<b>C</b>,3 x 10-15,,0.557,1.092,'-,[1.061-1.124],FLJ31356,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,2:28391927
rs10495903-<b>T</b>,8 x 10-12,,0.13,1.086,'-,[1.041-1.131],THADA,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,2:43579779
rs7608910-<b>G</b>,9 x 10-32,,0.394,1.138,'-,[1.105-1.171],PUS10,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,2:60977721
rs6740462-<b>A</b>,2 x 10-8,,0.739,1.081,'-,[1.046-1.116],"DNAJB12P1, SPRED2",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,2:65440138
rs917997-<b>T</b>,3 x 10-20,,0.231,1.103,'-,[1.067-1.14],"IL18RAP, SLC9A4",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,2:102454108
rs2111485-<b>A</b>,2 x 10-8,,0.404,1.066,'-,[1.035-1.097],'-,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,Mapping not available
rs1517352-<b>C</b>,3 x 10-11,,0.6,1.077,'-,[1.046-1.109],STAT4,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,2:191066738
rs2382817-<b>A</b>,4 x 10-12,,0.408,1.073,'-,[1.042-1.104],"TMBIM1, PNKD",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,2:218286495
rs3749171-<b>T</b>,3 x 10-21,,0.167,1.135,'-,[1.093-1.177],GPR35,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,2:240630275
rs4256159-<b>T</b>,9 x 10-15,,0.14,1.107,'-,[1.063-1.152],SATB1-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,3:18725912
rs3197999-<b>A</b>,1 x 10-47,,0.296,1.18,'-,[1.144-1.216],MST1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,3:49684099
rs2472649-<b>G</b>,3 x 10-8,,0.824,1.095,'-,[1.046-1.146],"CXCL5, PPBP",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,4:73991991
rs7657746-<b>A</b>,3 x 10-13,,0.753,1.116,'-,[1.08-1.154],KIAA1109,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,4:122240464
rs2930047-<b>C</b>,1 x 10-8,,0.382,1.065,'-,[1.034-1.096],DAP,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,5:10695414
rs11742570-<b>C</b>,2 x 10-82,,0.605,1.198,'-,[1.164-1.234],'-,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,5:40410482
rs4836519-<b>T</b>,4 x 10-10,,0.768,1.072,'-,[1.039-1.106],'-,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,5:130681594
rs2188962-<b>T</b>,1 x 10-52,,0.425,1.158,'-,[1.125-1.191],IRF1-AS1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,5:132435113
rs6863411-<b>T</b>,4 x 10-14,,0.63,1.089,'-,[1.057-1.121],NDFIP1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,5:142133639
rs6871626-<b>A</b>,1 x 10-42,,0.337,1.181,'-,[1.146-1.216],"IL12B, LINC01845",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,5:159399784
rs12654812-<b>A</b>,2 x 10-8,,0.335,1.068,'-,[1.036-1.10],RGS14,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,5:177367190
rs17119-<b>A</b>,3 x 10-11,,0.786,1.071,'-,[1.032-1.11],"PPIAP9, RNU6-793P",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,6:14719265
rs1847472-<b>C</b>,2 x 10-10,,0.655,1.06,'-,[1.029-1.092],BACH2,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,6:90263440
rs6568421-<b>G</b>,8 x 10-20,,0.301,1.108,'-,[1.074-1.142],"PRDM1, RN7SKP211",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,6:105987150
rs6920220-<b>A</b>,1 x 10-21,,0.206,1.102,'-,[1.064-1.141],LINC02539,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,6:137685367
rs12199775-<b>A</b>,2 x 10-8,,0.929,1.129,'-,[1.066-1.195],PHACTR2,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,6:143577757
rs1819333-<b>T</b>,7 x 10-21,,0.523,1.081,'-,[1.051-1.113],"MIR3939, RNASET2",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,6:166960059
rs1456896-<b>T</b>,7 x 10-15,,0.688,1.088,'-,[1.055-1.123],IKZF1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,7:50264865
rs9297145-<b>C</b>,8 x 10-12,,0.265,1.082,'-,[1.047-1.117],"SMURF1, KPNA7",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,7:99161494
rs1734907-<b>A</b>,2 x 10-13,,0.149,1.114,'-,[1.071-1.158],"POP7, EPO",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,7:100717894
rs38904-<b>T</b>,1 x 10-8,,0.532,1.054,'-,[1.025-1.085],"ST7, MTND4P6",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,7:117252792
rs921720-<b>G</b>,8 x 10-20,,0.609,1.081,'-,[1.049-1.113],TRIB1,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,8:125522429
rs1991866-<b>G</b>,2 x 10-9,,0.422,1.054,'-,[1.024-1.084],CCDC26,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,8:129611859
rs10758669-<b>C</b>,8 x 10-45,,0.349,1.174,'-,[1.139-1.209],"JAK2, HNRNPA1P41",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,9:4981602
rs4743820-<b>T</b>,4 x 10-9,,0.702,1.056,'-,[1.023-1.089],LINC00484,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,9:91166134
rs4246905-<b>C</b>,3 x 10-32,,0.709,1.142,'-,[1.106-1.178],TNFSF15,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,9:114790969
rs10781499-<b>A</b>,4 x 10-56,,0.412,1.188,'-,[1.154-1.222],CARD9,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,9:136371953
rs12722515-<b>C</b>,4 x 10-10,,0.849,1.102,'-,[1.06-1.147],IL2RA,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,10:6039267
rs1042058-<b>C</b>,6 x 10-11,,0.592,1.075,'-,[1.044-1.106],MAP3K8,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,10:30439172
rs11010067-<b>G</b>,2 x 10-25,,0.346,1.115,'-,[1.082-1.148],"LINC02635, CUL2",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,10:35006503
rs2836878-<b>G</b>,5 x 10-48,,0.733,1.18,'-,[1.142-1.219],RPL23AP12,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,21:39093608
rs7282490-<b>G</b>,2 x 10-26,,0.391,1.105,'-,[1.072-1.138],GATD3A,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,21:44195858
rs2266959-<b>T</b>,1 x 10-16,,0.186,1.105,'-,[1.066-1.145],UBE2L3,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,22:21568615
rs2412970-<b>G</b>,3 x 10-14,,0.457,1.08,'-,[1.049-1.111],HORMAD2,Inflammatory bowel disease,inflammatory bowel disease,GCST001725,22:30090837
rs2413583-<b>C</b>,4 x 10-33,,0.833,1.209,'-,[1.163-1.257],"PDGFB, RPL3",Inflammatory bowel disease,inflammatory bowel disease,GCST001725,22:39263768
rs2412973-<b>?</b>,2 x 10-9,,0.46,1.15,'-,[1.01-1.31],HORMAD2,Inflammatory bowel disease (early onset),inflammatory bowel disease,GCST000531,22:30133642
rs8049439-<b>G</b>,2 x 10-9,,0.37,1.14,'-,[1.00-1.30],ATXN2L,Inflammatory bowel disease (early onset),inflammatory bowel disease,GCST000531,16:28826194
rs10500264-<b>?</b>,4 x 10-10,,0.18,1.21,'-,[1.11-1.31],"SLC7A10, CEBPA",Inflammatory bowel disease (early onset),inflammatory bowel disease,GCST000531,19:33259408
rs1250550-<b>?</b>,6 x 10-9,,0.68,1.16,'-,[1.09-1.25],ZMIZ1,Inflammatory bowel disease (early onset),inflammatory bowel disease,GCST000531,10:79300560
rs3774959-<b>A</b>,4 x 10-12,,0.358,1.118,'-,[1.077-1.159],NFKB1,Ulcerative colitis,ulcerative colitis,GCST001728,4:102589957
rs11739663-<b>T</b>,2 x 10-8,,0.76,1.071,'-,[1.027-1.117],"CEP72, MIR4456",Ulcerative colitis,ulcerative colitis,GCST001728,5:593968
rs254560-<b>A</b>,3 x 10-9,,0.397,1.056,'-,[1.019-1.093],C5orf66,Ulcerative colitis,ulcerative colitis,GCST001728,5:135107916
rs6927022-<b>A</b>,5 x 10-133,,0.535,1.444,'-,[1.387-1.503],HLA-DQA1,Ulcerative colitis,ulcerative colitis,GCST001728,6:32644620
rs798502-<b>A</b>,6 x 10-17,,0.709,1.127,'-,[1.084-1.171],"AMZ1, GNA12",Ulcerative colitis,ulcerative colitis,GCST001728,7:2750246
rs4722672-<b>C</b>,2 x 10-8,,0.183,1.091,'-,[1.043-1.14],"HOXA11-AS, HOXA13",Ulcerative colitis,ulcerative colitis,GCST001728,7:27192143
rs4380874-<b>T</b>,2 x 10-26,,0.405,1.137,'-,[1.097-1.177],"PIGCP2, DLD",Ulcerative colitis,ulcerative colitis,GCST001728,7:107839870
rs4728142-<b>A</b>,4 x 10-14,,0.444,1.104,'-,[1.066-1.143],"IRF5, KCP",Ulcerative colitis,ulcerative colitis,GCST001728,7:128933913
rs28374715-<b>A</b>,2 x 10-8,,0.738,1.082,'-,[1.04-1.126],CHP1,Ulcerative colitis,ulcerative colitis,GCST001728,15:41271752
rs11150589-<b>T</b>,6 x 10-10,,0.463,1.09,'-,[1.052-1.128],Y_RNA,Ulcerative colitis,ulcerative colitis,GCST001728,16:30471173
rs17229285-<b>C</b>,2 x 10-13,,0.496,1.117,'-,[1.079-1.157],PLCL1,Ulcerative colitis,ulcerative colitis,GCST001728,2:198658398
rs9847710-<b>C</b>,1 x 10-8,,0.416,1.064,'-,[1.027-1.102],SFMBT1,Ulcerative colitis,ulcerative colitis,GCST001728,3:53028645
rs483905-<b>A</b>,1 x 10-8,,0.292,1.056,'-,[1.017-1.096],MAML2,Ulcerative colitis,ulcerative colitis,GCST001728,11:96290263
rs561722-<b>C</b>,5 x 10-17,,0.663,1.12,'-,[1.079-1.163],"NXPE1, NXPE2P1",Ulcerative colitis,ulcerative colitis,GCST001728,11:114516108
rs1728785-<b>C</b>,4 x 10-8,,0.767,1.075,'-,[1.031-1.121],ZFP90,Ulcerative colitis,ulcerative colitis,GCST001728,16:68557327
rs7210086-<b>A</b>,2 x 10-9,,0.797,1.111,'-,[1.062-1.163],"LINC00511, SLC39A11",Ulcerative colitis,ulcerative colitis,GCST001728,17:72645559
rs1126510-<b>G</b>,2 x 10-9,,0.363,1.075,'-,[1.037-1.113],PTGIR,Ulcerative colitis,ulcerative colitis,GCST001728,19:46620526
rs6088765-<b>G</b>,2 x 10-8,,0.437,1.079,'-,[1.041-1.117],"MMP24OS, PROCR",Ulcerative colitis,ulcerative colitis,GCST001728,20:35211477
rs6017342-<b>C</b>,1 x 10-43,,0.53,1.228,'-,[1.185-1.273],LINC01620,Ulcerative colitis,ulcerative colitis,GCST001728,20:44436388
rs10797432-<b>C</b>,3 x 10-12,,0.522,1.078,'-,[1.041-1.116],"TNFRSF14, PRXL2B",Ulcerative colitis,ulcerative colitis,GCST001728,1:2569899
rs6426833-<b>A</b>,2 x 10-68,,0.542,1.265,'-,[1.221-1.31],"OTUD3, RNF186",Ulcerative colitis,ulcerative colitis,GCST001728,1:19845367
rs2816958-<b>G</b>,2 x 10-17,,0.887,1.23,'-,[1.161-1.302],NR5A2,Ulcerative colitis,ulcerative colitis,GCST001728,1:200132792
rs1016883-<b>G</b>,3 x 10-8,,0.817,1.1,'-,[1.051-1.15],PLCL1,Ulcerative colitis,ulcerative colitis,GCST001728,2:198016944
rs7524102-<b>A</b>,3 x 10-7,,0.83,1.1,'-,[1.00-1.21],"PPIAP34, ZBTB40",Ulcerative colitis,ulcerative colitis,GCST000527,1:22371954
rs3024493-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,IL10,Ulcerative colitis,ulcerative colitis,GCST000527,1:206770623
rs1728785-<b>G</b>,3 x 10-8,,0.76,1.17,'-,[1.07-1.27],ZFP90,Ulcerative colitis,ulcerative colitis,GCST000527,16:68557327
rs886774-<b>G</b>,3 x 10-8,,0.41,1.11,'-,[1.03-1.19],"PIGCP2, DLD",Ulcerative colitis,ulcerative colitis,GCST000527,7:107854989
rs10781500-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,"SNAPC4, CARD9",Ulcerative colitis,ulcerative colitis,GCST000527,9:136374886
rs6017342-<b>C</b>,9 x 10-17,,0.52,1.17,'-,[1.09-1.26],LINC01620,Ulcerative colitis,ulcerative colitis,GCST000527,20:44436388
rs9548988-<b>T</b>,3 x 10-7,,0.46,1.1,'-,[1.03-1.19],SNORD116,Ulcerative colitis,ulcerative colitis,GCST000527,13:39931373
rs11209026-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,IL23R,Ulcerative colitis,ulcerative colitis,GCST000527,1:67240275
rs6426833-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,"OTUD3, RNF186",Ulcerative colitis,ulcerative colitis,GCST000527,1:19845367
rs9268877-<b>?</b>,4 x 10-23,,NR,'-,'-,'-,HLA-DRB9,Ulcerative colitis,ulcerative colitis,GCST000527,6:32463370
rs7554511-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,INAVA,Ulcerative colitis,ulcerative colitis,GCST000527,1:200908434
rs9858542-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,BSN,Ulcerative colitis,ulcerative colitis,GCST000527,3:49664550
rs6584283-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,LINC01475,Ulcerative colitis,ulcerative colitis,GCST000527,10:99530544
rs2872507-<b>A</b>,5 x 10-11,,0.46,1.15,'-,[1.10-1.19],"GSDMB, ZPBP2",Ulcerative colitis,ulcerative colitis,GCST000964,17:39884510
rs1801274-<b>A</b>,2 x 10-20,,0.51,1.21,'-,[1.16-1.26],FCGR2A,Ulcerative colitis,ulcerative colitis,GCST000964,1:161509955
rs7608910-<b>G</b>,2 x 10-14,,0.39,1.19,'-,[1.14-1.24],PUS10,Ulcerative colitis,ulcerative colitis,GCST000964,2:60977721
rs35675666-<b>G</b>,5 x 10-9,,0.83,1.08,'-,[1.02-1.15],PARK7,Ulcerative colitis,ulcerative colitis,GCST000964,1:7961913
rs7524102-<b>A</b>,2 x 10-13,,0.83,1.1,'-,[1.05-1.16],"PPIAP34, ZBTB40",Ulcerative colitis,ulcerative colitis,GCST000964,1:22371954
rs4676406-<b>T</b>,8 x 10-11,,0.52,1.14,'-,[1.09-1.18],"AQP12B, GPR35",Ulcerative colitis,ulcerative colitis,GCST000964,2:240639691
rs9822268-<b>A</b>,2 x 10-17,,0.3,1.21,'-,[1.16-1.26],APEH,Ulcerative colitis,ulcerative colitis,GCST000964,3:49682296
rs17388568-<b>A</b>,9 x 10-7,,0.27,1.12,'-,[1.07-1.17],ADAD1,Ulcerative colitis,ulcerative colitis,GCST000964,4:122408207
rs11209026-<b>G</b>,5 x 10-28,,0.94,1.74,'-,[1.57-1.92],IL23R,Ulcerative colitis,ulcerative colitis,GCST000964,1:67240275
rs4728142-<b>A</b>,2 x 10-8,,0.44,1.07,'-,[1.03-1.11],"IRF5, KCP",Ulcerative colitis,ulcerative colitis,GCST000964,7:128933913
rs6584283-<b>T</b>,8 x 10-21,,0.47,1.21,'-,[1.16-1.26],LINC01475,Ulcerative colitis,ulcerative colitis,GCST000964,10:99530544
rs10781499-<b>A</b>,3 x 10-19,,0.41,1.12,'-,[1.08-1.17],CARD9,Ulcerative colitis,ulcerative colitis,GCST000964,9:136371953
rs734999-<b>C</b>,3 x 10-9,,0.52,1.05,'-,[1.01-1.09],"PRXL2B, TNFRSF14",Ulcerative colitis,ulcerative colitis,GCST000964,1:2581777
rs941823-<b>C</b>,4 x 10-12,,0.76,1.12,'-,[1.07-1.17],LINC00598,Ulcerative colitis,ulcerative colitis,GCST000964,13:40439840
rs267939-<b>C</b>,6 x 10-12,,0.37,1.1,'-,[1.06-1.15],DAP,Ulcerative colitis,ulcerative colitis,GCST000964,5:10752203
rs3194051-<b>G</b>,4 x 10-8,,0.27,1.07,'-,[1.02-1.12],IL7R,Ulcerative colitis,ulcerative colitis,GCST000964,5:35876172
rs6871626-<b>A</b>,1 x 10-21,,0.33,1.17,'-,[1.12-1.22],"IL12B, LINC01845",Ulcerative colitis,ulcerative colitis,GCST000964,5:159399784
rs6911490-<b>T</b>,1 x 10-8,,0.21,1.08,'-,[1.03-1.13],"PRDM1, ATG5",Ulcerative colitis,ulcerative colitis,GCST000964,6:106074152
rs12261843-<b>G</b>,7 x 10-10,,0.29,1.07,'-,[1.03-1.12],CCNY,Ulcerative colitis,ulcerative colitis,GCST000964,10:35265126
rs16940202-<b>C</b>,6 x 10-19,,0.18,1.15,'-,[1.10-1.21],LINC02132,Ulcerative colitis,ulcerative colitis,GCST000964,16:85980635
rs3024505-<b>A</b>,6 x 10-17,,0.16,1.25,'-,[1.19-1.32],"IL10, Y_RNA",Ulcerative colitis,ulcerative colitis,GCST000964,1:206766559
rs1297265-<b>A</b>,7 x 10-13,,0.56,1.11,'-,[1.06-1.15],CYCSP42,Ulcerative colitis,ulcerative colitis,GCST000964,21:15444732
rs17085007-<b>C</b>,1 x 10-16,,0.18,1.16,'-,[1.10-1.21],"FGFR1OP2P1, RPS21P8",Ulcerative colitis,ulcerative colitis,GCST000964,13:26957130
rs2297441-<b>A</b>,2 x 10-10,,0.77,1.09,'-,[1.04-1.15],"RTEL1-TNFRSF6B, RTEL1",Ulcerative colitis,ulcerative colitis,GCST000964,20:63696229
rs2838519-<b>G</b>,6 x 10-11,,0.39,1.14,'-,[1.05-1.22],GATD3A,Ulcerative colitis,ulcerative colitis,GCST000964,21:44195140
rs6499188-<b>A</b>,4 x 10-8,,0.75,1.14,'-,[1.09-1.20],CDH3,Ulcerative colitis,ulcerative colitis,GCST000964,16:68640885
rs6426833-<b>A</b>,4 x 10-35,,0.54,1.3,'-,[1.25-1.35],"OTUD3, RNF186",Ulcerative colitis,ulcerative colitis,GCST000964,1:19845367
rs6017342-<b>C</b>,1 x 10-20,,0.54,1.2,'-,[1.15-1.26],LINC01620,Ulcerative colitis,ulcerative colitis,GCST000964,20:44436388
rs2836878-<b>G</b>,2 x 10-22,,0.74,1.25,'-,[1.20-1.32],RPL23AP12,Ulcerative colitis,ulcerative colitis,GCST000964,21:39093608
rs5771069-<b>G</b>,2 x 10-7,,0.51,1.11,'-,[1.07-1.16],IL17REL,Ulcerative colitis,ulcerative colitis,GCST000964,22:49997051
rs9268853-<b>T</b>,1 x 10-55,,0.66,1.4,'-,[1.34-1.47],HLA-DRB9,Ulcerative colitis,ulcerative colitis,GCST000964,6:32461866
rs2310173-<b>T</b>,3 x 10-12,,0.46,1.09,'-,[1.05-1.14],"IL1R2, IL1R1",Ulcerative colitis,ulcerative colitis,GCST000964,2:102047167
rs254560-<b>A</b>,1 x 10-9,,0.4,1.07,'-,[1.03-1.12],C5orf66,Ulcerative colitis,ulcerative colitis,GCST000964,5:135107916
rs4246905-<b>C</b>,6 x 10-12,,0.71,1.1,'-,[1.05-1.15],TNFSF15,Ulcerative colitis,ulcerative colitis,GCST000964,9:114790969
rs798502-<b>A</b>,3 x 10-15,,0.71,1.13,'-,[1.08-1.18],"AMZ1, GNA12",Ulcerative colitis,ulcerative colitis,GCST000964,7:2750246
rs11739663-<b>T</b>,3 x 10-8,,0.77,1.15,'-,[1.09-1.21],"CEP72, MIR4456",Ulcerative colitis,ulcerative colitis,GCST000964,5:593968
rs4510766-<b>A</b>,2 x 10-16,,0.56,1.2,'-,[1.15-1.26],"PIGCP2, DLD",Ulcerative colitis,ulcerative colitis,GCST000964,7:107852344
rs10758669-<b>C</b>,2 x 10-25,,0.35,1.17,'-,[1.12-1.21],"JAK2, HNRNPA1P41",Ulcerative colitis,ulcerative colitis,GCST000964,9:4981602
rs7134599-<b>A</b>,1 x 10-16,,0.39,1.19,'-,[1.19-1.24],IFNG-AS1,Ulcerative colitis,ulcerative colitis,GCST000964,12:68106295
rs2155219-<b>T</b>,5 x 10-16,,0.5,1.13,'-,[1.08-1.17],"EMSY, LINC02757",Ulcerative colitis,ulcerative colitis,GCST000964,11:76588150
rs11676348-<b>T</b>,1 x 10-10,,0.49,1.07,'-,[1.03-1.11],"CXCR1, CXCR2",Ulcerative colitis,ulcerative colitis,GCST000964,2:218145423
rs7554511-<b>C</b>,2 x 10-13,,0.72,1.19,'-,[1.14-1.25],INAVA,Ulcerative colitis,ulcerative colitis,GCST000964,1:200908434
rs6451493-<b>T</b>,3 x 10-9,,0.61,1.08,'-,[1.04-1.12],'-,Ulcerative colitis,ulcerative colitis,GCST000964,5:40410833
rs943072-<b>G</b>,2 x 10-10,,0.09,1.15,'-,[1.08-1.23],"VEGFA, LINC02537",Ulcerative colitis,ulcerative colitis,GCST000964,6:43828231
rs6920220-<b>A</b>,8 x 10-17,,0.21,1.14,'-,[1.09-1.20],LINC02539,Ulcerative colitis,ulcerative colitis,GCST000964,6:137685367
rs678170-<b>A</b>,5 x 10-14,,0.66,1.09,'-,[1.05-1.14],"NXPE1, NXPE4",Ulcerative colitis,ulcerative colitis,GCST000964,11:114561234
rs907611-<b>A</b>,1 x 10-10,,0.32,1.08,'-,[1.03-1.13],LSP1,Ulcerative colitis,ulcerative colitis,GCST000964,11:1852842
rs59825600-<b>A</b>,4 x 10-8,,0.0905,'-,0.0751 unit decrease,[0.048-0.102],KAZN,Urinary albumin-to-creatinine ratio in diabetes,"diabetes mellitus, urinary albumin to creatinine ratio",GCST008792,1:14806568
rs6688849-<b>A</b>,4 x 10-9,,0.8195,'-,0.0485 unit decrease,[0.032-0.065],"ATP6V0E1P4, RPL21P24",Urinary albumin-to-creatinine ratio in diabetes,"diabetes mellitus, urinary albumin to creatinine ratio",GCST008792,1:47530532
rs780093-<b>T</b>,1 x 10-13,,0.373,'-,0.0485 unit increase,[0.036-0.061],GCKR,Urinary albumin-to-creatinine ratio in diabetes,"diabetes mellitus, urinary albumin to creatinine ratio",GCST008792,2:27519736
rs6706313-<b>A</b>,3 x 10-8,,0.7416,'-,0.0408 unit decrease,[0.026-0.055],MIR4432HG,Urinary albumin-to-creatinine ratio in diabetes,"diabetes mellitus, urinary albumin to creatinine ratio",GCST008792,2:60311754
rs17137004-<b>A</b>,3 x 10-8,,0.6176,'-,0.0364 unit decrease,[0.024-0.049],FOXP2,Urinary albumin-to-creatinine ratio in diabetes,"diabetes mellitus, urinary albumin to creatinine ratio",GCST008792,7:114389196
rs74375025-<b>A</b>,1 x 10-24,,0.1071,'-,0.1064 unit increase,[0.086-0.127],CUBN,Urinary albumin-to-creatinine ratio in diabetes,"diabetes mellitus, urinary albumin to creatinine ratio",GCST008792,10:16905665
rs4258701-<b>T</b>,1 x 10-8,,0.3272,'-,0.0385 unit increase,[0.025-0.052],CDH2,Urinary albumin-to-creatinine ratio in diabetes,"diabetes mellitus, urinary albumin to creatinine ratio",GCST008792,18:27895834
rs149131600-<b>T</b>,3 x 10-8,,0.1614,'-,0.0501 unit increase,[0.032-0.068],"HPN-AS1, HPN",Urinary albumin-to-creatinine ratio in diabetes,"diabetes mellitus, urinary albumin to creatinine ratio",GCST008792,19:35058218
rs12917707-<b>T</b>,2 x 10-8,,NR,'-,0.0266 unit increase,[NR],"PDILT, UMOD",Glomerular filtration rate in diabetics (creatinine),"creatinine measurement, glomerular filtration rate, diabetes mellitus",GCST003373,16:20356368
rs6051080-<b>A</b>,1 x 10-7,(same direction),0.649,1.12,'-,[1.08-1.17],FAM182A,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,20:25995038
rs11085466-<b>G</b>,2 x 10-7,(same direction),0.782,1.15,'-,[1.09-1.22],ZNF429,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,19:21569009
rs17503919-<b>A</b>,2 x 10-7,(same direction),0.862,1.17,'-,[1.11-1.25],RNGTT,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,6:88856018
rs76225372-<b>A</b>,2 x 10-7,(same direction),0.912,1.21,'-,[1.13-1.31],MALRD1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,10:19031157
rs7740797-<b>G</b>,2 x 10-7,(same direction),0.513,1.12,'-,[1.07-1.16],SCAF8,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,6:154800125
rs3181245-<b>C</b>,2 x 10-7,(same direction),0.514,1.12,'-,[1.07-1.16],TDP2,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,6:24651092
rs9901225-<b>T</b>,1 x 10-6,(same direction),0.55,1.11,'-,[1.06-1.16],RETREG3,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,17:42603793
rs2052678-<b>?</b>,1 x 10-7,(same direction),0.139,1.1627907,'-,[1.1-1.23],TMTC1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,12:29680396
rs34462569-<b>G</b>,4 x 10-6,(opposite direction),0.934,1.22,'-,[1.12-1.33],"GALNT3, CSRNP3",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,2:165696408
rs4727012-<b>C</b>,1 x 10-6,(opposite direction),0.891,1.18,'-,[1.10-1.26],"RNU6-650P, COX6B1P1",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,7:149043401
rs112541862-<b>A</b>,4 x 10-6,(opposite direction),0.962,1.3,'-,[1.16-1.45],"AOPEP, FBP1",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,9:94720876
rs606460-<b>G</b>,4 x 10-6,(opposite direction),0.725,1.11,'-,[1.06-1.17],"SERPINH1, GDPD5",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,11:75537412
rs11607499-<b>T</b>,2 x 10-6,(opposite direction),0.954,1.27,'-,[1.15-1.40],MIR4300HG,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,11:82100187
rs12817211-<b>C</b>,3 x 10-6,(opposite direction),0.767,1.12,'-,[1.07-1.18],LIMA1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,12:50185615
rs11150038-<b>G</b>,1 x 10-6,(opposite direction),0.944,1.27,'-,[1.15-1.39],CLEC3A,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,16:78042662
rs4816890-<b>?</b>,2 x 10-6,(opposite direction),0.363,1.1111112,'-,[1.06-1.16],MIR6130,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003209,21:23048180
rs10457678-<b>A</b>,4 x 10-7,(same direction),0.773,1.1,'-,[1.06-1.14],ECT2L,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,6:138801103
rs17035310-<b>C</b>,6 x 10-7,(same direction),0.876,1.13,'-,[1.08-1.18],TET2,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,4:105143597
rs3184504-<b>C</b>,8 x 10-9,(same direction),0.52,1.1,'-,[1.06-1.13],"SH2B3, ATXN2",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,12:111446804
rs1512436-<b>?</b>,1 x 10-6,(same direction),0.447,1.0752687,'-,[1.05-1.11],'-,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,11:106436144
rs10217586-<b>?</b>,2 x 10-6,(same direction),0.461,1.0752687,'-,[1.04-1.11],CDKN2B-AS1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,9:22121350
rs4853036-<b>?</b>,6 x 10-6,(same direction),0.264,1.0869565,'-,[1.05-1.12],GMCL1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,2:69832692
rs4789378-<b>?</b>,9 x 10-6,(same direction),0.352,1.0752687,'-,[1.04-1.11],MGAT5B,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,17:76934284
rs12446552-<b>?</b>,3 x 10-6,(same direction),0.277,1.0869565,'-,[1.05-1.12],LITAF,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,16:11626210
rs4378954-<b>C</b>,4 x 10-7,(same direction),0.898,1.15,'-,[1.09-1.21],LSAMP,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,3:115931601
rs77922938-<b>?</b>,8 x 10-6,(opposite direction),0.047,1.1764705,'-,[1.1-1.27],'-,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,9:108297916
rs1952157-<b>C</b>,6 x 10-6,(opposite direction),0.69,1.08,'-,[1.05-1.12],NPAS3,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,14:33820232
rs76525880-<b>A</b>,7 x 10-6,(opposite direction),0.929,1.16,'-,[1.09-1.24],"HOXB1, HOXB2",Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,17:48536888
rs12970291-<b>T</b>,5 x 10-8,(opposite direction),0.965,1.27,'-,[1.16-1.38],TSHZ1,Colorectal or endometrial cancer,"colorectal cancer, endometrial neoplasm",GCST003208,18:75305279
rs3536032-<b>A</b>,2 x 10-8,(EA),0.16,1.14,'-,[1.09–1.19],'-,Colorectal cancer,colorectal cancer,GCST003017,3:40883471
rs812481-<b>G</b>,3 x 10-8,(EA),0.58,1.09,'-,[1.05–1.12],LRIG1,Colorectal cancer,colorectal cancer,GCST003017,3:66392011
rs73208120-<b>G</b>,3 x 10-8,(EA),0.11,1.16,'-,[1.11–1.23],NOS1,Colorectal cancer,colorectal cancer,GCST003017,12:117309785
rs11190164-<b>G</b>,8 x 10-7,(EA),0.29,1.1,'-,[1.05–1.14],"SLC25A28, NKX2-3",Colorectal cancer,colorectal cancer,GCST003017,10:99591947
rs3184504-<b>C</b>,2 x 10-8,(EA),0.53,1.09,'-,[1.06–1.12],"SH2B3, ATXN2",Colorectal cancer,colorectal cancer,GCST003017,12:111446804
rs4946260-<b>T</b>,5 x 10-7,(EA),0.53,1.08,'-,[1.05–1.11],DCBLD1,Colorectal cancer,colorectal cancer,GCST003017,6:117501830
rs35360328-<b>A</b>,3 x 10-9,,0.16,1.14,'-,[1.09-1.19],'-,Colorectal cancer,colorectal cancer,GCST003017,3:40883471
rs812481-<b>G</b>,2 x 10-8,,0.58,1.09,'-,[1.05-1.11],LRIG1,Colorectal cancer,colorectal cancer,GCST003017,3:66392011
rs11190164-<b>G</b>,4 x 10-8,,0.29,1.09,'-,[1.06-1.12],"SLC25A28, NKX2-3",Colorectal cancer,colorectal cancer,GCST003017,10:99591947
rs3184504-<b>C</b>,2 x 10-8,,0.53,1.09,'-,[1.06-1.12],"SH2B3, ATXN2",Colorectal cancer,colorectal cancer,GCST003017,12:111446804
rs73208120-<b>G</b>,3 x 10-8,,0.11,1.16,'-,[1.11-1.23],NOS1,Colorectal cancer,colorectal cancer,GCST003017,12:117309785
rs6066825-<b>A</b>,4 x 10-9,,0.64,1.09,'-,[1.06-1.12],PREX1,Colorectal cancer,colorectal cancer,GCST003017,20:48723580
rs4946260-<b>T</b>,6 x 10-8,,0.53,1.07,'-,[1.05-1.10],DCBLD1,Colorectal cancer,colorectal cancer,GCST003017,6:117501830
rs16892766-<b>C</b>,3 x 10-12,,0.1,1.2048193,'-,[1.15-1.26],EIF3H,Colorectal cancer,colorectal cancer,GCST003017,8:116618444
rs6983267-<b>G</b>,4 x 10-14,,0.5,1.1235955,'-,[1.09-1.15],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST003017,8:127401060
rs3824999-<b>G</b>,1 x 10-6,,0.53,1.0752687,'-,[1.05-1.1],POLD3,Colorectal cancer,colorectal cancer,GCST003017,11:74634505
rs3802842-<b>C</b>,1 x 10-10,,0.28,1.1235955,'-,[1.09-1.16],"COLCA1, COLCA2",Colorectal cancer,colorectal cancer,GCST003017,11:111300984
rs3217901-<b>G</b>,2 x 10-6,,0.41,1.0869565,'-,[1.05-1.12],CCND2,Colorectal cancer,colorectal cancer,GCST003017,12:4296223
rs4444235-<b>C</b>,5 x 10-8,,0.49,1.0869565,'-,[1.06-1.12],"LINC02331, MIR5580",Colorectal cancer,colorectal cancer,GCST003017,14:53944201
rs4779584-<b>T</b>,1 x 10-8,,0.81,1.12,'-,[1.08-1.16],"SCG5, GREM1",Colorectal cancer,colorectal cancer,GCST003017,15:32702555
rs4939827-<b>T</b>,2 x 10-15,,0.54,1.13,'-,[1.1-1.16],SMAD7,Colorectal cancer,colorectal cancer,GCST003017,18:48927093
rs961253-<b>A</b>,1 x 10-7,,0.37,1.09,'-,[1.06-1.12],CASC20,Colorectal cancer,colorectal cancer,GCST003017,20:6423634
rs12022676-<b>A</b>,1 x 10-10,,0.281894585,1.1319561,'-,[1.090259108-1.175247727],"LINC02474, LINC02257",Colorectal cancer,colorectal cancer,GCST90013697,1:221972743
rs12241008-<b>C</b>,3 x 10-11,,0.252938392,1.1408169,'-,[1.097285168-1.186075571],VTI1A,Colorectal cancer,colorectal cancer,GCST90013697,10:112520943
rs704017-<b>G</b>,1 x 10-9,,0.344166543,1.1166658,'-,[1.077679122-1.157062862],ZMIZ1-AS1,Colorectal cancer,colorectal cancer,GCST90013697,10:79059375
rs9733843-<b>G</b>,1 x 10-14,,0.383615307,0.8701625,'-,[0.840056322-0.901347604],RNA5SP299,Colorectal cancer,colorectal cancer,GCST90013697,10:8676041
rs140989504-<b>T</b>,2 x 10-8,,0.028748356,1.3655896,'-,[1.224448851-1.522999458],RN7SL222P,Colorectal cancer,colorectal cancer,GCST90013697,11:100568503
rs11066015-<b>A</b>,1 x 10-13,,0.239580915,0.86299574,'-,[0.82991439-0.897395817],ACAD10,Colorectal cancer,colorectal cancer,GCST90013697,12:111730205
rs11874392-<b>T</b>,2 x 10-20,,0.656781841,0.8433536,'-,[0.81344516-0.874361716],SMAD7,Colorectal cancer,colorectal cancer,GCST90013697,18:48926786
rs6140071-<b>T</b>,2 x 10-9,,0.201635225,1.1400142,'-,[1.09254882-1.189541761],LINC01713,Colorectal cancer,colorectal cancer,GCST90013697,20:6725846
rs2049942-<b>G</b>,1 x 10-9,,0.672765772,0.8929148,'-,[0.861041474-0.925967892],HAO1,Colorectal cancer,colorectal cancer,GCST90013697,20:7864739
rs7722513-<b>G</b>,1 x 10-13,,0.71600577,0.86136234,'-,[0.82802136-0.896045818],C5orf66,Colorectal cancer,colorectal cancer,GCST90013697,5:135128376
rs2437841-<b>A</b>,2 x 10-8,,0.460497819,0.90708834,'-,[0.876599941-0.938637177],EIF3H,Colorectal cancer,colorectal cancer,GCST90013697,8:116607873
rs4871022-<b>T</b>,1 x 10-24,,0.681929434,0.8269473,'-,[0.797418023-0.857570068],"CASC8, POU5F1B, PCAT1",Colorectal cancer,colorectal cancer,GCST90013697,8:127415475
rs10811654-<b>G</b>,4 x 10-9,,0.47237368,0.9026533,'-,[0.872332719-0.934027684],CDKN2B-AS1,Colorectal cancer,colorectal cancer,GCST90013697,9:22092925
rs7068313-<b>T</b>,7 x 10-10,,NR,1.1248943,'-,[1.08363385941129-1.16772565013563],TCF7L2,Colorectal cancer,colorectal cancer,GCST90013697,10:112966167
rs1321311-<b>?</b>,1 x 10-10,,NR,1.1,'-,[1.07-1.13],"Y_RNA, RNU1-88P",Colorectal cancer,colorectal cancer,GCST001544,6:36655123
rs3824999-<b>?</b>,4 x 10-10,,NR,1.08,'-,[1.05-1.10],POLD3,Colorectal cancer,colorectal cancer,GCST001544,11:74634505
rs5934683-<b>?</b>,7 x 10-10,,NR,1.07,'-,[1.04-1.10],GPR143,Colorectal cancer,colorectal cancer,GCST001544,X:9783434
rs6983267-<b>?</b>,7 x 10-11,,0.48,1.24,'-,[1.17-1.33],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST000169,8:127401060
rs16892766-<b>A</b>,3 x 10-18,,0.07,1.27,'-,[1.20-1.34],EIF3H,Colorectal cancer,colorectal cancer,GCST000169,8:116618444
rs4939827-<b>?</b>,2 x 10-6,,0.53,1.18,'-,[1.10-1.25],SMAD7,Colorectal cancer,colorectal cancer,GCST000169,18:48927093
rs4779584-<b>?</b>,5 x 10-7,,0.19,1.23,'-,[1.14-1.34],"SCG5, GREM1",Colorectal cancer,colorectal cancer,GCST000169,15:32702555
rs10795668-<b>A</b>,3 x 10-13,,0.67,1.12,'-,[1.10-1.16],RNA5SP299,Colorectal cancer,colorectal cancer,GCST000169,10:8659256
rs6983267-<b>G</b>,1 x 10-11,,0.5,1.13,'-,[1.09-1.18],"PCAT1, CCAT2, CASC8, POU5F1B",Colorectal cancer,colorectal cancer,GCST001787,8:127401060
rs3802842-<b>?</b>,4 x 10-7,,0.29,1.11,'-,[1.06-1.15],"COLCA1, COLCA2",Colorectal cancer,colorectal cancer,GCST001787,11:111300984
rs4779584-<b>?</b>,5 x 10-7,,0.18,1.12,'-,[1.08-1.19],"SCG5, GREM1",Colorectal cancer,colorectal cancer,GCST001787,15:32702555
rs4939827-<b>?</b>,2 x 10-10,,0.52,1.12,'-,[1.09-1.16],SMAD7,Colorectal cancer,colorectal cancer,GCST001787,18:48927093
rs4813802-<b>G</b>,7 x 10-6,,0.34,1.1,'-,[1.05-1.14],LINC01713,Colorectal cancer,colorectal cancer,GCST001787,20:6718948
rs11903757-<b>C</b>,4 x 10-8,,0.16,1.16,'-,[1.10-1.22],NABP1,Colorectal cancer,colorectal cancer,GCST001787,2:191722478
rs10911251-<b>A</b>,9 x 10-8,,0.57,1.09,'-,[1.06-1.13],LAMC1,Colorectal cancer,colorectal cancer,GCST001787,1:183112059
rs3217810-<b>T</b>,6 x 10-8,,0.16,1.2,'-,[1.12-1.28],CCND2,Colorectal cancer,colorectal cancer,GCST001787,12:4279105
rs3217901-<b>G</b>,3 x 10-7,,0.41,1.1,'-,[1.06-1.14],CCND2,Colorectal cancer,colorectal cancer,GCST001787,12:4296223
rs59336-<b>T</b>,4 x 10-7,,0.48,1.09,'-,[1.06-1.13],TBX3,Colorectal cancer,colorectal cancer,GCST001787,12:114678547
rs1912453-<b>?</b>,9 x 10-6,,0.41,1.07,'-,[1.04-1.11],CCDC190,Colorectal cancer,colorectal cancer,GCST001787,1:162851501
rs13130787-<b>?</b>,3 x 10-7,,0.43,1.09,'-,[1.06-1.13],'-,Colorectal cancer,colorectal cancer,GCST001787,4:93965880
rs2057314-<b>?</b>,3 x 10-6,,0.5,1.08,'-,[1.04-1.11],DCBLD1,Colorectal cancer,colorectal cancer,GCST001787,6:117498194
rs2128382-<b>?</b>,8 x 10-6,,0.82,1.11,'-,[1.06-1.16],"CYRIB, GSDMC",Colorectal cancer,colorectal cancer,GCST001787,8:129807793
rs17094983-<b>?</b>,3 x 10-6,,0.13,1.13,'-,[1.08-1.20],LINC01500,Colorectal cancer,colorectal cancer,GCST001787,14:58722643
rs116216059-<b>A</b>,1 x 10-8,,0.016,8.73,'-,[NR],STAC,Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes,"type I diabetes mellitus, diabetic nephropathy",GCST009280,3:36524820
rs212388-<b>C</b>,3 x 10-14,,0.41,1.105,'-,[1.069-1.141],TAGAP-AS1,Crohn's disease,Crohn's disease,GCST001729,6:159069404
rs13126505-<b>A</b>,2 x 10-12,,0.096,1.172,'-,[1.10-1.248],BANK1,Crohn's disease,Crohn's disease,GCST001729,4:101944147
rs10865331-<b>A</b>,1 x 10-9,,0.396,1.098,'-,[1.062-1.134],RN7SL51P,Crohn's disease,Crohn's disease,GCST001729,2:62324337
rs10065637-<b>C</b>,4 x 10-12,,0.773,1.123,'-,[1.079-1.17],ANKRD55,Crohn's disease,Crohn's disease,GCST001729,5:56143024
rs1728918-<b>A</b>,5 x 10-16,,0.299,1.123,'-,[1.086-1.16],"PPM1G, NRBP1",Crohn's disease,Crohn's disease,GCST001729,2:27412596
rs12663356-<b>C</b>,4 x 10-12,,0.533,1.095,'-,[1.06-1.131],LINC00581,Crohn's disease,Crohn's disease,GCST001729,6:21430497
rs6716753-<b>C</b>,1 x 10-16,,0.196,1.134,'-,[1.089-1.18],SP140,Crohn's disease,Crohn's disease,GCST001729,2:230232414
rs12994997-<b>A</b>,4 x 10-70,,0.523,1.233,'-,[1.193-1.274],ATG16L1,Crohn's disease,Crohn's disease,GCST001729,2:233264857
rs6837335-<b>G</b>,2 x 10-8,,0.647,1.086,'-,[1.049-1.123],SLAIN2,Crohn's disease,Crohn's disease,GCST001729,4:48361966
rs10486483-<b>A</b>,3 x 10-8,,0.247,1.089,'-,[1.048-1.13],SKAP2,Crohn's disease,Crohn's disease,GCST001729,7:26852821
rs6679677-<b>C</b>,2 x 10-15,,0.907,1.196,'-,[1.129-1.268],"RSBN1, PHTF1",Crohn's disease,Crohn's disease,GCST001729,1:113761186
rs3897478-<b>T</b>,2 x 10-11,,0.891,1.161,'-,[1.101-1.224],"NOTCH2, ADAM30",Crohn's disease,Crohn's disease,GCST001729,1:119908567
rs9286879-<b>G</b>,6 x 10-22,,0.249,1.125,'-,[1.083-1.167],AIMP1P2,Crohn's disease,Crohn's disease,GCST001729,1:172893094
rs864745-<b>T</b>,4 x 10-9,,0.497,1.087,'-,[1.052-1.123],JAZF1,Crohn's disease,Crohn's disease,GCST001729,7:28140937
rs7015630-<b>T</b>,1 x 10-8,,0.739,1.075,'-,[1.035-1.116],"RNU6-925P, COX6B1P6",Crohn's disease,Crohn's disease,GCST001729,8:89863690
rs6651252-<b>T</b>,1 x 10-16,,0.865,1.185,'-,[1.128-1.246],LINC00824,Crohn's disease,Crohn's disease,GCST001729,8:128554935
rs3764147-<b>G</b>,2 x 10-21,,0.248,1.155,'-,[1.112-1.199],LACC1,Crohn's disease,Crohn's disease,GCST001729,13:43883789
rs16967103-<b>C</b>,4 x 10-9,,0.203,1.088,'-,[1.045-1.132],"RASGRP1, LINC02694",Crohn's disease,Crohn's disease,GCST001729,15:38606989
rs2066847-<b>T</b>,6 x 10-209,,0.024,3.103,'-,[1.497-1.618],"CYLD-AS1, NOD2",Crohn's disease,Crohn's disease,GCST001729,16:50729868
rs2945412-<b>A</b>,9 x 10-17,,0.587,1.137,'-,[1.10-1.175],KSR1,Crohn's disease,Crohn's disease,GCST001729,17:27516617
rs2024092-<b>A</b>,8 x 10-22,,0.215,1.156,'-,[1.112-1.201],SBNO2,Crohn's disease,Crohn's disease,GCST001729,19:1124032
rs4802307-<b>G</b>,2 x 10-10,,0.706,1.099,'-,[1.06-1.139],"PPP5C, HIF3A",Crohn's disease,Crohn's disease,GCST001729,19:46346549
rs516246-<b>T</b>,1 x 10-15,,0.483,1.107,'-,[1.071-1.143],FUT2,Crohn's disease,Crohn's disease,GCST001729,19:48702915
rs2284553-<b>G</b>,2 x 10-16,,0.599,1.123,'-,[1.086-1.162],IFNGR2,Crohn's disease,Crohn's disease,GCST001729,21:33404389
rs17391694-<b>C</b>,3 x 10-9,,0.889,1.134,'-,[1.077-1.194],"GIPC2, RNFT1P2",Crohn's disease,Crohn's disease,GCST001729,1:78157942
rs9491697-<b>G</b>,4 x 10-10,,0.439,1.077,'-,[1.042-1.112],RSPO3,Crohn's disease,Crohn's disease,GCST001729,6:127134977
rs13204742-<b>T</b>,8 x 10-15,,0.124,1.173,'-,[1.118-1.23],"THEMIS, PTPRK",Crohn's disease,Crohn's disease,GCST001729,6:127924620
rs7702331-<b>A</b>,6 x 10-10,,0.621,1.088,'-,[1.05-1.126],"LINC02230, TMEM174",Crohn's disease,Crohn's disease,GCST001729,5:73255307
rs17695092-<b>T</b>,5 x 10-9,,0.703,1.095,'-,[1.055-1.136],CPEB4,Crohn's disease,Crohn's disease,GCST001729,5:173910850
rs9264942-<b>C</b>,5 x 10-28,,0.378,1.145,'-,[1.107-1.184],"LINC02571, HLA-B",Crohn's disease,Crohn's disease,GCST001729,6:31306603
rs3764147-<b>G</b>,1 x 10-10,,0.245,1.17,'-,[1.12-1.23],LACC1,Crohn's disease,Crohn's disease,GCST000879,13:43883789
rs151181-<b>G</b>,2 x 10-11,,0.386,1.07,'-,[1.03-1.12],CLN3,Crohn's disease,Crohn's disease,GCST000879,16:28479196
rs1250550-<b>G</b>,1 x 10-30,,0.669,1.19,'-,[1.15-1.23],ZMIZ1,Crohn's disease,Crohn's disease,GCST000879,10:79300560
rs4902642-<b>G</b>,2 x 10-10,,0.584,1.07,'-,[1.11-1.04],"ZFP36L1, RNU6-921P",Crohn's disease,Crohn's disease,GCST000879,14:68743482
rs181359-<b>T</b>,5 x 10-16,,0.203,1.1,'-,[1.06-1.15],UBE2L3,Crohn's disease,Crohn's disease,GCST000879,22:21574352
rs6556412-<b>A</b>,5 x 10-14,,0.332,1.18,'-,[1.13-1.24],"LINC01845, IL12B",Crohn's disease,Crohn's disease,GCST000879,5:159360377
rs2797685-<b>A</b>,7 x 10-9,,0.19,1.05,'-,[1.01-1.10],PER3,Crohn's disease,Crohn's disease,GCST000879,1:7819003
rs7517810-<b>T</b>,2 x 10-15,,0.246,1.22,'-,[1.16-1.28],AIMP1P2,Crohn's disease,Crohn's disease,GCST000879,1:172884320
rs3810936-<b>C</b>,1 x 10-15,,0.682,1.21,'-,[1.15-1.27],TNFSF15,Crohn's disease,Crohn's disease,GCST000879,9:114790605
rs2062305-<b>G</b>,5 x 10-10,,0.346,1.1,'-,[1.05-1.15],LINC02341,Crohn's disease,Crohn's disease,GCST000879,13:42478744
rs10495903-<b>T</b>,2 x 10-14,,0.129,1.14,'-,[1.09-1.20],THADA,Crohn's disease,Crohn's disease,GCST000879,2:43579779
rs2872507-<b>A</b>,2 x 10-9,,0.458,1.14,'-,[1.09-1.19],"GSDMB, ZPBP2",Crohn's disease,Crohn's disease,GCST000879,17:39884510
rs17293632-<b>T</b>,3 x 10-19,,0.233,1.12,'-,[1.07-1.16],SMAD3,Crohn's disease,Crohn's disease,GCST000879,15:67150258
rs780093-<b>T</b>,5 x 10-11,,0.418,1.15,'-,[1.10-1.21],GCKR,Crohn's disease,Crohn's disease,GCST000879,2:27519736
rs8005161-<b>T</b>,4 x 10-18,,0.119,1.23,'-,[1.16-1.31],GPR65,Crohn's disease,Crohn's disease,GCST000879,14:88006251
rs4809330-<b>G</b>,3 x 10-15,,0.709,1.12,'-,[1.06-1.18],ZGPAT,Crohn's disease,Crohn's disease,GCST000879,20:63718234
rs11564258-<b>A</b>,6 x 10-21,,0.025,1.74,'-,[1.55-1.95],MUC19,Crohn's disease,Crohn's disease,GCST000879,12:40398498
rs713875-<b>C</b>,7 x 10-12,,0.471,1.08,'-,[1.04-1.13],"LIF-AS1, HORMAD2",Crohn's disease,Crohn's disease,GCST000879,22:30196498
rs2549794-<b>C</b>,1 x 10-10,,0.409,1.05,'-,[1.02-1.09],ERAP2,Crohn's disease,Crohn's disease,GCST000879,5:96908845
rs11871801-<b>A</b>,3 x 10-8,,0.756,1.15,'-,[1.10-1.21],CAVIN1,Crohn's disease,Crohn's disease,GCST000879,17:42418754
rs2413583-<b>C</b>,1 x 10-26,,0.83,1.23,'-,[1.17-1.29],"PDGFB, RPL3",Crohn's disease,Crohn's disease,GCST000879,22:39263768
rs1799964-<b>C</b>,4 x 10-11,,0.209,1.19,'-,[1.13-1.25],"TNF, LTA",Crohn's disease,Crohn's disease,GCST000879,6:31574531
rs10758669-<b>C</b>,1 x 10-13,,0.349,1.18,'-,[1.13-1.23],"JAK2, HNRNPA1P41",Crohn's disease,Crohn's disease,GCST000879,9:4981602
rs7714584-<b>G</b>,8 x 10-19,,0.088,1.37,'-,[1.28-1.47],IRGM,Crohn's disease,Crohn's disease,GCST000879,5:150890858
rs12722489-<b>C</b>,3 x 10-9,,0.852,1.11,'-,[1.05-1.16],IL2RA,Crohn's disease,Crohn's disease,GCST000879,10:6060049
rs10761659-<b>G</b>,4 x 10-22,,0.538,1.23,'-,[1.18-1.29],ALDH7A1P4,Crohn's disease,Crohn's disease,GCST000879,10:62685804
rs11209026-<b>G</b>,1 x 10-64,,0.932,2.66,'-,[2.36-3.00],IL23R,Crohn's disease,Crohn's disease,GCST000879,1:67240275
rs2058660-<b>G</b>,2 x 10-12,,0.231,1.19,'-,[1.14-1.26],IL18RAP,Crohn's disease,Crohn's disease,GCST000879,2:102437989
rs1819658-<b>C</b>,9 x 10-17,,0.774,1.19,'-,[1.13-1.25],IPMK,Crohn's disease,Crohn's disease,GCST000879,10:58153390
rs12720356-<b>G</b>,1 x 10-12,,0.084,1.12,'-,[1.06-1.19],TYK2,Crohn's disease,Crohn's disease,GCST000879,19:10359299
rs3024505-<b>T</b>,2 x 10-14,,0.157,1.12,'-,[1.07-1.17],"IL10, Y_RNA",Crohn's disease,Crohn's disease,GCST000879,1:206766559
rs1456896-<b>T</b>,1 x 10-8,,0.69,1.14,'-,[1.09-1.20],IKZF1,Crohn's disease,Crohn's disease,GCST000879,7:50264865
rs2838519-<b>G</b>,2 x 10-14,,0.391,1.18,'-,[1.13-1.23],GATD3A,Crohn's disease,Crohn's disease,GCST000879,21:44195140
rs212388-<b>G</b>,2 x 10-11,,0.393,1.1,'-,[1.05-1.14],TAGAP-AS1,Crohn's disease,Crohn's disease,GCST000879,6:159069404
rs7423615-<b>T</b>,3 x 10-13,,0.187,1.12,'-,[1.07-1.18],SP140,Crohn's disease,Crohn's disease,GCST000879,2:230252159
rs740495-<b>G</b>,8 x 10-12,,0.247,1.16,'-,[1.10-1.21],SBNO2,Crohn's disease,Crohn's disease,GCST000879,19:1124836
rs12521868-<b>T</b>,1 x 10-20,,0.422,1.23,'-,[1.18-1.28],"IRF1-AS1, IRF1",Crohn's disease,Crohn's disease,GCST000879,5:132448701
rs3180018-<b>A</b>,2 x 10-13,,0.25,1.13,'-,[1.06-1.19],SCAMP3,Crohn's disease,Crohn's disease,GCST000879,1:155260340
rs281379-<b>A</b>,7 x 10-12,,0.487,1.07,'-,[1.04-1.11],"FUT2, MAMSTR",Crohn's disease,Crohn's disease,GCST000879,19:48711017
rs102275-<b>C</b>,2 x 10-11,,0.341,1.08,'-,[1.04-1.12],TMEM258,Crohn's disease,Crohn's disease,GCST000879,11:61790331
rs3197999-<b>A</b>,6 x 10-17,,0.297,1.22,'-,[1.16-1.27],MST1,Crohn's disease,Crohn's disease,GCST000879,3:49684099
rs13428812-<b>G</b>,9 x 10-10,,0.326,1.06,'-,[1.03-1.10],DNMT3A,Crohn's disease,Crohn's disease,GCST000879,2:25269598
rs1998598-<b>G</b>,9 x 10-9,,0.302,1.04,'-,[1.00-1.09],DENND1B,Crohn's disease,Crohn's disease,GCST000879,1:197758512
rs12242110-<b>G</b>,1 x 10-9,,0.315,1.15,'-,[1.10-1.20],"CCNY, RNU6-794P",Crohn's disease,Crohn's disease,GCST000879,10:35246767
rs359457-<b>T</b>,3 x 10-12,,0.571,1.08,'-,[1.04-1.12],"CPEB4, LINC01485",Crohn's disease,Crohn's disease,GCST000879,5:173852839
rs4656940-<b>A</b>,6 x 10-7,,0.801,1.15,'-,[1.09-1.21],CD244,Crohn's disease,Crohn's disease,GCST000879,1:160860478
rs415890-<b>C</b>,3 x 10-12,,0.522,1.17,'-,[1.12-1.22],"MIR3939, RNASET2",Crohn's disease,Crohn's disease,GCST000879,6:166993145
rs4077515-<b>T</b>,1 x 10-36,,0.411,1.18,'-,[1.13-1.22],CARD9,Crohn's disease,Crohn's disease,GCST000879,9:136372044
rs10181042-<b>T</b>,7 x 10-9,,0.42,1.14,'-,[1.09-1.19],PUS10,Crohn's disease,Crohn's disease,GCST000879,2:60997124
rs7554511-<b>C</b>,2 x 10-7,,0.726,1.14,'-,[1.08-1.19],INAVA,Crohn's disease,Crohn's disease,GCST000879,1:200908434
rs2476601-<b>G</b>,4 x 10-9,,0.907,1.26,'-,[1.17-1.37],PTPN22,Crohn's disease,Crohn's disease,GCST000879,1:113834946
rs1893217-<b>G</b>,1 x 10-14,,0.153,1.25,'-,[1.18-1.32],PTPN2,Crohn's disease,Crohn's disease,GCST000879,18:12809341
rs11742570-<b>C</b>,7 x 10-36,,0.606,1.33,'-,[1.27-1.39],'-,Crohn's disease,Crohn's disease,GCST000879,5:40410482
rs694739-<b>A</b>,6 x 10-10,,0.626,1.1,'-,[1.05-1.16],"CCDC88B, PRDX5",Crohn's disease,Crohn's disease,GCST000879,11:64329761
rs6568421-<b>G</b>,4 x 10-8,,0.301,1.13,'-,[1.07-1.18],"PRDM1, RN7SKP211",Crohn's disease,Crohn's disease,GCST000879,6:105987150
rs2076756-<b>G</b>,4 x 10-69,,0.26,1.53,'-,[1.46-1.60],NOD2,Crohn's disease,Crohn's disease,GCST000879,16:50722970
rs4409764-<b>T</b>,2 x 10-20,,0.492,1.22,'-,[1.17-1.27],"LINC01475, GOT1",Crohn's disease,Crohn's disease,GCST000879,10:99524480
rs6738825-<b>A</b>,4 x 10-9,,0.473,1.06,'-,[1.02-1.11],PLCL1,Crohn's disease,Crohn's disease,GCST000879,2:198032171
rs11167764-<b>C</b>,2 x 10-9,,0.796,1.06,'-,[1.02-1.11],"NDFIP1, GNPDA1",Crohn's disease,Crohn's disease,GCST000879,5:142099500
rs6908425-<b>C</b>,1 x 10-8,,0.784,1.17,'-,[1.11-1.23],CDKAL1,Crohn's disease,Crohn's disease,GCST000879,6:20728500
rs3091315-<b>A</b>,2 x 10-13,,0.723,1.2,'-,[1.14-1.26],"CCL7, CCL2",Crohn's disease,Crohn's disease,GCST000879,17:34266646
rs3792109-<b>A</b>,7 x 10-41,,0.529,1.34,'-,[1.29-1.40],"SCARNA5, ATG16L1",Crohn's disease,Crohn's disease,GCST000879,2:233275771
rs6651252-<b>T</b>,4 x 10-18,,0.865,1.23,'-,[1.17-1.30],LINC00824,Crohn's disease,Crohn's disease,GCST000879,8:128554935
rs4871611-<b>A</b>,2 x 10-12,,0.609,1.17,'-,[1.12-1.23],TRIB1,Crohn's disease,Crohn's disease,GCST000879,8:125525328
rs7927997-<b>T</b>,6 x 10-13,,0.389,1.17,'-,[1.12-1.22],"EMSY, LINC02757",Crohn's disease,Crohn's disease,GCST000879,11:76590331
rs1847472-<b>G</b>,5 x 10-9,,0.658,1.07,'-,[1.03-1.11],BACH2,Crohn's disease,Crohn's disease,GCST000879,6:90263440
rs13073817-<b>A</b>,7 x 10-9,,0.322,1.08,'-,[1.03-1.13],SATB1-AS1,Crohn's disease,Crohn's disease,GCST000879,3:18665366
rs7702331-<b>A</b>,6 x 10-12,,0.6,1.12,'-,[1.07-1.17],"LINC02230, TMEM174",Crohn's disease,Crohn's disease,GCST000879,5:73255307
rs17309827-<b>T</b>,7 x 10-9,,0.639,1.1,'-,[1.05-1.16],SLC22A23,Crohn's disease,Crohn's disease,GCST000879,6:3433084
rs736289-<b>T</b>,9 x 10-9,,0.612,1.06,'-,[1.02-1.11],"CEBPA, SLC7A10",Crohn's disease,Crohn's disease,GCST000879,19:33266156
rs1736020-<b>C</b>,9 x 10-12,,0.579,1.16,'-,[1.11-1.21],CYCSP42,Crohn's disease,Crohn's disease,GCST000879,21:15440233
rs34872471-<b>C</b>,6 x 10-53,,0.28,1.31,'-,[1.26-1.35],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST003619,10:112994312
rs11927381-<b>C</b>,3 x 10-14,,0.325,1.14,'-,[1.10-1.17],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST003619,3:185790803
rs849134-<b>A</b>,6 x 10-13,,0.531,1.12,'-,[1.09-1.16],JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST003619,7:28156603
rs13266634-<b>C</b>,1 x 10-11,,0.695,1.12,'-,[1.09-1.16],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST003619,8:117172544
rs7766070-<b>A</b>,2 x 10-11,,0.274,1.12,'-,[1.09-1.16],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST003619,6:20686342
rs10811661-<b>T</b>,2 x 10-10,,0.815,1.14,'-,[1.09-1.19],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST003619,9:22134095
rs9273401-<b>G</b>,2 x 10-9,,0.112,1.16,'-,[1.11-1.22],"HLA-DQB1, HLA-DQA1",Type 2 diabetes,type II diabetes mellitus,GCST003619,6:32659352
rs3768321-<b>T</b>,2 x 10-9,,0.185,1.13,'-,[1.08-1.17],"PABPC4, PABPC4-AS1",Type 2 diabetes,type II diabetes mellitus,GCST003619,1:39570256
rs6857-<b>C</b>,7 x 10-9,,0.844,1.12,'-,[1.08-1.16],NECTIN2,Type 2 diabetes,type II diabetes mellitus,GCST003619,19:44888997
rs9687833-<b>A</b>,3 x 10-9,,0.2,1.12,'-,[1.08-1.16],C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST003619,5:56565774
rs1058018-<b>T</b>,3 x 10-8,(EA),0.57,1.09,'-,[1.05-1.11],UBE2Z,Type 2 diabetes,type II diabetes mellitus,GCST005716,17:48922889
rs140306040-<b>?</b>,7 x 10-7,,NR,1.9646366,'-,[1.5-2.57],'-,Diabetic maculopathy in type 2 diabetes,"diabetic maculopathy, type II diabetes mellitus",GCST008546,7:62860773
rs2972144-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,'-,Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,2:226236695
rs13389219-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,Mapping not available
rs780094-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,Mapping not available
rs7621569-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SYN2,Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,3:12143057
rs702634-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,ARL15,Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,5:53975590
rs3776720-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,ARL15,Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,5:54000328
rs3996352-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"H4P1, KLF14",Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,7:130760175
rs4237150-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,GLIS3,Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,9:4290085
rs2488075-<b>?</b>,2 x 10-15,,NR,'-,'-,'-,"Y_RNA, EXOC6",Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,10:92730417
rs11257655-<b>?</b>,9 x 10-11,,NR,'-,'-,'-,"RN7SL198P, CDC123",Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,10:12265895
rs7896811-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,TCF7L2,Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,10:113006958
rs5215-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,'-,Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,Mapping not available
rs7330796-<b>T</b>,1 x 10-14,,0.22,4.43,'-,'-,TBC1D4,Type 2 diabetes,type II diabetes mellitus,GCST009732,13:75324027
rs870992-<b>G</b>,2 x 10-8,,0.23,2.79,'-,'-,ITGA1,Type 2 diabetes,type II diabetes mellitus,GCST009732,5:52897406
rs16993330-<b>A</b>,1 x 10-7,,0.16,3.52,'-,'-,"LARGE1, LINC01643",Type 2 diabetes,type II diabetes mellitus,GCST009732,22:33947708
rs164368-<b>T</b>,6 x 10-6,(Genotype model),0.785,1.12,'-,[0.89-1.40],GABRB2,Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,5:161197451
rs7493-<b>C</b>,5 x 10-6,(Genotype model),0.177,1.06,'-,[0.74-1.51],PON2,Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,7:95405463
rs4526895-<b>C</b>,2 x 10-6,(Genotype model),0.414,1.38,'-,[0.93-2.04],FREM2,Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,13:38776753
rs194045-<b>G</b>,6 x 10-6,(Trend model),0.888,2.13,'-,[1.51-3.02],'-,Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,16:29234781
rs8093481-<b>A</b>,1 x 10-6,(Trend model),0.656,1.79,'-,[1.16-2.77],PIEZO2,Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,18:10695159
rs1133146-<b>A</b>,5 x 10-6,(Allele model),0.956,1.52,'-,[1.01-2.29],ZNF665,Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,19:53163407
rs871913-<b>A</b>,8 x 10-6,(Trend model),0.045,1.86,'-,[0.78-4.44],PPIAP17,Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,20:16163700
rs1932064-<b>T</b>,6 x 10-6,(Dominant model),0.7,1.62,'-,[1.05-2.51],"CASP3P1, CHORDC1P5",Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,1:70608238
rs12036718-<b>T</b>,8 x 10-6,(Trend model),0.103,1.68,'-,[0.95-2.99],LINC02794,Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,1:48083641
rs7565310-<b>A</b>,9 x 10-6,(Trend model),0.38,1.53,'-,[1.27-1.84],"Y_RNA, RNA5SP103",Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,2:128386380
rs7694118-<b>C</b>,6 x 10-6,(Genotype model),0.663,1.3,'-,[0.85-1.99],"PCDH10, R3HDM2P1",Yu-Zhi constitution type in type 2 diabetes,"Yu-Zhi constitution type, type II diabetes mellitus",GCST003026,4:133147480
rs716316-<b>?</b>,8 x 10-6,,NR,'-,0.129 unit increase,[0.074-0.184],"MACROD2-AS1, MACROD2",Advanced glycation end-product levels,"advanced glycation end-product measurement, type II diabetes mellitus",GCST003457,20:14928095
rs17054480-<b>?</b>,8 x 10-7,,NR,'-,0.312 unit decrease,[0.19-0.43],PALLD,Advanced glycation end-product levels,"advanced glycation end-product measurement, type II diabetes mellitus",GCST003457,4:168687639
rs11159086-<b>?</b>,3 x 10-6,,NR,'-,0.18 unit decrease,[0.11-0.25],ISCA2,Advanced glycation end-product levels,"advanced glycation end-product measurement, type II diabetes mellitus",GCST003457,14:74495572
rs4454866-<b>?</b>,5 x 10-6,,NR,'-,0.281 unit increase,[0.16-0.4],'-,Advanced glycation end-product levels,"advanced glycation end-product measurement, type II diabetes mellitus",GCST003457,14:40207714
rs6795197-<b>?</b>,8 x 10-6,,NR,'-,0.131 unit decrease,[0.074-0.188],"PXYLP1, ZBTB38",Advanced glycation end-product levels,"advanced glycation end-product measurement, type II diabetes mellitus",GCST003457,3:141328230
rs76703216-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,'-,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,10:9470063
rs646123-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,MLX,Type 2 diabetes (time to event),"age at diagnosis, type II diabetes mellitus",GCST010766,17:42568614
rs146886108-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,ANKH,Type 2 diabetes (time to event),"age at diagnosis, type II diabetes mellitus",GCST010766,5:14751196
rs3810291-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,ZC3H4,Type 2 diabetes (time to event),"age at diagnosis, type II diabetes mellitus",GCST010766,19:47065746
rs2477088-<b>T</b>,6 x 10-10,,0.32,2.5,'-,[1.87-3.34],PDE4DIP,Macrovascular complications in type 2 diabetes,"vascular disease, type II diabetes mellitus",GCST011161,1:148948136
rs522521-<b>A</b>,7 x 10-10,,0.6,0.42,'-,[17.32-0.56],"LINC02087, SPECC1P1",Macrovascular complications in type 2 diabetes,"vascular disease, type II diabetes mellitus",GCST011161,17:15830231
rs4852954-<b>T</b>,1 x 10-8,,0.31,2.27,'-,[2.71-3.01],ALMS1P1,Macrovascular complications in type 2 diabetes,"vascular disease, type II diabetes mellitus",GCST011161,2:73642883
rs6032-<b>T</b>,3 x 10-8,,0.37,2.12,'-,[1.63-2.77],F5,Macrovascular complications in type 2 diabetes,"vascular disease, type II diabetes mellitus",GCST011161,1:169542317
rs6935464-<b>A</b>,4 x 10-8,,0.26,2.25,'-,[6.69-3.01],RPS6KA2,Macrovascular complications in type 2 diabetes,"vascular disease, type II diabetes mellitus",GCST011161,6:166700720
rs7236163-<b>T</b>,5 x 10-8,,0.27,2.14,'-,[18.63-2.82],"FRG2LP, NF1P5",Macrovascular complications in type 2 diabetes,"vascular disease, type II diabetes mellitus",GCST011161,18:14150725
rs3095447-<b>A</b>,5 x 10-8,,0.37,2.16,'-,[7.64-2.84],CCDC146,Macrovascular complications in type 2 diabetes,"vascular disease, type II diabetes mellitus",GCST011161,7:77135653
rs3095447-<b>A</b>,3 x 10-8,,0.4,2.18,'-,[1.66-2.87],CCDC146,Ophthalmic complications in type 2 diabetes,"type II diabetes mellitus, diabetic eye disease",GCST011160,7:77135653
rs2074356-<b>T</b>,1 x 10-16,(1-hPG),'-,'-,0.321 mmol-1 decrease,[0.24-0.40],HECTD4,Glycemic traits,type II diabetes mellitus,GCST001965,12:112207597
rs1799884-<b>A</b>,3 x 10-10,(2-hPG),'-,'-,0.162 mmol-1 increase,[0.11-0.21],GCK,Glycemic traits,type II diabetes mellitus,GCST001965,7:44189469
rs2074356-<b>T</b>,6 x 10-9,(2-hPG),'-,'-,0.165 mmol-1 decrease,[0.11-0.22],HECTD4,Glycemic traits,type II diabetes mellitus,GCST001965,12:112207597
rs11066453-<b>G</b>,5 x 10-9,(1-hPG),'-,'-,0.242 mmol-1 decrease,[0.16-0.32],OAS1,Glycemic traits,type II diabetes mellitus,GCST001965,12:112927816
rs1799884-<b>A</b>,5 x 10-18,(FPG),'-,'-,0.063 mmol-1 increase,[0.049-0.077],GCK,Glycemic traits,type II diabetes mellitus,GCST001965,7:44189469
rs10830962-<b>C</b>,5 x 10-13,(FPG),'-,'-,0.041 mmol-1 increase,[0.029-0.053],"MTNR1B, SNRPGP16",Glycemic traits,type II diabetes mellitus,GCST001965,11:92965261
rs2074356-<b>T</b>,6 x 10-14,(FPG),'-,'-,0.061 mmol-1 decrease,[0.045-0.077],HECTD4,Glycemic traits,type II diabetes mellitus,GCST001965,12:112207597
rs9348440-<b>A</b>,3 x 10-19,(1-hPG),'-,'-,0.246 mmol-1 increase,[0.19-0.30],CDKAL1,Glycemic traits,type II diabetes mellitus,GCST001965,6:20641105
rs1799884-<b>A</b>,3 x 10-9,(1-hPG),'-,'-,0.208 mmol-1 increase,[0.14-0.28],GCK,Glycemic traits,type II diabetes mellitus,GCST001965,7:44189469
rs10830962-<b>C</b>,3 x 10-12,(1-hPG),'-,'-,0.191 mmol-1 increase,[0.14-0.24],"MTNR1B, SNRPGP16",Glycemic traits,type II diabetes mellitus,GCST001965,11:92965261
rs12229654-<b>G</b>,9 x 10-13,(1-hPG),'-,'-,0.277 mmol-1 decrease,[0.20-0.35],"CUX2, LINC01405",Glycemic traits,type II diabetes mellitus,GCST001965,12:110976657
rs7766070-<b>A</b>,9 x 10-9,,0.29,1.38,'-,[1.24-1.54],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST002718,6:20686342
rs1873747-<b>T</b>,4 x 10-6,,0.13,1.41,'-,[1.22-1.63],ROR2,Type 2 diabetes,type II diabetes mellitus,GCST002718,9:91633578
rs34872471-<b>C</b>,8 x 10-8,,0.4,1.32,'-,[1.19-1.46],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST002718,10:112994312
rs275856-<b>T</b>,1 x 10-6,,0.11,1.51,'-,[1.28-1.77],OSBPL1A,Type 2 diabetes,type II diabetes mellitus,GCST002718,18:24259188
rs73954691-<b>G</b>,3 x 10-6,,0.98,2.6,'-,[1.74-3.88],LIMS2,Type 2 diabetes,type II diabetes mellitus,GCST002718,2:127663671
rs35209784-<b>T</b>,5 x 10-6,,0.01,3.57,'-,[1.92-6.25],DAAM1,Type 2 diabetes,type II diabetes mellitus,GCST002718,14:59285112
rs34669198-<b>?</b>,1 x 10-6,,NR,'-,0.3 unit increase,[0.18-0.42],SRBD1,Type 2 diabetes,type II diabetes mellitus,GCST002806,2:45521138
rs75260059-<b>?</b>,9 x 10-7,,NR,'-,0.34 unit increase,[0.20-0.48],"FTCDNL1, LINC01877",Type 2 diabetes,type II diabetes mellitus,GCST002806,2:199751534
rs12496230-<b>?</b>,4 x 10-6,,NR,'-,0.54 unit increase,[0.30-0.78],'-,Type 2 diabetes,type II diabetes mellitus,GCST002806,3:66779484
rs138306797-<b>?</b>,3 x 10-6,,NR,'-,0.78 unit increase,[0.47-1.09],"IGF2BP2, TRA2B",Type 2 diabetes,type II diabetes mellitus,GCST002806,3:185827931
rs149049329-<b>?</b>,2 x 10-6,,NR,'-,0.71 unit increase,[0.42-1.00],LINC01991,Type 2 diabetes,type II diabetes mellitus,GCST002806,3:187880139
rs11454281-<b>?</b>,9 x 10-6,,NR,'-,0.6 unit increase,[0.33-0.87],LGMNP1,Type 2 diabetes,type II diabetes mellitus,GCST002806,13:64920645
rs149358103-<b>?</b>,5 x 10-6,,NR,'-,0.58 unit increase,[0.33-0.83],"LINC02541, RPS27AP11",Type 2 diabetes,type II diabetes mellitus,GCST002806,6:113586847
rs9478961-<b>?</b>,2 x 10-7,,NR,'-,0.44 unit increase,[0.28-0.60],"MTHFD1L, RNU6-300P",Type 2 diabetes,type II diabetes mellitus,GCST002806,6:151135457
rs7978895-<b>?</b>,9 x 10-6,,NR,'-,0.14 unit increase,[0.081-0.199],LINC02461,Type 2 diabetes,type II diabetes mellitus,GCST002806,12:43176712
rs79490558-<b>?</b>,1 x 10-6,,NR,'-,0.31 unit increase,[0.17-0.45],"GTF2F2, TPT1",Type 2 diabetes,type II diabetes mellitus,GCST002806,13:45312051
rs78319313-<b>?</b>,3 x 10-6,,NR,'-,0.49 unit increase,[0.27-0.71],LINC00348,Type 2 diabetes,type II diabetes mellitus,GCST002806,13:71021178
rs6506284-<b>?</b>,3 x 10-6,,NR,'-,0.32 unit increase,[0.18-0.46],"LINC01892, PPIAP14",Type 2 diabetes,type II diabetes mellitus,GCST002806,18:5030024
rs138128600-<b>?</b>,2 x 10-7,,NR,'-,0.53 unit increase,[0.33-0.73],"RNU4-10P, RNU6-66P",Type 2 diabetes,type II diabetes mellitus,GCST002806,13:73190488
rs189178161-<b>?</b>,8 x 10-6,,NR,'-,0.64 unit increase,[0.37-0.91],"CPPED1, SNX29",Type 2 diabetes,type II diabetes mellitus,GCST002806,16:12624996
rs13036344-<b>?</b>,9 x 10-6,,NR,'-,0.2 unit increase,[0.12-0.28],COMMD7,Type 2 diabetes,type II diabetes mellitus,GCST002806,20:32725930
rs11240074-<b>?</b>,6 x 10-6,,NR,'-,0.21 unit increase,[0.11-0.31],"BCL9, LINC00624",Type 2 diabetes,type II diabetes mellitus,GCST002806,1:147524657
rs4703911-<b>?</b>,7 x 10-6,,NR,'-,0.22 unit increase,[0.12-0.32],RPL5P16,Type 2 diabetes,type II diabetes mellitus,GCST002806,5:82717035
rs2055942-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,GABRA4,Type 2 diabetes,type II diabetes mellitus,GCST002123,4:46966033
rs649891-<b>C</b>,6 x 10-6,,0.35,'-,'-,'-,PTPRD,Type 2 diabetes,type II diabetes mellitus,GCST001092,9:10430602
rs3792615-<b>T</b>,9 x 10-6,(Indian),0.95,1.93,'-,[1.45-2.59],MARCHF1,Type 2 diabetes,type II diabetes mellitus,GCST001033,4:163611649
rs12027542-<b>A</b>,4 x 10-7,(Malay),0.61,1.41,'-,[1.23-1.61],PCNX2,Type 2 diabetes,type II diabetes mellitus,GCST001033,1:233204408
rs10460009-<b>C</b>,9 x 10-6,(Malay),0.6,1.35,'-,[1.18-1.54],LPIN2,Type 2 diabetes,type II diabetes mellitus,GCST001033,18:2948031
rs9295474-<b>G</b>,9 x 10-6,(Chinese+Malay+Indian),0.36,1.16,'-,[1.09-1.24],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST001033,6:20652486
rs11677370-<b>T</b>,3 x 10-6,(Indian),0.4,1.35,'-,[1.19-1.53],DCDC2C,Type 2 diabetes,type II diabetes mellitus,GCST001033,2:3793830
rs7119-<b>T</b>,5 x 10-7,(Chinese+Malay+Indian),0.19,1.24,'-,[1.14-1.34],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST001033,15:77485290
rs2833610-<b>A</b>,4 x 10-6,(Chinese+Malay+Indian),0.57,1.17,'-,[1.09-1.24],HUNK,Type 2 diabetes,type II diabetes mellitus,GCST001033,21:32012873
rs6583826-<b>G</b>,7 x 10-6,(Chinese+Malay+Indian),0.26,1.18,'-,[1.10-1.27],KIF11,Type 2 diabetes,type II diabetes mellitus,GCST001033,10:92588073
rs7630877-<b>A</b>,7 x 10-6,(Chinese),0.17,1.32,'-,[1.17-1.49],PEX5L,Type 2 diabetes,type II diabetes mellitus,GCST001033,3:179943530
rs17045328-<b>G</b>,7 x 10-6,(Malay),0.3,1.38,'-,[1.20-1.59],CR2,Type 2 diabetes,type II diabetes mellitus,GCST001033,1:207478831
rs1048886-<b>G</b>,3 x 10-8,(Indian),0.18,1.54,'-,[1.32-1.80],SDHAF4,Type 2 diabetes,type II diabetes mellitus,GCST001033,6:70579486
rs642858-<b>A</b>,2 x 10-6,(Indian),0.4,1.35,'-,[1.19-1.53],FILNC1,Type 2 diabetes,type II diabetes mellitus,GCST001033,6:139952510
rs7636-<b>A</b>,5 x 10-6,(Indian),0.06,1.85,'-,[1.42-2.41],ACHE,Type 2 diabetes,type II diabetes mellitus,GCST001033,7:100892456
rs10741243-<b>G</b>,5 x 10-6,(Indian),0.93,1.75,'-,[1.38-2.23],TCERG1L,Type 2 diabetes,type II diabetes mellitus,GCST001033,10:131149699
rs2063640-<b>A</b>,3 x 10-6,(Chinese+Malay+Indian),0.17,1.23,'-,[1.13-1.34],ZPLD1,Type 2 diabetes,type II diabetes mellitus,GCST001033,3:102484201
rs472265-<b>G</b>,9 x 10-6,(Indian),0.22,1.39,'-,[1.20-1.61],ACP7,Type 2 diabetes,type II diabetes mellitus,GCST001033,19:39090097
rs3773506-<b>C</b>,9 x 10-6,(Indian),0.06,1.81,'-,[1.39-2.35],PLS1,Type 2 diabetes,type II diabetes mellitus,GCST001033,3:142712158
rs4712523-<b>G</b>,7 x 10-20,,0.41,1.27,'-,[1.21-1.33],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST000383,6:20657333
rs2383208-<b>A</b>,2 x 10-29,,0.55,1.34,'-,[1.27-1.41],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST000383,9:22132077
rs2237892-<b>C</b>,1 x 10-26,,0.59,1.33,'-,[1.27-1.41],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST000383,11:2818521
rs13266634-<b>C</b>,2 x 10-14,,0.57,1.22,'-,[1.16-1.28],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST000383,8:117172544
rs1111875-<b>C</b>,7 x 10-12,,0.28,1.21,'-,[1.15-1.28],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST000383,10:92703125
rs7903146-<b>T</b>,8 x 10-12,,0.04,1.54,'-,[1.36-1.74],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000383,10:112998590
rs4402960-<b>T</b>,1 x 10-6,,0.31,1.14,'-,[1.08-1.21],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST000383,3:185793899
rs7903146-<b>A</b>,7 x 10-7,(T2D),0.3,1.33,'-,[1.19-1.49],TCF7L2,Metabolic syndrome,"type II diabetes mellitus, metabolic syndrome",GCST000753,10:112998590
rs531676-<b>?</b>,9 x 10-6,(T2D),0.45,'-,'-,'-,CRTAC1,Metabolic syndrome,"type II diabetes mellitus, metabolic syndrome",GCST000753,10:97877821
rs7018475-<b>?</b>,3 x 10-8,,NR,1.35,'-,[1.18-1.56],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST001397,9:22137686
rs17584499-<b>T</b>,9 x 10-10,,0.06,1.57,'-,[1.36-1.82],PTPRD,Type 2 diabetes,type II diabetes mellitus,GCST000601,9:8879118
rs2237895-<b>C</b>,1 x 10-9,,0.33,1.29,'-,[1.19-1.40],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST000601,11:2835964
rs391300-<b>G</b>,3 x 10-9,,0.62,1.28,'-,[1.18-1.39],SRR,Type 2 diabetes,type II diabetes mellitus,GCST000601,17:2312964
rs17177078-<b>?</b>,5 x 10-6,,NR,'-,0.83 unit increase,[NR],TNRC6A,Type 2 diabetes (dietary heme iron intake interaction),"type II diabetes mellitus, dietary heme iron intake measurement",GCST001843,16:24799360
rs1525739-<b>?</b>,6 x 10-6,,NR,'-,0.44 unit decrease,[NR],"AGR2, AGR3",Type 2 diabetes (dietary heme iron intake interaction),"type II diabetes mellitus, dietary heme iron intake measurement",GCST001843,7:16850188
rs10980508-<b>?</b>,1 x 10-6,,NR,'-,0.64 unit increase,[NR],"SVEP1, MUSK",Type 2 diabetes (dietary heme iron intake interaction),"type II diabetes mellitus, dietary heme iron intake measurement",GCST001843,9:110657479
rs470089-<b>?</b>,9 x 10-6,,NR,'-,0.55 unit decrease,[NR],SULT4A1,Type 2 diabetes (dietary heme iron intake interaction),"type II diabetes mellitus, dietary heme iron intake measurement",GCST001843,22:43852624
rs163182-<b>C</b>,2 x 10-17,,0.34,1.28,'-,[NR],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST001173,11:2822986
rs1436953-<b>G</b>,8 x 10-6,,0.64,1.14,'-,[NR],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST001173,15:62121815
rs2261181-<b>T</b>,9 x 10-17,,0.096470033,'-,0.0985 unit increase,[0.075-0.122],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST006867,12:65818538
rs1480474-<b>G</b>,2 x 10-8,,0.415993966,'-,0.0411 unit increase,[0.027-0.055],HMGA2,Type 2 diabetes,type II diabetes mellitus,GCST006867,12:65933163
rs7138300-<b>C</b>,6 x 10-10,,0.443165036,'-,0.0443 unit increase,[0.03-0.058],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST006867,12:71045809
rs11107116-<b>T</b>,4 x 10-8,,0.219714311,'-,0.0467 unit increase,[0.03-0.063],"SOCS2, CRADD",Type 2 diabetes,type II diabetes mellitus,GCST006867,12:93584728
rs61953351-<b>T</b>,2 x 10-14,,0.249902348,'-,0.07 unit decrease,[0.052-0.088],OASL,Type 2 diabetes,type II diabetes mellitus,GCST006867,12:121018813
rs940904-<b>G</b>,2 x 10-9,,0.256626737,'-,0.0499 unit decrease,[0.034-0.066],PITPNM2,Type 2 diabetes,type II diabetes mellitus,GCST006867,12:123007025
rs825476-<b>C</b>,7 x 10-13,,0.419450711,'-,0.0524 unit decrease,[0.038-0.067],RFLNA,Type 2 diabetes,type II diabetes mellitus,GCST006867,12:124083909
rs576674-<b>G</b>,2 x 10-11,,0.167485416,'-,0.0654 unit increase,[0.046-0.084],"KL, TOMM22P3",Type 2 diabetes,type II diabetes mellitus,GCST006867,13:32980164
rs963740-<b>T</b>,2 x 10-8,,0.294299268,'-,0.0479 unit decrease,[0.031-0.065],"DLEU7, DLEU1",Type 2 diabetes,type II diabetes mellitus,GCST006867,13:50521959
rs1359790-<b>A</b>,3 x 10-23,,0.286699864,'-,0.0796 unit decrease,[0.064-0.095],'-,Type 2 diabetes,type II diabetes mellitus,GCST006867,13:80143021
rs7144011-<b>T</b>,2 x 10-8,,0.221063371,'-,0.0482 unit increase,[0.032-0.065],NRXN3,Type 2 diabetes,type II diabetes mellitus,GCST006867,14:79474040
rs4502156-<b>C</b>,2 x 10-8,,0.435857045,'-,0.0411 unit decrease,[0.027-0.055],"C2CD4B, NPM1P47",Type 2 diabetes,type II diabetes mellitus,GCST006867,15:62090956
rs982077-<b>A</b>,3 x 10-10,,0.434479032,'-,0.0453 unit increase,[0.031-0.059],USP3,Type 2 diabetes,type II diabetes mellitus,GCST006867,15:63531102
rs7177055-<b>G</b>,3 x 10-16,,0.281711332,'-,0.0647 unit decrease,[0.049-0.08],"LINGO1, HMG20A",Type 2 diabetes,type II diabetes mellitus,GCST006867,15:77540420
rs4932143-<b>G</b>,6 x 10-11,,0.279055867,'-,0.0568 unit increase,[0.04-0.074],"AP3S2, ANPEP",Type 2 diabetes,type II diabetes mellitus,GCST006867,15:89828835
rs12910825-<b>G</b>,2 x 10-12,,0.360390809,'-,0.0517 unit increase,[0.037-0.066],"PRC1-AS1, PRC1",Type 2 diabetes,type II diabetes mellitus,GCST006867,15:90968030
rs9940149-<b>A</b>,9 x 10-10,,0.178555946,'-,0.058 unit decrease,[0.039-0.077],FAM234A,Type 2 diabetes,type II diabetes mellitus,GCST006867,16:250642
rs7185735-<b>G</b>,2 x 10-47,,0.397306062,'-,0.1056 unit increase,[0.091-0.12],FTO,Type 2 diabetes,type II diabetes mellitus,GCST006867,16:53788739
rs244415-<b>A</b>,4 x 10-9,,0.412872431,'-,0.0467 unit decrease,[0.031-0.062],NFAT5,Type 2 diabetes,type II diabetes mellitus,GCST006867,16:69632780
rs77258096-<b>A</b>,2 x 10-18,,0.101383462,'-,0.1171 unit decrease,[0.091-0.143],"CTRB2, CTRB1",Type 2 diabetes,type II diabetes mellitus,GCST006867,16:75209874
rs2925979-<b>T</b>,9 x 10-12,,0.299149856,'-,0.0534 unit increase,[0.038-0.069],CMIP,Type 2 diabetes,type II diabetes mellitus,GCST006867,16:81501185
rs8068804-<b>A</b>,4 x 10-14,,0.325096537,'-,0.0587 unit increase,[0.043-0.074],ZZEF1,Type 2 diabetes,type II diabetes mellitus,GCST006867,17:4082570
rs12945601-<b>T</b>,2 x 10-9,,0.386396556,'-,0.048 unit increase,[0.032-0.064],RAI1,Type 2 diabetes,type II diabetes mellitus,GCST006867,17:17750097
rs11651755-<b>C</b>,9 x 10-22,,0.484669254,'-,0.0741 unit increase,[0.059-0.089],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST006867,17:37739849
rs17405722-<b>A</b>,2 x 10-9,,0.074152649,'-,0.087 unit increase,[0.058-0.116],"STAT3, CAVIN1",Type 2 diabetes,type II diabetes mellitus,GCST006867,17:42390483
rs9911983-<b>C</b>,5 x 10-8,,0.433426851,'-,0.0397 unit decrease,[0.025-0.054],OSBPL7,Type 2 diabetes,type II diabetes mellitus,GCST006867,17:47808390
rs9894220-<b>G</b>,2 x 10-13,,0.433739993,'-,0.0585 unit decrease,[0.043-0.074],UBE2Z,Type 2 diabetes,type II diabetes mellitus,GCST006867,17:48911792
rs302864-<b>A</b>,2 x 10-8,,0.08702566,'-,0.071 unit increase,[0.046-0.096],"IGBP1P2, TEX14",Type 2 diabetes,type II diabetes mellitus,GCST006867,17:58680223
rs17631783-<b>T</b>,4 x 10-8,,0.263459811,'-,0.0487 unit decrease,[0.031-0.066],"MAP3K3, TACO1",Type 2 diabetes,type II diabetes mellitus,GCST006867,17:63610240
rs7240767-<b>C</b>,2 x 10-8,,0.383677477,'-,0.0451 unit increase,[0.029-0.061],LAMA1,Type 2 diabetes,type II diabetes mellitus,GCST006867,18:7070643
rs12970134-<b>A</b>,5 x 10-12,,0.265120386,'-,0.0555 unit increase,[0.04-0.071],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST006867,18:60217517
rs10401969-<b>C</b>,4 x 10-12,,0.076585755,'-,0.0921 unit increase,[0.066-0.118],SUGP1,Type 2 diabetes,type II diabetes mellitus,GCST006867,19:19296909
rs8108269-<b>G</b>,3 x 10-16,,0.281015346,'-,0.0644 unit increase,[0.049-0.08],"RN7SL836P, GIPR",Type 2 diabetes,type II diabetes mellitus,GCST006867,19:45655255
rs6515236-<b>C</b>,3 x 10-8,,0.249330468,'-,0.0504 unit decrease,[0.033-0.068],LINC00261,Type 2 diabetes,type II diabetes mellitus,GCST006867,20:22455111
rs6059662-<b>A</b>,2 x 10-8,,0.336824454,'-,0.0446 unit decrease,[0.029-0.06],RALY,Type 2 diabetes,type II diabetes mellitus,GCST006867,20:34087921
rs4810426-<b>T</b>,2 x 10-8,,0.0967888,'-,0.0726 unit increase,[0.047-0.098],"HNF4A-AS1, HNF4A",Type 2 diabetes,type II diabetes mellitus,GCST006867,20:44373081
rs6066138-<b>A</b>,2 x 10-9,,0.278361954,'-,0.049 unit decrease,[0.033-0.065],EYA2,Type 2 diabetes,type II diabetes mellitus,GCST006867,20:46966072
rs16988333-<b>G</b>,9 x 10-9,,0.090403549,'-,0.0745 unit decrease,[0.049-0.1],HORMAD2,Type 2 diabetes,type II diabetes mellitus,GCST006867,22:30156824
rs4823182-<b>G</b>,3 x 10-10,,0.335747643,'-,0.0482 unit increase,[0.033-0.063],SAMM50,Type 2 diabetes,type II diabetes mellitus,GCST006867,22:43981562
rs527320094-<b>C</b>,5 x 10-9,,2.30E-04,2.77,'-,[1.81-3.74],RPL31P12,Type 2 diabetes,type II diabetes mellitus,GCST006868,1:72387303
rs184847416-<b>T</b>,1 x 10-8,,1.20E-04,3.54,'-,[1.95-5.12],"HNRNPKP2, UBBP1",Type 2 diabetes,type II diabetes mellitus,GCST006868,2:136287660
rs146886108-<b>C</b>,4 x 10-9,,0.99286,1.4084507,'-,[1.27-1.59],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST006868,5:14751196
rs78408340-<b>G</b>,4 x 10-14,,0.0096,1.34,'-,[1.24-1.43],PAM,Type 2 diabetes,type II diabetes mellitus,GCST006868,5:103003035
rs551513405-<b>A</b>,2 x 10-8,,1.60E-04,3.05,'-,[1.83-4.28],"PSPH, NIPSNAP2",Type 2 diabetes,type II diabetes mellitus,GCST006868,7:56003690
rs79768058-<b>G</b>,1 x 10-8,,2.00E-04,2.87,'-,[1.81-3.93],CFAP77,Type 2 diabetes,type II diabetes mellitus,GCST006868,9:132436281
rs117229942-<b>C</b>,4 x 10-11,,0.99182,1.4285715,'-,[1.3-1.61],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST006868,10:112978018
rs576083050-<b>T</b>,3 x 10-8,,3.50E-04,2.34,'-,[1.62-3.05],"B4GALNT3, CCDC77",Type 2 diabetes,type II diabetes mellitus,GCST006868,12:450654
rs559651557-<b>C</b>,3 x 10-8,,2.30E-04,2.67,'-,[1.72-3.62],"RNU7-93P, SFTA3",Type 2 diabetes,type II diabetes mellitus,GCST006868,14:36430441
rs79890196-<b>C</b>,2 x 10-8,,2.60E-04,2.6,'-,[1.71-3.48],'-,Type 2 diabetes,type II diabetes mellitus,GCST006868,15:95945146
rs551640889-<b>G</b>,5 x 10-9,,1.20E-04,3.61,'-,[2.01-5.21],XYLT1,Type 2 diabetes,type II diabetes mellitus,GCST006868,16:17166334
rs994965583-<b>G</b>,2 x 10-7,,0.2979,6.252,'-,'-,TFDP1P3,Type 2 diabetes,type II diabetes mellitus,GCST006484,15:79571143
rs1914711-<b>A</b>,1 x 10-9,,0.484,6.824,'-,'-,"AGTR2, API5P1",Type 2 diabetes,type II diabetes mellitus,GCST006484,X:116157221
rs11635657-<b>T</b>,2 x 10-7,,0.3226,6.077,'-,'-,TRPM1,Type 2 diabetes,type II diabetes mellitus,GCST006484,15:31105879
rs2838820-<b>T</b>,6 x 10-7,,0.4628,4.723,'-,'-,ADARB1,Type 2 diabetes,type II diabetes mellitus,GCST006484,21:45226090
rs199639153-<b>?</b>,4 x 10-6,,0.8065,8.264462,'-,'-,"ITGA2, ITGA1",Type 2 diabetes,type II diabetes mellitus,GCST006484,5:52984030
rs3864095-<b>A</b>,8 x 10-7,,0.2979,5.72,'-,'-,MASP1,Type 2 diabetes,type II diabetes mellitus,GCST006484,3:187219249
rs1631619-<b>G</b>,9 x 10-7,,0.3804,5,'-,'-,MTND5P17,Type 2 diabetes,type II diabetes mellitus,GCST006484,10:36349497
rs11095909-<b>T</b>,5 x 10-7,,0.4255,4.909,'-,'-,MAGEC3,Type 2 diabetes,type II diabetes mellitus,GCST006484,X:141879379
rs59457600-<b>T</b>,8 x 10-7,,0.3883,4.838,'-,'-,LINC02030,Type 2 diabetes,type II diabetes mellitus,GCST006484,3:55234434
rs29582-<b>A</b>,1 x 10-6,,0.3989,4.831,'-,'-,LINC02152,Type 2 diabetes,type II diabetes mellitus,GCST006484,16:8335727
rs10823559-<b>C</b>,1 x 10-6,,0.4255,4.63,'-,'-,PALD1,Type 2 diabetes,type II diabetes mellitus,GCST006484,10:70528546
rs11034036-<b>?</b>,2 x 10-6,,0.6223,4.7393365,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST006484,11:37234640
rs904372-<b>?</b>,8 x 10-7,,0.6117,4.830918,'-,'-,OCA2,Type 2 diabetes,type II diabetes mellitus,GCST006484,15:27683945
rs77989445-<b>G</b>,9 x 10-7,,0.1436,17.692,'-,'-,"RNU11-5P, PRKD1",Type 2 diabetes,type II diabetes mellitus,GCST006484,14:29500776
rs1670754-<b>A</b>,5 x 10-7,,0.2394,7.697,'-,'-,"LINC02506, LINC02353",Type 2 diabetes,type II diabetes mellitus,GCST006484,4:32263375
rs7213402-<b>T</b>,6 x 10-7,,0.25,7.167,'-,'-,"MYH10, CCDC42",Type 2 diabetes,type II diabetes mellitus,GCST006484,17:8691776
rs7646242-<b>?</b>,5 x 10-7,,0.5798,4.8543687,'-,'-,TOMM22P6,Type 2 diabetes,type II diabetes mellitus,GCST006484,3:162563848
rs4817543-<b>?</b>,6 x 10-7,,0.6489,5.263158,'-,'-,"IFNAR2, LINC01548",Type 2 diabetes,type II diabetes mellitus,GCST006484,21:33183197
rs2088315-<b>?</b>,8 x 10-7,,0.6755,5.263158,'-,'-,'-,Type 2 diabetes,type II diabetes mellitus,GCST006484,3:162664729
rs7566955-<b>?</b>,8 x 10-7,,0.6809,5.263158,'-,'-,"RN7SL283P, LINC01853",Type 2 diabetes,type II diabetes mellitus,GCST006484,2:140059972
rs2049477-<b>?</b>,9 x 10-7,,0.7021,5.714286,'-,'-,SDK1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST006484,7:3273238
rs136867-<b>?</b>,3 x 10-7,,0.6915,6.329114,'-,'-,DEPDC5,Type 2 diabetes,type II diabetes mellitus,GCST006484,22:31876672
rs10261386-<b>?</b>,3 x 10-7,,0.734,6.711409,'-,'-,CPED1,Type 2 diabetes,type II diabetes mellitus,GCST006484,7:121071801
rs137893140-<b>?</b>,8 x 10-7,,0.8138,10.526316,'-,'-,CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST006484,9:22157832
rs186507655-<b>A</b>,5 x 10-10,(subset analysis),NR,'-,'-,'-,"DVL1, MXRA8",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,1:1351675
rs2075570-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,MTX1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,1:155212373
rs481519-<b>T</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,NEK10,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,3:27285723
rs7679673-<b>A</b>,1 x 10-10,(subset analysis),NR,'-,'-,'-,TET2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,4:105140377
rs7725218-<b>A</b>,2 x 10-10,(subset analysis),NR,'-,'-,'-,TERT,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,5:1282299
rs1862626-<b>T</b>,4 x 10-12,(subset analysis),NR,'-,'-,'-,MAP3K1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,5:56737113
rs147680653-<b>G</b>,1 x 10-6,(subset analysis),NR,'-,'-,'-,"HLA-V, IFITM4P",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:29785031
rs115707823-<b>A</b>,5 x 10-7,(subset analysis),NR,'-,'-,'-,"MICC, UBQLN1P1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:30374976
rs115392158-<b>G</b>,3 x 10-7,(subset analysis),NR,'-,'-,'-,"LINC02571, HLA-B",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:31347004
rs147527678-<b>C</b>,6 x 10-8,(subset analysis),NR,'-,'-,'-,"HLA-DQB1, MTCO3P1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,6:32699696
rs1011970-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,CDKN2B-AS1,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,9:22062135
rs11200014-<b>A</b>,8 x 10-35,(subset analysis),NR,'-,'-,'-,FGFR2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,10:121575416
rs7931342-<b>G</b>,4 x 10-14,(subset analysis),NR,'-,'-,'-,"MYEOV, SMIM38",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:69227030
rs148883465-<b>G</b>,3 x 10-8,(subset analysis),NR,'-,'-,'-,MIR4693,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:103813371
rs11168936-<b>C</b>,9 x 10-7,(subset analysis),NR,'-,'-,'-,TUBA1C,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:49251457
rs73110464-<b>T</b>,2 x 10-15,(subset analysis),NR,'-,'-,'-,KRT8,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:52918828
rs3184504-<b>C</b>,1 x 10-6,(subset analysis),NR,'-,'-,'-,"SH2B3, ATXN2",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma",GCST003588,12:111446804
rs11571818-<b>C</b>,5 x 10-10,(subset analysis),NR,'-,'-,'-,BRCA2,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,13:32394673
rs11844632-<b>A</b>,3 x 10-10,(subset analysis),NR,'-,'-,'-,RAD51B,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,14:68559662
rs12601991-<b>T</b>,7 x 10-28,(subset analysis),NR,'-,'-,'-,HNF1B,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,17:37741642
rs4808075-<b>C</b>,2 x 10-9,(subset analysis),NR,'-,'-,'-,"BABAM1, USHBP1",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,19:17279482
rs11907546-<b>T</b>,3 x 10-6,(subset analysis),NR,'-,'-,'-,"RPS2P1, ASIP",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,20:34131991
rs141752671-<b>G</b>,1 x 10-7,(subset analysis),NR,'-,'-,'-,'-,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,11:103745837
rs11065979-<b>T</b>,5 x 10-6,(subset analysis),NR,'-,'-,'-,"BRAP, ATXN2-AS",Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,12:111621753
rs2300206-<b>C</b>,6 x 10-6,(subset analysis),NR,'-,'-,'-,RALY,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,20:34002002
rs56084662-<b>A</b>,4 x 10-9,(subset analysis),NR,'-,'-,'-,FRY,Cancer (pleiotropy),"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003588,13:32295727
rs1057941-<b>A</b>,2 x 10-7,,NR,1.1,'-,[NR],GBAP1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:155216951
rs2974935-<b>T</b>,2 x 10-7,,NR,1.1,'-,[NR],MTX1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:155212052
rs11119608-<b>T</b>,1 x 10-7,,NR,1.1111112,'-,[NR],KCNH1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,1:210816167
rs75316749-<b>G</b>,2 x 10-7,,NR,1.1,'-,[NR],"MECOM, LINC01997",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,3:169043635
rs115707823-<b>A</b>,2 x 10-6,,NR,1.1,'-,[NR],"MICC, UBQLN1P1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:30374976
rs115392158-<b>G</b>,9 x 10-6,,NR,1.1,'-,[NR],"LINC02571, HLA-B",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:31347004
rs147527678-<b>C</b>,5 x 10-7,,NR,1.1,'-,[NR],"HLA-DQB1, MTCO3P1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:32699696
rs4604234-<b>C</b>,6 x 10-6,,NR,1.1,'-,[NR],"RPSAP72, RPL17P25",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,6:80398959
rs12349081-<b>A</b>,6 x 10-6,,NR,1.1,'-,[NR],"CDKN2A-DT, MTAP",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,9:21951903
rs1011970-<b>T</b>,2 x 10-7,,NR,1.1,'-,[NR],CDKN2B-AS1,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,9:22062135
rs3184504-<b>C</b>,2 x 10-6,,NR,1.1,'-,[NR],"SH2B3, ATXN2",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,12:111446804
rs11571833-<b>T</b>,8 x 10-12,,NR,1.6,'-,[NR],BRCA2,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,13:32398489
rs12601991-<b>T</b>,1 x 10-9,,NR,1.1,'-,[NR],HNF1B,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,17:37741642
rs4808075-<b>C</b>,4 x 10-7,,NR,1.1,'-,[NR],"BABAM1, USHBP1",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,19:17279482
rs11907546-<b>C</b>,3 x 10-9,,NR,1.1111112,'-,[NR],"RPS2P1, ASIP",Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,20:34131991
rs56404467-<b>A</b>,1 x 10-7,,NR,1.2,'-,[NR],FRY,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,13:32265853
rs2300206-<b>G</b>,2 x 10-8,,NR,1.1111112,'-,[NR],RALY,Cancer,"lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma",GCST003587,20:34002002
rs9966620-<b>A</b>,7 x 10-8,,0.0964,1.95,'-,[1.71-2.19],TTC39C,Diabetic maculopathy with decreased visual acuity in type 2 diabetes,"visual acuity measurement, diabetic maculopathy, type II diabetes mellitus",GCST008545,18:24100771
rs11706588-<b>C</b>,7 x 10-7,,0.1305,1.89,'-,[1.64-2.14],CHCHD6,Diabetic maculopathy with decreased visual acuity in type 2 diabetes,"visual acuity measurement, diabetic maculopathy, type II diabetes mellitus",GCST008545,3:126729670
rs35498131-<b>?</b>,7 x 10-7,,NR,1.7869906,'-,[1.42-2.25],"C16orf72, USP7",Diabetic maculopathy in type 2 diabetes,"diabetic maculopathy, type II diabetes mellitus",GCST008546,16:9026952
rs34954281-<b>?</b>,9 x 10-7,,NR,1.4838997,'-,[1.27-1.74],TNFAIP6,Diabetic maculopathy in type 2 diabetes,"diabetic maculopathy, type II diabetes mellitus",GCST008546,2:151369363
rs1406230-<b>?</b>,5 x 10-7,,NR,1.4444604,'-,[1.25-1.67],ALK,Diabetic maculopathy in type 2 diabetes,"diabetic maculopathy, type II diabetes mellitus",GCST008546,2:29360455
rs1149833-<b>?</b>,5 x 10-7,,NR,1.338688,'-,[1.19-1.5],DLEU1,Diabetic maculopathy in type 2 diabetes,"diabetic maculopathy, type II diabetes mellitus",GCST008546,13:50176740
rs12629668-<b>?</b>,4 x 10-7,,NR,1.397,'-,[1.228-1.591],ZIC1,Diabetic maculopathy in type 2 diabetes,"diabetic maculopathy, type II diabetes mellitus",GCST008546,3:147491392
rs3818329-<b>?</b>,2 x 10-7,,NR,1.865,'-,[1.474-2.361],RGS13,Diabetic maculopathy in type 2 diabetes,"diabetic maculopathy, type II diabetes mellitus",GCST008546,1:192658630
rs117482282-<b>?</b>,4 x 10-7,,NR,3.079,'-,[1.991-4.762],RPL17P25,Diabetic maculopathy in type 2 diabetes,"diabetic maculopathy, type II diabetes mellitus",GCST008546,6:165097982
rs614288-<b>T</b>,2 x 10-8,,NR,'-,0.05 unit increase,[0.030-0.070],"ALDOAP1, POC1A",Bipolar disorder or type 2 diabetes,"bipolar disorder, type II diabetes mellitus",GCST009372,3:52186187
rs6091248-<b>A</b>,4 x 10-8,,NR,'-,0.05 unit increase,[0.030-0.070],KCNG1,Bipolar disorder or type 2 diabetes,"bipolar disorder, type II diabetes mellitus",GCST009372,20:51014081
rs1990145-<b>A</b>,4 x 10-6,,0.268,2.02,'-,[1.50-2.72],'-,Diabetic macular edema in type 2 diabetes,"diabetic macular edema, type II diabetes mellitus",GCST006282,Mapping not available
rs4771506-<b>C</b>,7 x 10-6,,0.263,1.97,'-,[1.46-2.64],LINC00343,Diabetic macular edema in type 2 diabetes,"diabetic macular edema, type II diabetes mellitus",GCST006282,13:105843651
rs918519-<b>?</b>,4 x 10-6,,0.769,2.86,'-,[1.85-4.55],"IL12B, LINC01845",Proliferative diabetic retinopathy in type 2 diabetes,"proliferative diabetic retinopathy, type II diabetes mellitus",GCST006283,5:159399349
rs1158314-<b>G</b>,4 x 10-6,,0.4,2.16,'-,[1.56-3.00],NRXN3,Proliferative diabetic retinopathy in type 2 diabetes,"proliferative diabetic retinopathy, type II diabetes mellitus",GCST006283,14:79961389
rs9896052-<b>A</b>,7 x 10-7,(EA),0.294,1.67,'-,[1.30-2.15],"RNU6-938P, Y_RNA",Sight-threatening diabetic retinopathy in type 2 diabetes,"diabetic retinopathy, type II diabetes mellitus",GCST003042,17:75422781
rs11099942-<b>?</b>,4 x 10-6,(Celtic),NR,'-,'-,'-,DCHS2,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,4:154211555
rs9502478-<b>?</b>,4 x 10-6,(Celtic),NR,'-,'-,'-,"LY86, LY86-AS1",Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,6:6593462
rs2107167-<b>?</b>,8 x 10-6,(Celtic),NR,'-,'-,'-,EIF3IP1,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,7:109950854
rs34428389-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,"STIMATE-MUSTN1, STIMATE",Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,3:52860127
rs17447640-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,ATP8A1,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,4:42553794
rs34620785-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"HSPE1P14, RNU6ATAC8P",Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,8:102440080
rs12743974-<b>?</b>,5 x 10-6,(Celtic),NR,'-,'-,'-,IL23R,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,1:67242674
rs12736701-<b>?</b>,8 x 10-6,(Celtic),NR,'-,'-,'-,AK5,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,1:77349740
rs7412314-<b>?</b>,4 x 10-6,(Celtic),NR,'-,'-,'-,FMO4,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,1:171318113
rs10973627-<b>?</b>,4 x 10-6,(Celtic),NR,'-,'-,'-,SHB,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,9:37971392
rs10512488-<b>?</b>,3 x 10-6,(Celtic),NR,'-,'-,'-,BECN1,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,17:42811886
rs340841-<b>?</b>,9 x 10-6,(Slavic),NR,'-,'-,'-,PROX1-AS1,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,1:213951127
rs12714314-<b>?</b>,3 x 10-6,(Slavic),NR,'-,'-,'-,MYT1L,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,2:1939845
rs58383906-<b>?</b>,3 x 10-6,(Slavic),NR,'-,'-,'-,"RBMS3-AS3, RBMS3",Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,3:29204690
rs13166103-<b>?</b>,4 x 10-6,(Slavic),NR,'-,'-,'-,PLK2,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,5:58446375
rs9384193-<b>?</b>,9 x 10-6,(Slavic),NR,'-,'-,'-,"OPRM1, IPCEF1",Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,6:154233115
rs11060464-<b>?</b>,4 x 10-6,(Slavic),NR,'-,'-,'-,TMEM132D,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,12:129613305
rs1754680-<b>?</b>,8 x 10-6,(Slavic),NR,'-,'-,'-,'-,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,14:38378799
rs13043901-<b>?</b>,5 x 10-6,(Slavic),NR,'-,'-,'-,"ZNF217, Y_RNA",Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,20:53554244
rs11298745-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,HDAC9,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,7:18508630
rs35372009-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,CLEC14A,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,14:38313138
rs148077446-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,ADAMTS18,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,16:77276712
rs113932007-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,"RPL12P46, LINC02698",Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,11:115620719
rs35372009-<b>?</b>,9 x 10-6,(Slavic),NR,'-,'-,'-,CLEC14A,Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,14:38313138
rs113932007-<b>?</b>,6 x 10-7,(Celtic),NR,'-,'-,'-,"RPL12P46, LINC02698",Type 2 diabetes (age of onset),type II diabetes mellitus,GCST004125,11:115620719
rs35260355-<b>T</b>,4 x 10-7,,0.16,1.66,'-,[1.37-2.02],ZSCAN20,Neuropathic pain in type 2 diabetes,"neuropathic pain, type II diabetes mellitus",GCST003063,1:33480230
rs71647933-<b>G</b>,3 x 10-7,(females),0.16,2.31,'-,[1.68-3.17],ZSCAN20,Neuropathic pain in type 2 diabetes,"neuropathic pain, type II diabetes mellitus",GCST003063,1:33480000
rs6986153-<b>G</b>,8 x 10-7,(males),0.19,1.67,'-,[1.34-2.08],'-,Neuropathic pain in type 2 diabetes,"neuropathic pain, type II diabetes mellitus",GCST003063,8:107059816
rs11717195-<b>T</b>,5 x 10-6,,0.75,1.24,'-,[1.13-1.36],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST004758,3:123363551
rs7903146-<b>T</b>,1 x 10-11,,0.25,1.36,'-,[1.25-1.49],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST004758,10:112998590
rs163184-<b>G</b>,1 x 10-7,,0.41,1.24,'-,[1.14-1.34],'-,Type 2 diabetes,type II diabetes mellitus,GCST004758,Mapping not available
rs10830963-<b>G</b>,2 x 10-7,,0.2,1.28,'-,[1.17-1.41],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST004758,11:92975544
rs7403531-<b>T</b>,6 x 10-6,,0.33,1.21,'-,[1.11-1.31],RASGRP1,Type 2 diabetes,type II diabetes mellitus,GCST004758,15:38530704
rs2283228-<b>A</b>,8 x 10-13,,0.79,1.5,'-,[1.35-1.66],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST004758,11:2828300
"rs2237896-<b>A</b>, rs163184-<b>T</b>, rs1049549-<b>T</b>, rs3888647-<b>G</b>",1 x 10-14,,NR,0.61,'-,'-,KCNQ1; No mapped genes; No mapped genes; No mapped genes,Type 2 diabetes,type II diabetes mellitus,GCST004758,11:2837210
"rs2237896-<b>A</b>, rs163184-<b>T</b>, rs1049549-<b>T</b>, rs3888647-<b>A</b>",7 x 10-11,,NR,0.38,'-,'-,KCNQ1; No mapped genes; No mapped genes; No mapped genes,Type 2 diabetes,type II diabetes mellitus,GCST004758,11:2837210
rs1132787-<b>T</b>,3 x 10-11,,0.16,2.71,'-,[2.02-3.64],GYPA,Diabetic neuropathy in type 2 diabetes,"diabetic neuropathy, type II diabetes mellitus",GCST011163,4:144109393
rs522521-<b>A</b>,5 x 10-8,,0.56,0.49,'-,[0.38-0.64],"LINC02087, SPECC1P1",Diabetic neuropathy in type 2 diabetes,"diabetic neuropathy, type II diabetes mellitus",GCST011163,17:15830231
rs7756992-<b>G</b>,6 x 10-128,,0.2706,'-,0.1217 unit increase,[0.11-0.13],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
rs6947395-<b>T</b>,5 x 10-16,,0.2,1.09,'-,1.07-1.12,AUTS2,Type 2 diabetes,type II diabetes mellitus,GCST007847,7:69941675
rs10965247-<b>A</b>,1 x 10-87,,0.56,1.19,'-,1.17-1.21,CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST007847,9:22132730
rs10440833-<b>A</b>,2 x 10-85,,0.42,1.19,'-,1.17-1.21,CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST007847,6:20687890
rs2233580-<b>T</b>,4 x 10-74,,0.09,1.32,'-,1.28-1.36,PAX4,Type 2 diabetes,type II diabetes mellitus,GCST007847,7:127613496
rs1894299-<b>G</b>,9 x 10-58,,0.68,1.13,'-,1.11-1.15,DUSP9,Type 2 diabetes,type II diabetes mellitus,GCST007847,X:153643433
rs7901695-<b>C</b>,3 x 10-49,,0.04,1.34,'-,1.29-1.40,TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST007847,10:112994329
rs13092876-<b>A</b>,6 x 10-39,,0.34,1.14,'-,1.12-1.16,IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST007847,3:185777532
rs12219514-<b>A</b>,5 x 10-39,,0.13,1.18,'-,1.15-1.21,"Y_RNA, HHEX",Type 2 diabetes,type II diabetes mellitus,GCST007847,10:92706682
rs11390176-<b>T</b>,1 x 10-14,,0.44,1.06,'-,1.04-1.07,IL13RA1,Type 2 diabetes,type II diabetes mellitus,GCST007847,X:118781201
rs34204798-<b>C</b>,3 x 10-14,,0.56,1.07,'-,1.05-1.09,ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST007847,10:79191374
rs791595-<b>A</b>,4 x 10-14,,0.08,1.1235955,'-,[1.09-1.16],"LEP, MIR129-1",Type 2 diabetes,type II diabetes mellitus,GCST007847,7:128222749
rs746673-<b>G</b>,4 x 10-14,,0.41,1.07,'-,1.05-1.10,"PHGR1, CCDC9B",Type 2 diabetes,type II diabetes mellitus,GCST007847,15:40344217
rs9394574-<b>A</b>,4 x 10-14,,0.82,1.09,'-,1.07-1.12,GLP1R,Type 2 diabetes,type II diabetes mellitus,GCST007847,6:39071364
rs33981001-<b>GGT</b>,8 x 10-23,,0.44,1.09,'-,1.07-1.11,ANK1,Type 2 diabetes,type II diabetes mellitus,GCST007847,8:41655130
rs28624681-<b>C</b>,6 x 10-21,,0.88,1.14,'-,1.11-1.18,GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST007847,9:136343450
rs1327315-<b>C</b>,2 x 10-19,,0.73,1.1,'-,1.08-1.12,'-,Type 2 diabetes,type II diabetes mellitus,GCST007847,13:80134597
rs2796441-<b>G</b>,3 x 10-19,,0.38,1.08,'-,1.06-1.10,"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST007847,9:81694033
rs77300780-<b>T</b>,3 x 10-19,,0.54,1.08,'-,1.06-1.10,"GIPR, RN7SL836P",Type 2 diabetes,type II diabetes mellitus,GCST007847,19:45663346
rs2844623-<b>C</b>,1 x 10-17,,0.78,1.1,'-,1.08-1.12,"HLA-C, HCG27",Type 2 diabetes,type II diabetes mellitus,GCST007847,6:31264766
rs3214606-<b>C</b>,2 x 10-17,,0.2,1.11,'-,1.08-1.13,SINHCAF,Type 2 diabetes,type II diabetes mellitus,GCST007847,12:31324008
rs1575972-<b>T</b>,5 x 10-13,,0.94,1.15,'-,1.11-1.19,'-,Type 2 diabetes,type II diabetes mellitus,GCST007847,9:22301093
rs201597274-<b>T</b>,2 x 10-12,,0.96,1.17,'-,1.12-1.23,'-,Type 2 diabetes,type II diabetes mellitus,GCST007847,4:84380717
rs17168486-<b>T</b>,2 x 10-12,,0.4,1.06,'-,1.05-1.08,DGKB,Type 2 diabetes,type II diabetes mellitus,GCST007847,7:14858657
rs117267808-<b>A</b>,3 x 10-12,,0.08,1.12,'-,1.08-1.16,GP2,Type 2 diabetes,type II diabetes mellitus,GCST007847,16:20311846
rs12454712-<b>T</b>,3 x 10-12,,0.48,1.06,'-,1.05-1.08,BCL2,Type 2 diabetes,type II diabetes mellitus,GCST007847,18:63178651
rs233449-<b>G</b>,5 x 10-12,(Conditioned),0.82,'-,'-,'-,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:2822573
rs2908279-<b>G</b>,5 x 10-12,,0.6,1.07,'-,1.05-1.09,"RNA5SP230, MYL7",Type 2 diabetes,type II diabetes mellitus,GCST007847,7:44135258
rs187150787-<b>A</b>,6 x 10-12,,0.04,1.2,'-,1.14-1.27,SPPL3,Type 2 diabetes,type II diabetes mellitus,GCST007847,12:120890006
rs7034200-<b>A</b>,8 x 10-12,,0.41,1.06,'-,1.04-1.08,GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST007847,9:4289050
rs2237897-<b>C</b>,3 x 10-168,,0.62,1.3,'-,1.27-1.32,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:2837316
rs74577409-<b>G</b>,6 x 10-16,,0.08,1.14,'-,1.11-1.18,"CLEC10A, SLC16A11",Type 2 diabetes,type II diabetes mellitus,GCST007847,17:7044134
rs10507349-<b>G</b>,1 x 10-15,,0.55,1.07,'-,1.05-1.09,RNF6,Type 2 diabetes,type II diabetes mellitus,GCST007847,13:26207391
rs3816157-<b>G</b>,3 x 10-15,,0.68,1.08,'-,1.06-1.10,"PSMD6, PSMD6-AS1",Type 2 diabetes,type II diabetes mellitus,GCST007847,3:64013646
rs67148051-<b>AAGAC</b>,3 x 10-15,,0.14,1.11,'-,1.08-1.13,"TOMM22P3, KL",Type 2 diabetes,type II diabetes mellitus,GCST007847,13:32979947
rs6547692-<b>A</b>,4 x 10-15,,0.44,1.07,'-,1.05-1.09,GCKR,Type 2 diabetes,type II diabetes mellitus,GCST007847,2:27512105
rs11651052-<b>A</b>,2 x 10-34,,0.32,1.12,'-,1.10-1.14,HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST007847,17:37742390
rs13266634-<b>C</b>,3 x 10-30,,0.59,1.11,'-,1.09-1.13,SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST007847,8:117172544
rs1421085-<b>C</b>,1 x 10-28,,0.2,1.13,'-,1.11-1.15,FTO,Type 2 diabetes,type II diabetes mellitus,GCST007847,16:53767042
rs10795945-<b>T</b>,8 x 10-27,,0.45,1.11,'-,1.09-1.13,"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST007847,10:12260608
rs79407053-<b>G</b>,1 x 10-24,,0.69,1.11,'-,1.09-1.13,CTBP1-DT,Type 2 diabetes,type II diabetes mellitus,GCST007847,4:1250430
rs77402029-<b>G</b>,3 x 10-24,,0.9,1.17,'-,1.13-1.20,"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST007847,11:2619190
rs12633613-<b>T</b>,3 x 10-23,,0.67,1.1,'-,1.08-1.12,UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST007847,3:23349016
rs663129-<b>A</b>,5 x 10-14,,0.22,1.08,'-,1.06-1.10,RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST007847,18:60171168
rs2327777-<b>T</b>,5 x 10-14,,0.39,1.07,'-,1.05-1.09,"RPL35AP3, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST007847,6:136972090
rs3751237-<b>T</b>,7 x 10-14,,0.69,1.07,'-,1.05-1.09,RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST007847,12:27810574
rs4929965-<b>A</b>,3 x 10-13,,0.08,1.1235955,'-,[1.09-1.16],"MIR4686, ASCL2",Type 2 diabetes,type II diabetes mellitus,GCST007847,11:2176056
rs7660590-<b>C</b>,4 x 10-13,,0.5,1.07,'-,1.05-1.08,FBXW7,Type 2 diabetes,type II diabetes mellitus,GCST007847,4:152476671
rs8037894-<b>G</b>,2 x 10-17,,0.58,1.08,'-,1.06-1.10,"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST007847,15:62102065
rs10011838-<b>G</b>,3 x 10-17,,0.46,1.08,'-,1.06-1.10,"TMEM154, RPS3AP18",Type 2 diabetes,type II diabetes mellitus,GCST007847,4:152599127
rs256903-<b>A</b>,2 x 10-16,,0.47,1.08,'-,1.06-1.09,C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST007847,5:56513311
rs80196932-<b>T</b>,8 x 10-12,,0.75,1.07,'-,1.05-1.10,"NEPNP, NUS1",Type 2 diabetes,type II diabetes mellitus,GCST007847,6:117675468
rs112332300-<b>CT</b>,1 x 10-11,(Conditioned),0.46,'-,'-,'-,UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST007847,3:23588427
rs12910361-<b>G</b>,1 x 10-11,,0.41,1.06,'-,1.04-1.08,HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST007847,15:77489993
rs76550717-<b>A</b>,1 x 10-11,,0.95,1.16,'-,1.11-1.20,ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:72717127
rs12031188-<b>C</b>,3 x 10-11,,0.8,1.08,'-,1.06-1.11,FAF1,Type 2 diabetes,type II diabetes mellitus,GCST007847,1:50637596
rs148316037-<b>T</b>,5 x 10-11,,0.97,1.26,'-,1.17-1.34,ZNF257,Type 2 diabetes,type II diabetes mellitus,GCST007847,19:22074756
rs10231021-<b>A</b>,8 x 10-11,,0.64,1.06,'-,1.04-1.08,GTF3AP5,Type 2 diabetes,type II diabetes mellitus,GCST007847,7:15020804
rs11073333-<b>G</b>,1 x 10-10,,0.47,1.06,'-,1.04-1.08,RASGRP1,Type 2 diabetes,type II diabetes mellitus,GCST007847,15:38528446
rs2290203-<b>A</b>,2 x 10-10,,0.47,1.06,'-,1.04-1.08,"PRC1, PRC1-AS1",Type 2 diabetes,type II diabetes mellitus,GCST007847,15:90968837
rs72156956-<b>C</b>,3 x 10-10,,0.9,1.1,'-,1.07-1.13,"LINC01875, TMEM18",Type 2 diabetes,type II diabetes mellitus,GCST007847,2:640987
rs3135911-<b>A</b>,4 x 10-10,,0.44,1.06,'-,1.04-1.08,"FGFR4, ZNF346",Type 2 diabetes,type II diabetes mellitus,GCST007847,5:177086895
rs56337234-<b>C</b>,7 x 10-10,,0.28,1.0752687,'-,[1.05-1.1],"FGFR3, TACC3",Type 2 diabetes,type II diabetes mellitus,GCST007847,4:1782676
rs115321690-<b>G</b>,8 x 10-10,,0.6,1.06,'-,1.04-1.08,CCHCR1,Type 2 diabetes,type II diabetes mellitus,GCST007847,6:31148749
rs75536691-<b>A</b>,9 x 10-10,,0.98,1.21,'-,1.14-1.29,GRB14,Type 2 diabetes,type II diabetes mellitus,GCST007847,2:164525008
rs34247110-<b>A</b>,1 x 10-9,,0.37,1.06,'-,1.04-1.08,"KCNK16, KCNK17",Type 2 diabetes,type II diabetes mellitus,GCST007847,6:39314595
rs116549635-<b>A</b>,1 x 10-9,(Conditioned),0.057,'-,'-,'-,ASCL2,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:2269820
rs1825307-<b>A</b>,2 x 10-9,,0.25,1.06,'-,1.04-1.09,USP48,Type 2 diabetes,type II diabetes mellitus,GCST007847,1:21741833
rs6021276-<b>T</b>,2 x 10-9,,0.43,1.06,'-,1.04-1.07,NFATC2,Type 2 diabetes,type II diabetes mellitus,GCST007847,20:51538847
rs838720-<b>G</b>,2 x 10-9,,0.45,1.05,'-,1.04-1.07,DGKD,Type 2 diabetes,type II diabetes mellitus,GCST007847,2:233394635
rs10938398-<b>A</b>,2 x 10-9,,0.3,1.06,'-,1.04-1.08,'-,Type 2 diabetes,type II diabetes mellitus,GCST007847,4:45184122
rs7900112-<b>T</b>,2 x 10-9,,0.51,1.05,'-,1.04-1.07,LRMDA,Type 2 diabetes,type II diabetes mellitus,GCST007847,10:75554859
rs56805921-<b>C</b>,3 x 10-9,,0.43,1.06,'-,1.04-1.08,ETV1,Type 2 diabetes,type II diabetes mellitus,GCST007847,7:13849074
rs1955163-<b>G</b>,3 x 10-9,,0.51,1.05,'-,1.04-1.07,"TMEM256P1, TSPAN15",Type 2 diabetes,type II diabetes mellitus,GCST007847,10:69513601
rs58432198-<b>C</b>,3 x 10-9,,0.91,1.098901,'-,[1.06-1.14],FAF1,Type 2 diabetes,type II diabetes mellitus,GCST007847,1:50790419
rs77792157-<b>G</b>,3 x 10-9,,0.95,1.15,'-,1.10-1.20,CPA1,Type 2 diabetes,type II diabetes mellitus,GCST007847,7:130385872
rs10886863-<b>C</b>,3 x 10-9,,0.7,1.06,'-,1.04-1.08,"RPL19P16, LINC01153",Type 2 diabetes,type II diabetes mellitus,GCST007847,10:121169979
rs12649012-<b>G</b>,3 x 10-9,,0.21,1.07,'-,1.04-1.09,"MOB1B, RNU6-891P",Type 2 diabetes,type II diabetes mellitus,GCST007847,4:70882528
rs16988991-<b>A</b>,4 x 10-9,,0.45,1.05,'-,1.04-1.07,HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST007847,20:44361137
rs144226500-<b>AT</b>,5 x 10-9,,0.3,1.05,'-,1.03-1.06,"SPIN2A, PPP1R11P2",Type 2 diabetes,type II diabetes mellitus,GCST007847,X:57144349
rs782100977-<b>C</b>,5 x 10-9,,0.63,1.06,'-,1.04-1.08,"PCSK1N, PQBP1",Type 2 diabetes,type II diabetes mellitus,GCST007847,X:48866249
rs123378-<b>G</b>,5 x 10-9,,0.22,1.06,'-,1.04-1.09,DLEU1,Type 2 diabetes,type II diabetes mellitus,GCST007847,13:50514673
rs16829174-<b>A</b>,5 x 10-9,,0.59,1.05,'-,1.03-1.07,EPC2,Type 2 diabetes,type II diabetes mellitus,GCST007847,2:148697816
rs2134223-<b>A</b>,5 x 10-9,,0.47,1.05,'-,1.03-1.07,CASR,Type 2 diabetes,type II diabetes mellitus,GCST007847,3:122238106
rs2421897-<b>G</b>,7 x 10-9,,0.88,1.08,'-,1.05-1.11,SLC1A2,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:35416316
rs113547729-<b>A</b>,8 x 10-9,,0.12,1.09,'-,1.06-1.12,ZZEF1,Type 2 diabetes,type II diabetes mellitus,GCST007847,17:4121530
rs16884025-<b>C</b>,8 x 10-9,,0.93,1.14,'-,1.09-1.19,PARP8,Type 2 diabetes,type II diabetes mellitus,GCST007847,5:50657625
rs3963364-<b>C</b>,9 x 10-9,,0.96,1.16,'-,1.10-1.22,PPARG,Type 2 diabetes,type II diabetes mellitus,GCST007847,3:12343858
rs11819995-<b>T</b>,1 x 10-8,,0.22,1.06,'-,1.04-1.08,ETS1,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:128519496
rs150626020-<b>T</b>,1 x 10-8,,0.026,1.19,'-,1.12-1.26,SND1,Type 2 diabetes,type II diabetes mellitus,GCST007847,7:128050855
rs1182389-<b>G</b>,1 x 10-8,,0.46,1.05,'-,1.03-1.07,UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST007847,7:157246109
rs11113776-<b>G</b>,1 x 10-8,,0.46,1.05,'-,1.03-1.07,WSCD2,Type 2 diabetes,type II diabetes mellitus,GCST007847,12:108219374
rs13417036-<b>A</b>,2 x 10-8,,0.16,1.07,'-,1.05-1.10,LINC01122,Type 2 diabetes,type II diabetes mellitus,GCST007847,2:58694642
rs35678078-<b>T</b>,2 x 10-8,,0.5,1.06,'-,1.04-1.08,PPP2R2C,Type 2 diabetes,type II diabetes mellitus,GCST007847,4:6331942
rs11410487-<b>A</b>,2 x 10-8,,0.17,1.07,'-,1.04-1.09,"ITGA1, PELO",Type 2 diabetes,type II diabetes mellitus,GCST007847,5:52798411
rs3731600-<b>C</b>,2 x 10-8,,0.95,1.13,'-,1.08-1.18,SCTR,Type 2 diabetes,type II diabetes mellitus,GCST007847,2:119473494
rs79310463-<b>T</b>,2 x 10-8,,0.26,1.06,'-,1.04-1.08,KSR2,Type 2 diabetes,type II diabetes mellitus,GCST007847,12:117968891
rs7072204-<b>A</b>,2 x 10-8,,0.43,1.05,'-,1.03-1.07,PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST007847,10:122435969
rs6633421-<b>A</b>,3 x 10-8,,0.68,1.04,'-,1.03-1.06,CNKSR2,Type 2 diabetes,type II diabetes mellitus,GCST007847,X:21551802
rs9505085-<b>C</b>,3 x 10-8,,0.67,1.05,'-,1.03-1.07,RREB1,Type 2 diabetes,type II diabetes mellitus,GCST007847,6:7226726
rs531347476-<b>C</b>,3 x 10-8,,0.997,2.16,'-,1.64-2.83,SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST007847,8:117012076
rs386418874-<b>?</b>,6 x 10-11,,NR,'-,6.536 z score increase,NR,TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST008464,10:112988102
rs4532315-<b>?</b>,1 x 10-8,,NR,'-,5.734 z score decrease,NR,CSPG4BP,Type 2 diabetes,type II diabetes mellitus,GCST008464,5:54768502
rs4072825-<b>?</b>,2 x 10-8,,NR,'-,5.584 z score increase,NR,TH,Type 2 diabetes,type II diabetes mellitus,GCST008464,11:2166212
rs111248619-<b>?</b>,3 x 10-8,,NR,'-,5.559 z score increase,NR,KCNQ3,Type 2 diabetes,type II diabetes mellitus,GCST008464,8:132453251
rs1465146591-<b>A</b>,7 x 10-9,,0.069,'-,0.652 unit decrease,[0.43-0.87],ZRANB3,Type 2 diabetes,type II diabetes mellitus,GCST008463,2:135262159
rs702634-<b>A</b>,8 x 10-6,,0.82,1.05,'-,1.03-1.08,ARL15,Type 2 diabetes,type II diabetes mellitus,GCST007847,5:53975590
rs1260326-<b>C</b>,3 x 10-42,,0.5946,'-,0.0638 unit increase,[0.055-0.073],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
rs13389219-<b>C</b>,7 x 10-44,,0.6033,'-,0.0648 unit increase,[0.056-0.074],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
rs429358-<b>C</b>,4 x 10-28,,0.1454,'-,0.073 unit decrease,[0.06-0.086],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
rs11435035-<b>C</b>,3 x 10-8,,0.34,1.07,'-,1.04-1.09,"ARPIN-AP3S2, AP3S2, MIR5094",Type 2 diabetes,type II diabetes mellitus,GCST007847,15:89850718
rs68062313-<b>TA</b>,3 x 10-8,,0.09,1.1,'-,1.06-1.13,ATP8B2,Type 2 diabetes,type II diabetes mellitus,GCST007847,1:154337120
rs9892728-<b>C</b>,4 x 10-8,,0.47,1.05,'-,1.03-1.07,RAMP2,Type 2 diabetes,type II diabetes mellitus,GCST007847,17:42761348
rs11199755-<b>C</b>,5 x 10-8,(Conditioned),0.81,'-,'-,'-,RPL19P16,Type 2 diabetes,type II diabetes mellitus,GCST007847,10:121077345
rs2800733-<b>A</b>,9 x 10-8,,0.86,1.0752687,'-,[1.05-1.11],RSPO3,Type 2 diabetes,type II diabetes mellitus,GCST007847,6:127095785
rs377247337-<b>G</b>,1 x 10-7,,0.99,1.33,'-,1.20-1.48,TSPAN3,Type 2 diabetes,type II diabetes mellitus,GCST007847,15:77047154
rs202178099-<b>C</b>,2 x 10-7,(Conditioned),0.044,'-,'-,'-,"PARP8, LINC02106",Type 2 diabetes,type II diabetes mellitus,GCST007847,5:50927276
rs3887925-<b>T</b>,3 x 10-7,,0.43,1.05,'-,1.03-1.06,ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST007847,3:186947857
rs10406327-<b>C</b>,3 x 10-7,,0.53,1.0416667,'-,[1.03-1.06],PEPD,Type 2 diabetes,type II diabetes mellitus,GCST007847,19:33399932
rs6459733-<b>G</b>,3 x 10-7,,0.46,1.0526316,'-,[1.03-1.06],UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST007847,7:157137856
rs76868685-<b>C</b>,3 x 10-7,(Conditioned),0.995,'-,'-,'-,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:2836784
rs12569857-<b>C</b>,3 x 10-7,,0.3,1.05,'-,1.03-1.07,CAMK1D,Type 2 diabetes,type II diabetes mellitus,GCST007847,10:12555882
rs243024-<b>A</b>,3 x 10-7,,0.68,1.05,'-,1.03-1.07,MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST007847,2:60356530
rs7985179-<b>T</b>,4 x 10-7,,0.82,1.06,'-,1.04-1.09,"MIR17HG, PPIAP23",Type 2 diabetes,type II diabetes mellitus,GCST007847,13:91287915
rs10195252-<b>T</b>,4 x 10-7,,0.92,1.0869565,'-,[1.05-1.12],COBLL1,Type 2 diabetes,type II diabetes mellitus,GCST007847,2:164656581
rs140751051-<b>G</b>,6 x 10-7,,0.88,1.09,'-,1.05-1.12,MNX1,Type 2 diabetes,type II diabetes mellitus,GCST007847,7:157000757
rs77820034-<b>C</b>,8 x 10-7,(Conditioned),0.024,'-,'-,'-,"C2CD4B, NPM1P47",Type 2 diabetes,type II diabetes mellitus,GCST007847,15:62094596
rs11820019-<b>T</b>,1 x 10-6,,0.98,1.2345679,'-,[1.14-1.35],CCND1,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:69633990
rs665268-<b>G</b>,2 x 10-6,,0.47,1.04,'-,1.02-1.06,MLX,Type 2 diabetes,type II diabetes mellitus,GCST007847,17:42570011
rs17791513-<b>A</b>,3 x 10-6,,0.95,1.098901,'-,[1.05-1.14],'-,Type 2 diabetes,type II diabetes mellitus,GCST007847,9:79290675
rs11699802-<b>C</b>,4 x 10-6,,0.54,1.0416667,'-,[1.02-1.06],"CEBPB, PELATON",Type 2 diabetes,type II diabetes mellitus,GCST007847,20:50215598
rs4709746-<b>C</b>,4 x 10-6,,0.87,1.0638298,'-,[1.04-1.1],'-,Type 2 diabetes,type II diabetes mellitus,GCST007847,6:163711969
rs5219-<b>T</b>,4 x 10-6,,0.37,1.04,'-,1.02-1.06,KCNJ11,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:17388025
rs348330-<b>G</b>,4 x 10-6,,0.7,1.0526316,'-,[1.03-1.08],ABCB10,Type 2 diabetes,type II diabetes mellitus,GCST007847,1:229537208
rs9967620-<b>C</b>,5 x 10-6,,0.9,1.07,'-,1.04-1.10,"NANOS2, MYPOP",Type 2 diabetes,type II diabetes mellitus,GCST007847,19:45912438
rs1374910-<b>T</b>,1 x 10-7,,NR,1.24,'-,[1.15-1.34],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST001070,3:185813873
rs1333051-<b>A</b>,6 x 10-10,,NR,1.22,'-,[1.15-1.30],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST001070,9:22136490
rs2237892-<b>C</b>,4 x 10-6,,NR,1.2,'-,[1.11-1.29],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST001070,11:2818521
rs7305618-<b>C</b>,2 x 10-8,,NR,1.14,'-,[1.09-1.20],HNF1A-AS1,Type 2 diabetes,type II diabetes mellitus,GCST001070,12:120965129
rs730570-<b>G</b>,8 x 10-6,,NR,1.14,'-,[1.08-1.21],"DLK1, LINC00523",Type 2 diabetes,type II diabetes mellitus,GCST001070,14:100676553
rs13266634-<b>C</b>,6 x 10-8,,0.7,1.18,'-,[0.69-1.67],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST000012,8:117172544
rs1111875-<b>G</b>,3 x 10-6,,0.6,1.19,'-,[0.82-1.56],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST000012,10:92703125
rs7903146-<b>T</b>,2 x 10-34,,0.3,1.65,'-,"[1.28, 2.02]",TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000012,10:112998590
rs1861612-<b>T</b>,7 x 10-8,,0.64,1.29,'-,[NR],DNER,Type 2 diabetes,type II diabetes mellitus,GCST002224,2:229657682
rs8181588-<b>A</b>,5 x 10-9,,0.48,1.3,'-,[NR],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002224,11:2810311
rs7903146-<b>?</b>,2 x 10-10,,0.3,1.38,'-,[NR],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000027,10:112998590
rs13266634-<b>C</b>,3 x 10-6,,0.67,1.15,'-,[1.08-1.22],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST000027,8:117172544
rs7756992-<b>G</b>,8 x 10-9,,0.26,1.2,'-,[1.13-1.27],'-,Type 2 diabetes,type II diabetes mellitus,GCST000027,Mapping not available
rs16862964-<b>G</b>,7 x 10-6,,0.262,2.59,'-,[1.71-3.94],"LINC01991, LPP-AS2",Type 2 diabetes (young onset) and obesity,"type II diabetes mellitus, obesity",GCST002339,3:188074923
rs6595551-<b>G</b>,6 x 10-6,,0.53,2.63,'-,[1.72-4.01],"ZNF608, LINC02240",Type 2 diabetes (young onset) and obesity,"type II diabetes mellitus, obesity",GCST002339,5:124804202
rs75493593-<b>?</b>,5 x 10-15,,NR,1.25,'-,[1.18-1.32],SLC16A11,Type 2 diabetes,type II diabetes mellitus,GCST002317,17:7041768
rs824248-<b>T</b>,8 x 10-6,,NR,1.18,'-,[1.10-1.26],MIR876,Type 2 diabetes,type II diabetes mellitus,GCST002317,9:28772702
rs7903146-<b>T</b>,1 x 10-14,,NR,1.37,'-,[1.27-1.48],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST002317,10:112998590
rs2237897-<b>C</b>,9 x 10-15,,NR,1.31,'-,[1.22-1.41],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002317,11:2837316
rs9362054-<b>T</b>,1 x 10-6,,0.291,1.4,'-,[NR],LINC01611,Diabetic retinopathy in type 2 diabetes,"diabetic retinopathy, type II diabetes mellitus",GCST002684,6:84468550
rs4077468-<b>A</b>,1 x 10-9,,0.58,1.39,'-,[1.25-1.54],"SLC26A9, RAB7B",Cystic fibrosis-related diabetes,"Cystic fibrosis, type II diabetes mellitus",GCST002025,1:205945629
rs10886471-<b>C</b>,7 x 10-9,,0.778,1.12,'-,[1.08-1.16],GRK5,Type 2 diabetes,type II diabetes mellitus,GCST001666,10:119389891
rs7403531-<b>T</b>,4 x 10-9,,0.346,1.1,'-,[1.06-1.13],RASGRP1,Type 2 diabetes,type II diabetes mellitus,GCST001666,15:38530704
rs10814916-<b>C</b>,6 x 10-12,,0.439,1.11,'-,[1.08-1.15],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST001666,9:4293150
rs2383208-<b>A</b>,3 x 10-17,,0.558,1.22,'-,[1.17-1.28],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST001666,9:22132077
rs11257655-<b>T</b>,7 x 10-9,,0.564,1.15,'-,[1.10-1.20],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST001666,10:12265895
rs4430796-<b>G</b>,2 x 10-11,,0.276,1.19,'-,[1.13-1.25],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST001666,17:37738049
rs12010175-<b>G</b>,2 x 10-9,,0.786,1.21,'-,[1.14-1.28],CCNQ,Type 2 diabetes,type II diabetes mellitus,GCST001666,X:153597180
rs5945326-<b>A</b>,7 x 10-16,,0.606,1.18,'-,[1.13-1.23],"KRT18P48, DUSP9",Type 2 diabetes,type II diabetes mellitus,GCST001666,X:153634467
rs7754840-<b>C</b>,7 x 10-10,,0.411,1.35,'-,[1.23-1.48],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST001666,6:20661019
rs2237892-<b>C</b>,1 x 10-7,,0.657,1.32,'-,[1.19-1.46],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST001666,11:2818521
rs1470579-<b>C</b>,5 x 10-14,,0.34,1.19,'-,[1.14-1.24],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST002128,3:185811292
rs6780569-<b>G</b>,4 x 10-7,,0.83,1.17,'-,[1.10-1.24],"RPL24P7, UBE2E2-AS1",Type 2 diabetes,type II diabetes mellitus,GCST002128,3:23156993
rs6815464-<b>G</b>,2 x 10-7,,0.64,1.1236,'-,[1.08-1.18],MAEA,Type 2 diabetes,type II diabetes mellitus,GCST002128,4:1316113
rs7754840-<b>C</b>,2 x 10-13,,0.42,1.18,'-,[1.13-1.23],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST002128,6:20661019
rs13266634-<b>C</b>,5 x 10-7,,0.58,1.12,'-,[1.07-1.17],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST002128,8:117172544
rs10811661-<b>T</b>,1 x 10-18,,0.55,1.23,'-,[1.18-1.29],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST002128,9:22134095
rs7903146-<b>T</b>,2 x 10-15,,0.04,1.48,'-,[1.34-1.63],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST002128,10:112998590
rs1111875-<b>C</b>,2 x 10-8,,0.29,1.14,'-,[1.09-1.20],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST002128,10:92703125
rs2237892-<b>C</b>,4 x 10-29,,0.61,1.3,'-,[1.24-1.36],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002128,11:2818521
rs7172432-<b>A</b>,1 x 10-6,,0.57,1.11,'-,[1.07-1.16],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST002128,15:62104190
rs2028299-<b>C</b>,3 x 10-6,,0.23,1.13,'-,[1.07-1.19],AP3S2,Type 2 diabetes,type II diabetes mellitus,GCST002128,15:89831025
rs4430796-<b>G</b>,4 x 10-6,,0.37,1.11,'-,[1.06-1.16],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST002128,17:37738049
rs5945326-<b>A</b>,2 x 10-12,,0.68,1.14,'-,[1.10-1.18],"KRT18P48, DUSP9",Type 2 diabetes,type II diabetes mellitus,GCST002128,X:153634467
rs791595-<b>A</b>,3 x 10-13,,0.08,1.17,'-,[1.12-1.22],"LEP, MIR129-1",Type 2 diabetes,type II diabetes mellitus,GCST002128,7:128222749
rs11787792-<b>A</b>,2 x 10-10,,0.874,1.15,'-,[1.10-1.20],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST002128,9:136357696
rs312457-<b>G</b>,8 x 10-13,,0.078,1.2,'-,[1.14-1.26],SLC16A13,Type 2 diabetes,type II diabetes mellitus,GCST002128,17:7037074
rs5219-<b>?</b>,1 x 10-9,(non-obese),NR,1.25,'-,[1.16-1.34],KCNJ11,Type 2 diabetes,type II diabetes mellitus,GCST000277,11:17388025
rs10811661-<b>?</b>,7 x 10-7,(non-obese),NR,1.26,'-,[1.15-1.38],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST000277,9:22134095
rs8050136-<b>?</b>,2 x 10-17,(obese),NR,1.3,'-,[1.23-1.39],FTO,Type 2 diabetes,type II diabetes mellitus,GCST000277,16:53782363
rs5219-<b>?</b>,5 x 10-7,(obese),NR,1.19,'-,[1.11-1.27],KCNJ11,Type 2 diabetes,type II diabetes mellitus,GCST000277,11:17388025
rs10946398-<b>?</b>,7 x 10-7,(non-obese),NR,1.18,'-,[1.11-1.26],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST000277,6:20660803
rs13266634-<b>?</b>,7 x 10-6,(non-obese),NR,1.18,'-,[1.10-1.27],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST000277,8:117172544
rs7903146-<b>?</b>,6 x 10-16,(obese),NR,1.31,'-,[1.23-1.40],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000277,10:112998590
rs7903146-<b>?</b>,9 x 10-30,(non-obese),NR,1.49,'-,[1.39-1.59],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000277,10:112998590
rs7744392-<b>G</b>,3 x 10-6,,NR,'-,'-,'-,PPARD,Cataracts in type 2 diabetes,"cataract, type II diabetes mellitus",GCST001736,6:35354986
rs8052123-<b>C</b>,5 x 10-6,,NR,'-,'-,'-,CCDC102A,Cataracts in type 2 diabetes,"cataract, type II diabetes mellitus",GCST001736,16:57529759
rs17428041-<b>T</b>,2 x 10-7,,0.7092,1.49,'-,[NR],"GFRA2, DOK2",Neuropathic pain in type 2 diabetes,"neuropathic pain, type II diabetes mellitus",GCST002507,8:21853920
rs11615866-<b>T</b>,1 x 10-6,,0.12,2.26,'-,[NR],LINC02443,Neuropathic pain in type 2 diabetes,"neuropathic pain, type II diabetes mellitus",GCST002507,12:5284163
rs7172432-<b>?</b>,9 x 10-14,,0.58,1.11,'-,[1.08-1.14],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST000787,15:62104190
rs2237897-<b>C</b>,1 x 10-16,,0.34,1.33,'-,[1.24-1.41],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST000221,11:2837316
rs4712524-<b>G</b>,3 x 10-10,,0.42,1.22,'-,[1.15-1.31],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST000221,6:20657634
rs6769511-<b>C</b>,1 x 10-9,,0.32,1.23,'-,[1.15-1.31],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST000221,3:185812502
rs8050136-<b>A</b>,7 x 10-14,,0.4,1.23,'-,[1.18-1.32],FTO,Type 2 diabetes,type II diabetes mellitus,GCST000025,16:53782363
rs4402960-<b>T</b>,9 x 10-16,(DGI+FUSION+WTCCC),0.32,1.14,'-,[1.11-1.18],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST000025,3:185793899
rs13266634-<b>C</b>,5 x 10-8,(DGI+FUSION+WTCCC),0.69,1.12,'-,[1.07-1.16],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST000025,8:117172544
rs10946398-<b>C</b>,1 x 10-8,,0.32,1.16,'-,[1.10-1.22],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST000025,6:20660803
rs5015480-<b>C</b>,5 x 10-6,,0.57,1.13,'-,[1.07-1.19],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST000025,10:92705802
rs7901695-<b>C</b>,1 x 10-48,(DGI+FUSION+WTCCC),NR,1.37,'-,[1.31-1.43],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000025,10:112994329
rs564398-<b>T</b>,1 x 10-6,,0.56,1.13,'-,[1.08-1.19],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST000025,9:22029548
rs5215-<b>C</b>,5 x 10-11,(DGI+FUSION+WTCCC),NR,1.14,'-,[1.10-1.19],'-,Type 2 diabetes,type II diabetes mellitus,GCST000025,Mapping not available
rs1801282-<b>C</b>,2 x 10-6,(DGI+FUSION+WTCCC),NR,1.14,'-,[1.08-1.20],'-,Type 2 diabetes,type II diabetes mellitus,GCST000025,Mapping not available
rs10811661-<b>T</b>,5 x 10-6,,0.83,1.19,'-,[1.11-1.28],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST000025,9:22134095
rs2237892-<b>C</b>,2 x 10-42,,0.61,1.45,'-,[1.34-1.47],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST000219,11:2818521
rs6712932-<b>?</b>,6 x 10-6,,NR,1.52,'-,[1.27-1.82],"GPR45, LINC01918",Type 2 diabetes,type II diabetes mellitus,GCST000049,2:105221141
rs7903146-<b>A</b>,5 x 10-8,,NR,1.71,'-,[1.41-2.08],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000049,10:112998590
rs7593730-<b>?</b>,4 x 10-8,,0.78,1.11,'-,[1.08-1.16],RBMS1,Type 2 diabetes,type II diabetes mellitus,GCST000665,2:160314943
rs5219-<b>T</b>,7 x 10-11,(DGI+FUSION+WTCCC),0.46,1.14,'-,[1.10-1.19],KCNJ11,Type 2 diabetes,type II diabetes mellitus,GCST000024,11:17388025
rs9300039-<b>C</b>,6 x 10-8,,0.89,1.48,'-,[1.28-1.71],"LINC02745, LINC01499",Type 2 diabetes,type II diabetes mellitus,GCST000024,11:41893816
rs4402960-<b>T</b>,9 x 10-16,(DGI+FUSION+WTCCC),0.3,1.14,'-,[1.11-1.18],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST000024,3:185793899
rs8050136-<b>A</b>,1 x 10-12,(DGI+FUSION+WTCCC),0.38,1.17,'-,[1.12-1.22],FTO,Type 2 diabetes,type II diabetes mellitus,GCST000024,16:53782363
rs1801282-<b>C</b>,2 x 10-6,(DGI+FUSION+WTCCC),0.82,1.14,'-,[1.08-1.20],'-,Type 2 diabetes,type II diabetes mellitus,GCST000024,Mapping not available
rs1111875-<b>C</b>,6 x 10-10,(DGI+FUSION+WTCCC),0.52,1.13,'-,[1.09-1.17],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST000024,10:92703125
rs10811661-<b>T</b>,8 x 10-15,(DGI+FUSION+WTCCC),0.85,1.2,'-,[1.14-1.25],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST000024,9:22134095
rs7754840-<b>C</b>,4 x 10-11,(DGI+FUSION+WTCCC),0.36,1.12,'-,[1.08-1.16],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST000024,6:20661019
rs7903146-<b>T</b>,1 x 10-8,,0.18,1.34,'-,[1.21-1.49],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000024,10:112998590
rs13266634-<b>C</b>,5 x 10-8,(DGI+FUSION+WTCCC),0.61,1.12,'-,[1.07-1.16],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST000024,8:117172544
rs2943641-<b>C</b>,9 x 10-12,,0.63,1.19,'-,[1.13-1.25],'-,Type 2 diabetes,type II diabetes mellitus,GCST000478,2:226229029
rs4689388-<b>T</b>,1 x 10-8,,0.57,1.16,'-,[1.10-1.21],"WFS1, LINC02495",Type 2 diabetes,type II diabetes mellitus,GCST000478,4:6268329
rs12518099-<b>C</b>,7 x 10-7,,0.23,1.16,'-,[1.10-1.22],LINC01339,Type 2 diabetes,type II diabetes mellitus,GCST000478,5:90250292
rs4712523-<b>G</b>,2 x 10-12,,0.32,1.2,'-,[1.14-1.26],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST000478,6:20657333
rs7903146-<b>T</b>,1 x 10-30,,0.27,1.48,'-,[1.39-1.57],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000478,10:112998590
rs13266634-<b>C</b>,8 x 10-8,,0.68,1.16,'-,[1.10-1.22],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST000478,8:117172544
rs7903146-<b>T</b>,2 x 10-15,,0.26 (EA+AA),1.46,'-,[NR],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST001326,10:112998590
rs6723108-<b>T</b>,7 x 10-8,(All South Asians),0.86,1.27,'-,[1.17-1.39],"TMEM163, CCNT2-AS1",Type 2 diabetes,type II diabetes mellitus,GCST001759,2:134722410
rs10461617-<b>A</b>,4 x 10-6,(All South Asians),0.21,1.17,'-,[1.09-1.25],MAP3K1,Type 2 diabetes,type II diabetes mellitus,GCST001759,5:56808481
rs11165354-<b>A</b>,4 x 10-6,(All South Asians),0.78,1.17,'-,[1.10-1.25],TGFBR3,Type 2 diabetes,type II diabetes mellitus,GCST001759,1:91728765
rs7903146-<b>T</b>,1 x 10-35,(Indo-European South Asians),0.3,1.51,'-,[1.42-1.62],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST001759,10:112998590
rs2383208-<b>T</b>,3 x 10-6,(Indo-European South Asians),0.85,1.23,'-,[1.13-1.34],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST001759,9:22132077
rs8050136-<b>A</b>,6 x 10-6,(Indo-European South Asians),0.34,1.16,'-,[1.09-1.24],FTO,Type 2 diabetes,type II diabetes mellitus,GCST001759,16:53782363
rs10906115-<b>A</b>,1 x 10-8,,0.57,1.13,'-,[1.08-1.18],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST000796,10:12272998
rs1359790-<b>G</b>,6 x 10-9,,0.71,1.15,'-,[1.10-1.20],'-,Type 2 diabetes,type II diabetes mellitus,GCST000796,13:80143021
rs5015480-<b>C</b>,9 x 10-6,,0.17,1.17,'-,[1.11-1.24],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST000796,10:92705802
rs1436955-<b>C</b>,7 x 10-7,,0.73,1.13,'-,[1.08-1.19],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST000796,15:62112183
rs515071-<b>?</b>,1 x 10-8,,0.794,1.18,'-,[1.12-1.25],ANK1,Type 2 diabetes,type II diabetes mellitus,GCST001461,8:41661944
rs7656416-<b>?</b>,1 x 10-8,,0.675,1.15,'-,[1.10-1.21],CTBP1-DT,Type 2 diabetes,type II diabetes mellitus,GCST001461,4:1260747
rs1327796-<b>?</b>,3 x 10-6,,0.235,1.13,'-,[1.08-1.20],PALM2AKAP2,Type 2 diabetes,type II diabetes mellitus,GCST001461,9:109764009
rs10993738-<b>?</b>,5 x 10-6,,0.152,1.16,'-,[1.09-1.23],SYK,Type 2 diabetes,type II diabetes mellitus,GCST001461,9:90870958
rs254271-<b>?</b>,4 x 10-7,(EA),NR,'-,'-,'-,PRPF31,Change in HbA1c levels in response to metformin treatment in type 2 diabetes,"HbA1c measurement, type II diabetes mellitus, response to metformin",GCST005753,19:54127382
rs10883365-<b>G</b>,6 x 10-8,,0.48,1.2,'-,[1.03-1.39],LINC01475,Crohn's disease,Crohn's disease,GCST000042,10:99528007
rs6596075-<b>C</b>,3 x 10-6,,0.17,1.55,'-,[1.00-2.39],"SLC22A5, IRF1-AS1",Crohn's disease,Crohn's disease,GCST000042,5:132406536
rs10210302-<b>T</b>,5 x 10-14,,0.48,1.19,'-,[1.01-1.41],ATG16L1,Crohn's disease,Crohn's disease,GCST000042,2:233250193
rs9858542-<b>A</b>,4 x 10-8,,0.28,1.09,'-,[0.96-1.24],BSN,Crohn's disease,Crohn's disease,GCST000042,3:49664550
rs1000113-<b>T</b>,3 x 10-7,,0.07,1.54,'-,[1.31-1.82],IRGM,Crohn's disease,Crohn's disease,GCST000042,5:150860514
rs2542151-<b>G</b>,2 x 10-7,,0.16,1.3,'-,[1.14-1.48],"PTPN2, LINC01882",Crohn's disease,Crohn's disease,GCST000042,18:12779948
rs9469220-<b>A</b>,2 x 10-6,,0.48,1.14,'-,[0.98-1.32],"MTCO3P1, HLA-DQB1",Crohn's disease,Crohn's disease,GCST000042,6:32690533
rs17221417-<b>G</b>,4 x 10-11,,0.29,1.29,'-,[1.13-1.46],NOD2,Crohn's disease,Crohn's disease,GCST000042,16:50705671
rs10761659-<b>G</b>,2 x 10-6,,0.46,1.23,'-,[1.05-1.45],ALDH7A1P4,Crohn's disease,Crohn's disease,GCST000042,10:62685804
rs11805303-<b>T</b>,6 x 10-12,,0.32,1.39,'-,[1.22-1.58],"IL23R, C1orf141",Crohn's disease,Crohn's disease,GCST000042,1:67209833
rs7807268-<b>G</b>,4 x 10-6,,0.46,1.38,'-,[1.20-1.60],RPL32P17,Crohn's disease,Crohn's disease,GCST000042,7:148560956
rs6601764-<b>C</b>,9 x 10-6,,0.41,1.16,'-,[1.01-1.33],"LINC02639, KLF6",Crohn's disease,Crohn's disease,GCST000042,10:3820350
rs17234657-<b>G</b>,2 x 10-12,,0.13,1.54,'-,[1.34-1.76],'-,Crohn's disease,Crohn's disease,GCST000042,5:40401407
rs17696736-<b>G</b>,2 x 10-14,,0.42,1.34,'-,[1.16-1.53],NAA25,Type 1 diabetes,type I diabetes mellitus,GCST000043,12:112049014
rs6534347-<b>A</b>,2 x 10-6,,0.35,1.3,'-,[1.10-1.55],KIAA1109,Type 1 diabetes,type I diabetes mellitus,GCST000043,4:122277280
rs6679677-<b>A</b>,5 x 10-26,,0.1,1.82,'-,[1.59-2.09],"RSBN1, PHTF1",Type 1 diabetes,type I diabetes mellitus,GCST000043,1:113761186
rs11171739-<b>C</b>,1 x 10-11,,0.42,1.34,'-,[1.17-1.54],ERBB3,Type 1 diabetes,type I diabetes mellitus,GCST000043,12:56076841
rs12708716-<b>A</b>,5 x 10-7,,0.65,1.19,'-,[0.97-1.45],CLEC16A,Type 1 diabetes,type I diabetes mellitus,GCST000043,16:11086016
rs11052552-<b>G</b>,7 x 10-7,,0.49,1.49,'-,[1.28-1.73],"LINC02390, CLEC2D",Type 1 diabetes,type I diabetes mellitus,GCST000043,12:9703362
rs17388568-<b>A</b>,3 x 10-6,,0.26,1.26,'-,[1.11-1.42],ADAD1,Type 1 diabetes,type I diabetes mellitus,GCST000043,4:122408207
rs3764021-<b>C</b>,5 x 10-8,,0.47,1.57,'-,[1.38-1.79],CLEC2D,Type 1 diabetes,type I diabetes mellitus,GCST000043,12:9681032
rs17166496-<b>G</b>,5 x 10-6,,0.61,1.3,'-,[1.15-1.47],FSTL4,Type 1 diabetes,type I diabetes mellitus,GCST000043,5:133293192
rs9272346-<b>G</b>,5 x 10-134,,0.61,5.49,'-,[4.83-6.24],HLA-DQA1,Type 1 diabetes,type I diabetes mellitus,GCST000043,6:32636595
rs6813195-<b>T</b>,2 x 10-15,,0.2913,'-,0.061 unit decrease,[0.045-0.077],"TMEM154, RPS3AP18",Type 2 diabetes,type II diabetes mellitus,GCST004894,4:152599323
rs702634-<b>A</b>,3 x 10-9,,0.6938,'-,0.05 unit increase,[0.034-0.066],ARL15,Type 2 diabetes,type II diabetes mellitus,GCST004894,5:53975590
rs459193-<b>G</b>,5 x 10-19,,0.7087,'-,0.075 unit increase,[0.059-0.091],"C5orf67, RPL26P19",Type 2 diabetes,type II diabetes mellitus,GCST004894,5:56510924
rs4457053-<b>A</b>,5 x 10-10,,0.67,'-,0.066 unit decrease,[0.044-0.088],ZBED3-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004894,5:77129124
rs329122-<b>A</b>,3 x 10-9,,0.43,1.04,'-,[1.03-1.06],JADE2,Type 2 diabetes,type II diabetes mellitus,GCST004894,5:134528909
rs9505118-<b>G</b>,2 x 10-8,,0.4165,'-,0.044 unit decrease,[0.028-0.06],SSR1,Type 2 diabetes,type II diabetes mellitus,GCST004894,6:7290204
rs7754840-<b>C</b>,2 x 10-56,,0.3181,'-,0.127 unit increase,[0.11-0.14],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST004894,6:20661019
rs3130501-<b>G</b>,4 x 10-12,,0.7833,'-,0.063 unit increase,[0.045-0.081],POU5F1,Type 2 diabetes,type II diabetes mellitus,GCST004894,6:31168676
rs2050188-<b>T</b>,8 x 10-9,,0.67,1.06,'-,[1.04-1.08],TSBP1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004894,6:32372120
rs1535500-<b>T</b>,5 x 10-7,,0.493,'-,0.053 unit increase,[0.031-0.075],KCNK16,Type 2 diabetes,type II diabetes mellitus,GCST004894,6:39316274
rs4897182-<b>G</b>,3 x 10-8,,0.4553,'-,0.047 unit increase,[0.031-0.063],"MIR588, CENPW",Type 2 diabetes,type II diabetes mellitus,GCST004894,6:126434496
rs622217-<b>T</b>,2 x 10-10,,0.52,1.05,'-,[1.03-1.07],"SLC22A2, SLC22A3",Type 2 diabetes,type II diabetes mellitus,GCST004894,6:160345738
rs17168486-<b>T</b>,1 x 10-12,,0.166,'-,0.065 unit increase,[0.047-0.083],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST004894,7:14858657
rs2191349-<b>T</b>,1 x 10-9,,0.505,'-,0.048 unit increase,[0.032-0.064],GTF3AP5,Type 2 diabetes,type II diabetes mellitus,GCST004894,7:15024684
rs864745-<b>C</b>,4 x 10-19,,0.5199,'-,0.07 unit decrease,[0.054-0.086],JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST004894,7:28140937
rs9648716-<b>T</b>,1 x 10-9,,0.15,1.06,'-,[1.04-1.09],BRAF,Type 2 diabetes,type II diabetes mellitus,GCST004894,7:140912363
rs12681990-<b>C</b>,3 x 10-9,,0.15,1.05,'-,[1.04-1.07],"SMARCE1P4, KCNU1",Type 2 diabetes,type II diabetes mellitus,GCST004894,8:37001668
rs516946-<b>C</b>,2 x 10-21,,0.7694,'-,0.086 unit increase,[0.068-0.104],ANK1,Type 2 diabetes,type II diabetes mellitus,GCST004894,8:41661730
rs896854-<b>C</b>,2 x 10-6,,0.5398,'-,0.038 unit decrease,[0.022-0.054],"NDUFAF6, TP53INP1",Type 2 diabetes,type II diabetes mellitus,GCST004894,8:94948283
rs13266634-<b>T</b>,4 x 10-42,,0.2833,'-,0.109 unit decrease,[0.093-0.125],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST004894,8:117172544
rs7041847-<b>G</b>,3 x 10-8,,0.4672,'-,0.043 unit decrease,[0.027-0.059],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST004894,9:4287466
rs10811661-<b>C</b>,2 x 10-68,,0.168,'-,0.174 unit decrease,[0.15-0.19],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004894,9:22134095
rs13292136-<b>T</b>,2 x 10-9,,0.0646,'-,0.094 unit decrease,[0.063-0.125],CHCHD2P9,Type 2 diabetes,type II diabetes mellitus,GCST004894,9:79337213
rs2796441-<b>A</b>,2 x 10-14,,0.4155,'-,0.057 unit decrease,[0.043-0.071],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST004894,9:81694033
rs11787792-<b>A</b>,2 x 10-12,,0.673,'-,0.108 unit increase,[0.079-0.137],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST004894,9:136357696
rs9940149-<b>G</b>,1 x 10-9,,0.83,1.05,'-,[1.04-1.07],FAM234A,Type 2 diabetes,type II diabetes mellitus,GCST004894,16:250642
rs8050136-<b>A</b>,3 x 10-39,,0.4135,'-,0.106 unit increase,[0.09-0.122],FTO,Type 2 diabetes,type II diabetes mellitus,GCST004894,16:53782363
rs7202877-<b>G</b>,4 x 10-6,,0.1034,'-,0.055 unit decrease,[0.031-0.079],"CTRB2, CTRB1",Type 2 diabetes,type II diabetes mellitus,GCST004894,16:75213347
rs2925979-<b>T</b>,2 x 10-8,,0.29,1.05,'-,[1.03-1.07],CMIP,Type 2 diabetes,type II diabetes mellitus,GCST004894,16:81501185
rs4430796-<b>A</b>,3 x 10-15,,0.5249,'-,0.083 unit decrease,[0.061-0.105],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST004894,17:37738049
rs12970134-<b>A</b>,3 x 10-12,,0.2674,'-,0.062 unit increase,[0.044-0.08],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST004894,18:60217517
rs11873305-<b>C</b>,4 x 10-7,,0.0308,'-,0.129 unit decrease,[0.08-0.178],MC4R,Type 2 diabetes,type II diabetes mellitus,GCST004894,18:60381959
rs12454712-<b>C</b>,4 x 10-8,,0.3857,'-,0.048 unit decrease,[0.03-0.066],BCL2,Type 2 diabetes,type II diabetes mellitus,GCST004894,18:63178651
rs3794991-<b>T</b>,4 x 10-9,,0.0775,'-,0.077 unit increase,[0.052-0.102],GATAD2A,Type 2 diabetes,type II diabetes mellitus,GCST004894,19:19499787
rs3786897-<b>G</b>,5 x 10-6,,0.4026,'-,0.037 unit decrease,[0.021-0.053],PEPD,Type 2 diabetes,type II diabetes mellitus,GCST004894,19:33402102
rs4420638-<b>G</b>,9 x 10-8,,0.1978,'-,0.077 unit decrease,[0.05-0.104],"APOC1, APOC1P1",Type 2 diabetes,type II diabetes mellitus,GCST004894,19:44919689
rs11671664-<b>A</b>,3 x 10-12,,0.1074,'-,0.076 unit increase,[0.054-0.098],GIPR,Type 2 diabetes,type II diabetes mellitus,GCST004894,19:45669020
rs4812829-<b>A</b>,4 x 10-10,,0.16,'-,0.057 unit increase,[0.039-0.075],HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST004894,20:44360627
rs7674212-<b>G</b>,7 x 10-9,(EA),0.58,1.07,'-,[1.04-1.09],SLC9B2,Type 2 diabetes,type II diabetes mellitus,GCST004894,4:103067742
rs2296172-<b>G</b>,3 x 10-6,(EA),0.1948,'-,0.0581 unit increase,[0.034-0.083],MACF1,Type 2 diabetes,type II diabetes mellitus,GCST004894,1:39370145
rs17106184-<b>A</b>,6 x 10-7,(EA),0.0964,'-,0.0897 unit decrease,[0.055-0.125],FAF1,Type 2 diabetes,type II diabetes mellitus,GCST004894,1:50444313
rs10923931-<b>T</b>,1 x 10-6,(EA),0.1093,'-,0.0769 unit increase,[0.046-0.108],NOTCH2,Type 2 diabetes,type II diabetes mellitus,GCST004894,1:119975336
rs340874-<b>C</b>,1 x 10-8,(EA),0.5308,'-,0.0597 unit increase,[0.039-0.08],"PROX1-AS1, PROX1",Type 2 diabetes,type II diabetes mellitus,GCST004894,1:213985913
rs780094-<b>C</b>,2 x 10-7,(EA),0.5895,'-,0.0552 unit increase,[0.035-0.076],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,Mapping not available
rs7578597-<b>C</b>,5 x 10-14,(EA),0.0905,'-,0.1377 unit decrease,[0.1-0.17],THADA,Type 2 diabetes,type II diabetes mellitus,GCST004894,2:43505684
rs243021-<b>A</b>,6 x 10-7,(EA),0.4473,'-,0.0768 unit increase,[0.047-0.107],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST004894,2:60357684
rs11123406-<b>C</b>,1 x 10-6,(EA),0.6382,'-,0.0494 unit decrease,[0.029-0.069],MIR4435-2HG,Type 2 diabetes,type II diabetes mellitus,GCST004894,2:111192964
rs3923113-<b>C</b>,4 x 10-10,(EA),0.4085,'-,0.0686 unit decrease,[0.047-0.09],"COBLL1, GRB14",Type 2 diabetes,type II diabetes mellitus,GCST004894,2:164645339
rs7607980-<b>C</b>,2 x 10-9,(EA),0.1541,'-,0.0927 unit decrease,[0.063-0.123],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,Mapping not available
rs7578326-<b>G</b>,3 x 10-13,(EA),0.3539,'-,0.0796 unit decrease,[0.058-0.101],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,2:226155937
rs11257655-<b>T</b>,3 x 10-29,,0.2266,'-,0.092 unit increase,[0.076-0.108],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST004894,10:12265895
rs12571751-<b>G</b>,2 x 10-20,,0.4503,'-,0.067 unit decrease,[0.053-0.081],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST004894,10:79182874
rs1111875-<b>T</b>,6 x 10-39,,0.4245,'-,0.102 unit decrease,[0.086-0.118],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST004894,10:92703125
rs7903146-<b>T</b>,1 x 10-219,,0.3171,'-,0.301 unit increase,[0.28-0.32],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST004894,10:112998590
rs2421016-<b>C</b>,4 x 10-11,,0.53,1.05,'-,[1.03-1.06],PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST004894,10:122407996
rs7111341-<b>T</b>,3 x 10-11,,0.2614,'-,0.067 unit increase,[0.047-0.087],"MIR4686, ASCL2",Type 2 diabetes,type II diabetes mellitus,GCST004894,11:2191936
rs231362-<b>G</b>,2 x 10-11,,0.498,'-,0.064 unit increase,[0.044-0.084],"KCNQ1OT1, KCNQ1",Type 2 diabetes,type II diabetes mellitus,GCST004894,11:2670241
rs2237892-<b>T</b>,2 x 10-63,,0.0626,'-,0.215 unit decrease,[0.19-0.24],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST004894,11:2818521
rs5215-<b>T</b>,1 x 10-20,,0.6471,'-,0.068 unit decrease,[0.054-0.082],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,Mapping not available
rs1552224-<b>C</b>,3 x 10-17,,0.1501,'-,0.097 unit decrease,[0.073-0.121],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST004894,11:72722053
rs10830963-<b>G</b>,4 x 10-18,,0.2883,'-,0.075 unit increase,[0.057-0.093],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST004894,11:92975544
rs11063069-<b>G</b>,3 x 10-8,,0.2018,'-,0.064 unit increase,[0.04-0.088],CCND2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:4265207
rs10842994-<b>T</b>,9 x 10-12,,0.2078,'-,0.069 unit decrease,[0.049-0.089],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:27812217
rs1531343-<b>C</b>,5 x 10-7,,0.1272,'-,0.069 unit increase,[0.042-0.096],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:65781114
rs7961581-<b>T</b>,7 x 10-6,,0.7018,'-,0.048 unit decrease,[0.026-0.07],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:71269322
rs7957197-<b>A</b>,1 x 10-9,,0.1988,'-,0.075 unit decrease,[0.051-0.099],OASL,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:121022883
rs4275659-<b>C</b>,2 x 10-7,,0.6899,'-,0.043 unit increase,[0.027-0.059],ABCB9,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:122963381
rs10507349-<b>G</b>,1 x 10-9,,0.78,1.05,'-,[1.04-1.07],RNF6,Type 2 diabetes,type II diabetes mellitus,GCST004894,13:26207391
rs576674-<b>G</b>,9 x 10-13,,0.16,1.07,'-,[1.05-1.10],"KL, TOMM22P3",Type 2 diabetes,type II diabetes mellitus,GCST004894,13:32980164
rs1359790-<b>A</b>,1 x 10-15,,0.2674,'-,0.071 unit decrease,[0.053-0.089],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,13:80143021
rs7985179-<b>T</b>,4 x 10-9,,0.72,1.07,'-,[1.05-1.10],"MIR17HG, PPIAP23",Type 2 diabetes,type II diabetes mellitus,GCST004894,13:91287915
rs7172432-<b>G</b>,5 x 10-9,,0.4115,'-,0.057 unit decrease,[0.037-0.077],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST004894,15:62104190
rs7178572-<b>G</b>,1 x 10-17,,0.4836,'-,0.065 unit increase,[0.049-0.081],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST004894,15:77454848
rs2028299-<b>A</b>,4 x 10-8,,0.7326,'-,0.062 unit decrease,[0.04-0.084],AP3S2,Type 2 diabetes,type II diabetes mellitus,GCST004894,15:89831025
rs8042680-<b>A</b>,2 x 10-9,,0.331,'-,0.057 unit increase,[0.039-0.075],"PRC1, PRC1-AS1",Type 2 diabetes,type II diabetes mellitus,GCST004894,15:90978107
rs3794991-<b>T</b>,9 x 10-13,(EA),0.0775,'-,0.1299 unit increase,[0.094-0.166],GATAD2A,Type 2 diabetes,type II diabetes mellitus,GCST004894,19:19499787
rs4420638-<b>G</b>,2 x 10-7,(EA),0.1978,'-,0.1028 unit decrease,[0.064-0.142],"APOC1, APOC1P1",Type 2 diabetes,type II diabetes mellitus,GCST004894,19:44919689
rs1470579-<b>C</b>,4 x 10-14,(South Asian),0.4571,'-,0.1264 unit increase,[0.094-0.159],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST004894,3:185811292
rs13266634-<b>T</b>,2 x 10-7,(South Asian),0.2546,'-,0.0955 unit decrease,[0.059-0.132],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST004894,8:117172544
rs10811661-<b>C</b>,9 x 10-11,(South Asian),0.1319,'-,0.1831 unit decrease,[0.13-0.24],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004894,9:22134095
rs7903146-<b>T</b>,3 x 10-23,(South Asian),0.2986,'-,0.1981 unit increase,[0.16-0.24],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST004894,10:112998590
rs7178572-<b>G</b>,6 x 10-7,(South Asian),0.4836,'-,0.0783 unit increase,[0.048-0.109],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST004894,15:77454848
rs2296172-<b>G</b>,6 x 10-7,,0.1948,'-,0.05 unit increase,[0.03-0.07],MACF1,Type 2 diabetes,type II diabetes mellitus,GCST004894,1:39370145
rs17106184-<b>A</b>,1 x 10-8,,0.0964,'-,0.08 unit decrease,[0.053-0.107],FAF1,Type 2 diabetes,type II diabetes mellitus,GCST004894,1:50444313
rs340874-<b>C</b>,6 x 10-10,,0.5308,'-,0.049 unit increase,[0.033-0.065],"PROX1-AS1, PROX1",Type 2 diabetes,type II diabetes mellitus,GCST004894,1:213985913
rs2867125-<b>C</b>,2 x 10-9,,0.83,1.06,'-,[1.04-1.08],"LINC01875, TMEM18",Type 2 diabetes,type II diabetes mellitus,GCST004894,2:622827
rs780094-<b>C</b>,2 x 10-17,,0.5895,'-,0.064 unit increase,[0.048-0.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,Mapping not available
rs7578597-<b>C</b>,6 x 10-11,,0.0905,'-,0.099 unit decrease,[0.07-0.128],THADA,Type 2 diabetes,type II diabetes mellitus,GCST004894,2:43505684
rs243021-<b>A</b>,2 x 10-7,,0.4473,'-,0.051 unit increase,[0.031-0.071],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST004894,2:60357684
rs11123406-<b>T</b>,9 x 10-9,,0.36,1.04,'-,[1.03-1.06],MIR4435-2HG,Type 2 diabetes,type II diabetes mellitus,GCST004894,2:111192964
rs3923113-<b>C</b>,1 x 10-13,,0.4085,'-,0.071 unit decrease,[0.051-0.091],"COBLL1, GRB14",Type 2 diabetes,type II diabetes mellitus,GCST004894,2:164645339
rs2943640-<b>C</b>,5 x 10-18,,0.6362,'-,0.078 unit increase,[0.060-0.096],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,2:226228869
rs1801282-<b>G</b>,2 x 10-19,,0.1203,'-,0.113 unit decrease,[0.088-0.138],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,Mapping not available
rs7612463-<b>A</b>,4 x 10-14,,0.1322,'-,0.098 unit decrease,[0.073-0.123],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST004894,3:23294959
rs11708067-<b>G</b>,5 x 10-20,,0.171,'-,0.095 unit decrease,[0.075-0.115],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST004894,3:123346931
rs1470579-<b>C</b>,1 x 10-45,,0.3042,'-,0.13 unit increase,[0.11-0.15],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST004894,3:185811292
rs6808574-<b>C</b>,1 x 10-6,,0.6054,'-,0.046 unit increase,[0.026-0.066],LINC01991,Type 2 diabetes,type II diabetes mellitus,GCST004894,3:188022735
rs6815464-<b>G</b>,1 x 10-8,,0.0258,'-,0.083 unit decrease,[0.054-0.112],MAEA,Type 2 diabetes,type II diabetes mellitus,GCST004894,4:1316113
rs4689388-<b>A</b>,1 x 10-15,,0.6193,'-,0.075 unit increase,[0.057-0.093],"WFS1, LINC02495",Type 2 diabetes,type II diabetes mellitus,GCST004894,4:6268329
rs2706785-<b>G</b>,2 x 10-8,,0.05,1.13,'-,[1.08-1.17],"ANXA5, SMIM43",Type 2 diabetes,type II diabetes mellitus,GCST004894,4:121739095
rs2943640-<b>C</b>,3 x 10-15,(EA),0.6362,'-,0.0822 unit increase,[0.062-0.103],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,2:226228869
rs1801282-<b>G</b>,2 x 10-14,(EA),0.1203,'-,0.1134 unit decrease,[0.084-0.142],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,Mapping not available
rs4607103-<b>T</b>,2 x 10-8,(EA),0.2326,'-,0.0648 unit decrease,[0.042-0.088],ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST004894,3:64726228
rs11708067-<b>G</b>,2 x 10-17,(EA),0.171,'-,0.1044 unit decrease,[0.08-0.129],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST004894,3:123346931
rs1470579-<b>C</b>,8 x 10-12,(EA),0.3042,'-,0.1031 unit increase,[0.074-0.133],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST004894,3:185811292
rs4689388-<b>A</b>,8 x 10-15,(EA),0.6193,'-,0.0835 unit increase,[0.063-0.104],"WFS1, LINC02495",Type 2 diabetes,type II diabetes mellitus,GCST004894,4:6268329
rs2706785-<b>G</b>,1 x 10-7,(EA),0.0487,'-,0.1282 unit increase,[0.081-0.176],"ANXA5, SMIM43",Type 2 diabetes,type II diabetes mellitus,GCST004894,4:121739095
rs2421016-<b>T</b>,2 x 10-8,(EA),0.4652,'-,0.0564 unit decrease,[0.037-0.076],PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST004894,10:122407996
rs702634-<b>A</b>,3 x 10-6,(EA),0.6938,'-,0.0498 unit increase,[0.029-0.071],ARL15,Type 2 diabetes,type II diabetes mellitus,GCST004894,5:53975590
rs459193-<b>G</b>,1 x 10-11,(EA),0.7087,'-,0.078 unit increase,[0.055-0.101],"C5orf67, RPL26P19",Type 2 diabetes,type II diabetes mellitus,GCST004894,5:56510924
rs4457053-<b>A</b>,9 x 10-11,(EA),0.67,'-,0.0796 unit decrease,[0.055-0.104],ZBED3-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004894,5:77129124
rs1552224-<b>C</b>,1 x 10-13,(EA),0.1501,'-,0.1011 unit decrease,[0.074-0.128],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST004894,11:72722053
rs9505118-<b>G</b>,1 x 10-9,(EA),0.4165,'-,0.0626 unit decrease,[0.042-0.083],SSR1,Type 2 diabetes,type II diabetes mellitus,GCST004894,6:7290204
rs7754840-<b>C</b>,2 x 10-31,(EA),0.3181,'-,0.1226 unit increase,[0.1-0.14],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST004894,6:20661019
rs2129869-<b>T</b>,2 x 10-7,(EA),0.2217,'-,0.077 unit increase,[0.048-0.106],"ITPR2, SSPN",Type 2 diabetes,type II diabetes mellitus,GCST004894,12:26304717
rs10842994-<b>T</b>,2 x 10-10,(EA),0.2078,'-,0.0809 unit decrease,[0.056-0.106],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:27812217
rs1531343-<b>C</b>,4 x 10-6,(EA),0.1272,'-,0.1121 unit increase,[0.064-0.16],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:65781114
rs7957197-<b>A</b>,3 x 10-9,(EA),0.1988,'-,0.0766 unit decrease,[0.051-0.102],OASL,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:121022883
rs4275659-<b>C</b>,2 x 10-7,(EA),0.6899,'-,0.0576 unit increase,[0.036-0.079],ABCB9,Type 2 diabetes,type II diabetes mellitus,GCST004894,12:122963381
rs10507349-<b>A</b>,2 x 10-6,(EA),0.2247,'-,0.0561 unit decrease,[0.033-0.079],RNF6,Type 2 diabetes,type II diabetes mellitus,GCST004894,13:26207391
rs576674-<b>A</b>,6 x 10-7,(EA),0.837,'-,0.0734 unit decrease,[0.045-0.102],"KL, TOMM22P3",Type 2 diabetes,type II diabetes mellitus,GCST004894,13:32980164
rs1359790-<b>A</b>,8 x 10-12,(EA),0.2674,'-,0.0766 unit decrease,[0.055-0.099],'-,Type 2 diabetes,type II diabetes mellitus,GCST004894,13:80143021
rs7985179-<b>A</b>,6 x 10-7,(EA),0.2783,'-,0.089 unit decrease,[0.054-0.124],"MIR17HG, PPIAP23",Type 2 diabetes,type II diabetes mellitus,GCST004894,13:91287915
rs7178572-<b>G</b>,2 x 10-8,(EA),0.6928,'-,0.0618 unit increase,[0.04-0.083],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST004894,15:77454848
rs8042680-<b>A</b>,6 x 10-9,(EA),0.331,'-,0.0627 unit increase,[0.042-0.084],"PRC1, PRC1-AS1",Type 2 diabetes,type II diabetes mellitus,GCST004894,15:90978107
rs9940149-<b>A</b>,4 x 10-6,(EA),0.173,'-,0.0622 unit decrease,[0.036-0.088],FAM234A,Type 2 diabetes,type II diabetes mellitus,GCST004894,16:250642
rs8050136-<b>A</b>,3 x 10-26,(EA),0.4135,'-,0.107 unit increase,[0.087-0.127],FTO,Type 2 diabetes,type II diabetes mellitus,GCST004894,16:53782363
rs7202877-<b>G</b>,5 x 10-10,(EA),0.1034,'-,0.1064 unit decrease,[0.073-0.14],"CTRB2, CTRB1",Type 2 diabetes,type II diabetes mellitus,GCST004894,16:75213347
rs13266634-<b>T</b>,2 x 10-22,(EA),0.2833,'-,0.1113 unit decrease,[0.089-0.134],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST004894,8:117172544
rs944801-<b>C</b>,1 x 10-11,(EA),0.5795,'-,0.0707 unit increase,[0.05-0.091],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST004894,9:22051671
rs79046683-<b>T</b>,3 x 10-8,,0.0048,2.34,'-,[1.73-3.16],"TMEM127, STARD7-AS1",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,2:96248180
rs113414093-<b>A</b>,7 x 10-9,,0.051,1.12,'-,[1.08-1.17],"MIR375, CRYBA2",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,2:218994449
rs4976033-<b>G</b>,1 x 10-9,,0.4105,1.05,'-,[1.03-1.06],'-,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,5:68418419
rs3934712-<b>C</b>,3 x 10-8,,0.2057,1.05,'-,[1.03-1.07],LINC02227,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,5:158501188
rs77136196-<b>T</b>,2 x 10-8,,0.042,1.11,'-,[1.07-1.16],"NUDT3, RPL35P2",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,6:34279270
rs2233632-<b>T</b>,5 x 10-7,,0.688,1.04,'-,[1.03-1.06],"SPDEF, IFITM3P3",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,6:34556921
rs2982521-<b>A</b>,1 x 10-9,,0.38,1.05,'-,[1.03-1.06],LINC01625,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,6:139514192
rs616279-<b>A</b>,7 x 10-7,,0.7379,1.04,'-,[1.03-1.06],FILNC1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,6:139928329
rs11202627-<b>T</b>,5 x 10-8,,0.1518,1.06,'-,[1.04-1.08],"MED6P1, PTEN",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,10:88009583
rs72631105-<b>A</b>,4 x 10-9,,0.1899,1.06,'-,[1.04-1.08],"LINC01153, RPL19P16",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,10:121155831
rs4923543-<b>A</b>,5 x 10-8,,0.332,1.04,'-,[1.03-1.06],METTL15,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,11:28513351
rs7978610-<b>G</b>,2 x 10-8,,0.6655,1.27,'-,[1.17-1.38],"RFLNA, ZNF664",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,12:123984025
rs825452-<b>A</b>,2 x 10-6,,0.6031,1.04,'-,[1.02-1.05],RFLNA,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,12:124024630
rs1641523-<b>C</b>,1 x 10-10,,0.4276,1.05,'-,[1.04-1.07],"ATP1B2, SHBG",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,17:7646363
rs62059712-<b>T</b>,5 x 10-6,,0.9184,1.07,'-,[1.04-1.10],KDM6B,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,17:7836852
rs6011155-<b>T</b>,6 x 10-6,,0.6297,1.04,'-,[1.02-1.05],ZBTB46,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,20:63819311
rs59944054-<b>A</b>,2 x 10-8,,0.2382,1.06,'-,[1.04-1.08],TCEA2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST009380,20:64061822
rs3768321-<b>T</b>,3 x 10-26,,0.2004,1.09,'-,[1.07-1.10],"PABPC4, PABPC4-AS1",Type 2 diabetes,type II diabetes mellitus,GCST009379,1:39570256
rs58432198-<b>C</b>,2 x 10-10,,0.8811,1.07,'-,[1.05-1.09],FAF1,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:50790419
rs12140153-<b>G</b>,1 x 10-8,,0.9051,1.07,'-,[1.04-1.09],PATJ,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:62114219
rs184660829-<b>C</b>,3 x 10-8,,2.00E-04,8.05,'-,[3.86-16.8],DENND2C,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:114602278
rs1127215-<b>C</b>,2 x 10-13,,0.5838,1.05,'-,[1.04-1.06],PTGFRN,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:116990168
rs1493694-<b>T</b>,3 x 10-16,,0.1089,1.09,'-,[1.07-1.11],NOTCH2,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:119984359
rs10305745-<b>A</b>,4 x 10-6,,0.0145,1.28,'-,[1.15-1.42],ARNT,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:150813562
rs145904381-<b>T</b>,3 x 10-8,,0.9867,1.19,'-,[1.12-1.26],BNIPL,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:151045515
rs11688931-<b>C</b>,8 x 10-6,,0.8494,1.04,'-,[1.02-1.06],"LINC01101, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST009379,2:120560590
rs11688682-<b>G</b>,4 x 10-9,,0.7278,1.05,'-,[1.03-1.06],Y_RNA,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:120590036
rs66477705-<b>T</b>,3 x 10-6,,0.967,1.09,'-,[1.05-1.13],"Y_RNA, LINC01871",Type 2 diabetes,type II diabetes mellitus,GCST009379,2:120621276
rs35999103-<b>T</b>,1 x 10-8,,0.1547,1.05,'-,[1.03-1.07],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:147104065
rs13426680-<b>A</b>,7 x 10-10,,0.9373,1.09,'-,[1.06-1.11],CYTIP,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:157483038
rs3772071-<b>T</b>,1 x 10-11,,0.7135,1.05,'-,[1.03-1.06],RBMS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:160279033
rs10195252-<b>T</b>,6 x 10-25,,0.5864,1.07,'-,[1.06-1.08],COBLL1,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:164656581
rs13024606-<b>T</b>,2 x 10-8,,0.0472,1.09,'-,[1.06-1.13],COBLL1,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:164716684
rs2972144-<b>G</b>,2 x 10-46,,0.6385,1.1,'-,[1.08-1.11],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:226236695
rs11709077-<b>G</b>,2 x 10-36,,0.8765,1.14,'-,[1.11-1.16],PPARG,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:12295008
rs17819328-<b>G</b>,5 x 10-16,,0.4249,1.06,'-,[1.04-1.07],"PPARG, TSEN2",Type 2 diabetes,type II diabetes mellitus,GCST009379,3:12447843
rs35352848-<b>T</b>,1 x 10-17,,0.7878,1.07,'-,[1.05-1.09],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:23414091
rs17013314-<b>G</b>,8 x 10-9,,0.0313,1.11,'-,[1.07-1.15],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:23468553
rs11926707-<b>C</b>,2 x 10-8,,0.6262,1.27,'-,[1.17-1.38],PTH1R,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:46884049
rs75423501-<b>G</b>,8 x 10-6,,0.1007,1.05,'-,[1.03-1.08],KIF9-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:47201433
rs4688760-<b>T</b>,4 x 10-10,,0.6842,1.04,'-,[1.03-1.06],RBM6,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:49943163
rs2581787-<b>T</b>,2 x 10-8,,0.5634,1.04,'-,[1.02-1.05],RFT1,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:53093661
rs76263492-<b>T</b>,6 x 10-9,,0.0452,1.09,'-,[1.06-1.13],CACNA2D3,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:54794800
rs3774723-<b>G</b>,2 x 10-13,,0.8442,1.07,'-,[1.05-1.09],ATXN7,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:63976663
rs74368513-<b>G</b>,7 x 10-6,,0.9956,1.31,'-,[1.16-1.47],"PRICKLE2-DT, RNU6-739P",Type 2 diabetes,type II diabetes mellitus,GCST009379,3:64475018
rs9860730-<b>A</b>,5 x 10-15,,0.7036,1.06,'-,[1.04-1.07],ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:64715470
rs13085136-<b>C</b>,2 x 10-8,,0.9283,1.08,'-,[1.05-1.10],SHQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:72816032
rs2272163-<b>C</b>,1 x 10-8,,0.6184,1.04,'-,[1.02-1.05],ROBO2,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:77622570
rs11708067-<b>A</b>,5 x 10-32,,0.7723,1.09,'-,[1.08-1.11],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:123346931
rs649961-<b>T</b>,1 x 10-9,,0.4651,1.04,'-,[1.03-1.05],SLC12A8,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:125207793
rs148766658-<b>C</b>,6 x 10-7,,0.0378,1.09,'-,[1.05-1.13],ANK1,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:41694528
rs11786992-<b>A</b>,5 x 10-6,,0.644,1.03,'-,[1.02-1.04],ESRP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:94672919
rs10097617-<b>T</b>,3 x 10-11,,0.4847,1.04,'-,[1.03-1.06],NDUFAF6,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:94949398
rs187936726-<b>G</b>,5 x 10-6,,0.0239,1.11,'-,[1.06-1.16],NDUFAF6,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:95080194
rs149364428-<b>A</b>,2 x 10-12,,0.0104,1.27,'-,[1.19-1.36],CPQ,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:96725513
rs12680028-<b>C</b>,3 x 10-8,,0.5342,1.04,'-,[1.02-1.05],TRHR,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:109110954
rs3802177-<b>G</b>,1 x 10-55,,0.6851,1.11,'-,[1.10-1.13],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:117172786
rs80244329-<b>G</b>,7 x 10-6,,0.9781,1.11,'-,[1.06-1.17],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:117392433
rs17772814-<b>G</b>,5 x 10-10,,0.9151,1.08,'-,[1.05-1.11],CASC11,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:127699497
rs1561927-<b>C</b>,2 x 10-9,,0.2686,1.04,'-,[1.03-1.06],LINC00824,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:128555832
rs4977213-<b>C</b>,9 x 10-14,,0.3749,1.05,'-,[1.04-1.07],BOP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:144283538
rs12719778-<b>T</b>,5 x 10-9,,0.5376,1.04,'-,[1.03-1.05],"Metazoa_SRP, ARHGAP39",Type 2 diabetes,type II diabetes mellitus,GCST009379,8:144654498
rs510807-<b>A</b>,1 x 10-6,,0.4906,1.03,'-,[1.02-1.04],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:3965689
rs79103584-<b>T</b>,4 x 10-6,,0.9862,1.14,'-,[1.08-1.21],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:4243045
rs10974438-<b>C</b>,2 x 10-14,,0.3567,1.05,'-,[1.04-1.07],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:4291928
rs7022807-<b>G</b>,3 x 10-10,,0.4014,1.04,'-,[1.03-1.05],HAUS6,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:19067835
rs7867635-<b>C</b>,4 x 10-8,,0.4123,1.04,'-,[1.02-1.05],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:20241071
rs7847880-<b>C</b>,2 x 10-6,,0.8431,1.04,'-,[1.03-1.06],FOCAD,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:20662704
rs1412830-<b>C</b>,9 x 10-8,,0.6278,1.04,'-,[1.02-1.05],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:22043613
rs76011118-<b>A</b>,1 x 10-7,,0.0341,1.11,'-,[1.07-1.15],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:22133774
rs10811660-<b>G</b>,1 x 10-115,,0.8282,1.27,'-,[1.24-1.29],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,Mapping not available
rs10757283-<b>T</b>,2 x 10-41,,0.4298,1.11,'-,[1.09-1.13],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:22134173
rs1333052-<b>A</b>,6 x 10-7,,0.6599,1.03,'-,[1.02-1.05],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:22157909
rs13262861-<b>C</b>,4 x 10-12,,0.8292,1.07,'-,[1.05-1.09],"ANK1, NKX6-3",Type 2 diabetes,type II diabetes mellitus,GCST009379,8:41651058
rs4736819-<b>T</b>,5 x 10-7,,0.5537,1.04,'-,[1.02-1.05],"ANK1, NKX6-3",Type 2 diabetes,type II diabetes mellitus,GCST009379,8:41652396
rs140242150-<b>A</b>,2 x 10-8,,0.005,1.36,'-,[1.22-1.52],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:112943203
rs7918400-<b>T</b>,2 x 10-15,,0.4761,1.06,'-,[1.04-1.07],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:112943377
rs184509201-<b>C</b>,1 x 10-13,,0.9818,1.21,'-,[1.15-1.27],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:112980578
rs180988137-<b>G</b>,6 x 10-6,,0.0104,1.17,'-,[1.09-1.25],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:112991414
rs7903146-<b>T</b>,6 x 10-447,,0.295,1.37,'-,[1.35-1.39],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:112998590
rs78025551-<b>C</b>,2 x 10-7,,0.851,1.05,'-,[1.03-1.07],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:112998197
rs34855922-<b>A</b>,6 x 10-12,,0.7162,1.05,'-,[1.04-1.07],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:113111835
rs2280141-<b>T</b>,1 x 10-13,,0.5161,1.05,'-,[1.03-1.06],PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:122433665
rs12802972-<b>A</b>,2 x 10-6,,0.4281,1.03,'-,[1.02-1.05],FAM99B,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:1683366
rs11042596-<b>G</b>,2 x 10-8,,0.6649,1.04,'-,[1.03-1.05],"H19, IGF2",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2097630
rs555759341-<b>C</b>,4 x 10-8,,0.0049,1.38,'-,[1.23-1.55],IGF2,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2130531
rs571342427-<b>C</b>,1 x 10-6,,0.0015,1.68,'-,[1.36-2.07],"INS, TH",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2161289
rs4929965-<b>A</b>,4 x 10-26,,0.3829,1.07,'-,[1.06-1.09],"MIR4686, ASCL2",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2176056
rs4930091-<b>C</b>,4 x 10-6,,0.7594,1.04,'-,[1.02-1.05],CD81-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2351126
rs2283164-<b>A</b>,1 x 10-7,,0.9468,1.08,'-,[1.05-1.12],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2557933
rs80102379-<b>G</b>,9 x 10-8,,0.9822,1.15,'-,[1.09-1.21],"KCNQ1OT1, KCNQ1",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2612947
rs231349-<b>T</b>,2 x 10-11,,0.1024,1.07,'-,[1.05-1.10],"KCNQ1OT1, KCNQ1",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2651591
rs231361-<b>A</b>,5 x 10-25,,0.2564,1.08,'-,[1.07-1.10],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2670270
rs2283220-<b>A</b>,1 x 10-9,,0.6896,1.05,'-,[1.03-1.06],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2734318
rs234853-<b>G</b>,7 x 10-16,,0.2482,1.08,'-,[1.06-1.10],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2829598
rs2237895-<b>C</b>,6 x 10-52,,0.426,1.12,'-,[1.11-1.14],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2835964
rs2237897-<b>C</b>,8 x 10-32,,0.9543,1.23,'-,[1.19-1.27],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2837316
rs445084-<b>G</b>,2 x 10-6,,0.3613,1.03,'-,[1.02-1.05],SLC22A18AS,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2887524
rs141521721-<b>A</b>,3 x 10-8,,0.0236,1.13,'-,[1.08-1.17],PDE3B,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:14742282
rs5213-<b>C</b>,4 x 10-27,,0.3624,1.07,'-,[1.06-1.09],KCNJ11,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:17386857
rs35895680-<b>C</b>,3 x 10-15,,0.678,1.06,'-,[1.04-1.07],"GIP, IGF2BP1",Type 2 diabetes,type II diabetes mellitus,GCST009379,17:48982960
rs569511541-<b>G</b>,2 x 10-8,,2.00E-04,7.63,'-,[3.78-15.4],CCDC47,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:54063444
rs2727301-<b>T</b>,1 x 10-6,,0.7538,1.04,'-,[1.02-1.05],"GH2, CSH1",Type 2 diabetes,type II diabetes mellitus,GCST009379,17:63887683
rs60276348-<b>T</b>,3 x 10-8,,0.1397,1.05,'-,[1.03-1.07],ERN1,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:64125944
rs11657492-<b>G</b>,6 x 10-8,,0.1002,1.06,'-,[1.04-1.08],PITPNC1,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:67652311
rs558308082-<b>C</b>,7 x 10-6,,8.00E-04,2.04,'-,[1.49-2.77],"RPL17P41, BPTF",Type 2 diabetes,type II diabetes mellitus,GCST009379,17:67824037
rs61676547-<b>C</b>,3 x 10-11,,0.1924,1.06,'-,[1.04-1.07],BPTF,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:67896391
rs7240767-<b>C</b>,2 x 10-8,,0.3762,1.04,'-,[1.02-1.05],LAMA1,Type 2 diabetes,type II diabetes mellitus,GCST009379,18:7070643
rs62080313-<b>C</b>,1 x 10-8,,0.1233,1.06,'-,[1.04-1.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,18:38698745
rs76197067-<b>G</b>,8 x 10-6,,5.00E-04,2.68,'-,[1.74-4.12],CCDC68,Type 2 diabetes,type II diabetes mellitus,GCST009379,18:54937724
rs72926932-<b>C</b>,1 x 10-14,,0.0839,1.09,'-,[1.07-1.12],TCF4,Type 2 diabetes,type II diabetes mellitus,GCST009379,18:55383415
rs28719468-<b>C</b>,2 x 10-6,,0.1586,1.04,'-,[1.02-1.06],"LINC01416, LINC01415",Type 2 diabetes,type II diabetes mellitus,GCST009379,18:55784913
rs17684074-<b>G</b>,3 x 10-8,,0.7403,1.04,'-,[1.03-1.06],WDR7,Type 2 diabetes,type II diabetes mellitus,GCST009379,18:57008153
rs9957145-<b>G</b>,8 x 10-9,,0.829,1.05,'-,[1.03-1.07],"GRP, SEC11C",Type 2 diabetes,type II diabetes mellitus,GCST009379,18:59208996
rs523288-<b>T</b>,8 x 10-13,,0.2377,1.05,'-,[1.04-1.07],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST009379,18:60181136
rs74452128-<b>C</b>,1 x 10-9,,0.9763,1.15,'-,[1.10-1.20],MC4R,Type 2 diabetes,type II diabetes mellitus,GCST009379,18:60389333
rs10469140-<b>G</b>,7 x 10-6,,0.4849,1.03,'-,[1.02-1.04],PHLPP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,18:63001037
rs12454712-<b>T</b>,5 x 10-13,,0.6142,1.05,'-,[1.04-1.06],BCL2,Type 2 diabetes,type II diabetes mellitus,GCST009379,18:63178651
rs7249758-<b>A</b>,3 x 10-9,,0.2039,1.05,'-,[1.03-1.07],UHRF1,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:4948850
rs116953931-<b>A</b>,6 x 10-6,,0.0371,1.08,'-,[1.04-1.12],PTPRS,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:5224987
rs75253922-<b>C</b>,3 x 10-8,,0.1909,1.05,'-,[1.03-1.06],INSR,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:7240837
rs4804833-<b>A</b>,8 x 10-13,,0.3902,1.05,'-,[1.03-1.06],MAP2K7,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:7905750
rs755734872-<b>T</b>,8 x 10-6,,5.00E-04,2.37,'-,[1.62-3.46],"RTBDN, HOOK2",Type 2 diabetes,type II diabetes mellitus,GCST009379,19:12827657
rs3111316-<b>A</b>,6 x 10-13,,0.5885,1.05,'-,[1.03-1.06],FARSA,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:12927601
rs8107974-<b>T</b>,3 x 10-15,,0.0769,1.1,'-,[1.07-1.12],SUGP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,19:19277691
rs9828772-<b>C</b>,4 x 10-8,,0.8983,1.06,'-,[1.04-1.08],"TMCC1, PLXND1",Type 2 diabetes,type II diabetes mellitus,GCST009379,3:129614339
rs559138871-<b>T</b>,7 x 10-6,,0.002,1.49,'-,[1.25-1.77],TMCC1,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:129751224
rs62271373-<b>A</b>,1 x 10-9,,0.0553,1.09,'-,[1.06-1.12],"TSC22D2, LINC01214",Type 2 diabetes,type II diabetes mellitus,GCST009379,3:150348753
rs13065698-<b>A</b>,8 x 10-13,,0.6002,1.05,'-,[1.03-1.06],MBNL1,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:152368744
rs74653713-<b>C</b>,1 x 10-8,,0.9571,1.1,'-,[1.06-1.13],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:152700092
rs35497231-<b>C</b>,8 x 10-8,,0.3169,1.04,'-,[1.02-1.05],ATP5MGP5,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:152715839
rs7629630-<b>A</b>,3 x 10-8,,0.8567,1.05,'-,[1.03-1.07],EGFEM1P,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:168501053
rs9873618-<b>G</b>,5 x 10-21,,0.71,1.07,'-,[1.05-1.08],SLC2A2,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:171015287
rs2872246-<b>A</b>,2 x 10-8,,0.4538,1.04,'-,[1.02-1.05],"ABCC5, EEF1A1P8",Type 2 diabetes,type II diabetes mellitus,GCST009379,3:184020672
rs6780171-<b>A</b>,9 x 10-56,,0.3138,1.14,'-,[1.12-1.16],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:185785668
rs150111048-<b>G</b>,3 x 10-7,,0.2388,1.12,'-,[1.07-1.16],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:185796633
rs11717959-<b>G</b>,3 x 10-6,,0.6208,1.04,'-,[1.02-1.06],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:185823425
rs1516728-<b>A</b>,6 x 10-6,,0.759,1.03,'-,[1.02-1.05],DGKG,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:186112102
rs3887925-<b>T</b>,3 x 10-22,,0.5468,1.07,'-,[1.05-1.08],ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:186947857
rs7645517-<b>A</b>,3 x 10-8,,0.0576,1.08,'-,[1.05-1.11],ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:186957489
rs4686471-<b>C</b>,2 x 10-20,,0.6104,1.06,'-,[1.05-1.08],LINC01991,Type 2 diabetes,type II diabetes mellitus,GCST009379,3:188023111
rs111827885-<b>C</b>,8 x 10-6,,0.0156,1.18,'-,[1.10-1.27],"TMEM271, PDE6B",Type 2 diabetes,type II diabetes mellitus,GCST009379,4:622819
rs1531583-<b>T</b>,4 x 10-14,,0.0458,1.13,'-,[1.09-1.16],PCGF3,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:751184
rs35654957-<b>C</b>,4 x 10-7,,0.367,1.03,'-,[1.02-1.05],FGFRL1,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:1016289
rs56337234-<b>C</b>,9 x 10-18,,0.5026,1.06,'-,[1.04-1.07],"FGFR3, TACC3",Type 2 diabetes,type II diabetes mellitus,GCST009379,4:1782676
rs362307-<b>T</b>,1 x 10-9,,0.0768,1.08,'-,[1.05-1.10],HTT,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:3240118
rs1801212-<b>A</b>,5 x 10-6,,0.7087,1.05,'-,[1.03-1.07],WFS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:6300792
rs10937721-<b>C</b>,2 x 10-8,,0.588,1.06,'-,[1.04-1.08],"PPP2R2C, WFS1",Type 2 diabetes,type II diabetes mellitus,GCST009379,4:6305036
rs12640250-<b>C</b>,4 x 10-8,,0.7149,1.04,'-,[1.03-1.05],"DCAF16, FAM184B",Type 2 diabetes,type II diabetes mellitus,GCST009379,4:17791246
rs10938398-<b>A</b>,4 x 10-12,,0.4289,1.05,'-,[1.03-1.06],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,4:45184122
rs2431115-<b>A</b>,4 x 10-10,,0.4015,1.04,'-,[1.03-1.06],C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:56552842
rs9687832-<b>A</b>,2 x 10-20,,0.1975,1.08,'-,[1.06-1.10],C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:56565768
rs96844-<b>G</b>,5 x 10-8,,0.2622,1.04,'-,[1.03-1.05],"SETD9, MAP3K1",Type 2 diabetes,type II diabetes mellitus,GCST009379,5:56900777
rs2307111-<b>T</b>,2 x 10-16,,0.6053,1.05,'-,[1.04-1.07],POC5,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:75707853
rs1316776-<b>C</b>,3 x 10-12,,0.6476,1.05,'-,[1.03-1.06],DMGDH,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:79134784
rs78408340-<b>G</b>,2 x 10-24,,0.0083,1.47,'-,[1.37-1.59],PAM,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:103003035
rs115505614-<b>T</b>,1 x 10-30,,0.0499,1.19,'-,[1.15-1.22],GIN1,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:103087264
rs601945-<b>G</b>,5 x 10-8,,0.1775,1.06,'-,[1.04-1.08],"HLA-DQA1, HLA-DRB1",Type 2 diabetes,type II diabetes mellitus,GCST009379,6:32605638
rs34298980-<b>T</b>,9 x 10-10,,0.4967,1.04,'-,[1.03-1.05],LRFN2,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:40441504
rs11967262-<b>G</b>,9 x 10-10,,0.4855,1.04,'-,[1.03-1.05],"VEGFA, LINC02537",Type 2 diabetes,type II diabetes mellitus,GCST009379,6:43792590
rs4457053-<b>G</b>,8 x 10-18,,0.3036,1.06,'-,[1.05-1.08],ZBED3-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:77129124
rs7719891-<b>G</b>,2 x 10-8,,0.2585,1.04,'-,[1.03-1.06],RASA1,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:87281535
rs138337556-<b>G</b>,5 x 10-9,,0.0036,1.56,'-,[1.34-1.81],OR7H2P,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:101897240
rs329122-<b>A</b>,4 x 10-9,,0.4286,1.04,'-,[1.03-1.05],JADE2,Type 2 diabetes,type II diabetes mellitus,GCST009379,5:134528909
rs112498319-<b>C</b>,4 x 10-7,,0.4085,1.03,'-,[1.02-1.05],"RREB1, RN7SL554P",Type 2 diabetes,type II diabetes mellitus,GCST009379,6:7035501
rs9379084-<b>G</b>,3 x 10-21,,0.8873,1.11,'-,[1.08-1.13],RREB1,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:7231610
rs9505097-<b>C</b>,9 x 10-10,,0.7994,1.05,'-,[1.03-1.07],"RREB1, SSR1",Type 2 diabetes,type II diabetes mellitus,GCST009379,6:7255417
rs7756992-<b>G</b>,2 x 10-88,,0.2735,1.15,'-,[1.13-1.17],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,Mapping not available
rs6458354-<b>C</b>,2 x 10-12,,0.289,1.05,'-,[1.04-1.07],LINC02537,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:43846453
rs3798519-<b>C</b>,3 x 10-12,,0.1844,1.06,'-,[1.04-1.08],TFAP2B,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:50821065
rs2465043-<b>G</b>,3 x 10-6,,0.6441,1.03,'-,[1.02-1.04],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:51315967
rs555402748-<b>T</b>,5 x 10-8,,4.00E-04,3.67,'-,[2.30-5.86],RNU7-66P,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:66677597
rs4946812-<b>G</b>,8 x 10-9,,0.6743,1.04,'-,[1.03-1.05],BEND3,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:107110484
rs11759026-<b>G</b>,2 x 10-18,,0.2321,1.07,'-,[1.05-1.08],MIR588,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:126470949
rs2800733-<b>A</b>,6 x 10-11,,0.7165,1.05,'-,[1.03-1.06],RSPO3,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:127095785
rs2066827-<b>G</b>,4 x 10-8,,0.235,1.05,'-,[1.03-1.06],CDKN1B,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:12718165
rs718314-<b>G</b>,8 x 10-11,,0.2532,1.05,'-,[1.03-1.06],"SSPN, ITPR2",Type 2 diabetes,type II diabetes mellitus,GCST009379,12:26300350
rs10842994-<b>C</b>,4 x 10-20,,0.8054,1.08,'-,[1.06-1.09],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:27812217
rs2258238-<b>T</b>,5 x 10-21,,0.1042,1.1,'-,[1.08-1.13],HMGA2,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:65827280
rs1042725-<b>T</b>,2 x 10-13,,0.4902,1.05,'-,[1.03-1.06],HMGA2,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:65964567
rs1796330-<b>G</b>,2 x 10-14,,0.5711,1.05,'-,[1.04-1.06],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:71129173
rs2197973-<b>T</b>,4 x 10-8,,0.5375,1.04,'-,[1.02-1.05],USP44,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:95534784
rs759111467-<b>A</b>,2 x 10-6,,3.00E-04,3.07,'-,[1.94-4.85],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:97168978
rs557027608-<b>A</b>,3 x 10-7,,6.00E-04,2.34,'-,[1.69-3.24],RMST,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:97385470
rs77864822-<b>A</b>,1 x 10-8,,0.9324,1.08,'-,[1.05-1.11],RMST,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:97454997
rs1426371-<b>G</b>,8 x 10-12,,0.7389,1.05,'-,[1.04-1.07],WSCD2,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:108236003
rs34965774-<b>A</b>,2 x 10-9,,0.1438,1.06,'-,[1.04-1.08],"KSR2, RFC5",Type 2 diabetes,type II diabetes mellitus,GCST009379,12:117974568
rs12578639-<b>A</b>,2 x 10-6,,0.8278,1.04,'-,[1.02-1.06],WSB2,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:118051831
rs11065299-<b>A</b>,6 x 10-7,,0.0754,1.06,'-,[1.04-1.09],SPPL3,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:120860012
rs73226260-<b>G</b>,6 x 10-11,,0.9669,1.13,'-,[1.09-1.17],HNF1A-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:120942738
rs1800574-<b>T</b>,2 x 10-12,,0.0296,1.14,'-,[1.10-1.19],"HNF1A-AS1, HNF1A",Type 2 diabetes,type II diabetes mellitus,GCST009379,12:120979061
rs56348580-<b>G</b>,2 x 10-13,,0.6889,1.05,'-,[1.04-1.07],HNF1A,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:120994314
rs28638142-<b>A</b>,3 x 10-6,,0.0442,1.08,'-,[1.04-1.11],"SNORA70, OASL2P",Type 2 diabetes,type II diabetes mellitus,GCST009379,12:121063658
rs73224262-<b>T</b>,9 x 10-7,,0.0068,1.24,'-,[1.14-1.34],KDM2B,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:121444592
rs4148856-<b>C</b>,2 x 10-10,,0.7814,1.05,'-,[1.03-1.07],ABCB9,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:122966218
rs12811407-<b>A</b>,2 x 10-12,,0.3305,1.05,'-,[1.04-1.07],FBRSL1,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:132493112
rs34584161-<b>A</b>,2 x 10-10,,0.7598,1.05,'-,[1.03-1.06],RNF6,Type 2 diabetes,type II diabetes mellitus,GCST009379,13:26202862
rs11842871-<b>G</b>,1 x 10-8,,0.7345,1.04,'-,[1.03-1.06],HMGB1,Type 2 diabetes,type II diabetes mellitus,GCST009379,13:30468315
rs576674-<b>G</b>,8 x 10-10,,0.1694,1.05,'-,[1.04-1.07],"KL, TOMM22P3",Type 2 diabetes,type II diabetes mellitus,GCST009379,13:32980164
rs963740-<b>A</b>,2 x 10-8,,0.7128,1.04,'-,[1.03-1.05],"DLEU7, DLEU1",Type 2 diabetes,type II diabetes mellitus,GCST009379,13:50521959
rs9537803-<b>C</b>,5 x 10-8,,0.2771,1.04,'-,[1.03-1.06],PCDH17,Type 2 diabetes,type II diabetes mellitus,GCST009379,13:57792500
rs9569864-<b>C</b>,9 x 10-8,,0.8247,1.05,'-,[1.03-1.06],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,13:58391301
rs9563615-<b>A</b>,6 x 10-11,,0.7101,1.05,'-,[1.03-1.06],RNY4P29,Type 2 diabetes,type II diabetes mellitus,GCST009379,13:58503272
rs76251711-<b>G</b>,2 x 10-6,,0.0126,1.16,'-,[1.09-1.23],CTAGE16P,Type 2 diabetes,type II diabetes mellitus,GCST009379,13:58610100
rs1359790-<b>G</b>,2 x 10-31,,0.7201,1.09,'-,[1.07-1.10],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,13:80143021
rs7987740-<b>T</b>,4 x 10-8,,0.6094,1.04,'-,[1.02-1.05],LINC00370,Type 2 diabetes,type II diabetes mellitus,GCST009379,13:109294865
rs4771648-<b>G</b>,9 x 10-8,,0.6685,1.04,'-,[1.02-1.05],IRS2,Type 2 diabetes,type II diabetes mellitus,GCST009379,13:109779279
rs17122772-<b>G</b>,2 x 10-8,,0.228,1.04,'-,[1.03-1.06],SLC7A7,Type 2 diabetes,type II diabetes mellitus,GCST009379,14:22819726
rs17522122-<b>T</b>,3 x 10-9,,0.4742,1.04,'-,[1.03-1.05],AKAP6,Type 2 diabetes,type II diabetes mellitus,GCST009379,14:32833676
rs8017808-<b>G</b>,2 x 10-8,,0.7431,1.04,'-,[1.03-1.06],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,14:38379215
rs17836088-<b>C</b>,7 x 10-14,,0.2171,1.06,'-,[1.04-1.08],NRXN3,Type 2 diabetes,type II diabetes mellitus,GCST009379,14:79465698
rs8010382-<b>G</b>,7 x 10-9,,0.4214,1.04,'-,[1.03-1.05],PPP4R3A,Type 2 diabetes,type II diabetes mellitus,GCST009379,14:91497378
rs62007683-<b>G</b>,3 x 10-8,,0.6532,1.04,'-,[1.02-1.05],MARK3,Type 2 diabetes,type II diabetes mellitus,GCST009379,14:103427734
rs8032939-<b>C</b>,4 x 10-14,,0.246,1.06,'-,[1.04-1.07],RASGRP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,15:38541832
rs34715063-<b>C</b>,2 x 10-19,,0.1235,1.1,'-,[1.07-1.12],"LINC02694, RASGRP1",Type 2 diabetes,type II diabetes mellitus,GCST009379,15:38580914
rs11070332-<b>A</b>,1 x 10-13,,0.3578,1.05,'-,[1.04-1.06],"RPAP1, LTK",Type 2 diabetes,type II diabetes mellitus,GCST009379,15:41517007
rs543786825-<b>T</b>,5 x 10-6,,4.00E-04,3.15,'-,[1.93-5.15],EHD4,Type 2 diabetes,type II diabetes mellitus,GCST009379,15:41909212
rs2456530-<b>T</b>,5 x 10-9,,0.1272,1.06,'-,[1.04-1.08],"ONECUT1, RPSAP55",Type 2 diabetes,type II diabetes mellitus,GCST009379,15:52799356
rs528350911-<b>G</b>,2 x 10-8,,0.0068,1.27,'-,[1.17-1.38],WDR72,Type 2 diabetes,type II diabetes mellitus,GCST009379,15:53455031
rs117483894-<b>G</b>,4 x 10-8,,0.0369,1.1,'-,[1.06-1.13],TCF12,Type 2 diabetes,type II diabetes mellitus,GCST009379,15:57164604
rs8037894-<b>G</b>,3 x 10-13,,0.5663,1.05,'-,[1.03-1.06],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST009379,15:62102065
rs7178762-<b>C</b>,5 x 10-10,,0.4595,1.04,'-,[1.03-1.05],"USP3, USP3-AS1",Type 2 diabetes,type II diabetes mellitus,GCST009379,15:63579093
rs4776970-<b>A</b>,5 x 10-9,,0.6406,1.04,'-,[1.03-1.05],MAP2K5,Type 2 diabetes,type II diabetes mellitus,GCST009379,15:67788548
rs13737-<b>G</b>,6 x 10-10,,0.7586,1.05,'-,[1.03-1.06],IMP3,Type 2 diabetes,type II diabetes mellitus,GCST009379,15:75639788
rs1005752-<b>A</b>,3 x 10-29,,0.7154,1.08,'-,[1.07-1.10],"LINGO1, HMG20A",Type 2 diabetes,type II diabetes mellitus,GCST009379,15:77525786
rs9494624-<b>A</b>,6 x 10-9,,0.2899,1.04,'-,[1.03-1.06],"RPL35AP3, NHEG1",Type 2 diabetes,type II diabetes mellitus,GCST009379,6:136979823
rs474513-<b>A</b>,8 x 10-10,,0.5169,1.04,'-,[1.03-1.05],SLC22A3,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:160349280
rs4709746-<b>C</b>,6 x 10-9,,0.8676,1.06,'-,[1.04-1.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:163711969
rs17168486-<b>T</b>,2 x 10-17,,0.1808,1.07,'-,[1.06-1.09],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:14858657
rs10228066-<b>T</b>,1 x 10-28,,0.5373,1.07,'-,[1.06-1.09],GTF3AP5,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:15023944
rs2908334-<b>T</b>,6 x 10-6,,0.6308,1.03,'-,[1.02-1.04],AGMO,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:15166614
rs78840640-<b>G</b>,3 x 10-6,,0.022,1.11,'-,[1.06-1.16],IGF2BP3,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:23394987
rs4279506-<b>G</b>,5 x 10-8,,0.6102,1.06,'-,[1.04-1.08],"RPS2P32, IGF2BP3",Type 2 diabetes,type II diabetes mellitus,GCST009379,7:23473277
rs1708302-<b>C</b>,1 x 10-48,,0.5124,1.1,'-,[1.08-1.11],JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:28159058
rs917195-<b>C</b>,4 x 10-11,,0.77,1.05,'-,[1.04-1.07],CRHR2,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:30688836
rs878521-<b>A</b>,2 x 10-13,,0.2451,1.06,'-,[1.04-1.07],"CAMK2B, YKT6",Type 2 diabetes,type II diabetes mellitus,GCST009379,7:44216044
rs116913033-<b>C</b>,7 x 10-6,,0.83,1.04,'-,[1.02-1.06],CAMK2B,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:44325950
rs56376556-<b>T</b>,2 x 10-6,,0.0533,1.08,'-,[1.04-1.11],PRKRIP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:102397871
rs11496066-<b>T</b>,1 x 10-8,,0.8181,1.08,'-,[1.05-1.11],FBXL13,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:102845807
rs62482405-<b>G</b>,7 x 10-6,,0.0819,1.05,'-,[1.03-1.08],PSMC2,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:103347136
rs39328-<b>T</b>,4 x 10-8,,0.4334,1.04,'-,[1.02-1.05],RELN,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:103804531
rs6976111-<b>A</b>,1 x 10-8,,0.3127,1.04,'-,[1.03-1.06],CTTNBP2,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:117855613
rs2268382-<b>C</b>,7 x 10-6,,0.3271,1.03,'-,[1.02-1.04],CPA1,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:130387196
rs1562396-<b>G</b>,1 x 10-17,,0.3186,1.06,'-,[1.05-1.08],"H4P1, KLF14",Type 2 diabetes,type II diabetes mellitus,GCST009379,7:130773155
rs62492368-<b>A</b>,1 x 10-10,,0.3081,1.05,'-,[1.03-1.06],AOC1,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:150840547
rs6459733-<b>G</b>,2 x 10-17,,0.6729,1.06,'-,[1.05-1.07],UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST009379,7:157137856
rs17689007-<b>G</b>,3 x 10-9,,0.5329,1.04,'-,[1.03-1.05],MSRA,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:10117314
rs57327348-<b>A</b>,5 x 10-8,,0.782,1.04,'-,[1.02-1.06],XKR6,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:10951177
rs10096633-<b>C</b>,1 x 10-12,,0.8766,1.07,'-,[1.05-1.09],LPL,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:19973410
rs10954772-<b>T</b>,2 x 10-9,,0.3135,1.04,'-,[1.03-1.06],PURG,Type 2 diabetes,type II diabetes mellitus,GCST009379,8:31006422
rs4932265-<b>T</b>,4 x 10-20,,0.2672,1.07,'-,[1.05-1.08],"AP3S2, ARPIN-AP3S2",Type 2 diabetes,type II diabetes mellitus,GCST009379,15:89880061
rs12910825-<b>G</b>,2 x 10-15,,0.3612,1.05,'-,[1.04-1.07],"PRC1-AS1, PRC1",Type 2 diabetes,type II diabetes mellitus,GCST009379,15:90968030
rs6600191-<b>T</b>,9 x 10-13,,0.8246,1.06,'-,[1.05-1.08],FAM234A,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:245796
rs3751837-<b>T</b>,1 x 10-8,,0.22,1.04,'-,[1.03-1.06],CLUAP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:3533173
rs8046545-<b>G</b>,2 x 10-8,,0.3589,1.04,'-,[1.02-1.05],ATP2A1,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:28903896
rs11642430-<b>G</b>,2 x 10-9,,0.399,1.04,'-,[1.03-1.05],TLCD3B,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:30034468
rs199795270-<b>C</b>,1 x 10-6,,0.0065,1.25,'-,[1.14-1.36],ZNF771,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:30408063
rs4281707-<b>G</b>,3 x 10-10,,0.5442,1.04,'-,[1.03-1.05],RBL2,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:53468034
rs78020297-<b>A</b>,7 x 10-9,,0.0517,1.09,'-,[1.06-1.12],FTO,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:53724808
rs1421085-<b>C</b>,3 x 10-84,,0.415,1.13,'-,[1.12-1.15],FTO,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:53767042
rs862320-<b>C</b>,4 x 10-11,,0.5783,1.04,'-,[1.03-1.06],NFAT5,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:69617963
rs72802342-<b>C</b>,4 x 10-32,,0.9231,1.17,'-,[1.14-1.20],"ZFP1, CTRB2",Type 2 diabetes,type II diabetes mellitus,GCST009379,16:75200974
rs3115960-<b>G</b>,3 x 10-6,,0.37,1.03,'-,[1.02-1.05],CHST6,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:75482636
rs2925979-<b>T</b>,1 x 10-14,,0.2996,1.05,'-,[1.04-1.07],CMIP,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:81501185
rs12920022-<b>A</b>,3 x 10-9,,0.1575,1.05,'-,[1.04-1.07],SPG7,Type 2 diabetes,type II diabetes mellitus,GCST009379,16:89497647
rs1043246-<b>G</b>,8 x 10-7,,0.1568,1.05,'-,[1.03-1.07],ATP2A3,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:3924792
rs3826482-<b>A</b>,2 x 10-7,,0.5756,1.03,'-,[1.02-1.05],ATP2A3,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:3957062
rs1377807-<b>C</b>,4 x 10-13,,0.3118,1.05,'-,[1.04-1.07],ZZEF1,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:4142146
rs7222481-<b>C</b>,1 x 10-8,,0.3238,1.04,'-,[1.03-1.05],GLP2R,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:9881870
rs4925109-<b>A</b>,3 x 10-12,,0.3164,1.05,'-,[1.03-1.06],RAI1,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:17758488
rs71372253-<b>C</b>,4 x 10-8,,0.0642,1.08,'-,[1.05-1.10],"RNF135, MIR4733HG",Type 2 diabetes,type II diabetes mellitus,GCST009379,17:31086001
rs10962-<b>C</b>,1 x 10-9,,0.2257,1.05,'-,[1.03-1.07],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:37686448
rs2189301-<b>G</b>,7 x 10-8,,0.8716,1.05,'-,[1.03-1.08],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:37703678
rs10908278-<b>T</b>,6 x 10-36,,0.4808,1.08,'-,[1.07-1.10],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST009379,17:37739961
rs34855406-<b>C</b>,2 x 10-12,,0.2772,1.05,'-,[1.04-1.07],"RETREG3, PSMC3IP",Type 2 diabetes,type II diabetes mellitus,GCST009379,17:42579393
rs1575972-<b>T</b>,3 x 10-7,,0.9671,1.1,'-,[1.06-1.14],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:22301093
rs1412234-<b>C</b>,2 x 10-10,,0.3229,1.04,'-,[1.03-1.06],LINGO2,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:28410685
rs12001437-<b>C</b>,3 x 10-10,,0.3722,1.04,'-,[1.03-1.06],"RN7SKP114, DCAF12",Type 2 diabetes,type II diabetes mellitus,GCST009379,9:34074478
rs11137820-<b>C</b>,3 x 10-8,,0.5751,1.04,'-,[1.02-1.05],MTND2P8,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:78744197
rs17791513-<b>A</b>,3 x 10-14,,0.9317,1.1,'-,[1.08-1.13],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:79290675
rs2796441-<b>G</b>,4 x 10-24,,0.5924,1.07,'-,[1.05-1.08],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST009379,9:81694033
rs55653563-<b>A</b>,2 x 10-9,,0.7321,1.04,'-,[1.03-1.06],LINC02603,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:94239400
rs12236906-<b>T</b>,3 x 10-6,,0.9872,1.15,'-,[1.08-1.22],AOPEP,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:94735212
rs505922-<b>C</b>,4 x 10-12,,0.3317,1.05,'-,[1.03-1.06],ABO,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:133273813
rs78403475-<b>G</b>,1 x 10-6,,0.8956,1.06,'-,[1.03-1.08],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:136341149
rs28505901-<b>G</b>,7 x 10-26,,0.752,1.09,'-,[1.07-1.11],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:136346577
rs11793035-<b>C</b>,2 x 10-7,,0.3311,1.04,'-,[1.02-1.05],LINC01451,Type 2 diabetes,type II diabetes mellitus,GCST009379,9:136612760
9:139737088:G:A-<b>A</b>,8 x 10-6,,7.00E-04,2.74,'-,[1.76-4.25],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,Mapping not available
rs11257655-<b>T</b>,2 x 10-32,,0.2184,1.09,'-,[1.08-1.11],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST009379,10:12265895
rs177045-<b>G</b>,7 x 10-18,,0.3155,1.07,'-,[1.05-1.08],"NEUROG3, TMEM256P1",Type 2 diabetes,type II diabetes mellitus,GCST009379,10:69561523
rs61850200-<b>C</b>,7 x 10-6,,0.2768,1.04,'-,[1.02-1.05],"NEUROG3, TMEM256P1",Type 2 diabetes,type II diabetes mellitus,GCST009379,10:69561902
rs41277236-<b>T</b>,2 x 10-6,,0.0431,1.09,'-,[1.05-1.12],NEUROG3,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:69572545
rs549498088-<b>T</b>,5 x 10-7,,0.006,1.56,'-,[1.31-1.86],"NEUROG3, MTATP6P23",Type 2 diabetes,type II diabetes mellitus,GCST009379,10:69587555
rs2642588-<b>G</b>,2 x 10-14,,0.7016,1.05,'-,[1.04-1.07],"LINC02651, RPL5P26",Type 2 diabetes,type II diabetes mellitus,GCST009379,10:69706822
rs703972-<b>G</b>,2 x 10-29,,0.533,1.07,'-,[1.06-1.09],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:79193069
rs1317617-<b>G</b>,2 x 10-6,,0.7976,1.04,'-,[1.02-1.06],"ZMIZ1, PPIF",Type 2 diabetes,type II diabetes mellitus,GCST009379,10:79336832
rs7078559-<b>T</b>,4 x 10-7,,0.5783,1.03,'-,[1.02-1.05],CPEB3,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:92164906
rs10882101-<b>T</b>,1 x 10-8,,0.5872,1.06,'-,[1.04-1.08],"Y_RNA, HHEX",Type 2 diabetes,type II diabetes mellitus,GCST009379,10:92702670
rs1112718-<b>A</b>,5 x 10-7,,0.5984,1.06,'-,[1.03-1.08],Y_RNA,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:92719350
rs536643418-<b>G</b>,3 x 10-8,,0.0052,1.5,'-,[1.30-1.73],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST009379,10:112940076
rs67254669-<b>G</b>,1 x 10-8,,0.0011,1.89,'-,[1.52-2.35],ABCC8,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:17448596
rs7943101-<b>T</b>,9 x 10-6,,0.1614,1.04,'-,[1.02-1.06],WT1-AS,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:32439327
rs145678014-<b>G</b>,2 x 10-10,,0.9567,1.11,'-,[1.07-1.14],QSER1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:32906232
rs528122639-<b>A</b>,2 x 10-7,,9.00E-04,2.09,'-,[1.59-2.76],TCP11L1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:33070189
rs286925-<b>A</b>,5 x 10-6,,0.1815,1.04,'-,[1.02-1.06],EHF,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:34621121
rs2767036-<b>C</b>,3 x 10-8,,0.2908,1.04,'-,[1.02-1.05],PDHX,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:34960601
rs1061810-<b>A</b>,6 x 10-13,,0.288,1.05,'-,[1.04-1.07],HSD17B12,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:43856384
rs7115753-<b>A</b>,4 x 10-9,,0.4494,1.04,'-,[1.03-1.05],MAPK8IP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:45890462
rs7124681-<b>A</b>,5 x 10-9,,0.4097,1.04,'-,[1.03-1.05],CELF1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:47508395
rs1783541-<b>T</b>,2 x 10-14,,0.2035,1.06,'-,[1.05-1.08],SCYL1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:65527328
rs61881115-<b>G</b>,4 x 10-7,,0.838,1.05,'-,[1.03-1.06],"MYEOV, SMIM38",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:69229758
rs11820019-<b>T</b>,5 x 10-12,,0.9733,1.16,'-,[1.11-1.20],CCND1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:69633990
rs77464186-<b>A</b>,5 x 10-33,,0.8363,1.11,'-,[1.09-1.13],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:72749353
rs10830963-<b>G</b>,5 x 10-43,,0.2765,1.1,'-,[1.09-1.12],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:92975544
rs57235767-<b>C</b>,6 x 10-10,,0.7057,1.04,'-,[1.03-1.06],"DEUP1, SLC36A4",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:93280365
rs10893829-<b>T</b>,1 x 10-10,,0.8533,1.06,'-,[1.04-1.08],LINC02725,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:128172680
rs10750397-<b>A</b>,8 x 10-13,,0.2817,1.05,'-,[1.04-1.07],ETS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:128364249
rs67232546-<b>T</b>,1 x 10-11,,0.207,1.06,'-,[1.04-1.07],"ETS1-AS1, ETS1",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:128529043
rs112595469-<b>T</b>,6 x 10-6,,0.0284,1.1,'-,[1.05-1.14],FLI1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:128714080
rs10848958-<b>C</b>,2 x 10-7,,0.8039,1.04,'-,[1.03-1.06],PARP11-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:3921938
rs11063028-<b>C</b>,9 x 10-11,,0.18,1.06,'-,[1.04-1.07],"HSPA8P5, CCND2-AS1",Type 2 diabetes,type II diabetes mellitus,GCST009379,12:4191006
rs4238013-<b>C</b>,3 x 10-11,,0.2087,1.06,'-,[1.04-1.07],CCND2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:4266923
rs3217792-<b>C</b>,3 x 10-21,,0.9131,1.12,'-,[1.10-1.15],"CCND2-AS1, CCND2",Type 2 diabetes,type II diabetes mellitus,GCST009379,12:4275530
rs76895963-<b>T</b>,1 x 10-69,,0.9802,1.62,'-,[1.54-1.71],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,Mapping not available
rs3217860-<b>G</b>,4 x 10-9,,0.258,1.05,'-,[1.03-1.06],CCND2,Type 2 diabetes,type II diabetes mellitus,GCST009379,12:4289884
rs539515-<b>C</b>,2 x 10-10,,0.1981,1.05,'-,[1.04-1.07],SEC16B,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:177919890
rs12048743-<b>G</b>,4 x 10-9,,0.4417,1.04,'-,[1.03-1.05],DSTYK,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:205145745
rs9430095-<b>C</b>,2 x 10-8,,0.494,1.04,'-,[1.02-1.05],SRGAP2,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:206420549
rs79687284-<b>C</b>,3 x 10-16,,0.0348,1.16,'-,[1.12-1.21],PROX1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:213977478
rs340874-<b>C</b>,2 x 10-22,,0.5555,1.07,'-,[1.05-1.08],"PROX1-AS1, PROX1",Type 2 diabetes,type II diabetes mellitus,GCST009379,1:213985913
rs114526150-<b>G</b>,4 x 10-7,,0.0225,1.12,'-,[1.07-1.17],PROX1,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:214002188
rs553014999-<b>C</b>,8 x 10-6,,0.0013,1.9,'-,[1.43-2.51],LYPLAL1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:219410822
rs2820446-<b>C</b>,3 x 10-16,,0.7055,1.06,'-,[1.04-1.07],ZC3H11B,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:219575476
rs348330-<b>G</b>,3 x 10-14,,0.3605,1.05,'-,[1.04-1.07],ABCB10,Type 2 diabetes,type II diabetes mellitus,GCST009379,1:229537208
rs291367-<b>G</b>,5 x 10-10,,0.6322,1.04,'-,[1.03-1.06],"MTND6P14, MTCYBP14",Type 2 diabetes,type II diabetes mellitus,GCST009379,1:235527499
rs62107261-<b>T</b>,4 x 10-12,,0.9536,1.12,'-,[1.08-1.15],"LINC01865, LINC01874",Type 2 diabetes,type II diabetes mellitus,GCST009379,2:422144
rs35913461-<b>C</b>,2 x 10-11,,0.8291,1.06,'-,[1.04-1.08],TMEM18,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:653575
rs11680058-<b>A</b>,1 x 10-8,,0.863,1.06,'-,[1.04-1.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:16393401
rs17802463-<b>G</b>,3 x 10-8,,0.7314,1.04,'-,[1.03-1.05],DTNB,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:25420352
rs1260326-<b>C</b>,7 x 10-25,,0.6069,1.07,'-,[1.06-1.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,Mapping not available
rs28525376-<b>G</b>,3 x 10-6,,0.4216,1.03,'-,[1.02-1.04],LINC01819,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:42980732
rs6708643-<b>A</b>,4 x 10-8,,0.5007,1.04,'-,[1.02-1.05],"ZFP36L2, LINC02580",Type 2 diabetes,type II diabetes mellitus,GCST009379,2:43203301
rs80147536-<b>A</b>,3 x 10-29,,0.9043,1.13,'-,[1.11-1.16],THADA,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:43470889
rs10193538-<b>T</b>,9 x 10-9,,0.6103,1.04,'-,[1.02-1.05],LINC01122,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:58753929
rs6545714-<b>G</b>,9 x 10-9,,0.392,1.04,'-,[1.02-1.05],LINC01122,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:59080590
rs243024-<b>A</b>,3 x 10-20,,0.4599,1.06,'-,[1.05-1.07],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:60356530
rs2249105-<b>A</b>,2 x 10-14,,0.6343,1.1,'-,[1.08-1.13],CEP68,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:65060762
rs2052261-<b>G</b>,3 x 10-6,,0.3038,1.07,'-,[1.04-1.09],RAB1A,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:65128136
rs2028150-<b>C</b>,2 x 10-12,,0.5979,1.05,'-,[1.03-1.06],SPRED2,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:65427878
rs562386202-<b>G</b>,4 x 10-8,,6.00E-04,3.2,'-,[2.11-4.86],'-,Type 2 diabetes,type II diabetes mellitus,GCST009379,2:117313485
rs149483638-<b>C</b>,6 x 10-14,,0.86,1.28,'-,[1.20-1.37],"IGF2, INS-IGF2",Type 2 diabetes,type II diabetes mellitus,GCST006145,11:2140300
rs34872471-<b>C</b>,3 x 10-23,(Japanese),NR,1.4288245,'-,[1.33153664655159-1.53322028389107],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST003400,10:112994312
rs2237896-<b>G</b>,3 x 10-70,(Japanese),NR,1.32546,'-,[1.28479-1.36741],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST003400,11:2837210
rs34773007-<b>A</b>,2 x 10-14,(Japanese),0.04,1.28,'-,[1.20-1.37],EXOC6,Type 2 diabetes,type II diabetes mellitus,GCST003400,10:92898450
rs77106637-<b>G</b>,3 x 10-6,(Japanese),NR,1.22079,'-,[1.12338-1.32665],"ARAP1, STARD10",Type 2 diabetes,type II diabetes mellitus,GCST003400,11:72767275
rs3751237-<b>T</b>,2 x 10-6,(Japanese),NR,1.08528,'-,[1.04907-1.12274],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST003400,12:27810574
rs11616380-<b>G</b>,3 x 10-6,(Japanese),NR,1.08429,'-,[1.04812-1.12172],'-,Type 2 diabetes,type II diabetes mellitus,GCST003400,13:80131180
rs79548680-<b>C</b>,4 x 10-6,(Japanese),NR,1.07581,'-,[1.04281-1.10986],RCCD1,Type 2 diabetes,type II diabetes mellitus,GCST003400,15:90962549
rs1421085-<b>C</b>,4 x 10-15,(Japanese),NR,1.1618342,'-,[1.1191628661761-1.20613294479771],FTO,Type 2 diabetes,type II diabetes mellitus,GCST003400,16:53767042
rs75418188-<b>T</b>,8 x 10-11,(Japanese),NR,1.1986958,'-,[1.13497329407839-1.26599585766155],SLC16A11,Type 2 diabetes,type II diabetes mellitus,GCST003400,17:7042164
rs10908278-<b>T</b>,4 x 10-15,(Japanese),NR,1.139592,'-,[1.10309893584046-1.17729192248239],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST003400,17:37739961
rs7507912-<b>G</b>,9 x 10-8,(Japanese),NR,1.11182,'-,[1.0695-1.15581],"RN7SL836P, GIPR",Type 2 diabetes,type II diabetes mellitus,GCST003400,19:45654658
rs8032416-<b>G</b>,5 x 10-9,(Japanese),NR,1.09767,'-,[1.06399-1.12331],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST003400,15:62116871
rs1116357-<b>G</b>,7 x 10-10,(Japanese),0.279,1.09,'-,[1.06-1.12],EIF2S2P7,Type 2 diabetes,type II diabetes mellitus,GCST003400,2:57060276
rs4731420-<b>C</b>,8 x 10-8,(Japanese),NR,1.1570164,'-,[1.09703252701443-1.22028007868366],"MIR129-1, LEP",Type 2 diabetes,type II diabetes mellitus,GCST003400,7:128223242
rs1575972-<b>T</b>,2 x 10-9,(Japanese),0.935,1.19,'-,[1.13-1.26],'-,Type 2 diabetes,type II diabetes mellitus,GCST003400,9:22301093
rs13266634-<b>C</b>,9 x 10-13,(Japanese),NR,1.12039,'-,[1.08602-1.15585],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST003400,8:117172544
rs67156297-<b>A</b>,2 x 10-8,(Japanese),0.087,1.14,'-,[1.09-1.19],"ATP8B2, RPSAP17",Type 2 diabetes,type II diabetes mellitus,GCST003400,1:154364240
rs2383208-<b>A</b>,5 x 10-33,(Japanese),NR,1.22274,'-,[1.18315-1.26366],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST003400,9:22132077
rs67839313-<b>C</b>,2 x 10-8,(Japanese),0.264,1.09,'-,[1.06-1.12],"CCDC9B, INAFM2",Type 2 diabetes,type II diabetes mellitus,GCST003400,15:40327523
rs35668226-<b>A</b>,3 x 10-7,(Japanese),0.792,1.09,'-,[1.05-1.13],RPL19P16,Type 2 diabetes,type II diabetes mellitus,GCST003400,10:121090153
rs377457-<b>A</b>,6 x 10-7,(Japanese),0.697,1.08,'-,[1.05-1.11],C16orf74,Type 2 diabetes,type II diabetes mellitus,GCST003400,16:85702046
rs79976124-<b>A</b>,2 x 10-6,(Japanese),0.063,1.14,'-,[1.08-1.12],ADH5P4,Type 2 diabetes,type II diabetes mellitus,GCST003400,6:65908764
rs73230612-<b>T</b>,3 x 10-6,(Japanese),0.634,1.07,'-,[1.04-1.09],ZBTB20,Type 2 diabetes,type II diabetes mellitus,GCST003400,3:115131989
rs2946504-<b>T</b>,4 x 10-6,(Japanese),0.401,1.06,'-,[1.04-1.09],TRMT9B,Type 2 diabetes,type II diabetes mellitus,GCST003400,8:12954071
rs2688419-<b>T</b>,5 x 10-6,(Japanese),0.652,1.07,'-,[1.04-1.1],"RPL24P7, SALL4P5",Type 2 diabetes,type II diabetes mellitus,GCST003400,3:23036270
rs67156297-<b>A</b>,5 x 10-6,,NR,1.05,'-,[ 1.03 - 1.08 ],"ATP8B2, RPSAP17",Type 2 diabetes,type II diabetes mellitus,GCST003400,1:154364240
rs7107784-<b>G</b>,1 x 10-11,,NR,1.07,'-,[ 1.05 - 1.09 ],"MIR4686, ASCL2",Type 2 diabetes,type II diabetes mellitus,GCST003400,11:2193859
rs67839313-<b>C</b>,2 x 10-10,,NR,1.06,'-,[ 1.04 - 1.08 ],"CCDC9B, INAFM2",Type 2 diabetes,type II diabetes mellitus,GCST003400,15:40327523
rs55783344-<b>T</b>,5 x 10-6,(Japanese),0.228,1.07,'-,[1.04-1.11],HNF1A,Type 2 diabetes,type II diabetes mellitus,GCST003400,12:120994496
rs78627331-<b>C</b>,2 x 10-14,(Japanese),0.032,1.33,'-,[1.24-1.44],EXOC6,Type 2 diabetes,type II diabetes mellitus,GCST003400,10:93052497
rs117601636-<b>A</b>,1 x 10-7,(Japanese),NR,1.15959,'-,[1.09783-1.22483],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST003400,11:2620807
rs35072907-<b>C</b>,1 x 10-7,(Japanese),NR,1.11071,'-,[1.06843-1.15466],FAF1,Type 2 diabetes,type II diabetes mellitus,GCST003400,1:50723884
rs780093-<b>C</b>,2 x 10-6,(Japanese),NR,1.0758183,'-,[1.04425991211509-1.10832920480705],GCKR,Type 2 diabetes,type II diabetes mellitus,GCST003400,2:27519736
rs1845900-<b>A</b>,2 x 10-14,(Japanese),NR,1.17954,'-,[1.13074-1.23045],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST003400,3:23413074
rs9828933-<b>T</b>,1 x 10-7,(Japanese),NR,1.09155,'-,[1.05659-1.12766],PSMD6,Type 2 diabetes,type II diabetes mellitus,GCST003400,3:64017221
rs79223353-<b>G</b>,7 x 10-6,(Japanese),NR,1.08275,'-,[1.04587-1.12092],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST003400,3:123421016
rs1470579-<b>C</b>,2 x 10-24,(Japanese),NR,1.176043,'-,[1.13996358956295-1.21326535811954],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST003400,3:185811292
rs73069940-<b>C</b>,1 x 10-12,(Japanese),NR,1.12862,'-,[1.0917-1.1668],CTBP1,Type 2 diabetes,type II diabetes mellitus,GCST003400,4:1242714
rs459193-<b>G</b>,1 x 10-10,(Japanese),NR,1.10572,'-,[1.07252-1.13996],"C5orf67, RPL26P19",Type 2 diabetes,type II diabetes mellitus,GCST003400,5:56510924
rs35612982-<b>C</b>,6 x 10-36,(Japanese),NR,1.2094473,'-,[1.17396934296458-1.24599723388614],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST003400,6:20682391
rs62481355-<b>T</b>,3 x 10-7,(Japanese),NR,1.0909,'-,[1.05521-1.12779],"GCC1, CACNA2D1",Type 2 diabetes,type II diabetes mellitus,GCST003400,7:127561610
rs806215-<b>C</b>,8 x 10-10,(Japanese),NR,1.10969,'-,[1.07348-1.14712],FSCN3,Type 2 diabetes,type II diabetes mellitus,GCST003400,7:127597258
rs147538848-<b>A</b>,8 x 10-10,(Japanese),0.184,1.11,'-,[1.07-1.15],SINHCAF,Type 2 diabetes,type II diabetes mellitus,GCST003400,12:31313679
rs12549902-<b>A</b>,1 x 10-12,(Japanese),NR,1.1138276,'-,[1.08115471648339-1.14748774769957],"ANK1, NKX6-3",Type 2 diabetes,type II diabetes mellitus,GCST003400,8:41651740
rs9309245-<b>G</b>,1 x 10-8,(Japanese),0.168,1.1,'-,[1.07-1.14],'-,Type 2 diabetes,type II diabetes mellitus,GCST003400,2:53169910
rs4258054-<b>T</b>,6 x 10-8,(Japanese),NR,1.10466,'-,[1.06565-1.1451],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST003400,9:4297892
rs7107784-<b>G</b>,2 x 10-8,(Japanese),0.09,1.14,'-,[1.09-1.2],"MIR4686, ASCL2",Type 2 diabetes,type II diabetes mellitus,GCST003400,11:2193859
rs13292262-<b>T</b>,6 x 10-6,(Japanese),NR,1.16969,'-,[1.09294-1.25182],CHCHD2P9,Type 2 diabetes,type II diabetes mellitus,GCST003400,9:79300468
rs2506125-<b>G</b>,3 x 10-6,(Japanese),NR,1.0772983,'-,[1.04424682653389-1.1113951343121],TLE1,Type 2 diabetes,type II diabetes mellitus,GCST003400,9:81678538
rs28642252-<b>G</b>,1 x 10-8,(Japanese),NR,1.15867,'-,[1.10166-1.21864],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST003400,9:136350837
rs11257655-<b>T</b>,1 x 10-12,(Japanese),NR,1.11739,'-,[1.08384-1.15199],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST003400,10:12265895
rs703980-<b>G</b>,3 x 10-8,(Japanese),NR,1.08981,'-,[1.05708-1.12355],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST003400,10:79184084
rs7087591-<b>G</b>,6 x 10-20,(Japanese),NR,1.1866591,'-,[1.14388991203487-1.23102679945342],Y_RNA,Type 2 diabetes,type II diabetes mellitus,GCST003400,10:92713872
rs1116357-<b>?</b>,5 x 10-6,,NR,1.04,'-,[ 1.02 - 1.06 ],EIF2S2P7,Type 2 diabetes,type II diabetes mellitus,GCST003400,2:57060276
rs147538848-<b>?</b>,8 x 10-13,,NR,1.11,'-,[ 1.08 - 1.14 ],SINHCAF,Type 2 diabetes,type II diabetes mellitus,GCST003400,12:31313679
rs1575972-<b>T</b>,6 x 10-15,,NR,1.15,'-,[ 1.11 - 1.19 ],'-,Type 2 diabetes,type II diabetes mellitus,GCST003400,9:22301093
rs11155073-<b>C</b>,1 x 10-12,,0.5159,'-,0.0275 unit decrease,[0.02-0.035],"LINC01625, ATP5PBP6",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:139515991
rs13365225-<b>G</b>,2 x 10-12,,0.2605,'-,0.0327 unit increase,[0.024-0.042],"KCNU1, SMARCE1P4",Type 2 diabetes,type II diabetes mellitus,GCST010557,8:37000965
rs654629-<b>G</b>,5 x 10-12,,0.6079,'-,0.0266 unit increase,[0.019-0.034],RPS6P12,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:82697160
rs13406280-<b>C</b>,6 x 10-12,,0.566,'-,0.0269 unit increase,[0.019-0.035],GALNT3,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:165754317
rs111765639-<b>G</b>,5 x 10-12,,0.876,'-,0.0581 unit increase,[0.042-0.075],JMJD1C,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:63211168
rs10818763-<b>C</b>,2 x 10-12,,0.676,'-,0.0358 unit increase,[0.026-0.046],ZBTB26,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:122927415
rs1567353-<b>G</b>,7 x 10-12,,0.3612,'-,0.0278 unit increase,[0.02-0.036],"H3P29, LINC01230",Type 2 diabetes,type II diabetes mellitus,GCST010557,9:1033773
rs41304257-<b>G</b>,8 x 10-12,,0.2441,'-,0.0318 unit decrease,[0.023-0.041],IPO9,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:201880798
rs2725370-<b>C</b>,3 x 10-12,,0.7126,'-,0.0319 unit decrease,[0.023-0.041],"PURG, TEX15",Type 2 diabetes,type II diabetes mellitus,GCST010557,8:30995310
rs7246440-<b>G</b>,4 x 10-12,,0.6201,'-,0.0299 unit increase,[0.021-0.038],ZNF799,Type 2 diabetes,type II diabetes mellitus,GCST010557,19:12395059
rs7752666-<b>C</b>,2 x 10-12,,0.7047,'-,0.0305 unit increase,[0.022-0.039],"BEND3, RNU6-1299P",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:107124062
rs3887059-<b>G</b>,5 x 10-12,,0.7364,'-,0.0295 unit decrease,[0.021-0.038],"RPL37P6, LINC00968",Type 2 diabetes,type II diabetes mellitus,GCST010557,8:56583505
rs4776970-<b>T</b>,1 x 10-12,,0.4472,'-,0.0287 unit decrease,[0.021-0.037],MAP2K5,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:67788548
rs3845843-<b>C</b>,2 x 10-12,,0.4918,'-,0.0264 unit decrease,[0.019-0.034],"NMI, TNFAIP6",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:151342084
rs12505942-<b>C</b>,2 x 10-12,,0.3133,'-,0.0294 unit decrease,[0.021-0.038],MAML3,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:139985236
rs2608953-<b>C</b>,3 x 10-12,,0.7889,'-,0.0348 unit decrease,[0.025-0.045],MED23,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:131605194
rs3020781-<b>G</b>,7 x 10-12,,0.3719,'-,0.0294 unit increase,[0.021-0.038],PKLR,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:155299985
rs6766859-<b>C</b>,8 x 10-12,,0.3864,'-,0.0275 unit increase,[0.02-0.035],"MRAS, NME9",Type 2 diabetes,type II diabetes mellitus,GCST010557,3:138336294
rs60251368-<b>G</b>,2 x 10-12,,0.0681,'-,0.0549 unit increase,[0.04-0.07],BRAF,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:140822273
rs152839-<b>C</b>,1 x 10-12,,0.6058,'-,0.0281 unit increase,[0.02-0.036],PARP8,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:50849432
rs2482506-<b>G</b>,2 x 10-12,,0.2389,'-,0.0316 unit decrease,[0.023-0.04],"WBP1L, RNU6-1231P",Type 2 diabetes,type II diabetes mellitus,GCST010557,10:102803986
rs187653072-<b>C</b>,2 x 10-12,,0.0271,'-,0.0967 unit increase,[0.07-0.124],"DNAJC2, PSMC2",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:103335938
rs7029718-<b>G</b>,1 x 10-12,,0.596,'-,0.0273 unit decrease,[0.02-0.035],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:23358497
rs2605281-<b>G</b>,7 x 10-12,,0.6128,'-,0.0283 unit decrease,[0.02-0.036],CWH43,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:49065306
rs5762925-<b>C</b>,8 x 10-12,,0.3776,'-,0.0267 unit increase,[0.019-0.034],ZNRF3,Type 2 diabetes,type II diabetes mellitus,GCST010557,22:28973410
rs6978327-<b>C</b>,5 x 10-9,,0.4111,'-,0.0233 unit decrease,[0.015-0.031],AOAH,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:36703281
rs2272163-<b>C</b>,4 x 10-9,,0.6367,'-,0.0235 unit increase,[0.016-0.031],ROBO2,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:77622570
rs11173646-<b>T</b>,1 x 10-9,,0.7362,'-,0.0285 unit decrease,[0.019-0.038],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:60857033
rs9991328-<b>C</b>,2 x 10-9,,0.4796,'-,0.0227 unit decrease,[0.015-0.03],FAM13A,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:88791970
rs35753840-<b>C</b>,1 x 10-9,,0.34,'-,0.0254 unit increase,[0.017-0.034],SGCZ,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:14291481
rs11199116-<b>C</b>,1 x 10-9,,0.1909,'-,0.0306 unit increase,[0.021-0.04],SEC23IP,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:119900888
rs28758542-<b>G</b>,2 x 10-9,,0.3408,'-,0.0256 unit decrease,[0.017-0.034],GACAT3,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:16097879
rs705145-<b>C</b>,3 x 10-9,,0.6475,'-,0.0234 unit decrease,[0.016-0.031],LINC02641,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:123466662
rs3735491-<b>C</b>,7 x 10-9,,0.6921,'-,0.025 unit decrease,[0.017-0.033],"CCM2, NACAD",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:45076869
rs6479591-<b>G</b>,1 x 10-9,,0.2053,'-,0.0326 unit decrease,[0.022-0.043],AOPEP,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:95033139
rs13238568-<b>G</b>,2 x 10-9,,0.381,'-,0.0248 unit increase,[0.017-0.033],GTF2I,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:74662156
rs117642733-<b>C</b>,9 x 10-9,,0.9584,'-,0.0762 unit decrease,[0.05-0.102],KCNJ12,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:21381598
rs10048404-<b>C</b>,6 x 10-9,,0.6597,'-,0.0313 unit increase,[0.021-0.042],WDR7,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:56911251
rs10159026-<b>C</b>,2 x 10-9,,0.7491,'-,0.0273 unit increase,[0.018-0.036],LINC02790,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:95938906
rs9411425-<b>G</b>,5 x 10-9,,0.3531,'-,0.0236 unit increase,[0.016-0.031],MED27,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:131993030
rs4129858-<b>G</b>,4 x 10-9,,0.4167,'-,0.0223 unit increase,[0.015-0.03],LAMC1,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:183035199
rs79598313-<b>C</b>,5 x 10-9,,0.9767,'-,0.0867 unit decrease,[0.058-0.116],KDF1,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:26958422
rs4252505-<b>G</b>,5 x 10-9,,0.1846,'-,0.0413 unit increase,[0.028-0.055],TRPV5,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:142910135
rs58090211-<b>C</b>,3 x 10-9,,0.8433,'-,0.0539 unit increase,[0.036-0.072],SLC1A2,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:35412165
rs6597649-<b>C</b>,2 x 10-9,,0.5196,'-,0.0234 unit decrease,[0.016-0.031],FIBCD1,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:130911265
rs4658234-<b>G</b>,9 x 10-9,,0.7716,'-,0.0295 unit decrease,[0.02-0.039],"HSP90B3P, WDR82P2",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:91583222
rs2633311-<b>C</b>,3 x 10-9,,0.4972,'-,0.0237 unit increase,[0.016-0.032],CAMK2G,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:73838341
rs858519-<b>C</b>,1 x 10-9,,0.5049,'-,0.024 unit decrease,[0.016-0.032],SHBG,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:7628647
rs4833687-<b>C</b>,3 x 10-9,,0.7415,'-,0.0267 unit decrease,[0.018-0.036],PRDM5,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:120844633
rs148106383-<b>C</b>,3 x 10-9,,0.9747,'-,0.0928 unit decrease,[0.062-0.123],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:39420085
rs993380-<b>G</b>,4 x 10-12,,0.6352,'-,0.0272 unit decrease,[0.02-0.035],SCD5,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:82663343
rs6021276-<b>C</b>,2 x 10-12,,0.6262,'-,0.0283 unit decrease,[0.02-0.036],NFATC2,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:51538847
rs34845373-<b>G</b>,5 x 10-12,,0.2557,'-,0.0334 unit decrease,[0.024-0.043],DTNB,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:25412902
rs8010382-<b>G</b>,3 x 10-12,,0.4692,'-,0.0266 unit increase,[0.019-0.034],PPP4R3A,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:91497378
rs7645613-<b>C</b>,2 x 10-12,,0.3572,'-,0.034 unit increase,[0.025-0.043],EIF4E2P2,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:115344825
rs11561066-<b>C</b>,3 x 10-12,,0.1301,'-,0.0451 unit increase,[0.032-0.058],"PHKG1P3, GTF2IP11",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:50151426
rs112324411-<b>C</b>,1 x 10-12,,0.9377,'-,0.0729 unit increase,[0.053-0.093],MEG3,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:100792247
rs117233795-<b>C</b>,1 x 10-12,,0.9555,'-,0.1426 unit increase,[0.1-0.18],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:84376801
chr8:97724430-<b>G</b>,6 x 10-12,,0.9921,'-,0.2392 unit decrease,[0.17-0.31],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,Mapping not available
rs149027146-<b>T</b>,2 x 10-12,,0.0602,'-,0.0738 unit increase,[0.053-0.094],"OR4C9P, OR4R1P",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:48467808
rs7554251-<b>C</b>,3 x 10-11,,0.7016,'-,0.0297 unit increase,[0.021-0.039],MTOR,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:11257875
rs6549112-<b>G</b>,2 x 10-11,,0.3328,'-,0.0268 unit decrease,[0.019-0.035],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:86707721
rs2188848-<b>G</b>,1 x 10-11,,0.2109,'-,0.0325 unit decrease,[0.023-0.042],STK31,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:23845078
rs2032217-<b>G</b>,3 x 10-11,,0.6671,'-,0.0268 unit decrease,[0.019-0.035],CDH7,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:65759743
rs9814945-<b>C</b>,3 x 10-11,,0.7128,'-,0.0316 unit decrease,[0.022-0.041],SHQ1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:72754439
rs2613499-<b>G</b>,1 x 10-11,,0.199,'-,0.0363 unit decrease,[0.026-0.047],"RPL31P12, NEGR1",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:72285869
rs2255703-<b>C</b>,4 x 10-11,,0.404,'-,0.0256 unit decrease,[0.018-0.033],PLXND1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:129574413
rs9587811-<b>C</b>,5 x 10-11,,0.5464,'-,0.0248 unit increase,[0.017-0.032],LINC00370,Type 2 diabetes,type II diabetes mellitus,GCST010557,13:109294534
rs61579137-<b>G</b>,5 x 10-11,,0.6599,'-,0.0309 unit decrease,[0.022-0.04],EHHADH-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:185164227
rs12918782-<b>G</b>,5 x 10-11,,0.2568,'-,0.0308 unit increase,[0.022-0.04],LMF1,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:917241
rs4671799-<b>G</b>,5 x 10-11,,0.6669,'-,0.0262 unit decrease,[0.018-0.034],LINC01829,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:67395111
rs112515915-<b>G</b>,3 x 10-11,,0.0691,'-,0.0562 unit decrease,[0.04-0.073],ZFPM2,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:104650145
rs10737818-<b>G</b>,2 x 10-11,,0.622,'-,0.0352 unit increase,[0.025-0.045],TBCE,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:235378708
rs2056857-<b>C</b>,5 x 10-11,,0.5888,'-,0.0256 unit increase,[0.018-0.033],LRRC74A,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:76834520
rs7742292-<b>C</b>,5 x 10-11,,0.4778,'-,0.0261 unit increase,[0.018-0.034],NHSL1,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:138543352
rs61736066-<b>G</b>,5 x 10-11,,0.881,'-,0.0421 unit increase,[0.03-0.055],SLC39A11,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:72648893
rs4343858-<b>G</b>,5 x 10-11,,0.7216,'-,0.0295 unit increase,[0.021-0.038],NSD1,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:177252406
rs4397977-<b>G</b>,1 x 10-11,,0.5764,'-,0.0283 unit decrease,[0.02-0.037],"MIR3168, RN7SL597P",Type 2 diabetes,type II diabetes mellitus,GCST010557,13:41114265
rs17662402-<b>C</b>,2 x 10-11,,0.053,'-,0.067 unit decrease,[0.047-0.087],RNU6-526P,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:9407595
rs7970687-<b>C</b>,3 x 10-11,,0.4978,'-,0.026 unit decrease,[0.018-0.034],ZNF10,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:133153914
rs3872707-<b>G</b>,1 x 10-11,,0.844,'-,0.037 unit decrease,[0.026-0.048],SETD5,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:9472332
rs28712435-<b>C</b>,6 x 10-11,,0.5483,'-,0.0254 unit increase,[0.018-0.033],"TM4SF4, WWTR1",Type 2 diabetes,type II diabetes mellitus,GCST010557,3:149503776
rs3755879-<b>G</b>,6 x 10-11,,0.6555,'-,0.0273 unit decrease,[0.019-0.036],UNC5C,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:95193234
rs2289739-<b>G</b>,4 x 10-11,,0.6873,'-,0.0364 unit decrease,[0.026-0.047],LTK,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:41509314
rs61817176-<b>C</b>,4 x 10-11,,0.4527,'-,0.0263 unit decrease,[0.018-0.034],SRGAP2,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:206447682
rs11646052-<b>G</b>,3 x 10-11,,0.4116,'-,0.026 unit increase,[0.018-0.034],GINS2,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:85682857
rs6714523-<b>G</b>,6 x 10-11,,0.8807,'-,0.0401 unit decrease,[0.028-0.052],"BMPR2, RN7SL40P",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:202370416
rs56799554-<b>G</b>,4 x 10-11,,0.1971,'-,0.0327 unit increase,[0.023-0.042],LINC00910,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:43379045
rs12746673-<b>C</b>,3 x 10-10,,0.2076,'-,0.0308 unit increase,[0.021-0.04],PLEKHM2,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:15723975
rs2240716-<b>C</b>,5 x 10-10,,0.7069,'-,0.0262 unit decrease,[0.018-0.034],ARVCF,Type 2 diabetes,type II diabetes mellitus,GCST010557,22:19982173
rs3122231-<b>C</b>,6 x 10-10,,0.6586,'-,0.0271 unit increase,[0.018-0.036],"ZNF239, ZNF487",Type 2 diabetes,type II diabetes mellitus,GCST010557,10:43531908
rs16881572-<b>G</b>,6 x 10-10,,0.9448,'-,0.0681 unit decrease,[0.047-0.09],PKHD1,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:51548215
rs2447198-<b>C</b>,5 x 10-10,,0.2235,'-,0.034 unit decrease,[0.023-0.045],"STRC, CKMT1B",Type 2 diabetes,type II diabetes mellitus,GCST010557,15:43602920
rs9257408-<b>G</b>,2 x 10-10,,0.4934,'-,0.0314 unit decrease,[0.022-0.041],"KRT18P1, LINC01556",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:28958443
rs3012060-<b>T</b>,6 x 10-10,,0.1852,'-,0.0342 unit increase,[0.023-0.045],LRMDA,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:75484578
rs6558173-<b>G</b>,7 x 10-10,,0.6556,'-,0.0245 unit decrease,[0.017-0.032],BIN3,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:22634590
rs9857204-<b>G</b>,2 x 10-10,,0.7085,'-,0.0272 unit decrease,[0.019-0.036],CPNE4,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:132032000
rs11913442-<b>C</b>,8 x 10-10,,0.3799,'-,0.0245 unit decrease,[0.017-0.032],"L3MBTL2, EP300-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010557,22:41197577
rs2513505-<b>C</b>,4 x 10-10,,0.4068,'-,0.024 unit decrease,[0.017-0.031],EMSY,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:76519313
rs9438610-<b>G</b>,7 x 10-10,,0.1966,'-,0.0313 unit decrease,[0.021-0.041],"PDIK1L, TRIM63",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:26069574
rs60573766-<b>C</b>,4 x 10-10,,0.635,1.04,'-,[1.03-1.06],LINC01141,Type 2 diabetes,type II diabetes mellitus,GCST010118,1:20361859
rs371894931-<b>CA</b>,3 x 10-11,,0.157,1.06,'-,[1.04-1.08],MACF1,Type 2 diabetes,type II diabetes mellitus,GCST010118,1:39476571
rs562138031-<b>C</b>,4 x 10-12,,0.726,1.06,'-,[1.04-1.07],"MAST2, IPP",Type 2 diabetes,type II diabetes mellitus,GCST010118,1:45779229
rs11205766-<b>T</b>,7 x 10-15,,0.903,1.09,'-,[1.07-1.12],FAF1,Type 2 diabetes,type II diabetes mellitus,GCST010118,1:50726263
rs2269245-<b>G</b>,5 x 10-10,,0.815,1.06,'-,[1.04-1.07],PGM1,Type 2 diabetes,type II diabetes mellitus,GCST010118,1:63642222
rs532504-<b>A</b>,7 x 10-12,,0.213,1.06,'-,[1.04-1.07],SEC16B,Type 2 diabetes,type II diabetes mellitus,GCST010118,1:177909798
rs1327123-<b>C</b>,7 x 10-9,,0.46,1.04,'-,[1.03-1.05],"TSEN15, COLGALT2",Type 2 diabetes,type II diabetes mellitus,GCST010118,1:184045459
rs201297151-<b>CAAAAAAAA</b>,3 x 10-8,,0.44,1.04,'-,[1.03-1.05],"PIK3C2B, MDM4",Type 2 diabetes,type II diabetes mellitus,GCST010118,1:204505454
rs12403994-<b>C</b>,6 x 10-12,,0.623,1.05,'-,[1.04-1.07],PROX1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010118,1:213982055
rs238763-<b>T</b>,5 x 10-11,,0.678,1.05,'-,[1.04-1.07],NUP133,Type 2 diabetes,type II diabetes mellitus,GCST010118,1:229506752
rs10634531-<b>CTTG</b>,2 x 10-17,,0.906,1.1,'-,[1.08-1.13],"LINC01875, TMEM18",Type 2 diabetes,type II diabetes mellitus,GCST010118,2:632790
rs1260326-<b>C</b>,1 x 10-21,,0.456,1.07,'-,[1.05-1.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST010118,Mapping not available
rs12712928-<b>C</b>,2 x 10-14,,0.402,1.06,'-,[1.04-1.07],"KRTCAP2P1, SIX3",Type 2 diabetes,type II diabetes mellitus,GCST010118,2:44964941
rs243018-<b>G</b>,2 x 10-15,,0.666,1.06,'-,[1.05-1.08],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST010118,2:60359572
rs3731600-<b>C</b>,7 x 10-9,,0.968,1.13,'-,[1.08-1.18],SCTR,Type 2 diabetes,type II diabetes mellitus,GCST010118,2:119473494
rs200576292-<b>CT</b>,1 x 10-9,,0.66,1.05,'-,[1.03-1.06],"RNU2-9P, EPC2",Type 2 diabetes,type II diabetes mellitus,GCST010118,2:148810693
rs75536691-<b>A</b>,1 x 10-15,,0.976,1.2,'-,[1.15-1.25],GRB14,Type 2 diabetes,type II diabetes mellitus,GCST010118,2:164525008
rs75179644-<b>T</b>,5 x 10-10,,0.899,1.08,'-,[1.05-1.10],"LINC01878, PCED1CP",Type 2 diabetes,type II diabetes mellitus,GCST010118,2:212822379
rs117809958-<b>A</b>,2 x 10-15,,0.018,1.25,'-,[1.18-1.32],ATG16L1,Type 2 diabetes,type II diabetes mellitus,GCST010118,2:233282457
rs3963364-<b>C</b>,3 x 10-11,,0.95,1.12,'-,[1.08-1.16],PPARG,Type 2 diabetes,type II diabetes mellitus,GCST010118,3:12343858
rs11926494-<b>G</b>,3 x 10-37,,0.82,1.12,'-,[1.10-1.14],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST010118,3:23217123
rs67114627-<b>AAG</b>,9 x 10-32,,0.646,1.09,'-,[1.07-1.10],ATXN7,Type 2 diabetes,type II diabetes mellitus,GCST010118,3:63919040
rs6806156-<b>T</b>,2 x 10-11,,0.611,1.05,'-,[1.03-1.06],EIF4E2P2,Type 2 diabetes,type II diabetes mellitus,GCST010118,3:115249171
rs9859381-<b>G</b>,3 x 10-9,,0.486,1.04,'-,[1.03-1.05],CASR,Type 2 diabetes,type II diabetes mellitus,GCST010118,3:122246352
rs60054445-<b>C</b>,6 x 10-12,,0.664,1.05,'-,[1.04-1.07],"ADCY5, HACD2",Type 2 diabetes,type II diabetes mellitus,GCST010118,3:123455985
rs12497133-<b>A</b>,1 x 10-8,,0.323,1.04,'-,[1.03-1.06],SLC12A8,Type 2 diabetes,type II diabetes mellitus,GCST010118,3:125203076
rs1850421-<b>A</b>,1 x 10-9,,0.278,1.05,'-,[1.03-1.06],'-,Type 2 diabetes,type II diabetes mellitus,GCST010118,3:152664563
rs201018682-<b>T</b>,1 x 10-11,,0.816,1.06,'-,[1.04-1.08],"EIF5A2, KLF7P1",Type 2 diabetes,type II diabetes mellitus,GCST010118,3:170925999
rs13092876-<b>A</b>,2 x 10-66,,0.312,1.13,'-,[1.12-1.15],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST010118,3:185777532
rs11332772-<b>C</b>,1 x 10-10,,0.557,1.05,'-,[1.03-1.06],ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST010118,3:186932143
rs13086331-<b>T</b>,7 x 10-9,,0.819,1.05,'-,[1.03-1.07],LINC01991,Type 2 diabetes,type II diabetes mellitus,GCST010118,3:187980545
rs9866168-<b>T</b>,2 x 10-9,,0.639,1.05,'-,[1.03-1.06],"TFRC, LINC00885",Type 2 diabetes,type II diabetes mellitus,GCST010118,3:196103439
rs7656416-<b>C</b>,9 x 10-42,,0.683,1.11,'-,[1.09-1.12],CTBP1-DT,Type 2 diabetes,type II diabetes mellitus,GCST010118,4:1260747
rs6831006-<b>G</b>,3 x 10-16,,0.274,1.07,'-,[1.05-1.09],"TACC3, FGFR3",Type 2 diabetes,type II diabetes mellitus,GCST010118,4:1782878
rs147834269-<b>G</b>,9 x 10-12,,0.978,1.23,'-,[1.16-1.30],WFS1,Type 2 diabetes,type II diabetes mellitus,GCST010118,4:6302004
rs10938398-<b>A</b>,4 x 10-10,,0.292,1.05,'-,[1.03-1.06],'-,Type 2 diabetes,type II diabetes mellitus,GCST010118,4:45184122
rs28599782-<b>A</b>,5 x 10-16,,0.209,1.07,'-,[1.05-1.09],MOB1B,Type 2 diabetes,type II diabetes mellitus,GCST010118,4:70978401
rs117624659-<b>T</b>,2 x 10-16,,0.977,1.23,'-,[1.17-1.29],NKX6-1,Type 2 diabetes,type II diabetes mellitus,GCST010118,4:84418465
rs10011838-<b>G</b>,1 x 10-27,,0.493,1.08,'-,[1.06-1.09],"TMEM154, RPS3AP18",Type 2 diabetes,type II diabetes mellitus,GCST010118,4:152599127
rs6885132-<b>C</b>,3 x 10-9,,0.556,1.04,'-,[1.03-1.06],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST010118,5:14767983
rs16902871-<b>G</b>,3 x 10-9,,0.149,1.06,'-,[1.04-1.08],RANBP3L,Type 2 diabetes,type II diabetes mellitus,GCST010118,5:36256916
rs74334916-<b>C</b>,4 x 10-8,,0.075,1.07,'-,[1.05-1.10],PARP8,Type 2 diabetes,type II diabetes mellitus,GCST010118,5:50783769
rs12109081-<b>T</b>,1 x 10-8,,0.361,1.04,'-,[1.03-1.06],'-,Type 2 diabetes,type II diabetes mellitus,GCST010118,5:52455740
rs256904-<b>T</b>,4 x 10-29,,0.492,1.08,'-,[1.06-1.09],C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST010118,5:56514478
rs2126736-<b>A</b>,2 x 10-8,,0.428,1.04,'-,[1.02-1.05],"ANKRD31, HMGCR",Type 2 diabetes,type II diabetes mellitus,GCST010118,5:75279159
rs6556925-<b>C</b>,3 x 10-9,,0.416,1.04,'-,[1.03-1.05],"CAST, PCSK1",Type 2 diabetes,type II diabetes mellitus,GCST010118,5:96512799
rs329122-<b>A</b>,2 x 10-8,,0.387,1.04,'-,[1.03-1.05],JADE2,Type 2 diabetes,type II diabetes mellitus,GCST010118,5:134528909
rs3135911-<b>A</b>,2 x 10-12,,0.432,1.05,'-,[1.04-1.06],"FGFR4, ZNF346",Type 2 diabetes,type II diabetes mellitus,GCST010118,5:177086895
rs9379084-<b>G</b>,2 x 10-14,,0.799,1.07,'-,[1.05-1.09],RREB1,Type 2 diabetes,type II diabetes mellitus,GCST010118,6:7231610
rs9350271-<b>A</b>,5 x 10-183,,0.423,1.21,'-,[1.20-1.23],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST010118,6:20682933
rs73085586-<b>G</b>,2 x 10-9,,0.644,1.04,'-,[1.03-1.06],LINC00261,Type 2 diabetes,type II diabetes mellitus,GCST010118,20:22449603
rs12625671-<b>C</b>,2 x 10-21,,0.442,1.07,'-,[1.05-1.08],HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST010118,20:44366172
rs13040225-<b>A</b>,2 x 10-14,,0.513,1.05,'-,[1.04-1.07],"PELATON, CEBPB",Type 2 diabetes,type II diabetes mellitus,GCST010118,20:50214235
rs6021276-<b>T</b>,7 x 10-10,,0.41,1.04,'-,[1.03-1.06],NFATC2,Type 2 diabetes,type II diabetes mellitus,GCST010118,20:51538847
rs11477757-<b>TC</b>,1 x 10-8,,0.669,1.06,'-,[1.04-1.08],GNAS,Type 2 diabetes,type II diabetes mellitus,GCST010118,20:58902123
rs147413364-<b>T</b>,3 x 10-8,,0.357,1.04,'-,[1.03-1.06],ZNRF3,Type 2 diabetes,type II diabetes mellitus,GCST010118,22:28984132
rs28637892-<b>T</b>,4 x 10-9,,0.215,1.05,'-,[1.04-1.07],"ATXN10, WNT7B",Type 2 diabetes,type II diabetes mellitus,GCST010118,22:45917738
rs28691713-<b>C</b>,2 x 10-17,,0.555,1.07,'-,[1.05-1.08],PIM3,Type 2 diabetes,type II diabetes mellitus,GCST010118,22:49962654
rs76541615-<b>T</b>,1 x 10-17,,0.796,1.08,'-,[1.06-1.09],HCG22,Type 2 diabetes,type II diabetes mellitus,GCST010118,6:31058459
rs4711389-<b>A</b>,7 x 10-17,,0.893,1.1,'-,[1.07-1.12],SMIM29,Type 2 diabetes,type II diabetes mellitus,GCST010118,6:34246893
rs742762-<b>A</b>,2 x 10-22,,0.712,1.08,'-,[1.06-1.09],GLP1R,Type 2 diabetes,type II diabetes mellitus,GCST010118,6:39078868
rs62405419-<b>T</b>,4 x 10-9,,0.268,1.05,'-,[1.03-1.06],TFAP2B,Type 2 diabetes,type II diabetes mellitus,GCST010118,6:50819746
rs80196932-<b>T</b>,8 x 10-13,,0.786,1.06,'-,[1.04-1.08],"NEPNP, NUS1",Type 2 diabetes,type II diabetes mellitus,GCST010118,6:117675468
rs4273712-<b>G</b>,3 x 10-12,,0.469,1.05,'-,[1.03-1.06],"RNU6-200P, PRELID1P1",Type 2 diabetes,type II diabetes mellitus,GCST010118,6:126643364
rs7739842-<b>G</b>,2 x 10-11,,0.356,1.05,'-,[1.03-1.06],ENPP3,Type 2 diabetes,type II diabetes mellitus,GCST010118,6:131633657
rs35389258-<b>T</b>,9 x 10-14,,0.45,1.05,'-,[1.04-1.07],"RPL35AP3, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST010118,6:136973635
rs9376382-<b>C</b>,2 x 10-8,,0.599,1.04,'-,[1.03-1.05],ECT2L,Type 2 diabetes,type II diabetes mellitus,GCST010118,6:138884249
rs9390022-<b>T</b>,6 x 10-9,,0.8,1.05,'-,[1.03-1.07],HIVEP2,Type 2 diabetes,type II diabetes mellitus,GCST010118,6:142735419
rs7787720-<b>T</b>,2 x 10-15,,0.421,1.06,'-,[1.04-1.07],ETV1,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:13847029
rs17168486-<b>T</b>,8 x 10-22,,0.418,1.07,'-,[1.05-1.08],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:14858657
rs3735567-<b>G</b>,3 x 10-12,,0.778,1.06,'-,[1.04-1.08],JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:28179691
rs2908279-<b>G</b>,8 x 10-11,,0.627,1.05,'-,[1.03-1.06],"RNA5SP230, MYL7",Type 2 diabetes,type II diabetes mellitus,GCST010118,7:44135258
rs565050730-<b>GA</b>,4 x 10-8,,0.334,1.04,'-,[1.03-1.06],ZNF713,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:55917261
rs610930-<b>A</b>,1 x 10-19,,0.287,1.07,'-,[1.05-1.08],AUTS2,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:69724740
rs12698877-<b>G</b>,7 x 10-22,,0.336,1.07,'-,[1.06-1.08],AUTS2,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:70231919
rs62469016-<b>C</b>,2 x 10-15,,0.223,1.07,'-,[1.05-1.08],"STEAP2-AS1, DPY19L2P4",Type 2 diabetes,type II diabetes mellitus,GCST010118,7:90122924
rs2074120-<b>A</b>,8 x 10-9,,0.323,1.04,'-,[1.03-1.06],CALCR,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:93477781
rs75990271-<b>T</b>,3 x 10-11,,0.815,1.07,'-,[1.05-1.09],"FAM185A, RASA4DP",Type 2 diabetes,type II diabetes mellitus,GCST010118,7:102696532
rs117737118-<b>G</b>,3 x 10-31,,0.093,1.18,'-,[1.14-1.21],GRM8,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:126886937
rs2233580-<b>T</b>,3 x 10-132,,0.086,1.34,'-,[1.31-1.37],PAX4,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:127613496
rs61342118-<b>A</b>,5 x 10-105,,0.083,1.34,'-,[1.30-1.37],"SND1, MIR129-1",Type 2 diabetes,type II diabetes mellitus,GCST010118,7:128121865
rs71170768-<b>TA</b>,2 x 10-10,,0.316,1.07,'-,[1.05-1.09],BRAF,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:140879551
rs1182444-<b>G</b>,2 x 10-12,,0.495,1.05,'-,[1.03-1.06],UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST010118,7:157231816
rs34642578-<b>T</b>,2 x 10-9,,0.053,1.09,'-,[1.06-1.13],ASAH1,Type 2 diabetes,type II diabetes mellitus,GCST010118,8:18070100
rs56687477-<b>A</b>,2 x 10-10,,0.323,1.05,'-,[1.03-1.06],KCNU1,Type 2 diabetes,type II diabetes mellitus,GCST010118,8:36974792
rs4739515-<b>G</b>,2 x 10-11,,0.538,1.05,'-,[1.03-1.06],LINC01605,Type 2 diabetes,type II diabetes mellitus,GCST010118,8:37533685
rs328301-<b>T</b>,4 x 10-8,,0.328,1.04,'-,[1.03-1.06],"FGFR1, C8orf86",Type 2 diabetes,type II diabetes mellitus,GCST010118,8:38485494
rs33981001-<b>GGT</b>,5 x 10-28,,0.389,1.08,'-,[1.06-1.09],ANK1,Type 2 diabetes,type II diabetes mellitus,GCST010118,8:41655130
rs349359-<b>C</b>,3 x 10-8,,0.242,1.04,'-,[1.03-1.06],KCNB2,Type 2 diabetes,type II diabetes mellitus,GCST010118,8:72591508
rs149265787-<b>G</b>,6 x 10-10,,0.024,1.14,'-,[1.10-1.19],JPH1,Type 2 diabetes,type II diabetes mellitus,GCST010118,8:74302163
rs896852-<b>G</b>,6 x 10-9,,0.3,1.04,'-,[1.03-1.06],"NDUFAF6, TP53INP1",Type 2 diabetes,type II diabetes mellitus,GCST010118,8:94948658
rs13266634-<b>C</b>,4 x 10-67,,0.586,1.12,'-,[1.11-1.14],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST010118,8:117172544
rs60089934-<b>A</b>,3 x 10-9,,0.378,1.04,'-,[1.03-1.06],TRIB1,Type 2 diabetes,type II diabetes mellitus,GCST010118,8:125459032
rs73708054-<b>C</b>,4 x 10-8,,0.252,1.04,'-,[1.03-1.06],EFR3A,Type 2 diabetes,type II diabetes mellitus,GCST010118,8:131867548
rs1016565-<b>A</b>,2 x 10-8,,0.421,1.04,'-,[1.02-1.05],"LINC01230, H3P29",Type 2 diabetes,type II diabetes mellitus,GCST010118,9:1032567
rs4237150-<b>C</b>,4 x 10-27,,0.426,1.07,'-,[1.06-1.09],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST010118,9:4290085
rs10965248-<b>T</b>,4 x 10-164,,0.563,1.2,'-,[1.19-1.22],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010118,9:22132879
rs1328412-<b>T</b>,6 x 10-11,,0.945,1.1,'-,[1.07-1.13],CHCHD2P9,Type 2 diabetes,type II diabetes mellitus,GCST010118,9:79302212
rs2796441-<b>G</b>,1 x 10-28,,0.39,1.08,'-,[1.06-1.09],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST010118,9:81694033
rs113154802-<b>C</b>,4 x 10-8,,0.889,1.06,'-,[1.04-1.08],PTCH1,Type 2 diabetes,type II diabetes mellitus,GCST010118,9:95516131
rs201375651-<b>CA</b>,3 x 10-8,,0.395,1.04,'-,[1.03-1.06],ABCA1,Type 2 diabetes,type II diabetes mellitus,GCST010118,9:104835247
rs529565-<b>C</b>,2 x 10-10,,0.445,1.04,'-,[1.03-1.06],ABO,Type 2 diabetes,type II diabetes mellitus,GCST010118,9:133274084
rs376993806-<b>G</b>,5 x 10-26,,0.882,1.14,'-,[1.11-1.17],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST010118,9:136352136
rs11257657-<b>G</b>,1 x 10-61,,0.483,1.12,'-,[1.11-1.14],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST010118,10:12267140
rs77065181-<b>A</b>,2 x 10-8,,0.047,1.09,'-,[1.06-1.13],"C10orf67, PTF1A",Type 2 diabetes,type II diabetes mellitus,GCST010118,10:23198849
rs141583966-<b>G</b>,8 x 10-10,,0.909,1.08,'-,[1.05-1.11],ARID5B,Type 2 diabetes,type II diabetes mellitus,GCST010118,10:61952844
rs148928116-<b>T</b>,3 x 10-13,,0.795,1.06,'-,[1.04-1.08],JMJD1C,Type 2 diabetes,type II diabetes mellitus,GCST010118,10:63216374
rs1955163-<b>G</b>,2 x 10-11,,0.541,1.05,'-,[1.03-1.06],"TMEM256P1, TSPAN15",Type 2 diabetes,type II diabetes mellitus,GCST010118,10:69513601
rs34907385-<b>C</b>,5 x 10-12,,0.491,1.05,'-,[1.03-1.06],LRMDA,Type 2 diabetes,type II diabetes mellitus,GCST010118,10:75563885
rs34204798-<b>C</b>,5 x 10-19,,0.568,1.06,'-,[1.05-1.08],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST010118,10:79191374
rs1236816-<b>A</b>,4 x 10-10,,0.499,1.04,'-,[1.03-1.06],PTEN,Type 2 diabetes,type II diabetes mellitus,GCST010118,10:87924457
rs147689733-<b>T</b>,1 x 10-27,,0.021,1.31,'-,[1.25-1.38],TNKS2,Type 2 diabetes,type II diabetes mellitus,GCST010118,10:91832946
rs35906730-<b>G</b>,1 x 10-71,,0.265,1.15,'-,[1.13-1.17],"EIF2S2P3, HHEX",Type 2 diabetes,type II diabetes mellitus,GCST010118,10:92675916
rs565236700-<b>C</b>,6 x 10-19,,0.024,1.23,'-,[1.17-1.29],"RPL17P34, XRCC6P1",Type 2 diabetes,type II diabetes mellitus,GCST010118,10:93249423
rs10736116-<b>C</b>,9 x 10-11,,0.306,1.05,'-,[1.03-1.06],"ARHGAP19, Metazoa_SRP",Type 2 diabetes,type II diabetes mellitus,GCST010118,10:97297164
rs7895872-<b>T</b>,1 x 10-11,,0.579,1.05,'-,[1.03-1.06],BBIP1,Type 2 diabetes,type II diabetes mellitus,GCST010118,10:110918899
rs7901695-<b>C</b>,8 x 10-62,,0.038,1.32,'-,[1.27-1.36],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST010118,10:112994329
rs10886863-<b>C</b>,5 x 10-17,,0.664,1.06,'-,[1.05-1.08],"RPL19P16, LINC01153",Type 2 diabetes,type II diabetes mellitus,GCST010118,10:121169979
rs112820281-<b>C</b>,1 x 10-10,,0.41,1.05,'-,[1.03-1.06],PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST010118,10:122390827
rs11043003-<b>C</b>,1 x 10-16,,0.082,1.11,'-,[1.08-1.13],"MIR4686, ASCL2",Type 2 diabetes,type II diabetes mellitus,GCST010118,11:2181924
rs2237897-<b>C</b>,2 x 10-245,,0.632,1.28,'-,[1.26-1.30],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010118,11:2837316
rs4148646-<b>C</b>,2 x 10-26,,0.385,1.08,'-,[1.06-1.09],ABCC8,Type 2 diabetes,type II diabetes mellitus,GCST010118,11:17393643
rs4922793-<b>A</b>,2 x 10-10,,0.566,1.04,'-,[1.03-1.06],BDNF,Type 2 diabetes,type II diabetes mellitus,GCST010118,11:27707958
rs602652-<b>A</b>,5 x 10-9,,0.809,1.06,'-,[1.04-1.07],CCND1,Type 2 diabetes,type II diabetes mellitus,GCST010118,11:69647874
rs7109575-<b>G</b>,5 x 10-21,,0.945,1.15,'-,[1.12-1.19],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST010118,11:72752390
rs10830963-<b>G</b>,4 x 10-8,,0.421,1.04,'-,[1.02-1.05],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST010118,11:92975544
rs7304270-<b>C</b>,1 x 10-12,,0.761,1.07,'-,[1.05-1.09],"CCND2-AS1, CCND2",Type 2 diabetes,type II diabetes mellitus,GCST010118,12:4272815
rs3751236-<b>G</b>,7 x 10-21,,0.672,1.07,'-,[1.05-1.08],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:27810469
rs80234489-<b>C</b>,4 x 10-32,,0.17,1.11,'-,[1.09-1.13],SINHCAF,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:31288245
rs77978149-<b>T</b>,6 x 10-9,,0.09,1.08,'-,[1.05-1.10],FAIM2,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:49876080
rs2583934-<b>T</b>,5 x 10-16,,0.34,1.06,'-,[1.04-1.07],HMGA2,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:65839030
rs7313668-<b>T</b>,5 x 10-11,,0.374,1.05,'-,[1.03-1.06],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:71055741
rs10860209-<b>C</b>,6 x 10-9,,0.589,1.04,'-,[1.03-1.06],RMST,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:97456437
rs1426371-<b>G</b>,8 x 10-12,,0.491,1.05,'-,[1.03-1.06],WSCD2,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:108236003
rs149212747-<b>A</b>,2 x 10-11,,0.795,1.07,'-,[1.05-1.09],LINC02356,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:111398968
rs77768175-<b>A</b>,1 x 10-10,,0.807,1.07,'-,[1.05-1.09],HECTD4,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:112298314
rs7307263-<b>G</b>,4 x 10-8,,0.427,1.04,'-,[1.02-1.05],LINC01234,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:113685917
rs111246699-<b>A</b>,2 x 10-15,,0.257,1.06,'-,[1.05-1.08],KSR2,Type 2 diabetes,type II diabetes mellitus,GCST010118,12:117963051
rs118074491-<b>G</b>,9 x 10-20,,0.032,1.21,'-,[1.16-1.25],"RPL12P33, HNF1A-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010118,12:120925703
rs9316706-<b>A</b>,3 x 10-9,,0.351,1.04,'-,[1.03-1.06],LINC00540,Type 2 diabetes,type II diabetes mellitus,GCST010118,13:22015744
rs568052023-<b>C</b>,3 x 10-22,,0.581,1.07,'-,[1.06-1.09],RNF6,Type 2 diabetes,type II diabetes mellitus,GCST010118,13:26207231
rs7983505-<b>T</b>,3 x 10-18,,0.157,1.08,'-,[1.06-1.10],"TOMM22P3, KL",Type 2 diabetes,type II diabetes mellitus,GCST010118,13:32983035
rs123378-<b>G</b>,2 x 10-10,,0.195,1.05,'-,[1.04-1.07],DLEU1,Type 2 diabetes,type II diabetes mellitus,GCST010118,13:50514673
rs1215468-<b>A</b>,1 x 10-31,,0.719,1.09,'-,[1.08-1.11],'-,Type 2 diabetes,type II diabetes mellitus,GCST010118,13:80133294
rs9515905-<b>A</b>,7 x 10-18,,0.831,1.08,'-,[1.06-1.10],"MIR17HG, PPIAP23",Type 2 diabetes,type II diabetes mellitus,GCST010118,13:91297308
rs12437434-<b>C</b>,1 x 10-9,,0.713,1.05,'-,[1.03-1.06],NYNRIN,Type 2 diabetes,type II diabetes mellitus,GCST010118,14:24409164
rs61975988-<b>A</b>,2 x 10-9,,0.457,1.04,'-,[1.03-1.05],CLEC14A,Type 2 diabetes,type II diabetes mellitus,GCST010118,14:38340457
rs58524310-<b>G</b>,8 x 10-11,,0.327,1.05,'-,[1.03-1.06],"LINC01629, RN7SKP17",Type 2 diabetes,type II diabetes mellitus,GCST010118,14:76916160
rs73347525-<b>A</b>,7 x 10-11,,0.756,1.06,'-,[1.04-1.08],MEG3,Type 2 diabetes,type II diabetes mellitus,GCST010118,14:100788835
rs55700915-<b>A</b>,2 x 10-8,,0.434,1.04,'-,[1.03-1.06],"RCOR1, TRAF3",Type 2 diabetes,type II diabetes mellitus,GCST010118,14:102771615
rs76704029-<b>T</b>,3 x 10-8,,0.732,1.06,'-,[1.04-1.08],HERC2,Type 2 diabetes,type II diabetes mellitus,GCST010118,15:28301027
rs8043085-<b>T</b>,2 x 10-14,,0.449,1.05,'-,[1.04-1.07],RASGRP1,Type 2 diabetes,type II diabetes mellitus,GCST010118,15:38535939
rs12907887-<b>C</b>,2 x 10-20,,0.229,1.08,'-,[1.06-1.10],"PLCB2, INAFM2",Type 2 diabetes,type II diabetes mellitus,GCST010118,15:40323671
rs149336329-<b>G</b>,2 x 10-9,,0.949,1.11,'-,[1.07-1.14],MYO5C,Type 2 diabetes,type II diabetes mellitus,GCST010118,15:52295543
rs8037894-<b>G</b>,7 x 10-33,,0.586,1.08,'-,[1.07-1.10],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST010118,15:62102065
rs4776970-<b>A</b>,3 x 10-8,,0.221,1.04,'-,[1.03-1.06],MAP2K5,Type 2 diabetes,type II diabetes mellitus,GCST010118,15:67788548
rs8038760-<b>A</b>,2 x 10-11,,0.608,1.05,'-,[1.03-1.06],SIN3A,Type 2 diabetes,type II diabetes mellitus,GCST010118,15:75449754
rs952472-<b>C</b>,2 x 10-26,,0.395,1.07,'-,[1.06-1.09],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST010118,15:77484220
rs7758002-<b>G</b>,5 x 10-16,,0.5238,'-,0.0317 unit decrease,[0.024-0.039],RGS17,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:153119635
rs12883788-<b>C</b>,3 x 10-16,,0.5887,'-,0.0327 unit decrease,[0.025-0.041],AKAP6,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:32834334
rs10998338-<b>G</b>,1 x 10-15,,0.5189,'-,0.0308 unit decrease,[0.023-0.038],TET1,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:68622422
rs2277339-<b>G</b>,7 x 10-15,,0.1427,'-,0.0437 unit increase,[0.033-0.055],"HSD17B6, PRIM1",Type 2 diabetes,type II diabetes mellitus,GCST010557,12:56752285
rs73239895-<b>C</b>,3 x 10-15,,0.914,'-,0.0869 unit decrease,[0.065-0.108],"CLEC10A, SLC16A11",Type 2 diabetes,type II diabetes mellitus,GCST010557,17:7050239
rs539515-<b>C</b>,5 x 10-15,,0.2066,'-,0.0358 unit increase,[0.027-0.045],SEC16B,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:177919890
rs4335-<b>G</b>,1 x 10-15,,0.4783,'-,0.0304 unit increase,[0.023-0.038],ACE,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:63487664
rs2169033-<b>C</b>,1 x 10-15,,0.34,'-,0.0325 unit decrease,[0.024-0.041],LCORL,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:18042734
rs7224711-<b>C</b>,1 x 10-15,,0.5196,'-,0.0307 unit increase,[0.023-0.038],CYTH1,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:78776206
rs314879-<b>C</b>,3 x 10-15,,0.2288,'-,0.0364 unit increase,[0.027-0.045],"DDX39AP1, SNORD36",Type 2 diabetes,type II diabetes mellitus,GCST010557,13:22735243
rs12001437-<b>C</b>,4 x 10-15,,0.4071,'-,0.0301 unit increase,[0.023-0.038],"RN7SKP114, DCAF12",Type 2 diabetes,type II diabetes mellitus,GCST010557,9:34074478
rs34247110-<b>G</b>,2 x 10-15,,0.5159,'-,0.0305 unit decrease,[0.023-0.038],"KCNK16, KCNK17",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:39314595
rs7178762-<b>C</b>,2 x 10-15,,0.4889,'-,0.0323 unit increase,[0.024-0.04],"USP3, USP3-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010557,15:63579093
rs117316450-<b>G</b>,9 x 10-15,,0.0183,'-,0.1328 unit increase,[0.099-0.166],COPB1,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:14496873
rs2040792-<b>C</b>,2 x 10-15,,0.461,'-,0.031 unit increase,[0.023-0.039],NF1,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:31301531
rs6741676-<b>G</b>,7 x 10-15,,0.3067,'-,0.0324 unit decrease,[0.024-0.041],SCHLAP1,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:180753927
rs2591392-<b>G</b>,2 x 10-15,,0.6247,'-,0.0306 unit increase,[0.023-0.038],JMY,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:79250470
rs4810145-<b>C</b>,1 x 10-15,,0.5221,'-,0.0303 unit increase,[0.023-0.038],GNAS-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:58821440
rs28819812-<b>C</b>,3 x 10-15,,0.6586,'-,0.033 unit increase,[0.025-0.041],"PDGFC, LINC02272",Type 2 diabetes,type II diabetes mellitus,GCST010557,4:156731601
rs9872347-<b>C</b>,5 x 10-14,,0.6736,'-,0.0318 unit increase,[0.024-0.04],"TFRC, LINC00885",Type 2 diabetes,type II diabetes mellitus,GCST010557,3:196104366
rs7629-<b>G</b>,8 x 10-14,,0.5279,'-,0.0311 unit decrease,[0.023-0.039],TRIM59,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:160435517
rs2297508-<b>G</b>,2 x 10-14,,0.5583,'-,0.0305 unit decrease,[0.023-0.038],SREBF1,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:17812003
rs8061528-<b>C</b>,3 x 10-14,,0.7573,'-,0.0346 unit decrease,[0.026-0.043],SLX4,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:3606481
rs6792892-<b>C</b>,1 x 10-14,,0.4822,'-,0.0306 unit increase,[0.023-0.038],RBM6,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:49958085
rs56392746-<b>G</b>,3 x 10-14,,0.9169,'-,0.0579 unit increase,[0.043-0.073],HORMAD2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,22:30055699
rs1260326-<b>C</b>,2 x 10-57,,0.5805,'-,0.0625 unit increase,[0.055-0.07],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,Mapping not available
rs2796441-<b>G</b>,3 x 10-55,,0.5596,'-,0.0609 unit increase,[0.053-0.069],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST010557,9:81694033
rs10184004-<b>C</b>,4 x 10-54,,0.5951,'-,0.0636 unit increase,[0.056-0.072],"GRB14, COBLL1",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:164651879
rs697239-<b>C</b>,5 x 10-54,,0.4453,'-,0.0587 unit decrease,[0.051-0.066],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:79187681
rs17036160-<b>C</b>,2 x 10-53,,0.8874,'-,0.1007 unit increase,[0.088-0.113],PPARG,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:12288284
rs757110-<b>C</b>,5 x 10-52,,0.3704,'-,0.0599 unit increase,[0.052-0.068],ABCC8,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:17396930
rs61779284-<b>G</b>,1 x 10-48,,0.7976,'-,0.0703 unit decrease,[0.061-0.08],MACF1,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:39389505
rs2257883-<b>G</b>,4 x 10-47,,0.7363,'-,0.071 unit decrease,[0.061-0.081],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:65822382
rs3751239-<b>G</b>,2 x 10-47,,0.2193,'-,0.0687 unit decrease,[0.059-0.078],"GRIP1, RN7SKP15",Type 2 diabetes,type II diabetes mellitus,GCST010557,12:27810743
rs17866443-<b>C</b>,9 x 10-47,,0.8385,'-,0.2003 unit decrease,[0.17-0.23],ZNF800,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:127418899
rs340874-<b>C</b>,6 x 10-45,,0.4991,'-,0.0543 unit increase,[0.047-0.062],"PROX1-AS1, PROX1",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:213985913
rs13094957-<b>C</b>,2 x 10-42,,0.2196,'-,0.0637 unit decrease,[0.054-0.073],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:23415589
rs8107527-<b>G</b>,4 x 10-41,,0.6245,'-,0.0542 unit decrease,[0.046-0.062],"GIPR, RN7SL836P",Type 2 diabetes,type II diabetes mellitus,GCST010557,19:45655159
rs72802365-<b>G</b>,1 x 10-40,,0.928,'-,0.1074 unit increase,[0.092-0.123],"CTRB2, CTRB1",Type 2 diabetes,type II diabetes mellitus,GCST010557,16:75212137
rs243018-<b>G</b>,1 x 10-39,,0.5038,'-,0.0508 unit increase,[0.043-0.058],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:60359572
rs893617-<b>C</b>,2 x 10-38,,0.2813,'-,0.0537 unit increase,[0.046-0.062],"ARPIN-AP3S2, AP3S2",Type 2 diabetes,type II diabetes mellitus,GCST010557,15:89838046
rs34584161-<b>G</b>,2 x 10-37,,0.2837,'-,0.0565 unit decrease,[0.048-0.065],RNF6,Type 2 diabetes,type II diabetes mellitus,GCST010557,13:26202862
rs75432112-<b>G</b>,6 x 10-37,,0.9536,'-,0.1319 unit decrease,[0.11-0.15],"PPIP5K2, MACIR",Type 2 diabetes,type II diabetes mellitus,GCST010557,5:103250706
rs6777684-<b>G</b>,2 x 10-35,,0.6279,'-,0.0548 unit increase,[0.046-0.063],LINC01991,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:188024054
rs6567160-<b>C</b>,8 x 10-34,,0.2362,'-,0.0539 unit increase,[0.045-0.063],"RNU4-17P, RPS3AP49",Type 2 diabetes,type II diabetes mellitus,GCST010557,18:60161902
rs730831-<b>G</b>,5 x 10-34,,0.1945,'-,0.0878 unit decrease,[0.074-0.102],CTBP1,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:1246511
rs2876354-<b>C</b>,1 x 10-34,,0.5168,'-,0.0465 unit increase,[0.039-0.054],RPL35AP3,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:136974215
rs6946660-<b>C</b>,3 x 10-33,,0.4145,'-,0.0472 unit decrease,[0.04-0.055],UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:157155954
rs57286125-<b>G</b>,2 x 10-33,,0.8324,'-,0.0609 unit decrease,[0.051-0.071],"TOMM22P3, KL",Type 2 diabetes,type II diabetes mellitus,GCST010557,13:32983506
rs3130931-<b>C</b>,2 x 10-32,,0.6765,'-,0.0482 unit increase,[0.04-0.056],"POU5F1, TCF19",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:31167111
rs35011184-<b>G</b>,2 x 10-543,,0.7797,'-,0.2508 unit decrease,[0.24-0.26],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:112989975
rs2237897-<b>C</b>,2 x 10-226,,0.7624,'-,0.2199 unit increase,[0.21-0.23],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:2837316
rs10440833-<b>T</b>,5 x 10-215,,0.7028,'-,0.1286 unit decrease,[0.12-0.14],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:20687890
rs10811661-<b>C</b>,1 x 10-205,,0.2442,'-,0.1471 unit decrease,[0.14-0.16],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:22134095
rs1421085-<b>C</b>,1 x 10-189,,0.367,'-,0.1182 unit increase,[0.11-0.13],FTO,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:53767042
rs9859406-<b>G</b>,2 x 10-169,,0.6476,'-,0.1117 unit decrease,[0.1-0.12],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:185816694
rs13266634-<b>C</b>,4 x 10-136,,0.6814,'-,0.1024 unit increase,[0.094-0.11],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:117172544
rs1111875-<b>C</b>,1 x 10-128,,0.549,'-,0.0928 unit increase,[0.085-0.1],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST010557,10:92703125
rs76895963-<b>G</b>,1 x 10-96,,0.019,'-,0.4223 unit decrease,[0.38-0.46],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,Mapping not available
rs860262-<b>C</b>,3 x 10-82,,0.5683,'-,0.0747 unit increase,[0.067-0.082],JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:28154778
rs2943650-<b>C</b>,2 x 10-81,,0.3616,'-,0.0805 unit decrease,[0.072-0.089],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:226241205
rs13262861-<b>C</b>,8 x 10-79,,0.8326,'-,0.1021 unit increase,[0.092-0.113],"ANK1, NKX6-3",Type 2 diabetes,type II diabetes mellitus,GCST010557,8:41651058
rs10228796-<b>G</b>,2 x 10-71,,0.5666,'-,0.0672 unit increase,[0.06-0.075],"RBM33, GTF3AP5",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:15024565
rs10937721-<b>G</b>,7 x 10-70,,0.3904,'-,0.0755 unit decrease,[0.067-0.084],"PPP2R2C, WFS1",Type 2 diabetes,type II diabetes mellitus,GCST010557,4:6305036
rs11616380-<b>G</b>,1 x 10-69,,0.7299,'-,0.0764 unit increase,[0.068-0.085],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,13:80131180
rs28642213-<b>G</b>,6 x 10-68,,0.7572,'-,0.0822 unit increase,[0.073-0.091],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:136353630
rs11651755-<b>C</b>,9 x 10-67,,0.4671,'-,0.0663 unit increase,[0.059-0.074],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:37739849
rs464605-<b>C</b>,8 x 10-66,,0.3465,'-,0.07 unit decrease,[0.062-0.078],"RPL26P19, C5orf67",Type 2 diabetes,type II diabetes mellitus,GCST010557,5:56511543
rs10830963-<b>G</b>,1 x 10-66,,0.3057,'-,0.0731 unit increase,[0.065-0.081],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:92975544
rs12910361-<b>G</b>,5 x 10-65,,0.614,'-,0.0686 unit increase,[0.061-0.076],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:77489993
rs11257655-<b>C</b>,1 x 10-63,,0.7044,'-,0.0946 unit decrease,[0.084-0.106],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST010557,10:12265895
rs11602873-<b>T</b>,2 x 10-62,,0.1459,'-,0.0987 unit decrease,[0.087-0.11],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:72749717
rs76675804-<b>C</b>,1 x 10-59,,0.0941,'-,0.1208 unit decrease,[0.11-0.14],THADA,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:43384744
rs11708067-<b>G</b>,2 x 10-57,,0.2229,'-,0.0804 unit decrease,[0.071-0.09],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:123346931
rs4929965-<b>G</b>,5 x 10-57,,0.6147,'-,0.0676 unit decrease,[0.059-0.076],"MIR4686, ASCL2",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:2176056
rs202209118-<b>TCC</b>,8 x 10-9,,0.047008167,1.1583176,'-,[1.101941207-1.217578223],SETBP1,Type 2 diabetes,type II diabetes mellitus,GCST90013735,18:44781459
rs58202132-<b>A</b>,1 x 10-8,,0.200822638,1.0771675,'-,[1.049931474-1.105110005],SNTB1,Type 2 diabetes,type II diabetes mellitus,GCST90013735,8:120752281
rs2526678-<b>A</b>,2 x 10-8,,0.293196046,0.93297774,'-,[0.910507623-0.956002438],FADS2,Type 2 diabetes,type II diabetes mellitus,GCST90013735,11:61856321
rs7732130-<b>G</b>,2 x 10-32,,0.2954,'-,0.0554 unit increase,[0.046-0.065],ZBED3-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:77139179
rs13434089-<b>C</b>,4 x 10-31,,0.2034,'-,0.0607 unit decrease,[0.051-0.071],ATXN7,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:63962890
rs6813195-<b>C</b>,8 x 10-31,,0.6486,'-,0.0463 unit increase,[0.038-0.054],"TMEM154, RPS3AP18",Type 2 diabetes,type II diabetes mellitus,GCST010557,4:152599323
rs9379084-<b>G</b>,5 x 10-31,,0.843,'-,0.0715 unit increase,[0.059-0.084],RREB1,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:7231610
rs2290203-<b>G</b>,2 x 10-31,,0.6998,'-,0.0506 unit decrease,[0.042-0.059],"PRC1, PRC1-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010557,15:90968837
rs4237150-<b>G</b>,7 x 10-31,,0.5708,'-,0.0433 unit decrease,[0.036-0.051],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:4290085
rs146886108-<b>C</b>,2 x 10-31,,0.9942,'-,0.3814 unit increase,[0.32-0.45],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:14751196
rs10938398-<b>G</b>,1 x 10-30,,0.6065,'-,0.0445 unit decrease,[0.037-0.052],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:45184122
rs4865796-<b>G</b>,5 x 10-30,,0.2906,'-,0.0481 unit decrease,[0.04-0.056],ARL15,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:53976834
rs8071043-<b>C</b>,5 x 10-30,,0.3318,'-,0.0465 unit increase,[0.038-0.055],ZZEF1,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:4085157
rs7163757-<b>C</b>,6 x 10-30,,0.5556,'-,0.043 unit increase,[0.036-0.05],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST010557,15:62099409
rs730497-<b>G</b>,9 x 10-29,,0.8275,'-,0.0552 unit decrease,[0.045-0.065],GCK,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:44184122
rs79090772-<b>C</b>,1 x 10-28,,0.0971,'-,0.0728 unit decrease,[0.06-0.086],FAF1,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:50743476
rs12625671-<b>C</b>,6 x 10-28,,0.2326,'-,0.0603 unit increase,[0.05-0.071],HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:44366172
rs2723065-<b>G</b>,7 x 10-28,,0.3817,'-,0.0422 unit decrease,[0.035-0.05],"LINC02245, LINC02576",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:65052280
rs9515905-<b>G</b>,2 x 10-27,,0.2606,'-,0.0472 unit decrease,[0.039-0.056],"MIR17HG, PPIAP23",Type 2 diabetes,type II diabetes mellitus,GCST010557,13:91297308
rs7156625-<b>G</b>,5 x 10-27,,0.7662,'-,0.053 unit decrease,[0.043-0.063],NRXN3,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:79476304
rs529565-<b>C</b>,8 x 10-27,,0.3648,'-,0.0415 unit increase,[0.034-0.049],ABO,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:133274084
rs3130283-<b>C</b>,6 x 10-27,,0.8533,'-,0.0617 unit increase,[0.051-0.073],"PPT2-EGFL8, AGPAT1",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:32170768
rs12454712-<b>C</b>,2 x 10-27,,0.4059,'-,0.0424 unit decrease,[0.035-0.05],BCL2,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:63178651
rs56348580-<b>G</b>,1 x 10-27,,0.7058,'-,0.0507 unit increase,[0.041-0.06],HNF1A,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:120994314
rs35895680-<b>C</b>,8 x 10-27,,0.7066,'-,0.0499 unit increase,[0.041-0.059],"GIP, IGF2BP1",Type 2 diabetes,type II diabetes mellitus,GCST010557,17:48982960
rs8192675-<b>C</b>,4 x 10-27,,0.3167,'-,0.0452 unit decrease,[0.037-0.053],SLC2A2,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:171007094
rs429358-<b>C</b>,2 x 10-26,,0.1469,'-,0.0585 unit decrease,[0.048-0.069],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,Mapping not available
rs1127215-<b>C</b>,2 x 10-26,,0.6041,'-,0.0412 unit increase,[0.034-0.049],PTGFRN,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:116990168
rs61910828-<b>A</b>,1 x 10-9,,0.078016408,0.90669537,'-,[0.878354686-0.935950435],"CCND2-AS1, HSPA8P5",Type 2 diabetes,type II diabetes mellitus,GCST90013693,12:4179925
rs2277339-<b>G</b>,5 x 10-8,,0.201701193,1.0573972,'-,[1.036457663-1.078759974],"HSD17B6, PRIM1",Type 2 diabetes,type II diabetes mellitus,GCST90013693,12:56752285
rs11414025-<b>GT</b>,2 x 10-10,,0.339681848,1.0572194,'-,[1.039355749-1.075389946],HMGA2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,12:65831409
rs35773834-<b>CA</b>,8 x 10-14,,0.429659514,0.93660927,'-,[0.920659551-0.952835276],RNF6,Type 2 diabetes,type II diabetes mellitus,GCST90013693,13:26207231
rs488166-<b>G</b>,9 x 10-15,,0.867918873,0.91063005,'-,[0.88933745-0.932432404],"TOMM22P3, KL",Type 2 diabetes,type II diabetes mellitus,GCST90013693,13:32980214
rs200752045-<b>A</b>,2 x 10-18,,0.283632571,0.9213114,'-,[0.904556459-0.938376648],'-,Type 2 diabetes,type II diabetes mellitus,GCST90013693,13:80143707
rs28620036-<b>T</b>,2 x 10-9,,0.179906154,0.9378038,'-,[0.918216665-0.957808819],"PPIAP23, MIR17HG",Type 2 diabetes,type II diabetes mellitus,GCST90013693,13:91288024
rs36027443-<b>A</b>,4 x 10-11,,0.496178281,1.0558116,'-,[1.038952718-1.072944246],RASGRP1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,15:38554146
rs4924455-<b>T</b>,1 x 10-17,,0.590252018,0.92777807,'-,[0.912019171-0.943809248],CCDC9B,Type 2 diabetes,type II diabetes mellitus,GCST90013693,15:40340937
rs7167878-<b>A</b>,1 x 10-22,,0.427927219,0.9215823,'-,[0.90665858-0.936751661],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST90013693,15:62103990
rs6495168-<b>C</b>,3 x 10-11,,0.672273071,1.0666659,'-,[1.046505427-1.087214806],COMMD4,Type 2 diabetes,type II diabetes mellitus,GCST90013693,15:75337819
rs965480-<b>G</b>,2 x 10-15,,0.409671867,1.0688976,'-,[1.051479164-1.086604578],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST90013693,15:77489584
rs7163629-<b>C</b>,1 x 10-9,,0.775619392,0.9404153,'-,[0.92201188-0.959186109],"AP3S2, ARPIN-AP3S2",Type 2 diabetes,type II diabetes mellitus,GCST90013693,15:89873508
rs2290203-<b>A</b>,3 x 10-10,,0.47043929,1.0533636,'-,[1.036497938-1.070503529],"PRC1, PRC1-AS1",Type 2 diabetes,type II diabetes mellitus,GCST90013693,15:90968837
rs117267808-<b>A</b>,7 x 10-15,,0.077401796,1.1281587,'-,[1.094448277-1.162907503],GP2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,16:20311846
rs11642015-<b>T</b>,1 x 10-35,,0.199307382,1.1362573,'-,[1.113644322-1.159329518],FTO,Type 2 diabetes,type II diabetes mellitus,GCST90013693,16:53768582
rs2854313-<b>A</b>,3 x 10-8,,0.381133092,0.9530285,'-,[0.937024209-0.969306161],NF1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,17:31346201
rs10908278-<b>A</b>,2 x 10-38,,0.695586179,0.8866894,'-,[0.870709604-0.902962461],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST90013693,17:37739961
rs747360-<b>A</b>,1 x 10-8,,0.134831263,1.0701156,'-,[1.045316033-1.095503414],ZZEF1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,17:4102227
rs9892728-<b>T</b>,2 x 10-8,,0.531095537,0.9503636,'-,[0.93365308-0.967373215],RAMP2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,17:42761348
rs75418188-<b>T</b>,6 x 10-18,,0.076104258,1.1413156,'-,[1.107589097-1.176069036],SLC16A11,Type 2 diabetes,type II diabetes mellitus,GCST90013693,17:7042164
rs476828-<b>C</b>,2 x 10-15,,0.249389048,1.0779732,'-,[1.058136616-1.098181715],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST90013693,18:60185354
rs12454712-<b>C</b>,1 x 10-12,,0.522754069,0.9430086,'-,[0.927830168-0.958435389],BCL2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,18:63178651
rs150182828-<b>C</b>,2 x 10-13,,0.033328465,0.82112134,'-,[0.778956662-0.865568316],MTDHP3,Type 2 diabetes,type II diabetes mellitus,GCST90013693,19:21673944
rs4805881-<b>C</b>,1 x 10-9,,0.47688208,0.9511641,'-,[0.93591891-0.966657645],PEPD,Type 2 diabetes,type II diabetes mellitus,GCST90013693,19:33405526
rs113036890-<b>C</b>,2 x 10-17,,0.220886039,0.91620564,'-,[0.89784933-0.934937308],"RN7SL836P, GIPR",Type 2 diabetes,type II diabetes mellitus,GCST90013693,19:45654671
rs3731600-<b>G</b>,3 x 10-8,,0.047934387,0.8976583,'-,[0.863912232-0.932722542],SCTR,Type 2 diabetes,type II diabetes mellitus,GCST90013693,2:119473494
rs56008953-<b>G</b>,2 x 10-8,,0.585195982,1.0482911,'-,[1.031212994-1.065651995],"EPC2, RNU2-9P",Type 2 diabetes,type II diabetes mellitus,GCST90013693,2:148801884
rs75536691-<b>G</b>,7 x 10-10,,0.022730208,0.84158844,'-,[0.796745484-0.888955249],GRB14,Type 2 diabetes,type II diabetes mellitus,GCST90013693,2:164525008
rs28403309-<b>C</b>,4 x 10-8,,0.362795015,1.0555881,'-,[1.035439715-1.076128671],TNS1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,2:217917817
rs6759355-<b>T</b>,9 x 10-9,,0.547552909,0.9525407,'-,[0.936891606-0.968451213],DGKD,Type 2 diabetes,type II diabetes mellitus,GCST90013693,2:233394691
rs1260326-<b>C</b>,9 x 10-20,,0.437337429,1.0786191,'-,[1.061192016-1.096332338],'-,Type 2 diabetes,type II diabetes mellitus,GCST90013693,Mapping not available
rs243018-<b>G</b>,4 x 10-8,,0.675140993,1.0512488,'-,[1.032594914-1.070239627],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST90013693,2:60359572
rs5017300-<b>G</b>,3 x 10-13,,0.903864898,1.1077554,'-,[1.07764172-1.138710501],"LINC01875, TMEM18",Type 2 diabetes,type II diabetes mellitus,GCST90013693,2:631099
rs6031563-<b>T</b>,2 x 10-12,,0.79373998,1.0751232,'-,[1.053691765-1.096990514],"HNF4A-AS1, HNF4A",Type 2 diabetes,type II diabetes mellitus,GCST90013693,20:44374270
rs6021276-<b>C</b>,2 x 10-9,,0.573133784,0.9506334,'-,[0.935053891-0.966472462],NFATC2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,20:51538847
rs5762925-<b>C</b>,4 x 10-9,,0.514868781,1.0500168,'-,[1.033093627-1.0672172],ZNRF3,Type 2 diabetes,type II diabetes mellitus,GCST90013693,22:28973410
rs7644981-<b>A</b>,5 x 10-11,,0.469895631,1.0554535,'-,[1.038591941-1.072588834],CASR,Type 2 diabetes,type II diabetes mellitus,GCST90013693,3:122250865
rs12497133-<b>A</b>,2 x 10-8,,0.327226651,1.051326,'-,[1.033193658-1.069776677],SLC12A8,Type 2 diabetes,type II diabetes mellitus,GCST90013693,3:125203076
rs4686392-<b>G</b>,2 x 10-47,,0.331192627,1.1344565,'-,[1.115245375-1.153998496],'-,Type 2 diabetes,type II diabetes mellitus,GCST90013693,Mapping not available
rs3887925-<b>T</b>,4 x 10-8,,0.422257612,1.0467451,'-,[1.029827168-1.063940797],ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,3:186947857
rs12633613-<b>C</b>,5 x 10-25,,0.333956966,0.91351265,'-,[0.897966557-0.929327822],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,3:23349016
rs3816157-<b>A</b>,3 x 10-19,,0.324482853,0.92405266,'-,[0.908228207-0.940152838],"PSMD6, PSMD6-AS1",Type 2 diabetes,type II diabetes mellitus,GCST90013693,3:64013646
rs730831-<b>G</b>,6 x 10-29,,0.311973487,0.90297467,'-,[0.88694636-0.919292571],CTBP1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,4:1246511
rs10011838-<b>A</b>,1 x 10-21,,0.543665882,0.92266905,'-,[0.907575767-0.938013345],"TMEM154, RPS3AP18",Type 2 diabetes,type II diabetes mellitus,GCST90013693,4:152599127
rs12507026-<b>T</b>,5 x 10-9,,0.296092152,1.0541047,'-,[1.035672199-1.072865332],'-,Type 2 diabetes,type II diabetes mellitus,GCST90013693,4:45179317
rs13129612-<b>T</b>,1 x 10-9,,0.791051481,0.9402179,'-,[0.921680636-0.959127986],"MOB1B, RNU6-891P",Type 2 diabetes,type II diabetes mellitus,GCST90013693,4:70880099
rs201597274-<b>C</b>,5 x 10-11,,0.045822935,0.874661,'-,[0.840425132-0.910291608],'-,Type 2 diabetes,type II diabetes mellitus,GCST90013693,4:84380717
rs200525873-<b>G</b>,5 x 10-9,,0.076918548,0.90745986,'-,[0.878413444-0.937466738],CEP120,Type 2 diabetes,type II diabetes mellitus,GCST90013693,5:123317220
rs193457-<b>G</b>,9 x 10-12,,0.401058055,1.0616504,'-,[1.043578781-1.080034887],"FGFR4, NSD1",Type 2 diabetes,type II diabetes mellitus,GCST90013693,5:177105216
rs72751723-<b>T</b>,2 x 10-8,,0.069009826,1.1128823,'-,[1.072143173-1.155169253],EMB,Type 2 diabetes,type II diabetes mellitus,GCST90013693,5:50441389
rs6879147-<b>G</b>,2 x 10-10,,0.836053325,0.93223417,'-,[0.912252684-0.952653359],"PELO, ITGA1",Type 2 diabetes,type II diabetes mellitus,GCST90013693,5:52792018
rs459193-<b>G</b>,2 x 10-17,,0.463814486,1.0725552,'-,[1.055383029-1.09000669],"C5orf67, RPL26P19",Type 2 diabetes,type II diabetes mellitus,GCST90013693,5:56510924
rs5744598-<b>A</b>,2 x 10-10,,0.358552841,0.94649076,'-,[0.93065503-0.962595923],POLK,Type 2 diabetes,type II diabetes mellitus,GCST90013693,5:75550788
rs7721099-<b>C</b>,1 x 10-9,,0.441549644,1.0527418,'-,[1.03537085-1.070404076],LINC00461,Type 2 diabetes,type II diabetes mellitus,GCST90013693,5:88640561
rs72951506-<b>T</b>,3 x 10-9,,0.251669467,0.9433856,'-,[0.925435688-0.961683649],NUS1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,6:117690560
rs6918311-<b>G</b>,5 x 10-17,,0.6033391,0.930273,'-,[0.914676828-0.946135144],"Y_RNA, RPL35AP3",Type 2 diabetes,type II diabetes mellitus,GCST90013693,6:136966564
rs9350271-<b>A</b>,2 x 10-93,,0.417612465,1.1879035,'-,[1.168513109-1.207615704],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,6:20682933
rs9380826-<b>C</b>,1 x 10-17,,0.182588269,0.91200566,'-,[0.89298234-0.931434249],GLP1R,Type 2 diabetes,type II diabetes mellitus,GCST90013693,6:39069886
rs2233580-<b>T</b>,6 x 10-90,,0.088031697,1.3345873,'-,[1.297564889-1.372666019],PAX4,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:127613496
rs77792157-<b>A</b>,5 x 10-12,,0.049109653,0.8693601,'-,[0.835455198-0.904640896],CPA1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:130385872
rs56805921-<b>C</b>,3 x 10-10,,0.430727859,1.0561278,'-,[1.038309874-1.074251352],ETV1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:13849074
rs569319774-<b>GA</b>,6 x 10-9,,0.064552806,1.1131161,'-,[1.073681356-1.153999397],BRAF,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:140853226
rs10281892-<b>G</b>,1 x 10-12,,0.411700528,1.0617586,'-,[1.044293048-1.079516224],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:14880227
rs6950739-<b>C</b>,2 x 10-10,,0.542415541,0.9483176,'-,[0.932872168-0.964018754],UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:157189756
rs2908279-<b>G</b>,1 x 10-10,,0.596113968,1.0560962,'-,[1.038766738-1.073714807],"RNA5SP230, MYL7",Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:44135258
rs10618080-<b>C</b>,9 x 10-18,,0.301264798,1.0840224,'-,[1.064246742-1.10416545],AUTS2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:70197262
rs39218-<b>C</b>,1 x 10-9,,0.229497779,1.0622305,'-,[1.041723245-1.083141276],STEAP2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:90110704
rs13266634-<b>T</b>,1 x 10-37,,0.411647138,0.89813375,'-,[0.883505425-0.913004259],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST90013693,8:117172544
rs12549902-<b>A</b>,2 x 10-21,,0.5053991,1.0811037,'-,[1.063847304-1.098640033],"ANK1, NKX6-3",Type 2 diabetes,type II diabetes mellitus,GCST90013693,8:41651740
rs28445975-<b>G</b>,3 x 10-22,,0.877513927,1.1365756,'-,[1.107579607-1.166330658],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,9:136349924
rs10965247-<b>G</b>,3 x 10-99,,0.444418668,0.8382419,'-,[0.824642358-0.85206566],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,9:22132730
rs34494309-<b>A</b>,1 x 10-15,,0.420826065,1.0707946,'-,[1.053007719-1.088881797],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST90013693,9:4284962
rs2796441-<b>A</b>,3 x 10-19,,0.624604208,0.92672306,'-,[0.911471445-0.942229857],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST90013693,9:81694033
rs2495637-<b>A</b>,2 x 10-16,,NR,1.0559335,'-,[1.04237410513696-1.06966933500035],"IL13RA1, DOCK11",Type 2 diabetes,type II diabetes mellitus,GCST90013693,X:118726116
rs1825307-<b>G</b>,4 x 10-9,,0.755655613,0.9442747,'-,[0.926410162-0.962483721],USP48,Type 2 diabetes,type II diabetes mellitus,GCST90013693,1:21741833
rs201468966-<b>CA</b>,3 x 10-8,,0.184250638,1.0625932,'-,[1.040092982-1.085580261],BMP8A,Type 2 diabetes,type II diabetes mellitus,GCST90013693,1:39510388
rs12031188-<b>C</b>,3 x 10-10,,0.797394309,1.0717143,'-,[1.048861552-1.095064828],FAF1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,1:50637596
rs7901695-<b>C</b>,7 x 10-52,,0.042503062,1.3568672,'-,[1.304370287-1.411477054],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,10:112994329
rs10886863-<b>C</b>,7 x 10-10,,0.695264199,1.0574176,'-,[1.038804664-1.076364048],"RPL19P16, LINC01153",Type 2 diabetes,type II diabetes mellitus,GCST90013693,10:121169979
rs4747971-<b>C</b>,6 x 10-33,,0.552565223,0.89885247,'-,[0.883278455-0.914701128],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST90013693,10:12261372
rs1955163-<b>A</b>,3 x 10-9,,0.495327916,0.95232046,'-,[0.937047002-0.967842853],"TMEM256P1, TSPAN15",Type 2 diabetes,type II diabetes mellitus,GCST90013693,10:69513601
rs7900112-<b>A</b>,2 x 10-10,,0.495584809,0.9487103,'-,[0.933468465-0.964201013],LRMDA,Type 2 diabetes,type II diabetes mellitus,GCST90013693,10:75554859
rs703980-<b>A</b>,1 x 10-14,,0.449189131,0.93830585,'-,[0.923216132-0.953642255],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,10:79184084
rs200861498-<b>A</b>,5 x 10-8,,0.345219692,1.0486423,'-,[1.030918616-1.066670728],PTEN,Type 2 diabetes,type II diabetes mellitus,GCST90013693,10:87939534
rs35906730-<b>A</b>,8 x 10-43,,0.740884648,0.87733376,'-,[0.86108598-0.89388817],"EIF2S2P3, HHEX",Type 2 diabetes,type II diabetes mellitus,GCST90013693,10:92675916
rs757110-<b>A</b>,8 x 10-10,,0.610741048,0.94955945,'-,[0.93400913-0.965368627],ABCC8,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:17396930
rs2237897-<b>T</b>,3 x 10-168,,0.388979615,0.7859327,'-,[0.772628119-0.799466407],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2837316
rs11033115-<b>C</b>,5 x 10-9,,0.125327248,0.9293968,'-,[0.906847932-0.952506358],SLC1A2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:35413886
rs55816909-<b>C</b>,4 x 10-10,,0.018652235,0.80245423,'-,[0.74886186-0.859881976],CCND1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:69643662
rs1552224-<b>C</b>,1 x 10-10,,0.039030794,0.8700702,'-,[0.834060832-0.907634201],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:72722053
rs17105012-<b>A</b>,2 x 10-8,,0.316946766,1.0520282,'-,[1.033701575-1.070679656],"RN7SKP17, LINC01629",Type 2 diabetes,type II diabetes mellitus,GCST90013693,14:76909348
rs4964665-<b>C</b>,1 x 10-9,,0.550003804,0.9497181,'-,[0.934114756-0.965582058],WSCD2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,12:108234290
rs79310463-<b>T</b>,1 x 10-8,,0.264009786,1.0558721,'-,[1.036349858-1.075762081],KSR2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,12:117968891
rs187150787-<b>A</b>,7 x 10-15,,0.034648308,1.2271333,'-,[1.165543028-1.291978183],SPPL3,Type 2 diabetes,type II diabetes mellitus,GCST90013693,12:120890006
rs12578595-<b>T</b>,8 x 10-15,,0.315771011,0.9333884,'-,[0.917287373-0.949772025],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST90013693,12:27812063
rs3214606-<b>C</b>,3 x 10-25,,0.193425294,1.1226496,'-,[1.098380535-1.147454891],SINHCAF,Type 2 diabetes,type II diabetes mellitus,GCST90013693,12:31324008
rs10750397-<b>G</b>,2 x 10-21,,0.7146,'-,0.04 unit decrease,[0.032-0.048],ETS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:128364249
rs12986742-<b>C</b>,6 x 10-21,,0.4727,'-,0.0353 unit increase,[0.028-0.043],LINC01122,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:58748008
rs3747207-<b>G</b>,4 x 10-21,,0.7178,'-,0.0412 unit decrease,[0.033-0.05],PNPLA3,Type 2 diabetes,type II diabetes mellitus,GCST010557,22:43928975
rs66815886-<b>G</b>,1 x 10-21,,0.6877,'-,0.04 unit increase,[0.032-0.048],ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:64717718
rs79310463-<b>C</b>,7 x 10-21,,0.8257,'-,0.05 unit decrease,[0.04-0.06],KSR2,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:117968891
rs2280141-<b>G</b>,6 x 10-21,,0.512,'-,0.0455 unit decrease,[0.036-0.055],PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:122433665
rs1426371-<b>G</b>,1 x 10-21,,0.692,'-,0.0429 unit increase,[0.034-0.052],WSCD2,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:108236003
rs67269808-<b>G</b>,1 x 10-20,,0.0722,'-,0.0731 unit decrease,[0.058-0.088],CHCHD2P9,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:79293071
rs12789028-<b>G</b>,4 x 10-20,,0.8198,'-,0.0459 unit decrease,[0.036-0.056],LTBP3,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:65558683
rs2115107-<b>G</b>,2 x 10-20,,0.5948,'-,0.0357 unit decrease,[0.028-0.043],"MAP2K7, LRRC8E",Type 2 diabetes,type II diabetes mellitus,GCST010557,19:7903283
rs13268508-<b>C</b>,4 x 10-20,,0.6277,'-,0.0376 unit decrease,[0.03-0.046],HSF1,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:144301594
rs4923864-<b>G</b>,2 x 10-20,,0.6905,'-,0.0568 unit increase,[0.045-0.069],"CCDC9B, PHGR1",Type 2 diabetes,type II diabetes mellitus,GCST010557,15:40342516
rs348330-<b>G</b>,3 x 10-20,,0.4544,'-,0.0497 unit increase,[0.039-0.06],ABCB10,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:229537208
rs72926932-<b>C</b>,4 x 10-20,,0.0755,'-,0.0733 unit increase,[0.058-0.089],TCF4,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:55383415
rs917195-<b>C</b>,1 x 10-20,,0.7224,'-,0.0424 unit increase,[0.033-0.051],CRHR2,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:30688836
rs56823429-<b>C</b>,3 x 10-20,,0.2685,'-,0.0418 unit increase,[0.033-0.051],CMIP,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:81500184
rs11048457-<b>G</b>,2 x 10-19,,0.3857,'-,0.0385 unit increase,[0.03-0.047],"ITPR2, SSPN",Type 2 diabetes,type II diabetes mellitus,GCST010557,12:26310241
rs12603589-<b>C</b>,1 x 10-19,,0.3128,'-,0.0421 unit increase,[0.033-0.051],BPTF,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:67829132
rs11614914-<b>C</b>,3 x 10-19,,0.7033,'-,0.0394 unit decrease,[0.031-0.048],FBRSL1,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:132493708
rs1650505-<b>G</b>,2 x 10-19,,0.7722,'-,0.0409 unit decrease,[0.032-0.05],EBF1,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:158602726
rs11583755-<b>C</b>,1 x 10-19,,0.3287,'-,0.0369 unit increase,[0.029-0.045],KLHL21,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:6612669
rs6066138-<b>G</b>,6 x 10-19,,0.7376,'-,0.042 unit increase,[0.033-0.051],EYA2,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:46966072
rs3802219-<b>C</b>,1 x 10-19,,0.6082,'-,0.0357 unit decrease,[0.028-0.043],TRPS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:115553138
rs10879261-<b>G</b>,7 x 10-19,,0.388,'-,0.0341 unit increase,[0.027-0.042],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:71126981
rs80196932-<b>C</b>,1 x 10-19,,0.1828,'-,0.0479 unit decrease,[0.038-0.058],"NEPNP, NUS1",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:117675468
rs10993072-<b>C</b>,3 x 10-14,,0.6647,'-,0.0315 unit decrease,[0.023-0.04],"MIRLET7A1HG, PTPDC1",Type 2 diabetes,type II diabetes mellitus,GCST010557,9:94152720
rs7132908-<b>G</b>,7 x 10-14,,0.6431,'-,0.0297 unit decrease,[0.022-0.038],FAIM2,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:49869365
rs62492368-<b>G</b>,2 x 10-14,,0.5958,'-,0.0311 unit decrease,[0.023-0.039],AOC1,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:150840547
rs9390022-<b>C</b>,5 x 10-14,,0.3361,'-,0.0306 unit decrease,[0.023-0.039],HIVEP2,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:142735419
rs7659468-<b>G</b>,1 x 10-14,,0.4984,'-,0.0287 unit decrease,[0.021-0.036],SLC9B1,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:102974160
rs6538805-<b>C</b>,1 x 10-14,,0.4736,'-,0.0303 unit decrease,[0.023-0.038],RMST,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:97455342
rs2732469-<b>T</b>,5 x 10-14,,0.584,'-,0.0316 unit increase,[0.023-0.04],H1-7,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:48319149
rs303760-<b>C</b>,2 x 10-14,,0.6887,'-,0.0334 unit decrease,[0.025-0.042],RMC1,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:23503774
rs11078916-<b>C</b>,1 x 10-14,,0.6474,'-,0.0326 unit decrease,[0.024-0.041],"NEUROD2, CDK12",Type 2 diabetes,type II diabetes mellitus,GCST010557,17:39590054
rs75253922-<b>C</b>,8 x 10-14,,0.1846,'-,0.0402 unit increase,[0.03-0.051],INSR,Type 2 diabetes,type II diabetes mellitus,GCST010557,19:7240837
rs1815591-<b>T</b>,3 x 10-14,,0.5927,'-,0.0313 unit decrease,[0.023-0.039],SLCO4A1,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:62645662
rs3816605-<b>C</b>,9 x 10-14,,0.4355,'-,0.0318 unit decrease,[0.023-0.04],NUP160,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:47835701
rs7227272-<b>G</b>,5 x 10-13,,0.8229,'-,0.0408 unit increase,[0.03-0.052],MIR924HG,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:39166659
rs7895872-<b>G</b>,1 x 10-13,,0.3225,'-,0.0306 unit decrease,[0.023-0.039],BBIP1,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:110918899
rs2730827-<b>C</b>,2 x 10-13,,0.5145,'-,0.0279 unit decrease,[0.02-0.035],PDZRN4,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:41469591
rs9479-<b>G</b>,4 x 10-13,,0.5244,'-,0.0271 unit increase,[0.02-0.034],PML,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:74036235
rs17035289-<b>C</b>,2 x 10-13,,0.2062,'-,0.0357 unit increase,[0.026-0.045],TET2,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:105127134
rs667920-<b>G</b>,6 x 10-13,,0.2332,'-,0.0324 unit decrease,[0.024-0.041],STAG1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:136350630
rs10916780-<b>G</b>,2 x 10-13,,0.2476,'-,0.0342 unit decrease,[0.025-0.043],LINC01141,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:20380660
rs6956980-<b>C</b>,1 x 10-13,,0.4669,'-,0.0284 unit increase,[0.021-0.036],"STEAP2-AS1, STEAP2",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:90174320
rs583769-<b>G</b>,8 x 10-13,,0.7164,'-,0.0307 unit decrease,[0.022-0.039],HDAC9,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:18292292
rs36062478-<b>C</b>,7 x 10-13,,0.178,'-,0.0389 unit increase,[0.028-0.049],PTEN,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:87962974
rs75080135-<b>C</b>,2 x 10-13,,0.2074,'-,0.0357 unit decrease,[0.026-0.045],GGNBP1,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:33584930
rs12419690-<b>G</b>,1 x 10-13,,0.5115,'-,0.0298 unit increase,[0.022-0.038],"CRY2, SLC35C1",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:45837033
rs1996617-<b>C</b>,7 x 10-13,,0.3914,'-,0.0289 unit increase,[0.021-0.037],"LRRC66, DCUN1D4",Type 2 diabetes,type II diabetes mellitus,GCST010557,4:51932458
rs3918298-<b>G</b>,8 x 10-25,,0.8823,'-,0.1038 unit increase,[0.084-0.124],CCND1,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:69648505
rs6975279-<b>C</b>,4 x 10-25,,0.7117,'-,0.0431 unit decrease,[0.035-0.051],AUTS2,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:70184697
rs34341-<b>T</b>,5 x 10-25,,0.5248,'-,0.0403 unit increase,[0.033-0.048],ANKDD1B,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:75638184
rs56337234-<b>C</b>,3 x 10-25,,0.4958,'-,0.0426 unit increase,[0.035-0.051],"FGFR3, TACC3",Type 2 diabetes,type II diabetes mellitus,GCST010557,4:1782676
rs3887925-<b>C</b>,1 x 10-25,,0.4984,'-,0.0401 unit decrease,[0.033-0.048],ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:186947857
rs3798519-<b>C</b>,6 x 10-24,,0.2086,'-,0.0474 unit increase,[0.038-0.057],TFAP2B,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:50821065
rs11759026-<b>G</b>,1 x 10-24,,0.3164,'-,0.0585 unit increase,[0.047-0.07],MIR588,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:126470949
rs676387-<b>C</b>,3 x 10-24,,0.6806,'-,0.0416 unit decrease,[0.034-0.05],"HSD17B1, HSD17B1-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010557,17:42554255
rs10188334-<b>C</b>,2 x 10-24,,0.8409,'-,0.0544 unit increase,[0.044-0.065],TMEM18,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:653874
rs9308614-<b>G</b>,5 x 10-23,,0.1338,'-,0.057 unit decrease,[0.046-0.068],Y_RNA,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:120579620
rs58542926-<b>C</b>,2 x 10-23,,0.9258,'-,0.0721 unit decrease,[0.058-0.086],TM6SF2,Type 2 diabetes,type II diabetes mellitus,GCST010557,19:19268740
rs9384-<b>G</b>,8 x 10-23,,0.6566,'-,0.0404 unit increase,[0.032-0.048],"GCDH, SYCE2",Type 2 diabetes,type II diabetes mellitus,GCST010557,19:12899829
rs2453051-<b>C</b>,1 x 10-23,,0.1522,'-,0.0609 unit increase,[0.049-0.073],NOTCH2,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:119956950
rs4805881-<b>C</b>,8 x 10-22,,0.6207,'-,0.0379 unit decrease,[0.03-0.046],PEPD,Type 2 diabetes,type II diabetes mellitus,GCST010557,19:33405526
rs6495182-<b>C</b>,2 x 10-22,,0.6845,'-,0.0405 unit increase,[0.032-0.049],PTPN9,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:75522047
rs9316500-<b>G</b>,1 x 10-22,,0.3528,'-,0.0401 unit decrease,[0.032-0.048],"DLEU7, DLEU1",Type 2 diabetes,type II diabetes mellitus,GCST010557,13:50519978
rs12192275-<b>G</b>,4 x 10-22,,0.7885,'-,0.0482 unit increase,[0.038-0.058],RSPO3,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:127091583
rs2820446-<b>G</b>,2 x 10-22,,0.2993,'-,0.0407 unit decrease,[0.032-0.049],ZC3H11B,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:219575476
rs244415-<b>G</b>,2 x 10-22,,0.6296,'-,0.0401 unit increase,[0.032-0.048],NFAT5,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:69632780
rs8043085-<b>G</b>,9 x 10-22,,0.6975,'-,0.0407 unit decrease,[0.032-0.049],RASGRP1,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:38535939
rs9873519-<b>C</b>,3 x 10-22,,0.5288,'-,0.0373 unit decrease,[0.03-0.045],SLC12A8,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:125202613
rs55857387-<b>C</b>,2 x 10-21,,0.2537,'-,0.0441 unit decrease,[0.035-0.053],FAM234A,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:250389
rs1412234-<b>C</b>,4 x 10-21,,0.2864,'-,0.0397 unit increase,[0.031-0.048],LINGO2,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:28410685
rs10808671-<b>G</b>,2 x 10-21,,0.5407,'-,0.0358 unit decrease,[0.028-0.043],NDUFAF6,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:94955144
rs4709746-<b>C</b>,2 x 10-21,,0.866,'-,0.0565 unit increase,[0.045-0.068],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:163711969
rs1894299-<b>A</b>,2 x 10-67,,NR,0.88433814,'-,[0.872134500364528-0.896712601828505],DUSP9,Type 2 diabetes,type II diabetes mellitus,GCST90013693,X:153643433
chrX:21534509-<b>ACC</b>,8 x 10-9,,NR,0.9572412,'-,[0.943129120129717-0.971564367308432],'-,Type 2 diabetes,type II diabetes mellitus,GCST90013693,Mapping not available
rs6609798-<b>C</b>,1 x 10-9,,NR,1.0478771,'-,[1.03212771130404-1.06386687599671],PCSK1N,Type 2 diabetes,type II diabetes mellitus,GCST90013693,X:48833101
rs4826580-<b>T</b>,4 x 10-9,,NR,1.0453861,'-,[1.03003386073169-1.06096700044454],"ZXDB, FAAH2",Type 2 diabetes,type II diabetes mellitus,GCST90013693,X:57533148
rs55854702-<b>C</b>,5 x 10-38,,NR,0.7778555,'-,[0.748696110700887-0.80815056359397],Y_RNA,Type 2 diabetes,type II diabetes mellitus,GCST90013693,10:92716842
rs2106463-<b>A</b>,3 x 10-24,,NR,0.8716614,'-,[0.848891758178977-0.895041827744204],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2618062
rs463924-<b>T</b>,4 x 10-15,,NR,1.0952718,'-,[1.07072996268252-1.12037619350107],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2696450
rs4930045-<b>C</b>,4 x 10-15,,NR,0.8860744,'-,[0.859706754085941-0.913250793697116],"ASCL2, MIR4686",Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2175194
rs3824004-<b>T</b>,9 x 10-13,,NR,1.1904252,'-,[1.13487927676633-1.2486895731033],PAX4,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:127613497
rs1575972-<b>A</b>,2 x 10-12,,NR,0.8833312,'-,[0.853214567283996-0.914510896110015],'-,Type 2 diabetes,type II diabetes mellitus,GCST90013693,9:22301093
rs2283159-<b>T</b>,1 x 10-11,,NR,0.8314428,'-,[0.788276051248055-0.876973378828353],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2548673
rs150626020-<b>T</b>,8 x 10-11,,NR,1.2053714,'-,[1.13942107435275-1.27513890610741],SND1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:128050855
rs80005921-<b>G</b>,2 x 10-10,,NR,1.0562805,'-,[1.03862776493174-1.07423333576492],"GTF3AP5, RAPGEF5",Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:15023754
rs138213721-<b>T</b>,3 x 10-10,,NR,0.6412598,'-,[0.558257428226303-0.736602991934226],SPPL3,Type 2 diabetes,type II diabetes mellitus,GCST90013693,12:120800804
rs56337234-<b>T</b>,4 x 10-9,,NR,0.9380843,'-,[0.918395990572455-0.958194709760036],"FGFR3, TACC3",Type 2 diabetes,type II diabetes mellitus,GCST90013693,4:1782676
rs10947804-<b>C</b>,9 x 10-9,,NR,1.0503607,'-,[1.03289077331286-1.06812618115103],KCNK17,Type 2 diabetes,type II diabetes mellitus,GCST90013693,6:39314260
rs11980500-<b>A</b>,2 x 10-8,,NR,1.0528978,'-,[1.0341474712256-1.07198803882948],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:14842803
rs10757282-<b>C</b>,2 x 10-7,,NR,0.956032,'-,[0.940033331253759-0.972302941794305],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,9:22133985
rs9349064-<b>G</b>,3 x 10-7,,NR,0.94415665,'-,[0.923703207784574-0.965062925192713],BTBD9,Type 2 diabetes,type II diabetes mellitus,GCST90013693,6:38285652
rs116549635-<b>A</b>,3 x 10-6,,NR,1.0882726,'-,[1.05043995286241-1.12746764619609],ASCL2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2269820
rs11199755-<b>T</b>,8 x 10-6,,NR,0.9521612,'-,[0.931884429138468-0.972879198203729],RPL19P16,Type 2 diabetes,type II diabetes mellitus,GCST90013693,10:121077345
rs565491-<b>A</b>,1 x 10-8,(conditional),NR,1.0780796,'-,[1.05047653421464-1.1064080335737],ANK1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,8:41660341
rs233450-<b>G</b>,3 x 10-13,(conditional),NR,0.92083675,'-,[0.900697932960294-0.941425809104531],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2822818
rs112332300-<b>CT</b>,3 x 10-12,(conditional),NR,1.0836402,'-,[1.05942295171475-1.10841107245715],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,3:23588427
rs2277339-<b>?</b>,3 x 10-10,,0.2063,1.0516965,'-,[1.03537648594243-1.0682737619078],"HSD17B6, PRIM1",Type 2 diabetes,type II diabetes mellitus,GCST90013693,12:56752285
rs73221116-<b>G</b>,2 x 10-19,,0.9577,'-,0.0955 unit decrease,[0.075-0.116],PCGF3,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:726892
rs4809906-<b>G</b>,5 x 10-18,,0.6206,'-,0.0345 unit increase,[0.027-0.042],LINC01524,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:52417142
rs7147483-<b>C</b>,9 x 10-18,,0.3364,'-,0.0352 unit decrease,[0.027-0.043],CLEC14A,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:38335471
rs149336329-<b>G</b>,3 x 10-18,,0.9566,'-,0.0869 unit increase,[0.067-0.107],MYO5C,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:52295543
rs838720-<b>G</b>,4 x 10-18,,0.384,'-,0.034 unit increase,[0.026-0.042],DGKD,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:233394635
rs4930726-<b>C</b>,8 x 10-18,,0.334,'-,0.0353 unit decrease,[0.027-0.043],CCDC92,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:123943784
rs3996350-<b>G</b>,1 x 10-18,,0.5585,'-,0.0347 unit increase,[0.027-0.042],"H4P1, KLF14",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:130742296
rs55691245-<b>G</b>,2 x 10-18,,0.8671,'-,0.0561 unit increase,[0.044-0.069],ACSL1,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:184794946
rs80234489-<b>C</b>,6 x 10-18,,0.1797,'-,0.0966 unit increase,[0.075-0.119],SINHCAF,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:31288245
rs13040225-<b>T</b>,1 x 10-17,,0.4649,'-,0.0329 unit decrease,[0.025-0.04],"PELATON, CEBPB",Type 2 diabetes,type II diabetes mellitus,GCST010557,20:50214235
rs9472139-<b>G</b>,1 x 10-17,,0.7397,'-,0.0376 unit decrease,[0.029-0.046],LINC02537,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:43845974
rs1801645-<b>C</b>,4 x 10-17,,0.2778,'-,0.0374 unit increase,[0.029-0.046],PIM3,Type 2 diabetes,type II diabetes mellitus,GCST010557,22:49963202
rs60384372-<b>G</b>,4 x 10-17,,0.4504,'-,0.0352 unit decrease,[0.027-0.043],MSRA,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:10117074
rs7941510-<b>C</b>,2 x 10-17,,0.6493,'-,0.0353 unit increase,[0.027-0.044],TRIM66,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:8655516
rs177045-<b>G</b>,3 x 10-17,,0.4055,'-,0.0335 unit increase,[0.026-0.041],"NEUROG3, TMEM256P1",Type 2 diabetes,type II diabetes mellitus,GCST010557,10:69561523
rs10773000-<b>G</b>,6 x 10-17,,0.672,'-,0.034 unit increase,[0.026-0.042],"CDK2AP1, C12orf65",Type 2 diabetes,type II diabetes mellitus,GCST010557,12:123251537
rs501470-<b>G</b>,2 x 10-17,,0.4559,'-,0.032 unit decrease,[0.025-0.039],SLC22A3,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:160349886
rs6059662-<b>G</b>,2 x 10-17,,0.6963,'-,0.0369 unit increase,[0.028-0.045],RALY,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:34087921
rs2282456-<b>G</b>,7 x 10-17,,0.7154,'-,0.0351 unit decrease,[0.027-0.043],TENT5C,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:117626841
rs7633673-<b>G</b>,8 x 10-16,,0.5904,'-,0.0306 unit increase,[0.023-0.038],MBNL1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:152366454
rs7674402-<b>G</b>,4 x 10-16,,0.7719,'-,0.0523 unit decrease,[0.04-0.065],MOB1B,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:70970105
rs8054556-<b>G</b>,2 x 10-16,,0.5699,'-,0.0317 unit decrease,[0.024-0.039],TMEM219,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:29946895
rs945187-<b>G</b>,8 x 10-16,,0.4199,'-,0.031 unit increase,[0.023-0.039],"FRAT1, FRAT2",Type 2 diabetes,type II diabetes mellitus,GCST010557,10:97331612
rs56243018-<b>C</b>,9 x 10-16,,0.046,'-,0.0833 unit decrease,[0.063-0.104],ZBTB38,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:141382997
rs2409742-<b>C</b>,3 x 10-16,,0.5255,'-,0.0341 unit increase,[0.026-0.042],"XKR6, LINC00529",Type 2 diabetes,type II diabetes mellitus,GCST010557,8:11212451
rs2303720-<b>?</b>,3 x 10-9,,0.084,0.9226194,'-,[0.898491559706878-0.947395208192873],CEP120,Type 2 diabetes,type II diabetes mellitus,GCST90013693,5:123346640
rs13163173-<b>?</b>,2 x 10-10,,0.5099,1.0429289,'-,[1.02952729848807-1.05650507764568],LINC00461,Type 2 diabetes,type II diabetes mellitus,GCST90013693,5:88647802
rs17105012-<b>?</b>,9 x 10-9,,0.2966,1.0407834,'-,[1.02670221020576-1.05505762111073],"RN7SKP17, LINC01629",Type 2 diabetes,type II diabetes mellitus,GCST90013693,14:76909348
rs5762925-<b>?</b>,1 x 10-10,,0.4623,1.0379962,'-,[1.02627605800756-1.04985002927918],ZNRF3,Type 2 diabetes,type II diabetes mellitus,GCST90013693,22:28973410
rs2526678-<b>?</b>,1 x 10-8,,0.4177,0.949788,'-,[0.933026052254639-0.966850970847483],FADS2,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:61856321
rs58202132-<b>?</b>,4 x 10-7,,0.1647,1.0516546,'-,[1.03137227889666-1.07233584531071],SNTB1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,8:120752281
rs39204-<b>?</b>,4 x 10-8,,0.1905,1.0344808,'-,[1.02201111164696-1.04710272234666],STEAP2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,7:90105004
rs12187734-<b>C</b>,2 x 10-13,,0.5665,'-,0.0287 unit increase,[0.021-0.036],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:52467831
rs144052331-<b>C</b>,4 x 10-13,,0.0539,'-,0.0709 unit decrease,[0.052-0.09],CEP120,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:123315191
rs113135335-<b>G</b>,2 x 10-13,,0.1038,'-,0.0533 unit decrease,[0.039-0.068],"MIR4435-2HG, BCL2L11",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:111130177
rs6565922-<b>C</b>,6 x 10-13,,0.5752,'-,0.0279 unit decrease,[0.02-0.036],ZNF236,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:76847043
rs13237518-<b>C</b>,2 x 10-13,,0.5207,'-,0.0283 unit decrease,[0.021-0.036],TMEM106B,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:12229967
rs1561927-<b>C</b>,5 x 10-13,,0.31,'-,0.0332 unit increase,[0.024-0.042],LINC00824,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:128555832
rs2269247-<b>C</b>,3 x 10-13,,0.8094,'-,0.0356 unit increase,[0.026-0.045],PGM1,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:63641613
rs329118-<b>C</b>,2 x 10-13,,0.5849,'-,0.0281 unit decrease,[0.021-0.036],JADE2,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:134525973
rs6716394-<b>G</b>,1 x 10-13,,0.4844,'-,0.0275 unit increase,[0.02-0.035],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:145593156
rs10408163-<b>C</b>,1 x 10-13,,0.6016,'-,0.0319 unit increase,[0.023-0.04],ZC3H4,Type 2 diabetes,type II diabetes mellitus,GCST010557,19:47093845
rs4382480-<b>G</b>,2 x 10-13,,0.5386,'-,0.0306 unit decrease,[0.022-0.039],MFHAS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:8863963
rs35251247-<b>G</b>,2 x 10-13,,0.7065,'-,0.0309 unit decrease,[0.023-0.039],"ALKBH3, HSD17B12",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:43856909
rs145904381-<b>C</b>,4 x 10-13,,0.0104,'-,0.1607 unit decrease,[0.12-0.2],BNIPL,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:151045515
rs62618693-<b>C</b>,1 x 10-13,,0.9582,'-,0.0819 unit increase,[0.06-0.104],QSER1,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:32934946
rs12380322-<b>G</b>,2 x 10-13,,0.3922,'-,0.0295 unit increase,[0.022-0.037],HAUS6,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:19074540
rs6710938-<b>C</b>,2 x 10-13,,0.228,'-,0.0342 unit decrease,[0.025-0.043],RBMS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:160477361
rs7787720-<b>C</b>,4 x 10-13,,0.5594,'-,0.0285 unit decrease,[0.021-0.036],ETV1,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:13847029
rs6011155-<b>C</b>,6 x 10-13,,0.4137,'-,0.0284 unit decrease,[0.021-0.036],ZBTB46,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:63819311
rs28490139-<b>G</b>,2 x 10-12,,0.8415,'-,0.0375 unit increase,[0.027-0.048],TCF12,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:57077652
rs10844519-<b>G</b>,1 x 10-12,,0.4092,'-,0.03 unit increase,[0.022-0.038],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:33257920
rs7071036-<b>C</b>,2 x 10-12,,0.1978,'-,0.051 unit decrease,[0.037-0.065],"RPL19P16, LINC01153",Type 2 diabetes,type II diabetes mellitus,GCST010557,10:121171054
rs11181613-<b>C</b>,2 x 10-12,,0.8686,'-,0.0418 unit increase,[0.03-0.054],LINC02451,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:42652647
rs57767539-<b>G</b>,7 x 10-12,,0.9362,'-,0.0622 unit decrease,[0.044-0.08],ERN1,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:64125699
rs8056890-<b>G</b>,2 x 10-12,,0.6775,'-,0.0295 unit decrease,[0.021-0.038],ATP2A1,Type 2 diabetes,type II diabetes mellitus,GCST010557,16:28886131
rs6073143-<b>C</b>,4 x 10-12,,0.7327,'-,0.0304 unit increase,[0.022-0.039],IFT52,Type 2 diabetes,type II diabetes mellitus,GCST010557,20:43602055
rs10852123-<b>A</b>,8 x 10-13,,0.201,1.06,'-,[1.04-1.08],"AP3S2, ARPIN-AP3S2",Type 2 diabetes,type II diabetes mellitus,GCST010118,15:89885662
rs8026714-<b>A</b>,1 x 10-22,,0.486,1.07,'-,[1.05-1.08],"PRC1-AS1, PRC1",Type 2 diabetes,type II diabetes mellitus,GCST010118,15:90979023
rs61021634-<b>A</b>,1 x 10-11,,0.438,1.05,'-,[1.03-1.06],'-,Type 2 diabetes,type II diabetes mellitus,GCST010118,15:93282155
rs79826452-<b>A</b>,3 x 10-8,,0.89,1.07,'-,[1.05-1.10],IGF1R,Type 2 diabetes,type II diabetes mellitus,GCST010118,15:98823180
rs2240885-<b>A</b>,3 x 10-9,,0.403,1.04,'-,[1.03-1.06],SLX4,Type 2 diabetes,type II diabetes mellitus,GCST010118,16:3597097
rs117267808-<b>A</b>,5 x 10-17,,0.078,1.11,'-,[1.08-1.14],GP2,Type 2 diabetes,type II diabetes mellitus,GCST010118,16:20311846
rs1421085-<b>C</b>,2 x 10-48,,0.167,1.14,'-,[1.12-1.16],FTO,Type 2 diabetes,type II diabetes mellitus,GCST010118,16:53767042
rs12600132-<b>T</b>,6 x 10-9,,0.432,1.04,'-,[1.03-1.05],PKD1L3,Type 2 diabetes,type II diabetes mellitus,GCST010118,16:71988635
rs6416749-<b>C</b>,3 x 10-12,,0.375,1.05,'-,[1.04-1.07],ZFHX3,Type 2 diabetes,type II diabetes mellitus,GCST010118,16:73066409
rs2925979-<b>T</b>,2 x 10-9,,0.364,1.04,'-,[1.03-1.06],CMIP,Type 2 diabetes,type II diabetes mellitus,GCST010118,16:81501185
rs186568031-<b>T</b>,9 x 10-24,,0.094,1.12,'-,[1.10-1.15],"SLC16A11, CLEC10A",Type 2 diabetes,type II diabetes mellitus,GCST010118,17:7050462
rs7502556-<b>T</b>,4 x 10-11,,0.535,1.05,'-,[1.03-1.06],NF1,Type 2 diabetes,type II diabetes mellitus,GCST010118,17:31315412
rs8064454-<b>A</b>,6 x 10-61,,0.305,1.13,'-,[1.11-1.14],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST010118,17:37741595
rs2706710-<b>T</b>,2 x 10-8,,0.081,1.07,'-,[1.05-1.10],PITPNC1,Type 2 diabetes,type II diabetes mellitus,GCST010118,17:67645535
rs35559984-<b>CA</b>,8 x 10-9,,0.652,1.05,'-,[1.03-1.07],"NUP85, SUMO2",Type 2 diabetes,type II diabetes mellitus,GCST010118,17:75190937
rs9948462-<b>T</b>,9 x 10-10,,0.705,1.05,'-,[1.03-1.06],LAMA1,Type 2 diabetes,type II diabetes mellitus,GCST010118,18:7076837
rs476828-<b>C</b>,5 x 10-27,,0.243,1.09,'-,[1.07-1.10],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST010118,18:60185354
rs12454712-<b>T</b>,1 x 10-15,,0.512,1.06,'-,[1.04-1.07],BCL2,Type 2 diabetes,type II diabetes mellitus,GCST010118,18:63178651
rs8101064-<b>T</b>,4 x 10-8,,0.128,1.07,'-,[1.04-1.09],INSR,Type 2 diabetes,type II diabetes mellitus,GCST010118,19:7293108
rs475002-<b>G</b>,1 x 10-9,,0.518,1.04,'-,[1.03-1.06],SNAPC2,Type 2 diabetes,type II diabetes mellitus,GCST010118,19:7921753
rs4804181-<b>A</b>,2 x 10-8,,0.514,1.04,'-,[1.03-1.06],ZNF799,Type 2 diabetes,type II diabetes mellitus,GCST010118,19:12398722
rs145389767-<b>G</b>,2 x 10-13,,0.979,1.22,'-,[1.16-1.29],"ZNF738, ZNF708",Type 2 diabetes,type II diabetes mellitus,GCST010118,19:21346774
rs142395395-<b>A</b>,7 x 10-23,,0.969,1.24,'-,[1.19-1.29],"ZNF43, ZNF208",Type 2 diabetes,type II diabetes mellitus,GCST010118,19:21917904
rs10422861-<b>C</b>,2 x 10-16,,0.536,1.06,'-,[1.04-1.07],PEPD,Type 2 diabetes,type II diabetes mellitus,GCST010118,19:33403940
rs113036890-<b>CAAAAAAAA</b>,1 x 10-32,,0.731,1.1,'-,[1.08-1.12],"RN7SL836P, GIPR",Type 2 diabetes,type II diabetes mellitus,GCST010118,19:45654671
rs6819331-<b>C</b>,2 x 10-16,,0.6796,'-,0.0404 unit increase,[0.031-0.05],"TMEM154, RPS3AP18",Type 2 diabetes,type II diabetes mellitus,GCST010555,4:152583143
rs28819812-<b>C</b>,3 x 10-14,,0.6747,'-,0.0384 unit increase,[0.028-0.048],"PDGFC, LINC02272",Type 2 diabetes,type II diabetes mellitus,GCST010555,4:156731601
rs72695645-<b>G</b>,9 x 10-20,,0.8599,'-,0.0611 unit increase,[0.048-0.074],ACSL1,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:184792454
rs146886108-<b>C</b>,2 x 10-31,,0.994,'-,0.39 unit increase,[0.32-0.46],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:14751196
rs13155752-<b>C</b>,1 x 10-11,,0.3965,'-,0.0316 unit increase,[0.022-0.041],"RN7SL383P, LINC02224",Type 2 diabetes,type II diabetes mellitus,GCST010555,5:44680585
rs152839-<b>C</b>,1 x 10-8,,0.5761,'-,0.0263 unit increase,[0.017-0.035],PARP8,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:50849432
rs12187734-<b>C</b>,2 x 10-10,,0.5234,'-,0.0293 unit increase,[0.02-0.038],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:52467831
rs4865796-<b>G</b>,5 x 10-21,,0.3184,'-,0.0466 unit decrease,[0.037-0.056],ARL15,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:53976834
rs256904-<b>T</b>,3 x 10-39,,0.7297,'-,0.0692 unit increase,[0.059-0.08],C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:56514478
rs4976033-<b>G</b>,2 x 10-9,,0.4114,'-,0.028 unit increase,[0.019-0.037],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:68418419
rs253412-<b>G</b>,3 x 10-21,,0.3476,'-,0.0459 unit decrease,[0.036-0.055],ANKDD1B,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:75660016
rs6878122-<b>G</b>,5 x 10-29,,0.3114,'-,0.0554 unit increase,[0.046-0.065],ZBED3-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:77131486
rs12519500-<b>C</b>,2 x 10-15,,0.6537,'-,0.038 unit increase,[0.029-0.047],DMGDH,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:79141082
rs7719891-<b>G</b>,9 x 10-9,,0.2605,'-,0.0401 unit increase,[0.026-0.054],RASA1,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:87281535
rs75432112-<b>G</b>,5 x 10-36,,0.9517,'-,0.1344 unit decrease,[0.11-0.16],"PPIP5K2, MACIR",Type 2 diabetes,type II diabetes mellitus,GCST010555,5:103250706
rs329122-<b>G</b>,1 x 10-8,,0.5729,'-,0.0264 unit decrease,[0.017-0.035],JADE2,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:134528909
rs890940-<b>C</b>,1 x 10-17,,0.7887,'-,0.0484 unit decrease,[0.037-0.059],EBF1,Type 2 diabetes,type II diabetes mellitus,GCST010555,5:158599736
rs9379084-<b>G</b>,4 x 10-22,,0.8803,'-,0.0747 unit increase,[0.06-0.09],RREB1,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:7231610
rs3094682-<b>C</b>,2 x 10-23,,0.8056,'-,0.0598 unit increase,[0.048-0.072],LINC02571,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:31296684
rs9275184-<b>C</b>,6 x 10-24,,0.1106,'-,0.0981 unit increase,[0.079-0.117],"MTCO3P1, HLA-DQB1",Type 2 diabetes,type II diabetes mellitus,GCST010555,6:32686937
rs10305420-<b>C</b>,3 x 10-11,,0.6161,'-,0.0316 unit increase,[0.022-0.041],GLP1R,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:39048860
rs34298980-<b>C</b>,4 x 10-9,,0.4995,'-,0.0381 unit decrease,[0.025-0.051],LRFN2,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:40441504
rs11967262-<b>G</b>,2 x 10-15,,0.4877,'-,0.0365 unit increase,[0.027-0.046],"VEGFA, LINC02537",Type 2 diabetes,type II diabetes mellitus,GCST010555,6:43792590
rs3798519-<b>C</b>,5 x 10-17,,0.1803,'-,0.0495 unit increase,[0.038-0.061],TFAP2B,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:50821065
rs2675662-<b>G</b>,8 x 10-9,,0.4361,'-,0.0267 unit decrease,[0.018-0.036],CAMK2G,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:73839369
rs7099048-<b>G</b>,9 x 10-10,,0.4964,'-,0.0282 unit decrease,[0.019-0.037],LRMDA,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:75887349
rs703981-<b>G</b>,2 x 10-40,,0.5439,'-,0.0613 unit increase,[0.052-0.07],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:79183098
rs10788575-<b>G</b>,4 x 10-8,,0.8512,'-,0.0352 unit decrease,[0.023-0.048],"MED6P1, PTEN",Type 2 diabetes,type II diabetes mellitus,GCST010555,10:88008827
rs7071943-<b>G</b>,2 x 10-19,,0.6532,'-,0.0443 unit increase,[0.035-0.054],CPEB3,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:92196795
rs1111875-<b>C</b>,5 x 10-89,,0.5924,'-,0.0923 unit increase,[0.083-0.101],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST010555,10:92703125
rs2862954-<b>C</b>,2 x 10-10,,0.4835,'-,0.0291 unit decrease,[0.02-0.038],ERLIN1,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:100152307
rs7903146-<b>C</b>,3 x 10-695,,0.7079,'-,0.28 unit decrease,[0.27-0.29],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:112998590
rs4929965-<b>G</b>,2 x 10-38,,0.6152,'-,0.0619 unit decrease,[0.052-0.071],"MIR4686, ASCL2",Type 2 diabetes,type II diabetes mellitus,GCST010555,11:2176056
rs2237895-<b>C</b>,3 x 10-54,,0.4231,'-,0.0725 unit increase,[0.063-0.082],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:2835964
rs117316450-<b>G</b>,2 x 10-13,,0.0188,'-,0.1308 unit increase,[0.096-0.166],COPB1,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:14496873
rs5219-<b>C</b>,3 x 10-48,,0.6272,'-,0.0685 unit decrease,[0.059-0.078],KCNJ11,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:17388025
rs62618693-<b>C</b>,7 x 10-14,,0.9566,'-,0.0853 unit increase,[0.063-0.108],QSER1,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:32934946
chr11:43876698-<b>C</b>,9 x 10-17,,0.6951,'-,0.0407 unit decrease,[0.031-0.05],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
rs11038672-<b>G</b>,1 x 10-10,,0.5238,'-,0.0294 unit decrease,[0.02-0.038],"CRY2, SLC35C1",Type 2 diabetes,type II diabetes mellitus,GCST010555,11:45824947
rs1783541-<b>C</b>,4 x 10-17,,0.7972,'-,0.0484 unit decrease,[0.037-0.06],SCYL1,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:65527328
rs144245804-<b>G</b>,1 x 10-17,,0.9731,'-,0.1304 unit increase,[0.1-0.16],CCND1,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:69638276
rs11602873-<b>T</b>,9 x 10-52,,0.1563,'-,0.0976 unit decrease,[0.085-0.11],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:72749717
rs10830963-<b>G</b>,5 x 10-68,,0.2781,'-,0.0885 unit increase,[0.079-0.098],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:92975544
rs10750397-<b>G</b>,1 x 10-20,,0.7102,'-,0.048 unit decrease,[0.038-0.058],ETS1,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:128364249
rs117233107-<b>G</b>,4 x 10-55,,0.9833,'-,0.3251 unit increase,[0.28-0.37],CCND2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:4219355
rs11048458-<b>C</b>,5 x 10-18,,0.7503,'-,0.0458 unit decrease,[0.035-0.056],"ITPR2, SSPN",Type 2 diabetes,type II diabetes mellitus,GCST010555,12:26312652
rs10771372-<b>C</b>,2 x 10-35,,0.8049,'-,0.0721 unit increase,[0.061-0.083],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:27809327
rs10771813-<b>C</b>,3 x 10-8,,0.5442,'-,0.0259 unit increase,[0.017-0.035],MREGP1,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:31214922
rs2583921-<b>C</b>,9 x 10-33,,0.0922,'-,0.0954 unit increase,[0.08-0.111],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:65776701
rs1819564-<b>T</b>,4 x 10-8,,0.9727,'-,0.0757 unit decrease,[0.049-0.103],PKHD1,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:51640539
rs60519666-<b>G</b>,3 x 10-12,,0.6769,'-,0.0347 unit increase,[0.025-0.044],BEND3,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:107105962
rs72951506-<b>C</b>,9 x 10-11,,0.8521,'-,0.0423 unit increase,[0.03-0.055],NUS1,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:117690560
rs11759026-<b>G</b>,7 x 10-19,,0.2307,'-,0.0646 unit increase,[0.05-0.079],MIR588,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:126470949
rs12194820-<b>T</b>,9 x 10-17,,0.2346,'-,0.0462 unit decrease,[0.035-0.057],RSPO3,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:127080833
rs7739842-<b>G</b>,2 x 10-8,,0.1939,'-,0.0329 unit increase,[0.021-0.044],ENPP3,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:131633657
rs1573090-<b>G</b>,4 x 10-22,,0.4648,'-,0.0446 unit decrease,[0.036-0.054],"RPL35AP3, NHEG1",Type 2 diabetes,type II diabetes mellitus,GCST010555,6:136981022
rs11155073-<b>C</b>,4 x 10-11,,0.579,'-,0.0304 unit decrease,[0.021-0.039],"LINC01625, ATP5PBP6",Type 2 diabetes,type II diabetes mellitus,GCST010555,6:139515991
rs543159-<b>C</b>,1 x 10-12,,0.5203,'-,0.0324 unit increase,[0.023-0.041],SLC22A3,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:160354985
rs4709746-<b>C</b>,1 x 10-16,,0.8687,'-,0.0581 unit increase,[0.044-0.072],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:163711969
rs1122518-<b>C</b>,1 x 10-8,,0.4728,'-,0.0263 unit increase,[0.017-0.035],ETV1,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:13860700
rs2191349-<b>G</b>,6 x 10-48,,0.461,'-,0.0661 unit decrease,[0.057-0.075],GTF3AP5,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:15024684
rs75693095-<b>G</b>,1 x 10-11,,0.9789,'-,0.112 unit decrease,[0.079-0.145],IGF2BP3,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:23400438
rs1513272-<b>C</b>,4 x 10-71,,0.5087,'-,0.0811 unit increase,[0.072-0.09],JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:28160478
rs917195-<b>C</b>,3 x 10-17,,0.7691,'-,0.0467 unit increase,[0.036-0.057],CRHR2,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:30688836
rs2908286-<b>C</b>,3 x 10-29,,0.8287,'-,0.0683 unit decrease,[0.056-0.08],GCK,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:44195138
rs2103132-<b>G</b>,2 x 10-9,,0.749,'-,0.0319 unit decrease,[0.022-0.042],AUTS2,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:70317087
rs1968204-<b>C</b>,1 x 10-12,,0.893,'-,0.0566 unit decrease,[0.041-0.072],"DPY19L2P2, RPL23AP95",Type 2 diabetes,type II diabetes mellitus,GCST010555,7:103159690
rs39328-<b>C</b>,3 x 10-9,,0.5733,'-,0.0275 unit decrease,[0.018-0.037],RELN,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:103804531
rs6976111-<b>C</b>,8 x 10-10,,0.6933,'-,0.0318 unit decrease,[0.022-0.042],CTTNBP2,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:117855613
rs1562398-<b>G</b>,2 x 10-18,,0.4169,'-,0.041 unit increase,[0.032-0.05],"H4P1, KLF14",Type 2 diabetes,type II diabetes mellitus,GCST010555,7:130773172
rs62492368-<b>G</b>,6 x 10-12,,0.6848,'-,0.0342 unit decrease,[0.024-0.044],AOC1,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:150840547
rs6459733-<b>G</b>,1 x 10-24,,0.6655,'-,0.0508 unit increase,[0.041-0.06],UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:157137856
rs34990153-<b>G</b>,2 x 10-16,,0.439,'-,0.0384 unit decrease,[0.029-0.048],MSRA,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:10138879
rs2409742-<b>C</b>,7 x 10-15,,0.5074,'-,0.0361 unit increase,[0.027-0.045],"XKR6, LINC00529",Type 2 diabetes,type II diabetes mellitus,GCST010555,8:11212451
rs17091891-<b>C</b>,3 x 10-9,,0.1226,'-,0.0421 unit decrease,[0.028-0.056],LPL,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:19985660
rs2725371-<b>G</b>,2 x 10-13,,0.6895,'-,0.0371 unit decrease,[0.027-0.047],PURG,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:30996517
rs13262861-<b>C</b>,3 x 10-59,,0.8238,'-,0.1016 unit increase,[0.089-0.114],"ANK1, NKX6-3",Type 2 diabetes,type II diabetes mellitus,GCST010555,8:41651058
rs10097617-<b>C</b>,2 x 10-16,,0.5196,'-,0.0374 unit decrease,[0.029-0.046],NDUFAF6,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:94949398
rs149364428-<b>G</b>,6 x 10-13,,0.991,'-,0.2239 unit decrease,[0.16-0.28],CPQ,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:96725513
rs4734193-<b>C</b>,4 x 10-8,,0.5318,'-,0.0341 unit increase,[0.022-0.046],TRHR,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:109128335
rs11558471-<b>G</b>,4 x 10-98,,0.3163,'-,0.1031 unit decrease,[0.093-0.113],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:117173494
rs17772814-<b>G</b>,3 x 10-9,,0.9154,'-,0.0752 unit increase,[0.05-0.1],CASC11,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:127699497
rs1561927-<b>C</b>,9 x 10-12,,0.2821,'-,0.0352 unit increase,[0.025-0.045],LINC00824,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:128555832
rs3757969-<b>G</b>,4 x 10-22,,0.3757,'-,0.0481 unit increase,[0.038-0.058],"SCRT1, DGAT1",Type 2 diabetes,type II diabetes mellitus,GCST010555,8:144327536
rs10974438-<b>C</b>,9 x 10-23,,0.3556,'-,0.047 unit increase,[0.038-0.056],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:4291928
rs10963942-<b>G</b>,4 x 10-15,,0.3965,'-,0.0371 unit increase,[0.028-0.046],HAUS6,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:19080354
rs7867635-<b>C</b>,4 x 10-9,,0.4106,'-,0.037 unit increase,[0.025-0.049],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:20241071
rs10811661-<b>C</b>,8 x 10-112,,0.1717,'-,0.1379 unit decrease,[0.13-0.15],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:22134095
rs1412234-<b>C</b>,4 x 10-19,,0.3192,'-,0.044 unit increase,[0.034-0.054],LINGO2,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:28410685
rs12001437-<b>C</b>,6 x 10-13,,0.3727,'-,0.0339 unit increase,[0.025-0.043],"RN7SKP114, DCAF12",Type 2 diabetes,type II diabetes mellitus,GCST010555,9:34074478
rs1929883-<b>G</b>,5 x 10-10,,0.58,'-,0.0386 unit increase,[0.026-0.051],MTND2P8,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:78729785
rs17791513-<b>G</b>,2 x 10-12,,0.0656,'-,0.0686 unit decrease,[0.049-0.088],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:79290675
rs2796441-<b>G</b>,1 x 10-36,,0.5906,'-,0.0589 unit increase,[0.05-0.068],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST010555,9:81694033
rs10821311-<b>G</b>,4 x 10-13,,0.681,'-,0.0358 unit decrease,[0.026-0.045],"MIRLET7A1HG, LINC02603",Type 2 diabetes,type II diabetes mellitus,GCST010555,9:94180777
rs7046845-<b>C</b>,2 x 10-8,,0.0903,'-,0.0465 unit decrease,[0.03-0.063],AOPEP,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:95042359
rs495203-<b>C</b>,1 x 10-24,,0.6651,'-,0.0493 unit decrease,[0.04-0.059],ABO,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:133269828
rs28429551-<b>T</b>,1 x 10-39,,0.2603,'-,0.0734 unit decrease,[0.062-0.084],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:136348882
rs11257655-<b>C</b>,7 x 10-35,,0.7809,'-,0.0907 unit decrease,[0.076-0.105],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST010555,10:12265895
rs177045-<b>G</b>,2 x 10-15,,0.3238,'-,0.0389 unit increase,[0.029-0.049],"NEUROG3, TMEM256P1",Type 2 diabetes,type II diabetes mellitus,GCST010555,10:69561523
rs10224002-<b>?</b>,5 x 10-8,,'-,'-,2.27 unit increase,[1.45-3.09],PRKAG2,Glomerular filtration rate in type 2 diabetes,"glomerular filtration rate, type II diabetes mellitus",GCST005892,7:151717955
rs1538583-<b>?</b>,4 x 10-6,,'-,'-,2.95 unit increase,[1.70-4.19],TJP2,Glomerular filtration rate in type 2 diabetes,"glomerular filtration rate, type II diabetes mellitus",GCST005892,9:69176631
rs11864909-?-<b>T</b>,4 x 10-12,,0.28,'-,2.34 unit increase,[1.68-3.00],PDILT,Glomerular filtration rate in type 2 diabetes,"glomerular filtration rate, type II diabetes mellitus",GCST005892,16:20389517
rs362307-<b>C</b>,3 x 10-8,,0.9265,'-,0.048 unit decrease,[0.031-0.065],HTT,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:3240118
rs36111056-<b>G</b>,1 x 10-8,,0.7922,'-,0.0303 unit increase,[0.02-0.041],FSD2,Type 2 diabetes,type II diabetes mellitus,GCST010557,15:82793121
rs142385484-<b>C</b>,2 x 10-8,,0.8518,'-,0.0336 unit increase,[0.022-0.045],FCGRT,Type 2 diabetes,type II diabetes mellitus,GCST010557,19:49513502
rs12680217-<b>C</b>,2 x 10-8,,0.301,'-,0.0397 unit decrease,[0.026-0.054],LINC01605,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:37540285
rs2662390-<b>C</b>,1 x 10-8,,0.7419,'-,0.0276 unit decrease,[0.018-0.037],RAB3C,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:58836875
rs620191-<b>G</b>,2 x 10-8,,0.6635,'-,0.0234 unit decrease,[0.015-0.031],"LBX1-AS1, RNU2-43P",Type 2 diabetes,type II diabetes mellitus,GCST010557,10:101306032
rs4832290-<b>C</b>,4 x 10-8,,0.7645,'-,0.0267 unit decrease,[0.017-0.036],KDM3A,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:86480381
rs1922879-<b>G</b>,2 x 10-8,,0.6293,'-,0.023 unit increase,[0.015-0.031],CNTNAP2,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:147961447
rs12992995-<b>C</b>,1 x 10-8,,0.7548,'-,0.0272 unit increase,[0.018-0.037],"LINC01305, SP9",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:174332817
rs13107325-<b>C</b>,3 x 10-8,,0.9265,'-,0.0473 unit decrease,[0.03-0.064],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,Mapping not available
rs3779272-<b>T</b>,1 x 10-8,,0.5782,'-,0.0213 unit increase,[0.014-0.029],MAGI2,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:78199674
rs12494424-<b>G</b>,2 x 10-8,,0.9582,'-,0.0656 unit decrease,[0.043-0.089],SAMMSON,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:70471766
rs6976111-<b>C</b>,2 x 10-8,,0.7218,'-,0.0258 unit decrease,[0.017-0.035],CTTNBP2,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:117855613
rs12892257-<b>G</b>,1 x 10-8,,0.4862,'-,0.0288 unit increase,[0.019-0.039],"PSMA3-AS1, ARMH4, PSMA3",Type 2 diabetes,type II diabetes mellitus,GCST010557,14:58266030
rs7912336-<b>T</b>,1 x 10-8,,0.5529,'-,0.0217 unit increase,[0.014-0.029],HSPA12A,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:116799225
rs2394186-<b>G</b>,2 x 10-8,,0.2192,'-,0.0271 unit decrease,[0.018-0.037],"HLA-G, HCP5B",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:29848644
rs34506349-<b>G</b>,1 x 10-8,,0.9609,'-,0.0665 unit increase,[0.044-0.089],AFF3,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:99982264
rs10469860-<b>G</b>,4 x 10-8,,0.2755,'-,0.0238 unit decrease,[0.015-0.032],LINC01102,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:104549216
rs6715901-<b>G</b>,1 x 10-8,,0.5728,'-,0.023 unit increase,[0.015-0.031],TTN,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:178786227
rs1662185-<b>G</b>,3 x 10-8,,0.576,'-,0.0226 unit decrease,[0.015-0.031],"CCDC88B, PRDX5",Type 2 diabetes,type II diabetes mellitus,GCST010557,11:64333304
rs1877712-<b>G</b>,5 x 10-8,,0.4523,'-,0.0211 unit increase,[0.013-0.029],PNKD,Type 2 diabetes,type II diabetes mellitus,GCST010557,2:218303709
rs34617913-<b>G</b>,3 x 10-8,,0.2966,'-,0.0239 unit decrease,[0.015-0.032],KCTD8,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:44501486
rs2952858-<b>G</b>,1 x 10-8,,0.5987,'-,0.0237 unit decrease,[0.016-0.032],LINC02465,Type 2 diabetes,type II diabetes mellitus,GCST010557,4:129865191
rs8188241-<b>G</b>,2 x 10-8,,0.5955,'-,0.0232 unit increase,[0.015-0.031],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:46204646
rs6885157-<b>G</b>,5 x 10-8,,0.7828,'-,0.0372 unit increase,[0.024-0.051],MGAT1,Type 2 diabetes,type II diabetes mellitus,GCST010557,5:180799516
rs72846863-<b>G</b>,5 x 10-8,,0.8557,'-,0.0335 unit increase,[0.022-0.045],"PI16, C6orf89",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:36943498
rs13288108-<b>C</b>,5 x 10-8,,0.8218,'-,0.0274 unit increase,[0.018-0.037],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:29089439
rs7130522-<b>C</b>,5 x 10-8,,0.3293,'-,0.0222 unit increase,[0.014-0.03],MAML2,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:95977329
rs61967710-<b>G</b>,3 x 10-8,,0.9413,'-,0.0554 unit decrease,[0.036-0.075],HS6ST3,Type 2 diabetes,type II diabetes mellitus,GCST010557,13:96524331
rs372558-<b>G</b>,5 x 10-8,,0.4202,'-,0.0213 unit decrease,[0.014-0.029],UBE2O,Type 2 diabetes,type II diabetes mellitus,GCST010557,17:76422094
rs12140153-<b>G</b>,5 x 10-8,,0.9128,'-,0.0453 unit increase,[0.029-0.062],PATJ,Type 2 diabetes,type II diabetes mellitus,GCST010557,1:62114219
rs113414093-<b>G</b>,2 x 10-8,,0.9459,'-,0.0724 unit decrease,[0.047-0.097],"MIR375, CRYBA2",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:218994449
rs62255926-<b>T</b>,4 x 10-8,,0.2629,'-,0.0252 unit decrease,[0.016-0.034],RFT1,Type 2 diabetes,type II diabetes mellitus,GCST010557,3:53091413
chr12:38342840-<b>?</b>,4 x 10-8,(conditional),0.916404,'-,0.141995 unit increase,[0.091-0.193],'-,Type 2 diabetes,type II diabetes mellitus,GCST010556,Mapping not available
chr12:57699377-<b>?</b>,4 x 10-6,(conditional),0.998716,'-,0.919323 unit decrease,[0.53-1.31],'-,Type 2 diabetes,type II diabetes mellitus,GCST010556,Mapping not available
chr12:80523250-<b>?</b>,5 x 10-6,(conditional),0.995855,'-,0.506641 unit increase,[0.29-0.72],'-,Type 2 diabetes,type II diabetes mellitus,GCST010556,Mapping not available
chr7:44223721-<b>?</b>,5 x 10-6,(conditional),0.820879,'-,0.0830026 unit decrease,[0.047-0.119],'-,Type 2 diabetes,type II diabetes mellitus,GCST010556,Mapping not available
chr8:118168054-<b>?</b>,2 x 10-9,(conditional),0.014291,'-,0.353524 unit decrease,[0.24-0.47],'-,Type 2 diabetes,type II diabetes mellitus,GCST010556,Mapping not available
chr11:2215228-<b>?</b>,5 x 10-8,(conditional),0.816301,'-,0.0968541 unit increase,[0.062-0.132],'-,Type 2 diabetes,type II diabetes mellitus,GCST010556,Mapping not available
chr16:53756885-<b>?</b>,5 x 10-6,(conditional),0.0294916,'-,0.189326 unit increase,[0.11-0.27],'-,Type 2 diabetes,type II diabetes mellitus,GCST010556,Mapping not available
rs7315028-<b>G</b>,2 x 10-8,,0.882,'-,0.124 unit increase,[0.081-0.167],"Y_RNA, ALG10B",Type 2 diabetes,type II diabetes mellitus,GCST010556,12:38316721
rs11172254-<b>G</b>,2 x 10-8,,0.817,'-,0.097 unit increase,[0.064-0.13],KIF5A,Type 2 diabetes,type II diabetes mellitus,GCST010556,12:57574955
rs10745460-<b>T</b>,4 x 10-8,,0.66,'-,0.079 unit increase,[0.052-0.106],RPS4XP15,Type 2 diabetes,type II diabetes mellitus,GCST010556,12:87944684
rs7781440-<b>C</b>,5 x 10-9,,0.284,'-,0.086 unit decrease,[0.057-0.115],GRB10,Type 2 diabetes,type II diabetes mellitus,GCST010556,7:50819477
rs1528287-<b>G</b>,8 x 10-10,,0.059,'-,0.494 unit decrease,[0.34-0.65],PTPRQ,Type 2 diabetes,type II diabetes mellitus,GCST010556,12:80592093
rs11708067-<b>G</b>,2 x 10-11,,0.151,'-,0.118 unit decrease,[0.083-0.153],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST010556,3:123346931
rs9859406-<b>G</b>,6 x 10-14,,0.257,'-,0.115 unit decrease,[0.086-0.144],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST010556,3:185816694
rs464605-<b>C</b>,1 x 10-9,,0.429,'-,0.077 unit decrease,[0.052-0.102],"RPL26P19, C5orf67",Type 2 diabetes,type II diabetes mellitus,GCST010556,5:56511543
rs10305420-<b>C</b>,9 x 10-9,,0.92,'-,0.142 unit increase,[0.093-0.191],GLP1R,Type 2 diabetes,type II diabetes mellitus,GCST010556,6:39048860
chr7:15064896-<b>G</b>,3 x 10-15,,0.565,'-,0.101 unit increase,[0.076-0.126],'-,Type 2 diabetes,type II diabetes mellitus,GCST010556,Mapping not available
rs11073147-<b>G</b>,4 x 10-8,,0.5396,'-,0.0252 unit increase,[0.016-0.034],LINC02853,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:36100361
rs8033609-<b>C</b>,1 x 10-8,,0.4549,'-,0.0265 unit decrease,[0.017-0.036],RORA,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:60646617
rs1874832-<b>G</b>,3 x 10-9,,0.1681,'-,0.0382 unit increase,[0.025-0.051],"LINC02206, HMGN2P47",Type 2 diabetes,type II diabetes mellitus,GCST010555,15:66967900
rs1656794-<b>G</b>,4 x 10-9,,0.7162,'-,0.0311 unit increase,[0.021-0.041],SEPTIN9,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:77390827
rs9912236-<b>C</b>,2 x 10-8,,0.7501,'-,0.0312 unit increase,[0.02-0.042],"LINC01978, LINC01979",Type 2 diabetes,type II diabetes mellitus,GCST010555,17:79921512
rs11662800-<b>G</b>,2 x 10-9,,0.5816,'-,0.0275 unit decrease,[0.018-0.037],LDLRAD4,Type 2 diabetes,type II diabetes mellitus,GCST010555,18:13271368
rs75756987-<b>G</b>,2 x 10-9,,0.8876,'-,0.0439 unit increase,[0.03-0.058],PCNT,Type 2 diabetes,type II diabetes mellitus,GCST010555,21:46347381
rs12741141-<b>G</b>,1 x 10-16,,0.3615,'-,0.0395 unit increase,[0.03-0.049],KLHL21,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:6609910
rs4845987-<b>G</b>,3 x 10-8,,0.3085,'-,0.0282 unit decrease,[0.018-0.038],MTOR,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:11246222
rs10916784-<b>G</b>,4 x 10-9,,0.5852,'-,0.0272 unit increase,[0.018-0.036],LINC01141,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:20402958
rs6685701-<b>G</b>,1 x 10-8,,0.7212,'-,0.0296 unit decrease,[0.019-0.04],RPS6KA1,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:26542148
rs111824905-<b>C</b>,4 x 10-9,,0.0549,'-,0.0693 unit increase,[0.046-0.092],STX12,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:27784286
rs10915188-<b>G</b>,4 x 10-10,,0.4153,'-,0.029 unit decrease,[0.02-0.038],GMEB1,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:28698444
rs2269247-<b>C</b>,6 x 10-9,,0.8135,'-,0.035 unit increase,[0.023-0.047],PGM1,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:63641613
rs10889560-<b>C</b>,4 x 10-9,,0.9118,'-,0.0473 unit decrease,[0.032-0.063],LEPR,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:65524195
rs4655617-<b>C</b>,2 x 10-9,,0.4343,'-,0.0277 unit increase,[0.019-0.037],SGIP1,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:66544971
rs2613503-<b>C</b>,7 x 10-11,,0.1988,'-,0.0392 unit decrease,[0.027-0.051],RPL31P12,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:72374091
rs197379-<b>C</b>,9 x 10-9,,0.387,'-,0.0269 unit increase,[0.018-0.036],INKA2,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:111749681
rs41276588-<b>G</b>,4 x 10-13,,0.717,'-,0.0375 unit decrease,[0.027-0.048],"VPS25P1, TENT5C",Type 2 diabetes,type II diabetes mellitus,GCST010555,1:117605762
rs72692805-<b>G</b>,6 x 10-10,,0.9244,'-,0.0539 unit increase,[0.037-0.071],"SF3B4, SV2A",Type 2 diabetes,type II diabetes mellitus,GCST010555,1:149922463
rs3020781-<b>G</b>,1 x 10-10,,0.2695,'-,0.0333 unit increase,[0.023-0.043],PKLR,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:155299985
rs4916253-<b>G</b>,3 x 10-9,,0.4311,'-,0.0274 unit increase,[0.018-0.036],"PIGC, DNM3",Type 2 diabetes,type II diabetes mellitus,GCST010555,1:172391892
rs567185-<b>C</b>,2 x 10-14,,0.3656,'-,0.037 unit decrease,[0.028-0.046],"NAV1, IPO9-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010555,1:201794371
rs7538321-<b>T</b>,1 x 10-9,,0.1253,'-,0.042 unit increase,[0.028-0.056],"SLC41A1, PM20D1",Type 2 diabetes,type II diabetes mellitus,GCST010555,1:205820327
rs7558413-<b>G</b>,6 x 10-10,,0.4305,'-,0.0286 unit decrease,[0.02-0.038],RDH14,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:18540396
rs34573045-<b>G</b>,2 x 10-11,,0.4202,'-,0.0311 unit increase,[0.022-0.04],TM4SF4,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:149478965
rs56394279-<b>C</b>,5 x 10-12,,0.468,'-,0.0314 unit increase,[0.022-0.04],"TRIM59, B3GAT3P1",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:160453304
rs686998-<b>G</b>,6 x 10-9,,0.539,'-,0.0267 unit increase,[0.018-0.036],NLGN1,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:173401978
rs10937208-<b>G</b>,1 x 10-10,,0.136,'-,0.0443 unit increase,[0.031-0.058],"EHHADH-AS1, C3orf70",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:185159838
rs7619708-<b>C</b>,3 x 10-10,,0.2418,'-,0.0334 unit decrease,[0.023-0.044],"LINC00885, TFRC",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:196083316
rs11940813-<b>G</b>,3 x 10-8,,0.137,'-,0.0371 unit increase,[0.024-0.05],SLIT2,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:20209330
rs62310934-<b>G</b>,1 x 10-10,,0.3888,'-,0.0304 unit decrease,[0.021-0.04],"OCIAD1, OCIAD2",Type 2 diabetes,type II diabetes mellitus,GCST010555,4:48878610
rs2055997-<b>G</b>,7 x 10-10,,0.7014,'-,0.0313 unit increase,[0.021-0.041],CDKL2,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:75609902
rs11723275-<b>C</b>,4 x 10-9,,0.4671,'-,0.0269 unit increase,[0.018-0.036],SHROOM3,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:76607668
rs3755879-<b>G</b>,6 x 10-11,,0.6847,'-,0.0326 unit decrease,[0.023-0.042],UNC5C,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:95193234
rs17035289-<b>C</b>,6 x 10-12,,0.1708,'-,0.0428 unit increase,[0.031-0.055],TET2,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:105127134
rs12509379-<b>G</b>,3 x 10-8,,0.7883,'-,0.0312 unit decrease,[0.02-0.042],"LARP1B, PGRMC2",Type 2 diabetes,type II diabetes mellitus,GCST010555,4:128258303
rs12505942-<b>C</b>,7 x 10-10,,0.3385,'-,0.0298 unit decrease,[0.02-0.039],MAML3,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:139985236
rs75686861-<b>G</b>,4 x 10-9,,0.907,'-,0.0469 unit decrease,[0.031-0.063],HHIP,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:144700176
rs35901985-<b>G</b>,2 x 10-8,,0.1759,'-,0.0352 unit decrease,[0.023-0.047],SORBS2,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:185658908
rs114136102-<b>C</b>,2 x 10-9,,0.0397,'-,0.072 unit increase,[0.048-0.096],"LMBRD2, UGT3A2",Type 2 diabetes,type II diabetes mellitus,GCST010555,5:36084324
rs2410767-<b>G</b>,7 x 10-9,,0.2211,'-,0.0325 unit decrease,[0.022-0.043],"TMEM161B-AS1, LINC02060",Type 2 diabetes,type II diabetes mellitus,GCST010555,5:88409451
rs112667817-<b>C</b>,6 x 10-9,,0.8789,'-,0.0609 unit increase,[0.04-0.081],"ETF1, RPL7P19",Type 2 diabetes,type II diabetes mellitus,GCST010555,5:138487467
rs727734-<b>T</b>,3 x 10-8,,0.2525,'-,0.0295 unit decrease,[0.019-0.04],JARID2,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:15474820
rs9368112-<b>C</b>,3 x 10-8,,0.4753,'-,0.0259 unit decrease,[0.017-0.035],LNC-LBCS,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:19717926
rs9296095-<b>C</b>,5 x 10-9,,0.197,'-,0.0341 unit decrease,[0.023-0.045],"GGNBP1, BAK1",Type 2 diabetes,type II diabetes mellitus,GCST010555,6:33574746
rs55812705-<b>C</b>,7 x 10-9,,0.2509,'-,0.0305 unit decrease,[0.02-0.041],"MFSD4B, REV3L",Type 2 diabetes,type II diabetes mellitus,GCST010555,6:111417590
rs2008027-<b>G</b>,4 x 10-9,,0.5043,'-,0.0272 unit increase,[0.018-0.036],"HEY2, LINC02523",Type 2 diabetes,type II diabetes mellitus,GCST010555,6:125731213
rs197482-<b>C</b>,3 x 10-10,,0.6162,'-,0.0298 unit increase,[0.021-0.039],"HIVEP2, LINC02828",Type 2 diabetes,type II diabetes mellitus,GCST010555,6:142748178
rs9383649-<b>G</b>,1 x 10-12,,0.4192,'-,0.0329 unit increase,[0.024-0.042],RGS17,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:153106967
rs4397977-<b>G</b>,3 x 10-9,,0.6565,'-,0.0291 unit decrease,[0.019-0.039],"MIR3168, RN7SL597P",Type 2 diabetes,type II diabetes mellitus,GCST010555,13:41114265
rs8005994-<b>G</b>,5 x 10-8,,0.3455,'-,0.0265 unit decrease,[0.017-0.036],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:29275326
rs799661-<b>C</b>,7 x 10-9,,0.8706,'-,0.043 unit increase,[0.028-0.058],SRP54-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:34920940
rs2933211-<b>G</b>,6 x 10-9,,0.499,'-,0.0268 unit decrease,[0.018-0.036],MDGA2,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:46844338
rs10137475-<b>G</b>,4 x 10-8,,0.4257,'-,0.0255 unit increase,[0.016-0.035],ARID4A,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:58331235
rs4899280-<b>C</b>,1 x 10-8,,0.67,'-,0.0276 unit decrease,[0.018-0.037],DCAF5,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:69059590
rs8008540-<b>C</b>,8 x 10-11,,0.5688,'-,0.0301 unit increase,[0.021-0.039],NPC2,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:74481477
rs2056857-<b>C</b>,3 x 10-8,,0.5944,'-,0.0261 unit increase,[0.017-0.035],LRRC74A,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:76834520
rs73347525-<b>G</b>,7 x 10-9,,0.1897,'-,0.0485 unit decrease,[0.032-0.065],MEG3,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:100788835
rs11639470-<b>G</b>,1 x 10-8,,0.4531,'-,0.0266 unit decrease,[0.017-0.036],C15orf54,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:39346970
rs74804697-<b>G</b>,5 x 10-12,,0.0434,'-,0.0837 unit decrease,[0.06-0.107],"MYO5C, MYO5A",Type 2 diabetes,type II diabetes mellitus,GCST010555,15:52296525
rs12917449-<b>C</b>,5 x 10-10,,0.197,'-,0.0364 unit increase,[0.025-0.048],PML,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:74039318
rs36111056-<b>G</b>,2 x 10-9,,0.7802,'-,0.0341 unit increase,[0.023-0.045],FSD2,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:82793121
rs4984980-<b>G</b>,4 x 10-9,,0.8117,'-,0.0351 unit decrease,[0.023-0.047],LMF1,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:918292
rs9927842-<b>C</b>,7 x 10-9,,0.8384,'-,0.0375 unit decrease,[0.025-0.05],PDXDC1,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:15059860
rs11646052-<b>G</b>,3 x 10-8,,0.3918,'-,0.0263 unit increase,[0.017-0.036],GINS2,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:85682857
rs11117364-<b>G</b>,8 x 10-9,,0.6655,'-,0.029 unit increase,[0.019-0.039],"BANP, LINC02182",Type 2 diabetes,type II diabetes mellitus,GCST010555,16:88098593
rs11870735-<b>C</b>,2 x 10-8,,0.8178,'-,0.0339 unit decrease,[0.022-0.046],VPS53,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:578364
rs2243102-<b>C</b>,5 x 10-8,,0.4224,'-,0.0255 unit increase,[0.016-0.035],"GP1BA, SLC25A11",Type 2 diabetes,type II diabetes mellitus,GCST010555,17:4935854
rs7220340-<b>G</b>,4 x 10-9,,0.545,'-,0.0272 unit decrease,[0.018-0.036],"TWF1P1, CRYBA1",Type 2 diabetes,type II diabetes mellitus,GCST010555,17:29239308
rs4796224-<b>G</b>,3 x 10-8,,0.4738,'-,0.0252 unit increase,[0.016-0.034],ZNHIT3,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:36486677
rs11078916-<b>C</b>,5 x 10-13,,0.7039,'-,0.0373 unit decrease,[0.027-0.047],"NEUROD2, CDK12",Type 2 diabetes,type II diabetes mellitus,GCST010555,17:39590054
rs61736066-<b>G</b>,2 x 10-9,,0.9165,'-,0.0506 unit increase,[0.034-0.067],SLC39A11,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:72648893
rs62075585-<b>G</b>,1 x 10-10,,0.4735,'-,0.0295 unit increase,[0.02-0.039],CYTH1,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:78765957
rs303760-<b>C</b>,1 x 10-12,,0.6522,'-,0.0342 unit decrease,[0.025-0.044],RMC1,Type 2 diabetes,type II diabetes mellitus,GCST010555,18:23503774
rs75886247-<b>?</b>,5 x 10-6,(EA),'-,1.45,'-,[1.29-1.63],NPHP4,Chronic kidney disease in type 2 diabetes,"chronic kidney disease, type II diabetes mellitus",GCST005882,1:5975370
rs17151401-<b>?</b>,3 x 10-6,(EA),'-,1.31,'-,[1.12-1.53],ATXN7L1,Chronic kidney disease in type 2 diabetes,"chronic kidney disease, type II diabetes mellitus",GCST005882,7:105705501
rs12251637-<b>?</b>,8 x 10-6,(EA),'-,1.5,'-,[1.16-1.94],LHPP,Chronic kidney disease in type 2 diabetes,"chronic kidney disease, type II diabetes mellitus",GCST005882,10:124549008
rs73206603-<b>?</b>,1 x 10-7,(EA),'-,1.83,'-,[1.17-2.87],RNU7-88P,End-stage renal disease in type 2 diabetes,"chronic kidney disease, type II diabetes mellitus",GCST005885,13:59495931
rs117897666-<b>?</b>,3 x 10-7,(EA),'-,3.02,'-,[0.95-9.59],"INSYN1-AS1, TBC1D21",End-stage renal disease in type 2 diabetes,"chronic kidney disease, type II diabetes mellitus",GCST005885,15:73811619
rs74796791-<b>?</b>,5 x 10-6,(EA),'-,2.04,'-,[1.13-3.70],TBC1D5,Late diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005887,3:17161837
rs158342-<b>?</b>,7 x 10-6,(EA),'-,1.25,'-,[1.15-1.36],"RNU6ATAC2P, HMGN1P17",Late diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005887,5:56329506
chr11:81277664:D-<b>?</b>,3 x 10-6,(EA),'-,1.28,'-,[1.14-1.44],'-,Late diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005887,Mapping not available
rs158342-<b>?</b>,4 x 10-6,,'-,1.24,'-,[1.15-1.34],"RNU6ATAC2P, HMGN1P17",Late diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005887,5:56329506
rs9942471-<b>A</b>,5 x 10-8,(EA),0.64,1.25,'-,[1.16-1.34],"GABRR2, GABRR1",Early diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005889,6:89238513
rs10224002-<b>?</b>,8 x 10-7,(EA),'-,'-,2.13 unit increase,[1.28-2.98],PRKAG2,Glomerular filtration rate in type 2 diabetes,"glomerular filtration rate, type II diabetes mellitus",GCST005892,7:151717955
rs13333226-<b>?</b>,2 x 10-9,(EA),'-,'-,2.68 unit increase,[1.80-3.55],UMOD,Glomerular filtration rate in type 2 diabetes,"glomerular filtration rate, type II diabetes mellitus",GCST005892,16:20354332
rs4289202-<b>?</b>,4 x 10-6,,'-,'-,2.51 unit increase,[1.44-3.58],"RN7SKP179, LINC01889",Glomerular filtration rate in type 2 diabetes,"glomerular filtration rate, type II diabetes mellitus",GCST005892,2:125848518
rs115114609-<b>?</b>,7 x 10-7,,'-,'-,5.8 unit increase,[3.51-8.09],"LINC00461, TMEM161B-AS1",Glomerular filtration rate in type 2 diabetes,"glomerular filtration rate, type II diabetes mellitus",GCST005892,5:88448197
rs864745-<b>C</b>,1 x 10-8,,0.257,'-,0.083 unit decrease,[0.056-0.11],JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST010556,7:28140937
rs2908274-<b>G</b>,5 x 10-11,,0.359,'-,0.089 unit decrease,[0.062-0.116],GCK,Type 2 diabetes,type II diabetes mellitus,GCST010556,7:44145489
rs12550613-<b>G</b>,6 x 10-16,,0.31,'-,0.114 unit decrease,[0.087-0.141],"ANK1, NKX6-3",Type 2 diabetes,type II diabetes mellitus,GCST010556,8:41652741
rs60461843-<b>T</b>,1 x 10-9,,0.939,'-,0.172 unit increase,[0.12-0.23],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST010556,8:117154088
rs28562046-<b>G</b>,3 x 10-8,,0.709,'-,0.08 unit increase,[0.053-0.107],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST010556,9:136347142
rs7903146-<b>C</b>,6 x 10-60,,0.706,'-,0.226 unit decrease,[0.2-0.25],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST010556,10:112998590
rs231361-<b>G</b>,2 x 10-9,,0.656,'-,0.08 unit decrease,[0.055-0.105],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST010556,11:2670270
rs2237897-<b>C</b>,2 x 10-9,,0.908,'-,0.143 unit increase,[0.096-0.19],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010556,11:2837316
rs2583938-<b>T</b>,3 x 10-12,,0.197,'-,0.123 unit decrease,[0.088-0.158],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST010556,12:65821434
rs952471-<b>G</b>,4 x 10-9,,0.534,'-,0.077 unit increase,[0.052-0.102],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST010556,15:77484156
rs62033400-<b>G</b>,6 x 10-13,,0.102,'-,0.151 unit increase,[0.11-0.19],FTO,Type 2 diabetes,type II diabetes mellitus,GCST010556,16:53777876
rs79489938-<b>G</b>,5 x 10-8,,0.986,'-,0.1131 unit increase,[0.073-0.154],ACP6,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:147649198
rs9842137-<b>C</b>,9 x 10-9,,0.9969,'-,0.4254 unit decrease,[0.28-0.57],SUMF1,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:3608166
rs11129735-<b>G</b>,2 x 10-8,,0.5383,'-,0.026 unit decrease,[0.017-0.035],TRANK1,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:36828739
rs11716527-<b>C</b>,7 x 10-9,,0.0945,'-,0.0492 unit increase,[0.033-0.066],U3,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:89937130
rs181752889-<b>C</b>,2 x 10-9,,0.996,'-,0.2822 unit decrease,[0.19-0.37],"ACAD9, MARK2P6",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:128860481
rs7656001-<b>G</b>,1 x 10-8,,0.4499,'-,0.026 unit decrease,[0.017-0.035],CCSER1,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:90322714
rs4714422-<b>G</b>,5 x 10-8,,0.2387,'-,0.0293 unit increase,[0.019-0.04],OARD1,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:41044666
rs4721089-<b>C</b>,8 x 10-10,,0.2432,'-,0.034 unit decrease,[0.023-0.045],MAD1L1,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:1833285
rs798549-<b>C</b>,1 x 10-8,,0.282,'-,0.0295 unit increase,[0.019-0.04],AMZ1,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:2721116
rs117173251-<b>C</b>,2 x 10-8,,0.9673,'-,0.077 unit decrease,[0.05-0.104],CSMD1,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:4329209
rs1752169-<b>C</b>,2 x 10-9,,0.7305,'-,0.0317 unit decrease,[0.021-0.042],DENND1A,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:123824284
rs12773019-<b>G</b>,5 x 10-8,,0.0275,'-,0.0885 unit increase,[0.057-0.12],SPOCK2,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:72075516
rs480840-<b>C</b>,4 x 10-8,,0.4232,'-,0.0254 unit increase,[0.016-0.034],XRRA1,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:74914952
rs9319382-<b>C</b>,3 x 10-8,,0.6786,'-,0.0276 unit increase,[0.018-0.037],POLR1D,Type 2 diabetes,type II diabetes mellitus,GCST010555,13:27670990
rs36051838-<b>C</b>,5 x 10-8,,0.0888,'-,0.044 unit increase,[0.028-0.06],LINC00838,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:33729802
rs12263348-<b>C</b>,8 x 10-9,,0.6615,'-,0.0282 unit decrease,[0.019-0.038],REEP3,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:63545492
rs10998304-<b>C</b>,2 x 10-11,,0.4517,'-,0.0306 unit increase,[0.022-0.039],TET1,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:68583018
rs827237-<b>C</b>,4 x 10-10,,0.795,'-,0.0365 unit decrease,[0.025-0.048],"LINC02622, PCBD1",Type 2 diabetes,type II diabetes mellitus,GCST010555,10:70888579
rs11201999-<b>C</b>,1 x 10-8,,0.5369,'-,0.0259 unit increase,[0.017-0.035],GRID1,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:86364744
rs10882891-<b>C</b>,2 x 10-11,,0.4153,'-,0.0313 unit increase,[0.022-0.041],"Metazoa_SRP, RPL12P27",Type 2 diabetes,type II diabetes mellitus,GCST010555,10:97299888
rs2250301-<b>G</b>,1 x 10-9,,0.7481,'-,0.0322 unit increase,[0.022-0.043],WBP1L,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:102788636
rs10787287-<b>C</b>,7 x 10-11,,0.2411,'-,0.036 unit decrease,[0.025-0.047],PDCD4,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:110887437
rs10769936-<b>C</b>,6 x 10-12,,0.7074,'-,0.0349 unit increase,[0.025-0.045],TRIM66,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:8632981
rs2403221-<b>G</b>,6 x 10-11,,0.3428,'-,0.0317 unit decrease,[0.022-0.041],SBF2,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:9830928
rs116861182-<b>C</b>,6 x 10-9,,0.0549,'-,0.0637 unit increase,[0.042-0.085],"OR5L2, OR5D18",Type 2 diabetes,type II diabetes mellitus,GCST010555,11:55820740
rs174541-<b>C</b>,9 x 10-10,,0.354,'-,0.0292 unit decrease,[0.02-0.039],FADS2,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:61798436
rs35169799-<b>C</b>,5 x 10-8,,0.9343,'-,0.0504 unit decrease,[0.032-0.068],PLCB3,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:64263769
rs10899283-<b>C</b>,1 x 10-8,,0.7712,'-,0.0314 unit increase,[0.021-0.042],TSKU,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:76794158
rs67013744-<b>G</b>,4 x 10-8,,0.1604,'-,0.035 unit increase,[0.022-0.048],CHD4,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:6572620
rs10841868-<b>G</b>,2 x 10-9,,0.7394,'-,0.0315 unit increase,[0.021-0.042],"LDHB, GYS2",Type 2 diabetes,type II diabetes mellitus,GCST010555,12:21628312
rs10844518-<b>G</b>,9 x 10-11,,0.2872,'-,0.0326 unit increase,[0.023-0.042],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:33257845
rs2733289-<b>C</b>,4 x 10-11,,0.4775,'-,0.0301 unit increase,[0.021-0.039],PDZRN4,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:41444433
rs11181613-<b>C</b>,1 x 10-10,,0.8547,'-,0.043 unit increase,[0.03-0.056],LINC02451,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:42652647
rs2732480-<b>C</b>,3 x 10-13,,0.5648,'-,0.0337 unit increase,[0.025-0.043],ZNF641,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:48342520
rs7132908-<b>G</b>,1 x 10-12,,0.6102,'-,0.033 unit decrease,[0.024-0.042],FAIM2,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:49869365
rs1872635-<b>G</b>,1 x 10-8,,0.3136,'-,0.0282 unit decrease,[0.019-0.038],SMUG1,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:54147966
rs11830243-<b>C</b>,2 x 10-9,,0.887,'-,0.0442 unit decrease,[0.03-0.059],EP400,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:132060149
rs12305809-<b>G</b>,1 x 10-12,,0.6065,'-,0.0333 unit increase,[0.024-0.043],ZNF268,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:133200880
rs314879-<b>C</b>,6 x 10-12,,0.2262,'-,0.0393 unit increase,[0.028-0.05],"DDX39AP1, SNORD36",Type 2 diabetes,type II diabetes mellitus,GCST010555,13:22735243
rs11680058-<b>G</b>,1 x 10-8,,0.162,'-,0.0556 unit decrease,[0.036-0.075],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:16393401
rs34845373-<b>G</b>,1 x 10-12,,0.2711,'-,0.0372 unit decrease,[0.027-0.047],DTNB,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:25412902
rs13414140-<b>C</b>,4 x 10-60,,0.8858,'-,0.1183 unit increase,[0.1-0.13],THADA,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:43444037
rs980183-<b>G</b>,1 x 10-14,,0.3942,'-,0.0363 unit increase,[0.027-0.046],LINC01122,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:59084401
rs243018-<b>G</b>,2 x 10-33,,0.463,'-,0.056 unit increase,[0.047-0.065],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:60359572
rs2540949-<b>T</b>,9 x 10-26,,0.3842,'-,0.0496 unit decrease,[0.04-0.059],CEP68,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:65057097
rs72836348-<b>G</b>,3 x 10-13,,0.8917,'-,0.0562 unit increase,[0.041-0.071],"MIR4435-2HG, BCL2L11",Type 2 diabetes,type II diabetes mellitus,GCST010555,2:111130466
rs9784137-<b>G</b>,5 x 10-21,,0.849,'-,0.0608 unit increase,[0.048-0.074],Y_RNA,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:120568332
rs7559658-<b>C</b>,3 x 10-9,,0.1899,'-,0.0344 unit increase,[0.023-0.046],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:147162645
rs7568172-<b>G</b>,3 x 10-12,,0.9396,'-,0.0674 unit increase,[0.049-0.086],CYTIP,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:157478828
rs6432613-<b>G</b>,7 x 10-14,,0.7236,'-,0.0393 unit increase,[0.029-0.05],RBMS1,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:160289101
rs2972145-<b>C</b>,7 x 10-80,,0.6354,'-,0.09 unit increase,[0.081-0.099],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:226236593
rs7561798-<b>G</b>,1 x 10-9,,0.4852,'-,0.0281 unit increase,[0.019-0.037],SPHKAP,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:228108944
rs838735-<b>G</b>,4 x 10-10,,0.6157,'-,0.0294 unit decrease,[0.02-0.039],DGKD,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:233415546
rs17036160-<b>C</b>,3 x 10-47,,0.8796,'-,0.1028 unit increase,[0.089-0.117],PPARG,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:12288284
rs35352848-<b>C</b>,7 x 10-28,,0.2069,'-,0.0623 unit decrease,[0.051-0.073],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:23414091
rs62262091-<b>C</b>,1 x 10-10,,0.9106,'-,0.0557 unit decrease,[0.039-0.073],SMARCC1,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:47652174
rs4688760-<b>C</b>,1 x 10-11,,0.326,'-,0.034 unit decrease,[0.024-0.044],RBM6,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:49943163
rs2581787-<b>G</b>,3 x 10-8,,0.4421,'-,0.0254 unit decrease,[0.016-0.034],RFT1,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:53093661
rs76263492-<b>G</b>,2 x 10-8,,0.9569,'-,0.0675 unit decrease,[0.044-0.091],CACNA2D3,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:54794800
rs2292662-<b>C</b>,8 x 10-18,,0.8436,'-,0.0556 unit increase,[0.043-0.068],"SCAANT1, ATXN7",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:63911539
rs4132228-<b>C</b>,6 x 10-21,,0.7026,'-,0.0471 unit increase,[0.037-0.057],ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:64722438
rs11922794-<b>G</b>,1 x 10-8,,0.7494,'-,0.0301 unit decrease,[0.02-0.04],SHQ1,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:72764431
rs11708067-<b>G</b>,2 x 10-46,,0.2286,'-,0.0782 unit decrease,[0.067-0.089],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:123346931
rs9873519-<b>C</b>,4 x 10-16,,0.466,'-,0.0375 unit decrease,[0.028-0.047],SLC12A8,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:125202613
rs9828772-<b>G</b>,3 x 10-11,,0.1013,'-,0.0517 unit decrease,[0.036-0.067],"TMCC1, PLXND1",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:129614339
rs62271373-<b>T</b>,4 x 10-11,,0.9442,'-,0.0685 unit decrease,[0.048-0.089],"TSC22D2, LINC01214",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:150348753
rs74672008-<b>G</b>,1 x 10-11,,0.9601,'-,0.0804 unit increase,[0.057-0.104],ATP5MGP5,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:152733827
rs1449348-<b>C</b>,7 x 10-12,,0.8585,'-,0.0448 unit increase,[0.032-0.058],EGFEM1P,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:168507267
rs9873618-<b>G</b>,2 x 10-30,,0.7094,'-,0.0581 unit increase,[0.048-0.068],SLC2A2,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:171015287
rs2313211-<b>T</b>,4 x 10-10,,0.4483,'-,0.0285 unit increase,[0.019-0.038],"EEF1A1P8, ABCC5",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:184020838
rs9854769-<b>G</b>,1 x 10-107,,0.319,'-,0.1075 unit increase,[0.098-0.117],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:185803160
rs3887925-<b>C</b>,7 x 10-20,,0.4548,'-,0.0424 unit decrease,[0.033-0.051],ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:186947857
rs6777684-<b>G</b>,4 x 10-33,,0.6076,'-,0.0569 unit increase,[0.048-0.066],LINC01991,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:188024054
rs1531583-<b>G</b>,7 x 10-19,,0.9553,'-,0.0994 unit decrease,[0.077-0.121],PCGF3,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:751184
rs72501964-<b>G</b>,2 x 10-10,,0.9606,'-,0.0831 unit increase,[0.057-0.109],CTBP1-DT,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:1273415
rs56337234-<b>C</b>,2 x 10-18,,0.5048,'-,0.0409 unit increase,[0.032-0.05],"FGFR3, TACC3",Type 2 diabetes,type II diabetes mellitus,GCST010555,4:1782676
rs362307-<b>C</b>,4 x 10-8,,0.9249,'-,0.0499 unit decrease,[0.032-0.068],HTT,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:3240118
rs10937721-<b>G</b>,6 x 10-70,,0.412,'-,0.0835 unit decrease,[0.074-0.093],"PPP2R2C, WFS1",Type 2 diabetes,type II diabetes mellitus,GCST010555,4:6305036
rs2011603-<b>G</b>,2 x 10-13,,0.2752,'-,0.0383 unit decrease,[0.028-0.048],LCORL,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:18023861
rs10938398-<b>G</b>,4 x 10-20,,0.5687,'-,0.0425 unit decrease,[0.033-0.052],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:45184122
rs114447556-<b>C</b>,8 x 10-11,,0.9166,'-,0.0578 unit decrease,[0.04-0.075],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:52340927
rs10471048-<b>G</b>,2 x 10-12,,0.3487,'-,0.0337 unit increase,[0.024-0.043],SCD5,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:82666409
rs987949-<b>G</b>,6 x 10-9,,0.9605,'-,0.153 unit decrease,[0.1-0.2],NKX6-1,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:84462916
rs7660000-<b>C</b>,1 x 10-9,,0.7131,'-,0.0309 unit increase,[0.021-0.041],FAM13A,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:88830707
rs6821438-<b>G</b>,4 x 10-10,,0.4691,'-,0.0289 unit decrease,[0.02-0.038],HMGB3P15,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:94170760
rs7695096-<b>C</b>,1 x 10-16,,0.5208,'-,0.0381 unit increase,[0.029-0.047],SLC9B1,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:103011399
rs1724557-<b>C</b>,5 x 10-8,,0.4175,'-,0.0254 unit increase,[0.016-0.035],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,4:136172893
rs1705263-<b>C</b>,1 x 10-17,,0.5688,'-,0.0398 unit increase,[0.031-0.049],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:71129263
rs11108094-<b>C</b>,1 x 10-10,,0.9318,'-,0.0601 unit decrease,[0.042-0.078],USP44,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:95534337
rs113036477-<b>C</b>,4 x 10-13,,0.9381,'-,0.0715 unit increase,[0.052-0.091],RMST,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:97454449
rs3764002-<b>C</b>,3 x 10-14,,0.7412,'-,0.0396 unit increase,[0.029-0.05],WSCD2,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:108224853
rs34965774-<b>G</b>,1 x 10-14,,0.8623,'-,0.0521 unit decrease,[0.039-0.065],"KSR2, RFC5",Type 2 diabetes,type II diabetes mellitus,GCST010555,12:117974568
rs56348580-<b>G</b>,2 x 10-30,,0.6958,'-,0.0575 unit increase,[0.048-0.067],HNF1A,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:120994314
rs12820906-<b>G</b>,2 x 10-15,,0.2436,'-,0.0433 unit decrease,[0.033-0.054],PITPNM2,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:123008576
rs12823740-<b>C</b>,1 x 10-17,,0.6614,'-,0.041 unit increase,[0.032-0.05],"ZNF664, RFLNA",Type 2 diabetes,type II diabetes mellitus,GCST010555,12:123973455
rs11614914-<b>C</b>,5 x 10-15,,0.6746,'-,0.0389 unit decrease,[0.029-0.049],FBRSL1,Type 2 diabetes,type II diabetes mellitus,GCST010555,12:132493708
rs34584161-<b>G</b>,4 x 10-22,,0.2394,'-,0.0521 unit decrease,[0.042-0.063],RNF6,Type 2 diabetes,type II diabetes mellitus,GCST010555,13:26202862
rs3742305-<b>G</b>,2 x 10-8,,0.2708,'-,0.03 unit decrease,[0.02-0.04],HMGB1,Type 2 diabetes,type II diabetes mellitus,GCST010555,13:30462505
rs576674-<b>G</b>,1 x 10-23,,0.1848,'-,0.0612 unit increase,[0.049-0.073],"KL, TOMM22P3",Type 2 diabetes,type II diabetes mellitus,GCST010555,13:32980164
rs9316500-<b>G</b>,1 x 10-20,,0.2924,'-,0.0473 unit decrease,[0.037-0.057],"DLEU7, DLEU1",Type 2 diabetes,type II diabetes mellitus,GCST010555,13:50519978
rs9563574-<b>C</b>,2 x 10-11,,0.177,'-,0.0406 unit decrease,[0.029-0.052],"LINC02338, RNA5SP30",Type 2 diabetes,type II diabetes mellitus,GCST010555,13:58082465
rs11616380-<b>G</b>,8 x 10-54,,0.7206,'-,0.0793 unit increase,[0.069-0.089],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,13:80131180
rs1475655-<b>T</b>,2 x 10-16,,0.2527,'-,0.0436 unit decrease,[0.033-0.054],"PPIAP23, MIR17HG",Type 2 diabetes,type II diabetes mellitus,GCST010555,13:91310826
rs9555581-<b>C</b>,4 x 10-10,,0.6102,'-,0.0296 unit increase,[0.02-0.039],LINC00370,Type 2 diabetes,type II diabetes mellitus,GCST010555,13:109291844
rs17522122-<b>G</b>,1 x 10-13,,0.5238,'-,0.0343 unit decrease,[0.025-0.043],AKAP6,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:32833676
rs8018512-<b>G</b>,1 x 10-12,,0.7417,'-,0.0369 unit increase,[0.027-0.047],CLEC14A,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:38349519
rs10145154-<b>C</b>,1 x 10-22,,0.7838,'-,0.0546 unit decrease,[0.044-0.066],NRXN3,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:79473182
rs8010382-<b>G</b>,6 x 10-12,,0.4373,'-,0.0322 unit increase,[0.023-0.041],PPP4R3A,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:91497378
rs12890750-<b>G</b>,3 x 10-9,,0.6392,'-,0.0284 unit increase,[0.019-0.038],MARK3,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:103393972
rs12912777-<b>C</b>,2 x 10-15,,0.8791,'-,0.0594 unit decrease,[0.045-0.074],RASGRP1,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:38560185
rs484943-<b>C</b>,8 x 10-11,,0.6824,'-,0.0332 unit decrease,[0.023-0.043],BMF,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:40106553
rs2289739-<b>G</b>,2 x 10-14,,0.6499,'-,0.0498 unit decrease,[0.037-0.063],LTK,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:41509314
rs149935213-<b>?</b>,3 x 10-10,,NR,'-,0.2759319 unit decrease,[0.19-0.36],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST008048,8:117158059
rs149935213-<b>?</b>,1 x 10-6,(AA),NR,'-,0.236386 unit decrease,[0.14-0.33],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST008048,8:117158059
rs3913535-<b>C</b>,4 x 10-9,,0.411,1.55,'-,[1.34-1.79],NOX4,Severe diabetic retinopathy in type 2 diabetes,"diabetic retinopathy, type II diabetes mellitus",GCST006424,11:89363589
rs11018670-<b>G</b>,1 x 10-8,,0.427,1.55,'-,[1.33-1.80],FOLH1B,Severe diabetic retinopathy in type 2 diabetes,"diabetic retinopathy, type II diabetes mellitus",GCST006424,11:89623460
rs75332279-<b>C</b>,5 x 10-12,,0.0964,'-,0.0559 unit increase,[0.04-0.072],"ONECUT1, RPSAP55",Type 2 diabetes,type II diabetes mellitus,GCST010555,15:52807109
rs2435907-<b>G</b>,1 x 10-9,,0.4112,'-,0.0285 unit decrease,[0.019-0.038],TCF12,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:57041218
rs7163757-<b>C</b>,2 x 10-18,,0.5741,'-,0.0405 unit increase,[0.031-0.05],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST010555,15:62099409
rs34143602-<b>G</b>,1 x 10-13,,0.4221,'-,0.0347 unit increase,[0.025-0.044],HERC1,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:63647859
rs4776970-<b>T</b>,6 x 10-10,,0.3618,'-,0.0294 unit decrease,[0.02-0.039],MAP2K5,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:67788548
rs6495182-<b>C</b>,3 x 10-14,,0.7484,'-,0.0406 unit increase,[0.03-0.051],PTPN9,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:75522047
rs12910361-<b>G</b>,3 x 10-44,,0.6982,'-,0.0716 unit increase,[0.062-0.082],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST010555,15:77489993
rs8031576-<b>C</b>,2 x 10-29,,0.289,'-,0.057 unit increase,[0.047-0.067],"ARPIN-AP3S2, AP3S2",Type 2 diabetes,type II diabetes mellitus,GCST010555,15:89836982
rs2290203-<b>G</b>,2 x 10-22,,0.7977,'-,0.0557 unit decrease,[0.045-0.067],"PRC1, PRC1-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010555,15:90968837
rs55857387-<b>C</b>,7 x 10-19,,0.1947,'-,0.0524 unit decrease,[0.041-0.064],FAM234A,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:250389
rs12933120-<b>C</b>,3 x 10-10,,0.8614,'-,0.0424 unit decrease,[0.029-0.056],SLX4,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:3584745
rs62034975-<b>G</b>,7 x 10-10,,0.6999,'-,0.031 unit decrease,[0.021-0.041],PDILT,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:20381093
rs7188071-<b>C</b>,1 x 10-9,,0.6365,'-,0.0292 unit decrease,[0.02-0.039],RABEP2,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:28906323
rs8054556-<b>G</b>,4 x 10-15,,0.5383,'-,0.0364 unit decrease,[0.027-0.045],TMEM219,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:29946895
rs1421085-<b>C</b>,6 x 10-144,,0.4142,'-,0.1177 unit increase,[0.11-0.13],FTO,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:53767042
rs2032912-<b>G</b>,2 x 10-19,,0.5843,'-,0.0421 unit increase,[0.033-0.051],"NFAT5, CYB5B",Type 2 diabetes,type II diabetes mellitus,GCST010555,16:69534400
rs72802342-<b>C</b>,6 x 10-38,,0.9206,'-,0.1154 unit increase,[0.098-0.133],"ZFP1, CTRB2",Type 2 diabetes,type II diabetes mellitus,GCST010555,16:75200974
rs2925979-<b>C</b>,2 x 10-19,,0.6916,'-,0.0448 unit decrease,[0.035-0.055],CMIP,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:81501185
rs12920022-<b>T</b>,2 x 10-9,,0.8397,'-,0.0391 unit decrease,[0.026-0.052],SPG7,Type 2 diabetes,type II diabetes mellitus,GCST010555,16:89497647
rs8071043-<b>C</b>,5 x 10-28,,0.3284,'-,0.0541 unit increase,[0.044-0.064],ZZEF1,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:4085157
rs858519-<b>C</b>,2 x 10-8,,0.5556,'-,0.0262 unit decrease,[0.017-0.035],SHBG,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:7628647
rs7219033-<b>G</b>,5 x 10-9,,0.6861,'-,0.0288 unit decrease,[0.019-0.038],GLP2R,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:9884641
rs2297508-<b>G</b>,2 x 10-12,,0.632,'-,0.0334 unit decrease,[0.024-0.043],SREBF1,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:17812003
rs12602834-<b>G</b>,7 x 10-10,,0.3912,'-,0.0289 unit increase,[0.02-0.038],"NF1, EVI2B",Type 2 diabetes,type II diabetes mellitus,GCST010555,17:31310290
rs11657964-<b>G</b>,1 x 10-36,,0.5957,'-,0.0589 unit decrease,[0.05-0.068],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:37740776
rs684214-<b>C</b>,3 x 10-16,,0.7268,'-,0.0424 unit decrease,[0.032-0.053],"NAGLU, HSD17B1P1",Type 2 diabetes,type II diabetes mellitus,GCST010555,17:42544897
rs9900074-<b>G</b>,3 x 10-10,,0.9245,'-,0.055 unit increase,[0.038-0.072],NFE2L1-DT,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:48046964
rs35895680-<b>C</b>,1 x 10-28,,0.6858,'-,0.0559 unit increase,[0.046-0.066],"GIP, IGF2BP1",Type 2 diabetes,type II diabetes mellitus,GCST010555,17:48982960
rs1451506-<b>G</b>,3 x 10-8,,0.8732,'-,0.0417 unit decrease,[0.027-0.056],"SNRPGP17, YPEL2",Type 2 diabetes,type II diabetes mellitus,GCST010555,17:59329658
rs4325-<b>C</b>,7 x 10-14,,0.5388,'-,0.0346 unit increase,[0.026-0.044],ACE,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:63485839
rs11655898-<b>C</b>,6 x 10-10,,0.0695,'-,0.0594 unit increase,[0.041-0.078],ERN1,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:64124014
rs2080090-<b>T</b>,8 x 10-19,,0.8116,'-,0.0525 unit decrease,[0.041-0.064],BPTF,Type 2 diabetes,type II diabetes mellitus,GCST010555,17:67832255
rs7240767-<b>C</b>,5 x 10-9,,0.3792,'-,0.0368 unit increase,[0.024-0.049],LAMA1,Type 2 diabetes,type II diabetes mellitus,GCST010555,18:7070643
rs72926932-<b>C</b>,8 x 10-20,,0.0783,'-,0.0749 unit increase,[0.059-0.091],TCF4,Type 2 diabetes,type II diabetes mellitus,GCST010555,18:55383415
rs17684074-<b>G</b>,4 x 10-9,,0.7389,'-,0.0312 unit increase,[0.021-0.042],WDR7,Type 2 diabetes,type II diabetes mellitus,GCST010555,18:57008153
rs1517037-<b>C</b>,3 x 10-10,,0.8132,'-,0.0375 unit increase,[0.026-0.049],"SEC11C, GRP",Type 2 diabetes,type II diabetes mellitus,GCST010555,18:59211042
rs663640-<b>C</b>,1 x 10-19,,0.7822,'-,0.0503 unit decrease,[0.04-0.061],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST010555,18:60178844
rs12454712-<b>C</b>,8 x 10-18,,0.3831,'-,0.0412 unit decrease,[0.032-0.051],BCL2,Type 2 diabetes,type II diabetes mellitus,GCST010555,18:63178651
rs12977104-<b>G</b>,1 x 10-12,,0.8005,'-,0.0412 unit decrease,[0.03-0.053],UHRF1,Type 2 diabetes,type II diabetes mellitus,GCST010555,19:4949909
rs17175860-<b>G</b>,3 x 10-14,,0.1919,'-,0.0445 unit increase,[0.033-0.056],INSR,Type 2 diabetes,type II diabetes mellitus,GCST010555,19:7235135
rs2115107-<b>G</b>,8 x 10-16,,0.6076,'-,0.0382 unit decrease,[0.029-0.047],"MAP2K7, LRRC8E",Type 2 diabetes,type II diabetes mellitus,GCST010555,19:7903283
rs11666603-<b>C</b>,2 x 10-9,,0.744,'-,0.0329 unit increase,[0.022-0.044],"RPS29P23, ZNF799",Type 2 diabetes,type II diabetes mellitus,GCST010555,19:12386120
rs3111316-<b>G</b>,3 x 10-21,,0.4116,'-,0.0442 unit decrease,[0.035-0.053],FARSA,Type 2 diabetes,type II diabetes mellitus,GCST010555,19:12927601
rs58542926-<b>C</b>,5 x 10-25,,0.9245,'-,0.089 unit decrease,[0.072-0.106],TM6SF2,Type 2 diabetes,type II diabetes mellitus,GCST010555,19:19268740
rs10406327-<b>G</b>,9 x 10-16,,0.4754,'-,0.037 unit decrease,[0.028-0.046],PEPD,Type 2 diabetes,type II diabetes mellitus,GCST010555,19:33399932
rs10407429-<b>G</b>,5 x 10-31,,0.5785,'-,0.0539 unit increase,[0.045-0.063],"GIPR, RN7SL836P",Type 2 diabetes,type II diabetes mellitus,GCST010555,19:45653979
rs11667244-<b>G</b>,2 x 10-12,,0.7024,'-,0.0354 unit increase,[0.026-0.045],ZC3H4,Type 2 diabetes,type II diabetes mellitus,GCST010555,19:47076928
rs2268078-<b>G</b>,2 x 10-15,,0.3447,'-,0.0387 unit decrease,[0.029-0.048],RALY,Type 2 diabetes,type II diabetes mellitus,GCST010555,20:34008898
rs12625671-<b>C</b>,7 x 10-19,,0.1135,'-,0.0653 unit increase,[0.051-0.08],HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST010555,20:44366172
rs6066138-<b>G</b>,2 x 10-18,,0.7252,'-,0.0451 unit increase,[0.035-0.055],EYA2,Type 2 diabetes,type II diabetes mellitus,GCST010555,20:46966072
rs867489-<b>C</b>,2 x 10-11,,0.5394,'-,0.0312 unit increase,[0.022-0.04],"PELATON, CEBPB",Type 2 diabetes,type II diabetes mellitus,GCST010555,20:50217420
rs2426439-<b>C</b>,2 x 10-14,,0.6323,'-,0.0365 unit increase,[0.027-0.046],LINC01524,Type 2 diabetes,type II diabetes mellitus,GCST010555,20:52383088
rs2252221-<b>G</b>,4 x 10-8,,0.5314,'-,0.0248 unit increase,[0.016-0.034],TSHZ2,Type 2 diabetes,type II diabetes mellitus,GCST010555,20:53005383
rs911300-<b>G</b>,5 x 10-14,,0.5422,'-,0.0348 unit increase,[0.026-0.044],"PIEZO1P2, MIR296",Type 2 diabetes,type II diabetes mellitus,GCST010555,20:58812207
rs4809369-<b>G</b>,4 x 10-13,,0.5548,'-,0.0337 unit increase,[0.025-0.043],"C20orf181, ZBTB46",Type 2 diabetes,type II diabetes mellitus,GCST010555,20:63839432
rs5753043-<b>C</b>,4 x 10-14,,0.8979,'-,0.0613 unit increase,[0.045-0.077],"HORMAD2, LIF-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010555,22:30192052
rs117001013-<b>C</b>,1 x 10-8,,0.9186,'-,0.0474 unit increase,[0.031-0.064],YWHAH,Type 2 diabetes,type II diabetes mellitus,GCST010555,22:31952854
rs5751061-<b>G</b>,3 x 10-8,,0.6144,'-,0.0261 unit increase,[0.017-0.035],"EP300-AS1, L3MBTL2",Type 2 diabetes,type II diabetes mellitus,GCST010555,22:41197869
rs3747207-<b>G</b>,9 x 10-18,,0.7791,'-,0.0471 unit decrease,[0.036-0.058],PNPLA3,Type 2 diabetes,type II diabetes mellitus,GCST010555,22:43928975
rs5771069-<b>G</b>,2 x 10-12,,0.505,'-,0.0325 unit increase,[0.023-0.042],IL17REL,Type 2 diabetes,type II diabetes mellitus,GCST010555,22:49997051
chr1:6676040-<b>?</b>,6 x 10-13,(conditional),NR,'-,0.0388512 unit increase,[0.028-0.049],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:11304720-<b>?</b>,3 x 10-7,(conditional),NR,'-,0.0289136 unit decrease,[0.018-0.04],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:20726556-<b>?</b>,4 x 10-7,(conditional),NR,'-,0.0375874 unit increase,[0.023-0.052],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:26466831-<b>?</b>,1 x 10-6,(conditional),NR,'-,0.0337123 unit decrease,[0.02-0.047],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:26803430-<b>?</b>,1 x 10-12,(conditional),NR,'-,0.0440389 unit increase,[0.032-0.056],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:27284913-<b>?</b>,1 x 10-8,(conditional),NR,'-,0.10193 unit decrease,[0.067-0.137],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:72838529-<b>?</b>,2 x 10-22,(conditional),NR,'-,0.0712657 unit increase,[0.057-0.086],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:155262613-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0297382 unit increase,[0.018-0.041],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:144765998-<b>?</b>,3 x 10-7,(conditional),NR,'-,0.0825307 unit decrease,[0.051-0.114],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:145256545-<b>?</b>,1 x 10-8,(conditional),NR,'-,0.0322497 unit increase,[0.021-0.043],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:145704420-<b>?</b>,7 x 10-10,(conditional),NR,'-,0.0344434 unit increase,[0.024-0.045],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:146352541-<b>?</b>,4 x 10-10,(conditional),NR,'-,0.0322683 unit decrease,[0.022-0.042],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:152198598-<b>?</b>,7 x 10-10,(conditional),NR,'-,0.0308955 unit decrease,[0.021-0.041],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:9521286-<b>?</b>,5 x 10-13,(conditional),NR,'-,0.0517581 unit decrease,[0.038-0.066],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:132042800-<b>?</b>,1 x 10-8,(conditional),NR,'-,0.411248 unit decrease,[0.27-0.55],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:141569324-<b>?</b>,9 x 10-8,(conditional),NR,'-,0.182225 unit increase,[0.12-0.25],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:185255752-<b>?</b>,9 x 10-13,(conditional),NR,'-,0.0638929 unit decrease,[0.046-0.081],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:185261528-<b>?</b>,7 x 10-15,(conditional),NR,'-,0.0622103 unit decrease,[0.047-0.078],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:185354394-<b>?</b>,3 x 10-15,(conditional),NR,'-,0.111031 unit decrease,[0.084-0.139],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr4:76496817-<b>?</b>,6 x 10-8,(conditional),NR,'-,0.029472 unit increase,[0.019-0.04],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr4:77503120-<b>?</b>,3 x 10-6,(conditional),NR,'-,0.0231935 unit decrease,[0.013-0.033],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr4:91288559-<b>?</b>,4 x 10-6,(conditional),NR,'-,0.0289289 unit increase,[0.017-0.041],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr4:106066820-<b>?</b>,2 x 10-8,(conditional),NR,'-,0.0387509 unit increase,[0.025-0.052],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr4:140877659-<b>?</b>,2 x 10-9,(conditional),NR,'-,0.0318113 unit decrease,[0.021-0.042],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:87682877-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0316018 unit decrease,[0.02-0.043],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:138116995-<b>?</b>,3 x 10-9,(conditional),NR,'-,0.373119 unit decrease,[0.25-0.5],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:19718141-<b>?</b>,6 x 10-10,(conditional),NR,'-,0.0607208 unit increase,[0.042-0.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:19811887-<b>?</b>,1 x 10-6,(conditional),NR,'-,0.0726361 unit increase,[0.044-0.102],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:41012117-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.029607 unit increase,[0.019-0.041],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:143098365-<b>?</b>,1 x 10-8,(conditional),NR,'-,0.0587401 unit increase,[0.039-0.079],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:153427706-<b>?</b>,1 x 10-11,(conditional),NR,'-,0.0335063 unit increase,[0.024-0.043],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:18604697-<b>?</b>,5 x 10-6,(conditional),NR,'-,0.245959 unit increase,[0.14-0.35],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:50365413-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0907358 unit decrease,[0.056-0.125],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:50659193-<b>?</b>,1 x 10-6,(conditional),NR,'-,0.0332083 unit decrease,[0.02-0.047],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:51028400-<b>?</b>,3 x 10-6,(conditional),NR,'-,0.0642319 unit decrease,[0.037-0.091],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:100295908-<b>?</b>,2 x 10-8,(conditional),NR,'-,0.0461894 unit increase,[0.03-0.062],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr8:26130329-<b>?</b>,4 x 10-15,(conditional),NR,'-,0.0519218 unit increase,[0.039-0.065],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr8:105958279-<b>?</b>,2 x 10-6,(conditional),NR,'-,0.351813 unit increase,[0.21-0.5],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:85316592-<b>?</b>,4 x 10-13,(conditional),NR,'-,0.0383682 unit decrease,[0.028-0.049],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
rs538801-<b>T</b>,5 x 10-8,,0.4302,'-,0.0211 unit decrease,[0.013-0.029],SUPT3H,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:44908025
rs12667919-<b>C</b>,4 x 10-8,,0.7087,'-,0.0256 unit decrease,[0.016-0.035],CAPZA1P4,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:131889849
rs12433335-<b>C</b>,2 x 10-8,,0.568,'-,0.0213 unit decrease,[0.014-0.029],PRKD1,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:29617275
rs11994255-<b>C</b>,2 x 10-8,,0.7191,'-,0.0239 unit decrease,[0.015-0.032],"ELP3, RPL5P22",Type 2 diabetes,type II diabetes mellitus,GCST010557,8:28238422
rs9958640-<b>G</b>,2 x 10-8,,0.6007,'-,0.0236 unit decrease,[0.015-0.032],'-,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:4845028
rs17747955-<b>C</b>,2 x 10-8,,0.4496,'-,0.0224 unit increase,[0.015-0.03],NOL4,Type 2 diabetes,type II diabetes mellitus,GCST010557,18:34002926
rs1929883-<b>G</b>,4 x 10-8,,0.601,'-,0.0275 unit increase,[0.018-0.037],MTND2P8,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:78729785
rs12116935-<b>G</b>,2 x 10-8,,0.3536,'-,0.0242 unit increase,[0.016-0.033],"SH3D21, EVA1B",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:36323945
rs73167517-<b>G</b>,1 x 10-8,,0.9131,'-,0.0411 unit decrease,[0.027-0.055],"LINC02144, CHD1",Type 2 diabetes,type II diabetes mellitus,GCST010557,5:87807164
rs114136102-<b>C</b>,3 x 10-8,,0.0384,'-,0.0631 unit increase,[0.041-0.085],"LMBRD2, UGT3A2",Type 2 diabetes,type II diabetes mellitus,GCST010557,5:36084324
rs75619936-<b>G</b>,2 x 10-8,,0.1329,'-,0.0314 unit increase,[0.02-0.042],RFX3,Type 2 diabetes,type II diabetes mellitus,GCST010557,9:3249708
rs59020573-<b>G</b>,1 x 10-8,,0.9075,'-,0.0503 unit decrease,[0.033-0.068],"KIAA1522, SYNC",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:32730519
rs9358912-<b>G</b>,2 x 10-8,,0.6514,'-,0.0249 unit increase,[0.016-0.034],"H2BC8, H4C5",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:26210918
rs10262104-<b>C</b>,1 x 10-8,,0.4575,'-,0.022 unit increase,[0.014-0.03],CALCR,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:93489424
rs2679745-<b>G</b>,2 x 10-8,,0.8139,'-,0.0278 unit increase,[0.018-0.037],AZIN1,Type 2 diabetes,type II diabetes mellitus,GCST010557,8:102864097
rs11830241-<b>C</b>,1 x 10-8,,0.9008,'-,0.0411 unit decrease,[0.027-0.055],EP400,Type 2 diabetes,type II diabetes mellitus,GCST010557,12:132060098
rs510062-<b>G</b>,1 x 10-8,,0.4036,'-,0.022 unit decrease,[0.014-0.03],"GDF6, GAPDHP30",Type 2 diabetes,type II diabetes mellitus,GCST010557,8:96126510
rs7538321-<b>T</b>,2 x 10-8,,0.1952,'-,0.0287 unit increase,[0.019-0.039],"SLC41A1, PM20D1",Type 2 diabetes,type II diabetes mellitus,GCST010557,1:205820327
rs853866-<b>T</b>,3 x 10-8,,0.6109,'-,0.0244 unit increase,[0.016-0.033],"FOXP1, EIF4E3",Type 2 diabetes,type II diabetes mellitus,GCST010557,3:71599717
rs62182438-<b>T</b>,1 x 10-8,,0.2595,'-,0.0257 unit increase,[0.017-0.035],"SLC25A12, HAT1",Type 2 diabetes,type II diabetes mellitus,GCST010557,2:171940254
rs827237-<b>C</b>,3 x 10-8,,0.8128,'-,0.0294 unit decrease,[0.019-0.04],"LINC02622, PCBD1",Type 2 diabetes,type II diabetes mellitus,GCST010557,10:70888579
rs10835690-<b>T</b>,2 x 10-8,,0.822,'-,0.029 unit decrease,[0.019-0.039],MPPED2-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:30598715
rs35164294-<b>G</b>,1 x 10-8,,0.9288,'-,0.0525 unit decrease,[0.034-0.071],"L3MBTL3, TMEM244",Type 2 diabetes,type II diabetes mellitus,GCST010557,6:129944121
rs146716733-<b>C</b>,1 x 10-8,,0.9213,'-,0.0451 unit increase,[0.03-0.061],ARID5B,Type 2 diabetes,type II diabetes mellitus,GCST010557,10:61957354
rs16907058-<b>G</b>,5 x 10-8,,0.941,'-,0.0461 unit decrease,[0.03-0.063],NELL1,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:20930691
chr4:101507002:D-<b>?</b>,1 x 10-6,(EA),'-,1.29,'-,[1.20-1.38],'-,Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,Mapping not available
rs9942471-<b>A</b>,4 x 10-7,(EA),0.64,1.18,'-,[1.11-1.25],"GABRR2, GABRR1",Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,6:89238513
rs2150814-<b>?</b>,2 x 10-6,(EA),'-,1.18,'-,[1.11-1.26],"GABRR2, GABRR1",Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,6:89233215
chr6:6415537:D-<b>?</b>,5 x 10-6,(EA),'-,1.19,'-,[1.09-1.31],'-,Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,Mapping not available
rs7916840-<b>?</b>,6 x 10-7,(EA),'-,1.27,'-,[1.19-1.37],GPR158,Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,10:25424152
rs768920-<b>?</b>,4 x 10-6,(EA),'-,1.44,'-,[1.14-1.80],"RPL26P31, MTNR1B",Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,11:93008790
chr15:30372504:D-<b>?</b>,2 x 10-6,(EA),'-,1.79,'-,[1.22-2.63],'-,Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,Mapping not available
chr17:39098885:D-<b>?</b>,4 x 10-6,(EA),'-,1.61,'-,[1.43-1.82],'-,Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,Mapping not available
rs139484064-<b>?</b>,2 x 10-6,(EA),'-,1.73,'-,[1.53-1.96],"SAMHD1, RBL1",Diabetic kidney disease in type 2 diabetes,"diabetic nephropathy, type II diabetes mellitus",GCST005895,20:36992576
rs62450857-<b>G</b>,2 x 10-8,,0.8671,'-,0.0388 unit decrease,[0.025-0.052],FOXK1,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:4643627
rs13237518-<b>C</b>,8 x 10-10,,0.5858,'-,0.0292 unit decrease,[0.02-0.038],TMEM106B,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:12229967
rs38221-<b>C</b>,7 x 10-10,,0.7401,'-,0.033 unit decrease,[0.023-0.043],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:15886603
rs583769-<b>G</b>,3 x 10-9,,0.7488,'-,0.0311 unit decrease,[0.021-0.041],HDAC9,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:18292292
rs17439448-<b>C</b>,3 x 10-8,,0.8794,'-,0.0404 unit decrease,[0.026-0.055],SUGCT,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:40777054
rs12539264-<b>G</b>,7 x 10-9,,0.2824,'-,0.0293 unit increase,[0.02-0.039],LINC02838,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:48799407
rs2876826-<b>G</b>,3 x 10-8,,0.2153,'-,0.0306 unit increase,[0.02-0.041],"DDC, FIGNL1",Type 2 diabetes,type II diabetes mellitus,GCST010555,7:50514274
rs67755137-<b>G</b>,2 x 10-8,,0.8098,'-,0.0333 unit decrease,[0.022-0.045],GTF2I,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:74693803
rs10240790-<b>G</b>,5 x 10-8,,0.7043,'-,0.0279 unit increase,[0.018-0.038],CFAP69,Type 2 diabetes,type II diabetes mellitus,GCST010555,7:90251635
rs534043-<b>G</b>,8 x 10-10,,0.8744,'-,0.0447 unit increase,[0.03-0.059],"EPO, POP7",Type 2 diabetes,type II diabetes mellitus,GCST010555,7:100715101
rs12056338-<b>G</b>,3 x 10-11,,0.5858,'-,0.0312 unit decrease,[0.022-0.04],"LINC00681, LONRF1",Type 2 diabetes,type II diabetes mellitus,GCST010555,8:12785546
rs17294565-<b>C</b>,5 x 10-9,,0.3813,'-,0.0274 unit increase,[0.018-0.037],SGCZ,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:14267300
rs1059592-<b>G</b>,2 x 10-8,,0.6463,'-,0.0269 unit decrease,[0.017-0.036],CCAR2,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:22620265
rs17818197-<b>G</b>,5 x 10-10,,0.2117,'-,0.0346 unit increase,[0.024-0.046],EBF2,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:26015118
rs62515938-<b>C</b>,3 x 10-8,,0.7395,'-,0.0286 unit decrease,[0.018-0.039],"LINC00968, RPL37P6",Type 2 diabetes,type II diabetes mellitus,GCST010555,8:56570454
rs34340810-<b>G</b>,4 x 10-10,,0.9272,'-,0.0544 unit increase,[0.037-0.071],ZFPM2,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:104649698
rs2737226-<b>C</b>,3 x 10-16,,0.6114,'-,0.0383 unit decrease,[0.029-0.048],TRPS1,Type 2 diabetes,type II diabetes mellitus,GCST010555,8:115627247
rs756145-<b>G</b>,6 x 10-9,,0.6907,'-,0.0286 unit decrease,[0.019-0.038],"LINC01230, H3P29",Type 2 diabetes,type II diabetes mellitus,GCST010555,9:1039939
rs11793831-<b>G</b>,4 x 10-9,,0.5949,'-,0.0274 unit decrease,[0.018-0.037],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:23362313
rs555784-<b>T</b>,2 x 10-10,,0.6158,'-,0.0301 unit increase,[0.021-0.039],RPS6P12,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:82703789
rs7858727-<b>C</b>,8 x 10-10,,0.2233,'-,0.0344 unit increase,[0.023-0.045],EPB41L4B,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:109173848
rs1431819-<b>G</b>,6 x 10-9,,0.6888,'-,0.0293 unit increase,[0.02-0.039],COL27A1,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:114181077
rs7026688-<b>G</b>,3 x 10-11,,0.8632,'-,0.0444 unit increase,[0.031-0.058],STRBP,Type 2 diabetes,type II diabetes mellitus,GCST010555,9:123213118
rs448918-<b>G</b>,1 x 10-9,,0.7126,'-,0.0327 unit decrease,[0.022-0.043],"BRD3OS, VAV2",Type 2 diabetes,type II diabetes mellitus,GCST010555,9:134020857
rs878017-<b>G</b>,1 x 10-8,,0.4591,'-,0.0348 unit decrease,[0.023-0.047],BEND7,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:13524204
rs72803684-<b>C</b>,6 x 10-9,,0.9538,'-,0.0685 unit decrease,[0.045-0.092],KIF3C,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:25969933
rs1430780-<b>C</b>,3 x 10-8,,0.677,'-,0.0273 unit decrease,[0.018-0.037],LINC02831,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:67651196
rs34506349-<b>G</b>,2 x 10-8,,0.9598,'-,0.0677 unit increase,[0.044-0.091],AFF3,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:99982264
rs17624303-<b>C</b>,5 x 10-8,,0.7247,'-,0.0285 unit increase,[0.018-0.039],LINC01102,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:104531960
rs34589210-<b>G</b>,7 x 10-9,,0.8571,'-,0.039 unit decrease,[0.026-0.052],"TMEM87B, MERTK",Type 2 diabetes,type II diabetes mellitus,GCST010555,2:112037915
rs2033159-<b>C</b>,5 x 10-10,,0.2341,'-,0.0352 unit increase,[0.024-0.046],ZEB2,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:144503607
rs7609422-<b>G</b>,3 x 10-10,,0.4095,'-,0.0295 unit increase,[0.02-0.039],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:145590469
rs13020443-<b>C</b>,3 x 10-11,,0.4983,'-,0.0305 unit increase,[0.021-0.04],"NMI, TNFAIP6",Type 2 diabetes,type II diabetes mellitus,GCST010555,2:151311316
rs12992995-<b>C</b>,2 x 10-9,,0.7323,'-,0.0312 unit increase,[0.021-0.041],"LINC01305, SP9",Type 2 diabetes,type II diabetes mellitus,GCST010555,2:174332817
rs6715901-<b>G</b>,3 x 10-9,,0.5116,'-,0.0273 unit increase,[0.018-0.036],TTN,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:178786227
rs6741676-<b>G</b>,4 x 10-11,,0.3321,'-,0.0324 unit decrease,[0.023-0.042],SCHLAP1,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:180753927
rs12463719-<b>G</b>,6 x 10-10,,0.7183,'-,0.0319 unit decrease,[0.022-0.042],"BMPR2, MTCO1P17",Type 2 diabetes,type II diabetes mellitus,GCST010555,2:202585957
rs34329895-<b>G</b>,3 x 10-9,,0.6026,'-,0.0279 unit decrease,[0.019-0.037],PLEKHM3,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:208005293
rs13005841-<b>T</b>,2 x 10-8,,0.287,'-,0.0285 unit decrease,[0.019-0.038],ERBB4,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:211437848
rs17354348-<b>G</b>,3 x 10-8,,0.2583,'-,0.0294 unit decrease,[0.019-0.04],"MIR4776-1, IKZF2",Type 2 diabetes,type II diabetes mellitus,GCST010555,2:212971253
rs3872707-<b>G</b>,3 x 10-11,,0.8599,'-,0.0446 unit decrease,[0.031-0.058],SETD5,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:9472332
rs4465929-<b>C</b>,5 x 10-11,,0.5956,'-,0.0304 unit decrease,[0.021-0.039],"BTD, ANKRD28",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:15699882
rs10490871-<b>G</b>,7 x 10-9,,0.3694,'-,0.0272 unit increase,[0.018-0.036],ARPP21,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:35626269
rs844215-<b>C</b>,2 x 10-8,,0.5867,'-,0.0262 unit increase,[0.017-0.035],"FOXP1, EIF4E3",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:71606894
rs1437055-<b>C</b>,1 x 10-8,,0.3872,'-,0.0267 unit decrease,[0.017-0.036],VGLL3,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:86781927
rs6438247-<b>C</b>,4 x 10-11,,0.1546,'-,0.044 unit increase,[0.031-0.057],EIF4E2P2,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:115365233
rs1225052-<b>G</b>,1 x 10-8,,0.3705,'-,0.0271 unit increase,[0.018-0.036],CPNE4,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:131926093
rs9852406-<b>C</b>,9 x 10-13,,0.7464,'-,0.0375 unit decrease,[0.027-0.048],NDUFS6P1,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:135906656
rs6766859-<b>C</b>,7 x 10-12,,0.3763,'-,0.0329 unit increase,[0.023-0.042],"MRAS, NME9",Type 2 diabetes,type II diabetes mellitus,GCST010555,3:138336294
rs73872717-<b>C</b>,5 x 10-15,,0.9534,'-,0.0856 unit increase,[0.064-0.107],ZBTB38,Type 2 diabetes,type II diabetes mellitus,GCST010555,3:141415727
rs346240-<b>G</b>,4 x 10-8,,0.2231,'-,0.031 unit increase,[0.02-0.042],LINC00907,Type 2 diabetes,type II diabetes mellitus,GCST010555,18:42483865
rs2658746-<b>C</b>,1 x 10-10,,0.3897,'-,0.0303 unit increase,[0.021-0.04],ZNF236,Type 2 diabetes,type II diabetes mellitus,GCST010555,18:76870384
rs35004890-<b>G</b>,9 x 10-10,,0.779,'-,0.0363 unit decrease,[0.025-0.048],STK11,Type 2 diabetes,type II diabetes mellitus,GCST010555,19:1224287
rs10404726-<b>C</b>,3 x 10-9,,0.5305,'-,0.0277 unit increase,[0.018-0.037],CRTC1,Type 2 diabetes,type II diabetes mellitus,GCST010555,19:18723704
rs4805681-<b>C</b>,1 x 10-8,,0.6101,'-,0.0269 unit increase,[0.018-0.036],TSHZ3,Type 2 diabetes,type II diabetes mellitus,GCST010555,19:31344610
rs17265513-<b>C</b>,1 x 10-8,,0.1981,'-,0.0325 unit increase,[0.021-0.044],ZHX3,Type 2 diabetes,type II diabetes mellitus,GCST010555,20:41203988
rs419842-<b>T</b>,7 x 10-11,,0.8208,'-,0.0408 unit increase,[0.028-0.053],MYBL2,Type 2 diabetes,type II diabetes mellitus,GCST010555,20:43682171
rs1815591-<b>T</b>,5 x 10-12,,0.6019,'-,0.0337 unit decrease,[0.024-0.043],SLCO4A1,Type 2 diabetes,type II diabetes mellitus,GCST010555,20:62645662
rs75401573-<b>C</b>,6 x 10-9,,0.9243,'-,0.0511 unit increase,[0.034-0.068],"AP1B1, RFPL4AP6",Type 2 diabetes,type II diabetes mellitus,GCST010555,22:29409455
rs133015-<b>G</b>,5 x 10-10,,0.44,'-,0.0285 unit decrease,[0.019-0.038],PLA2G6,Type 2 diabetes,type II diabetes mellitus,GCST010555,22:38176519
rs61779275-<b>C</b>,3 x 10-43,,0.7804,'-,0.0753 unit decrease,[0.065-0.086],MACF1,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:39354638
rs3176466-<b>C</b>,9 x 10-16,,0.9033,'-,0.0642 unit increase,[0.049-0.08],CDKN2C,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:50972693
rs1127215-<b>C</b>,2 x 10-20,,0.5853,'-,0.043 unit increase,[0.034-0.052],PTGFRN,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:116990168
rs1493694-<b>C</b>,7 x 10-22,,0.8928,'-,0.0705 unit decrease,[0.056-0.085],NOTCH2,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:119984359
rs145904381-<b>C</b>,4 x 10-14,,0.0104,'-,0.1735 unit decrease,[0.13-0.22],BNIPL,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:151045515
rs1194606-<b>C</b>,3 x 10-8,,0.2334,'-,0.0301 unit increase,[0.019-0.041],AQP10,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:154321784
rs545608-<b>G</b>,7 x 10-10,,0.8024,'-,0.0355 unit decrease,[0.024-0.047],"SEC16B, CRYZL2P-SEC16B",Type 2 diabetes,type II diabetes mellitus,GCST010555,1:177929986
rs12048743-<b>G</b>,2 x 10-12,,0.4399,'-,0.0324 unit increase,[0.023-0.041],DSTYK,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:205145745
rs2336938-<b>C</b>,1 x 10-10,,0.5162,'-,0.0299 unit decrease,[0.021-0.039],SRGAP2,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:206445453
rs340874-<b>C</b>,5 x 10-48,,0.5528,'-,0.0668 unit increase,[0.058-0.076],"PROX1-AS1, PROX1",Type 2 diabetes,type II diabetes mellitus,GCST010555,1:213985913
rs2820444-<b>G</b>,9 x 10-21,,0.713,'-,0.0472 unit increase,[0.037-0.057],ZC3H11B,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:219568478
rs2280141-<b>G</b>,1 x 10-13,,0.4801,'-,0.0453 unit decrease,[0.033-0.057],PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST010555,10:122433665
rs348330-<b>G</b>,7 x 10-16,,0.3693,'-,0.0525 unit increase,[0.04-0.065],ABCB10,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:229537208
rs10737818-<b>G</b>,7 x 10-10,,0.6385,'-,0.0395 unit increase,[0.027-0.052],TBCE,Type 2 diabetes,type II diabetes mellitus,GCST010555,1:235378708
rs10188334-<b>C</b>,8 x 10-16,,0.8277,'-,0.0503 unit increase,[0.038-0.062],TMEM18,Type 2 diabetes,type II diabetes mellitus,GCST010555,2:653874
chr9:116942415-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0291204 unit increase,[0.018-0.04],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr10:99061386-<b>?</b>,5 x 10-8,(conditional),NR,'-,0.0282209 unit decrease,[0.018-0.038],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr10:112195772-<b>?</b>,2 x 10-17,(conditional),NR,'-,0.445451 unit increase,[0.34-0.55],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:6302626-<b>?</b>,6 x 10-8,(conditional),NR,'-,0.0309295 unit increase,[0.02-0.042],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:21781181-<b>?</b>,4 x 10-7,(conditional),NR,'-,0.029394 unit decrease,[0.018-0.041],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:33222686-<b>?</b>,5 x 10-17,(conditional),NR,'-,0.153962 unit decrease,[0.12-0.19],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:33409575-<b>?</b>,9 x 10-13,(conditional),NR,'-,0.0412136 unit increase,[0.03-0.053],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:41806405-<b>?</b>,1 x 10-6,(conditional),NR,'-,0.0251014 unit decrease,[0.015-0.035],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:43046179-<b>?</b>,7 x 10-10,(conditional),NR,'-,0.0443743 unit increase,[0.03-0.058],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr13:23770096-<b>?</b>,1 x 10-26,(conditional),NR,'-,0.511388 unit increase,[0.42-0.61],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr14:30087621-<b>?</b>,1 x 10-7,(conditional),NR,'-,0.0369712 unit decrease,[0.023-0.051],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr14:101258584-<b>?</b>,5 x 10-13,(conditional),NR,'-,0.0868963 unit increase,[0.063-0.11],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr16:88210774-<b>?</b>,3 x 10-7,(conditional),NR,'-,0.0336797 unit increase,[0.021-0.047],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:27562990-<b>?</b>,6 x 10-7,(conditional),NR,'-,0.0275532 unit decrease,[0.017-0.038],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:34952964-<b>?</b>,7 x 10-6,(conditional),NR,'-,0.0276108 unit decrease,[0.016-0.04],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr18:13260027-<b>?</b>,9 x 10-8,(conditional),NR,'-,0.0276249 unit increase,[0.017-0.038],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr19:1653120-<b>?</b>,4 x 10-7,(conditional),NR,'-,0.0388458 unit decrease,[0.024-0.054],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr19:18826975-<b>?</b>,2 x 10-21,(conditional),NR,'-,0.0638402 unit increase,[0.051-0.077],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr19:18860041-<b>?</b>,3 x 10-12,(conditional),NR,'-,0.214153 unit increase,[0.15-0.27],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr19:19325963-<b>?</b>,2 x 10-9,(conditional),NR,'-,0.0523288 unit decrease,[0.035-0.069],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr20:39681683-<b>?</b>,3 x 10-7,(conditional),NR,'-,0.0321382 unit increase,[0.02-0.044],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr22:30304334-<b>?</b>,7 x 10-9,(conditional),NR,'-,0.0595957 unit decrease,[0.039-0.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:39855177-<b>?</b>,8 x 10-44,(conditional),NR,'-,0.091086 unit decrease,[0.078-0.104],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:214145731-<b>?</b>,8 x 10-29,(conditional),NR,'-,0.061119 unit increase,[0.05-0.072],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:214272242-<b>?</b>,1 x 10-18,(conditional),NR,'-,0.189805 unit increase,[0.15-0.23],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr1:214362046-<b>?</b>,5 x 10-7,(conditional),NR,'-,0.15113 unit decrease,[0.092-0.21],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:25635264-<b>?</b>,2 x 10-9,(conditional),NR,'-,0.0345313 unit increase,[0.023-0.046],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:43227262-<b>?</b>,1 x 10-18,(conditional),NR,'-,0.0454739 unit increase,[0.035-0.056],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:43432975-<b>?</b>,5 x 10-8,(conditional),NR,'-,0.0311244 unit decrease,[0.02-0.042],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:65279805-<b>?</b>,2 x 10-12,(conditional),NR,'-,0.036803 unit decrease,[0.027-0.047],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:65574192-<b>?</b>,3 x 10-6,(conditional),NR,'-,0.0741047 unit increase,[0.043-0.105],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:65665641-<b>?</b>,7 x 10-12,(conditional),NR,'-,0.0403627 unit increase,[0.029-0.052],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:147905651-<b>?</b>,2 x 10-8,(conditional),NR,'-,0.0354079 unit decrease,[0.023-0.048],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:158449081-<b>?</b>,2 x 10-9,(conditional),NR,'-,0.156277 unit decrease,[0.11-0.21],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:161147528-<b>?</b>,7 x 10-37,(conditional),NR,'-,0.0760946 unit increase,[0.064-0.088],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:161263858-<b>?</b>,2 x 10-15,(conditional),NR,'-,0.593655 unit decrease,[0.45-0.74],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:165501747-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0687732 unit increase,[0.043-0.094],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:165513091-<b>?</b>,9 x 10-23,(conditional),NR,'-,0.0603543 unit decrease,[0.048-0.072],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:165821268-<b>?</b>,8 x 10-6,(conditional),NR,'-,0.0298531 unit decrease,[0.017-0.043],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr2:227083411-<b>?</b>,9 x 10-49,(conditional),NR,'-,0.0823226 unit increase,[0.071-0.093],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:12488882-<b>?</b>,3 x 10-20,(conditional),NR,'-,0.0485147 unit decrease,[0.038-0.059],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:23589676-<b>?</b>,5 x 10-12,(conditional),NR,'-,0.0960652 unit decrease,[0.069-0.123],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:54575859-<b>?</b>,7 x 10-8,(conditional),NR,'-,0.221374 unit increase,[0.14-0.3],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:151993809-<b>?</b>,1 x 10-13,(conditional),NR,'-,0.0422151 unit increase,[0.031-0.053],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:152450489-<b>?</b>,6 x 10-10,(conditional),NR,'-,0.084844 unit increase,[0.058-0.112],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:170709193-<b>?</b>,2 x 10-25,(conditional),NR,'-,0.057187 unit increase,[0.046-0.068],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:185514393-<b>?</b>,2 x 10-79,(conditional),NR,'-,0.102124 unit increase,[0.092-0.113],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:185830488-<b>?</b>,2 x 10-8,(conditional),NR,'-,0.0370372 unit increase,[0.024-0.05],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr3:186675277-<b>?</b>,1 x 10-11,(conditional),NR,'-,0.072295 unit decrease,[0.051-0.093],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr4:1193722-<b>?</b>,1 x 10-6,(conditional),NR,'-,0.116676 unit increase,[0.07-0.164],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr4:17595536-<b>?</b>,2 x 10-6,(conditional),NR,'-,0.0682823 unit decrease,[0.04-0.097],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr4:17922866-<b>?</b>,3 x 10-8,(conditional),NR,'-,0.0377255 unit increase,[0.024-0.051],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr4:103895317-<b>?</b>,8 x 10-15,(conditional),NR,'-,0.0386051 unit decrease,[0.029-0.048],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr4:153025603-<b>?</b>,1 x 10-6,(conditional),NR,'-,0.0453796 unit increase,[0.027-0.064],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:14717795-<b>?</b>,3 x 10-12,(conditional),NR,'-,0.0657248 unit increase,[0.047-0.084],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:14768766-<b>?</b>,7 x 10-8,(conditional),NR,'-,0.105771 unit decrease,[0.067-0.144],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:14788344-<b>?</b>,2 x 10-13,(conditional),NR,'-,0.0381988 unit decrease,[0.028-0.048],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:14896794-<b>?</b>,1 x 10-6,(conditional),NR,'-,0.104123 unit decrease,[0.062-0.146],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:50328197-<b>?</b>,5 x 10-6,(conditional),NR,'-,0.293055 unit decrease,[0.17-0.42],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:51791225-<b>?</b>,2 x 10-8,(conditional),NR,'-,0.0288864 unit decrease,[0.019-0.039],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:52110814-<b>?</b>,7 x 10-7,(conditional),NR,'-,0.0264636 unit decrease,[0.016-0.037],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:55806751-<b>?</b>,9 x 10-48,(conditional),NR,'-,0.0877071 unit increase,[0.076-0.1],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:55848972-<b>?</b>,2 x 10-11,(conditional),NR,'-,0.0402532 unit decrease,[0.029-0.052],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:55861786-<b>?</b>,5 x 10-29,(conditional),NR,'-,0.071762 unit decrease,[0.059-0.084],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:102338739-<b>?</b>,1 x 10-24,(conditional),NR,'-,0.331543 unit increase,[0.27-0.39],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:134151809-<b>?</b>,6 x 10-10,(conditional),NR,'-,0.419052 unit decrease,[0.29-0.55],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr5:158477522-<b>?</b>,2 x 10-15,(conditional),NR,'-,0.526349 unit decrease,[0.4-0.66],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:7269548-<b>?</b>,6 x 10-11,(conditional),NR,'-,0.040531 unit decrease,[0.028-0.053],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:20601020-<b>?</b>,8 x 10-124,(conditional),NR,'-,0.186535 unit decrease,[0.17-0.2],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:20607784-<b>?</b>,3 x 10-20,(conditional),NR,'-,0.0588099 unit increase,[0.046-0.071],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:20719393-<b>?</b>,1 x 10-47,(conditional),NR,'-,0.12151 unit increase,[0.11-0.14],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:31029282-<b>?</b>,6 x 10-13,(conditional),NR,'-,0.0972751 unit decrease,[0.071-0.124],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:31475563-<b>?</b>,2 x 10-22,(conditional),NR,'-,0.159055 unit decrease,[0.13-0.19],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:39033168-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0440738 unit decrease,[0.028-0.061],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:39281456-<b>?</b>,1 x 10-9,(conditional),NR,'-,0.045422 unit increase,[0.031-0.06],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
rs10229583-<b>G</b>,2 x 10-10,(East Asian),0.825,1.14,'-,[1.09-1.19],"PAX4, FSCN3",Type 2 diabetes,type II diabetes mellitus,GCST001919,7:127606849
rs3916765-<b>A</b>,1 x 10-6,(Lean),0.12,1.21,'-,[1.12-1.31],"MTCO3P1, HLA-DQB3",Type 2 diabetes,type II diabetes mellitus,GCST001550,6:32717773
rs8090011-<b>G</b>,8 x 10-9,(Lean),0.38,1.13,'-,[1.09-1.18],LAMA1,Type 2 diabetes,type II diabetes mellitus,GCST001550,18:7068463
rs7178572-<b>G</b>,1 x 10-8,(Obese),0.7,1.11,'-,[1.07-1.15],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST001550,15:77454848
rs3802177-<b>G</b>,4 x 10-8,(Lean),0.68,1.23,'-,[1.15-1.33],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST001550,8:117172786
rs11708067-<b>A</b>,6 x 10-8,(Lean),0.78,1.25,'-,[1.15-1.35],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST001550,3:123346931
rs7903146-<b>T</b>,4 x 10-21,(Obese),0.29,1.26,'-,[1.20 - 1.32],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST001550,10:112998590
rs9939609-<b>A</b>,1 x 10-20,(Obese),0.4,1.25,'-,[1.19-1.30],FTO,Type 2 diabetes,type II diabetes mellitus,GCST001550,16:53786615
rs7766070-<b>A</b>,6 x 10-11,(Obese),0.27,1.21,'-,[1.14-1.28],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST001550,6:20686342
rs5015480-<b>C</b>,2 x 10-9,(Obese),0.57,1.18,'-,[1.11-1.23],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST001550,10:92705802
rs4402960-<b>T</b>,3 x 10-9,(Obese),0.31,1.15,'-,[1.10-1.21],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST001550,3:185793899
rs7903146-<b>T</b>,2 x 10-40,(Lean),0.29,1.58,'-,[1.47-1.68],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST001550,10:112998590
rs7766070-<b>A</b>,7 x 10-10,(Lean),0.27,1.26,'-,[1.17-1.35],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST001550,6:20686342
rs3923113-<b>A</b>,1 x 10-8,,0.74,1.09,'-,[1.06-1.13],"COBLL1, GRB14",Type 2 diabetes,type II diabetes mellitus,GCST001213,2:164645339
rs16861329-<b>G</b>,3 x 10-8,,0.75,1.09,'-,[1.06-1.12],ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST001213,3:186948673
rs1802295-<b>A</b>,4 x 10-8,,0.26,1.08,'-,[1.05-1.12],VPS26A,Type 2 diabetes,type II diabetes mellitus,GCST001213,10:69171718
rs7178572-<b>G</b>,7 x 10-11,,0.52,1.09,'-,[1.06-1.12],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST001213,15:77454848
rs2028299-<b>C</b>,2 x 10-11,,0.31,1.1,'-,[1.07-1.13],AP3S2,Type 2 diabetes,type II diabetes mellitus,GCST001213,15:89831025
rs4812829-<b>A</b>,3 x 10-10,,0.29,1.09,'-,[1.06-1.12],HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST001213,20:44360627
rs6815464-<b>C</b>,2 x 10-20,,0.58,1.13,'-,[1.10–1.16],MAEA,Type 2 diabetes,type II diabetes mellitus,GCST001351,4:1316113
rs6467136-<b>G</b>,5 x 10-11,,0.79,1.11,'-,[1.07–1.14],"GCC1, ZNF800",Type 2 diabetes,type II diabetes mellitus,GCST001351,7:127524904
rs9470794-<b>C</b>,2 x 10-10,,0.27,1.12,'-,[1.08–1.16],ZFAND3,Type 2 diabetes,type II diabetes mellitus,GCST001351,6:38139068
rs1535500-<b>T</b>,2 x 10-8,,0.42,1.08,'-,[1.05–1.11],KCNK16,Type 2 diabetes,type II diabetes mellitus,GCST001351,6:39316274
rs7041847-<b>A</b>,2 x 10-14,,0.41,1.1,'-,[1.07–1.13],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST001351,9:4287466
rs6017317-<b>G</b>,1 x 10-11,,0.48,1.09,'-,[1.07–1.12],"R3HDML, FITM2",Type 2 diabetes,type II diabetes mellitus,GCST001351,20:44318326
rs831571-<b>c</b>,8 x 10-11,,0.61,1.09,'-,[1.06–1.12],"PSMD6, PRICKLE2-AS1",Type 2 diabetes,type II diabetes mellitus,GCST001351,3:64062621
rs3786897-<b>A</b>,1 x 10-8,,0.56,1.1,'-,[1.07–1.14],PEPD,Type 2 diabetes,type II diabetes mellitus,GCST001351,19:33402102
rs16955379-<b>C</b>,3 x 10-7,,0.8,1.08,'-,[1.05–1.12],CMIP,Type 2 diabetes,type II diabetes mellitus,GCST001351,16:81455768
rs17797882-<b>T</b>,9 x 10-7,,0.32,1.08,'-,[1.05–1.12],'-,Type 2 diabetes,type II diabetes mellitus,GCST001351,16:79373021
rs679992-<b>T</b>,1 x 10-6,(AA),0.5,1.09,'-,[1.05-1.13],RGS7,Type 2 diabetes,type II diabetes mellitus,GCST002560,1:241024982
rs12613372-<b>G</b>,2 x 10-7,(AA),0.07,1.24,'-,[1.14-1.34],"GALNT14, CAPN13",Type 2 diabetes,type II diabetes mellitus,GCST002560,2:30845153
rs2244020-<b>G</b>,1 x 10-6,(AA),0.69,1.11,'-,[1.07-1.16],"ZDHHC20P2, FGFR3P1",Type 2 diabetes,type II diabetes mellitus,GCST002560,6:31379674
rs10231619-<b>T</b>,4 x 10-6,(AA),0.74,1.13,'-,[1.07-1.18],HECW1,Type 2 diabetes,type II diabetes mellitus,GCST002560,7:43280995
rs7003257-<b>T</b>,9 x 10-6,(AA),0.73,1.1,'-,[1.06-1.15],CPA6,Type 2 diabetes,type II diabetes mellitus,GCST002560,8:67701155
rs17359493-<b>G</b>,1 x 10-7,(AA),0.22,1.13,'-,[1.08-1.18],INTS8,Type 2 diabetes,type II diabetes mellitus,GCST002560,8:94844683
rs7903146-<b>T</b>,5 x 10-44,(AA),0.3,1.33,'-,[1.28-1.39],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST002560,10:112998590
rs3842770-<b>A</b>,3 x 10-8,(AA),0.23,1.14,'-,[1.09-1.19],INS-IGF2,Type 2 diabetes,type II diabetes mellitus,GCST002560,11:2157440
rs11043007-<b>G</b>,1 x 10-7,(AA),0.81,1.19,'-,[1.11-1.26],"ASCL2, MIR4686",Type 2 diabetes,type II diabetes mellitus,GCST002560,11:2183058
rs2283228-<b>A</b>,1 x 10-10,(AA),0.89,1.2,'-,[1.14-1.27],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002560,11:2828300
rs343092-<b>T</b>,9 x 10-9,(AA),0.81,1.16,'-,[1.1-1.22],"HMGA2-AS1, HMGA2",Type 2 diabetes,type II diabetes mellitus,GCST002560,12:65857160
rs335810-<b>A</b>,7 x 10-6,(AA),0.69,1.1,'-,[1.06-1.15],FOXB1,Type 2 diabetes,type II diabetes mellitus,GCST002560,15:60076007
rs2244020-<b>G</b>,7 x 10-9,,0.69,1.09,'-,[1.06-1.13],"ZDHHC20P2, FGFR3P1",Type 2 diabetes,type II diabetes mellitus,GCST002560,6:31379674
rs17359493-<b>G</b>,1 x 10-7,,0.22,1.1,'-,[1.06-1.13],INTS8,Type 2 diabetes,type II diabetes mellitus,GCST002560,8:94844683
rs7903146-<b>T</b>,4 x 10-94,,0.3,1.36,'-,[1.32-1.40],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST002560,10:112998590
rs2283228-<b>A</b>,5 x 10-13,,0.89,1.19,'-,[1.13-1.24],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002560,11:2828300
rs343092-<b>T</b>,3 x 10-12,,0.81,1.14,'-,[1.10-1.19],"HMGA2-AS1, HMGA2",Type 2 diabetes,type II diabetes mellitus,GCST002560,12:65857160
rs2290402-<b>?</b>,7 x 10-6,(AA),NR,'-,'-,'-,TMEM175,Type 2 diabetes,type II diabetes mellitus,GCST002560,4:947730
rs231356-<b>T</b>,4 x 10-8,,0.27,1.09,'-,[1.06-1.13],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST002560,11:2684113
rs335810-<b>A</b>,7 x 10-6,,0.69,1.1,'-,[1.06-1.15],FOXB1,Type 2 diabetes,type II diabetes mellitus,GCST002560,15:60076007
rs13266634-<b>C</b>,5 x 10-8,,0.65,1.12,'-,[1.07-1.16],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST000028,8:117172544
rs10811661-<b>T</b>,8 x 10-15,,0.83,1.2,'-,[1.14-1.25],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST000028,9:22134095
rs5219-<b>T</b>,7 x 10-11,,0.47,1.14,'-,[1.10-1.19],KCNJ11,Type 2 diabetes,type II diabetes mellitus,GCST000028,11:17388025
rs1111875-<b>C</b>,6 x 10-10,,0.53,1.13,'-,[1.08-1.17],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST000028,10:92703125
rs1801282-<b>C</b>,2 x 10-6,,0.86,1.14,'-,[1.08-1.20],'-,Type 2 diabetes,type II diabetes mellitus,GCST000028,Mapping not available
rs7754840-<b>C</b>,4 x 10-11,,0.31,1.12,'-,[1.08-1.16],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST000028,6:20661019
rs4402960-<b>T</b>,9 x 10-16,,0.29,1.14,'-,[1.11-1.18],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST000028,3:185793899
rs7903146-<b>T</b>,1 x 10-48,,0.26,1.37,'-,[1.31-1.43],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000028,10:112998590
rs864745-<b>T</b>,5 x 10-14,,0.5,1.1,'-,[1.07-1.13],JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST000167,7:28140937
rs12779790-<b>G</b>,1 x 10-10,,0.18,1.11,'-,[1.07-1.14],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST000167,10:12286011
rs7961581-<b>C</b>,1 x 10-9,,0.27,1.09,'-,[1.06-1.12],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST000167,12:71269322
rs7578597-<b>T</b>,1 x 10-9,,0.9,1.15,'-,[1.10-1.20],THADA,Type 2 diabetes,type II diabetes mellitus,GCST000167,2:43505684
rs7020996-<b>C</b>,2 x 10-7,,NR,1.26,'-,[1.15-1.38],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST000167,9:22129580
rs7903146-<b>T</b>,3 x 10-23,,NR,1.37,'-,[1.28-1.47],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000167,10:112998590
rs9472138-<b>T</b>,4 x 10-6,,0.28,1.06,'-,[1.04-1.09],"VEGFA, LINC02537",Type 2 diabetes,type II diabetes mellitus,GCST000167,6:43844025
rs10923931-<b>T</b>,4 x 10-8,,0.11,1.13,'-,[1.08-1.17],NOTCH2,Type 2 diabetes,type II diabetes mellitus,GCST000167,1:119975336
rs1153188-<b>A</b>,2 x 10-7,,0.73,1.08,'-,[1.05-1.11],"VDAC1P5, DCD",Type 2 diabetes,type II diabetes mellitus,GCST000167,12:54705212
rs17036101-<b>G</b>,2 x 10-7,,0.93,1.15,'-,[1.10-1.21],"GSTM5P1, SYN2",Type 2 diabetes,type II diabetes mellitus,GCST000167,3:12236345
rs4402960-<b>T</b>,8 x 10-8,,NR,1.17,'-,[1.10-1.25],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST000167,3:185793899
rs6931514-<b>G</b>,1 x 10-11,,NR,1.25,'-,[1.17-1.33],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST000167,6:20703721
rs5015480-<b>C</b>,7 x 10-8,,NR,1.17,'-,[1.11-1.24],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST000167,10:92705802
rs5215-<b>C</b>,4 x 10-7,,NR,1.16,'-,[1.09-1.23],'-,Type 2 diabetes,type II diabetes mellitus,GCST000167,Mapping not available
rs8050136-<b>A</b>,7 x 10-6,,NR,1.15,'-,[1.09-1.22],FTO,Type 2 diabetes,type II diabetes mellitus,GCST000167,16:53782363
rs4607103-<b>C</b>,1 x 10-8,,0.76,1.09,'-,[1.06-1.12],ADAMTS9-AS2,Type 2 diabetes,type II diabetes mellitus,GCST000167,3:64726228
rs13424957-<b>?</b>,3 x 10-6,(T2D),0.81,1.242236,'-,[1.14-1.36],"RNA5SP111, RNA5SP110",Type 2 diabetes,type II diabetes mellitus,GCST000976,2:164893880
rs7901695-<b>?</b>,1 x 10-6,(T2D),0.45,1.1947432,'-,[1.11-1.28],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000976,10:112994329
rs7903146-<b>T</b>,3 x 10-19,(Punjabi Sikhs),0.31,1.44,'-,[1.33 - 1.56],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST001809,10:112998590
rs9552911-<b>G</b>,2 x 10-8,(Punjabi Sikhs),0.93,1.49,'-,[1.30-1.72],"SGCG, SACS",Type 2 diabetes,type II diabetes mellitus,GCST001809,13:23290518
rs17053082-<b>T</b>,4 x 10-7,(Punjabi Sikhs),0.1,1.49,'-,[1.28 - 1.73],SGCD,Type 2 diabetes,type II diabetes mellitus,GCST001809,5:155967220
rs6426514-<b>A</b>,2 x 10-6,(Punjabi Sikhs),0.06,1.51,'-,[1.27 - 1.78],RHOU,Type 2 diabetes,type II diabetes mellitus,GCST001809,1:228744368
rs4527850-<b>T</b>,2 x 10-6,(Punjabi Sikhs),0.75,1.23,'-,[1.13 - 1.34],"CCN4, TG",Type 2 diabetes,type II diabetes mellitus,GCST001809,8:133184606
rs623323-<b>T</b>,4 x 10-6,(Punjabi Sikhs),0.15,1.28,'-,[1.15 - 1.42],"NXN, MRM3",Type 2 diabetes,type II diabetes mellitus,GCST001809,17:796780
rs1470579-<b>C</b>,5 x 10-6,(Punjabi Sikhs),0.41,1.19,'-,[1.11-1.28],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST001809,3:185811292
rs7903146-<b>T</b>,6 x 10-22,(All Punjabi),0.31,1.3,'-,[1.23 - 1.37],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST001809,10:112998590
rs17053082-<b>T</b>,4 x 10-7,(All Punjabi),0.1,1.49,'-,[1.28 - 1.73],SGCD,Type 2 diabetes,type II diabetes mellitus,GCST001809,5:155967220
rs1470579-<b>C</b>,4 x 10-7,(All Punjabi),0.41,1.14,'-,[1.09-1.20],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST001809,3:185811292
rs7903146-<b>T</b>,3 x 10-35,(South Asians),0.3,1.15,'-,[1.13 - 1.18],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST001809,10:112998590
rs1470579-<b>C</b>,4 x 10-9,(South Asians),0.45,1.06,'-,[1.04-1.09],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST001809,3:185811292
rs328506-<b>C</b>,2 x 10-6,(South Asians),0.8,1.11,'-,[1.06-1.15],"HMGB1P1, RBM38",Type 2 diabetes,type II diabetes mellitus,GCST001809,20:57454548
rs7903146-<b>T</b>,2 x 10-38,"(South Asians, East Asians)",0.3,1.15,'-,[1.12 - 1.17],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST001809,10:112998590
rs1470579-<b>C</b>,2 x 10-13,"(South Asians, East Asians)",0.45,1.06,'-,[1.04-1.08],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST001809,3:185811292
rs7903146-<b>T</b>,9 x 10-75,"(South Asian, East Asian, Europeans)",0.5,1.19,'-,[1.17 - 1.21],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST001809,10:112998590
rs1470579-<b>C</b>,2 x 10-19,"(South Asian, East Asian, Europeans)",0.5,1.08,'-,[1.05-1.09],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST001809,3:185811292
rs10911021-<b>C</b>,2 x 10-8,,0.679,1.36,'-,[1.22-1.51],LINC01344,Cardiovascular heart disease in diabetics,"cardiovascular disease, type II diabetes mellitus",GCST002153,1:182112825
rs6547692-<b>G</b>,1 x 10-15,,0.5585,'-,0.0697 unit decrease,[0.053-0.087],GCKR,Type 2 diabetes,type II diabetes mellitus,GCST010553,2:27512105
rs13428870-<b>G</b>,2 x 10-8,,0.1769,'-,0.0653 unit increase,[0.043-0.088],LINC01122,Type 2 diabetes,type II diabetes mellitus,GCST010553,2:58729422
rs3731600-<b>G</b>,2 x 10-8,,0.0462,'-,0.1234 unit decrease,[0.08-0.167],SCTR,Type 2 diabetes,type II diabetes mellitus,GCST010553,2:119473494
rs7558502-<b>G</b>,9 x 10-9,,0.4121,'-,0.0501 unit decrease,[0.033-0.067],EPC2,Type 2 diabetes,type II diabetes mellitus,GCST010553,2:148675516
rs75536691-<b>G</b>,8 x 10-10,,0.0218,'-,0.1951 unit decrease,[0.13-0.26],GRB14,Type 2 diabetes,type II diabetes mellitus,GCST010553,2:164525008
rs838720-<b>G</b>,4 x 10-9,,0.4475,'-,0.0512 unit increase,[0.034-0.068],DGKD,Type 2 diabetes,type II diabetes mellitus,GCST010553,2:233394635
rs3963364-<b>C</b>,9 x 10-9,,0.9598,'-,0.1502 unit increase,[0.099-0.201],PPARG,Type 2 diabetes,type II diabetes mellitus,GCST010553,3:12343858
rs148462165-<b>C</b>,1 x 10-22,,0.6674,'-,0.0911 unit increase,[0.073-0.109],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST010553,3:23354829
rs3816157-<b>G</b>,7 x 10-15,,0.6788,'-,0.0735 unit increase,[0.055-0.092],"PSMD6, PSMD6-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010553,3:64013646
rs2134223-<b>G</b>,3 x 10-9,,0.5286,'-,0.0517 unit decrease,[0.035-0.069],CASR,Type 2 diabetes,type II diabetes mellitus,GCST010553,3:122238106
rs13092876-<b>G</b>,4 x 10-44,,0.6606,'-,0.1299 unit decrease,[0.11-0.15],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST010553,3:185777532
rs3755934-<b>C</b>,3 x 10-25,,0.6901,'-,0.1044 unit increase,[0.085-0.124],CTBP1,Type 2 diabetes,type II diabetes mellitus,GCST010553,4:1242295
rs4865473-<b>G</b>,2 x 10-9,,0.2919,'-,0.0716 unit increase,[0.048-0.095],"TACC3, FGFR3",Type 2 diabetes,type II diabetes mellitus,GCST010553,4:1780859
rs35678078-<b>G</b>,2 x 10-8,,0.4962,'-,0.0587 unit decrease,[0.038-0.079],PPP2R2C,Type 2 diabetes,type II diabetes mellitus,GCST010553,4:6331942
rs10938398-<b>G</b>,2 x 10-9,,0.7038,'-,0.057 unit decrease,[0.038-0.076],'-,Type 2 diabetes,type II diabetes mellitus,GCST010553,4:45184122
rs2361478-<b>C</b>,3 x 10-9,,0.7894,'-,0.0642 unit decrease,[0.043-0.085],"MOB1B, RNU6-891P",Type 2 diabetes,type II diabetes mellitus,GCST010553,4:70887798
rs117834099-<b>G</b>,1 x 10-11,,0.9549,'-,0.1509 unit increase,[0.11-0.19],'-,Type 2 diabetes,type II diabetes mellitus,GCST010553,4:84379162
rs10011838-<b>G</b>,1 x 10-17,,0.4621,'-,0.0746 unit increase,[0.058-0.092],"TMEM154, RPS3AP18",Type 2 diabetes,type II diabetes mellitus,GCST010553,4:152599127
rs16884025-<b>C</b>,8 x 10-9,,0.9291,'-,0.1297 unit increase,[0.086-0.174],PARP8,Type 2 diabetes,type II diabetes mellitus,GCST010553,5:50657625
rs2548498-<b>T</b>,2 x 10-8,,0.8336,'-,0.0663 unit decrease,[0.043-0.089],ITGA1,Type 2 diabetes,type II diabetes mellitus,GCST010553,5:52776811
rs173964-<b>G</b>,1 x 10-16,,0.4696,'-,0.0725 unit increase,[0.055-0.09],C5orf67,Type 2 diabetes,type II diabetes mellitus,GCST010553,5:56513638
rs3135911-<b>C</b>,3 x 10-10,,0.5586,'-,0.0549 unit decrease,[0.038-0.072],"FGFR4, ZNF346",Type 2 diabetes,type II diabetes mellitus,GCST010553,5:177086895
rs9505085-<b>C</b>,5 x 10-8,,0.6671,'-,0.0511 unit increase,[0.033-0.069],RREB1,Type 2 diabetes,type II diabetes mellitus,GCST010553,6:7226726
rs10440833-<b>T</b>,7 x 10-87,,0.5769,'-,0.1725 unit decrease,[0.16-0.19],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST010553,6:20687890
rs3869115-<b>G</b>,1 x 10-17,,0.1981,'-,0.1004 unit decrease,[0.077-0.123],"HLA-C, HCG27",Type 2 diabetes,type II diabetes mellitus,GCST010553,6:31236917
chr11:2776059-<b>?</b>,7 x 10-7,(conditional),NR,'-,0.0334509 unit increase,[0.02-0.047],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:2891279-<b>?</b>,6 x 10-13,(conditional),NR,'-,0.115023 unit increase,[0.084-0.146],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:45392426-<b>?</b>,2 x 10-28,(conditional),NR,'-,0.0905979 unit decrease,[0.075-0.107],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:45768401-<b>?</b>,1 x 10-20,(conditional),NR,'-,0.0613154 unit increase,[0.048-0.074],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:65405600-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0336708 unit increase,[0.021-0.046],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:69178568-<b>?</b>,2 x 10-26,(conditional),NR,'-,0.0795173 unit decrease,[0.065-0.094],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:69457547-<b>?</b>,3 x 10-6,(conditional),NR,'-,0.0463661 unit decrease,[0.027-0.066],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:72428148-<b>?</b>,2 x 10-13,(conditional),NR,'-,0.0489454 unit increase,[0.036-0.062],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:93014343-<b>?</b>,3 x 10-15,(conditional),NR,'-,0.0447373 unit increase,[0.034-0.056],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:4031169-<b>?</b>,7 x 10-7,(conditional),NR,'-,0.0319109 unit increase,[0.019-0.045],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:4205600-<b>?</b>,5 x 10-8,(conditional),NR,'-,0.278858 unit increase,[0.18-0.38],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:4384696-<b>?</b>,4 x 10-30,(conditional),NR,'-,0.104253 unit increase,[0.086-0.122],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:4384844-<b>?</b>,4 x 10-76,(conditional),NR,'-,0.419045 unit decrease,[0.37-0.46],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:4399050-<b>?</b>,2 x 10-9,(conditional),NR,'-,0.0387548 unit increase,[0.026-0.051],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:4419628-<b>?</b>,3 x 10-7,(conditional),NR,'-,0.0846074 unit decrease,[0.052-0.117],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:66363070-<b>?</b>,3 x 10-21,(conditional),NR,'-,0.0539147 unit increase,[0.043-0.065],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:97844983-<b>?</b>,4 x 10-11,(conditional),NR,'-,0.0713807 unit increase,[0.05-0.093],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:97850215-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0367766 unit increase,[0.023-0.051],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:117958283-<b>?</b>,1 x 10-6,(conditional),NR,'-,0.122653 unit decrease,[0.074-0.172],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:118394008-<b>?</b>,2 x 10-10,(conditional),NR,'-,0.0538814 unit increase,[0.037-0.07],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:120989183-<b>?</b>,3 x 10-12,(conditional),NR,'-,0.0385446 unit increase,[0.028-0.049],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:121416864-<b>?</b>,1 x 10-41,(conditional),NR,'-,0.211418 unit decrease,[0.18-0.24],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:121429194-<b>?</b>,3 x 10-35,(conditional),NR,'-,0.070881 unit increase,[0.06-0.082],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:123985834-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0320685 unit increase,[0.02-0.044],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr12:124423817-<b>?</b>,6 x 10-19,(conditional),NR,'-,0.0476729 unit decrease,[0.037-0.058],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:47091420-<b>?</b>,2 x 10-23,(conditional),NR,'-,0.0579968 unit increase,[0.047-0.069],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:61564052-<b>?</b>,2 x 10-8,(conditional),NR,'-,0.030816 unit decrease,[0.02-0.042],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:61636709-<b>?</b>,3 x 10-9,(conditional),NR,'-,0.0431655 unit increase,[0.029-0.057],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:61739101-<b>?</b>,2 x 10-8,(conditional),NR,'-,0.0687073 unit decrease,[0.045-0.093],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr18:54565881-<b>?</b>,2 x 10-6,(conditional),NR,'-,0.0345671 unit increase,[0.02-0.049],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr18:54876377-<b>?</b>,3 x 10-17,(conditional),NR,'-,0.259128 unit decrease,[0.2-0.32],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr18:56957256-<b>?</b>,8 x 10-168,(conditional),NR,'-,0.432362 unit increase,[0.4-0.46],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr18:57551147-<b>?</b>,2 x 10-13,(conditional),NR,'-,0.313156 unit decrease,[0.23-0.4],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr18:58036384-<b>?</b>,2 x 10-10,(conditional),NR,'-,0.121946 unit increase,[0.084-0.16],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr18:60903978-<b>?</b>,9 x 10-7,(conditional),NR,'-,0.030358 unit increase,[0.018-0.042],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr19:8429323-<b>?</b>,9 x 10-7,(conditional),NR,'-,0.0969563 unit increase,[0.058-0.136],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr19:12624750-<b>?</b>,5 x 10-178,(conditional),NR,'-,0.52662 unit increase,[0.49-0.56],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr20:50977861-<b>?</b>,8 x 10-10,(conditional),NR,'-,0.0339353 unit decrease,[0.023-0.045],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr20:51233000-<b>?</b>,1 x 10-8,(conditional),NR,'-,0.0375023 unit increase,[0.025-0.05],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr20:57009166-<b>?</b>,8 x 10-6,(conditional),NR,'-,0.0240705 unit increase,[0.014-0.035],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr20:62314863-<b>?</b>,6 x 10-6,(conditional),NR,'-,0.124441 unit decrease,[0.071-0.178],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr20:62581009-<b>?</b>,5 x 10-10,(conditional),NR,'-,0.0476696 unit increase,[0.033-0.063],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr22:32092981-<b>?</b>,1 x 10-11,(conditional),NR,'-,0.0749592 unit increase,[0.053-0.097],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr22:41593636-<b>?</b>,3 x 10-6,(conditional),NR,'-,0.0267853 unit decrease,[0.016-0.038],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
rs7903146-<b>T</b>,3 x 10-19,,0.260835,'-,0.227926 unit increase,[0.18-0.28],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST010554,10:112998590
rs2237897-<b>T</b>,8 x 10-11,,0.198644,'-,0.192775 unit decrease,[0.13-0.25],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010554,11:2837316
rs62024526-<b>C</b>,5 x 10-8,,0.7574,'-,0.0558 unit decrease,[0.036-0.076],IGF1R,Type 2 diabetes,type II diabetes mellitus,GCST010553,15:98737959
rs1825307-<b>G</b>,6 x 10-9,,0.7545,'-,0.0595 unit decrease,[0.04-0.079],USP48,Type 2 diabetes,type II diabetes mellitus,GCST010553,1:21741833
rs12031188-<b>C</b>,2 x 10-11,,0.7953,'-,0.0802 unit increase,[0.057-0.104],FAF1,Type 2 diabetes,type II diabetes mellitus,GCST010553,1:50637596
rs5017301-<b>G</b>,6 x 10-10,,0.0941,'-,0.0959 unit decrease,[0.066-0.126],"TMEM18, LINC01875",Type 2 diabetes,type II diabetes mellitus,GCST010553,2:631096
chr13:33507267-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0338902 unit decrease,[0.021-0.047],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr13:80715893-<b>?</b>,1 x 10-48,(conditional),NR,'-,0.080579 unit increase,[0.07-0.091],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr13:109927086-<b>?</b>,4 x 10-22,(conditional),NR,'-,0.067254 unit decrease,[0.054-0.081],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr14:32999922-<b>?</b>,3 x 10-13,(conditional),NR,'-,0.460055 unit increase,[0.34-0.58],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr14:38803947-<b>?</b>,4 x 10-11,(conditional),NR,'-,0.0382613 unit increase,[0.027-0.05],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr14:92358529-<b>?</b>,2 x 10-6,(conditional),NR,'-,0.374051 unit decrease,[0.22-0.53],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr14:103876454-<b>?</b>,1 x 10-8,(conditional),NR,'-,0.0302422 unit increase,[0.02-0.041],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr15:38828140-<b>?</b>,2 x 10-17,(conditional),NR,'-,0.0518086 unit decrease,[0.04-0.064],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr15:57328867-<b>?</b>,4 x 10-11,(conditional),NR,'-,0.0359134 unit increase,[0.025-0.047],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr15:90381258-<b>?</b>,8 x 10-23,(conditional),NR,'-,0.0574729 unit increase,[0.046-0.069],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr15:91492100-<b>?</b>,5 x 10-9,(conditional),NR,'-,0.101997 unit increase,[0.068-0.136],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr15:91525197-<b>?</b>,1 x 10-10,(conditional),NR,'-,0.0415318 unit decrease,[0.029-0.054],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr15:91715496-<b>?</b>,2 x 10-10,(conditional),NR,'-,0.0691321 unit decrease,[0.048-0.09],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr16:401096-<b>?</b>,2 x 10-9,(conditional),NR,'-,0.0433356 unit increase,[0.029-0.058],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr16:3500560-<b>?</b>,8 x 10-7,(conditional),NR,'-,0.354577 unit decrease,[0.21-0.5],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr16:3802388-<b>?</b>,7 x 10-7,(conditional),NR,'-,0.416192 unit decrease,[0.25-0.58],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr16:28913787-<b>?</b>,6 x 10-7,(conditional),NR,'-,0.0275878 unit decrease,[0.017-0.038],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr16:53429173-<b>?</b>,5 x 10-14,(conditional),NR,'-,0.0403838 unit increase,[0.03-0.051],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr16:53770578-<b>?</b>,9 x 10-10,(conditional),NR,'-,0.0757345 unit increase,[0.052-0.1],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr16:69581354-<b>?</b>,2 x 10-10,(conditional),NR,'-,0.0343425 unit increase,[0.024-0.045],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:3828086-<b>?</b>,1 x 10-6,(conditional),NR,'-,0.0362149 unit increase,[0.022-0.051],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:3858204-<b>?</b>,2 x 10-8,(conditional),NR,'-,0.031683 unit decrease,[0.021-0.043],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:36046451-<b>?</b>,5 x 10-14,(conditional),NR,'-,0.0495841 unit decrease,[0.037-0.062],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:36099840-<b>?</b>,1 x 10-21,(conditional),NR,'-,0.0561361 unit increase,[0.045-0.068],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr17:40768629-<b>?</b>,5 x 10-12,(conditional),NR,'-,0.0428511 unit decrease,[0.031-0.055],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:40576652-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0289158 unit decrease,[0.018-0.04],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:43757082-<b>?</b>,1 x 10-15,(conditional),NR,'-,0.03899 unit decrease,[0.029-0.049],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:43801582-<b>?</b>,4 x 10-7,(conditional),NR,'-,0.0348394 unit decrease,[0.021-0.048],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:51157279-<b>?</b>,2 x 10-6,(conditional),NR,'-,0.0404786 unit decrease,[0.024-0.057],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:51520386-<b>?</b>,3 x 10-8,(conditional),NR,'-,0.0660157 unit increase,[0.043-0.089],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:117850608-<b>?</b>,1 x 10-64,(conditional),NR,'-,0.0969296 unit decrease,[0.086-0.108],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:139835689-<b>?</b>,2 x 10-10,(conditional),NR,'-,0.0317058 unit increase,[0.022-0.041],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:140250879-<b>?</b>,2 x 10-11,(conditional),NR,'-,0.037352 unit decrease,[0.026-0.048],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr6:160770918-<b>?</b>,1 x 10-18,(conditional),NR,'-,0.043858 unit decrease,[0.034-0.054],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:13988513-<b>?</b>,1 x 10-8,(conditional),NR,'-,0.0411919 unit increase,[0.027-0.055],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:14923907-<b>?</b>,7 x 10-24,(conditional),NR,'-,0.0669091 unit increase,[0.054-0.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:15203359-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0264604 unit increase,[0.017-0.036],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:44232833-<b>?</b>,3 x 10-28,(conditional),NR,'-,0.074056 unit decrease,[0.061-0.087],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:44362545-<b>?</b>,3 x 10-7,(conditional),NR,'-,0.0359006 unit increase,[0.022-0.05],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:69689483-<b>?</b>,5 x 10-8,(conditional),NR,'-,0.0956543 unit decrease,[0.061-0.13],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:102976385-<b>?</b>,9 x 10-9,(conditional),NR,'-,0.0939553 unit increase,[0.062-0.126],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:130339988-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0596592 unit increase,[0.037-0.082],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr7:150636257-<b>?</b>,3 x 10-8,(conditional),NR,'-,0.0676859 unit increase,[0.044-0.092],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr8:9974824-<b>?</b>,8 x 10-6,(conditional),NR,'-,0.024714 unit increase,[0.014-0.036],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr8:41492584-<b>?</b>,1 x 10-8,(conditional),NR,'-,0.0925476 unit decrease,[0.061-0.124],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr8:95728877-<b>?</b>,2 x 10-6,(conditional),NR,'-,0.0316442 unit increase,[0.019-0.045],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:4298589-<b>?</b>,2 x 10-19,(conditional),NR,'-,0.0490224 unit decrease,[0.038-0.06],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:18912869-<b>?</b>,6 x 10-7,(conditional),NR,'-,0.244575 unit increase,[0.15-0.34],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:20736589-<b>?</b>,5 x 10-8,(conditional),NR,'-,0.0415892 unit decrease,[0.027-0.057],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:22134068-<b>?</b>,6 x 10-90,(conditional),NR,'-,0.137219 unit increase,[0.12-0.15],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:22136440-<b>?</b>,2 x 10-42,(conditional),NR,'-,0.0875097 unit decrease,[0.075-0.1],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:28851878-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.0506719 unit increase,[0.032-0.07],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:84311800-<b>?</b>,7 x 10-28,(conditional),NR,'-,0.0567795 unit decrease,[0.047-0.067],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:97050286-<b>?</b>,7 x 10-7,(conditional),NR,'-,0.0662732 unit increase,[0.04-0.092],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:97179626-<b>?</b>,1 x 10-34,(conditional),NR,'-,0.155451 unit increase,[0.13-0.18],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:97407717-<b>?</b>,4 x 10-33,(conditional),NR,'-,0.112339 unit decrease,[0.094-0.131],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:136143372-<b>?</b>,2 x 10-21,(conditional),NR,'-,0.0511253 unit decrease,[0.041-0.062],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:136502684-<b>?</b>,1 x 10-6,(conditional),NR,'-,0.290325 unit decrease,[0.17-0.41],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr9:139244376-<b>?</b>,8 x 10-14,(conditional),NR,'-,0.0556243 unit increase,[0.041-0.07],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr10:12127375-<b>?</b>,9 x 10-13,(conditional),NR,'-,0.544833 unit decrease,[0.4-0.69],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr10:71099888-<b>?</b>,9 x 10-8,(conditional),NR,'-,0.0392886 unit increase,[0.025-0.054],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr10:71314539-<b>?</b>,1 x 10-7,(conditional),NR,'-,0.16566 unit decrease,[0.1-0.23],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr10:94424422-<b>?</b>,4 x 10-31,(conditional),NR,'-,0.160435 unit decrease,[0.13-0.19],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr10:114738287-<b>?</b>,2 x 10-8,(conditional),NR,'-,0.222062 unit decrease,[0.14-0.3],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr10:114743091-<b>?</b>,4 x 10-19,(conditional),NR,'-,0.176405 unit decrease,[0.14-0.22],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:1702929-<b>?</b>,4 x 10-9,(conditional),NR,'-,0.0302966 unit decrease,[0.02-0.04],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:2193840-<b>?</b>,1 x 10-31,(conditional),NR,'-,0.0618745 unit decrease,[0.051-0.072],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:2287356-<b>?</b>,6 x 10-8,(conditional),NR,'-,0.0945969 unit decrease,[0.06-0.129],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:2526429-<b>?</b>,6 x 10-8,(conditional),NR,'-,0.0296746 unit decrease,[0.019-0.04],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:2579163-<b>?</b>,4 x 10-10,(conditional),NR,'-,0.0770274 unit decrease,[0.053-0.101],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:2632430-<b>?</b>,4 x 10-13,(conditional),NR,'-,0.072812 unit increase,[0.053-0.092],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:2634177-<b>?</b>,2 x 10-7,(conditional),NR,'-,0.111296 unit increase,[0.069-0.153],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:2672821-<b>?</b>,3 x 10-15,(conditional),NR,'-,0.0646517 unit decrease,[0.049-0.081],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:2691500-<b>?</b>,6 x 10-36,(conditional),NR,'-,0.0740206 unit decrease,[0.062-0.086],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
chr11:2754833-<b>?</b>,6 x 10-11,(conditional),NR,'-,0.0427349 unit decrease,[0.03-0.056],'-,Type 2 diabetes,type II diabetes mellitus,GCST010555,Mapping not available
rs9892728-<b>C</b>,9 x 10-9,,0.4717,'-,0.0536 unit increase,[0.035-0.072],RAMP2,Type 2 diabetes,type II diabetes mellitus,GCST010553,17:42761348
rs663129-<b>G</b>,2 x 10-14,,0.7844,'-,0.0794 unit decrease,[0.059-0.1],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST010553,18:60171168
rs12454712-<b>C</b>,3 x 10-12,,0.5195,'-,0.061 unit decrease,[0.044-0.078],BCL2,Type 2 diabetes,type II diabetes mellitus,GCST010553,18:63178651
rs148316037-<b>C</b>,6 x 10-12,,0.0257,'-,0.2365 unit decrease,[0.17-0.3],ZNF257,Type 2 diabetes,type II diabetes mellitus,GCST010553,19:22074756
rs77300780-<b>C</b>,1 x 10-19,,0.4604,'-,0.0794 unit decrease,[0.062-0.096],"GIPR, RN7SL836P",Type 2 diabetes,type II diabetes mellitus,GCST010553,19:45663346
rs113810779-<b>C</b>,2 x 10-9,,0.1952,'-,0.0666 unit decrease,[0.045-0.088],HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST010553,20:44364688
rs6021276-<b>C</b>,9 x 10-10,,0.5734,'-,0.0547 unit decrease,[0.037-0.072],NFATC2,Type 2 diabetes,type II diabetes mellitus,GCST010553,20:51538847
rs34857077-<b>GA</b>,6 x 10-19,,0.237,'-,'-,'-,UMOD,Chronic kidney disease x type 2 diabetes interaction,"chronic kidney disease, type II diabetes mellitus",GCST010552,16:20344691
rs2177223-<b>C</b>,3 x 10-8,,0.038,'-,'-,'-,'-,Chronic kidney disease x type 2 diabetes interaction,"chronic kidney disease, type II diabetes mellitus",GCST010552,4:180895717
rs3104154-<b>T</b>,3 x 10-8,,0.044,'-,'-,'-,PTDSS1,Peripheral arterial disease x type 2 diabetes interaction,"type II diabetes mellitus, peripheral arterial disease",GCST010549,8:96318798
rs1831733-<b>C</b>,2 x 10-13,,0.482,'-,'-,'-,CDKN2B-AS1,Coronary heart disease x type 2 diabetes interaction,"type II diabetes mellitus, coronary artery disease",GCST010551,9:22076072
rs602633-<b>T</b>,4 x 10-10,,0.216,'-,'-,'-,"CELSR2, PSRC1",Coronary heart disease x type 2 diabetes interaction,"type II diabetes mellitus, coronary artery disease",GCST010551,1:109278889
rs71039916-<b>T</b>,8 x 10-9,,0.034,'-,'-,'-,LINC02398,Coronary heart disease x type 2 diabetes interaction,"type II diabetes mellitus, coronary artery disease",GCST010551,12:20078593
rs491203-<b>A</b>,8 x 10-9,,0.057,'-,'-,'-,KAZN,Acute ischemic stroke x type 2 diabetes interaction,"Ischemic stroke, type II diabetes mellitus",GCST010550,1:15102737
rs2134937-<b>C</b>,3 x 10-8,,0.049,'-,'-,'-,"MIR8084, C8orf87",Acute ischemic stroke x type 2 diabetes interaction,"Ischemic stroke, type II diabetes mellitus",GCST010550,8:93044145
rs76754787-<b>AT</b>,1 x 10-11,,0.03,'-,'-,'-,"PRKAB2, NBPF13P",Retinopathy x type 2 diabetes interaction,"retinopathy, type II diabetes mellitus",GCST010548,1:147134477
rs10733997-<b>G</b>,1 x 10-8,,0.037,'-,'-,'-,SVIL2P,Retinopathy x type 2 diabetes interaction,"retinopathy, type II diabetes mellitus",GCST010548,10:30703953
rs2255624-<b>G</b>,2 x 10-8,,0.032,'-,'-,'-,'-,Retinopathy x type 2 diabetes interaction,"retinopathy, type II diabetes mellitus",GCST010548,10:117886706
rs4132670-<b>A</b>,2 x 10-8,,0.319,'-,'-,'-,TCF7L2,Retinopathy x type 2 diabetes interaction,"retinopathy, type II diabetes mellitus",GCST010548,10:113008012
rs78977169-<b>C</b>,3 x 10-8,,0.023,'-,'-,'-,"NRP2, RN7SKP178",Neuropathy x type 2 diabetes interaction,"type II diabetes mellitus, neuropathy",GCST010547,2:205803395
rs7072204-<b>G</b>,2 x 10-8,,0.5738,'-,0.0492 unit decrease,[0.032-0.066],PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST010553,10:122435969
rs2237897-<b>C</b>,8 x 10-171,,0.6218,'-,0.26 unit increase,[0.24-0.28],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010553,11:2837316
rs2421897-<b>G</b>,3 x 10-9,,0.8771,'-,0.0802 unit increase,[0.054-0.107],SLC1A2,Type 2 diabetes,type II diabetes mellitus,GCST010553,11:35416316
rs73541184-<b>G</b>,7 x 10-11,,0.9426,'-,0.1367 unit increase,[0.096-0.178],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST010553,11:72717103
rs11819995-<b>C</b>,8 x 10-9,,0.7799,'-,0.0599 unit decrease,[0.04-0.08],ETS1,Type 2 diabetes,type II diabetes mellitus,GCST010553,11:128519496
rs3751236-<b>G</b>,4 x 10-13,,0.6903,'-,0.0684 unit increase,[0.05-0.087],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST010553,12:27810469
rs147538848-<b>G</b>,3 x 10-17,,0.8121,'-,0.0993 unit decrease,[0.076-0.122],SINHCAF,Type 2 diabetes,type II diabetes mellitus,GCST010553,12:31313679
rs11113776-<b>G</b>,6 x 10-9,,0.4591,'-,0.0507 unit increase,[0.034-0.068],WSCD2,Type 2 diabetes,type II diabetes mellitus,GCST010553,12:108219374
rs79310463-<b>C</b>,2 x 10-8,,0.7366,'-,0.0574 unit decrease,[0.037-0.077],KSR2,Type 2 diabetes,type II diabetes mellitus,GCST010553,12:117968891
rs187150787-<b>G</b>,7 x 10-12,,0.9627,'-,0.1838 unit decrease,[0.13-0.24],SPPL3,Type 2 diabetes,type II diabetes mellitus,GCST010553,12:120890006
rs9581591-<b>C</b>,1 x 10-15,,0.4483,'-,0.0698 unit decrease,[0.053-0.087],RNF6,Type 2 diabetes,type II diabetes mellitus,GCST010553,13:26210802
rs488321-<b>C</b>,1 x 10-14,,0.864,'-,0.098 unit decrease,[0.073-0.123],"TOMM22P3, KL",Type 2 diabetes,type II diabetes mellitus,GCST010553,13:32980267
rs123378-<b>G</b>,2 x 10-9,,0.2204,'-,0.063 unit increase,[0.043-0.083],DLEU1,Type 2 diabetes,type II diabetes mellitus,GCST010553,13:50514673
rs1327315-<b>C</b>,6 x 10-19,,0.7342,'-,0.0908 unit increase,[0.071-0.111],'-,Type 2 diabetes,type II diabetes mellitus,GCST010553,13:80134597
rs11073333-<b>G</b>,5 x 10-11,,0.4718,'-,0.0575 unit increase,[0.04-0.075],RASGRP1,Type 2 diabetes,type II diabetes mellitus,GCST010553,15:38528446
rs746673-<b>G</b>,5 x 10-14,,0.4084,'-,0.0722 unit increase,[0.053-0.091],"PHGR1, CCDC9B",Type 2 diabetes,type II diabetes mellitus,GCST010553,15:40344217
rs8037894-<b>G</b>,7 x 10-18,,0.5764,'-,0.0752 unit increase,[0.058-0.092],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST010553,15:62102065
rs2055901-<b>G</b>,2 x 10-11,,0.5932,'-,0.059 unit decrease,[0.042-0.076],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST010553,15:77466953
rs7174878-<b>G</b>,4 x 10-8,,0.7504,'-,0.0569 unit decrease,[0.037-0.077],"ARPIN-AP3S2, AP3S2",Type 2 diabetes,type II diabetes mellitus,GCST010553,15:89891656
rs2290203-<b>G</b>,2 x 10-10,,0.526,'-,0.0559 unit decrease,[0.039-0.073],"PRC1, PRC1-AS1",Type 2 diabetes,type II diabetes mellitus,GCST010553,15:90968837
rs117267808-<b>G</b>,6 x 10-12,,0.9209,'-,0.1103 unit decrease,[0.079-0.142],GP2,Type 2 diabetes,type II diabetes mellitus,GCST010553,16:20311846
rs1421085-<b>C</b>,1 x 10-28,,0.2018,'-,0.1211 unit increase,[0.1-0.142],FTO,Type 2 diabetes,type II diabetes mellitus,GCST010553,16:53767042
rs113547729-<b>G</b>,9 x 10-9,,0.8815,'-,0.0819 unit decrease,[0.054-0.11],ZZEF1,Type 2 diabetes,type II diabetes mellitus,GCST010553,17:4121530
rs13342232-<b>G</b>,1 x 10-15,,0.0779,'-,0.1297 unit increase,[0.098-0.161],SLC16A11,Type 2 diabetes,type II diabetes mellitus,GCST010553,17:7042621
rs8064454-<b>C</b>,5 x 10-35,,0.6742,'-,0.1152 unit decrease,[0.097-0.133],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST010553,17:37741595
rs2856721-<b>C</b>,5 x 10-10,,0.4659,'-,0.0572 unit decrease,[0.039-0.075],"HLA-DQB1, MTCO3P1",Type 2 diabetes,type II diabetes mellitus,GCST010553,6:32700254
rs9380826-<b>G</b>,2 x 10-14,,0.8196,'-,0.0895 unit increase,[0.067-0.112],GLP1R,Type 2 diabetes,type II diabetes mellitus,GCST010553,6:39069886
rs80196932-<b>C</b>,4 x 10-12,,0.247,'-,0.071 unit decrease,[0.051-0.091],"NEPNP, NUS1",Type 2 diabetes,type II diabetes mellitus,GCST010553,6:117675468
rs2327777-<b>C</b>,7 x 10-14,,0.6036,'-,0.0654 unit decrease,[0.048-0.082],"RPL35AP3, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST010553,6:136972090
rs7787720-<b>C</b>,1 x 10-8,,0.5541,'-,0.0498 unit decrease,[0.033-0.067],ETV1,Type 2 diabetes,type II diabetes mellitus,GCST010553,7:13847029
rs17168486-<b>C</b>,9 x 10-13,,0.6005,'-,0.0623 unit decrease,[0.045-0.079],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST010553,7:14858657
rs2908279-<b>G</b>,1 x 10-11,,0.5983,'-,0.0628 unit increase,[0.045-0.081],"RNA5SP230, MYL7",Type 2 diabetes,type II diabetes mellitus,GCST010553,7:44135258
rs6947395-<b>T</b>,3 x 10-16,,0.1981,'-,0.0898 unit increase,[0.068-0.111],AUTS2,Type 2 diabetes,type II diabetes mellitus,GCST010553,7:69941675
rs2233580-<b>C</b>,1 x 10-74,,0.9085,'-,0.2764 unit decrease,[0.25-0.31],PAX4,Type 2 diabetes,type II diabetes mellitus,GCST010553,7:127613496
rs77792157-<b>G</b>,4 x 10-9,,0.9532,'-,0.1354 unit increase,[0.09-0.18],CPA1,Type 2 diabetes,type II diabetes mellitus,GCST010553,7:130385872
rs1182394-<b>G</b>,3 x 10-8,,0.5412,'-,0.0524 unit decrease,[0.034-0.071],UBE3C,Type 2 diabetes,type II diabetes mellitus,GCST010553,7:157242980
rs4736999-<b>G</b>,1 x 10-22,,0.5053,'-,0.0854 unit increase,[0.068-0.102],NKX6-3,Type 2 diabetes,type II diabetes mellitus,GCST010553,8:41648633
rs13266634-<b>C</b>,1 x 10-30,,0.5931,'-,0.1004 unit increase,[0.083-0.117],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST010553,8:117172544
rs7034200-<b>C</b>,3 x 10-12,,0.5866,'-,0.0608 unit decrease,[0.044-0.078],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST010553,9:4289050
rs10965247-<b>G</b>,4 x 10-89,,0.4353,'-,0.1769 unit decrease,[0.16-0.19],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST010553,9:22132730
rs2796441-<b>G</b>,2 x 10-19,,0.378,'-,0.0794 unit increase,[0.062-0.097],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST010553,9:81694033
rs28641468-<b>C</b>,2 x 10-21,,0.8765,'-,0.1345 unit increase,[0.11-0.16],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST010553,9:136345132
rs10795945-<b>C</b>,4 x 10-27,,0.5498,'-,0.1013 unit decrease,[0.083-0.12],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST010553,10:12260608
rs1955163-<b>G</b>,5 x 10-9,,0.5105,'-,0.0512 unit increase,[0.034-0.068],"TMEM256P1, TSPAN15",Type 2 diabetes,type II diabetes mellitus,GCST010553,10:69513601
rs10762670-<b>C</b>,7 x 10-9,,0.4949,'-,0.0505 unit decrease,[0.033-0.068],LRMDA,Type 2 diabetes,type II diabetes mellitus,GCST010553,10:75550258
rs703980-<b>G</b>,2 x 10-14,,0.5556,'-,0.0669 unit increase,[0.05-0.084],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST010553,10:79184084
rs12219514-<b>G</b>,5 x 10-40,,0.8696,'-,0.1666 unit decrease,[0.14-0.19],"Y_RNA, HHEX",Type 2 diabetes,type II diabetes mellitus,GCST010553,10:92706682
rs12782078-<b>G</b>,2 x 10-8,,0.0536,'-,0.1135 unit decrease,[0.074-0.153],CPN1,Type 2 diabetes,type II diabetes mellitus,GCST010553,10:100060908
rs34872471-<b>C</b>,1 x 10-49,,0.0449,'-,0.2937 unit increase,[0.25-0.33],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST010553,10:112994312
rs7922045-<b>C</b>,4 x 10-9,,0.5268,'-,0.0555 unit increase,[0.037-0.074],LINC01153,Type 2 diabetes,type II diabetes mellitus,GCST010553,10:121242218
rs4927186-<b>?</b>,8 x 10-6,(EA),'-,1.43,'-,[1.30-1.57],BSND,Chronic kidney disease and diabetic kidney disease in type 2 diabetes,"chronic kidney disease, diabetic nephropathy, type II diabetes mellitus",GCST005883,1:55006692
rs12647735-<b>?</b>,2 x 10-6,(EA),'-,1.45,'-,[1.33-1.59],LINC02511,Chronic kidney disease and diabetic kidney disease in type 2 diabetes,"chronic kidney disease, diabetic nephropathy, type II diabetes mellitus",GCST005883,4:137078372
rs6997279-<b>?</b>,1 x 10-7,,'-,1.48,'-,[1.19-1.84],SLC30A8,Chronic kidney disease and diabetic kidney disease in type 2 diabetes,"chronic kidney disease, diabetic nephropathy, type II diabetes mellitus",GCST005883,8:116961613
chr19:48475266:I-<b>?</b>,7 x 10-6,,'-,1.38,'-,[1.23-1.53],'-,Chronic kidney disease and diabetic kidney disease in type 2 diabetes,"chronic kidney disease, diabetic nephropathy, type II diabetes mellitus",GCST005883,Mapping not available
rs4457053-<b>G</b>,3 x 10-12,,'-,1.08,'-,[1.06-1.11],ZBED3-AS1,Type 2 diabetes,type II diabetes mellitus,GCST000712,5:77129124
rs972283-<b>G</b>,2 x 10-10,,'-,1.07,'-,[1.05-1.10],"KLF14, H4P1",Type 2 diabetes,type II diabetes mellitus,GCST000712,7:130782095
rs896854-<b>T</b>,1 x 10-9,,'-,1.06,'-,[1.04-1.09],"NDUFAF6, TP53INP1",Type 2 diabetes,type II diabetes mellitus,GCST000712,8:94948283
rs1552224-<b>A</b>,1 x 10-22,,'-,1.14,'-,[1.11-1.17],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST000712,11:72722053
rs5945326-<b>A</b>,3 x 10-10,,'-,1.27,'-,[1.18-1.37],"KRT18P48, DUSP9",Type 2 diabetes,type II diabetes mellitus,GCST000712,X:153634467
rs243021-<b>A</b>,3 x 10-15,,'-,1.08,'-,[1.06-1.10],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST000712,2:60357684
rs13292136-<b>C</b>,3 x 10-8,,'-,1.11,'-,[1.07-1.15],CHCHD2P9,Type 2 diabetes,type II diabetes mellitus,GCST000712,9:79337213
rs7578326-<b>A</b>,5 x 10-20,,'-,1.11,'-,[1.08-1.13],'-,Type 2 diabetes,type II diabetes mellitus,GCST000712,2:226155937
rs11634397-<b>G</b>,2 x 10-9,,'-,1.06,'-,[1.04-1.08],"FAH, ZFAND6",Type 2 diabetes,type II diabetes mellitus,GCST000712,15:80139880
rs1801214-<b>T</b>,3 x 10-8,,'-,1.13,'-,[1.08-1.18],WFS1,Type 2 diabetes,type II diabetes mellitus,GCST000712,4:6301295
rs4760790-<b>A</b>,4 x 10-6,,'-,1.11,'-,[1.06-1.16],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST000712,12:71241014
rs4430796-<b>G</b>,2 x 10-6,,'-,1.14,'-,[1.08-1.20],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST000712,17:37738049
rs11642841-<b>A</b>,3 x 10-8,,'-,1.13,'-,[1.08-1.18],FTO,Type 2 diabetes,type II diabetes mellitus,GCST000712,16:53811575
rs231362-<b>G</b>,3 x 10-13,,'-,1.08,'-,[1.06-1.10],"KCNQ1OT1, KCNQ1",Type 2 diabetes,type II diabetes mellitus,GCST000712,11:2670241
rs1531343-<b>C</b>,4 x 10-9,,'-,1.1,'-,[1.07-1.14],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST000712,12:65781114
rs7957197-<b>T</b>,2 x 10-8,,'-,1.07,'-,[1.05-1.10],OASL,Type 2 diabetes,type II diabetes mellitus,GCST000712,12:121022883
rs8042680-<b>A</b>,2 x 10-10,,'-,1.07,'-,[1.05-1.09],"PRC1, PRC1-AS1",Type 2 diabetes,type II diabetes mellitus,GCST000712,15:90978107
rs1387153-<b>T</b>,8 x 10-15,,'-,1.09,'-,[1.06-1.11],"MTNR1B, SNRPGP16",Type 2 diabetes,type II diabetes mellitus,GCST000712,11:92940662
rs1470579-<b>C</b>,2 x 10-9,,'-,1.14,'-,[1.09-1.19],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST000712,3:185811292
rs849134-<b>A</b>,3 x 10-9,,'-,1.13,'-,[1.09-1.18],JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST000712,7:28156603
rs5015480-<b>C</b>,1 x 10-15,,'-,1.18,'-,[1.13-1.23],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST000712,10:92705802
rs13081389-<b>A</b>,2 x 10-7,,'-,1.24,'-,[1.15-1.35],"GSTM5P1, SYN2",Type 2 diabetes,type II diabetes mellitus,GCST000712,3:12248301
rs10440833-<b>A</b>,2 x 10-22,,'-,1.25,'-,[1.20-1.31],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST000712,6:20687890
rs3802177-<b>G</b>,1 x 10-8,,'-,1.15,'-,[1.10-1.21],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST000712,8:117172786
rs10965250-<b>G</b>,1 x 10-10,,'-,1.2,'-,[1.13-1.27],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST000712,9:22133285
rs7903146-<b>T</b>,2 x 10-51,,'-,1.4,'-,[1.34-1.46],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000712,10:112998590
rs2237896-<b>G</b>,1 x 10-32,,0.26,1.3623978,'-,NR,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST008833,11:2837210
rs3802177-<b>G</b>,8 x 10-14,,0.31,1.1600928,'-,NR,SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST008833,8:117172786
chr7:69534694-<b>GT</b>,1 x 10-7,,0.23,1.1389521,'-,NR,'-,Type 2 diabetes,type II diabetes mellitus,GCST008833,Mapping not available
rs4684848-<b>G</b>,4 x 10-8,,0.2,1.1325028,'-,NR,PPARG,Type 2 diabetes,type II diabetes mellitus,GCST008833,3:12354146
rs376993806-<b>G</b>,2 x 10-8,,0.26,1.1299435,'-,NR,GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST008833,9:136352136
rs6103716-<b>C</b>,5 x 10-10,,0.39,1.1210762,'-,NR,HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST008833,20:44370990
rs1359790-<b>G</b>,2 x 10-8,,0.31,1.1160713,'-,NR,'-,Type 2 diabetes,type II diabetes mellitus,GCST008833,13:80143021
rs10734252-<b>G</b>,4 x 10-10,,0.38,1.1111112,'-,NR,KCNJ11,Type 2 diabetes,type II diabetes mellitus,GCST008833,11:17383292
rs1573219-<b>G</b>,2 x 10-7,,0.3,1.1074197,'-,NR,NTRK2,Type 2 diabetes,type II diabetes mellitus,GCST008833,9:84772707
rs896911-<b>C</b>,6 x 10-8,,0.38,1.1013216,'-,NR,'-,Type 2 diabetes,type II diabetes mellitus,GCST008833,2:5236832
rs7903146-<b>T</b>,1 x 10-41,,0.25,1.34,'-,NR,TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST008833,10:112998590
rs11257600-<b>T</b>,6 x 10-17,,0.31,1.16,'-,NR,CDC123,Type 2 diabetes,type II diabetes mellitus,GCST008833,10:12213658
rs9460550-<b>A</b>,7 x 10-15,,0.32,1.15,'-,NR,CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST008833,6:20719330
rs4414887-<b>T</b>,4 x 10-13,,0.32,1.13,'-,NR,IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST008833,3:185789104
rs72501962-<b>A</b>,8 x 10-12,,0.28,1.15,'-,NR,CTBP1-DT,Type 2 diabetes,type II diabetes mellitus,GCST008833,4:1252250
rs2153827-<b>T</b>,1 x 10-9,,0.34,1.11,'-,NR,"RN7SL644P, EIF2S2P3",Type 2 diabetes,type II diabetes mellitus,GCST008833,10:92664316
rs17737404-<b>A</b>,4 x 10-10,,0.23,1.22,'-,NR,"ASCL2, MIR4686",Type 2 diabetes,type II diabetes mellitus,GCST008833,11:2249112
rs2236033-<b>A</b>,4 x 10-9,,0.3,1.11,'-,NR,SFI1,Type 2 diabetes,type II diabetes mellitus,GCST008833,22:31605064
rs703978-<b>C</b>,2 x 10-9,,0.31,1.11,'-,NR,ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST008833,10:79184390
rs1635852-<b>T</b>,4 x 10-9,,0.34,1.12,'-,NR,JAZF1,Type 2 diabetes,type II diabetes mellitus,GCST008833,7:28149792
rs2943657-<b>T</b>,3 x 10-9,,0.26,1.12,'-,NR,'-,Type 2 diabetes,type II diabetes mellitus,GCST008833,2:226258723
chr4:6301628-<b>T</b>,4 x 10-8,,0.21,1.14,'-,NR,'-,Type 2 diabetes,type II diabetes mellitus,GCST008833,Mapping not available
chr2:42506923-<b>T</b>,3 x 10-8,,0.44,1.43,'-,NR,'-,Type 2 diabetes,type II diabetes mellitus,GCST008833,Mapping not available
rs12692738-<b>T</b>,2 x 10-7,,0.23,1.12,'-,NR,COBLL1,Type 2 diabetes,type II diabetes mellitus,GCST008833,2:164701742
rs76895963-<b>T</b>,1 x 10-7,,0.023,2.84,'-,NR,'-,Type 2 diabetes,type II diabetes mellitus,GCST008833,Mapping not available
rs1800961-<b>T</b>,5 x 10-8,,0.0316,1.1,'-,[1.06-1.14],HNF4A,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,20:44413724
rs28265-<b>C</b>,4 x 10-14,,0.925,1.09,'-,[1.07-1.12],ASCC2,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,22:29804772
rs738409-<b>G</b>,3 x 10-11,,0.239,1.05,'-,[1.03-1.06],PNPLA3,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,22:43928847
rs4077129-<b>T</b>,4 x 10-8,,0.276,1.04,'-,[1.02-1.06],PIM3,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,22:49963045
rs35742417-<b>C</b>,3 x 10-6,,0.807,1.04,'-,[1.02-1.06],RREB1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,6:7247111
rs1800574-<b>T</b>,2 x 10-7,,0.033,1.1,'-,[1.06-1.15],"HNF1A-AS1, HNF1A",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,12:120979061
rs16826069-<b>G</b>,9 x 10-9,,0.221,1.05,'-,[1.03-1.07],MACF1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,1:39331383
rs140386498-<b>A</b>,6 x 10-8,,0.986,1.2,'-,[1.13-1.28],MINDY1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,1:151000483
rs1260326-<b>C</b>,1 x 10-14,,0.617,1.05,'-,[1.04-1.07],'-,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,Mapping not available
rs35720761-<b>C</b>,1 x 10-14,,0.889,1.08,'-,[1.06-1.10],THADA,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,2:43292838
rs7572857-<b>G</b>,6 x 10-6,,0.833,1.05,'-,[1.03-1.07],CEP68,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,2:65069664
rs7607980-<b>T</b>,7 x 10-19,,0.881,1.09,'-,[1.07-1.12],'-,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,Mapping not available
rs1801282-<b>C</b>,1 x 10-16,,0.871,1.09,'-,[1.07-1.12],'-,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,Mapping not available
rs6780013-<b>G</b>,2 x 10-7,,0.616,1.03,'-,[1.02-1.05],PTPN23,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,3:47410628
rs1801212-<b>A</b>,2 x 10-17,,0.71,1.06,'-,[1.05-1.08],WFS1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,4:6300792
rs146886108-<b>C</b>,1 x 10-7,,0.995,1.28,'-,[1.14-1.43],ANKH,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,5:14751196
rs2307111-<b>T</b>,3 x 10-6,,0.597,1.03,'-,[1.02-1.05],POC5,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,5:75707853
rs35658696-<b>G</b>,4 x 10-13,,0.051,1.13,'-,[1.09-1.17],PAM,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,5:103003107
rs9379084-<b>G</b>,2 x 10-13,,0.887,1.09,'-,[1.06-1.12],RREB1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,6:7231610
rs2073721-<b>G</b>,6 x 10-10,,0.742,1.04,'-,[1.03-1.06],TCF19,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,6:31161839
rs328-<b>C</b>,3 x 10-6,,0.902,1.05,'-,[1.03-1.07],LPL,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,8:19962213
rs13266634-<b>C</b>,8 x 10-36,,0.68,1.09,'-,[1.07-1.11],SLC30A8,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,8:117172544
rs60980157-<b>C</b>,2 x 10-15,,0.747,1.07,'-,[1.05-1.08],GPSM1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,9:136340958
rs5215-<b>C</b>,5 x 10-22,,0.389,1.07,'-,[1.05-1.08],'-,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,Mapping not available
rs35169799-<b>T</b>,2 x 10-7,,0.071,1.06,'-,[1.03-1.09],PLCB3,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007518,11:64263769
rs328-<b>C</b>,3 x 10-6,,0.902,1.05,'-,[1.03-1.08],LPL,Type 2 diabetes,type II diabetes mellitus,GCST007517,8:19962213
rs13266634-<b>C</b>,6 x 10-30,,0.68,1.09,'-,[1.07-1.10],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST007517,8:117172544
rs60980157-<b>C</b>,5 x 10-15,,0.747,1.07,'-,[1.05-1.09],GPSM1,Type 2 diabetes,type II diabetes mellitus,GCST007517,9:136340958
rs5215-<b>C</b>,4 x 10-17,,0.389,1.06,'-,[1.05-1.08],'-,Type 2 diabetes,type II diabetes mellitus,GCST007517,Mapping not available
rs35264875-<b>A</b>,2 x 10-6,,0.827,1.07,'-,[1.04-1.09],TPCN2,Type 2 diabetes,type II diabetes mellitus,GCST007517,11:69078931
rs1127787-<b>G</b>,2 x 10-9,,0.84,1.06,'-,[1.04-1.08],MRPS35,Type 2 diabetes,type II diabetes mellitus,GCST007517,12:27714794
rs3764002-<b>C</b>,9 x 10-8,,0.726,1.04,'-,[1.02-1.05],WSCD2,Type 2 diabetes,type II diabetes mellitus,GCST007517,12:108224853
rs1169288-<b>C</b>,2 x 10-7,,0.337,1.04,'-,[1.02-1.06],"HNF1A-AS1, HNF1A",Type 2 diabetes,type II diabetes mellitus,GCST007517,12:120978847
rs781852-<b>G</b>,9 x 10-11,,0.387,1.05,'-,[1.03-1.07],ZZEF1,Type 2 diabetes,type II diabetes mellitus,GCST007517,17:4049808
rs10278-<b>C</b>,3 x 10-8,,0.706,1.05,'-,[1.03-1.06],CALCOCO2,Type 2 diabetes,type II diabetes mellitus,GCST007517,17:48862296
rs58542926-<b>T</b>,2 x 10-10,,0.079,1.09,'-,[1.06-1.12],TM6SF2,Type 2 diabetes,type II diabetes mellitus,GCST007517,19:19268740
rs17265513-<b>C</b>,9 x 10-8,,0.211,1.05,'-,[1.03-1.07],ZHX3,Type 2 diabetes,type II diabetes mellitus,GCST007517,20:41203988
rs1800961-<b>T</b>,3 x 10-6,,0.035,1.09,'-,[1.04-1.13],HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST007517,20:44413724
rs41278853-<b>A</b>,4 x 10-11,,0.917,1.09,'-,[1.06-1.12],"HORMAD2-AS1, MTMR3",Type 2 diabetes,type II diabetes mellitus,GCST007517,22:30020538
rs738409-<b>G</b>,8 x 10-7,,0.227,1.04,'-,[1.02-1.06],PNPLA3,Type 2 diabetes,type II diabetes mellitus,GCST007517,22:43928847
rs4077129-<b>T</b>,7 x 10-6,,0.259,1.04,'-,[1.02-1.06],PIM3,Type 2 diabetes,type II diabetes mellitus,GCST007517,22:49963045
rs9891146-<b>T</b>,1 x 10-7,,0.277,1.04,'-,(1.02-1.06),C17orf58,Type 2 diabetes,type II diabetes mellitus,GCST007517,17:67991933
rs1800574-<b>T</b>,4 x 10-7,,0.033,1.11,'-,(1.06-1.16),"HNF1A-AS1, HNF1A",Type 2 diabetes,type II diabetes mellitus,GCST007517,12:120979061
rs35742417-<b>C</b>,6 x 10-6,,0.807,1.04,'-,(1.02-1.06),RREB1,Type 2 diabetes,type II diabetes mellitus,GCST007517,6:7247111
rs1800574-<b>T</b>,1 x 10-7,,NR,1.1,'-,[1.06-1.15],"HNF1A-AS1, HNF1A",Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,12:120979061
rs35742417-<b>C</b>,2 x 10-7,,NR,1.04,'-,[1.02-1.06],RREB1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,6:7247111
rs16826069-<b>G</b>,7 x 10-9,,0.212,1.05,'-,[1.03-1.06],MACF1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,1:39331383
rs140386498-<b>A</b>,7 x 10-7,,0.988,1.19,'-,[1.12-1.26],MINDY1,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,1:151000483
rs1260326-<b>C</b>,3 x 10-18,,0.63,1.06,'-,[1.04-1.07],'-,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,Mapping not available
rs35720761-<b>C</b>,8 x 10-16,,0.895,1.07,'-,[1.05-1.10],THADA,Type 2 diabetes (adjusted for BMI),type II diabetes mellitus,GCST007516,2:43292838
rs1169288-<b>C</b>,1 x 10-11,,0.323,1.04,'-,[1.03-1.06],"HNF1A-AS1, HNF1A",Type 2 diabetes,type II diabetes mellitus,GCST007515,12:120978847
rs1060105-<b>C</b>,6 x 10-7,,0.815,1.04,'-,[1.02-1.06],SBNO1,Type 2 diabetes,type II diabetes mellitus,GCST007515,12:123321672
rs781831-<b>C</b>,8 x 10-11,,0.422,1.04,'-,[1.03-1.05],ZZEF1,Type 2 diabetes,type II diabetes mellitus,GCST007515,17:4044350
rs665268-<b>G</b>,2 x 10-8,,0.294,1.04,'-,[1.02-1.05],MLX,Type 2 diabetes,type II diabetes mellitus,GCST007515,17:42570011
rs2032844-<b>C</b>,1 x 10-7,,0.754,1.04,'-,[1.02-1.06],TTLL6,Type 2 diabetes,type II diabetes mellitus,GCST007515,17:48770002
rs9891146-<b>T</b>,7 x 10-7,,0.332,1.04,'-,[1.02-1.05],C17orf58,Type 2 diabetes,type II diabetes mellitus,GCST007515,17:67991933
rs58542926-<b>T</b>,5 x 10-12,,0.0755,1.07,'-,[1.05-1.10],TM6SF2,Type 2 diabetes,type II diabetes mellitus,GCST007515,19:19268740
rs17265513-<b>C</b>,7 x 10-6,,0.174,1.04,'-,[1.02-1.06],ZHX3,Type 2 diabetes,type II diabetes mellitus,GCST007515,20:41203988
rs1800961-<b>T</b>,3 x 10-8,,0.0316,1.09,'-,[1.05-1.13],HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST007515,20:44413724
rs41278853-<b>A</b>,6 x 10-13,,0.926,1.09,'-,[1.06-1.11],"HORMAD2-AS1, MTMR3",Type 2 diabetes,type II diabetes mellitus,GCST007515,22:30020538
rs738409-<b>G</b>,2 x 10-10,,0.239,1.04,'-,[1.03-1.05],PNPLA3,Type 2 diabetes,type II diabetes mellitus,GCST007515,22:43928847
rs4077129-<b>T</b>,2 x 10-7,,0.276,1.04,'-,[1.02-1.05],PIM3,Type 2 diabetes,type II diabetes mellitus,GCST007515,22:49963045
rs16826069-<b>G</b>,9 x 10-11,,0.221,1.06,'-,[1.04-1.08],MACF1,Type 2 diabetes,type II diabetes mellitus,GCST007517,1:39331383
rs140386498-<b>A</b>,6 x 10-8,,0.986,1.22,'-,[1.14-1.30],MINDY1,Type 2 diabetes,type II diabetes mellitus,GCST007517,1:151000483
rs1260326-<b>C</b>,1 x 10-15,,0.617,1.06,'-,[1.04-1.07],'-,Type 2 diabetes,type II diabetes mellitus,GCST007517,Mapping not available
rs35720761-<b>C</b>,1 x 10-12,,0.889,1.08,'-,[1.05-1.10],THADA,Type 2 diabetes,type II diabetes mellitus,GCST007517,2:43292838
rs7572857-<b>G</b>,8 x 10-6,,0.833,1.05,'-,[1.03-1.07],CEP68,Type 2 diabetes,type II diabetes mellitus,GCST007517,2:65069664
rs7607980-<b>T</b>,5 x 10-15,,0.881,1.09,'-,[1.06-1.11],'-,Type 2 diabetes,type II diabetes mellitus,GCST007517,Mapping not available
rs1801282-<b>C</b>,5 x 10-12,,0.871,1.08,'-,[1.05-1.10],'-,Type 2 diabetes,type II diabetes mellitus,GCST007517,Mapping not available
rs1801212-<b>A</b>,7 x 10-20,,0.71,1.07,'-,[1.05-1.09],WFS1,Type 2 diabetes,type II diabetes mellitus,GCST007517,4:6300792
rs146886108-<b>C</b>,2 x 10-7,,0.995,1.29,'-,[1.15-1.45],ANKH,Type 2 diabetes,type II diabetes mellitus,GCST007517,5:14751196
rs2307111-<b>T</b>,5 x 10-12,,0.597,1.06,'-,[1.04-1.07],POC5,Type 2 diabetes,type II diabetes mellitus,GCST007517,5:75707853
rs35658696-<b>G</b>,6 x 10-12,,0.051,1.13,'-,[1.09-1.17],PAM,Type 2 diabetes,type II diabetes mellitus,GCST007517,5:103003107
rs9379084-<b>G</b>,2 x 10-12,,0.887,1.1,'-,[1.07-1.13],RREB1,Type 2 diabetes,type II diabetes mellitus,GCST007517,6:7231610
rs2073721-<b>G</b>,6 x 10-9,,0.742,1.04,'-,[1.02-1.06],TCF19,Type 2 diabetes,type II diabetes mellitus,GCST007517,6:31161839
rs6808574-<b>C</b>,6 x 10-9,,'-,1.07,'-,[1.04-1.09],LINC01991,Type 2 diabetes,type II diabetes mellitus,GCST002352,3:188022735
rs2284219-<b>T</b>,8 x 10-6,,'-,1.05,'-,[1.03-1.08],CRHR2,Type 2 diabetes,type II diabetes mellitus,GCST002352,7:30674820
rs319598-<b>C</b>,2 x 10-6,,'-,1.05,'-,[1.03-1.07],"PCBD2, TXNDC15",Type 2 diabetes,type II diabetes mellitus,GCST002352,5:134904545
rs7756992-<b>G</b>,2 x 10-26,,0.26,1.2,'-,[1.16-1.25],'-,Type 2 diabetes,type II diabetes mellitus,GCST002352,Mapping not available
rs10788575-<b>A</b>,9 x 10-6,,'-,1.06,'-,[1.03-1.08],"MED6P1, PTEN",Type 2 diabetes,type II diabetes mellitus,GCST002352,10:88008827
rs17791513-<b>A</b>,3 x 10-8,,0.93,1.21,'-,[1.13-1.31],'-,Type 2 diabetes,type II diabetes mellitus,GCST002352,9:79290675
rs1111875-<b>C</b>,3 x 10-19,,0.58,1.15,'-,[1.11-1.19],"HHEX, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST002352,10:92703125
rs11257655-<b>T</b>,3 x 10-9,,0.23,1.06,'-,[1.01-1.11],"RN7SL198P, CDC123",Type 2 diabetes,type II diabetes mellitus,GCST002352,10:12265895
rs1552224-<b>A</b>,1 x 10-7,,0.83,1.13,'-,[1.08-1.19],ARAP1,Type 2 diabetes,type II diabetes mellitus,GCST002352,11:72722053
rs163184-<b>G</b>,2 x 10-14,,0.5,1.09,'-,[1.04-1.13],'-,Type 2 diabetes,type II diabetes mellitus,GCST002352,Mapping not available
rs3802177-<b>G</b>,2 x 10-18,,0.7,1.16,'-,[1.11-1.22],SLC30A8,Type 2 diabetes,type II diabetes mellitus,GCST002352,8:117172786
rs7612463-<b>C</b>,7 x 10-9,,0.87,1.1,'-,[1.04-1.16],UBE2E2,Type 2 diabetes,type II diabetes mellitus,GCST002352,3:23294959
rs1535500-<b>T</b>,8 x 10-6,,0.59,1.13,'-,[1.08-1.19],KCNK16,Type 2 diabetes,type II diabetes mellitus,GCST002352,6:39316274
rs6813195-<b>C</b>,4 x 10-14,,'-,1.08,'-,[1.06-1.10],"TMEM154, RPS3AP18",Type 2 diabetes,type II diabetes mellitus,GCST002352,4:152599323
rs10830963-<b>G</b>,2 x 10-7,,0.27,1.11,'-,[1.06-1.16],MTNR1B,Type 2 diabetes,type II diabetes mellitus,GCST002352,11:92975544
rs17106184-<b>G</b>,4 x 10-9,,'-,1.1,'-,[1.07-1.14],FAF1,Type 2 diabetes,type II diabetes mellitus,GCST002352,1:50444313
rs4812829-<b>A</b>,5 x 10-8,,0.16,1.07,'-,[1.01-1.12],HNF4A,Type 2 diabetes,type II diabetes mellitus,GCST002352,20:44360627
rs8108269-<b>G</b>,5 x 10-6,,0.3,1.06,'-,[1.02-1.11],"RN7SL836P, GIPR",Type 2 diabetes,type II diabetes mellitus,GCST002352,19:45655255
rs2261181-<b>T</b>,4 x 10-8,,0.09,1.16,'-,[1.10-1.23],RPSAP52,Type 2 diabetes,type II diabetes mellitus,GCST002352,12:65818538
rs1359790-<b>G</b>,6 x 10-6,,0.73,1.1,'-,[1.05-1.14],'-,Type 2 diabetes,type II diabetes mellitus,GCST002352,13:80143021
rs2028299-<b>C</b>,5 x 10-7,,0.29,1.04,'-,[1.00-1.09],AP3S2,Type 2 diabetes,type II diabetes mellitus,GCST002352,15:89831025
rs9936385-<b>C</b>,1 x 10-12,,0.39,1.13,'-,[1.09-1.18],FTO,Type 2 diabetes,type II diabetes mellitus,GCST002352,16:53785257
rs4402960-<b>T</b>,1 x 10-17,,0.31,1.13,'-,[1.09-1.17],IGF2BP2,Type 2 diabetes,type II diabetes mellitus,GCST002352,3:185793899
rs1801282-<b>C</b>,6 x 10-10,,0.88,1.16,'-,[1.10-1.23],'-,Type 2 diabetes,type II diabetes mellitus,GCST002352,Mapping not available
rs4430796-<b>G</b>,9 x 10-10,,0.53,1.13,'-,[1.07-1.09],HNF1B,Type 2 diabetes,type II diabetes mellitus,GCST002352,17:37738049
rs10811661-<b>T</b>,1 x 10-27,,0.82,1.18,'-,[1.13-1.24],CDKN2B-AS1,Type 2 diabetes,type II diabetes mellitus,GCST002352,9:22134095
rs12427353-<b>G</b>,4 x 10-6,,0.77,1.12,'-,[1.07-1.18],HNF1A,Type 2 diabetes,type II diabetes mellitus,GCST002352,12:120989098
rs10842994-<b>C</b>,8 x 10-6,,0.8,1.09,'-,[1.04-1.13],RN7SKP15,Type 2 diabetes,type II diabetes mellitus,GCST002352,12:27812217
rs7163757-<b>C</b>,4 x 10-6,,0.56,1.06,'-,[1.02-1.11],"NPM1P47, C2CD4B",Type 2 diabetes,type II diabetes mellitus,GCST002352,15:62099409
rs243088-<b>T</b>,3 x 10-6,,0.46,1.09,'-,[1.04-1.13],MIR4432HG,Type 2 diabetes,type II diabetes mellitus,GCST002352,2:60341610
rs4458523-<b>G</b>,2 x 10-9,,0.59,1.09,'-,[1.06-1.13],WFS1,Type 2 diabetes,type II diabetes mellitus,GCST002352,4:6288259
rs2796441-<b>G</b>,2 x 10-6,,0.63,1.07,'-,[1.03-1.12],"TLE1, RNU6-1035P",Type 2 diabetes,type II diabetes mellitus,GCST002352,9:81694033
rs2943640-<b>C</b>,7 x 10-9,,0.63,1.09,'-,[1.05-1.13],'-,Type 2 diabetes,type II diabetes mellitus,GCST002352,2:226228869
rs7178572-<b>G</b>,2 x 10-11,,0.7,1.08,'-,[1.04-1.13],HMG20A,Type 2 diabetes,type II diabetes mellitus,GCST002352,15:77454848
rs12571751-<b>A</b>,2 x 10-10,,0.51,1.09,'-,[1.06-1.13],ZMIZ1,Type 2 diabetes,type II diabetes mellitus,GCST002352,10:79182874
rs11717195-<b>T</b>,2 x 10-8,,0.78,1.09,'-,[1.05-1.14],ADCY5,Type 2 diabetes,type II diabetes mellitus,GCST002352,3:123363551
rs6937795-<b>A</b>,7 x 10-6,,'-,1.04,'-,[1.02-1.06],"RPL35AP3, Y_RNA",Type 2 diabetes,type II diabetes mellitus,GCST002352,6:136970143
rs1561927-<b>C</b>,1 x 10-7,,'-,1.06,'-,[1.04-1.09],LINC00824,Type 2 diabetes,type II diabetes mellitus,GCST002352,8:128555832
rs7903146-<b>T</b>,8 x 10-75,,0.3,1.4,'-,[1.35-1.46],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST002352,10:112998590
rs2812533-<b>C</b>,5 x 10-6,,'-,1.07,'-,[1.04-1.09],"RPL5P26, LINC02651",Type 2 diabetes,type II diabetes mellitus,GCST002352,10:69692529
rs3923113-<b>A</b>,2 x 10-6,,0.61,1.04,'-,[1.00-1.09],"COBLL1, GRB14",Type 2 diabetes,type II diabetes mellitus,GCST002352,2:164645339
rs7041847-<b>A</b>,5 x 10-6,,0.5,1.05,'-,[1.01-1.09],GLIS3,Type 2 diabetes,type II diabetes mellitus,GCST002352,9:4287466
rs12899811-<b>G</b>,6 x 10-7,,0.3,1.09,'-,[1.04-1.13],VPS33B,Type 2 diabetes,type II diabetes mellitus,GCST002352,15:91000846
rs516946-<b>C</b>,2 x 10-7,,0.77,1.1,'-,[1.06-1.15],ANK1,Type 2 diabetes,type II diabetes mellitus,GCST002352,8:41661730
rs7845219-<b>T</b>,6 x 10-8,,0.53,1.08,'-,[1.04-1.12],NDUFAF6,Type 2 diabetes,type II diabetes mellitus,GCST002352,8:94925274
rs849135-<b>G</b>,2 x 10-9,,0.52,1.12,'-,[1.08-1.17],'-,Type 2 diabetes,type II diabetes mellitus,GCST002352,Mapping not available
rs5215-<b>C</b>,3 x 10-11,,0.38,1.08,'-,[1.04-1.12],'-,Type 2 diabetes,type II diabetes mellitus,GCST002352,Mapping not available
rs17168486-<b>T</b>,3 x 10-7,,0.19,1.13,'-,[1.07-1.19],DGKB,Type 2 diabetes,type II diabetes mellitus,GCST002352,7:14858657
rs12970134-<b>A</b>,3 x 10-8,,0.27,1.08,'-,[1.03-1.12],RNU4-17P,Type 2 diabetes,type II diabetes mellitus,GCST002352,18:60217517
rs16861329-<b>C</b>,9 x 10-6,,0.85,1.03,'-,[0.96-1.10],ST6GAL1,Type 2 diabetes,type II diabetes mellitus,GCST002352,3:186948673
rs9502570-<b>A</b>,1 x 10-9,,'-,1.06,'-,[1.04-1.08],"SSR1, RREB1",Type 2 diabetes,type II diabetes mellitus,GCST002352,6:7258384
rs2075423-<b>G</b>,2 x 10-6,,0.66,1.08,'-,[1.04-1.12],PROX1-AS1,Type 2 diabetes,type II diabetes mellitus,GCST002352,1:213981376
rs3132524-<b>G</b>,4 x 10-9,,'-,1.07,'-,[1.04-1.09],POU5F1,Type 2 diabetes,type II diabetes mellitus,GCST002352,6:31168937
rs702634-<b>A</b>,7 x 10-9,,'-,1.06,'-,[1.04-1.09],ARL15,Type 2 diabetes,type II diabetes mellitus,GCST002352,5:53975590
rs1727313-<b>C</b>,1 x 10-8,,'-,1.06,'-,[1.04-1.08],MPHOSPH9,Type 2 diabetes,type II diabetes mellitus,GCST002352,12:123156306
rs10510110-<b>C</b>,1 x 10-7,,'-,1.05,'-,[1.03-1.07],PLEKHA1,Type 2 diabetes,type II diabetes mellitus,GCST002352,10:122432914
rs10190052-<b>C</b>,2 x 10-7,,'-,1.07,'-,[1.04-1.10],TMEM18,Type 2 diabetes,type II diabetes mellitus,GCST002352,2:646674
rs10507349-<b>G</b>,2 x 10-7,,'-,1.06,'-,[1.04-1.08],RNF6,Type 2 diabetes,type II diabetes mellitus,GCST002352,13:26207391
rs9472138-<b>T</b>,2 x 10-7,,'-,1.06,'-,[1.04-1.08],"VEGFA, LINC02537",Type 2 diabetes,type II diabetes mellitus,GCST002352,6:43844025
rs7795991-<b>G</b>,7 x 10-7,,'-,1.05,'-,[1.03-1.07],ETV1,Type 2 diabetes,type II diabetes mellitus,GCST002352,7:13861106
rs2820446-<b>C</b>,2 x 10-6,,'-,1.05,'-,[1.03-1.07],ZC3H11B,Type 2 diabetes,type II diabetes mellitus,GCST002352,1:219575476
rs4273712-<b>G</b>,3 x 10-6,,'-,1.05,'-,[1.03-1.07],"RNU6-200P, PRELID1P1",Type 2 diabetes,type II diabetes mellitus,GCST002352,6:126643364
rs1495377-<b>G</b>,7 x 10-6,,0.5,1.28,'-,[1.11-1.49],TSPAN8,Type 2 diabetes,type II diabetes mellitus,GCST000047,12:71183321
rs9465871-<b>C</b>,3 x 10-7,,0.18,1.18,'-,[1.04-1.34],CDKAL1,Type 2 diabetes,type II diabetes mellitus,GCST000047,6:20717024
rs9939609-<b>A</b>,2 x 10-7,,0.4,1.34,'-,[1.17-1.52],FTO,Type 2 diabetes,type II diabetes mellitus,GCST000047,16:53786615
rs358806-<b>?</b>,3 x 10-6,,0.8,1.16,'-,[1.03-1.33],LINC02030,Type 2 diabetes,type II diabetes mellitus,GCST000047,3:55279372
rs12304921-<b>G</b>,7 x 10-6,,0.15,2.5,'-,[1.53-4.09],HIGD1C,Type 2 diabetes,type II diabetes mellitus,GCST000047,12:50963759
rs4506565-<b>T</b>,5 x 10-12,,0.32,1.36,'-,[1.20-1.54],TCF7L2,Type 2 diabetes,type II diabetes mellitus,GCST000047,10:112996282
rs7659604-<b>T</b>,9 x 10-6,,0.38,1.35,'-,[1.19-1.54],"SMIM43, ANXA5",Type 2 diabetes,type II diabetes mellitus,GCST000047,4:121744359
rs7542900-<b>C</b>,6 x 10-6,,0.56,1.16,'-,[1.09-1.25],"SLC44A3-AS1, F3",Type 2 diabetes,type II diabetes mellitus,GCST001369,1:94604485
rs7560163-<b>C</b>,7 x 10-9,,0.86,1.33,'-,[1.19-1.49],'-,Type 2 diabetes,type II diabetes mellitus,GCST001369,2:150781422
rs7107217-<b>C</b>,3 x 10-7,,0.91,1.18,'-,[1.10-1.27],"LINC01395, RPS27P20",Type 2 diabetes,type II diabetes mellitus,GCST001369,11:129603795
rs2722769-<b>C</b>,2 x 10-6,,0.53,1.35,'-,[1.19-1.54],"MTND5P21, LINC02752",Type 2 diabetes,type II diabetes mellitus,GCST001369,11:11206827
